STUDYID|DOMAIN|USUBJID|RPSEQ|RPGRPID|RPREFID|RPSPID|RPLNKID|RPLNKGRP|RPTESTCD|RPTEST|RPCAT|RPSCAT|RPORRES|RPORRESU|RPSTRESC|RPSTRESN|RPSTRESU|RPSTAT|RPREASND|RPLOBXFL|RPBLFL|RPDRVFL|VISITNUM|VISIT|VISITDY|TAETORD|EPOCH|RPDTC|RPDY|RPDUR|RPTPT|RPTPTNUM|RPELTM|RPTPTREF|RPRFTDTC
TRIAL STUDY 134XCP|RP|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1||||||INABOIND|INDUCED ABORTION INDICATOR||||DROP|||LOG10 CCID 50/DOSE|NOT DONE||U|U|N|1||38||FOLLOW-UP|1963-08-23||1966-06-10|||1967-03-28||1962-09-25
TRIAL STUDY 134XCP|RP|28FBEC95-59B8-4821-BD7A-125E2C87D71C|2||||||BRTHN|NUMBER OF BIRTHS||||OHM|||FIU|NOT DONE||NA|NA|U|1||38||INDUCTION TREATMENT|1962-07-27||1970-10-16|||1964-12-05||1963-02-15
TRIAL STUDY 134XCP|RP|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1||||||STILBIND|STILLBIRTH INDICATOR||||L/L|||CS|NOT DONE||N|NA|NA|2||58||OPEN LABEL TREATMENT|1973-08-23||1961-07-29|||1967-07-22||1961-02-07
TRIAL STUDY 134XCP|RP|28FBEC95-59B8-4821-BD7A-125E2C87D71C|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||GTT|||NL|NOT DONE||NA|NA|N|2||58||FOLLOW-UP|1973-06-03||1971-10-26|||1966-10-26||1960-04-10
TRIAL STUDY 134XCP|RP|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1||||||PREGNN|NUMBER OF PREGNANCIES||||DPM/0.5 ML|||MAMP|NOT DONE||U|N|N|3||39||LONG-TERM FOLLOW-UP|1962-04-27||1971-03-26|||1965-10-22||1963-04-14
TRIAL STUDY 134XCP|RP|28FBEC95-59B8-4821-BD7A-125E2C87D71C|2||||||MENARAGE|MENARCHE AGE||||MMHG|||%(V/V)|NOT DONE||NA|U|NA|3||39||RUN-IN|1962-05-25||1966-03-10|||1964-07-03||1968-06-28
TRIAL STUDY 134XCP|RP|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1||||||GRAVIND|GRAVIDA INDICATOR||||PG/DL|||FT|NOT DONE||NA|U|N|4||88||OBSERVATION|1964-06-18||1969-11-06|||1964-07-08||1961-06-21
TRIAL STUDY 134XCP|RP|28FBEC95-59B8-4821-BD7A-125E2C87D71C|2||||||PUSTIND|PUSTULE INDICATOR||||VOXEL|||G/G|NOT DONE||N|Y|N|4||88||TREATMENT|1964-11-08||1960-10-22|||1961-11-19||1972-03-31
TRIAL STUDY 134XCP|RP|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||U/G/MIN|||DAGU|NOT DONE||N|N|Y|5||7||RUN-IN|1960-05-02||1968-12-07|||1966-05-06||1966-09-14
TRIAL STUDY 134XCP|RP|28FBEC95-59B8-4821-BD7A-125E2C87D71C|2||||||ABORTN|NUMBER OF ABORTIONS||||HOURS|||G/M2/DAY|NOT DONE||U|NA|U|5||7||INDUCTION TREATMENT|1972-08-27||1973-05-26|||1964-04-09||1969-10-12
TRIAL STUDY 134XCP|RP|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|1||||||BCMETHOD|BIRTH CONTROL METHOD||||PPTH|||DL|NOT DONE||NA|Y|Y|1||38||INDUCTION TREATMENT|1970-06-07||1963-09-27|||1971-08-22||1968-02-22
TRIAL STUDY 134XCP|RP|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2||||||BRTHN|NUMBER OF BIRTHS||||10^8/L|||CAN|NOT DONE||N|N|Y|1||38||SCREENING|1971-08-07||1965-01-17|||1966-09-28||1967-05-04
TRIAL STUDY 134XCP|RP|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^7 PFU|||MG/ML/MIN|NOT DONE||Y|U|N|2||58||RUN-IN|1963-10-31||1971-08-31|||1960-12-08||1963-03-03
TRIAL STUDY 134XCP|RP|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MMOL/G|||MMOL/KG|NOT DONE||U|NA|U|2||58||OBSERVATION|1964-07-27||1965-04-01|||1965-03-05||1969-06-23
TRIAL STUDY 134XCP|RP|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|1||||||PREGIND|PREGNANT INDICATOR||||PMOL/10^10 CELLS|||CI/ML|NOT DONE||Y|NA|Y|3||39||CONTINUATION TREATMENT|1961-03-31||1972-01-02|||1972-12-10||1968-05-06
TRIAL STUDY 134XCP|RP|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2||||||MENARAGE|MENARCHE AGE||||GY/H|||10^9/DOSE|NOT DONE||N|NA|N|3||39||CONTINUATION TREATMENT|1961-12-25||1964-09-01|||1960-05-22||1971-02-19
TRIAL STUDY 134XCP|RP|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||UG/ML/H|||SPRAY|NOT DONE||N|Y|U|4||88||TREATMENT|1964-06-19||1968-05-02|||1970-07-11||1969-06-13
TRIAL STUDY 134XCP|RP|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2||||||MENFDUR|MENSES FLOW DURATION||||GY/H|||GBQ/G|NOT DONE||Y|U|N|4||88||WASHOUT|1964-12-30||1968-11-17|||1965-10-21||1969-12-14
TRIAL STUDY 134XCP|RP|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||PG/CELL|||/HPF|NOT DONE||N|U|NA|5||7||FOLLOW-UP|1966-05-17||1961-07-21|||1964-02-11||1963-04-28
TRIAL STUDY 134XCP|RP|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||10^9 CFU|||G/ANIMAL|NOT DONE||NA|NA|U|5||7||OBSERVATION|1971-04-15||1970-08-30|||1966-11-22||1961-01-21
TRIAL STUDY 134XCP|RP|1117C221-3530-45CB-82B2-B831C4DAD86B|1||||||THICK|THICKNESS||||SHOCK WAVE|||/MBP|NOT DONE||NA|Y|N|1||38||BLINDED TREATMENT|1968-10-08||1962-04-22|||1965-06-10||1965-01-05
TRIAL STUDY 134XCP|RP|1117C221-3530-45CB-82B2-B831C4DAD86B|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||ENZYME U/M2|||ENZYME U|NOT DONE||NA|U|Y|1||38||WASHOUT|1968-06-23||1972-08-03|||1960-06-06||1972-10-20
TRIAL STUDY 134XCP|RP|1117C221-3530-45CB-82B2-B831C4DAD86B|1||||||GRAVIND|GRAVIDA INDICATOR||||FT2|||CI|NOT DONE||U|Y|N|2||58||BLINDED TREATMENT|1969-10-05||1969-09-23|||1960-03-24||1965-06-11
TRIAL STUDY 134XCP|RP|1117C221-3530-45CB-82B2-B831C4DAD86B|2||||||MASSIND|MASS INDICATOR||||MG/DOSE|||MSEC|NOT DONE||Y|U|Y|2||58||CONTINUATION TREATMENT|1972-03-10||1972-06-01|||1961-07-22||1965-06-02
TRIAL STUDY 134XCP|RP|1117C221-3530-45CB-82B2-B831C4DAD86B|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||EQ|||MBQ|NOT DONE||Y|U|U|3||39||OBSERVATION|1968-04-29||1961-01-08|||1969-06-24||1964-04-10
TRIAL STUDY 134XCP|RP|1117C221-3530-45CB-82B2-B831C4DAD86B|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||DPM/0.5 ML|||IU/ML|NOT DONE||N|U|N|3||39||BASELINE|1963-08-24||1960-06-06|||1967-08-02||1969-05-13
TRIAL STUDY 134XCP|RP|1117C221-3530-45CB-82B2-B831C4DAD86B|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||G/KG/DAY|||MEQ/MMOL|NOT DONE||U|N|Y|4||88||OBSERVATION|1960-07-14||1964-04-19|||1973-08-05||1967-11-17
TRIAL STUDY 134XCP|RP|1117C221-3530-45CB-82B2-B831C4DAD86B|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^3 ORGANISMS/ML|||UEQ/L|NOT DONE||NA|U|U|4||88||OPEN LABEL TREATMENT|1965-09-27||1972-12-14|||1970-03-14||1964-11-23
TRIAL STUDY 134XCP|RP|1117C221-3530-45CB-82B2-B831C4DAD86B|1||||||ERYTHIND|ERYTHEMA INDICATOR||||PATCH|||PMOL|NOT DONE||Y|Y|N|5||7||SCREENING|1973-02-11||1962-06-24|||1969-05-29||1971-10-18
TRIAL STUDY 134XCP|RP|1117C221-3530-45CB-82B2-B831C4DAD86B|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||SHOCK WAVE|||EID 50/DOSE|NOT DONE||Y|Y|U|5||7||BASELINE|1965-08-09||1969-04-20|||1967-01-03||1972-06-07
TRIAL STUDY 134XCP|RP|3ACFF838-5B16-4898-9640-A60C85096F64|1||||||MENOAGE|MENOPAUSE AGE||||U/ANIMAL|||10^6 RNA COPIES/ML|NOT DONE||N|Y|Y|1||38||RUN-IN|1972-09-17||1964-08-21|||1970-02-08||1961-03-10
TRIAL STUDY 134XCP|RP|3ACFF838-5B16-4898-9640-A60C85096F64|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MET*MIN|||MEQ/KG|NOT DONE||NA|NA|N|1||38||LONG-TERM FOLLOW-UP|1967-08-14||1973-06-17|||1963-10-26||1971-01-13
TRIAL STUDY 134XCP|RP|3ACFF838-5B16-4898-9640-A60C85096F64|1||||||DSCHGIND|DISCHARGE INDICATOR||||CIGARETTE|||JAR|NOT DONE||NA|NA|N|2||58||BLINDED TREATMENT|1965-01-03||1973-01-21|||1968-09-28||1972-04-01
TRIAL STUDY 134XCP|RP|3ACFF838-5B16-4898-9640-A60C85096F64|2||||||MENARAGE|MENARCHE AGE||||MILE|||MM3/MM2/YEAR|NOT DONE||Y|NA|NA|2||58||BASELINE|1966-06-26||1961-04-11|||1963-10-14||1969-06-22
TRIAL STUDY 134XCP|RP|3ACFF838-5B16-4898-9640-A60C85096F64|1||||||MASSIND|MASS INDICATOR||||MIN/DAY|||U/KG|NOT DONE||N|U|U|3||39||CONTINUATION TREATMENT|1972-02-02||1968-02-06|||1966-06-27||1960-08-18
TRIAL STUDY 134XCP|RP|3ACFF838-5B16-4898-9640-A60C85096F64|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||BOLUS|||NMOL BCE/MMOL|NOT DONE||U|U|NA|3||39||LONG-TERM FOLLOW-UP|1971-06-12||1961-07-02|||1968-09-30||1969-12-10
TRIAL STUDY 134XCP|RP|3ACFF838-5B16-4898-9640-A60C85096F64|1||||||PRGENDTC|DATE PREGNANCY ENDED||||ML/SEC/1.73M2|||ANTI-XA IU/ML|NOT DONE||Y|N|Y|4||88||OBSERVATION|1964-06-16||1968-07-14|||1961-06-08||1964-04-23
TRIAL STUDY 134XCP|RP|3ACFF838-5B16-4898-9640-A60C85096F64|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PMOL/G|||/KG|NOT DONE||N|NA|NA|4||88||BLINDED TREATMENT|1973-02-18||1971-10-14|||1965-12-25||1964-12-15
TRIAL STUDY 134XCP|RP|3ACFF838-5B16-4898-9640-A60C85096F64|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||LOG10 IU/ML|||POUCH|NOT DONE||N|Y|Y|5||7||OBSERVATION|1960-06-20||1972-02-26|||1963-02-20||1971-06-08
TRIAL STUDY 134XCP|RP|3ACFF838-5B16-4898-9640-A60C85096F64|2||||||FUNDHT|FUNDAL HEIGHT||||H/WK|||KCAL/DAY|NOT DONE||NA|N|NA|5||7||TREATMENT|1968-07-28||1963-11-08|||1972-01-30||1967-01-16
TRIAL STUDY 134XCP|RP|308F422A-B02B-4C76-86E7-834AAC127FE3|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||CI/ML|||EJACULATE U|NOT DONE||NA|NA|Y|1||38||FOLLOW-UP|1967-02-03||1972-04-07|||1971-08-23||1967-11-11
TRIAL STUDY 134XCP|RP|308F422A-B02B-4C76-86E7-834AAC127FE3|2||||||PRGENDTC|DATE PREGNANCY ENDED||||10^3/L|||KIU|NOT DONE||N|U|N|1||38||BASELINE|1961-05-24||1967-01-27|||1970-01-22||1965-01-29
TRIAL STUDY 134XCP|RP|308F422A-B02B-4C76-86E7-834AAC127FE3|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||KM|||NMOL/L/MIN|NOT DONE||N|Y|U|2||58||RUN-IN|1964-06-21||1966-05-02|||1961-11-08||1960-05-10
TRIAL STUDY 134XCP|RP|308F422A-B02B-4C76-86E7-834AAC127FE3|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||JOULE|||MMU/ML|NOT DONE||NA|N|N|2||58||INDUCTION TREATMENT|1971-10-18||1972-06-23|||1966-12-10||1965-04-01
TRIAL STUDY 134XCP|RP|308F422A-B02B-4C76-86E7-834AAC127FE3|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||EID 50/ML|||EVENTS|NOT DONE||U|U|U|3||39||LONG-TERM FOLLOW-UP|1965-11-09||1964-12-31|||1966-04-07||1961-04-18
TRIAL STUDY 134XCP|RP|308F422A-B02B-4C76-86E7-834AAC127FE3|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||%(W/W)|||DL|NOT DONE||Y|U|N|3||39||FOLLOW-UP|1967-10-27||1968-07-18|||1967-10-28||1969-10-15
TRIAL STUDY 134XCP|RP|308F422A-B02B-4C76-86E7-834AAC127FE3|1||||||PEELIND|PEELING INDICATOR||||UV2|||PNU/ML|NOT DONE||NA|U|Y|4||88||OPEN LABEL TREATMENT|1961-03-24||1961-06-14|||1961-09-03||1971-05-17
TRIAL STUDY 134XCP|RP|308F422A-B02B-4C76-86E7-834AAC127FE3|2||||||BCMETHOD|BIRTH CONTROL METHOD||||UV2|||MEQ/DL|NOT DONE||N|NA|NA|4||88||TREATMENT|1961-06-16||1971-03-25|||1967-12-01||1960-03-29
TRIAL STUDY 134XCP|RP|308F422A-B02B-4C76-86E7-834AAC127FE3|1||||||THICK|THICKNESS||||PRESSOR UNITS|||PFU/ML|NOT DONE||U|U|N|5||7||BLINDED TREATMENT|1960-10-09||1966-04-25|||1960-01-04||1972-08-14
TRIAL STUDY 134XCP|RP|308F422A-B02B-4C76-86E7-834AAC127FE3|2||||||EDEMAIND|EDEMA INDICATOR||||U/KG/MIN|||PACK YEAR|NOT DONE||NA|U|NA|5||7||BLINDED TREATMENT|1965-07-25||1971-05-25|||1963-12-25||1964-05-28
TRIAL STUDY 134XCP|RP|34A3AA01-3595-42C2-95C3-44E3AF77B28D|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||AMFI|||PA|NOT DONE||U|Y|NA|1||38||OBSERVATION|1971-07-02||1962-12-24|||1961-08-20||1962-04-02
TRIAL STUDY 134XCP|RP|34A3AA01-3595-42C2-95C3-44E3AF77B28D|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||K|||UG/H|NOT DONE||U|Y|N|1||38||SCREENING|1972-01-21||1968-12-10|||1966-08-28||1967-08-09
TRIAL STUDY 134XCP|RP|34A3AA01-3595-42C2-95C3-44E3AF77B28D|1||||||STILBIND|STILLBIRTH INDICATOR||||MG/M2/DAY|||PMOL|NOT DONE||U|U|NA|2||58||SCREENING|1969-11-09||1962-08-03|||1960-03-20||1965-01-17
TRIAL STUDY 134XCP|RP|34A3AA01-3595-42C2-95C3-44E3AF77B28D|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MM/2H|||JAR|NOT DONE||N|NA|NA|2||58||RUN-IN|1972-03-07||1971-08-03|||1966-01-06||1962-11-12
TRIAL STUDY 134XCP|RP|34A3AA01-3595-42C2-95C3-44E3AF77B28D|1||||||EDEMAIND|EDEMA INDICATOR||||SEC|||G/DAY|NOT DONE||N|N|Y|3||39||WASHOUT|1970-03-26||1969-12-12|||1964-09-11||1962-01-24
TRIAL STUDY 134XCP|RP|34A3AA01-3595-42C2-95C3-44E3AF77B28D|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||%|||ML/M2/DAY|NOT DONE||NA|Y|U|3||39||BASELINE|1962-06-10||1960-10-30|||1960-05-20||1964-05-18
TRIAL STUDY 134XCP|RP|34A3AA01-3595-42C2-95C3-44E3AF77B28D|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||CM/S|||COULOMB|NOT DONE||Y|Y|N|4||88||BASELINE|1961-07-23||1960-09-30|||1973-01-24||1961-05-23
TRIAL STUDY 134XCP|RP|34A3AA01-3595-42C2-95C3-44E3AF77B28D|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||LOG EID 50/DOSE|||L/H/M2|NOT DONE||N|N|NA|4||88||BASELINE|1962-10-11||1964-06-24|||1969-01-25||1968-07-16
TRIAL STUDY 134XCP|RP|34A3AA01-3595-42C2-95C3-44E3AF77B28D|1||||||ERYTHIND|ERYTHEMA INDICATOR||||KG/CM|||KHZ|NOT DONE||NA|N|Y|5||7||CONTINUATION TREATMENT|1970-02-09||1966-06-13|||1967-02-11||1963-06-29
TRIAL STUDY 134XCP|RP|34A3AA01-3595-42C2-95C3-44E3AF77B28D|2||||||FUNDHT|FUNDAL HEIGHT||||10^9/DOSE|||MEQ|NOT DONE||Y|Y|N|5||7||RUN-IN|1970-10-21||1965-01-14|||1966-03-14||1971-06-01
TRIAL STUDY 134XCP|RP|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||APS U|||10^6 CFU/G|NOT DONE||U|Y|Y|1||38||TREATMENT|1963-10-19||1963-10-30|||1972-07-15||1962-06-13
TRIAL STUDY 134XCP|RP|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^7 CFU/ML|||S/H|NOT DONE||NA|Y|N|1||38||SCREENING|1965-04-20||1970-02-02|||1964-09-19||1973-03-22
TRIAL STUDY 134XCP|RP|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|1||||||MENFDUR|MENSES FLOW DURATION||||CCID 50/ML|||ECL UNIT|NOT DONE||Y|N|Y|2||58||OPEN LABEL TREATMENT|1966-10-18||1969-06-15|||1964-04-19||1973-03-18
TRIAL STUDY 134XCP|RP|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||DEG/MM|||ARBITRARY U|NOT DONE||N|U|N|2||58||OPEN LABEL TREATMENT|1973-07-02||1961-11-04|||1966-11-12||1971-05-25
TRIAL STUDY 134XCP|RP|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|1||||||RASHIND|RASH INDICATOR||||MOSM|||AU/ML|NOT DONE||Y|Y|U|3||39||SCREENING|1960-07-08||1967-03-15|||1970-06-03||1963-06-03
TRIAL STUDY 134XCP|RP|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/MM2|||TABLET|NOT DONE||N|U|NA|3||39||TREATMENT|1968-02-09||1969-04-09|||1970-10-29||1971-05-23
TRIAL STUDY 134XCP|RP|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|1||||||INABOIND|INDUCED ABORTION INDICATOR||||NMOL/DAY|||10^9/L|NOT DONE||U|NA|N|4||88||WASHOUT|1969-10-25||1965-09-04|||1967-09-05||1971-05-18
TRIAL STUDY 134XCP|RP|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|2||||||DLVRMODE|MODE OF DELIVERY||||CG|||U/G/DAY|NOT DONE||U|N|NA|4||88||SCREENING|1964-04-25||1967-05-25|||1970-03-20||1971-06-02
TRIAL STUDY 134XCP|RP|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||KIT|||ML/G/MIN|NOT DONE||U|N|N|5||7||FOLLOW-UP|1969-11-04||1968-10-16|||1962-08-10||1962-08-10
TRIAL STUDY 134XCP|RP|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MKAT|||PMOL|NOT DONE||NA|N|Y|5||7||LONG-TERM FOLLOW-UP|1960-11-30||1961-07-06|||1965-05-21||1973-07-13
TRIAL STUDY 134XCP|RP|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||ML/ANIMAL/WK|||10^7/L|NOT DONE||N|N|N|1||38||WASHOUT|1970-06-13||1968-01-29|||1971-08-18||1962-06-08
TRIAL STUDY 134XCP|RP|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|2||||||INABOIND|INDUCED ABORTION INDICATOR||||CM|||LOG10 PFU/ML|NOT DONE||Y|NA|Y|1||38||INDUCTION TREATMENT|1961-08-16||1972-04-23|||1968-09-06||1960-10-25
TRIAL STUDY 134XCP|RP|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^6 IU|||ML/H|NOT DONE||U|N|NA|2||58||OBSERVATION|1965-10-19||1965-04-14|||1962-02-16||1961-05-28
TRIAL STUDY 134XCP|RP|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UG/DAY|||U/G/DAY|NOT DONE||NA|N|U|2||58||BLINDED TREATMENT|1970-03-17||1962-05-07|||1967-03-18||1967-09-21
TRIAL STUDY 134XCP|RP|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^4 CFU/ML|||RFU|NOT DONE||U|N|N|3||39||LONG-TERM FOLLOW-UP|1971-01-07||1972-07-11|||1969-12-12||1969-04-16
TRIAL STUDY 134XCP|RP|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||KBQ|||GY/MIN|NOT DONE||Y|NA|Y|3||39||WASHOUT|1973-03-07||1973-02-05|||1966-04-21||1966-12-07
TRIAL STUDY 134XCP|RP|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|1||||||MASSIND|MASS INDICATOR||||UL/ML|||HOUNSFIELD UNIT|NOT DONE||Y|U|NA|4||88||CONTINUATION TREATMENT|1964-06-21||1973-06-10|||1973-08-31||1969-06-14
TRIAL STUDY 134XCP|RP|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|2||||||ULCERIND|ULCER INDICATOR||||PT_US|||SEC|NOT DONE||U|NA|NA|4||88||FOLLOW-UP|1963-03-23||1969-12-06|||1962-04-17||1960-06-15
TRIAL STUDY 134XCP|RP|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||ML/KG/H|||LENS|NOT DONE||NA|NA|U|5||7||OBSERVATION|1963-01-27||1965-12-30|||1963-09-11||1966-02-10
TRIAL STUDY 134XCP|RP|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|2||||||MASSIND|MASS INDICATOR||||MBQ|||MG/M2|NOT DONE||Y|U|N|5||7||TREATMENT|1964-09-11||1966-03-14|||1969-01-14||1965-07-14
TRIAL STUDY 134XCP|RP|ECA054C6-EA0F-4D7B-905C-849EA4592624|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||EP U|||PATCH|NOT DONE||N|Y|Y|1||38||BASELINE|1961-01-12||1962-01-24|||1969-05-27||1964-02-01
TRIAL STUDY 134XCP|RP|ECA054C6-EA0F-4D7B-905C-849EA4592624|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MONTHS|||UG/DL|NOT DONE||U|Y|N|1||38||RUN-IN|1968-09-01||1961-02-11|||1968-01-30||1970-03-28
TRIAL STUDY 134XCP|RP|ECA054C6-EA0F-4D7B-905C-849EA4592624|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MM/SEC|||KDA|NOT DONE||U|Y|Y|2||58||INDUCTION TREATMENT|1969-02-04||1961-08-30|||1971-03-05||1965-08-15
TRIAL STUDY 134XCP|RP|ECA054C6-EA0F-4D7B-905C-849EA4592624|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||LOZENGE|||MG/DL|NOT DONE||U|NA|NA|2||58||RUN-IN|1961-09-24||1969-05-30|||1964-02-16||1967-02-02
TRIAL STUDY 134XCP|RP|ECA054C6-EA0F-4D7B-905C-849EA4592624|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||CAPFUL|||BQ/UG|NOT DONE||U|N|U|3||39||TREATMENT|1961-09-13||1972-03-31|||1967-02-19||1966-09-20
TRIAL STUDY 134XCP|RP|ECA054C6-EA0F-4D7B-905C-849EA4592624|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||DL|||UG/G/H|NOT DONE||NA|U|U|3||39||BASELINE|1963-02-08||1970-01-13|||1970-12-25||1972-09-23
TRIAL STUDY 134XCP|RP|ECA054C6-EA0F-4D7B-905C-849EA4592624|1||||||TNDRIND|TENDERNESS INDICATOR||||U/10^12 RBC|||10^6/L|NOT DONE||NA|NA|NA|4||88||CONTINUATION TREATMENT|1969-11-11||1971-07-22|||1963-02-02||1962-12-07
TRIAL STUDY 134XCP|RP|ECA054C6-EA0F-4D7B-905C-849EA4592624|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||DEG/MM|||PACKAGE|NOT DONE||U|N|NA|4||88||OBSERVATION|1970-06-17||1963-03-17|||1961-07-13||1964-07-12
TRIAL STUDY 134XCP|RP|ECA054C6-EA0F-4D7B-905C-849EA4592624|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||HZ|||HENRY|NOT DONE||NA|N|NA|5||7||OBSERVATION|1965-09-24||1963-03-27|||1962-11-14||1969-03-07
TRIAL STUDY 134XCP|RP|ECA054C6-EA0F-4D7B-905C-849EA4592624|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||ECL UNIT|||UG/KG/H|NOT DONE||U|U|Y|5||7||RUN-IN|1964-07-09||1971-07-28|||1972-08-27||1963-04-03
TRIAL STUDY 134XCP|RP|83823CA3-1C1D-455E-BE49-DC5E3651A939|1||||||MENOSTAT|MENOPAUSE STATUS||||PG/L|||ML/CM|NOT DONE||N|U|Y|1||38||RUN-IN|1963-09-05||1971-02-06|||1963-07-20||1966-05-22
TRIAL STUDY 134XCP|RP|83823CA3-1C1D-455E-BE49-DC5E3651A939|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||ML/(MIN*100ML)|||OZ|NOT DONE||NA|N|NA|1||38||RUN-IN|1971-10-10||1972-03-26|||1963-01-21||1964-03-21
TRIAL STUDY 134XCP|RP|83823CA3-1C1D-455E-BE49-DC5E3651A939|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||G/G|||FOZ_US|NOT DONE||NA|N|NA|2||58||OPEN LABEL TREATMENT|1964-05-26||1969-01-04|||1971-07-07||1972-08-20
TRIAL STUDY 134XCP|RP|83823CA3-1C1D-455E-BE49-DC5E3651A939|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MMOL/S|||10^9 CFU/ML|NOT DONE||N|N|N|2||58||FOLLOW-UP|1960-10-07||1969-05-19|||1966-02-16||1971-12-06
TRIAL STUDY 134XCP|RP|83823CA3-1C1D-455E-BE49-DC5E3651A939|1||||||DSCHGIND|DISCHARGE INDICATOR||||EQ|||ML/CAGE/WK|NOT DONE||NA|U|Y|3||39||FOLLOW-UP|1970-05-09||1967-04-09|||1970-05-19||1969-08-14
TRIAL STUDY 134XCP|RP|83823CA3-1C1D-455E-BE49-DC5E3651A939|2||||||GRAVIND|GRAVIDA INDICATOR||||MMHG/SEC|||SUPPOSITORY|NOT DONE||U|Y|N|3||39||INDUCTION TREATMENT|1969-02-23||1971-12-23|||1971-10-27||1970-03-27
TRIAL STUDY 134XCP|RP|83823CA3-1C1D-455E-BE49-DC5E3651A939|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||LOG EID 50/DOSE|||AG|NOT DONE||U|N|N|4||88||FOLLOW-UP|1962-10-10||1970-05-05|||1961-10-27||1969-01-12
TRIAL STUDY 134XCP|RP|83823CA3-1C1D-455E-BE49-DC5E3651A939|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||TUBERCULIN UNIT/ML|||PLUG|NOT DONE||Y|U|NA|4||88||BLINDED TREATMENT|1964-12-23||1964-01-03|||1965-11-07||1964-09-10
TRIAL STUDY 134XCP|RP|83823CA3-1C1D-455E-BE49-DC5E3651A939|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||G/G/DAY|||DIOPTER|NOT DONE||U|N|Y|5||7||WASHOUT|1964-01-08||1972-02-04|||1972-02-17||1968-08-12
TRIAL STUDY 134XCP|RP|83823CA3-1C1D-455E-BE49-DC5E3651A939|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||U/L|||FEU|NOT DONE||Y|Y|U|5||7||TREATMENT|1967-07-03||1969-09-01|||1969-06-26||1961-04-09
TRIAL STUDY 134XCP|RP|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|1||||||BLISTIND|BLISTERING INDICATOR||||GMFI|||USEC|NOT DONE||Y|U|U|1||38||RUN-IN|1964-06-10||1967-12-25|||1964-11-02||1961-09-21
TRIAL STUDY 134XCP|RP|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|2||||||BLISTIND|BLISTERING INDICATOR||||100 IU/ML|||DMOL|NOT DONE||N|Y|NA|1||38||CONTINUATION TREATMENT|1964-10-23||1969-07-05|||1964-12-06||1972-01-17
TRIAL STUDY 134XCP|RP|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MM/H|||HEP|NOT DONE||Y|U|NA|2||58||TREATMENT|1968-02-04||1964-10-12|||1960-06-21||1963-02-17
TRIAL STUDY 134XCP|RP|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||AMOL|||L|NOT DONE||N|Y|N|2||58||OBSERVATION|1964-10-30||1963-08-29|||1967-08-05||1970-04-09
TRIAL STUDY 134XCP|RP|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||ABSORBANCE U|||10^8/L|NOT DONE||U|Y|N|3||39||RUN-IN|1967-09-12||1962-06-27|||1969-01-17||1967-02-08
TRIAL STUDY 134XCP|RP|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||V|||PACK YEAR|NOT DONE||Y|Y|NA|3||39||WASHOUT|1972-08-05||1961-08-24|||1970-04-30||1960-12-31
TRIAL STUDY 134XCP|RP|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||AGU/ML|||PG|NOT DONE||NA|Y|U|4||88||LONG-TERM FOLLOW-UP|1960-10-18||1971-09-18|||1966-07-20||1971-10-02
TRIAL STUDY 134XCP|RP|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MHZ|||FMOL|NOT DONE||U|NA|NA|4||88||LONG-TERM FOLLOW-UP|1962-10-13||1964-11-05|||1970-01-23||1960-07-03
TRIAL STUDY 134XCP|RP|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|1||||||PREGST|PREGNANT DURING THE STUDY||||ML/MMHG/MIN/L|||CAL|NOT DONE||Y|U|U|5||7||OPEN LABEL TREATMENT|1971-04-17||1971-08-11|||1972-07-26||1964-10-22
TRIAL STUDY 134XCP|RP|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||GLOBULE|||KV|NOT DONE||Y|U|U|5||7||RUN-IN|1971-11-04||1970-08-09|||1972-05-13||1963-01-01
TRIAL STUDY 134XCP|RP|9C24F018-315A-4B9C-B89B-F54CA26452E7|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||TORR|||BQ/ML|NOT DONE||N|Y|NA|1||38||OBSERVATION|1965-01-23||1973-09-01|||1963-08-28||1969-02-07
TRIAL STUDY 134XCP|RP|9C24F018-315A-4B9C-B89B-F54CA26452E7|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||U/G|||BQ/MG|NOT DONE||N|U|U|1||38||SCREENING|1973-05-28||1968-05-22|||1961-01-03||1965-07-22
TRIAL STUDY 134XCP|RP|9C24F018-315A-4B9C-B89B-F54CA26452E7|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||CAPFUL|||KBQ/UL|NOT DONE||U|Y|NA|2||58||INDUCTION TREATMENT|1963-09-04||1965-12-04|||1971-09-25||1960-01-13
TRIAL STUDY 134XCP|RP|9C24F018-315A-4B9C-B89B-F54CA26452E7|2||||||PUSTIND|PUSTULE INDICATOR||||/MIN|||MAMP|NOT DONE||U|U|Y|2||58||RUN-IN|1968-04-22||1971-06-26|||1966-12-20||1971-01-10
TRIAL STUDY 134XCP|RP|9C24F018-315A-4B9C-B89B-F54CA26452E7|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||BOWL|||NMOL/L/H|NOT DONE||N|Y|N|3||39||INDUCTION TREATMENT|1964-06-25||1971-03-23|||1963-07-17||1962-06-10
TRIAL STUDY 134XCP|RP|9C24F018-315A-4B9C-B89B-F54CA26452E7|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||FRACTION OF 1|||MASK|NOT DONE||N|U|N|3||39||TREATMENT|1972-10-27||1966-11-10|||1973-08-28||1969-05-23
TRIAL STUDY 134XCP|RP|9C24F018-315A-4B9C-B89B-F54CA26452E7|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MG/L|||/2500 WBC|NOT DONE||Y|NA|NA|4||88||LONG-TERM FOLLOW-UP|1964-05-22||1972-08-30|||1970-06-28||1967-10-15
TRIAL STUDY 134XCP|RP|9C24F018-315A-4B9C-B89B-F54CA26452E7|2||||||PUSTIND|PUSTULE INDICATOR||||ELISA UNIT/DOSE|||COPIES/UL|NOT DONE||NA|NA|NA|4||88||INDUCTION TREATMENT|1970-07-05||1967-01-27|||1966-01-15||1973-09-04
TRIAL STUDY 134XCP|RP|9C24F018-315A-4B9C-B89B-F54CA26452E7|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||AGU/ML|||UCI/L|NOT DONE||N|N|N|5||7||WASHOUT|1969-12-19||1963-08-20|||1966-12-25||1964-10-17
TRIAL STUDY 134XCP|RP|9C24F018-315A-4B9C-B89B-F54CA26452E7|2||||||PREGNN|NUMBER OF PREGNANCIES||||G/U|||FARAD|NOT DONE||U|NA|N|5||7||CONTINUATION TREATMENT|1969-11-17||1965-07-22|||1967-11-10||1962-05-25
TRIAL STUDY 134XCP|RP|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||CFU/G|||NMOL/L/H|NOT DONE||U|N|Y|1||38||CONTINUATION TREATMENT|1964-07-19||1966-03-29|||1967-02-12||1960-05-10
TRIAL STUDY 134XCP|RP|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|2||||||DSCHGIND|DISCHARGE INDICATOR||||G/ANIMAL/WK|||/SEC|NOT DONE||NA|Y|NA|1||38||LONG-TERM FOLLOW-UP|1973-05-12||1971-02-21|||1960-10-08||1968-03-22
TRIAL STUDY 134XCP|RP|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||EU|||LOG10 PFU/ML|NOT DONE||Y|N|N|2||58||CONTINUATION TREATMENT|1971-05-25||1966-03-14|||1960-04-16||1964-04-22
TRIAL STUDY 134XCP|RP|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||L/MIN|||MU|NOT DONE||NA|N|U|2||58||BASELINE|1967-01-18||1969-05-31|||1967-02-12||1969-01-14
TRIAL STUDY 134XCP|RP|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|1||||||PREGIND|PREGNANT INDICATOR||||CAPSULE|||ML/SEC/1.73M2|NOT DONE||N|N|Y|3||39||FOLLOW-UP|1966-11-06||1962-06-13|||1972-03-24||1967-07-01
TRIAL STUDY 134XCP|RP|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||L/KG|||10^3 ORGANISMS/ML|NOT DONE||U|Y|N|3||39||OBSERVATION|1970-11-18||1965-06-20|||1965-06-07||1966-10-09
TRIAL STUDY 134XCP|RP|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||10^5/HPF|||MM3/MM2/YEAR|NOT DONE||U|U|Y|4||88||OBSERVATION|1965-01-25||1966-12-28|||1967-05-12||1971-11-14
TRIAL STUDY 134XCP|RP|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^7 PFU|||PRESSOR UNITS|NOT DONE||N|U|U|4||88||OBSERVATION|1972-03-02||1960-11-13|||1967-05-11||1968-10-29
TRIAL STUDY 134XCP|RP|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MG/L|||ML/DL|NOT DONE||U|U|U|5||7||BLINDED TREATMENT|1971-08-03||1971-04-28|||1970-12-23||1970-10-10
TRIAL STUDY 134XCP|RP|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||LOZENGE|||U|NOT DONE||U|NA|NA|5||7||INDUCTION TREATMENT|1964-07-08||1967-07-23|||1969-09-03||1969-08-18
TRIAL STUDY 134XCP|RP|8D48F229-F38B-4335-B8A7-0AA24C928707|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||UG/M2|||10^6/L|NOT DONE||N|Y|U|1||38||RUN-IN|1961-06-20||1968-07-26|||1968-02-01||1967-02-24
TRIAL STUDY 134XCP|RP|8D48F229-F38B-4335-B8A7-0AA24C928707|2||||||DSCHGIND|DISCHARGE INDICATOR||||/10^4|||UL/KG/DAY|NOT DONE||U|U|N|1||38||CONTINUATION TREATMENT|1966-03-04||1971-04-05|||1964-08-11||1970-05-19
TRIAL STUDY 134XCP|RP|8D48F229-F38B-4335-B8A7-0AA24C928707|1||||||RASHIND|RASH INDICATOR||||UMOL/DAY|||CD/M2|NOT DONE||N|Y|U|2||58||BLINDED TREATMENT|1964-01-29||1973-05-21|||1963-03-14||1964-12-18
TRIAL STUDY 134XCP|RP|8D48F229-F38B-4335-B8A7-0AA24C928707|2||||||STILBIND|STILLBIRTH INDICATOR||||%(V/V)|||ANTI-XA IU/ML|NOT DONE||NA|U|U|2||58||OBSERVATION|1969-01-05||1962-05-21|||1965-08-24||1961-06-11
TRIAL STUDY 134XCP|RP|8D48F229-F38B-4335-B8A7-0AA24C928707|1||||||BCMETHOD|BIRTH CONTROL METHOD||||G/MOL|||GPELISA UNIT/ML|NOT DONE||N|NA|NA|3||39||INDUCTION TREATMENT|1970-06-21||1970-12-27|||1965-11-13||1962-01-07
TRIAL STUDY 134XCP|RP|8D48F229-F38B-4335-B8A7-0AA24C928707|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||TUBE|||10^11/L|NOT DONE||N|Y|NA|3||39||SCREENING|1968-10-22||1964-07-08|||1970-07-22||1965-03-29
TRIAL STUDY 134XCP|RP|8D48F229-F38B-4335-B8A7-0AA24C928707|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UG/ML/H|||MAC50|NOT DONE||N|U|N|4||88||BASELINE|1962-08-19||1962-04-08|||1973-03-20||1970-11-23
TRIAL STUDY 134XCP|RP|8D48F229-F38B-4335-B8A7-0AA24C928707|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||GBQ|||10^3 CFU/ML|NOT DONE||Y|U|U|4||88||SCREENING|1961-12-11||1968-04-15|||1971-06-22||1962-01-31
TRIAL STUDY 134XCP|RP|8D48F229-F38B-4335-B8A7-0AA24C928707|1||||||ERYTHIND|ERYTHEMA INDICATOR||||MG/M2|||ML/G/H|NOT DONE||N|NA|N|5||7||OPEN LABEL TREATMENT|1961-05-17||1961-12-02|||1970-03-10||1972-08-27
TRIAL STUDY 134XCP|RP|8D48F229-F38B-4335-B8A7-0AA24C928707|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||EP U|||IU/ML|NOT DONE||NA|NA|Y|5||7||TREATMENT|1970-02-27||1963-10-01|||1965-09-22||1961-01-20
TRIAL STUDY 134XCP|RP|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^3 COPIES/ML|||ML/ANIMAL/WK|NOT DONE||Y|N|N|1||38||CONTINUATION TREATMENT|1972-06-02||1960-06-12|||1960-03-29||1963-06-01
TRIAL STUDY 134XCP|RP|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|2||||||PEELIND|PEELING INDICATOR||||MAC50|||MPL U/ML|NOT DONE||Y|NA|U|1||38||INDUCTION TREATMENT|1960-06-26||1961-05-07|||1960-10-21||1962-03-18
TRIAL STUDY 134XCP|RP|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|1||||||DSCHGIND|DISCHARGE INDICATOR||||MMHG|||GTT|NOT DONE||U|NA|Y|2||58||FOLLOW-UP|1972-03-06||1971-07-05|||1969-10-16||1966-08-01
TRIAL STUDY 134XCP|RP|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|2||||||BRTHN|NUMBER OF BIRTHS||||G/CAGE/WK|||UU/L|NOT DONE||U|N|NA|2||58||RUN-IN|1972-12-31||1963-11-07|||1962-02-20||1972-07-07
TRIAL STUDY 134XCP|RP|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MEQ/UL|||FMOL/G|NOT DONE||N|N|U|3||39||LONG-TERM FOLLOW-UP|1967-12-08||1972-10-31|||1961-01-29||1972-03-13
TRIAL STUDY 134XCP|RP|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|2||||||STILBIND|STILLBIRTH INDICATOR||||MIN/DAY|||FOZ_US|NOT DONE||N|N|NA|3||39||BASELINE|1964-12-31||1964-04-26|||1963-03-07||1968-04-16
TRIAL STUDY 134XCP|RP|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||L/DAY|||MG2/DL2|NOT DONE||Y|Y|Y|4||88||INDUCTION TREATMENT|1968-01-04||1967-10-11|||1962-01-12||1967-05-14
TRIAL STUDY 134XCP|RP|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||PPB|||DNA COPIES/UG|NOT DONE||NA|N|U|4||88||CONTINUATION TREATMENT|1966-05-06||1963-02-20|||1972-01-31||1960-07-24
TRIAL STUDY 134XCP|RP|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||10^7 TCID 50/DOSE|||BQ/KG|NOT DONE||Y|Y|U|5||7||FOLLOW-UP|1969-11-03||1966-02-27|||1962-07-06||1970-04-06
TRIAL STUDY 134XCP|RP|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|2||||||PREGST|PREGNANT DURING THE STUDY||||MONTHS|||MG/G/H|NOT DONE||N|NA|NA|5||7||TREATMENT|1965-10-10||1972-10-26|||1969-09-25||1973-01-15
TRIAL STUDY 134XCP|RP|C882CB1F-C0DE-4BE5-B762-611333949C74|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||EID 50/ML|||ABSORBANCE U/ML|NOT DONE||N|Y|Y|1||38||LONG-TERM FOLLOW-UP|1963-12-28||1972-11-17|||1970-07-31||1963-11-17
TRIAL STUDY 134XCP|RP|C882CB1F-C0DE-4BE5-B762-611333949C74|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||L/H|||U/ML|NOT DONE||U|N|U|1||38||LONG-TERM FOLLOW-UP|1966-04-02||1961-03-04|||1963-06-19||1961-01-01
TRIAL STUDY 134XCP|RP|C882CB1F-C0DE-4BE5-B762-611333949C74|1||||||EDEMAIND|EDEMA INDICATOR||||FIU|||PNU/ML|NOT DONE||U|U|Y|2||58||WASHOUT|1961-08-12||1962-08-23|||1964-10-15||1968-05-08
TRIAL STUDY 134XCP|RP|C882CB1F-C0DE-4BE5-B762-611333949C74|2||||||DLVRMODE|MODE OF DELIVERY||||ENZYME U|||CUP EQ|NOT DONE||Y|Y|NA|2||58||OBSERVATION|1962-08-31||1966-08-18|||1968-11-17||1965-06-05
TRIAL STUDY 134XCP|RP|C882CB1F-C0DE-4BE5-B762-611333949C74|1||||||THICK|THICKNESS||||ML/G/MIN|||MG/DAY|NOT DONE||N|U|Y|3||39||FOLLOW-UP|1969-07-10||1967-12-27|||1969-03-10||1964-05-15
TRIAL STUDY 134XCP|RP|C882CB1F-C0DE-4BE5-B762-611333949C74|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||CM/S|||UM|NOT DONE||U|U|N|3||39||FOLLOW-UP|1963-10-05||1968-05-20|||1963-07-04||1962-08-25
TRIAL STUDY 134XCP|RP|C882CB1F-C0DE-4BE5-B762-611333949C74|1||||||PREGNN|NUMBER OF PREGNANCIES||||UKAT|||MCI/KG|NOT DONE||Y|Y|Y|4||88||SCREENING|1965-11-25||1968-01-30|||1961-05-22||1973-03-18
TRIAL STUDY 134XCP|RP|C882CB1F-C0DE-4BE5-B762-611333949C74|2||||||DLVRMODE|MODE OF DELIVERY||||COPIES/UG|||MAC50|NOT DONE||U|NA|U|4||88||WASHOUT|1962-08-15||1966-11-17|||1971-10-19||1969-12-08
TRIAL STUDY 134XCP|RP|C882CB1F-C0DE-4BE5-B762-611333949C74|1||||||PUSTIND|PUSTULE INDICATOR||||GBQ/G|||LB|NOT DONE||Y|U|Y|5||7||CONTINUATION TREATMENT|1962-03-17||1962-12-22|||1964-12-05||1963-07-01
TRIAL STUDY 134XCP|RP|C882CB1F-C0DE-4BE5-B762-611333949C74|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||CCID 50/ML|||FT2|NOT DONE||NA|Y|NA|5||7||LONG-TERM FOLLOW-UP|1967-04-16||1960-10-24|||1972-03-31||1969-07-01
TRIAL STUDY 134XCP|RP|7F3C3801-607B-4141-AA83-383FDFFD7152|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||LOG10 TCID 50/ML|||DAYS/MONTH|NOT DONE||N|NA|NA|1||38||WASHOUT|1970-01-13||1967-06-28|||1963-12-09||1960-06-14
TRIAL STUDY 134XCP|RP|7F3C3801-607B-4141-AA83-383FDFFD7152|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||FMOL/G|||KM/H|NOT DONE||N|NA|NA|1||38||BLINDED TREATMENT|1963-11-21||1960-09-01|||1963-08-30||1970-08-25
TRIAL STUDY 134XCP|RP|7F3C3801-607B-4141-AA83-383FDFFD7152|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^6/HPF|||UMOL/H/MMOL|NOT DONE||Y|N|U|2||58||SCREENING|1964-10-05||1967-04-30|||1967-03-05||1966-10-22
TRIAL STUDY 134XCP|RP|7F3C3801-607B-4141-AA83-383FDFFD7152|2||||||PREGNN|NUMBER OF PREGNANCIES||||DISK|||MMOL2/L2|NOT DONE||U|Y|U|2||58||SCREENING|1970-08-12||1965-03-18|||1961-03-13||1970-01-14
TRIAL STUDY 134XCP|RP|7F3C3801-607B-4141-AA83-383FDFFD7152|1||||||FUNDHT|FUNDAL HEIGHT||||COPIES/ML|||U/CL|NOT DONE||N|N|N|3||39||TREATMENT|1960-10-27||1963-06-21|||1963-03-14||1963-06-12
TRIAL STUDY 134XCP|RP|7F3C3801-607B-4141-AA83-383FDFFD7152|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||KG|||MM/2H|NOT DONE||U|NA|Y|3||39||CONTINUATION TREATMENT|1960-10-15||1962-03-20|||1972-07-01||1970-04-22
TRIAL STUDY 134XCP|RP|7F3C3801-607B-4141-AA83-383FDFFD7152|1||||||MASSIND|MASS INDICATOR||||MG/KG/H|||UL/KG/DAY|NOT DONE||NA|N|N|4||88||BLINDED TREATMENT|1968-11-23||1973-02-04|||1964-05-06||1964-04-03
TRIAL STUDY 134XCP|RP|7F3C3801-607B-4141-AA83-383FDFFD7152|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MBP|||MIN*MG/ML|NOT DONE||NA|U|U|4||88||SCREENING|1964-06-09||1969-06-01|||1972-06-26||1971-02-04
TRIAL STUDY 134XCP|RP|7F3C3801-607B-4141-AA83-383FDFFD7152|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||/10^4|||IMPLANT|NOT DONE||Y|Y|Y|5||7||TREATMENT|1960-10-03||1970-08-19|||1970-03-27||1972-10-23
TRIAL STUDY 134XCP|RP|7F3C3801-607B-4141-AA83-383FDFFD7152|2||||||PREGNN|NUMBER OF PREGNANCIES||||DRUM|||NMOL/KG/DAY|NOT DONE||N|N|N|5||7||FOLLOW-UP|1963-05-25||1968-12-04|||1963-07-07||1972-09-05
TRIAL STUDY 134XCP|RP|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|1||||||MENOSTAT|MENOPAUSE STATUS||||PPB|||NG/MOL|NOT DONE||N|U|U|1||38||CONTINUATION TREATMENT|1972-09-09||1968-11-26|||1966-01-10||1964-01-09
TRIAL STUDY 134XCP|RP|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|2||||||ULCERIND|ULCER INDICATOR||||KPA|||WATT|NOT DONE||N|NA|Y|1||38||SCREENING|1962-12-19||1972-01-06|||1969-09-14||1968-03-25
TRIAL STUDY 134XCP|RP|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||FMOL/L/SEC|||BQ/KG|NOT DONE||NA|N|NA|2||58||LONG-TERM FOLLOW-UP|1965-12-15||1963-10-05|||1964-01-22||1973-06-09
TRIAL STUDY 134XCP|RP|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|2||||||RASHIND|RASH INDICATOR||||/H|||UMOL/L/MIN|NOT DONE||N|Y|U|2||58||BASELINE|1961-01-30||1965-08-22|||1965-11-14||1962-10-31
TRIAL STUDY 134XCP|RP|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||10^6 COPIES/ML|||KHZ|NOT DONE||Y|NA|Y|3||39||INDUCTION TREATMENT|1971-05-16||1973-06-27|||1963-04-29||1967-10-31
TRIAL STUDY 134XCP|RP|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||LOG10 CFU/ML|||UG/L FEU|NOT DONE||U|U|NA|3||39||INDUCTION TREATMENT|1963-04-16||1965-05-04|||1968-11-18||1967-10-20
TRIAL STUDY 134XCP|RP|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||WATT|||KM/H|NOT DONE||NA|Y|N|4||88||OBSERVATION|1970-10-02||1967-09-27|||1960-07-23||1961-07-07
TRIAL STUDY 134XCP|RP|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|2||||||FUNDHT|FUNDAL HEIGHT||||10^6 ORGANISMS|||10^6/HPF|NOT DONE||Y|NA|Y|4||88||TREATMENT|1960-06-12||1973-08-24|||1968-06-03||1961-11-14
TRIAL STUDY 134XCP|RP|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UMOL/KG/MIN|||MONTHS|NOT DONE||Y|NA|U|5||7||RUN-IN|1968-09-28||1961-01-22|||1969-06-03||1972-01-13
TRIAL STUDY 134XCP|RP|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|2||||||FUNDHT|FUNDAL HEIGHT||||10^5/HPF|||U/CL|NOT DONE||NA|U|Y|5||7||LONG-TERM FOLLOW-UP|1971-04-30||1971-04-08|||1964-07-12||1961-01-29
TRIAL STUDY 134XCP|RP|67025219-DBC0-4222-9D04-7F23EE3D5806|1||||||TNDRIND|TENDERNESS INDICATOR||||MMHG/L/MIN|||FT3|NOT DONE||U|U|U|1||38||RUN-IN|1967-06-20||1969-03-10|||1963-09-03||1966-02-19
TRIAL STUDY 134XCP|RP|67025219-DBC0-4222-9D04-7F23EE3D5806|2||||||GRAVIND|GRAVIDA INDICATOR||||SEC|||MM/SEC|NOT DONE||N|Y|N|1||38||INDUCTION TREATMENT|1965-05-01||1969-09-07|||1966-06-21||1961-03-01
TRIAL STUDY 134XCP|RP|67025219-DBC0-4222-9D04-7F23EE3D5806|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||10^4/L|||MV*MIN|NOT DONE||NA|N|NA|2||58||INDUCTION TREATMENT|1964-03-31||1960-06-29|||1963-09-10||1960-06-30
TRIAL STUDY 134XCP|RP|67025219-DBC0-4222-9D04-7F23EE3D5806|2||||||FUNDHT|FUNDAL HEIGHT||||G/DAY|||CMH2O*S/ML|NOT DONE||N|U|NA|2||58||WASHOUT|1966-03-01||1970-12-23|||1964-07-26||1962-08-09
TRIAL STUDY 134XCP|RP|67025219-DBC0-4222-9D04-7F23EE3D5806|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||U/G/H|||10^6/L|NOT DONE||U|NA|N|3||39||SCREENING|1969-09-28||1960-04-22|||1973-08-26||1963-10-15
TRIAL STUDY 134XCP|RP|67025219-DBC0-4222-9D04-7F23EE3D5806|2||||||PEELIND|PEELING INDICATOR||||P|||MMOL/KG|NOT DONE||NA|NA|NA|3||39||OBSERVATION|1963-06-03||1966-10-01|||1960-05-15||1972-04-19
TRIAL STUDY 134XCP|RP|67025219-DBC0-4222-9D04-7F23EE3D5806|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||DNA COPIES/ML|||ELISA UNIT/DOSE|NOT DONE||NA|Y|NA|4||88||CONTINUATION TREATMENT|1965-09-19||1971-03-27|||1962-12-28||1972-12-22
TRIAL STUDY 134XCP|RP|67025219-DBC0-4222-9D04-7F23EE3D5806|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UKAT/L|||/MS|NOT DONE||NA|N|N|4||88||LONG-TERM FOLLOW-UP|1965-11-05||1968-06-01|||1965-07-03||1972-12-02
TRIAL STUDY 134XCP|RP|67025219-DBC0-4222-9D04-7F23EE3D5806|1||||||DLVRMODE|MODE OF DELIVERY||||MPL U/ML|||UG/MOL|NOT DONE||NA|NA|Y|5||7||WASHOUT|1964-04-01||1963-11-08|||1968-03-18||1961-12-02
TRIAL STUDY 134XCP|RP|67025219-DBC0-4222-9D04-7F23EE3D5806|2||||||ERYTHIND|ERYTHEMA INDICATOR||||ML/BREATH|||/100 HPFS|NOT DONE||Y|NA|NA|5||7||TREATMENT|1963-05-09||1966-05-17|||1973-03-28||1962-06-14
TRIAL STUDY 134XCP|RP|A865B860-E5F2-423D-8110-58EBF7E470F3|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||HZ/S|||UG|NOT DONE||N|Y|NA|1||38||SCREENING|1964-02-14||1967-10-02|||1968-04-25||1972-05-23
TRIAL STUDY 134XCP|RP|A865B860-E5F2-423D-8110-58EBF7E470F3|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UL|||DRUM|NOT DONE||NA|N|U|1||38||SCREENING|1970-05-27||1965-09-22|||1968-10-24||1965-10-23
TRIAL STUDY 134XCP|RP|A865B860-E5F2-423D-8110-58EBF7E470F3|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||HZ/S|||OZ EQ|NOT DONE||Y|N|Y|2||58||SCREENING|1964-05-12||1968-04-29|||1967-09-03||1962-08-02
TRIAL STUDY 134XCP|RP|A865B860-E5F2-423D-8110-58EBF7E470F3|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||CAPLET|||DISK|NOT DONE||NA|U|U|2||58||WASHOUT|1960-01-05||1971-07-06|||1968-08-08||1960-12-30
TRIAL STUDY 134XCP|RP|A865B860-E5F2-423D-8110-58EBF7E470F3|1||||||MASSIND|MASS INDICATOR||||NMOL BCE/NMOL|||10^9 ORGANISMS/ML|NOT DONE||N|Y|N|3||39||FOLLOW-UP|1972-03-10||1962-05-25|||1972-09-17||1962-01-02
TRIAL STUDY 134XCP|RP|A865B860-E5F2-423D-8110-58EBF7E470F3|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||L/MIN|||UCI/L|NOT DONE||Y|Y|U|3||39||TREATMENT|1970-09-13||1963-01-18|||1964-01-22||1971-10-02
TRIAL STUDY 134XCP|RP|A865B860-E5F2-423D-8110-58EBF7E470F3|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^6 DNA COPIES/ML|||ML/MMHG/MIN/L|NOT DONE||Y|N|Y|4||88||SCREENING|1969-09-04||1969-04-11|||1970-05-17||1970-10-26
TRIAL STUDY 134XCP|RP|A865B860-E5F2-423D-8110-58EBF7E470F3|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||GBQ|||U/L|NOT DONE||N|NA|N|4||88||WASHOUT|1970-07-23||1968-01-19|||1968-06-22||1970-12-09
TRIAL STUDY 134XCP|RP|A865B860-E5F2-423D-8110-58EBF7E470F3|1||||||INTP|INTERPRETATION||||TRACE|||CI/UL|NOT DONE||U|U|U|5||7||SCREENING|1960-06-18||1962-04-22|||1967-08-20||1963-09-26
TRIAL STUDY 134XCP|RP|A865B860-E5F2-423D-8110-58EBF7E470F3|2||||||MENOSTAT|MENOPAUSE STATUS||||CIGARETTE|||HOURS|NOT DONE||U|U|NA|5||7||INDUCTION TREATMENT|1967-12-20||1966-06-29|||1967-07-31||1965-03-21
TRIAL STUDY 134XCP|RP|E78B2C0E-81D6-4898-B78A-FE136029AEA4|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||KS|||G/CAGE|NOT DONE||N|U|N|1||38||LONG-TERM FOLLOW-UP|1963-07-31||1962-08-27|||1969-12-11||1960-03-22
TRIAL STUDY 134XCP|RP|E78B2C0E-81D6-4898-B78A-FE136029AEA4|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MSEC|||UMOL/L/H|NOT DONE||NA|NA|NA|1||38||WASHOUT|1963-06-18||1962-04-24|||1966-01-24||1965-07-13
TRIAL STUDY 134XCP|RP|E78B2C0E-81D6-4898-B78A-FE136029AEA4|1||||||FUNDHT|FUNDAL HEIGHT||||/CMH2O|||CIGARETTE|NOT DONE||NA|Y|Y|2||58||LONG-TERM FOLLOW-UP|1961-07-16||1965-03-28|||1962-05-15||1970-10-31
TRIAL STUDY 134XCP|RP|E78B2C0E-81D6-4898-B78A-FE136029AEA4|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||UL/KG/DAY|||PL|NOT DONE||U|NA|U|2||58||FOLLOW-UP|1961-02-24||1966-10-29|||1970-10-09||1962-06-21
TRIAL STUDY 134XCP|RP|E78B2C0E-81D6-4898-B78A-FE136029AEA4|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ML/CM3/MIN|||ML/CAGE|NOT DONE||N|Y|NA|3||39||BLINDED TREATMENT|1972-06-08||1961-04-05|||1972-10-12||1972-01-18
TRIAL STUDY 134XCP|RP|E78B2C0E-81D6-4898-B78A-FE136029AEA4|2||||||PREGIND|PREGNANT INDICATOR||||CM/S|||KG/L|NOT DONE||Y|N|Y|3||39||RUN-IN|1960-07-12||1966-09-19|||1967-11-09||1971-04-15
TRIAL STUDY 134XCP|RP|E78B2C0E-81D6-4898-B78A-FE136029AEA4|1||||||PUSTIND|PUSTULE INDICATOR||||MMOL/L|||CI/UL|NOT DONE||U|Y|U|4||88||LONG-TERM FOLLOW-UP|1965-12-05||1972-04-30|||1973-07-04||1968-11-24
TRIAL STUDY 134XCP|RP|E78B2C0E-81D6-4898-B78A-FE136029AEA4|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||U/MMOL|||UG/DAY|NOT DONE||NA|N|U|4||88||OPEN LABEL TREATMENT|1966-08-26||1970-07-31|||1973-06-23||1973-05-12
TRIAL STUDY 134XCP|RP|E78B2C0E-81D6-4898-B78A-FE136029AEA4|1||||||DSCHGIND|DISCHARGE INDICATOR||||CI/ML|||ATM|NOT DONE||N|U|U|5||7||FOLLOW-UP|1971-09-19||1971-09-10|||1964-08-01||1968-09-23
TRIAL STUDY 134XCP|RP|E78B2C0E-81D6-4898-B78A-FE136029AEA4|2||||||MENOAGE|MENOPAUSE AGE||||10^4/HPF|||FOZ_US|NOT DONE||N|U|U|5||7||TREATMENT|1966-05-03||1972-12-22|||1960-07-27||1970-10-12
TRIAL STUDY 134XCP|RP|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|1||||||PRGENDTC|DATE PREGNANCY ENDED||||U/KG/MIN|||LOG10 TCID 50/ML|NOT DONE||NA|N|N|1||38||WASHOUT|1965-05-13||1973-01-10|||1970-01-02||1963-11-01
TRIAL STUDY 134XCP|RP|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MG/M2/H|||MEQ|NOT DONE||N|N|NA|1||38||OBSERVATION|1962-02-02||1971-09-11|||1964-12-19||1961-04-15
TRIAL STUDY 134XCP|RP|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||BEATS/MIN|||MG/M2/DAY|NOT DONE||Y|NA|U|2||58||OBSERVATION|1962-05-16||1968-06-01|||1964-04-08||1960-07-16
TRIAL STUDY 134XCP|RP|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|2||||||MENOAGE|MENOPAUSE AGE||||UIU/L|||1/(S*KPA)|NOT DONE||N|NA|NA|2||58||LONG-TERM FOLLOW-UP|1960-02-08||1973-07-15|||1970-12-07||1962-02-18
TRIAL STUDY 134XCP|RP|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||SYRINGE|||KBQ/UL|NOT DONE||Y|Y|N|3||39||OPEN LABEL TREATMENT|1960-05-06||1961-08-23|||1973-08-19||1962-08-14
TRIAL STUDY 134XCP|RP|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|2||||||TNDRIND|TENDERNESS INDICATOR||||PG|||M/SEC2|NOT DONE||U|N|U|3||39||OBSERVATION|1965-08-05||1960-08-07|||1965-07-26||1960-03-10
TRIAL STUDY 134XCP|RP|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||COAT|||CPM|NOT DONE||U|Y|Y|4||88||FOLLOW-UP|1972-09-28||1965-08-21|||1964-11-24||1965-03-04
TRIAL STUDY 134XCP|RP|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|2||||||ABORTN|NUMBER OF ABORTIONS||||10^6 ORGANISMS/G|||MMHG*MIN/L|NOT DONE||NA|U|Y|4||88||LONG-TERM FOLLOW-UP|1970-04-09||1965-01-01|||1971-07-17||1961-06-02
TRIAL STUDY 134XCP|RP|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|1||||||ABORTN|NUMBER OF ABORTIONS||||UG/G/DAY|||ML/ANIMAL/WK|NOT DONE||N|U|N|5||7||SCREENING|1969-08-10||1969-08-28|||1961-04-02||1970-05-21
TRIAL STUDY 134XCP|RP|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||LOG10 PFU|||UG/M2/DAY|NOT DONE||Y|U|U|5||7||INDUCTION TREATMENT|1968-01-16||1963-06-28|||1971-06-07||1965-04-05
TRIAL STUDY 134XCP|RP|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||CM/S|||MG/G/H|NOT DONE||Y|Y|NA|1||38||FOLLOW-UP|1968-06-29||1961-11-09|||1971-02-28||1973-04-07
TRIAL STUDY 134XCP|RP|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|2||||||MENFDUR|MENSES FLOW DURATION||||NG/DAY|||ML*CMH2O|NOT DONE||N|U|N|1||38||BLINDED TREATMENT|1961-09-21||1967-02-16|||1970-05-07||1966-11-05
TRIAL STUDY 134XCP|RP|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|1||||||RASHIND|RASH INDICATOR||||L/KG|||MG/DAY|NOT DONE||Y|NA|U|2||58||SCREENING|1966-03-20||1969-09-07|||1964-07-15||1973-08-22
TRIAL STUDY 134XCP|RP|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||ML/100G/MIN|||EID 50/DOSE|NOT DONE||N|N|Y|2||58||TREATMENT|1961-05-22||1961-04-28|||1964-06-27||1970-08-09
TRIAL STUDY 134XCP|RP|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||SYRINGE|||/100 HPFS|NOT DONE||U|Y|Y|3||39||OPEN LABEL TREATMENT|1960-07-10||1970-09-17|||1972-02-10||1965-04-28
TRIAL STUDY 134XCP|RP|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||DL|||PPTH|NOT DONE||Y|N|Y|3||39||FOLLOW-UP|1964-12-12||1967-12-29|||1963-12-24||1970-11-05
TRIAL STUDY 134XCP|RP|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||IU/ML|||PT_BR|NOT DONE||NA|Y|Y|4||88||TREATMENT|1962-05-14||1961-10-05|||1970-05-12||1973-05-11
TRIAL STUDY 134XCP|RP|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|2||||||INABOIND|INDUCED ABORTION INDICATOR||||FT2|||GTT|NOT DONE||N|NA|Y|4||88||FOLLOW-UP|1972-12-05||1971-02-07|||1960-08-27||1972-05-07
TRIAL STUDY 134XCP|RP|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|1||||||STILBIND|STILLBIRTH INDICATOR||||LOG10 CFU/G|||KM|NOT DONE||NA|U|N|5||7||TREATMENT|1970-03-19||1966-03-06|||1970-12-07||1973-05-11
TRIAL STUDY 134XCP|RP|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|2||||||MENARAGE|MENARCHE AGE||||FRACTION OF 1|||LM|NOT DONE||N|Y|NA|5||7||RUN-IN|1966-12-01||1962-07-29|||1972-04-23||1970-04-07
TRIAL STUDY 134XCP|RP|55210E20-F6B9-446F-994D-2D9149E33BAF|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^8/L|||MMOL|NOT DONE||Y|Y|U|1||38||INDUCTION TREATMENT|1972-04-22||1969-06-20|||1968-12-18||1970-07-24
TRIAL STUDY 134XCP|RP|55210E20-F6B9-446F-994D-2D9149E33BAF|2||||||PREGST|PREGNANT DURING THE STUDY||||/100 HPFS|||10^6 RNA COPIES/ML|NOT DONE||N|N|N|1||38||WASHOUT|1967-05-08||1960-04-07|||1970-05-25||1962-10-04
TRIAL STUDY 134XCP|RP|55210E20-F6B9-446F-994D-2D9149E33BAF|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||DROP|||PUFF|NOT DONE||N|Y|N|2||58||FOLLOW-UP|1970-01-19||1964-11-20|||1969-11-28||1964-08-28
TRIAL STUDY 134XCP|RP|55210E20-F6B9-446F-994D-2D9149E33BAF|2||||||MENARAGE|MENARCHE AGE||||DRAM|||UV2|NOT DONE||U|Y|NA|2||58||WASHOUT|1966-04-26||1962-07-08|||1970-07-04||1962-08-29
TRIAL STUDY 134XCP|RP|55210E20-F6B9-446F-994D-2D9149E33BAF|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||EIA UNIT|||CAPFUL|NOT DONE||N|NA|N|3||39||CONTINUATION TREATMENT|1969-03-09||1962-08-27|||1973-06-17||1970-01-08
TRIAL STUDY 134XCP|RP|55210E20-F6B9-446F-994D-2D9149E33BAF|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UIU/DL|||NMOL BCE/NMOL|NOT DONE||N|NA|N|3||39||WASHOUT|1963-03-26||1971-01-31|||1973-08-21||1973-08-04
TRIAL STUDY 134XCP|RP|55210E20-F6B9-446F-994D-2D9149E33BAF|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||U/MMOL|||10^6 ORGANISMS/MG|NOT DONE||Y|N|N|4||88||INDUCTION TREATMENT|1960-09-21||1963-03-13|||1971-08-31||1970-05-24
TRIAL STUDY 134XCP|RP|55210E20-F6B9-446F-994D-2D9149E33BAF|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||PSI|||MG/L FEU|NOT DONE||NA|NA|NA|4||88||OPEN LABEL TREATMENT|1969-12-10||1970-11-02|||1969-08-23||1962-02-17
TRIAL STUDY 134XCP|RP|55210E20-F6B9-446F-994D-2D9149E33BAF|1||||||PUSTIND|PUSTULE INDICATOR||||DIP|||NFIU|NOT DONE||U|N|NA|5||7||RUN-IN|1965-08-27||1961-04-10|||1972-03-21||1964-10-07
TRIAL STUDY 134XCP|RP|55210E20-F6B9-446F-994D-2D9149E33BAF|2||||||ERYTHIND|ERYTHEMA INDICATOR||||ML/DOSE|||ML/KG/H|NOT DONE||N|NA|U|5||7||BASELINE|1968-06-02||1961-04-27|||1971-01-04||1964-03-29
TRIAL STUDY 134XCP|RP|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||KG/L|||LOG10 COPIES/ML|NOT DONE||NA|Y|U|1||38||INDUCTION TREATMENT|1965-01-18||1966-06-09|||1963-12-14||1965-01-03
TRIAL STUDY 134XCP|RP|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||UIU/DL|||10^9 ORGANISMS/G|NOT DONE||N|Y|NA|1||38||INDUCTION TREATMENT|1963-03-20||1962-11-06|||1971-05-06||1961-05-08
TRIAL STUDY 134XCP|RP|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|1||||||ULCERIND|ULCER INDICATOR||||KIU|||10^3/L|NOT DONE||N|NA|U|2||58||CONTINUATION TREATMENT|1963-04-05||1970-11-01|||1967-04-26||1965-12-13
TRIAL STUDY 134XCP|RP|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|2||||||TNDRIND|TENDERNESS INDICATOR||||KUSP|||INHALATION|NOT DONE||U|NA|Y|2||58||OPEN LABEL TREATMENT|1971-05-25||1965-08-14|||1965-05-06||1969-03-02
TRIAL STUDY 134XCP|RP|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||/200 HPFS|||MG/G/H|NOT DONE||N|Y|Y|3||39||LONG-TERM FOLLOW-UP|1964-06-02||1960-07-27|||1968-07-16||1962-08-19
TRIAL STUDY 134XCP|RP|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|2||||||MENOSTAT|MENOPAUSE STATUS||||CYCLE/MIN|||MMOL/DAY|NOT DONE||N|N|Y|3||39||LONG-TERM FOLLOW-UP|1961-03-24||1960-06-11|||1970-03-07||1965-08-09
TRIAL STUDY 134XCP|RP|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|1||||||PEELIND|PEELING INDICATOR||||ML/ANIMAL/WK|||/H|NOT DONE||NA|Y|Y|4||88||TREATMENT|1963-08-11||1972-05-30|||1965-11-17||1964-11-11
TRIAL STUDY 134XCP|RP|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|2||||||ULCERIND|ULCER INDICATOR||||DPM/0.5 ML|||F|NOT DONE||U|N|N|4||88||SCREENING|1965-11-28||1960-03-10|||1965-08-24||1967-07-16
TRIAL STUDY 134XCP|RP|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|1||||||PRGENDTC|DATE PREGNANCY ENDED||||ENZYME U/G HB|||EID 50/ML|NOT DONE||U|U|NA|5||7||FOLLOW-UP|1964-12-29||1963-05-05|||1973-05-03||1964-08-22
TRIAL STUDY 134XCP|RP|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||FEU|||ROENTGEN|NOT DONE||Y|Y|N|5||7||INDUCTION TREATMENT|1962-12-13||1969-12-23|||1962-03-10||1960-10-14
TRIAL STUDY 134XCP|RP|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MJOULE/CM2|||U/M2/H|NOT DONE||U|NA|N|1||38||WASHOUT|1962-06-19||1964-06-20|||1972-07-23||1966-12-21
TRIAL STUDY 134XCP|RP|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|2||||||EDEMAIND|EDEMA INDICATOR||||BQ/G|||UG/DAY|NOT DONE||Y|N|N|1||38||CONTINUATION TREATMENT|1973-02-16||1971-04-26|||1970-11-16||1970-04-08
TRIAL STUDY 134XCP|RP|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||FG|||UV|NOT DONE||U|NA|Y|2||58||OPEN LABEL TREATMENT|1967-07-17||1967-07-05|||1960-11-09||1971-12-06
TRIAL STUDY 134XCP|RP|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|2||||||MASSIND|MASS INDICATOR||||SACHET|||MPL U/ML|NOT DONE||N|Y|Y|2||58||WASHOUT|1966-01-27||1973-05-27|||1970-03-04||1963-05-23
TRIAL STUDY 134XCP|RP|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MG2/DL2|||CMH2O*S2/ML|NOT DONE||U|N|N|3||39||OBSERVATION|1963-02-20||1961-05-27|||1970-01-16||1961-06-07
TRIAL STUDY 134XCP|RP|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||LENS|||ML/ANIMAL/DAY|NOT DONE||Y|NA|N|3||39||WASHOUT|1966-12-29||1967-01-27|||1972-06-10||1965-01-06
TRIAL STUDY 134XCP|RP|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||KBQ|||AMPULE|NOT DONE||N|U|NA|4||88||OPEN LABEL TREATMENT|1972-03-07||1960-06-13|||1964-12-16||1973-05-05
TRIAL STUDY 134XCP|RP|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||LENS|||10^12/L|NOT DONE||U|N|N|4||88||OPEN LABEL TREATMENT|1963-04-12||1961-01-25|||1967-01-01||1969-08-06
TRIAL STUDY 134XCP|RP|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|1||||||GRAVIND|GRAVIDA INDICATOR||||%(V/V)|||PRESSOR UNITS|NOT DONE||N|Y|N|5||7||SCREENING|1969-11-16||1960-12-14|||1964-10-21||1966-12-11
TRIAL STUDY 134XCP|RP|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UMOL/L/MIN|||ML/G/MIN|NOT DONE||NA|U|Y|5||7||TREATMENT|1965-10-05||1960-01-21|||1969-02-09||1969-07-02
TRIAL STUDY 134XCP|RP|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|1||||||PEELIND|PEELING INDICATOR||||/MBP|||FMOL/L|NOT DONE||Y|N|U|1||38||WASHOUT|1966-05-16||1970-06-14|||1963-10-05||1966-09-11
TRIAL STUDY 134XCP|RP|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/M2|||MM/SEC|NOT DONE||NA|Y|N|1||38||BLINDED TREATMENT|1967-05-18||1967-03-16|||1964-11-11||1965-05-26
TRIAL STUDY 134XCP|RP|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|1||||||PREGIND|PREGNANT INDICATOR||||10^10/L|||DAYS/WK|NOT DONE||Y|NA|Y|2||58||BLINDED TREATMENT|1973-07-16||1961-11-25|||1961-07-07||1967-08-15
TRIAL STUDY 134XCP|RP|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|2||||||PEELIND|PEELING INDICATOR||||U/G/H|||PMOL/G|NOT DONE||N|N|NA|2||58||OBSERVATION|1971-02-16||1971-04-17|||1963-09-29||1961-07-04
TRIAL STUDY 134XCP|RP|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UL|||10^9 ORGANISMS|NOT DONE||U|NA|N|3||39||WASHOUT|1963-11-30||1960-03-09|||1968-09-19||1965-01-15
TRIAL STUDY 134XCP|RP|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|2||||||MENOSTAT|MENOPAUSE STATUS||||GENEQ/ML|||CAL|NOT DONE||Y|Y|N|3||39||OPEN LABEL TREATMENT|1968-07-20||1962-09-06|||1968-10-16||1965-12-11
TRIAL STUDY 134XCP|RP|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|1||||||MENFDUR|MENSES FLOW DURATION||||TITER|||/MONTH|NOT DONE||N|Y|NA|4||88||OBSERVATION|1965-06-19||1963-09-15|||1962-01-31||1973-07-22
TRIAL STUDY 134XCP|RP|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^4/L|||APL U|NOT DONE||Y|U|NA|4||88||CONTINUATION TREATMENT|1970-04-03||1962-01-24|||1961-12-12||1961-04-29
TRIAL STUDY 134XCP|RP|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|1||||||MENOAGE|MENOPAUSE AGE||||UMOL/L/H|||DAGU/ML|NOT DONE||U|NA|Y|5||7||BASELINE|1972-10-02||1960-07-09|||1970-10-06||1962-04-13
TRIAL STUDY 134XCP|RP|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|2||||||MENOAGE|MENOPAUSE AGE||||MMOL/MOL|||BAG|NOT DONE||U|NA|NA|5||7||RUN-IN|1962-02-05||1960-01-03|||1972-05-02||1961-09-07
TRIAL STUDY 134XCP|RP|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ML/CM|||CMOL|NOT DONE||NA|NA|Y|1||38||FOLLOW-UP|1967-02-14||1972-11-12|||1971-04-22||1970-11-03
TRIAL STUDY 134XCP|RP|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|2||||||GRAVIND|GRAVIDA INDICATOR||||IN2|||NG/MOL|NOT DONE||NA|Y|NA|1||38||CONTINUATION TREATMENT|1972-03-11||1963-10-04|||1965-10-31||1967-01-26
TRIAL STUDY 134XCP|RP|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|1||||||BCMETHOD|BIRTH CONTROL METHOD||||CI/MG|||DRUM|NOT DONE||N|NA|N|2||58||OBSERVATION|1973-03-10||1972-09-28|||1968-08-04||1960-04-20
TRIAL STUDY 134XCP|RP|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|2||||||MENOAGE|MENOPAUSE AGE||||OSM|||P|NOT DONE||U|Y|NA|2||58||SCREENING|1970-10-24||1970-04-18|||1965-11-06||1963-07-13
TRIAL STUDY 134XCP|RP|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||U/10^12 RBC|||10^3 RNA COPIES/ML|NOT DONE||Y|Y|NA|3||39||FOLLOW-UP|1969-07-27||1967-11-21|||1963-08-25||1972-05-29
TRIAL STUDY 134XCP|RP|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||NMOL|||EVENTS|NOT DONE||Y|Y|Y|3||39||WASHOUT|1963-02-19||1966-08-07|||1971-09-22||1966-03-06
TRIAL STUDY 134XCP|RP|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||ELISA UNIT/ML|||MM/SEC|NOT DONE||Y|U|N|4||88||SCREENING|1961-03-13||1969-11-29|||1972-08-15||1969-01-31
TRIAL STUDY 134XCP|RP|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||BREATHS/MIN|||BEATS/MIN|NOT DONE||Y|NA|Y|4||88||FOLLOW-UP|1969-04-25||1972-08-02|||1965-11-09||1962-08-02
TRIAL STUDY 134XCP|RP|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|1||||||DLVRMODE|MODE OF DELIVERY||||L/MIN/M2|||UMOL/MG/MIN|NOT DONE||N|NA|U|5||7||FOLLOW-UP|1968-11-30||1961-02-24|||1967-05-08||1967-08-14
TRIAL STUDY 134XCP|RP|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MS/MMHG|||CAPSULE|NOT DONE||Y|U|NA|5||7||TREATMENT|1968-11-30||1970-06-30|||1969-03-22||1960-03-30
TRIAL STUDY 134XCP|RP|CAD0ED37-954A-4935-8A7E-589EC108E141|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||GLOBULE|||TRACE|NOT DONE||NA|NA|U|1||38||OBSERVATION|1966-01-30||1969-07-18|||1963-11-18||1972-05-24
TRIAL STUDY 134XCP|RP|CAD0ED37-954A-4935-8A7E-589EC108E141|2||||||MENOSTAT|MENOPAUSE STATUS||||CMHG|||DPM|NOT DONE||NA|U|NA|1||38||OBSERVATION|1967-03-16||1968-02-01|||1960-05-17||1969-05-28
TRIAL STUDY 134XCP|RP|CAD0ED37-954A-4935-8A7E-589EC108E141|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||AMU|||10^6 CFU/ML|NOT DONE||N|NA|Y|2||58||SCREENING|1963-03-07||1970-07-24|||1973-03-18||1963-03-10
TRIAL STUDY 134XCP|RP|CAD0ED37-954A-4935-8A7E-589EC108E141|2||||||ULCERIND|ULCER INDICATOR||||EVENTS|||AGU/ML|NOT DONE||Y|U|NA|2||58||INDUCTION TREATMENT|1960-11-20||1967-12-09|||1973-05-09||1967-10-10
TRIAL STUDY 134XCP|RP|CAD0ED37-954A-4935-8A7E-589EC108E141|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||L/S|||/MM|NOT DONE||U|Y|U|3||39||RUN-IN|1972-01-31||1966-08-31|||1960-08-26||1962-12-06
TRIAL STUDY 134XCP|RP|CAD0ED37-954A-4935-8A7E-589EC108E141|2||||||STILBIND|STILLBIRTH INDICATOR||||ML/KG/H|||CG|NOT DONE||U|N|N|3||39||OPEN LABEL TREATMENT|1961-04-21||1968-02-10|||1972-07-03||1969-06-03
TRIAL STUDY 134XCP|RP|CAD0ED37-954A-4935-8A7E-589EC108E141|1||||||EDEMAIND|EDEMA INDICATOR||||10^9 CFU|||G/CM2|NOT DONE||NA|NA|NA|4||88||INDUCTION TREATMENT|1961-05-31||1968-07-14|||1960-02-26||1968-07-23
TRIAL STUDY 134XCP|RP|CAD0ED37-954A-4935-8A7E-589EC108E141|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||DRUM|||CS|NOT DONE||NA|NA|N|4||88||RUN-IN|1969-10-09||1960-04-20|||1962-12-15||1966-04-14
TRIAL STUDY 134XCP|RP|CAD0ED37-954A-4935-8A7E-589EC108E141|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||UG/ML/H|||FOZ_US|NOT DONE||NA|NA|NA|5||7||RUN-IN|1966-12-23||1968-06-19|||1967-03-16||1970-05-15
TRIAL STUDY 134XCP|RP|CAD0ED37-954A-4935-8A7E-589EC108E141|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||BQ/G|||NMOL BCE/L|NOT DONE||U|U|N|5||7||BLINDED TREATMENT|1968-02-10||1966-02-18|||1967-11-13||1970-12-16
TRIAL STUDY 134XCP|RP|BC9A31E2-100C-4AC3-8910-A04309854590|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ABSORBANCE U/ML|||BQ/MG|NOT DONE||NA|N|NA|1||38||BLINDED TREATMENT|1962-07-28||1961-05-01|||1969-05-12||1962-08-08
TRIAL STUDY 134XCP|RP|BC9A31E2-100C-4AC3-8910-A04309854590|2||||||PREGST|PREGNANT DURING THE STUDY||||V/V|||G/M2|NOT DONE||N|U|NA|1||38||OBSERVATION|1961-09-08||1966-08-03|||1971-04-25||1962-08-03
TRIAL STUDY 134XCP|RP|BC9A31E2-100C-4AC3-8910-A04309854590|1||||||MASSIND|MASS INDICATOR||||MV*MIN|||10^3 CFU/ML|NOT DONE||U|Y|NA|2||58||WASHOUT|1971-11-10||1964-05-29|||1960-01-13||1962-09-20
TRIAL STUDY 134XCP|RP|BC9A31E2-100C-4AC3-8910-A04309854590|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MG/KG/H|||CCID 50/DOSE|NOT DONE||NA|U|Y|2||58||RUN-IN|1962-12-14||1972-12-19|||1963-08-25||1966-01-03
TRIAL STUDY 134XCP|RP|BC9A31E2-100C-4AC3-8910-A04309854590|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||NMOL/L|||PPB|NOT DONE||NA|U|U|3||39||TREATMENT|1962-06-27||1964-06-22|||1968-07-20||1962-05-30
TRIAL STUDY 134XCP|RP|BC9A31E2-100C-4AC3-8910-A04309854590|2||||||BCMETHOD|BIRTH CONTROL METHOD||||PACKAGE|||HOURS|NOT DONE||Y|U|Y|3||39||RUN-IN|1962-01-06||1970-03-06|||1961-03-14||1964-05-19
TRIAL STUDY 134XCP|RP|BC9A31E2-100C-4AC3-8910-A04309854590|1||||||RASHIND|RASH INDICATOR||||MOL/DAY|||ML|NOT DONE||U|NA|N|4||88||OBSERVATION|1963-04-30||1960-01-11|||1966-10-08||1969-05-19
TRIAL STUDY 134XCP|RP|BC9A31E2-100C-4AC3-8910-A04309854590|2||||||INTP|INTERPRETATION||||/VF|||MHZ|NOT DONE||U|Y|U|4||88||BASELINE|1963-02-14||1964-01-23|||1970-11-17||1972-01-17
TRIAL STUDY 134XCP|RP|BC9A31E2-100C-4AC3-8910-A04309854590|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||PACKET|||G/ANIMAL|NOT DONE||N|Y|N|5||7||CONTINUATION TREATMENT|1967-10-21||1960-05-23|||1968-12-26||1961-02-08
TRIAL STUDY 134XCP|RP|BC9A31E2-100C-4AC3-8910-A04309854590|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MBQ/UL|||CP|NOT DONE||U|N|Y|5||7||WASHOUT|1969-08-19||1967-06-23|||1973-03-23||1964-02-22
TRIAL STUDY 134XCP|RP|13A424BB-CC85-41EC-BDED-165A29532DFF|1||||||PREGST|PREGNANT DURING THE STUDY||||10^3 ORGANISMS/G|||HPA|NOT DONE||N|U|NA|1||38||TREATMENT|1968-02-17||1963-11-07|||1961-11-26||1963-06-29
TRIAL STUDY 134XCP|RP|13A424BB-CC85-41EC-BDED-165A29532DFF|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||U.CARR|||UG/DL|NOT DONE||Y|NA|U|1||38||INDUCTION TREATMENT|1963-05-14||1968-03-14|||1971-11-14||1966-06-29
TRIAL STUDY 134XCP|RP|13A424BB-CC85-41EC-BDED-165A29532DFF|1||||||FUNDHT|FUNDAL HEIGHT||||BOWL|||NEBULE|NOT DONE||NA|Y|Y|2||58||TREATMENT|1963-04-02||1967-11-30|||1963-11-30||1967-07-21
TRIAL STUDY 134XCP|RP|13A424BB-CC85-41EC-BDED-165A29532DFF|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MG/M2|||NGEQ/L|NOT DONE||Y|Y|N|2||58||OBSERVATION|1969-02-07||1970-07-13|||1972-02-06||1962-08-28
TRIAL STUDY 134XCP|RP|13A424BB-CC85-41EC-BDED-165A29532DFF|1||||||PREGNN|NUMBER OF PREGNANCIES||||U/KG/DAY|||U/G/H|NOT DONE||N|N|NA|3||39||OBSERVATION|1967-05-13||1971-10-10|||1962-10-23||1970-07-20
TRIAL STUDY 134XCP|RP|13A424BB-CC85-41EC-BDED-165A29532DFF|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||HEP|||U/G/H|NOT DONE||NA|Y|N|3||39||OPEN LABEL TREATMENT|1961-02-15||1971-09-12|||1964-09-01||1963-02-18
TRIAL STUDY 134XCP|RP|13A424BB-CC85-41EC-BDED-165A29532DFF|1||||||MENFDUR|MENSES FLOW DURATION||||CI|||DISK|NOT DONE||U|N|U|4||88||INDUCTION TREATMENT|1962-11-27||1972-11-25|||1962-02-18||1962-05-05
TRIAL STUDY 134XCP|RP|13A424BB-CC85-41EC-BDED-165A29532DFF|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||NSEC|||BOX|NOT DONE||N|U|U|4||88||BLINDED TREATMENT|1961-07-19||1960-03-19|||1965-05-27||1965-02-14
TRIAL STUDY 134XCP|RP|13A424BB-CC85-41EC-BDED-165A29532DFF|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||ELISA UNIT|||ENZYME U|NOT DONE||NA|Y|U|5||7||BASELINE|1966-01-30||1963-12-28|||1965-07-21||1973-06-21
TRIAL STUDY 134XCP|RP|13A424BB-CC85-41EC-BDED-165A29532DFF|2||||||BRTHN|NUMBER OF BIRTHS||||AMPULE|||FEU|NOT DONE||N|NA|N|5||7||RUN-IN|1960-02-23||1970-07-19|||1970-05-07||1960-11-05
TRIAL STUDY 134XCP|RP|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|1||||||PUSTIND|PUSTULE INDICATOR||||MMHG/L/MIN|||CY/CM|NOT DONE||NA|N|NA|1||38||INDUCTION TREATMENT|1970-04-29||1970-01-26|||1960-01-07||1965-07-20
TRIAL STUDY 134XCP|RP|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||/MM|||10^8 PFU|NOT DONE||NA|N|U|1||38||FOLLOW-UP|1967-05-23||1966-12-21|||1966-11-07||1961-12-19
TRIAL STUDY 134XCP|RP|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|1||||||BLISTIND|BLISTERING INDICATOR||||10^9 ORGANISMS/ML|||U/M2/DAY|NOT DONE||U|N|Y|2||58||CONTINUATION TREATMENT|1970-04-19||1971-01-19|||1972-06-11||1964-07-19
TRIAL STUDY 134XCP|RP|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||ML/CM|||BOLUS|NOT DONE||Y|NA|U|2||58||OPEN LABEL TREATMENT|1969-01-16||1963-04-01|||1960-11-01||1968-02-17
TRIAL STUDY 134XCP|RP|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||PG/DL|||LOG10 IU/ML|NOT DONE||NA|U|Y|3||39||RUN-IN|1969-04-15||1972-09-02|||1972-11-30||1961-09-24
TRIAL STUDY 134XCP|RP|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|2||||||BRTHN|NUMBER OF BIRTHS||||AMPULE|||PL|NOT DONE||Y|NA|U|3||39||OPEN LABEL TREATMENT|1963-11-29||1968-04-18|||1970-02-03||1968-01-19
TRIAL STUDY 134XCP|RP|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||10^8 PFU|||RNA COPIES/ML|NOT DONE||Y|U|Y|4||88||BLINDED TREATMENT|1964-06-04||1967-12-10|||1965-06-05||1971-10-29
TRIAL STUDY 134XCP|RP|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||UG/DAY|||UEQ|NOT DONE||Y|N|U|4||88||TREATMENT|1972-11-07||1970-09-21|||1961-10-27||1964-07-27
TRIAL STUDY 134XCP|RP|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|1||||||MENARAGE|MENARCHE AGE||||ELISA UNIT/ML|||APL U/ML|NOT DONE||N|N|N|5||7||CONTINUATION TREATMENT|1962-11-29||1963-12-21|||1970-05-11||1963-07-02
TRIAL STUDY 134XCP|RP|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||PHERESIS UNIT|||10^9 CFU|NOT DONE||N|N|U|5||7||WASHOUT|1963-06-06||1969-07-17|||1969-02-24||1968-04-12
TRIAL STUDY 134XCP|RP|059FE504-DEE4-4E24-AA80-3C64264636BF|1||||||BLISTIND|BLISTERING INDICATOR||||QUANTITY SUFFICIENT|||LINEAR FT*LB|NOT DONE||NA|U|N|1||38||CONTINUATION TREATMENT|1966-09-22||1960-02-05|||1972-10-22||1971-12-30
TRIAL STUDY 134XCP|RP|059FE504-DEE4-4E24-AA80-3C64264636BF|2||||||GRAVIND|GRAVIDA INDICATOR||||IU/G|||10^6 ORGANISMS/ML|NOT DONE||NA|U|NA|1||38||BLINDED TREATMENT|1964-03-10||1965-12-07|||1970-05-16||1971-12-30
TRIAL STUDY 134XCP|RP|059FE504-DEE4-4E24-AA80-3C64264636BF|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MG/L FEU|||UG/MIN|NOT DONE||Y|Y|N|2||58||CONTINUATION TREATMENT|1969-01-30||1973-08-08|||1963-08-31||1966-12-25
TRIAL STUDY 134XCP|RP|059FE504-DEE4-4E24-AA80-3C64264636BF|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MMU/ML|||10^7 PFU|NOT DONE||U|U|N|2||58||SCREENING|1963-08-16||1971-01-19|||1965-03-31||1972-07-31
TRIAL STUDY 134XCP|RP|059FE504-DEE4-4E24-AA80-3C64264636BF|1||||||MENOAGE|MENOPAUSE AGE||||KIU|||IU/G HB|NOT DONE||N|NA|Y|3||39||WASHOUT|1966-01-17||1960-12-20|||1965-03-19||1960-06-12
TRIAL STUDY 134XCP|RP|059FE504-DEE4-4E24-AA80-3C64264636BF|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UV|||BAU/ML|NOT DONE||Y|U|Y|3||39||INDUCTION TREATMENT|1960-07-28||1961-09-03|||1965-12-28||1969-07-18
TRIAL STUDY 134XCP|RP|059FE504-DEE4-4E24-AA80-3C64264636BF|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||QUANTITY SUFFICIENT|||10^6 IU/ML|NOT DONE||U|NA|Y|4||88||OBSERVATION|1964-10-14||1972-12-10|||1961-07-17||1963-10-25
TRIAL STUDY 134XCP|RP|059FE504-DEE4-4E24-AA80-3C64264636BF|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||G/MOL|||/KG|NOT DONE||NA|NA|Y|4||88||RUN-IN|1968-02-24||1967-02-15|||1968-12-11||1973-06-22
TRIAL STUDY 134XCP|RP|059FE504-DEE4-4E24-AA80-3C64264636BF|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||NG/L|||MET*H|NOT DONE||NA|Y|N|5||7||OPEN LABEL TREATMENT|1965-11-04||1968-04-02|||1972-03-18||1964-05-03
TRIAL STUDY 134XCP|RP|059FE504-DEE4-4E24-AA80-3C64264636BF|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||BU|||MG/G/MIN|NOT DONE||Y|N|N|5||7||BLINDED TREATMENT|1961-08-01||1960-10-08|||1968-12-13||1963-06-12
TRIAL STUDY 134XCP|RP|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|1||||||FUNDHT|FUNDAL HEIGHT||||NM|||KALLIKREIN INHIBITOR UNIT|NOT DONE||U|U|U|1||38||TREATMENT|1962-05-07||1962-09-12|||1960-07-13||1972-03-22
TRIAL STUDY 134XCP|RP|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|2||||||ABORTN|NUMBER OF ABORTIONS||||CI/ML|||ARBITRARY U|NOT DONE||U|N|NA|1||38||LONG-TERM FOLLOW-UP|1972-10-21||1972-07-03|||1962-01-08||1961-12-02
TRIAL STUDY 134XCP|RP|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||/100 HPFS|||MEQ/DAY|NOT DONE||N|NA|NA|2||58||LONG-TERM FOLLOW-UP|1966-08-26||1968-12-31|||1970-12-06||1971-06-08
TRIAL STUDY 134XCP|RP|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|2||||||DLVRMODE|MODE OF DELIVERY||||DAGU|||10^6 COPIES/ML|NOT DONE||U|N|NA|2||58||RUN-IN|1960-03-02||1970-11-06|||1967-04-02||1970-11-29
TRIAL STUDY 134XCP|RP|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|1||||||ERYTHIND|ERYTHEMA INDICATOR||||UU/L|||BQ|NOT DONE||U|N|N|3||39||FOLLOW-UP|1960-05-22||1972-12-25|||1967-11-02||1973-05-23
TRIAL STUDY 134XCP|RP|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|2||||||PUSTIND|PUSTULE INDICATOR||||MG/L FEU|||EID 50/ML|NOT DONE||U|NA|U|3||39||FOLLOW-UP|1972-04-17||1971-04-16|||1961-07-27||1961-12-01
TRIAL STUDY 134XCP|RP|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||LENS|||LENS|NOT DONE||U|Y|Y|4||88||OPEN LABEL TREATMENT|1967-03-08||1965-01-26|||1963-09-11||1970-06-23
TRIAL STUDY 134XCP|RP|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|2||||||MENOAGE|MENOPAUSE AGE||||HOUNSFIELD UNIT|||G/ANIMAL/DAY|NOT DONE||Y|N|Y|4||88||FOLLOW-UP|1969-04-05||1961-04-03|||1966-06-22||1971-08-25
TRIAL STUDY 134XCP|RP|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ATM|||DEG2|NOT DONE||NA|NA|N|5||7||FOLLOW-UP|1972-06-09||1967-12-11|||1961-07-30||1965-07-07
TRIAL STUDY 134XCP|RP|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MPL U|||UEQ/L|NOT DONE||U|N|Y|5||7||FOLLOW-UP|1963-04-01||1962-06-22|||1970-04-20||1969-12-08
TRIAL STUDY 134XCP|RP|69BCF810-6748-43AA-BDFC-64EE1536CB47|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/G/MIN|||ECL UNIT|NOT DONE||N|U|U|1||38||SCREENING|1971-11-12||1964-08-04|||1965-10-21||1970-09-06
TRIAL STUDY 134XCP|RP|69BCF810-6748-43AA-BDFC-64EE1536CB47|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||KCAL|||PKAT/L|NOT DONE||N|N|NA|1||38||LONG-TERM FOLLOW-UP|1967-12-17||1963-01-18|||1964-01-21||1963-02-18
TRIAL STUDY 134XCP|RP|69BCF810-6748-43AA-BDFC-64EE1536CB47|1||||||THICK|THICKNESS||||BREATHS/30S|||POINT|NOT DONE||NA|N|Y|2||58||RUN-IN|1968-04-13||1963-11-03|||1969-04-17||1963-07-14
TRIAL STUDY 134XCP|RP|69BCF810-6748-43AA-BDFC-64EE1536CB47|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||DEG/MM|||MMOL/G|NOT DONE||N|N|Y|2||58||OPEN LABEL TREATMENT|1970-10-27||1965-03-06|||1970-10-02||1960-10-08
TRIAL STUDY 134XCP|RP|69BCF810-6748-43AA-BDFC-64EE1536CB47|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||KPA/L/SEC|||HOUNSFIELD UNIT|NOT DONE||NA|NA|Y|3||39||RUN-IN|1961-08-15||1970-03-18|||1968-12-31||1967-01-15
TRIAL STUDY 134XCP|RP|69BCF810-6748-43AA-BDFC-64EE1536CB47|2||||||PRGENDTC|DATE PREGNANCY ENDED||||NMOL BCE/L|||MG/ANIMAL|NOT DONE||NA|U|Y|3||39||OBSERVATION|1965-01-15||1963-07-10|||1963-01-08||1963-02-02
TRIAL STUDY 134XCP|RP|69BCF810-6748-43AA-BDFC-64EE1536CB47|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||NEBULE|||10^10/L|NOT DONE||U|U|N|4||88||SCREENING|1971-04-13||1970-01-28|||1971-06-06||1969-12-07
TRIAL STUDY 134XCP|RP|69BCF810-6748-43AA-BDFC-64EE1536CB47|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||PUFF|||FT2|NOT DONE||NA|U|N|4||88||BASELINE|1973-05-16||1962-01-21|||1972-03-31||1967-05-25
TRIAL STUDY 134XCP|RP|69BCF810-6748-43AA-BDFC-64EE1536CB47|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UG/L DDU|||%(W/W)|NOT DONE||N|Y|NA|5||7||SCREENING|1963-09-04||1963-03-29|||1964-03-17||1965-01-18
TRIAL STUDY 134XCP|RP|69BCF810-6748-43AA-BDFC-64EE1536CB47|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||GY|||L/MIN/M2|NOT DONE||Y|U|U|5||7||BLINDED TREATMENT|1973-07-30||1969-06-03|||1963-07-11||1966-05-18
TRIAL STUDY 134XCP|RP|DCE71DE9-8DFB-4796-BC41-21930EC21925|1||||||MENOAGE|MENOPAUSE AGE||||RAD|||GENEQ/ML|NOT DONE||N|U|Y|1||38||TREATMENT|1967-12-24||1971-05-27|||1966-09-06||1966-07-12
TRIAL STUDY 134XCP|RP|DCE71DE9-8DFB-4796-BC41-21930EC21925|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||G/ANIMAL|||PPM|NOT DONE||U|U|U|1||38||INDUCTION TREATMENT|1962-05-24||1963-08-06|||1966-07-18||1971-01-22
TRIAL STUDY 134XCP|RP|DCE71DE9-8DFB-4796-BC41-21930EC21925|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MG/DOSE|||L/DAY|NOT DONE||N|U|Y|2||58||BLINDED TREATMENT|1960-05-14||1962-01-10|||1964-12-04||1967-08-12
TRIAL STUDY 134XCP|RP|DCE71DE9-8DFB-4796-BC41-21930EC21925|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MG/ANIMAL|||ML/CM3/MIN|NOT DONE||Y|Y|N|2||58||LONG-TERM FOLLOW-UP|1963-03-10||1965-11-22|||1968-07-25||1962-03-10
TRIAL STUDY 134XCP|RP|DCE71DE9-8DFB-4796-BC41-21930EC21925|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||PA|||10^4 CFU/ML|NOT DONE||U|NA|Y|3||39||RUN-IN|1961-04-25||1969-11-20|||1973-04-16||1971-08-23
TRIAL STUDY 134XCP|RP|DCE71DE9-8DFB-4796-BC41-21930EC21925|2||||||TNDRIND|TENDERNESS INDICATOR||||KAT|||MG/ANIMAL|NOT DONE||N|U|Y|3||39||OPEN LABEL TREATMENT|1972-02-22||1961-01-24|||1972-03-30||1963-11-09
TRIAL STUDY 134XCP|RP|DCE71DE9-8DFB-4796-BC41-21930EC21925|1||||||RASHIND|RASH INDICATOR||||10^3 DNA COPIES/ML|||CI/G|NOT DONE||N|N|NA|4||88||FOLLOW-UP|1970-04-14||1973-03-29|||1963-12-23||1963-04-07
TRIAL STUDY 134XCP|RP|DCE71DE9-8DFB-4796-BC41-21930EC21925|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MOSM|||UG/L|NOT DONE||Y|N|NA|4||88||FOLLOW-UP|1968-10-09||1969-02-27|||1969-12-05||1962-04-20
TRIAL STUDY 134XCP|RP|DCE71DE9-8DFB-4796-BC41-21930EC21925|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^9 CFU|||UMOL/MIN|NOT DONE||NA|NA|N|5||7||BLINDED TREATMENT|1970-07-09||1969-11-17|||1970-03-23||1970-05-27
TRIAL STUDY 134XCP|RP|DCE71DE9-8DFB-4796-BC41-21930EC21925|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MEQ/ML|||MG/CM2|NOT DONE||Y|NA|Y|5||7||BASELINE|1968-12-25||1960-06-25|||1961-03-22||1972-08-05
TRIAL STUDY 134XCP|RP|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|1||||||MENOSTAT|MENOPAUSE STATUS||||MG/ANIMAL|||NMOL/KG/DAY|NOT DONE||Y|NA|NA|1||38||LONG-TERM FOLLOW-UP|1970-06-23||1962-09-18|||1971-06-28||1962-12-15
TRIAL STUDY 134XCP|RP|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|2||||||PRGENDTC|DATE PREGNANCY ENDED||||BOWL|||NKAT/L|NOT DONE||NA|U|U|1||38||OBSERVATION|1965-01-15||1962-04-10|||1968-05-11||1961-12-06
TRIAL STUDY 134XCP|RP|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||ML*CMH2O|||ML/M2/DAY|NOT DONE||Y|Y|Y|2||58||RUN-IN|1963-07-06||1966-05-31|||1967-03-26||1966-09-15
TRIAL STUDY 134XCP|RP|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||DEG|||MS/MMHG|NOT DONE||NA|Y|NA|2||58||OBSERVATION|1964-10-03||1966-10-05|||1972-08-23||1962-03-16
TRIAL STUDY 134XCP|RP|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||G/CM2|||U/MMOL|NOT DONE||N|N|Y|3||39||FOLLOW-UP|1968-07-21||1972-05-29|||1968-09-08||1966-10-17
TRIAL STUDY 134XCP|RP|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||PPM|||MG/KG/H|NOT DONE||U|NA|NA|3||39||INDUCTION TREATMENT|1960-01-03||1960-02-13|||1966-11-17||1960-01-14
TRIAL STUDY 134XCP|RP|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|1||||||ULCERIND|ULCER INDICATOR||||MG/M2/DAY|||MOSM/KG|NOT DONE||U|N|NA|4||88||CONTINUATION TREATMENT|1965-10-26||1973-03-20|||1972-12-29||1960-08-20
TRIAL STUDY 134XCP|RP|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|2||||||DLVRMODE|MODE OF DELIVERY||||UGEQ/L|||ML/BEAT|NOT DONE||Y|Y|NA|4||88||OBSERVATION|1973-04-11||1965-12-01|||1969-07-07||1969-01-10
TRIAL STUDY 134XCP|RP|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|1||||||PUSTIND|PUSTULE INDICATOR||||BU/ML|||TBSP|NOT DONE||U|N|U|5||7||OBSERVATION|1969-08-14||1972-06-22|||1972-08-25||1969-08-02
TRIAL STUDY 134XCP|RP|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|2||||||MENOSTAT|MENOPAUSE STATUS||||NKAT/L|||UMOL/L/H|NOT DONE||Y|U|U|5||7||BLINDED TREATMENT|1967-07-15||1963-10-19|||1963-06-22||1966-12-26
TRIAL STUDY 134XCP|RP|97D06076-FE6B-4C77-BD5C-2E665F707C7A|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||AGU/ML|||10^6/G|NOT DONE||N|N|Y|1||38||OPEN LABEL TREATMENT|1971-11-17||1972-07-20|||1965-04-14||1973-06-07
TRIAL STUDY 134XCP|RP|97D06076-FE6B-4C77-BD5C-2E665F707C7A|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||CIGARETTE|||10^9 ORGANISMS/G|NOT DONE||NA|NA|U|1||38||WASHOUT|1961-04-28||1969-09-28|||1972-10-31||1961-03-04
TRIAL STUDY 134XCP|RP|97D06076-FE6B-4C77-BD5C-2E665F707C7A|1||||||ERYTHIND|ERYTHEMA INDICATOR||||UV*SEC|||NU/CL|NOT DONE||N|N|NA|2||58||INDUCTION TREATMENT|1969-06-01||1967-11-08|||1968-07-12||1968-07-01
TRIAL STUDY 134XCP|RP|97D06076-FE6B-4C77-BD5C-2E665F707C7A|2||||||DLVRMODE|MODE OF DELIVERY||||CIGARETTE|||PIXEL|NOT DONE||U|NA|U|2||58||FOLLOW-UP|1968-01-20||1962-09-25|||1962-09-21||1971-10-11
TRIAL STUDY 134XCP|RP|97D06076-FE6B-4C77-BD5C-2E665F707C7A|1||||||MENARAGE|MENARCHE AGE||||RATIO|||L/MIN/M2|NOT DONE||NA|U|U|3||39||LONG-TERM FOLLOW-UP|1964-05-19||1962-11-13|||1968-02-27||1961-10-11
TRIAL STUDY 134XCP|RP|97D06076-FE6B-4C77-BD5C-2E665F707C7A|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/10^5|||UMOL/L/SEC|NOT DONE||Y|N|Y|3||39||LONG-TERM FOLLOW-UP|1965-02-26||1966-02-10|||1970-05-18||1960-10-22
TRIAL STUDY 134XCP|RP|97D06076-FE6B-4C77-BD5C-2E665F707C7A|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UG/ML/H|||NKAT/G HB|NOT DONE||U|N|Y|4||88||FOLLOW-UP|1964-03-19||1965-04-20|||1963-07-31||1961-12-04
TRIAL STUDY 134XCP|RP|97D06076-FE6B-4C77-BD5C-2E665F707C7A|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MMOL/KG|||ML/G/H|NOT DONE||Y|N|NA|4||88||TREATMENT|1964-01-18||1971-10-15|||1968-03-23||1963-03-20
TRIAL STUDY 134XCP|RP|97D06076-FE6B-4C77-BD5C-2E665F707C7A|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||CG|||UG/DOSE|NOT DONE||N|U|U|5||7||OPEN LABEL TREATMENT|1971-09-27||1967-01-22|||1972-11-07||1970-03-16
TRIAL STUDY 134XCP|RP|97D06076-FE6B-4C77-BD5C-2E665F707C7A|2||||||THICK|THICKNESS||||LOG10 COPIES/ML|||CL|NOT DONE||N|N|U|5||7||INDUCTION TREATMENT|1960-06-21||1969-06-10|||1963-02-25||1962-09-09
TRIAL STUDY 134XCP|RP|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||ML/MMHG|||TITER|NOT DONE||NA|U|U|1||38||SCREENING|1968-02-09||1966-08-31|||1968-06-29||1964-01-08
TRIAL STUDY 134XCP|RP|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|2||||||MENOSTAT|MENOPAUSE STATUS||||BOX|||LB|NOT DONE||N|N|Y|1||38||OPEN LABEL TREATMENT|1966-04-15||1962-08-14|||1973-06-23||1968-02-07
TRIAL STUDY 134XCP|RP|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||/200 HPFS|||MJOULE/CM2|NOT DONE||Y|N|U|2||58||BASELINE|1964-07-15||1972-02-06|||1966-06-17||1966-06-05
TRIAL STUDY 134XCP|RP|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||10^4 CFU/ML|||UMOL/MG/MIN|NOT DONE||U|N|N|2||58||BASELINE|1963-06-01||1960-01-09|||1961-01-15||1966-03-31
TRIAL STUDY 134XCP|RP|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|1||||||PREGIND|PREGNANT INDICATOR||||ARBITRARY U|||MONTHS|NOT DONE||Y|N|U|3||39||LONG-TERM FOLLOW-UP|1971-02-06||1967-06-21|||1972-10-07||1973-07-12
TRIAL STUDY 134XCP|RP|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||CL|||SEC|NOT DONE||N|NA|Y|3||39||TREATMENT|1963-11-02||1971-01-12|||1968-10-02||1971-06-14
TRIAL STUDY 134XCP|RP|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||KG/MOL|||KBQ|NOT DONE||Y|N|N|4||88||OBSERVATION|1970-09-21||1972-06-20|||1972-04-11||1971-10-21
TRIAL STUDY 134XCP|RP|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|2||||||INABOIND|INDUCED ABORTION INDICATOR||||ML/H|||PM|NOT DONE||Y|N|N|4||88||CONTINUATION TREATMENT|1965-10-14||1964-10-19|||1965-01-08||1972-03-01
TRIAL STUDY 134XCP|RP|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|1||||||MENOAGE|MENOPAUSE AGE||||MIN|||MG/M2/H|NOT DONE||NA|N|U|5||7||OBSERVATION|1968-02-03||1973-02-26|||1963-06-11||1968-01-30
TRIAL STUDY 134XCP|RP|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||FOZ_US|||APS U|NOT DONE||N|NA|U|5||7||WASHOUT|1967-04-20||1962-05-17|||1968-11-25||1963-02-08
TRIAL STUDY 134XCP|RP|D5A1EB38-77EA-49A5-84CA-740A83D258AF|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||VG/ML|||IU/DL|NOT DONE||N|Y|NA|1||38||INDUCTION TREATMENT|1960-05-03||1968-04-25|||1972-04-30||1969-03-29
TRIAL STUDY 134XCP|RP|D5A1EB38-77EA-49A5-84CA-740A83D258AF|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||S/H|||10^9 ORGANISMS/ML|NOT DONE||Y|NA|N|1||38||CONTINUATION TREATMENT|1963-07-11||1969-11-29|||1962-09-15||1963-04-10
TRIAL STUDY 134XCP|RP|D5A1EB38-77EA-49A5-84CA-740A83D258AF|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||/MM|||NEWTON|NOT DONE||NA|Y|NA|2||58||OBSERVATION|1968-01-30||1970-05-09|||1969-04-15||1973-03-01
TRIAL STUDY 134XCP|RP|D5A1EB38-77EA-49A5-84CA-740A83D258AF|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||ABSORBANCE U/ML|||ANTI-XA IU|NOT DONE||NA|N|Y|2||58||OPEN LABEL TREATMENT|1962-07-01||1966-09-14|||1970-02-04||1966-01-24
TRIAL STUDY 134XCP|RP|D5A1EB38-77EA-49A5-84CA-740A83D258AF|1||||||BRTHN|NUMBER OF BIRTHS||||PIXEL|||%(W/W)|NOT DONE||Y|N|N|3||39||LONG-TERM FOLLOW-UP|1970-06-22||1966-02-02|||1964-02-11||1963-01-04
TRIAL STUDY 134XCP|RP|D5A1EB38-77EA-49A5-84CA-740A83D258AF|2||||||ULCERIND|ULCER INDICATOR||||SQU/ML|||DAMOL/L|NOT DONE||NA|NA|NA|3||39||OBSERVATION|1961-08-18||1968-08-28|||1964-04-14||1969-03-18
TRIAL STUDY 134XCP|RP|D5A1EB38-77EA-49A5-84CA-740A83D258AF|1||||||ULCERIND|ULCER INDICATOR||||TUBERCULIN UNIT|||ML/(MIN*100ML)|NOT DONE||N|Y|U|4||88||OBSERVATION|1965-09-27||1967-07-06|||1972-05-23||1964-08-19
TRIAL STUDY 134XCP|RP|D5A1EB38-77EA-49A5-84CA-740A83D258AF|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UG/DL|||PFU/ANIMAL|NOT DONE||NA|NA|N|4||88||BLINDED TREATMENT|1965-02-05||1973-02-04|||1968-12-22||1962-11-22
TRIAL STUDY 134XCP|RP|D5A1EB38-77EA-49A5-84CA-740A83D258AF|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||PA|||10^5/L|NOT DONE||N|Y|U|5||7||BLINDED TREATMENT|1973-08-09||1961-03-12|||1962-05-01||1970-09-20
TRIAL STUDY 134XCP|RP|D5A1EB38-77EA-49A5-84CA-740A83D258AF|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MET*MIN|||VIRTUAL PIXEL|NOT DONE||Y|Y|N|5||7||INDUCTION TREATMENT|1973-01-26||1960-07-31|||1972-03-07||1973-04-29
TRIAL STUDY 134XCP|RP|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|1||||||MENOAGE|MENOPAUSE AGE||||ABSORBANCE U/MIN|||TITER|NOT DONE||NA|N|Y|1||38||CONTINUATION TREATMENT|1961-09-01||1965-02-05|||1960-05-09||1971-08-04
TRIAL STUDY 134XCP|RP|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MMOL/DAY|||MM/SEC|NOT DONE||U|N|Y|1||38||BASELINE|1963-09-02||1961-03-25|||1961-04-18||1962-01-18
TRIAL STUDY 134XCP|RP|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|1||||||GRAVIND|GRAVIDA INDICATOR||||ML/SEC/1.73M2|||UIU/DL|NOT DONE||U|Y|U|2||58||OBSERVATION|1973-01-15||1970-01-22|||1965-01-24||1967-02-24
TRIAL STUDY 134XCP|RP|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MMOL/L|||IU/KG|NOT DONE||N|N|U|2||58||FOLLOW-UP|1966-03-20||1960-02-24|||1960-03-07||1972-09-16
TRIAL STUDY 134XCP|RP|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|1||||||EDEMAIND|EDEMA INDICATOR||||MBQ|||LOG10 IU/ML|NOT DONE||N|NA|Y|3||39||TREATMENT|1971-11-01||1966-01-12|||1962-01-03||1970-05-09
TRIAL STUDY 134XCP|RP|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||OHM|||ARBITRARY U|NOT DONE||U|N|NA|3||39||BASELINE|1973-01-08||1962-08-14|||1962-09-18||1972-05-17
TRIAL STUDY 134XCP|RP|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|1||||||BCMETHOD|BIRTH CONTROL METHOD||||IN2|||STEPS/MIN|NOT DONE||Y|U|N|4||88||SCREENING|1960-10-04||1972-01-05|||1970-04-03||1966-04-29
TRIAL STUDY 134XCP|RP|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||KBQ/UL|||NCI|NOT DONE||Y|Y|NA|4||88||BLINDED TREATMENT|1973-01-02||1960-08-20|||1969-04-25||1968-03-14
TRIAL STUDY 134XCP|RP|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|1||||||MASSIND|MASS INDICATOR||||UGEQ/L|||PMOL/G|NOT DONE||Y|Y|U|5||7||FOLLOW-UP|1972-06-18||1970-12-06|||1960-04-08||1973-01-26
TRIAL STUDY 134XCP|RP|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||FMOL/G|||VG/KG|NOT DONE||NA|NA|Y|5||7||CONTINUATION TREATMENT|1960-01-13||1966-02-28|||1968-01-18||1960-02-13
TRIAL STUDY 134XCP|RP|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MU/G|||10^3 ORGANISMS/ML|NOT DONE||Y|U|U|1||38||SCREENING|1961-09-21||1969-05-18|||1963-04-14||1973-05-16
TRIAL STUDY 134XCP|RP|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|2||||||PREGNN|NUMBER OF PREGNANCIES||||DMOL|||KHZ|NOT DONE||Y|NA|U|1||38||FOLLOW-UP|1968-01-17||1972-05-24|||1971-10-03||1968-10-23
TRIAL STUDY 134XCP|RP|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|1||||||DSCHGIND|DISCHARGE INDICATOR||||G/G|||BE/ML|NOT DONE||U|N|U|2||58||BLINDED TREATMENT|1960-02-16||1971-06-12|||1968-04-22||1971-07-31
TRIAL STUDY 134XCP|RP|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|2||||||TNDRIND|TENDERNESS INDICATOR||||ML/BREATH|||MONTHS|NOT DONE||Y|U|U|2||58||OBSERVATION|1960-03-23||1965-02-27|||1969-05-20||1964-05-13
TRIAL STUDY 134XCP|RP|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|1||||||MENOSTAT|MENOPAUSE STATUS||||POINT|||KEV|NOT DONE||NA|NA|Y|3||39||BASELINE|1965-12-23||1973-07-23|||1972-08-18||1970-12-15
TRIAL STUDY 134XCP|RP|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||G/KG|||/CMH2O|NOT DONE||Y|Y|Y|3||39||INDUCTION TREATMENT|1969-03-30||1971-11-18|||1964-02-20||1972-04-13
TRIAL STUDY 134XCP|RP|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|1||||||MENOAGE|MENOPAUSE AGE||||UG/G/MIN|||KG/L|NOT DONE||U|NA|NA|4||88||SCREENING|1963-10-05||1968-07-24|||1969-11-20||1967-04-18
TRIAL STUDY 134XCP|RP|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|2||||||INABOIND|INDUCED ABORTION INDICATOR||||KG/CM2|||KG/L|NOT DONE||NA|NA|U|4||88||RUN-IN|1962-07-08||1968-09-22|||1971-08-23||1962-02-02
TRIAL STUDY 134XCP|RP|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|1||||||DSCHGIND|DISCHARGE INDICATOR||||CD*S/M2|||NM|NOT DONE||NA|N|U|5||7||INDUCTION TREATMENT|1967-02-13||1970-11-20|||1969-08-01||1968-06-16
TRIAL STUDY 134XCP|RP|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||U/G/MIN|||G/U|NOT DONE||NA|U|Y|5||7||BASELINE|1971-09-23||1969-08-12|||1964-11-10||1968-07-31
TRIAL STUDY 134XCP|RP|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||NCI|||SFC/10^6 PBMC|NOT DONE||Y|Y|Y|1||38||CONTINUATION TREATMENT|1960-06-27||1970-04-02|||1964-08-19||1967-05-22
TRIAL STUDY 134XCP|RP|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|2||||||PEELIND|PEELING INDICATOR||||MEQ/KG|||CAPLET|NOT DONE||N|Y|NA|1||38||LONG-TERM FOLLOW-UP|1964-12-30||1960-07-30|||1969-01-27||1967-06-29
TRIAL STUDY 134XCP|RP|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||FMOL/L|||TABLET|NOT DONE||NA|N|U|2||58||LONG-TERM FOLLOW-UP|1968-01-21||1966-08-13|||1964-08-16||1972-12-04
TRIAL STUDY 134XCP|RP|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||AMP|||LOG10 CFU/G|NOT DONE||N|NA|NA|2||58||WASHOUT|1960-11-17||1961-11-06|||1960-11-27||1961-11-23
TRIAL STUDY 134XCP|RP|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|1||||||MASSIND|MASS INDICATOR||||BEAM BREAKS|||USEC|NOT DONE||U|U|N|3||39||INDUCTION TREATMENT|1964-12-12||1969-08-31|||1973-05-26||1970-11-21
TRIAL STUDY 134XCP|RP|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||SCM|||UG/G/DAY|NOT DONE||Y|N|NA|3||39||CONTINUATION TREATMENT|1967-01-16||1972-12-28|||1973-06-07||1961-05-05
TRIAL STUDY 134XCP|RP|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|1||||||STILBIND|STILLBIRTH INDICATOR||||GLOBULE|||IU/ML|NOT DONE||N|U|N|4||88||TREATMENT|1961-04-26||1972-04-13|||1964-04-08||1962-07-20
TRIAL STUDY 134XCP|RP|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||KG/CM2|||DL|NOT DONE||Y|Y|NA|4||88||INDUCTION TREATMENT|1965-11-24||1963-09-22|||1973-08-06||1970-02-03
TRIAL STUDY 134XCP|RP|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|1||||||INABOIND|INDUCED ABORTION INDICATOR||||NMOL/KG/DAY|||CP|NOT DONE||NA|U|Y|5||7||OBSERVATION|1970-10-27||1973-04-28|||1968-03-27||1972-02-26
TRIAL STUDY 134XCP|RP|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||ML/KG/DAY|||PT_US|NOT DONE||U|Y|U|5||7||LONG-TERM FOLLOW-UP|1963-05-05||1964-11-04|||1963-02-23||1965-05-07
TRIAL STUDY 134XCP|RP|640DDEF5-748A-4F92-A13D-15D1C7CE0800|1||||||FUNDHT|FUNDAL HEIGHT||||UG/M2/DAY|||IU/L|NOT DONE||U|U|U|1||38||CONTINUATION TREATMENT|1968-10-20||1963-01-03|||1965-01-24||1969-08-07
TRIAL STUDY 134XCP|RP|640DDEF5-748A-4F92-A13D-15D1C7CE0800|2||||||BCMETHOD|BIRTH CONTROL METHOD||||ML/100G/MIN|||FG|NOT DONE||N|N|NA|1||38||OBSERVATION|1960-08-07||1961-04-19|||1968-11-26||1964-04-24
TRIAL STUDY 134XCP|RP|640DDEF5-748A-4F92-A13D-15D1C7CE0800|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MG/M2/MIN|||EIA UNIT|NOT DONE||Y|U|U|2||58||OBSERVATION|1964-12-26||1973-06-28|||1964-06-02||1973-05-05
TRIAL STUDY 134XCP|RP|640DDEF5-748A-4F92-A13D-15D1C7CE0800|2||||||MENOSTAT|MENOPAUSE STATUS||||CMHG|||UG/KG/H|NOT DONE||U|U|N|2||58||LONG-TERM FOLLOW-UP|1972-07-07||1961-05-30|||1960-08-22||1971-09-22
TRIAL STUDY 134XCP|RP|640DDEF5-748A-4F92-A13D-15D1C7CE0800|1||||||PEELIND|PEELING INDICATOR||||L/KG|||FRACTION OF 1|NOT DONE||Y|Y|U|3||39||BASELINE|1966-12-10||1960-05-29|||1960-03-23||1969-09-16
TRIAL STUDY 134XCP|RP|640DDEF5-748A-4F92-A13D-15D1C7CE0800|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||AFU|||10^9 ORGANISMS|NOT DONE||U|Y|N|3||39||OBSERVATION|1965-12-06||1972-01-20|||1969-07-08||1970-10-31
TRIAL STUDY 134XCP|RP|640DDEF5-748A-4F92-A13D-15D1C7CE0800|1||||||ERYTHIND|ERYTHEMA INDICATOR||||GBQ/MG|||COULOMB|NOT DONE||U|NA|N|4||88||OPEN LABEL TREATMENT|1963-09-23||1966-06-09|||1961-08-13||1967-07-04
TRIAL STUDY 134XCP|RP|640DDEF5-748A-4F92-A13D-15D1C7CE0800|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^4 CFU|||WEEKS|NOT DONE||Y|NA|NA|4||88||TREATMENT|1970-08-01||1971-06-21|||1967-03-15||1964-08-13
TRIAL STUDY 134XCP|RP|640DDEF5-748A-4F92-A13D-15D1C7CE0800|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||TITER|||SCM|NOT DONE||N|N|Y|5||7||CONTINUATION TREATMENT|1963-04-15||1960-05-05|||1962-05-04||1969-09-21
TRIAL STUDY 134XCP|RP|640DDEF5-748A-4F92-A13D-15D1C7CE0800|2||||||MENFDUR|MENSES FLOW DURATION||||10^4/L|||MN|NOT DONE||Y|U|U|5||7||TREATMENT|1971-08-23||1966-06-18|||1969-08-12||1973-06-23
TRIAL STUDY 134XCP|RP|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|1||||||MENFDUR|MENSES FLOW DURATION||||BQ/G|||KPA/L/SEC|NOT DONE||Y|U|NA|1||38||SCREENING|1962-02-08||1962-08-26|||1961-01-26||1960-11-24
TRIAL STUDY 134XCP|RP|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|2||||||DSCHGIND|DISCHARGE INDICATOR||||L/DAY|||MM/MIN|NOT DONE||N|N|N|1||38||OBSERVATION|1972-07-19||1968-12-26|||1969-08-15||1960-02-26
TRIAL STUDY 134XCP|RP|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|1||||||TNDRIND|TENDERNESS INDICATOR||||LOG10 COPIES/ML|||MEQ|NOT DONE||U|Y|U|2||58||RUN-IN|1962-12-27||1960-07-20|||1967-02-13||1973-06-07
TRIAL STUDY 134XCP|RP|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|2||||||EDEMAIND|EDEMA INDICATOR||||MG/M2|||MV2/HZ|NOT DONE||U|N|Y|2||58||BASELINE|1967-03-10||1972-09-30|||1966-09-26||1965-01-15
TRIAL STUDY 134XCP|RP|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||AG|||MS/MMHG|NOT DONE||N|Y|Y|3||39||TREATMENT|1968-11-04||1970-01-05|||1969-07-05||1972-02-14
TRIAL STUDY 134XCP|RP|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||YEARS|||MAC50|NOT DONE||N|Y|NA|3||39||LONG-TERM FOLLOW-UP|1960-11-03||1960-06-03|||1967-01-17||1962-05-13
TRIAL STUDY 134XCP|RP|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||TUBERCULIN UNIT/ML|||%(W/V)|NOT DONE||NA|Y|NA|4||88||SCREENING|1962-10-17||1969-03-04|||1964-08-24||1963-11-18
TRIAL STUDY 134XCP|RP|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MET*MIN|||CY/CM|NOT DONE||Y|U|Y|4||88||BLINDED TREATMENT|1967-07-18||1966-10-15|||1962-11-11||1972-04-15
TRIAL STUDY 134XCP|RP|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|1||||||PUSTIND|PUSTULE INDICATOR||||10^3 ORGANISMS|||M/SEC|NOT DONE||NA|NA|NA|5||7||WASHOUT|1964-09-28||1961-05-13|||1967-05-25||1969-02-02
TRIAL STUDY 134XCP|RP|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|2||||||EDEMAIND|EDEMA INDICATOR||||C|||/MS|NOT DONE||Y|N|NA|5||7||SCREENING|1968-03-18||1967-02-15|||1960-01-29||1971-09-26
TRIAL STUDY 134XCP|RP|EBC7BF7B-18C6-463C-8500-027B2A6966DB|1||||||RASHIND|RASH INDICATOR||||APPLICATION|||UIU/DL|NOT DONE||Y|N|N|1||38||LONG-TERM FOLLOW-UP|1965-04-21||1973-08-01|||1964-06-05||1962-05-27
TRIAL STUDY 134XCP|RP|EBC7BF7B-18C6-463C-8500-027B2A6966DB|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||/VF|||G/CAGE|NOT DONE||U|U|NA|1||38||RUN-IN|1968-12-03||1972-09-27|||1969-02-11||1967-02-12
TRIAL STUDY 134XCP|RP|EBC7BF7B-18C6-463C-8500-027B2A6966DB|1||||||DSCHGIND|DISCHARGE INDICATOR||||MOL/MOL|||DYN|NOT DONE||N|Y|Y|2||58||WASHOUT|1971-09-10||1964-02-24|||1973-05-19||1962-11-11
TRIAL STUDY 134XCP|RP|EBC7BF7B-18C6-463C-8500-027B2A6966DB|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||ML/CAGE|||MMOL/MIN/KPA/L|NOT DONE||Y|U|U|2||58||SCREENING|1967-05-16||1965-05-24|||1964-11-07||1963-07-12
TRIAL STUDY 134XCP|RP|EBC7BF7B-18C6-463C-8500-027B2A6966DB|1||||||MENOSTAT|MENOPAUSE STATUS||||FMOL|||EP U|NOT DONE||U|U|NA|3||39||LONG-TERM FOLLOW-UP|1973-07-22||1961-06-08|||1971-08-12||1973-04-14
TRIAL STUDY 134XCP|RP|EBC7BF7B-18C6-463C-8500-027B2A6966DB|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||CD/M2|||/2000 RBC|NOT DONE||Y|NA|U|3||39||BLINDED TREATMENT|1961-08-16||1973-01-31|||1961-04-11||1962-07-26
TRIAL STUDY 134XCP|RP|EBC7BF7B-18C6-463C-8500-027B2A6966DB|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||ML|||UG/M2/H|NOT DONE||U|N|NA|4||88||CONTINUATION TREATMENT|1960-02-10||1971-01-10|||1962-01-10||1963-06-13
TRIAL STUDY 134XCP|RP|EBC7BF7B-18C6-463C-8500-027B2A6966DB|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MM3/MM2/YEAR|||IU/L|NOT DONE||N|Y|Y|4||88||BASELINE|1972-06-23||1967-06-04|||1962-03-09||1966-10-25
TRIAL STUDY 134XCP|RP|EBC7BF7B-18C6-463C-8500-027B2A6966DB|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MET*MIN|||VIRTUAL PIXEL|NOT DONE||NA|Y|Y|5||7||INDUCTION TREATMENT|1962-02-08||1966-01-05|||1962-08-30||1962-02-21
TRIAL STUDY 134XCP|RP|EBC7BF7B-18C6-463C-8500-027B2A6966DB|2||||||STILBIND|STILLBIRTH INDICATOR||||PACK|||FMOL/G|NOT DONE||NA|NA|Y|5||7||LONG-TERM FOLLOW-UP|1969-03-01||1965-05-16|||1960-07-03||1968-01-11
TRIAL STUDY 134XCP|RP|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|1||||||MENARAGE|MENARCHE AGE||||DAYS|||ML/CM|NOT DONE||U|NA|Y|1||38||RUN-IN|1964-05-11||1963-09-01|||1966-11-20||1969-10-05
TRIAL STUDY 134XCP|RP|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MM/2H|||CIGAR|NOT DONE||Y|NA|Y|1||38||BASELINE|1970-04-19||1971-06-30|||1965-12-16||1972-10-27
TRIAL STUDY 134XCP|RP|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||UMOL/DAY|||ABSORBANCE U|NOT DONE||NA|NA|N|2||58||BASELINE|1962-04-02||1960-05-21|||1965-05-20||1962-05-22
TRIAL STUDY 134XCP|RP|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UMOL/L|||10^3/L|NOT DONE||N|U|U|2||58||LONG-TERM FOLLOW-UP|1969-07-09||1964-08-09|||1964-02-24||1960-03-24
TRIAL STUDY 134XCP|RP|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||% INHIBITION|||UMOL|NOT DONE||NA|U|NA|3||39||LONG-TERM FOLLOW-UP|1972-06-30||1961-04-08|||1961-11-15||1966-05-22
TRIAL STUDY 134XCP|RP|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||UMOL/L/MIN|||GBQ/MG|NOT DONE||NA|U|U|3||39||TREATMENT|1973-08-16||1961-08-06|||1962-10-11||1972-07-17
TRIAL STUDY 134XCP|RP|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||AFU|||DB|NOT DONE||Y|Y|U|4||88||CONTINUATION TREATMENT|1968-05-07||1968-09-22|||1968-04-20||1964-11-25
TRIAL STUDY 134XCP|RP|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^6 RNA COPIES/ML|||DYN|NOT DONE||U|NA|Y|4||88||TREATMENT|1960-07-26||1969-07-09|||1968-05-06||1965-03-11
TRIAL STUDY 134XCP|RP|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|1||||||ABORTN|NUMBER OF ABORTIONS||||10^9 CFU/G|||MM/MIN|NOT DONE||NA|Y|U|5||7||CONTINUATION TREATMENT|1965-03-03||1963-07-11|||1966-10-12||1967-06-28
TRIAL STUDY 134XCP|RP|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|2||||||BCMETHOD|BIRTH CONTROL METHOD||||U.CARR|||10^3 ORGANISMS/ML|NOT DONE||NA|N|Y|5||7||INDUCTION TREATMENT|1961-12-27||1961-10-23|||1961-03-25||1972-05-26
TRIAL STUDY 134XCP|RP|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^6 RNA COPIES/ML|||UG/CM2|NOT DONE||N|Y|N|1||38||OPEN LABEL TREATMENT|1969-09-29||1971-07-26|||1963-08-29||1961-06-27
TRIAL STUDY 134XCP|RP|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UGEQ/L|||ML/MIN/MMHG|NOT DONE||NA|NA|Y|1||38||WASHOUT|1970-01-17||1971-04-20|||1964-08-22||1967-05-16
TRIAL STUDY 134XCP|RP|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||GBQ/G|||U/M2|NOT DONE||N|U|NA|2||58||OPEN LABEL TREATMENT|1960-07-27||1966-05-17|||1964-08-05||1963-06-18
TRIAL STUDY 134XCP|RP|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||RATIO|||AMFI|NOT DONE||U|U|NA|2||58||WASHOUT|1967-06-18||1970-12-24|||1960-06-28||1963-06-12
TRIAL STUDY 134XCP|RP|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|1||||||RASHIND|RASH INDICATOR||||EID 50/ML|||MG/ANIMAL|NOT DONE||N|Y|U|3||39||RUN-IN|1962-11-06||1962-07-10|||1961-05-31||1969-03-24
TRIAL STUDY 134XCP|RP|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||PPB|||UMOL/L/H|NOT DONE||NA|NA|Y|3||39||OPEN LABEL TREATMENT|1967-01-28||1962-07-01|||1966-08-03||1968-07-29
TRIAL STUDY 134XCP|RP|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||KALLIKREIN INHIBITOR UNIT|||HR/DAY|NOT DONE||N|Y|Y|4||88||SCREENING|1971-12-10||1970-07-06|||1971-09-27||1971-10-21
TRIAL STUDY 134XCP|RP|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||UEQ/L|||MOSM/KG|NOT DONE||N|Y|Y|4||88||RUN-IN|1964-05-01||1973-03-07|||1971-08-21||1968-09-17
TRIAL STUDY 134XCP|RP|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|1||||||EDEMAIND|EDEMA INDICATOR||||NEBULE|||HZ/S|NOT DONE||Y|NA|Y|5||7||BLINDED TREATMENT|1961-12-29||1968-11-24|||1963-11-28||1966-02-08
TRIAL STUDY 134XCP|RP|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|2||||||MENARAGE|MENARCHE AGE||||CG|||GLOBULE|NOT DONE||U|U|Y|5||7||WASHOUT|1970-06-25||1963-04-26|||1961-02-13||1962-09-07
TRIAL STUDY 134XCP|RP|74741526-F925-4AA5-9BE3-F3B3884BEE68|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||BQ/KG|||IU/DL|NOT DONE||NA|Y|NA|1||38||TREATMENT|1970-12-22||1967-05-26|||1967-12-22||1966-02-22
TRIAL STUDY 134XCP|RP|74741526-F925-4AA5-9BE3-F3B3884BEE68|2||||||PREGNN|NUMBER OF PREGNANCIES||||GPS U|||PLUG|NOT DONE||Y|Y|Y|1||38||FOLLOW-UP|1968-01-27||1960-09-14|||1966-06-28||1967-08-24
TRIAL STUDY 134XCP|RP|74741526-F925-4AA5-9BE3-F3B3884BEE68|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||U/MMOL|||EID 50/DOSE|NOT DONE||U|N|Y|2||58||SCREENING|1960-06-29||1969-03-20|||1965-07-08||1963-04-11
TRIAL STUDY 134XCP|RP|74741526-F925-4AA5-9BE3-F3B3884BEE68|2||||||ULCERIND|ULCER INDICATOR||||%|||KG/CM2|NOT DONE||U|Y|NA|2||58||OBSERVATION|1962-04-11||1963-04-23|||1972-10-28||1962-08-21
TRIAL STUDY 134XCP|RP|74741526-F925-4AA5-9BE3-F3B3884BEE68|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||CFU/ML|||LOG10 PFU/ML|NOT DONE||Y|Y|U|3||39||TREATMENT|1961-08-30||1969-08-07|||1968-02-27||1962-07-10
TRIAL STUDY 134XCP|RP|74741526-F925-4AA5-9BE3-F3B3884BEE68|2||||||INTP|INTERPRETATION||||U/ANIMAL|||MG/L FEU|NOT DONE||NA|Y|NA|3||39||INDUCTION TREATMENT|1973-03-06||1968-10-09|||1971-03-30||1961-03-29
TRIAL STUDY 134XCP|RP|74741526-F925-4AA5-9BE3-F3B3884BEE68|1||||||MENOSTAT|MENOPAUSE STATUS||||IN|||KALLIKREIN INHIBITOR UNIT|NOT DONE||N|U|Y|4||88||RUN-IN|1966-10-03||1971-07-30|||1970-02-17||1972-02-26
TRIAL STUDY 134XCP|RP|74741526-F925-4AA5-9BE3-F3B3884BEE68|2||||||BLISTIND|BLISTERING INDICATOR||||OSM|||GLOBULE|NOT DONE||N|NA|Y|4||88||SCREENING|1960-02-14||1967-06-30|||1960-12-20||1963-08-11
TRIAL STUDY 134XCP|RP|74741526-F925-4AA5-9BE3-F3B3884BEE68|1||||||ERYTHIND|ERYTHEMA INDICATOR||||KIT|||EP U|NOT DONE||U|N|NA|5||7||CONTINUATION TREATMENT|1972-01-03||1966-08-29|||1966-09-16||1967-11-21
TRIAL STUDY 134XCP|RP|74741526-F925-4AA5-9BE3-F3B3884BEE68|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UG|||/100 WBC|NOT DONE||N|Y|NA|5||7||CONTINUATION TREATMENT|1966-01-29||1968-10-12|||1969-07-07||1969-09-25
TRIAL STUDY 134XCP|RP|25088C28-0FA3-4005-90C3-CCF9C6FF5851|1||||||PEELIND|PEELING INDICATOR||||DEG/S|||MMOL/S|NOT DONE||NA|N|N|1||38||BLINDED TREATMENT|1962-08-01||1961-07-15|||1967-08-18||1961-03-17
TRIAL STUDY 134XCP|RP|25088C28-0FA3-4005-90C3-CCF9C6FF5851|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||MG/DAY|||C|NOT DONE||NA|NA|NA|1||38||BASELINE|1968-08-13||1967-09-15|||1961-02-15||1965-08-26
TRIAL STUDY 134XCP|RP|25088C28-0FA3-4005-90C3-CCF9C6FF5851|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MJOULE/CM2|||/MM|NOT DONE||N|N|N|2||58||BLINDED TREATMENT|1966-10-31||1968-11-26|||1963-09-25||1969-11-11
TRIAL STUDY 134XCP|RP|25088C28-0FA3-4005-90C3-CCF9C6FF5851|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||/MIN|||TABLET|NOT DONE||U|N|U|2||58||SCREENING|1961-01-12||1966-08-11|||1960-03-12||1970-11-18
TRIAL STUDY 134XCP|RP|25088C28-0FA3-4005-90C3-CCF9C6FF5851|1||||||BLISTIND|BLISTERING INDICATOR||||UM2|||U/ML|NOT DONE||N|N|N|3||39||CONTINUATION TREATMENT|1960-10-16||1965-05-10|||1967-02-21||1972-01-14
TRIAL STUDY 134XCP|RP|25088C28-0FA3-4005-90C3-CCF9C6FF5851|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MG/ML/MIN|||FOZ_BR|NOT DONE||NA|U|NA|3||39||FOLLOW-UP|1964-04-14||1969-10-30|||1971-08-26||1963-01-01
TRIAL STUDY 134XCP|RP|25088C28-0FA3-4005-90C3-CCF9C6FF5851|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||CM/MIN|||IU/ML|NOT DONE||NA|NA|N|4||88||FOLLOW-UP|1962-04-08||1964-03-31|||1972-03-09||1968-11-10
TRIAL STUDY 134XCP|RP|25088C28-0FA3-4005-90C3-CCF9C6FF5851|2||||||MENFDUR|MENSES FLOW DURATION||||GBQ/G|||BAR|NOT DONE||U|U|N|4||88||TREATMENT|1963-12-28||1971-04-11|||1965-10-22||1973-02-03
TRIAL STUDY 134XCP|RP|25088C28-0FA3-4005-90C3-CCF9C6FF5851|1||||||MENARAGE|MENARCHE AGE||||NMOL BCE/MMOL|||BQ/L|NOT DONE||N|Y|U|5||7||SCREENING|1971-01-27||1967-01-04|||1964-07-15||1963-10-20
TRIAL STUDY 134XCP|RP|25088C28-0FA3-4005-90C3-CCF9C6FF5851|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||IU/G HB|||MMU/ML|NOT DONE||N|N|U|5||7||OBSERVATION|1968-02-23||1967-01-11|||1965-08-12||1960-09-25
TRIAL STUDY 134XCP|RP|9BF13738-0A50-46E6-A3DA-AC956A361B97|1||||||EDEMAIND|EDEMA INDICATOR||||DL|||MCI/L|NOT DONE||NA|NA|N|1||38||LONG-TERM FOLLOW-UP|1966-10-16||1964-04-29|||1970-02-11||1968-04-15
TRIAL STUDY 134XCP|RP|9BF13738-0A50-46E6-A3DA-AC956A361B97|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||DAGU/ML|||HOMEOPATHIC DILUTION|NOT DONE||Y|U|U|1||38||FOLLOW-UP|1971-04-14||1960-05-25|||1963-06-17||1970-05-08
TRIAL STUDY 134XCP|RP|9BF13738-0A50-46E6-A3DA-AC956A361B97|1||||||MASSIND|MASS INDICATOR||||10^7 TCID 50/DOSE|||GBQ|NOT DONE||NA|U|NA|2||58||INDUCTION TREATMENT|1960-08-24||1970-12-21|||1968-01-08||1965-10-13
TRIAL STUDY 134XCP|RP|9BF13738-0A50-46E6-A3DA-AC956A361B97|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||CI/KG|||10^6 CFU|NOT DONE||Y|Y|N|2||58||LONG-TERM FOLLOW-UP|1967-11-24||1962-02-10|||1971-02-04||1971-10-31
TRIAL STUDY 134XCP|RP|9BF13738-0A50-46E6-A3DA-AC956A361B97|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||ML/CAGE|||USIEMENS|NOT DONE||Y|U|N|3||39||LONG-TERM FOLLOW-UP|1965-06-16||1972-08-10|||1961-12-09||1969-09-25
TRIAL STUDY 134XCP|RP|9BF13738-0A50-46E6-A3DA-AC956A361B97|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||10^6 ORGANISMS/G|||U/G|NOT DONE||Y|NA|NA|3||39||RUN-IN|1968-07-23||1968-08-20|||1963-07-31||1970-03-27
TRIAL STUDY 134XCP|RP|9BF13738-0A50-46E6-A3DA-AC956A361B97|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||G/MOL|||BISCUIT|NOT DONE||NA|U|N|4||88||TREATMENT|1973-05-27||1970-01-05|||1969-01-15||1973-06-30
TRIAL STUDY 134XCP|RP|9BF13738-0A50-46E6-A3DA-AC956A361B97|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||RATIO|||MV|NOT DONE||NA|N|NA|4||88||CONTINUATION TREATMENT|1971-12-05||1967-11-15|||1962-08-08||1973-05-12
TRIAL STUDY 134XCP|RP|9BF13738-0A50-46E6-A3DA-AC956A361B97|1||||||BLISTIND|BLISTERING INDICATOR||||MG/ML/DAY|||YEARS|NOT DONE||NA|NA|NA|5||7||FOLLOW-UP|1966-10-21||1961-05-11|||1964-09-27||1970-10-28
TRIAL STUDY 134XCP|RP|9BF13738-0A50-46E6-A3DA-AC956A361B97|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||EQ|||ENZYME U/M2|NOT DONE||N|NA|NA|5||7||CONTINUATION TREATMENT|1960-05-24||1961-01-08|||1962-12-14||1963-03-15
TRIAL STUDY 134XCP|RP|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ATM|||LOG EID 50/DOSE|NOT DONE||NA|N|U|1||38||FOLLOW-UP|1962-10-22||1961-07-20|||1972-06-14||1962-10-26
TRIAL STUDY 134XCP|RP|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||CL|||DEG/S|NOT DONE||U|U|NA|1||38||SCREENING|1972-06-06||1971-11-13|||1968-03-05||1971-01-17
TRIAL STUDY 134XCP|RP|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||COPIES/ML|||G/G|NOT DONE||NA|Y|N|2||58||SCREENING|1965-10-04||1969-11-21|||1963-02-07||1968-04-30
TRIAL STUDY 134XCP|RP|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|2||||||BRTHN|NUMBER OF BIRTHS||||ML/G/MIN|||GY/MIN|NOT DONE||Y|Y|Y|2||58||BLINDED TREATMENT|1967-04-11||1966-06-02|||1963-11-21||1965-04-11
TRIAL STUDY 134XCP|RP|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|1||||||ULCERIND|ULCER INDICATOR||||MANSON U/ML|||UIU/DL|NOT DONE||U|Y|U|3||39||LONG-TERM FOLLOW-UP|1970-01-08||1968-08-27|||1964-09-16||1970-06-08
TRIAL STUDY 134XCP|RP|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|2||||||PEELIND|PEELING INDICATOR||||MAMP|||10^6 ORGANISMS/ML|NOT DONE||U|Y|Y|3||39||RUN-IN|1963-07-26||1968-02-28|||1972-07-18||1971-09-03
TRIAL STUDY 134XCP|RP|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||10^9 CFU/ML|||FMOL/L/SEC|NOT DONE||NA|NA|N|4||88||SCREENING|1964-05-18||1960-11-23|||1963-06-08||1966-01-06
TRIAL STUDY 134XCP|RP|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|2||||||PUSTIND|PUSTULE INDICATOR||||STRIP|||MPS U|NOT DONE||U|Y|Y|4||88||LONG-TERM FOLLOW-UP|1967-11-20||1968-04-02|||1965-10-09||1962-02-17
TRIAL STUDY 134XCP|RP|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|1||||||INABOIND|INDUCED ABORTION INDICATOR||||L/S|||ML/MMHG/MIN/L|NOT DONE||Y|Y|N|5||7||LONG-TERM FOLLOW-UP|1964-01-19||1968-09-18|||1970-04-19||1962-08-11
TRIAL STUDY 134XCP|RP|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|2||||||EDEMAIND|EDEMA INDICATOR||||FINGERTIP UNIT|||PIXELS/CM|NOT DONE||Y|N|Y|5||7||SCREENING|1960-01-05||1963-11-11|||1963-05-14||1963-03-11
TRIAL STUDY 134XCP|RP|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||HOURS|||UG/MIN|NOT DONE||Y|NA|U|1||38||SCREENING|1972-07-08||1970-06-29|||1966-09-27||1963-08-22
TRIAL STUDY 134XCP|RP|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MG/G/MIN|||JDF UNIT|NOT DONE||U|NA|Y|1||38||TREATMENT|1971-01-20||1960-01-05|||1972-07-18||1970-07-11
TRIAL STUDY 134XCP|RP|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||L/MIN|||PIXELS/IN|NOT DONE||NA|NA|N|2||58||INDUCTION TREATMENT|1967-02-07||1966-11-17|||1967-05-13||1963-04-05
TRIAL STUDY 134XCP|RP|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||LENS|||LENS|NOT DONE||Y|Y|NA|2||58||OPEN LABEL TREATMENT|1970-01-24||1960-03-27|||1961-11-03||1969-11-01
TRIAL STUDY 134XCP|RP|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|1||||||ERYTHIND|ERYTHEMA INDICATOR||||BP|||10^6 U|NOT DONE||U|N|Y|3||39||LONG-TERM FOLLOW-UP|1972-04-06||1960-11-11|||1971-05-07||1970-07-20
TRIAL STUDY 134XCP|RP|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|2||||||MASSIND|MASS INDICATOR||||LOG10 TCID 50/ML|||UKAT/10^12 RBC|NOT DONE||U|NA|NA|3||39||LONG-TERM FOLLOW-UP|1961-12-27||1971-12-22|||1970-09-11||1961-08-28
TRIAL STUDY 134XCP|RP|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||10^6 ORGANISMS|||UCI|NOT DONE||U|U|N|4||88||SCREENING|1960-11-09||1963-05-04|||1965-09-25||1960-11-24
TRIAL STUDY 134XCP|RP|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||DPM/0.5 ML|||BQ|NOT DONE||N|N|Y|4||88||BASELINE|1967-04-28||1962-04-21|||1972-04-23||1967-03-26
TRIAL STUDY 134XCP|RP|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||10^4 CFU|||ML/BEAT|NOT DONE||N|NA|N|5||7||LONG-TERM FOLLOW-UP|1964-04-05||1971-04-25|||1966-05-19||1965-03-14
TRIAL STUDY 134XCP|RP|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||DNA COPIES/UG|||/MBP|NOT DONE||Y|NA|U|5||7||FOLLOW-UP|1961-10-12||1972-09-30|||1962-07-02||1968-01-08
TRIAL STUDY 134XCP|RP|5AEA7EE9-1095-4967-B833-7665B6A71B31|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||BOTTLE|||BQ/MG|NOT DONE||N|NA|NA|1||38||BLINDED TREATMENT|1971-01-10||1961-08-15|||1970-05-10||1971-02-03
TRIAL STUDY 134XCP|RP|5AEA7EE9-1095-4967-B833-7665B6A71B31|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||P|||MET*MIN|NOT DONE||U|N|U|1||38||TREATMENT|1972-10-20||1970-03-16|||1970-12-28||1962-04-12
TRIAL STUDY 134XCP|RP|5AEA7EE9-1095-4967-B833-7665B6A71B31|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MEQ|||MG/ML/MIN|NOT DONE||N|Y|NA|2||58||INDUCTION TREATMENT|1968-12-10||1965-09-19|||1968-02-29||1969-09-08
TRIAL STUDY 134XCP|RP|5AEA7EE9-1095-4967-B833-7665B6A71B31|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||KN/CM2|||G/DAY|NOT DONE||N|NA|NA|2||58||CONTINUATION TREATMENT|1961-08-21||1971-01-31|||1973-08-04||1962-01-07
TRIAL STUDY 134XCP|RP|5AEA7EE9-1095-4967-B833-7665B6A71B31|1||||||FUNDHT|FUNDAL HEIGHT||||FOZ_BR|||DEG2|NOT DONE||Y|Y|N|3||39||CONTINUATION TREATMENT|1967-12-21||1966-05-23|||1964-09-22||1967-09-05
TRIAL STUDY 134XCP|RP|5AEA7EE9-1095-4967-B833-7665B6A71B31|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||10^11/L|||GRAVITATIONAL UNIT|NOT DONE||NA|N|Y|3||39||WASHOUT|1961-03-01||1962-05-09|||1969-04-15||1972-01-27
TRIAL STUDY 134XCP|RP|5AEA7EE9-1095-4967-B833-7665B6A71B31|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||U/ML|||KPA/L/SEC|NOT DONE||N|Y|Y|4||88||BLINDED TREATMENT|1961-07-14||1968-08-17|||1962-02-16||1961-10-13
TRIAL STUDY 134XCP|RP|5AEA7EE9-1095-4967-B833-7665B6A71B31|2||||||ULCERIND|ULCER INDICATOR||||10^3/L|||AMP|NOT DONE||NA|N|Y|4||88||CONTINUATION TREATMENT|1972-01-15||1964-05-20|||1961-01-15||1962-07-04
TRIAL STUDY 134XCP|RP|5AEA7EE9-1095-4967-B833-7665B6A71B31|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||%(W/W)|||10^7/L|NOT DONE||NA|U|U|5||7||INDUCTION TREATMENT|1961-08-10||1972-06-16|||1970-02-08||1967-03-03
TRIAL STUDY 134XCP|RP|5AEA7EE9-1095-4967-B833-7665B6A71B31|2||||||ERYTHIND|ERYTHEMA INDICATOR||||UL/KG/DAY|||IU|NOT DONE||Y|N|U|5||7||LONG-TERM FOLLOW-UP|1962-07-19||1964-09-21|||1964-07-27||1965-09-30
TRIAL STUDY 134XCP|RP|241CD521-D0BD-40BB-ABA2-B8C8E500B491|1||||||MENARAGE|MENARCHE AGE||||/10^3|||U|NOT DONE||Y|U|N|1||38||FOLLOW-UP|1961-09-20||1963-11-04|||1969-03-11||1968-01-12
TRIAL STUDY 134XCP|RP|241CD521-D0BD-40BB-ABA2-B8C8E500B491|2||||||THICK|THICKNESS||||TUBERCULIN UNIT/ML|||UU/L|NOT DONE||N|Y|N|1||38||SCREENING|1972-11-07||1967-12-07|||1969-05-26||1969-09-03
TRIAL STUDY 134XCP|RP|241CD521-D0BD-40BB-ABA2-B8C8E500B491|1||||||INABOIND|INDUCED ABORTION INDICATOR||||KAT|||APPLICATION|NOT DONE||NA|N|Y|2||58||TREATMENT|1968-05-08||1966-05-26|||1970-12-13||1965-11-23
TRIAL STUDY 134XCP|RP|241CD521-D0BD-40BB-ABA2-B8C8E500B491|2||||||MENFDUR|MENSES FLOW DURATION||||10^12/L|||UG/DOSE|NOT DONE||NA|N|Y|2||58||OPEN LABEL TREATMENT|1962-06-26||1965-07-18|||1964-07-01||1971-10-11
TRIAL STUDY 134XCP|RP|241CD521-D0BD-40BB-ABA2-B8C8E500B491|1||||||ULCERIND|ULCER INDICATOR||||BLOCKS|||GBQ/MG|NOT DONE||Y|U|Y|3||39||CONTINUATION TREATMENT|1964-08-01||1966-09-30|||1966-10-30||1961-05-11
TRIAL STUDY 134XCP|RP|241CD521-D0BD-40BB-ABA2-B8C8E500B491|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MEQ/UG|||ML/CAGE|NOT DONE||NA|N|NA|3||39||OPEN LABEL TREATMENT|1967-12-15||1967-02-27|||1963-05-03||1964-12-26
TRIAL STUDY 134XCP|RP|241CD521-D0BD-40BB-ABA2-B8C8E500B491|1||||||MENFDUR|MENSES FLOW DURATION||||UCI|||IU/MMOL|NOT DONE||Y|Y|Y|4||88||LONG-TERM FOLLOW-UP|1971-02-11||1970-05-22|||1970-07-19||1969-03-13
TRIAL STUDY 134XCP|RP|241CD521-D0BD-40BB-ABA2-B8C8E500B491|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||PLUG|||MG|NOT DONE||N|Y|NA|4||88||LONG-TERM FOLLOW-UP|1961-02-19||1961-12-05|||1961-06-28||1972-12-07
TRIAL STUDY 134XCP|RP|241CD521-D0BD-40BB-ABA2-B8C8E500B491|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||IU/MG|||FMOL/L|NOT DONE||NA|NA|NA|5||7||OPEN LABEL TREATMENT|1972-07-22||1962-01-10|||1971-10-05||1972-12-27
TRIAL STUDY 134XCP|RP|241CD521-D0BD-40BB-ABA2-B8C8E500B491|2||||||MENOAGE|MENOPAUSE AGE||||MG/KG/MIN|||KCAL/DAY|NOT DONE||U|U|Y|5||7||LONG-TERM FOLLOW-UP|1968-09-21||1961-07-23|||1970-01-24||1965-03-13
TRIAL STUDY 134XCP|RP|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|1||||||PEELIND|PEELING INDICATOR||||DDU|||EU|NOT DONE||U|U|Y|1||38||WASHOUT|1965-11-27||1961-10-04|||1969-01-24||1969-12-29
TRIAL STUDY 134XCP|RP|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||CG|||VIRTUAL PIXEL|NOT DONE||Y|U|N|1||38||SCREENING|1961-01-11||1964-12-04|||1969-01-14||1966-12-06
TRIAL STUDY 134XCP|RP|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||/2000 RBC|||COAT|NOT DONE||U|U|NA|2||58||LONG-TERM FOLLOW-UP|1963-05-04||1961-03-21|||1960-11-30||1970-09-15
TRIAL STUDY 134XCP|RP|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||HZ|||/4.0 ML|NOT DONE||NA|Y|U|2||58||OPEN LABEL TREATMENT|1970-06-27||1972-01-22|||1973-04-10||1972-03-20
TRIAL STUDY 134XCP|RP|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||FRACTION OF 1|||MPH|NOT DONE||U|N|Y|3||39||BASELINE|1971-05-23||1972-03-17|||1969-12-14||1962-06-01
TRIAL STUDY 134XCP|RP|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||JOULE|||U.CARR|NOT DONE||Y|Y|N|3||39||OPEN LABEL TREATMENT|1967-04-16||1960-08-16|||1969-03-05||1972-08-24
TRIAL STUDY 134XCP|RP|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||CI/UL|||10^9 CFU|NOT DONE||Y|Y|NA|4||88||TREATMENT|1963-07-03||1962-06-14|||1969-11-15||1964-10-02
TRIAL STUDY 134XCP|RP|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|2||||||EDEMAIND|EDEMA INDICATOR||||F|||MG/KG/MIN|NOT DONE||NA|N|Y|4||88||SCREENING|1960-08-26||1966-10-05|||1964-06-18||1972-05-20
TRIAL STUDY 134XCP|RP|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||M/SEC2|||NMOL|NOT DONE||N|Y|NA|5||7||INDUCTION TREATMENT|1960-07-07||1968-04-02|||1962-12-18||1969-01-27
TRIAL STUDY 134XCP|RP|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||CM2|||U/G/MIN|NOT DONE||N|NA|NA|5||7||SCREENING|1972-02-21||1960-03-17|||1967-03-14||1963-02-10
TRIAL STUDY 134XCP|RP|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|1||||||MENFDUR|MENSES FLOW DURATION||||COAT|||MMOL/KG|NOT DONE||N|N|N|1||38||FOLLOW-UP|1969-01-12||1964-05-03|||1960-12-12||1968-11-29
TRIAL STUDY 134XCP|RP|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||UL/ML|||NMOL/L|NOT DONE||N|Y|U|1||38||CONTINUATION TREATMENT|1972-05-27||1968-08-15|||1964-03-22||1962-05-24
TRIAL STUDY 134XCP|RP|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MIN/DAY|||CYLINDER|NOT DONE||NA|Y|NA|2||58||FOLLOW-UP|1973-09-06||1970-05-08|||1966-09-26||1965-06-03
TRIAL STUDY 134XCP|RP|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|2||||||MENARAGE|MENARCHE AGE||||VIRTUAL PIXEL|||ML/DAY|NOT DONE||N|Y|NA|2||58||CONTINUATION TREATMENT|1966-12-02||1969-09-05|||1970-06-23||1961-12-06
TRIAL STUDY 134XCP|RP|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UG/CM2|||UMOL/DAY|NOT DONE||N|NA|NA|3||39||SCREENING|1972-03-04||1973-06-01|||1964-06-21||1971-08-09
TRIAL STUDY 134XCP|RP|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||ECL UNIT|||CPM|NOT DONE||U|U|U|3||39||OBSERVATION|1963-12-13||1963-01-12|||1971-08-19||1971-05-05
TRIAL STUDY 134XCP|RP|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^6 U|||GBQ/UG|NOT DONE||NA|NA|N|4||88||BLINDED TREATMENT|1960-09-16||1965-04-16|||1970-04-04||1963-08-21
TRIAL STUDY 134XCP|RP|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|2||||||DLVRMODE|MODE OF DELIVERY||||MG/H|||ML/KG|NOT DONE||Y|U|N|4||88||LONG-TERM FOLLOW-UP|1968-04-12||1965-06-24|||1967-11-30||1967-10-04
TRIAL STUDY 134XCP|RP|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|1||||||PUSTIND|PUSTULE INDICATOR||||MMOL|||UG/L|NOT DONE||NA|NA|NA|5||7||SCREENING|1961-09-09||1971-12-22|||1960-12-21||1966-10-03
TRIAL STUDY 134XCP|RP|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^10/L|||ML/MMHG|NOT DONE||Y|NA|U|5||7||BLINDED TREATMENT|1966-03-23||1960-10-29|||1962-11-08||1967-03-30
TRIAL STUDY 134XCP|RP|FD609B1C-D1E7-4349-B036-DF0126D96A52|1||||||ULCERIND|ULCER INDICATOR||||DEG|||/100 HPFS|NOT DONE||U|NA|Y|1||38||OBSERVATION|1962-12-31||1969-09-19|||1971-10-12||1962-06-19
TRIAL STUDY 134XCP|RP|FD609B1C-D1E7-4349-B036-DF0126D96A52|2||||||BCMETHOD|BIRTH CONTROL METHOD||||NEEDLE GAUGE|||MIN|NOT DONE||N|N|U|1||38||OBSERVATION|1962-09-01||1972-04-10|||1968-04-06||1962-12-31
TRIAL STUDY 134XCP|RP|FD609B1C-D1E7-4349-B036-DF0126D96A52|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||CUP EQ|||GENEQ|NOT DONE||NA|U|NA|2||58||WASHOUT|1968-11-29||1962-11-22|||1972-09-21||1963-08-07
TRIAL STUDY 134XCP|RP|FD609B1C-D1E7-4349-B036-DF0126D96A52|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||GPELISA UNIT/ML|||S*KPA|NOT DONE||NA|Y|Y|2||58||BASELINE|1964-05-07||1973-04-05|||1962-02-14||1965-12-18
TRIAL STUDY 134XCP|RP|FD609B1C-D1E7-4349-B036-DF0126D96A52|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||U/ML|||/SEC|NOT DONE||Y|U|U|3||39||TREATMENT|1971-12-25||1960-05-25|||1966-06-01||1964-09-23
TRIAL STUDY 134XCP|RP|FD609B1C-D1E7-4349-B036-DF0126D96A52|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MMHG/SEC|||GRAIN|NOT DONE||NA|N|NA|3||39||OPEN LABEL TREATMENT|1966-11-05||1963-05-25|||1971-11-20||1968-07-12
TRIAL STUDY 134XCP|RP|FD609B1C-D1E7-4349-B036-DF0126D96A52|1||||||PUSTIND|PUSTULE INDICATOR||||NL|||%(W/W)|NOT DONE||NA|NA|Y|4||88||SCREENING|1966-06-29||1968-06-20|||1967-11-12||1960-12-14
TRIAL STUDY 134XCP|RP|FD609B1C-D1E7-4349-B036-DF0126D96A52|2||||||DSCHGIND|DISCHARGE INDICATOR||||MG/G/H|||LINEAR FT*LB|NOT DONE||U|N|N|4||88||WASHOUT|1969-09-23||1960-08-16|||1966-04-09||1970-02-16
TRIAL STUDY 134XCP|RP|FD609B1C-D1E7-4349-B036-DF0126D96A52|1||||||FUNDHT|FUNDAL HEIGHT||||MEQ/MMOL|||TCID 50/DOSE|NOT DONE||Y|NA|N|5||7||WASHOUT|1960-12-13||1963-11-06|||1962-04-24||1968-04-17
TRIAL STUDY 134XCP|RP|FD609B1C-D1E7-4349-B036-DF0126D96A52|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/U|||BQ/KG|NOT DONE||U|N|NA|5||7||SCREENING|1965-10-25||1960-04-09|||1964-12-22||1960-07-09
TRIAL STUDY 134XCP|RP|DEB0593B-E3FD-471C-A800-43058AC5FD86|1||||||RASHIND|RASH INDICATOR||||APS U|||DPM|NOT DONE||U|U|U|1||38||SCREENING|1966-04-22||1962-05-29|||1963-02-25||1969-04-07
TRIAL STUDY 134XCP|RP|DEB0593B-E3FD-471C-A800-43058AC5FD86|2||||||PREGST|PREGNANT DURING THE STUDY||||OHM|||ABSORBANCE U/ML|NOT DONE||Y|N|N|1||38||SCREENING|1961-12-11||1964-06-19|||1969-03-21||1964-05-20
TRIAL STUDY 134XCP|RP|DEB0593B-E3FD-471C-A800-43058AC5FD86|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||GY/H|||U/DL|NOT DONE||N|Y|N|2||58||BASELINE|1970-09-23||1966-05-14|||1964-11-27||1973-01-10
TRIAL STUDY 134XCP|RP|DEB0593B-E3FD-471C-A800-43058AC5FD86|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MG/ANIMAL|||MIN*MG/ML|NOT DONE||N|N|U|2||58||BASELINE|1967-11-26||1962-10-20|||1970-10-31||1968-11-25
TRIAL STUDY 134XCP|RP|DEB0593B-E3FD-471C-A800-43058AC5FD86|1||||||PEELIND|PEELING INDICATOR||||USP U|||APL U|NOT DONE||U|NA|Y|3||39||OBSERVATION|1966-11-16||1963-11-04|||1962-01-04||1961-08-02
TRIAL STUDY 134XCP|RP|DEB0593B-E3FD-471C-A800-43058AC5FD86|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||GMFI|||IU/MG|NOT DONE||NA|NA|N|3||39||OBSERVATION|1961-09-07||1960-06-21|||1961-01-20||1967-07-20
TRIAL STUDY 134XCP|RP|DEB0593B-E3FD-471C-A800-43058AC5FD86|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||BAR|||UMOL/L/MIN|NOT DONE||U|U|N|4||88||LONG-TERM FOLLOW-UP|1964-07-07||1961-05-19|||1969-10-28||1967-10-30
TRIAL STUDY 134XCP|RP|DEB0593B-E3FD-471C-A800-43058AC5FD86|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||WEEKS|||GAUSS|NOT DONE||U|Y|U|4||88||OBSERVATION|1971-05-30||1961-12-15|||1971-05-16||1970-05-07
TRIAL STUDY 134XCP|RP|DEB0593B-E3FD-471C-A800-43058AC5FD86|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PL|||PACKET|NOT DONE||N|Y|U|5||7||WASHOUT|1961-06-20||1970-01-27|||1960-01-08||1966-05-26
TRIAL STUDY 134XCP|RP|DEB0593B-E3FD-471C-A800-43058AC5FD86|2||||||DLVRMODE|MODE OF DELIVERY||||OZ EQ|||G/G|NOT DONE||U|Y|NA|5||7||CONTINUATION TREATMENT|1960-12-18||1963-09-17|||1971-11-13||1972-06-26
TRIAL STUDY 134XCP|RP|596BD728-2487-44E4-AFB1-8A4331EEDDF6|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MG/M2/H|||G|NOT DONE||U|U|NA|1||38||BLINDED TREATMENT|1969-08-01||1970-12-14|||1962-06-08||1972-03-12
TRIAL STUDY 134XCP|RP|596BD728-2487-44E4-AFB1-8A4331EEDDF6|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||PFU|||10^9 CFU/G|NOT DONE||U|NA|NA|1||38||RUN-IN|1965-01-20||1965-06-02|||1971-10-15||1968-07-15
TRIAL STUDY 134XCP|RP|596BD728-2487-44E4-AFB1-8A4331EEDDF6|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||CFU/G|||MU|NOT DONE||Y|U|NA|2||58||LONG-TERM FOLLOW-UP|1971-05-05||1970-09-06|||1963-02-23||1972-08-02
TRIAL STUDY 134XCP|RP|596BD728-2487-44E4-AFB1-8A4331EEDDF6|2||||||BRTHN|NUMBER OF BIRTHS||||UG/DL|||CCID 50/DOSE|NOT DONE||U|N|Y|2||58||RUN-IN|1961-04-23||1968-01-11|||1970-02-16||1973-01-16
TRIAL STUDY 134XCP|RP|596BD728-2487-44E4-AFB1-8A4331EEDDF6|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MU/L|||PMOL/G|NOT DONE||N|N|NA|3||39||OBSERVATION|1962-09-02||1970-08-31|||1960-03-23||1968-01-05
TRIAL STUDY 134XCP|RP|596BD728-2487-44E4-AFB1-8A4331EEDDF6|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||BAG|||MG/KG/WEEK|NOT DONE||NA|U|U|3||39||TREATMENT|1973-04-12||1972-07-03|||1969-03-20||1965-10-19
TRIAL STUDY 134XCP|RP|596BD728-2487-44E4-AFB1-8A4331EEDDF6|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||LOG10 TCID 50/DOSE|||% INHIBITION|NOT DONE||NA|U|Y|4||88||SCREENING|1972-10-08||1972-02-10|||1972-12-02||1969-10-22
TRIAL STUDY 134XCP|RP|596BD728-2487-44E4-AFB1-8A4331EEDDF6|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||UL/DOSE|||STRIP|NOT DONE||NA|U|N|4||88||OPEN LABEL TREATMENT|1971-03-26||1962-08-16|||1969-01-09||1962-12-19
TRIAL STUDY 134XCP|RP|596BD728-2487-44E4-AFB1-8A4331EEDDF6|1||||||TNDRIND|TENDERNESS INDICATOR||||GY/MIN|||/100 HPFS|NOT DONE||Y|U|U|5||7||RUN-IN|1965-02-17||1970-07-20|||1965-11-18||1963-05-12
TRIAL STUDY 134XCP|RP|596BD728-2487-44E4-AFB1-8A4331EEDDF6|2||||||STILBIND|STILLBIRTH INDICATOR||||NG/DL|||MG/KG/H|NOT DONE||U|Y|NA|5||7||SCREENING|1964-10-04||1967-05-30|||1970-07-23||1971-01-28
TRIAL STUDY 134XCP|RP|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UG/KG|||PIXELS/CM|NOT DONE||NA|Y|U|1||38||LONG-TERM FOLLOW-UP|1966-01-06||1967-09-02|||1970-04-03||1967-04-17
TRIAL STUDY 134XCP|RP|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||%(W/V)|||K|NOT DONE||Y|Y|NA|1||38||SCREENING|1963-07-19||1966-03-21|||1965-07-15||1965-08-09
TRIAL STUDY 134XCP|RP|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|1||||||ERYTHIND|ERYTHEMA INDICATOR||||MOL/ML|||MDFI|NOT DONE||N|NA|Y|2||58||OPEN LABEL TREATMENT|1969-11-07||1967-06-12|||1963-01-06||1963-08-03
TRIAL STUDY 134XCP|RP|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||DEG2|||CIGARETTE|NOT DONE||N|NA|N|2||58||BLINDED TREATMENT|1960-09-16||1966-02-07|||1971-01-05||1963-06-15
TRIAL STUDY 134XCP|RP|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MEQ/DAY|||MBQ/UL|NOT DONE||U|NA|Y|3||39||TREATMENT|1971-09-03||1970-05-16|||1971-09-14||1968-09-29
TRIAL STUDY 134XCP|RP|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||LOG EID 50/DOSE|||FT2|NOT DONE||N|U|U|3||39||BLINDED TREATMENT|1972-01-17||1967-05-11|||1970-10-10||1965-10-12
TRIAL STUDY 134XCP|RP|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|1||||||ULCERIND|ULCER INDICATOR||||S*KPA|||OHM|NOT DONE||Y|U|Y|4||88||LONG-TERM FOLLOW-UP|1969-12-19||1968-08-11|||1968-02-02||1973-03-24
TRIAL STUDY 134XCP|RP|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||CY/CM|||BAG|NOT DONE||NA|NA|Y|4||88||OPEN LABEL TREATMENT|1962-11-25||1970-11-17|||1962-08-07||1971-11-28
TRIAL STUDY 134XCP|RP|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|1||||||RASHIND|RASH INDICATOR||||GTT|||PPTH|NOT DONE||U|N|N|5||7||LONG-TERM FOLLOW-UP|1960-12-15||1965-03-03|||1966-07-04||1962-10-08
TRIAL STUDY 134XCP|RP|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|2||||||RASHIND|RASH INDICATOR||||PMOL/DL|||/10^4|NOT DONE||Y|U|NA|5||7||CONTINUATION TREATMENT|1967-03-27||1967-09-24|||1971-05-05||1971-11-05
TRIAL STUDY 134XCP|RP|0365EB5F-7364-4B1F-8919-543D8D21B045|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||L/MIN|||UG/KG/DAY|NOT DONE||Y|Y|N|1||38||OPEN LABEL TREATMENT|1964-09-01||1962-08-21|||1969-11-29||1966-07-28
TRIAL STUDY 134XCP|RP|0365EB5F-7364-4B1F-8919-543D8D21B045|2||||||INABOIND|INDUCED ABORTION INDICATOR||||CM/MIN|||% INHIBITION|NOT DONE||N|N|N|1||38||BLINDED TREATMENT|1973-07-05||1965-12-24|||1968-07-27||1963-06-20
TRIAL STUDY 134XCP|RP|0365EB5F-7364-4B1F-8919-543D8D21B045|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/DL|||UG/KG|NOT DONE||U|NA|NA|2||58||LONG-TERM FOLLOW-UP|1971-08-10||1972-12-06|||1962-04-09||1963-01-01
TRIAL STUDY 134XCP|RP|0365EB5F-7364-4B1F-8919-543D8D21B045|2||||||BLISTIND|BLISTERING INDICATOR||||/100 HPFS|||10^8/L|NOT DONE||Y|NA|NA|2||58||OBSERVATION|1965-11-09||1962-11-11|||1966-03-14||1963-04-06
TRIAL STUDY 134XCP|RP|0365EB5F-7364-4B1F-8919-543D8D21B045|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^6 ORGANISMS/G|||CGY|NOT DONE||NA|Y|Y|3||39||INDUCTION TREATMENT|1960-08-30||1964-05-09|||1962-10-19||1960-04-18
TRIAL STUDY 134XCP|RP|0365EB5F-7364-4B1F-8919-543D8D21B045|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MJOULE/CM2|||CD|NOT DONE||Y|U|NA|3||39||SCREENING|1968-12-16||1969-01-09|||1971-11-23||1967-05-11
TRIAL STUDY 134XCP|RP|0365EB5F-7364-4B1F-8919-543D8D21B045|1||||||MENOAGE|MENOPAUSE AGE||||ENZYME U|||CD/M2|NOT DONE||U|Y|U|4||88||TREATMENT|1969-07-05||1963-07-12|||1967-11-19||1968-05-28
TRIAL STUDY 134XCP|RP|0365EB5F-7364-4B1F-8919-543D8D21B045|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||PKAT|||U/G HB|NOT DONE||NA|U|N|4||88||OPEN LABEL TREATMENT|1966-07-17||1970-12-17|||1969-12-21||1960-12-03
TRIAL STUDY 134XCP|RP|0365EB5F-7364-4B1F-8919-543D8D21B045|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||LENS|||FINGERTIP UNIT|NOT DONE||Y|U|Y|5||7||OPEN LABEL TREATMENT|1961-04-23||1970-07-11|||1966-08-30||1960-07-26
TRIAL STUDY 134XCP|RP|0365EB5F-7364-4B1F-8919-543D8D21B045|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||CD/M2|||PIXELS/CM|NOT DONE||U|U|N|5||7||RUN-IN|1972-03-11||1962-04-16|||1964-03-03||1961-07-30
TRIAL STUDY 134XCP|RP|364277A8-875C-4A6F-93C3-C913BB3C97CA|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||ANTI-XA IU|||U/KG/MIN|NOT DONE||NA|Y|Y|1||38||SCREENING|1970-10-09||1961-02-20|||1965-03-14||1972-02-19
TRIAL STUDY 134XCP|RP|364277A8-875C-4A6F-93C3-C913BB3C97CA|2||||||ULCERIND|ULCER INDICATOR||||ML/DOSE|||UMOL/MOL|NOT DONE||N|N|Y|1||38||OBSERVATION|1971-01-21||1970-09-06|||1963-05-29||1968-06-09
TRIAL STUDY 134XCP|RP|364277A8-875C-4A6F-93C3-C913BB3C97CA|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/100 WBC|||MG/MIN|NOT DONE||U|U|NA|2||58||BASELINE|1971-06-08||1971-02-16|||1964-06-10||1973-07-29
TRIAL STUDY 134XCP|RP|364277A8-875C-4A6F-93C3-C913BB3C97CA|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||IU/ML|||UL/DOSE|NOT DONE||N|NA|NA|2||58||CONTINUATION TREATMENT|1964-02-20||1963-06-24|||1965-06-19||1971-11-22
TRIAL STUDY 134XCP|RP|364277A8-875C-4A6F-93C3-C913BB3C97CA|1||||||ERYTHIND|ERYTHEMA INDICATOR||||MBQ/UL|||MG/ANIMAL|NOT DONE||U|U|Y|3||39||WASHOUT|1962-10-19||1965-07-01|||1962-09-30||1972-09-05
TRIAL STUDY 134XCP|RP|364277A8-875C-4A6F-93C3-C913BB3C97CA|2||||||EDEMAIND|EDEMA INDICATOR||||U/M2|||%/S|NOT DONE||U|Y|N|3||39||OPEN LABEL TREATMENT|1962-09-20||1964-04-21|||1966-12-19||1963-10-09
TRIAL STUDY 134XCP|RP|364277A8-875C-4A6F-93C3-C913BB3C97CA|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MU|||UU/L|NOT DONE||U|Y|NA|4||88||BLINDED TREATMENT|1973-08-08||1966-12-10|||1963-08-02||1961-07-22
TRIAL STUDY 134XCP|RP|364277A8-875C-4A6F-93C3-C913BB3C97CA|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||U/G/DAY|||U/M2|NOT DONE||NA|NA|NA|4||88||BLINDED TREATMENT|1963-06-21||1969-09-01|||1963-01-09||1967-03-05
TRIAL STUDY 134XCP|RP|364277A8-875C-4A6F-93C3-C913BB3C97CA|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MEQ/KG|||PIXELS/IN|NOT DONE||Y|N|N|5||7||BLINDED TREATMENT|1968-11-09||1964-03-23|||1963-03-14||1968-12-01
TRIAL STUDY 134XCP|RP|364277A8-875C-4A6F-93C3-C913BB3C97CA|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||OI50|||MS/MMHG|NOT DONE||U|U|Y|5||7||RUN-IN|1967-12-25||1973-07-12|||1972-05-18||1970-06-30
TRIAL STUDY 134XCP|RP|B824951F-58EE-4003-A2AD-A91AADBBAC0D|1||||||STILBIND|STILLBIRTH INDICATOR||||IU/ML|||UM/DAY|NOT DONE||NA|NA|Y|1||38||FOLLOW-UP|1962-05-29||1972-02-19|||1971-11-15||1964-09-07
TRIAL STUDY 134XCP|RP|B824951F-58EE-4003-A2AD-A91AADBBAC0D|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||WAFER|||MN|NOT DONE||U|U|N|1||38||SCREENING|1970-04-27||1964-03-28|||1965-11-16||1971-03-19
TRIAL STUDY 134XCP|RP|B824951F-58EE-4003-A2AD-A91AADBBAC0D|1||||||ABORTN|NUMBER OF ABORTIONS||||IU/ML|||DAMOL/L|NOT DONE||Y|U|Y|2||58||TREATMENT|1966-11-21||1967-03-18|||1960-10-17||1964-11-11
TRIAL STUDY 134XCP|RP|B824951F-58EE-4003-A2AD-A91AADBBAC0D|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||ML/CAGE/DAY|||UM/S|NOT DONE||N|Y|Y|2||58||BLINDED TREATMENT|1960-02-27||1960-09-05|||1968-02-12||1966-07-03
TRIAL STUDY 134XCP|RP|B824951F-58EE-4003-A2AD-A91AADBBAC0D|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||DAYS/MONTH|||DEG|NOT DONE||NA|Y|N|3||39||FOLLOW-UP|1963-05-13||1971-03-17|||1965-12-01||1964-12-25
TRIAL STUDY 134XCP|RP|B824951F-58EE-4003-A2AD-A91AADBBAC0D|2||||||MENOSTAT|MENOPAUSE STATUS||||DIOPTER|||HEP|NOT DONE||Y|NA|U|3||39||BLINDED TREATMENT|1968-10-11||1964-05-25|||1964-07-09||1966-03-01
TRIAL STUDY 134XCP|RP|B824951F-58EE-4003-A2AD-A91AADBBAC0D|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||NEWTON|||PFU|NOT DONE||N|U|Y|4||88||RUN-IN|1964-12-12||1968-02-09|||1966-03-18||1966-04-05
TRIAL STUDY 134XCP|RP|B824951F-58EE-4003-A2AD-A91AADBBAC0D|2||||||DLVRMODE|MODE OF DELIVERY||||CI/KG|||U/KG/MIN|NOT DONE||N|U|Y|4||88||SCREENING|1969-07-21||1961-03-17|||1970-01-31||1965-03-27
TRIAL STUDY 134XCP|RP|B824951F-58EE-4003-A2AD-A91AADBBAC0D|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||K|||/10^5|NOT DONE||N|N|NA|5||7||RUN-IN|1973-07-26||1960-06-04|||1968-03-04||1971-05-30
TRIAL STUDY 134XCP|RP|B824951F-58EE-4003-A2AD-A91AADBBAC0D|2||||||PRGENDTC|DATE PREGNANCY ENDED||||UIU/DL|||PKAT|NOT DONE||Y|NA|U|5||7||INDUCTION TREATMENT|1961-06-02||1963-06-05|||1969-03-16||1966-07-19
TRIAL STUDY 134XCP|RP|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||KBQ/UL|||ML/G/H|NOT DONE||Y|Y|U|1||38||RUN-IN|1962-01-11||1966-01-09|||1973-05-01||1963-11-02
TRIAL STUDY 134XCP|RP|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||WEBER|||U/CL|NOT DONE||N|N|Y|1||38||TREATMENT|1960-03-27||1969-06-13|||1967-08-11||1967-05-28
TRIAL STUDY 134XCP|RP|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PPTH|||ML/KG/H|NOT DONE||NA|NA|N|2||58||BLINDED TREATMENT|1966-09-19||1966-10-04|||1965-07-24||1961-08-04
TRIAL STUDY 134XCP|RP|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|2||||||THICK|THICKNESS||||RING|||10^3 COPIES/ML|NOT DONE||N|Y|NA|2||58||LONG-TERM FOLLOW-UP|1964-10-19||1971-10-04|||1967-10-05||1965-05-11
TRIAL STUDY 134XCP|RP|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||AG|||10^9 CFU|NOT DONE||NA|U|Y|3||39||OBSERVATION|1962-09-22||1967-11-05|||1960-07-31||1962-12-08
TRIAL STUDY 134XCP|RP|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|2||||||MENFDUR|MENSES FLOW DURATION||||MIU/L|||PKAT/L|NOT DONE||Y|N|Y|3||39||SCREENING|1963-06-01||1967-07-26|||1966-03-03||1971-11-12
TRIAL STUDY 134XCP|RP|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|1||||||PREGST|PREGNANT DURING THE STUDY||||ML/G/H|||COAT|NOT DONE||U|N|N|4||88||RUN-IN|1962-12-16||1969-01-02|||1970-10-17||1961-05-13
TRIAL STUDY 134XCP|RP|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MIN*MG/ML|||STEPS/MIN|NOT DONE||U|N|U|4||88||FOLLOW-UP|1960-01-07||1969-11-04|||1960-07-28||1961-03-19
TRIAL STUDY 134XCP|RP|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||TROCHE|||DAYS/WK|NOT DONE||N|N|N|5||7||WASHOUT|1969-06-17||1960-08-12|||1962-06-04||1971-05-25
TRIAL STUDY 134XCP|RP|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|2||||||MENFDUR|MENSES FLOW DURATION||||WAFER|||MG/DL|NOT DONE||N|NA|Y|5||7||LONG-TERM FOLLOW-UP|1971-11-15||1960-11-10|||1968-08-26||1960-05-11
TRIAL STUDY 134XCP|RP|A108F408-906C-4320-965A-D5D295BC5C31|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||NMOL/DAY|||HOMEOPATHIC DILUTION|NOT DONE||Y|N|N|1||38||OBSERVATION|1968-05-14||1970-05-26|||1967-06-26||1970-11-19
TRIAL STUDY 134XCP|RP|A108F408-906C-4320-965A-D5D295BC5C31|2||||||THICK|THICKNESS||||UG/DOSE|||/CMH2O|NOT DONE||N|N|U|1||38||WASHOUT|1962-12-19||1969-02-24|||1965-11-26||1973-05-18
TRIAL STUDY 134XCP|RP|A108F408-906C-4320-965A-D5D295BC5C31|1||||||PREGNN|NUMBER OF PREGNANCIES||||DYN|||U/MG|NOT DONE||N|N|N|2||58||FOLLOW-UP|1960-03-14||1966-09-22|||1971-10-12||1970-01-10
TRIAL STUDY 134XCP|RP|A108F408-906C-4320-965A-D5D295BC5C31|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||G/ANIMAL/WK|||AMU|NOT DONE||U|NA|N|2||58||OBSERVATION|1966-06-26||1969-07-28|||1963-12-30||1971-06-24
TRIAL STUDY 134XCP|RP|A108F408-906C-4320-965A-D5D295BC5C31|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||NGEQ/L|||DRINK|NOT DONE||N|NA|N|3||39||RUN-IN|1971-03-08||1960-05-07|||1962-04-22||1963-03-04
TRIAL STUDY 134XCP|RP|A108F408-906C-4320-965A-D5D295BC5C31|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||NMOL/ML/MIN|||YD|NOT DONE||Y|Y|N|3||39||BLINDED TREATMENT|1965-06-14||1968-03-23|||1970-09-09||1971-03-22
TRIAL STUDY 134XCP|RP|A108F408-906C-4320-965A-D5D295BC5C31|1||||||ERYTHIND|ERYTHEMA INDICATOR||||YEARS|||ML/MMHG/MIN/L|NOT DONE||NA|NA|N|4||88||WASHOUT|1960-02-15||1967-07-11|||1962-01-19||1967-06-20
TRIAL STUDY 134XCP|RP|A108F408-906C-4320-965A-D5D295BC5C31|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||KDA|||LOZENGE|NOT DONE||U|Y|Y|4||88||INDUCTION TREATMENT|1964-03-15||1969-01-08|||1965-05-06||1965-08-28
TRIAL STUDY 134XCP|RP|A108F408-906C-4320-965A-D5D295BC5C31|1||||||STILBIND|STILLBIRTH INDICATOR||||FFU|||NMOL/DAY|NOT DONE||NA|U|U|5||7||OPEN LABEL TREATMENT|1973-08-02||1964-04-27|||1971-02-01||1965-11-11
TRIAL STUDY 134XCP|RP|A108F408-906C-4320-965A-D5D295BC5C31|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||BREATHS/MIN|||DISK|NOT DONE||N|NA|Y|5||7||OPEN LABEL TREATMENT|1964-12-05||1964-10-15|||1965-09-26||1961-08-31
TRIAL STUDY 134XCP|RP|8E627D27-4855-4E1B-B823-1E14368973AF|1||||||INABOIND|INDUCED ABORTION INDICATOR||||ML/DAY|||APL U|NOT DONE||N|Y|U|1||38||OBSERVATION|1969-01-07||1969-09-23|||1971-06-15||1969-06-02
TRIAL STUDY 134XCP|RP|8E627D27-4855-4E1B-B823-1E14368973AF|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MOL/MG|||FMOL/L/SEC|NOT DONE||U|U|U|1||38||BLINDED TREATMENT|1963-07-28||1971-12-27|||1961-09-11||1967-12-07
TRIAL STUDY 134XCP|RP|8E627D27-4855-4E1B-B823-1E14368973AF|1||||||FUNDHT|FUNDAL HEIGHT||||G/M2/DAY|||MBQ/UL|NOT DONE||Y|N|N|2||58||OBSERVATION|1967-05-12||1969-04-25|||1968-11-01||1964-01-28
TRIAL STUDY 134XCP|RP|8E627D27-4855-4E1B-B823-1E14368973AF|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^3 DNA COPIES/ML|||AFU|NOT DONE||Y|U|Y|2||58||LONG-TERM FOLLOW-UP|1960-07-20||1961-05-16|||1962-07-18||1972-11-14
TRIAL STUDY 134XCP|RP|8E627D27-4855-4E1B-B823-1E14368973AF|1||||||FUNDHT|FUNDAL HEIGHT||||VG/KG|||ANTI-XA IU|NOT DONE||N|Y|NA|3||39||OBSERVATION|1966-01-11||1964-06-04|||1960-10-18||1970-07-21
TRIAL STUDY 134XCP|RP|8E627D27-4855-4E1B-B823-1E14368973AF|2||||||BRTHN|NUMBER OF BIRTHS||||/200 HPFS|||C|NOT DONE||NA|N|N|3||39||WASHOUT|1965-09-21||1972-04-20|||1962-04-25||1966-06-22
TRIAL STUDY 134XCP|RP|8E627D27-4855-4E1B-B823-1E14368973AF|1||||||BCMETHOD|BIRTH CONTROL METHOD||||FT|||MU/L|NOT DONE||Y|Y|NA|4||88||OPEN LABEL TREATMENT|1963-07-16||1972-07-11|||1962-10-13||1968-07-20
TRIAL STUDY 134XCP|RP|8E627D27-4855-4E1B-B823-1E14368973AF|2||||||FUNDHT|FUNDAL HEIGHT||||EVENTS|||NMOL/L/H|NOT DONE||U|U|Y|4||88||OPEN LABEL TREATMENT|1968-02-03||1970-08-22|||1973-02-08||1969-04-03
TRIAL STUDY 134XCP|RP|8E627D27-4855-4E1B-B823-1E14368973AF|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||KV|||STEPS|NOT DONE||U|Y|Y|5||7||SCREENING|1962-12-06||1967-02-05|||1961-12-29||1960-05-09
TRIAL STUDY 134XCP|RP|8E627D27-4855-4E1B-B823-1E14368973AF|2||||||TNDRIND|TENDERNESS INDICATOR||||10^6 ORGANISMS/ML|||MGEQ|NOT DONE||Y|Y|Y|5||7||BASELINE|1968-11-18||1961-04-16|||1965-01-24||1960-05-31
TRIAL STUDY 134XCP|RP|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||IU/G|||SPRAY|NOT DONE||Y|N|Y|1||38||LONG-TERM FOLLOW-UP|1970-02-27||1970-08-24|||1964-03-05||1970-09-14
TRIAL STUDY 134XCP|RP|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||L/MIN|||MG|NOT DONE||NA|N|N|1||38||TREATMENT|1967-12-13||1966-03-16|||1969-09-09||1968-09-11
TRIAL STUDY 134XCP|RP|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|1||||||ABORTN|NUMBER OF ABORTIONS||||MSEC|||MMHG/L/MIN|NOT DONE||U|N|NA|2||58||SCREENING|1961-12-13||1963-10-25|||1969-06-24||1967-05-15
TRIAL STUDY 134XCP|RP|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||G/CM2|||DAYS/MONTH|NOT DONE||NA|Y|N|2||58||LONG-TERM FOLLOW-UP|1966-03-12||1967-12-08|||1972-05-11||1968-07-15
TRIAL STUDY 134XCP|RP|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||GPELISA UNIT/ML|||%(V/V)|NOT DONE||N|N|N|3||39||INDUCTION TREATMENT|1963-01-10||1966-10-10|||1964-03-11||1965-08-28
TRIAL STUDY 134XCP|RP|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|2||||||FUNDHT|FUNDAL HEIGHT||||TABLET|||BQ/KG|NOT DONE||Y|N|Y|3||39||WASHOUT|1971-04-14||1970-11-09|||1970-11-13||1966-02-06
TRIAL STUDY 134XCP|RP|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||10^7 CFU|||NG|NOT DONE||N|U|NA|4||88||TREATMENT|1962-02-04||1963-08-18|||1963-12-08||1971-04-18
TRIAL STUDY 134XCP|RP|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||COPIES/UG|||VP/ML|NOT DONE||N|NA|Y|4||88||OBSERVATION|1968-08-23||1962-08-03|||1971-09-11||1966-07-16
TRIAL STUDY 134XCP|RP|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|1||||||DLVRMODE|MODE OF DELIVERY||||PSEC|||CG|NOT DONE||N|NA|N|5||7||BLINDED TREATMENT|1968-11-10||1960-03-06|||1967-07-10||1963-10-12
TRIAL STUDY 134XCP|RP|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|2||||||RASHIND|RASH INDICATOR||||ML/100G/MIN|||CYCLE/MIN|NOT DONE||Y|NA|Y|5||7||CONTINUATION TREATMENT|1962-11-07||1967-01-28|||1962-09-28||1972-02-21
TRIAL STUDY 134XCP|RP|483D89E1-45FD-41D4-B9E0-22FFB41D323A|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^3/L|||S^-1(%O2)^-1|NOT DONE||N|U|Y|1||38||LONG-TERM FOLLOW-UP|1961-05-03||1961-02-04|||1965-04-19||1971-01-18
TRIAL STUDY 134XCP|RP|483D89E1-45FD-41D4-B9E0-22FFB41D323A|2||||||ABORTN|NUMBER OF ABORTIONS||||PACKAGE|||UU/L|NOT DONE||Y|NA|U|1||38||OPEN LABEL TREATMENT|1968-10-28||1971-05-01|||1971-09-20||1970-07-30
TRIAL STUDY 134XCP|RP|483D89E1-45FD-41D4-B9E0-22FFB41D323A|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MMOL/G|||UG/DOSE|NOT DONE||N|NA|NA|2||58||WASHOUT|1964-11-20||1964-11-27|||1973-03-09||1964-09-21
TRIAL STUDY 134XCP|RP|483D89E1-45FD-41D4-B9E0-22FFB41D323A|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||KCAL/DAY|||UG/KG|NOT DONE||Y|Y|U|2||58||OBSERVATION|1963-12-23||1964-06-25|||1967-08-18||1967-06-14
TRIAL STUDY 134XCP|RP|483D89E1-45FD-41D4-B9E0-22FFB41D323A|1||||||PEELIND|PEELING INDICATOR||||FRACTION OF 1|||MG/M2|NOT DONE||NA|N|NA|3||39||SCREENING|1965-10-08||1970-05-17|||1970-01-07||1971-01-28
TRIAL STUDY 134XCP|RP|483D89E1-45FD-41D4-B9E0-22FFB41D323A|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||LX|||EID 50/ML|NOT DONE||NA|N|U|3||39||BASELINE|1964-05-27||1968-01-14|||1971-03-11||1970-03-12
TRIAL STUDY 134XCP|RP|483D89E1-45FD-41D4-B9E0-22FFB41D323A|1||||||MENOAGE|MENOPAUSE AGE||||MG/M2/H|||UG/KG/DAY|NOT DONE||Y|Y|NA|4||88||WASHOUT|1973-07-18||1964-01-11|||1961-05-17||1970-07-12
TRIAL STUDY 134XCP|RP|483D89E1-45FD-41D4-B9E0-22FFB41D323A|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||/100 HPFS|||MV/SEC|NOT DONE||U|N|U|4||88||TREATMENT|1960-07-07||1967-10-03|||1964-05-06||1960-12-09
TRIAL STUDY 134XCP|RP|483D89E1-45FD-41D4-B9E0-22FFB41D323A|1||||||THICK|THICKNESS||||UMOL/L/SEC|||MG/M2/MIN|NOT DONE||Y|NA|Y|5||7||OBSERVATION|1965-01-18||1970-03-16|||1966-06-24||1960-09-06
TRIAL STUDY 134XCP|RP|483D89E1-45FD-41D4-B9E0-22FFB41D323A|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MEQ/G|||MG/M2/H|NOT DONE||NA|NA|U|5||7||BLINDED TREATMENT|1967-01-22||1971-08-31|||1971-02-18||1965-05-22
TRIAL STUDY 134XCP|RP|2CCBED9D-5F24-4ED8-B575-8523C820A227|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||ML/CM3/MIN|||KEV|NOT DONE||N|NA|NA|1||38||OPEN LABEL TREATMENT|1970-09-18||1970-07-23|||1972-11-29||1963-02-11
TRIAL STUDY 134XCP|RP|2CCBED9D-5F24-4ED8-B575-8523C820A227|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||PACKAGE|||PKAT|NOT DONE||U|NA|Y|1||38||BASELINE|1968-10-07||1971-07-30|||1970-01-09||1965-09-11
TRIAL STUDY 134XCP|RP|2CCBED9D-5F24-4ED8-B575-8523C820A227|1||||||THICK|THICKNESS||||PFU/ML|||PFU|NOT DONE||Y|NA|NA|2||58||CONTINUATION TREATMENT|1960-07-21||1973-05-13|||1966-11-02||1965-01-30
TRIAL STUDY 134XCP|RP|2CCBED9D-5F24-4ED8-B575-8523C820A227|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||/7.5 ML|||KAT|NOT DONE||N|NA|N|2||58||WASHOUT|1970-03-18||1969-08-31|||1968-04-15||1968-12-14
TRIAL STUDY 134XCP|RP|2CCBED9D-5F24-4ED8-B575-8523C820A227|1||||||PREGST|PREGNANT DURING THE STUDY||||CMHG|||MBQ|NOT DONE||N|U|Y|3||39||RUN-IN|1966-07-26||1969-04-03|||1965-12-16||1972-02-19
TRIAL STUDY 134XCP|RP|2CCBED9D-5F24-4ED8-B575-8523C820A227|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||UG/KG/DAY|||MG/DAY|NOT DONE||Y|U|NA|3||39||BASELINE|1962-09-16||1964-05-22|||1970-06-02||1972-05-11
TRIAL STUDY 134XCP|RP|2CCBED9D-5F24-4ED8-B575-8523C820A227|1||||||MASSIND|MASS INDICATOR||||PATCH|||OZ|NOT DONE||N|NA|NA|4||88||BASELINE|1969-10-25||1973-04-17|||1969-05-05||1971-05-19
TRIAL STUDY 134XCP|RP|2CCBED9D-5F24-4ED8-B575-8523C820A227|2||||||MENOSTAT|MENOPAUSE STATUS||||NMOL/MOL|||UMOL|NOT DONE||Y|U|NA|4||88||WASHOUT|1971-10-19||1968-04-23|||1970-12-14||1967-04-24
TRIAL STUDY 134XCP|RP|2CCBED9D-5F24-4ED8-B575-8523C820A227|1||||||BRTHN|NUMBER OF BIRTHS||||EID 50/ML|||UG/DOSE|NOT DONE||NA|U|N|5||7||WASHOUT|1969-10-19||1961-10-29|||1960-11-20||1961-11-16
TRIAL STUDY 134XCP|RP|2CCBED9D-5F24-4ED8-B575-8523C820A227|2||||||BRTHN|NUMBER OF BIRTHS||||MEQ/UG|||GPL U|NOT DONE||Y|Y|NA|5||7||TREATMENT|1968-08-31||1968-11-30|||1971-11-26||1961-12-29
TRIAL STUDY 134XCP|RP|F4D6A28D-569F-4639-ACE2-10EB517128B2|1||||||MENARAGE|MENARCHE AGE||||COAT|||RPM|NOT DONE||U|U|Y|1||38||RUN-IN|1964-10-23||1960-02-12|||1967-04-25||1970-12-08
TRIAL STUDY 134XCP|RP|F4D6A28D-569F-4639-ACE2-10EB517128B2|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^3/HPF|||GY/H|NOT DONE||N|U|NA|1||38||TREATMENT|1970-04-17||1963-11-24|||1965-01-16||1968-12-28
TRIAL STUDY 134XCP|RP|F4D6A28D-569F-4639-ACE2-10EB517128B2|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||U.CARR|||U.CARR|NOT DONE||NA|Y|U|2||58||LONG-TERM FOLLOW-UP|1970-02-25||1964-03-02|||1973-01-08||1965-10-15
TRIAL STUDY 134XCP|RP|F4D6A28D-569F-4639-ACE2-10EB517128B2|2||||||ULCERIND|ULCER INDICATOR||||UV*SEC|||UMOL/KG/MIN|NOT DONE||U|N|U|2||58||CONTINUATION TREATMENT|1962-05-03||1960-09-25|||1966-04-04||1961-06-19
TRIAL STUDY 134XCP|RP|F4D6A28D-569F-4639-ACE2-10EB517128B2|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||BQ/L|||10^5/HPF|NOT DONE||U|U|NA|3||39||RUN-IN|1972-06-14||1963-09-23|||1970-12-05||1965-10-30
TRIAL STUDY 134XCP|RP|F4D6A28D-569F-4639-ACE2-10EB517128B2|2||||||DLVRMODE|MODE OF DELIVERY||||CI/UL|||DAMOL/L|NOT DONE||N|Y|NA|3||39||INDUCTION TREATMENT|1962-07-06||1972-04-03|||1966-12-29||1964-06-13
TRIAL STUDY 134XCP|RP|F4D6A28D-569F-4639-ACE2-10EB517128B2|1||||||EDEMAIND|EDEMA INDICATOR||||LOG10 CFU/ML|||FFU|NOT DONE||N|Y|NA|4||88||WASHOUT|1967-04-21||1966-11-20|||1963-07-27||1963-02-06
TRIAL STUDY 134XCP|RP|F4D6A28D-569F-4639-ACE2-10EB517128B2|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||PMOL/10^10 CELLS|||CMHG|NOT DONE||N|N|U|4||88||LONG-TERM FOLLOW-UP|1965-11-15||1960-06-26|||1967-07-26||1971-05-19
TRIAL STUDY 134XCP|RP|F4D6A28D-569F-4639-ACE2-10EB517128B2|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||10^6 COPIES/ML|||10^6 DNA COPIES/ML|NOT DONE||NA|NA|NA|5||7||OPEN LABEL TREATMENT|1972-02-02||1965-01-15|||1973-06-10||1964-04-30
TRIAL STUDY 134XCP|RP|F4D6A28D-569F-4639-ACE2-10EB517128B2|2||||||PUSTIND|PUSTULE INDICATOR||||/4.0 ML|||G/G|NOT DONE||N|NA|NA|5||7||LONG-TERM FOLLOW-UP|1962-01-10||1968-09-29|||1967-06-07||1972-03-07
TRIAL STUDY 134XCP|RP|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||ML/ANIMAL|||BAG|NOT DONE||N|N|N|1||38||SCREENING|1963-12-17||1966-02-21|||1972-08-08||1966-04-01
TRIAL STUDY 134XCP|RP|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|2||||||INTP|INTERPRETATION||||10^4/HPF|||MG2/DL2|NOT DONE||NA|N|U|1||38||BLINDED TREATMENT|1960-07-19||1969-05-24|||1964-09-21||1963-09-25
TRIAL STUDY 134XCP|RP|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|1||||||DLVRMODE|MODE OF DELIVERY||||10^9 CFU/G|||MOL|NOT DONE||NA|Y|N|2||58||BASELINE|1966-12-29||1971-11-29|||1961-01-15||1961-08-09
TRIAL STUDY 134XCP|RP|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|2||||||INABOIND|INDUCED ABORTION INDICATOR||||CI/L|||ENZYME U/M2|NOT DONE||N|U|Y|2||58||CONTINUATION TREATMENT|1966-03-31||1963-01-09|||1967-11-11||1963-01-07
TRIAL STUDY 134XCP|RP|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|1||||||MENOAGE|MENOPAUSE AGE||||ABSORBANCE U|||DAYS/MONTH|NOT DONE||NA|NA|N|3||39||TREATMENT|1965-06-05||1961-08-10|||1970-12-08||1963-03-06
TRIAL STUDY 134XCP|RP|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||STRIP|||IU/MMOL|NOT DONE||Y|NA|NA|3||39||CONTINUATION TREATMENT|1969-08-18||1963-05-22|||1968-11-29||1966-04-04
TRIAL STUDY 134XCP|RP|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||%(V/V)|||ENZYME U/M2|NOT DONE||U|NA|Y|4||88||OPEN LABEL TREATMENT|1967-12-08||1966-12-22|||1973-07-27||1966-10-08
TRIAL STUDY 134XCP|RP|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||CCID 50/DOSE|||/LPF|NOT DONE||U|U|Y|4||88||RUN-IN|1961-02-24||1970-08-16|||1962-03-02||1964-10-28
TRIAL STUDY 134XCP|RP|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||NMOL/G|||UU/L|NOT DONE||U|U|U|5||7||SCREENING|1962-01-10||1960-10-22|||1970-05-09||1973-06-17
TRIAL STUDY 134XCP|RP|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|2||||||MENARAGE|MENARCHE AGE||||MM|||HZ/S|NOT DONE||NA|U|N|5||7||BASELINE|1973-08-01||1970-04-20|||1969-07-15||1960-01-19
TRIAL STUDY 134XCP|RP|415EF35E-6D99-48F8-80A1-89A4CDC621B8|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MMOL2/L2|||L/DAY|NOT DONE||U|NA|N|1||38||FOLLOW-UP|1961-03-12||1968-05-09|||1964-08-28||1965-05-01
TRIAL STUDY 134XCP|RP|415EF35E-6D99-48F8-80A1-89A4CDC621B8|2||||||ABORTN|NUMBER OF ABORTIONS||||10^6 ORGANISMS|||UIU/DL|NOT DONE||NA|U|N|1||38||FOLLOW-UP|1970-05-03||1967-09-16|||1960-05-06||1967-04-19
TRIAL STUDY 134XCP|RP|415EF35E-6D99-48F8-80A1-89A4CDC621B8|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||NKAT/G HB|||TCID 50/DOSE|NOT DONE||NA|NA|U|2||58||BASELINE|1965-08-31||1962-04-07|||1966-06-08||1962-03-18
TRIAL STUDY 134XCP|RP|415EF35E-6D99-48F8-80A1-89A4CDC621B8|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||KG/M2|||DRAM|NOT DONE||Y|NA|Y|2||58||LONG-TERM FOLLOW-UP|1970-09-02||1961-07-23|||1970-05-18||1967-09-30
TRIAL STUDY 134XCP|RP|415EF35E-6D99-48F8-80A1-89A4CDC621B8|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MM|||DL|NOT DONE||Y|NA|U|3||39||OBSERVATION|1970-03-28||1973-02-17|||1965-05-17||1962-06-25
TRIAL STUDY 134XCP|RP|415EF35E-6D99-48F8-80A1-89A4CDC621B8|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MMHG/SEC|||% INHIBITION|NOT DONE||U|NA|N|3||39||OBSERVATION|1963-07-20||1963-03-19|||1968-10-09||1970-02-04
TRIAL STUDY 134XCP|RP|415EF35E-6D99-48F8-80A1-89A4CDC621B8|1||||||THICK|THICKNESS||||CPM|||CYCLE/MIN|NOT DONE||NA|N|U|4||88||CONTINUATION TREATMENT|1963-01-28||1963-08-30|||1965-03-01||1965-09-10
TRIAL STUDY 134XCP|RP|415EF35E-6D99-48F8-80A1-89A4CDC621B8|2||||||ULCERIND|ULCER INDICATOR||||L/S/KPA|||BQ|NOT DONE||U|Y|N|4||88||INDUCTION TREATMENT|1960-03-04||1961-09-09|||1961-03-15||1960-04-13
TRIAL STUDY 134XCP|RP|415EF35E-6D99-48F8-80A1-89A4CDC621B8|1||||||STILBIND|STILLBIRTH INDICATOR||||NMOL/ML/MIN|||LOG10 PFU/ML|NOT DONE||NA|N|Y|5||7||RUN-IN|1971-03-28||1970-06-17|||1961-05-19||1960-10-29
TRIAL STUDY 134XCP|RP|415EF35E-6D99-48F8-80A1-89A4CDC621B8|2||||||THICK|THICKNESS||||APPLICATION|||KHZ|NOT DONE||N|U|N|5||7||SCREENING|1968-06-08||1970-06-27|||1971-07-30||1969-05-02
TRIAL STUDY 134XCP|RP|AA0F6192-A377-43C6-8203-BDF7553AEA88|1||||||PREGIND|PREGNANT INDICATOR||||GENEQ|||UM|NOT DONE||NA|U|N|1||38||WASHOUT|1968-10-01||1966-08-04|||1967-06-04||1971-10-18
TRIAL STUDY 134XCP|RP|AA0F6192-A377-43C6-8203-BDF7553AEA88|2||||||MENFDUR|MENSES FLOW DURATION||||MM/MIN|||ML/M2/DAY|NOT DONE||N|U|N|1||38||OBSERVATION|1973-06-19||1960-03-17|||1971-04-20||1964-02-03
TRIAL STUDY 134XCP|RP|AA0F6192-A377-43C6-8203-BDF7553AEA88|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||LOG10 COPIES/ML|||GTT|NOT DONE||Y|Y|Y|2||58||SCREENING|1964-04-13||1967-07-13|||1972-07-07||1969-08-05
TRIAL STUDY 134XCP|RP|AA0F6192-A377-43C6-8203-BDF7553AEA88|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UG/M2|||DPM|NOT DONE||Y|U|Y|2||58||OPEN LABEL TREATMENT|1962-02-01||1965-03-09|||1964-10-09||1961-11-23
TRIAL STUDY 134XCP|RP|AA0F6192-A377-43C6-8203-BDF7553AEA88|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UG/KG/H|||NL|NOT DONE||U|NA|U|3||39||LONG-TERM FOLLOW-UP|1965-11-01||1966-09-28|||1968-08-10||1962-05-09
TRIAL STUDY 134XCP|RP|AA0F6192-A377-43C6-8203-BDF7553AEA88|2||||||INTP|INTERPRETATION||||UCI/KG|||ENZYME U/G HB|NOT DONE||N|NA|N|3||39||BASELINE|1973-03-05||1969-02-23|||1960-09-03||1970-02-16
TRIAL STUDY 134XCP|RP|AA0F6192-A377-43C6-8203-BDF7553AEA88|1||||||EDEMAIND|EDEMA INDICATOR||||CM2|||CM H2O|NOT DONE||N|NA|N|4||88||OBSERVATION|1961-10-16||1967-11-30|||1967-01-21||1964-03-12
TRIAL STUDY 134XCP|RP|AA0F6192-A377-43C6-8203-BDF7553AEA88|2||||||INABOIND|INDUCED ABORTION INDICATOR||||GPL U/ML|||OD UNIT|NOT DONE||N|NA|NA|4||88||SCREENING|1965-01-03||1963-02-10|||1967-03-28||1970-06-27
TRIAL STUDY 134XCP|RP|AA0F6192-A377-43C6-8203-BDF7553AEA88|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||IN|||DAMOL/L|NOT DONE||N|N|U|5||7||RUN-IN|1971-05-20||1963-05-14|||1964-10-22||1961-03-28
TRIAL STUDY 134XCP|RP|AA0F6192-A377-43C6-8203-BDF7553AEA88|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||DAYS|||NMOL/ML/MIN|NOT DONE||Y|N|N|5||7||CONTINUATION TREATMENT|1968-07-23||1972-08-03|||1962-09-28||1973-06-08
TRIAL STUDY 134XCP|RP|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|1||||||GRAVIND|GRAVIDA INDICATOR||||10^5/L|||IU/G HB|NOT DONE||Y|U|N|1||38||FOLLOW-UP|1968-01-31||1968-01-16|||1969-01-08||1960-08-14
TRIAL STUDY 134XCP|RP|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|2||||||BLISTIND|BLISTERING INDICATOR||||MET|||MEQ/KG|NOT DONE||U|N|NA|1||38||WASHOUT|1965-11-17||1963-03-19|||1960-06-01||1962-11-26
TRIAL STUDY 134XCP|RP|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||10^3 RNA COPIES/ML|||U/KG|NOT DONE||NA|NA|NA|2||58||SCREENING|1964-12-01||1970-05-15|||1973-06-03||1968-04-26
TRIAL STUDY 134XCP|RP|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|2||||||PREGST|PREGNANT DURING THE STUDY||||ENZYME U|||P|NOT DONE||NA|N|N|2||58||OPEN LABEL TREATMENT|1963-07-09||1972-09-02|||1971-03-30||1970-06-13
TRIAL STUDY 134XCP|RP|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||SACHET|||MG/KG|NOT DONE||N|NA|Y|3||39||RUN-IN|1960-09-18||1966-01-10|||1972-03-15||1972-06-30
TRIAL STUDY 134XCP|RP|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||ML/CM H2O|||FMOL/L/SEC|NOT DONE||Y|N|Y|3||39||INDUCTION TREATMENT|1967-04-26||1960-07-26|||1973-02-25||1962-09-11
TRIAL STUDY 134XCP|RP|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||UG/M2|||SCOOPFUL|NOT DONE||NA|N|U|4||88||FOLLOW-UP|1970-11-14||1969-12-04|||1963-09-15||1964-04-09
TRIAL STUDY 134XCP|RP|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|2||||||ULCERIND|ULCER INDICATOR||||/7.5 ML|||WATT|NOT DONE||Y|N|Y|4||88||WASHOUT|1965-03-09||1972-05-19|||1963-08-12||1962-03-15
TRIAL STUDY 134XCP|RP|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|1||||||FUNDHT|FUNDAL HEIGHT||||LENS|||YEARS|NOT DONE||N|U|NA|5||7||SCREENING|1967-12-25||1965-05-11|||1966-02-04||1971-01-17
TRIAL STUDY 134XCP|RP|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|2||||||BCMETHOD|BIRTH CONTROL METHOD||||AMP|||MESF|NOT DONE||NA|N|U|5||7||CONTINUATION TREATMENT|1966-05-18||1969-12-01|||1962-05-25||1973-08-01
TRIAL STUDY 134XCP|RP|A848B1B5-679F-4C45-AD73-6506604C835E|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^5/L|||HZ|NOT DONE||U|NA|N|1||38||LONG-TERM FOLLOW-UP|1968-04-05||1960-08-26|||1973-02-24||1964-02-05
TRIAL STUDY 134XCP|RP|A848B1B5-679F-4C45-AD73-6506604C835E|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||U/10^12 RBC|||BOTTLE|NOT DONE||Y|Y|N|1||38||OPEN LABEL TREATMENT|1961-08-12||1960-11-26|||1968-03-14||1968-04-21
TRIAL STUDY 134XCP|RP|A848B1B5-679F-4C45-AD73-6506604C835E|1||||||PEELIND|PEELING INDICATOR||||UL/DOSE|||FG|NOT DONE||NA|U|N|2||58||FOLLOW-UP|1972-08-22||1965-03-09|||1964-07-31||1971-08-14
TRIAL STUDY 134XCP|RP|A848B1B5-679F-4C45-AD73-6506604C835E|2||||||PREGST|PREGNANT DURING THE STUDY||||TORR|||UG/M2|NOT DONE||Y|N|N|2||58||SCREENING|1962-12-30||1968-08-05|||1971-06-13||1966-12-23
TRIAL STUDY 134XCP|RP|A848B1B5-679F-4C45-AD73-6506604C835E|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||AMOL|||CY/CM|NOT DONE||Y|U|U|3||39||TREATMENT|1972-11-20||1963-01-14|||1970-06-25||1965-04-25
TRIAL STUDY 134XCP|RP|A848B1B5-679F-4C45-AD73-6506604C835E|2||||||MASSIND|MASS INDICATOR||||PT_US|||GBQ/UG|NOT DONE||NA|NA|NA|3||39||FOLLOW-UP|1963-12-22||1972-05-23|||1972-11-06||1971-03-02
TRIAL STUDY 134XCP|RP|A848B1B5-679F-4C45-AD73-6506604C835E|1||||||PREGIND|PREGNANT INDICATOR||||KM/H|||BU|NOT DONE||NA|N|NA|4||88||OPEN LABEL TREATMENT|1968-09-26||1966-09-20|||1966-10-29||1970-03-27
TRIAL STUDY 134XCP|RP|A848B1B5-679F-4C45-AD73-6506604C835E|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||TSP|||BQ/ML|NOT DONE||U|N|U|4||88||RUN-IN|1967-02-17||1973-07-09|||1973-07-15||1969-11-22
TRIAL STUDY 134XCP|RP|A848B1B5-679F-4C45-AD73-6506604C835E|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||BREATHS/30S|||UEQ/L|NOT DONE||U|NA|N|5||7||RUN-IN|1970-08-07||1962-02-06|||1963-12-24||1973-07-27
TRIAL STUDY 134XCP|RP|A848B1B5-679F-4C45-AD73-6506604C835E|2||||||DLVRMODE|MODE OF DELIVERY||||ATM|||UG/G/MIN|NOT DONE||Y|Y|N|5||7||LONG-TERM FOLLOW-UP|1967-10-27||1966-04-06|||1972-11-03||1973-02-11
TRIAL STUDY 134XCP|RP|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|1||||||MASSIND|MASS INDICATOR||||ML/DL|||GPS U|NOT DONE||U|N|U|1||38||OPEN LABEL TREATMENT|1963-10-17||1968-03-22|||1960-08-20||1973-05-03
TRIAL STUDY 134XCP|RP|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||CAPLET|||LINEAR FT*LB|NOT DONE||NA|U|Y|1||38||INDUCTION TREATMENT|1969-05-07||1966-02-15|||1970-08-09||1970-08-25
TRIAL STUDY 134XCP|RP|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||GENEQ|||KHZ|NOT DONE||U|NA|U|2||58||LONG-TERM FOLLOW-UP|1969-05-07||1967-09-12|||1960-06-02||1962-03-09
TRIAL STUDY 134XCP|RP|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||KG/L|||GPL U/ML|NOT DONE||NA|N|U|2||58||LONG-TERM FOLLOW-UP|1963-12-19||1964-07-18|||1971-12-13||1972-08-01
TRIAL STUDY 134XCP|RP|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MM/2H|||/100 WBC|NOT DONE||Y|U|NA|3||39||BASELINE|1962-08-30||1961-06-17|||1962-04-05||1960-10-03
TRIAL STUDY 134XCP|RP|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|2||||||PRGENDTC|DATE PREGNANCY ENDED||||KG/MOL|||MG/ANIMAL|NOT DONE||Y|N|N|3||39||BLINDED TREATMENT|1967-03-27||1965-03-31|||1973-06-06||1969-05-09
TRIAL STUDY 134XCP|RP|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||CI/UG|||IMPLANT|NOT DONE||U|U|Y|4||88||SCREENING|1960-11-29||1966-09-06|||1970-05-11||1967-01-08
TRIAL STUDY 134XCP|RP|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|2||||||EDEMAIND|EDEMA INDICATOR||||KCAL|||MHZ|NOT DONE||NA|NA|NA|4||88||INDUCTION TREATMENT|1964-07-14||1967-12-27|||1960-11-17||1973-06-17
TRIAL STUDY 134XCP|RP|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|1||||||BLISTIND|BLISTERING INDICATOR||||ATM|||ANSON U|NOT DONE||U|Y|U|5||7||OBSERVATION|1963-08-12||1970-12-07|||1961-05-18||1970-01-28
TRIAL STUDY 134XCP|RP|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|2||||||MENOSTAT|MENOPAUSE STATUS||||/H|||OZ EQ|NOT DONE||Y|NA|U|5||7||RUN-IN|1965-10-19||1971-04-17|||1967-08-11||1963-06-19
TRIAL STUDY 134XCP|RP|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|1||||||ERYTHIND|ERYTHEMA INDICATOR||||PA|||10^8/L|NOT DONE||U|U|NA|1||38||SCREENING|1964-03-16||1970-08-31|||1964-12-31||1962-11-10
TRIAL STUDY 134XCP|RP|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||NCI|||ML/S|NOT DONE||Y|Y|Y|1||38||BLINDED TREATMENT|1965-04-11||1963-06-03|||1973-02-02||1966-06-02
TRIAL STUDY 134XCP|RP|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|1||||||ULCERIND|ULCER INDICATOR||||IU/DL|||M3|NOT DONE||NA|Y|N|2||58||TREATMENT|1968-08-29||1967-12-15|||1971-06-15||1972-03-11
TRIAL STUDY 134XCP|RP|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||UG/KG|||MG/DOSE|NOT DONE||U|U|Y|2||58||RUN-IN|1967-08-19||1972-02-18|||1960-05-17||1971-02-06
TRIAL STUDY 134XCP|RP|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|1||||||BLISTIND|BLISTERING INDICATOR||||NMOL/MOL|||CAL|NOT DONE||NA|NA|N|3||39||WASHOUT|1966-01-16||1962-05-09|||1971-08-22||1965-08-07
TRIAL STUDY 134XCP|RP|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||ML/M2|||TUBERCULIN UNIT|NOT DONE||U|NA|N|3||39||SCREENING|1970-01-31||1967-02-05|||1973-07-25||1969-12-18
TRIAL STUDY 134XCP|RP|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|1||||||GRAVIND|GRAVIDA INDICATOR||||V/SEC|||MEQ/DAY|NOT DONE||NA|Y|NA|4||88||OBSERVATION|1965-08-24||1964-05-29|||1963-03-17||1968-07-29
TRIAL STUDY 134XCP|RP|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||JOULE|||MPL U|NOT DONE||Y|U|N|4||88||FOLLOW-UP|1973-09-01||1968-12-09|||1973-08-26||1962-04-21
TRIAL STUDY 134XCP|RP|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|1||||||GRAVIND|GRAVIDA INDICATOR||||DEG/MM|||RNA COPIES/ML|NOT DONE||N|N|Y|5||7||BLINDED TREATMENT|1967-11-28||1963-04-21|||1960-01-18||1963-11-09
TRIAL STUDY 134XCP|RP|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||SEC|||MEQ/DAY|NOT DONE||N|Y|U|5||7||TREATMENT|1962-05-15||1967-03-02|||1960-09-18||1972-06-21
TRIAL STUDY 134XCP|RP|FC155F37-522F-4620-BBFF-4999D37C1379|1||||||PREGIND|PREGNANT INDICATOR||||PMOL/DL|||U/G HB|NOT DONE||N|NA|Y|1||38||SCREENING|1961-06-29||1970-10-31|||1971-12-28||1962-03-05
TRIAL STUDY 134XCP|RP|FC155F37-522F-4620-BBFF-4999D37C1379|2||||||MENARAGE|MENARCHE AGE||||JOULE|||U/M2|NOT DONE||U|NA|U|1||38||BASELINE|1967-07-22||1962-02-14|||1961-04-14||1969-01-04
TRIAL STUDY 134XCP|RP|FC155F37-522F-4620-BBFF-4999D37C1379|1||||||PREGST|PREGNANT DURING THE STUDY||||MG/KG/DOSE|||S^-1(%O2)^-1|NOT DONE||N|Y|Y|2||58||LONG-TERM FOLLOW-UP|1971-01-11||1962-08-05|||1966-08-22||1972-06-07
TRIAL STUDY 134XCP|RP|FC155F37-522F-4620-BBFF-4999D37C1379|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||CUP|||/2000 RBC|NOT DONE||N|NA|U|2||58||WASHOUT|1967-11-14||1965-09-30|||1961-09-10||1966-01-26
TRIAL STUDY 134XCP|RP|FC155F37-522F-4620-BBFF-4999D37C1379|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||GENEQ|||BEL|NOT DONE||Y|N|NA|3||39||BLINDED TREATMENT|1965-07-15||1968-10-12|||1968-07-10||1965-06-05
TRIAL STUDY 134XCP|RP|FC155F37-522F-4620-BBFF-4999D37C1379|2||||||RASHIND|RASH INDICATOR||||10^7 PFU|||UG/KG/H|NOT DONE||Y|NA|Y|3||39||INDUCTION TREATMENT|1962-01-02||1970-09-04|||1972-07-28||1964-07-24
TRIAL STUDY 134XCP|RP|FC155F37-522F-4620-BBFF-4999D37C1379|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^9 CFU|||10^6/HPF|NOT DONE||U|NA|N|4||88||SCREENING|1969-12-29||1964-12-02|||1973-03-30||1971-12-13
TRIAL STUDY 134XCP|RP|FC155F37-522F-4620-BBFF-4999D37C1379|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MANSON U/ML|||MM2|NOT DONE||N|NA|N|4||88||LONG-TERM FOLLOW-UP|1964-12-17||1960-04-14|||1960-08-20||1964-08-21
TRIAL STUDY 134XCP|RP|FC155F37-522F-4620-BBFF-4999D37C1379|1||||||ERYTHIND|ERYTHEMA INDICATOR||||ML/DL|||10^9 CFU/G|NOT DONE||NA|Y|NA|5||7||LONG-TERM FOLLOW-UP|1966-07-22||1971-04-05|||1960-03-28||1965-10-01
TRIAL STUDY 134XCP|RP|FC155F37-522F-4620-BBFF-4999D37C1379|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||TAMPON|||ANTIBODY UNIT|NOT DONE||N|Y|N|5||7||OPEN LABEL TREATMENT|1964-07-17||1964-11-11|||1967-11-19||1969-09-08
TRIAL STUDY 134XCP|RP|20F817BC-4C89-4F6C-AA45-36CE786A73A8|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||UEQ|||UG/G/MIN|NOT DONE||Y|Y|NA|1||38||FOLLOW-UP|1973-06-16||1968-02-05|||1962-05-31||1964-12-21
TRIAL STUDY 134XCP|RP|20F817BC-4C89-4F6C-AA45-36CE786A73A8|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MIN|||NMOL/KG/DAY|NOT DONE||Y|NA|N|1||38||CONTINUATION TREATMENT|1960-06-22||1961-12-22|||1961-07-22||1966-08-05
TRIAL STUDY 134XCP|RP|20F817BC-4C89-4F6C-AA45-36CE786A73A8|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||PMOL/DL|||10^12 IU/L|NOT DONE||NA|N|N|2||58||RUN-IN|1963-07-18||1962-06-21|||1969-08-11||1965-12-02
TRIAL STUDY 134XCP|RP|20F817BC-4C89-4F6C-AA45-36CE786A73A8|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UG/ANIMAL|||NSEC|NOT DONE||U|NA|N|2||58||LONG-TERM FOLLOW-UP|1973-09-01||1973-03-24|||1962-01-11||1968-11-13
TRIAL STUDY 134XCP|RP|20F817BC-4C89-4F6C-AA45-36CE786A73A8|1||||||BCMETHOD|BIRTH CONTROL METHOD||||/10^5|||ML/KG/DAY|NOT DONE||U|Y|NA|3||39||RUN-IN|1969-02-11||1965-05-15|||1967-07-02||1971-06-21
TRIAL STUDY 134XCP|RP|20F817BC-4C89-4F6C-AA45-36CE786A73A8|2||||||ULCERIND|ULCER INDICATOR||||MMU/ML|||KHZ|NOT DONE||Y|Y|Y|3||39||TREATMENT|1968-01-31||1965-03-24|||1970-06-07||1960-03-23
TRIAL STUDY 134XCP|RP|20F817BC-4C89-4F6C-AA45-36CE786A73A8|1||||||GRAVIND|GRAVIDA INDICATOR||||BQ/L|||MS2|NOT DONE||Y|U|Y|4||88||BASELINE|1970-04-14||1961-12-17|||1965-04-14||1972-11-18
TRIAL STUDY 134XCP|RP|20F817BC-4C89-4F6C-AA45-36CE786A73A8|2||||||MASSIND|MASS INDICATOR||||FMOL/L/SEC|||DAGU/ML|NOT DONE||Y|NA|N|4||88||WASHOUT|1964-09-20||1960-03-27|||1972-12-22||1960-02-01
TRIAL STUDY 134XCP|RP|20F817BC-4C89-4F6C-AA45-36CE786A73A8|1||||||BRTHN|NUMBER OF BIRTHS||||MM/H|||CI/UL|NOT DONE||Y|NA|Y|5||7||OPEN LABEL TREATMENT|1970-08-13||1960-10-17|||1966-05-11||1963-10-25
TRIAL STUDY 134XCP|RP|20F817BC-4C89-4F6C-AA45-36CE786A73A8|2||||||THICK|THICKNESS||||CS|||MG/G/MIN|NOT DONE||N|NA|N|5||7||SCREENING|1972-08-02||1966-02-18|||1972-01-21||1963-12-03
TRIAL STUDY 134XCP|RP|99058E64-9873-4CD5-BB31-28C08758A1B5|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||ELISA UNIT/ML|||/MM|NOT DONE||N|N|U|1||38||TREATMENT|1970-03-08||1971-06-18|||1965-05-05||1969-05-22
TRIAL STUDY 134XCP|RP|99058E64-9873-4CD5-BB31-28C08758A1B5|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MMOL/MOL|||CI|NOT DONE||U|NA|N|1||38||BLINDED TREATMENT|1966-03-03||1969-11-05|||1963-05-23||1970-10-06
TRIAL STUDY 134XCP|RP|99058E64-9873-4CD5-BB31-28C08758A1B5|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||PACKET|||VP/DOSE|NOT DONE||N|N|Y|2||58||RUN-IN|1962-10-20||1969-01-11|||1970-06-30||1962-01-24
TRIAL STUDY 134XCP|RP|99058E64-9873-4CD5-BB31-28C08758A1B5|2||||||INTP|INTERPRETATION||||IU/DAY|||MG/M2|NOT DONE||U|N|U|2||58||BASELINE|1973-08-20||1960-02-08|||1972-08-25||1971-04-21
TRIAL STUDY 134XCP|RP|99058E64-9873-4CD5-BB31-28C08758A1B5|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||U/M2/MIN|||V/V|NOT DONE||NA|Y|U|3||39||SCREENING|1969-02-24||1972-06-21|||1960-03-26||1965-10-22
TRIAL STUDY 134XCP|RP|99058E64-9873-4CD5-BB31-28C08758A1B5|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||ARBITRARY U|||MBQ/UL|NOT DONE||Y|NA|N|3||39||RUN-IN|1965-06-13||1971-09-25|||1969-09-14||1965-06-27
TRIAL STUDY 134XCP|RP|99058E64-9873-4CD5-BB31-28C08758A1B5|1||||||PREGIND|PREGNANT INDICATOR||||DAYS/WK|||KBQ/UL|NOT DONE||U|Y|U|4||88||TREATMENT|1967-03-21||1967-04-21|||1963-07-06||1972-02-23
TRIAL STUDY 134XCP|RP|99058E64-9873-4CD5-BB31-28C08758A1B5|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MBQ|||L/MIN|NOT DONE||N|U|U|4||88||SCREENING|1961-07-15||1967-08-14|||1965-12-16||1969-12-14
TRIAL STUDY 134XCP|RP|99058E64-9873-4CD5-BB31-28C08758A1B5|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||NMOL|||MG/ML/MIN|NOT DONE||N|N|N|5||7||BASELINE|1968-01-04||1960-02-10|||1970-09-06||1960-11-24
TRIAL STUDY 134XCP|RP|99058E64-9873-4CD5-BB31-28C08758A1B5|2||||||INTP|INTERPRETATION||||JDF UNIT|||UG/L/H|NOT DONE||NA|N|Y|5||7||TREATMENT|1969-04-29||1973-05-19|||1971-02-02||1971-01-16
TRIAL STUDY 134XCP|RP|656B6693-1C1C-433B-84E3-77E89F0B543E|1||||||INTP|INTERPRETATION||||%(W/V)|||UG/DAY|NOT DONE||Y|N|N|1||38||BLINDED TREATMENT|1972-12-03||1965-04-11|||1968-05-12||1971-12-09
TRIAL STUDY 134XCP|RP|656B6693-1C1C-433B-84E3-77E89F0B543E|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||PACK YEAR|||G/G|NOT DONE||N|Y|U|1||38||WASHOUT|1969-05-21||1973-08-14|||1964-03-01||1973-09-03
TRIAL STUDY 134XCP|RP|656B6693-1C1C-433B-84E3-77E89F0B543E|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||CONTAINER|||DEG/S|NOT DONE||N|N|N|2||58||BLINDED TREATMENT|1966-03-25||1964-09-21|||1962-04-02||1971-04-27
TRIAL STUDY 134XCP|RP|656B6693-1C1C-433B-84E3-77E89F0B543E|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||10^3 DNA COPIES/ML|||NG/MOL|NOT DONE||NA|N|U|2||58||OPEN LABEL TREATMENT|1970-10-22||1960-06-20|||1970-05-18||1962-01-05
TRIAL STUDY 134XCP|RP|656B6693-1C1C-433B-84E3-77E89F0B543E|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||UV*SEC|||ML/KG|NOT DONE||NA|U|NA|3||39||INDUCTION TREATMENT|1968-07-20||1965-07-17|||1970-02-27||1972-07-04
TRIAL STUDY 134XCP|RP|656B6693-1C1C-433B-84E3-77E89F0B543E|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||G/DL|||KBQ|NOT DONE||NA|Y|N|3||39||LONG-TERM FOLLOW-UP|1972-01-26||1972-12-16|||1966-06-26||1967-09-29
TRIAL STUDY 134XCP|RP|656B6693-1C1C-433B-84E3-77E89F0B543E|1||||||BLISTIND|BLISTERING INDICATOR||||BOLUS|||S*KPA|NOT DONE||U|NA|Y|4||88||TREATMENT|1971-07-04||1967-10-11|||1971-06-05||1969-07-27
TRIAL STUDY 134XCP|RP|656B6693-1C1C-433B-84E3-77E89F0B543E|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||IN|||MG|NOT DONE||N|NA|U|4||88||BLINDED TREATMENT|1962-12-23||1963-07-23|||1962-05-21||1969-07-09
TRIAL STUDY 134XCP|RP|656B6693-1C1C-433B-84E3-77E89F0B543E|1||||||ULCERIND|ULCER INDICATOR||||ML/H|||/500 WBC|NOT DONE||NA|U|U|5||7||INDUCTION TREATMENT|1965-07-27||1960-12-23|||1969-06-08||1967-02-17
TRIAL STUDY 134XCP|RP|656B6693-1C1C-433B-84E3-77E89F0B543E|2||||||PEELIND|PEELING INDICATOR||||DPM/MG|||10^9 CFU|NOT DONE||N|NA|N|5||7||INDUCTION TREATMENT|1972-07-11||1966-01-11|||1963-12-03||1972-08-06
TRIAL STUDY 134XCP|RP|43C443F9-AB0F-44BE-B28B-63A60EE09205|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UG/ML/H|||VP/ML|NOT DONE||NA|Y|U|1||38||CONTINUATION TREATMENT|1972-08-10||1968-04-12|||1966-12-06||1968-10-07
TRIAL STUDY 134XCP|RP|43C443F9-AB0F-44BE-B28B-63A60EE09205|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MAMP|||CARTRIDGE|NOT DONE||U|Y|U|1||38||BASELINE|1965-12-14||1967-04-11|||1970-08-02||1967-05-31
TRIAL STUDY 134XCP|RP|43C443F9-AB0F-44BE-B28B-63A60EE09205|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||LB|||MG/H|NOT DONE||Y|U|NA|2||58||OBSERVATION|1965-06-19||1962-11-20|||1962-04-18||1973-06-01
TRIAL STUDY 134XCP|RP|43C443F9-AB0F-44BE-B28B-63A60EE09205|2||||||DSCHGIND|DISCHARGE INDICATOR||||CI/G|||IU/KG/H|NOT DONE||U|NA|N|2||58||TREATMENT|1972-01-26||1971-10-09|||1971-05-27||1960-12-31
TRIAL STUDY 134XCP|RP|43C443F9-AB0F-44BE-B28B-63A60EE09205|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||APL U/ML|||NG/DAY|NOT DONE||U|U|N|3||39||WASHOUT|1972-08-30||1964-10-29|||1963-06-10||1971-09-07
TRIAL STUDY 134XCP|RP|43C443F9-AB0F-44BE-B28B-63A60EE09205|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MMOL/KG|||L/S|NOT DONE||U|U|Y|3||39||FOLLOW-UP|1972-08-06||1960-04-13|||1969-12-25||1960-10-12
TRIAL STUDY 134XCP|RP|43C443F9-AB0F-44BE-B28B-63A60EE09205|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||IU/DL|||10^4/L|NOT DONE||N|NA|NA|4||88||OBSERVATION|1966-09-14||1972-04-01|||1971-03-05||1963-07-02
TRIAL STUDY 134XCP|RP|43C443F9-AB0F-44BE-B28B-63A60EE09205|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||GBQ/MG|||LOG10 PFU/ML|NOT DONE||U|U|N|4||88||RUN-IN|1967-04-05||1972-06-21|||1962-01-16||1964-03-11
TRIAL STUDY 134XCP|RP|43C443F9-AB0F-44BE-B28B-63A60EE09205|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||/MS|||TABLET|NOT DONE||Y|Y|NA|5||7||SCREENING|1971-06-12||1960-12-18|||1970-11-16||1972-02-27
TRIAL STUDY 134XCP|RP|43C443F9-AB0F-44BE-B28B-63A60EE09205|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||IU/KG|||PMOL/DL|NOT DONE||N|NA|NA|5||7||BLINDED TREATMENT|1965-08-14||1961-05-23|||1971-01-03||1972-04-27
TRIAL STUDY 134XCP|RP|37FF91B1-CE3C-4587-85CE-F76B880D40E7|1||||||TNDRIND|TENDERNESS INDICATOR||||HEP|||NMOL BCE/NMOL|NOT DONE||N|NA|N|1||38||LONG-TERM FOLLOW-UP|1969-04-08||1964-07-02|||1964-05-25||1969-06-07
TRIAL STUDY 134XCP|RP|37FF91B1-CE3C-4587-85CE-F76B880D40E7|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||NMOL/L/MIN|||SPRAY|NOT DONE||N|N|Y|1||38||BLINDED TREATMENT|1970-12-02||1971-09-30|||1973-05-11||1969-06-28
TRIAL STUDY 134XCP|RP|37FF91B1-CE3C-4587-85CE-F76B880D40E7|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||H*%|||UM|NOT DONE||Y|U|NA|2||58||BASELINE|1967-12-30||1965-04-16|||1971-11-21||1973-08-03
TRIAL STUDY 134XCP|RP|37FF91B1-CE3C-4587-85CE-F76B880D40E7|2||||||PEELIND|PEELING INDICATOR||||UG/G/H|||SHOCK WAVE|NOT DONE||Y|NA|U|2||58||LONG-TERM FOLLOW-UP|1966-07-01||1970-12-27|||1972-08-21||1964-02-20
TRIAL STUDY 134XCP|RP|37FF91B1-CE3C-4587-85CE-F76B880D40E7|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||UG/KG|||ML/CAGE/DAY|NOT DONE||N|NA|NA|3||39||INDUCTION TREATMENT|1963-05-13||1962-02-17|||1961-10-27||1966-05-08
TRIAL STUDY 134XCP|RP|37FF91B1-CE3C-4587-85CE-F76B880D40E7|2||||||TNDRIND|TENDERNESS INDICATOR||||CY/CM|||ML/SEC/1.73M2|NOT DONE||N|NA|Y|3||39||CONTINUATION TREATMENT|1963-12-21||1968-10-04|||1965-08-30||1970-02-06
TRIAL STUDY 134XCP|RP|37FF91B1-CE3C-4587-85CE-F76B880D40E7|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||CMOL/L|||MM2|NOT DONE||Y|NA|Y|4||88||LONG-TERM FOLLOW-UP|1967-11-19||1968-01-14|||1960-01-21||1963-07-17
TRIAL STUDY 134XCP|RP|37FF91B1-CE3C-4587-85CE-F76B880D40E7|2||||||ULCERIND|ULCER INDICATOR||||MM/2H|||PFU/DOSE|NOT DONE||Y|N|Y|4||88||BASELINE|1967-03-28||1969-12-31|||1968-12-08||1962-03-14
TRIAL STUDY 134XCP|RP|37FF91B1-CE3C-4587-85CE-F76B880D40E7|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MG/M2/MIN|||AMOL|NOT DONE||N|U|NA|5||7||BASELINE|1966-02-18||1973-06-26|||1960-07-06||1962-01-07
TRIAL STUDY 134XCP|RP|37FF91B1-CE3C-4587-85CE-F76B880D40E7|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MV/SEC|||MILE|NOT DONE||U|NA|U|5||7||TREATMENT|1964-12-25||1966-02-20|||1967-12-04||1963-06-24
TRIAL STUDY 134XCP|RP|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||VIRTUAL PIXEL|||AMU|NOT DONE||NA|Y|N|1||38||SCREENING|1971-11-11||1971-06-25|||1965-10-29||1966-10-27
TRIAL STUDY 134XCP|RP|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||NEWTON|||GBQ|NOT DONE||Y|NA|U|1||38||BLINDED TREATMENT|1973-01-17||1972-07-20|||1969-04-20||1961-05-13
TRIAL STUDY 134XCP|RP|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|1||||||BLISTIND|BLISTERING INDICATOR||||WEEKS|||NEWTON|NOT DONE||NA|N|U|2||58||WASHOUT|1967-08-04||1967-01-19|||1972-06-01||1967-04-08
TRIAL STUDY 134XCP|RP|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||UMOL/L/SEC|||BP|NOT DONE||Y|U|U|2||58||OBSERVATION|1970-06-24||1962-08-02|||1966-12-11||1969-06-14
TRIAL STUDY 134XCP|RP|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|1||||||ABORTN|NUMBER OF ABORTIONS||||NMOL/L|||10^7 TCID 50/DOSE|NOT DONE||Y|NA|U|3||39||RUN-IN|1972-03-05||1963-04-12|||1972-01-03||1970-04-23
TRIAL STUDY 134XCP|RP|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||G/ANIMAL/DAY|||BOLUS|NOT DONE||NA|N|U|3||39||TREATMENT|1962-04-28||1970-04-12|||1963-08-21||1964-09-05
TRIAL STUDY 134XCP|RP|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|1||||||INTP|INTERPRETATION||||KIU|||MEQ/ML|NOT DONE||U|Y|Y|4||88||BASELINE|1960-03-04||1964-08-11|||1964-12-27||1962-08-19
TRIAL STUDY 134XCP|RP|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|2||||||PUSTIND|PUSTULE INDICATOR||||TAMPON|||UEQ|NOT DONE||U|NA|N|4||88||FOLLOW-UP|1973-03-17||1963-10-11|||1962-11-27||1973-04-15
TRIAL STUDY 134XCP|RP|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||VIRTUAL PIXEL|||DRAM|NOT DONE||U|U|N|5||7||OBSERVATION|1962-01-01||1970-06-17|||1971-12-01||1966-01-08
TRIAL STUDY 134XCP|RP|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|2||||||PRGENDTC|DATE PREGNANCY ENDED||||MOL|||LINEAR FT*LB|NOT DONE||N|Y|NA|5||7||OPEN LABEL TREATMENT|1970-10-20||1965-02-19|||1961-06-04||1963-03-12
TRIAL STUDY 134XCP|RP|49017491-2C28-4F86-BF72-CF83651052F6|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MBQ|||M/SEC2|NOT DONE||N|N|NA|1||38||BLINDED TREATMENT|1969-10-21||1971-07-08|||1961-05-22||1968-08-18
TRIAL STUDY 134XCP|RP|49017491-2C28-4F86-BF72-CF83651052F6|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||/VF|||BQ/L|NOT DONE||U|NA|NA|1||38||OPEN LABEL TREATMENT|1968-11-11||1965-01-05|||1965-03-15||1964-12-25
TRIAL STUDY 134XCP|RP|49017491-2C28-4F86-BF72-CF83651052F6|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MG/G/H|||FOZ_US|NOT DONE||Y|NA|Y|2||58||BLINDED TREATMENT|1972-11-25||1962-06-12|||1971-05-18||1971-10-29
TRIAL STUDY 134XCP|RP|49017491-2C28-4F86-BF72-CF83651052F6|2||||||EDEMAIND|EDEMA INDICATOR||||MG/DAY|||DAYS/WK|NOT DONE||NA|Y|NA|2||58||SCREENING|1969-04-02||1965-05-30|||1967-10-28||1968-08-30
TRIAL STUDY 134XCP|RP|49017491-2C28-4F86-BF72-CF83651052F6|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||G/ANIMAL|||OHM|NOT DONE||NA|U|U|3||39||INDUCTION TREATMENT|1963-01-01||1963-09-11|||1970-10-11||1963-12-09
TRIAL STUDY 134XCP|RP|49017491-2C28-4F86-BF72-CF83651052F6|2||||||STILBIND|STILLBIRTH INDICATOR||||PT_BR|||CIGARETTE|NOT DONE||U|NA|N|3||39||WASHOUT|1961-01-06||1970-06-30|||1960-09-05||1969-09-01
TRIAL STUDY 134XCP|RP|49017491-2C28-4F86-BF72-CF83651052F6|1||||||BCMETHOD|BIRTH CONTROL METHOD||||10^9/DOSE|||L/H/M2|NOT DONE||U|U|N|4||88||INDUCTION TREATMENT|1965-11-18||1969-07-13|||1967-07-14||1963-06-07
TRIAL STUDY 134XCP|RP|49017491-2C28-4F86-BF72-CF83651052F6|2||||||MASSIND|MASS INDICATOR||||G/KG/DAY|||BQ/L|NOT DONE||NA|Y|U|4||88||SCREENING|1971-09-02||1963-03-02|||1964-03-10||1970-09-23
TRIAL STUDY 134XCP|RP|49017491-2C28-4F86-BF72-CF83651052F6|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||NMOL|||GENEQ/ML|NOT DONE||U|NA|Y|5||7||OPEN LABEL TREATMENT|1965-01-31||1969-05-07|||1971-10-11||1962-08-09
TRIAL STUDY 134XCP|RP|49017491-2C28-4F86-BF72-CF83651052F6|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ANTI-XA IU|||CI/UG|NOT DONE||Y|N|U|5||7||LONG-TERM FOLLOW-UP|1960-05-16||1970-01-22|||1962-10-31||1964-05-02
TRIAL STUDY 134XCP|RP|DAA65EE6-66ED-4354-935B-1347E1B572A5|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||KIU|||G|NOT DONE||N|NA|NA|1||38||OBSERVATION|1963-04-14||1968-04-05|||1963-04-16||1962-03-14
TRIAL STUDY 134XCP|RP|DAA65EE6-66ED-4354-935B-1347E1B572A5|2||||||INABOIND|INDUCED ABORTION INDICATOR||||10^6 DNA COPIES/ML|||ML/G/DAY|NOT DONE||NA|U|Y|1||38||INDUCTION TREATMENT|1970-04-09||1963-03-07|||1969-03-07||1969-09-01
TRIAL STUDY 134XCP|RP|DAA65EE6-66ED-4354-935B-1347E1B572A5|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PHERESIS UNIT|||SYRINGE|NOT DONE||Y|U|U|2||58||INDUCTION TREATMENT|1962-01-17||1968-06-17|||1971-08-12||1971-05-08
TRIAL STUDY 134XCP|RP|DAA65EE6-66ED-4354-935B-1347E1B572A5|2||||||EDEMAIND|EDEMA INDICATOR||||PMOL/10^10 CELLS|||FMOL/L/SEC|NOT DONE||U|U|U|2||58||TREATMENT|1964-05-09||1972-10-04|||1964-11-17||1964-12-24
TRIAL STUDY 134XCP|RP|DAA65EE6-66ED-4354-935B-1347E1B572A5|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||GENEQ/ML|||L/L|NOT DONE||U|U|N|3||39||CONTINUATION TREATMENT|1960-03-31||1969-05-28|||1973-07-16||1971-01-11
TRIAL STUDY 134XCP|RP|DAA65EE6-66ED-4354-935B-1347E1B572A5|2||||||MASSIND|MASS INDICATOR||||10^6 ORGANISMS/ML|||MOL/G|NOT DONE||N|NA|U|3||39||OPEN LABEL TREATMENT|1970-12-03||1972-07-21|||1962-04-01||1962-06-04
TRIAL STUDY 134XCP|RP|DAA65EE6-66ED-4354-935B-1347E1B572A5|1||||||PREGST|PREGNANT DURING THE STUDY||||UCI/KG|||DPM/ML|NOT DONE||Y|U|U|4||88||LONG-TERM FOLLOW-UP|1960-12-24||1969-08-16|||1971-08-18||1969-01-08
TRIAL STUDY 134XCP|RP|DAA65EE6-66ED-4354-935B-1347E1B572A5|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MG/MOL|||DYN|NOT DONE||NA|N|Y|4||88||SCREENING|1964-12-17||1968-06-28|||1960-10-20||1972-10-22
TRIAL STUDY 134XCP|RP|DAA65EE6-66ED-4354-935B-1347E1B572A5|1||||||PREGNN|NUMBER OF PREGNANCIES||||H/WK|||UCI|NOT DONE||N|Y|N|5||7||LONG-TERM FOLLOW-UP|1967-08-17||1972-11-19|||1970-01-06||1971-07-05
TRIAL STUDY 134XCP|RP|DAA65EE6-66ED-4354-935B-1347E1B572A5|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^11/L|||PIXEL|NOT DONE||NA|Y|NA|5||7||OPEN LABEL TREATMENT|1960-03-26||1961-05-04|||1963-02-11||1969-01-16
TRIAL STUDY 134XCP|RP|A440A3E5-F87D-4306-9195-3A842F0DDE33|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||BREATHS/30S|||MS2|NOT DONE||NA|N|NA|1||38||CONTINUATION TREATMENT|1961-09-12||1965-01-30|||1968-08-14||1973-02-25
TRIAL STUDY 134XCP|RP|A440A3E5-F87D-4306-9195-3A842F0DDE33|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||PKAT/L|||10^8 PFU|NOT DONE||NA|NA|Y|1||38||CONTINUATION TREATMENT|1964-05-31||1967-08-30|||1968-01-14||1962-09-20
TRIAL STUDY 134XCP|RP|A440A3E5-F87D-4306-9195-3A842F0DDE33|1||||||MENARAGE|MENARCHE AGE||||MEQ/MMOL|||BEATS/MIN|NOT DONE||Y|U|N|2||58||TREATMENT|1964-05-03||1960-09-06|||1965-07-15||1966-05-07
TRIAL STUDY 134XCP|RP|A440A3E5-F87D-4306-9195-3A842F0DDE33|2||||||PREGNN|NUMBER OF PREGNANCIES||||UMOL|||MS/MMHG|NOT DONE||N|N|U|2||58||TREATMENT|1965-10-11||1970-11-30|||1972-10-10||1963-10-10
TRIAL STUDY 134XCP|RP|A440A3E5-F87D-4306-9195-3A842F0DDE33|1||||||DSCHGIND|DISCHARGE INDICATOR||||U/MMOL|||UG/MOL|NOT DONE||NA|N|Y|3||39||RUN-IN|1970-08-12||1967-04-23|||1973-06-12||1970-03-19
TRIAL STUDY 134XCP|RP|A440A3E5-F87D-4306-9195-3A842F0DDE33|2||||||PREGNN|NUMBER OF PREGNANCIES||||P|||CONTAINER|NOT DONE||U|N|N|3||39||BASELINE|1969-04-05||1966-06-04|||1971-05-11||1960-08-11
TRIAL STUDY 134XCP|RP|A440A3E5-F87D-4306-9195-3A842F0DDE33|1||||||TNDRIND|TENDERNESS INDICATOR||||MEQ/DAY|||USIEMENS|NOT DONE||U|U|U|4||88||SCREENING|1966-02-21||1969-09-10|||1962-03-03||1964-11-09
TRIAL STUDY 134XCP|RP|A440A3E5-F87D-4306-9195-3A842F0DDE33|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||ML/CAGE/WK|||UV2|NOT DONE||NA|NA|N|4||88||LONG-TERM FOLLOW-UP|1960-05-02||1971-03-09|||1970-04-03||1971-11-05
TRIAL STUDY 134XCP|RP|A440A3E5-F87D-4306-9195-3A842F0DDE33|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||ML/M2|||FRAMES/S|NOT DONE||Y|N|U|5||7||BASELINE|1970-02-01||1962-03-21|||1967-04-29||1960-07-08
TRIAL STUDY 134XCP|RP|A440A3E5-F87D-4306-9195-3A842F0DDE33|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||ML/CM|||IN2|NOT DONE||NA|Y|NA|5||7||SCREENING|1966-08-05||1964-05-31|||1972-01-06||1966-06-06
TRIAL STUDY 134XCP|RP|48BBE085-BD68-451A-9700-6A1AB18D84EE|1||||||INTP|INTERPRETATION||||GPELISA UNIT/ML|||UGEQ|NOT DONE||NA|N|N|1||38||OPEN LABEL TREATMENT|1961-06-06||1961-11-21|||1968-09-24||1964-08-07
TRIAL STUDY 134XCP|RP|48BBE085-BD68-451A-9700-6A1AB18D84EE|2||||||INABOIND|INDUCED ABORTION INDICATOR||||JAR|||MG/ML/MIN|NOT DONE||U|U|NA|1||38||RUN-IN|1966-05-23||1960-12-25|||1964-10-31||1969-09-24
TRIAL STUDY 134XCP|RP|48BBE085-BD68-451A-9700-6A1AB18D84EE|1||||||MENFDUR|MENSES FLOW DURATION||||MM2|||PACK YEAR|NOT DONE||U|NA|U|2||58||FOLLOW-UP|1960-07-25||1971-09-12|||1972-06-01||1962-03-02
TRIAL STUDY 134XCP|RP|48BBE085-BD68-451A-9700-6A1AB18D84EE|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MEQ/L|||UCI/KG|NOT DONE||NA|Y|N|2||58||TREATMENT|1960-09-11||1972-05-23|||1970-04-15||1962-05-10
TRIAL STUDY 134XCP|RP|48BBE085-BD68-451A-9700-6A1AB18D84EE|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||GAUSS|||TUBE|NOT DONE||N|Y|NA|3||39||FOLLOW-UP|1971-08-13||1964-03-09|||1965-08-20||1962-05-09
TRIAL STUDY 134XCP|RP|48BBE085-BD68-451A-9700-6A1AB18D84EE|2||||||BLISTIND|BLISTERING INDICATOR||||UG/ANIMAL|||/SEC|NOT DONE||Y|U|N|3||39||RUN-IN|1962-03-23||1962-01-19|||1965-09-25||1973-03-17
TRIAL STUDY 134XCP|RP|48BBE085-BD68-451A-9700-6A1AB18D84EE|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MG/KG/DOSE|||ENZYME U/L|NOT DONE||U|N|NA|4||88||LONG-TERM FOLLOW-UP|1960-10-29||1973-08-12|||1961-06-28||1962-05-02
TRIAL STUDY 134XCP|RP|48BBE085-BD68-451A-9700-6A1AB18D84EE|2||||||BRTHN|NUMBER OF BIRTHS||||SIEMENS|||MG/ML/DAY|NOT DONE||Y|U|U|4||88||OPEN LABEL TREATMENT|1963-08-29||1967-03-23|||1973-06-25||1967-05-27
TRIAL STUDY 134XCP|RP|48BBE085-BD68-451A-9700-6A1AB18D84EE|1||||||INTP|INTERPRETATION||||TBSP|||UM/DAY|NOT DONE||Y|N|NA|5||7||WASHOUT|1960-08-03||1961-10-07|||1969-01-08||1966-06-23
TRIAL STUDY 134XCP|RP|48BBE085-BD68-451A-9700-6A1AB18D84EE|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||/LSQN|||UG/M2/MIN|NOT DONE||U|U|NA|5||7||INDUCTION TREATMENT|1969-10-03||1961-09-09|||1968-07-07||1964-04-07
TRIAL STUDY 134XCP|RP|F38055A2-11E2-437B-BD6A-662D81521F1D|1||||||ERYTHIND|ERYTHEMA INDICATOR||||ML/M2/H|||G|NOT DONE||N|NA|Y|1||38||INDUCTION TREATMENT|1966-02-13||1971-01-07|||1970-10-02||1965-07-28
TRIAL STUDY 134XCP|RP|F38055A2-11E2-437B-BD6A-662D81521F1D|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^4/L|||10^6 IU/ML|NOT DONE||U|Y|U|1||38||TREATMENT|1966-07-16||1964-10-19|||1963-05-14||1966-09-10
TRIAL STUDY 134XCP|RP|F38055A2-11E2-437B-BD6A-662D81521F1D|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UG/L FEU|||PIXEL|NOT DONE||N|U|N|2||58||BLINDED TREATMENT|1962-05-01||1966-10-21|||1969-12-20||1964-06-08
TRIAL STUDY 134XCP|RP|F38055A2-11E2-437B-BD6A-662D81521F1D|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||CI/L|||JAR|NOT DONE||Y|N|N|2||58||OBSERVATION|1961-06-03||1973-01-30|||1973-01-06||1961-05-31
TRIAL STUDY 134XCP|RP|F38055A2-11E2-437B-BD6A-662D81521F1D|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||NMOL BCE/NMOL|||MOSM/KG|NOT DONE||N|Y|U|3||39||CONTINUATION TREATMENT|1971-10-26||1963-06-06|||1960-06-23||1966-03-13
TRIAL STUDY 134XCP|RP|F38055A2-11E2-437B-BD6A-662D81521F1D|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||U/KG/DAY|||10^3 CFU|NOT DONE||U|NA|NA|3||39||OBSERVATION|1972-01-11||1966-03-12|||1972-07-04||1968-03-15
TRIAL STUDY 134XCP|RP|F38055A2-11E2-437B-BD6A-662D81521F1D|1||||||RASHIND|RASH INDICATOR||||CPM|||UMOL/MG/MIN|NOT DONE||NA|U|U|4||88||SCREENING|1965-03-29||1973-06-15|||1970-08-08||1972-04-16
TRIAL STUDY 134XCP|RP|F38055A2-11E2-437B-BD6A-662D81521F1D|2||||||BCMETHOD|BIRTH CONTROL METHOD||||K|||CMOL/L|NOT DONE||N|NA|Y|4||88||LONG-TERM FOLLOW-UP|1965-04-20||1964-11-03|||1965-05-15||1964-08-24
TRIAL STUDY 134XCP|RP|F38055A2-11E2-437B-BD6A-662D81521F1D|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||SCM|||MSEC|NOT DONE||NA|N|N|5||7||TREATMENT|1965-10-30||1971-04-03|||1964-12-26||1964-09-18
TRIAL STUDY 134XCP|RP|F38055A2-11E2-437B-BD6A-662D81521F1D|2||||||PREGNN|NUMBER OF PREGNANCIES||||FRAMES/S|||DAGU/ML|NOT DONE||NA|Y|NA|5||7||OBSERVATION|1973-04-30||1970-03-10|||1965-05-24||1961-08-16
TRIAL STUDY 134XCP|RP|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MMHG|||UM/S|NOT DONE||NA|Y|N|1||38||TREATMENT|1968-01-04||1964-10-12|||1964-09-29||1962-11-30
TRIAL STUDY 134XCP|RP|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|2||||||PREGST|PREGNANT DURING THE STUDY||||ML/100G/MIN|||VIAL|NOT DONE||NA|U|Y|1||38||RUN-IN|1964-06-19||1965-06-19|||1969-01-10||1971-07-14
TRIAL STUDY 134XCP|RP|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||CUP EQ|||ML/M2/MIN|NOT DONE||N|U|N|2||58||CONTINUATION TREATMENT|1970-10-30||1973-03-19|||1968-02-15||1967-01-02
TRIAL STUDY 134XCP|RP|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|2||||||RASHIND|RASH INDICATOR||||PFU/ANIMAL|||FMOL/L/SEC|NOT DONE||U|NA|NA|2||58||FOLLOW-UP|1962-09-19||1961-09-08|||1971-11-19||1969-02-10
TRIAL STUDY 134XCP|RP|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|1||||||MENOSTAT|MENOPAUSE STATUS||||MASK|||UMOL/L|NOT DONE||U|Y|Y|3||39||TREATMENT|1972-04-11||1967-10-16|||1971-11-04||1964-06-25
TRIAL STUDY 134XCP|RP|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MG/KG|||MMHG/SEC|NOT DONE||Y|Y|N|3||39||OPEN LABEL TREATMENT|1964-03-14||1972-07-20|||1972-11-16||1966-08-08
TRIAL STUDY 134XCP|RP|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|1||||||BRTHN|NUMBER OF BIRTHS||||MMOL2/L2|||KG/CM|NOT DONE||N|Y|Y|4||88||WASHOUT|1964-10-30||1963-07-03|||1960-02-26||1962-08-07
TRIAL STUDY 134XCP|RP|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|2||||||BRTHN|NUMBER OF BIRTHS||||BQ/ML|||HZ/S|NOT DONE||U|Y|U|4||88||WASHOUT|1966-04-20||1972-12-29|||1966-04-11||1963-04-17
TRIAL STUDY 134XCP|RP|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||BP|||MM|NOT DONE||N|NA|NA|5||7||CONTINUATION TREATMENT|1966-08-17||1961-01-21|||1972-02-21||1973-08-11
TRIAL STUDY 134XCP|RP|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||KBQ/UL|||1/(S*KPA)|NOT DONE||Y|NA|NA|5||7||OPEN LABEL TREATMENT|1964-02-17||1968-03-20|||1962-03-05||1964-03-17
TRIAL STUDY 134XCP|RP|22B0F097-D571-4E65-9B58-BEF2C3482F05|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MEQ/L|||DRUM|NOT DONE||NA|NA|NA|1||38||FOLLOW-UP|1971-02-04||1970-08-30|||1967-05-25||1967-08-15
TRIAL STUDY 134XCP|RP|22B0F097-D571-4E65-9B58-BEF2C3482F05|2||||||PREGNN|NUMBER OF PREGNANCIES||||BE/ML|||MKAT|NOT DONE||N|U|U|1||38||WASHOUT|1969-04-05||1962-02-22|||1963-01-19||1964-05-23
TRIAL STUDY 134XCP|RP|22B0F097-D571-4E65-9B58-BEF2C3482F05|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||10^7 CFU/ML|||CM/MIN|NOT DONE||N|U|U|2||58||INDUCTION TREATMENT|1972-08-19||1963-01-23|||1965-12-18||1963-08-02
TRIAL STUDY 134XCP|RP|22B0F097-D571-4E65-9B58-BEF2C3482F05|2||||||MASSIND|MASS INDICATOR||||CONTAINER|||CGY|NOT DONE||N|Y|NA|2||58||SCREENING|1973-01-10||1968-04-05|||1963-12-03||1971-03-23
TRIAL STUDY 134XCP|RP|22B0F097-D571-4E65-9B58-BEF2C3482F05|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||CAPLET|||MMOL/S|NOT DONE||U|U|N|3||39||CONTINUATION TREATMENT|1965-09-04||1971-06-23|||1973-04-05||1962-01-19
TRIAL STUDY 134XCP|RP|22B0F097-D571-4E65-9B58-BEF2C3482F05|2||||||BCMETHOD|BIRTH CONTROL METHOD||||CMOL/L|||CMH2O*S2/ML|NOT DONE||Y|N|Y|3||39||BLINDED TREATMENT|1973-02-08||1971-02-25|||1971-10-21||1966-11-14
TRIAL STUDY 134XCP|RP|22B0F097-D571-4E65-9B58-BEF2C3482F05|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||FIU|||PNU/ML|NOT DONE||NA|U|N|4||88||BLINDED TREATMENT|1967-09-18||1966-05-07|||1964-03-25||1968-01-04
TRIAL STUDY 134XCP|RP|22B0F097-D571-4E65-9B58-BEF2C3482F05|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||10^6 CFU/G|||POUCH|NOT DONE||Y|N|NA|4||88||TREATMENT|1960-04-20||1964-03-02|||1967-02-12||1960-03-27
TRIAL STUDY 134XCP|RP|22B0F097-D571-4E65-9B58-BEF2C3482F05|1||||||DLVRMODE|MODE OF DELIVERY||||L/MIN/M2|||FRAMES/S|NOT DONE||NA|U|N|5||7||INDUCTION TREATMENT|1964-07-14||1964-05-14|||1962-10-27||1968-06-16
TRIAL STUDY 134XCP|RP|22B0F097-D571-4E65-9B58-BEF2C3482F05|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||HOUNSFIELD UNIT|||10^9 CFU/G|NOT DONE||N|U|U|5||7||INDUCTION TREATMENT|1961-08-07||1964-03-22|||1962-03-02||1972-04-16
TRIAL STUDY 134XCP|RP|F56B6C70-0513-4032-A0BE-B961F6F2EF30|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||BOX|||ML/SEC/1.73M2|NOT DONE||Y|U|N|1||38||OPEN LABEL TREATMENT|1966-10-24||1968-02-04|||1960-12-16||1964-09-26
TRIAL STUDY 134XCP|RP|F56B6C70-0513-4032-A0BE-B961F6F2EF30|2||||||MENOAGE|MENOPAUSE AGE||||UKAT/L|||G/CAGE/WK|NOT DONE||Y|Y|U|1||38||SCREENING|1969-08-20||1966-03-08|||1968-07-01||1971-12-22
TRIAL STUDY 134XCP|RP|F56B6C70-0513-4032-A0BE-B961F6F2EF30|1||||||ULCERIND|ULCER INDICATOR||||NG/L|||/CMH2O|NOT DONE||Y|N|N|2||58||TREATMENT|1970-12-28||1972-07-13|||1964-01-14||1969-10-02
TRIAL STUDY 134XCP|RP|F56B6C70-0513-4032-A0BE-B961F6F2EF30|2||||||MENOSTAT|MENOPAUSE STATUS||||BE/ML|||U/KG/H|NOT DONE||U|N|U|2||58||SCREENING|1973-03-02||1972-02-25|||1964-10-24||1973-01-14
TRIAL STUDY 134XCP|RP|F56B6C70-0513-4032-A0BE-B961F6F2EF30|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||MV|||10^9/G|NOT DONE||Y|Y|Y|3||39||OBSERVATION|1970-02-21||1967-01-13|||1961-09-24||1965-04-25
TRIAL STUDY 134XCP|RP|F56B6C70-0513-4032-A0BE-B961F6F2EF30|2||||||BLISTIND|BLISTERING INDICATOR||||EP U|||NMOL BCE/L|NOT DONE||U|U|Y|3||39||RUN-IN|1970-08-28||1970-03-17|||1967-02-28||1963-06-14
TRIAL STUDY 134XCP|RP|F56B6C70-0513-4032-A0BE-B961F6F2EF30|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MG/MIN|||PG/L|NOT DONE||NA|NA|U|4||88||FOLLOW-UP|1973-01-18||1964-07-19|||1966-08-20||1963-09-17
TRIAL STUDY 134XCP|RP|F56B6C70-0513-4032-A0BE-B961F6F2EF30|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UMOL/MIN|||CM/MIN|NOT DONE||U|U|U|4||88||RUN-IN|1965-04-06||1962-08-12|||1968-11-08||1967-01-08
TRIAL STUDY 134XCP|RP|F56B6C70-0513-4032-A0BE-B961F6F2EF30|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||VG/DOSE|||PLUG|NOT DONE||U|NA|NA|5||7||OPEN LABEL TREATMENT|1968-01-01||1967-10-13|||1966-06-12||1960-03-24
TRIAL STUDY 134XCP|RP|F56B6C70-0513-4032-A0BE-B961F6F2EF30|2||||||ABORTN|NUMBER OF ABORTIONS||||ML/ANIMAL/WK|||MAMP|NOT DONE||U|Y|Y|5||7||SCREENING|1962-08-11||1973-05-11|||1968-06-19||1960-05-15
TRIAL STUDY 134XCP|RP|8E385A66-25C9-417E-9298-FB87A73B661F|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||CAPLET|||10^9/DOSE|NOT DONE||Y|Y|Y|1||38||CONTINUATION TREATMENT|1967-11-01||1969-04-07|||1966-04-24||1961-01-06
TRIAL STUDY 134XCP|RP|8E385A66-25C9-417E-9298-FB87A73B661F|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||/5X10^4 WBC|||BREATHS/30S|NOT DONE||N|U|N|1||38||WASHOUT|1967-12-11||1972-02-26|||1967-11-27||1962-02-11
TRIAL STUDY 134XCP|RP|8E385A66-25C9-417E-9298-FB87A73B661F|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MG/H|||ENZYME U|NOT DONE||N|U|N|2||58||OPEN LABEL TREATMENT|1965-10-21||1963-12-19|||1968-01-20||1961-07-07
TRIAL STUDY 134XCP|RP|8E385A66-25C9-417E-9298-FB87A73B661F|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||U/MMOL|||UV*SEC|NOT DONE||Y|Y|U|2||58||INDUCTION TREATMENT|1965-11-07||1965-06-15|||1965-06-11||1968-11-16
TRIAL STUDY 134XCP|RP|8E385A66-25C9-417E-9298-FB87A73B661F|1||||||GRAVIND|GRAVIDA INDICATOR||||ENZYME U/M2|||CM2|NOT DONE||NA|N|Y|3||39||CONTINUATION TREATMENT|1960-06-09||1972-07-03|||1966-11-05||1968-01-31
TRIAL STUDY 134XCP|RP|8E385A66-25C9-417E-9298-FB87A73B661F|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UMOL/DL|||MBQ/UL|NOT DONE||NA|N|N|3||39||OPEN LABEL TREATMENT|1967-08-17||1967-03-02|||1969-06-28||1969-07-24
TRIAL STUDY 134XCP|RP|8E385A66-25C9-417E-9298-FB87A73B661F|1||||||RASHIND|RASH INDICATOR||||UG/CM2|||/200 HPFS|NOT DONE||NA|U|N|4||88||OBSERVATION|1963-08-07||1961-12-23|||1962-01-24||1967-08-19
TRIAL STUDY 134XCP|RP|8E385A66-25C9-417E-9298-FB87A73B661F|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||%|||G/DAY|NOT DONE||U|Y|NA|4||88||SCREENING|1967-09-20||1972-01-27|||1971-02-20||1970-05-24
TRIAL STUDY 134XCP|RP|8E385A66-25C9-417E-9298-FB87A73B661F|1||||||PREGST|PREGNANT DURING THE STUDY||||UOSM|||JAR|NOT DONE||U|NA|Y|5||7||RUN-IN|1967-02-27||1960-11-21|||1967-02-17||1971-01-12
TRIAL STUDY 134XCP|RP|8E385A66-25C9-417E-9298-FB87A73B661F|2||||||GRAVIND|GRAVIDA INDICATOR||||UKAT/L|||/5X10^4 WBC|NOT DONE||Y|U|U|5||7||BLINDED TREATMENT|1969-11-30||1968-01-20|||1967-06-29||1962-07-20
TRIAL STUDY 134XCP|RP|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|1||||||MENFDUR|MENSES FLOW DURATION||||DAGU|||MNFI|NOT DONE||Y|N|NA|1||38||SCREENING|1968-04-30||1964-12-18|||1972-01-25||1967-08-27
TRIAL STUDY 134XCP|RP|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|2||||||BRTHN|NUMBER OF BIRTHS||||KM/H|||UG/DOSE|NOT DONE||U|NA|U|1||38||OBSERVATION|1964-12-25||1966-03-10|||1964-01-21||1972-09-07
TRIAL STUDY 134XCP|RP|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|1||||||BCMETHOD|BIRTH CONTROL METHOD||||/2500 WBC|||IN2|NOT DONE||NA|U|NA|2||58||BLINDED TREATMENT|1964-03-25||1966-05-27|||1962-01-25||1964-10-28
TRIAL STUDY 134XCP|RP|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|2||||||FUNDHT|FUNDAL HEIGHT||||LOG EID 50/DOSE|||MG/M2/MIN|NOT DONE||U|NA|N|2||58||OPEN LABEL TREATMENT|1970-02-19||1966-03-27|||1963-03-25||1960-12-28
TRIAL STUDY 134XCP|RP|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||L|||10^9 ORGANISMS/ML|NOT DONE||N|Y|Y|3||39||CONTINUATION TREATMENT|1972-09-27||1968-04-29|||1963-01-30||1966-07-27
TRIAL STUDY 134XCP|RP|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||U/KG|||MOL/ML|NOT DONE||Y|U|NA|3||39||BASELINE|1970-06-29||1967-10-31|||1963-05-09||1972-01-17
TRIAL STUDY 134XCP|RP|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||10^9/G|||MOL/L|NOT DONE||U|NA|N|4||88||FOLLOW-UP|1967-01-07||1962-04-07|||1971-03-31||1968-05-16
TRIAL STUDY 134XCP|RP|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|2||||||GRAVIND|GRAVIDA INDICATOR||||CI/MG|||NMOL|NOT DONE||N|U|U|4||88||OBSERVATION|1962-02-25||1967-03-02|||1966-03-09||1962-09-01
TRIAL STUDY 134XCP|RP|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|1||||||ULCERIND|ULCER INDICATOR||||TORR|||DAGU|NOT DONE||Y|U|NA|5||7||OPEN LABEL TREATMENT|1965-09-11||1965-02-09|||1963-08-03||1966-03-04
TRIAL STUDY 134XCP|RP|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||L/DAY|||UMOL/MIN|NOT DONE||U|N|N|5||7||TREATMENT|1972-10-30||1961-08-25|||1963-09-23||1968-09-08
TRIAL STUDY 134XCP|RP|D0AE2069-B430-4771-9A8C-0F5442DFCECE|1||||||BCMETHOD|BIRTH CONTROL METHOD||||MMOL/G|||OSM|NOT DONE||U|N|N|1||38||LONG-TERM FOLLOW-UP|1968-08-22||1973-08-25|||1973-06-20||1972-10-02
TRIAL STUDY 134XCP|RP|D0AE2069-B430-4771-9A8C-0F5442DFCECE|2||||||DSCHGIND|DISCHARGE INDICATOR||||PIXEL|||MBP|NOT DONE||NA|NA|U|1||38||CONTINUATION TREATMENT|1965-07-12||1962-10-18|||1965-10-29||1967-01-24
TRIAL STUDY 134XCP|RP|D0AE2069-B430-4771-9A8C-0F5442DFCECE|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UG/DL|||PSEC|NOT DONE||Y|N|N|2||58||CONTINUATION TREATMENT|1965-09-18||1962-10-13|||1966-07-17||1973-05-29
TRIAL STUDY 134XCP|RP|D0AE2069-B430-4771-9A8C-0F5442DFCECE|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||FG|||DPM/ML|NOT DONE||N|NA|N|2||58||BLINDED TREATMENT|1963-05-13||1968-10-06|||1963-12-29||1972-08-29
TRIAL STUDY 134XCP|RP|D0AE2069-B430-4771-9A8C-0F5442DFCECE|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||NMOL/L/H|||CI/MG|NOT DONE||Y|Y|N|3||39||WASHOUT|1961-08-26||1961-06-11|||1962-10-20||1973-07-13
TRIAL STUDY 134XCP|RP|D0AE2069-B430-4771-9A8C-0F5442DFCECE|2||||||INTP|INTERPRETATION||||BQ/ML|||HOMEOPATHIC DILUTION|NOT DONE||NA|NA|Y|3||39||WASHOUT|1965-07-31||1966-11-02|||1969-09-07||1972-02-08
TRIAL STUDY 134XCP|RP|D0AE2069-B430-4771-9A8C-0F5442DFCECE|1||||||MENFDUR|MENSES FLOW DURATION||||GY/MIN|||UG/L|NOT DONE||N|N|N|4||88||SCREENING|1964-09-05||1968-05-08|||1969-08-15||1963-11-10
TRIAL STUDY 134XCP|RP|D0AE2069-B430-4771-9A8C-0F5442DFCECE|2||||||ABORTN|NUMBER OF ABORTIONS||||ML/ANIMAL/WK|||KIU|NOT DONE||Y|U|NA|4||88||SCREENING|1966-08-03||1963-02-18|||1970-01-05||1971-04-19
TRIAL STUDY 134XCP|RP|D0AE2069-B430-4771-9A8C-0F5442DFCECE|1||||||MENOSTAT|MENOPAUSE STATUS||||UG/DOSE|||MCI/L|NOT DONE||Y|N|N|5||7||BASELINE|1961-01-05||1969-09-17|||1972-07-04||1972-06-09
TRIAL STUDY 134XCP|RP|D0AE2069-B430-4771-9A8C-0F5442DFCECE|2||||||BLISTIND|BLISTERING INDICATOR||||UG/DAY|||CAPFUL|NOT DONE||NA|U|Y|5||7||RUN-IN|1972-09-22||1969-06-19|||1973-05-18||1970-09-13
TRIAL STUDY 134XCP|RP|CF214007-AC24-4760-AEDE-F78CDE3D9351|1||||||DSCHGIND|DISCHARGE INDICATOR||||MG/KG/DOSE|||/WK|NOT DONE||NA|N|U|1||38||OBSERVATION|1960-10-06||1962-09-09|||1973-04-13||1965-03-26
TRIAL STUDY 134XCP|RP|CF214007-AC24-4760-AEDE-F78CDE3D9351|2||||||TNDRIND|TENDERNESS INDICATOR||||U/L|||L/MIN/M2|NOT DONE||NA|N|N|1||38||BASELINE|1967-12-09||1962-05-25|||1973-09-05||1965-03-01
TRIAL STUDY 134XCP|RP|CF214007-AC24-4760-AEDE-F78CDE3D9351|1||||||RASHIND|RASH INDICATOR||||MEQ/UL|||GENEQ/ML|NOT DONE||NA|U|NA|2||58||OPEN LABEL TREATMENT|1970-11-20||1970-03-06|||1963-09-17||1971-01-29
TRIAL STUDY 134XCP|RP|CF214007-AC24-4760-AEDE-F78CDE3D9351|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||/HPF|||UG/G/DAY|NOT DONE||U|U|NA|2||58||INDUCTION TREATMENT|1973-01-14||1973-06-29|||1960-12-31||1971-09-25
TRIAL STUDY 134XCP|RP|CF214007-AC24-4760-AEDE-F78CDE3D9351|1||||||ABORTN|NUMBER OF ABORTIONS||||PMOL/G|||FL|NOT DONE||U|N|N|3||39||OBSERVATION|1961-12-28||1963-11-12|||1970-04-19||1963-10-23
TRIAL STUDY 134XCP|RP|CF214007-AC24-4760-AEDE-F78CDE3D9351|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UMOL/H/MMOL|||EQ|NOT DONE||Y|N|N|3||39||CONTINUATION TREATMENT|1964-03-06||1968-05-06|||1968-02-23||1971-12-27
TRIAL STUDY 134XCP|RP|CF214007-AC24-4760-AEDE-F78CDE3D9351|1||||||ULCERIND|ULCER INDICATOR||||FMOL/G|||CD/M2|NOT DONE||NA|N|Y|4||88||WASHOUT|1965-10-11||1968-08-27|||1961-08-05||1963-08-02
TRIAL STUDY 134XCP|RP|CF214007-AC24-4760-AEDE-F78CDE3D9351|2||||||DSCHGIND|DISCHARGE INDICATOR||||ANTI-XA IU/ML|||ML/MIN/1.73M2|NOT DONE||Y|N|N|4||88||TREATMENT|1967-01-22||1968-06-27|||1964-08-23||1972-12-17
TRIAL STUDY 134XCP|RP|CF214007-AC24-4760-AEDE-F78CDE3D9351|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||SV|||IN|NOT DONE||NA|U|Y|5||7||TREATMENT|1972-12-14||1968-07-05|||1961-09-20||1967-08-21
TRIAL STUDY 134XCP|RP|CF214007-AC24-4760-AEDE-F78CDE3D9351|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MMOL/L|||L|NOT DONE||N|N|Y|5||7||WASHOUT|1969-03-03||1969-07-20|||1966-09-26||1972-10-09
TRIAL STUDY 134XCP|RP|E996BE19-2824-49D3-944F-B777F3D8E746|1||||||DLVRMODE|MODE OF DELIVERY||||ML/BREATH|||STEPS/MIN|NOT DONE||U|Y|Y|1||38||TREATMENT|1966-01-01||1963-08-09|||1970-03-05||1970-08-05
TRIAL STUDY 134XCP|RP|E996BE19-2824-49D3-944F-B777F3D8E746|2||||||TNDRIND|TENDERNESS INDICATOR||||NMOL BCE/L|||KIT|NOT DONE||U|Y|NA|1||38||OPEN LABEL TREATMENT|1961-02-05||1973-03-12|||1972-01-15||1965-01-21
TRIAL STUDY 134XCP|RP|E996BE19-2824-49D3-944F-B777F3D8E746|1||||||ABORTN|NUMBER OF ABORTIONS||||MG/G/MIN|||U/G HB|NOT DONE||N|Y|NA|2||58||LONG-TERM FOLLOW-UP|1972-11-18||1968-06-11|||1969-07-06||1963-03-26
TRIAL STUDY 134XCP|RP|E996BE19-2824-49D3-944F-B777F3D8E746|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||POUCH|||TCID 50/DOSE|NOT DONE||Y|N|N|2||58||LONG-TERM FOLLOW-UP|1969-07-24||1968-06-15|||1972-04-06||1963-06-05
TRIAL STUDY 134XCP|RP|E996BE19-2824-49D3-944F-B777F3D8E746|1||||||PEELIND|PEELING INDICATOR||||MG/DL|||MG/M2|NOT DONE||NA|N|NA|3||39||CONTINUATION TREATMENT|1972-05-17||1963-10-30|||1960-06-05||1969-11-27
TRIAL STUDY 134XCP|RP|E996BE19-2824-49D3-944F-B777F3D8E746|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MNFI|||H/WK|NOT DONE||Y|NA|N|3||39||CONTINUATION TREATMENT|1962-06-12||1968-01-03|||1972-05-09||1961-09-07
TRIAL STUDY 134XCP|RP|E996BE19-2824-49D3-944F-B777F3D8E746|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||ML/BEAT|||BE/ML|NOT DONE||NA|U|NA|4||88||WASHOUT|1967-02-25||1969-10-28|||1961-11-21||1969-09-18
TRIAL STUDY 134XCP|RP|E996BE19-2824-49D3-944F-B777F3D8E746|2||||||EDEMAIND|EDEMA INDICATOR||||CM|||CD/M2|NOT DONE||U|Y|U|4||88||OBSERVATION|1966-02-16||1969-03-02|||1960-08-15||1967-01-21
TRIAL STUDY 134XCP|RP|E996BE19-2824-49D3-944F-B777F3D8E746|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||10^6 ORGANISMS/G|||/100 HPFS|NOT DONE||Y|NA|NA|5||7||RUN-IN|1966-07-22||1964-06-19|||1968-09-19||1967-03-25
TRIAL STUDY 134XCP|RP|E996BE19-2824-49D3-944F-B777F3D8E746|2||||||MENOSTAT|MENOPAUSE STATUS||||DB|||MG/DL|NOT DONE||U|U|N|5||7||WASHOUT|1962-01-07||1966-12-24|||1972-04-27||1964-04-25
TRIAL STUDY 134XCP|RP|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UMOL/MOL|||RATIO|NOT DONE||Y|NA|Y|1||38||FOLLOW-UP|1971-10-16||1969-08-01|||1964-04-13||1972-01-12
TRIAL STUDY 134XCP|RP|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||EVENTS|||PNU/ML|NOT DONE||Y|U|Y|1||38||TREATMENT|1967-11-26||1970-11-17|||1967-12-02||1969-04-24
TRIAL STUDY 134XCP|RP|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|1||||||PREGNN|NUMBER OF PREGNANCIES||||L|||MOL/MOL|NOT DONE||N|Y|NA|2||58||FOLLOW-UP|1972-04-14||1963-04-06|||1973-07-22||1964-09-24
TRIAL STUDY 134XCP|RP|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MG/KG/MIN|||NMOL BCE/L|NOT DONE||U|Y|Y|2||58||OBSERVATION|1970-06-26||1972-07-20|||1962-09-04||1965-02-10
TRIAL STUDY 134XCP|RP|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MV/SEC|||/WK|NOT DONE||U|N|Y|3||39||RUN-IN|1960-01-09||1968-11-28|||1969-06-19||1960-03-28
TRIAL STUDY 134XCP|RP|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|2||||||BLISTIND|BLISTERING INDICATOR||||BQ/KG|||U/M2/DAY|NOT DONE||N|NA|U|3||39||BLINDED TREATMENT|1960-03-23||1967-02-12|||1972-04-09||1968-07-08
TRIAL STUDY 134XCP|RP|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||DROP|||FMOL/L|NOT DONE||Y|Y|NA|4||88||INDUCTION TREATMENT|1966-12-15||1970-05-14|||1970-08-30||1961-05-27
TRIAL STUDY 134XCP|RP|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MG/KG/DOSE|||U/KG/MIN|NOT DONE||Y|N|N|4||88||LONG-TERM FOLLOW-UP|1973-03-14||1973-04-11|||1966-11-14||1970-12-06
TRIAL STUDY 134XCP|RP|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||IU/ML|||ML/ANIMAL/DAY|NOT DONE||N|N|NA|5||7||BLINDED TREATMENT|1966-09-04||1971-06-08|||1961-12-28||1965-02-15
TRIAL STUDY 134XCP|RP|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|2||||||MENFDUR|MENSES FLOW DURATION||||NSEC|||PG/CELL|NOT DONE||U|U|N|5||7||FOLLOW-UP|1963-12-22||1964-08-30|||1969-09-15||1969-02-11
TRIAL STUDY 134XCP|RP|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||BP|||PSEC|NOT DONE||N|Y|NA|1||38||LONG-TERM FOLLOW-UP|1961-03-17||1972-01-22|||1962-12-05||1967-12-13
TRIAL STUDY 134XCP|RP|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||GY/MIN|||ANTIBODY UNIT|NOT DONE||NA|NA|U|1||38||CONTINUATION TREATMENT|1965-10-17||1969-02-11|||1964-05-18||1970-06-24
TRIAL STUDY 134XCP|RP|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|1||||||PREGIND|PREGNANT INDICATOR||||/H|||10^3 ORGANISMS/G|NOT DONE||N|N|U|2||58||FOLLOW-UP|1966-01-05||1960-05-15|||1972-07-11||1963-11-18
TRIAL STUDY 134XCP|RP|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||DRUM|||TUBERCULIN UNIT/ML|NOT DONE||N|NA|NA|2||58||SCREENING|1960-09-20||1960-03-16|||1968-06-27||1969-09-26
TRIAL STUDY 134XCP|RP|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||DRAM|||ABSORBANCE U/ML|NOT DONE||Y|NA|N|3||39||WASHOUT|1961-09-29||1969-02-12|||1972-08-10||1964-12-15
TRIAL STUDY 134XCP|RP|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|2||||||MENFDUR|MENSES FLOW DURATION||||ABSORBANCE U/ML|||COPIES/UG|NOT DONE||U|NA|Y|3||39||RUN-IN|1969-05-23||1969-12-21|||1972-04-22||1967-05-24
TRIAL STUDY 134XCP|RP|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||LOG10 TCID 50/ML|||UMOL/L/SEC|NOT DONE||NA|NA|Y|4||88||TREATMENT|1963-06-24||1970-04-09|||1968-11-09||1967-01-14
TRIAL STUDY 134XCP|RP|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|2||||||PRGENDTC|DATE PREGNANCY ENDED||||DAGU|||DROP|NOT DONE||U|NA|U|4||88||LONG-TERM FOLLOW-UP|1967-09-11||1969-05-26|||1960-01-16||1965-05-12
TRIAL STUDY 134XCP|RP|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MPA|||AG|NOT DONE||Y|N|N|5||7||FOLLOW-UP|1972-11-03||1962-01-07|||1962-08-31||1969-01-19
TRIAL STUDY 134XCP|RP|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|2||||||PUSTIND|PUSTULE INDICATOR||||/HPF|||MBQ/UL|NOT DONE||U|U|Y|5||7||FOLLOW-UP|1972-08-23||1970-02-26|||1960-08-04||1961-07-20
TRIAL STUDY 134XCP|RP|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||ABSORBANCE U/ML|||10^12 IU/L|NOT DONE||Y|NA|N|1||38||BLINDED TREATMENT|1972-11-18||1961-03-26|||1964-09-01||1960-09-13
TRIAL STUDY 134XCP|RP|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||VOXEL|||SHOCK WAVE|NOT DONE||U|Y|NA|1||38||RUN-IN|1971-06-03||1968-10-17|||1963-06-13||1960-07-03
TRIAL STUDY 134XCP|RP|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|1||||||ULCERIND|ULCER INDICATOR||||HOURS|||10^5/HPF|NOT DONE||N|NA|NA|2||58||RUN-IN|1960-07-24||1973-05-15|||1968-06-03||1972-11-20
TRIAL STUDY 134XCP|RP|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|2||||||TNDRIND|TENDERNESS INDICATOR||||FMOL/L/SEC|||MMOL/KG|NOT DONE||U|NA|Y|2||58||FOLLOW-UP|1967-12-19||1971-03-19|||1971-07-29||1970-06-12
TRIAL STUDY 134XCP|RP|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ML/CAGE/DAY|||10^3 ORGANISMS/ML|NOT DONE||Y|Y|U|3||39||OPEN LABEL TREATMENT|1966-01-11||1968-12-26|||1960-01-24||1967-02-06
TRIAL STUDY 134XCP|RP|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||PSI|||UV|NOT DONE||NA|U|N|3||39||OBSERVATION|1968-09-14||1968-04-29|||1965-03-27||1970-09-27
TRIAL STUDY 134XCP|RP|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||U/G|||KM|NOT DONE||N|NA|NA|4||88||BLINDED TREATMENT|1963-06-06||1972-09-29|||1971-11-13||1968-12-08
TRIAL STUDY 134XCP|RP|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|2||||||TNDRIND|TENDERNESS INDICATOR||||/500 WBC|||CI/L|NOT DONE||Y|NA|NA|4||88||OBSERVATION|1962-10-09||1972-03-07|||1971-01-06||1967-06-19
TRIAL STUDY 134XCP|RP|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||ML/ANIMAL/WK|||MCI/L|NOT DONE||U|N|N|5||7||BLINDED TREATMENT|1964-03-23||1963-04-30|||1972-01-28||1966-08-02
TRIAL STUDY 134XCP|RP|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||KM|||10^5/HPF|NOT DONE||U|N|N|5||7||SCREENING|1970-08-08||1964-12-06|||1972-07-07||1961-04-12
TRIAL STUDY 134XCP|RP|1F75D53C-E8AA-45DA-8410-F00266080E80|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||DEG2|||CG|NOT DONE||U|N|U|1||38||FOLLOW-UP|1973-09-06||1968-01-08|||1965-03-14||1966-03-31
TRIAL STUDY 134XCP|RP|1F75D53C-E8AA-45DA-8410-F00266080E80|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||DRAM|||GRAVITATIONAL UNIT|NOT DONE||NA|U|NA|1||38||FOLLOW-UP|1960-01-24||1971-04-20|||1964-05-27||1971-12-20
TRIAL STUDY 134XCP|RP|1F75D53C-E8AA-45DA-8410-F00266080E80|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||ML/MMHG|||MIN|NOT DONE||Y|U|N|2||58||BLINDED TREATMENT|1971-12-17||1961-11-03|||1967-08-16||1973-02-26
TRIAL STUDY 134XCP|RP|1F75D53C-E8AA-45DA-8410-F00266080E80|2||||||MENFDUR|MENSES FLOW DURATION||||MANSON U/ML|||CD|NOT DONE||U|U|NA|2||58||OBSERVATION|1960-12-19||1964-04-24|||1960-12-21||1964-09-21
TRIAL STUDY 134XCP|RP|1F75D53C-E8AA-45DA-8410-F00266080E80|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||APL U|||MM/2H|NOT DONE||Y|NA|N|3||39||BLINDED TREATMENT|1963-05-17||1966-07-19|||1970-05-23||1963-11-29
TRIAL STUDY 134XCP|RP|1F75D53C-E8AA-45DA-8410-F00266080E80|2||||||MASSIND|MASS INDICATOR||||GRAIN|||PSI|NOT DONE||Y|Y|U|3||39||SCREENING|1968-02-12||1964-10-15|||1970-05-29||1971-02-12
TRIAL STUDY 134XCP|RP|1F75D53C-E8AA-45DA-8410-F00266080E80|1||||||PREGST|PREGNANT DURING THE STUDY||||PG/DL|||KM/H|NOT DONE||U|NA|U|4||88||BLINDED TREATMENT|1968-02-11||1971-04-08|||1969-12-23||1965-01-31
TRIAL STUDY 134XCP|RP|1F75D53C-E8AA-45DA-8410-F00266080E80|2||||||RASHIND|RASH INDICATOR||||CP|||AFU|NOT DONE||N|N|U|4||88||BASELINE|1961-08-03||1968-02-18|||1961-08-09||1967-05-18
TRIAL STUDY 134XCP|RP|1F75D53C-E8AA-45DA-8410-F00266080E80|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UG/M2/MIN|||PMOL/DL|NOT DONE||Y|Y|NA|5||7||BASELINE|1965-12-23||1964-02-18|||1973-05-01||1972-12-22
TRIAL STUDY 134XCP|RP|1F75D53C-E8AA-45DA-8410-F00266080E80|2||||||PEELIND|PEELING INDICATOR||||APL U|||ML/H|NOT DONE||Y|Y|U|5||7||LONG-TERM FOLLOW-UP|1960-08-21||1961-06-16|||1968-06-29||1967-12-07
TRIAL STUDY 134XCP|RP|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|1||||||DLVRMODE|MODE OF DELIVERY||||NG|||NEBULE|NOT DONE||Y|NA|U|1||38||LONG-TERM FOLLOW-UP|1966-09-28||1970-09-20|||1971-05-29||1961-11-12
TRIAL STUDY 134XCP|RP|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|2||||||BCMETHOD|BIRTH CONTROL METHOD||||PSI|||DISK|NOT DONE||U|N|U|1||38||BLINDED TREATMENT|1973-01-19||1971-02-06|||1970-08-17||1965-02-20
TRIAL STUDY 134XCP|RP|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|1||||||PREGIND|PREGNANT INDICATOR||||MBP|||DB|NOT DONE||U|N|NA|2||58||RUN-IN|1962-04-04||1962-01-10|||1968-05-27||1960-10-17
TRIAL STUDY 134XCP|RP|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|2||||||ULCERIND|ULCER INDICATOR||||UG/G/DAY|||/MONTH|NOT DONE||Y|NA|NA|2||58||BLINDED TREATMENT|1965-04-17||1969-07-07|||1968-04-16||1968-02-08
TRIAL STUDY 134XCP|RP|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|1||||||INABOIND|INDUCED ABORTION INDICATOR||||ML/DAY|||100 IU/ML|NOT DONE||N|NA|Y|3||39||OBSERVATION|1972-02-19||1963-11-05|||1970-06-30||1968-10-08
TRIAL STUDY 134XCP|RP|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|2||||||BRTHN|NUMBER OF BIRTHS||||KHZ|||GBQ|NOT DONE||U|NA|NA|3||39||FOLLOW-UP|1963-05-22||1968-11-03|||1964-03-31||1968-09-17
TRIAL STUDY 134XCP|RP|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MG/G/H|||PIXEL|NOT DONE||N|NA|Y|4||88||BLINDED TREATMENT|1971-06-15||1966-12-09|||1962-02-28||1971-07-16
TRIAL STUDY 134XCP|RP|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||PFU/DOSE|||ML/CM|NOT DONE||U|NA|U|4||88||BLINDED TREATMENT|1964-06-12||1965-08-13|||1966-06-07||1967-04-04
TRIAL STUDY 134XCP|RP|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|1||||||BLISTIND|BLISTERING INDICATOR||||TORR|||UMOL/L/H|NOT DONE||U|Y|N|5||7||FOLLOW-UP|1964-10-08||1970-05-01|||1972-01-24||1961-06-17
TRIAL STUDY 134XCP|RP|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||APL U|||IU/L|NOT DONE||NA|NA|NA|5||7||OPEN LABEL TREATMENT|1965-06-01||1971-11-25|||1962-12-14||1972-09-22
TRIAL STUDY 134XCP|RP|EE14E53E-19A8-4441-BF82-31444CBC8B49|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||LOG10 COPIES/ML|||MMOL/DAY|NOT DONE||NA|NA|U|1||38||BASELINE|1971-11-02||1965-12-24|||1962-04-24||1966-09-18
TRIAL STUDY 134XCP|RP|EE14E53E-19A8-4441-BF82-31444CBC8B49|2||||||ULCERIND|ULCER INDICATOR||||U/MMOL|||G/KG|NOT DONE||N|Y|N|1||38||RUN-IN|1972-05-18||1968-07-26|||1971-09-14||1968-03-29
TRIAL STUDY 134XCP|RP|EE14E53E-19A8-4441-BF82-31444CBC8B49|1||||||RASHIND|RASH INDICATOR||||CI/ML|||UCI/KG|NOT DONE||NA|N|NA|2||58||WASHOUT|1961-11-19||1965-06-03|||1973-01-17||1964-02-05
TRIAL STUDY 134XCP|RP|EE14E53E-19A8-4441-BF82-31444CBC8B49|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||ML/KG/H|||UL/ML|NOT DONE||U|Y|Y|2||58||FOLLOW-UP|1973-03-03||1960-01-29|||1971-01-02||1960-12-30
TRIAL STUDY 134XCP|RP|EE14E53E-19A8-4441-BF82-31444CBC8B49|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MG/H|||FINGERTIP UNIT|NOT DONE||N|N|U|3||39||OPEN LABEL TREATMENT|1962-07-15||1963-08-18|||1972-10-17||1968-09-22
TRIAL STUDY 134XCP|RP|EE14E53E-19A8-4441-BF82-31444CBC8B49|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||NMOL/KG/DAY|||LOG10 CCID 50/DOSE|NOT DONE||NA|U|Y|3||39||BASELINE|1968-06-14||1961-08-20|||1962-11-16||1966-06-09
TRIAL STUDY 134XCP|RP|EE14E53E-19A8-4441-BF82-31444CBC8B49|1||||||BLISTIND|BLISTERING INDICATOR||||UG/H|||FG|NOT DONE||Y|N|N|4||88||SCREENING|1963-08-05||1970-12-19|||1966-12-03||1971-11-04
TRIAL STUDY 134XCP|RP|EE14E53E-19A8-4441-BF82-31444CBC8B49|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||CI/UL|||MOL/MG|NOT DONE||Y|U|N|4||88||OBSERVATION|1961-10-10||1962-05-06|||1965-05-28||1970-05-15
TRIAL STUDY 134XCP|RP|EE14E53E-19A8-4441-BF82-31444CBC8B49|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||GY|||MMOL/S|NOT DONE||U|N|Y|5||7||OPEN LABEL TREATMENT|1970-04-23||1963-03-31|||1965-03-29||1968-12-01
TRIAL STUDY 134XCP|RP|EE14E53E-19A8-4441-BF82-31444CBC8B49|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UMOL|||ML/CAGE/DAY|NOT DONE||Y|Y|Y|5||7||INDUCTION TREATMENT|1969-06-12||1965-03-31|||1963-04-22||1963-08-31
TRIAL STUDY 134XCP|RP|DAF741EF-DCCF-4E18-844B-05640A94C181|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||DEG2|||% INHIBITION|NOT DONE||U|U|Y|1||38||FOLLOW-UP|1967-11-20||1960-02-03|||1966-06-07||1961-04-25
TRIAL STUDY 134XCP|RP|DAF741EF-DCCF-4E18-844B-05640A94C181|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||IN|||POUCH|NOT DONE||Y|U|U|1||38||OBSERVATION|1962-12-19||1965-01-16|||1960-02-14||1967-11-11
TRIAL STUDY 134XCP|RP|DAF741EF-DCCF-4E18-844B-05640A94C181|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||FIU|||CFU/G|NOT DONE||Y|U|NA|2||58||WASHOUT|1967-04-07||1962-09-12|||1969-03-14||1967-05-14
TRIAL STUDY 134XCP|RP|DAF741EF-DCCF-4E18-844B-05640A94C181|2||||||PUSTIND|PUSTULE INDICATOR||||PIXEL|||U/M2/H|NOT DONE||U|U|NA|2||58||RUN-IN|1966-08-02||1961-07-20|||1964-02-16||1960-10-26
TRIAL STUDY 134XCP|RP|DAF741EF-DCCF-4E18-844B-05640A94C181|1||||||ABORTN|NUMBER OF ABORTIONS||||DRUM|||IU/G|NOT DONE||U|U|N|3||39||BASELINE|1961-12-24||1961-11-11|||1968-11-20||1970-05-17
TRIAL STUDY 134XCP|RP|DAF741EF-DCCF-4E18-844B-05640A94C181|2||||||PREGNN|NUMBER OF PREGNANCIES||||FOZ_BR|||NCI|NOT DONE||U|Y|U|3||39||WASHOUT|1966-05-13||1972-12-27|||1972-11-19||1963-01-05
TRIAL STUDY 134XCP|RP|DAF741EF-DCCF-4E18-844B-05640A94C181|1||||||INTP|INTERPRETATION||||NEWTON|||CMOL/L|NOT DONE||Y|NA|NA|4||88||SCREENING|1971-06-01||1964-03-28|||1970-09-01||1970-03-20
TRIAL STUDY 134XCP|RP|DAF741EF-DCCF-4E18-844B-05640A94C181|2||||||BLISTIND|BLISTERING INDICATOR||||UV2|||NMOL/L/H|NOT DONE||U|Y|U|4||88||FOLLOW-UP|1964-01-31||1967-08-24|||1967-10-26||1960-08-05
TRIAL STUDY 134XCP|RP|DAF741EF-DCCF-4E18-844B-05640A94C181|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UM/DAY|||UU/L|NOT DONE||N|Y|Y|5||7||INDUCTION TREATMENT|1964-07-14||1970-02-22|||1970-09-17||1963-04-14
TRIAL STUDY 134XCP|RP|DAF741EF-DCCF-4E18-844B-05640A94C181|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ABSORBANCE U/ML|||MMHG/SEC|NOT DONE||NA|Y|Y|5||7||WASHOUT|1965-07-25||1964-08-21|||1966-09-16||1966-12-05
TRIAL STUDY 134XCP|RP|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|1||||||INABOIND|INDUCED ABORTION INDICATOR||||10^5/HPF|||AMU|NOT DONE||U|N|NA|1||38||OPEN LABEL TREATMENT|1964-09-19||1960-08-19|||1961-07-11||1971-04-16
TRIAL STUDY 134XCP|RP|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|2||||||DLVRMODE|MODE OF DELIVERY||||MIU/L|||TRANSDUCING UNIT|NOT DONE||U|NA|Y|1||38||CONTINUATION TREATMENT|1972-01-01||1967-12-02|||1970-03-15||1966-04-30
TRIAL STUDY 134XCP|RP|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MDFI|||10^3 COPIES/ML|NOT DONE||Y|Y|NA|2||58||OPEN LABEL TREATMENT|1963-04-22||1973-03-02|||1964-01-15||1964-07-09
TRIAL STUDY 134XCP|RP|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^6/HPF|||ML/CM3/MIN|NOT DONE||U|NA|U|2||58||INDUCTION TREATMENT|1960-05-08||1968-10-26|||1964-08-25||1971-07-17
TRIAL STUDY 134XCP|RP|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|1||||||PRGENDTC|DATE PREGNANCY ENDED||||U/10^12 RBC|||ML/KG|NOT DONE||NA|Y|N|3||39||RUN-IN|1961-06-30||1960-02-07|||1960-06-20||1963-06-27
TRIAL STUDY 134XCP|RP|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||U/G/DAY|||TAMPON|NOT DONE||N|N|N|3||39||RUN-IN|1965-04-03||1973-05-07|||1961-03-28||1966-09-09
TRIAL STUDY 134XCP|RP|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||DROP|||U/M2/MIN|NOT DONE||NA|U|N|4||88||OBSERVATION|1962-05-10||1971-11-21|||1962-01-02||1966-11-19
TRIAL STUDY 134XCP|RP|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|2||||||MENFDUR|MENSES FLOW DURATION||||DAGU/ML|||VIRTUAL PIXEL|NOT DONE||U|U|U|4||88||WASHOUT|1966-11-12||1968-10-25|||1972-06-23||1967-08-17
TRIAL STUDY 134XCP|RP|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||DEG2|||K|NOT DONE||U|N|U|5||7||SCREENING|1964-04-15||1960-10-15|||1967-10-19||1962-05-30
TRIAL STUDY 134XCP|RP|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||ML/M2|||ML/MIN|NOT DONE||U|N|NA|5||7||OPEN LABEL TREATMENT|1966-02-25||1971-01-13|||1964-12-24||1969-05-09
TRIAL STUDY 134XCP|RP|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|1||||||ABORTN|NUMBER OF ABORTIONS||||UKAT/L|||VOXEL|NOT DONE||Y|N|N|1||38||FOLLOW-UP|1970-03-19||1964-12-27|||1962-12-15||1965-03-22
TRIAL STUDY 134XCP|RP|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|2||||||MENOSTAT|MENOPAUSE STATUS||||OZ EQ|||MG/L|NOT DONE||N|Y|N|1||38||RUN-IN|1961-01-27||1965-07-15|||1971-03-21||1970-10-21
TRIAL STUDY 134XCP|RP|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|1||||||PREGST|PREGNANT DURING THE STUDY||||10^6 ORGANISMS/MG|||10^3 COPIES/ML|NOT DONE||NA|U|Y|2||58||FOLLOW-UP|1965-03-17||1968-11-16|||1969-10-31||1972-09-08
TRIAL STUDY 134XCP|RP|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||IU/G HB|||UMOL/DL|NOT DONE||Y|Y|N|2||58||INDUCTION TREATMENT|1965-06-28||1962-09-27|||1965-11-27||1969-08-15
TRIAL STUDY 134XCP|RP|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MG/DAY|||ML/M2/MIN|NOT DONE||N|Y|NA|3||39||OPEN LABEL TREATMENT|1968-11-28||1963-10-05|||1966-05-07||1966-02-15
TRIAL STUDY 134XCP|RP|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||STEPS|||10^6/HPF|NOT DONE||U|U|N|3||39||RUN-IN|1969-10-14||1962-02-06|||1971-07-26||1961-06-25
TRIAL STUDY 134XCP|RP|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|1||||||GRAVIND|GRAVIDA INDICATOR||||UMOL/MG/MIN|||PA|NOT DONE||U|NA|NA|4||88||SCREENING|1966-10-18||1962-04-29|||1968-02-09||1963-11-04
TRIAL STUDY 134XCP|RP|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|2||||||PREGNN|NUMBER OF PREGNANCIES||||MM/H|||BREATHS/MIN|NOT DONE||N|U|Y|4||88||BASELINE|1964-12-27||1966-08-24|||1963-11-13||1965-03-19
TRIAL STUDY 134XCP|RP|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||GTT|||GBQ/G|NOT DONE||U|Y|N|5||7||SCREENING|1966-05-25||1968-03-14|||1973-07-07||1970-12-10
TRIAL STUDY 134XCP|RP|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||/2500 WBC|||IU/KG/H|NOT DONE||N|N|U|5||7||LONG-TERM FOLLOW-UP|1972-12-21||1960-06-22|||1969-09-24||1964-03-28
TRIAL STUDY 134XCP|RP|CF3E1636-762F-4821-A44E-455F33F5E4CC|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||L/KG|||UIU/L|NOT DONE||U|U|NA|1||38||BASELINE|1971-07-25||1972-10-03|||1964-10-27||1965-10-21
TRIAL STUDY 134XCP|RP|CF3E1636-762F-4821-A44E-455F33F5E4CC|2||||||MENFDUR|MENSES FLOW DURATION||||LENS|||ENZYME U|NOT DONE||NA|N|U|1||38||LONG-TERM FOLLOW-UP|1971-12-10||1967-05-05|||1972-02-26||1968-05-02
TRIAL STUDY 134XCP|RP|CF3E1636-762F-4821-A44E-455F33F5E4CC|1||||||ABORTN|NUMBER OF ABORTIONS||||MMOL/MIN/KPA/L|||PLUG|NOT DONE||Y|N|N|2||58||BASELINE|1967-11-10||1964-12-05|||1962-04-06||1968-10-27
TRIAL STUDY 134XCP|RP|CF3E1636-762F-4821-A44E-455F33F5E4CC|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||DAYS|||USP U|NOT DONE||U|Y|U|2||58||INDUCTION TREATMENT|1972-08-17||1970-03-02|||1960-12-27||1969-07-26
TRIAL STUDY 134XCP|RP|CF3E1636-762F-4821-A44E-455F33F5E4CC|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||PMOL/L|||HOMEOPATHIC DILUTION|NOT DONE||Y|U|NA|3||39||INDUCTION TREATMENT|1969-04-03||1963-09-05|||1960-01-04||1960-12-15
TRIAL STUDY 134XCP|RP|CF3E1636-762F-4821-A44E-455F33F5E4CC|2||||||BLISTIND|BLISTERING INDICATOR||||APL U/ML|||CP|NOT DONE||NA|U|U|3||39||INDUCTION TREATMENT|1969-02-16||1962-11-11|||1968-05-12||1964-03-29
TRIAL STUDY 134XCP|RP|CF3E1636-762F-4821-A44E-455F33F5E4CC|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||G/CM2|||FIU|NOT DONE||U|NA|NA|4||88||CONTINUATION TREATMENT|1960-04-18||1965-09-23|||1967-04-11||1972-02-01
TRIAL STUDY 134XCP|RP|CF3E1636-762F-4821-A44E-455F33F5E4CC|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||L/S/KPA|||MG/KG/DAY|NOT DONE||U|U|NA|4||88||BASELINE|1971-03-24||1964-08-13|||1970-01-06||1973-01-13
TRIAL STUDY 134XCP|RP|CF3E1636-762F-4821-A44E-455F33F5E4CC|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||UKAT/L|||ML/BEAT|NOT DONE||N|Y|NA|5||7||LONG-TERM FOLLOW-UP|1961-03-25||1964-10-29|||1970-05-29||1963-03-02
TRIAL STUDY 134XCP|RP|CF3E1636-762F-4821-A44E-455F33F5E4CC|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||JAR|||U/G/MIN|NOT DONE||NA|NA|U|5||7||SCREENING|1966-03-01||1966-04-08|||1972-09-18||1962-04-01
TRIAL STUDY 134XCP|RP|3846A0A8-2D38-44C9-A579-84C66315C436|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MEQ|||MN|NOT DONE||NA|Y|NA|1||38||BASELINE|1966-03-11||1967-01-06|||1973-01-17||1969-01-31
TRIAL STUDY 134XCP|RP|3846A0A8-2D38-44C9-A579-84C66315C436|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||G/ANIMAL|||APL U/ML|NOT DONE||U|U|Y|1||38||BLINDED TREATMENT|1963-11-06||1960-10-31|||1972-01-16||1966-04-07
TRIAL STUDY 134XCP|RP|3846A0A8-2D38-44C9-A579-84C66315C436|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MMOL/MIN/KPA/L|||TRANSDUCING UNIT/ML|NOT DONE||Y|N|Y|2||58||RUN-IN|1965-07-16||1972-11-07|||1966-08-17||1969-01-08
TRIAL STUDY 134XCP|RP|3846A0A8-2D38-44C9-A579-84C66315C436|2||||||RASHIND|RASH INDICATOR||||IN2|||G/CAGE/DAY|NOT DONE||NA|U|NA|2||58||SCREENING|1969-05-22||1966-05-12|||1963-05-13||1962-04-18
TRIAL STUDY 134XCP|RP|3846A0A8-2D38-44C9-A579-84C66315C436|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||QUANTITY SUFFICIENT|||APL U|NOT DONE||N|U|N|3||39||BLINDED TREATMENT|1962-06-12||1964-03-26|||1962-03-25||1965-08-02
TRIAL STUDY 134XCP|RP|3846A0A8-2D38-44C9-A579-84C66315C436|2||||||MENOSTAT|MENOPAUSE STATUS||||UG/KG/DAY|||DYN|NOT DONE||NA|U|U|3||39||BLINDED TREATMENT|1973-05-06||1970-05-26|||1972-01-28||1960-05-17
TRIAL STUDY 134XCP|RP|3846A0A8-2D38-44C9-A579-84C66315C436|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||S*KPA|||FMOL/L|NOT DONE||NA|U|Y|4||88||BLINDED TREATMENT|1967-04-07||1971-10-07|||1968-11-08||1969-02-12
TRIAL STUDY 134XCP|RP|3846A0A8-2D38-44C9-A579-84C66315C436|2||||||MENOAGE|MENOPAUSE AGE||||PHERESIS UNIT|||GTT|NOT DONE||NA|N|NA|4||88||SCREENING|1960-06-29||1970-03-26|||1969-11-17||1963-10-06
TRIAL STUDY 134XCP|RP|3846A0A8-2D38-44C9-A579-84C66315C436|1||||||TNDRIND|TENDERNESS INDICATOR||||GPL U/ML|||UIU/DL|NOT DONE||U|Y|Y|5||7||OPEN LABEL TREATMENT|1968-08-02||1963-01-27|||1972-12-08||1965-06-16
TRIAL STUDY 134XCP|RP|3846A0A8-2D38-44C9-A579-84C66315C436|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||/KG|||L/L|NOT DONE||N|U|Y|5||7||OBSERVATION|1960-09-05||1964-11-20|||1960-07-08||1963-07-01
TRIAL STUDY 134XCP|RP|75B429C2-E173-4F72-8D4A-76F62C97F006|1||||||TNDRIND|TENDERNESS INDICATOR||||SIEMENS|||BQ/UG|NOT DONE||N|U|NA|1||38||WASHOUT|1969-05-14||1973-03-22|||1963-03-07||1966-08-12
TRIAL STUDY 134XCP|RP|75B429C2-E173-4F72-8D4A-76F62C97F006|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UG/ANIMAL|||ML/ANIMAL|NOT DONE||N|U|Y|1||38||LONG-TERM FOLLOW-UP|1962-12-19||1962-04-07|||1967-10-24||1971-07-22
TRIAL STUDY 134XCP|RP|75B429C2-E173-4F72-8D4A-76F62C97F006|1||||||EDEMAIND|EDEMA INDICATOR||||IMPLANT|||DROP|NOT DONE||N|NA|N|2||58||BASELINE|1967-08-21||1964-08-11|||1968-12-31||1966-07-09
TRIAL STUDY 134XCP|RP|75B429C2-E173-4F72-8D4A-76F62C97F006|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MMAL|||10^3/HPF|NOT DONE||N|Y|U|2||58||FOLLOW-UP|1966-11-22||1965-12-28|||1971-10-18||1961-06-16
TRIAL STUDY 134XCP|RP|75B429C2-E173-4F72-8D4A-76F62C97F006|1||||||MASSIND|MASS INDICATOR||||ML/ANIMAL/WK|||CIGARETTE|NOT DONE||NA|Y|Y|3||39||LONG-TERM FOLLOW-UP|1968-08-04||1966-05-03|||1964-07-06||1965-08-07
TRIAL STUDY 134XCP|RP|75B429C2-E173-4F72-8D4A-76F62C97F006|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||USP U|||MAMP|NOT DONE||NA|NA|U|3||39||BLINDED TREATMENT|1967-05-06||1970-09-05|||1970-05-08||1961-04-20
TRIAL STUDY 134XCP|RP|75B429C2-E173-4F72-8D4A-76F62C97F006|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MG/M2|||U|NOT DONE||NA|Y|U|4||88||CONTINUATION TREATMENT|1971-07-09||1972-05-28|||1968-06-03||1963-06-23
TRIAL STUDY 134XCP|RP|75B429C2-E173-4F72-8D4A-76F62C97F006|2||||||ULCERIND|ULCER INDICATOR||||MOL/L|||10^6 COPIES/ML|NOT DONE||Y|U|NA|4||88||OPEN LABEL TREATMENT|1963-08-12||1969-07-17|||1969-10-29||1961-03-08
TRIAL STUDY 134XCP|RP|75B429C2-E173-4F72-8D4A-76F62C97F006|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MOL/MG|||MOSM/L|NOT DONE||N|U|Y|5||7||WASHOUT|1969-09-27||1969-03-31|||1960-12-11||1972-09-24
TRIAL STUDY 134XCP|RP|75B429C2-E173-4F72-8D4A-76F62C97F006|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MM/SEC|||PKAT/L|NOT DONE||NA|N|Y|5||7||BLINDED TREATMENT|1966-07-25||1961-03-05|||1967-07-20||1963-07-06
TRIAL STUDY 134XCP|RP|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||DPM|||FMOL|NOT DONE||N|NA|Y|1||38||INDUCTION TREATMENT|1967-07-03||1963-09-14|||1963-09-05||1960-11-01
TRIAL STUDY 134XCP|RP|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|2||||||DSCHGIND|DISCHARGE INDICATOR||||/10^5|||UL/KG/DAY|NOT DONE||Y|NA|NA|1||38||FOLLOW-UP|1972-08-16||1961-08-28|||1968-04-22||1968-07-28
TRIAL STUDY 134XCP|RP|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|1||||||INTP|INTERPRETATION||||10^6 ORGANISMS/ML|||U/G/H|NOT DONE||NA|N|U|2||58||CONTINUATION TREATMENT|1966-08-25||1972-12-31|||1968-12-18||1971-11-30
TRIAL STUDY 134XCP|RP|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||TAMPON|||TCID 50/DOSE|NOT DONE||NA|N|N|2||58||CONTINUATION TREATMENT|1961-06-07||1966-04-23|||1966-03-12||1965-05-23
TRIAL STUDY 134XCP|RP|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||NL|||G/U|NOT DONE||U|Y|N|3||39||BLINDED TREATMENT|1969-10-08||1965-05-21|||1968-09-01||1962-03-17
TRIAL STUDY 134XCP|RP|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||PMOL/L|||KA_U/DL|NOT DONE||Y|U|Y|3||39||WASHOUT|1967-12-29||1960-07-26|||1966-05-07||1961-12-13
TRIAL STUDY 134XCP|RP|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MG/ANIMAL|||HEP|NOT DONE||NA|N|U|4||88||LONG-TERM FOLLOW-UP|1971-07-04||1960-03-29|||1961-12-01||1962-04-15
TRIAL STUDY 134XCP|RP|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||KG/M2|||DPM/ML|NOT DONE||N|NA|U|4||88||RUN-IN|1967-08-26||1964-02-15|||1964-06-24||1962-04-03
TRIAL STUDY 134XCP|RP|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||FEU|||PACK YEAR|NOT DONE||U|NA|Y|5||7||OBSERVATION|1967-05-22||1963-03-03|||1962-08-22||1963-11-11
TRIAL STUDY 134XCP|RP|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|2||||||MENOAGE|MENOPAUSE AGE||||BEAM BREAKS|||PHERESIS UNIT|NOT DONE||U|U|Y|5||7||FOLLOW-UP|1961-05-17||1962-03-13|||1969-12-11||1967-03-11
TRIAL STUDY 134XCP|RP|8065F0B9-9183-43E4-998A-D2F096D87998|1||||||STILBIND|STILLBIRTH INDICATOR||||FG|||L/L|NOT DONE||NA|U|NA|1||38||LONG-TERM FOLLOW-UP|1967-10-10||1969-07-01|||1963-04-28||1962-11-12
TRIAL STUDY 134XCP|RP|8065F0B9-9183-43E4-998A-D2F096D87998|2||||||TNDRIND|TENDERNESS INDICATOR||||APL U|||G/G/DAY|NOT DONE||U|N|Y|1||38||LONG-TERM FOLLOW-UP|1972-12-06||1972-11-02|||1973-03-17||1960-12-01
TRIAL STUDY 134XCP|RP|8065F0B9-9183-43E4-998A-D2F096D87998|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||JAR|||10^9 ORGANISMS/MG|NOT DONE||U|N|Y|2||58||WASHOUT|1967-08-02||1964-09-27|||1960-09-14||1963-11-15
TRIAL STUDY 134XCP|RP|8065F0B9-9183-43E4-998A-D2F096D87998|2||||||INABOIND|INDUCED ABORTION INDICATOR||||PPTH|||10^3 ORGANISMS/ML|NOT DONE||N|Y|N|2||58||TREATMENT|1968-12-31||1968-10-18|||1970-11-25||1970-07-22
TRIAL STUDY 134XCP|RP|8065F0B9-9183-43E4-998A-D2F096D87998|1||||||MENOAGE|MENOPAUSE AGE||||MEQ/ML|||MDFI|NOT DONE||U|N|N|3||39||RUN-IN|1961-06-11||1961-07-24|||1961-11-09||1963-12-21
TRIAL STUDY 134XCP|RP|8065F0B9-9183-43E4-998A-D2F096D87998|2||||||DLVRMODE|MODE OF DELIVERY||||MCI|||DMOL|NOT DONE||Y|Y|Y|3||39||BLINDED TREATMENT|1964-11-14||1966-06-06|||1964-03-29||1969-11-03
TRIAL STUDY 134XCP|RP|8065F0B9-9183-43E4-998A-D2F096D87998|1||||||PRGENDTC|DATE PREGNANCY ENDED||||KALLIKREIN INHIBITOR UNIT|||DAYS/WK|NOT DONE||NA|Y|Y|4||88||OBSERVATION|1973-07-28||1969-09-07|||1971-12-18||1960-07-20
TRIAL STUDY 134XCP|RP|8065F0B9-9183-43E4-998A-D2F096D87998|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||CFU/G|||G/KG|NOT DONE||NA|Y|Y|4||88||WASHOUT|1972-05-01||1967-09-27|||1972-02-22||1965-06-20
TRIAL STUDY 134XCP|RP|8065F0B9-9183-43E4-998A-D2F096D87998|1||||||PREGST|PREGNANT DURING THE STUDY||||MET|||UG/L DDU|NOT DONE||N|N|N|5||7||FOLLOW-UP|1968-06-18||1967-06-06|||1970-01-13||1967-06-29
TRIAL STUDY 134XCP|RP|8065F0B9-9183-43E4-998A-D2F096D87998|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MG/H|||NKAT/G HB|NOT DONE||Y|U|U|5||7||OBSERVATION|1967-05-28||1968-05-16|||1973-07-25||1969-07-08
TRIAL STUDY 134XCP|RP|697EB3B7-5AD1-4D1D-BB53-BB0556915957|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||L/L|||MU/L|NOT DONE||Y|NA|N|1||38||TREATMENT|1966-12-12||1960-10-14|||1964-12-19||1973-08-22
TRIAL STUDY 134XCP|RP|697EB3B7-5AD1-4D1D-BB53-BB0556915957|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||UOSM|||/H|NOT DONE||U|N|NA|1||38||CONTINUATION TREATMENT|1960-05-18||1972-08-15|||1965-06-24||1960-11-29
TRIAL STUDY 134XCP|RP|697EB3B7-5AD1-4D1D-BB53-BB0556915957|1||||||MENARAGE|MENARCHE AGE||||/10^4|||FARAD|NOT DONE||N|Y|Y|2||58||LONG-TERM FOLLOW-UP|1967-06-09||1971-06-29|||1961-01-13||1961-04-15
TRIAL STUDY 134XCP|RP|697EB3B7-5AD1-4D1D-BB53-BB0556915957|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||BU|||MV|NOT DONE||Y|NA|N|2||58||OBSERVATION|1966-06-22||1960-07-29|||1964-09-25||1962-11-22
TRIAL STUDY 134XCP|RP|697EB3B7-5AD1-4D1D-BB53-BB0556915957|1||||||GRAVIND|GRAVIDA INDICATOR||||MONTHS|||10^6 CFU/G|NOT DONE||N|U|U|3||39||CONTINUATION TREATMENT|1971-05-27||1962-08-11|||1965-05-10||1968-07-20
TRIAL STUDY 134XCP|RP|697EB3B7-5AD1-4D1D-BB53-BB0556915957|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||CM|||KM|NOT DONE||NA|N|N|3||39||OBSERVATION|1961-01-01||1965-11-25|||1969-02-14||1972-01-31
TRIAL STUDY 134XCP|RP|697EB3B7-5AD1-4D1D-BB53-BB0556915957|1||||||ULCERIND|ULCER INDICATOR||||MEQ|||SFC/10^6 PBMC|NOT DONE||NA|NA|NA|4||88||OBSERVATION|1961-01-23||1960-03-02|||1965-04-10||1961-11-19
TRIAL STUDY 134XCP|RP|697EB3B7-5AD1-4D1D-BB53-BB0556915957|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MG|||SFC/10^6 PBMC|NOT DONE||N|NA|U|4||88||OBSERVATION|1960-05-08||1969-08-10|||1970-09-16||1961-05-14
TRIAL STUDY 134XCP|RP|697EB3B7-5AD1-4D1D-BB53-BB0556915957|1||||||PREGNN|NUMBER OF PREGNANCIES||||10^9 ORGANISMS/ML|||DL|NOT DONE||NA|N|Y|5||7||FOLLOW-UP|1963-06-18||1969-04-01|||1971-09-05||1964-12-18
TRIAL STUDY 134XCP|RP|697EB3B7-5AD1-4D1D-BB53-BB0556915957|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||IU/ML|||EQ|NOT DONE||NA|N|U|5||7||FOLLOW-UP|1969-04-21||1965-03-30|||1963-02-14||1965-06-02
TRIAL STUDY 134XCP|RP|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|1||||||TNDRIND|TENDERNESS INDICATOR||||G/G|||TUBERCULIN UNIT|NOT DONE||NA|N|NA|1||38||WASHOUT|1970-02-08||1960-01-11|||1960-04-15||1966-11-18
TRIAL STUDY 134XCP|RP|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|2||||||MENARAGE|MENARCHE AGE||||L/S|||KG/MOL|NOT DONE||NA|U|NA|1||38||FOLLOW-UP|1961-12-16||1965-06-27|||1973-04-24||1963-05-23
TRIAL STUDY 134XCP|RP|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||PFU/ANIMAL|||COAT|NOT DONE||U|NA|N|2||58||WASHOUT|1969-05-22||1970-04-18|||1971-08-15||1970-01-08
TRIAL STUDY 134XCP|RP|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|2||||||DLVRMODE|MODE OF DELIVERY||||CMOL/L|||LOG10 TCID 50/UL|NOT DONE||Y|U|U|2||58||BLINDED TREATMENT|1961-10-09||1970-12-27|||1966-10-06||1965-01-01
TRIAL STUDY 134XCP|RP|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|1||||||FUNDHT|FUNDAL HEIGHT||||ELISA UNIT|||ATM|NOT DONE||N|Y|U|3||39||INDUCTION TREATMENT|1972-02-01||1973-03-28|||1960-08-24||1969-01-31
TRIAL STUDY 134XCP|RP|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||10^6 CFU/ML|||%|NOT DONE||Y|N|NA|3||39||BLINDED TREATMENT|1960-09-20||1963-03-19|||1966-02-15||1960-03-12
TRIAL STUDY 134XCP|RP|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|1||||||ERYTHIND|ERYTHEMA INDICATOR||||10^5/L|||TUBERCULIN UNIT|NOT DONE||U|N|Y|4||88||LONG-TERM FOLLOW-UP|1965-02-23||1967-10-29|||1963-08-11||1970-12-07
TRIAL STUDY 134XCP|RP|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MMAL|||10^6 DNA COPIES/ML|NOT DONE||U|N|NA|4||88||WASHOUT|1970-08-14||1973-03-04|||1973-08-19||1964-04-26
TRIAL STUDY 134XCP|RP|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|1||||||PUSTIND|PUSTULE INDICATOR||||MM/H|||DISK|NOT DONE||U|NA|NA|5||7||INDUCTION TREATMENT|1962-07-07||1962-05-05|||1970-06-14||1966-05-15
TRIAL STUDY 134XCP|RP|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|2||||||BLISTIND|BLISTERING INDICATOR||||BOTTLE|||G/DL|NOT DONE||N|Y|N|5||7||LONG-TERM FOLLOW-UP|1962-04-08||1968-03-20|||1967-11-14||1966-08-08
TRIAL STUDY 134XCP|RP|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||PT_US|||AMPULE|NOT DONE||NA|NA|U|1||38||OPEN LABEL TREATMENT|1963-04-20||1963-02-18|||1961-03-27||1969-07-09
TRIAL STUDY 134XCP|RP|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||TESLA|||CY/CM|NOT DONE||Y|N|N|1||38||CONTINUATION TREATMENT|1968-10-23||1972-07-27|||1966-06-12||1961-07-27
TRIAL STUDY 134XCP|RP|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||UV2|||U/G/DAY|NOT DONE||N|Y|NA|2||58||FOLLOW-UP|1964-02-13||1968-02-13|||1966-10-15||1972-05-14
TRIAL STUDY 134XCP|RP|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|2||||||INTP|INTERPRETATION||||DEG|||MASK|NOT DONE||Y|N|NA|2||58||TREATMENT|1968-04-19||1963-12-05|||1964-03-30||1966-02-25
TRIAL STUDY 134XCP|RP|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||10^8 PFU|||PMOL/DL|NOT DONE||Y|N|N|3||39||FOLLOW-UP|1965-07-13||1965-04-16|||1972-11-06||1965-05-08
TRIAL STUDY 134XCP|RP|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||ML/G/H|||MG/KG|NOT DONE||U|NA|N|3||39||OBSERVATION|1965-07-01||1968-04-25|||1971-08-22||1967-05-20
TRIAL STUDY 134XCP|RP|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|1||||||PREGST|PREGNANT DURING THE STUDY||||POINT|||U/M2/MIN|NOT DONE||NA|NA|NA|4||88||TREATMENT|1963-08-26||1972-12-07|||1971-09-09||1965-07-28
TRIAL STUDY 134XCP|RP|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||KIT|||UG/DL|NOT DONE||U|Y|Y|4||88||OPEN LABEL TREATMENT|1970-02-07||1971-08-14|||1964-09-25||1961-06-04
TRIAL STUDY 134XCP|RP|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|1||||||PUSTIND|PUSTULE INDICATOR||||MILE|||CONTAINER|NOT DONE||Y|NA|N|5||7||WASHOUT|1968-06-19||1964-04-12|||1966-11-02||1965-02-18
TRIAL STUDY 134XCP|RP|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|2||||||FUNDHT|FUNDAL HEIGHT||||G/ANIMAL|||MMHG*MIN/L|NOT DONE||N|U|N|5||7||TREATMENT|1973-06-03||1970-04-02|||1970-05-27||1960-06-24
TRIAL STUDY 134XCP|RP|52EC57AA-56E4-47A8-AADA-36F62653B423|1||||||PEELIND|PEELING INDICATOR||||UMOL/MG/MIN|||MG/ML/MIN|NOT DONE||U|Y|N|1||38||LONG-TERM FOLLOW-UP|1969-02-23||1960-10-27|||1971-08-07||1970-10-26
TRIAL STUDY 134XCP|RP|52EC57AA-56E4-47A8-AADA-36F62653B423|2||||||BRTHN|NUMBER OF BIRTHS||||GY|||USP U|NOT DONE||NA|N|Y|1||38||WASHOUT|1973-01-21||1963-11-21|||1966-03-25||1961-03-03
TRIAL STUDY 134XCP|RP|52EC57AA-56E4-47A8-AADA-36F62653B423|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||RFU|||NMOL|NOT DONE||Y|N|N|2||58||OBSERVATION|1964-08-18||1973-02-22|||1964-08-21||1973-06-01
TRIAL STUDY 134XCP|RP|52EC57AA-56E4-47A8-AADA-36F62653B423|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||UEQ|||ML/CAGE|NOT DONE||N|U|U|2||58||CONTINUATION TREATMENT|1970-03-11||1967-02-08|||1961-03-12||1971-04-17
TRIAL STUDY 134XCP|RP|52EC57AA-56E4-47A8-AADA-36F62653B423|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MMOL/MOL|||CS|NOT DONE||U|N|U|3||39||CONTINUATION TREATMENT|1972-11-10||1969-10-26|||1970-10-19||1967-01-24
TRIAL STUDY 134XCP|RP|52EC57AA-56E4-47A8-AADA-36F62653B423|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||S^-1(%O2)^-1|||UG/G/H|NOT DONE||N|U|NA|3||39||OPEN LABEL TREATMENT|1971-08-18||1961-11-21|||1969-04-05||1973-04-24
TRIAL STUDY 134XCP|RP|52EC57AA-56E4-47A8-AADA-36F62653B423|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||FG|||/WK|NOT DONE||NA|NA|NA|4||88||FOLLOW-UP|1970-02-18||1966-12-23|||1971-02-10||1968-03-18
TRIAL STUDY 134XCP|RP|52EC57AA-56E4-47A8-AADA-36F62653B423|2||||||PREGST|PREGNANT DURING THE STUDY||||NMOL BCE/NMOL|||NMOL/L|NOT DONE||N|N|NA|4||88||SCREENING|1972-01-31||1972-08-09|||1973-03-15||1962-11-03
TRIAL STUDY 134XCP|RP|52EC57AA-56E4-47A8-AADA-36F62653B423|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||NL|||PMOL|NOT DONE||U|U|NA|5||7||FOLLOW-UP|1967-08-28||1967-04-12|||1962-09-08||1960-06-07
TRIAL STUDY 134XCP|RP|52EC57AA-56E4-47A8-AADA-36F62653B423|2||||||PUSTIND|PUSTULE INDICATOR||||10^3 DNA COPIES/ML|||UMOL/MIN|NOT DONE||NA|NA|N|5||7||CONTINUATION TREATMENT|1966-06-07||1972-12-18|||1963-10-04||1968-02-10
TRIAL STUDY 134XCP|RP|F09C04A4-4F9E-4033-9115-81C6007DE8B4|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||VP/DOSE|||%/S|NOT DONE||U|NA|NA|1||38||BLINDED TREATMENT|1968-01-04||1970-07-23|||1967-04-18||1973-03-27
TRIAL STUDY 134XCP|RP|F09C04A4-4F9E-4033-9115-81C6007DE8B4|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/ANIMAL/DAY|||MMOL/MOL|NOT DONE||Y|Y|N|1||38||RUN-IN|1969-05-11||1961-05-29|||1969-09-13||1972-01-22
TRIAL STUDY 134XCP|RP|F09C04A4-4F9E-4033-9115-81C6007DE8B4|1||||||MENFDUR|MENSES FLOW DURATION||||TRANSDUCING UNIT/ML|||MG/ANIMAL|NOT DONE||Y|U|N|2||58||BASELINE|1970-03-20||1968-06-22|||1963-08-24||1964-09-13
TRIAL STUDY 134XCP|RP|F09C04A4-4F9E-4033-9115-81C6007DE8B4|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||BOX|||CM|NOT DONE||Y|U|U|2||58||TREATMENT|1970-04-22||1971-05-22|||1967-10-14||1968-07-20
TRIAL STUDY 134XCP|RP|F09C04A4-4F9E-4033-9115-81C6007DE8B4|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||H/WK|||MMOL/G|NOT DONE||Y|N|N|3||39||LONG-TERM FOLLOW-UP|1970-07-16||1971-05-14|||1971-06-06||1962-07-04
TRIAL STUDY 134XCP|RP|F09C04A4-4F9E-4033-9115-81C6007DE8B4|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||SFC/10^6 PBMC|||MOSM|NOT DONE||NA|Y|N|3||39||OPEN LABEL TREATMENT|1962-09-02||1968-06-24|||1967-03-15||1962-03-06
TRIAL STUDY 134XCP|RP|F09C04A4-4F9E-4033-9115-81C6007DE8B4|1||||||PREGIND|PREGNANT INDICATOR||||U/KG|||IU/DL|NOT DONE||Y|N|NA|4||88||CONTINUATION TREATMENT|1969-01-25||1966-10-07|||1971-03-06||1972-06-28
TRIAL STUDY 134XCP|RP|F09C04A4-4F9E-4033-9115-81C6007DE8B4|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||ML/H|||ML/(MIN*100ML)|NOT DONE||Y|NA|U|4||88||OPEN LABEL TREATMENT|1966-05-03||1967-06-08|||1961-02-02||1962-06-30
TRIAL STUDY 134XCP|RP|F09C04A4-4F9E-4033-9115-81C6007DE8B4|1||||||BLISTIND|BLISTERING INDICATOR||||UG/KG/MIN|||LOG10 TCID 50/UL|NOT DONE||NA|U|U|5||7||OPEN LABEL TREATMENT|1972-03-02||1962-07-27|||1971-12-29||1969-10-23
TRIAL STUDY 134XCP|RP|F09C04A4-4F9E-4033-9115-81C6007DE8B4|2||||||BRTHN|NUMBER OF BIRTHS||||ML/S|||KG/CM2|NOT DONE||N|U|N|5||7||CONTINUATION TREATMENT|1973-06-10||1969-07-17|||1967-01-20||1973-07-22
TRIAL STUDY 134XCP|RP|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||IU/G HB|||10^6/G|NOT DONE||Y|N|N|1||38||OBSERVATION|1972-05-31||1972-09-15|||1968-08-07||1971-08-13
TRIAL STUDY 134XCP|RP|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|2||||||MENFDUR|MENSES FLOW DURATION||||BAU|||DEG/S|NOT DONE||N|U|U|1||38||INDUCTION TREATMENT|1965-11-21||1963-11-25|||1968-03-27||1970-11-21
TRIAL STUDY 134XCP|RP|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|1||||||RASHIND|RASH INDICATOR||||CIGARETTE|||SFC/10^6 PBMC|NOT DONE||Y|N|N|2||58||FOLLOW-UP|1969-12-14||1973-01-21|||1970-09-16||1968-09-15
TRIAL STUDY 134XCP|RP|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|2||||||BCMETHOD|BIRTH CONTROL METHOD||||RNA COPIES/ML|||10^9/G|NOT DONE||NA|U|U|2||58||WASHOUT|1960-09-07||1960-10-31|||1965-04-17||1963-01-24
TRIAL STUDY 134XCP|RP|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|1||||||ABORTN|NUMBER OF ABORTIONS||||HZ|||DMOL|NOT DONE||U|U|Y|3||39||OPEN LABEL TREATMENT|1960-11-11||1969-04-16|||1962-04-28||1961-07-21
TRIAL STUDY 134XCP|RP|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||PA|||DIP|NOT DONE||Y|Y|NA|3||39||TREATMENT|1971-08-13||1971-11-16|||1966-04-09||1966-07-23
TRIAL STUDY 134XCP|RP|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||INHALATION|||KIT|NOT DONE||N|Y|Y|4||88||CONTINUATION TREATMENT|1961-01-24||1967-01-31|||1963-03-21||1963-03-06
TRIAL STUDY 134XCP|RP|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|2||||||EDEMAIND|EDEMA INDICATOR||||MPH|||FOZ_BR|NOT DONE||U|Y|U|4||88||SCREENING|1961-02-28||1966-05-05|||1965-05-02||1964-12-26
TRIAL STUDY 134XCP|RP|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|1||||||ABORTN|NUMBER OF ABORTIONS||||SV|||MNFI|NOT DONE||Y|Y|N|5||7||SCREENING|1968-07-09||1969-10-20|||1972-07-13||1963-04-25
TRIAL STUDY 134XCP|RP|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||DISK|||FARAD|NOT DONE||N|NA|Y|5||7||BASELINE|1960-03-14||1968-12-15|||1961-06-07||1968-05-25
TRIAL STUDY 134XCP|RP|4779A01C-1219-46AC-B0F7-71C9717A2B45|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||F|||/WK|NOT DONE||Y|Y|Y|1||38||OPEN LABEL TREATMENT|1968-06-24||1962-11-15|||1963-08-22||1963-05-29
TRIAL STUDY 134XCP|RP|4779A01C-1219-46AC-B0F7-71C9717A2B45|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||10^9 CFU/G|||ML/G/MIN|NOT DONE||U|U|Y|1||38||OPEN LABEL TREATMENT|1971-07-05||1973-04-13|||1972-06-15||1969-05-15
TRIAL STUDY 134XCP|RP|4779A01C-1219-46AC-B0F7-71C9717A2B45|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||ARBITRARY U|||LENS|NOT DONE||U|N|N|2||58||FOLLOW-UP|1968-06-09||1965-01-12|||1971-11-07||1966-12-22
TRIAL STUDY 134XCP|RP|4779A01C-1219-46AC-B0F7-71C9717A2B45|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||C|||M/SEC|NOT DONE||NA|U|U|2||58||BASELINE|1961-06-15||1964-09-19|||1963-08-17||1963-01-25
TRIAL STUDY 134XCP|RP|4779A01C-1219-46AC-B0F7-71C9717A2B45|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MOL/MOL|||MM2|NOT DONE||Y|NA|U|3||39||FOLLOW-UP|1972-01-25||1970-06-05|||1970-05-30||1963-04-13
TRIAL STUDY 134XCP|RP|4779A01C-1219-46AC-B0F7-71C9717A2B45|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||/10^3|||BQ/ML|NOT DONE||Y|U|Y|3||39||OPEN LABEL TREATMENT|1972-10-22||1970-09-10|||1967-06-08||1971-02-05
TRIAL STUDY 134XCP|RP|4779A01C-1219-46AC-B0F7-71C9717A2B45|1||||||FUNDHT|FUNDAL HEIGHT||||UMOL/L/MIN|||IU/G HB|NOT DONE||NA|U|Y|4||88||FOLLOW-UP|1965-02-12||1972-04-04|||1968-12-03||1965-01-09
TRIAL STUDY 134XCP|RP|4779A01C-1219-46AC-B0F7-71C9717A2B45|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^3 DNA COPIES/ML|||MG/M2/MIN|NOT DONE||U|N|Y|4||88||SCREENING|1970-01-19||1971-12-23|||1971-01-01||1970-02-28
TRIAL STUDY 134XCP|RP|4779A01C-1219-46AC-B0F7-71C9717A2B45|1||||||PRGENDTC|DATE PREGNANCY ENDED||||KG/CM|||MG/KG/WEEK|NOT DONE||Y|Y|NA|5||7||OBSERVATION|1971-03-16||1971-07-24|||1973-07-12||1968-11-29
TRIAL STUDY 134XCP|RP|4779A01C-1219-46AC-B0F7-71C9717A2B45|2||||||PREGIND|PREGNANT INDICATOR||||TAMPON|||10^6 ORGANISMS/G|NOT DONE||Y|Y|NA|5||7||RUN-IN|1971-07-26||1971-02-09|||1963-09-13||1961-02-26
TRIAL STUDY 134XCP|RP|5F5C5DED-7547-40D2-9B34-77B37CCD7732|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||SPRAY|||PUFF|NOT DONE||N|U|Y|1||38||SCREENING|1967-09-11||1963-11-24|||1969-07-15||1967-10-09
TRIAL STUDY 134XCP|RP|5F5C5DED-7547-40D2-9B34-77B37CCD7732|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||BAU|||MG/KG/DOSE|NOT DONE||Y|Y|N|1||38||WASHOUT|1972-04-05||1964-02-01|||1971-03-10||1973-04-16
TRIAL STUDY 134XCP|RP|5F5C5DED-7547-40D2-9B34-77B37CCD7732|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||SEC|||/LSQN|NOT DONE||N|NA|U|2||58||BASELINE|1961-08-06||1960-08-27|||1960-01-09||1970-07-16
TRIAL STUDY 134XCP|RP|5F5C5DED-7547-40D2-9B34-77B37CCD7732|2||||||DSCHGIND|DISCHARGE INDICATOR||||MASK|||/100 WBC|NOT DONE||U|Y|Y|2||58||RUN-IN|1964-07-06||1962-08-06|||1967-03-19||1968-09-17
TRIAL STUDY 134XCP|RP|5F5C5DED-7547-40D2-9B34-77B37CCD7732|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||BAU|||TRANSDUCING UNIT|NOT DONE||Y|Y|Y|3||39||SCREENING|1961-03-21||1965-05-17|||1968-03-20||1967-02-02
TRIAL STUDY 134XCP|RP|5F5C5DED-7547-40D2-9B34-77B37CCD7732|2||||||BLISTIND|BLISTERING INDICATOR||||MMAL|||L/MIN/M2|NOT DONE||U|U|Y|3||39||FOLLOW-UP|1965-01-27||1966-01-31|||1960-11-21||1969-04-18
TRIAL STUDY 134XCP|RP|5F5C5DED-7547-40D2-9B34-77B37CCD7732|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||CM|||ML/H|NOT DONE||Y|U|U|4||88||BASELINE|1966-02-01||1966-01-20|||1973-06-10||1969-11-17
TRIAL STUDY 134XCP|RP|5F5C5DED-7547-40D2-9B34-77B37CCD7732|2||||||MENOSTAT|MENOPAUSE STATUS||||SHOCK WAVE|||ML/G/H|NOT DONE||NA|Y|NA|4||88||RUN-IN|1972-08-16||1964-07-29|||1964-07-24||1968-08-02
TRIAL STUDY 134XCP|RP|5F5C5DED-7547-40D2-9B34-77B37CCD7732|1||||||PUSTIND|PUSTULE INDICATOR||||/LSQN|||KM/H|NOT DONE||N|U|Y|5||7||BASELINE|1971-09-04||1960-07-13|||1967-08-23||1969-03-15
TRIAL STUDY 134XCP|RP|5F5C5DED-7547-40D2-9B34-77B37CCD7732|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||COPIES/UL|||CM/MIN|NOT DONE||NA|U|NA|5||7||INDUCTION TREATMENT|1965-11-28||1961-10-30|||1963-03-28||1965-06-22
TRIAL STUDY 134XCP|RP|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||L/KG|||/4.0 ML|NOT DONE||N|NA|U|1||38||RUN-IN|1968-07-26||1973-02-14|||1961-01-11||1969-01-21
TRIAL STUDY 134XCP|RP|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||/MBP|||UG/ML/H|NOT DONE||U|Y|Y|1||38||RUN-IN|1967-02-04||1969-03-22|||1966-11-27||1963-02-19
TRIAL STUDY 134XCP|RP|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|1||||||PUSTIND|PUSTULE INDICATOR||||CY/CM|||KCAL|NOT DONE||Y|U|U|2||58||OPEN LABEL TREATMENT|1966-02-07||1966-12-14|||1969-04-24||1973-07-11
TRIAL STUDY 134XCP|RP|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||10^6/L|||PSI|NOT DONE||U|N|U|2||58||SCREENING|1961-06-20||1972-07-20|||1965-05-18||1968-02-14
TRIAL STUDY 134XCP|RP|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|1||||||GRAVIND|GRAVIDA INDICATOR||||PL|||ML/KG/H|NOT DONE||NA|N|NA|3||39||TREATMENT|1970-06-05||1967-03-29|||1966-03-05||1968-04-15
TRIAL STUDY 134XCP|RP|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|2||||||BLISTIND|BLISTERING INDICATOR||||WATT|||PA|NOT DONE||NA|NA|N|3||39||OPEN LABEL TREATMENT|1963-12-03||1971-01-03|||1967-08-28||1973-07-22
TRIAL STUDY 134XCP|RP|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||U/10^12 RBC|||10^3 ORGANISMS/ML|NOT DONE||U|Y|U|4||88||OPEN LABEL TREATMENT|1967-01-04||1967-11-02|||1962-05-12||1963-12-29
TRIAL STUDY 134XCP|RP|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|2||||||EDEMAIND|EDEMA INDICATOR||||LOG10 ELISA UNIT|||10^6 RNA COPIES/ML|NOT DONE||Y|N|Y|4||88||OPEN LABEL TREATMENT|1973-05-10||1964-01-12|||1971-10-19||1961-12-02
TRIAL STUDY 134XCP|RP|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||KG/M2|||PIXELS/IN|NOT DONE||U|N|U|5||7||BLINDED TREATMENT|1967-12-23||1966-12-11|||1961-02-02||1964-01-17
TRIAL STUDY 134XCP|RP|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||IU/KG|||BQ/G|NOT DONE||Y|N|Y|5||7||OBSERVATION|1964-01-03||1970-12-06|||1970-06-20||1967-01-20
TRIAL STUDY 134XCP|RP|48348DF0-33DA-457F-86C6-797FF7B32857|1||||||FUNDHT|FUNDAL HEIGHT||||% INHIBITION|||ECL UNIT|NOT DONE||N|NA|Y|1||38||INDUCTION TREATMENT|1972-01-19||1970-07-06|||1969-06-10||1966-06-12
TRIAL STUDY 134XCP|RP|48348DF0-33DA-457F-86C6-797FF7B32857|2||||||PREGST|PREGNANT DURING THE STUDY||||USIEMENS|||MPA|NOT DONE||Y|N|U|1||38||CONTINUATION TREATMENT|1969-08-01||1966-04-24|||1962-01-17||1969-05-10
TRIAL STUDY 134XCP|RP|48348DF0-33DA-457F-86C6-797FF7B32857|1||||||EDEMAIND|EDEMA INDICATOR||||ML/BREATH|||ML/KG/H|NOT DONE||NA|U|U|2||58||RUN-IN|1969-09-04||1971-12-06|||1968-08-27||1963-06-17
TRIAL STUDY 134XCP|RP|48348DF0-33DA-457F-86C6-797FF7B32857|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ML/ANIMAL/DAY|||UG/G/DAY|NOT DONE||NA|U|N|2||58||WASHOUT|1971-03-17||1970-03-09|||1967-08-21||1962-07-17
TRIAL STUDY 134XCP|RP|48348DF0-33DA-457F-86C6-797FF7B32857|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ABSORBANCE U/ML|||MG/ANIMAL|NOT DONE||N|Y|U|3||39||WASHOUT|1967-01-12||1967-10-26|||1972-06-10||1964-04-12
TRIAL STUDY 134XCP|RP|48348DF0-33DA-457F-86C6-797FF7B32857|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||U/L|||G/G/DAY|NOT DONE||N|U|NA|3||39||RUN-IN|1968-02-08||1968-08-20|||1968-10-10||1963-05-27
TRIAL STUDY 134XCP|RP|48348DF0-33DA-457F-86C6-797FF7B32857|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||ML/ANIMAL/WK|||DDU|NOT DONE||NA|N|U|4||88||BASELINE|1960-11-12||1968-02-19|||1961-09-26||1969-11-27
TRIAL STUDY 134XCP|RP|48348DF0-33DA-457F-86C6-797FF7B32857|2||||||PUSTIND|PUSTULE INDICATOR||||L/DAY|||MOSM/KG|NOT DONE||U|U|N|4||88||OBSERVATION|1963-05-22||1962-09-28|||1971-12-17||1971-02-26
TRIAL STUDY 134XCP|RP|48348DF0-33DA-457F-86C6-797FF7B32857|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||WAFER|||10^8/L|NOT DONE||NA|Y|NA|5||7||BLINDED TREATMENT|1969-10-25||1960-12-06|||1971-08-04||1961-04-14
TRIAL STUDY 134XCP|RP|48348DF0-33DA-457F-86C6-797FF7B32857|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||ML/ANIMAL/DAY|||/LSQN|NOT DONE||N|U|Y|5||7||OBSERVATION|1963-06-29||1963-06-30|||1967-07-05||1970-10-27
TRIAL STUDY 134XCP|RP|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MKAT|||G/M2/DAY|NOT DONE||NA|NA|NA|1||38||SCREENING|1970-08-23||1961-11-29|||1968-08-28||1970-04-23
TRIAL STUDY 134XCP|RP|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MET*MIN|||IU/G|NOT DONE||N|Y|U|1||38||BLINDED TREATMENT|1962-01-11||1969-07-17|||1960-08-08||1971-02-01
TRIAL STUDY 134XCP|RP|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||LOG10 IU/ML|||DDU|NOT DONE||NA|N|Y|2||58||TREATMENT|1971-01-22||1968-11-20|||1962-03-01||1971-04-05
TRIAL STUDY 134XCP|RP|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|2||||||MENARAGE|MENARCHE AGE||||10^5/HPF|||RPM|NOT DONE||U|U|N|2||58||TREATMENT|1966-09-08||1970-02-08|||1968-02-27||1964-11-20
TRIAL STUDY 134XCP|RP|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||10^5/HPF|||MMOL/G|NOT DONE||U|N|NA|3||39||WASHOUT|1972-05-22||1961-09-16|||1966-11-25||1967-02-02
TRIAL STUDY 134XCP|RP|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||UL|||MEQ/L|NOT DONE||U|NA|U|3||39||WASHOUT|1973-04-30||1961-02-25|||1972-01-26||1964-09-17
TRIAL STUDY 134XCP|RP|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||G/CAGE/WK|||LINEAR FT*LB|NOT DONE||U|N|N|4||88||RUN-IN|1973-05-28||1960-02-03|||1960-08-30||1968-04-03
TRIAL STUDY 134XCP|RP|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|2||||||PRGENDTC|DATE PREGNANCY ENDED||||10^7 TCID 50/DOSE|||BREATHS/MIN|NOT DONE||Y|Y|N|4||88||OPEN LABEL TREATMENT|1963-08-04||1968-09-28|||1971-01-18||1960-12-17
TRIAL STUDY 134XCP|RP|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MEQ/DAY|||NMOL/KG/DAY|NOT DONE||U|NA|NA|5||7||INDUCTION TREATMENT|1967-11-17||1962-09-24|||1964-09-08||1960-07-18
TRIAL STUDY 134XCP|RP|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||G/CAGE/DAY|||CMH2O*S2/ML|NOT DONE||U|NA|NA|5||7||TREATMENT|1969-12-10||1970-12-29|||1961-07-24||1966-07-15
TRIAL STUDY 134XCP|RP|396CC122-5F23-418D-A75E-572ADF4FD6C1|1||||||MENARAGE|MENARCHE AGE||||RPM|||/SEC|NOT DONE||Y|U|N|1||38||BASELINE|1963-09-12||1970-01-22|||1965-05-11||1964-01-29
TRIAL STUDY 134XCP|RP|396CC122-5F23-418D-A75E-572ADF4FD6C1|2||||||ABORTN|NUMBER OF ABORTIONS||||NMOL/KG/DAY|||TBSP|NOT DONE||NA|NA|U|1||38||INDUCTION TREATMENT|1968-05-28||1963-02-21|||1970-02-03||1971-04-09
TRIAL STUDY 134XCP|RP|396CC122-5F23-418D-A75E-572ADF4FD6C1|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MMHG/L/MIN|||MMHG/L/MIN|NOT DONE||U|NA|N|2||58||OPEN LABEL TREATMENT|1968-03-11||1973-03-08|||1962-03-16||1967-06-03
TRIAL STUDY 134XCP|RP|396CC122-5F23-418D-A75E-572ADF4FD6C1|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||IU/L|||10^6/G|NOT DONE||Y|Y|N|2||58||BASELINE|1963-09-25||1973-02-12|||1960-01-05||1968-07-31
TRIAL STUDY 134XCP|RP|396CC122-5F23-418D-A75E-572ADF4FD6C1|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||KS|||UU/DL|NOT DONE||NA|NA|NA|3||39||BASELINE|1970-04-28||1963-01-26|||1972-03-18||1967-03-06
TRIAL STUDY 134XCP|RP|396CC122-5F23-418D-A75E-572ADF4FD6C1|2||||||EDEMAIND|EDEMA INDICATOR||||MOSM/KG|||10^8 PFU|NOT DONE||N|U|N|3||39||BLINDED TREATMENT|1969-09-04||1965-11-11|||1971-02-17||1970-04-13
TRIAL STUDY 134XCP|RP|396CC122-5F23-418D-A75E-572ADF4FD6C1|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MPS U|||SACHET|NOT DONE||U|N|Y|4||88||OBSERVATION|1972-08-04||1963-03-10|||1972-09-24||1960-09-16
TRIAL STUDY 134XCP|RP|396CC122-5F23-418D-A75E-572ADF4FD6C1|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||L/H|||MG/M2|NOT DONE||N|N|NA|4||88||INDUCTION TREATMENT|1964-04-19||1972-02-13|||1962-03-24||1963-06-06
TRIAL STUDY 134XCP|RP|396CC122-5F23-418D-A75E-572ADF4FD6C1|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||%/S|||CFU/ML|NOT DONE||N|U|U|5||7||RUN-IN|1966-02-10||1967-10-05|||1968-03-01||1970-01-02
TRIAL STUDY 134XCP|RP|396CC122-5F23-418D-A75E-572ADF4FD6C1|2||||||FUNDHT|FUNDAL HEIGHT||||LINEAR FT*LB|||CI/KG|NOT DONE||NA|NA|Y|5||7||FOLLOW-UP|1970-12-18||1969-03-23|||1966-08-22||1961-11-21
TRIAL STUDY 134XCP|RP|9CF3CD51-5D5B-40E6-8F13-B314911BE461|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||PPB|||SHOCK WAVE|NOT DONE||U|Y|Y|1||38||WASHOUT|1972-06-25||1964-09-18|||1964-08-03||1972-12-03
TRIAL STUDY 134XCP|RP|9CF3CD51-5D5B-40E6-8F13-B314911BE461|2||||||INABOIND|INDUCED ABORTION INDICATOR||||ML/CM3/MIN|||ML/M2/MIN|NOT DONE||Y|NA|NA|1||38||RUN-IN|1969-02-25||1964-06-12|||1963-06-14||1966-07-05
TRIAL STUDY 134XCP|RP|9CF3CD51-5D5B-40E6-8F13-B314911BE461|1||||||PREGST|PREGNANT DURING THE STUDY||||10^3 ORGANISMS|||KUSP|NOT DONE||U|NA|NA|2||58||WASHOUT|1963-01-12||1961-08-23|||1965-10-14||1969-05-04
TRIAL STUDY 134XCP|RP|9CF3CD51-5D5B-40E6-8F13-B314911BE461|2||||||PREGST|PREGNANT DURING THE STUDY||||AGU/ML|||IU/G HB|NOT DONE||Y|NA|Y|2||58||TREATMENT|1967-03-07||1966-04-14|||1961-03-22||1968-10-11
TRIAL STUDY 134XCP|RP|9CF3CD51-5D5B-40E6-8F13-B314911BE461|1||||||ERYTHIND|ERYTHEMA INDICATOR||||MG/KG/DOSE|||L/S/KPA|NOT DONE||NA|NA|N|3||39||SCREENING|1966-04-01||1963-03-29|||1964-06-11||1966-07-01
TRIAL STUDY 134XCP|RP|9CF3CD51-5D5B-40E6-8F13-B314911BE461|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^9 ORGANISMS/ML|||COPIES/UG|NOT DONE||N|U|NA|3||39||RUN-IN|1964-08-31||1972-06-16|||1963-03-07||1969-09-10
TRIAL STUDY 134XCP|RP|9CF3CD51-5D5B-40E6-8F13-B314911BE461|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||PPB|||PG|NOT DONE||U|N|U|4||88||RUN-IN|1965-01-28||1971-01-28|||1964-04-01||1966-05-25
TRIAL STUDY 134XCP|RP|9CF3CD51-5D5B-40E6-8F13-B314911BE461|2||||||MENFDUR|MENSES FLOW DURATION||||MV/SEC|||MMOL/MIN/KPA/L|NOT DONE||Y|N|NA|4||88||WASHOUT|1967-06-25||1970-06-26|||1963-01-09||1960-11-10
TRIAL STUDY 134XCP|RP|9CF3CD51-5D5B-40E6-8F13-B314911BE461|1||||||THICK|THICKNESS||||RATIO|||WEBER|NOT DONE||NA|N|N|5||7||FOLLOW-UP|1967-07-26||1968-06-23|||1964-10-15||1970-01-10
TRIAL STUDY 134XCP|RP|9CF3CD51-5D5B-40E6-8F13-B314911BE461|2||||||DSCHGIND|DISCHARGE INDICATOR||||DYN|||UCI|NOT DONE||NA|N|U|5||7||OBSERVATION|1969-07-18||1963-05-25|||1971-03-13||1962-09-20
TRIAL STUDY 134XCP|RP|CB3B9054-5CDC-418D-8071-7429B1702587|1||||||ULCERIND|ULCER INDICATOR||||FIU|||BAU|NOT DONE||U|N|U|1||38||WASHOUT|1967-12-01||1966-11-18|||1962-05-13||1965-05-19
TRIAL STUDY 134XCP|RP|CB3B9054-5CDC-418D-8071-7429B1702587|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PG/L|||UMOL/DAY|NOT DONE||N|U|NA|1||38||WASHOUT|1960-11-26||1961-02-18|||1966-11-04||1962-06-29
TRIAL STUDY 134XCP|RP|CB3B9054-5CDC-418D-8071-7429B1702587|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||/H|||NFIU|NOT DONE||Y|U|U|2||58||TREATMENT|1965-10-07||1961-09-13|||1970-01-18||1964-08-27
TRIAL STUDY 134XCP|RP|CB3B9054-5CDC-418D-8071-7429B1702587|2||||||DLVRMODE|MODE OF DELIVERY||||KG/L|||NL|NOT DONE||U|NA|Y|2||58||CONTINUATION TREATMENT|1970-12-26||1965-05-19|||1970-06-18||1970-12-11
TRIAL STUDY 134XCP|RP|CB3B9054-5CDC-418D-8071-7429B1702587|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||OZ EQ|||DAGU/ML|NOT DONE||N|N|U|3||39||LONG-TERM FOLLOW-UP|1960-09-02||1962-03-18|||1960-03-18||1964-08-10
TRIAL STUDY 134XCP|RP|CB3B9054-5CDC-418D-8071-7429B1702587|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||NG|||KDA|NOT DONE||U|NA|Y|3||39||OBSERVATION|1968-10-06||1962-10-11|||1972-09-28||1963-10-13
TRIAL STUDY 134XCP|RP|CB3B9054-5CDC-418D-8071-7429B1702587|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||KPA/L/SEC|||MBQ|NOT DONE||NA|U|NA|4||88||LONG-TERM FOLLOW-UP|1972-08-20||1970-03-10|||1960-06-03||1967-12-13
TRIAL STUDY 134XCP|RP|CB3B9054-5CDC-418D-8071-7429B1702587|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||BP|||ML/KG/H|NOT DONE||N|NA|U|4||88||OBSERVATION|1972-05-06||1967-12-18|||1963-10-31||1964-11-16
TRIAL STUDY 134XCP|RP|CB3B9054-5CDC-418D-8071-7429B1702587|1||||||FUNDHT|FUNDAL HEIGHT||||MPL U/ML|||BAG|NOT DONE||N|Y|U|5||7||BASELINE|1961-03-30||1972-07-18|||1962-02-17||1973-03-01
TRIAL STUDY 134XCP|RP|CB3B9054-5CDC-418D-8071-7429B1702587|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UM|||PSI|NOT DONE||U|U|NA|5||7||RUN-IN|1971-01-25||1962-10-27|||1961-11-13||1967-08-16
TRIAL STUDY 134XCP|RP|1AC4DE34-3486-41FB-A979-8B368912F75A|1||||||MENFDUR|MENSES FLOW DURATION||||UG/MIN|||NMOL/DAY|NOT DONE||N|NA|U|1||38||OPEN LABEL TREATMENT|1960-01-06||1960-03-15|||1963-11-20||1962-11-21
TRIAL STUDY 134XCP|RP|1AC4DE34-3486-41FB-A979-8B368912F75A|2||||||BRTHN|NUMBER OF BIRTHS||||M3|||U/KG/MIN|NOT DONE||N|NA|Y|1||38||CONTINUATION TREATMENT|1962-10-06||1963-11-13|||1960-06-20||1965-04-13
TRIAL STUDY 134XCP|RP|1AC4DE34-3486-41FB-A979-8B368912F75A|1||||||INTP|INTERPRETATION||||10^9 CFU/G|||SPRAY|NOT DONE||Y|NA|NA|2||58||OPEN LABEL TREATMENT|1961-09-30||1964-08-30|||1973-07-31||1969-11-24
TRIAL STUDY 134XCP|RP|1AC4DE34-3486-41FB-A979-8B368912F75A|2||||||PEELIND|PEELING INDICATOR||||RATIO|||MV|NOT DONE||NA|U|Y|2||58||TREATMENT|1969-08-04||1964-10-06|||1969-06-10||1972-08-10
TRIAL STUDY 134XCP|RP|1AC4DE34-3486-41FB-A979-8B368912F75A|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||APPLICATION|||BQ/L|NOT DONE||NA|N|U|3||39||WASHOUT|1965-01-13||1968-05-22|||1968-02-06||1965-06-10
TRIAL STUDY 134XCP|RP|1AC4DE34-3486-41FB-A979-8B368912F75A|2||||||DLVRMODE|MODE OF DELIVERY||||FOZ_US|||MG/MIN|NOT DONE||U|Y|N|3||39||BASELINE|1971-07-29||1965-11-05|||1961-12-30||1972-07-20
TRIAL STUDY 134XCP|RP|1AC4DE34-3486-41FB-A979-8B368912F75A|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||G/G|||MM/H|NOT DONE||NA|Y|NA|4||88||LONG-TERM FOLLOW-UP|1967-02-15||1966-09-25|||1968-10-09||1971-05-22
TRIAL STUDY 134XCP|RP|1AC4DE34-3486-41FB-A979-8B368912F75A|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MEQ|||G/CAGE/WK|NOT DONE||Y|Y|N|4||88||OBSERVATION|1968-04-18||1965-10-22|||1970-11-22||1966-07-17
TRIAL STUDY 134XCP|RP|1AC4DE34-3486-41FB-A979-8B368912F75A|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||CI/KG|||CI/L|NOT DONE||Y|N|U|5||7||TREATMENT|1963-09-30||1960-12-04|||1963-07-06||1966-12-19
TRIAL STUDY 134XCP|RP|1AC4DE34-3486-41FB-A979-8B368912F75A|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UEQ/L|||SBE/ML|NOT DONE||U|Y|NA|5||7||INDUCTION TREATMENT|1960-07-02||1970-03-11|||1965-04-24||1973-01-21
TRIAL STUDY 134XCP|RP|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|1||||||THICK|THICKNESS||||CM/S|||%(V/V)|NOT DONE||N|U|U|1||38||CONTINUATION TREATMENT|1962-01-25||1969-10-09|||1960-01-21||1971-08-27
TRIAL STUDY 134XCP|RP|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||APS U|||LOG EID 50/DOSE|NOT DONE||U|NA|U|1||38||CONTINUATION TREATMENT|1965-09-08||1967-12-17|||1968-02-14||1973-04-16
TRIAL STUDY 134XCP|RP|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|1||||||STILBIND|STILLBIRTH INDICATOR||||YEARS|||MMOL|NOT DONE||NA|U|U|2||58||CONTINUATION TREATMENT|1961-11-23||1964-07-29|||1963-09-17||1967-12-11
TRIAL STUDY 134XCP|RP|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||AMU|||FT3|NOT DONE||N|Y|N|2||58||INDUCTION TREATMENT|1963-09-15||1969-03-03|||1965-09-24||1962-03-08
TRIAL STUDY 134XCP|RP|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UG/L/H|||SYRINGE|NOT DONE||U|N|N|3||39||INDUCTION TREATMENT|1973-01-05||1961-11-24|||1971-09-22||1964-04-05
TRIAL STUDY 134XCP|RP|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UEQ/L|||BOLUS|NOT DONE||N|Y|U|3||39||BLINDED TREATMENT|1968-07-12||1962-03-11|||1967-01-20||1971-08-24
TRIAL STUDY 134XCP|RP|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MET*H|||ML*CMH2O|NOT DONE||N|U|NA|4||88||BASELINE|1973-03-30||1960-01-27|||1965-02-08||1973-08-02
TRIAL STUDY 134XCP|RP|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||ML/H|||MV|NOT DONE||Y|N|Y|4||88||WASHOUT|1962-01-07||1964-07-16|||1973-09-06||1963-01-05
TRIAL STUDY 134XCP|RP|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|1||||||THICK|THICKNESS||||CS|||PMOL/DL|NOT DONE||U|N|Y|5||7||INDUCTION TREATMENT|1969-11-28||1971-02-03|||1961-09-05||1972-02-25
TRIAL STUDY 134XCP|RP|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|2||||||BLISTIND|BLISTERING INDICATOR||||CD*S/M2|||UL|NOT DONE||Y|U|N|5||7||SCREENING|1962-03-05||1966-07-22|||1966-06-24||1969-05-10
TRIAL STUDY 134XCP|RP|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|1||||||RASHIND|RASH INDICATOR||||MONTHS|||AMU|NOT DONE||Y|NA|NA|1||38||BLINDED TREATMENT|1964-12-10||1969-12-23|||1970-02-02||1961-05-29
TRIAL STUDY 134XCP|RP|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||G/L|||CMOL|NOT DONE||N|U|U|1||38||SCREENING|1960-02-10||1972-05-20|||1969-11-23||1963-05-20
TRIAL STUDY 134XCP|RP|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||KPA/L/SEC|||CCID 50/ML|NOT DONE||Y|Y|Y|2||58||OBSERVATION|1968-10-07||1973-03-05|||1962-04-23||1970-08-15
TRIAL STUDY 134XCP|RP|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|2||||||MENFDUR|MENSES FLOW DURATION||||COPIES/UL|||UG/DAY|NOT DONE||N|N|U|2||58||OPEN LABEL TREATMENT|1964-12-14||1967-10-15|||1961-12-17||1969-05-23
TRIAL STUDY 134XCP|RP|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||NCI|||NSEC|NOT DONE||U|N|N|3||39||WASHOUT|1963-05-30||1960-04-24|||1968-01-13||1970-02-01
TRIAL STUDY 134XCP|RP|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MG/M2/DAY|||G/L|NOT DONE||N|N|NA|3||39||BASELINE|1967-07-13||1972-09-09|||1962-08-30||1962-06-11
TRIAL STUDY 134XCP|RP|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||PHERESIS UNIT|||MMHG/L/MIN|NOT DONE||N|Y|Y|4||88||BASELINE|1961-09-19||1967-08-14|||1961-09-12||1960-08-21
TRIAL STUDY 134XCP|RP|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||UCI/KG|||UG/M2/DAY|NOT DONE||U|N|Y|4||88||INDUCTION TREATMENT|1973-04-16||1970-04-25|||1966-08-19||1966-09-16
TRIAL STUDY 134XCP|RP|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|1||||||ULCERIND|ULCER INDICATOR||||APPLICATION|||UG/H|NOT DONE||U|U|NA|5||7||SCREENING|1969-05-26||1967-12-20|||1971-01-18||1968-12-03
TRIAL STUDY 134XCP|RP|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||SEC|||10^6 ORGANISMS/ML|NOT DONE||U|N|NA|5||7||LONG-TERM FOLLOW-UP|1961-09-28||1962-04-19|||1963-12-27||1973-06-18
TRIAL STUDY 134XCP|RP|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|1||||||TNDRIND|TENDERNESS INDICATOR||||NCI|||IU/G|NOT DONE||U|U|Y|1||38||TREATMENT|1973-04-25||1963-05-31|||1968-03-23||1964-12-22
TRIAL STUDY 134XCP|RP|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||FMOL/G|||NKAT|NOT DONE||N|NA|N|1||38||LONG-TERM FOLLOW-UP|1967-09-30||1963-10-01|||1972-11-30||1962-11-21
TRIAL STUDY 134XCP|RP|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|1||||||PRGENDTC|DATE PREGNANCY ENDED||||ML/MIN/1.73M2|||MPH|NOT DONE||Y|N|Y|2||58||OBSERVATION|1971-07-31||1965-05-26|||1962-12-24||1961-06-22
TRIAL STUDY 134XCP|RP|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||BREATHS/MIN|||10^10/L|NOT DONE||Y|N|NA|2||58||OPEN LABEL TREATMENT|1971-08-27||1966-12-01|||1968-04-03||1969-09-04
TRIAL STUDY 134XCP|RP|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||KCAL/DAY|||MPL U/ML|NOT DONE||N|N|N|3||39||BLINDED TREATMENT|1964-01-14||1960-11-07|||1966-01-22||1962-08-21
TRIAL STUDY 134XCP|RP|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||PLUG|||ANSON U|NOT DONE||U|NA|NA|3||39||BASELINE|1963-02-18||1970-08-06|||1967-09-20||1970-09-22
TRIAL STUDY 134XCP|RP|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||UM|||CM H2O|NOT DONE||N|U|Y|4||88||FOLLOW-UP|1966-10-28||1967-01-26|||1966-06-18||1973-04-27
TRIAL STUDY 134XCP|RP|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||CFU/ML|||PIXEL|NOT DONE||Y|N|N|4||88||SCREENING|1963-10-12||1967-05-26|||1966-11-18||1961-03-21
TRIAL STUDY 134XCP|RP|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||CI/UL|||CG|NOT DONE||Y|NA|U|5||7||OBSERVATION|1965-01-29||1964-02-22|||1967-04-02||1966-02-10
TRIAL STUDY 134XCP|RP|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|2||||||ERYTHIND|ERYTHEMA INDICATOR||||DPM/MG|||MMHG/SEC|NOT DONE||NA|NA|N|5||7||RUN-IN|1963-08-26||1960-07-18|||1966-04-19||1960-10-25
TRIAL STUDY 134XCP|RP|0194CD2F-7ABE-4BEE-A6FC-61298880173D|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||CONTAINER|||MEQ/G|NOT DONE||N|U|NA|1||38||SCREENING|1970-05-16||1972-02-27|||1973-08-12||1967-08-22
TRIAL STUDY 134XCP|RP|0194CD2F-7ABE-4BEE-A6FC-61298880173D|2||||||GRAVIND|GRAVIDA INDICATOR||||CMH2O*S/ML|||SACHET|NOT DONE||U|Y|N|1||38||SCREENING|1961-05-15||1965-09-26|||1962-12-05||1963-12-05
TRIAL STUDY 134XCP|RP|0194CD2F-7ABE-4BEE-A6FC-61298880173D|1||||||DSCHGIND|DISCHARGE INDICATOR||||MM/SEC|||CP|NOT DONE||N|NA|NA|2||58||CONTINUATION TREATMENT|1962-06-18||1960-05-25|||1961-01-05||1971-01-21
TRIAL STUDY 134XCP|RP|0194CD2F-7ABE-4BEE-A6FC-61298880173D|2||||||PREGIND|PREGNANT INDICATOR||||10^3 RNA COPIES/ML|||COPIES/UL|NOT DONE||N|NA|Y|2||58||FOLLOW-UP|1968-09-16||1970-12-22|||1967-04-29||1966-07-04
TRIAL STUDY 134XCP|RP|0194CD2F-7ABE-4BEE-A6FC-61298880173D|1||||||INTP|INTERPRETATION||||VIRTUAL PIXEL|||EVENTS|NOT DONE||N|NA|N|3||39||FOLLOW-UP|1966-08-02||1969-05-11|||1962-11-17||1960-08-25
TRIAL STUDY 134XCP|RP|0194CD2F-7ABE-4BEE-A6FC-61298880173D|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MU/L|||MPH|NOT DONE||NA|NA|Y|3||39||OBSERVATION|1965-12-26||1966-04-30|||1969-06-30||1961-01-15
TRIAL STUDY 134XCP|RP|0194CD2F-7ABE-4BEE-A6FC-61298880173D|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MNFI|||IU/DL|NOT DONE||NA|NA|Y|4||88||LONG-TERM FOLLOW-UP|1964-05-20||1972-04-22|||1972-09-20||1968-10-10
TRIAL STUDY 134XCP|RP|0194CD2F-7ABE-4BEE-A6FC-61298880173D|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||UG/ANIMAL|||U/KG/MIN|NOT DONE||U|NA|N|4||88||BLINDED TREATMENT|1960-07-27||1963-06-18|||1966-12-25||1970-03-01
TRIAL STUDY 134XCP|RP|0194CD2F-7ABE-4BEE-A6FC-61298880173D|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UOSM|||ML/MMHG|NOT DONE||N|NA|N|5||7||OBSERVATION|1965-06-01||1961-03-12|||1964-08-09||1972-06-25
TRIAL STUDY 134XCP|RP|0194CD2F-7ABE-4BEE-A6FC-61298880173D|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||U/G|||GRAVITATIONAL UNIT|NOT DONE||NA|NA|Y|5||7||BASELINE|1961-09-18||1962-08-05|||1969-09-27||1961-06-08
TRIAL STUDY 134XCP|RP|A6E531C7-1BC1-402E-9B2E-03B44313487B|1||||||ULCERIND|ULCER INDICATOR||||KG/MOL|||MOL/G|NOT DONE||Y|Y|N|1||38||SCREENING|1968-04-11||1963-02-25|||1965-12-30||1964-10-13
TRIAL STUDY 134XCP|RP|A6E531C7-1BC1-402E-9B2E-03B44313487B|2||||||EDEMAIND|EDEMA INDICATOR||||10^3 ORGANISMS/ML|||WAFER|NOT DONE||N|U|NA|1||38||FOLLOW-UP|1972-01-27||1970-03-23|||1961-01-18||1966-05-28
TRIAL STUDY 134XCP|RP|A6E531C7-1BC1-402E-9B2E-03B44313487B|1||||||PREGST|PREGNANT DURING THE STUDY||||FL|||10^3 CFU/G|NOT DONE||N|N|NA|2||58||TREATMENT|1961-12-22||1969-11-21|||1973-05-06||1961-03-29
TRIAL STUDY 134XCP|RP|A6E531C7-1BC1-402E-9B2E-03B44313487B|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MMOL/KG|||ML*CMH2O|NOT DONE||NA|U|U|2||58||INDUCTION TREATMENT|1963-03-13||1969-06-20|||1972-04-15||1971-03-14
TRIAL STUDY 134XCP|RP|A6E531C7-1BC1-402E-9B2E-03B44313487B|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||CI/UG|||10^3 ORGANISMS/G|NOT DONE||N|NA|Y|3||39||CONTINUATION TREATMENT|1971-10-09||1971-01-11|||1968-08-12||1969-03-17
TRIAL STUDY 134XCP|RP|A6E531C7-1BC1-402E-9B2E-03B44313487B|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||PFU|||/100 WBC|NOT DONE||Y|NA|Y|3||39||WASHOUT|1962-10-18||1963-08-26|||1963-08-13||1963-01-25
TRIAL STUDY 134XCP|RP|A6E531C7-1BC1-402E-9B2E-03B44313487B|1||||||DLVRMODE|MODE OF DELIVERY||||DROP|||ML/ANIMAL|NOT DONE||N|N|N|4||88||SCREENING|1960-07-20||1966-10-05|||1968-06-04||1972-09-08
TRIAL STUDY 134XCP|RP|A6E531C7-1BC1-402E-9B2E-03B44313487B|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||GLOBULE|||/KG|NOT DONE||Y|U|U|4||88||WASHOUT|1969-08-26||1972-10-27|||1966-11-01||1961-08-25
TRIAL STUDY 134XCP|RP|A6E531C7-1BC1-402E-9B2E-03B44313487B|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||VP/ML|||PPM|NOT DONE||U|N|N|5||7||OPEN LABEL TREATMENT|1964-06-27||1961-06-04|||1967-05-11||1969-10-30
TRIAL STUDY 134XCP|RP|A6E531C7-1BC1-402E-9B2E-03B44313487B|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||%|||AMFI|NOT DONE||U|N|U|5||7||LONG-TERM FOLLOW-UP|1960-10-20||1963-07-19|||1968-11-04||1967-06-06
TRIAL STUDY 134XCP|RP|47C0D833-BEAB-4BF2-B028-891808E729F1|1||||||ERYTHIND|ERYTHEMA INDICATOR||||MG/M2/H|||KCAL/DAY|NOT DONE||N|N|NA|1||38||CONTINUATION TREATMENT|1962-03-03||1961-09-05|||1966-04-23||1972-08-22
TRIAL STUDY 134XCP|RP|47C0D833-BEAB-4BF2-B028-891808E729F1|2||||||BCMETHOD|BIRTH CONTROL METHOD||||G/CAGE/DAY|||G/M2|NOT DONE||NA|Y|U|1||38||TREATMENT|1968-09-21||1962-12-31|||1967-08-17||1968-01-10
TRIAL STUDY 134XCP|RP|47C0D833-BEAB-4BF2-B028-891808E729F1|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||GBQ|||/5X10^4 WBC|NOT DONE||U|Y|U|2||58||FOLLOW-UP|1967-01-09||1968-05-04|||1971-01-13||1972-09-06
TRIAL STUDY 134XCP|RP|47C0D833-BEAB-4BF2-B028-891808E729F1|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||NMOL|||UL|NOT DONE||U|N|N|2||58||WASHOUT|1960-08-14||1966-07-17|||1970-09-10||1962-11-10
TRIAL STUDY 134XCP|RP|47C0D833-BEAB-4BF2-B028-891808E729F1|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^6/G|||AFU|NOT DONE||Y|NA|U|3||39||TREATMENT|1966-09-05||1968-04-20|||1967-07-12||1969-08-25
TRIAL STUDY 134XCP|RP|47C0D833-BEAB-4BF2-B028-891808E729F1|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||LOG10 CCID 50/DOSE|||SPRAY|NOT DONE||Y|Y|NA|3||39||BASELINE|1964-06-27||1963-01-13|||1960-01-27||1968-03-02
TRIAL STUDY 134XCP|RP|47C0D833-BEAB-4BF2-B028-891808E729F1|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MPL U/ML|||UG/ANIMAL|NOT DONE||NA|N|N|4||88||FOLLOW-UP|1964-08-03||1968-01-21|||1965-07-06||1965-04-28
TRIAL STUDY 134XCP|RP|47C0D833-BEAB-4BF2-B028-891808E729F1|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MMHG/L/MIN|||L/DAY|NOT DONE||N|U|Y|4||88||TREATMENT|1970-01-17||1963-07-31|||1960-02-12||1970-05-04
TRIAL STUDY 134XCP|RP|47C0D833-BEAB-4BF2-B028-891808E729F1|1||||||FUNDHT|FUNDAL HEIGHT||||MESF|||MM/H|NOT DONE||U|N|N|5||7||RUN-IN|1963-06-25||1972-11-17|||1961-06-05||1967-11-03
TRIAL STUDY 134XCP|RP|47C0D833-BEAB-4BF2-B028-891808E729F1|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||PATCH|||U/G/DAY|NOT DONE||NA|U|NA|5||7||SCREENING|1970-07-21||1966-09-20|||1973-04-26||1965-09-27
TRIAL STUDY 134XCP|RP|BA1773BD-AA89-45FC-B7C6-C5267770B197|1||||||MENARAGE|MENARCHE AGE||||EJACULATE U|||PIXELS/IN|NOT DONE||N|Y|Y|1||38||SCREENING|1967-05-02||1961-03-28|||1972-05-07||1970-10-01
TRIAL STUDY 134XCP|RP|BA1773BD-AA89-45FC-B7C6-C5267770B197|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||PFU|||U/M2/DAY|NOT DONE||NA|Y|N|1||38||SCREENING|1966-07-28||1962-01-23|||1968-04-09||1973-03-27
TRIAL STUDY 134XCP|RP|BA1773BD-AA89-45FC-B7C6-C5267770B197|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||%(W/V)|||FT2|NOT DONE||Y|NA|N|2||58||OBSERVATION|1967-09-27||1970-04-03|||1964-07-09||1967-11-28
TRIAL STUDY 134XCP|RP|BA1773BD-AA89-45FC-B7C6-C5267770B197|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||FEU|||PIXELS/IN|NOT DONE||U|Y|NA|2||58||RUN-IN|1965-10-06||1967-11-27|||1962-07-20||1967-07-19
TRIAL STUDY 134XCP|RP|BA1773BD-AA89-45FC-B7C6-C5267770B197|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||LOG10 CFU/ML|||10^6/L|NOT DONE||Y|U|U|3||39||OBSERVATION|1960-08-11||1964-01-23|||1962-10-11||1972-02-19
TRIAL STUDY 134XCP|RP|BA1773BD-AA89-45FC-B7C6-C5267770B197|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||DAYS/MONTH|||MET*H|NOT DONE||N|U|NA|3||39||BLINDED TREATMENT|1963-03-28||1970-11-05|||1965-02-02||1964-06-21
TRIAL STUDY 134XCP|RP|BA1773BD-AA89-45FC-B7C6-C5267770B197|1||||||RASHIND|RASH INDICATOR||||10^8 PFU|||KN/CM2|NOT DONE||Y|U|U|4||88||RUN-IN|1968-03-09||1964-07-31|||1965-01-08||1965-11-24
TRIAL STUDY 134XCP|RP|BA1773BD-AA89-45FC-B7C6-C5267770B197|2||||||PREGNN|NUMBER OF PREGNANCIES||||UL/KG/DAY|||10^3/L|NOT DONE||N|U|N|4||88||BASELINE|1969-10-02||1973-07-27|||1961-05-30||1967-10-22
TRIAL STUDY 134XCP|RP|BA1773BD-AA89-45FC-B7C6-C5267770B197|1||||||INABOIND|INDUCED ABORTION INDICATOR||||UMOL/MG/MIN|||TUBERCULIN UNIT|NOT DONE||Y|Y|U|5||7||RUN-IN|1962-12-14||1970-03-22|||1966-01-05||1962-06-27
TRIAL STUDY 134XCP|RP|BA1773BD-AA89-45FC-B7C6-C5267770B197|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||GLOBULE|||MS/MMHG|NOT DONE||Y|N|N|5||7||LONG-TERM FOLLOW-UP|1964-05-31||1963-09-16|||1960-07-19||1961-08-26
TRIAL STUDY 134XCP|RP|03D3DDC6-03FA-469A-B8A4-D504919B68F1|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||DRINK|||LOG10 CFU/G|NOT DONE||N|N|U|1||38||WASHOUT|1960-11-24||1967-09-06|||1968-12-31||1971-06-17
TRIAL STUDY 134XCP|RP|03D3DDC6-03FA-469A-B8A4-D504919B68F1|2||||||PREGNN|NUMBER OF PREGNANCIES||||CI/UL|||UG/G/MIN|NOT DONE||U|U|N|1||38||CONTINUATION TREATMENT|1972-02-26||1969-10-08|||1970-12-27||1968-06-07
TRIAL STUDY 134XCP|RP|03D3DDC6-03FA-469A-B8A4-D504919B68F1|1||||||TNDRIND|TENDERNESS INDICATOR||||ML/CAGE/WK|||DAYS|NOT DONE||NA|U|U|2||58||CONTINUATION TREATMENT|1970-04-20||1971-05-26|||1965-01-11||1961-11-06
TRIAL STUDY 134XCP|RP|03D3DDC6-03FA-469A-B8A4-D504919B68F1|2||||||ABORTN|NUMBER OF ABORTIONS||||ANTI-XA IU/ML|||ARBITRARY U|NOT DONE||N|U|NA|2||58||TREATMENT|1963-10-03||1969-01-13|||1962-03-02||1972-10-21
TRIAL STUDY 134XCP|RP|03D3DDC6-03FA-469A-B8A4-D504919B68F1|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MU/L|||BP|NOT DONE||U|Y|Y|3||39||OBSERVATION|1961-02-12||1962-08-24|||1963-02-20||1964-11-15
TRIAL STUDY 134XCP|RP|03D3DDC6-03FA-469A-B8A4-D504919B68F1|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||PMOL/10^9 CELLS|||CL|NOT DONE||Y|NA|U|3||39||CONTINUATION TREATMENT|1973-04-22||1965-02-22|||1971-01-12||1962-11-25
TRIAL STUDY 134XCP|RP|03D3DDC6-03FA-469A-B8A4-D504919B68F1|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||G/CM2|||GY|NOT DONE||U|N|Y|4||88||SCREENING|1965-08-05||1968-01-20|||1960-12-22||1965-03-18
TRIAL STUDY 134XCP|RP|03D3DDC6-03FA-469A-B8A4-D504919B68F1|2||||||ABORTN|NUMBER OF ABORTIONS||||BAU|||UG/CM2|NOT DONE||NA|Y|Y|4||88||RUN-IN|1962-04-29||1968-05-09|||1973-05-25||1966-06-16
TRIAL STUDY 134XCP|RP|03D3DDC6-03FA-469A-B8A4-D504919B68F1|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MET*H|||UG/G/DAY|NOT DONE||NA|NA|Y|5||7||BASELINE|1964-07-11||1967-07-14|||1971-12-14||1960-07-09
TRIAL STUDY 134XCP|RP|03D3DDC6-03FA-469A-B8A4-D504919B68F1|2||||||ABORTN|NUMBER OF ABORTIONS||||YD|||MIN*MG/ML|NOT DONE||N|N|NA|5||7||BASELINE|1963-09-01||1972-05-11|||1971-07-03||1971-05-31
TRIAL STUDY 134XCP|RP|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||SBE/ML|||10^6 IU|NOT DONE||U|NA|Y|1||38||CONTINUATION TREATMENT|1972-04-07||1962-04-10|||1973-07-17||1964-01-14
TRIAL STUDY 134XCP|RP|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||TRANSDUCING UNIT|||SPRAY|NOT DONE||NA|U|NA|1||38||OBSERVATION|1970-01-13||1968-07-23|||1963-09-20||1965-10-12
TRIAL STUDY 134XCP|RP|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|1||||||THICK|THICKNESS||||JOULE|||ML/G/DAY|NOT DONE||U|U|Y|2||58||INDUCTION TREATMENT|1960-02-14||1970-02-15|||1973-06-18||1961-12-20
TRIAL STUDY 134XCP|RP|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||DPM/MG|||EU|NOT DONE||NA|Y|N|2||58||TREATMENT|1970-10-02||1962-05-20|||1965-10-09||1973-07-07
TRIAL STUDY 134XCP|RP|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|1||||||FUNDHT|FUNDAL HEIGHT||||LENS|||OI50|NOT DONE||Y|Y|NA|3||39||BLINDED TREATMENT|1967-05-10||1968-08-16|||1966-02-23||1966-08-07
TRIAL STUDY 134XCP|RP|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||LOG10 CFU/ML|||JDF UNIT|NOT DONE||Y|U|Y|3||39||WASHOUT|1970-07-29||1961-08-17|||1964-01-15||1964-12-16
TRIAL STUDY 134XCP|RP|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||FRAMES/S|||U/G|NOT DONE||U|U|Y|4||88||OBSERVATION|1966-08-18||1962-01-04|||1966-07-29||1962-01-26
TRIAL STUDY 134XCP|RP|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|2||||||PEELIND|PEELING INDICATOR||||10^11/L|||VG/ML|NOT DONE||U|NA|NA|4||88||OBSERVATION|1971-09-19||1970-05-28|||1962-10-30||1963-01-16
TRIAL STUDY 134XCP|RP|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||STEPS/MIN|||KPA|NOT DONE||NA|U|U|5||7||BLINDED TREATMENT|1966-05-11||1960-02-23|||1966-02-06||1961-05-05
TRIAL STUDY 134XCP|RP|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|2||||||BLISTIND|BLISTERING INDICATOR||||G/L|||ML/KG/H|NOT DONE||N|U|N|5||7||OBSERVATION|1970-02-17||1960-11-27|||1962-10-18||1962-01-17
TRIAL STUDY 134XCP|RP|1873D4CC-40B7-4303-9F07-8FE0E4595361|1||||||MENFDUR|MENSES FLOW DURATION||||PL|||RPM|NOT DONE||U|N|U|1||38||INDUCTION TREATMENT|1972-04-06||1966-03-11|||1969-02-06||1964-09-27
TRIAL STUDY 134XCP|RP|1873D4CC-40B7-4303-9F07-8FE0E4595361|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||GTT|||PMOL/10^10 CELLS|NOT DONE||N|U|U|1||38||WASHOUT|1970-12-27||1969-07-09|||1965-05-18||1963-11-23
TRIAL STUDY 134XCP|RP|1873D4CC-40B7-4303-9F07-8FE0E4595361|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MOL/L|||RATIO|NOT DONE||Y|U|Y|2||58||LONG-TERM FOLLOW-UP|1970-04-23||1973-04-14|||1970-07-20||1972-12-10
TRIAL STUDY 134XCP|RP|1873D4CC-40B7-4303-9F07-8FE0E4595361|2||||||ERYTHIND|ERYTHEMA INDICATOR||||UMOL/H/MMOL|||U/ML|NOT DONE||Y|N|N|2||58||INDUCTION TREATMENT|1966-03-02||1970-12-08|||1960-03-19||1969-06-09
TRIAL STUDY 134XCP|RP|1873D4CC-40B7-4303-9F07-8FE0E4595361|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||SPRAY|||CD*S/M2|NOT DONE||N|U|U|3||39||OBSERVATION|1971-08-09||1964-04-09|||1973-02-28||1966-11-03
TRIAL STUDY 134XCP|RP|1873D4CC-40B7-4303-9F07-8FE0E4595361|2||||||THICK|THICKNESS||||CFU/ML|||MCI|NOT DONE||U|N|N|3||39||OPEN LABEL TREATMENT|1971-03-03||1967-05-29|||1970-03-09||1960-06-04
TRIAL STUDY 134XCP|RP|1873D4CC-40B7-4303-9F07-8FE0E4595361|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||S/H|||CM2|NOT DONE||U|N|N|4||88||SCREENING|1969-06-13||1973-08-14|||1969-01-29||1962-11-17
TRIAL STUDY 134XCP|RP|1873D4CC-40B7-4303-9F07-8FE0E4595361|2||||||INABOIND|INDUCED ABORTION INDICATOR||||PT_US|||AG|NOT DONE||N|NA|Y|4||88||INDUCTION TREATMENT|1964-12-13||1965-11-08|||1961-05-12||1964-07-26
TRIAL STUDY 134XCP|RP|1873D4CC-40B7-4303-9F07-8FE0E4595361|1||||||PREGNN|NUMBER OF PREGNANCIES||||PA|||UGEQ/L|NOT DONE||N|NA|U|5||7||FOLLOW-UP|1962-07-01||1969-08-17|||1960-04-15||1973-06-06
TRIAL STUDY 134XCP|RP|1873D4CC-40B7-4303-9F07-8FE0E4595361|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ABSORBANCE U/MIN|||SACHET|NOT DONE||NA|NA|NA|5||7||LONG-TERM FOLLOW-UP|1967-02-14||1960-03-30|||1969-05-21||1972-12-17
TRIAL STUDY 134XCP|RP|23E5569E-B324-4399-AC8A-5EC7C343C1D3|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||ML/M2/H|||LOG10 PFU|NOT DONE||U|U|Y|1||38||LONG-TERM FOLLOW-UP|1963-09-20||1961-05-13|||1970-05-16||1967-10-22
TRIAL STUDY 134XCP|RP|23E5569E-B324-4399-AC8A-5EC7C343C1D3|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MG/KG/DOSE|||MMOL/S|NOT DONE||U|U|NA|1||38||BLINDED TREATMENT|1969-07-19||1962-11-03|||1967-10-26||1970-06-17
TRIAL STUDY 134XCP|RP|23E5569E-B324-4399-AC8A-5EC7C343C1D3|1||||||MENOAGE|MENOPAUSE AGE||||CAN|||MEQ/L|NOT DONE||Y|N|Y|2||58||INDUCTION TREATMENT|1964-12-22||1972-10-02|||1963-12-21||1964-12-01
TRIAL STUDY 134XCP|RP|23E5569E-B324-4399-AC8A-5EC7C343C1D3|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||RING|||VOXEL|NOT DONE||Y|U|N|2||58||TREATMENT|1970-02-18||1965-02-27|||1965-04-23||1967-11-28
TRIAL STUDY 134XCP|RP|23E5569E-B324-4399-AC8A-5EC7C343C1D3|1||||||MENFDUR|MENSES FLOW DURATION||||ML/M2|||UG/G/H|NOT DONE||NA|N|U|3||39||LONG-TERM FOLLOW-UP|1970-09-26||1961-04-08|||1962-03-22||1970-11-27
TRIAL STUDY 134XCP|RP|23E5569E-B324-4399-AC8A-5EC7C343C1D3|2||||||INTP|INTERPRETATION||||ML/M2/MIN|||STEPS|NOT DONE||U|N|N|3||39||LONG-TERM FOLLOW-UP|1960-05-15||1965-07-26|||1966-11-17||1971-06-06
TRIAL STUDY 134XCP|RP|23E5569E-B324-4399-AC8A-5EC7C343C1D3|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||ABSORBANCE U|||CFU/G|NOT DONE||N|U|U|4||88||INDUCTION TREATMENT|1968-11-06||1970-03-18|||1966-08-11||1960-08-13
TRIAL STUDY 134XCP|RP|23E5569E-B324-4399-AC8A-5EC7C343C1D3|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||CI/KG|||BAU|NOT DONE||U|Y|Y|4||88||OPEN LABEL TREATMENT|1973-07-01||1971-12-22|||1960-04-18||1965-02-04
TRIAL STUDY 134XCP|RP|23E5569E-B324-4399-AC8A-5EC7C343C1D3|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||FRACTION OF 1|||MOSM|NOT DONE||U|U|Y|5||7||OPEN LABEL TREATMENT|1962-10-01||1972-10-20|||1961-08-12||1973-08-15
TRIAL STUDY 134XCP|RP|23E5569E-B324-4399-AC8A-5EC7C343C1D3|2||||||MENFDUR|MENSES FLOW DURATION||||CI/ML|||UMOL/MIN|NOT DONE||N|Y|Y|5||7||OPEN LABEL TREATMENT|1972-03-29||1970-04-02|||1970-05-19||1961-01-15
TRIAL STUDY 134XCP|RP|B349DD89-C41F-470E-8B54-B3589F0982FE|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MEQ/KG|||APL U/ML|NOT DONE||Y|NA|NA|1||38||FOLLOW-UP|1961-09-23||1971-03-25|||1971-03-22||1961-12-26
TRIAL STUDY 134XCP|RP|B349DD89-C41F-470E-8B54-B3589F0982FE|2||||||GRAVIND|GRAVIDA INDICATOR||||AMFI|||MEQ/G|NOT DONE||U|NA|Y|1||38||RUN-IN|1972-10-23||1961-03-14|||1966-06-29||1969-04-20
TRIAL STUDY 134XCP|RP|B349DD89-C41F-470E-8B54-B3589F0982FE|1||||||DLVRMODE|MODE OF DELIVERY||||DPM/ML|||DAGU/ML|NOT DONE||U|U|N|2||58||CONTINUATION TREATMENT|1969-02-17||1969-03-03|||1970-05-13||1960-08-08
TRIAL STUDY 134XCP|RP|B349DD89-C41F-470E-8B54-B3589F0982FE|2||||||BLISTIND|BLISTERING INDICATOR||||HOURS|||BE/ML|NOT DONE||NA|N|U|2||58||SCREENING|1972-10-08||1973-04-24|||1964-12-07||1966-01-22
TRIAL STUDY 134XCP|RP|B349DD89-C41F-470E-8B54-B3589F0982FE|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||TITER|||L/MIN/M2|NOT DONE||U|N|N|3||39||LONG-TERM FOLLOW-UP|1971-09-01||1973-06-21|||1963-09-04||1966-06-13
TRIAL STUDY 134XCP|RP|B349DD89-C41F-470E-8B54-B3589F0982FE|2||||||STILBIND|STILLBIRTH INDICATOR||||VOXEL|||MPS U|NOT DONE||U|NA|NA|3||39||WASHOUT|1973-01-15||1966-01-04|||1960-09-15||1968-01-11
TRIAL STUDY 134XCP|RP|B349DD89-C41F-470E-8B54-B3589F0982FE|1||||||BLISTIND|BLISTERING INDICATOR||||RPM|||UG/G/MIN|NOT DONE||Y|N|U|4||88||RUN-IN|1967-06-22||1963-08-09|||1964-03-31||1965-08-23
TRIAL STUDY 134XCP|RP|B349DD89-C41F-470E-8B54-B3589F0982FE|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UG/L|||CGY|NOT DONE||Y|NA|Y|4||88||WASHOUT|1965-03-23||1970-07-06|||1973-05-14||1969-12-25
TRIAL STUDY 134XCP|RP|B349DD89-C41F-470E-8B54-B3589F0982FE|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MMOL2/L2|||BQ/UL|NOT DONE||U|Y|U|5||7||WASHOUT|1973-06-05||1972-06-23|||1972-07-08||1962-08-01
TRIAL STUDY 134XCP|RP|B349DD89-C41F-470E-8B54-B3589F0982FE|2||||||MENARAGE|MENARCHE AGE||||JAR|||DPM/MG|NOT DONE||U|NA|NA|5||7||WASHOUT|1973-02-21||1968-07-22|||1964-02-15||1973-08-13
TRIAL STUDY 134XCP|RP|415D178A-275A-440C-8617-154441A48F8D|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||TORR|||NM|NOT DONE||Y|N|N|1||38||TREATMENT|1972-07-11||1965-12-30|||1966-10-23||1970-08-20
TRIAL STUDY 134XCP|RP|415D178A-275A-440C-8617-154441A48F8D|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||TUBERCULIN UNIT|||AMP|NOT DONE||N|N|U|1||38||WASHOUT|1961-07-25||1972-03-05|||1969-04-06||1960-05-02
TRIAL STUDY 134XCP|RP|415D178A-275A-440C-8617-154441A48F8D|1||||||MENARAGE|MENARCHE AGE||||LOG10 TCID 50/ML|||ML/G/DAY|NOT DONE||Y|NA|NA|2||58||RUN-IN|1962-05-05||1965-06-24|||1972-03-14||1964-09-21
TRIAL STUDY 134XCP|RP|415D178A-275A-440C-8617-154441A48F8D|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||PIXELS/IN|||SCM|NOT DONE||U|N|N|2||58||TREATMENT|1972-09-29||1966-01-29|||1969-05-28||1964-05-05
TRIAL STUDY 134XCP|RP|415D178A-275A-440C-8617-154441A48F8D|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UMOL/KG/MIN|||ARBITRARY U|NOT DONE||Y|Y|NA|3||39||CONTINUATION TREATMENT|1960-08-10||1961-04-30|||1967-07-24||1960-08-18
TRIAL STUDY 134XCP|RP|415D178A-275A-440C-8617-154441A48F8D|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MMOL|||IU/MG|NOT DONE||Y|NA|N|3||39||TREATMENT|1968-09-09||1971-07-18|||1969-12-31||1970-07-02
TRIAL STUDY 134XCP|RP|415D178A-275A-440C-8617-154441A48F8D|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||FEU|||CM/MIN|NOT DONE||NA|U|Y|4||88||OBSERVATION|1967-08-06||1970-06-05|||1966-09-07||1973-03-17
TRIAL STUDY 134XCP|RP|415D178A-275A-440C-8617-154441A48F8D|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||DAGU|||UG/KG/DAY|NOT DONE||N|Y|N|4||88||CONTINUATION TREATMENT|1962-02-25||1969-09-26|||1965-12-12||1970-09-06
TRIAL STUDY 134XCP|RP|415D178A-275A-440C-8617-154441A48F8D|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||PG/DL|||MANSON U/ML|NOT DONE||Y|U|U|5||7||FOLLOW-UP|1960-05-06||1963-03-17|||1965-12-31||1968-10-30
TRIAL STUDY 134XCP|RP|415D178A-275A-440C-8617-154441A48F8D|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||GRAIN|||L/S|NOT DONE||U|Y|NA|5||7||TREATMENT|1966-05-16||1963-10-22|||1969-03-26||1963-09-10
TRIAL STUDY 134XCP|RP|C23917E6-6CA5-4314-A59D-A0298483BF53|1||||||INABOIND|INDUCED ABORTION INDICATOR||||NMOL BCE/MMOL|||IU/MMOL|NOT DONE||NA|U|N|1||38||SCREENING|1966-06-20||1970-07-29|||1970-06-05||1967-02-02
TRIAL STUDY 134XCP|RP|C23917E6-6CA5-4314-A59D-A0298483BF53|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||KG/CM2|||MMOL/MIN/KPA|NOT DONE||U|U|U|1||38||RUN-IN|1966-01-23||1965-02-03|||1967-07-14||1970-12-26
TRIAL STUDY 134XCP|RP|C23917E6-6CA5-4314-A59D-A0298483BF53|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UL/KG/DAY|||HZ/S|NOT DONE||Y|NA|U|2||58||OBSERVATION|1973-06-15||1963-08-25|||1966-03-08||1969-08-09
TRIAL STUDY 134XCP|RP|C23917E6-6CA5-4314-A59D-A0298483BF53|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UG/MOL|||CYLINDER|NOT DONE||Y|U|Y|2||58||OPEN LABEL TREATMENT|1960-06-27||1969-07-23|||1971-11-08||1973-08-10
TRIAL STUDY 134XCP|RP|C23917E6-6CA5-4314-A59D-A0298483BF53|1||||||ULCERIND|ULCER INDICATOR||||NMOL BCE/L|||GMFI|NOT DONE||N|N|N|3||39||TREATMENT|1967-04-18||1969-07-17|||1971-11-13||1964-10-07
TRIAL STUDY 134XCP|RP|C23917E6-6CA5-4314-A59D-A0298483BF53|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MHZ|||GPL U|NOT DONE||Y|NA|U|3||39||FOLLOW-UP|1967-05-08||1964-06-01|||1961-07-15||1964-12-13
TRIAL STUDY 134XCP|RP|C23917E6-6CA5-4314-A59D-A0298483BF53|1||||||PEELIND|PEELING INDICATOR||||G/DAY|||MG/G/H|NOT DONE||Y|U|N|4||88||SCREENING|1966-11-20||1967-08-22|||1961-03-11||1968-02-25
TRIAL STUDY 134XCP|RP|C23917E6-6CA5-4314-A59D-A0298483BF53|2||||||MENOAGE|MENOPAUSE AGE||||CI/UG|||FT2|NOT DONE||N|N|U|4||88||OBSERVATION|1968-09-01||1962-12-29|||1971-09-09||1963-12-20
TRIAL STUDY 134XCP|RP|C23917E6-6CA5-4314-A59D-A0298483BF53|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MMOL2/L2|||PFU|NOT DONE||Y|Y|NA|5||7||WASHOUT|1962-12-15||1963-03-11|||1960-11-17||1966-10-31
TRIAL STUDY 134XCP|RP|C23917E6-6CA5-4314-A59D-A0298483BF53|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MIN*MG/ML|||NMOL/ML/MIN|NOT DONE||U|Y|NA|5||7||TREATMENT|1967-01-14||1964-03-20|||1965-02-14||1969-01-06
TRIAL STUDY 134XCP|RP|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||TSP EQ|||CS|NOT DONE||N|NA|U|1||38||BASELINE|1969-07-09||1968-11-12|||1968-05-29||1964-07-01
TRIAL STUDY 134XCP|RP|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||NSEC|||MET*H|NOT DONE||Y|U|Y|1||38||BLINDED TREATMENT|1963-06-12||1969-08-08|||1972-03-09||1963-12-17
TRIAL STUDY 134XCP|RP|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MG/H|||VP/ML|NOT DONE||Y|NA|NA|2||58||WASHOUT|1972-02-04||1966-08-20|||1967-03-02||1970-01-20
TRIAL STUDY 134XCP|RP|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|2||||||DLVRMODE|MODE OF DELIVERY||||CI/UL|||U.CARR|NOT DONE||U|NA|U|2||58||BASELINE|1967-06-23||1962-10-23|||1961-03-25||1972-11-23
TRIAL STUDY 134XCP|RP|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|1||||||THICK|THICKNESS||||HEP|||DIOPTER|NOT DONE||N|U|NA|3||39||FOLLOW-UP|1964-05-23||1970-08-31|||1971-12-15||1965-10-03
TRIAL STUDY 134XCP|RP|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|2||||||TNDRIND|TENDERNESS INDICATOR||||MAMP|||FOZ_US|NOT DONE||Y|U|U|3||39||RUN-IN|1969-03-10||1960-11-20|||1963-05-30||1969-10-29
TRIAL STUDY 134XCP|RP|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MM/SEC|||/MONTH|NOT DONE||N|N|N|4||88||TREATMENT|1965-01-13||1972-12-20|||1971-10-09||1960-05-25
TRIAL STUDY 134XCP|RP|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|2||||||BRTHN|NUMBER OF BIRTHS||||ECL UNIT|||LOG10 TCID 50/UL|NOT DONE||Y|N|Y|4||88||INDUCTION TREATMENT|1967-11-09||1961-12-14|||1966-05-17||1967-10-16
TRIAL STUDY 134XCP|RP|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UG/M2/MIN|||U/KG/MIN|NOT DONE||N|U|U|5||7||TREATMENT|1960-11-23||1969-08-04|||1970-08-17||1966-10-06
TRIAL STUDY 134XCP|RP|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MEQ/ML|||PACK|NOT DONE||Y|N|Y|5||7||SCREENING|1967-08-13||1969-04-12|||1965-04-22||1961-10-20
TRIAL STUDY 134XCP|RP|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||NG|||G/U|NOT DONE||N|Y|NA|1||38||WASHOUT|1967-05-09||1963-10-29|||1971-11-06||1964-05-26
TRIAL STUDY 134XCP|RP|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||HZ/S|||CMH2O*S2/ML|NOT DONE||Y|N|U|1||38||WASHOUT|1971-05-09||1968-06-05|||1970-04-04||1961-06-28
TRIAL STUDY 134XCP|RP|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|1||||||FUNDHT|FUNDAL HEIGHT||||STEPS/MIN|||MIN*MG/ML|NOT DONE||U|N|N|2||58||CONTINUATION TREATMENT|1967-05-28||1962-04-05|||1966-08-04||1960-02-16
TRIAL STUDY 134XCP|RP|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|2||||||THICK|THICKNESS||||BQ/L|||G/ANIMAL|NOT DONE||U|N|N|2||58||INDUCTION TREATMENT|1964-01-09||1964-11-19|||1968-07-15||1963-11-27
TRIAL STUDY 134XCP|RP|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|1||||||DSCHGIND|DISCHARGE INDICATOR||||10^5/HPF|||G/CM2|NOT DONE||N|U|N|3||39||LONG-TERM FOLLOW-UP|1961-05-10||1967-06-18|||1971-12-12||1971-11-06
TRIAL STUDY 134XCP|RP|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||10^4 CFU/ML|||ENZYME U/M2|NOT DONE||N|N|N|3||39||SCREENING|1968-05-08||1970-10-23|||1973-03-29||1964-09-14
TRIAL STUDY 134XCP|RP|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||FMOL/G|||NMOL/DAY|NOT DONE||N|N|N|4||88||SCREENING|1973-02-16||1968-09-21|||1973-05-21||1968-07-13
TRIAL STUDY 134XCP|RP|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|2||||||FUNDHT|FUNDAL HEIGHT||||UMOL/DAY|||TUBE|NOT DONE||U|Y|U|4||88||OBSERVATION|1960-04-05||1969-10-07|||1972-05-30||1963-08-27
TRIAL STUDY 134XCP|RP|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||CGY|||FMOL/G|NOT DONE||Y|U|U|5||7||CONTINUATION TREATMENT|1961-03-07||1963-09-04|||1970-05-17||1962-12-07
TRIAL STUDY 134XCP|RP|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||LOG10 COPIES/ML|||HOURS|NOT DONE||Y|N|N|5||7||RUN-IN|1964-12-15||1970-08-08|||1967-02-07||1963-02-18
TRIAL STUDY 134XCP|RP|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|1||||||MENOAGE|MENOPAUSE AGE||||PMOL/G|||NMOL/KG/DAY|NOT DONE||Y|Y|Y|1||38||INDUCTION TREATMENT|1970-10-28||1965-05-16|||1972-10-14||1963-09-03
TRIAL STUDY 134XCP|RP|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PPM|||NG|NOT DONE||N|N|U|1||38||INDUCTION TREATMENT|1962-03-27||1972-05-20|||1961-06-08||1971-03-10
TRIAL STUDY 134XCP|RP|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|1||||||THICK|THICKNESS||||UG/L/H|||OSM|NOT DONE||Y|N|NA|2||58||TREATMENT|1960-11-17||1973-05-05|||1961-05-23||1960-07-28
TRIAL STUDY 134XCP|RP|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|2||||||MENARAGE|MENARCHE AGE||||COULOMB|||BOX|NOT DONE||Y|N|Y|2||58||SCREENING|1969-10-22||1973-03-12|||1964-02-02||1971-06-03
TRIAL STUDY 134XCP|RP|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UEQ/L|||YEARS|NOT DONE||U|N|N|3||39||BLINDED TREATMENT|1968-06-06||1960-08-01|||1968-01-21||1967-12-20
TRIAL STUDY 134XCP|RP|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|2||||||DSCHGIND|DISCHARGE INDICATOR||||KIU|||ANTIBODY UNIT|NOT DONE||NA|Y|Y|3||39||BLINDED TREATMENT|1972-02-25||1972-09-28|||1972-12-11||1960-05-18
TRIAL STUDY 134XCP|RP|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|1||||||BRTHN|NUMBER OF BIRTHS||||PG/L|||PACKAGE|NOT DONE||Y|U|N|4||88||RUN-IN|1965-12-15||1962-09-26|||1968-05-18||1973-02-02
TRIAL STUDY 134XCP|RP|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||PFU/DOSE|||10^6 ORGANISMS/G|NOT DONE||N|NA|Y|4||88||INDUCTION TREATMENT|1968-03-23||1970-06-25|||1969-01-26||1970-04-29
TRIAL STUDY 134XCP|RP|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||/WK|||10^12 IU/L|NOT DONE||N|NA|NA|5||7||SCREENING|1971-09-01||1964-05-15|||1961-09-18||1965-02-13
TRIAL STUDY 134XCP|RP|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||HOMEOPATHIC DILUTION|||NMOL/KG/DAY|NOT DONE||U|Y|U|5||7||RUN-IN|1972-06-01||1966-06-14|||1961-12-16||1972-11-10
TRIAL STUDY 134XCP|RP|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|1||||||PREGIND|PREGNANT INDICATOR||||BEL|||UL/ML|NOT DONE||NA|NA|U|1||38||LONG-TERM FOLLOW-UP|1973-04-27||1969-05-13|||1971-02-25||1973-07-26
TRIAL STUDY 134XCP|RP|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|2||||||MENARAGE|MENARCHE AGE||||MU/L|||VG/ML|NOT DONE||Y|NA|U|1||38||CONTINUATION TREATMENT|1964-05-17||1973-01-04|||1970-07-07||1970-12-05
TRIAL STUDY 134XCP|RP|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||UEQ|||MKAT|NOT DONE||NA|U|N|2||58||TREATMENT|1969-09-30||1971-04-28|||1971-01-29||1967-11-25
TRIAL STUDY 134XCP|RP|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||NKAT|||ENZYME U/G HB|NOT DONE||N|NA|N|2||58||SCREENING|1960-08-17||1961-08-22|||1963-04-17||1966-06-03
TRIAL STUDY 134XCP|RP|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PACKAGE|||MMOL/DAY|NOT DONE||N|U|NA|3||39||OPEN LABEL TREATMENT|1973-08-24||1972-10-05|||1961-11-18||1961-04-29
TRIAL STUDY 134XCP|RP|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||PMOL/G|||AMFI|NOT DONE||NA|Y|U|3||39||LONG-TERM FOLLOW-UP|1964-04-08||1965-11-07|||1973-06-09||1962-07-21
TRIAL STUDY 134XCP|RP|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||S/H|||CYLINDER|NOT DONE||N|U|NA|4||88||OBSERVATION|1963-08-20||1962-09-26|||1965-09-01||1960-08-03
TRIAL STUDY 134XCP|RP|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||CARTRIDGE|||INHALATION|NOT DONE||Y|Y|Y|4||88||WASHOUT|1961-12-08||1966-02-26|||1960-08-02||1961-01-20
TRIAL STUDY 134XCP|RP|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||/200 HPFS|||U/CL|NOT DONE||NA|Y|U|5||7||LONG-TERM FOLLOW-UP|1961-02-06||1966-12-17|||1967-06-25||1960-01-16
TRIAL STUDY 134XCP|RP|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|2||||||PUSTIND|PUSTULE INDICATOR||||KG/CM|||ELISA UNIT/DOSE|NOT DONE||Y|Y|U|5||7||LONG-TERM FOLLOW-UP|1969-11-06||1970-10-09|||1968-05-15||1973-04-26
TRIAL STUDY 134XCP|RP|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||M|||/KG|NOT DONE||NA|NA|NA|1||38||LONG-TERM FOLLOW-UP|1960-05-28||1963-06-29|||1967-04-02||1966-03-08
TRIAL STUDY 134XCP|RP|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||/HPF|||ML/CAGE/DAY|NOT DONE||N|N|NA|1||38||SCREENING|1964-12-04||1968-06-27|||1972-07-15||1973-02-13
TRIAL STUDY 134XCP|RP|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||L/L|||%/S|NOT DONE||U|Y|U|2||58||OPEN LABEL TREATMENT|1969-05-26||1963-01-27|||1973-04-12||1972-08-14
TRIAL STUDY 134XCP|RP|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||UMOL/L/SEC|||COPIES/UG|NOT DONE||U|NA|NA|2||58||TREATMENT|1960-09-03||1963-11-02|||1973-07-01||1973-04-22
TRIAL STUDY 134XCP|RP|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|1||||||PREGNN|NUMBER OF PREGNANCIES||||TRACE|||HENRY|NOT DONE||U|U|N|3||39||RUN-IN|1970-06-10||1963-07-04|||1969-03-29||1963-07-01
TRIAL STUDY 134XCP|RP|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||ML/G/MIN|||MIN*MG/ML|NOT DONE||N|Y|U|3||39||LONG-TERM FOLLOW-UP|1973-08-24||1961-12-22|||1971-08-09||1960-03-11
TRIAL STUDY 134XCP|RP|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|1||||||PREGST|PREGNANT DURING THE STUDY||||PMOL/10^10 CELLS|||DAGU|NOT DONE||Y|Y|NA|4||88||BLINDED TREATMENT|1962-06-20||1964-06-19|||1965-06-03||1962-05-30
TRIAL STUDY 134XCP|RP|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||/VF|||ML/MIN|NOT DONE||NA|N|NA|4||88||BASELINE|1966-05-07||1969-10-26|||1970-01-31||1971-08-20
TRIAL STUDY 134XCP|RP|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||NKAT|||U/ANIMAL|NOT DONE||Y|Y|U|5||7||INDUCTION TREATMENT|1961-01-31||1964-10-04|||1969-10-07||1962-09-14
TRIAL STUDY 134XCP|RP|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||CYLINDER|||MOL/MOL|NOT DONE||N|NA|U|5||7||BLINDED TREATMENT|1970-10-12||1964-08-12|||1963-02-18||1964-09-23
TRIAL STUDY 134XCP|RP|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||S^-1(%O2)^-1|||COPIES/UG|NOT DONE||NA|U|U|1||38||TREATMENT|1965-07-04||1967-03-16|||1973-08-02||1967-04-10
TRIAL STUDY 134XCP|RP|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|2||||||DLVRMODE|MODE OF DELIVERY||||ML/S/M2|||CARTRIDGE|NOT DONE||NA|U|Y|1||38||CONTINUATION TREATMENT|1973-05-28||1964-06-29|||1970-11-30||1963-06-02
TRIAL STUDY 134XCP|RP|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|1||||||PREGNN|NUMBER OF PREGNANCIES||||UL/KG/DAY|||BU|NOT DONE||U|U|U|2||58||RUN-IN|1967-12-19||1963-12-15|||1966-09-23||1966-04-01
TRIAL STUDY 134XCP|RP|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||S^-1(%O2)^-1|||BAG|NOT DONE||Y|U|NA|2||58||INDUCTION TREATMENT|1961-10-28||1962-06-10|||1971-01-25||1970-11-16
TRIAL STUDY 134XCP|RP|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||BQ/UL|||NG/MOL|NOT DONE||N|N|U|3||39||CONTINUATION TREATMENT|1972-03-24||1970-10-16|||1963-02-23||1969-08-06
TRIAL STUDY 134XCP|RP|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|2||||||BLISTIND|BLISTERING INDICATOR||||STRIP|||U/L|NOT DONE||U|N|NA|3||39||OBSERVATION|1963-05-12||1961-06-13|||1964-10-28||1961-12-10
TRIAL STUDY 134XCP|RP|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|1||||||EDEMAIND|EDEMA INDICATOR||||UMOL/MOL|||NMOL BCE/L|NOT DONE||Y|U|NA|4||88||BLINDED TREATMENT|1963-12-09||1965-11-30|||1972-12-13||1960-07-24
TRIAL STUDY 134XCP|RP|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|2||||||PRGENDTC|DATE PREGNANCY ENDED||||ML/G/MIN|||UL|NOT DONE||U|U|U|4||88||RUN-IN|1966-01-18||1960-03-29|||1963-12-28||1963-05-07
TRIAL STUDY 134XCP|RP|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MESF|||HZ|NOT DONE||NA|Y|Y|5||7||INDUCTION TREATMENT|1966-02-25||1973-04-05|||1960-10-12||1963-12-18
TRIAL STUDY 134XCP|RP|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||UG/ANIMAL|||PMOL/10^9 CELLS|NOT DONE||Y|U|Y|5||7||WASHOUT|1970-01-03||1961-07-03|||1970-08-25||1962-06-11
TRIAL STUDY 134XCP|RP|EDB6B55B-7903-4F89-805C-32F067C2A230|1||||||PUSTIND|PUSTULE INDICATOR||||10^6 ORGANISMS/ML|||HOMEOPATHIC DILUTION|NOT DONE||U|Y|U|1||38||INDUCTION TREATMENT|1967-06-29||1969-03-12|||1971-10-09||1962-07-12
TRIAL STUDY 134XCP|RP|EDB6B55B-7903-4F89-805C-32F067C2A230|2||||||GRAVIND|GRAVIDA INDICATOR||||CL|||10^9/DOSE|NOT DONE||U|NA|Y|1||38||OBSERVATION|1969-12-06||1964-12-23|||1961-03-13||1966-07-19
TRIAL STUDY 134XCP|RP|EDB6B55B-7903-4F89-805C-32F067C2A230|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||ML/KG/DAY|||UG/KG|NOT DONE||Y|N|U|2||58||FOLLOW-UP|1965-09-23||1963-12-31|||1972-06-16||1961-02-11
TRIAL STUDY 134XCP|RP|EDB6B55B-7903-4F89-805C-32F067C2A230|2||||||TNDRIND|TENDERNESS INDICATOR||||HEP|||UMOL/L/H|NOT DONE||N|NA|NA|2||58||BLINDED TREATMENT|1971-04-20||1973-01-07|||1965-12-20||1970-02-26
TRIAL STUDY 134XCP|RP|EDB6B55B-7903-4F89-805C-32F067C2A230|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||/KG|||UG/DL|NOT DONE||N|Y|NA|3||39||WASHOUT|1972-03-17||1963-11-22|||1964-01-10||1966-12-14
TRIAL STUDY 134XCP|RP|EDB6B55B-7903-4F89-805C-32F067C2A230|2||||||DSCHGIND|DISCHARGE INDICATOR||||GBQ/MG|||PMOL/L|NOT DONE||Y|U|U|3||39||INDUCTION TREATMENT|1968-11-07||1961-03-23|||1960-02-24||1964-03-05
TRIAL STUDY 134XCP|RP|EDB6B55B-7903-4F89-805C-32F067C2A230|1||||||MENARAGE|MENARCHE AGE||||UCI/L|||OZ|NOT DONE||U|N|N|4||88||FOLLOW-UP|1962-07-11||1962-05-05|||1961-04-28||1961-04-12
TRIAL STUDY 134XCP|RP|EDB6B55B-7903-4F89-805C-32F067C2A230|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||BQ/UL|||MG/KG|NOT DONE||N|Y|U|4||88||LONG-TERM FOLLOW-UP|1971-10-06||1962-04-03|||1961-01-02||1967-05-06
TRIAL STUDY 134XCP|RP|EDB6B55B-7903-4F89-805C-32F067C2A230|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||CY/CM|||UMOL/L/MIN|NOT DONE||U|U|N|5||7||OPEN LABEL TREATMENT|1971-01-06||1960-06-06|||1969-04-17||1973-04-27
TRIAL STUDY 134XCP|RP|EDB6B55B-7903-4F89-805C-32F067C2A230|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||PIXEL|||GLOBULE|NOT DONE||U|Y|U|5||7||RUN-IN|1973-06-29||1968-11-22|||1970-02-20||1969-05-30
TRIAL STUDY 134XCP|RP|8F6772DE-E4CA-4706-8754-740D3859ABDF|1||||||BLISTIND|BLISTERING INDICATOR||||MOSM/L|||FEU|NOT DONE||NA|U|NA|1||38||BASELINE|1960-07-17||1964-08-16|||1966-08-28||1962-09-19
TRIAL STUDY 134XCP|RP|8F6772DE-E4CA-4706-8754-740D3859ABDF|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||PMOL/10^9 CELLS|||CI/UG|NOT DONE||Y|N|NA|1||38||INDUCTION TREATMENT|1973-08-30||1960-07-03|||1964-02-04||1968-02-14
TRIAL STUDY 134XCP|RP|8F6772DE-E4CA-4706-8754-740D3859ABDF|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^5/L|||ML/ANIMAL/WK|NOT DONE||U|U|U|2||58||CONTINUATION TREATMENT|1964-02-21||1971-10-25|||1962-10-24||1966-10-15
TRIAL STUDY 134XCP|RP|8F6772DE-E4CA-4706-8754-740D3859ABDF|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MEQ/UL|||MMHG|NOT DONE||Y|U|N|2||58||CONTINUATION TREATMENT|1964-05-17||1968-12-11|||1970-09-17||1970-07-12
TRIAL STUDY 134XCP|RP|8F6772DE-E4CA-4706-8754-740D3859ABDF|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||FEU|||G/CM2|NOT DONE||Y|N|NA|3||39||CONTINUATION TREATMENT|1962-03-01||1962-12-04|||1970-11-10||1973-02-23
TRIAL STUDY 134XCP|RP|8F6772DE-E4CA-4706-8754-740D3859ABDF|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||HZ/S|||MG/MIN|NOT DONE||N|NA|NA|3||39||LONG-TERM FOLLOW-UP|1968-08-02||1961-09-15|||1969-03-30||1967-05-24
TRIAL STUDY 134XCP|RP|8F6772DE-E4CA-4706-8754-740D3859ABDF|1||||||PEELIND|PEELING INDICATOR||||MG/DOSE|||NEWTON|NOT DONE||U|NA|NA|4||88||BASELINE|1973-01-29||1968-11-28|||1971-01-19||1962-01-07
TRIAL STUDY 134XCP|RP|8F6772DE-E4CA-4706-8754-740D3859ABDF|2||||||BRTHN|NUMBER OF BIRTHS||||ML/CAGE|||VG/KG|NOT DONE||Y|Y|NA|4||88||CONTINUATION TREATMENT|1963-01-08||1971-11-03|||1970-02-19||1967-05-29
TRIAL STUDY 134XCP|RP|8F6772DE-E4CA-4706-8754-740D3859ABDF|1||||||MENOAGE|MENOPAUSE AGE||||10^12 IU/L|||UL/ML|NOT DONE||Y|NA|N|5||7||BASELINE|1960-06-03||1961-01-20|||1966-05-14||1968-11-14
TRIAL STUDY 134XCP|RP|8F6772DE-E4CA-4706-8754-740D3859ABDF|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^6 COPIES/ML|||BQ/UG|NOT DONE||NA|U|NA|5||7||OPEN LABEL TREATMENT|1966-04-10||1960-10-25|||1968-04-15||1970-03-28
TRIAL STUDY 134XCP|RP|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||BQ/G|||GENEQ|NOT DONE||NA|N|U|1||38||LONG-TERM FOLLOW-UP|1970-09-07||1960-03-18|||1967-04-30||1972-04-23
TRIAL STUDY 134XCP|RP|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|2||||||PREGIND|PREGNANT INDICATOR||||MMHG/L/MIN|||ANSON U|NOT DONE||Y|U|Y|1||38||OPEN LABEL TREATMENT|1961-01-27||1965-10-08|||1960-12-11||1968-10-14
TRIAL STUDY 134XCP|RP|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||PATCH|||/40 HPFS|NOT DONE||NA|U|Y|2||58||OBSERVATION|1972-12-06||1964-07-18|||1964-08-25||1962-04-30
TRIAL STUDY 134XCP|RP|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|2||||||PUSTIND|PUSTULE INDICATOR||||CCID 50/DOSE|||ABSORBANCE U/MIN|NOT DONE||NA|U|N|2||58||LONG-TERM FOLLOW-UP|1963-07-30||1971-02-07|||1968-02-19||1968-12-30
TRIAL STUDY 134XCP|RP|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|1||||||BRTHN|NUMBER OF BIRTHS||||UMOL/MOL|||CARTRIDGE|NOT DONE||Y|N|Y|3||39||RUN-IN|1966-12-12||1961-09-17|||1969-09-08||1966-02-08
TRIAL STUDY 134XCP|RP|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||CARTRIDGE|||SUPPOSITORY|NOT DONE||N|N|U|3||39||BLINDED TREATMENT|1960-04-29||1972-04-07|||1966-07-03||1966-09-13
TRIAL STUDY 134XCP|RP|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ML/MIN|||PATCH|NOT DONE||N|NA|N|4||88||INDUCTION TREATMENT|1960-07-13||1966-12-03|||1964-10-22||1973-08-05
TRIAL STUDY 134XCP|RP|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|2||||||STILBIND|STILLBIRTH INDICATOR||||10^9/L|||10^6 DNA COPIES/ML|NOT DONE||NA|N|U|4||88||CONTINUATION TREATMENT|1963-01-02||1962-01-10|||1972-05-18||1963-02-28
TRIAL STUDY 134XCP|RP|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||ELISA UNIT/ML|||MS2|NOT DONE||NA|NA|Y|5||7||CONTINUATION TREATMENT|1960-08-10||1971-06-16|||1973-06-10||1965-05-25
TRIAL STUDY 134XCP|RP|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|2||||||THICK|THICKNESS||||NU/CL|||G|NOT DONE||N|N|NA|5||7||RUN-IN|1965-01-13||1972-01-03|||1969-12-24||1960-06-28
TRIAL STUDY 134XCP|RP|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|1||||||MASSIND|MASS INDICATOR||||DEG2|||MMOL/MIN/KPA|NOT DONE||Y|NA|N|1||38||RUN-IN|1967-06-04||1965-04-03|||1963-06-11||1960-07-21
TRIAL STUDY 134XCP|RP|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|2||||||DLVRMODE|MODE OF DELIVERY||||FMOL|||OZ EQ|NOT DONE||U|U|U|1||38||BLINDED TREATMENT|1969-06-18||1971-09-08|||1972-07-29||1965-11-30
TRIAL STUDY 134XCP|RP|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||FMOL/L|||K|NOT DONE||N|U|NA|2||58||CONTINUATION TREATMENT|1964-06-09||1964-10-23|||1963-10-28||1969-11-14
TRIAL STUDY 134XCP|RP|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|2||||||EDEMAIND|EDEMA INDICATOR||||MM/2H|||MMAL|NOT DONE||N|Y|Y|2||58||FOLLOW-UP|1966-10-07||1965-05-26|||1961-03-02||1970-05-18
TRIAL STUDY 134XCP|RP|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UMOL/L/H|||UG/L DDU|NOT DONE||N|U|U|3||39||CONTINUATION TREATMENT|1968-03-22||1966-03-01|||1962-12-05||1966-01-12
TRIAL STUDY 134XCP|RP|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|2||||||MENOSTAT|MENOPAUSE STATUS||||ML/MMHG/MIN/L|||LOG10 TCID 50/DOSE|NOT DONE||Y|NA|U|3||39||WASHOUT|1968-07-17||1964-12-21|||1962-07-09||1970-12-21
TRIAL STUDY 134XCP|RP|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||U/ANIMAL|||NEEDLE GAUGE|NOT DONE||N|NA|N|4||88||SCREENING|1970-05-12||1964-10-20|||1971-05-03||1965-01-21
TRIAL STUDY 134XCP|RP|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|2||||||INTP|INTERPRETATION||||CUP EQ|||PPM|NOT DONE||U|U|Y|4||88||INDUCTION TREATMENT|1969-05-28||1970-03-15|||1962-12-08||1970-10-02
TRIAL STUDY 134XCP|RP|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||DAYS/MONTH|||APL U|NOT DONE||U|Y|U|5||7||LONG-TERM FOLLOW-UP|1960-03-09||1967-08-12|||1963-08-04||1973-06-15
TRIAL STUDY 134XCP|RP|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^7 PFU|||BLOCKS|NOT DONE||Y|N|NA|5||7||FOLLOW-UP|1962-02-25||1966-04-24|||1972-12-14||1963-11-22
TRIAL STUDY 134XCP|RP|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|1||||||PREGST|PREGNANT DURING THE STUDY||||IU/ML|||10^7 CFU/ML|NOT DONE||Y|N|Y|1||38||LONG-TERM FOLLOW-UP|1966-07-17||1962-09-23|||1962-12-14||1972-09-04
TRIAL STUDY 134XCP|RP|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|2||||||DSCHGIND|DISCHARGE INDICATOR||||U/KG|||LENS|NOT DONE||NA|Y|Y|1||38||RUN-IN|1971-05-06||1965-09-22|||1971-10-06||1970-05-23
TRIAL STUDY 134XCP|RP|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^3 DNA COPIES/ML|||UMOL|NOT DONE||NA|NA|U|2||58||TREATMENT|1972-07-21||1967-10-05|||1970-07-08||1970-04-19
TRIAL STUDY 134XCP|RP|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||M/SEC|||UG/DL|NOT DONE||NA|U|NA|2||58||BASELINE|1966-03-01||1973-01-05|||1970-02-03||1967-12-03
TRIAL STUDY 134XCP|RP|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|1||||||FUNDHT|FUNDAL HEIGHT||||10^3 CFU/G|||10^3 CFU/G|NOT DONE||U|N|U|3||39||BLINDED TREATMENT|1964-10-12||1963-03-14|||1973-08-08||1962-05-09
TRIAL STUDY 134XCP|RP|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|2||||||PREGIND|PREGNANT INDICATOR||||KUSP|||ELISA UNIT/DOSE|NOT DONE||U|Y|NA|3||39||FOLLOW-UP|1969-12-29||1970-05-12|||1970-07-06||1961-02-26
TRIAL STUDY 134XCP|RP|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||/4.0 ML|||UMOL/L/H|NOT DONE||U|N|N|4||88||OPEN LABEL TREATMENT|1960-07-24||1968-11-13|||1961-10-09||1960-03-28
TRIAL STUDY 134XCP|RP|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||CCID 50/DOSE|||ENZYME U/G HB|NOT DONE||NA|N|Y|4||88||RUN-IN|1965-08-09||1963-05-21|||1968-10-08||1965-04-26
TRIAL STUDY 134XCP|RP|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^6/EJACULATE U|||L|NOT DONE||NA|N|NA|5||7||OBSERVATION|1962-11-09||1973-03-14|||1960-07-17||1972-02-03
TRIAL STUDY 134XCP|RP|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||SCOOPFUL|||MG/KG|NOT DONE||N|Y|NA|5||7||INDUCTION TREATMENT|1962-08-08||1962-01-31|||1962-03-19||1966-06-08
TRIAL STUDY 134XCP|RP|B3987A78-0D92-419D-A289-039C87C6C202|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||10^3 RNA COPIES/ML|||100 IU/ML|NOT DONE||N|U|U|1||38||CONTINUATION TREATMENT|1962-04-17||1970-03-02|||1966-07-17||1972-04-19
TRIAL STUDY 134XCP|RP|B3987A78-0D92-419D-A289-039C87C6C202|2||||||BCMETHOD|BIRTH CONTROL METHOD||||HENRY|||/10^3|NOT DONE||N|NA|NA|1||38||OBSERVATION|1964-11-28||1963-11-05|||1960-07-04||1964-08-11
TRIAL STUDY 134XCP|RP|B3987A78-0D92-419D-A289-039C87C6C202|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||DROP|||G/KG/DAY|NOT DONE||U|NA|U|2||58||TREATMENT|1961-05-04||1963-11-16|||1960-08-03||1966-09-15
TRIAL STUDY 134XCP|RP|B3987A78-0D92-419D-A289-039C87C6C202|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^9 CFU/G|||AGU/ML|NOT DONE||U|N|Y|2||58||BLINDED TREATMENT|1965-05-27||1961-10-02|||1966-12-21||1964-01-23
TRIAL STUDY 134XCP|RP|B3987A78-0D92-419D-A289-039C87C6C202|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||FL|||OZ EQ|NOT DONE||N|U|NA|3||39||WASHOUT|1961-12-14||1970-09-19|||1972-06-08||1968-05-31
TRIAL STUDY 134XCP|RP|B3987A78-0D92-419D-A289-039C87C6C202|2||||||INTP|INTERPRETATION||||IU/KG/H|||MM/2H|NOT DONE||U|N|Y|3||39||INDUCTION TREATMENT|1970-08-17||1965-10-07|||1971-08-08||1966-11-15
TRIAL STUDY 134XCP|RP|B3987A78-0D92-419D-A289-039C87C6C202|1||||||RASHIND|RASH INDICATOR||||ML/M2/H|||UG/G/MIN|NOT DONE||Y|N|Y|4||88||LONG-TERM FOLLOW-UP|1970-04-07||1968-01-24|||1968-12-15||1961-05-27
TRIAL STUDY 134XCP|RP|B3987A78-0D92-419D-A289-039C87C6C202|2||||||MENARAGE|MENARCHE AGE||||LB|||UKAT/L|NOT DONE||N|N|U|4||88||SCREENING|1962-05-06||1963-01-19|||1972-09-17||1969-12-03
TRIAL STUDY 134XCP|RP|B3987A78-0D92-419D-A289-039C87C6C202|1||||||PRGENDTC|DATE PREGNANCY ENDED||||10^3 CFU/ML|||CMOL|NOT DONE||NA|N|N|5||7||WASHOUT|1963-07-04||1971-03-11|||1963-07-20||1969-07-03
TRIAL STUDY 134XCP|RP|B3987A78-0D92-419D-A289-039C87C6C202|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||G/G|||GBQ/G|NOT DONE||Y|NA|U|5||7||TREATMENT|1962-08-24||1973-08-26|||1964-04-30||1972-07-20
TRIAL STUDY 134XCP|RP|2A0D27D8-EC46-4B40-B1BB-078268E03355|1||||||EDEMAIND|EDEMA INDICATOR||||U/MG|||NMOL/ML/MIN|NOT DONE||NA|U|N|1||38||LONG-TERM FOLLOW-UP|1969-10-11||1968-10-03|||1971-03-26||1969-06-11
TRIAL STUDY 134XCP|RP|2A0D27D8-EC46-4B40-B1BB-078268E03355|2||||||BRTHN|NUMBER OF BIRTHS||||10^6 IU|||BQ/UL|NOT DONE||Y|N|Y|1||38||BLINDED TREATMENT|1968-04-26||1968-10-19|||1971-09-15||1970-04-29
TRIAL STUDY 134XCP|RP|2A0D27D8-EC46-4B40-B1BB-078268E03355|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||SUPPOSITORY|||VOXEL|NOT DONE||U|U|NA|2||58||BLINDED TREATMENT|1962-05-12||1961-06-28|||1965-02-18||1973-08-30
TRIAL STUDY 134XCP|RP|2A0D27D8-EC46-4B40-B1BB-078268E03355|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MEQ/L|||MOL/G|NOT DONE||NA|NA|U|2||58||OPEN LABEL TREATMENT|1968-07-05||1972-05-26|||1971-06-11||1970-07-16
TRIAL STUDY 134XCP|RP|2A0D27D8-EC46-4B40-B1BB-078268E03355|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UM|||NEEDLE GAUGE|NOT DONE||U|NA|NA|3||39||BASELINE|1965-11-14||1971-06-04|||1970-01-21||1970-05-21
TRIAL STUDY 134XCP|RP|2A0D27D8-EC46-4B40-B1BB-078268E03355|2||||||STILBIND|STILLBIRTH INDICATOR||||MIU/L|||CG|NOT DONE||N|U|NA|3||39||SCREENING|1966-07-19||1969-07-24|||1967-11-04||1967-04-12
TRIAL STUDY 134XCP|RP|2A0D27D8-EC46-4B40-B1BB-078268E03355|1||||||MENFDUR|MENSES FLOW DURATION||||MG/CM2|||MEQ/UL|NOT DONE||Y|Y|N|4||88||BASELINE|1960-12-10||1963-04-08|||1962-12-19||1971-02-21
TRIAL STUDY 134XCP|RP|2A0D27D8-EC46-4B40-B1BB-078268E03355|2||||||STILBIND|STILLBIRTH INDICATOR||||RING|||MOSM|NOT DONE||N|Y|U|4||88||OPEN LABEL TREATMENT|1965-01-15||1964-07-09|||1969-03-06||1964-11-19
TRIAL STUDY 134XCP|RP|2A0D27D8-EC46-4B40-B1BB-078268E03355|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||GPS U|||BU|NOT DONE||N|N|N|5||7||SCREENING|1972-06-26||1970-10-07|||1960-08-03||1961-10-01
TRIAL STUDY 134XCP|RP|2A0D27D8-EC46-4B40-B1BB-078268E03355|2||||||THICK|THICKNESS||||UMOL/DL|||PMOL/L|NOT DONE||NA|Y|NA|5||7||LONG-TERM FOLLOW-UP|1967-09-05||1969-01-07|||1968-02-23||1965-06-26
TRIAL STUDY 134XCP|RP|65EBB2AF-B97A-403A-9FB5-31C1559074C4|1||||||FUNDHT|FUNDAL HEIGHT||||MG/KG|||MG|NOT DONE||N|U|N|1||38||OBSERVATION|1970-03-02||1960-06-17|||1967-04-24||1962-10-17
TRIAL STUDY 134XCP|RP|65EBB2AF-B97A-403A-9FB5-31C1559074C4|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||MIN/DAY|||10^9/DOSE|NOT DONE||Y|NA|N|1||38||OPEN LABEL TREATMENT|1964-09-03||1966-12-28|||1966-11-23||1962-05-30
TRIAL STUDY 134XCP|RP|65EBB2AF-B97A-403A-9FB5-31C1559074C4|1||||||EDEMAIND|EDEMA INDICATOR||||TRANSDUCING UNIT|||EID 50/ML|NOT DONE||N|Y|N|2||58||SCREENING|1964-06-27||1965-11-07|||1972-05-24||1962-09-30
TRIAL STUDY 134XCP|RP|65EBB2AF-B97A-403A-9FB5-31C1559074C4|2||||||GRAVIND|GRAVIDA INDICATOR||||UM/DAY|||BOLUS|NOT DONE||U|NA|Y|2||58||RUN-IN|1964-08-02||1972-08-27|||1962-11-12||1968-01-22
TRIAL STUDY 134XCP|RP|65EBB2AF-B97A-403A-9FB5-31C1559074C4|1||||||DLVRMODE|MODE OF DELIVERY||||MMOL/G|||S*KPA|NOT DONE||NA|U|U|3||39||LONG-TERM FOLLOW-UP|1970-07-02||1968-09-24|||1968-03-07||1962-03-24
TRIAL STUDY 134XCP|RP|65EBB2AF-B97A-403A-9FB5-31C1559074C4|2||||||BCMETHOD|BIRTH CONTROL METHOD||||SCM|||DIOPTER|NOT DONE||N|NA|Y|3||39||WASHOUT|1967-04-27||1964-06-12|||1973-06-10||1969-09-07
TRIAL STUDY 134XCP|RP|65EBB2AF-B97A-403A-9FB5-31C1559074C4|1||||||BCMETHOD|BIRTH CONTROL METHOD||||UG/L/H|||COULOMB|NOT DONE||N|Y|Y|4||88||CONTINUATION TREATMENT|1963-08-02||1961-07-05|||1963-03-23||1968-03-08
TRIAL STUDY 134XCP|RP|65EBB2AF-B97A-403A-9FB5-31C1559074C4|2||||||DLVRMODE|MODE OF DELIVERY||||HPA|||BAU|NOT DONE||Y|Y|Y|4||88||LONG-TERM FOLLOW-UP|1961-03-17||1967-07-22|||1969-11-07||1965-05-04
TRIAL STUDY 134XCP|RP|65EBB2AF-B97A-403A-9FB5-31C1559074C4|1||||||DLVRMODE|MODE OF DELIVERY||||M|||BU|NOT DONE||U|Y|U|5||7||LONG-TERM FOLLOW-UP|1972-07-22||1963-06-21|||1970-03-15||1967-06-15
TRIAL STUDY 134XCP|RP|65EBB2AF-B97A-403A-9FB5-31C1559074C4|2||||||ERYTHIND|ERYTHEMA INDICATOR||||LOG10 ELISA UNIT|||BQ/KG|NOT DONE||NA|U|NA|5||7||OBSERVATION|1964-01-30||1971-06-01|||1962-12-19||1966-09-02
TRIAL STUDY 134XCP|RP|90892428-99C3-4E7D-B3A8-3C526812EDD2|1||||||INTP|INTERPRETATION||||UG/KG|||MMOL/G|NOT DONE||U|U|U|1||38||INDUCTION TREATMENT|1965-03-09||1970-07-28|||1965-11-08||1966-01-28
TRIAL STUDY 134XCP|RP|90892428-99C3-4E7D-B3A8-3C526812EDD2|2||||||ERYTHIND|ERYTHEMA INDICATOR||||TBSP|||QUANTITY SUFFICIENT|NOT DONE||NA|U|Y|1||38||CONTINUATION TREATMENT|1960-05-09||1967-12-22|||1965-11-27||1971-03-03
TRIAL STUDY 134XCP|RP|90892428-99C3-4E7D-B3A8-3C526812EDD2|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||UG/MIN|||U/DL|NOT DONE||U|N|N|2||58||RUN-IN|1960-11-29||1971-12-22|||1969-04-13||1968-11-21
TRIAL STUDY 134XCP|RP|90892428-99C3-4E7D-B3A8-3C526812EDD2|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||KIT|||/5X10^4 WBC|NOT DONE||Y|N|NA|2||58||OBSERVATION|1964-05-25||1960-04-14|||1972-08-11||1968-01-23
TRIAL STUDY 134XCP|RP|90892428-99C3-4E7D-B3A8-3C526812EDD2|1||||||PREGIND|PREGNANT INDICATOR||||U/KG/DAY|||ELISA UNIT/ML|NOT DONE||N|N|U|3||39||BLINDED TREATMENT|1969-10-18||1964-01-07|||1968-08-25||1963-03-11
TRIAL STUDY 134XCP|RP|90892428-99C3-4E7D-B3A8-3C526812EDD2|2||||||TNDRIND|TENDERNESS INDICATOR||||GBQ/UG|||PL|NOT DONE||Y|U|N|3||39||RUN-IN|1961-03-22||1963-07-09|||1961-01-18||1964-12-09
TRIAL STUDY 134XCP|RP|90892428-99C3-4E7D-B3A8-3C526812EDD2|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^9 CFU/G|||LOG10 CFU/ML|NOT DONE||U|N|Y|4||88||BLINDED TREATMENT|1970-03-03||1965-09-14|||1967-11-01||1972-12-20
TRIAL STUDY 134XCP|RP|90892428-99C3-4E7D-B3A8-3C526812EDD2|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||UG/KG/DAY|||RAD|NOT DONE||Y|NA|Y|4||88||TREATMENT|1969-11-15||1973-01-24|||1960-07-09||1965-06-23
TRIAL STUDY 134XCP|RP|90892428-99C3-4E7D-B3A8-3C526812EDD2|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MG/KG/DOSE|||L/KG|NOT DONE||U|U|N|5||7||TREATMENT|1962-05-14||1964-12-21|||1970-02-09||1962-07-28
TRIAL STUDY 134XCP|RP|90892428-99C3-4E7D-B3A8-3C526812EDD2|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||CARTRIDGE|||MMOL|NOT DONE||NA|NA|N|5||7||OPEN LABEL TREATMENT|1969-07-07||1967-03-22|||1972-05-12||1968-05-15
TRIAL STUDY 134XCP|RP|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||PG|||UMOL/L/SEC|NOT DONE||NA|N|N|1||38||FOLLOW-UP|1960-09-06||1963-03-08|||1967-05-04||1962-05-03
TRIAL STUDY 134XCP|RP|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||DRUM|||HEP|NOT DONE||NA|Y|U|1||38||SCREENING|1971-12-04||1965-10-27|||1964-07-13||1962-04-17
TRIAL STUDY 134XCP|RP|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|1||||||MENFDUR|MENSES FLOW DURATION||||ML/BREATH|||PL|NOT DONE||Y|U|NA|2||58||RUN-IN|1967-07-06||1971-07-13|||1969-08-22||1973-06-23
TRIAL STUDY 134XCP|RP|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|2||||||ERYTHIND|ERYTHEMA INDICATOR||||TSP|||UM/DAY|NOT DONE||U|NA|U|2||58||LONG-TERM FOLLOW-UP|1972-09-01||1960-05-03|||1965-01-06||1971-12-17
TRIAL STUDY 134XCP|RP|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|1||||||PREGIND|PREGNANT INDICATOR||||VIAL|||UG/ANIMAL|NOT DONE||NA|Y|NA|3||39||TREATMENT|1967-09-02||1970-07-20|||1967-03-02||1973-06-16
TRIAL STUDY 134XCP|RP|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|2||||||DSCHGIND|DISCHARGE INDICATOR||||DEG/S|||CI/G|NOT DONE||U|U|U|3||39||INDUCTION TREATMENT|1962-01-17||1961-01-21|||1967-01-26||1969-07-17
TRIAL STUDY 134XCP|RP|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MG/MIN|||ML/KG/MIN|NOT DONE||N|U|U|4||88||BLINDED TREATMENT|1964-10-14||1965-12-29|||1962-06-20||1965-05-18
TRIAL STUDY 134XCP|RP|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||HOMEOPATHIC DILUTION|||10^6 ORGANISMS|NOT DONE||NA|N|NA|4||88||SCREENING|1973-05-07||1961-11-11|||1970-05-26||1963-07-14
TRIAL STUDY 134XCP|RP|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||IU/G|||ROENTGEN|NOT DONE||N|Y|Y|5||7||CONTINUATION TREATMENT|1971-02-15||1971-03-29|||1966-10-07||1972-05-31
TRIAL STUDY 134XCP|RP|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||ML/DL|||G/U|NOT DONE||Y|NA|N|5||7||WASHOUT|1967-11-25||1967-07-21|||1965-02-14||1961-04-30
TRIAL STUDY 134XCP|RP|2B443EEA-B98B-47D9-8D27-801582804AB5|1||||||MENOSTAT|MENOPAUSE STATUS||||BQ|||UCI/KG|NOT DONE||U|U|Y|1||38||WASHOUT|1961-04-18||1972-07-28|||1962-04-30||1972-04-12
TRIAL STUDY 134XCP|RP|2B443EEA-B98B-47D9-8D27-801582804AB5|2||||||DLVRMODE|MODE OF DELIVERY||||NMOL BCE/MMOL|||MG/ML/DAY|NOT DONE||N|NA|N|1||38||WASHOUT|1973-04-15||1962-08-24|||1972-06-14||1960-05-30
TRIAL STUDY 134XCP|RP|2B443EEA-B98B-47D9-8D27-801582804AB5|1||||||PREGIND|PREGNANT INDICATOR||||MMHG/L/MIN|||MG/ANIMAL|NOT DONE||N|NA|NA|2||58||SCREENING|1970-10-07||1962-07-21|||1961-08-09||1964-07-10
TRIAL STUDY 134XCP|RP|2B443EEA-B98B-47D9-8D27-801582804AB5|2||||||PREGNN|NUMBER OF PREGNANCIES||||NMOL BCE/MMOL|||ML/M2/MIN|NOT DONE||Y|U|N|2||58||RUN-IN|1960-02-04||1966-07-21|||1969-06-09||1968-07-04
TRIAL STUDY 134XCP|RP|2B443EEA-B98B-47D9-8D27-801582804AB5|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ML/CM H2O|||UIU/DL|NOT DONE||Y|Y|N|3||39||FOLLOW-UP|1970-05-20||1962-05-13|||1962-04-01||1971-02-03
TRIAL STUDY 134XCP|RP|2B443EEA-B98B-47D9-8D27-801582804AB5|2||||||PREGST|PREGNANT DURING THE STUDY||||10^9/DOSE|||U/ML|NOT DONE||Y|NA|N|3||39||FOLLOW-UP|1971-02-06||1967-04-09|||1960-11-19||1964-06-08
TRIAL STUDY 134XCP|RP|2B443EEA-B98B-47D9-8D27-801582804AB5|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||ENZYME U|||BU|NOT DONE||Y|U|NA|4||88||CONTINUATION TREATMENT|1963-10-10||1971-10-29|||1971-05-31||1960-03-11
TRIAL STUDY 134XCP|RP|2B443EEA-B98B-47D9-8D27-801582804AB5|2||||||MENARAGE|MENARCHE AGE||||CUP EQ|||KG|NOT DONE||Y|N|U|4||88||INDUCTION TREATMENT|1962-05-28||1963-12-28|||1965-07-04||1970-12-20
TRIAL STUDY 134XCP|RP|2B443EEA-B98B-47D9-8D27-801582804AB5|1||||||THICK|THICKNESS||||DAYS/MONTH|||KM|NOT DONE||U|N|N|5||7||INDUCTION TREATMENT|1961-05-06||1965-07-15|||1962-09-09||1971-04-22
TRIAL STUDY 134XCP|RP|2B443EEA-B98B-47D9-8D27-801582804AB5|2||||||ERYTHIND|ERYTHEMA INDICATOR||||ML|||ENZYME U/L|NOT DONE||U|Y|NA|5||7||SCREENING|1973-06-12||1968-12-02|||1967-09-27||1963-08-15
TRIAL STUDY 134XCP|RP|0278D57A-30D6-4B7A-A45C-EB973F6686C6|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||PLUG|||10^3 COPIES/ML|NOT DONE||Y|NA|NA|1||38||OPEN LABEL TREATMENT|1964-04-01||1972-08-17|||1970-01-28||1965-01-08
TRIAL STUDY 134XCP|RP|0278D57A-30D6-4B7A-A45C-EB973F6686C6|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^6/EJACULATE U|||PT_US|NOT DONE||N|N|N|1||38||CONTINUATION TREATMENT|1970-09-24||1970-04-07|||1964-06-11||1960-10-07
TRIAL STUDY 134XCP|RP|0278D57A-30D6-4B7A-A45C-EB973F6686C6|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UU/DL|||FOZ_BR|NOT DONE||NA|Y|Y|2||58||INDUCTION TREATMENT|1961-07-23||1964-07-02|||1965-11-21||1968-08-24
TRIAL STUDY 134XCP|RP|0278D57A-30D6-4B7A-A45C-EB973F6686C6|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||CYLINDER|||MEQ/MMOL|NOT DONE||N|Y|Y|2||58||LONG-TERM FOLLOW-UP|1973-04-03||1971-11-28|||1961-05-02||1971-08-28
TRIAL STUDY 134XCP|RP|0278D57A-30D6-4B7A-A45C-EB973F6686C6|1||||||THICK|THICKNESS||||KALLIKREIN INHIBITOR UNIT|||MM/2H|NOT DONE||NA|N|NA|3||39||OPEN LABEL TREATMENT|1969-02-24||1964-03-09|||1962-08-10||1973-07-20
TRIAL STUDY 134XCP|RP|0278D57A-30D6-4B7A-A45C-EB973F6686C6|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||TUBERCULIN UNIT|||/MM2|NOT DONE||NA|N|NA|3||39||OBSERVATION|1960-03-11||1961-06-22|||1972-06-22||1965-02-22
TRIAL STUDY 134XCP|RP|0278D57A-30D6-4B7A-A45C-EB973F6686C6|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||U/KG/H|||BQ/UG|NOT DONE||U|NA|NA|4||88||OBSERVATION|1969-01-04||1968-10-30|||1965-11-10||1962-05-10
TRIAL STUDY 134XCP|RP|0278D57A-30D6-4B7A-A45C-EB973F6686C6|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MU/L|||G/ANIMAL|NOT DONE||Y|N|N|4||88||BASELINE|1966-01-15||1963-09-07|||1967-06-19||1963-06-27
TRIAL STUDY 134XCP|RP|0278D57A-30D6-4B7A-A45C-EB973F6686C6|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||10^3/L|||UV|NOT DONE||U|N|NA|5||7||WASHOUT|1970-04-09||1965-02-28|||1964-07-25||1970-02-10
TRIAL STUDY 134XCP|RP|0278D57A-30D6-4B7A-A45C-EB973F6686C6|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||PMOL|||AMPULE|NOT DONE||N|U|U|5||7||SCREENING|1966-07-29||1973-05-02|||1967-08-20||1970-08-11
TRIAL STUDY 134XCP|RP|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||GTT|||UG/DL|NOT DONE||NA|U|U|1||38||BASELINE|1971-04-02||1968-06-18|||1965-12-09||1965-08-23
TRIAL STUDY 134XCP|RP|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|2||||||DLVRMODE|MODE OF DELIVERY||||UMOL/L/H|||MSEC|NOT DONE||Y|N|Y|1||38||FOLLOW-UP|1961-08-01||1967-07-20|||1964-05-09||1972-02-03
TRIAL STUDY 134XCP|RP|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^12 IU/L|||10^6 RNA COPIES/ML|NOT DONE||N|Y|U|2||58||RUN-IN|1962-10-11||1963-12-09|||1972-03-25||1969-06-30
TRIAL STUDY 134XCP|RP|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|2||||||INABOIND|INDUCED ABORTION INDICATOR||||LOG10 PFU/ML|||RFU|NOT DONE||Y|NA|Y|2||58||WASHOUT|1965-04-11||1963-09-07|||1971-05-03||1960-06-19
TRIAL STUDY 134XCP|RP|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|1||||||PREGNN|NUMBER OF PREGNANCIES||||U/M2|||S/H|NOT DONE||N|U|Y|3||39||SCREENING|1963-03-18||1972-08-15|||1964-10-03||1960-01-31
TRIAL STUDY 134XCP|RP|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|2||||||PREGST|PREGNANT DURING THE STUDY||||ML/100G/MIN|||MPL U|NOT DONE||NA|U|U|3||39||OPEN LABEL TREATMENT|1961-10-06||1970-09-29|||1966-05-14||1966-08-01
TRIAL STUDY 134XCP|RP|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||HOUNSFIELD UNIT|||UMOL/KG/MIN|NOT DONE||U|Y|NA|4||88||LONG-TERM FOLLOW-UP|1970-09-28||1960-01-21|||1967-10-26||1965-10-05
TRIAL STUDY 134XCP|RP|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MM/2H|||MEQ/L|NOT DONE||N|Y|N|4||88||CONTINUATION TREATMENT|1965-09-16||1964-12-25|||1963-11-04||1962-11-25
TRIAL STUDY 134XCP|RP|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|1||||||RASHIND|RASH INDICATOR||||KDA|||IU/DL|NOT DONE||NA|Y|N|5||7||BLINDED TREATMENT|1965-02-22||1965-09-30|||1960-02-14||1967-01-27
TRIAL STUDY 134XCP|RP|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|2||||||MENFDUR|MENSES FLOW DURATION||||UEQ|||G/U|NOT DONE||Y|NA|NA|5||7||TREATMENT|1971-11-13||1972-12-09|||1964-02-11||1962-11-03
TRIAL STUDY 134XCP|RP|67D6A191-10C7-4414-BA63-DB7701998DF0|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||U/M2|||DAMOL/L|NOT DONE||U|NA|U|1||38||LONG-TERM FOLLOW-UP|1965-12-21||1962-01-01|||1963-10-28||1972-05-21
TRIAL STUDY 134XCP|RP|67D6A191-10C7-4414-BA63-DB7701998DF0|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||DNA COPIES/UG|||KIU|NOT DONE||U|N|Y|1||38||INDUCTION TREATMENT|1973-05-27||1969-12-27|||1967-12-10||1960-10-26
TRIAL STUDY 134XCP|RP|67D6A191-10C7-4414-BA63-DB7701998DF0|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||TRANSDUCING UNIT/ML|||SBE/ML|NOT DONE||Y|Y|N|2||58||TREATMENT|1969-11-27||1968-05-21|||1968-10-23||1968-03-24
TRIAL STUDY 134XCP|RP|67D6A191-10C7-4414-BA63-DB7701998DF0|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^6 CFU/G|||MU/G|NOT DONE||Y|Y|N|2||58||OPEN LABEL TREATMENT|1973-01-06||1962-11-10|||1970-04-19||1970-09-08
TRIAL STUDY 134XCP|RP|67D6A191-10C7-4414-BA63-DB7701998DF0|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||G|||COAT|NOT DONE||NA|NA|NA|3||39||INDUCTION TREATMENT|1973-01-21||1961-06-04|||1970-05-29||1972-08-01
TRIAL STUDY 134XCP|RP|67D6A191-10C7-4414-BA63-DB7701998DF0|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||KG/CM2|||POUCH|NOT DONE||NA|U|U|3||39||FOLLOW-UP|1967-11-05||1972-08-10|||1972-10-11||1965-04-02
TRIAL STUDY 134XCP|RP|67D6A191-10C7-4414-BA63-DB7701998DF0|1||||||FUNDHT|FUNDAL HEIGHT||||APL U|||FT|NOT DONE||NA|U|NA|4||88||INDUCTION TREATMENT|1963-01-04||1964-04-17|||1962-01-06||1968-04-05
TRIAL STUDY 134XCP|RP|67D6A191-10C7-4414-BA63-DB7701998DF0|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||FOZ_US|||NMOL/L|NOT DONE||N|NA|U|4||88||FOLLOW-UP|1970-08-31||1972-11-15|||1962-01-28||1961-09-09
TRIAL STUDY 134XCP|RP|67D6A191-10C7-4414-BA63-DB7701998DF0|1||||||MENARAGE|MENARCHE AGE||||GMFI|||KG/L|NOT DONE||Y|U|N|5||7||SCREENING|1967-03-18||1968-04-22|||1972-09-24||1962-05-26
TRIAL STUDY 134XCP|RP|67D6A191-10C7-4414-BA63-DB7701998DF0|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||PMOL/10^10 CELLS|||PMOL/L|NOT DONE||Y|N|N|5||7||BASELINE|1967-10-14||1962-04-17|||1970-09-12||1963-03-13
TRIAL STUDY 134XCP|RP|499B5A47-893A-40DE-9B64-60967378C81A|1||||||PREGIND|PREGNANT INDICATOR||||NMOL/L/MIN|||DB|NOT DONE||Y|U|Y|1||38||CONTINUATION TREATMENT|1965-02-02||1965-09-25|||1971-02-01||1968-03-09
TRIAL STUDY 134XCP|RP|499B5A47-893A-40DE-9B64-60967378C81A|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||OI50|||/LPF|NOT DONE||NA|Y|N|1||38||CONTINUATION TREATMENT|1964-04-04||1962-02-26|||1969-05-08||1963-04-19
TRIAL STUDY 134XCP|RP|499B5A47-893A-40DE-9B64-60967378C81A|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||HOURS|||ARBITRARY U|NOT DONE||NA|U|N|2||58||OPEN LABEL TREATMENT|1961-06-03||1962-05-18|||1965-11-30||1967-03-04
TRIAL STUDY 134XCP|RP|499B5A47-893A-40DE-9B64-60967378C81A|2||||||GRAVIND|GRAVIDA INDICATOR||||U/CL|||KBQ/UL|NOT DONE||Y|U|N|2||58||CONTINUATION TREATMENT|1972-12-02||1969-01-22|||1971-07-02||1961-04-05
TRIAL STUDY 134XCP|RP|499B5A47-893A-40DE-9B64-60967378C81A|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||BAU/ML|||UG/G/DAY|NOT DONE||Y|NA|N|3||39||RUN-IN|1965-10-25||1971-05-24|||1962-12-13||1960-11-01
TRIAL STUDY 134XCP|RP|499B5A47-893A-40DE-9B64-60967378C81A|2||||||DSCHGIND|DISCHARGE INDICATOR||||TCID 50/DOSE|||/2000 RBC|NOT DONE||U|Y|Y|3||39||OBSERVATION|1963-09-11||1962-05-27|||1961-09-11||1973-01-12
TRIAL STUDY 134XCP|RP|499B5A47-893A-40DE-9B64-60967378C81A|1||||||ULCERIND|ULCER INDICATOR||||TESLA|||COAT|NOT DONE||Y|N|Y|4||88||RUN-IN|1967-06-29||1969-06-08|||1962-09-29||1960-08-02
TRIAL STUDY 134XCP|RP|499B5A47-893A-40DE-9B64-60967378C81A|2||||||INTP|INTERPRETATION||||MOSM/L|||MOL|NOT DONE||U|NA|NA|4||88||OBSERVATION|1962-03-21||1964-11-20|||1968-02-06||1967-02-11
TRIAL STUDY 134XCP|RP|499B5A47-893A-40DE-9B64-60967378C81A|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||GRAIN|||INHALATION|NOT DONE||NA|U|NA|5||7||CONTINUATION TREATMENT|1969-06-14||1967-11-16|||1966-01-21||1971-10-04
TRIAL STUDY 134XCP|RP|499B5A47-893A-40DE-9B64-60967378C81A|2||||||INABOIND|INDUCED ABORTION INDICATOR||||RNA COPIES/ML|||RPM|NOT DONE||Y|N|U|5||7||TREATMENT|1966-10-17||1971-10-14|||1961-09-08||1970-03-17
TRIAL STUDY 134XCP|RP|984103CA-F301-4510-A9DD-4916FA858EA2|1||||||PREGNN|NUMBER OF PREGNANCIES||||AMOL|||NG|NOT DONE||U|U|U|1||38||WASHOUT|1962-06-23||1960-05-29|||1963-11-28||1961-03-31
TRIAL STUDY 134XCP|RP|984103CA-F301-4510-A9DD-4916FA858EA2|2||||||EDEMAIND|EDEMA INDICATOR||||MMOL2/L2|||STRIP|NOT DONE||N|N|NA|1||38||CONTINUATION TREATMENT|1970-10-30||1969-07-16|||1970-09-08||1960-04-21
TRIAL STUDY 134XCP|RP|984103CA-F301-4510-A9DD-4916FA858EA2|1||||||PEELIND|PEELING INDICATOR||||DAYS/MONTH|||PUFF|NOT DONE||U|U|NA|2||58||TREATMENT|1969-07-21||1963-11-14|||1969-11-19||1967-05-22
TRIAL STUDY 134XCP|RP|984103CA-F301-4510-A9DD-4916FA858EA2|2||||||MENOAGE|MENOPAUSE AGE||||PUFF|||BAR|NOT DONE||NA|Y|NA|2||58||OBSERVATION|1972-12-29||1969-03-08|||1967-10-14||1965-11-19
TRIAL STUDY 134XCP|RP|984103CA-F301-4510-A9DD-4916FA858EA2|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MIU/L|||GENEQ/ML|NOT DONE||Y|NA|NA|3||39||BLINDED TREATMENT|1972-01-03||1972-11-20|||1973-04-08||1961-08-02
TRIAL STUDY 134XCP|RP|984103CA-F301-4510-A9DD-4916FA858EA2|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MG/L|||ML/DOSE|NOT DONE||NA|N|Y|3||39||WASHOUT|1960-09-12||1960-02-05|||1965-02-01||1960-12-10
TRIAL STUDY 134XCP|RP|984103CA-F301-4510-A9DD-4916FA858EA2|1||||||MENFDUR|MENSES FLOW DURATION||||PPTH|||F|NOT DONE||U|U|Y|4||88||SCREENING|1971-05-16||1960-03-21|||1972-10-24||1962-06-07
TRIAL STUDY 134XCP|RP|984103CA-F301-4510-A9DD-4916FA858EA2|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||CM H2O|||MMOL/L|NOT DONE||NA|NA|NA|4||88||FOLLOW-UP|1960-08-11||1966-03-12|||1971-03-16||1964-05-28
TRIAL STUDY 134XCP|RP|984103CA-F301-4510-A9DD-4916FA858EA2|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||HENRY|||U/ML|NOT DONE||NA|N|Y|5||7||SCREENING|1961-08-21||1966-09-11|||1962-05-03||1965-12-28
TRIAL STUDY 134XCP|RP|984103CA-F301-4510-A9DD-4916FA858EA2|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||DRAM|||COPIES/UG|NOT DONE||NA|NA|N|5||7||OPEN LABEL TREATMENT|1970-08-24||1973-05-28|||1964-04-17||1971-02-18
TRIAL STUDY 134XCP|RP|50E626B3-9133-4A50-8907-2388DAC22AD1|1||||||PRGENDTC|DATE PREGNANCY ENDED||||10^12/L|||FFU|NOT DONE||N|NA|U|1||38||WASHOUT|1973-04-06||1968-10-19|||1962-05-11||1973-08-03
TRIAL STUDY 134XCP|RP|50E626B3-9133-4A50-8907-2388DAC22AD1|2||||||INTP|INTERPRETATION||||UL/KG/DAY|||ENZYME U/G HB|NOT DONE||Y|N|U|1||38||BASELINE|1973-01-10||1965-04-27|||1967-09-20||1967-06-11
TRIAL STUDY 134XCP|RP|50E626B3-9133-4A50-8907-2388DAC22AD1|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||L/H|||OZ EQ|NOT DONE||NA|N|Y|2||58||INDUCTION TREATMENT|1962-12-30||1972-08-23|||1970-10-30||1965-03-01
TRIAL STUDY 134XCP|RP|50E626B3-9133-4A50-8907-2388DAC22AD1|2||||||MENOAGE|MENOPAUSE AGE||||PG/DL|||L/H|NOT DONE||U|NA|U|2||58||RUN-IN|1969-08-07||1970-09-26|||1970-03-30||1968-04-03
TRIAL STUDY 134XCP|RP|50E626B3-9133-4A50-8907-2388DAC22AD1|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||RFU|||ML/MIN/1.73M2|NOT DONE||U|U|NA|3||39||TREATMENT|1960-08-19||1962-02-24|||1968-08-17||1971-05-02
TRIAL STUDY 134XCP|RP|50E626B3-9133-4A50-8907-2388DAC22AD1|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||ML/KG|||PKAT|NOT DONE||N|NA|N|3||39||BLINDED TREATMENT|1969-10-28||1970-01-21|||1962-04-03||1961-11-24
TRIAL STUDY 134XCP|RP|50E626B3-9133-4A50-8907-2388DAC22AD1|1||||||DLVRMODE|MODE OF DELIVERY||||10^3/L|||L/MIN/M2|NOT DONE||Y|NA|NA|4||88||SCREENING|1973-04-04||1962-05-29|||1971-10-07||1972-06-20
TRIAL STUDY 134XCP|RP|50E626B3-9133-4A50-8907-2388DAC22AD1|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||PG/L|||MEQ/DAY|NOT DONE||Y|N|NA|4||88||BLINDED TREATMENT|1965-12-25||1968-06-30|||1965-01-15||1962-03-07
TRIAL STUDY 134XCP|RP|50E626B3-9133-4A50-8907-2388DAC22AD1|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||ENZYME U/M2|||VOXEL|NOT DONE||NA|Y|U|5||7||RUN-IN|1969-10-21||1970-05-28|||1963-11-25||1966-11-29
TRIAL STUDY 134XCP|RP|50E626B3-9133-4A50-8907-2388DAC22AD1|2||||||PEELIND|PEELING INDICATOR||||FOZ_BR|||COAT|NOT DONE||U|Y|NA|5||7||OBSERVATION|1969-12-14||1966-06-26|||1961-02-04||1964-12-14
TRIAL STUDY 134XCP|RP|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|1||||||STILBIND|STILLBIRTH INDICATOR||||KA_U/DL|||KM/H|NOT DONE||U|N|U|1||38||LONG-TERM FOLLOW-UP|1965-11-27||1969-02-12|||1973-05-06||1972-02-26
TRIAL STUDY 134XCP|RP|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|2||||||INTP|INTERPRETATION||||PM|||ML/MIN/MMHG|NOT DONE||N|NA|Y|1||38||CONTINUATION TREATMENT|1967-11-23||1965-02-27|||1971-01-21||1967-10-20
TRIAL STUDY 134XCP|RP|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||OSM|||PPB|NOT DONE||Y|Y|N|2||58||BASELINE|1961-11-13||1966-01-24|||1966-11-30||1971-04-17
TRIAL STUDY 134XCP|RP|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||BAR|||FIU|NOT DONE||U|U|NA|2||58||RUN-IN|1960-07-03||1961-01-23|||1970-12-30||1972-01-02
TRIAL STUDY 134XCP|RP|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||10^5/HPF|||KUSP|NOT DONE||U|U|Y|3||39||CONTINUATION TREATMENT|1969-06-30||1970-07-14|||1969-09-19||1963-01-22
TRIAL STUDY 134XCP|RP|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|2||||||RASHIND|RASH INDICATOR||||MMOL|||KS|NOT DONE||N|Y|Y|3||39||CONTINUATION TREATMENT|1967-07-27||1970-10-19|||1960-12-28||1961-08-07
TRIAL STUDY 134XCP|RP|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||HOMEOPATHIC DILUTION|||G/MOL|NOT DONE||Y|Y|U|4||88||OBSERVATION|1970-10-02||1972-11-11|||1963-05-21||1970-12-27
TRIAL STUDY 134XCP|RP|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||BEATS/MIN|||ML/M2|NOT DONE||N|Y|NA|4||88||CONTINUATION TREATMENT|1966-08-15||1966-03-14|||1970-06-06||1961-04-18
TRIAL STUDY 134XCP|RP|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ANSON U|||CY/CM|NOT DONE||N|U|Y|5||7||WASHOUT|1967-12-26||1964-08-11|||1970-07-04||1968-01-26
TRIAL STUDY 134XCP|RP|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|2||||||TNDRIND|TENDERNESS INDICATOR||||ML/CAGE|||/MS|NOT DONE||Y|NA|NA|5||7||FOLLOW-UP|1963-10-22||1971-07-30|||1963-03-01||1970-12-21
TRIAL STUDY 134XCP|RP|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|1||||||THICK|THICKNESS||||DMOL|||10^4/HPF|NOT DONE||NA|Y|Y|1||38||BLINDED TREATMENT|1966-07-31||1971-12-14|||1970-02-13||1961-10-07
TRIAL STUDY 134XCP|RP|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|2||||||MENOSTAT|MENOPAUSE STATUS||||MM2|||U/KG/DAY|NOT DONE||N|U|Y|1||38||CONTINUATION TREATMENT|1967-01-10||1972-10-31|||1964-08-16||1966-04-29
TRIAL STUDY 134XCP|RP|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||UG/DL|||TABLET|NOT DONE||U|U|U|2||58||BASELINE|1960-11-22||1966-07-21|||1960-03-03||1966-08-12
TRIAL STUDY 134XCP|RP|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||KG|||PMOL/DAY|NOT DONE||NA|U|NA|2||58||FOLLOW-UP|1973-02-24||1963-12-09|||1968-06-25||1969-05-22
TRIAL STUDY 134XCP|RP|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||CAL|||CM H2O|NOT DONE||U|U|N|3||39||BLINDED TREATMENT|1961-03-15||1966-06-05|||1963-07-04||1972-02-05
TRIAL STUDY 134XCP|RP|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|2||||||BCMETHOD|BIRTH CONTROL METHOD||||ML/CAGE/WK|||MG/ANIMAL|NOT DONE||U|NA|U|3||39||TREATMENT|1963-09-03||1966-07-06|||1964-09-10||1966-07-17
TRIAL STUDY 134XCP|RP|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||USEC|||UG/L FEU|NOT DONE||NA|U|N|4||88||FOLLOW-UP|1966-06-14||1969-08-06|||1965-02-13||1970-02-07
TRIAL STUDY 134XCP|RP|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|2||||||BLISTIND|BLISTERING INDICATOR||||MV2/HZ|||MMOL/MIN/KPA/L|NOT DONE||U|U|U|4||88||WASHOUT|1970-11-25||1964-06-26|||1962-03-14||1960-02-02
TRIAL STUDY 134XCP|RP|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|1||||||TNDRIND|TENDERNESS INDICATOR||||UMOL|||%/S|NOT DONE||U|NA|U|5||7||OBSERVATION|1960-02-15||1960-08-03|||1968-01-14||1960-06-23
TRIAL STUDY 134XCP|RP|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|2||||||BLISTIND|BLISTERING INDICATOR||||MOL/G|||SEC|NOT DONE||U|U|Y|5||7||LONG-TERM FOLLOW-UP|1964-12-22||1963-02-15|||1966-06-29||1967-03-26
TRIAL STUDY 134XCP|RP|F8F17A43-A74B-4570-8A06-D7657A4636B4|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||L/MIN|||DRUM|NOT DONE||N|U|Y|1||38||CONTINUATION TREATMENT|1969-12-04||1961-05-01|||1961-04-15||1960-08-02
TRIAL STUDY 134XCP|RP|F8F17A43-A74B-4570-8A06-D7657A4636B4|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PPTH|||/200 HPFS|NOT DONE||NA|NA|NA|1||38||RUN-IN|1970-10-06||1960-12-06|||1970-11-02||1961-01-06
TRIAL STUDY 134XCP|RP|F8F17A43-A74B-4570-8A06-D7657A4636B4|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||UG/MOL|||MGEQ|NOT DONE||NA|Y|NA|2||58||INDUCTION TREATMENT|1971-01-23||1970-06-09|||1965-05-04||1963-10-08
TRIAL STUDY 134XCP|RP|F8F17A43-A74B-4570-8A06-D7657A4636B4|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||L/DAY|||SEC|NOT DONE||NA|NA|N|2||58||SCREENING|1972-11-03||1960-10-18|||1967-02-26||1962-04-26
TRIAL STUDY 134XCP|RP|F8F17A43-A74B-4570-8A06-D7657A4636B4|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UG/KG/MIN|||L/KG|NOT DONE||N|N|NA|3||39||SCREENING|1969-04-19||1972-05-30|||1972-11-03||1970-05-25
TRIAL STUDY 134XCP|RP|F8F17A43-A74B-4570-8A06-D7657A4636B4|2||||||BLISTIND|BLISTERING INDICATOR||||MONTHS|||G/DAY|NOT DONE||NA|N|U|3||39||LONG-TERM FOLLOW-UP|1963-02-13||1968-09-02|||1966-02-16||1962-02-17
TRIAL STUDY 134XCP|RP|F8F17A43-A74B-4570-8A06-D7657A4636B4|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||UG/DL|||CM2|NOT DONE||N|U|Y|4||88||CONTINUATION TREATMENT|1972-03-26||1960-07-04|||1972-01-31||1965-01-26
TRIAL STUDY 134XCP|RP|F8F17A43-A74B-4570-8A06-D7657A4636B4|2||||||PUSTIND|PUSTULE INDICATOR||||DEG/S|||CMH2O*S2/ML|NOT DONE||U|Y|Y|4||88||INDUCTION TREATMENT|1966-05-05||1971-05-16|||1968-06-05||1972-12-31
TRIAL STUDY 134XCP|RP|F8F17A43-A74B-4570-8A06-D7657A4636B4|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||IU/KG|||10^3 ORGANISMS/ML|NOT DONE||N|NA|N|5||7||LONG-TERM FOLLOW-UP|1967-07-29||1973-03-22|||1970-09-26||1972-09-16
TRIAL STUDY 134XCP|RP|F8F17A43-A74B-4570-8A06-D7657A4636B4|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||LOG10 COPIES/ML|||PT_BR|NOT DONE||Y|U|U|5||7||BASELINE|1973-08-17||1962-10-20|||1973-07-09||1963-04-10
TRIAL STUDY 134XCP|RP|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|1||||||DLVRMODE|MODE OF DELIVERY||||PKAT/L|||UMOL/KG/MIN|NOT DONE||NA|N|NA|1||38||TREATMENT|1964-01-19||1968-01-27|||1969-12-17||1960-10-30
TRIAL STUDY 134XCP|RP|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||GRAVITATIONAL UNIT|||BAU|NOT DONE||NA|N|U|1||38||LONG-TERM FOLLOW-UP|1962-02-09||1971-12-12|||1962-02-03||1962-03-31
TRIAL STUDY 134XCP|RP|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||10^6 CFU|||NEWTON|NOT DONE||N|U|NA|2||58||OPEN LABEL TREATMENT|1960-05-24||1966-08-31|||1973-09-04||1972-12-04
TRIAL STUDY 134XCP|RP|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||ML/KG|||GRAIN|NOT DONE||NA|Y|NA|2||58||WASHOUT|1968-05-02||1971-08-17|||1969-07-27||1967-03-15
TRIAL STUDY 134XCP|RP|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|1||||||MENFDUR|MENSES FLOW DURATION||||SV|||MU|NOT DONE||NA|Y|U|3||39||WASHOUT|1973-05-18||1969-09-09|||1972-12-16||1972-03-30
TRIAL STUDY 134XCP|RP|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||ML/DL|||MV*MIN|NOT DONE||Y|U|U|3||39||CONTINUATION TREATMENT|1967-01-14||1960-11-03|||1971-02-11||1962-07-26
TRIAL STUDY 134XCP|RP|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|1||||||BRTHN|NUMBER OF BIRTHS||||10^12/L|||10^9 ORGANISMS/MG|NOT DONE||NA|Y|N|4||88||TREATMENT|1961-03-24||1961-01-18|||1967-04-05||1967-04-09
TRIAL STUDY 134XCP|RP|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||SEC|||UMOL/DL|NOT DONE||N|NA|U|4||88||RUN-IN|1972-10-17||1966-08-03|||1963-01-01||1966-03-14
TRIAL STUDY 134XCP|RP|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|1||||||MENOSTAT|MENOPAUSE STATUS||||MEQ|||MILE|NOT DONE||Y|U|N|5||7||TREATMENT|1965-04-14||1963-08-18|||1971-01-27||1968-12-22
TRIAL STUDY 134XCP|RP|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||EID 50/ML|||QUANTITY SUFFICIENT|NOT DONE||Y|Y|N|5||7||OBSERVATION|1963-07-25||1970-12-23|||1967-09-26||1973-06-20
TRIAL STUDY 134XCP|RP|1177FD36-AAE8-4139-991A-A8C98B607565|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UEQ|||K|NOT DONE||NA|N|N|1||38||LONG-TERM FOLLOW-UP|1970-09-12||1964-07-30|||1962-01-14||1960-09-06
TRIAL STUDY 134XCP|RP|1177FD36-AAE8-4139-991A-A8C98B607565|2||||||MENFDUR|MENSES FLOW DURATION||||FT2|||NGEQ/L|NOT DONE||NA|Y|U|1||38||OBSERVATION|1966-09-21||1963-06-14|||1962-11-19||1969-06-09
TRIAL STUDY 134XCP|RP|1177FD36-AAE8-4139-991A-A8C98B607565|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MG/KG/MIN|||LOG EID 50/DOSE|NOT DONE||U|NA|NA|2||58||TREATMENT|1971-01-09||1966-03-15|||1965-02-02||1966-09-04
TRIAL STUDY 134XCP|RP|1177FD36-AAE8-4139-991A-A8C98B607565|2||||||MASSIND|MASS INDICATOR||||/VF|||KUSP|NOT DONE||NA|NA|N|2||58||BLINDED TREATMENT|1965-03-20||1964-06-15|||1965-02-16||1967-09-17
TRIAL STUDY 134XCP|RP|1177FD36-AAE8-4139-991A-A8C98B607565|1||||||PREGST|PREGNANT DURING THE STUDY||||MMHG|||PG/L|NOT DONE||Y|NA|NA|3||39||BLINDED TREATMENT|1973-01-08||1967-02-12|||1967-08-21||1965-10-07
TRIAL STUDY 134XCP|RP|1177FD36-AAE8-4139-991A-A8C98B607565|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||KCAL/DAY|||VIAL|NOT DONE||Y|NA|U|3||39||INDUCTION TREATMENT|1968-02-16||1970-08-04|||1971-10-21||1962-10-28
TRIAL STUDY 134XCP|RP|1177FD36-AAE8-4139-991A-A8C98B607565|1||||||PREGST|PREGNANT DURING THE STUDY||||MM2|||COPIES/UG|NOT DONE||Y|NA|N|4||88||RUN-IN|1967-06-16||1963-07-31|||1966-06-14||1965-02-27
TRIAL STUDY 134XCP|RP|1177FD36-AAE8-4139-991A-A8C98B607565|2||||||PUSTIND|PUSTULE INDICATOR||||/MIN|||MV|NOT DONE||NA|Y|U|4||88||OBSERVATION|1965-03-12||1969-03-23|||1963-06-27||1968-04-03
TRIAL STUDY 134XCP|RP|1177FD36-AAE8-4139-991A-A8C98B607565|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||DB|||GPL U/ML|NOT DONE||Y|U|Y|5||7||OPEN LABEL TREATMENT|1960-01-02||1966-04-08|||1966-09-27||1964-04-02
TRIAL STUDY 134XCP|RP|1177FD36-AAE8-4139-991A-A8C98B607565|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||KBQ/UL|||MPS U|NOT DONE||Y|Y|N|5||7||RUN-IN|1966-04-09||1960-10-31|||1967-05-30||1960-06-08
TRIAL STUDY 134XCP|RP|8C57F469-7CDF-493A-9839-C179D912A8A5|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||NGEQ/L|||GBQ/MG|NOT DONE||Y|NA|NA|1||38||BASELINE|1971-04-16||1962-07-16|||1963-09-20||1966-08-01
TRIAL STUDY 134XCP|RP|8C57F469-7CDF-493A-9839-C179D912A8A5|2||||||PEELIND|PEELING INDICATOR||||10^3/HPF|||PKAT|NOT DONE||Y|Y|Y|1||38||RUN-IN|1970-09-23||1972-01-22|||1968-05-16||1963-02-04
TRIAL STUDY 134XCP|RP|8C57F469-7CDF-493A-9839-C179D912A8A5|1||||||PEELIND|PEELING INDICATOR||||LOG10 COPIES/ML|||FEU|NOT DONE||U|N|U|2||58||BASELINE|1960-04-08||1960-02-01|||1969-10-30||1970-09-23
TRIAL STUDY 134XCP|RP|8C57F469-7CDF-493A-9839-C179D912A8A5|2||||||PREGNN|NUMBER OF PREGNANCIES||||MKAT|||L|NOT DONE||N|N|NA|2||58||INDUCTION TREATMENT|1971-06-23||1967-12-29|||1970-02-22||1968-07-01
TRIAL STUDY 134XCP|RP|8C57F469-7CDF-493A-9839-C179D912A8A5|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||CL|||KN/CM2|NOT DONE||U|U|Y|3||39||WASHOUT|1965-01-20||1973-08-05|||1964-03-14||1966-02-04
TRIAL STUDY 134XCP|RP|8C57F469-7CDF-493A-9839-C179D912A8A5|2||||||EDEMAIND|EDEMA INDICATOR||||MMOL/L|||NG/DAY|NOT DONE||NA|N|U|3||39||WASHOUT|1966-02-13||1962-02-02|||1963-12-30||1968-02-24
TRIAL STUDY 134XCP|RP|8C57F469-7CDF-493A-9839-C179D912A8A5|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MEQ/G|||10^3 ORGANISMS/G|NOT DONE||N|NA|Y|4||88||BLINDED TREATMENT|1972-06-30||1972-08-15|||1971-03-28||1971-07-20
TRIAL STUDY 134XCP|RP|8C57F469-7CDF-493A-9839-C179D912A8A5|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||CY/CM|||ROENTGEN|NOT DONE||Y|N|N|4||88||OPEN LABEL TREATMENT|1960-04-16||1973-01-06|||1966-09-25||1963-04-27
TRIAL STUDY 134XCP|RP|8C57F469-7CDF-493A-9839-C179D912A8A5|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||UMOL/L/SEC|||MM|NOT DONE||Y|N|N|5||7||BASELINE|1960-05-08||1969-02-26|||1963-02-17||1971-03-17
TRIAL STUDY 134XCP|RP|8C57F469-7CDF-493A-9839-C179D912A8A5|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||V/SEC|||MCI|NOT DONE||NA|Y|U|5||7||OPEN LABEL TREATMENT|1965-03-25||1970-05-16|||1970-09-05||1971-04-16
TRIAL STUDY 134XCP|RP|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|1||||||GRAVIND|GRAVIDA INDICATOR||||IU/MG|||MIN|NOT DONE||NA|NA|U|1||38||BLINDED TREATMENT|1963-03-05||1967-04-28|||1972-05-24||1966-05-21
TRIAL STUDY 134XCP|RP|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||10^3 COPIES/ML|||/100 WBC|NOT DONE||U|NA|N|1||38||CONTINUATION TREATMENT|1964-05-31||1962-03-28|||1965-09-21||1969-05-23
TRIAL STUDY 134XCP|RP|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|1||||||INTP|INTERPRETATION||||FMOL/G|||/200 HPFS|NOT DONE||N|N|N|2||58||CONTINUATION TREATMENT|1962-12-06||1961-08-06|||1970-02-24||1972-02-24
TRIAL STUDY 134XCP|RP|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|2||||||THICK|THICKNESS||||PL|||MIU/L|NOT DONE||U|NA|N|2||58||RUN-IN|1969-04-06||1966-04-29|||1960-12-20||1967-10-04
TRIAL STUDY 134XCP|RP|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MM|||/MONTH|NOT DONE||U|N|N|3||39||OBSERVATION|1971-10-01||1969-10-26|||1961-06-07||1963-01-24
TRIAL STUDY 134XCP|RP|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MOL/L|||MBQ/UL|NOT DONE||NA|Y|N|3||39||OBSERVATION|1963-09-09||1965-10-19|||1967-01-12||1964-05-12
TRIAL STUDY 134XCP|RP|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||FG|||TROCHE|NOT DONE||Y|Y|NA|4||88||OBSERVATION|1972-06-27||1963-08-23|||1964-08-21||1966-04-28
TRIAL STUDY 134XCP|RP|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|2||||||MENFDUR|MENSES FLOW DURATION||||MEQ/ML|||G/M2|NOT DONE||N|N|U|4||88||OPEN LABEL TREATMENT|1962-07-18||1961-09-01|||1966-06-22||1964-10-09
TRIAL STUDY 134XCP|RP|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|1||||||INTP|INTERPRETATION||||MMHG/L/MIN|||10^6 CFU/G|NOT DONE||NA|U|N|5||7||SCREENING|1966-03-21||1970-02-27|||1961-02-16||1970-05-09
TRIAL STUDY 134XCP|RP|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|2||||||BCMETHOD|BIRTH CONTROL METHOD||||10^3 CFU|||C|NOT DONE||U|U|U|5||7||RUN-IN|1965-11-10||1964-11-17|||1970-10-03||1970-06-26
TRIAL STUDY 134XCP|RP|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||EID 50/DOSE|||YD|NOT DONE||NA|N|Y|1||38||WASHOUT|1963-09-12||1962-10-22|||1969-02-07||1963-08-22
TRIAL STUDY 134XCP|RP|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|2||||||ERYTHIND|ERYTHEMA INDICATOR||||DAYS/MONTH|||IU/DL|NOT DONE||N|U|NA|1||38||RUN-IN|1967-02-24||1961-04-13|||1964-11-20||1970-06-06
TRIAL STUDY 134XCP|RP|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||PPTH|||CD/M2|NOT DONE||Y|N|NA|2||58||WASHOUT|1964-02-15||1968-12-29|||1964-08-19||1966-11-14
TRIAL STUDY 134XCP|RP|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MDFI|||COPIES/UL|NOT DONE||NA|N|NA|2||58||LONG-TERM FOLLOW-UP|1973-06-05||1972-02-06|||1964-05-10||1973-07-17
TRIAL STUDY 134XCP|RP|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||PA|||V|NOT DONE||NA|N|NA|3||39||CONTINUATION TREATMENT|1970-04-06||1965-02-23|||1970-02-09||1971-09-06
TRIAL STUDY 134XCP|RP|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|2||||||PREGIND|PREGNANT INDICATOR||||10^9/L|||CARTRIDGE|NOT DONE||Y|Y|Y|3||39||TREATMENT|1968-04-10||1967-11-29|||1972-10-21||1960-12-28
TRIAL STUDY 134XCP|RP|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|1||||||RASHIND|RASH INDICATOR||||ML/KG|||APL U/ML|NOT DONE||Y|U|N|4||88||LONG-TERM FOLLOW-UP|1961-06-01||1967-10-17|||1964-05-12||1960-01-06
TRIAL STUDY 134XCP|RP|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ELISA UNIT/ML|||BREATHS/30S|NOT DONE||Y|U|N|4||88||TREATMENT|1961-11-26||1962-08-12|||1970-05-25||1967-10-21
TRIAL STUDY 134XCP|RP|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|1||||||BLISTIND|BLISTERING INDICATOR||||ML/CAGE/WK|||UMOL/L/MIN|NOT DONE||NA|NA|N|5||7||SCREENING|1969-11-15||1969-06-07|||1973-06-09||1973-07-03
TRIAL STUDY 134XCP|RP|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|2||||||BLISTIND|BLISTERING INDICATOR||||10^5/HPF|||MPL U/ML|NOT DONE||Y|U|U|5||7||LONG-TERM FOLLOW-UP|1967-05-19||1972-11-26|||1970-02-06||1971-09-19
TRIAL STUDY 134XCP|RP|0AE36450-F37E-4F97-A250-79166011FCD7|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/CAGE/DAY|||S*KPA|NOT DONE||N|NA|NA|1||38||TREATMENT|1972-01-05||1972-05-08|||1966-03-21||1969-10-22
TRIAL STUDY 134XCP|RP|0AE36450-F37E-4F97-A250-79166011FCD7|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||UL/DOSE|||10^9/G|NOT DONE||U|U|U|1||38||RUN-IN|1969-05-06||1964-05-10|||1971-10-23||1963-01-23
TRIAL STUDY 134XCP|RP|0AE36450-F37E-4F97-A250-79166011FCD7|1||||||BRTHN|NUMBER OF BIRTHS||||BU/ML|||U/ML|NOT DONE||N|NA|Y|2||58||WASHOUT|1970-05-25||1961-01-20|||1972-08-29||1970-05-23
TRIAL STUDY 134XCP|RP|0AE36450-F37E-4F97-A250-79166011FCD7|2||||||ULCERIND|ULCER INDICATOR||||CM/MIN|||UL/ML|NOT DONE||U|NA|U|2||58||BLINDED TREATMENT|1971-03-30||1968-08-04|||1967-11-19||1964-09-04
TRIAL STUDY 134XCP|RP|0AE36450-F37E-4F97-A250-79166011FCD7|1||||||FUNDHT|FUNDAL HEIGHT||||/7.5 ML|||CCID 50/ML|NOT DONE||Y|U|U|3||39||TREATMENT|1972-05-23||1970-01-01|||1966-07-20||1962-07-16
TRIAL STUDY 134XCP|RP|0AE36450-F37E-4F97-A250-79166011FCD7|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||GRAVITATIONAL UNIT|||MET*H|NOT DONE||Y|NA|NA|3||39||FOLLOW-UP|1964-10-10||1963-02-27|||1965-06-28||1962-10-18
TRIAL STUDY 134XCP|RP|0AE36450-F37E-4F97-A250-79166011FCD7|1||||||FUNDHT|FUNDAL HEIGHT||||DNA COPIES/UG|||BQ|NOT DONE||NA|NA|N|4||88||TREATMENT|1960-10-08||1968-10-03|||1969-11-14||1962-08-18
TRIAL STUDY 134XCP|RP|0AE36450-F37E-4F97-A250-79166011FCD7|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||VG/KG|||MMOL/S|NOT DONE||N|Y|NA|4||88||INDUCTION TREATMENT|1968-05-09||1973-08-16|||1969-11-20||1966-02-19
TRIAL STUDY 134XCP|RP|0AE36450-F37E-4F97-A250-79166011FCD7|1||||||RASHIND|RASH INDICATOR||||L/H|||/KG|NOT DONE||NA|Y|Y|5||7||SCREENING|1967-12-01||1963-09-22|||1973-06-10||1961-03-26
TRIAL STUDY 134XCP|RP|0AE36450-F37E-4F97-A250-79166011FCD7|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||RPM|||UEQ|NOT DONE||U|N|NA|5||7||TREATMENT|1964-03-26||1965-08-25|||1962-11-07||1963-10-07
TRIAL STUDY 134XCP|RP|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|1||||||PEELIND|PEELING INDICATOR||||U/G/MIN|||UG/L FEU|NOT DONE||U|Y|U|1||38||OPEN LABEL TREATMENT|1961-05-13||1968-07-04|||1971-03-08||1960-10-26
TRIAL STUDY 134XCP|RP|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|2||||||THICK|THICKNESS||||S^-1(%O2)^-1|||PIXELS/IN|NOT DONE||U|U|U|1||38||SCREENING|1964-12-03||1963-04-29|||1960-05-21||1966-01-23
TRIAL STUDY 134XCP|RP|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|1||||||FUNDHT|FUNDAL HEIGHT||||MBP|||LOG10 CCID 50/DOSE|NOT DONE||NA|U|Y|2||58||OBSERVATION|1963-12-02||1972-08-22|||1964-07-09||1960-02-14
TRIAL STUDY 134XCP|RP|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|2||||||BCMETHOD|BIRTH CONTROL METHOD||||DNA COPIES/ML|||BE/ML|NOT DONE||NA|Y|U|2||58||WASHOUT|1963-03-28||1960-03-12|||1962-10-10||1965-06-01
TRIAL STUDY 134XCP|RP|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|1||||||PREGIND|PREGNANT INDICATOR||||WEEKS|||ML/DL|NOT DONE||NA|U|NA|3||39||LONG-TERM FOLLOW-UP|1966-03-05||1965-11-17|||1966-05-09||1968-02-12
TRIAL STUDY 134XCP|RP|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UMOL/MOL|||DMOL|NOT DONE||N|NA|N|3||39||WASHOUT|1964-12-01||1970-08-12|||1967-10-10||1961-07-01
TRIAL STUDY 134XCP|RP|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||FT2|||CAPFUL|NOT DONE||U|NA|Y|4||88||WASHOUT|1960-09-24||1971-09-17|||1964-08-03||1970-07-25
TRIAL STUDY 134XCP|RP|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|2||||||ERYTHIND|ERYTHEMA INDICATOR||||CY/CM|||MMHG/L/MIN|NOT DONE||N|U|Y|4||88||BASELINE|1968-03-08||1961-02-09|||1966-02-19||1964-01-26
TRIAL STUDY 134XCP|RP|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||YD|||MMOL/DAY|NOT DONE||U|N|Y|5||7||FOLLOW-UP|1967-02-10||1972-07-14|||1964-08-26||1973-05-30
TRIAL STUDY 134XCP|RP|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||BQ/ML|||GBQ/UG|NOT DONE||NA|Y|Y|5||7||TREATMENT|1969-11-27||1960-10-16|||1960-08-23||1962-03-22
TRIAL STUDY 134XCP|RP|707FC46F-B8B1-456B-9E09-CABC86EA61D5|1||||||INTP|INTERPRETATION||||RNA COPIES/ML|||EID 50/ML|NOT DONE||U|NA|Y|1||38||OBSERVATION|1973-01-19||1962-04-05|||1963-01-31||1965-10-02
TRIAL STUDY 134XCP|RP|707FC46F-B8B1-456B-9E09-CABC86EA61D5|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||NMOL/MOL|||UCI/L|NOT DONE||N|U|U|1||38||INDUCTION TREATMENT|1969-10-07||1967-04-03|||1960-01-20||1963-01-03
TRIAL STUDY 134XCP|RP|707FC46F-B8B1-456B-9E09-CABC86EA61D5|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||RNA COPIES/ML|||CUP|NOT DONE||U|U|N|2||58||RUN-IN|1964-05-18||1966-12-01|||1967-10-22||1963-04-13
TRIAL STUDY 134XCP|RP|707FC46F-B8B1-456B-9E09-CABC86EA61D5|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||PNU/ML|||ABSORBANCE U/MIN|NOT DONE||N|N|U|2||58||OBSERVATION|1970-06-01||1966-04-03|||1962-04-27||1968-06-05
TRIAL STUDY 134XCP|RP|707FC46F-B8B1-456B-9E09-CABC86EA61D5|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||UGEQ/L|||U/L|NOT DONE||NA|Y|NA|3||39||BASELINE|1970-04-01||1973-04-20|||1973-04-19||1971-07-04
TRIAL STUDY 134XCP|RP|707FC46F-B8B1-456B-9E09-CABC86EA61D5|2||||||INABOIND|INDUCED ABORTION INDICATOR||||BAR|||MM/MIN|NOT DONE||Y|Y|U|3||39||BASELINE|1964-10-14||1969-06-27|||1973-03-28||1964-02-16
TRIAL STUDY 134XCP|RP|707FC46F-B8B1-456B-9E09-CABC86EA61D5|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||ABSORBANCE U|||UG/MIN|NOT DONE||NA|U|U|4||88||WASHOUT|1964-07-25||1962-08-11|||1966-05-19||1972-11-28
TRIAL STUDY 134XCP|RP|707FC46F-B8B1-456B-9E09-CABC86EA61D5|2||||||EDEMAIND|EDEMA INDICATOR||||MMHG/SEC|||WEBER|NOT DONE||Y|Y|U|4||88||LONG-TERM FOLLOW-UP|1960-12-19||1960-11-19|||1968-12-27||1963-09-28
TRIAL STUDY 134XCP|RP|707FC46F-B8B1-456B-9E09-CABC86EA61D5|1||||||PUSTIND|PUSTULE INDICATOR||||LOG10 ELISA UNIT/DOSE|||LM|NOT DONE||Y|NA|N|5||7||SCREENING|1962-11-15||1962-10-22|||1973-04-27||1973-02-16
TRIAL STUDY 134XCP|RP|707FC46F-B8B1-456B-9E09-CABC86EA61D5|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||10^10/L|||TRANSDUCING UNIT/ML|NOT DONE||Y|NA|N|5||7||INDUCTION TREATMENT|1971-12-30||1963-04-20|||1963-05-29||1965-01-23
TRIAL STUDY 134XCP|RP|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||U/M2/DAY|||M2|NOT DONE||NA|Y|NA|1||38||OPEN LABEL TREATMENT|1961-09-07||1973-06-02|||1962-05-02||1966-01-11
TRIAL STUDY 134XCP|RP|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|2||||||MENFDUR|MENSES FLOW DURATION||||STRIP|||NSEC|NOT DONE||NA|NA|Y|1||38||INDUCTION TREATMENT|1970-08-29||1967-07-17|||1968-05-12||1971-07-06
TRIAL STUDY 134XCP|RP|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|1||||||BRTHN|NUMBER OF BIRTHS||||FMOL/L|||STRIP|NOT DONE||U|NA|Y|2||58||OPEN LABEL TREATMENT|1965-09-19||1961-12-12|||1969-05-09||1972-06-18
TRIAL STUDY 134XCP|RP|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|2||||||MASSIND|MASS INDICATOR||||10^6 ORGANISMS/MG|||USIEMENS|NOT DONE||U|NA|NA|2||58||SCREENING|1971-07-13||1968-09-17|||1970-12-25||1965-11-28
TRIAL STUDY 134XCP|RP|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|1||||||MASSIND|MASS INDICATOR||||10^6/HPF|||PMOL/L|NOT DONE||NA|Y|NA|3||39||INDUCTION TREATMENT|1968-11-21||1966-10-25|||1962-11-18||1968-02-27
TRIAL STUDY 134XCP|RP|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|2||||||ERYTHIND|ERYTHEMA INDICATOR||||PHERESIS UNIT|||BISCUIT|NOT DONE||U|Y|U|3||39||BLINDED TREATMENT|1971-12-11||1962-05-07|||1963-06-23||1962-01-11
TRIAL STUDY 134XCP|RP|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|1||||||ABORTN|NUMBER OF ABORTIONS||||VP/ML|||CI|NOT DONE||NA|U|NA|4||88||OPEN LABEL TREATMENT|1962-09-08||1971-09-30|||1971-06-10||1967-12-20
TRIAL STUDY 134XCP|RP|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||BAG|||MSEC|NOT DONE||N|Y|N|4||88||BASELINE|1972-04-16||1963-06-14|||1962-07-08||1966-06-02
TRIAL STUDY 134XCP|RP|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||LOG10 CFU/G|||PG/L|NOT DONE||U|N|U|5||7||LONG-TERM FOLLOW-UP|1973-04-14||1970-04-21|||1969-08-22||1973-07-10
TRIAL STUDY 134XCP|RP|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||AMFI|||PRESSOR UNITS|NOT DONE||N|U|U|5||7||OPEN LABEL TREATMENT|1969-02-27||1971-05-19|||1961-10-29||1969-04-20
TRIAL STUDY 134XCP|RP|70196099-5D40-4048-AABF-EB40CE345328|1||||||TNDRIND|TENDERNESS INDICATOR||||UG/L|||MONTHS|NOT DONE||U|N|N|1||38||TREATMENT|1969-06-11||1966-03-20|||1970-08-08||1973-01-30
TRIAL STUDY 134XCP|RP|70196099-5D40-4048-AABF-EB40CE345328|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||AGU/ML|||EVENTS|NOT DONE||Y|N|U|1||38||FOLLOW-UP|1963-06-12||1967-01-23|||1960-05-23||1966-09-20
TRIAL STUDY 134XCP|RP|70196099-5D40-4048-AABF-EB40CE345328|1||||||MENOSTAT|MENOPAUSE STATUS||||FINGERTIP UNIT|||GBQ/G|NOT DONE||NA|NA|N|2||58||TREATMENT|1960-06-14||1960-01-06|||1960-09-07||1965-03-15
TRIAL STUDY 134XCP|RP|70196099-5D40-4048-AABF-EB40CE345328|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||CI/MG|||UCI/L|NOT DONE||U|Y|Y|2||58||BLINDED TREATMENT|1962-07-09||1967-03-22|||1967-07-01||1966-03-10
TRIAL STUDY 134XCP|RP|70196099-5D40-4048-AABF-EB40CE345328|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||ENZYME U|||COPIES/ML|NOT DONE||Y|NA|U|3||39||OBSERVATION|1967-05-12||1969-04-26|||1962-05-29||1960-02-09
TRIAL STUDY 134XCP|RP|70196099-5D40-4048-AABF-EB40CE345328|2||||||PEELIND|PEELING INDICATOR||||UKAT/10^12 RBC|||ML/ANIMAL/DAY|NOT DONE||Y|NA|NA|3||39||CONTINUATION TREATMENT|1963-11-18||1964-02-29|||1973-04-01||1967-09-29
TRIAL STUDY 134XCP|RP|70196099-5D40-4048-AABF-EB40CE345328|1||||||TNDRIND|TENDERNESS INDICATOR||||L/S/KPA|||NMOL BCE/L|NOT DONE||NA|NA|N|4||88||WASHOUT|1972-01-11||1971-08-27|||1963-08-13||1969-03-03
TRIAL STUDY 134XCP|RP|70196099-5D40-4048-AABF-EB40CE345328|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UMOL/L|||PATCH|NOT DONE||U|Y|N|4||88||WASHOUT|1973-04-04||1961-09-16|||1972-03-11||1962-04-03
TRIAL STUDY 134XCP|RP|70196099-5D40-4048-AABF-EB40CE345328|1||||||DSCHGIND|DISCHARGE INDICATOR||||/2500 WBC|||10^6 ORGANISMS/ML|NOT DONE||Y|U|U|5||7||WASHOUT|1973-06-23||1963-08-11|||1970-07-03||1964-02-12
TRIAL STUDY 134XCP|RP|70196099-5D40-4048-AABF-EB40CE345328|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||EQ|||PACKAGE|NOT DONE||NA|Y|NA|5||7||TREATMENT|1972-03-21||1968-03-06|||1961-09-12||1967-12-31
TRIAL STUDY 134XCP|RP|F9D4C544-F217-4676-AC40-F71CC48045AF|1||||||INTP|INTERPRETATION||||LOG10 COPIES/ML|||MG/M2/MIN|NOT DONE||U|Y|NA|1||38||RUN-IN|1967-11-11||1968-11-14|||1970-03-26||1961-08-19
TRIAL STUDY 134XCP|RP|F9D4C544-F217-4676-AC40-F71CC48045AF|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||10^6 IU/ML|||ML/ANIMAL|NOT DONE||U|Y|NA|1||38||OPEN LABEL TREATMENT|1966-09-25||1960-06-17|||1970-03-18||1972-12-09
TRIAL STUDY 134XCP|RP|F9D4C544-F217-4676-AC40-F71CC48045AF|1||||||DLVRMODE|MODE OF DELIVERY||||/MONTH|||PIXELS/IN|NOT DONE||U|Y|U|2||58||FOLLOW-UP|1964-04-26||1970-04-14|||1973-02-22||1967-09-10
TRIAL STUDY 134XCP|RP|F9D4C544-F217-4676-AC40-F71CC48045AF|2||||||INABOIND|INDUCED ABORTION INDICATOR||||CMH2O*S/ML|||STRIP|NOT DONE||N|NA|N|2||58||CONTINUATION TREATMENT|1973-05-19||1969-05-10|||1966-01-19||1960-10-18
TRIAL STUDY 134XCP|RP|F9D4C544-F217-4676-AC40-F71CC48045AF|1||||||PREGIND|PREGNANT INDICATOR||||BOWL|||U/ML|NOT DONE||Y|U|NA|3||39||INDUCTION TREATMENT|1971-05-18||1960-12-05|||1968-08-25||1960-10-04
TRIAL STUDY 134XCP|RP|F9D4C544-F217-4676-AC40-F71CC48045AF|2||||||FUNDHT|FUNDAL HEIGHT||||ML/KG/DAY|||IU/MMOL|NOT DONE||N|U|U|3||39||BLINDED TREATMENT|1965-09-28||1965-11-12|||1966-11-14||1961-11-18
TRIAL STUDY 134XCP|RP|F9D4C544-F217-4676-AC40-F71CC48045AF|1||||||MASSIND|MASS INDICATOR||||DPM/0.5 ML|||ELISA UNIT/DOSE|NOT DONE||U|Y|Y|4||88||BLINDED TREATMENT|1965-04-06||1960-05-06|||1973-03-14||1965-03-04
TRIAL STUDY 134XCP|RP|F9D4C544-F217-4676-AC40-F71CC48045AF|2||||||PREGIND|PREGNANT INDICATOR||||LOG10 PFU/ML|||BREATHS/MIN|NOT DONE||NA|NA|U|4||88||RUN-IN|1967-09-18||1966-07-11|||1963-11-02||1961-09-03
TRIAL STUDY 134XCP|RP|F9D4C544-F217-4676-AC40-F71CC48045AF|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^3 DNA COPIES/ML|||/100 WBC|NOT DONE||U|N|Y|5||7||RUN-IN|1969-11-09||1960-02-03|||1972-12-18||1962-10-20
TRIAL STUDY 134XCP|RP|F9D4C544-F217-4676-AC40-F71CC48045AF|2||||||PUSTIND|PUSTULE INDICATOR||||BEL|||%(W/W)|NOT DONE||U|U|U|5||7||SCREENING|1962-03-17||1973-04-27|||1963-02-21||1971-06-04
TRIAL STUDY 134XCP|RP|E6A42133-B082-4BD7-B840-A60E49E0562B|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||TCID 50/DOSE|||100 IU/ML|NOT DONE||U|N|Y|1||38||BLINDED TREATMENT|1969-11-17||1966-09-14|||1967-02-01||1962-05-09
TRIAL STUDY 134XCP|RP|E6A42133-B082-4BD7-B840-A60E49E0562B|2||||||STILBIND|STILLBIRTH INDICATOR||||UMOL/L/H|||PPB|NOT DONE||NA|U|Y|1||38||OPEN LABEL TREATMENT|1971-01-01||1969-09-15|||1970-09-11||1960-11-23
TRIAL STUDY 134XCP|RP|E6A42133-B082-4BD7-B840-A60E49E0562B|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MM/SEC|||PT_BR|NOT DONE||NA|Y|NA|2||58||BASELINE|1963-07-14||1962-12-02|||1970-07-17||1966-09-02
TRIAL STUDY 134XCP|RP|E6A42133-B082-4BD7-B840-A60E49E0562B|2||||||PREGIND|PREGNANT INDICATOR||||FRAMES/S|||10^11/L|NOT DONE||U|U|U|2||58||LONG-TERM FOLLOW-UP|1967-02-04||1968-06-01|||1962-08-30||1968-01-09
TRIAL STUDY 134XCP|RP|E6A42133-B082-4BD7-B840-A60E49E0562B|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MCI|||POINT|NOT DONE||U|U|NA|3||39||SCREENING|1963-08-05||1971-01-04|||1973-03-23||1964-06-30
TRIAL STUDY 134XCP|RP|E6A42133-B082-4BD7-B840-A60E49E0562B|2||||||INTP|INTERPRETATION||||MOSM|||L/DAY|NOT DONE||N|N|NA|3||39||TREATMENT|1972-02-14||1969-12-28|||1965-03-14||1966-09-13
TRIAL STUDY 134XCP|RP|E6A42133-B082-4BD7-B840-A60E49E0562B|1||||||PRGENDTC|DATE PREGNANCY ENDED||||FEU|||BOLUS|NOT DONE||Y|NA|NA|4||88||TREATMENT|1966-03-02||1963-07-08|||1971-08-07||1970-09-10
TRIAL STUDY 134XCP|RP|E6A42133-B082-4BD7-B840-A60E49E0562B|2||||||FUNDHT|FUNDAL HEIGHT||||DROP|||DAYS/MONTH|NOT DONE||NA|N|NA|4||88||OBSERVATION|1970-06-10||1965-01-25|||1972-04-25||1962-01-16
TRIAL STUDY 134XCP|RP|E6A42133-B082-4BD7-B840-A60E49E0562B|1||||||ERYTHIND|ERYTHEMA INDICATOR||||IU/G HB|||SCM|NOT DONE||Y|N|Y|5||7||TREATMENT|1966-11-10||1961-10-01|||1961-02-23||1960-10-26
TRIAL STUDY 134XCP|RP|E6A42133-B082-4BD7-B840-A60E49E0562B|2||||||PUSTIND|PUSTULE INDICATOR||||CONTAINER|||UIU/L|NOT DONE||N|N|N|5||7||RUN-IN|1967-05-01||1960-02-16|||1972-08-02||1967-06-16
TRIAL STUDY 134XCP|RP|72C9FDBC-AA86-4001-9820-90AAF5422074|1||||||PRGENDTC|DATE PREGNANCY ENDED||||10^6/HPF|||ML*CMH2O|NOT DONE||N|Y|N|1||38||LONG-TERM FOLLOW-UP|1961-03-24||1965-12-15|||1970-02-28||1967-06-12
TRIAL STUDY 134XCP|RP|72C9FDBC-AA86-4001-9820-90AAF5422074|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||CAL|||ELISA UNIT|NOT DONE||N|Y|NA|1||38||BASELINE|1960-01-01||1973-02-01|||1969-06-16||1964-06-25
TRIAL STUDY 134XCP|RP|72C9FDBC-AA86-4001-9820-90AAF5422074|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||DAYS/MONTH|||UG/G/MIN|NOT DONE||N|U|Y|2||58||RUN-IN|1963-08-19||1965-03-19|||1968-07-04||1962-05-26
TRIAL STUDY 134XCP|RP|72C9FDBC-AA86-4001-9820-90AAF5422074|2||||||INTP|INTERPRETATION||||NMOL|||IU/G HB|NOT DONE||N|Y|NA|2||58||LONG-TERM FOLLOW-UP|1971-11-25||1966-06-16|||1970-04-19||1973-03-12
TRIAL STUDY 134XCP|RP|72C9FDBC-AA86-4001-9820-90AAF5422074|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||DDU|||MG/KG/MIN|NOT DONE||N|Y|U|3||39||CONTINUATION TREATMENT|1964-09-05||1967-02-11|||1973-02-23||1963-01-18
TRIAL STUDY 134XCP|RP|72C9FDBC-AA86-4001-9820-90AAF5422074|2||||||INTP|INTERPRETATION||||MOL/DAY|||10^9 ORGANISMS/ML|NOT DONE||NA|Y|U|3||39||SCREENING|1961-02-10||1961-08-27|||1961-04-18||1968-07-04
TRIAL STUDY 134XCP|RP|72C9FDBC-AA86-4001-9820-90AAF5422074|1||||||BLISTIND|BLISTERING INDICATOR||||M3|||UG/M2/DAY|NOT DONE||U|N|Y|4||88||INDUCTION TREATMENT|1969-08-14||1968-06-27|||1969-03-31||1971-07-26
TRIAL STUDY 134XCP|RP|72C9FDBC-AA86-4001-9820-90AAF5422074|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||MPL U|||%|NOT DONE||U|U|N|4||88||BLINDED TREATMENT|1970-07-16||1968-11-23|||1971-06-24||1968-09-25
TRIAL STUDY 134XCP|RP|72C9FDBC-AA86-4001-9820-90AAF5422074|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||OI50|||HEP|NOT DONE||Y|N|N|5||7||CONTINUATION TREATMENT|1965-05-29||1964-08-27|||1962-03-31||1973-08-25
TRIAL STUDY 134XCP|RP|72C9FDBC-AA86-4001-9820-90AAF5422074|2||||||THICK|THICKNESS||||ANSON U|||10^6 ORGANISMS/ML|NOT DONE||U|U|U|5||7||FOLLOW-UP|1968-03-01||1966-03-26|||1962-04-28||1960-07-21
TRIAL STUDY 134XCP|RP|186520B9-8AAD-4063-B48F-16040EF49944|1||||||RASHIND|RASH INDICATOR||||UEQ/L|||MEQ/UL|NOT DONE||U|U|NA|1||38||INDUCTION TREATMENT|1970-07-23||1965-05-11|||1972-04-01||1963-02-10
TRIAL STUDY 134XCP|RP|186520B9-8AAD-4063-B48F-16040EF49944|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||ML/G/H|||SHOCK WAVE|NOT DONE||N|U|U|1||38||LONG-TERM FOLLOW-UP|1961-06-11||1966-07-19|||1965-05-27||1966-01-18
TRIAL STUDY 134XCP|RP|186520B9-8AAD-4063-B48F-16040EF49944|1||||||FUNDHT|FUNDAL HEIGHT||||LOG10 ELISA UNIT/DOSE|||DPM/100MG|NOT DONE||U|U|N|2||58||TREATMENT|1962-01-28||1961-07-09|||1960-12-24||1962-04-19
TRIAL STUDY 134XCP|RP|186520B9-8AAD-4063-B48F-16040EF49944|2||||||MENFDUR|MENSES FLOW DURATION||||ML/MMHG/MIN/L|||%(W/V)|NOT DONE||U|N|Y|2||58||SCREENING|1964-03-30||1969-11-02|||1968-11-14||1964-04-11
TRIAL STUDY 134XCP|RP|186520B9-8AAD-4063-B48F-16040EF49944|1||||||EDEMAIND|EDEMA INDICATOR||||NMOL BCE/NMOL|||FG|NOT DONE||NA|Y|N|3||39||TREATMENT|1965-12-20||1965-11-16|||1967-03-26||1972-03-27
TRIAL STUDY 134XCP|RP|186520B9-8AAD-4063-B48F-16040EF49944|2||||||DSCHGIND|DISCHARGE INDICATOR||||NEBULE|||PATCH|NOT DONE||U|U|N|3||39||CONTINUATION TREATMENT|1960-01-01||1973-03-28|||1964-03-25||1967-08-12
TRIAL STUDY 134XCP|RP|186520B9-8AAD-4063-B48F-16040EF49944|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||ECL UNIT|||UU/L|NOT DONE||NA|NA|N|4||88||TREATMENT|1964-01-15||1970-08-13|||1965-11-08||1964-08-20
TRIAL STUDY 134XCP|RP|186520B9-8AAD-4063-B48F-16040EF49944|2||||||BCMETHOD|BIRTH CONTROL METHOD||||IU/G HB|||/LPF|NOT DONE||NA|N|U|4||88||WASHOUT|1964-08-20||1965-05-05|||1962-01-08||1965-03-14
TRIAL STUDY 134XCP|RP|186520B9-8AAD-4063-B48F-16040EF49944|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||BQ/KG|||PMOL/10^9 CELLS|NOT DONE||N|Y|Y|5||7||SCREENING|1963-12-06||1961-05-19|||1972-08-30||1962-05-30
TRIAL STUDY 134XCP|RP|186520B9-8AAD-4063-B48F-16040EF49944|2||||||STILBIND|STILLBIRTH INDICATOR||||VG/ML|||KV|NOT DONE||N|NA|U|5||7||SCREENING|1969-11-18||1967-07-10|||1971-03-14||1972-02-28
TRIAL STUDY 134XCP|RP|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||CM|||NMOL/L|NOT DONE||U|N|U|1||38||BLINDED TREATMENT|1962-04-20||1961-10-28|||1970-07-10||1968-12-18
TRIAL STUDY 134XCP|RP|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|2||||||INABOIND|INDUCED ABORTION INDICATOR||||BQ/ML|||/MM2|NOT DONE||Y|U|N|1||38||LONG-TERM FOLLOW-UP|1969-03-15||1973-01-22|||1964-05-23||1970-03-24
TRIAL STUDY 134XCP|RP|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|1||||||BCMETHOD|BIRTH CONTROL METHOD||||KG/CM|||UG/L DDU|NOT DONE||N|N|U|2||58||FOLLOW-UP|1963-12-06||1963-01-03|||1971-08-26||1972-07-08
TRIAL STUDY 134XCP|RP|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|2||||||BRTHN|NUMBER OF BIRTHS||||U/ML|||AU/ML|NOT DONE||U|N|NA|2||58||SCREENING|1968-06-05||1963-01-11|||1961-06-16||1973-04-01
TRIAL STUDY 134XCP|RP|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|1||||||ABORTN|NUMBER OF ABORTIONS||||UM/S|||U/KG|NOT DONE||N|Y|N|3||39||OPEN LABEL TREATMENT|1962-06-17||1968-04-23|||1969-11-04||1961-05-07
TRIAL STUDY 134XCP|RP|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|2||||||PUSTIND|PUSTULE INDICATOR||||ROENTGEN|||ECL UNIT|NOT DONE||U|Y|U|3||39||RUN-IN|1966-08-05||1971-01-17|||1973-01-29||1972-12-22
TRIAL STUDY 134XCP|RP|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||BAU/ML|||MOL/MG|NOT DONE||N|U|N|4||88||OBSERVATION|1971-12-20||1967-08-26|||1971-12-05||1972-03-20
TRIAL STUDY 134XCP|RP|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||LENS|||NMOL BCE/NMOL|NOT DONE||Y|Y|Y|4||88||SCREENING|1965-08-08||1967-10-20|||1961-01-29||1960-05-04
TRIAL STUDY 134XCP|RP|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||UMOL/L/SEC|||MV/SEC|NOT DONE||N|Y|NA|5||7||OBSERVATION|1966-11-21||1960-10-12|||1962-07-22||1967-12-22
TRIAL STUDY 134XCP|RP|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||%/MIN|||CGY|NOT DONE||N|N|U|5||7||BASELINE|1961-06-07||1973-02-28|||1960-11-20||1960-08-21
TRIAL STUDY 134XCP|RP|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||LB|||ML/S/M2|NOT DONE||U|NA|U|1||38||WASHOUT|1964-10-27||1969-09-02|||1972-01-23||1960-12-05
TRIAL STUDY 134XCP|RP|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||DMOL|||VG/DOSE|NOT DONE||NA|U|U|1||38||OBSERVATION|1970-01-25||1972-08-09|||1969-09-09||1961-03-24
TRIAL STUDY 134XCP|RP|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||SFC/10^6 PBMC|||CAL|NOT DONE||N|U|Y|2||58||SCREENING|1967-09-13||1965-02-15|||1966-09-18||1965-07-19
TRIAL STUDY 134XCP|RP|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||BQ/MG|||DAMOL/L|NOT DONE||Y|NA|Y|2||58||INDUCTION TREATMENT|1962-11-10||1961-11-11|||1971-05-29||1968-01-30
TRIAL STUDY 134XCP|RP|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|1||||||ULCERIND|ULCER INDICATOR||||GPS U|||SBE/ML|NOT DONE||N|NA|U|3||39||SCREENING|1969-04-20||1964-06-22|||1963-02-08||1960-05-09
TRIAL STUDY 134XCP|RP|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||NFIU|||RING|NOT DONE||Y|N|Y|3||39||CONTINUATION TREATMENT|1964-03-09||1965-03-03|||1960-07-30||1971-01-27
TRIAL STUDY 134XCP|RP|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|1||||||PUSTIND|PUSTULE INDICATOR||||10^4/L|||UG/DAY|NOT DONE||Y|NA|NA|4||88||CONTINUATION TREATMENT|1962-06-15||1970-12-23|||1961-01-01||1970-07-24
TRIAL STUDY 134XCP|RP|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|2||||||INTP|INTERPRETATION||||KCAL/DAY|||PPTR|NOT DONE||Y|N|Y|4||88||CONTINUATION TREATMENT|1963-08-28||1971-07-01|||1969-11-25||1970-07-28
TRIAL STUDY 134XCP|RP|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||TUBERCULIN UNIT/ML|||EVENTS|NOT DONE||U|NA|Y|5||7||WASHOUT|1960-05-11||1960-08-19|||1970-11-07||1963-11-09
TRIAL STUDY 134XCP|RP|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|2||||||BCMETHOD|BIRTH CONTROL METHOD||||DPM|||S^-1(%O2)^-1|NOT DONE||Y|NA|Y|5||7||CONTINUATION TREATMENT|1968-08-16||1969-01-12|||1965-02-21||1960-07-18
TRIAL STUDY 134XCP|RP|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UMOL/L/H|||DRUM|NOT DONE||N|U|NA|1||38||CONTINUATION TREATMENT|1962-04-13||1970-02-07|||1965-02-24||1963-10-24
TRIAL STUDY 134XCP|RP|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|2||||||MENOAGE|MENOPAUSE AGE||||MSEC|||MSEC|NOT DONE||Y|NA|Y|1||38||WASHOUT|1971-09-04||1960-02-17|||1962-06-30||1962-07-22
TRIAL STUDY 134XCP|RP|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MPH|||GBQ|NOT DONE||Y|U|U|2||58||INDUCTION TREATMENT|1972-01-21||1961-11-24|||1966-08-23||1971-10-15
TRIAL STUDY 134XCP|RP|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||CYLINDER|||ROENTGEN|NOT DONE||Y|Y|Y|2||58||LONG-TERM FOLLOW-UP|1964-01-05||1971-03-08|||1970-09-05||1966-08-06
TRIAL STUDY 134XCP|RP|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MMOL2/L2|||MEQ/KG|NOT DONE||N|Y|U|3||39||BASELINE|1971-12-26||1972-12-05|||1966-05-07||1961-08-16
TRIAL STUDY 134XCP|RP|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MPA|||GLOBULE|NOT DONE||Y|U|NA|3||39||FOLLOW-UP|1960-03-16||1971-03-26|||1969-01-04||1970-03-29
TRIAL STUDY 134XCP|RP|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||KG/MOL|||CI|NOT DONE||U|U|U|4||88||OPEN LABEL TREATMENT|1962-01-31||1970-07-31|||1965-11-17||1967-04-01
TRIAL STUDY 134XCP|RP|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||NL|||MMOL/L|NOT DONE||N|NA|NA|4||88||WASHOUT|1968-01-25||1964-05-30|||1968-07-06||1964-04-19
TRIAL STUDY 134XCP|RP|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||10^3 CFU|||MG/MOL|NOT DONE||N|Y|NA|5||7||CONTINUATION TREATMENT|1969-09-17||1960-07-05|||1967-05-10||1965-11-30
TRIAL STUDY 134XCP|RP|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|2||||||MENFDUR|MENSES FLOW DURATION||||CONTAINER|||NCI|NOT DONE||Y|NA|Y|5||7||LONG-TERM FOLLOW-UP|1972-11-16||1960-06-02|||1966-05-26||1969-12-29
TRIAL STUDY 134XCP|RP|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|1||||||ULCERIND|ULCER INDICATOR||||MOL/ML|||V/V|NOT DONE||N|U|N|1||38||WASHOUT|1960-10-27||1971-05-23|||1972-09-18||1972-07-03
TRIAL STUDY 134XCP|RP|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||COPIES/ML|||UG/ML/H|NOT DONE||U|Y|U|1||38||BASELINE|1965-03-30||1971-10-25|||1962-05-18||1972-03-06
TRIAL STUDY 134XCP|RP|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||/SEC|||M3|NOT DONE||U|N|N|2||58||FOLLOW-UP|1970-05-04||1967-06-29|||1969-11-23||1960-11-17
TRIAL STUDY 134XCP|RP|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||FG|||ML/CAGE|NOT DONE||N|Y|U|2||58||BASELINE|1960-11-02||1969-10-31|||1966-02-04||1963-10-26
TRIAL STUDY 134XCP|RP|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|1||||||DLVRMODE|MODE OF DELIVERY||||ML/MIN/1.73M2|||HENRY|NOT DONE||N|N|U|3||39||FOLLOW-UP|1966-09-06||1964-04-02|||1973-04-21||1971-06-22
TRIAL STUDY 134XCP|RP|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|2||||||ABORTN|NUMBER OF ABORTIONS||||RING|||GPL U|NOT DONE||U|N|Y|3||39||LONG-TERM FOLLOW-UP|1966-05-17||1961-03-20|||1968-07-04||1960-10-13
TRIAL STUDY 134XCP|RP|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||ML/KG/DAY|||COPIES/ML|NOT DONE||N|N|NA|4||88||TREATMENT|1965-11-18||1962-01-17|||1961-01-18||1965-08-13
TRIAL STUDY 134XCP|RP|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||10^6/HPF|||FG|NOT DONE||N|U|Y|4||88||SCREENING|1968-06-14||1972-05-25|||1962-02-20||1968-12-04
TRIAL STUDY 134XCP|RP|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||SPRAY|||10^6 CFU/G|NOT DONE||N|N|Y|5||7||CONTINUATION TREATMENT|1964-10-23||1967-01-05|||1963-05-07||1965-09-22
TRIAL STUDY 134XCP|RP|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||ML/MIN/MMHG|||U/10^12 RBC|NOT DONE||NA|Y|N|5||7||BLINDED TREATMENT|1968-04-26||1966-07-05|||1962-01-26||1960-12-23
TRIAL STUDY 134XCP|RP|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|1||||||GRAVIND|GRAVIDA INDICATOR||||PPM|||CM/MIN|NOT DONE||Y|Y|N|1||38||BLINDED TREATMENT|1964-02-26||1971-04-01|||1970-10-16||1963-03-10
TRIAL STUDY 134XCP|RP|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^5/HPF|||USP U|NOT DONE||NA|NA|NA|1||38||OBSERVATION|1969-09-05||1973-05-04|||1964-03-29||1969-02-16
TRIAL STUDY 134XCP|RP|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||DYN|||UMOL/L/MIN|NOT DONE||Y|NA|U|2||58||WASHOUT|1968-07-25||1969-07-26|||1964-12-15||1968-07-04
TRIAL STUDY 134XCP|RP|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MEQ/DL|||NGEQ/L|NOT DONE||N|NA|Y|2||58||SCREENING|1965-03-22||1969-06-19|||1973-04-08||1966-08-05
TRIAL STUDY 134XCP|RP|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MMOL/G|||NKAT|NOT DONE||N|N|NA|3||39||INDUCTION TREATMENT|1965-11-09||1970-02-10|||1965-12-28||1968-02-17
TRIAL STUDY 134XCP|RP|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|2||||||BCMETHOD|BIRTH CONTROL METHOD||||S^-1(%O2)^-1|||MONTHS|NOT DONE||U|U|NA|3||39||LONG-TERM FOLLOW-UP|1972-01-30||1973-03-23|||1965-07-20||1967-12-20
TRIAL STUDY 134XCP|RP|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|1||||||PREGIND|PREGNANT INDICATOR||||/CMH2O|||RPM|NOT DONE||Y|N|U|4||88||RUN-IN|1961-10-11||1961-01-31|||1972-05-26||1968-04-09
TRIAL STUDY 134XCP|RP|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|2||||||PRGENDTC|DATE PREGNANCY ENDED||||NM|||WEEKS|NOT DONE||Y|U|N|4||88||TREATMENT|1972-03-19||1962-05-10|||1969-08-08||1971-11-01
TRIAL STUDY 134XCP|RP|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|1||||||FUNDHT|FUNDAL HEIGHT||||UG/L FEU|||GBQ/G|NOT DONE||U|N|N|5||7||WASHOUT|1963-04-10||1962-10-20|||1972-11-08||1973-06-07
TRIAL STUDY 134XCP|RP|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||FARAD|||PG/DL|NOT DONE||U|U|Y|5||7||WASHOUT|1971-04-03||1962-10-11|||1964-01-27||1972-11-27
TRIAL STUDY 134XCP|RP|460486B3-B7C8-4B54-848B-21BA899EAAD6|1||||||MASSIND|MASS INDICATOR||||CUP|||MPL U/ML|NOT DONE||Y|N|Y|1||38||TREATMENT|1967-03-02||1963-09-04|||1960-05-03||1968-06-28
TRIAL STUDY 134XCP|RP|460486B3-B7C8-4B54-848B-21BA899EAAD6|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||NL|||IU/G HB|NOT DONE||U|Y|U|1||38||SCREENING|1962-06-25||1963-02-09|||1965-12-21||1960-03-24
TRIAL STUDY 134XCP|RP|460486B3-B7C8-4B54-848B-21BA899EAAD6|1||||||MENOAGE|MENOPAUSE AGE||||G/M2|||NMOL/DAY|NOT DONE||N|Y|Y|2||58||SCREENING|1962-02-24||1970-11-15|||1967-11-05||1969-02-06
TRIAL STUDY 134XCP|RP|460486B3-B7C8-4B54-848B-21BA899EAAD6|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||SQU/ML|||IU/G|NOT DONE||N|NA|N|2||58||CONTINUATION TREATMENT|1963-01-17||1969-09-06|||1964-12-30||1968-07-25
TRIAL STUDY 134XCP|RP|460486B3-B7C8-4B54-848B-21BA899EAAD6|1||||||RASHIND|RASH INDICATOR||||SCM|||UMOL/MOL|NOT DONE||N|NA|N|3||39||BLINDED TREATMENT|1964-11-19||1970-07-05|||1962-12-29||1964-04-20
TRIAL STUDY 134XCP|RP|460486B3-B7C8-4B54-848B-21BA899EAAD6|2||||||ULCERIND|ULCER INDICATOR||||/10^3|||UMOL|NOT DONE||U|U|NA|3||39||OPEN LABEL TREATMENT|1971-01-10||1963-01-25|||1970-02-09||1967-09-07
TRIAL STUDY 134XCP|RP|460486B3-B7C8-4B54-848B-21BA899EAAD6|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||VIAL|||CS|NOT DONE||NA|NA|U|4||88||WASHOUT|1963-05-24||1967-06-10|||1970-08-29||1964-05-03
TRIAL STUDY 134XCP|RP|460486B3-B7C8-4B54-848B-21BA899EAAD6|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||KCAL/DAY|||GBQ/G|NOT DONE||N|NA|U|4||88||BLINDED TREATMENT|1960-03-02||1965-10-07|||1960-07-08||1969-07-04
TRIAL STUDY 134XCP|RP|460486B3-B7C8-4B54-848B-21BA899EAAD6|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||CIGAR|||UG/MOL|NOT DONE||U|Y|Y|5||7||CONTINUATION TREATMENT|1972-07-12||1960-06-18|||1972-05-03||1971-12-22
TRIAL STUDY 134XCP|RP|460486B3-B7C8-4B54-848B-21BA899EAAD6|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||DRAM|||SCM|NOT DONE||N|U|U|5||7||OBSERVATION|1962-09-27||1970-02-13|||1972-10-05||1963-03-14
TRIAL STUDY 134XCP|RP|A068436F-E26E-44C5-8959-0BCBA28832D1|1||||||PREGIND|PREGNANT INDICATOR||||10^9 ORGANISMS|||CM H2O|NOT DONE||U|NA|N|1||38||CONTINUATION TREATMENT|1961-09-20||1963-05-29|||1967-01-12||1965-09-26
TRIAL STUDY 134XCP|RP|A068436F-E26E-44C5-8959-0BCBA28832D1|2||||||ULCERIND|ULCER INDICATOR||||/2500 WBC|||NMOL/L/MIN|NOT DONE||Y|NA|Y|1||38||BLINDED TREATMENT|1963-12-26||1965-05-10|||1967-10-16||1969-05-01
TRIAL STUDY 134XCP|RP|A068436F-E26E-44C5-8959-0BCBA28832D1|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||AGU/ML|||10^9/G|NOT DONE||U|U|Y|2||58||TREATMENT|1968-07-12||1972-09-12|||1972-12-07||1967-09-22
TRIAL STUDY 134XCP|RP|A068436F-E26E-44C5-8959-0BCBA28832D1|2||||||ABORTN|NUMBER OF ABORTIONS||||BOWL|||PRESSOR UNITS|NOT DONE||NA|Y|N|2||58||LONG-TERM FOLLOW-UP|1965-11-24||1964-08-19|||1965-02-26||1972-04-09
TRIAL STUDY 134XCP|RP|A068436F-E26E-44C5-8959-0BCBA28832D1|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ML/KG|||MG/ANIMAL|NOT DONE||NA|NA|NA|3||39||LONG-TERM FOLLOW-UP|1963-02-20||1973-04-26|||1962-06-15||1968-04-10
TRIAL STUDY 134XCP|RP|A068436F-E26E-44C5-8959-0BCBA28832D1|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MEQ/DL|||GBQ/UG|NOT DONE||Y|NA|NA|3||39||RUN-IN|1961-04-06||1960-07-27|||1962-01-28||1967-01-18
TRIAL STUDY 134XCP|RP|A068436F-E26E-44C5-8959-0BCBA28832D1|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||SCM|||FOZ_BR|NOT DONE||U|Y|N|4||88||OBSERVATION|1963-01-10||1965-09-12|||1962-04-18||1963-06-28
TRIAL STUDY 134XCP|RP|A068436F-E26E-44C5-8959-0BCBA28832D1|2||||||PREGST|PREGNANT DURING THE STUDY||||EID 50/DOSE|||COPIES/UL|NOT DONE||Y|N|NA|4||88||OBSERVATION|1966-01-26||1969-11-18|||1961-06-01||1969-09-18
TRIAL STUDY 134XCP|RP|A068436F-E26E-44C5-8959-0BCBA28832D1|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||S/H|||10^5/HPF|NOT DONE||N|Y|U|5||7||OBSERVATION|1972-11-10||1962-08-13|||1961-03-22||1970-07-27
TRIAL STUDY 134XCP|RP|A068436F-E26E-44C5-8959-0BCBA28832D1|2||||||EDEMAIND|EDEMA INDICATOR||||CCID 50/DOSE|||KA_U/DL|NOT DONE||U|U|U|5||7||INDUCTION TREATMENT|1972-01-23||1965-05-06|||1963-03-24||1963-04-27
TRIAL STUDY 134XCP|RP|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|1||||||PUSTIND|PUSTULE INDICATOR||||UU/L|||AG|NOT DONE||U|NA|NA|1||38||RUN-IN|1968-07-25||1965-09-07|||1970-02-09||1962-10-06
TRIAL STUDY 134XCP|RP|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|2||||||PUSTIND|PUSTULE INDICATOR||||STEPS/MIN|||/KG|NOT DONE||N|N|U|1||38||LONG-TERM FOLLOW-UP|1962-01-02||1967-01-28|||1962-07-21||1967-05-13
TRIAL STUDY 134XCP|RP|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||EQ|||L/H/M2|NOT DONE||N|U|NA|2||58||SCREENING|1963-07-19||1971-08-19|||1962-02-20||1961-11-20
TRIAL STUDY 134XCP|RP|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||IU/MMOL|||/VF|NOT DONE||NA|Y|Y|2||58||TREATMENT|1960-03-15||1972-08-13|||1963-10-02||1961-06-18
TRIAL STUDY 134XCP|RP|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|1||||||ULCERIND|ULCER INDICATOR||||H/WK|||CD/M2|NOT DONE||U|U|NA|3||39||OPEN LABEL TREATMENT|1965-02-01||1970-08-16|||1965-01-31||1960-06-09
TRIAL STUDY 134XCP|RP|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MMOL/KG|||DRUM|NOT DONE||NA|Y|NA|3||39||WASHOUT|1965-09-04||1960-06-05|||1967-08-04||1963-08-17
TRIAL STUDY 134XCP|RP|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|1||||||BRTHN|NUMBER OF BIRTHS||||CY/CM|||MS2|NOT DONE||N|Y|N|4||88||WASHOUT|1969-11-21||1967-09-02|||1967-10-22||1972-09-26
TRIAL STUDY 134XCP|RP|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|2||||||MENOSTAT|MENOPAUSE STATUS||||HR/DAY|||EID 50/ML|NOT DONE||U|Y|NA|4||88||FOLLOW-UP|1969-11-24||1963-01-14|||1969-05-16||1971-04-29
TRIAL STUDY 134XCP|RP|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||GRAVITATIONAL UNIT|||UMOL/MG/MIN|NOT DONE||N|Y|U|5||7||TREATMENT|1973-02-17||1969-11-18|||1973-03-01||1969-01-04
TRIAL STUDY 134XCP|RP|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|2||||||MENARAGE|MENARCHE AGE||||SV|||GBQ/G|NOT DONE||Y|NA|U|5||7||SCREENING|1963-08-12||1973-06-12|||1972-12-12||1970-04-03
TRIAL STUDY 134XCP|RP|E065D436-92D2-453F-86A7-27F70FE1FD03|1||||||ABORTN|NUMBER OF ABORTIONS||||IU/DAY|||CM2|NOT DONE||U|NA|NA|1||38||TREATMENT|1967-06-25||1968-04-20|||1967-04-04||1966-04-14
TRIAL STUDY 134XCP|RP|E065D436-92D2-453F-86A7-27F70FE1FD03|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||NGEQ/L|||MV*MIN|NOT DONE||U|NA|Y|1||38||FOLLOW-UP|1969-12-17||1969-12-30|||1972-06-07||1960-10-25
TRIAL STUDY 134XCP|RP|E065D436-92D2-453F-86A7-27F70FE1FD03|1||||||GRAVIND|GRAVIDA INDICATOR||||UV*SEC|||PMOL/10^9 CELLS|NOT DONE||NA|U|U|2||58||BLINDED TREATMENT|1965-02-11||1966-09-01|||1963-01-30||1972-08-24
TRIAL STUDY 134XCP|RP|E065D436-92D2-453F-86A7-27F70FE1FD03|2||||||ERYTHIND|ERYTHEMA INDICATOR||||NG/L|||CMOL/L|NOT DONE||U|NA|NA|2||58||OBSERVATION|1972-07-24||1961-08-02|||1962-12-29||1960-04-06
TRIAL STUDY 134XCP|RP|E065D436-92D2-453F-86A7-27F70FE1FD03|1||||||PEELIND|PEELING INDICATOR||||BEAM BREAKS|||U/KG/MIN|NOT DONE||Y|N|N|3||39||BASELINE|1970-01-09||1964-05-13|||1970-08-22||1973-06-03
TRIAL STUDY 134XCP|RP|E065D436-92D2-453F-86A7-27F70FE1FD03|2||||||INABOIND|INDUCED ABORTION INDICATOR||||KUSP|||G/KG|NOT DONE||U|U|N|3||39||FOLLOW-UP|1965-10-03||1963-05-14|||1971-03-31||1965-07-04
TRIAL STUDY 134XCP|RP|E065D436-92D2-453F-86A7-27F70FE1FD03|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||NFIU|||ATM|NOT DONE||NA|N|N|4||88||SCREENING|1962-05-22||1967-03-16|||1971-12-17||1964-04-21
TRIAL STUDY 134XCP|RP|E065D436-92D2-453F-86A7-27F70FE1FD03|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||CD*S/M2|||TUBERCULIN UNIT/ML|NOT DONE||U|U|Y|4||88||OBSERVATION|1963-08-26||1971-09-02|||1962-09-22||1967-07-16
TRIAL STUDY 134XCP|RP|E065D436-92D2-453F-86A7-27F70FE1FD03|1||||||TNDRIND|TENDERNESS INDICATOR||||UG/KG/H|||MG/G/MIN|NOT DONE||U|NA|NA|5||7||FOLLOW-UP|1967-10-22||1965-03-08|||1970-05-28||1963-05-23
TRIAL STUDY 134XCP|RP|E065D436-92D2-453F-86A7-27F70FE1FD03|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||ML/KG|||G/G|NOT DONE||NA|U|Y|5||7||FOLLOW-UP|1970-11-21||1966-10-24|||1971-03-16||1963-12-27
TRIAL STUDY 134XCP|RP|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|1||||||INTP|INTERPRETATION||||MPH|||USIEMENS|NOT DONE||NA|N|N|1||38||FOLLOW-UP|1966-06-01||1970-12-24|||1966-12-16||1970-06-21
TRIAL STUDY 134XCP|RP|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||APS U|||CMH2O*S2/ML|NOT DONE||U|NA|Y|1||38||BLINDED TREATMENT|1963-12-11||1970-03-02|||1964-01-06||1969-02-14
TRIAL STUDY 134XCP|RP|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|1||||||INTP|INTERPRETATION||||CI/G|||BQ/UG|NOT DONE||N|NA|Y|2||58||LONG-TERM FOLLOW-UP|1967-08-07||1961-02-27|||1968-11-21||1962-10-28
TRIAL STUDY 134XCP|RP|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||STEPS/MIN|||CI/ML|NOT DONE||NA|N|U|2||58||LONG-TERM FOLLOW-UP|1967-03-16||1967-06-09|||1968-01-21||1961-08-02
TRIAL STUDY 134XCP|RP|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||CI/UG|||KUSP|NOT DONE||U|N|NA|3||39||OBSERVATION|1964-03-28||1967-01-11|||1965-04-01||1968-04-28
TRIAL STUDY 134XCP|RP|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MG/ML/DAY|||IU/DAY|NOT DONE||NA|Y|Y|3||39||BASELINE|1967-09-20||1962-03-06|||1970-08-24||1965-08-31
TRIAL STUDY 134XCP|RP|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|1||||||THICK|THICKNESS||||YEARS|||PPB|NOT DONE||NA|N|U|4||88||SCREENING|1960-04-09||1962-10-30|||1966-01-30||1971-06-12
TRIAL STUDY 134XCP|RP|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|2||||||BLISTIND|BLISTERING INDICATOR||||BQ|||KPA/L/SEC|NOT DONE||U|Y|NA|4||88||BASELINE|1972-09-29||1965-03-16|||1969-11-05||1961-09-28
TRIAL STUDY 134XCP|RP|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MEQ/G|||COULOMB|NOT DONE||N|U|Y|5||7||LONG-TERM FOLLOW-UP|1966-05-31||1962-02-26|||1967-01-30||1960-09-09
TRIAL STUDY 134XCP|RP|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MCI/L|||MG/KG|NOT DONE||Y|N|NA|5||7||BASELINE|1961-01-17||1967-08-18|||1967-02-23||1969-10-15
TRIAL STUDY 134XCP|RP|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/DOSE|||EVENTS|NOT DONE||U|U|Y|1||38||BLINDED TREATMENT|1963-10-10||1966-02-12|||1970-02-24||1967-12-21
TRIAL STUDY 134XCP|RP|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||DPM/0.5 ML|||BQ/KG|NOT DONE||NA|NA|NA|1||38||BLINDED TREATMENT|1972-05-13||1967-03-02|||1964-01-29||1972-08-28
TRIAL STUDY 134XCP|RP|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||%(W/W)|||TAMPON|NOT DONE||Y|N|Y|2||58||OPEN LABEL TREATMENT|1966-05-04||1968-05-02|||1972-08-26||1969-06-28
TRIAL STUDY 134XCP|RP|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|2||||||PRGENDTC|DATE PREGNANCY ENDED||||MIN|||10^4/L|NOT DONE||Y|U|NA|2||58||BASELINE|1963-11-19||1964-08-20|||1967-10-06||1971-05-08
TRIAL STUDY 134XCP|RP|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||YEARS|||UGEQ|NOT DONE||NA|N|NA|3||39||OPEN LABEL TREATMENT|1968-01-27||1966-06-06|||1963-08-13||1961-09-12
TRIAL STUDY 134XCP|RP|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UMOL/DAY|||PMOL/DL|NOT DONE||NA|U|U|3||39||BLINDED TREATMENT|1970-07-11||1966-01-05|||1970-10-06||1970-11-01
TRIAL STUDY 134XCP|RP|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||PPTR|||VIAL|NOT DONE||NA|U|U|4||88||OBSERVATION|1968-05-08||1963-01-22|||1963-03-04||1970-12-17
TRIAL STUDY 134XCP|RP|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|2||||||DSCHGIND|DISCHARGE INDICATOR||||HPA|||/2000 RBC|NOT DONE||N|Y|NA|4||88||BASELINE|1962-05-14||1962-08-05|||1972-02-12||1963-08-10
TRIAL STUDY 134XCP|RP|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|1||||||RASHIND|RASH INDICATOR||||DNA COPIES/ML|||MM/MIN|NOT DONE||U|Y|Y|5||7||INDUCTION TREATMENT|1961-07-24||1969-10-08|||1965-07-07||1964-04-28
TRIAL STUDY 134XCP|RP|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||BQ/ML|||ATM|NOT DONE||NA|NA|Y|5||7||FOLLOW-UP|1963-05-07||1967-01-30|||1965-11-13||1967-05-25
TRIAL STUDY 134XCP|RP|D108D040-7177-4A14-8CA7-748D59DC5F8B|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||CCID 50/DOSE|||FT|NOT DONE||NA|Y|NA|1||38||WASHOUT|1968-12-18||1961-09-01|||1963-06-27||1971-02-11
TRIAL STUDY 134XCP|RP|D108D040-7177-4A14-8CA7-748D59DC5F8B|2||||||GRAVIND|GRAVIDA INDICATOR||||NM|||NEBULE|NOT DONE||Y|NA|N|1||38||SCREENING|1970-08-19||1964-11-06|||1968-06-24||1962-04-14
TRIAL STUDY 134XCP|RP|D108D040-7177-4A14-8CA7-748D59DC5F8B|1||||||ABORTN|NUMBER OF ABORTIONS||||PMOL/10^10 CELLS|||10^9 CFU|NOT DONE||Y|NA|NA|2||58||WASHOUT|1971-10-31||1961-03-29|||1966-12-30||1969-09-11
TRIAL STUDY 134XCP|RP|D108D040-7177-4A14-8CA7-748D59DC5F8B|2||||||PEELIND|PEELING INDICATOR||||UKAT|||DAGU/ML|NOT DONE||N|NA|Y|2||58||BASELINE|1972-11-20||1960-09-12|||1969-03-23||1969-06-10
TRIAL STUDY 134XCP|RP|D108D040-7177-4A14-8CA7-748D59DC5F8B|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||CI|||NG|NOT DONE||U|N|N|3||39||FOLLOW-UP|1961-11-16||1969-04-30|||1971-10-18||1965-09-23
TRIAL STUDY 134XCP|RP|D108D040-7177-4A14-8CA7-748D59DC5F8B|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||BAG|||/WK|NOT DONE||N|Y|NA|3||39||FOLLOW-UP|1970-05-22||1970-11-05|||1971-11-17||1967-12-08
TRIAL STUDY 134XCP|RP|D108D040-7177-4A14-8CA7-748D59DC5F8B|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||EID 50/ML|||MMOL/KG|NOT DONE||N|N|NA|4||88||BLINDED TREATMENT|1960-11-25||1966-12-22|||1961-06-29||1966-09-05
TRIAL STUDY 134XCP|RP|D108D040-7177-4A14-8CA7-748D59DC5F8B|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||CAN|||KBQ|NOT DONE||NA|Y|N|4||88||LONG-TERM FOLLOW-UP|1971-02-01||1973-07-13|||1963-05-02||1965-04-10
TRIAL STUDY 134XCP|RP|D108D040-7177-4A14-8CA7-748D59DC5F8B|1||||||PREGST|PREGNANT DURING THE STUDY||||IU/DAY|||KG/CM|NOT DONE||U|NA|N|5||7||BASELINE|1960-02-21||1973-06-06|||1969-03-26||1964-12-05
TRIAL STUDY 134XCP|RP|D108D040-7177-4A14-8CA7-748D59DC5F8B|2||||||PREGST|PREGNANT DURING THE STUDY||||GPL U/ML|||UCI/L|NOT DONE||N|Y|U|5||7||WASHOUT|1970-12-20||1968-01-29|||1965-06-06||1968-09-20
TRIAL STUDY 134XCP|RP|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|1||||||MENOSTAT|MENOPAUSE STATUS||||10^6/HPF|||NMOL/ML/MIN|NOT DONE||NA|N|U|1||38||SCREENING|1960-11-22||1969-06-15|||1965-06-15||1967-04-13
TRIAL STUDY 134XCP|RP|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|2||||||ULCERIND|ULCER INDICATOR||||/100 HPFS|||BEAM BREAKS|NOT DONE||N|N|NA|1||38||SCREENING|1971-02-25||1967-09-05|||1971-01-11||1964-07-20
TRIAL STUDY 134XCP|RP|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||EJACULATE U|||10^4/HPF|NOT DONE||U|N|NA|2||58||BASELINE|1960-05-14||1962-12-23|||1972-04-18||1962-08-01
TRIAL STUDY 134XCP|RP|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||SACHET|||UMOL/MG/MIN|NOT DONE||NA|Y|N|2||58||BASELINE|1971-08-19||1960-10-14|||1965-05-04||1972-09-04
TRIAL STUDY 134XCP|RP|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||UEQ|||BQ/MG|NOT DONE||N|Y|U|3||39||BASELINE|1967-09-30||1968-03-11|||1970-08-17||1961-04-28
TRIAL STUDY 134XCP|RP|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||TUBE|||U/MMOL|NOT DONE||NA|NA|N|3||39||TREATMENT|1962-07-14||1972-07-01|||1961-06-27||1964-12-04
TRIAL STUDY 134XCP|RP|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MGEQ|||ML/CM|NOT DONE||Y|N|U|4||88||LONG-TERM FOLLOW-UP|1967-05-15||1966-05-26|||1967-01-18||1961-03-19
TRIAL STUDY 134XCP|RP|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|2||||||ERYTHIND|ERYTHEMA INDICATOR||||NG/DAY|||MM/MIN|NOT DONE||U|NA|Y|4||88||RUN-IN|1964-07-30||1961-03-25|||1969-03-27||1970-01-30
TRIAL STUDY 134XCP|RP|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|1||||||BCMETHOD|BIRTH CONTROL METHOD||||MV2/HZ|||LM|NOT DONE||NA|NA|Y|5||7||CONTINUATION TREATMENT|1971-11-04||1968-04-15|||1964-11-28||1965-06-25
TRIAL STUDY 134XCP|RP|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||PIXELS/CM|||VP/ML|NOT DONE||U|U|U|5||7||WASHOUT|1966-12-14||1967-08-25|||1965-03-11||1963-06-22
TRIAL STUDY 134XCP|RP|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||IMPLANT|||DEG/MM|NOT DONE||N|U|NA|1||38||INDUCTION TREATMENT|1964-07-20||1966-04-21|||1971-02-24||1968-10-16
TRIAL STUDY 134XCP|RP|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^4/L|||UMOL/L/MIN|NOT DONE||U|N|NA|1||38||SCREENING|1962-12-31||1965-08-08|||1964-04-12||1964-09-22
TRIAL STUDY 134XCP|RP|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||FOZ_US|||G/CAGE/DAY|NOT DONE||Y|U|Y|2||58||CONTINUATION TREATMENT|1966-05-22||1964-08-08|||1965-12-20||1961-08-11
TRIAL STUDY 134XCP|RP|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|2||||||PEELIND|PEELING INDICATOR||||FFU|||FMOL/L/SEC|NOT DONE||Y|NA|N|2||58||BASELINE|1972-05-19||1965-09-01|||1966-10-23||1971-01-19
TRIAL STUDY 134XCP|RP|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|1||||||MENFDUR|MENSES FLOW DURATION||||CMOL|||JDF UNIT|NOT DONE||Y|NA|N|3||39||WASHOUT|1964-04-09||1964-09-01|||1971-02-24||1972-06-19
TRIAL STUDY 134XCP|RP|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MIU/L|||CI/L|NOT DONE||Y|N|NA|3||39||TREATMENT|1966-05-13||1962-03-19|||1965-05-31||1963-03-01
TRIAL STUDY 134XCP|RP|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||OI50|||MG/KG/H|NOT DONE||N|Y|N|4||88||CONTINUATION TREATMENT|1969-07-23||1969-03-30|||1971-03-23||1967-10-22
TRIAL STUDY 134XCP|RP|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|2||||||PREGNN|NUMBER OF PREGNANCIES||||10^3 ORGANISMS/ML|||ML/MIN|NOT DONE||U|Y|U|4||88||OBSERVATION|1972-10-05||1969-03-07|||1962-04-29||1961-02-14
TRIAL STUDY 134XCP|RP|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|1||||||BCMETHOD|BIRTH CONTROL METHOD||||MS/MMHG|||ELISA UNIT/ML|NOT DONE||Y|Y|Y|5||7||FOLLOW-UP|1963-05-28||1967-08-03|||1972-08-26||1963-11-13
TRIAL STUDY 134XCP|RP|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||PPTH|||LOG10 TCID 50/ML|NOT DONE||Y|Y|NA|5||7||BLINDED TREATMENT|1969-11-07||1960-09-15|||1967-03-19||1960-02-25
TRIAL STUDY 134XCP|RP|580CCA66-3D51-4A5C-80E1-361A90369055|1||||||MASSIND|MASS INDICATOR||||DEG2|||PMOL/DAY|NOT DONE||N|N|Y|1||38||LONG-TERM FOLLOW-UP|1969-04-13||1967-08-20|||1963-04-18||1970-12-26
TRIAL STUDY 134XCP|RP|580CCA66-3D51-4A5C-80E1-361A90369055|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ML/BEAT|||MG/M2/MIN|NOT DONE||NA|Y|U|1||38||BLINDED TREATMENT|1964-08-29||1970-07-21|||1963-04-19||1970-01-26
TRIAL STUDY 134XCP|RP|580CCA66-3D51-4A5C-80E1-361A90369055|1||||||RASHIND|RASH INDICATOR||||G/G/DAY|||10^6 CFU/G|NOT DONE||NA|Y|N|2||58||OBSERVATION|1966-05-09||1968-06-19|||1964-02-12||1969-02-07
TRIAL STUDY 134XCP|RP|580CCA66-3D51-4A5C-80E1-361A90369055|2||||||PRGENDTC|DATE PREGNANCY ENDED||||CM H2O|||NKAT/L|NOT DONE||Y|NA|U|2||58||SCREENING|1970-09-07||1966-02-22|||1973-06-11||1962-08-18
TRIAL STUDY 134XCP|RP|580CCA66-3D51-4A5C-80E1-361A90369055|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||UEQ/L|||CM/MIN|NOT DONE||U|Y|U|3||39||SCREENING|1970-04-29||1966-06-15|||1964-12-25||1964-02-10
TRIAL STUDY 134XCP|RP|580CCA66-3D51-4A5C-80E1-361A90369055|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||DAYS/MONTH|||L/H|NOT DONE||Y|NA|U|3||39||LONG-TERM FOLLOW-UP|1971-02-24||1972-10-12|||1964-07-27||1971-11-12
TRIAL STUDY 134XCP|RP|580CCA66-3D51-4A5C-80E1-361A90369055|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MG/KG/DOSE|||AMOL|NOT DONE||N|Y|U|4||88||OBSERVATION|1966-03-24||1972-05-22|||1969-03-28||1971-07-08
TRIAL STUDY 134XCP|RP|580CCA66-3D51-4A5C-80E1-361A90369055|2||||||MASSIND|MASS INDICATOR||||DAGU/ML|||/MIN|NOT DONE||U|NA|U|4||88||BASELINE|1964-12-25||1962-09-03|||1972-04-15||1972-03-05
TRIAL STUDY 134XCP|RP|580CCA66-3D51-4A5C-80E1-361A90369055|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||KIU|||CI|NOT DONE||NA|U|U|5||7||FOLLOW-UP|1967-12-29||1965-10-17|||1970-05-21||1971-03-25
TRIAL STUDY 134XCP|RP|580CCA66-3D51-4A5C-80E1-361A90369055|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||DMOL|||ML/H|NOT DONE||NA|Y|Y|5||7||WASHOUT|1962-02-08||1963-07-02|||1970-10-03||1961-06-26
TRIAL STUDY 134XCP|RP|DAB276EB-3581-4C20-88AC-5A3D267E54D8|1||||||ULCERIND|ULCER INDICATOR||||KM|||UL/DOSE|NOT DONE||N|Y|NA|1||38||WASHOUT|1969-03-21||1965-07-22|||1961-03-06||1973-06-15
TRIAL STUDY 134XCP|RP|DAB276EB-3581-4C20-88AC-5A3D267E54D8|2||||||PUSTIND|PUSTULE INDICATOR||||UM/S|||U/L|NOT DONE||NA|Y|U|1||38||SCREENING|1972-10-10||1965-12-03|||1966-04-24||1969-03-27
TRIAL STUDY 134XCP|RP|DAB276EB-3581-4C20-88AC-5A3D267E54D8|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||CI/KG|||KHZ|NOT DONE||Y|NA|N|2||58||BASELINE|1973-07-03||1969-11-04|||1960-07-05||1971-05-26
TRIAL STUDY 134XCP|RP|DAB276EB-3581-4C20-88AC-5A3D267E54D8|2||||||DSCHGIND|DISCHARGE INDICATOR||||PG/L|||IU|NOT DONE||N|U|Y|2||58||SCREENING|1970-01-07||1963-01-12|||1968-04-27||1963-09-13
TRIAL STUDY 134XCP|RP|DAB276EB-3581-4C20-88AC-5A3D267E54D8|1||||||RASHIND|RASH INDICATOR||||FARAD|||VOXEL|NOT DONE||NA|NA|Y|3||39||OPEN LABEL TREATMENT|1961-09-05||1964-09-24|||1966-01-21||1971-10-19
TRIAL STUDY 134XCP|RP|DAB276EB-3581-4C20-88AC-5A3D267E54D8|2||||||INTP|INTERPRETATION||||10^6/L|||UCI|NOT DONE||Y|Y|Y|3||39||FOLLOW-UP|1969-11-13||1965-04-09|||1960-07-21||1970-07-06
TRIAL STUDY 134XCP|RP|DAB276EB-3581-4C20-88AC-5A3D267E54D8|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||M/SEC|||MG/DAY|NOT DONE||NA|U|Y|4||88||OPEN LABEL TREATMENT|1962-10-23||1963-04-30|||1961-04-22||1968-09-01
TRIAL STUDY 134XCP|RP|DAB276EB-3581-4C20-88AC-5A3D267E54D8|2||||||TNDRIND|TENDERNESS INDICATOR||||MBQ/UL|||MKAT|NOT DONE||U|U|NA|4||88||WASHOUT|1970-12-16||1966-09-11|||1970-06-04||1961-02-27
TRIAL STUDY 134XCP|RP|DAB276EB-3581-4C20-88AC-5A3D267E54D8|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||ML/(MIN*100ML)|||PMOL/10^10 CELLS|NOT DONE||NA|N|Y|5||7||OPEN LABEL TREATMENT|1969-10-17||1966-02-01|||1973-04-05||1966-02-02
TRIAL STUDY 134XCP|RP|DAB276EB-3581-4C20-88AC-5A3D267E54D8|2||||||MENOAGE|MENOPAUSE AGE||||CMH2O*S2/ML|||FT3|NOT DONE||NA|U|Y|5||7||RUN-IN|1960-09-19||1966-05-07|||1965-09-08||1966-02-15
TRIAL STUDY 134XCP|RP|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|1||||||MENFDUR|MENSES FLOW DURATION||||SQU/ML|||CONTAINER|NOT DONE||NA|NA|U|1||38||LONG-TERM FOLLOW-UP|1968-04-03||1970-07-18|||1960-10-03||1969-07-22
TRIAL STUDY 134XCP|RP|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||HZ/S|||UGEQ|NOT DONE||N|NA|U|1||38||OPEN LABEL TREATMENT|1961-08-20||1962-10-03|||1961-03-22||1961-05-08
TRIAL STUDY 134XCP|RP|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|1||||||FUNDHT|FUNDAL HEIGHT||||CI/L|||PT_BR|NOT DONE||U|U|U|2||58||OBSERVATION|1968-07-04||1970-06-10|||1968-09-13||1962-12-27
TRIAL STUDY 134XCP|RP|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||KS|||DEG/MM|NOT DONE||N|NA|NA|2||58||OPEN LABEL TREATMENT|1971-01-01||1970-05-02|||1961-03-26||1965-08-06
TRIAL STUDY 134XCP|RP|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|1||||||INTP|INTERPRETATION||||U/G/DAY|||L/DAY|NOT DONE||Y|N|NA|3||39||OBSERVATION|1967-12-31||1967-03-02|||1971-08-19||1973-06-22
TRIAL STUDY 134XCP|RP|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||FARAD|||BEAM BREAKS|NOT DONE||U|U|U|3||39||LONG-TERM FOLLOW-UP|1960-01-16||1969-06-11|||1964-02-08||1963-10-21
TRIAL STUDY 134XCP|RP|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||MOL|||10^10/L|NOT DONE||Y|NA|U|4||88||OBSERVATION|1965-07-04||1968-10-12|||1961-10-29||1965-02-12
TRIAL STUDY 134XCP|RP|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||DPM/MG|||NCI|NOT DONE||N|NA|U|4||88||OBSERVATION|1971-05-02||1964-05-11|||1972-01-04||1966-09-26
TRIAL STUDY 134XCP|RP|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||LM|||PRESSOR UNITS|NOT DONE||U|NA|NA|5||7||BLINDED TREATMENT|1964-02-05||1961-11-14|||1969-09-06||1970-02-15
TRIAL STUDY 134XCP|RP|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||MMOL2/L2|||NEEDLE GAUGE|NOT DONE||NA|Y|Y|5||7||BLINDED TREATMENT|1972-05-01||1968-08-18|||1969-12-18||1966-09-11
TRIAL STUDY 134XCP|RP|5B703A43-A280-4D6A-AC40-FF5187521DB2|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||/LPF|||G/KG/DAY|NOT DONE||N|NA|U|1||38||TREATMENT|1964-08-04||1963-02-15|||1969-07-05||1972-12-16
TRIAL STUDY 134XCP|RP|5B703A43-A280-4D6A-AC40-FF5187521DB2|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||UG/M2/MIN|||GRAVITATIONAL UNIT|NOT DONE||NA|U|N|1||38||TREATMENT|1964-12-08||1964-05-05|||1972-02-20||1972-01-09
TRIAL STUDY 134XCP|RP|5B703A43-A280-4D6A-AC40-FF5187521DB2|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||L/MIN|||USEC|NOT DONE||U|NA|Y|2||58||RUN-IN|1965-01-12||1968-10-03|||1969-01-02||1968-02-28
TRIAL STUDY 134XCP|RP|5B703A43-A280-4D6A-AC40-FF5187521DB2|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||APPLICATION|||UG/G/DAY|NOT DONE||N|Y|NA|2||58||SCREENING|1968-06-13||1962-11-29|||1968-12-23||1967-01-31
TRIAL STUDY 134XCP|RP|5B703A43-A280-4D6A-AC40-FF5187521DB2|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UV2|||AMPULE|NOT DONE||Y|N|N|3||39||SCREENING|1964-09-06||1965-05-12|||1968-01-20||1967-12-05
TRIAL STUDY 134XCP|RP|5B703A43-A280-4D6A-AC40-FF5187521DB2|2||||||BLISTIND|BLISTERING INDICATOR||||POINT|||ML/M2/H|NOT DONE||N|NA|N|3||39||OBSERVATION|1970-10-03||1964-08-01|||1973-04-19||1973-04-13
TRIAL STUDY 134XCP|RP|5B703A43-A280-4D6A-AC40-FF5187521DB2|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||TRANSDUCING UNIT/ML|||V/SEC|NOT DONE||NA|Y|Y|4||88||LONG-TERM FOLLOW-UP|1966-05-29||1967-11-18|||1971-06-15||1971-10-12
TRIAL STUDY 134XCP|RP|5B703A43-A280-4D6A-AC40-FF5187521DB2|2||||||PREGNN|NUMBER OF PREGNANCIES||||UL/ML|||MEQ/DAY|NOT DONE||U|N|U|4||88||OBSERVATION|1963-02-14||1971-09-29|||1972-04-16||1961-11-21
TRIAL STUDY 134XCP|RP|5B703A43-A280-4D6A-AC40-FF5187521DB2|1||||||MENOSTAT|MENOPAUSE STATUS||||ML/DL|||ML/CM|NOT DONE||U|Y|Y|5||7||LONG-TERM FOLLOW-UP|1962-05-31||1969-09-27|||1968-05-20||1971-11-06
TRIAL STUDY 134XCP|RP|5B703A43-A280-4D6A-AC40-FF5187521DB2|2||||||DLVRMODE|MODE OF DELIVERY||||CAPFUL|||NMOL BCE/MMOL|NOT DONE||N|U|N|5||7||CONTINUATION TREATMENT|1960-08-31||1965-08-05|||1971-12-18||1968-12-04
TRIAL STUDY 134XCP|RP|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||U/M2/DAY|||K|NOT DONE||N|N|U|1||38||CONTINUATION TREATMENT|1965-01-15||1972-10-29|||1963-08-15||1968-10-17
TRIAL STUDY 134XCP|RP|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MMOL/S|||ML/KG/MIN|NOT DONE||NA|NA|Y|1||38||SCREENING|1964-09-03||1967-05-10|||1960-01-23||1960-02-09
TRIAL STUDY 134XCP|RP|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UMOL/H/MMOL|||GPELISA UNIT/ML|NOT DONE||Y|U|Y|2||58||LONG-TERM FOLLOW-UP|1962-03-14||1973-08-05|||1972-09-17||1973-04-12
TRIAL STUDY 134XCP|RP|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|2||||||MENOAGE|MENOPAUSE AGE||||MASK|||ML/CM|NOT DONE||NA|NA|Y|2||58||BASELINE|1971-01-17||1960-12-15|||1964-08-19||1967-02-14
TRIAL STUDY 134XCP|RP|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|1||||||PREGST|PREGNANT DURING THE STUDY||||G/U|||MS/MMHG|NOT DONE||U|U|Y|3||39||BLINDED TREATMENT|1968-11-08||1961-05-09|||1968-06-21||1966-06-10
TRIAL STUDY 134XCP|RP|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||GPL U/ML|||DEG/S|NOT DONE||Y|NA|N|3||39||BLINDED TREATMENT|1963-08-23||1966-04-06|||1964-03-07||1969-09-16
TRIAL STUDY 134XCP|RP|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||HEP|||10^3 ORGANISMS|NOT DONE||Y|NA|Y|4||88||TREATMENT|1966-12-06||1972-07-02|||1962-03-13||1967-11-23
TRIAL STUDY 134XCP|RP|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|2||||||TNDRIND|TENDERNESS INDICATOR||||1/(S*KPA)|||NEEDLE GAUGE|NOT DONE||U|Y|Y|4||88||OBSERVATION|1962-10-08||1970-01-05|||1961-06-21||1965-11-02
TRIAL STUDY 134XCP|RP|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|1||||||PREGNN|NUMBER OF PREGNANCIES||||USEC|||CUP|NOT DONE||Y|Y|NA|5||7||RUN-IN|1971-10-01||1970-08-24|||1970-12-18||1960-12-20
TRIAL STUDY 134XCP|RP|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||MG/L FEU|||ML/100G/MIN|NOT DONE||N|Y|N|5||7||INDUCTION TREATMENT|1966-09-14||1973-04-06|||1971-12-16||1966-01-16
TRIAL STUDY 134XCP|RP|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|1||||||PREGST|PREGNANT DURING THE STUDY||||FEU|||10^9/G|NOT DONE||NA|N|NA|1||38||RUN-IN|1960-03-29||1964-02-02|||1968-02-11||1967-09-10
TRIAL STUDY 134XCP|RP|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||GRAIN|||CYCLE/MIN|NOT DONE||Y|NA|Y|1||38||WASHOUT|1968-02-01||1960-07-02|||1971-10-07||1973-02-03
TRIAL STUDY 134XCP|RP|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|1||||||MASSIND|MASS INDICATOR||||L/DAY|||MET*MIN|NOT DONE||NA|N|U|2||58||OPEN LABEL TREATMENT|1972-09-03||1968-10-26|||1962-05-03||1972-04-17
TRIAL STUDY 134XCP|RP|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||KEV|||G/KG|NOT DONE||Y|Y|N|2||58||INDUCTION TREATMENT|1965-11-23||1970-12-08|||1960-05-09||1962-05-13
TRIAL STUDY 134XCP|RP|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MG/CM2|||ANSON U|NOT DONE||NA|Y|NA|3||39||OBSERVATION|1960-11-06||1962-09-18|||1962-01-15||1965-09-19
TRIAL STUDY 134XCP|RP|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||TCID 50/DOSE|||TRACE|NOT DONE||NA|NA|U|3||39||LONG-TERM FOLLOW-UP|1966-10-04||1964-12-31|||1966-11-03||1964-08-14
TRIAL STUDY 134XCP|RP|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||DIOPTER|||C|NOT DONE||U|Y|U|4||88||WASHOUT|1971-09-12||1965-10-05|||1962-04-28||1970-04-05
TRIAL STUDY 134XCP|RP|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UG/ML/H|||QUANTITY SUFFICIENT|NOT DONE||U|U|U|4||88||WASHOUT|1961-10-11||1973-03-13|||1969-08-12||1962-09-11
TRIAL STUDY 134XCP|RP|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|1||||||INABOIND|INDUCED ABORTION INDICATOR||||CI/MG|||MMAL|NOT DONE||U|N|Y|5||7||BASELINE|1969-10-14||1970-12-23|||1972-04-24||1961-12-25
TRIAL STUDY 134XCP|RP|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|2||||||ERYTHIND|ERYTHEMA INDICATOR||||DEG2|||KCAL/DAY|NOT DONE||U|U|NA|5||7||RUN-IN|1960-09-27||1968-05-08|||1964-01-01||1967-12-25
TRIAL STUDY 134XCP|RP|51F3D3C1-3361-499F-B037-CCE8AB989989|1||||||DSCHGIND|DISCHARGE INDICATOR||||/7.5 ML|||NG/MOL|NOT DONE||U|NA|Y|1||38||SCREENING|1970-07-12||1968-10-11|||1971-01-28||1973-04-09
TRIAL STUDY 134XCP|RP|51F3D3C1-3361-499F-B037-CCE8AB989989|2||||||THICK|THICKNESS||||CI|||TESLA|NOT DONE||N|Y|Y|1||38||BASELINE|1972-05-30||1965-10-06|||1964-11-20||1970-07-07
TRIAL STUDY 134XCP|RP|51F3D3C1-3361-499F-B037-CCE8AB989989|1||||||MASSIND|MASS INDICATOR||||U/KG/MIN|||100 IU/ML|NOT DONE||U|Y|N|2||58||RUN-IN|1969-08-29||1966-05-12|||1971-02-24||1966-09-03
TRIAL STUDY 134XCP|RP|51F3D3C1-3361-499F-B037-CCE8AB989989|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||UG/G/DAY|||UG/M2|NOT DONE||N|Y|U|2||58||INDUCTION TREATMENT|1962-09-12||1971-04-07|||1970-01-15||1970-10-11
TRIAL STUDY 134XCP|RP|51F3D3C1-3361-499F-B037-CCE8AB989989|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||BISCUIT|||10^7 CFU/ML|NOT DONE||NA|N|Y|3||39||FOLLOW-UP|1972-09-22||1965-11-28|||1962-02-05||1963-09-04
TRIAL STUDY 134XCP|RP|51F3D3C1-3361-499F-B037-CCE8AB989989|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||10^9 CFU|||V|NOT DONE||N|U|U|3||39||LONG-TERM FOLLOW-UP|1969-06-27||1970-07-12|||1966-10-20||1965-06-09
TRIAL STUDY 134XCP|RP|51F3D3C1-3361-499F-B037-CCE8AB989989|1||||||PRGENDTC|DATE PREGNANCY ENDED||||TUBERCULIN UNIT/ML|||PSI|NOT DONE||U|Y|Y|4||88||OBSERVATION|1963-07-26||1971-08-14|||1966-06-04||1972-08-14
TRIAL STUDY 134XCP|RP|51F3D3C1-3361-499F-B037-CCE8AB989989|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||KEV|||MBQ/UL|NOT DONE||U|NA|NA|4||88||SCREENING|1966-01-23||1967-05-11|||1961-09-27||1961-09-08
TRIAL STUDY 134XCP|RP|51F3D3C1-3361-499F-B037-CCE8AB989989|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||NKAT|||MJOULE/CM2|NOT DONE||NA|U|U|5||7||BASELINE|1971-06-10||1973-08-11|||1964-09-24||1963-02-17
TRIAL STUDY 134XCP|RP|51F3D3C1-3361-499F-B037-CCE8AB989989|2||||||DSCHGIND|DISCHARGE INDICATOR||||NMOL/L|||IU/L|NOT DONE||N|Y|N|5||7||OBSERVATION|1967-03-15||1967-08-11|||1972-07-31||1971-11-29
TRIAL STUDY 134XCP|RP|231D401F-CA93-49E0-AC5C-C7F636343D2F|1||||||TNDRIND|TENDERNESS INDICATOR||||U/MMOL|||CMH2O/ML|NOT DONE||Y|Y|Y|1||38||SCREENING|1973-06-14||1970-06-19|||1971-12-15||1966-04-14
TRIAL STUDY 134XCP|RP|231D401F-CA93-49E0-AC5C-C7F636343D2F|2||||||BLISTIND|BLISTERING INDICATOR||||CUP|||USEC|NOT DONE||Y|NA|NA|1||38||FOLLOW-UP|1962-06-19||1966-01-26|||1963-10-14||1965-12-19
TRIAL STUDY 134XCP|RP|231D401F-CA93-49E0-AC5C-C7F636343D2F|1||||||RASHIND|RASH INDICATOR||||PM|||UG/KG/DAY|NOT DONE||Y|N|NA|2||58||LONG-TERM FOLLOW-UP|1970-09-19||1962-04-14|||1969-06-01||1971-01-01
TRIAL STUDY 134XCP|RP|231D401F-CA93-49E0-AC5C-C7F636343D2F|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||NEWTON|||MMOL/MIN/KPA/L|NOT DONE||Y|N|U|2||58||INDUCTION TREATMENT|1969-11-22||1962-05-15|||1963-03-12||1961-04-26
TRIAL STUDY 134XCP|RP|231D401F-CA93-49E0-AC5C-C7F636343D2F|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MMOL/MOL|||M/SEC|NOT DONE||NA|N|Y|3||39||BLINDED TREATMENT|1965-09-11||1966-02-03|||1965-02-02||1961-02-02
TRIAL STUDY 134XCP|RP|231D401F-CA93-49E0-AC5C-C7F636343D2F|2||||||MENARAGE|MENARCHE AGE||||DYN|||EU|NOT DONE||U|NA|N|3||39||BLINDED TREATMENT|1960-09-06||1973-02-17|||1970-06-17||1960-11-06
TRIAL STUDY 134XCP|RP|231D401F-CA93-49E0-AC5C-C7F636343D2F|1||||||TNDRIND|TENDERNESS INDICATOR||||10^3/HPF|||BLOCKS|NOT DONE||U|U|U|4||88||INDUCTION TREATMENT|1971-01-06||1962-03-02|||1973-05-15||1970-03-31
TRIAL STUDY 134XCP|RP|231D401F-CA93-49E0-AC5C-C7F636343D2F|2||||||TNDRIND|TENDERNESS INDICATOR||||COPIES/ML|||G/ANIMAL|NOT DONE||N|N|Y|4||88||CONTINUATION TREATMENT|1968-10-27||1968-11-13|||1967-03-27||1967-03-09
TRIAL STUDY 134XCP|RP|231D401F-CA93-49E0-AC5C-C7F636343D2F|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||UG/CM2|||/MS|NOT DONE||NA|NA|N|5||7||OPEN LABEL TREATMENT|1962-12-28||1973-06-27|||1966-03-25||1965-04-20
TRIAL STUDY 134XCP|RP|231D401F-CA93-49E0-AC5C-C7F636343D2F|2||||||FUNDHT|FUNDAL HEIGHT||||ELISA UNIT/DOSE|||BP|NOT DONE||N|Y|U|5||7||SCREENING|1968-07-27||1964-07-11|||1970-08-18||1969-12-14
TRIAL STUDY 134XCP|RP|2704A3C0-3345-48E5-AC9B-C00EA51AB085|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||UU/DL|||IU/DAY|NOT DONE||U|U|NA|1||38||BLINDED TREATMENT|1966-11-20||1968-07-01|||1964-07-07||1973-07-05
TRIAL STUDY 134XCP|RP|2704A3C0-3345-48E5-AC9B-C00EA51AB085|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||ML/CM3/MIN|||DRINK|NOT DONE||U|Y|NA|1||38||OBSERVATION|1973-05-30||1967-03-03|||1963-11-28||1963-07-24
TRIAL STUDY 134XCP|RP|2704A3C0-3345-48E5-AC9B-C00EA51AB085|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||DB|||HOMEOPATHIC DILUTION|NOT DONE||NA|U|Y|2||58||SCREENING|1967-02-08||1961-07-09|||1967-03-08||1966-11-13
TRIAL STUDY 134XCP|RP|2704A3C0-3345-48E5-AC9B-C00EA51AB085|2||||||ERYTHIND|ERYTHEMA INDICATOR||||10^6 CFU/G|||UCI/KG|NOT DONE||U|N|N|2||58||OBSERVATION|1972-03-06||1962-06-17|||1960-12-13||1965-05-13
TRIAL STUDY 134XCP|RP|2704A3C0-3345-48E5-AC9B-C00EA51AB085|1||||||RASHIND|RASH INDICATOR||||DYN|||BQ/G|NOT DONE||N|U|NA|3||39||BLINDED TREATMENT|1972-09-17||1967-10-09|||1972-04-13||1967-04-05
TRIAL STUDY 134XCP|RP|2704A3C0-3345-48E5-AC9B-C00EA51AB085|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MG/M2|||NMOL/G|NOT DONE||N|Y|Y|3||39||LONG-TERM FOLLOW-UP|1966-10-07||1961-09-06|||1964-08-10||1970-09-19
TRIAL STUDY 134XCP|RP|2704A3C0-3345-48E5-AC9B-C00EA51AB085|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||ML/KG/MIN|||MM/SEC|NOT DONE||Y|N|NA|4||88||OPEN LABEL TREATMENT|1973-08-30||1968-03-22|||1970-11-05||1962-06-21
TRIAL STUDY 134XCP|RP|2704A3C0-3345-48E5-AC9B-C00EA51AB085|2||||||ERYTHIND|ERYTHEMA INDICATOR||||RATIO|||MG/M2/DAY|NOT DONE||NA|NA|NA|4||88||BLINDED TREATMENT|1969-01-29||1973-08-01|||1967-07-21||1969-04-17
TRIAL STUDY 134XCP|RP|2704A3C0-3345-48E5-AC9B-C00EA51AB085|1||||||PREGIND|PREGNANT INDICATOR||||U/M2/H|||UMOL|NOT DONE||N|Y|Y|5||7||INDUCTION TREATMENT|1962-10-06||1967-03-17|||1973-04-19||1973-08-26
TRIAL STUDY 134XCP|RP|2704A3C0-3345-48E5-AC9B-C00EA51AB085|2||||||MENOSTAT|MENOPAUSE STATUS||||CAN|||UG/G/H|NOT DONE||Y|NA|N|5||7||LONG-TERM FOLLOW-UP|1961-05-31||1973-08-18|||1962-01-03||1962-06-05
TRIAL STUDY 134XCP|RP|2F636370-94FE-4BC0-9E16-DDD42D19A985|1||||||ERYTHIND|ERYTHEMA INDICATOR||||AMPULE|||/2000 RBC|NOT DONE||U|N|N|1||38||TREATMENT|1963-12-29||1960-08-13|||1971-04-27||1961-05-15
TRIAL STUDY 134XCP|RP|2F636370-94FE-4BC0-9E16-DDD42D19A985|2||||||BLISTIND|BLISTERING INDICATOR||||KBQ|||DAYS|NOT DONE||Y|NA|Y|1||38||TREATMENT|1967-09-27||1962-01-27|||1969-12-17||1971-09-13
TRIAL STUDY 134XCP|RP|2F636370-94FE-4BC0-9E16-DDD42D19A985|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||U/KG/H|||MPA|NOT DONE||Y|U|NA|2||58||BLINDED TREATMENT|1965-04-01||1961-09-27|||1965-01-24||1969-10-12
TRIAL STUDY 134XCP|RP|2F636370-94FE-4BC0-9E16-DDD42D19A985|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||TRANSDUCING UNIT/ML|||G/CAGE/DAY|NOT DONE||N|NA|U|2||58||FOLLOW-UP|1960-09-22||1966-03-10|||1961-07-26||1972-10-10
TRIAL STUDY 134XCP|RP|2F636370-94FE-4BC0-9E16-DDD42D19A985|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MPS U|||MCI|NOT DONE||NA|U|U|3||39||FOLLOW-UP|1961-04-28||1969-07-22|||1963-08-02||1962-03-18
TRIAL STUDY 134XCP|RP|2F636370-94FE-4BC0-9E16-DDD42D19A985|2||||||ERYTHIND|ERYTHEMA INDICATOR||||KCAL|||/HPF|NOT DONE||Y|U|N|3||39||INDUCTION TREATMENT|1970-07-05||1963-07-15|||1962-02-20||1964-11-19
TRIAL STUDY 134XCP|RP|2F636370-94FE-4BC0-9E16-DDD42D19A985|1||||||MENOAGE|MENOPAUSE AGE||||/200 HPFS|||BQ|NOT DONE||NA|U|N|4||88||CONTINUATION TREATMENT|1963-01-20||1969-10-01|||1972-10-28||1972-11-07
TRIAL STUDY 134XCP|RP|2F636370-94FE-4BC0-9E16-DDD42D19A985|2||||||MENARAGE|MENARCHE AGE||||GMFI|||MG/L FEU|NOT DONE||NA|N|NA|4||88||BASELINE|1968-07-23||1967-04-28|||1970-01-07||1972-06-18
TRIAL STUDY 134XCP|RP|2F636370-94FE-4BC0-9E16-DDD42D19A985|1||||||DSCHGIND|DISCHARGE INDICATOR||||10^9 CFU|||U|NOT DONE||NA|N|NA|5||7||SCREENING|1965-08-22||1967-06-14|||1973-03-08||1969-03-14
TRIAL STUDY 134XCP|RP|2F636370-94FE-4BC0-9E16-DDD42D19A985|2||||||PUSTIND|PUSTULE INDICATOR||||CY/CM|||U.CARR|NOT DONE||U|N|N|5||7||BLINDED TREATMENT|1970-01-06||1972-09-19|||1964-02-02||1963-08-15
TRIAL STUDY 134XCP|RP|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||FFU|||UCI/L|NOT DONE||N|N|U|1||38||BLINDED TREATMENT|1961-09-17||1970-07-24|||1973-05-22||1970-10-09
TRIAL STUDY 134XCP|RP|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|2||||||INABOIND|INDUCED ABORTION INDICATOR||||SHOCK WAVE|||UG/L FEU|NOT DONE||NA|Y|NA|1||38||BLINDED TREATMENT|1961-12-30||1972-11-30|||1965-01-05||1964-01-29
TRIAL STUDY 134XCP|RP|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||ML/ANIMAL/WK|||TORR|NOT DONE||U|NA|Y|2||58||CONTINUATION TREATMENT|1970-08-23||1964-03-29|||1967-02-26||1961-03-13
TRIAL STUDY 134XCP|RP|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||NMOL BCE/L|||GBQ|NOT DONE||Y|U|NA|2||58||CONTINUATION TREATMENT|1963-03-29||1972-05-18|||1964-08-07||1973-07-01
TRIAL STUDY 134XCP|RP|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||CI/G|||MM3/MM2/YEAR|NOT DONE||Y|U|N|3||39||CONTINUATION TREATMENT|1965-01-18||1963-12-24|||1970-03-08||1961-09-24
TRIAL STUDY 134XCP|RP|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||ML/MMHG|||PMOL/DAY|NOT DONE||N|Y|NA|3||39||OBSERVATION|1967-06-01||1964-08-23|||1970-05-18||1960-05-01
TRIAL STUDY 134XCP|RP|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|1||||||ABORTN|NUMBER OF ABORTIONS||||PFU/ML|||NMOL|NOT DONE||N|N|Y|4||88||OPEN LABEL TREATMENT|1968-07-08||1969-06-02|||1972-08-19||1968-11-19
TRIAL STUDY 134XCP|RP|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|2||||||MENOSTAT|MENOPAUSE STATUS||||PPTR|||UG/ML/H|NOT DONE||U|U|U|4||88||WASHOUT|1965-11-26||1966-04-10|||1960-09-09||1961-07-28
TRIAL STUDY 134XCP|RP|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||UKAT|||ARBITRARY U|NOT DONE||U|NA|N|5||7||INDUCTION TREATMENT|1963-11-01||1964-11-21|||1963-04-11||1967-04-04
TRIAL STUDY 134XCP|RP|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|2||||||PREGIND|PREGNANT INDICATOR||||UIU/DL|||10^7 TCID 50/DOSE|NOT DONE||N|U|U|5||7||SCREENING|1960-07-30||1970-02-22|||1964-09-16||1966-10-04
TRIAL STUDY 134XCP|RP|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||HPA|||G/ANIMAL/DAY|NOT DONE||Y|NA|U|1||38||OBSERVATION|1967-01-29||1966-06-23|||1964-09-05||1960-02-08
TRIAL STUDY 134XCP|RP|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|2||||||MENFDUR|MENSES FLOW DURATION||||UMOL/H/MMOL|||MG/KG/MIN|NOT DONE||Y|U|NA|1||38||OBSERVATION|1968-04-11||1973-07-16|||1972-03-31||1963-10-03
TRIAL STUDY 134XCP|RP|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||KPA|||PMOL/DAY|NOT DONE||Y|NA|N|2||58||WASHOUT|1968-12-30||1971-09-12|||1971-11-25||1968-10-07
TRIAL STUDY 134XCP|RP|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||UL/DOSE|||UG/DOSE|NOT DONE||U|Y|U|2||58||WASHOUT|1967-07-27||1970-03-16|||1962-04-07||1962-04-15
TRIAL STUDY 134XCP|RP|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||UG/L|||AU/ML|NOT DONE||Y|N|Y|3||39||BLINDED TREATMENT|1969-06-28||1969-06-07|||1965-09-04||1969-02-04
TRIAL STUDY 134XCP|RP|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|2||||||TNDRIND|TENDERNESS INDICATOR||||MONTHS|||CGY|NOT DONE||NA|N|N|3||39||OBSERVATION|1961-10-22||1972-04-12|||1970-04-26||1963-05-02
TRIAL STUDY 134XCP|RP|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MG/CM2|||BAR|NOT DONE||U|Y|NA|4||88||OBSERVATION|1972-10-02||1960-05-02|||1960-10-02||1967-11-07
TRIAL STUDY 134XCP|RP|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||OZ EQ|||INHALATION|NOT DONE||U|U|U|4||88||LONG-TERM FOLLOW-UP|1968-12-18||1972-09-19|||1966-11-03||1962-07-28
TRIAL STUDY 134XCP|RP|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|1||||||BRTHN|NUMBER OF BIRTHS||||10^3/L|||MEQ/DL|NOT DONE||N|U|N|5||7||BLINDED TREATMENT|1971-04-10||1966-03-14|||1964-03-03||1961-09-17
TRIAL STUDY 134XCP|RP|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||/4.0 ML|||EIA UNIT|NOT DONE||U|Y|NA|5||7||CONTINUATION TREATMENT|1971-10-17||1973-06-15|||1969-01-24||1968-11-09
TRIAL STUDY 134XCP|RP|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||DAGU/ML|||CD*S/M2|NOT DONE||NA|U|N|1||38||CONTINUATION TREATMENT|1960-05-12||1964-07-26|||1969-10-24||1967-04-09
TRIAL STUDY 134XCP|RP|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||10^3 CFU/ML|||10^6 RNA COPIES/ML|NOT DONE||Y|NA|Y|1||38||FOLLOW-UP|1967-12-02||1965-08-11|||1966-07-25||1966-11-03
TRIAL STUDY 134XCP|RP|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||USIEMENS|||MEQ|NOT DONE||U|N|Y|2||58||INDUCTION TREATMENT|1968-04-26||1968-06-28|||1966-06-29||1966-08-28
TRIAL STUDY 134XCP|RP|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||U/MMOL|||FT2|NOT DONE||U|NA|Y|2||58||FOLLOW-UP|1969-11-09||1963-07-15|||1972-06-11||1961-03-30
TRIAL STUDY 134XCP|RP|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|1||||||TNDRIND|TENDERNESS INDICATOR||||MPA|||CY/CM|NOT DONE||U|U|U|3||39||WASHOUT|1969-10-09||1968-07-09|||1963-02-18||1972-02-08
TRIAL STUDY 134XCP|RP|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||%|||UG/L/H|NOT DONE||Y|U|Y|3||39||BASELINE|1964-06-19||1967-09-16|||1969-08-02||1971-06-23
TRIAL STUDY 134XCP|RP|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|1||||||EDEMAIND|EDEMA INDICATOR||||PFU/DOSE|||LM|NOT DONE||N|N|U|4||88||BLINDED TREATMENT|1963-05-12||1971-12-29|||1963-06-02||1964-06-27
TRIAL STUDY 134XCP|RP|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|2||||||BRTHN|NUMBER OF BIRTHS||||USIEMENS|||DL|NOT DONE||N|N|N|4||88||WASHOUT|1961-07-13||1969-09-30|||1963-10-21||1961-04-20
TRIAL STUDY 134XCP|RP|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||KS|||MG/DOSE|NOT DONE||NA|N|Y|5||7||FOLLOW-UP|1962-09-30||1965-12-11|||1968-10-14||1965-02-05
TRIAL STUDY 134XCP|RP|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||BOWL|||FIU|NOT DONE||N|Y|NA|5||7||BLINDED TREATMENT|1968-01-09||1969-10-25|||1970-12-07||1964-09-14
TRIAL STUDY 134XCP|RP|A1FAB383-1757-4832-B888-90C133842EF8|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^5/HPF|||PKAT|NOT DONE||NA|N|Y|1||38||SCREENING|1966-06-29||1967-01-27|||1968-08-11||1968-04-22
TRIAL STUDY 134XCP|RP|A1FAB383-1757-4832-B888-90C133842EF8|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||L/KG|||BEL|NOT DONE||U|N|NA|1||38||RUN-IN|1960-09-29||1971-03-30|||1962-05-02||1971-01-30
TRIAL STUDY 134XCP|RP|A1FAB383-1757-4832-B888-90C133842EF8|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MKAT|||1/(S*KPA)|NOT DONE||NA|NA|Y|2||58||SCREENING|1966-07-13||1968-04-07|||1969-05-11||1962-08-31
TRIAL STUDY 134XCP|RP|A1FAB383-1757-4832-B888-90C133842EF8|2||||||MENFDUR|MENSES FLOW DURATION||||PMOL/10^9 CELLS|||OHM|NOT DONE||N|NA|NA|2||58||RUN-IN|1961-03-07||1973-07-04|||1961-11-10||1963-06-05
TRIAL STUDY 134XCP|RP|A1FAB383-1757-4832-B888-90C133842EF8|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||BU/ML|||PRESSOR UNITS|NOT DONE||N|Y|N|3||39||BLINDED TREATMENT|1969-08-11||1966-01-15|||1964-09-07||1970-04-16
TRIAL STUDY 134XCP|RP|A1FAB383-1757-4832-B888-90C133842EF8|2||||||FUNDHT|FUNDAL HEIGHT||||UM/DAY|||FL|NOT DONE||N|NA|NA|3||39||TREATMENT|1971-11-21||1968-07-24|||1967-09-08||1965-02-20
TRIAL STUDY 134XCP|RP|A1FAB383-1757-4832-B888-90C133842EF8|1||||||STILBIND|STILLBIRTH INDICATOR||||PIPE|||10^5/HPF|NOT DONE||N|Y|N|4||88||OPEN LABEL TREATMENT|1961-09-04||1965-06-07|||1972-03-20||1970-10-13
TRIAL STUDY 134XCP|RP|A1FAB383-1757-4832-B888-90C133842EF8|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||10^3 RNA COPIES/ML|||UM/DAY|NOT DONE||Y|N|NA|4||88||LONG-TERM FOLLOW-UP|1971-08-27||1969-01-08|||1971-06-14||1968-03-18
TRIAL STUDY 134XCP|RP|A1FAB383-1757-4832-B888-90C133842EF8|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||KG/CM2|||KG|NOT DONE||NA|NA|N|5||7||LONG-TERM FOLLOW-UP|1968-06-18||1964-09-05|||1963-03-19||1972-09-18
TRIAL STUDY 134XCP|RP|A1FAB383-1757-4832-B888-90C133842EF8|2||||||PREGST|PREGNANT DURING THE STUDY||||U/KG/MIN|||MEQ/DL|NOT DONE||N|Y|U|5||7||RUN-IN|1965-06-01||1969-11-15|||1960-10-08||1968-05-02
TRIAL STUDY 134XCP|RP|72AA1945-E676-4485-BD7F-6B969E314D83|1||||||THICK|THICKNESS||||/H|||TBSP|NOT DONE||NA|Y|Y|1||38||OPEN LABEL TREATMENT|1960-09-25||1969-02-17|||1969-07-15||1969-03-10
TRIAL STUDY 134XCP|RP|72AA1945-E676-4485-BD7F-6B969E314D83|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UM/S|||QUANTITY SUFFICIENT|NOT DONE||N|U|U|1||38||TREATMENT|1971-02-19||1969-06-24|||1964-02-25||1973-02-24
TRIAL STUDY 134XCP|RP|72AA1945-E676-4485-BD7F-6B969E314D83|1||||||GRAVIND|GRAVIDA INDICATOR||||G/CAGE/DAY|||MM3/MM2/YEAR|NOT DONE||NA|N|Y|2||58||TREATMENT|1966-10-24||1967-03-01|||1971-01-11||1971-08-30
TRIAL STUDY 134XCP|RP|72AA1945-E676-4485-BD7F-6B969E314D83|2||||||PREGIND|PREGNANT INDICATOR||||VG/ML|||CIGAR|NOT DONE||N|U|U|2||58||FOLLOW-UP|1970-11-18||1968-04-13|||1967-07-01||1965-09-18
TRIAL STUDY 134XCP|RP|72AA1945-E676-4485-BD7F-6B969E314D83|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||CCID 50/DOSE|||PT_US|NOT DONE||Y|U|NA|3||39||INDUCTION TREATMENT|1960-08-08||1966-02-19|||1965-03-15||1969-10-14
TRIAL STUDY 134XCP|RP|72AA1945-E676-4485-BD7F-6B969E314D83|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||GY/H|||MJOULE/CM2|NOT DONE||NA|Y|N|3||39||SCREENING|1963-04-14||1969-04-16|||1960-10-04||1963-03-21
TRIAL STUDY 134XCP|RP|72AA1945-E676-4485-BD7F-6B969E314D83|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MNFI|||UMOL/KG/MIN|NOT DONE||Y|U|Y|4||88||INDUCTION TREATMENT|1971-10-26||1965-01-19|||1967-02-09||1967-01-27
TRIAL STUDY 134XCP|RP|72AA1945-E676-4485-BD7F-6B969E314D83|2||||||INABOIND|INDUCED ABORTION INDICATOR||||ML/DAY|||G/CM2|NOT DONE||NA|U|U|4||88||INDUCTION TREATMENT|1961-05-19||1966-06-03|||1963-04-20||1967-11-03
TRIAL STUDY 134XCP|RP|72AA1945-E676-4485-BD7F-6B969E314D83|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||HOMEOPATHIC DILUTION|||VIRTUAL PIXEL|NOT DONE||U|U|U|5||7||OBSERVATION|1966-12-25||1965-09-09|||1966-12-25||1970-03-31
TRIAL STUDY 134XCP|RP|72AA1945-E676-4485-BD7F-6B969E314D83|2||||||INTP|INTERPRETATION||||U/KG/H|||ML/ANIMAL/DAY|NOT DONE||U|Y|Y|5||7||SCREENING|1964-08-18||1961-06-18|||1966-10-27||1967-07-27
TRIAL STUDY 134XCP|RP|B297C689-0D99-4E36-9F27-F93D4F43E2DD|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||TUBE|||ML/G/DAY|NOT DONE||NA|N|NA|1||38||FOLLOW-UP|1968-08-22||1966-07-15|||1970-07-30||1967-08-24
TRIAL STUDY 134XCP|RP|B297C689-0D99-4E36-9F27-F93D4F43E2DD|2||||||EDEMAIND|EDEMA INDICATOR||||PG/L|||DRUM|NOT DONE||N|N|NA|1||38||SCREENING|1968-06-06||1960-01-13|||1969-02-03||1967-01-08
TRIAL STUDY 134XCP|RP|B297C689-0D99-4E36-9F27-F93D4F43E2DD|1||||||ABORTN|NUMBER OF ABORTIONS||||ML*CMH2O|||LENS|NOT DONE||U|U|U|2||58||CONTINUATION TREATMENT|1970-02-24||1970-03-11|||1961-11-06||1970-05-29
TRIAL STUDY 134XCP|RP|B297C689-0D99-4E36-9F27-F93D4F43E2DD|2||||||MENOSTAT|MENOPAUSE STATUS||||UG/M2/DAY|||NMOL/L|NOT DONE||NA|U|NA|2||58||CONTINUATION TREATMENT|1971-05-04||1966-12-07|||1968-05-24||1967-10-03
TRIAL STUDY 134XCP|RP|B297C689-0D99-4E36-9F27-F93D4F43E2DD|1||||||BLISTIND|BLISTERING INDICATOR||||DAYS/WK|||PL|NOT DONE||NA|NA|N|3||39||BLINDED TREATMENT|1972-05-02||1965-05-16|||1972-01-30||1964-09-03
TRIAL STUDY 134XCP|RP|B297C689-0D99-4E36-9F27-F93D4F43E2DD|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||10^10/L|||DAMOL/L|NOT DONE||N|NA|N|3||39||BLINDED TREATMENT|1960-04-17||1962-08-26|||1964-01-13||1962-08-07
TRIAL STUDY 134XCP|RP|B297C689-0D99-4E36-9F27-F93D4F43E2DD|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MASK|||MET|NOT DONE||U|U|Y|4||88||TREATMENT|1972-03-13||1966-03-26|||1963-02-02||1967-12-07
TRIAL STUDY 134XCP|RP|B297C689-0D99-4E36-9F27-F93D4F43E2DD|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||FT3|||MOL/MG|NOT DONE||Y|U|NA|4||88||OPEN LABEL TREATMENT|1968-10-23||1967-05-22|||1966-08-04||1966-01-30
TRIAL STUDY 134XCP|RP|B297C689-0D99-4E36-9F27-F93D4F43E2DD|1||||||ERYTHIND|ERYTHEMA INDICATOR||||ENZYME U/M2|||KIT|NOT DONE||N|U|Y|5||7||CONTINUATION TREATMENT|1961-11-04||1973-07-26|||1960-05-13||1970-09-02
TRIAL STUDY 134XCP|RP|B297C689-0D99-4E36-9F27-F93D4F43E2DD|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||GPL U|||/VF|NOT DONE||NA|Y|U|5||7||FOLLOW-UP|1969-10-17||1960-12-30|||1970-02-08||1961-12-19
TRIAL STUDY 134XCP|RP|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|1||||||PREGIND|PREGNANT INDICATOR||||10^6 CFU|||10^7 PFU|NOT DONE||N|U|N|1||38||SCREENING|1962-09-06||1968-01-20|||1965-10-11||1965-01-12
TRIAL STUDY 134XCP|RP|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||BAR|||ML/H|NOT DONE||Y|Y|N|1||38||WASHOUT|1966-08-16||1969-05-31|||1963-02-20||1962-12-29
TRIAL STUDY 134XCP|RP|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||IU|||TCID 50/DOSE|NOT DONE||NA|NA|N|2||58||WASHOUT|1972-05-16||1964-09-25|||1964-08-04||1962-12-18
TRIAL STUDY 134XCP|RP|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|2||||||BRTHN|NUMBER OF BIRTHS||||IU/DAY|||ML/M2/DAY|NOT DONE||N|NA|NA|2||58||SCREENING|1971-01-17||1971-02-17|||1963-06-11||1971-07-12
TRIAL STUDY 134XCP|RP|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||DEG/MM|||MPL U/ML|NOT DONE||N|N|U|3||39||BLINDED TREATMENT|1963-08-12||1961-05-29|||1969-03-09||1968-10-17
TRIAL STUDY 134XCP|RP|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|2||||||PRGENDTC|DATE PREGNANCY ENDED||||PMOL/10^9 CELLS|||PL|NOT DONE||Y|N|NA|3||39||BASELINE|1968-11-21||1969-12-01|||1962-01-12||1970-06-06
TRIAL STUDY 134XCP|RP|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||ML/S/M2|||MG/MIN|NOT DONE||Y|Y|Y|4||88||BLINDED TREATMENT|1970-11-11||1965-09-29|||1970-04-20||1970-03-18
TRIAL STUDY 134XCP|RP|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|2||||||STILBIND|STILLBIRTH INDICATOR||||MG/M2/DAY|||NMOL BCE/MMOL|NOT DONE||U|U|U|4||88||WASHOUT|1961-10-06||1969-09-15|||1966-03-19||1963-06-11
TRIAL STUDY 134XCP|RP|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|1||||||DLVRMODE|MODE OF DELIVERY||||10^3 ORGANISMS/G|||ELISA UNIT|NOT DONE||NA|Y|U|5||7||BLINDED TREATMENT|1962-04-11||1968-02-29|||1969-07-30||1963-11-14
TRIAL STUDY 134XCP|RP|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||VIRTUAL PIXEL|||MG/KG/DOSE|NOT DONE||Y|N|NA|5||7||TREATMENT|1961-01-22||1967-02-14|||1967-02-11||1973-06-16
TRIAL STUDY 134XCP|RP|3F18534E-367D-45C8-BB08-C82151A0CF00|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||FMOL/L|||STRIP|NOT DONE||Y|N|NA|1||38||WASHOUT|1967-01-23||1965-10-06|||1964-12-27||1960-05-27
TRIAL STUDY 134XCP|RP|3F18534E-367D-45C8-BB08-C82151A0CF00|2||||||EDEMAIND|EDEMA INDICATOR||||%/S|||LOG10 CCID 50/DOSE|NOT DONE||NA|NA|Y|1||38||BLINDED TREATMENT|1971-04-08||1961-02-18|||1962-02-14||1971-05-25
TRIAL STUDY 134XCP|RP|3F18534E-367D-45C8-BB08-C82151A0CF00|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MOSM/KG|||MOSM/L|NOT DONE||N|U|Y|2||58||FOLLOW-UP|1972-03-06||1971-02-03|||1966-06-15||1966-01-24
TRIAL STUDY 134XCP|RP|3F18534E-367D-45C8-BB08-C82151A0CF00|2||||||TNDRIND|TENDERNESS INDICATOR||||NEEDLE GAUGE|||EQ|NOT DONE||Y|Y|Y|2||58||LONG-TERM FOLLOW-UP|1967-09-17||1963-11-04|||1970-07-12||1970-12-25
TRIAL STUDY 134XCP|RP|3F18534E-367D-45C8-BB08-C82151A0CF00|1||||||ERYTHIND|ERYTHEMA INDICATOR||||DPM/ML|||CI/G|NOT DONE||U|N|U|3||39||OPEN LABEL TREATMENT|1972-06-02||1967-10-08|||1971-04-04||1965-03-20
TRIAL STUDY 134XCP|RP|3F18534E-367D-45C8-BB08-C82151A0CF00|2||||||PUSTIND|PUSTULE INDICATOR||||IU/ML|||GMFI|NOT DONE||N|Y|N|3||39||LONG-TERM FOLLOW-UP|1972-08-18||1968-08-22|||1962-09-23||1970-01-21
TRIAL STUDY 134XCP|RP|3F18534E-367D-45C8-BB08-C82151A0CF00|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||IU/MMOL|||MEQ/ML|NOT DONE||Y|NA|Y|4||88||RUN-IN|1972-01-12||1966-11-30|||1965-06-12||1967-06-18
TRIAL STUDY 134XCP|RP|3F18534E-367D-45C8-BB08-C82151A0CF00|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||FOZ_US|||CMH2O*S/ML|NOT DONE||N|NA|Y|4||88||LONG-TERM FOLLOW-UP|1960-02-17||1973-07-31|||1962-10-19||1964-05-14
TRIAL STUDY 134XCP|RP|3F18534E-367D-45C8-BB08-C82151A0CF00|1||||||DLVRMODE|MODE OF DELIVERY||||ML/M2/H|||WEEKS|NOT DONE||N|U|Y|5||7||BASELINE|1968-12-20||1961-01-04|||1962-07-25||1965-12-01
TRIAL STUDY 134XCP|RP|3F18534E-367D-45C8-BB08-C82151A0CF00|2||||||MASSIND|MASS INDICATOR||||VOXEL|||PHERESIS UNIT|NOT DONE||NA|U|U|5||7||RUN-IN|1962-02-19||1971-09-14|||1972-02-13||1969-07-20
TRIAL STUDY 134XCP|RP|81C10FB0-3B47-46D8-B8B7-9C772246CA55|1||||||DSCHGIND|DISCHARGE INDICATOR||||IU/ML|||10^4/HPF|NOT DONE||N|U|N|1||38||OBSERVATION|1973-02-16||1972-06-01|||1964-09-06||1965-04-29
TRIAL STUDY 134XCP|RP|81C10FB0-3B47-46D8-B8B7-9C772246CA55|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||BOX|||ECL UNIT|NOT DONE||NA|NA|U|1||38||FOLLOW-UP|1968-05-13||1966-10-08|||1962-01-31||1969-08-20
TRIAL STUDY 134XCP|RP|81C10FB0-3B47-46D8-B8B7-9C772246CA55|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||DNA COPIES/ML|||USP U|NOT DONE||N|Y|U|2||58||RUN-IN|1967-11-12||1964-03-07|||1963-04-07||1960-10-11
TRIAL STUDY 134XCP|RP|81C10FB0-3B47-46D8-B8B7-9C772246CA55|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^9 CFU/ML|||10^7 TCID 50/DOSE|NOT DONE||Y|U|NA|2||58||OPEN LABEL TREATMENT|1971-11-15||1968-07-26|||1971-11-08||1970-11-12
TRIAL STUDY 134XCP|RP|81C10FB0-3B47-46D8-B8B7-9C772246CA55|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||10^6 ORGANISMS/ML|||TROCHE|NOT DONE||NA|Y|Y|3||39||WASHOUT|1970-09-05||1968-07-26|||1967-06-01||1967-04-14
TRIAL STUDY 134XCP|RP|81C10FB0-3B47-46D8-B8B7-9C772246CA55|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||PHERESIS UNIT|||L/MIN/M2|NOT DONE||U|U|NA|3||39||WASHOUT|1961-09-12||1966-02-23|||1972-05-12||1965-06-05
TRIAL STUDY 134XCP|RP|81C10FB0-3B47-46D8-B8B7-9C772246CA55|1||||||RASHIND|RASH INDICATOR||||FMOL/G|||STEPS/MIN|NOT DONE||Y|NA|NA|4||88||LONG-TERM FOLLOW-UP|1969-07-21||1970-09-03|||1960-12-17||1968-01-10
TRIAL STUDY 134XCP|RP|81C10FB0-3B47-46D8-B8B7-9C772246CA55|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||NMOL BCE/MMOL|||M/SEC2|NOT DONE||Y|U|U|4||88||INDUCTION TREATMENT|1960-07-14||1970-05-20|||1971-12-02||1966-12-26
TRIAL STUDY 134XCP|RP|81C10FB0-3B47-46D8-B8B7-9C772246CA55|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||CIGAR|||U/M2/H|NOT DONE||NA|N|Y|5||7||TREATMENT|1960-06-14||1966-12-19|||1968-06-09||1962-06-19
TRIAL STUDY 134XCP|RP|81C10FB0-3B47-46D8-B8B7-9C772246CA55|2||||||INTP|INTERPRETATION||||UL/KG/DAY|||MANSON U/ML|NOT DONE||Y|U|N|5||7||OBSERVATION|1964-03-25||1969-07-17|||1967-07-05||1960-01-28
TRIAL STUDY 134XCP|RP|67C99F41-D839-4B8E-9220-6EC161FCD457|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MU/L|||UM/S|NOT DONE||N|NA|N|1||38||RUN-IN|1963-12-07||1964-11-13|||1971-11-07||1973-02-06
TRIAL STUDY 134XCP|RP|67C99F41-D839-4B8E-9220-6EC161FCD457|2||||||PREGST|PREGNANT DURING THE STUDY||||ML/KG/DAY|||U/MG|NOT DONE||NA|U|N|1||38||INDUCTION TREATMENT|1965-06-09||1968-01-21|||1964-12-15||1960-02-20
TRIAL STUDY 134XCP|RP|67C99F41-D839-4B8E-9220-6EC161FCD457|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UIU/DL|||FMOL|NOT DONE||Y|N|NA|2||58||CONTINUATION TREATMENT|1968-06-20||1971-01-12|||1965-04-18||1961-10-17
TRIAL STUDY 134XCP|RP|67C99F41-D839-4B8E-9220-6EC161FCD457|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||PMOL/DL|||MM/2H|NOT DONE||N|NA|NA|2||58||FOLLOW-UP|1970-10-07||1968-02-19|||1965-04-28||1966-07-03
TRIAL STUDY 134XCP|RP|67C99F41-D839-4B8E-9220-6EC161FCD457|1||||||ERYTHIND|ERYTHEMA INDICATOR||||MMHG*MIN/L|||10^9 ORGANISMS/ML|NOT DONE||NA|U|Y|3||39||OBSERVATION|1973-09-01||1972-08-10|||1962-10-05||1962-08-18
TRIAL STUDY 134XCP|RP|67C99F41-D839-4B8E-9220-6EC161FCD457|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PHERESIS UNIT|||MS2|NOT DONE||NA|Y|N|3||39||WASHOUT|1963-11-26||1962-03-08|||1961-08-08||1966-02-25
TRIAL STUDY 134XCP|RP|67C99F41-D839-4B8E-9220-6EC161FCD457|1||||||PRGENDTC|DATE PREGNANCY ENDED||||10^3 ORGANISMS|||/40 HPFS|NOT DONE||N|Y|N|4||88||OBSERVATION|1969-09-27||1971-03-31|||1970-12-17||1970-04-26
TRIAL STUDY 134XCP|RP|67C99F41-D839-4B8E-9220-6EC161FCD457|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||ML/BEAT|||ML/DAY|NOT DONE||U|NA|U|4||88||TREATMENT|1972-06-18||1970-11-17|||1960-12-24||1963-10-19
TRIAL STUDY 134XCP|RP|67C99F41-D839-4B8E-9220-6EC161FCD457|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MOSM/L|||CI/MG|NOT DONE||Y|Y|U|5||7||OPEN LABEL TREATMENT|1972-07-05||1973-05-28|||1968-11-26||1969-07-13
TRIAL STUDY 134XCP|RP|67C99F41-D839-4B8E-9220-6EC161FCD457|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||10^3 ORGANISMS/G|||MOL/MOL|NOT DONE||NA|N|N|5||7||LONG-TERM FOLLOW-UP|1963-11-15||1962-03-29|||1970-01-11||1972-02-22
TRIAL STUDY 134XCP|RP|76B9C25F-B418-4979-9E18-4372C8AA700C|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PFU/DOSE|||CFU/ML|NOT DONE||N|N|NA|1||38||OPEN LABEL TREATMENT|1972-06-21||1970-08-14|||1961-06-12||1960-01-19
TRIAL STUDY 134XCP|RP|76B9C25F-B418-4979-9E18-4372C8AA700C|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||/100 WBC|||CMOL|NOT DONE||U|U|Y|1||38||OBSERVATION|1965-06-04||1967-10-31|||1962-07-14||1967-03-20
TRIAL STUDY 134XCP|RP|76B9C25F-B418-4979-9E18-4372C8AA700C|1||||||ABORTN|NUMBER OF ABORTIONS||||U/KG|||TROCHE|NOT DONE||Y|N|N|2||58||OBSERVATION|1962-09-30||1966-04-13|||1965-04-03||1966-01-27
TRIAL STUDY 134XCP|RP|76B9C25F-B418-4979-9E18-4372C8AA700C|2||||||MASSIND|MASS INDICATOR||||MMHG/L/MIN|||MM/SEC|NOT DONE||N|Y|NA|2||58||BASELINE|1962-07-17||1966-01-06|||1970-08-16||1970-03-26
TRIAL STUDY 134XCP|RP|76B9C25F-B418-4979-9E18-4372C8AA700C|1||||||TNDRIND|TENDERNESS INDICATOR||||MEQ/ML|||CI|NOT DONE||N|U|Y|3||39||RUN-IN|1963-02-23||1965-09-11|||1971-02-11||1963-10-25
TRIAL STUDY 134XCP|RP|76B9C25F-B418-4979-9E18-4372C8AA700C|2||||||PREGIND|PREGNANT INDICATOR||||CGY|||ECL UNIT|NOT DONE||NA|N|Y|3||39||INDUCTION TREATMENT|1961-08-02||1967-11-25|||1971-09-20||1970-11-24
TRIAL STUDY 134XCP|RP|76B9C25F-B418-4979-9E18-4372C8AA700C|1||||||FUNDHT|FUNDAL HEIGHT||||PACKET|||L|NOT DONE||N|N|Y|4||88||BLINDED TREATMENT|1972-05-16||1960-05-27|||1967-01-03||1972-10-23
TRIAL STUDY 134XCP|RP|76B9C25F-B418-4979-9E18-4372C8AA700C|2||||||MENOSTAT|MENOPAUSE STATUS||||10^6/G|||DEG/S|NOT DONE||N|U|U|4||88||FOLLOW-UP|1971-10-11||1972-01-30|||1964-11-30||1964-12-17
TRIAL STUDY 134XCP|RP|76B9C25F-B418-4979-9E18-4372C8AA700C|1||||||GRAVIND|GRAVIDA INDICATOR||||NG/DAY|||KV|NOT DONE||Y|NA|NA|5||7||CONTINUATION TREATMENT|1964-09-04||1971-07-20|||1964-05-15||1969-10-08
TRIAL STUDY 134XCP|RP|76B9C25F-B418-4979-9E18-4372C8AA700C|2||||||DSCHGIND|DISCHARGE INDICATOR||||PA|||KIU|NOT DONE||N|N|Y|5||7||OPEN LABEL TREATMENT|1972-11-15||1969-10-29|||1966-08-31||1972-08-13
TRIAL STUDY 134XCP|RP|9F622B53-71F8-4362-99A5-251993E3A946|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||SV|||MMOL/DAY|NOT DONE||U|U|NA|1||38||RUN-IN|1961-11-22||1965-12-09|||1963-08-29||1971-03-14
TRIAL STUDY 134XCP|RP|9F622B53-71F8-4362-99A5-251993E3A946|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||PMOL/DAY|||/MONTH|NOT DONE||Y|Y|U|1||38||TREATMENT|1971-09-29||1960-08-24|||1965-03-13||1965-04-29
TRIAL STUDY 134XCP|RP|9F622B53-71F8-4362-99A5-251993E3A946|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||USP U|||ML/CM H2O|NOT DONE||N|NA|U|2||58||LONG-TERM FOLLOW-UP|1962-11-16||1973-05-24|||1966-12-25||1966-07-17
TRIAL STUDY 134XCP|RP|9F622B53-71F8-4362-99A5-251993E3A946|2||||||ERYTHIND|ERYTHEMA INDICATOR||||PA|||G/ANIMAL/WK|NOT DONE||N|U|U|2||58||CONTINUATION TREATMENT|1961-05-02||1964-04-04|||1963-07-31||1972-05-23
TRIAL STUDY 134XCP|RP|9F622B53-71F8-4362-99A5-251993E3A946|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||EU|||MIU/L|NOT DONE||N|NA|U|3||39||INDUCTION TREATMENT|1965-11-08||1973-05-15|||1961-12-07||1970-12-21
TRIAL STUDY 134XCP|RP|9F622B53-71F8-4362-99A5-251993E3A946|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MG/M2/MIN|||10^3 ORGANISMS/G|NOT DONE||N|U|Y|3||39||OBSERVATION|1971-08-06||1964-02-14|||1967-03-08||1963-07-28
TRIAL STUDY 134XCP|RP|9F622B53-71F8-4362-99A5-251993E3A946|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||1/(S*KPA)|||ELISA UNIT/DOSE|NOT DONE||U|N|NA|4||88||CONTINUATION TREATMENT|1972-10-10||1961-02-15|||1972-03-12||1969-04-29
TRIAL STUDY 134XCP|RP|9F622B53-71F8-4362-99A5-251993E3A946|2||||||EDEMAIND|EDEMA INDICATOR||||SQU/ML|||10^3 ORGANISMS/ML|NOT DONE||Y|N|U|4||88||INDUCTION TREATMENT|1965-06-27||1969-12-18|||1967-09-23||1970-10-10
TRIAL STUDY 134XCP|RP|9F622B53-71F8-4362-99A5-251993E3A946|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||LOG10 ELISA UNIT|||10^7/L|NOT DONE||Y|N|Y|5||7||OBSERVATION|1973-05-03||1967-08-24|||1969-01-20||1969-02-20
TRIAL STUDY 134XCP|RP|9F622B53-71F8-4362-99A5-251993E3A946|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||U/MG|||TUBE|NOT DONE||U|Y|U|5||7||TREATMENT|1961-05-20||1964-03-02|||1965-10-17||1965-01-18
TRIAL STUDY 134XCP|RP|8F2DC6EB-0264-4112-B379-17896F4266E4|1||||||EDEMAIND|EDEMA INDICATOR||||GPL U|||/5X10^4 WBC|NOT DONE||N|U|U|1||38||OBSERVATION|1966-07-23||1968-11-30|||1961-06-15||1971-03-13
TRIAL STUDY 134XCP|RP|8F2DC6EB-0264-4112-B379-17896F4266E4|2||||||EDEMAIND|EDEMA INDICATOR||||MEQ|||U/MG|NOT DONE||N|NA|U|1||38||BLINDED TREATMENT|1972-07-11||1967-03-16|||1972-12-27||1960-04-24
TRIAL STUDY 134XCP|RP|8F2DC6EB-0264-4112-B379-17896F4266E4|1||||||PRGENDTC|DATE PREGNANCY ENDED||||APL U/ML|||PMOL/L|NOT DONE||NA|Y|N|2||58||BLINDED TREATMENT|1963-09-10||1972-02-07|||1967-08-20||1970-08-26
TRIAL STUDY 134XCP|RP|8F2DC6EB-0264-4112-B379-17896F4266E4|2||||||MASSIND|MASS INDICATOR||||U/M2/DAY|||OZ EQ|NOT DONE||N|Y|Y|2||58||OBSERVATION|1963-03-21||1963-07-21|||1960-04-13||1965-03-31
TRIAL STUDY 134XCP|RP|8F2DC6EB-0264-4112-B379-17896F4266E4|1||||||DSCHGIND|DISCHARGE INDICATOR||||BOX|||UMOL/L|NOT DONE||NA|N|U|3||39||BASELINE|1965-11-30||1973-01-26|||1968-09-08||1970-11-25
TRIAL STUDY 134XCP|RP|8F2DC6EB-0264-4112-B379-17896F4266E4|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||U/M2/MIN|||UIU/L|NOT DONE||U|Y|Y|3||39||INDUCTION TREATMENT|1961-02-08||1971-01-23|||1965-05-20||1970-01-26
TRIAL STUDY 134XCP|RP|8F2DC6EB-0264-4112-B379-17896F4266E4|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||/40 HPFS|||GENEQ/ML|NOT DONE||U|U|U|4||88||LONG-TERM FOLLOW-UP|1965-09-21||1969-10-02|||1966-06-28||1963-09-01
TRIAL STUDY 134XCP|RP|8F2DC6EB-0264-4112-B379-17896F4266E4|2||||||PREGIND|PREGNANT INDICATOR||||L/H/M2|||IU/DL|NOT DONE||NA|NA|U|4||88||BASELINE|1965-05-03||1972-03-27|||1964-10-11||1962-12-26
TRIAL STUDY 134XCP|RP|8F2DC6EB-0264-4112-B379-17896F4266E4|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UG/H|||L/DAY|NOT DONE||N|NA|U|5||7||SCREENING|1970-02-27||1971-10-10|||1962-06-16||1971-11-01
TRIAL STUDY 134XCP|RP|8F2DC6EB-0264-4112-B379-17896F4266E4|2||||||PRGENDTC|DATE PREGNANCY ENDED||||%|||STEPS/MIN|NOT DONE||N|Y|N|5||7||OPEN LABEL TREATMENT|1972-01-18||1972-08-29|||1967-10-11||1971-09-16
TRIAL STUDY 134XCP|RP|448246D1-5625-4F69-B214-3A8848E86C28|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MG/L FEU|||MJOULE/CM2|NOT DONE||U|Y|N|1||38||SCREENING|1968-11-05||1964-01-22|||1970-03-28||1968-06-28
TRIAL STUDY 134XCP|RP|448246D1-5625-4F69-B214-3A8848E86C28|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||GENEQ|||/10^5|NOT DONE||Y|Y|U|1||38||INDUCTION TREATMENT|1967-11-16||1965-05-26|||1969-09-29||1966-07-17
TRIAL STUDY 134XCP|RP|448246D1-5625-4F69-B214-3A8848E86C28|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MAC50|||10^12/L|NOT DONE||N|NA|U|2||58||INDUCTION TREATMENT|1971-03-31||1966-11-04|||1965-10-12||1961-02-04
TRIAL STUDY 134XCP|RP|448246D1-5625-4F69-B214-3A8848E86C28|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||CAL|||YEARS|NOT DONE||Y|Y|NA|2||58||FOLLOW-UP|1963-08-30||1963-05-09|||1970-09-13||1964-03-01
TRIAL STUDY 134XCP|RP|448246D1-5625-4F69-B214-3A8848E86C28|1||||||INTP|INTERPRETATION||||CFU/ML|||/10^3|NOT DONE||N|N|NA|3||39||BLINDED TREATMENT|1971-03-20||1962-04-11|||1961-03-20||1969-08-19
TRIAL STUDY 134XCP|RP|448246D1-5625-4F69-B214-3A8848E86C28|2||||||STILBIND|STILLBIRTH INDICATOR||||UMOL/MIN|||MG/ML/DAY|NOT DONE||U|N|N|3||39||WASHOUT|1965-12-02||1966-10-31|||1966-05-31||1961-08-04
TRIAL STUDY 134XCP|RP|448246D1-5625-4F69-B214-3A8848E86C28|1||||||INTP|INTERPRETATION||||MG/M2/DAY|||MEQ|NOT DONE||U|N|U|4||88||BASELINE|1968-06-16||1971-09-07|||1960-01-06||1970-11-24
TRIAL STUDY 134XCP|RP|448246D1-5625-4F69-B214-3A8848E86C28|2||||||PREGST|PREGNANT DURING THE STUDY||||LOG10 ELISA UNIT|||NMOL BCE/NMOL|NOT DONE||U|Y|N|4||88||TREATMENT|1960-05-26||1964-10-14|||1965-02-26||1960-12-23
TRIAL STUDY 134XCP|RP|448246D1-5625-4F69-B214-3A8848E86C28|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MBQ|||10^6 CFU/G|NOT DONE||Y|U|NA|5||7||WASHOUT|1965-09-06||1965-03-20|||1962-09-01||1972-06-11
TRIAL STUDY 134XCP|RP|448246D1-5625-4F69-B214-3A8848E86C28|2||||||BRTHN|NUMBER OF BIRTHS||||MCI|||IU/KG/H|NOT DONE||U|NA|NA|5||7||SCREENING|1960-03-20||1973-03-26|||1971-01-17||1965-11-02
TRIAL STUDY 134XCP|RP|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UMOL/L/MIN|||PATCH|NOT DONE||U|U|N|1||38||SCREENING|1970-01-14||1960-08-09|||1971-10-11||1963-12-20
TRIAL STUDY 134XCP|RP|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|2||||||ABORTN|NUMBER OF ABORTIONS||||SHOCK WAVE|||DEG/S|NOT DONE||Y|U|Y|1||38||INDUCTION TREATMENT|1966-11-08||1967-11-27|||1963-03-28||1964-05-25
TRIAL STUDY 134XCP|RP|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|1||||||RASHIND|RASH INDICATOR||||MM/SEC|||UMOL/MIN|NOT DONE||NA|U|U|2||58||SCREENING|1968-08-30||1973-04-20|||1962-12-07||1962-09-03
TRIAL STUDY 134XCP|RP|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||PG/DL|||MG/KG/MIN|NOT DONE||NA|NA|N|2||58||SCREENING|1962-10-04||1970-07-08|||1968-09-11||1971-09-07
TRIAL STUDY 134XCP|RP|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|1||||||ERYTHIND|ERYTHEMA INDICATOR||||ML/S/M2|||U/M2|NOT DONE||NA|Y|U|3||39||BASELINE|1960-05-31||1972-02-10|||1972-04-13||1972-10-09
TRIAL STUDY 134XCP|RP|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|2||||||STILBIND|STILLBIRTH INDICATOR||||ML/KG/H|||U/G|NOT DONE||N|Y|Y|3||39||WASHOUT|1972-10-30||1968-09-23|||1970-07-08||1971-07-27
TRIAL STUDY 134XCP|RP|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^6 CFU/G|||GBQ|NOT DONE||U|NA|Y|4||88||BLINDED TREATMENT|1967-03-03||1969-02-16|||1961-02-16||1967-01-03
TRIAL STUDY 134XCP|RP|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||DPM/100MG|||CD*S/M2|NOT DONE||U|N|N|4||88||RUN-IN|1962-03-13||1966-10-15|||1969-10-04||1964-01-08
TRIAL STUDY 134XCP|RP|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||KBQ/UL|||ML/DAY|NOT DONE||NA|U|N|5||7||FOLLOW-UP|1973-03-28||1973-03-14|||1961-04-02||1963-04-29
TRIAL STUDY 134XCP|RP|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||L|||FOZ_US|NOT DONE||U|N|Y|5||7||OBSERVATION|1965-06-20||1969-03-16|||1966-09-21||1960-09-03
TRIAL STUDY 134XCP|RP|27DDBB16-ED11-45B6-987D-FB0D8223B993|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||HOUNSFIELD UNIT|||GLOBULE|NOT DONE||U|N|N|1||38||WASHOUT|1971-09-02||1971-04-04|||1970-07-20||1963-02-03
TRIAL STUDY 134XCP|RP|27DDBB16-ED11-45B6-987D-FB0D8223B993|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||G/CAGE|||MPS U|NOT DONE||Y|U|N|1||38||CONTINUATION TREATMENT|1968-12-04||1970-12-03|||1961-03-03||1963-03-14
TRIAL STUDY 134XCP|RP|27DDBB16-ED11-45B6-987D-FB0D8223B993|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||CI/MG|||UEQ/L|NOT DONE||Y|NA|N|2||58||FOLLOW-UP|1966-11-25||1966-06-04|||1973-04-11||1966-01-04
TRIAL STUDY 134XCP|RP|27DDBB16-ED11-45B6-987D-FB0D8223B993|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||DRINK|||HZ/S|NOT DONE||Y|NA|Y|2||58||BLINDED TREATMENT|1961-03-02||1965-06-16|||1972-07-17||1965-03-22
TRIAL STUDY 134XCP|RP|27DDBB16-ED11-45B6-987D-FB0D8223B993|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MS/MMHG|||CIGARETTE|NOT DONE||Y|NA|U|3||39||INDUCTION TREATMENT|1972-08-04||1961-01-26|||1971-09-25||1961-01-26
TRIAL STUDY 134XCP|RP|27DDBB16-ED11-45B6-987D-FB0D8223B993|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||G/KG/DAY|||ML/M2/MIN|NOT DONE||U|Y|U|3||39||FOLLOW-UP|1971-04-30||1969-07-23|||1962-02-07||1962-04-06
TRIAL STUDY 134XCP|RP|27DDBB16-ED11-45B6-987D-FB0D8223B993|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||NMOL/ML/MIN|||10^9 ORGANISMS/G|NOT DONE||Y|N|N|4||88||RUN-IN|1965-12-09||1967-12-08|||1972-12-26||1963-06-28
TRIAL STUDY 134XCP|RP|27DDBB16-ED11-45B6-987D-FB0D8223B993|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||CMH2O*S2/ML|||MG/ANIMAL|NOT DONE||U|N|Y|4||88||OPEN LABEL TREATMENT|1961-10-18||1964-05-23|||1970-06-27||1972-06-24
TRIAL STUDY 134XCP|RP|27DDBB16-ED11-45B6-987D-FB0D8223B993|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||PL|||NEEDLE GAUGE|NOT DONE||NA|U|N|5||7||CONTINUATION TREATMENT|1972-05-29||1960-12-05|||1962-05-23||1969-08-13
TRIAL STUDY 134XCP|RP|27DDBB16-ED11-45B6-987D-FB0D8223B993|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||OHM|||DYN|NOT DONE||Y|NA|Y|5||7||CONTINUATION TREATMENT|1965-04-28||1965-10-13|||1972-06-27||1973-06-22
TRIAL STUDY 134XCP|RP|5545846C-F90F-4346-A075-05999641B872|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||DNA COPIES/UG|||ML/BEAT|NOT DONE||U|U|N|1||38||OBSERVATION|1966-01-29||1968-08-22|||1961-12-27||1965-08-15
TRIAL STUDY 134XCP|RP|5545846C-F90F-4346-A075-05999641B872|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||COPIES/UL|||BOLUS|NOT DONE||N|NA|NA|1||38||WASHOUT|1967-09-05||1972-05-25|||1968-01-29||1965-04-02
TRIAL STUDY 134XCP|RP|5545846C-F90F-4346-A075-05999641B872|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||LOG10 PFU/ML|||UG/DOSE|NOT DONE||U|N|U|2||58||WASHOUT|1973-01-11||1969-07-31|||1970-11-12||1968-06-17
TRIAL STUDY 134XCP|RP|5545846C-F90F-4346-A075-05999641B872|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||PPM|||UMOL/KG/MIN|NOT DONE||NA|N|NA|2||58||FOLLOW-UP|1963-03-11||1961-06-14|||1966-07-03||1961-11-05
TRIAL STUDY 134XCP|RP|5545846C-F90F-4346-A075-05999641B872|1||||||PREGIND|PREGNANT INDICATOR||||CCID 50/DOSE|||%(W/W)|NOT DONE||U|U|Y|3||39||WASHOUT|1962-02-27||1964-09-24|||1966-10-24||1972-07-26
TRIAL STUDY 134XCP|RP|5545846C-F90F-4346-A075-05999641B872|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||KDA|||10^6/HPF|NOT DONE||U|N|N|3||39||SCREENING|1972-10-21||1966-10-14|||1960-06-15||1969-02-17
TRIAL STUDY 134XCP|RP|5545846C-F90F-4346-A075-05999641B872|1||||||PREGIND|PREGNANT INDICATOR||||CONTAINER|||LOG10 TCID 50/UL|NOT DONE||Y|NA|N|4||88||BLINDED TREATMENT|1963-05-19||1968-11-21|||1966-05-14||1960-02-26
TRIAL STUDY 134XCP|RP|5545846C-F90F-4346-A075-05999641B872|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||WEBER|||BU|NOT DONE||U|NA|NA|4||88||OPEN LABEL TREATMENT|1971-07-20||1965-07-20|||1961-05-04||1965-02-17
TRIAL STUDY 134XCP|RP|5545846C-F90F-4346-A075-05999641B872|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^6/G|||CMHG|NOT DONE||U|U|U|5||7||LONG-TERM FOLLOW-UP|1961-01-17||1961-02-18|||1969-08-27||1968-08-23
TRIAL STUDY 134XCP|RP|5545846C-F90F-4346-A075-05999641B872|2||||||INTP|INTERPRETATION||||KM|||FRACTION OF 1|NOT DONE||U|Y|Y|5||7||INDUCTION TREATMENT|1964-05-09||1969-11-18|||1962-12-28||1967-01-29
TRIAL STUDY 134XCP|RP|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|1||||||MASSIND|MASS INDICATOR||||/KG|||MV*MIN|NOT DONE||Y|U|NA|1||38||WASHOUT|1970-11-25||1967-02-04|||1969-01-09||1971-10-25
TRIAL STUDY 134XCP|RP|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|2||||||GRAVIND|GRAVIDA INDICATOR||||UV2|||G/ANIMAL|NOT DONE||NA|Y|NA|1||38||BASELINE|1969-12-26||1964-07-11|||1970-10-17||1969-02-26
TRIAL STUDY 134XCP|RP|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MM3/MM2/YEAR|||UL/KG/DAY|NOT DONE||Y|Y|U|2||58||BASELINE|1973-02-09||1966-07-19|||1961-10-20||1972-01-15
TRIAL STUDY 134XCP|RP|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|2||||||PREGST|PREGNANT DURING THE STUDY||||CD|||UKAT|NOT DONE||U|NA|NA|2||58||SCREENING|1966-04-03||1970-08-06|||1964-07-11||1963-06-20
TRIAL STUDY 134XCP|RP|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|1||||||DLVRMODE|MODE OF DELIVERY||||TROCHE|||PELLET|NOT DONE||NA|NA|U|3||39||BLINDED TREATMENT|1963-12-20||1971-05-04|||1972-01-06||1969-04-08
TRIAL STUDY 134XCP|RP|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||H*%|||10^9 CFU|NOT DONE||Y|NA|NA|3||39||BASELINE|1967-09-25||1965-12-16|||1971-10-06||1962-06-25
TRIAL STUDY 134XCP|RP|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||BAR|||10^9 ORGANISMS|NOT DONE||NA|Y|NA|4||88||TREATMENT|1966-11-19||1967-11-29|||1965-02-21||1968-04-09
TRIAL STUDY 134XCP|RP|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|2||||||MENFDUR|MENSES FLOW DURATION||||TUBERCULIN UNIT|||MM3/MM2/YEAR|NOT DONE||Y|NA|N|4||88||OBSERVATION|1966-01-28||1963-06-06|||1969-09-04||1961-02-16
TRIAL STUDY 134XCP|RP|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UGEQ|||FFU|NOT DONE||U|U|NA|5||7||LONG-TERM FOLLOW-UP|1968-04-18||1969-03-09|||1971-10-27||1965-06-14
TRIAL STUDY 134XCP|RP|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||WATT|||MMOL/MIN/KPA|NOT DONE||NA|U|N|5||7||WASHOUT|1963-01-16||1964-07-07|||1968-03-10||1963-09-03
TRIAL STUDY 134XCP|RP|111541DB-D863-4C68-9E62-B8741A62401C|1||||||MENOAGE|MENOPAUSE AGE||||/MM2|||TRANSDUCING UNIT|NOT DONE||U|N|U|1||38||INDUCTION TREATMENT|1964-09-04||1962-03-13|||1972-03-09||1972-11-11
TRIAL STUDY 134XCP|RP|111541DB-D863-4C68-9E62-B8741A62401C|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||S/H|||10^4 CFU|NOT DONE||NA|NA|U|1||38||WASHOUT|1966-01-03||1967-01-16|||1963-10-14||1962-09-19
TRIAL STUDY 134XCP|RP|111541DB-D863-4C68-9E62-B8741A62401C|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||FOZ_BR|||ML/ANIMAL/DAY|NOT DONE||N|NA|NA|2||58||CONTINUATION TREATMENT|1967-04-24||1961-12-28|||1972-06-03||1969-11-24
TRIAL STUDY 134XCP|RP|111541DB-D863-4C68-9E62-B8741A62401C|2||||||RASHIND|RASH INDICATOR||||TRANSDUCING UNIT/ML|||KG/CM|NOT DONE||Y|Y|U|2||58||WASHOUT|1973-08-16||1961-01-29|||1972-08-08||1960-11-04
TRIAL STUDY 134XCP|RP|111541DB-D863-4C68-9E62-B8741A62401C|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||ML/KG/MIN|||FFU|NOT DONE||U|N|Y|3||39||WASHOUT|1966-01-28||1964-02-26|||1964-11-23||1960-11-07
TRIAL STUDY 134XCP|RP|111541DB-D863-4C68-9E62-B8741A62401C|2||||||ERYTHIND|ERYTHEMA INDICATOR||||G/CAGE/DAY|||MCI/KG|NOT DONE||NA|N|N|3||39||CONTINUATION TREATMENT|1965-07-16||1966-07-28|||1972-07-19||1965-08-21
TRIAL STUDY 134XCP|RP|111541DB-D863-4C68-9E62-B8741A62401C|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||ML/DOSE|||BQ/UL|NOT DONE||NA|Y|NA|4||88||OBSERVATION|1963-03-28||1965-06-23|||1968-08-04||1972-05-02
TRIAL STUDY 134XCP|RP|111541DB-D863-4C68-9E62-B8741A62401C|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||LOG10 ELISA UNIT/DOSE|||USEC|NOT DONE||NA|NA|NA|4||88||OPEN LABEL TREATMENT|1965-12-30||1969-09-19|||1963-03-29||1967-07-12
TRIAL STUDY 134XCP|RP|111541DB-D863-4C68-9E62-B8741A62401C|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MPL U|||BQ/L|NOT DONE||NA|U|NA|5||7||TREATMENT|1966-10-11||1973-03-12|||1971-04-12||1967-01-31
TRIAL STUDY 134XCP|RP|111541DB-D863-4C68-9E62-B8741A62401C|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||IU/L|||USP U|NOT DONE||Y|NA|N|5||7||WASHOUT|1970-04-19||1963-06-05|||1968-11-10||1968-01-22
TRIAL STUDY 134XCP|RP|5095C113-7278-4D41-B860-0DF6B9B98738|1||||||TNDRIND|TENDERNESS INDICATOR||||BEAM BREAKS|||/40 HPFS|NOT DONE||U|Y|N|1||38||TREATMENT|1968-09-01||1962-02-16|||1967-05-02||1971-04-11
TRIAL STUDY 134XCP|RP|5095C113-7278-4D41-B860-0DF6B9B98738|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MPA|||LM|NOT DONE||NA|U|N|1||38||FOLLOW-UP|1963-11-10||1973-02-23|||1961-10-07||1969-04-16
TRIAL STUDY 134XCP|RP|5095C113-7278-4D41-B860-0DF6B9B98738|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||ABSORBANCE U/ML|||M|NOT DONE||U|NA|Y|2||58||LONG-TERM FOLLOW-UP|1967-07-28||1960-07-08|||1962-03-04||1973-08-09
TRIAL STUDY 134XCP|RP|5095C113-7278-4D41-B860-0DF6B9B98738|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||10^5/L|||ATM|NOT DONE||N|Y|NA|2||58||BASELINE|1968-01-27||1960-11-03|||1964-10-24||1963-03-18
TRIAL STUDY 134XCP|RP|5095C113-7278-4D41-B860-0DF6B9B98738|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MMOL/MIN/KPA/L|||BOLUS|NOT DONE||N|NA|NA|3||39||TREATMENT|1971-07-05||1970-08-28|||1968-01-27||1963-03-22
TRIAL STUDY 134XCP|RP|5095C113-7278-4D41-B860-0DF6B9B98738|2||||||PUSTIND|PUSTULE INDICATOR||||MEQ/UL|||IMPLANT|NOT DONE||N|U|Y|3||39||LONG-TERM FOLLOW-UP|1962-02-14||1965-11-24|||1966-11-05||1960-07-04
TRIAL STUDY 134XCP|RP|5095C113-7278-4D41-B860-0DF6B9B98738|1||||||PREGIND|PREGNANT INDICATOR||||USIEMENS|||SHOCK WAVE|NOT DONE||NA|NA|N|4||88||TREATMENT|1961-09-04||1962-04-30|||1964-01-01||1963-12-03
TRIAL STUDY 134XCP|RP|5095C113-7278-4D41-B860-0DF6B9B98738|2||||||ULCERIND|ULCER INDICATOR||||CCID 50/DOSE|||MOL|NOT DONE||Y|Y|N|4||88||RUN-IN|1970-03-26||1961-07-04|||1968-08-26||1971-09-09
TRIAL STUDY 134XCP|RP|5095C113-7278-4D41-B860-0DF6B9B98738|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||GENEQ/ML|||OZ EQ|NOT DONE||U|NA|U|5||7||FOLLOW-UP|1969-06-23||1970-09-11|||1963-01-13||1962-11-28
TRIAL STUDY 134XCP|RP|5095C113-7278-4D41-B860-0DF6B9B98738|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||UCI/KG|||STRIP|NOT DONE||N|Y|U|5||7||INDUCTION TREATMENT|1971-02-15||1973-05-13|||1963-07-30||1970-05-04
TRIAL STUDY 134XCP|RP|61319D2E-A512-425F-9301-BAD27B5F5C9B|1||||||PREGST|PREGNANT DURING THE STUDY||||GLOBULE|||KBQ/UL|NOT DONE||N|Y|U|1||38||WASHOUT|1961-07-07||1968-07-19|||1961-01-01||1963-09-08
TRIAL STUDY 134XCP|RP|61319D2E-A512-425F-9301-BAD27B5F5C9B|2||||||RASHIND|RASH INDICATOR||||MEQ/DL|||KIU|NOT DONE||NA|Y|U|1||38||OBSERVATION|1963-11-08||1973-02-03|||1963-06-23||1967-04-19
TRIAL STUDY 134XCP|RP|61319D2E-A512-425F-9301-BAD27B5F5C9B|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||ABSORBANCE U/ML|||PFU/ANIMAL|NOT DONE||U|N|NA|2||58||CONTINUATION TREATMENT|1963-10-12||1971-08-23|||1963-10-27||1965-02-03
TRIAL STUDY 134XCP|RP|61319D2E-A512-425F-9301-BAD27B5F5C9B|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||G/G|||10^6/G|NOT DONE||NA|Y|N|2||58||TREATMENT|1969-10-26||1964-05-05|||1972-04-02||1971-05-21
TRIAL STUDY 134XCP|RP|61319D2E-A512-425F-9301-BAD27B5F5C9B|1||||||MENFDUR|MENSES FLOW DURATION||||CI/UG|||KV|NOT DONE||NA|NA|Y|3||39||SCREENING|1970-01-09||1963-06-20|||1960-04-30||1965-10-28
TRIAL STUDY 134XCP|RP|61319D2E-A512-425F-9301-BAD27B5F5C9B|2||||||EDEMAIND|EDEMA INDICATOR||||MMOL/L|||10^6 ORGANISMS/G|NOT DONE||N|Y|NA|3||39||TREATMENT|1963-08-07||1963-06-05|||1970-11-28||1965-10-15
TRIAL STUDY 134XCP|RP|61319D2E-A512-425F-9301-BAD27B5F5C9B|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||KAT|||10^4/HPF|NOT DONE||NA|Y|Y|4||88||WASHOUT|1968-11-10||1969-01-18|||1961-12-17||1966-08-25
TRIAL STUDY 134XCP|RP|61319D2E-A512-425F-9301-BAD27B5F5C9B|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ML/DOSE|||CUP|NOT DONE||U|U|NA|4||88||WASHOUT|1961-10-05||1960-03-17|||1972-02-12||1970-01-23
TRIAL STUDY 134XCP|RP|61319D2E-A512-425F-9301-BAD27B5F5C9B|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||AFU|||10^9 ORGANISMS/ML|NOT DONE||U|N|NA|5||7||INDUCTION TREATMENT|1972-07-23||1963-09-11|||1968-02-15||1968-12-07
TRIAL STUDY 134XCP|RP|61319D2E-A512-425F-9301-BAD27B5F5C9B|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||UOSM|||ML/DL|NOT DONE||Y|N|Y|5||7||SCREENING|1968-10-21||1965-10-20|||1964-01-19||1960-01-22
TRIAL STUDY 134XCP|RP|3B865A8F-949B-4B64-A818-85472EABB8FB|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||TBSP|||MOL/MG|NOT DONE||NA|Y|NA|1||38||OPEN LABEL TREATMENT|1966-09-23||1971-10-01|||1969-01-01||1960-03-02
TRIAL STUDY 134XCP|RP|3B865A8F-949B-4B64-A818-85472EABB8FB|2||||||GRAVIND|GRAVIDA INDICATOR||||BAR|||ROENTGEN|NOT DONE||Y|N|NA|1||38||WASHOUT|1960-08-04||1969-12-31|||1964-06-24||1965-07-24
TRIAL STUDY 134XCP|RP|3B865A8F-949B-4B64-A818-85472EABB8FB|1||||||BCMETHOD|BIRTH CONTROL METHOD||||COPIES/UL|||UG/KG/MIN|NOT DONE||NA|N|N|2||58||BASELINE|1966-04-04||1966-10-02|||1970-04-30||1971-03-09
TRIAL STUDY 134XCP|RP|3B865A8F-949B-4B64-A818-85472EABB8FB|2||||||ULCERIND|ULCER INDICATOR||||NCI|||HZ|NOT DONE||U|NA|NA|2||58||LONG-TERM FOLLOW-UP|1970-10-06||1972-09-26|||1971-03-22||1966-10-14
TRIAL STUDY 134XCP|RP|3B865A8F-949B-4B64-A818-85472EABB8FB|1||||||PREGNN|NUMBER OF PREGNANCIES||||KN/CM2|||MBP|NOT DONE||U|N|U|3||39||TREATMENT|1962-06-25||1962-03-13|||1968-02-26||1969-06-20
TRIAL STUDY 134XCP|RP|3B865A8F-949B-4B64-A818-85472EABB8FB|2||||||PRGENDTC|DATE PREGNANCY ENDED||||PMOL/DL|||CCID 50/ML|NOT DONE||N|N|N|3||39||OBSERVATION|1962-02-01||1971-03-16|||1962-11-15||1972-07-14
TRIAL STUDY 134XCP|RP|3B865A8F-949B-4B64-A818-85472EABB8FB|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||ML/MIN/MMHG|||L/H/M2|NOT DONE||NA|NA|NA|4||88||OBSERVATION|1966-08-03||1972-04-29|||1961-11-21||1961-10-21
TRIAL STUDY 134XCP|RP|3B865A8F-949B-4B64-A818-85472EABB8FB|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||RNA COPIES/ML|||10^8/L|NOT DONE||NA|U|NA|4||88||BASELINE|1960-05-01||1963-12-16|||1969-05-13||1969-03-14
TRIAL STUDY 134XCP|RP|3B865A8F-949B-4B64-A818-85472EABB8FB|1||||||MENARAGE|MENARCHE AGE||||MS/MMHG|||OD UNIT|NOT DONE||N|NA|NA|5||7||TREATMENT|1973-06-30||1968-01-29|||1964-03-07||1961-08-29
TRIAL STUDY 134XCP|RP|3B865A8F-949B-4B64-A818-85472EABB8FB|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||BQ/ML|||LOG10 CFU/G|NOT DONE||U|Y|NA|5||7||BASELINE|1971-11-05||1962-08-12|||1967-08-09||1969-03-07
TRIAL STUDY 134XCP|RP|A6909912-22B9-4EE7-AEDF-F791F243A6B7|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||TUBE|||UV2|NOT DONE||Y|NA|N|1||38||SCREENING|1968-12-19||1968-07-21|||1969-11-28||1970-12-22
TRIAL STUDY 134XCP|RP|A6909912-22B9-4EE7-AEDF-F791F243A6B7|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||AGU/ML|||FMOL/L/SEC|NOT DONE||N|NA|U|1||38||BLINDED TREATMENT|1972-11-12||1964-10-26|||1968-03-28||1962-10-07
TRIAL STUDY 134XCP|RP|A6909912-22B9-4EE7-AEDF-F791F243A6B7|1||||||TNDRIND|TENDERNESS INDICATOR||||ML/M2/DAY|||NMOL/L/MIN|NOT DONE||N|N|N|2||58||SCREENING|1971-03-27||1960-10-27|||1962-03-20||1969-10-24
TRIAL STUDY 134XCP|RP|A6909912-22B9-4EE7-AEDF-F791F243A6B7|2||||||ERYTHIND|ERYTHEMA INDICATOR||||DDU|||EID 50/ML|NOT DONE||U|U|N|2||58||WASHOUT|1966-08-10||1962-08-19|||1965-09-18||1969-03-24
TRIAL STUDY 134XCP|RP|A6909912-22B9-4EE7-AEDF-F791F243A6B7|1||||||PREGNN|NUMBER OF PREGNANCIES||||PM|||LB|NOT DONE||U|NA|Y|3||39||OBSERVATION|1964-10-09||1973-04-13|||1967-11-28||1964-03-31
TRIAL STUDY 134XCP|RP|A6909912-22B9-4EE7-AEDF-F791F243A6B7|2||||||BRTHN|NUMBER OF BIRTHS||||TRANSDUCING UNIT|||PFU|NOT DONE||NA|N|U|3||39||RUN-IN|1968-10-04||1972-10-12|||1967-10-21||1966-01-20
TRIAL STUDY 134XCP|RP|A6909912-22B9-4EE7-AEDF-F791F243A6B7|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||U/DL|||OI50|NOT DONE||N|U|NA|4||88||OPEN LABEL TREATMENT|1962-05-14||1963-01-03|||1966-04-24||1966-10-06
TRIAL STUDY 134XCP|RP|A6909912-22B9-4EE7-AEDF-F791F243A6B7|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MG/M2/H|||RFU|NOT DONE||Y|NA|Y|4||88||INDUCTION TREATMENT|1962-01-04||1973-07-23|||1967-12-26||1961-09-05
TRIAL STUDY 134XCP|RP|A6909912-22B9-4EE7-AEDF-F791F243A6B7|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||APPLICATION|||MEQ/DAY|NOT DONE||N|N|NA|5||7||FOLLOW-UP|1971-12-07||1963-08-21|||1966-02-24||1971-04-13
TRIAL STUDY 134XCP|RP|A6909912-22B9-4EE7-AEDF-F791F243A6B7|2||||||MENOSTAT|MENOPAUSE STATUS||||ML/MIN/MMHG|||PA|NOT DONE||Y|Y|N|5||7||OPEN LABEL TREATMENT|1971-05-17||1965-09-27|||1964-07-20||1972-07-29
TRIAL STUDY 134XCP|RP|83C8AAD3-B22D-42C6-870A-D069FAC601F3|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||GRAIN|||APL U|NOT DONE||U|NA|NA|1||38||SCREENING|1964-05-08||1970-05-02|||1965-01-29||1968-03-12
TRIAL STUDY 134XCP|RP|83C8AAD3-B22D-42C6-870A-D069FAC601F3|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||BREATHS/MIN|||GBQ|NOT DONE||Y|NA|NA|1||38||SCREENING|1960-01-05||1961-04-10|||1960-12-24||1973-05-16
TRIAL STUDY 134XCP|RP|83C8AAD3-B22D-42C6-870A-D069FAC601F3|1||||||DSCHGIND|DISCHARGE INDICATOR||||KN/CM2|||MET*MIN|NOT DONE||U|NA|U|2||58||RUN-IN|1964-04-08||1970-10-16|||1961-04-26||1960-07-23
TRIAL STUDY 134XCP|RP|83C8AAD3-B22D-42C6-870A-D069FAC601F3|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||10^12 IU/L|||MMHG*MIN/L|NOT DONE||N|Y|N|2||58||OBSERVATION|1961-04-24||1964-12-27|||1965-01-28||1967-02-07
TRIAL STUDY 134XCP|RP|83C8AAD3-B22D-42C6-870A-D069FAC601F3|1||||||TNDRIND|TENDERNESS INDICATOR||||SIEMENS|||MG/H|NOT DONE||U|N|NA|3||39||INDUCTION TREATMENT|1970-07-08||1965-07-20|||1961-09-17||1966-10-05
TRIAL STUDY 134XCP|RP|83C8AAD3-B22D-42C6-870A-D069FAC601F3|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||VG/KG|||FT2|NOT DONE||NA|NA|N|3||39||LONG-TERM FOLLOW-UP|1968-05-30||1970-09-03|||1972-08-07||1963-01-19
TRIAL STUDY 134XCP|RP|83C8AAD3-B22D-42C6-870A-D069FAC601F3|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||TAMPON|||MG/CM2|NOT DONE||N|Y|Y|4||88||BASELINE|1966-09-14||1962-01-06|||1962-06-18||1965-02-18
TRIAL STUDY 134XCP|RP|83C8AAD3-B22D-42C6-870A-D069FAC601F3|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MBP|||APS U|NOT DONE||NA|NA|N|4||88||FOLLOW-UP|1960-05-27||1970-06-05|||1967-02-18||1972-04-18
TRIAL STUDY 134XCP|RP|83C8AAD3-B22D-42C6-870A-D069FAC601F3|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MOL/DAY|||PMOL/10^10 CELLS|NOT DONE||N|N|N|5||7||TREATMENT|1969-04-20||1965-07-27|||1966-10-02||1960-09-08
TRIAL STUDY 134XCP|RP|83C8AAD3-B22D-42C6-870A-D069FAC601F3|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||TAMPON|||PSI|NOT DONE||NA|U|Y|5||7||FOLLOW-UP|1972-05-06||1973-05-23|||1961-12-27||1966-06-10
TRIAL STUDY 134XCP|RP|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||PFU/ANIMAL|||MG/KG/DOSE|NOT DONE||Y|N|NA|1||38||CONTINUATION TREATMENT|1967-05-02||1964-09-24|||1964-05-19||1967-08-31
TRIAL STUDY 134XCP|RP|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||CMH2O*S/ML|||10^9 CFU/G|NOT DONE||N|Y|U|1||38||WASHOUT|1970-01-03||1960-04-28|||1960-01-05||1963-05-21
TRIAL STUDY 134XCP|RP|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||IU/KG/H|||GENEQ|NOT DONE||N|N|Y|2||58||WASHOUT|1973-03-31||1967-03-10|||1965-03-01||1969-10-09
TRIAL STUDY 134XCP|RP|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MS2|||PUFF|NOT DONE||NA|Y|Y|2||58||OBSERVATION|1964-02-06||1964-08-25|||1970-02-08||1964-03-08
TRIAL STUDY 134XCP|RP|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|1||||||PUSTIND|PUSTULE INDICATOR||||IN2|||NEBULE|NOT DONE||NA|NA|U|3||39||TREATMENT|1960-06-28||1967-11-03|||1966-10-01||1969-12-30
TRIAL STUDY 134XCP|RP|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||KUSP|||MG/M2/H|NOT DONE||U|Y|N|3||39||WASHOUT|1971-09-26||1961-06-09|||1972-10-24||1963-12-25
TRIAL STUDY 134XCP|RP|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||FT2|||10^5/HPF|NOT DONE||NA|NA|U|4||88||BLINDED TREATMENT|1964-11-14||1964-02-24|||1964-10-03||1972-09-13
TRIAL STUDY 134XCP|RP|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||BQ/UL|||AMPULE|NOT DONE||Y|N|N|4||88||SCREENING|1962-11-10||1963-02-02|||1960-01-21||1972-07-17
TRIAL STUDY 134XCP|RP|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|1||||||PREGNN|NUMBER OF PREGNANCIES||||UU/DL|||KA_U/DL|NOT DONE||NA|U|N|5||7||BASELINE|1970-01-02||1971-03-07|||1969-10-03||1972-02-25
TRIAL STUDY 134XCP|RP|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||UEQ/L|||ML/G/H|NOT DONE||U|N|NA|5||7||RUN-IN|1964-07-05||1972-10-27|||1970-04-02||1963-07-16
TRIAL STUDY 134XCP|RP|937BF41A-157D-45F6-9797-2C5D19D100E6|1||||||ULCERIND|ULCER INDICATOR||||NMOL|||PIXELS/CM|NOT DONE||Y|NA|NA|1||38||LONG-TERM FOLLOW-UP|1962-03-10||1964-01-09|||1961-08-06||1963-01-31
TRIAL STUDY 134XCP|RP|937BF41A-157D-45F6-9797-2C5D19D100E6|2||||||MASSIND|MASS INDICATOR||||PKAT/L|||MOL/MOL|NOT DONE||Y|N|Y|1||38||CONTINUATION TREATMENT|1972-10-21||1960-04-30|||1967-05-15||1972-12-15
TRIAL STUDY 134XCP|RP|937BF41A-157D-45F6-9797-2C5D19D100E6|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||H/WK|||PKAT|NOT DONE||NA|Y|NA|2||58||OPEN LABEL TREATMENT|1971-07-19||1971-08-13|||1966-07-18||1960-08-29
TRIAL STUDY 134XCP|RP|937BF41A-157D-45F6-9797-2C5D19D100E6|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||M3|||EVENTS|NOT DONE||NA|U|Y|2||58||TREATMENT|1968-06-04||1973-05-16|||1960-06-25||1965-02-23
TRIAL STUDY 134XCP|RP|937BF41A-157D-45F6-9797-2C5D19D100E6|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||CG|||PPTH|NOT DONE||Y|N|N|3||39||OPEN LABEL TREATMENT|1965-05-07||1965-06-13|||1971-02-19||1968-03-25
TRIAL STUDY 134XCP|RP|937BF41A-157D-45F6-9797-2C5D19D100E6|2||||||BCMETHOD|BIRTH CONTROL METHOD||||10^10/L|||PMOL/L|NOT DONE||N|U|N|3||39||TREATMENT|1967-01-30||1968-12-21|||1965-07-09||1972-12-22
TRIAL STUDY 134XCP|RP|937BF41A-157D-45F6-9797-2C5D19D100E6|1||||||MENFDUR|MENSES FLOW DURATION||||MBP|||NEWTON|NOT DONE||U|NA|Y|4||88||FOLLOW-UP|1967-10-24||1972-04-25|||1971-10-08||1967-03-29
TRIAL STUDY 134XCP|RP|937BF41A-157D-45F6-9797-2C5D19D100E6|2||||||PEELIND|PEELING INDICATOR||||U/CL|||VG/ML|NOT DONE||N|U|Y|4||88||TREATMENT|1973-01-07||1971-04-27|||1965-04-08||1967-10-11
TRIAL STUDY 134XCP|RP|937BF41A-157D-45F6-9797-2C5D19D100E6|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||UMOL/MG/MIN|||MG/ML/MIN|NOT DONE||U|Y|Y|5||7||FOLLOW-UP|1971-05-02||1971-06-18|||1969-01-16||1971-10-24
TRIAL STUDY 134XCP|RP|937BF41A-157D-45F6-9797-2C5D19D100E6|2||||||PREGIND|PREGNANT INDICATOR||||STEPS|||AFU|NOT DONE||N|N|U|5||7||OBSERVATION|1965-05-14||1971-05-31|||1962-08-19||1960-01-22
TRIAL STUDY 134XCP|RP|1BA56D89-E536-491E-AD6A-190A07331BEA|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||PPTR|||PMOL|NOT DONE||U|NA|N|1||38||SCREENING|1966-08-20||1960-10-26|||1968-08-17||1967-06-01
TRIAL STUDY 134XCP|RP|1BA56D89-E536-491E-AD6A-190A07331BEA|2||||||STILBIND|STILLBIRTH INDICATOR||||ABSORBANCE U/ML|||PG/L|NOT DONE||U|NA|U|1||38||SCREENING|1964-03-28||1961-03-19|||1966-07-13||1971-01-10
TRIAL STUDY 134XCP|RP|1BA56D89-E536-491E-AD6A-190A07331BEA|1||||||GRAVIND|GRAVIDA INDICATOR||||LOG10 COPIES/ML|||PFU|NOT DONE||U|U|NA|2||58||INDUCTION TREATMENT|1964-05-30||1961-08-04|||1963-05-15||1968-03-31
TRIAL STUDY 134XCP|RP|1BA56D89-E536-491E-AD6A-190A07331BEA|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||CG|||PKAT|NOT DONE||U|Y|U|2||58||TREATMENT|1963-10-02||1964-04-23|||1970-07-08||1965-12-26
TRIAL STUDY 134XCP|RP|1BA56D89-E536-491E-AD6A-190A07331BEA|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UG/CM2|||AMOL|NOT DONE||Y|N|Y|3||39||BLINDED TREATMENT|1961-07-13||1961-02-10|||1969-05-22||1962-05-01
TRIAL STUDY 134XCP|RP|1BA56D89-E536-491E-AD6A-190A07331BEA|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||BOX|||CM H2O|NOT DONE||N|N|Y|3||39||FOLLOW-UP|1961-02-01||1965-12-27|||1962-10-29||1964-01-20
TRIAL STUDY 134XCP|RP|1BA56D89-E536-491E-AD6A-190A07331BEA|1||||||PREGIND|PREGNANT INDICATOR||||IU/KG|||PFU/ML|NOT DONE||NA|N|NA|4||88||CONTINUATION TREATMENT|1962-12-18||1963-03-25|||1969-04-27||1971-06-28
TRIAL STUDY 134XCP|RP|1BA56D89-E536-491E-AD6A-190A07331BEA|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UG/G/MIN|||ANSON U|NOT DONE||N|U|NA|4||88||BLINDED TREATMENT|1970-09-04||1961-04-19|||1969-11-01||1965-03-03
TRIAL STUDY 134XCP|RP|1BA56D89-E536-491E-AD6A-190A07331BEA|1||||||MASSIND|MASS INDICATOR||||10^9/DOSE|||KCAL/DAY|NOT DONE||Y|U|Y|5||7||OPEN LABEL TREATMENT|1966-01-18||1967-03-13|||1973-04-20||1964-06-08
TRIAL STUDY 134XCP|RP|1BA56D89-E536-491E-AD6A-190A07331BEA|2||||||FUNDHT|FUNDAL HEIGHT||||HENRY|||UV|NOT DONE||Y|N|U|5||7||BASELINE|1971-11-25||1960-08-18|||1972-07-27||1967-06-01
TRIAL STUDY 134XCP|RP|BE208D93-7322-427F-A8E5-1DBE5040BE8F|1||||||BRTHN|NUMBER OF BIRTHS||||10^12/L|||MV*MIN|NOT DONE||N|N|N|1||38||OBSERVATION|1973-03-26||1960-11-06|||1972-09-16||1966-02-08
TRIAL STUDY 134XCP|RP|BE208D93-7322-427F-A8E5-1DBE5040BE8F|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MMOL/MIN/KPA|||KBQ/UL|NOT DONE||N|N|Y|1||38||BASELINE|1963-01-01||1961-03-03|||1967-07-31||1961-09-10
TRIAL STUDY 134XCP|RP|BE208D93-7322-427F-A8E5-1DBE5040BE8F|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||G/KG/DAY|||HZ|NOT DONE||N|Y|NA|2||58||WASHOUT|1962-02-13||1964-11-26|||1965-04-03||1968-04-02
TRIAL STUDY 134XCP|RP|BE208D93-7322-427F-A8E5-1DBE5040BE8F|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MBP|||LM|NOT DONE||NA|NA|NA|2||58||RUN-IN|1967-08-03||1964-07-05|||1961-01-04||1961-08-02
TRIAL STUDY 134XCP|RP|BE208D93-7322-427F-A8E5-1DBE5040BE8F|1||||||ERYTHIND|ERYTHEMA INDICATOR||||INHALATION|||NKAT/G HB|NOT DONE||NA|N|N|3||39||TREATMENT|1965-12-29||1971-04-24|||1965-04-07||1970-12-30
TRIAL STUDY 134XCP|RP|BE208D93-7322-427F-A8E5-1DBE5040BE8F|2||||||PUSTIND|PUSTULE INDICATOR||||SYRINGE|||PHERESIS UNIT|NOT DONE||N|NA|NA|3||39||WASHOUT|1967-08-07||1965-08-03|||1963-01-16||1971-01-15
TRIAL STUDY 134XCP|RP|BE208D93-7322-427F-A8E5-1DBE5040BE8F|1||||||TNDRIND|TENDERNESS INDICATOR||||HOURS|||ANTIBODY UNIT|NOT DONE||N|NA|NA|4||88||OBSERVATION|1963-02-17||1968-12-17|||1963-04-10||1960-03-03
TRIAL STUDY 134XCP|RP|BE208D93-7322-427F-A8E5-1DBE5040BE8F|2||||||PEELIND|PEELING INDICATOR||||10^9/G|||ML/MIN|NOT DONE||U|NA|Y|4||88||OPEN LABEL TREATMENT|1967-01-05||1962-07-27|||1962-09-25||1962-12-24
TRIAL STUDY 134XCP|RP|BE208D93-7322-427F-A8E5-1DBE5040BE8F|1||||||MENFDUR|MENSES FLOW DURATION||||DB|||UL/DOSE|NOT DONE||Y|N|Y|5||7||BASELINE|1971-01-30||1966-07-14|||1966-06-05||1968-06-17
TRIAL STUDY 134XCP|RP|BE208D93-7322-427F-A8E5-1DBE5040BE8F|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UU/DL|||MPH|NOT DONE||Y|NA|Y|5||7||INDUCTION TREATMENT|1963-07-09||1961-07-16|||1969-06-21||1964-08-06
TRIAL STUDY 134XCP|RP|A58C5E7B-21EC-4F59-BB74-3264AC945F61|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||DRUM|||NEWTON|NOT DONE||U|NA|U|1||38||BLINDED TREATMENT|1965-01-25||1965-08-22|||1968-12-19||1967-06-14
TRIAL STUDY 134XCP|RP|A58C5E7B-21EC-4F59-BB74-3264AC945F61|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||UGEQ|||USP U|NOT DONE||N|U|Y|1||38||BLINDED TREATMENT|1971-03-22||1962-08-05|||1963-04-25||1973-07-27
TRIAL STUDY 134XCP|RP|A58C5E7B-21EC-4F59-BB74-3264AC945F61|1||||||PREGST|PREGNANT DURING THE STUDY||||PFU/DOSE|||ML/CM|NOT DONE||NA|U|N|2||58||FOLLOW-UP|1968-08-04||1971-12-16|||1962-08-18||1971-04-20
TRIAL STUDY 134XCP|RP|A58C5E7B-21EC-4F59-BB74-3264AC945F61|2||||||THICK|THICKNESS||||GBQ/G|||10^6 U|NOT DONE||N|NA|NA|2||58||SCREENING|1964-06-06||1971-09-03|||1964-03-31||1961-08-03
TRIAL STUDY 134XCP|RP|A58C5E7B-21EC-4F59-BB74-3264AC945F61|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MG2/DL2|||10^4 CFU/ML|NOT DONE||Y|Y|U|3||39||INDUCTION TREATMENT|1970-05-28||1973-03-07|||1967-04-01||1972-11-25
TRIAL STUDY 134XCP|RP|A58C5E7B-21EC-4F59-BB74-3264AC945F61|2||||||ERYTHIND|ERYTHEMA INDICATOR||||APL U|||10^6 U|NOT DONE||N|Y|NA|3||39||BASELINE|1963-12-06||1966-12-10|||1967-06-07||1971-09-08
TRIAL STUDY 134XCP|RP|A58C5E7B-21EC-4F59-BB74-3264AC945F61|1||||||TNDRIND|TENDERNESS INDICATOR||||G/ANIMAL/WK|||HENRY|NOT DONE||N|Y|U|4||88||FOLLOW-UP|1961-09-25||1961-10-07|||1966-12-23||1965-10-21
TRIAL STUDY 134XCP|RP|A58C5E7B-21EC-4F59-BB74-3264AC945F61|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||DISK|||CI/UG|NOT DONE||U|Y|NA|4||88||RUN-IN|1963-08-01||1960-09-12|||1971-07-04||1960-03-03
TRIAL STUDY 134XCP|RP|A58C5E7B-21EC-4F59-BB74-3264AC945F61|1||||||DLVRMODE|MODE OF DELIVERY||||APS U|||USEC|NOT DONE||N|NA|N|5||7||TREATMENT|1973-04-30||1961-11-22|||1970-01-30||1972-01-25
TRIAL STUDY 134XCP|RP|A58C5E7B-21EC-4F59-BB74-3264AC945F61|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||G/M2|||LOG EID 50/DOSE|NOT DONE||NA|U|NA|5||7||FOLLOW-UP|1969-06-19||1967-05-03|||1965-01-19||1969-09-06
TRIAL STUDY 134XCP|RP|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|1||||||PREGST|PREGNANT DURING THE STUDY||||DPM|||HOUNSFIELD UNIT|NOT DONE||NA|NA|NA|1||38||BLINDED TREATMENT|1966-11-09||1970-08-28|||1971-07-23||1972-11-11
TRIAL STUDY 134XCP|RP|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||LENS|||%(W/W)|NOT DONE||Y|NA|Y|1||38||OBSERVATION|1960-10-11||1960-07-10|||1969-12-06||1963-08-08
TRIAL STUDY 134XCP|RP|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||PMOL/L/H|||MEQ|NOT DONE||NA|Y|Y|2||58||WASHOUT|1960-12-08||1960-05-17|||1973-01-14||1960-09-27
TRIAL STUDY 134XCP|RP|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MMU/ML|||UU/L|NOT DONE||U|Y|Y|2||58||BLINDED TREATMENT|1970-03-08||1961-02-13|||1966-05-05||1964-06-10
TRIAL STUDY 134XCP|RP|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UG/L FEU|||LOG10 TCID 50/DOSE|NOT DONE||U|Y|Y|3||39||SCREENING|1971-03-07||1967-02-20|||1961-01-15||1970-11-29
TRIAL STUDY 134XCP|RP|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|2||||||PUSTIND|PUSTULE INDICATOR||||OHM|||PG/CELL|NOT DONE||N|NA|U|3||39||LONG-TERM FOLLOW-UP|1969-02-07||1962-02-04|||1967-06-28||1962-11-06
TRIAL STUDY 134XCP|RP|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|1||||||INABOIND|INDUCED ABORTION INDICATOR||||10^3 ORGANISMS/G|||NU/CL|NOT DONE||N|NA|U|4||88||BLINDED TREATMENT|1962-06-14||1965-03-03|||1970-05-12||1962-01-04
TRIAL STUDY 134XCP|RP|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||%|||UG/G/DAY|NOT DONE||NA|N|NA|4||88||TREATMENT|1966-06-02||1961-11-07|||1970-11-26||1972-09-23
TRIAL STUDY 134XCP|RP|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||IU/G HB|||MM3/MM2/YEAR|NOT DONE||NA|U|N|5||7||INDUCTION TREATMENT|1970-05-18||1960-03-24|||1971-09-18||1965-12-13
TRIAL STUDY 134XCP|RP|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||ML/M2/H|||/MM2|NOT DONE||U|U|U|5||7||TREATMENT|1969-11-09||1966-01-25|||1970-05-19||1967-07-03
TRIAL STUDY 134XCP|RP|434B4F6A-C436-4F92-8FA5-9C2F1964098A|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||NMOL|||KCAL/DAY|NOT DONE||N|U|Y|1||38||OPEN LABEL TREATMENT|1972-10-19||1965-08-08|||1961-11-02||1971-04-18
TRIAL STUDY 134XCP|RP|434B4F6A-C436-4F92-8FA5-9C2F1964098A|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MG/MIN|||QUANTITY SUFFICIENT|NOT DONE||N|U|NA|1||38||OPEN LABEL TREATMENT|1960-07-29||1970-11-03|||1970-08-10||1960-02-29
TRIAL STUDY 134XCP|RP|434B4F6A-C436-4F92-8FA5-9C2F1964098A|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ENZYME U/L|||MG2/DL2|NOT DONE||U|U|U|2||58||FOLLOW-UP|1971-08-05||1961-04-02|||1961-02-12||1960-12-19
TRIAL STUDY 134XCP|RP|434B4F6A-C436-4F92-8FA5-9C2F1964098A|2||||||ABORTN|NUMBER OF ABORTIONS||||TRANSDUCING UNIT/ML|||KA_U/DL|NOT DONE||U|NA|U|2||58||OPEN LABEL TREATMENT|1973-06-17||1969-12-11|||1962-05-05||1971-09-12
TRIAL STUDY 134XCP|RP|434B4F6A-C436-4F92-8FA5-9C2F1964098A|1||||||PREGNN|NUMBER OF PREGNANCIES||||ML/MIN/MMHG|||MEQ/ML|NOT DONE||Y|N|U|3||39||OPEN LABEL TREATMENT|1973-07-07||1964-07-02|||1973-05-28||1966-08-21
TRIAL STUDY 134XCP|RP|434B4F6A-C436-4F92-8FA5-9C2F1964098A|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||P|||DEG2|NOT DONE||U|Y|NA|3||39||TREATMENT|1969-06-09||1960-05-26|||1961-02-03||1972-07-08
TRIAL STUDY 134XCP|RP|434B4F6A-C436-4F92-8FA5-9C2F1964098A|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||U/10^12 RBC|||BQ/G|NOT DONE||NA|Y|N|4||88||OPEN LABEL TREATMENT|1967-09-15||1961-09-06|||1965-04-30||1968-04-15
TRIAL STUDY 134XCP|RP|434B4F6A-C436-4F92-8FA5-9C2F1964098A|2||||||TNDRIND|TENDERNESS INDICATOR||||UG/H|||MM|NOT DONE||U|U|Y|4||88||TREATMENT|1965-10-16||1968-12-04|||1971-12-21||1960-02-17
TRIAL STUDY 134XCP|RP|434B4F6A-C436-4F92-8FA5-9C2F1964098A|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||GBQ/UG|||%(V/V)|NOT DONE||Y|Y|U|5||7||LONG-TERM FOLLOW-UP|1960-07-31||1969-12-24|||1968-07-27||1964-12-29
TRIAL STUDY 134XCP|RP|434B4F6A-C436-4F92-8FA5-9C2F1964098A|2||||||THICK|THICKNESS||||DNA COPIES/ML|||MOSM|NOT DONE||Y|Y|Y|5||7||INDUCTION TREATMENT|1961-03-05||1971-03-20|||1970-09-22||1966-07-31
TRIAL STUDY 134XCP|RP|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|1||||||GRAVIND|GRAVIDA INDICATOR||||FMOL|||FL|NOT DONE||N|U|U|1||38||CONTINUATION TREATMENT|1972-11-20||1968-01-11|||1971-11-11||1960-08-23
TRIAL STUDY 134XCP|RP|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MG/M2/H|||/10^5|NOT DONE||Y|U|N|1||38||RUN-IN|1963-01-12||1968-11-08|||1968-03-05||1970-09-15
TRIAL STUDY 134XCP|RP|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MDFI|||/40 HPFS|NOT DONE||N|NA|N|2||58||LONG-TERM FOLLOW-UP|1962-07-12||1967-01-12|||1969-09-08||1965-04-17
TRIAL STUDY 134XCP|RP|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||NMOL/G|||PFU/ANIMAL|NOT DONE||Y|Y|U|2||58||OBSERVATION|1968-12-02||1970-07-01|||1967-02-14||1967-12-21
TRIAL STUDY 134XCP|RP|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|1||||||FUNDHT|FUNDAL HEIGHT||||GY|||G/G|NOT DONE||N|NA|N|3||39||FOLLOW-UP|1971-03-11||1966-02-14|||1964-11-28||1964-03-22
TRIAL STUDY 134XCP|RP|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MG/MIN|||DEG2|NOT DONE||U|Y|U|3||39||INDUCTION TREATMENT|1964-07-14||1972-03-01|||1971-06-09||1962-01-08
TRIAL STUDY 134XCP|RP|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|1||||||EDEMAIND|EDEMA INDICATOR||||MMHG/SEC|||USEC|NOT DONE||Y|U|U|4||88||WASHOUT|1962-12-30||1972-08-12|||1961-01-23||1965-08-05
TRIAL STUDY 134XCP|RP|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|2||||||FUNDHT|FUNDAL HEIGHT||||UM/S|||CM|NOT DONE||Y|Y|U|4||88||BLINDED TREATMENT|1968-05-26||1970-07-10|||1964-10-20||1971-04-22
TRIAL STUDY 134XCP|RP|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|1||||||TNDRIND|TENDERNESS INDICATOR||||CPM|||PSI|NOT DONE||Y|NA|U|5||7||INDUCTION TREATMENT|1961-02-22||1969-05-01|||1965-10-23||1972-09-10
TRIAL STUDY 134XCP|RP|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||/500 WBC|||UIU/L|NOT DONE||Y|U|U|5||7||WASHOUT|1969-12-10||1965-04-24|||1971-08-02||1962-07-06
TRIAL STUDY 134XCP|RP|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||UIU/L|||MU/G|NOT DONE||NA|NA|NA|1||38||OPEN LABEL TREATMENT|1961-06-03||1965-08-23|||1961-08-15||1968-07-05
TRIAL STUDY 134XCP|RP|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||/100 HPFS|||AMP|NOT DONE||NA|U|N|1||38||OBSERVATION|1966-03-31||1960-08-03|||1969-06-30||1971-11-30
TRIAL STUDY 134XCP|RP|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||CG|||EID 50/ML|NOT DONE||NA|NA|N|2||58||BASELINE|1960-04-06||1961-11-09|||1966-08-28||1961-04-18
TRIAL STUDY 134XCP|RP|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|2||||||INABOIND|INDUCED ABORTION INDICATOR||||UIU/DL|||TUBERCULIN UNIT|NOT DONE||NA|N|N|2||58||BASELINE|1965-12-31||1963-08-12|||1968-02-24||1968-10-13
TRIAL STUDY 134XCP|RP|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|1||||||EDEMAIND|EDEMA INDICATOR||||ML/MIN/1.73M2|||ML/MIN/MMHG|NOT DONE||Y|Y|Y|3||39||OPEN LABEL TREATMENT|1970-03-15||1965-10-30|||1968-03-02||1964-02-11
TRIAL STUDY 134XCP|RP|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||/40 HPFS|||SBE/ML|NOT DONE||N|N|Y|3||39||FOLLOW-UP|1961-09-25||1961-01-15|||1967-11-25||1961-03-28
TRIAL STUDY 134XCP|RP|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||ML/SEC/1.73M2|||U/KG/DAY|NOT DONE||N|Y|NA|4||88||FOLLOW-UP|1970-03-28||1961-01-22|||1961-04-04||1960-05-02
TRIAL STUDY 134XCP|RP|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||CMHG|||WAFER|NOT DONE||N|U|U|4||88||BLINDED TREATMENT|1966-08-14||1965-01-13|||1962-09-12||1965-03-13
TRIAL STUDY 134XCP|RP|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^4/HPF|||ENZYME U|NOT DONE||NA|N|Y|5||7||BASELINE|1961-09-21||1969-04-01|||1962-11-24||1967-06-30
TRIAL STUDY 134XCP|RP|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|2||||||PEELIND|PEELING INDICATOR||||U|||UMOL/KG/MIN|NOT DONE||NA|N|U|5||7||INDUCTION TREATMENT|1969-02-14||1973-03-28|||1961-11-14||1967-01-17
TRIAL STUDY 134XCP|RP|73C4A4D7-2177-47F3-818A-C0774F5E4A08|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||G/DAY|||MM2|NOT DONE||Y|Y|NA|1||38||INDUCTION TREATMENT|1964-01-03||1963-05-13|||1970-12-16||1971-01-24
TRIAL STUDY 134XCP|RP|73C4A4D7-2177-47F3-818A-C0774F5E4A08|2||||||MENOSTAT|MENOPAUSE STATUS||||CFU/ML|||BQ/UG|NOT DONE||NA|NA|Y|1||38||SCREENING|1967-07-20||1965-06-04|||1962-12-01||1965-05-15
TRIAL STUDY 134XCP|RP|73C4A4D7-2177-47F3-818A-C0774F5E4A08|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UM2|||USP U|NOT DONE||NA|NA|U|2||58||TREATMENT|1972-02-29||1962-04-27|||1960-06-06||1972-01-16
TRIAL STUDY 134XCP|RP|73C4A4D7-2177-47F3-818A-C0774F5E4A08|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||LX|||L/H|NOT DONE||NA|Y|Y|2||58||INDUCTION TREATMENT|1967-05-25||1969-01-30|||1965-08-05||1968-06-08
TRIAL STUDY 134XCP|RP|73C4A4D7-2177-47F3-818A-C0774F5E4A08|1||||||MENOSTAT|MENOPAUSE STATUS||||MM3/MM2/YEAR|||PA|NOT DONE||Y|Y|Y|3||39||FOLLOW-UP|1967-03-31||1970-02-08|||1963-03-10||1972-05-28
TRIAL STUDY 134XCP|RP|73C4A4D7-2177-47F3-818A-C0774F5E4A08|2||||||EDEMAIND|EDEMA INDICATOR||||GBQ|||NMOL/KG/DAY|NOT DONE||U|U|U|3||39||INDUCTION TREATMENT|1962-06-06||1970-02-28|||1964-08-02||1967-12-16
TRIAL STUDY 134XCP|RP|73C4A4D7-2177-47F3-818A-C0774F5E4A08|1||||||INABOIND|INDUCED ABORTION INDICATOR||||/5X10^4 WBC|||NMOL/MOL|NOT DONE||Y|Y|U|4||88||SCREENING|1966-09-12||1961-08-28|||1962-11-24||1961-01-14
TRIAL STUDY 134XCP|RP|73C4A4D7-2177-47F3-818A-C0774F5E4A08|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||KV|||UKAT|NOT DONE||U|N|NA|4||88||BLINDED TREATMENT|1971-02-18||1965-12-19|||1960-02-15||1960-11-10
TRIAL STUDY 134XCP|RP|73C4A4D7-2177-47F3-818A-C0774F5E4A08|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||ELISA UNIT/DOSE|||GENEQ/ML|NOT DONE||U|NA|NA|5||7||BASELINE|1963-04-09||1968-02-07|||1965-01-18||1963-04-14
TRIAL STUDY 134XCP|RP|73C4A4D7-2177-47F3-818A-C0774F5E4A08|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ML/ANIMAL/DAY|||UMOL/H/MMOL|NOT DONE||U|Y|Y|5||7||RUN-IN|1968-11-11||1960-12-22|||1966-07-05||1967-12-17
TRIAL STUDY 134XCP|RP|4E3929B3-63F2-4E89-8EB4-60991E7284E1|1||||||MENOSTAT|MENOPAUSE STATUS||||PIXELS/CM|||/SEC|NOT DONE||NA|U|N|1||38||TREATMENT|1964-10-18||1972-03-20|||1961-04-12||1973-07-31
TRIAL STUDY 134XCP|RP|4E3929B3-63F2-4E89-8EB4-60991E7284E1|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||CI/MG|||SEC|NOT DONE||U|NA|Y|1||38||WASHOUT|1968-12-05||1963-10-28|||1964-06-27||1961-07-19
TRIAL STUDY 134XCP|RP|4E3929B3-63F2-4E89-8EB4-60991E7284E1|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||POUCH|||OI50|NOT DONE||NA|U|N|2||58||RUN-IN|1963-09-27||1971-04-29|||1973-08-23||1965-04-10
TRIAL STUDY 134XCP|RP|4E3929B3-63F2-4E89-8EB4-60991E7284E1|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||10^11/L|||PNU/ML|NOT DONE||NA|NA|NA|2||58||TREATMENT|1967-02-18||1960-03-18|||1971-04-13||1961-06-06
TRIAL STUDY 134XCP|RP|4E3929B3-63F2-4E89-8EB4-60991E7284E1|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UM2|||/2500 WBC|NOT DONE||NA|U|Y|3||39||TREATMENT|1971-04-20||1969-01-05|||1972-11-03||1961-11-21
TRIAL STUDY 134XCP|RP|4E3929B3-63F2-4E89-8EB4-60991E7284E1|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||U/ANIMAL|||SIEMENS|NOT DONE||NA|U|Y|3||39||OBSERVATION|1972-10-07||1966-01-21|||1970-11-10||1965-01-27
TRIAL STUDY 134XCP|RP|4E3929B3-63F2-4E89-8EB4-60991E7284E1|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||LX|||CD|NOT DONE||NA|NA|U|4||88||LONG-TERM FOLLOW-UP|1972-01-25||1967-02-22|||1962-01-26||1966-09-08
TRIAL STUDY 134XCP|RP|4E3929B3-63F2-4E89-8EB4-60991E7284E1|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MM/MIN|||10^4/L|NOT DONE||Y|NA|N|4||88||WASHOUT|1973-01-21||1961-02-14|||1970-09-20||1972-03-06
TRIAL STUDY 134XCP|RP|4E3929B3-63F2-4E89-8EB4-60991E7284E1|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||PFU|||CMH2O*S2/ML|NOT DONE||NA|NA|N|5||7||OPEN LABEL TREATMENT|1969-09-24||1972-07-11|||1970-02-12||1970-01-03
TRIAL STUDY 134XCP|RP|4E3929B3-63F2-4E89-8EB4-60991E7284E1|2||||||DSCHGIND|DISCHARGE INDICATOR||||MG/L|||10^3 ORGANISMS/ML|NOT DONE||NA|Y|Y|5||7||INDUCTION TREATMENT|1966-02-16||1961-03-31|||1970-03-06||1968-09-13
TRIAL STUDY 134XCP|RP|F26E2F67-3F90-448C-92BB-AD60E71D5664|1||||||PEELIND|PEELING INDICATOR||||DAYS|||UMOL/MIN|NOT DONE||U|NA|NA|1||38||TREATMENT|1969-07-07||1971-08-31|||1966-03-16||1962-10-27
TRIAL STUDY 134XCP|RP|F26E2F67-3F90-448C-92BB-AD60E71D5664|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||DYN|||10^3 DNA COPIES/ML|NOT DONE||U|NA|U|1||38||FOLLOW-UP|1972-11-05||1965-02-21|||1965-10-29||1960-05-07
TRIAL STUDY 134XCP|RP|F26E2F67-3F90-448C-92BB-AD60E71D5664|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||UIU/DL|||SCOOPFUL|NOT DONE||Y|N|U|2||58||CONTINUATION TREATMENT|1961-07-22||1964-06-14|||1967-08-30||1960-01-06
TRIAL STUDY 134XCP|RP|F26E2F67-3F90-448C-92BB-AD60E71D5664|2||||||DLVRMODE|MODE OF DELIVERY||||ML|||10^9 ORGANISMS/G|NOT DONE||U|U|N|2||58||TREATMENT|1965-11-24||1961-03-03|||1968-10-18||1963-10-18
TRIAL STUDY 134XCP|RP|F26E2F67-3F90-448C-92BB-AD60E71D5664|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||CCID 50/ML|||M/SEC|NOT DONE||Y|N|Y|3||39||TREATMENT|1970-06-18||1971-10-22|||1966-09-09||1960-04-26
TRIAL STUDY 134XCP|RP|F26E2F67-3F90-448C-92BB-AD60E71D5664|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||ELISA UNIT/ML|||U/M2/H|NOT DONE||Y|N|N|3||39||CONTINUATION TREATMENT|1970-07-14||1960-12-25|||1963-01-16||1966-09-25
TRIAL STUDY 134XCP|RP|F26E2F67-3F90-448C-92BB-AD60E71D5664|1||||||ULCERIND|ULCER INDICATOR||||ELISA UNIT/ML|||MANSON U/ML|NOT DONE||N|Y|NA|4||88||RUN-IN|1965-04-20||1960-03-01|||1961-08-14||1967-02-24
TRIAL STUDY 134XCP|RP|F26E2F67-3F90-448C-92BB-AD60E71D5664|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||IU|||CM H2O|NOT DONE||U|NA|Y|4||88||BLINDED TREATMENT|1960-06-21||1972-11-29|||1963-08-26||1964-12-10
TRIAL STUDY 134XCP|RP|F26E2F67-3F90-448C-92BB-AD60E71D5664|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||RATIO|||PIPE|NOT DONE||U|N|N|5||7||BASELINE|1970-01-22||1972-01-04|||1964-10-02||1965-05-03
TRIAL STUDY 134XCP|RP|F26E2F67-3F90-448C-92BB-AD60E71D5664|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UIU/L|||FEU|NOT DONE||N|NA|Y|5||7||CONTINUATION TREATMENT|1961-08-02||1960-02-02|||1968-11-12||1968-08-22
TRIAL STUDY 134XCP|RP|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||BQ/L|||ELISA UNIT|NOT DONE||N|Y|NA|1||38||BLINDED TREATMENT|1973-05-10||1967-09-28|||1965-09-28||1960-11-23
TRIAL STUDY 134XCP|RP|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||UL/ML|||MKAT|NOT DONE||U|N|Y|1||38||WASHOUT|1960-07-20||1961-02-16|||1963-07-28||1968-12-17
TRIAL STUDY 134XCP|RP|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||ML/BREATH|||10^9 CFU/G|NOT DONE||N|U|NA|2||58||OPEN LABEL TREATMENT|1964-09-27||1973-01-08|||1964-04-15||1963-07-10
TRIAL STUDY 134XCP|RP|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||ML/KG|||MSEC|NOT DONE||Y|N|N|2||58||BLINDED TREATMENT|1967-02-24||1960-11-25|||1965-10-24||1963-06-10
TRIAL STUDY 134XCP|RP|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|1||||||PREGIND|PREGNANT INDICATOR||||PMOL/L|||10^9 CFU|NOT DONE||N|NA|N|3||39||FOLLOW-UP|1971-04-26||1971-06-27|||1971-11-24||1971-09-18
TRIAL STUDY 134XCP|RP|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|2||||||INABOIND|INDUCED ABORTION INDICATOR||||RAD|||LOG10 PFU|NOT DONE||Y|NA|NA|3||39||RUN-IN|1960-04-17||1965-12-01|||1968-02-21||1972-04-27
TRIAL STUDY 134XCP|RP|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|1||||||MENFDUR|MENSES FLOW DURATION||||BOX|||BISCUIT|NOT DONE||N|U|U|4||88||OPEN LABEL TREATMENT|1970-01-28||1972-04-25|||1960-11-08||1966-06-20
TRIAL STUDY 134XCP|RP|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|2||||||GRAVIND|GRAVIDA INDICATOR||||G/G|||CMOL/L|NOT DONE||NA|Y|U|4||88||LONG-TERM FOLLOW-UP|1963-01-04||1967-08-12|||1963-02-18||1964-06-08
TRIAL STUDY 134XCP|RP|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||/10^5|||MBP|NOT DONE||NA|N|Y|5||7||TREATMENT|1972-07-22||1973-06-29|||1973-08-07||1964-04-27
TRIAL STUDY 134XCP|RP|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|2||||||PREGST|PREGNANT DURING THE STUDY||||COULOMB|||SCM|NOT DONE||N|Y|U|5||7||WASHOUT|1973-07-10||1972-02-26|||1972-08-21||1962-09-29
TRIAL STUDY 134XCP|RP|F2F1151C-F987-49CE-BC16-719DD339DBE7|1||||||BRTHN|NUMBER OF BIRTHS||||ML/KG/H|||KCAL|NOT DONE||Y|U|Y|1||38||LONG-TERM FOLLOW-UP|1969-09-12||1968-03-12|||1967-02-01||1972-10-13
TRIAL STUDY 134XCP|RP|F2F1151C-F987-49CE-BC16-719DD339DBE7|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||TAMPON|||UG/CM2|NOT DONE||NA|U|N|1||38||RUN-IN|1965-08-24||1963-08-13|||1969-01-03||1973-07-23
TRIAL STUDY 134XCP|RP|F2F1151C-F987-49CE-BC16-719DD339DBE7|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||RATIO|||MPA|NOT DONE||N|U|N|2||58||BLINDED TREATMENT|1971-08-06||1967-03-22|||1972-04-14||1971-02-02
TRIAL STUDY 134XCP|RP|F2F1151C-F987-49CE-BC16-719DD339DBE7|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||CMH2O*S/ML|||L|NOT DONE||U|U|U|2||58||INDUCTION TREATMENT|1971-09-30||1972-06-10|||1967-08-18||1960-07-26
TRIAL STUDY 134XCP|RP|F2F1151C-F987-49CE-BC16-719DD339DBE7|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||HEP|||WEBER|NOT DONE||NA|Y|N|3||39||FOLLOW-UP|1965-10-29||1960-08-13|||1965-03-18||1968-10-10
TRIAL STUDY 134XCP|RP|F2F1151C-F987-49CE-BC16-719DD339DBE7|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||KPA/L/SEC|||MG/MIN|NOT DONE||NA|Y|NA|3||39||LONG-TERM FOLLOW-UP|1964-04-22||1964-03-07|||1961-10-08||1969-02-14
TRIAL STUDY 134XCP|RP|F2F1151C-F987-49CE-BC16-719DD339DBE7|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||FARAD|||RNA COPIES/ML|NOT DONE||NA|N|N|4||88||OPEN LABEL TREATMENT|1972-04-29||1969-02-20|||1971-11-03||1962-07-15
TRIAL STUDY 134XCP|RP|F2F1151C-F987-49CE-BC16-719DD339DBE7|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||GPELISA UNIT/ML|||/DAY|NOT DONE||N|Y|NA|4||88||OPEN LABEL TREATMENT|1965-01-30||1963-08-06|||1964-06-14||1971-12-24
TRIAL STUDY 134XCP|RP|F2F1151C-F987-49CE-BC16-719DD339DBE7|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PSEC|||STRIP|NOT DONE||Y|Y|Y|5||7||SCREENING|1961-09-02||1968-01-14|||1966-01-04||1971-12-27
TRIAL STUDY 134XCP|RP|F2F1151C-F987-49CE-BC16-719DD339DBE7|2||||||PUSTIND|PUSTULE INDICATOR||||G/ANIMAL/WK|||10^3 ORGANISMS/ML|NOT DONE||NA|NA|NA|5||7||OPEN LABEL TREATMENT|1968-08-11||1960-11-21|||1964-08-05||1972-12-25
TRIAL STUDY 134XCP|RP|F88FCFA6-90D7-4033-86DF-223A63A6152D|1||||||RASHIND|RASH INDICATOR||||KV|||PG/DL|NOT DONE||N|U|U|1||38||RUN-IN|1967-01-21||1972-02-10|||1965-12-03||1972-09-07
TRIAL STUDY 134XCP|RP|F88FCFA6-90D7-4033-86DF-223A63A6152D|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UG/MOL|||10^9 ORGANISMS/MG|NOT DONE||NA|N|U|1||38||CONTINUATION TREATMENT|1969-11-26||1973-02-03|||1971-02-21||1967-07-31
TRIAL STUDY 134XCP|RP|F88FCFA6-90D7-4033-86DF-223A63A6152D|1||||||THICK|THICKNESS||||UOSM|||MN|NOT DONE||NA|N|Y|2||58||OBSERVATION|1968-10-07||1963-02-16|||1967-07-02||1969-10-23
TRIAL STUDY 134XCP|RP|F88FCFA6-90D7-4033-86DF-223A63A6152D|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||TCID 50/DOSE|||VOXEL|NOT DONE||N|N|Y|2||58||WASHOUT|1963-06-04||1970-12-21|||1961-11-26||1972-06-04
TRIAL STUDY 134XCP|RP|F88FCFA6-90D7-4033-86DF-223A63A6152D|1||||||DLVRMODE|MODE OF DELIVERY||||%/S|||L/KG|NOT DONE||Y|Y|U|3||39||INDUCTION TREATMENT|1960-05-28||1964-12-15|||1965-03-25||1971-07-17
TRIAL STUDY 134XCP|RP|F88FCFA6-90D7-4033-86DF-223A63A6152D|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||NEWTON|||10^6 ORGANISMS/G|NOT DONE||N|NA|N|3||39||OPEN LABEL TREATMENT|1969-02-07||1962-05-27|||1973-03-17||1961-02-20
TRIAL STUDY 134XCP|RP|F88FCFA6-90D7-4033-86DF-223A63A6152D|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||SFC/10^6 PBMC|||U/KG/H|NOT DONE||U|U|U|4||88||OBSERVATION|1973-01-28||1961-02-10|||1964-01-15||1965-06-21
TRIAL STUDY 134XCP|RP|F88FCFA6-90D7-4033-86DF-223A63A6152D|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||KG/MOL|||LOG10 CFU/G|NOT DONE||U|U|NA|4||88||RUN-IN|1964-08-17||1965-05-24|||1968-06-30||1964-10-30
TRIAL STUDY 134XCP|RP|F88FCFA6-90D7-4033-86DF-223A63A6152D|1||||||DSCHGIND|DISCHARGE INDICATOR||||MBQ/UL|||CI/KG|NOT DONE||U|NA|Y|5||7||LONG-TERM FOLLOW-UP|1972-07-24||1972-07-28|||1970-11-06||1962-12-03
TRIAL STUDY 134XCP|RP|F88FCFA6-90D7-4033-86DF-223A63A6152D|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||KPA/L/SEC|||L|NOT DONE||U|N|Y|5||7||RUN-IN|1962-09-09||1960-07-27|||1963-03-21||1963-11-08
TRIAL STUDY 134XCP|RP|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|1||||||ABORTN|NUMBER OF ABORTIONS||||SBE/ML|||APL U|NOT DONE||U|U|N|1||38||BLINDED TREATMENT|1965-11-15||1965-01-28|||1971-04-07||1963-03-18
TRIAL STUDY 134XCP|RP|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||PA|||MG/M2/H|NOT DONE||Y|Y|N|1||38||OPEN LABEL TREATMENT|1968-11-06||1968-09-19|||1971-06-18||1967-02-04
TRIAL STUDY 134XCP|RP|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|1||||||PUSTIND|PUSTULE INDICATOR||||KCAL|||NG/DL|NOT DONE||NA|U|U|2||58||OPEN LABEL TREATMENT|1969-08-29||1964-07-09|||1963-09-14||1966-11-17
TRIAL STUDY 134XCP|RP|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MONTHS|||10^9/L|NOT DONE||N|Y|U|2||58||INDUCTION TREATMENT|1961-03-19||1969-09-18|||1973-02-01||1963-05-31
TRIAL STUDY 134XCP|RP|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||DISK|||10^9 CFU/ML|NOT DONE||N|Y|U|3||39||LONG-TERM FOLLOW-UP|1965-09-01||1961-03-22|||1969-01-29||1968-03-13
TRIAL STUDY 134XCP|RP|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||G/L|||TCID 50/DOSE|NOT DONE||N|NA|Y|3||39||TREATMENT|1972-12-15||1960-10-12|||1964-11-27||1972-08-13
TRIAL STUDY 134XCP|RP|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|1||||||BRTHN|NUMBER OF BIRTHS||||ABSORBANCE U|||ML/G/H|NOT DONE||Y|Y|N|4||88||INDUCTION TREATMENT|1971-08-23||1970-12-18|||1970-07-23||1966-08-02
TRIAL STUDY 134XCP|RP|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|2||||||GRAVIND|GRAVIDA INDICATOR||||DAYS/WK|||PACKET|NOT DONE||U|N|N|4||88||LONG-TERM FOLLOW-UP|1966-01-16||1960-07-02|||1961-06-06||1971-01-24
TRIAL STUDY 134XCP|RP|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|1||||||STILBIND|STILLBIRTH INDICATOR||||UMOL/MOL|||UMOL/L/MIN|NOT DONE||U|NA|Y|5||7||TREATMENT|1969-10-12||1967-03-26|||1966-11-26||1961-01-03
TRIAL STUDY 134XCP|RP|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||KAT|||10^3 COPIES/ML|NOT DONE||N|U|NA|5||7||INDUCTION TREATMENT|1963-09-26||1965-05-03|||1961-09-09||1971-07-12
TRIAL STUDY 134XCP|RP|7D35B2F5-7334-448B-B4E1-14671B850B6A|1||||||PREGIND|PREGNANT INDICATOR||||CM H2O|||USIEMENS|NOT DONE||NA|NA|N|1||38||WASHOUT|1960-02-22||1965-10-27|||1973-01-24||1967-09-05
TRIAL STUDY 134XCP|RP|7D35B2F5-7334-448B-B4E1-14671B850B6A|2||||||INABOIND|INDUCED ABORTION INDICATOR||||ROENTGEN|||BQ/KG|NOT DONE||NA|U|U|1||38||INDUCTION TREATMENT|1969-04-27||1961-08-30|||1964-05-14||1964-11-16
TRIAL STUDY 134XCP|RP|7D35B2F5-7334-448B-B4E1-14671B850B6A|1||||||EDEMAIND|EDEMA INDICATOR||||10^7 CFU/ML|||U|NOT DONE||NA|U|N|2||58||TREATMENT|1967-06-14||1967-07-18|||1969-09-06||1967-10-22
TRIAL STUDY 134XCP|RP|7D35B2F5-7334-448B-B4E1-14671B850B6A|2||||||RASHIND|RASH INDICATOR||||10^6 CFU/G|||COPIES/UG|NOT DONE||Y|U|N|2||58||SCREENING|1965-01-24||1971-12-05|||1964-01-23||1961-12-01
TRIAL STUDY 134XCP|RP|7D35B2F5-7334-448B-B4E1-14671B850B6A|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UEQ|||UKAT/L|NOT DONE||Y|N|NA|3||39||SCREENING|1973-07-17||1962-02-20|||1970-08-14||1963-07-24
TRIAL STUDY 134XCP|RP|7D35B2F5-7334-448B-B4E1-14671B850B6A|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MG/DOSE|||G/DAY|NOT DONE||Y|Y|U|3||39||TREATMENT|1966-04-14||1965-01-11|||1970-07-23||1967-07-15
TRIAL STUDY 134XCP|RP|7D35B2F5-7334-448B-B4E1-14671B850B6A|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||GY/H|||10^8 PFU|NOT DONE||NA|U|N|4||88||INDUCTION TREATMENT|1966-12-10||1966-03-24|||1967-06-01||1961-08-19
TRIAL STUDY 134XCP|RP|7D35B2F5-7334-448B-B4E1-14671B850B6A|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MHZ|||PT_US|NOT DONE||U|NA|NA|4||88||RUN-IN|1971-02-11||1972-03-26|||1963-06-10||1965-04-26
TRIAL STUDY 134XCP|RP|7D35B2F5-7334-448B-B4E1-14671B850B6A|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UV2|||ML/G/MIN|NOT DONE||U|Y|NA|5||7||BASELINE|1967-04-17||1961-11-01|||1968-06-24||1964-11-28
TRIAL STUDY 134XCP|RP|7D35B2F5-7334-448B-B4E1-14671B850B6A|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||U/DL|||MU/L|NOT DONE||N|N|U|5||7||OBSERVATION|1970-10-31||1968-06-26|||1973-03-12||1960-07-23
TRIAL STUDY 134XCP|RP|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|1||||||BCMETHOD|BIRTH CONTROL METHOD||||NL|||MG/H|NOT DONE||U|Y|NA|1||38||OPEN LABEL TREATMENT|1963-06-09||1960-11-14|||1971-01-11||1973-06-11
TRIAL STUDY 134XCP|RP|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||10^8/L|||NL|NOT DONE||NA|Y|U|1||38||RUN-IN|1963-08-14||1967-04-10|||1969-06-27||1967-05-31
TRIAL STUDY 134XCP|RP|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|1||||||MENFDUR|MENSES FLOW DURATION||||UMOL/KG/MIN|||SACHET|NOT DONE||Y|U|NA|2||58||OBSERVATION|1964-08-16||1968-02-02|||1963-05-11||1961-06-06
TRIAL STUDY 134XCP|RP|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||DAMOL/L|||MOL/MOL|NOT DONE||NA|U|U|2||58||TREATMENT|1961-09-29||1972-03-11|||1972-02-17||1969-07-24
TRIAL STUDY 134XCP|RP|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|1||||||DSCHGIND|DISCHARGE INDICATOR||||10^6/L|||G/KG|NOT DONE||Y|U|Y|3||39||SCREENING|1961-02-20||1967-06-01|||1966-05-04||1965-06-29
TRIAL STUDY 134XCP|RP|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|2||||||PUSTIND|PUSTULE INDICATOR||||GBQ/UG|||OZ EQ|NOT DONE||NA|N|U|3||39||SCREENING|1968-08-20||1973-09-06|||1962-08-08||1965-01-11
TRIAL STUDY 134XCP|RP|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MMAL|||%(W/W)|NOT DONE||N|Y|U|4||88||TREATMENT|1966-10-15||1968-12-16|||1968-08-15||1966-08-03
TRIAL STUDY 134XCP|RP|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|2||||||RASHIND|RASH INDICATOR||||ML/ANIMAL/WK|||MMU/ML|NOT DONE||Y|N|Y|4||88||OBSERVATION|1967-04-08||1962-12-02|||1969-04-05||1962-07-08
TRIAL STUDY 134XCP|RP|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|1||||||MENFDUR|MENSES FLOW DURATION||||MG/G/MIN|||G|NOT DONE||U|U|U|5||7||OBSERVATION|1965-08-09||1960-04-18|||1969-03-29||1969-09-24
TRIAL STUDY 134XCP|RP|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MM3/MM2/YEAR|||UMOL/L|NOT DONE||Y|NA|U|5||7||CONTINUATION TREATMENT|1964-07-28||1965-02-19|||1972-10-01||1965-11-29
TRIAL STUDY 134XCP|RP|B09D371C-2E5C-4F84-986E-5A603C0C4A28|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||ENZYME U/G HB|||MG/M2|NOT DONE||Y|NA|U|1||38||SCREENING|1970-10-29||1970-09-30|||1969-09-18||1972-10-10
TRIAL STUDY 134XCP|RP|B09D371C-2E5C-4F84-986E-5A603C0C4A28|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MMOL/MIN/KPA|||10^9/G|NOT DONE||NA|NA|Y|1||38||WASHOUT|1969-09-27||1960-09-20|||1970-05-28||1972-12-24
TRIAL STUDY 134XCP|RP|B09D371C-2E5C-4F84-986E-5A603C0C4A28|1||||||MENOAGE|MENOPAUSE AGE||||10^6 COPIES/ML|||SPRAY|NOT DONE||NA|Y|U|2||58||TREATMENT|1970-05-26||1972-11-18|||1969-11-16||1961-08-14
TRIAL STUDY 134XCP|RP|B09D371C-2E5C-4F84-986E-5A603C0C4A28|2||||||BCMETHOD|BIRTH CONTROL METHOD||||GRAVITATIONAL UNIT|||MAMP|NOT DONE||U|Y|N|2||58||TREATMENT|1963-02-16||1961-02-14|||1970-04-03||1960-03-06
TRIAL STUDY 134XCP|RP|B09D371C-2E5C-4F84-986E-5A603C0C4A28|1||||||MENOSTAT|MENOPAUSE STATUS||||G/U|||TUBERCULIN UNIT/ML|NOT DONE||U|NA|U|3||39||TREATMENT|1962-03-26||1960-01-26|||1964-11-01||1968-04-30
TRIAL STUDY 134XCP|RP|B09D371C-2E5C-4F84-986E-5A603C0C4A28|2||||||RASHIND|RASH INDICATOR||||ELISA UNIT/ML|||%(W/W)|NOT DONE||U|U|U|3||39||SCREENING|1972-01-03||1962-05-28|||1972-11-25||1960-01-20
TRIAL STUDY 134XCP|RP|B09D371C-2E5C-4F84-986E-5A603C0C4A28|1||||||ERYTHIND|ERYTHEMA INDICATOR||||MG2/DL2|||KDA|NOT DONE||U|N|U|4||88||CONTINUATION TREATMENT|1972-03-18||1964-07-07|||1971-03-30||1963-05-05
TRIAL STUDY 134XCP|RP|B09D371C-2E5C-4F84-986E-5A603C0C4A28|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MM2|||L/MIN|NOT DONE||N|NA|Y|4||88||OPEN LABEL TREATMENT|1965-09-03||1970-08-16|||1961-12-03||1969-01-27
TRIAL STUDY 134XCP|RP|B09D371C-2E5C-4F84-986E-5A603C0C4A28|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MCI/KG|||AFU|NOT DONE||N|Y|Y|5||7||RUN-IN|1967-01-17||1960-12-03|||1969-09-29||1963-09-17
TRIAL STUDY 134XCP|RP|B09D371C-2E5C-4F84-986E-5A603C0C4A28|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||KCAL/DAY|||CIGARETTE|NOT DONE||N|N|NA|5||7||OBSERVATION|1963-06-09||1971-06-29|||1960-07-09||1966-09-14
TRIAL STUDY 134XCP|RP|11CB653E-F113-4639-B15C-B236A2F65F47|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||FINGERTIP UNIT|||% INHIBITION|NOT DONE||U|N|Y|1||38||BLINDED TREATMENT|1966-05-24||1962-09-13|||1963-07-21||1961-12-14
TRIAL STUDY 134XCP|RP|11CB653E-F113-4639-B15C-B236A2F65F47|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MS/MMHG|||IN2|NOT DONE||NA|Y|NA|1||38||CONTINUATION TREATMENT|1971-10-26||1965-11-04|||1961-01-11||1970-05-27
TRIAL STUDY 134XCP|RP|11CB653E-F113-4639-B15C-B236A2F65F47|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||CAL|||DEG/MM|NOT DONE||Y|Y|NA|2||58||OBSERVATION|1960-09-24||1965-06-29|||1965-12-31||1960-02-14
TRIAL STUDY 134XCP|RP|11CB653E-F113-4639-B15C-B236A2F65F47|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||10^6 ORGANISMS/ML|||ML/M2|NOT DONE||N|U|U|2||58||WASHOUT|1960-03-13||1965-12-03|||1962-09-20||1967-04-11
TRIAL STUDY 134XCP|RP|11CB653E-F113-4639-B15C-B236A2F65F47|1||||||ERYTHIND|ERYTHEMA INDICATOR||||KG/MOL|||UEQ/L|NOT DONE||U|Y|Y|3||39||BLINDED TREATMENT|1972-11-03||1960-07-16|||1973-04-05||1962-09-04
TRIAL STUDY 134XCP|RP|11CB653E-F113-4639-B15C-B236A2F65F47|2||||||MENOSTAT|MENOPAUSE STATUS||||MMHG*MIN/L|||10^10/L|NOT DONE||N|NA|U|3||39||LONG-TERM FOLLOW-UP|1969-09-15||1971-07-29|||1967-10-20||1969-05-01
TRIAL STUDY 134XCP|RP|11CB653E-F113-4639-B15C-B236A2F65F47|1||||||EDEMAIND|EDEMA INDICATOR||||CMOL|||DPM/100MG|NOT DONE||Y|NA|N|4||88||FOLLOW-UP|1965-01-22||1967-04-29|||1964-07-18||1966-07-08
TRIAL STUDY 134XCP|RP|11CB653E-F113-4639-B15C-B236A2F65F47|2||||||PEELIND|PEELING INDICATOR||||CYLINDER|||WEBER|NOT DONE||N|N|NA|4||88||LONG-TERM FOLLOW-UP|1972-01-31||1962-12-05|||1971-09-28||1963-07-31
TRIAL STUDY 134XCP|RP|11CB653E-F113-4639-B15C-B236A2F65F47|1||||||PRGENDTC|DATE PREGNANCY ENDED||||10^3 CFU/G|||PUFF|NOT DONE||U|NA|U|5||7||OPEN LABEL TREATMENT|1965-04-15||1970-07-10|||1970-02-24||1962-07-11
TRIAL STUDY 134XCP|RP|11CB653E-F113-4639-B15C-B236A2F65F47|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||RFU|||10^9/DOSE|NOT DONE||NA|NA|U|5||7||RUN-IN|1972-08-19||1963-12-20|||1963-06-13||1963-11-11
TRIAL STUDY 134XCP|RP|2AB992E7-55B7-4327-987C-47FD605B7D78|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UV|||MBP|NOT DONE||Y|NA|U|1||38||OPEN LABEL TREATMENT|1966-07-14||1971-06-24|||1960-06-24||1965-08-15
TRIAL STUDY 134XCP|RP|2AB992E7-55B7-4327-987C-47FD605B7D78|2||||||BCMETHOD|BIRTH CONTROL METHOD||||10^8/L|||MSEC|NOT DONE||U|NA|Y|1||38||INDUCTION TREATMENT|1967-01-06||1965-11-20|||1961-02-14||1971-05-02
TRIAL STUDY 134XCP|RP|2AB992E7-55B7-4327-987C-47FD605B7D78|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||DNA COPIES/UG|||MET*MIN|NOT DONE||U|NA|NA|2||58||OPEN LABEL TREATMENT|1969-03-26||1961-03-27|||1961-02-04||1962-11-17
TRIAL STUDY 134XCP|RP|2AB992E7-55B7-4327-987C-47FD605B7D78|2||||||TNDRIND|TENDERNESS INDICATOR||||DRUM|||EJACULATE U|NOT DONE||U|Y|NA|2||58||INDUCTION TREATMENT|1961-09-13||1963-08-14|||1960-06-20||1967-03-16
TRIAL STUDY 134XCP|RP|2AB992E7-55B7-4327-987C-47FD605B7D78|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||KA_U/DL|||ML/M2/H|NOT DONE||N|N|NA|3||39||TREATMENT|1961-02-22||1970-03-08|||1968-02-23||1961-11-17
TRIAL STUDY 134XCP|RP|2AB992E7-55B7-4327-987C-47FD605B7D78|2||||||PRGENDTC|DATE PREGNANCY ENDED||||KG/L|||USP U|NOT DONE||U|U|U|3||39||OBSERVATION|1963-12-20||1961-12-30|||1967-11-30||1962-07-07
TRIAL STUDY 134XCP|RP|2AB992E7-55B7-4327-987C-47FD605B7D78|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MOL/L|||ML/DAY|NOT DONE||N|U|U|4||88||RUN-IN|1968-04-26||1970-06-04|||1968-10-15||1966-11-01
TRIAL STUDY 134XCP|RP|2AB992E7-55B7-4327-987C-47FD605B7D78|2||||||PREGIND|PREGNANT INDICATOR||||MG/G/MIN|||L|NOT DONE||NA|N|Y|4||88||BLINDED TREATMENT|1968-09-27||1968-04-02|||1962-03-08||1969-07-29
TRIAL STUDY 134XCP|RP|2AB992E7-55B7-4327-987C-47FD605B7D78|1||||||ERYTHIND|ERYTHEMA INDICATOR||||PUFF|||CI/G|NOT DONE||N|U|N|5||7||INDUCTION TREATMENT|1972-05-24||1966-08-05|||1964-07-10||1972-02-07
TRIAL STUDY 134XCP|RP|2AB992E7-55B7-4327-987C-47FD605B7D78|2||||||STILBIND|STILLBIRTH INDICATOR||||FT2|||UMOL/MG/MIN|NOT DONE||Y|NA|NA|5||7||TREATMENT|1961-09-23||1964-04-23|||1970-11-28||1972-04-06
TRIAL STUDY 134XCP|RP|6AF1B0B0-9923-459A-8629-5E628400AD00|1||||||INABOIND|INDUCED ABORTION INDICATOR||||CFU/G|||DAYS|NOT DONE||N|N|NA|1||38||RUN-IN|1973-05-03||1965-06-12|||1960-11-01||1971-10-29
TRIAL STUDY 134XCP|RP|6AF1B0B0-9923-459A-8629-5E628400AD00|2||||||FUNDHT|FUNDAL HEIGHT||||UMOL/L|||MM3/MM2/YEAR|NOT DONE||U|Y|U|1||38||OPEN LABEL TREATMENT|1964-09-12||1968-05-26|||1968-03-24||1970-08-20
TRIAL STUDY 134XCP|RP|6AF1B0B0-9923-459A-8629-5E628400AD00|1||||||ULCERIND|ULCER INDICATOR||||GPELISA UNIT/ML|||ML/G/MIN|NOT DONE||N|N|Y|2||58||OBSERVATION|1962-10-17||1965-03-06|||1960-04-17||1961-03-01
TRIAL STUDY 134XCP|RP|6AF1B0B0-9923-459A-8629-5E628400AD00|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MOL|||MMOL/S|NOT DONE||NA|Y|U|2||58||OBSERVATION|1967-07-25||1961-08-09|||1962-11-02||1967-06-09
TRIAL STUDY 134XCP|RP|6AF1B0B0-9923-459A-8629-5E628400AD00|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||UMOL/KG/MIN|||BOX|NOT DONE||NA|NA|Y|3||39||RUN-IN|1970-10-30||1970-11-19|||1967-03-15||1967-04-04
TRIAL STUDY 134XCP|RP|6AF1B0B0-9923-459A-8629-5E628400AD00|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||PM|||10^4 CFU|NOT DONE||N|U|N|3||39||OPEN LABEL TREATMENT|1962-08-04||1966-03-20|||1971-01-04||1963-01-21
TRIAL STUDY 134XCP|RP|6AF1B0B0-9923-459A-8629-5E628400AD00|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||ML/KG/H|||MU|NOT DONE||N|U|NA|4||88||BASELINE|1960-02-15||1970-11-10|||1971-10-21||1970-10-25
TRIAL STUDY 134XCP|RP|6AF1B0B0-9923-459A-8629-5E628400AD00|2||||||THICK|THICKNESS||||DB|||NMOL/ML/MIN|NOT DONE||N|NA|N|4||88||BASELINE|1971-10-10||1971-04-06|||1965-02-22||1973-04-06
TRIAL STUDY 134XCP|RP|6AF1B0B0-9923-459A-8629-5E628400AD00|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||L/MIN|||10^6 RNA COPIES/ML|NOT DONE||U|NA|Y|5||7||WASHOUT|1960-07-26||1972-12-22|||1970-01-27||1969-05-30
TRIAL STUDY 134XCP|RP|6AF1B0B0-9923-459A-8629-5E628400AD00|2||||||GRAVIND|GRAVIDA INDICATOR||||EU|||NMOL/DAY|NOT DONE||Y|U|N|5||7||FOLLOW-UP|1960-10-04||1964-01-02|||1971-03-15||1971-10-26
TRIAL STUDY 134XCP|RP|E1305E4E-DF64-4FD1-B0B2-131459AB629D|1||||||THICK|THICKNESS||||FEU|||PPM|NOT DONE||U|U|N|1||38||RUN-IN|1969-09-26||1962-03-17|||1970-05-19||1963-05-28
TRIAL STUDY 134XCP|RP|E1305E4E-DF64-4FD1-B0B2-131459AB629D|2||||||FUNDHT|FUNDAL HEIGHT||||HPA|||KCAL|NOT DONE||N|U|Y|1||38||BLINDED TREATMENT|1962-06-06||1962-03-07|||1970-04-06||1964-12-28
TRIAL STUDY 134XCP|RP|E1305E4E-DF64-4FD1-B0B2-131459AB629D|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||NMOL/L/H|||NMOL BCE/MMOL|NOT DONE||N|N|U|2||58||OBSERVATION|1973-08-31||1971-05-07|||1964-08-18||1964-08-28
TRIAL STUDY 134XCP|RP|E1305E4E-DF64-4FD1-B0B2-131459AB629D|2||||||RASHIND|RASH INDICATOR||||LM|||P|NOT DONE||U|Y|Y|2||58||OPEN LABEL TREATMENT|1969-01-05||1964-01-11|||1966-06-17||1970-10-15
TRIAL STUDY 134XCP|RP|E1305E4E-DF64-4FD1-B0B2-131459AB629D|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||% INHIBITION|||UG/KG/MIN|NOT DONE||NA|N|U|3||39||BASELINE|1965-08-16||1970-04-07|||1964-04-01||1960-11-24
TRIAL STUDY 134XCP|RP|E1305E4E-DF64-4FD1-B0B2-131459AB629D|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||PT_US|||L/L|NOT DONE||NA|Y|N|3||39||OPEN LABEL TREATMENT|1963-08-29||1962-10-17|||1968-02-25||1968-11-17
TRIAL STUDY 134XCP|RP|E1305E4E-DF64-4FD1-B0B2-131459AB629D|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||PUFF|||MMOL/DAY|NOT DONE||Y|Y|U|4||88||TREATMENT|1964-08-21||1963-09-20|||1964-04-23||1961-04-17
TRIAL STUDY 134XCP|RP|E1305E4E-DF64-4FD1-B0B2-131459AB629D|2||||||PREGIND|PREGNANT INDICATOR||||MG/KG/MIN|||MIN/DAY|NOT DONE||U|N|NA|4||88||LONG-TERM FOLLOW-UP|1961-11-18||1961-08-11|||1961-01-31||1960-02-07
TRIAL STUDY 134XCP|RP|E1305E4E-DF64-4FD1-B0B2-131459AB629D|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||DNA COPIES/UG|||ML/DAY|NOT DONE||Y|Y|N|5||7||LONG-TERM FOLLOW-UP|1963-05-18||1964-09-02|||1961-07-14||1968-04-18
TRIAL STUDY 134XCP|RP|E1305E4E-DF64-4FD1-B0B2-131459AB629D|2||||||FUNDHT|FUNDAL HEIGHT||||PG/DL|||MV2/HZ|NOT DONE||NA|Y|NA|5||7||BLINDED TREATMENT|1973-01-16||1962-07-08|||1963-02-06||1972-08-04
TRIAL STUDY 134XCP|RP|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MM|||LINEAR FT*LB|NOT DONE||Y|U|N|1||38||BLINDED TREATMENT|1962-01-02||1973-02-08|||1970-04-26||1966-08-06
TRIAL STUDY 134XCP|RP|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||ML/G/DAY|||MBQ|NOT DONE||Y|U|Y|1||38||SCREENING|1973-03-20||1961-02-16|||1969-04-09||1970-01-15
TRIAL STUDY 134XCP|RP|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||DPM/100MG|||NM|NOT DONE||NA|N|N|2||58||TREATMENT|1963-03-20||1973-05-18|||1966-06-02||1964-06-27
TRIAL STUDY 134XCP|RP|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|2||||||ULCERIND|ULCER INDICATOR||||10^3/L|||SCOOPFUL|NOT DONE||NA|U|Y|2||58||LONG-TERM FOLLOW-UP|1965-10-11||1968-06-15|||1967-11-28||1964-01-08
TRIAL STUDY 134XCP|RP|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||YD|||SBE/ML|NOT DONE||U|NA|N|3||39||TREATMENT|1966-07-20||1963-09-21|||1960-11-04||1967-09-30
TRIAL STUDY 134XCP|RP|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|2||||||PEELIND|PEELING INDICATOR||||CI/MG|||OSM|NOT DONE||U|N|U|3||39||INDUCTION TREATMENT|1960-02-06||1970-10-02|||1965-02-26||1967-09-07
TRIAL STUDY 134XCP|RP|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|1||||||PRGENDTC|DATE PREGNANCY ENDED||||CY/CM|||NEBULE|NOT DONE||Y|NA|U|4||88||OBSERVATION|1960-03-11||1962-07-07|||1970-04-11||1964-12-02
TRIAL STUDY 134XCP|RP|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^3 CFU|||10^3 DNA COPIES/ML|NOT DONE||Y|Y|U|4||88||LONG-TERM FOLLOW-UP|1970-06-05||1972-12-30|||1961-02-14||1970-01-11
TRIAL STUDY 134XCP|RP|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|1||||||PREGNN|NUMBER OF PREGNANCIES||||NMOL BCE/L|||KV|NOT DONE||U|NA|Y|5||7||LONG-TERM FOLLOW-UP|1970-09-14||1960-01-25|||1960-06-23||1965-08-09
TRIAL STUDY 134XCP|RP|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|2||||||DLVRMODE|MODE OF DELIVERY||||ML/M2/H|||/H|NOT DONE||Y|N|U|5||7||TREATMENT|1967-05-24||1965-10-07|||1962-04-15||1966-10-08
TRIAL STUDY 134XCP|RP|0FD7F837-3D76-4A1C-B414-373B55A39506|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MN|||BEAM BREAKS|NOT DONE||NA|U|N|1||38||INDUCTION TREATMENT|1960-05-05||1964-11-22|||1972-06-29||1969-02-07
TRIAL STUDY 134XCP|RP|0FD7F837-3D76-4A1C-B414-373B55A39506|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||L/DAY|||CMH2O*S/ML|NOT DONE||N|U|Y|1||38||BLINDED TREATMENT|1970-11-18||1971-06-05|||1964-05-21||1963-03-16
TRIAL STUDY 134XCP|RP|0FD7F837-3D76-4A1C-B414-373B55A39506|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||NMOL/L/MIN|||KCAL|NOT DONE||U|NA|Y|2||58||CONTINUATION TREATMENT|1973-07-02||1961-05-18|||1970-09-02||1970-05-01
TRIAL STUDY 134XCP|RP|0FD7F837-3D76-4A1C-B414-373B55A39506|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MEQ|||GENEQ/ML|NOT DONE||NA|NA|Y|2||58||OPEN LABEL TREATMENT|1970-02-01||1972-04-27|||1972-11-03||1969-09-11
TRIAL STUDY 134XCP|RP|0FD7F837-3D76-4A1C-B414-373B55A39506|1||||||MENARAGE|MENARCHE AGE||||10^3 CFU/G|||NG/DL|NOT DONE||N|NA|N|3||39||OPEN LABEL TREATMENT|1962-08-06||1971-06-25|||1972-11-07||1971-02-23
TRIAL STUDY 134XCP|RP|0FD7F837-3D76-4A1C-B414-373B55A39506|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ML/M2|||WEEKS|NOT DONE||N|U|Y|3||39||BASELINE|1962-06-10||1966-08-31|||1963-12-01||1963-09-09
TRIAL STUDY 134XCP|RP|0FD7F837-3D76-4A1C-B414-373B55A39506|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||EID 50/DOSE|||/10^5|NOT DONE||Y|N|N|4||88||FOLLOW-UP|1970-02-05||1972-05-19|||1968-12-13||1967-02-01
TRIAL STUDY 134XCP|RP|0FD7F837-3D76-4A1C-B414-373B55A39506|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||L/S/KPA|||NG/DAY|NOT DONE||N|Y|NA|4||88||CONTINUATION TREATMENT|1970-05-14||1969-08-08|||1965-08-19||1965-02-08
TRIAL STUDY 134XCP|RP|0FD7F837-3D76-4A1C-B414-373B55A39506|1||||||INABOIND|INDUCED ABORTION INDICATOR||||KM|||MG/MIN|NOT DONE||N|Y|NA|5||7||BLINDED TREATMENT|1961-12-22||1970-05-24|||1973-02-10||1967-06-20
TRIAL STUDY 134XCP|RP|0FD7F837-3D76-4A1C-B414-373B55A39506|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||VP/ML|||NG/L|NOT DONE||Y|U|U|5||7||LONG-TERM FOLLOW-UP|1963-08-06||1966-05-26|||1968-11-08||1967-04-13
TRIAL STUDY 134XCP|RP|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|1||||||ERYTHIND|ERYTHEMA INDICATOR||||PNU/ML|||CIGARETTE|NOT DONE||Y|Y|NA|1||38||OPEN LABEL TREATMENT|1965-08-03||1961-12-12|||1971-11-17||1963-10-15
TRIAL STUDY 134XCP|RP|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|2||||||BCMETHOD|BIRTH CONTROL METHOD||||DAMOL/L|||UG/G/DAY|NOT DONE||NA|Y|Y|1||38||SCREENING|1963-04-16||1965-10-09|||1960-09-20||1966-02-04
TRIAL STUDY 134XCP|RP|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||DRINK|||PIXELS/CM|NOT DONE||U|NA|NA|2||58||BASELINE|1973-09-06||1965-08-07|||1961-08-01||1971-05-24
TRIAL STUDY 134XCP|RP|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|2||||||MENOSTAT|MENOPAUSE STATUS||||/MIN|||G/KG|NOT DONE||NA|NA|U|2||58||OBSERVATION|1969-04-03||1968-07-05|||1969-01-14||1972-05-28
TRIAL STUDY 134XCP|RP|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||DAGU/ML|||ML/CAGE|NOT DONE||Y|Y|N|3||39||OBSERVATION|1970-06-05||1972-09-25|||1970-07-31||1962-03-15
TRIAL STUDY 134XCP|RP|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||SEC|||U/KG/H|NOT DONE||Y|U|Y|3||39||RUN-IN|1964-02-02||1973-04-27|||1965-03-23||1961-03-17
TRIAL STUDY 134XCP|RP|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MPS U|||FRAMES/S|NOT DONE||U|U|N|4||88||BLINDED TREATMENT|1966-05-31||1968-01-19|||1960-11-19||1962-02-04
TRIAL STUDY 134XCP|RP|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|2||||||MENOAGE|MENOPAUSE AGE||||MG2/DL2|||RAD|NOT DONE||U|Y|N|4||88||BASELINE|1973-08-18||1969-08-30|||1973-07-25||1972-07-09
TRIAL STUDY 134XCP|RP|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MG/H|||KG/CM2|NOT DONE||U|Y|NA|5||7||BASELINE|1972-12-22||1969-10-03|||1966-03-28||1971-04-15
TRIAL STUDY 134XCP|RP|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|2||||||PUSTIND|PUSTULE INDICATOR||||DAMOL/L|||CYLINDER|NOT DONE||Y|NA|U|5||7||SCREENING|1961-10-02||1960-06-29|||1965-02-21||1963-03-29
TRIAL STUDY 134XCP|RP|92FB0125-67D2-41CC-9116-8C949F15614A|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||DB|||/MONTH|NOT DONE||N|Y|U|1||38||RUN-IN|1960-04-24||1970-04-13|||1960-10-06||1966-11-08
TRIAL STUDY 134XCP|RP|92FB0125-67D2-41CC-9116-8C949F15614A|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MEQ|||DEG2|NOT DONE||U|NA|U|1||38||OBSERVATION|1966-03-05||1961-11-18|||1972-02-25||1973-01-13
TRIAL STUDY 134XCP|RP|92FB0125-67D2-41CC-9116-8C949F15614A|1||||||FUNDHT|FUNDAL HEIGHT||||TROCHE|||P|NOT DONE||Y|U|Y|2||58||LONG-TERM FOLLOW-UP|1964-05-24||1962-02-14|||1960-09-11||1970-06-21
TRIAL STUDY 134XCP|RP|92FB0125-67D2-41CC-9116-8C949F15614A|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||UL/DOSE|||EID 50/DOSE|NOT DONE||NA|Y|U|2||58||CONTINUATION TREATMENT|1961-10-21||1966-08-12|||1968-06-26||1963-05-30
TRIAL STUDY 134XCP|RP|92FB0125-67D2-41CC-9116-8C949F15614A|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||LOG EID 50/DOSE|||GPS U|NOT DONE||N|N|Y|3||39||WASHOUT|1964-07-30||1973-01-20|||1965-09-16||1961-07-02
TRIAL STUDY 134XCP|RP|92FB0125-67D2-41CC-9116-8C949F15614A|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||NKAT|||PG/CELL|NOT DONE||NA|N|Y|3||39||TREATMENT|1964-10-04||1962-02-14|||1961-11-13||1967-10-16
TRIAL STUDY 134XCP|RP|92FB0125-67D2-41CC-9116-8C949F15614A|1||||||DLVRMODE|MODE OF DELIVERY||||LX|||FEU|NOT DONE||U|N|Y|4||88||INDUCTION TREATMENT|1961-07-22||1964-02-16|||1964-09-24||1961-06-23
TRIAL STUDY 134XCP|RP|92FB0125-67D2-41CC-9116-8C949F15614A|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||10^9 CFU/ML|||KG/M2|NOT DONE||Y|N|U|4||88||FOLLOW-UP|1964-03-01||1967-04-09|||1961-06-07||1970-03-16
TRIAL STUDY 134XCP|RP|92FB0125-67D2-41CC-9116-8C949F15614A|1||||||THICK|THICKNESS||||GENEQ|||ML/MMHG|NOT DONE||NA|N|NA|5||7||FOLLOW-UP|1962-03-10||1967-03-11|||1968-02-23||1969-09-19
TRIAL STUDY 134XCP|RP|92FB0125-67D2-41CC-9116-8C949F15614A|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MM2|||GENEQ|NOT DONE||Y|NA|NA|5||7||INDUCTION TREATMENT|1960-11-08||1960-11-27|||1973-05-14||1963-05-06
TRIAL STUDY 134XCP|RP|7042617F-0C29-4928-B3ED-9549A53BC195|1||||||EDEMAIND|EDEMA INDICATOR||||DMOL|||KG|NOT DONE||N|U|N|1||38||OPEN LABEL TREATMENT|1961-08-01||1969-07-29|||1965-06-25||1967-04-11
TRIAL STUDY 134XCP|RP|7042617F-0C29-4928-B3ED-9549A53BC195|2||||||BLISTIND|BLISTERING INDICATOR||||IN|||PLUG|NOT DONE||NA|N|U|1||38||OBSERVATION|1966-12-26||1966-04-18|||1964-04-20||1971-02-01
TRIAL STUDY 134XCP|RP|7042617F-0C29-4928-B3ED-9549A53BC195|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||KHZ|||GPELISA UNIT/ML|NOT DONE||NA|Y|N|2||58||WASHOUT|1962-09-02||1972-01-19|||1969-05-14||1968-03-18
TRIAL STUDY 134XCP|RP|7042617F-0C29-4928-B3ED-9549A53BC195|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MU/L|||UOSM|NOT DONE||U|NA|Y|2||58||SCREENING|1965-04-29||1964-10-18|||1965-01-15||1967-12-10
TRIAL STUDY 134XCP|RP|7042617F-0C29-4928-B3ED-9549A53BC195|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/CAGE/DAY|||VOXEL|NOT DONE||NA|N|Y|3||39||OBSERVATION|1960-12-25||1963-01-15|||1972-04-10||1968-11-20
TRIAL STUDY 134XCP|RP|7042617F-0C29-4928-B3ED-9549A53BC195|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MM/H|||RAD|NOT DONE||Y|NA|N|3||39||LONG-TERM FOLLOW-UP|1963-06-26||1965-02-28|||1964-03-24||1964-12-15
TRIAL STUDY 134XCP|RP|7042617F-0C29-4928-B3ED-9549A53BC195|1||||||MENOSTAT|MENOPAUSE STATUS||||LINEAR FT*LB|||UMOL/L/MIN|NOT DONE||N|N|N|4||88||INDUCTION TREATMENT|1968-07-03||1972-04-17|||1969-06-10||1973-06-29
TRIAL STUDY 134XCP|RP|7042617F-0C29-4928-B3ED-9549A53BC195|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MEQ/G|||MG/H|NOT DONE||NA|NA|U|4||88||FOLLOW-UP|1966-05-27||1971-07-23|||1963-05-02||1971-07-05
TRIAL STUDY 134XCP|RP|7042617F-0C29-4928-B3ED-9549A53BC195|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||L/DAY|||MG/KG|NOT DONE||NA|NA|NA|5||7||WASHOUT|1962-08-29||1971-04-16|||1963-02-06||1966-04-27
TRIAL STUDY 134XCP|RP|7042617F-0C29-4928-B3ED-9549A53BC195|2||||||DSCHGIND|DISCHARGE INDICATOR||||M|||U/10^12 RBC|NOT DONE||NA|NA|NA|5||7||OBSERVATION|1962-05-01||1966-07-06|||1970-08-01||1960-01-03
TRIAL STUDY 134XCP|RP|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|1||||||PEELIND|PEELING INDICATOR||||ABSORBANCE U|||ECL UNIT|NOT DONE||NA|N|U|1||38||LONG-TERM FOLLOW-UP|1970-03-26||1970-10-20|||1966-05-11||1970-04-27
TRIAL STUDY 134XCP|RP|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|2||||||RASHIND|RASH INDICATOR||||MEQ/DAY|||NMOL|NOT DONE||Y|NA|N|1||38||SCREENING|1972-11-10||1972-01-28|||1968-05-14||1972-12-18
TRIAL STUDY 134XCP|RP|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MOL/MOL|||MOSM/L|NOT DONE||NA|NA|N|2||58||WASHOUT|1961-09-17||1963-07-30|||1972-07-27||1970-04-05
TRIAL STUDY 134XCP|RP|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|2||||||TNDRIND|TENDERNESS INDICATOR||||MG/DAY|||HZ/S|NOT DONE||N|NA|N|2||58||RUN-IN|1973-01-20||1972-07-09|||1967-05-17||1965-12-01
TRIAL STUDY 134XCP|RP|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|1||||||PREGST|PREGNANT DURING THE STUDY||||ROENTGEN|||ML/KG|NOT DONE||N|N|NA|3||39||CONTINUATION TREATMENT|1967-12-08||1961-10-22|||1961-04-17||1961-08-03
TRIAL STUDY 134XCP|RP|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|2||||||BRTHN|NUMBER OF BIRTHS||||%(W/W)|||TBSP|NOT DONE||N|U|N|3||39||OPEN LABEL TREATMENT|1968-02-03||1967-01-15|||1968-12-03||1964-04-13
TRIAL STUDY 134XCP|RP|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MDFI|||MOL/DAY|NOT DONE||N|N|N|4||88||INDUCTION TREATMENT|1964-09-29||1973-07-16|||1973-06-11||1971-11-07
TRIAL STUDY 134XCP|RP|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|2||||||ULCERIND|ULCER INDICATOR||||FRAMES/S|||MEQ/KG|NOT DONE||NA|N|U|4||88||LONG-TERM FOLLOW-UP|1970-03-19||1960-03-19|||1962-07-25||1966-01-19
TRIAL STUDY 134XCP|RP|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||GBQ/G|||10^3 CFU/G|NOT DONE||N|NA|NA|5||7||RUN-IN|1973-02-22||1969-12-24|||1960-06-17||1966-12-04
TRIAL STUDY 134XCP|RP|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|2||||||MASSIND|MASS INDICATOR||||G/KG|||COAT|NOT DONE||U|U|N|5||7||RUN-IN|1972-03-12||1973-07-12|||1969-01-23||1964-04-20
TRIAL STUDY 134XCP|RP|6633CC54-D711-4780-A833-A71756D8B234|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MG/L|||POUCH|NOT DONE||Y|Y|N|1||38||SCREENING|1973-04-29||1971-05-15|||1963-07-25||1971-10-16
TRIAL STUDY 134XCP|RP|6633CC54-D711-4780-A833-A71756D8B234|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||ML/S/M2|||/MIN|NOT DONE||Y|NA|NA|1||38||FOLLOW-UP|1961-07-02||1964-07-31|||1971-12-09||1973-05-02
TRIAL STUDY 134XCP|RP|6633CC54-D711-4780-A833-A71756D8B234|1||||||EDEMAIND|EDEMA INDICATOR||||KS|||10^6 ORGANISMS|NOT DONE||Y|NA|N|2||58||TREATMENT|1963-09-29||1963-10-19|||1963-11-26||1969-12-06
TRIAL STUDY 134XCP|RP|6633CC54-D711-4780-A833-A71756D8B234|2||||||BRTHN|NUMBER OF BIRTHS||||SACHET|||FOZ_US|NOT DONE||U|Y|NA|2||58||BASELINE|1968-02-25||1963-06-18|||1960-05-12||1963-04-19
TRIAL STUDY 134XCP|RP|6633CC54-D711-4780-A833-A71756D8B234|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MG/M2/DAY|||MEQ/DAY|NOT DONE||N|NA|Y|3||39||FOLLOW-UP|1970-08-21||1972-02-26|||1969-09-21||1961-02-16
TRIAL STUDY 134XCP|RP|6633CC54-D711-4780-A833-A71756D8B234|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||G/CM2|||UMOL/KG/MIN|NOT DONE||Y|U|U|3||39||CONTINUATION TREATMENT|1965-10-01||1968-03-30|||1966-11-24||1968-10-19
TRIAL STUDY 134XCP|RP|6633CC54-D711-4780-A833-A71756D8B234|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||SPRAY|||%/S|NOT DONE||N|NA|U|4||88||CONTINUATION TREATMENT|1970-04-07||1966-06-10|||1966-08-09||1972-11-03
TRIAL STUDY 134XCP|RP|6633CC54-D711-4780-A833-A71756D8B234|2||||||STILBIND|STILLBIRTH INDICATOR||||RATIO|||PACKAGE|NOT DONE||Y|N|N|4||88||FOLLOW-UP|1960-08-25||1968-10-14|||1971-10-05||1962-08-02
TRIAL STUDY 134XCP|RP|6633CC54-D711-4780-A833-A71756D8B234|1||||||MENOSTAT|MENOPAUSE STATUS||||IU/MMOL|||10^9 ORGANISMS/G|NOT DONE||U|N|Y|5||7||WASHOUT|1960-10-07||1960-08-11|||1962-08-17||1968-11-14
TRIAL STUDY 134XCP|RP|6633CC54-D711-4780-A833-A71756D8B234|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||LOG10 TCID 50/DOSE|||MONTHS|NOT DONE||Y|N|N|5||7||BASELINE|1971-07-29||1971-07-02|||1971-07-25||1964-11-27
TRIAL STUDY 134XCP|RP|84C642FE-6D84-4525-AB1C-15FAF740D63B|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||G/CAGE/DAY|||MMOL/MOL|NOT DONE||Y|U|Y|1||38||INDUCTION TREATMENT|1962-09-27||1962-10-12|||1969-11-16||1965-04-18
TRIAL STUDY 134XCP|RP|84C642FE-6D84-4525-AB1C-15FAF740D63B|2||||||PREGIND|PREGNANT INDICATOR||||UG/MOL|||MMOL/KG|NOT DONE||U|Y|U|1||38||SCREENING|1972-06-18||1961-08-16|||1967-08-24||1972-05-18
TRIAL STUDY 134XCP|RP|84C642FE-6D84-4525-AB1C-15FAF740D63B|1||||||PREGNN|NUMBER OF PREGNANCIES||||UG/L/H|||MEQ/ML|NOT DONE||NA|Y|NA|2||58||INDUCTION TREATMENT|1966-10-08||1968-09-17|||1966-12-04||1969-07-08
TRIAL STUDY 134XCP|RP|84C642FE-6D84-4525-AB1C-15FAF740D63B|2||||||ERYTHIND|ERYTHEMA INDICATOR||||STEPS/MIN|||ML/CAGE|NOT DONE||NA|N|Y|2||58||OPEN LABEL TREATMENT|1964-01-23||1973-06-12|||1960-11-28||1968-07-25
TRIAL STUDY 134XCP|RP|84C642FE-6D84-4525-AB1C-15FAF740D63B|1||||||INABOIND|INDUCED ABORTION INDICATOR||||U/KG|||ANTI-XA IU/ML|NOT DONE||N|Y|N|3||39||CONTINUATION TREATMENT|1970-02-17||1968-06-02|||1968-11-18||1972-05-01
TRIAL STUDY 134XCP|RP|84C642FE-6D84-4525-AB1C-15FAF740D63B|2||||||PRGENDTC|DATE PREGNANCY ENDED||||G/CM2|||KPA/L/SEC|NOT DONE||N|Y|NA|3||39||BLINDED TREATMENT|1971-05-07||1965-04-10|||1964-06-11||1961-06-15
TRIAL STUDY 134XCP|RP|84C642FE-6D84-4525-AB1C-15FAF740D63B|1||||||THICK|THICKNESS||||LB|||MASK|NOT DONE||N|NA|N|4||88||FOLLOW-UP|1962-10-20||1960-06-22|||1971-06-06||1969-11-18
TRIAL STUDY 134XCP|RP|84C642FE-6D84-4525-AB1C-15FAF740D63B|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||WATT|||NKAT/G HB|NOT DONE||Y|NA|U|4||88||RUN-IN|1970-10-19||1973-02-10|||1960-04-16||1973-05-07
TRIAL STUDY 134XCP|RP|84C642FE-6D84-4525-AB1C-15FAF740D63B|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||PIXELS/IN|||VP/ML|NOT DONE||U|Y|U|5||7||OBSERVATION|1960-08-06||1961-11-12|||1972-03-11||1972-05-24
TRIAL STUDY 134XCP|RP|84C642FE-6D84-4525-AB1C-15FAF740D63B|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||ML/MIN/1.73M2|||PMOL/L/H|NOT DONE||NA|NA|N|5||7||FOLLOW-UP|1968-09-01||1968-02-07|||1967-05-20||1960-12-25
TRIAL STUDY 134XCP|RP|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|1||||||PRGENDTC|DATE PREGNANCY ENDED||||CS|||MG/KG|NOT DONE||NA|U|Y|1||38||BLINDED TREATMENT|1963-04-08||1968-08-10|||1961-09-02||1966-09-06
TRIAL STUDY 134XCP|RP|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MEQ/ML|||NGEQ/L|NOT DONE||Y|N|NA|1||38||OBSERVATION|1964-07-04||1961-05-16|||1971-12-24||1966-07-04
TRIAL STUDY 134XCP|RP|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|1||||||DLVRMODE|MODE OF DELIVERY||||UL/DOSE|||CM/MIN|NOT DONE||U|U|Y|2||58||BASELINE|1965-11-04||1960-11-11|||1968-08-18||1972-01-15
TRIAL STUDY 134XCP|RP|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|2||||||THICK|THICKNESS||||UG/DL|||HPA|NOT DONE||Y|NA|Y|2||58||BLINDED TREATMENT|1966-02-08||1972-10-25|||1970-05-30||1960-06-10
TRIAL STUDY 134XCP|RP|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|1||||||MENOAGE|MENOPAUSE AGE||||LOZENGE|||ML/BEAT|NOT DONE||Y|Y|N|3||39||WASHOUT|1962-11-18||1967-10-10|||1961-09-07||1961-12-17
TRIAL STUDY 134XCP|RP|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|2||||||DSCHGIND|DISCHARGE INDICATOR||||UG/DAY|||UM/S|NOT DONE||U|N|N|3||39||OPEN LABEL TREATMENT|1967-06-03||1963-06-21|||1970-05-12||1965-06-23
TRIAL STUDY 134XCP|RP|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|1||||||MENOSTAT|MENOPAUSE STATUS||||BREATHS/30S|||PMOL/DAY|NOT DONE||N|NA|Y|4||88||OPEN LABEL TREATMENT|1964-10-31||1972-10-20|||1962-02-27||1967-04-06
TRIAL STUDY 134XCP|RP|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||NMOL BCE/MMOL|||BQ/L|NOT DONE||NA|U|N|4||88||FOLLOW-UP|1960-06-18||1967-10-19|||1970-10-16||1972-08-21
TRIAL STUDY 134XCP|RP|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||LOZENGE|||ML/(MIN*100ML)|NOT DONE||NA|Y|Y|5||7||SCREENING|1961-09-18||1968-03-08|||1964-10-24||1964-07-31
TRIAL STUDY 134XCP|RP|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|2||||||MENOSTAT|MENOPAUSE STATUS||||PL|||UMOL/MOL|NOT DONE||NA|Y|U|5||7||CONTINUATION TREATMENT|1961-08-23||1960-12-07|||1970-09-30||1965-12-11
TRIAL STUDY 134XCP|RP|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||G/KG|||V/SEC|NOT DONE||U|U|N|1||38||BASELINE|1964-12-22||1961-10-02|||1968-09-07||1968-03-31
TRIAL STUDY 134XCP|RP|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||PPTR|||MMOL/G|NOT DONE||U|U|Y|1||38||LONG-TERM FOLLOW-UP|1961-12-09||1967-10-17|||1966-12-07||1965-09-17
TRIAL STUDY 134XCP|RP|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MU/L|||NMOL/ML/MIN|NOT DONE||Y|U|N|2||58||TREATMENT|1970-06-18||1961-04-28|||1961-09-11||1960-01-31
TRIAL STUDY 134XCP|RP|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||PATCH|||MG/M2/MIN|NOT DONE||NA|NA|Y|2||58||INDUCTION TREATMENT|1969-05-10||1960-09-16|||1965-08-07||1965-06-25
TRIAL STUDY 134XCP|RP|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|1||||||BCMETHOD|BIRTH CONTROL METHOD||||EU|||LOZENGE|NOT DONE||N|Y|U|3||39||CONTINUATION TREATMENT|1967-10-22||1970-03-18|||1960-08-27||1973-05-23
TRIAL STUDY 134XCP|RP|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|2||||||RASHIND|RASH INDICATOR||||LOG10 IU/ML|||BEAM BREAKS|NOT DONE||Y|N|U|3||39||INDUCTION TREATMENT|1968-06-25||1969-09-12|||1969-02-21||1964-02-16
TRIAL STUDY 134XCP|RP|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MMHG/L/MIN|||UV*SEC|NOT DONE||NA|Y|Y|4||88||INDUCTION TREATMENT|1962-05-06||1962-09-20|||1966-12-10||1964-07-15
TRIAL STUDY 134XCP|RP|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|2||||||ABORTN|NUMBER OF ABORTIONS||||MG/ANIMAL|||ML/100G/MIN|NOT DONE||N|Y|N|4||88||INDUCTION TREATMENT|1965-01-05||1968-11-07|||1965-01-15||1969-10-29
TRIAL STUDY 134XCP|RP|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|1||||||PRGENDTC|DATE PREGNANCY ENDED||||10^6 ORGANISMS/ML|||RING|NOT DONE||Y|Y|U|5||7||SCREENING|1966-05-26||1970-07-16|||1963-06-05||1962-02-20
TRIAL STUDY 134XCP|RP|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|2||||||DLVRMODE|MODE OF DELIVERY||||G/G/DAY|||TBSP|NOT DONE||NA|NA|Y|5||7||FOLLOW-UP|1968-01-28||1961-12-27|||1967-04-16||1968-09-18
TRIAL STUDY 134XCP|RP|A0757669-2DF6-4E78-A021-9C777BEF5697|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||NEWTON|||PMOL/10^9 CELLS|NOT DONE||N|NA|Y|1||38||FOLLOW-UP|1972-12-16||1963-07-24|||1963-06-07||1961-08-25
TRIAL STUDY 134XCP|RP|A0757669-2DF6-4E78-A021-9C777BEF5697|2||||||PREGST|PREGNANT DURING THE STUDY||||ML/SEC/1.73M2|||10^3 CFU/G|NOT DONE||NA|U|U|1||38||CONTINUATION TREATMENT|1969-04-07||1961-02-19|||1960-11-02||1969-04-07
TRIAL STUDY 134XCP|RP|A0757669-2DF6-4E78-A021-9C777BEF5697|1||||||PREGST|PREGNANT DURING THE STUDY||||10^9/DOSE|||ML/DL|NOT DONE||N|NA|Y|2||58||INDUCTION TREATMENT|1973-03-21||1963-12-29|||1971-07-14||1967-11-29
TRIAL STUDY 134XCP|RP|A0757669-2DF6-4E78-A021-9C777BEF5697|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MV*MIN|||PIXEL|NOT DONE||Y|U|U|2||58||OBSERVATION|1970-07-10||1971-05-11|||1963-02-06||1963-06-17
TRIAL STUDY 134XCP|RP|A0757669-2DF6-4E78-A021-9C777BEF5697|1||||||PEELIND|PEELING INDICATOR||||GRAVITATIONAL UNIT|||KG|NOT DONE||U|N|NA|3||39||LONG-TERM FOLLOW-UP|1962-08-27||1964-08-28|||1963-06-30||1967-06-10
TRIAL STUDY 134XCP|RP|A0757669-2DF6-4E78-A021-9C777BEF5697|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||PACK YEAR|||LOG10 TCID 50/UL|NOT DONE||N|N|N|3||39||BLINDED TREATMENT|1962-03-17||1970-02-13|||1961-02-18||1967-12-15
TRIAL STUDY 134XCP|RP|A0757669-2DF6-4E78-A021-9C777BEF5697|1||||||STILBIND|STILLBIRTH INDICATOR||||DNA COPIES/UG|||MV2/HZ|NOT DONE||N|N|N|4||88||TREATMENT|1970-12-30||1970-12-03|||1970-03-12||1960-09-25
TRIAL STUDY 134XCP|RP|A0757669-2DF6-4E78-A021-9C777BEF5697|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||PACKAGE|||MEQ/MMOL|NOT DONE||N|U|Y|4||88||WASHOUT|1961-12-29||1966-08-26|||1963-03-23||1970-07-18
TRIAL STUDY 134XCP|RP|A0757669-2DF6-4E78-A021-9C777BEF5697|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||PIPE|||AU/ML|NOT DONE||U|U|NA|5||7||OPEN LABEL TREATMENT|1966-06-28||1964-10-13|||1968-06-25||1970-06-01
TRIAL STUDY 134XCP|RP|A0757669-2DF6-4E78-A021-9C777BEF5697|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||NEEDLE GAUGE|||BAU|NOT DONE||U|Y|N|5||7||FOLLOW-UP|1964-11-03||1962-11-23|||1971-06-22||1969-07-14
TRIAL STUDY 134XCP|RP|DAF7255A-888D-43D3-97B8-5E432938747F|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^7/L|||H/WK|NOT DONE||Y|N|U|1||38||OBSERVATION|1972-12-19||1972-04-17|||1961-07-09||1970-12-02
TRIAL STUDY 134XCP|RP|DAF7255A-888D-43D3-97B8-5E432938747F|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||U|||MEQ/ML|NOT DONE||NA|Y|NA|1||38||BASELINE|1973-07-24||1970-09-07|||1962-12-03||1967-04-29
TRIAL STUDY 134XCP|RP|DAF7255A-888D-43D3-97B8-5E432938747F|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||PPTH|||S^-1(%O2)^-1|NOT DONE||NA|U|Y|2||58||FOLLOW-UP|1969-08-29||1961-04-08|||1964-12-22||1972-12-20
TRIAL STUDY 134XCP|RP|DAF7255A-888D-43D3-97B8-5E432938747F|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||1/(S*KPA)|||ML/ANIMAL/DAY|NOT DONE||NA|N|U|2||58||SCREENING|1969-10-20||1960-12-23|||1966-06-30||1973-02-27
TRIAL STUDY 134XCP|RP|DAF7255A-888D-43D3-97B8-5E432938747F|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||ML/G/DAY|||APS U|NOT DONE||U|Y|Y|3||39||BLINDED TREATMENT|1969-02-07||1964-07-06|||1967-10-27||1964-04-11
TRIAL STUDY 134XCP|RP|DAF7255A-888D-43D3-97B8-5E432938747F|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^6/EJACULATE U|||/500 WBC|NOT DONE||N|N|U|3||39||LONG-TERM FOLLOW-UP|1961-05-09||1962-03-09|||1967-07-29||1967-03-14
TRIAL STUDY 134XCP|RP|DAF7255A-888D-43D3-97B8-5E432938747F|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||ML/CM|||MEQ/L|NOT DONE||NA|N|N|4||88||TREATMENT|1966-08-24||1965-12-16|||1966-06-21||1960-02-21
TRIAL STUDY 134XCP|RP|DAF7255A-888D-43D3-97B8-5E432938747F|2||||||STILBIND|STILLBIRTH INDICATOR||||LOG10 TCID 50/UL|||L/H|NOT DONE||U|Y|Y|4||88||FOLLOW-UP|1965-07-13||1961-10-02|||1970-10-12||1964-10-03
TRIAL STUDY 134XCP|RP|DAF7255A-888D-43D3-97B8-5E432938747F|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||/MM2|||IU/G|NOT DONE||NA|U|Y|5||7||BASELINE|1961-07-14||1960-05-21|||1964-11-01||1961-06-30
TRIAL STUDY 134XCP|RP|DAF7255A-888D-43D3-97B8-5E432938747F|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||CCID 50/DOSE|||/MM2|NOT DONE||U|Y|U|5||7||WASHOUT|1961-02-10||1968-06-04|||1972-11-09||1972-05-03
TRIAL STUDY 134XCP|RP|51989FEC-B63E-4F58-B748-2FF5E73E5D14|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UEQ/L|||KCAL|NOT DONE||Y|N|NA|1||38||BASELINE|1972-03-02||1969-10-28|||1973-03-04||1961-03-18
TRIAL STUDY 134XCP|RP|51989FEC-B63E-4F58-B748-2FF5E73E5D14|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||FT2|||BEATS/MIN|NOT DONE||Y|NA|N|1||38||INDUCTION TREATMENT|1973-08-07||1968-11-05|||1968-07-01||1962-09-22
TRIAL STUDY 134XCP|RP|51989FEC-B63E-4F58-B748-2FF5E73E5D14|1||||||PREGNN|NUMBER OF PREGNANCIES||||MCI/KG|||ENZYME U/G HB|NOT DONE||N|NA|U|2||58||LONG-TERM FOLLOW-UP|1965-02-18||1973-05-24|||1965-01-30||1967-05-24
TRIAL STUDY 134XCP|RP|51989FEC-B63E-4F58-B748-2FF5E73E5D14|2||||||EDEMAIND|EDEMA INDICATOR||||MCI/KG|||CAPFUL|NOT DONE||NA|N|N|2||58||WASHOUT|1966-05-15||1960-01-17|||1971-09-02||1969-11-30
TRIAL STUDY 134XCP|RP|51989FEC-B63E-4F58-B748-2FF5E73E5D14|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MMOL/G|||CY/CM|NOT DONE||Y|NA|Y|3||39||INDUCTION TREATMENT|1968-01-21||1962-02-21|||1963-02-15||1960-09-29
TRIAL STUDY 134XCP|RP|51989FEC-B63E-4F58-B748-2FF5E73E5D14|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||%(W/V)|||SFC/10^6 PBMC|NOT DONE||N|NA|Y|3||39||INDUCTION TREATMENT|1962-10-09||1962-04-07|||1960-11-05||1967-03-02
TRIAL STUDY 134XCP|RP|51989FEC-B63E-4F58-B748-2FF5E73E5D14|1||||||MENOSTAT|MENOPAUSE STATUS||||MANSON U/ML|||OZ|NOT DONE||N|N|N|4||88||LONG-TERM FOLLOW-UP|1967-01-23||1969-09-19|||1961-06-11||1968-01-05
TRIAL STUDY 134XCP|RP|51989FEC-B63E-4F58-B748-2FF5E73E5D14|2||||||PRGENDTC|DATE PREGNANCY ENDED||||PMOL/10^9 CELLS|||10^3 DNA COPIES/ML|NOT DONE||NA|N|Y|4||88||TREATMENT|1965-10-19||1960-11-09|||1966-12-02||1960-08-11
TRIAL STUDY 134XCP|RP|51989FEC-B63E-4F58-B748-2FF5E73E5D14|1||||||BRTHN|NUMBER OF BIRTHS||||LOG10 CCID 50/DOSE|||U/G|NOT DONE||Y|Y|NA|5||7||OBSERVATION|1961-01-24||1964-03-20|||1970-09-30||1970-03-29
TRIAL STUDY 134XCP|RP|51989FEC-B63E-4F58-B748-2FF5E73E5D14|2||||||GRAVIND|GRAVIDA INDICATOR||||BQ/G|||TUBERCULIN UNIT/ML|NOT DONE||NA|N|U|5||7||BLINDED TREATMENT|1962-02-22||1967-11-10|||1961-02-09||1963-11-10
TRIAL STUDY 134XCP|RP|776299DC-1CD5-448F-82C2-C1659CEE689D|1||||||ULCERIND|ULCER INDICATOR||||ANSON U|||CFU/ML|NOT DONE||N|N|NA|1||38||BASELINE|1968-09-06||1971-07-02|||1964-01-19||1967-05-18
TRIAL STUDY 134XCP|RP|776299DC-1CD5-448F-82C2-C1659CEE689D|2||||||PREGIND|PREGNANT INDICATOR||||WEEKS|||MMOL/DAY|NOT DONE||Y|U|NA|1||38||BLINDED TREATMENT|1962-10-13||1970-11-03|||1967-02-01||1963-03-12
TRIAL STUDY 134XCP|RP|776299DC-1CD5-448F-82C2-C1659CEE689D|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||CAPLET|||ML/G/DAY|NOT DONE||N|NA|Y|2||58||RUN-IN|1960-04-03||1961-10-08|||1967-07-28||1969-01-17
TRIAL STUDY 134XCP|RP|776299DC-1CD5-448F-82C2-C1659CEE689D|2||||||ULCERIND|ULCER INDICATOR||||MMAL|||KBQ/UL|NOT DONE||NA|N|Y|2||58||LONG-TERM FOLLOW-UP|1963-05-25||1969-11-25|||1961-03-28||1972-07-09
TRIAL STUDY 134XCP|RP|776299DC-1CD5-448F-82C2-C1659CEE689D|1||||||STILBIND|STILLBIRTH INDICATOR||||DAYS/WK|||NG/L|NOT DONE||NA|U|Y|3||39||LONG-TERM FOLLOW-UP|1960-05-21||1965-10-04|||1968-06-09||1961-09-21
TRIAL STUDY 134XCP|RP|776299DC-1CD5-448F-82C2-C1659CEE689D|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ML/DL|||BOX|NOT DONE||Y|N|N|3||39||BLINDED TREATMENT|1970-05-16||1967-09-27|||1964-09-07||1970-07-16
TRIAL STUDY 134XCP|RP|776299DC-1CD5-448F-82C2-C1659CEE689D|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MPL U/ML|||STRIP|NOT DONE||NA|NA|N|4||88||TREATMENT|1967-09-08||1969-07-23|||1972-02-05||1972-06-28
TRIAL STUDY 134XCP|RP|776299DC-1CD5-448F-82C2-C1659CEE689D|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MMOL|||KPA/L/SEC|NOT DONE||N|Y|N|4||88||BASELINE|1966-03-06||1972-11-30|||1966-06-25||1972-12-21
TRIAL STUDY 134XCP|RP|776299DC-1CD5-448F-82C2-C1659CEE689D|1||||||THICK|THICKNESS||||IU/MG|||LOG10 ELISA UNIT/DOSE|NOT DONE||U|NA|U|5||7||FOLLOW-UP|1963-03-31||1967-11-11|||1971-09-20||1972-01-17
TRIAL STUDY 134XCP|RP|776299DC-1CD5-448F-82C2-C1659CEE689D|2||||||BCMETHOD|BIRTH CONTROL METHOD||||KEV|||NMOL/L/MIN|NOT DONE||N|NA|N|5||7||WASHOUT|1969-03-25||1964-03-05|||1964-03-25||1971-09-28
TRIAL STUDY 134XCP|RP|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||MM/SEC|||CAN|NOT DONE||U|Y|U|1||38||CONTINUATION TREATMENT|1961-12-04||1972-07-01|||1971-07-22||1963-11-17
TRIAL STUDY 134XCP|RP|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||CD|||PMOL/L|NOT DONE||U|U|U|1||38||TREATMENT|1966-01-01||1965-01-14|||1972-07-20||1971-05-18
TRIAL STUDY 134XCP|RP|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MMOL/KG|||PG/CELL|NOT DONE||U|U|U|2||58||OPEN LABEL TREATMENT|1970-11-06||1960-06-11|||1970-01-30||1960-10-07
TRIAL STUDY 134XCP|RP|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||LENS|||MBP|NOT DONE||U|U|U|2||58||CONTINUATION TREATMENT|1968-07-06||1964-02-14|||1965-06-10||1971-10-26
TRIAL STUDY 134XCP|RP|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|1||||||DSCHGIND|DISCHARGE INDICATOR||||CI/ML|||UG/DL|NOT DONE||U|NA|N|3||39||WASHOUT|1965-08-15||1971-06-16|||1968-09-29||1964-08-20
TRIAL STUDY 134XCP|RP|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||DAGU/ML|||KBQ|NOT DONE||N|U|Y|3||39||FOLLOW-UP|1967-02-14||1968-10-27|||1962-07-15||1962-04-22
TRIAL STUDY 134XCP|RP|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|1||||||RASHIND|RASH INDICATOR||||TESLA|||UG/CM2|NOT DONE||Y|U|Y|4||88||SCREENING|1967-09-26||1961-03-08|||1971-04-08||1971-05-22
TRIAL STUDY 134XCP|RP|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||%(V/V)|||LB|NOT DONE||Y|Y|Y|4||88||OPEN LABEL TREATMENT|1964-08-07||1960-07-04|||1963-04-13||1969-01-14
TRIAL STUDY 134XCP|RP|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|1||||||INABOIND|INDUCED ABORTION INDICATOR||||LOG10 PFU/ML|||UG/L DDU|NOT DONE||NA|NA|NA|5||7||WASHOUT|1971-08-21||1960-01-14|||1964-12-02||1971-03-08
TRIAL STUDY 134XCP|RP|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|2||||||BRTHN|NUMBER OF BIRTHS||||PMOL|||MV|NOT DONE||N|U|Y|5||7||FOLLOW-UP|1966-05-24||1966-06-06|||1970-05-12||1966-03-07
TRIAL STUDY 134XCP|RP|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|1||||||PUSTIND|PUSTULE INDICATOR||||MMOL2/L2|||PHERESIS UNIT|NOT DONE||N|NA|Y|1||38||RUN-IN|1965-04-03||1961-02-04|||1969-10-22||1963-08-03
TRIAL STUDY 134XCP|RP|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MG/DL|||ML/ANIMAL/DAY|NOT DONE||Y|Y|NA|1||38||TREATMENT|1970-12-31||1972-08-26|||1969-09-27||1968-06-14
TRIAL STUDY 134XCP|RP|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||U/G|||AU/ML|NOT DONE||U|Y|N|2||58||LONG-TERM FOLLOW-UP|1969-01-22||1961-12-21|||1968-10-19||1969-03-17
TRIAL STUDY 134XCP|RP|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|2||||||INABOIND|INDUCED ABORTION INDICATOR||||UCI|||MMOL2/L2|NOT DONE||Y|N|NA|2||58||OPEN LABEL TREATMENT|1966-05-12||1963-08-23|||1969-02-27||1968-02-20
TRIAL STUDY 134XCP|RP|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|1||||||TNDRIND|TENDERNESS INDICATOR||||MDFI|||MG/M2/DAY|NOT DONE||U|U|N|3||39||RUN-IN|1972-06-26||1964-06-14|||1970-11-03||1970-05-29
TRIAL STUDY 134XCP|RP|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|2||||||INABOIND|INDUCED ABORTION INDICATOR||||/VF|||MONTHS|NOT DONE||NA|Y|U|3||39||OBSERVATION|1967-07-02||1967-05-24|||1971-04-24||1964-10-18
TRIAL STUDY 134XCP|RP|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||U/G/H|||G/DL|NOT DONE||NA|NA|N|4||88||LONG-TERM FOLLOW-UP|1964-05-25||1972-04-13|||1961-09-23||1963-10-18
TRIAL STUDY 134XCP|RP|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||G/L|||UL/ML|NOT DONE||Y|NA|NA|4||88||RUN-IN|1972-08-10||1969-06-24|||1965-01-27||1967-10-28
TRIAL STUDY 134XCP|RP|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|1||||||PUSTIND|PUSTULE INDICATOR||||MMHG*MIN/L|||MBQ|NOT DONE||Y|Y|Y|5||7||OBSERVATION|1963-11-12||1963-01-31|||1963-12-05||1962-07-20
TRIAL STUDY 134XCP|RP|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|2||||||ABORTN|NUMBER OF ABORTIONS||||10^4/HPF|||IU/ML|NOT DONE||U|N|N|5||7||INDUCTION TREATMENT|1965-05-18||1968-12-31|||1970-12-07||1972-01-26
TRIAL STUDY 134XCP|RP|054D4740-C675-4904-B912-B00A0B089F12|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||IU/DL|||UM|NOT DONE||NA|U|NA|1||38||LONG-TERM FOLLOW-UP|1970-12-11||1972-09-03|||1971-02-18||1962-06-15
TRIAL STUDY 134XCP|RP|054D4740-C675-4904-B912-B00A0B089F12|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MG/H|||BE/ML|NOT DONE||NA|NA|U|1||38||BASELINE|1969-01-03||1966-03-29|||1971-03-27||1963-08-16
TRIAL STUDY 134XCP|RP|054D4740-C675-4904-B912-B00A0B089F12|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||PMOL/L|||SYRINGE|NOT DONE||Y|U|N|2||58||SCREENING|1961-01-28||1960-02-21|||1960-07-23||1961-09-19
TRIAL STUDY 134XCP|RP|054D4740-C675-4904-B912-B00A0B089F12|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||DEG2|||PG/CELL|NOT DONE||Y|N|NA|2||58||FOLLOW-UP|1973-08-03||1972-12-10|||1968-10-30||1967-07-06
TRIAL STUDY 134XCP|RP|054D4740-C675-4904-B912-B00A0B089F12|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||% INHIBITION|||NM|NOT DONE||Y|Y|U|3||39||CONTINUATION TREATMENT|1962-08-30||1972-06-25|||1970-07-11||1962-07-31
TRIAL STUDY 134XCP|RP|054D4740-C675-4904-B912-B00A0B089F12|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||AMFI|||CI/UL|NOT DONE||N|U|U|3||39||CONTINUATION TREATMENT|1964-08-02||1970-08-26|||1968-02-03||1963-04-25
TRIAL STUDY 134XCP|RP|054D4740-C675-4904-B912-B00A0B089F12|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||H/WK|||UMOL/L/H|NOT DONE||NA|NA|N|4||88||OPEN LABEL TREATMENT|1960-02-29||1968-03-04|||1963-12-25||1961-12-25
TRIAL STUDY 134XCP|RP|054D4740-C675-4904-B912-B00A0B089F12|2||||||MENARAGE|MENARCHE AGE||||TUBE|||CUP|NOT DONE||N|Y|U|4||88||LONG-TERM FOLLOW-UP|1965-02-18||1961-06-18|||1968-08-11||1965-06-27
TRIAL STUDY 134XCP|RP|054D4740-C675-4904-B912-B00A0B089F12|1||||||STILBIND|STILLBIRTH INDICATOR||||UM2|||UM|NOT DONE||U|Y|U|5||7||SCREENING|1971-04-03||1964-12-19|||1971-02-03||1966-11-09
TRIAL STUDY 134XCP|RP|054D4740-C675-4904-B912-B00A0B089F12|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||/HPF|||CYLINDER|NOT DONE||Y|U|U|5||7||CONTINUATION TREATMENT|1962-12-29||1961-01-26|||1965-02-23||1962-04-23
TRIAL STUDY 134XCP|RP|9548556E-EECF-4460-A7DD-D93F853E9EA8|1||||||EDEMAIND|EDEMA INDICATOR||||MOL/MOL|||ML*CMH2O|NOT DONE||NA|Y|NA|1||38||LONG-TERM FOLLOW-UP|1963-05-16||1961-11-11|||1967-08-21||1962-07-19
TRIAL STUDY 134XCP|RP|9548556E-EECF-4460-A7DD-D93F853E9EA8|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||BAU/ML|||STEPS|NOT DONE||Y|NA|N|1||38||CONTINUATION TREATMENT|1970-02-11||1969-12-30|||1973-02-14||1967-04-09
TRIAL STUDY 134XCP|RP|9548556E-EECF-4460-A7DD-D93F853E9EA8|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MEQ/DL|||MV/SEC|NOT DONE||NA|NA|U|2||58||TREATMENT|1968-05-24||1960-08-03|||1966-10-18||1960-01-28
TRIAL STUDY 134XCP|RP|9548556E-EECF-4460-A7DD-D93F853E9EA8|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||RPM|||UM|NOT DONE||NA|Y|N|2||58||SCREENING|1964-09-06||1964-01-03|||1965-03-26||1963-08-26
TRIAL STUDY 134XCP|RP|9548556E-EECF-4460-A7DD-D93F853E9EA8|1||||||PREGIND|PREGNANT INDICATOR||||ENZYME U/L|||10^9 ORGANISMS/MG|NOT DONE||NA|U|N|3||39||CONTINUATION TREATMENT|1973-02-15||1965-01-04|||1966-07-21||1967-05-20
TRIAL STUDY 134XCP|RP|9548556E-EECF-4460-A7DD-D93F853E9EA8|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MIN|||MG/ML/DAY|NOT DONE||NA|N|U|3||39||BASELINE|1968-08-27||1971-08-24|||1961-03-27||1968-11-19
TRIAL STUDY 134XCP|RP|9548556E-EECF-4460-A7DD-D93F853E9EA8|1||||||DLVRMODE|MODE OF DELIVERY||||ML/G/MIN|||PPB|NOT DONE||NA|Y|NA|4||88||INDUCTION TREATMENT|1961-01-23||1970-06-04|||1962-08-01||1970-04-25
TRIAL STUDY 134XCP|RP|9548556E-EECF-4460-A7DD-D93F853E9EA8|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||POINT|||NKAT/G HB|NOT DONE||NA|NA|N|4||88||WASHOUT|1964-12-05||1963-04-06|||1966-09-02||1968-02-25
TRIAL STUDY 134XCP|RP|9548556E-EECF-4460-A7DD-D93F853E9EA8|1||||||ABORTN|NUMBER OF ABORTIONS||||10^3/HPF|||CAPSULE|NOT DONE||N|NA|N|5||7||WASHOUT|1964-06-26||1970-02-23|||1973-03-07||1966-07-15
TRIAL STUDY 134XCP|RP|9548556E-EECF-4460-A7DD-D93F853E9EA8|2||||||RASHIND|RASH INDICATOR||||UG/MOL|||CI/MG|NOT DONE||NA|U|U|5||7||SCREENING|1966-10-02||1967-07-17|||1961-08-22||1973-08-06
TRIAL STUDY 134XCP|RP|0BCF6152-3718-402C-9333-A3EFBB3086FF|1||||||DSCHGIND|DISCHARGE INDICATOR||||SCOOPFUL|||IN|NOT DONE||NA|N|N|1||38||TREATMENT|1966-08-10||1962-05-27|||1972-05-11||1965-11-18
TRIAL STUDY 134XCP|RP|0BCF6152-3718-402C-9333-A3EFBB3086FF|2||||||ULCERIND|ULCER INDICATOR||||10^5/HPF|||10^6 U|NOT DONE||NA|U|NA|1||38||OBSERVATION|1969-06-24||1970-06-10|||1972-08-03||1960-09-01
TRIAL STUDY 134XCP|RP|0BCF6152-3718-402C-9333-A3EFBB3086FF|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UMOL/DAY|||10^7/L|NOT DONE||NA|NA|Y|2||58||OBSERVATION|1967-09-17||1963-12-25|||1966-08-26||1960-01-20
TRIAL STUDY 134XCP|RP|0BCF6152-3718-402C-9333-A3EFBB3086FF|2||||||ULCERIND|ULCER INDICATOR||||PMOL/10^9 CELLS|||%/S|NOT DONE||U|N|N|2||58||RUN-IN|1964-05-08||1970-11-17|||1960-02-16||1964-05-01
TRIAL STUDY 134XCP|RP|0BCF6152-3718-402C-9333-A3EFBB3086FF|1||||||MENFDUR|MENSES FLOW DURATION||||DDU|||NMOL/KG/DAY|NOT DONE||N|Y|NA|3||39||RUN-IN|1961-02-25||1965-12-19|||1970-09-05||1969-03-19
TRIAL STUDY 134XCP|RP|0BCF6152-3718-402C-9333-A3EFBB3086FF|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^6 DNA COPIES/ML|||BQ/MG|NOT DONE||N|Y|Y|3||39||BASELINE|1961-02-21||1972-10-26|||1961-04-05||1962-12-04
TRIAL STUDY 134XCP|RP|0BCF6152-3718-402C-9333-A3EFBB3086FF|1||||||MASSIND|MASS INDICATOR||||NG/MOL|||AFU|NOT DONE||U|U|NA|4||88||OPEN LABEL TREATMENT|1961-08-01||1960-08-06|||1964-05-27||1971-03-20
TRIAL STUDY 134XCP|RP|0BCF6152-3718-402C-9333-A3EFBB3086FF|2||||||FUNDHT|FUNDAL HEIGHT||||10^3/L|||PIXEL|NOT DONE||NA|U|N|4||88||WASHOUT|1960-04-18||1964-10-19|||1969-12-08||1969-03-14
TRIAL STUDY 134XCP|RP|0BCF6152-3718-402C-9333-A3EFBB3086FF|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||BU|||UG/M2/MIN|NOT DONE||NA|NA|N|5||7||INDUCTION TREATMENT|1967-11-29||1970-06-24|||1964-12-21||1966-10-15
TRIAL STUDY 134XCP|RP|0BCF6152-3718-402C-9333-A3EFBB3086FF|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^3 ORGANISMS|||UMOL/H/MMOL|NOT DONE||N|U|N|5||7||CONTINUATION TREATMENT|1961-08-05||1966-05-03|||1971-03-31||1968-08-28
TRIAL STUDY 134XCP|RP|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||KBQ|||/100 HPFS|NOT DONE||U|U|NA|1||38||OBSERVATION|1960-03-23||1960-11-20|||1960-06-29||1965-04-17
TRIAL STUDY 134XCP|RP|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||L/DAY|||10^6 ORGANISMS|NOT DONE||NA|U|NA|1||38||WASHOUT|1973-04-12||1965-07-02|||1971-09-10||1969-12-10
TRIAL STUDY 134XCP|RP|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|1||||||ERYTHIND|ERYTHEMA INDICATOR||||YD|||ML/CM3/MIN|NOT DONE||U|N|Y|2||58||TREATMENT|1967-06-28||1967-06-21|||1963-05-13||1971-07-25
TRIAL STUDY 134XCP|RP|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||LM|||PPTH|NOT DONE||N|N|NA|2||58||WASHOUT|1963-11-22||1969-06-27|||1970-04-13||1969-07-28
TRIAL STUDY 134XCP|RP|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||G/U|||ML/M2/MIN|NOT DONE||N|U|N|3||39||INDUCTION TREATMENT|1963-04-13||1960-05-07|||1970-03-10||1973-03-20
TRIAL STUDY 134XCP|RP|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|2||||||MASSIND|MASS INDICATOR||||DEG/S|||U/KG/MIN|NOT DONE||Y|U|U|3||39||FOLLOW-UP|1961-02-17||1972-11-30|||1966-05-10||1968-10-28
TRIAL STUDY 134XCP|RP|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||PMOL/L/H|||MAMP|NOT DONE||U|U|Y|4||88||CONTINUATION TREATMENT|1965-05-18||1965-08-28|||1971-06-02||1969-01-03
TRIAL STUDY 134XCP|RP|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||NKAT/G HB|||TESLA|NOT DONE||NA|Y|NA|4||88||FOLLOW-UP|1973-02-22||1964-08-03|||1970-05-01||1971-04-22
TRIAL STUDY 134XCP|RP|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|1||||||ERYTHIND|ERYTHEMA INDICATOR||||VP/ML|||IU/MG|NOT DONE||Y|U|N|5||7||OBSERVATION|1961-08-03||1960-02-13|||1960-10-15||1965-07-19
TRIAL STUDY 134XCP|RP|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|2||||||FUNDHT|FUNDAL HEIGHT||||MM2|||GPS U|NOT DONE||U|NA|N|5||7||TREATMENT|1961-05-24||1966-01-12|||1965-04-24||1964-10-07
TRIAL STUDY 134XCP|RP|EED12AC0-1CBD-4D42-8786-91834AB33A46|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^3/HPF|||/LPF|NOT DONE||NA|U|NA|1||38||LONG-TERM FOLLOW-UP|1963-03-08||1965-10-13|||1973-05-27||1964-08-12
TRIAL STUDY 134XCP|RP|EED12AC0-1CBD-4D42-8786-91834AB33A46|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||ML/S/M2|||CARTRIDGE|NOT DONE||N|Y|Y|1||38||INDUCTION TREATMENT|1965-09-07||1961-01-26|||1969-03-21||1972-05-05
TRIAL STUDY 134XCP|RP|EED12AC0-1CBD-4D42-8786-91834AB33A46|1||||||BRTHN|NUMBER OF BIRTHS||||10^9/DOSE|||IU/KG|NOT DONE||U|Y|N|2||58||TREATMENT|1970-12-18||1970-09-23|||1963-09-27||1969-11-15
TRIAL STUDY 134XCP|RP|EED12AC0-1CBD-4D42-8786-91834AB33A46|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||HPA|||BQ/L|NOT DONE||N|Y|NA|2||58||SCREENING|1964-06-20||1964-04-17|||1965-12-20||1962-01-14
TRIAL STUDY 134XCP|RP|EED12AC0-1CBD-4D42-8786-91834AB33A46|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||10^12/L|||WAFER|NOT DONE||Y|U|NA|3||39||CONTINUATION TREATMENT|1972-10-02||1965-11-27|||1969-11-10||1962-10-09
TRIAL STUDY 134XCP|RP|EED12AC0-1CBD-4D42-8786-91834AB33A46|2||||||ERYTHIND|ERYTHEMA INDICATOR||||U/KG/MIN|||SYRINGE|NOT DONE||U|Y|NA|3||39||FOLLOW-UP|1973-07-12||1968-12-14|||1960-03-22||1968-07-24
TRIAL STUDY 134XCP|RP|EED12AC0-1CBD-4D42-8786-91834AB33A46|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||LOG10 CCID 50/DOSE|||MG/M2/H|NOT DONE||U|Y|NA|4||88||SCREENING|1961-10-22||1963-12-06|||1961-03-09||1971-05-15
TRIAL STUDY 134XCP|RP|EED12AC0-1CBD-4D42-8786-91834AB33A46|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||CFU/G|||/10^4|NOT DONE||Y|N|U|4||88||BLINDED TREATMENT|1967-02-15||1970-06-09|||1962-12-02||1963-05-23
TRIAL STUDY 134XCP|RP|EED12AC0-1CBD-4D42-8786-91834AB33A46|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||PG/DL|||10^6/L|NOT DONE||N|U|NA|5||7||OPEN LABEL TREATMENT|1964-03-16||1969-10-08|||1972-09-18||1972-01-08
TRIAL STUDY 134XCP|RP|EED12AC0-1CBD-4D42-8786-91834AB33A46|2||||||TNDRIND|TENDERNESS INDICATOR||||CI|||TABLET|NOT DONE||N|NA|Y|5||7||BASELINE|1971-04-24||1965-11-21|||1962-09-06||1970-02-05
TRIAL STUDY 134XCP|RP|F30DC3E9-E919-4920-87FE-103CD85D89FA|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MG/CM2|||G/ANIMAL/DAY|NOT DONE||U|NA|Y|1||38||FOLLOW-UP|1971-07-27||1969-04-10|||1962-04-21||1961-05-21
TRIAL STUDY 134XCP|RP|F30DC3E9-E919-4920-87FE-103CD85D89FA|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||/VF|||U/MG|NOT DONE||U|Y|Y|1||38||TREATMENT|1969-08-16||1962-03-15|||1965-04-21||1962-03-25
TRIAL STUDY 134XCP|RP|F30DC3E9-E919-4920-87FE-103CD85D89FA|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MG2/DL2|||MV|NOT DONE||U|U|Y|2||58||OPEN LABEL TREATMENT|1973-04-04||1965-09-08|||1964-07-20||1967-07-03
TRIAL STUDY 134XCP|RP|F30DC3E9-E919-4920-87FE-103CD85D89FA|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||VOXEL|||10^9 CFU/ML|NOT DONE||NA|Y|Y|2||58||RUN-IN|1962-09-25||1962-10-29|||1970-06-20||1961-02-17
TRIAL STUDY 134XCP|RP|F30DC3E9-E919-4920-87FE-103CD85D89FA|1||||||MENARAGE|MENARCHE AGE||||UG/DL|||PNU/ML|NOT DONE||NA|U|Y|3||39||BLINDED TREATMENT|1963-10-15||1970-01-10|||1972-04-24||1968-07-20
TRIAL STUDY 134XCP|RP|F30DC3E9-E919-4920-87FE-103CD85D89FA|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||UCI/L|||L/H|NOT DONE||U|U|Y|3||39||BASELINE|1963-03-08||1962-05-03|||1961-02-13||1961-10-13
TRIAL STUDY 134XCP|RP|F30DC3E9-E919-4920-87FE-103CD85D89FA|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MG/KG/WEEK|||/40 HPFS|NOT DONE||NA|N|U|4||88||SCREENING|1962-02-16||1960-01-23|||1962-03-06||1962-02-15
TRIAL STUDY 134XCP|RP|F30DC3E9-E919-4920-87FE-103CD85D89FA|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||CI|||UMOL/KG/MIN|NOT DONE||N|Y|NA|4||88||WASHOUT|1973-02-07||1970-09-07|||1972-08-20||1968-09-21
TRIAL STUDY 134XCP|RP|F30DC3E9-E919-4920-87FE-103CD85D89FA|1||||||PEELIND|PEELING INDICATOR||||GMFI|||NL|NOT DONE||NA|N|NA|5||7||TREATMENT|1970-01-27||1970-02-17|||1962-09-07||1969-12-13
TRIAL STUDY 134XCP|RP|F30DC3E9-E919-4920-87FE-103CD85D89FA|2||||||MENARAGE|MENARCHE AGE||||/100 HPFS|||EID 50/DOSE|NOT DONE||Y|U|NA|5||7||BLINDED TREATMENT|1961-11-04||1965-08-09|||1972-05-20||1965-11-02
TRIAL STUDY 134XCP|RP|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|1||||||BLISTIND|BLISTERING INDICATOR||||LINEAR FT*LB|||MEQ/ML|NOT DONE||U|NA|U|1||38||LONG-TERM FOLLOW-UP|1962-03-13||1962-11-02|||1968-03-25||1962-06-04
TRIAL STUDY 134XCP|RP|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MMOL/MOL|||HOURS|NOT DONE||Y|N|U|1||38||WASHOUT|1971-08-29||1964-02-02|||1960-01-30||1963-05-13
TRIAL STUDY 134XCP|RP|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|1||||||THICK|THICKNESS||||MM/MIN|||MG/MOL|NOT DONE||N|Y|NA|2||58||INDUCTION TREATMENT|1973-07-01||1961-12-13|||1966-07-08||1964-06-01
TRIAL STUDY 134XCP|RP|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||ML/BEAT|||DRUM|NOT DONE||Y|N|N|2||58||BLINDED TREATMENT|1970-02-28||1969-03-24|||1969-11-17||1964-01-25
TRIAL STUDY 134XCP|RP|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||ML/DOSE|||SYRINGE|NOT DONE||Y|U|U|3||39||INDUCTION TREATMENT|1963-07-29||1968-05-11|||1969-06-21||1967-08-19
TRIAL STUDY 134XCP|RP|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|2||||||INTP|INTERPRETATION||||10^9 CFU/G|||UV|NOT DONE||N|NA|Y|3||39||LONG-TERM FOLLOW-UP|1969-12-15||1969-06-21|||1964-10-26||1970-11-08
TRIAL STUDY 134XCP|RP|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|1||||||BRTHN|NUMBER OF BIRTHS||||IU/MMOL|||FEU|NOT DONE||Y|U|U|4||88||WASHOUT|1972-03-07||1969-09-04|||1970-07-28||1970-06-21
TRIAL STUDY 134XCP|RP|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|2||||||PREGST|PREGNANT DURING THE STUDY||||%(W/V)|||OI50|NOT DONE||U|N|Y|4||88||BASELINE|1961-09-12||1964-02-07|||1960-06-21||1964-07-04
TRIAL STUDY 134XCP|RP|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||FRACTION OF 1|||RFU|NOT DONE||Y|NA|Y|5||7||BASELINE|1966-04-03||1964-09-28|||1963-05-02||1965-04-01
TRIAL STUDY 134XCP|RP|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||L/S/KPA|||AFU|NOT DONE||NA|NA|Y|5||7||INDUCTION TREATMENT|1965-09-15||1968-04-03|||1960-06-07||1965-12-18
TRIAL STUDY 134XCP|RP|729D254F-628C-4D35-8906-A1344833A610|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||NL|||ML/M2/MIN|NOT DONE||U|U|NA|1||38||INDUCTION TREATMENT|1966-09-16||1964-02-26|||1960-03-01||1966-05-29
TRIAL STUDY 134XCP|RP|729D254F-628C-4D35-8906-A1344833A610|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||G/KG|||STEPS/MIN|NOT DONE||U|NA|Y|1||38||TREATMENT|1965-12-08||1973-04-26|||1962-12-15||1962-12-26
TRIAL STUDY 134XCP|RP|729D254F-628C-4D35-8906-A1344833A610|1||||||INTP|INTERPRETATION||||FT3|||PMOL/10^9 CELLS|NOT DONE||Y|U|U|2||58||FOLLOW-UP|1965-12-01||1970-07-10|||1964-12-29||1971-11-24
TRIAL STUDY 134XCP|RP|729D254F-628C-4D35-8906-A1344833A610|2||||||ERYTHIND|ERYTHEMA INDICATOR||||10^3 RNA COPIES/ML|||U/10^12 RBC|NOT DONE||Y|U|U|2||58||CONTINUATION TREATMENT|1966-03-27||1965-07-16|||1973-07-30||1970-08-22
TRIAL STUDY 134XCP|RP|729D254F-628C-4D35-8906-A1344833A610|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||10^3 RNA COPIES/ML|||ANTI-XA IU|NOT DONE||N|NA|N|3||39||BLINDED TREATMENT|1965-06-10||1960-04-19|||1963-05-09||1965-09-28
TRIAL STUDY 134XCP|RP|729D254F-628C-4D35-8906-A1344833A610|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MIU/L|||%(W/V)|NOT DONE||U|Y|NA|3||39||FOLLOW-UP|1973-01-18||1960-07-12|||1964-06-12||1966-03-24
TRIAL STUDY 134XCP|RP|729D254F-628C-4D35-8906-A1344833A610|1||||||ERYTHIND|ERYTHEMA INDICATOR||||YD|||UOSM|NOT DONE||NA|Y|N|4||88||LONG-TERM FOLLOW-UP|1966-05-16||1964-10-08|||1961-01-02||1962-08-04
TRIAL STUDY 134XCP|RP|729D254F-628C-4D35-8906-A1344833A610|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||/5X10^4 WBC|||10^6 DNA COPIES/ML|NOT DONE||Y|NA|NA|4||88||CONTINUATION TREATMENT|1965-05-20||1972-11-12|||1966-09-15||1960-08-21
TRIAL STUDY 134XCP|RP|729D254F-628C-4D35-8906-A1344833A610|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||UG/KG/MIN|||G/M2|NOT DONE||U|N|U|5||7||OBSERVATION|1966-04-05||1968-01-12|||1960-09-17||1964-03-20
TRIAL STUDY 134XCP|RP|729D254F-628C-4D35-8906-A1344833A610|2||||||PRGENDTC|DATE PREGNANCY ENDED||||LOG10 CFU/G|||UL/DOSE|NOT DONE||NA|NA|U|5||7||INDUCTION TREATMENT|1961-01-12||1965-07-22|||1970-03-15||1967-02-20
TRIAL STUDY 134XCP|RP|A78936A2-B8B1-4D07-8679-E324F6447EFF|1||||||ERYTHIND|ERYTHEMA INDICATOR||||NMOL/MOL|||10^6 ORGANISMS/G|NOT DONE||U|U|NA|1||38||RUN-IN|1960-02-25||1965-02-19|||1967-09-04||1970-02-06
TRIAL STUDY 134XCP|RP|A78936A2-B8B1-4D07-8679-E324F6447EFF|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||S/H|||CI/L|NOT DONE||Y|NA|N|1||38||TREATMENT|1970-10-31||1973-05-18|||1966-12-26||1972-12-31
TRIAL STUDY 134XCP|RP|A78936A2-B8B1-4D07-8679-E324F6447EFF|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MOL/MG|||PIXELS/IN|NOT DONE||U|U|U|2||58||FOLLOW-UP|1964-02-15||1964-01-14|||1961-11-02||1966-09-21
TRIAL STUDY 134XCP|RP|A78936A2-B8B1-4D07-8679-E324F6447EFF|2||||||BCMETHOD|BIRTH CONTROL METHOD||||CMOL/L|||UIU/DL|NOT DONE||N|NA|U|2||58||FOLLOW-UP|1967-05-19||1963-06-12|||1965-07-03||1971-10-24
TRIAL STUDY 134XCP|RP|A78936A2-B8B1-4D07-8679-E324F6447EFF|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||PMOL/L/H|||ML/MIN|NOT DONE||Y|Y|Y|3||39||LONG-TERM FOLLOW-UP|1962-05-05||1960-04-14|||1968-12-26||1964-02-16
TRIAL STUDY 134XCP|RP|A78936A2-B8B1-4D07-8679-E324F6447EFF|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||ENZYME U/L|||ML|NOT DONE||U|N|U|3||39||BASELINE|1963-11-23||1970-03-25|||1966-01-26||1961-07-26
TRIAL STUDY 134XCP|RP|A78936A2-B8B1-4D07-8679-E324F6447EFF|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||CI/UL|||BQ/KG|NOT DONE||Y|NA|Y|4||88||SCREENING|1972-03-17||1973-05-31|||1971-01-31||1967-09-21
TRIAL STUDY 134XCP|RP|A78936A2-B8B1-4D07-8679-E324F6447EFF|2||||||FUNDHT|FUNDAL HEIGHT||||MMOL/MOL|||10^6 CFU/ML|NOT DONE||NA|NA|NA|4||88||LONG-TERM FOLLOW-UP|1969-09-10||1970-04-30|||1962-07-16||1964-11-30
TRIAL STUDY 134XCP|RP|A78936A2-B8B1-4D07-8679-E324F6447EFF|1||||||GRAVIND|GRAVIDA INDICATOR||||TUBERCULIN UNIT/ML|||SCOOPFUL|NOT DONE||NA|N|NA|5||7||INDUCTION TREATMENT|1966-03-21||1972-12-16|||1963-06-01||1967-05-05
TRIAL STUDY 134XCP|RP|A78936A2-B8B1-4D07-8679-E324F6447EFF|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||EVENTS|||EP U|NOT DONE||Y|U|Y|5||7||RUN-IN|1969-03-19||1962-04-15|||1966-08-23||1972-12-10
TRIAL STUDY 134XCP|RP|239B331A-08CD-41D9-BBB8-CE229480FC12|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^6 IU|||CYCLE/MIN|NOT DONE||NA|U|Y|1||38||WASHOUT|1964-12-18||1970-04-01|||1967-10-15||1962-02-27
TRIAL STUDY 134XCP|RP|239B331A-08CD-41D9-BBB8-CE229480FC12|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||AU/ML|||LOG10 ELISA UNIT/DOSE|NOT DONE||NA|U|Y|1||38||SCREENING|1965-01-25||1963-08-18|||1964-05-22||1970-05-20
TRIAL STUDY 134XCP|RP|239B331A-08CD-41D9-BBB8-CE229480FC12|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||DRUM|||NEBULE|NOT DONE||Y|Y|NA|2||58||CONTINUATION TREATMENT|1969-04-02||1963-10-19|||1962-08-24||1968-10-19
TRIAL STUDY 134XCP|RP|239B331A-08CD-41D9-BBB8-CE229480FC12|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ML/CAGE/DAY|||ENZYME U/G HB|NOT DONE||NA|U|Y|2||58||INDUCTION TREATMENT|1962-02-08||1971-05-09|||1964-03-06||1971-12-22
TRIAL STUDY 134XCP|RP|239B331A-08CD-41D9-BBB8-CE229480FC12|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MPS U|||KM/H|NOT DONE||Y|N|Y|3||39||TREATMENT|1970-01-10||1960-07-16|||1963-04-18||1960-06-12
TRIAL STUDY 134XCP|RP|239B331A-08CD-41D9-BBB8-CE229480FC12|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PELLET|||TCID 50/DOSE|NOT DONE||Y|Y|N|3||39||INDUCTION TREATMENT|1968-05-10||1964-11-17|||1960-10-19||1966-03-28
TRIAL STUDY 134XCP|RP|239B331A-08CD-41D9-BBB8-CE229480FC12|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||%/MIN|||MG/KG|NOT DONE||NA|N|U|4||88||OBSERVATION|1969-12-09||1961-07-22|||1961-05-16||1972-04-04
TRIAL STUDY 134XCP|RP|239B331A-08CD-41D9-BBB8-CE229480FC12|2||||||DSCHGIND|DISCHARGE INDICATOR||||FMOL/G|||MASK|NOT DONE||N|Y|Y|4||88||SCREENING|1973-04-09||1960-03-04|||1960-02-14||1965-07-24
TRIAL STUDY 134XCP|RP|239B331A-08CD-41D9-BBB8-CE229480FC12|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||NMOL BCE/L|||ML/CAGE/DAY|NOT DONE||Y|NA|N|5||7||CONTINUATION TREATMENT|1970-06-01||1964-10-08|||1967-12-25||1967-11-06
TRIAL STUDY 134XCP|RP|239B331A-08CD-41D9-BBB8-CE229480FC12|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MDFI|||POINT|NOT DONE||N|NA|NA|5||7||INDUCTION TREATMENT|1963-10-11||1972-04-18|||1965-07-08||1965-02-08
TRIAL STUDY 134XCP|RP|958D39CD-D511-40C8-A0A6-8A138225470B|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||1/(S*KPA)|||GPL U|NOT DONE||Y|U|U|1||38||OBSERVATION|1971-12-27||1962-09-11|||1973-06-25||1971-04-30
TRIAL STUDY 134XCP|RP|958D39CD-D511-40C8-A0A6-8A138225470B|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||GPELISA UNIT/ML|||NG/DL|NOT DONE||NA|U|U|1||38||BASELINE|1968-08-12||1970-10-02|||1969-11-05||1965-03-24
TRIAL STUDY 134XCP|RP|958D39CD-D511-40C8-A0A6-8A138225470B|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||RAD|||MOL|NOT DONE||Y|N|Y|2||58||BLINDED TREATMENT|1973-05-27||1971-01-01|||1973-06-13||1968-12-02
TRIAL STUDY 134XCP|RP|958D39CD-D511-40C8-A0A6-8A138225470B|2||||||STILBIND|STILLBIRTH INDICATOR||||G/MOL|||CPM|NOT DONE||NA|NA|N|2||58||OBSERVATION|1960-06-26||1963-09-17|||1965-05-30||1965-10-05
TRIAL STUDY 134XCP|RP|958D39CD-D511-40C8-A0A6-8A138225470B|1||||||PREGIND|PREGNANT INDICATOR||||FG|||STRIP|NOT DONE||Y|Y|U|3||39||WASHOUT|1963-10-26||1960-04-21|||1965-03-31||1972-04-05
TRIAL STUDY 134XCP|RP|958D39CD-D511-40C8-A0A6-8A138225470B|2||||||BRTHN|NUMBER OF BIRTHS||||MMAL|||U/L|NOT DONE||Y|N|N|3||39||BASELINE|1968-06-24||1960-09-21|||1963-05-11||1971-04-22
TRIAL STUDY 134XCP|RP|958D39CD-D511-40C8-A0A6-8A138225470B|1||||||ABORTN|NUMBER OF ABORTIONS||||CI/UL|||NKAT|NOT DONE||N|Y|U|4||88||RUN-IN|1961-09-27||1962-03-06|||1969-01-16||1970-03-18
TRIAL STUDY 134XCP|RP|958D39CD-D511-40C8-A0A6-8A138225470B|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||IU/G HB|||CI/KG|NOT DONE||N|N|U|4||88||INDUCTION TREATMENT|1972-07-21||1966-02-06|||1967-06-03||1972-04-17
TRIAL STUDY 134XCP|RP|958D39CD-D511-40C8-A0A6-8A138225470B|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||%/S|||/MBP|NOT DONE||N|U|U|5||7||WASHOUT|1967-06-28||1965-04-04|||1968-09-26||1962-02-28
TRIAL STUDY 134XCP|RP|958D39CD-D511-40C8-A0A6-8A138225470B|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||CMH2O/ML|||UG/ANIMAL|NOT DONE||Y|U|N|5||7||SCREENING|1964-08-25||1966-01-29|||1964-10-18||1965-03-02
TRIAL STUDY 134XCP|RP|5DA21FE5-E5B9-4461-9509-94AA264B59A8|1||||||INABOIND|INDUCED ABORTION INDICATOR||||GY/MIN|||SFC/10^6 PBMC|NOT DONE||U|NA|NA|1||38||BLINDED TREATMENT|1966-11-06||1971-10-05|||1969-03-12||1967-09-28
TRIAL STUDY 134XCP|RP|5DA21FE5-E5B9-4461-9509-94AA264B59A8|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||V|||MU/G|NOT DONE||N|U|N|1||38||CONTINUATION TREATMENT|1966-08-09||1973-03-20|||1960-11-23||1967-10-28
TRIAL STUDY 134XCP|RP|5DA21FE5-E5B9-4461-9509-94AA264B59A8|1||||||ULCERIND|ULCER INDICATOR||||10^6/L|||MAMP|NOT DONE||N|NA|U|2||58||BASELINE|1965-01-29||1971-06-02|||1965-12-12||1973-05-03
TRIAL STUDY 134XCP|RP|5DA21FE5-E5B9-4461-9509-94AA264B59A8|2||||||DSCHGIND|DISCHARGE INDICATOR||||/HPF|||/H|NOT DONE||N|U|N|2||58||TREATMENT|1972-05-27||1971-03-06|||1962-02-18||1966-08-07
TRIAL STUDY 134XCP|RP|5DA21FE5-E5B9-4461-9509-94AA264B59A8|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MG/ML/MIN|||KG/MOL|NOT DONE||N|Y|N|3||39||LONG-TERM FOLLOW-UP|1968-09-20||1963-03-20|||1970-08-25||1962-03-02
TRIAL STUDY 134XCP|RP|5DA21FE5-E5B9-4461-9509-94AA264B59A8|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||UMOL/DL|||10^6 ORGANISMS|NOT DONE||Y|Y|U|3||39||LONG-TERM FOLLOW-UP|1969-07-04||1966-12-04|||1971-11-15||1966-12-21
TRIAL STUDY 134XCP|RP|5DA21FE5-E5B9-4461-9509-94AA264B59A8|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||UV2|||MOL/G|NOT DONE||Y|U|U|4||88||FOLLOW-UP|1960-05-12||1968-12-21|||1964-06-15||1971-01-04
TRIAL STUDY 134XCP|RP|5DA21FE5-E5B9-4461-9509-94AA264B59A8|2||||||BCMETHOD|BIRTH CONTROL METHOD||||DNA COPIES/ML|||LOG10 TCID 50/DOSE|NOT DONE||Y|Y|N|4||88||SCREENING|1967-04-18||1966-07-08|||1962-10-25||1971-06-05
TRIAL STUDY 134XCP|RP|5DA21FE5-E5B9-4461-9509-94AA264B59A8|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||UG/L|||RAD|NOT DONE||U|NA|Y|5||7||INDUCTION TREATMENT|1960-08-15||1962-12-09|||1965-11-15||1968-05-09
TRIAL STUDY 134XCP|RP|5DA21FE5-E5B9-4461-9509-94AA264B59A8|2||||||ERYTHIND|ERYTHEMA INDICATOR||||L/L|||/10^4|NOT DONE||Y|U|N|5||7||BASELINE|1970-03-31||1968-07-19|||1967-05-10||1964-09-07
TRIAL STUDY 134XCP|RP|B125DCB9-1705-430B-9982-A20E7C4CA6A8|1||||||PREGNN|NUMBER OF PREGNANCIES||||KIT|||ML/H|NOT DONE||Y|U|Y|1||38||CONTINUATION TREATMENT|1965-02-15||1971-01-01|||1964-03-31||1963-09-24
TRIAL STUDY 134XCP|RP|B125DCB9-1705-430B-9982-A20E7C4CA6A8|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||KAT|||10^4/L|NOT DONE||Y|U|Y|1||38||TREATMENT|1963-07-15||1969-03-27|||1962-01-22||1971-05-23
TRIAL STUDY 134XCP|RP|B125DCB9-1705-430B-9982-A20E7C4CA6A8|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||DRAM|||10^6 CFU/G|NOT DONE||NA|N|Y|2||58||CONTINUATION TREATMENT|1970-12-24||1965-12-07|||1972-10-05||1970-05-19
TRIAL STUDY 134XCP|RP|B125DCB9-1705-430B-9982-A20E7C4CA6A8|2||||||MASSIND|MASS INDICATOR||||ML/MIN/MMHG|||ML/S/M2|NOT DONE||N|N|Y|2||58||BLINDED TREATMENT|1962-11-06||1966-10-16|||1972-07-16||1970-12-18
TRIAL STUDY 134XCP|RP|B125DCB9-1705-430B-9982-A20E7C4CA6A8|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||PFU/DOSE|||GENEQ/ML|NOT DONE||Y|U|NA|3||39||CONTINUATION TREATMENT|1970-08-04||1963-06-10|||1973-08-07||1966-03-03
TRIAL STUDY 134XCP|RP|B125DCB9-1705-430B-9982-A20E7C4CA6A8|2||||||FUNDHT|FUNDAL HEIGHT||||UOSM|||PG|NOT DONE||NA|N|N|3||39||FOLLOW-UP|1966-07-15||1972-12-24|||1971-01-17||1965-11-28
TRIAL STUDY 134XCP|RP|B125DCB9-1705-430B-9982-A20E7C4CA6A8|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||G/CAGE/DAY|||ML/KG/DAY|NOT DONE||Y|Y|U|4||88||BASELINE|1962-04-27||1970-01-23|||1961-12-29||1965-07-13
TRIAL STUDY 134XCP|RP|B125DCB9-1705-430B-9982-A20E7C4CA6A8|2||||||ERYTHIND|ERYTHEMA INDICATOR||||ML/ANIMAL/WK|||/VF|NOT DONE||Y|NA|NA|4||88||OPEN LABEL TREATMENT|1969-08-22||1971-06-16|||1963-11-26||1966-01-07
TRIAL STUDY 134XCP|RP|B125DCB9-1705-430B-9982-A20E7C4CA6A8|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MN|||L/MIN/M2|NOT DONE||NA|N|NA|5||7||FOLLOW-UP|1969-02-06||1966-05-12|||1967-12-02||1971-08-03
TRIAL STUDY 134XCP|RP|B125DCB9-1705-430B-9982-A20E7C4CA6A8|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^7 PFU|||ML/KG/DAY|NOT DONE||Y|Y|U|5||7||SCREENING|1961-07-12||1965-01-17|||1966-01-17||1966-09-06
TRIAL STUDY 134XCP|RP|95C72325-301E-40D4-AA2D-49B80067FE23|1||||||MASSIND|MASS INDICATOR||||BLOCKS|||P|NOT DONE||Y|NA|NA|1||38||OBSERVATION|1969-07-27||1960-10-26|||1964-08-11||1971-04-26
TRIAL STUDY 134XCP|RP|95C72325-301E-40D4-AA2D-49B80067FE23|2||||||BRTHN|NUMBER OF BIRTHS||||10^6 CFU|||G/KG|NOT DONE||NA|N|NA|1||38||WASHOUT|1968-12-13||1966-04-28|||1967-07-30||1966-05-31
TRIAL STUDY 134XCP|RP|95C72325-301E-40D4-AA2D-49B80067FE23|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||CCID 50/DOSE|||10^8/L|NOT DONE||U|NA|N|2||58||OBSERVATION|1969-07-23||1965-10-27|||1968-09-11||1963-04-26
TRIAL STUDY 134XCP|RP|95C72325-301E-40D4-AA2D-49B80067FE23|2||||||DLVRMODE|MODE OF DELIVERY||||WATT|||DNA COPIES/UG|NOT DONE||NA|Y|NA|2||58||SCREENING|1967-01-05||1968-08-05|||1967-07-08||1966-01-23
TRIAL STUDY 134XCP|RP|95C72325-301E-40D4-AA2D-49B80067FE23|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||SIEMENS|||NMOL BCE/L|NOT DONE||U|U|Y|3||39||FOLLOW-UP|1971-12-24||1965-02-23|||1964-01-30||1973-06-06
TRIAL STUDY 134XCP|RP|95C72325-301E-40D4-AA2D-49B80067FE23|2||||||DSCHGIND|DISCHARGE INDICATOR||||U/KG/MIN|||MG/DOSE|NOT DONE||NA|U|N|3||39||LONG-TERM FOLLOW-UP|1972-02-24||1971-06-25|||1968-04-09||1968-03-19
TRIAL STUDY 134XCP|RP|95C72325-301E-40D4-AA2D-49B80067FE23|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||AMPULE|||PUFF|NOT DONE||U|NA|N|4||88||SCREENING|1968-07-01||1964-06-02|||1963-06-26||1963-05-21
TRIAL STUDY 134XCP|RP|95C72325-301E-40D4-AA2D-49B80067FE23|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||NMOL BCE/MMOL|||MMOL/KG|NOT DONE||Y|NA|Y|4||88||SCREENING|1969-08-02||1966-07-02|||1965-11-06||1962-11-28
TRIAL STUDY 134XCP|RP|95C72325-301E-40D4-AA2D-49B80067FE23|1||||||MENARAGE|MENARCHE AGE||||MIN/DAY|||/10^4|NOT DONE||U|Y|N|5||7||FOLLOW-UP|1961-05-18||1965-09-30|||1971-07-06||1971-04-05
TRIAL STUDY 134XCP|RP|95C72325-301E-40D4-AA2D-49B80067FE23|2||||||MENOSTAT|MENOPAUSE STATUS||||APL U|||FT|NOT DONE||U|N|U|5||7||SCREENING|1964-11-17||1968-09-22|||1964-08-17||1970-09-12
TRIAL STUDY 134XCP|RP|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||NMOL/KG/DAY|||BU/ML|NOT DONE||N|N|N|1||38||SCREENING|1961-06-18||1965-12-04|||1962-12-31||1961-08-21
TRIAL STUDY 134XCP|RP|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||/VF|||UL|NOT DONE||Y|N|NA|1||38||WASHOUT|1960-05-14||1969-06-08|||1961-12-14||1960-04-24
TRIAL STUDY 134XCP|RP|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||G/ANIMAL/DAY|||PFU/DOSE|NOT DONE||U|U|N|2||58||OBSERVATION|1965-01-29||1971-09-07|||1962-07-18||1970-10-11
TRIAL STUDY 134XCP|RP|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||YD|||U/M2/DAY|NOT DONE||NA|U|NA|2||58||OPEN LABEL TREATMENT|1962-11-23||1968-09-02|||1960-06-27||1965-10-23
TRIAL STUDY 134XCP|RP|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||PMOL/DAY|||POUCH|NOT DONE||Y|NA|Y|3||39||BASELINE|1964-10-15||1963-10-18|||1973-05-29||1969-10-20
TRIAL STUDY 134XCP|RP|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|2||||||MENARAGE|MENARCHE AGE||||G|||V/SEC|NOT DONE||NA|U|NA|3||39||SCREENING|1973-01-01||1962-04-01|||1964-10-16||1968-10-20
TRIAL STUDY 134XCP|RP|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||GBQ|||UG/KG/DAY|NOT DONE||Y|Y|Y|4||88||WASHOUT|1972-05-12||1963-03-08|||1968-12-14||1967-03-16
TRIAL STUDY 134XCP|RP|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||COPIES/UL|||MAMP|NOT DONE||NA|N|U|4||88||INDUCTION TREATMENT|1961-01-07||1966-03-06|||1969-05-11||1973-04-13
TRIAL STUDY 134XCP|RP|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||BQ/MG|||UG/M2/MIN|NOT DONE||U|N|Y|5||7||LONG-TERM FOLLOW-UP|1966-08-06||1970-10-29|||1967-03-20||1973-06-09
TRIAL STUDY 134XCP|RP|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||RAD|||MIN/DAY|NOT DONE||NA|N|U|5||7||SCREENING|1964-07-03||1960-09-20|||1969-11-04||1971-05-17
TRIAL STUDY 134XCP|RP|7DF25CA4-0846-4180-9356-F53C704F0233|1||||||MENARAGE|MENARCHE AGE||||CCID 50/DOSE|||ML/100G/MIN|NOT DONE||Y|U|U|1||38||LONG-TERM FOLLOW-UP|1960-04-21||1961-10-25|||1968-11-12||1965-01-27
TRIAL STUDY 134XCP|RP|7DF25CA4-0846-4180-9356-F53C704F0233|2||||||PREGIND|PREGNANT INDICATOR||||MMOL/MIN/KPA/L|||UMOL/H/MMOL|NOT DONE||Y|NA|NA|1||38||OPEN LABEL TREATMENT|1969-10-26||1971-05-15|||1969-07-18||1963-06-21
TRIAL STUDY 134XCP|RP|7DF25CA4-0846-4180-9356-F53C704F0233|1||||||MENOSTAT|MENOPAUSE STATUS||||G/MOL|||GENEQ/ML|NOT DONE||U|Y|U|2||58||RUN-IN|1970-04-09||1970-12-03|||1967-03-09||1970-06-16
TRIAL STUDY 134XCP|RP|7DF25CA4-0846-4180-9356-F53C704F0233|2||||||BCMETHOD|BIRTH CONTROL METHOD||||ML/(MIN*100ML)|||/DAY|NOT DONE||NA|NA|U|2||58||SCREENING|1972-08-07||1969-08-03|||1972-03-29||1969-08-18
TRIAL STUDY 134XCP|RP|7DF25CA4-0846-4180-9356-F53C704F0233|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||10^6 ORGANISMS/ML|||LOG10 CCID 50/DOSE|NOT DONE||U|NA|NA|3||39||OPEN LABEL TREATMENT|1969-03-16||1960-09-21|||1971-04-25||1973-08-16
TRIAL STUDY 134XCP|RP|7DF25CA4-0846-4180-9356-F53C704F0233|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MMAL|||KEV|NOT DONE||NA|U|U|3||39||RUN-IN|1960-06-10||1971-02-18|||1960-02-29||1963-05-19
TRIAL STUDY 134XCP|RP|7DF25CA4-0846-4180-9356-F53C704F0233|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||DB|||MMU/ML|NOT DONE||Y|Y|Y|4||88||RUN-IN|1970-04-30||1962-09-01|||1963-12-30||1962-07-28
TRIAL STUDY 134XCP|RP|7DF25CA4-0846-4180-9356-F53C704F0233|2||||||BLISTIND|BLISTERING INDICATOR||||1/(S*KPA)|||10^6 ORGANISMS/ML|NOT DONE||N|U|Y|4||88||BLINDED TREATMENT|1973-02-02||1967-05-29|||1960-05-26||1972-11-13
TRIAL STUDY 134XCP|RP|7DF25CA4-0846-4180-9356-F53C704F0233|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MM/2H|||MG/M2/DAY|NOT DONE||N|N|U|5||7||OPEN LABEL TREATMENT|1965-06-21||1972-09-11|||1960-11-26||1963-11-25
TRIAL STUDY 134XCP|RP|7DF25CA4-0846-4180-9356-F53C704F0233|2||||||RASHIND|RASH INDICATOR||||DPM/ML|||10^7/L|NOT DONE||NA|U|U|5||7||BLINDED TREATMENT|1962-05-31||1971-04-01|||1969-10-23||1960-11-11
TRIAL STUDY 134XCP|RP|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|1||||||FUNDHT|FUNDAL HEIGHT||||MM/SEC|||FT3|NOT DONE||NA|N|U|1||38||SCREENING|1971-08-05||1969-08-19|||1969-11-15||1961-07-11
TRIAL STUDY 134XCP|RP|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||ML/SEC/1.73M2|||10^8/L|NOT DONE||NA|U|N|1||38||INDUCTION TREATMENT|1967-04-04||1966-03-18|||1966-09-13||1963-08-12
TRIAL STUDY 134XCP|RP|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||CMHG|||GLOBULE|NOT DONE||N|Y|N|2||58||WASHOUT|1961-08-18||1972-06-22|||1966-08-04||1960-03-02
TRIAL STUDY 134XCP|RP|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|2||||||PRGENDTC|DATE PREGNANCY ENDED||||CI/L|||CAL|NOT DONE||Y|N|U|2||58||CONTINUATION TREATMENT|1963-09-23||1972-06-21|||1961-04-24||1960-06-15
TRIAL STUDY 134XCP|RP|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||G/CM2|||STEPS/MIN|NOT DONE||Y|N|NA|3||39||TREATMENT|1960-08-26||1970-09-06|||1968-06-19||1963-07-02
TRIAL STUDY 134XCP|RP|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||10^9/L|||DDU|NOT DONE||U|Y|U|3||39||LONG-TERM FOLLOW-UP|1973-05-01||1972-01-12|||1971-03-28||1967-07-05
TRIAL STUDY 134XCP|RP|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|1||||||PREGIND|PREGNANT INDICATOR||||USEC|||CM H2O|NOT DONE||NA|N|NA|4||88||WASHOUT|1963-04-16||1962-12-30|||1963-01-13||1962-06-27
TRIAL STUDY 134XCP|RP|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||U/KG/MIN|||FARAD|NOT DONE||U|U|U|4||88||RUN-IN|1965-10-31||1964-10-03|||1970-10-01||1966-12-11
TRIAL STUDY 134XCP|RP|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|1||||||PEELIND|PEELING INDICATOR||||SUPPOSITORY|||CUP|NOT DONE||NA|U|N|5||7||OPEN LABEL TREATMENT|1962-09-23||1965-03-17|||1970-08-12||1964-03-22
TRIAL STUDY 134XCP|RP|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|2||||||MASSIND|MASS INDICATOR||||LOG10 CFU/G|||MNFI|NOT DONE||NA|Y|U|5||7||CONTINUATION TREATMENT|1970-01-25||1964-04-01|||1970-04-15||1965-04-17
TRIAL STUDY 134XCP|RP|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||RATIO|||ML/MMHG/MIN/L|NOT DONE||Y|NA|N|1||38||OBSERVATION|1969-04-05||1961-01-02|||1960-07-02||1973-07-28
TRIAL STUDY 134XCP|RP|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|2||||||EDEMAIND|EDEMA INDICATOR||||UG/L/H|||DDU|NOT DONE||U|N|Y|1||38||SCREENING|1973-02-21||1964-03-18|||1972-05-13||1966-01-23
TRIAL STUDY 134XCP|RP|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|1||||||INTP|INTERPRETATION||||KIT|||/7.5 ML|NOT DONE||Y|Y|Y|2||58||RUN-IN|1972-03-05||1961-04-08|||1966-07-03||1966-11-20
TRIAL STUDY 134XCP|RP|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MPH|||HR/DAY|NOT DONE||N|U|Y|2||58||OPEN LABEL TREATMENT|1973-01-14||1970-01-06|||1961-10-28||1971-05-12
TRIAL STUDY 134XCP|RP|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|1||||||THICK|THICKNESS||||KPA/L/SEC|||ARBITRARY U|NOT DONE||U|Y|N|3||39||SCREENING|1960-09-15||1967-12-20|||1965-10-06||1961-02-01
TRIAL STUDY 134XCP|RP|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||GBQ|||10^6 IU|NOT DONE||NA|NA|U|3||39||SCREENING|1966-01-30||1972-08-07|||1963-09-04||1964-02-09
TRIAL STUDY 134XCP|RP|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||TITER|||MEQ/DAY|NOT DONE||NA|Y|U|4||88||WASHOUT|1967-02-22||1971-12-04|||1961-09-09||1960-12-15
TRIAL STUDY 134XCP|RP|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|2||||||RASHIND|RASH INDICATOR||||/DAY|||CI/KG|NOT DONE||N|NA|U|4||88||TREATMENT|1967-09-04||1962-11-23|||1961-09-02||1971-02-11
TRIAL STUDY 134XCP|RP|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|1||||||MENFDUR|MENSES FLOW DURATION||||MN|||ML/100G/MIN|NOT DONE||N|NA|Y|5||7||OPEN LABEL TREATMENT|1964-11-03||1969-05-01|||1965-12-15||1966-07-28
TRIAL STUDY 134XCP|RP|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||ML/BEAT|||AGU/ML|NOT DONE||N|U|NA|5||7||BASELINE|1971-01-24||1965-01-02|||1968-11-15||1962-08-04
TRIAL STUDY 134XCP|RP|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|1||||||BCMETHOD|BIRTH CONTROL METHOD||||CAPLET|||10^3 ORGANISMS|NOT DONE||N|U|NA|1||38||LONG-TERM FOLLOW-UP|1968-07-28||1966-10-26|||1972-11-12||1969-02-22
TRIAL STUDY 134XCP|RP|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|2||||||MENFDUR|MENSES FLOW DURATION||||UG/ANIMAL|||BQ/L|NOT DONE||NA|U|U|1||38||INDUCTION TREATMENT|1971-01-20||1963-09-15|||1971-12-18||1965-06-24
TRIAL STUDY 134XCP|RP|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|1||||||BCMETHOD|BIRTH CONTROL METHOD||||FG|||ML/MMHG/MIN/L|NOT DONE||N|NA|U|2||58||CONTINUATION TREATMENT|1964-08-11||1962-01-10|||1962-07-07||1972-01-11
TRIAL STUDY 134XCP|RP|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|2||||||ULCERIND|ULCER INDICATOR||||/100 WBC|||CS|NOT DONE||Y|NA|N|2||58||WASHOUT|1968-04-16||1970-09-30|||1973-02-07||1964-05-17
TRIAL STUDY 134XCP|RP|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||/100 HPFS|||USP U|NOT DONE||NA|N|NA|3||39||WASHOUT|1960-10-22||1973-02-28|||1961-05-18||1963-02-22
TRIAL STUDY 134XCP|RP|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|2||||||PUSTIND|PUSTULE INDICATOR||||NMOL/ML/MIN|||U/DL|NOT DONE||U|N|N|3||39||TREATMENT|1961-08-29||1968-10-06|||1966-05-03||1967-10-27
TRIAL STUDY 134XCP|RP|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||UMOL/MIN|||MG/DOSE|NOT DONE||Y|U|Y|4||88||OBSERVATION|1962-04-03||1970-05-11|||1972-01-12||1968-07-10
TRIAL STUDY 134XCP|RP|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||UG/KG/DAY|||NKAT/L|NOT DONE||Y|N|U|4||88||INDUCTION TREATMENT|1962-05-30||1970-05-16|||1966-05-04||1972-07-06
TRIAL STUDY 134XCP|RP|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|1||||||STILBIND|STILLBIRTH INDICATOR||||UL/KG/DAY|||VOXEL|NOT DONE||U|N|NA|5||7||OPEN LABEL TREATMENT|1968-12-15||1962-01-06|||1970-01-23||1973-07-06
TRIAL STUDY 134XCP|RP|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||U/G/H|||MMHG*MIN/L|NOT DONE||Y|U|N|5||7||LONG-TERM FOLLOW-UP|1965-03-02||1969-05-12|||1963-11-15||1967-02-15
TRIAL STUDY 134XCP|RP|2C15756E-1096-403B-989D-D2C3D31396A9|1||||||MENFDUR|MENSES FLOW DURATION||||CAPSULE|||UG/H|NOT DONE||U|Y|N|1||38||TREATMENT|1972-10-23||1965-03-23|||1964-03-06||1969-11-23
TRIAL STUDY 134XCP|RP|2C15756E-1096-403B-989D-D2C3D31396A9|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||SACHET|||UG/DOSE|NOT DONE||U|Y|U|1||38||TREATMENT|1969-06-22||1960-11-06|||1973-07-29||1970-07-20
TRIAL STUDY 134XCP|RP|2C15756E-1096-403B-989D-D2C3D31396A9|1||||||THICK|THICKNESS||||CYLINDER|||G/CAGE|NOT DONE||N|N|Y|2||58||LONG-TERM FOLLOW-UP|1967-01-21||1973-01-16|||1972-12-07||1967-08-14
TRIAL STUDY 134XCP|RP|2C15756E-1096-403B-989D-D2C3D31396A9|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||ML/CAGE/DAY|||UG/M2/H|NOT DONE||Y|Y|N|2||58||OPEN LABEL TREATMENT|1968-10-24||1973-07-17|||1963-07-13||1962-05-25
TRIAL STUDY 134XCP|RP|2C15756E-1096-403B-989D-D2C3D31396A9|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||TRACE|||S^-1(%O2)^-1|NOT DONE||NA|N|Y|3||39||LONG-TERM FOLLOW-UP|1973-07-21||1970-07-03|||1962-08-25||1968-03-14
TRIAL STUDY 134XCP|RP|2C15756E-1096-403B-989D-D2C3D31396A9|2||||||ABORTN|NUMBER OF ABORTIONS||||PLUG|||MSEC|NOT DONE||U|Y|N|3||39||INDUCTION TREATMENT|1966-05-07||1968-01-01|||1970-06-04||1963-08-31
TRIAL STUDY 134XCP|RP|2C15756E-1096-403B-989D-D2C3D31396A9|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||ML/MMHG/MIN/L|||%/S|NOT DONE||NA|Y|U|4||88||WASHOUT|1971-12-10||1966-09-25|||1968-12-21||1963-03-13
TRIAL STUDY 134XCP|RP|2C15756E-1096-403B-989D-D2C3D31396A9|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/CAGE/DAY|||NEWTON|NOT DONE||NA|NA|Y|4||88||RUN-IN|1970-08-21||1965-02-26|||1968-05-08||1962-04-09
TRIAL STUDY 134XCP|RP|2C15756E-1096-403B-989D-D2C3D31396A9|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||NFIU|||IU/KG|NOT DONE||N|NA|NA|5||7||RUN-IN|1960-02-11||1970-04-18|||1970-05-14||1969-05-13
TRIAL STUDY 134XCP|RP|2C15756E-1096-403B-989D-D2C3D31396A9|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||POINT|||LINEAR FT*LB|NOT DONE||N|U|N|5||7||WASHOUT|1963-05-05||1970-01-02|||1969-10-01||1970-01-29
TRIAL STUDY 134XCP|RP|CD103276-37FC-4E40-A0C8-8D1300D21AE1|1||||||TNDRIND|TENDERNESS INDICATOR||||NMOL/KG/DAY|||CS|NOT DONE||Y|NA|N|1||38||CONTINUATION TREATMENT|1965-06-10||1969-06-22|||1972-05-23||1968-09-15
TRIAL STUDY 134XCP|RP|CD103276-37FC-4E40-A0C8-8D1300D21AE1|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||/KG|||G/MOL|NOT DONE||U|U|NA|1||38||SCREENING|1968-01-03||1965-02-15|||1969-08-28||1969-05-01
TRIAL STUDY 134XCP|RP|CD103276-37FC-4E40-A0C8-8D1300D21AE1|1||||||MENARAGE|MENARCHE AGE||||MMHG/SEC|||TORR|NOT DONE||NA|NA|N|2||58||FOLLOW-UP|1970-10-03||1972-08-12|||1961-10-20||1961-09-22
TRIAL STUDY 134XCP|RP|CD103276-37FC-4E40-A0C8-8D1300D21AE1|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||10^7/L|||S*KPA|NOT DONE||N|NA|N|2||58||BLINDED TREATMENT|1960-05-14||1972-12-06|||1969-03-04||1967-05-25
TRIAL STUDY 134XCP|RP|CD103276-37FC-4E40-A0C8-8D1300D21AE1|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||UMOL/DL|||HOURS|NOT DONE||U|N|NA|3||39||FOLLOW-UP|1963-04-06||1966-03-01|||1972-09-23||1972-03-20
TRIAL STUDY 134XCP|RP|CD103276-37FC-4E40-A0C8-8D1300D21AE1|2||||||MENOSTAT|MENOPAUSE STATUS||||ML/100G/MIN|||UG/M2/MIN|NOT DONE||NA|U|Y|3||39||OBSERVATION|1965-12-14||1964-09-23|||1973-06-03||1969-06-20
TRIAL STUDY 134XCP|RP|CD103276-37FC-4E40-A0C8-8D1300D21AE1|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||U/G/DAY|||/MM2|NOT DONE||NA|N|NA|4||88||RUN-IN|1961-08-05||1967-10-10|||1966-04-02||1972-06-27
TRIAL STUDY 134XCP|RP|CD103276-37FC-4E40-A0C8-8D1300D21AE1|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||STEPS|||UEQ/L|NOT DONE||U|N|NA|4||88||RUN-IN|1970-09-21||1966-05-07|||1960-08-31||1967-12-03
TRIAL STUDY 134XCP|RP|CD103276-37FC-4E40-A0C8-8D1300D21AE1|1||||||THICK|THICKNESS||||MM3/MM2/YEAR|||NKAT/L|NOT DONE||U|U|Y|5||7||BLINDED TREATMENT|1966-10-12||1973-09-08|||1965-12-19||1968-05-17
TRIAL STUDY 134XCP|RP|CD103276-37FC-4E40-A0C8-8D1300D21AE1|2||||||STILBIND|STILLBIRTH INDICATOR||||10^3 RNA COPIES/ML|||/H|NOT DONE||N|U|Y|5||7||INDUCTION TREATMENT|1965-11-06||1962-07-27|||1962-06-21||1963-03-30
TRIAL STUDY 134XCP|RP|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|1||||||ULCERIND|ULCER INDICATOR||||MKAT|||10^9 ORGANISMS|NOT DONE||Y|N|U|1||38||TREATMENT|1966-09-28||1960-08-13|||1962-04-18||1962-12-17
TRIAL STUDY 134XCP|RP|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||PACK|||PG/CELL|NOT DONE||Y|NA|Y|1||38||TREATMENT|1964-10-05||1968-09-01|||1970-02-04||1964-05-18
TRIAL STUDY 134XCP|RP|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|1||||||MENARAGE|MENARCHE AGE||||CMH2O/ML|||ML/MIN|NOT DONE||Y|NA|NA|2||58||LONG-TERM FOLLOW-UP|1972-02-16||1972-02-25|||1960-03-18||1966-01-23
TRIAL STUDY 134XCP|RP|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||CMHG|||BQ/MG|NOT DONE||U|N|U|2||58||BLINDED TREATMENT|1967-10-06||1967-02-25|||1960-12-16||1962-09-14
TRIAL STUDY 134XCP|RP|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|1||||||BRTHN|NUMBER OF BIRTHS||||UG/CM2|||MOL/MOL|NOT DONE||Y|U|N|3||39||INDUCTION TREATMENT|1966-08-30||1971-06-27|||1970-06-14||1967-11-20
TRIAL STUDY 134XCP|RP|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||L/H/M2|||MS/MMHG|NOT DONE||N|U|U|3||39||WASHOUT|1965-01-06||1963-08-28|||1965-09-04||1965-05-19
TRIAL STUDY 134XCP|RP|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|1||||||FUNDHT|FUNDAL HEIGHT||||RNA COPIES/ML|||/10^5|NOT DONE||Y|Y|Y|4||88||RUN-IN|1972-03-14||1965-03-07|||1966-08-07||1965-10-07
TRIAL STUDY 134XCP|RP|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||CPM|||UL|NOT DONE||U|U|NA|4||88||RUN-IN|1964-07-23||1969-05-10|||1972-03-28||1967-06-04
TRIAL STUDY 134XCP|RP|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|1||||||MENFDUR|MENSES FLOW DURATION||||PHERESIS UNIT|||10^3 CFU/G|NOT DONE||Y|N|Y|5||7||OBSERVATION|1963-02-14||1966-07-18|||1968-11-21||1961-07-11
TRIAL STUDY 134XCP|RP|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||CCID 50/DOSE|||DYN|NOT DONE||NA|N|N|5||7||BASELINE|1969-09-14||1960-06-22|||1970-05-24||1963-11-24
TRIAL STUDY 134XCP|RP|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||BREATHS/MIN|||UL|NOT DONE||U|N|NA|1||38||SCREENING|1965-10-26||1962-05-02|||1972-09-04||1973-02-21
TRIAL STUDY 134XCP|RP|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|2||||||PUSTIND|PUSTULE INDICATOR||||RPM|||MBQ/UL|NOT DONE||NA|NA|NA|1||38||BLINDED TREATMENT|1966-11-04||1966-03-30|||1960-05-28||1968-01-11
TRIAL STUDY 134XCP|RP|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||AMP|||VP/DOSE|NOT DONE||Y|Y|U|2||58||WASHOUT|1969-01-27||1960-12-29|||1969-06-06||1963-04-07
TRIAL STUDY 134XCP|RP|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||UMOL/L/MIN|||USIEMENS|NOT DONE||NA|U|U|2||58||SCREENING|1965-01-03||1961-07-18|||1971-03-29||1973-04-16
TRIAL STUDY 134XCP|RP|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|1||||||ERYTHIND|ERYTHEMA INDICATOR||||G/ANIMAL/WK|||ELISA UNIT/ML|NOT DONE||Y|Y|U|3||39||OPEN LABEL TREATMENT|1962-02-10||1960-03-28|||1964-10-01||1968-03-20
TRIAL STUDY 134XCP|RP|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||ML/KG/H|||DIP|NOT DONE||N|Y|Y|3||39||SCREENING|1967-02-22||1968-02-29|||1963-09-22||1966-06-23
TRIAL STUDY 134XCP|RP|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||NMOL/ML/MIN|||ML/KG/MIN|NOT DONE||Y|U|U|4||88||OPEN LABEL TREATMENT|1965-06-06||1962-12-15|||1964-08-18||1966-07-23
TRIAL STUDY 134XCP|RP|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|2||||||PREGIND|PREGNANT INDICATOR||||10^9/DOSE|||IU/DAY|NOT DONE||NA|U|Y|4||88||SCREENING|1966-04-28||1962-05-13|||1972-04-10||1967-05-07
TRIAL STUDY 134XCP|RP|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||TSP EQ|||CI/G|NOT DONE||Y|NA|U|5||7||BASELINE|1963-04-13||1966-05-16|||1968-11-08||1970-01-03
TRIAL STUDY 134XCP|RP|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|2||||||PREGNN|NUMBER OF PREGNANCIES||||KBQ/UL|||CYLINDER|NOT DONE||N|Y|U|5||7||WASHOUT|1962-07-05||1963-01-16|||1972-05-19||1968-05-10
TRIAL STUDY 134XCP|RP|7B583F10-E460-4B25-8A6B-530A154442CD|1||||||PREGST|PREGNANT DURING THE STUDY||||UIU/L|||MPL U|NOT DONE||U|N|U|1||38||OBSERVATION|1968-08-11||1964-06-21|||1960-09-22||1970-04-01
TRIAL STUDY 134XCP|RP|7B583F10-E460-4B25-8A6B-530A154442CD|2||||||PREGIND|PREGNANT INDICATOR||||TSP EQ|||G/KG|NOT DONE||NA|U|NA|1||38||TREATMENT|1966-06-20||1965-05-20|||1968-12-21||1972-09-11
TRIAL STUDY 134XCP|RP|7B583F10-E460-4B25-8A6B-530A154442CD|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MET|||10^6 ORGANISMS/ML|NOT DONE||N|NA|U|2||58||BASELINE|1960-07-05||1964-09-30|||1970-10-18||1971-09-23
TRIAL STUDY 134XCP|RP|7B583F10-E460-4B25-8A6B-530A154442CD|2||||||PUSTIND|PUSTULE INDICATOR||||KG/CM|||UG/L/H|NOT DONE||NA|N|NA|2||58||WASHOUT|1969-11-15||1967-11-29|||1960-02-16||1972-08-18
TRIAL STUDY 134XCP|RP|7B583F10-E460-4B25-8A6B-530A154442CD|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MPH|||FOZ_US|NOT DONE||Y|NA|U|3||39||OPEN LABEL TREATMENT|1972-11-20||1962-04-23|||1973-08-02||1973-01-08
TRIAL STUDY 134XCP|RP|7B583F10-E460-4B25-8A6B-530A154442CD|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||10^6/EJACULATE U|||MU/L|NOT DONE||NA|N|NA|3||39||WASHOUT|1961-03-14||1960-06-21|||1969-07-31||1966-04-25
TRIAL STUDY 134XCP|RP|7B583F10-E460-4B25-8A6B-530A154442CD|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||BQ/L|||UM/DAY|NOT DONE||NA|NA|U|4||88||TREATMENT|1961-12-04||1968-09-10|||1968-07-21||1966-01-23
TRIAL STUDY 134XCP|RP|7B583F10-E460-4B25-8A6B-530A154442CD|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||CAPSULE|||UM/DAY|NOT DONE||NA|Y|N|4||88||BASELINE|1972-11-17||1971-01-17|||1970-02-23||1967-04-12
TRIAL STUDY 134XCP|RP|7B583F10-E460-4B25-8A6B-530A154442CD|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||BQ/G|||C|NOT DONE||NA|N|N|5||7||OBSERVATION|1964-07-19||1964-09-24|||1963-05-29||1964-06-21
TRIAL STUDY 134XCP|RP|7B583F10-E460-4B25-8A6B-530A154442CD|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||CAPFUL|||GRAIN|NOT DONE||N|U|N|5||7||INDUCTION TREATMENT|1965-03-28||1971-08-24|||1972-11-03||1969-01-17
TRIAL STUDY 134XCP|RP|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|1||||||ERYTHIND|ERYTHEMA INDICATOR||||UG/L DDU|||LOG10 PFU|NOT DONE||NA|Y|NA|1||38||BLINDED TREATMENT|1970-02-13||1968-04-07|||1972-11-09||1973-02-20
TRIAL STUDY 134XCP|RP|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||U/G/H|||UMOL/KG/MIN|NOT DONE||N|NA|Y|1||38||BASELINE|1973-05-27||1960-07-14|||1968-04-08||1969-05-22
TRIAL STUDY 134XCP|RP|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|1||||||RASHIND|RASH INDICATOR||||KV|||MKAT|NOT DONE||Y|Y|NA|2||58||LONG-TERM FOLLOW-UP|1966-03-23||1960-12-05|||1970-02-04||1968-09-20
TRIAL STUDY 134XCP|RP|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|2||||||PEELIND|PEELING INDICATOR||||STEPS/MIN|||ML/ANIMAL/WK|NOT DONE||N|U|NA|2||58||OPEN LABEL TREATMENT|1963-06-07||1969-01-13|||1965-09-27||1966-12-08
TRIAL STUDY 134XCP|RP|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|1||||||THICK|THICKNESS||||PFU/ML|||U/G/DAY|NOT DONE||Y|N|U|3||39||TREATMENT|1962-01-03||1971-10-11|||1960-03-13||1965-10-04
TRIAL STUDY 134XCP|RP|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||TAMPON|||VG/KG|NOT DONE||Y|NA|U|3||39||OBSERVATION|1967-07-02||1967-01-25|||1967-02-17||1969-01-13
TRIAL STUDY 134XCP|RP|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||EQ|||MG/ANIMAL|NOT DONE||NA|Y|NA|4||88||OPEN LABEL TREATMENT|1968-05-20||1960-12-05|||1968-05-08||1963-02-13
TRIAL STUDY 134XCP|RP|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||U.CARR|||/VF|NOT DONE||U|NA|N|4||88||INDUCTION TREATMENT|1963-11-21||1970-08-25|||1970-12-12||1970-04-20
TRIAL STUDY 134XCP|RP|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ML/ANIMAL|||G/ANIMAL/DAY|NOT DONE||U|Y|NA|5||7||LONG-TERM FOLLOW-UP|1972-10-17||1965-12-04|||1960-08-26||1964-03-14
TRIAL STUDY 134XCP|RP|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||PIXEL|||U.CARR|NOT DONE||NA|NA|Y|5||7||OPEN LABEL TREATMENT|1968-08-04||1968-07-11|||1969-03-23||1963-04-02
TRIAL STUDY 134XCP|RP|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||NG/MOL|||CM2|NOT DONE||Y|N|N|1||38||BASELINE|1963-02-06||1960-01-13|||1971-05-29||1963-01-30
TRIAL STUDY 134XCP|RP|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^5/L|||NM|NOT DONE||NA|N|U|1||38||OPEN LABEL TREATMENT|1961-07-21||1972-02-24|||1968-01-17||1965-10-28
TRIAL STUDY 134XCP|RP|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|1||||||FUNDHT|FUNDAL HEIGHT||||ML/CAGE|||BQ|NOT DONE||Y|N|Y|2||58||BASELINE|1961-02-17||1967-11-14|||1961-06-21||1965-08-10
TRIAL STUDY 134XCP|RP|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|2||||||BCMETHOD|BIRTH CONTROL METHOD||||ML/S/M2|||BQ/KG|NOT DONE||U|NA|U|2||58||SCREENING|1972-04-25||1962-12-25|||1964-10-16||1964-06-25
TRIAL STUDY 134XCP|RP|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||BEL|||UMOL/L/MIN|NOT DONE||Y|Y|U|3||39||INDUCTION TREATMENT|1963-03-19||1971-03-22|||1962-11-11||1971-02-27
TRIAL STUDY 134XCP|RP|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||CM2|||SCOOPFUL|NOT DONE||Y|NA|Y|3||39||CONTINUATION TREATMENT|1971-10-19||1968-11-12|||1970-02-22||1960-09-17
TRIAL STUDY 134XCP|RP|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|1||||||ULCERIND|ULCER INDICATOR||||YD|||BQ/UG|NOT DONE||NA|U|NA|4||88||TREATMENT|1962-04-07||1963-10-01|||1960-09-19||1969-03-27
TRIAL STUDY 134XCP|RP|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|2||||||MENFDUR|MENSES FLOW DURATION||||TSP|||PNU/ML|NOT DONE||U|N|U|4||88||SCREENING|1969-02-15||1965-11-28|||1972-10-12||1968-12-28
TRIAL STUDY 134XCP|RP|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|1||||||FUNDHT|FUNDAL HEIGHT||||UMOL/DAY|||IU/DL|NOT DONE||NA|U|U|5||7||OPEN LABEL TREATMENT|1971-10-22||1971-07-28|||1961-03-05||1972-05-30
TRIAL STUDY 134XCP|RP|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|2||||||FUNDHT|FUNDAL HEIGHT||||FG|||MG/M2/H|NOT DONE||NA|U|NA|5||7||RUN-IN|1970-08-02||1968-06-04|||1961-07-22||1966-12-21
TRIAL STUDY 134XCP|RP|51FE575E-2161-414B-B772-9F1888E7C5CC|1||||||ULCERIND|ULCER INDICATOR||||VP/DOSE|||BU|NOT DONE||U|N|N|1||38||BASELINE|1965-12-26||1966-05-22|||1968-12-29||1966-02-25
TRIAL STUDY 134XCP|RP|51FE575E-2161-414B-B772-9F1888E7C5CC|2||||||RASHIND|RASH INDICATOR||||STRIP|||HR/DAY|NOT DONE||U|NA|N|1||38||INDUCTION TREATMENT|1967-08-18||1971-04-23|||1967-10-12||1961-05-21
TRIAL STUDY 134XCP|RP|51FE575E-2161-414B-B772-9F1888E7C5CC|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||EIA UNIT|||PFU/DOSE|NOT DONE||N|N|N|2||58||RUN-IN|1968-12-21||1960-04-25|||1972-08-20||1967-11-20
TRIAL STUDY 134XCP|RP|51FE575E-2161-414B-B772-9F1888E7C5CC|2||||||PEELIND|PEELING INDICATOR||||MG/KG/MIN|||CM H2O|NOT DONE||U|N|NA|2||58||OPEN LABEL TREATMENT|1962-01-01||1964-05-17|||1973-03-07||1965-10-23
TRIAL STUDY 134XCP|RP|51FE575E-2161-414B-B772-9F1888E7C5CC|1||||||BRTHN|NUMBER OF BIRTHS||||MMU/ML|||PMOL/10^10 CELLS|NOT DONE||Y|Y|NA|3||39||LONG-TERM FOLLOW-UP|1969-08-01||1963-05-07|||1961-02-22||1964-01-29
TRIAL STUDY 134XCP|RP|51FE575E-2161-414B-B772-9F1888E7C5CC|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MG/DL|||U/M2/DAY|NOT DONE||NA|Y|N|3||39||WASHOUT|1966-07-31||1960-07-26|||1961-06-26||1965-09-04
TRIAL STUDY 134XCP|RP|51FE575E-2161-414B-B772-9F1888E7C5CC|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||TITER|||/2500 WBC|NOT DONE||Y|U|N|4||88||BLINDED TREATMENT|1969-07-22||1969-02-13|||1969-11-24||1972-04-25
TRIAL STUDY 134XCP|RP|51FE575E-2161-414B-B772-9F1888E7C5CC|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||NMOL/KG/DAY|||10^4 CFU/ML|NOT DONE||NA|N|Y|4||88||BASELINE|1972-03-21||1961-09-25|||1963-09-23||1969-04-23
TRIAL STUDY 134XCP|RP|51FE575E-2161-414B-B772-9F1888E7C5CC|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||UIU/DL|||U/M2|NOT DONE||Y|N|Y|5||7||LONG-TERM FOLLOW-UP|1967-02-07||1966-04-16|||1971-11-08||1968-03-25
TRIAL STUDY 134XCP|RP|51FE575E-2161-414B-B772-9F1888E7C5CC|2||||||ERYTHIND|ERYTHEMA INDICATOR||||UG/G/H|||TESLA|NOT DONE||N|U|NA|5||7||LONG-TERM FOLLOW-UP|1962-07-05||1972-01-12|||1972-02-18||1966-11-18
TRIAL STUDY 134XCP|RP|991C72FC-777F-4CED-824B-A4DECA57BE99|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||SBE/ML|||CMHG|NOT DONE||N|U|U|1||38||BASELINE|1962-04-05||1965-04-04|||1962-06-17||1970-05-31
TRIAL STUDY 134XCP|RP|991C72FC-777F-4CED-824B-A4DECA57BE99|2||||||DSCHGIND|DISCHARGE INDICATOR||||MG/KG/H|||MAMP|NOT DONE||U|N|NA|1||38||BLINDED TREATMENT|1966-01-13||1969-11-08|||1965-03-21||1971-03-29
TRIAL STUDY 134XCP|RP|991C72FC-777F-4CED-824B-A4DECA57BE99|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||KBQ/UL|||%(V/V)|NOT DONE||NA|N|U|2||58||FOLLOW-UP|1968-12-19||1964-09-09|||1972-05-22||1973-01-08
TRIAL STUDY 134XCP|RP|991C72FC-777F-4CED-824B-A4DECA57BE99|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||G/CAGE/WK|||U/KG/H|NOT DONE||Y|N|Y|2||58||INDUCTION TREATMENT|1973-06-12||1970-03-30|||1964-01-06||1962-03-01
TRIAL STUDY 134XCP|RP|991C72FC-777F-4CED-824B-A4DECA57BE99|1||||||ULCERIND|ULCER INDICATOR||||PA|||MG/M2|NOT DONE||NA|U|NA|3||39||OBSERVATION|1962-10-10||1965-09-09|||1970-02-15||1965-11-29
TRIAL STUDY 134XCP|RP|991C72FC-777F-4CED-824B-A4DECA57BE99|2||||||PEELIND|PEELING INDICATOR||||DAGU/ML|||UMOL/DL|NOT DONE||NA|N|NA|3||39||RUN-IN|1961-01-05||1969-09-30|||1963-08-11||1966-02-23
TRIAL STUDY 134XCP|RP|991C72FC-777F-4CED-824B-A4DECA57BE99|1||||||PREGST|PREGNANT DURING THE STUDY||||BOTTLE|||UG/DOSE|NOT DONE||U|U|Y|4||88||TREATMENT|1963-09-08||1969-03-22|||1972-01-18||1963-02-12
TRIAL STUDY 134XCP|RP|991C72FC-777F-4CED-824B-A4DECA57BE99|2||||||INABOIND|INDUCED ABORTION INDICATOR||||VIAL|||UGEQ/L|NOT DONE||NA|NA|Y|4||88||SCREENING|1961-11-16||1972-06-16|||1960-12-18||1962-04-15
TRIAL STUDY 134XCP|RP|991C72FC-777F-4CED-824B-A4DECA57BE99|1||||||FUNDHT|FUNDAL HEIGHT||||LOG10 IU/ML|||%(V/V)|NOT DONE||N|N|U|5||7||OPEN LABEL TREATMENT|1971-09-02||1971-08-08|||1970-03-30||1960-01-01
TRIAL STUDY 134XCP|RP|991C72FC-777F-4CED-824B-A4DECA57BE99|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||NMOL/KG/DAY|||JDF UNIT|NOT DONE||NA|Y|N|5||7||RUN-IN|1962-07-19||1969-10-04|||1967-07-28||1971-05-30
TRIAL STUDY 134XCP|RP|FFECA538-8D16-421C-ACA2-4A769BC15D7D|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||KPA|||UG/KG|NOT DONE||Y|U|NA|1||38||OBSERVATION|1961-06-12||1966-09-20|||1971-03-25||1973-05-15
TRIAL STUDY 134XCP|RP|FFECA538-8D16-421C-ACA2-4A769BC15D7D|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||KG|||FARAD|NOT DONE||N|U|NA|1||38||CONTINUATION TREATMENT|1963-03-25||1964-01-29|||1968-02-18||1966-04-29
TRIAL STUDY 134XCP|RP|FFECA538-8D16-421C-ACA2-4A769BC15D7D|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||BOTTLE|||UMOL/MG/MIN|NOT DONE||U|N|N|2||58||TREATMENT|1963-01-19||1963-04-25|||1969-06-12||1961-03-19
TRIAL STUDY 134XCP|RP|FFECA538-8D16-421C-ACA2-4A769BC15D7D|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||/100 HPFS|||BAU/ML|NOT DONE||NA|U|Y|2||58||FOLLOW-UP|1963-04-10||1961-01-20|||1969-03-26||1967-05-10
TRIAL STUDY 134XCP|RP|FFECA538-8D16-421C-ACA2-4A769BC15D7D|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MPA|||MMOL/MIN/KPA|NOT DONE||Y|Y|Y|3||39||TREATMENT|1966-05-09||1971-12-27|||1972-12-10||1962-08-04
TRIAL STUDY 134XCP|RP|FFECA538-8D16-421C-ACA2-4A769BC15D7D|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MG2/DL2|||SQU/ML|NOT DONE||N|NA|Y|3||39||BASELINE|1973-05-19||1960-06-09|||1966-08-31||1969-05-12
TRIAL STUDY 134XCP|RP|FFECA538-8D16-421C-ACA2-4A769BC15D7D|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MG/ML/MIN|||DNA COPIES/UG|NOT DONE||U|U|NA|4||88||FOLLOW-UP|1963-05-13||1973-08-12|||1962-10-27||1964-06-18
TRIAL STUDY 134XCP|RP|FFECA538-8D16-421C-ACA2-4A769BC15D7D|2||||||RASHIND|RASH INDICATOR||||LENS|||10^4/L|NOT DONE||U|Y|NA|4||88||SCREENING|1968-04-22||1973-04-25|||1967-07-23||1963-01-20
TRIAL STUDY 134XCP|RP|FFECA538-8D16-421C-ACA2-4A769BC15D7D|1||||||ABORTN|NUMBER OF ABORTIONS||||BOLUS|||SIEMENS|NOT DONE||U|Y|U|5||7||LONG-TERM FOLLOW-UP|1961-10-25||1966-03-27|||1968-07-15||1973-08-15
TRIAL STUDY 134XCP|RP|FFECA538-8D16-421C-ACA2-4A769BC15D7D|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MM/MIN|||CPM|NOT DONE||N|NA|U|5||7||WASHOUT|1971-02-06||1966-09-23|||1972-07-18||1960-01-09
TRIAL STUDY 134XCP|RP|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|1||||||PREGST|PREGNANT DURING THE STUDY||||CS|||ML/MMHG|NOT DONE||NA|NA|NA|1||38||LONG-TERM FOLLOW-UP|1972-09-04||1972-12-03|||1968-06-15||1964-09-15
TRIAL STUDY 134XCP|RP|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UMOL|||GRAVITATIONAL UNIT|NOT DONE||Y|NA|N|1||38||BLINDED TREATMENT|1970-10-29||1963-07-30|||1971-10-05||1963-12-10
TRIAL STUDY 134XCP|RP|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|1||||||THICK|THICKNESS||||VG/DOSE|||ML/M2/MIN|NOT DONE||NA|U|U|2||58||LONG-TERM FOLLOW-UP|1973-04-30||1972-04-13|||1965-04-12||1960-04-10
TRIAL STUDY 134XCP|RP|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||UMOL/DAY|||10^3 ORGANISMS/G|NOT DONE||NA|N|U|2||58||INDUCTION TREATMENT|1968-04-14||1964-05-21|||1971-10-02||1969-08-30
TRIAL STUDY 134XCP|RP|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||WATT|||DNA COPIES/ML|NOT DONE||Y|N|NA|3||39||LONG-TERM FOLLOW-UP|1963-03-29||1961-04-23|||1960-10-03||1962-11-02
TRIAL STUDY 134XCP|RP|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||PUFF|||EVENTS|NOT DONE||NA|U|N|3||39||LONG-TERM FOLLOW-UP|1970-01-16||1967-12-06|||1960-02-16||1964-03-01
TRIAL STUDY 134XCP|RP|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|1||||||INTP|INTERPRETATION||||DAYS/WK|||10^6 IU/ML|NOT DONE||Y|N|NA|4||88||RUN-IN|1960-04-07||1967-06-06|||1967-02-13||1972-08-30
TRIAL STUDY 134XCP|RP|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||IU/DAY|||L/MIN|NOT DONE||U|N|NA|4||88||SCREENING|1967-01-05||1971-04-11|||1965-09-09||1970-12-02
TRIAL STUDY 134XCP|RP|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||KG/MOL|||FOZ_US|NOT DONE||N|N|NA|5||7||INDUCTION TREATMENT|1973-03-15||1966-01-25|||1968-07-14||1962-10-03
TRIAL STUDY 134XCP|RP|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|2||||||MASSIND|MASS INDICATOR||||BOX|||PMOL|NOT DONE||NA|U|Y|5||7||FOLLOW-UP|1963-02-04||1967-06-21|||1971-07-18||1967-09-10
TRIAL STUDY 134XCP|RP|54507F00-0C16-4F35-A762-104B47390283|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||SYRINGE|||CIGARETTE|NOT DONE||U|U|Y|1||38||CONTINUATION TREATMENT|1966-12-07||1960-06-23|||1973-03-05||1970-08-09
TRIAL STUDY 134XCP|RP|54507F00-0C16-4F35-A762-104B47390283|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||LX|||MSEC|NOT DONE||Y|U|Y|1||38||CONTINUATION TREATMENT|1964-01-11||1963-04-15|||1969-06-13||1960-07-08
TRIAL STUDY 134XCP|RP|54507F00-0C16-4F35-A762-104B47390283|1||||||TNDRIND|TENDERNESS INDICATOR||||NEBULE|||ML/ANIMAL/DAY|NOT DONE||U|NA|N|2||58||CONTINUATION TREATMENT|1970-08-02||1960-03-21|||1973-06-18||1967-07-07
TRIAL STUDY 134XCP|RP|54507F00-0C16-4F35-A762-104B47390283|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||DAGU|||G/U|NOT DONE||Y|Y|Y|2||58||BASELINE|1968-07-04||1962-08-22|||1967-12-27||1970-05-26
TRIAL STUDY 134XCP|RP|54507F00-0C16-4F35-A762-104B47390283|1||||||EDEMAIND|EDEMA INDICATOR||||MIU/L|||U/KG|NOT DONE||NA|NA|U|3||39||BLINDED TREATMENT|1962-08-19||1970-01-15|||1960-02-17||1961-09-21
TRIAL STUDY 134XCP|RP|54507F00-0C16-4F35-A762-104B47390283|2||||||PRGENDTC|DATE PREGNANCY ENDED||||NMOL/ML/MIN|||NL|NOT DONE||NA|U|NA|3||39||FOLLOW-UP|1973-07-27||1971-11-25|||1969-02-24||1963-10-24
TRIAL STUDY 134XCP|RP|54507F00-0C16-4F35-A762-104B47390283|1||||||PREGST|PREGNANT DURING THE STUDY||||KM/H|||POINT|NOT DONE||Y|NA|U|4||88||OPEN LABEL TREATMENT|1964-06-19||1964-11-16|||1968-05-23||1967-03-03
TRIAL STUDY 134XCP|RP|54507F00-0C16-4F35-A762-104B47390283|2||||||TNDRIND|TENDERNESS INDICATOR||||10^6 RNA COPIES/ML|||MG/CM2|NOT DONE||N|N|NA|4||88||LONG-TERM FOLLOW-UP|1967-04-30||1969-03-14|||1969-08-09||1963-08-31
TRIAL STUDY 134XCP|RP|54507F00-0C16-4F35-A762-104B47390283|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||UEQ|||U/ML|NOT DONE||Y|U|NA|5||7||OPEN LABEL TREATMENT|1973-05-14||1961-09-06|||1964-10-19||1962-07-24
TRIAL STUDY 134XCP|RP|54507F00-0C16-4F35-A762-104B47390283|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MOL/MOL|||MPL U|NOT DONE||N|N|NA|5||7||OPEN LABEL TREATMENT|1971-07-17||1961-01-10|||1964-08-02||1970-11-21
TRIAL STUDY 134XCP|RP|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|1||||||PUSTIND|PUSTULE INDICATOR||||APL U|||G/U|NOT DONE||NA|NA|NA|1||38||WASHOUT|1961-02-17||1972-07-14|||1969-06-28||1966-05-25
TRIAL STUDY 134XCP|RP|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MMHG/L/MIN|||MG/MOL|NOT DONE||Y|N|Y|1||38||CONTINUATION TREATMENT|1973-01-23||1966-07-04|||1964-04-13||1965-06-02
TRIAL STUDY 134XCP|RP|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|1||||||RASHIND|RASH INDICATOR||||LM|||U/M2|NOT DONE||NA|Y|U|2||58||RUN-IN|1970-09-03||1967-09-08|||1971-02-13||1961-09-26
TRIAL STUDY 134XCP|RP|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||G/MOL|||MEQ/L|NOT DONE||NA|U|U|2||58||TREATMENT|1964-03-18||1971-09-01|||1962-08-04||1965-03-11
TRIAL STUDY 134XCP|RP|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||PIXELS/CM|||ML/SEC/1.73M2|NOT DONE||N|N|U|3||39||BASELINE|1972-05-17||1961-02-09|||1972-12-04||1972-02-20
TRIAL STUDY 134XCP|RP|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||10^12 IU/L|||IU/DL|NOT DONE||Y|U|NA|3||39||INDUCTION TREATMENT|1970-04-19||1972-05-06|||1963-07-31||1970-10-21
TRIAL STUDY 134XCP|RP|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||DEG|||G/ANIMAL/WK|NOT DONE||N|U|U|4||88||OBSERVATION|1962-05-12||1963-07-07|||1968-03-17||1965-12-25
TRIAL STUDY 134XCP|RP|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UOSM|||ENZYME U/G HB|NOT DONE||NA|N|Y|4||88||RUN-IN|1966-08-23||1967-02-14|||1970-02-07||1972-12-12
TRIAL STUDY 134XCP|RP|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||CAPFUL|||10^6/L|NOT DONE||NA|N|NA|5||7||SCREENING|1963-03-10||1961-05-31|||1966-03-26||1964-03-20
TRIAL STUDY 134XCP|RP|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|2||||||ERYTHIND|ERYTHEMA INDICATOR||||UG/L|||MMOL/MIN/KPA/L|NOT DONE||U|NA|N|5||7||LONG-TERM FOLLOW-UP|1973-07-17||1961-06-13|||1963-02-28||1971-10-10
TRIAL STUDY 134XCP|RP|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||FL|||MOL/ML|NOT DONE||N|U|Y|1||38||CONTINUATION TREATMENT|1968-08-13||1964-09-26|||1970-04-03||1962-02-06
TRIAL STUDY 134XCP|RP|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|2||||||PREGST|PREGNANT DURING THE STUDY||||MMOL/KG|||MEQ/G|NOT DONE||N|Y|U|1||38||OPEN LABEL TREATMENT|1967-03-26||1960-05-19|||1971-11-22||1969-08-26
TRIAL STUDY 134XCP|RP|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|1||||||ERYTHIND|ERYTHEMA INDICATOR||||KEV|||MV*MIN|NOT DONE||N|U|U|2||58||FOLLOW-UP|1972-05-04||1970-02-27|||1968-07-08||1967-06-07
TRIAL STUDY 134XCP|RP|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|2||||||PRGENDTC|DATE PREGNANCY ENDED||||%(W/W)|||TRACE|NOT DONE||NA|U|N|2||58||RUN-IN|1973-01-30||1969-07-10|||1961-08-27||1963-07-15
TRIAL STUDY 134XCP|RP|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MIN*MG/ML|||ELISA UNIT|NOT DONE||NA|U|U|3||39||TREATMENT|1963-03-03||1963-09-06|||1964-08-27||1971-07-19
TRIAL STUDY 134XCP|RP|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||KCAL/DAY|||DAMOL/L|NOT DONE||NA|N|N|3||39||FOLLOW-UP|1971-09-14||1970-07-19|||1961-11-09||1972-06-02
TRIAL STUDY 134XCP|RP|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||NCI|||GY/H|NOT DONE||Y|U|Y|4||88||FOLLOW-UP|1960-09-29||1964-06-07|||1971-01-14||1961-03-08
TRIAL STUDY 134XCP|RP|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|2||||||ERYTHIND|ERYTHEMA INDICATOR||||LOG10 COPIES/ML|||L/DAY|NOT DONE||Y|NA|Y|4||88||SCREENING|1966-02-02||1970-03-04|||1967-12-12||1961-10-29
TRIAL STUDY 134XCP|RP|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|1||||||PREGIND|PREGNANT INDICATOR||||UKAT/10^12 RBC|||10^3 COPIES/ML|NOT DONE||NA|U|NA|5||7||BLINDED TREATMENT|1966-05-02||1965-04-23|||1966-03-24||1968-03-18
TRIAL STUDY 134XCP|RP|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|2||||||DLVRMODE|MODE OF DELIVERY||||10^3 CFU/G|||COPIES/UG|NOT DONE||N|U|Y|5||7||FOLLOW-UP|1970-05-28||1970-03-14|||1964-08-30||1971-03-16
TRIAL STUDY 134XCP|RP|CF8F9036-3380-4A0B-B17A-7EF814B02700|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||WEEKS|||ENZYME U/L|NOT DONE||NA|N|U|1||38||WASHOUT|1964-02-07||1964-03-04|||1963-08-25||1965-10-12
TRIAL STUDY 134XCP|RP|CF8F9036-3380-4A0B-B17A-7EF814B02700|2||||||THICK|THICKNESS||||SIEMENS|||LX|NOT DONE||NA|NA|Y|1||38||RUN-IN|1972-11-29||1968-10-18|||1969-05-19||1965-08-18
TRIAL STUDY 134XCP|RP|CF8F9036-3380-4A0B-B17A-7EF814B02700|1||||||MENOAGE|MENOPAUSE AGE||||NMOL/KG/DAY|||PFU/DOSE|NOT DONE||N|NA|U|2||58||LONG-TERM FOLLOW-UP|1964-03-28||1966-02-23|||1966-04-15||1971-03-29
TRIAL STUDY 134XCP|RP|CF8F9036-3380-4A0B-B17A-7EF814B02700|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||CI/UG|||CAPFUL|NOT DONE||N|Y|U|2||58||TREATMENT|1969-11-10||1972-04-19|||1963-10-17||1964-08-27
TRIAL STUDY 134XCP|RP|CF8F9036-3380-4A0B-B17A-7EF814B02700|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||NMOL/KG/DAY|||10^9 CFU|NOT DONE||Y|N|Y|3||39||CONTINUATION TREATMENT|1967-11-01||1967-08-31|||1970-12-09||1961-08-15
TRIAL STUDY 134XCP|RP|CF8F9036-3380-4A0B-B17A-7EF814B02700|2||||||PRGENDTC|DATE PREGNANCY ENDED||||LOG10 PFU/ML|||DB|NOT DONE||NA|Y|U|3||39||TREATMENT|1973-06-01||1969-09-08|||1967-06-04||1963-02-20
TRIAL STUDY 134XCP|RP|CF8F9036-3380-4A0B-B17A-7EF814B02700|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||CM/MIN|||MM/SEC|NOT DONE||N|Y|Y|4||88||RUN-IN|1965-02-20||1967-12-12|||1972-12-10||1972-01-02
TRIAL STUDY 134XCP|RP|CF8F9036-3380-4A0B-B17A-7EF814B02700|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||PIXELS/CM|||TRANSDUCING UNIT|NOT DONE||Y|N|N|4||88||FOLLOW-UP|1965-08-19||1962-08-19|||1968-05-21||1963-08-16
TRIAL STUDY 134XCP|RP|CF8F9036-3380-4A0B-B17A-7EF814B02700|1||||||DLVRMODE|MODE OF DELIVERY||||MM/2H|||10^6 IU|NOT DONE||N|Y|N|5||7||INDUCTION TREATMENT|1970-09-04||1966-08-16|||1965-03-17||1965-01-11
TRIAL STUDY 134XCP|RP|CF8F9036-3380-4A0B-B17A-7EF814B02700|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||HOUNSFIELD UNIT|||10^3 ORGANISMS/G|NOT DONE||N|NA|NA|5||7||FOLLOW-UP|1972-08-10||1961-07-09|||1971-02-13||1965-08-24
TRIAL STUDY 134XCP|RP|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||FOZ_US|||MMHG*MIN/L|NOT DONE||N|NA|Y|1||38||RUN-IN|1967-06-19||1960-08-30|||1961-05-22||1967-02-05
TRIAL STUDY 134XCP|RP|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|2||||||INABOIND|INDUCED ABORTION INDICATOR||||TUBERCULIN UNIT/ML|||KALLIKREIN INHIBITOR UNIT|NOT DONE||NA|U|Y|1||38||BASELINE|1968-03-04||1971-03-19|||1971-11-14||1969-04-10
TRIAL STUDY 134XCP|RP|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|1||||||DSCHGIND|DISCHARGE INDICATOR||||MMOL/G|||DPM|NOT DONE||N|NA|N|2||58||FOLLOW-UP|1966-07-10||1967-08-05|||1964-12-12||1973-03-14
TRIAL STUDY 134XCP|RP|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|2||||||ABORTN|NUMBER OF ABORTIONS||||PMOL/L|||ELISA UNIT|NOT DONE||U|Y|NA|2||58||SCREENING|1972-09-03||1961-09-06|||1968-02-25||1972-06-14
TRIAL STUDY 134XCP|RP|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|1||||||ABORTN|NUMBER OF ABORTIONS||||DPM/100MG|||CMOL/L|NOT DONE||U|N|Y|3||39||BLINDED TREATMENT|1960-01-28||1963-02-16|||1967-10-23||1972-01-23
TRIAL STUDY 134XCP|RP|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||YD|||UGEQ|NOT DONE||NA|U|N|3||39||INDUCTION TREATMENT|1968-08-04||1970-07-19|||1960-03-27||1972-07-23
TRIAL STUDY 134XCP|RP|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|1||||||MENOAGE|MENOPAUSE AGE||||U/G/DAY|||VP/ML|NOT DONE||Y|N|Y|4||88||BLINDED TREATMENT|1970-07-29||1966-08-08|||1971-09-07||1960-12-11
TRIAL STUDY 134XCP|RP|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|2||||||DLVRMODE|MODE OF DELIVERY||||PRESSOR UNITS|||MG/M2/MIN|NOT DONE||NA|N|Y|4||88||CONTINUATION TREATMENT|1963-07-15||1971-03-09|||1968-04-03||1966-02-23
TRIAL STUDY 134XCP|RP|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||OSM|||MIN|NOT DONE||U|Y|N|5||7||SCREENING|1970-05-21||1967-04-09|||1970-02-23||1960-12-27
TRIAL STUDY 134XCP|RP|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|2||||||DLVRMODE|MODE OF DELIVERY||||EQ|||10^6/HPF|NOT DONE||NA|U|NA|5||7||BASELINE|1969-04-23||1972-01-03|||1971-01-01||1973-07-30
TRIAL STUDY 134XCP|RP|58360390-F6AB-41D7-9A0D-1039E795403E|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^12 IU/L|||NSEC|NOT DONE||U|U|Y|1||38||INDUCTION TREATMENT|1969-12-24||1964-08-03|||1967-06-13||1972-04-06
TRIAL STUDY 134XCP|RP|58360390-F6AB-41D7-9A0D-1039E795403E|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||POINT|||UEQ/L|NOT DONE||NA|NA|NA|1||38||BLINDED TREATMENT|1961-01-04||1963-11-26|||1970-01-05||1968-07-30
TRIAL STUDY 134XCP|RP|58360390-F6AB-41D7-9A0D-1039E795403E|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||ML/S|||PA|NOT DONE||U|U|NA|2||58||BASELINE|1971-07-20||1967-04-18|||1972-04-20||1972-05-05
TRIAL STUDY 134XCP|RP|58360390-F6AB-41D7-9A0D-1039E795403E|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MG/ML/DAY|||SEC|NOT DONE||N|Y|U|2||58||BASELINE|1970-04-10||1969-09-13|||1972-04-20||1964-01-25
TRIAL STUDY 134XCP|RP|58360390-F6AB-41D7-9A0D-1039E795403E|1||||||GRAVIND|GRAVIDA INDICATOR||||HOUNSFIELD UNIT|||ML/BEAT|NOT DONE||NA|NA|Y|3||39||CONTINUATION TREATMENT|1968-04-11||1962-05-25|||1960-09-04||1965-10-13
TRIAL STUDY 134XCP|RP|58360390-F6AB-41D7-9A0D-1039E795403E|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||IU/G|||HR/DAY|NOT DONE||N|NA|Y|3||39||FOLLOW-UP|1960-05-23||1970-11-20|||1964-08-02||1962-07-13
TRIAL STUDY 134XCP|RP|58360390-F6AB-41D7-9A0D-1039E795403E|1||||||BCMETHOD|BIRTH CONTROL METHOD||||10^9/L|||G/CAGE/DAY|NOT DONE||Y|N|NA|4||88||INDUCTION TREATMENT|1964-09-18||1972-10-27|||1965-05-08||1972-09-27
TRIAL STUDY 134XCP|RP|58360390-F6AB-41D7-9A0D-1039E795403E|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MG/MOL|||PPB|NOT DONE||N|N|NA|4||88||LONG-TERM FOLLOW-UP|1961-12-03||1962-09-02|||1971-08-15||1972-07-12
TRIAL STUDY 134XCP|RP|58360390-F6AB-41D7-9A0D-1039E795403E|1||||||MENOAGE|MENOPAUSE AGE||||PACKAGE|||NMOL/L|NOT DONE||U|U|U|5||7||BLINDED TREATMENT|1969-10-26||1971-02-16|||1961-12-11||1961-07-14
TRIAL STUDY 134XCP|RP|58360390-F6AB-41D7-9A0D-1039E795403E|2||||||BCMETHOD|BIRTH CONTROL METHOD||||APL U|||YD|NOT DONE||Y|U|Y|5||7||OPEN LABEL TREATMENT|1963-08-06||1965-01-04|||1969-01-22||1962-09-02
TRIAL STUDY 134XCP|RP|61B02780-0C99-47F8-93B2-CA839876604E|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||PMOL/10^10 CELLS|||UG/MIN|NOT DONE||Y|Y|NA|1||38||SCREENING|1963-01-25||1962-05-16|||1967-10-10||1963-11-15
TRIAL STUDY 134XCP|RP|61B02780-0C99-47F8-93B2-CA839876604E|2||||||MENOAGE|MENOPAUSE AGE||||ML/CAGE/WK|||10^6 ORGANISMS/G|NOT DONE||NA|NA|Y|1||38||TREATMENT|1973-02-24||1973-03-01|||1973-03-09||1971-09-11
TRIAL STUDY 134XCP|RP|61B02780-0C99-47F8-93B2-CA839876604E|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||TUBERCULIN UNIT|||/7.5 ML|NOT DONE||NA|Y|U|2||58||TREATMENT|1971-01-07||1960-05-01|||1961-04-25||1969-11-06
TRIAL STUDY 134XCP|RP|61B02780-0C99-47F8-93B2-CA839876604E|2||||||INABOIND|INDUCED ABORTION INDICATOR||||10^11/L|||ML/MIN|NOT DONE||NA|Y|U|2||58||LONG-TERM FOLLOW-UP|1965-11-08||1972-09-09|||1964-04-02||1966-07-30
TRIAL STUDY 134XCP|RP|61B02780-0C99-47F8-93B2-CA839876604E|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||H*%|||UIU/L|NOT DONE||Y|N|Y|3||39||SCREENING|1966-12-14||1971-09-05|||1962-09-02||1963-10-03
TRIAL STUDY 134XCP|RP|61B02780-0C99-47F8-93B2-CA839876604E|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||KG/L|||M/SEC|NOT DONE||N|U|Y|3||39||CONTINUATION TREATMENT|1965-09-12||1970-08-12|||1963-01-13||1961-01-19
TRIAL STUDY 134XCP|RP|61B02780-0C99-47F8-93B2-CA839876604E|1||||||INTP|INTERPRETATION||||10^6 DNA COPIES/ML|||KHZ|NOT DONE||Y|Y|U|4||88||SCREENING|1962-09-13||1961-03-30|||1966-01-19||1970-07-10
TRIAL STUDY 134XCP|RP|61B02780-0C99-47F8-93B2-CA839876604E|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||ML/CAGE/DAY|||HR/DAY|NOT DONE||U|U|U|4||88||TREATMENT|1966-09-12||1972-10-03|||1963-11-21||1963-05-25
TRIAL STUDY 134XCP|RP|61B02780-0C99-47F8-93B2-CA839876604E|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UM2|||MHZ|NOT DONE||N|N|Y|5||7||SCREENING|1964-09-05||1965-01-28|||1966-09-15||1964-08-23
TRIAL STUDY 134XCP|RP|61B02780-0C99-47F8-93B2-CA839876604E|2||||||PREGNN|NUMBER OF PREGNANCIES||||10^3 ORGANISMS|||10^3 RNA COPIES/ML|NOT DONE||NA|N|N|5||7||FOLLOW-UP|1964-10-19||1970-03-25|||1967-07-22||1971-06-02
TRIAL STUDY 134XCP|RP|1381458A-D702-467D-ADCA-984EE7BD894D|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UG/ANIMAL|||10^3 RNA COPIES/ML|NOT DONE||Y|N|U|1||38||OBSERVATION|1972-01-08||1960-03-16|||1964-11-18||1969-10-24
TRIAL STUDY 134XCP|RP|1381458A-D702-467D-ADCA-984EE7BD894D|2||||||BCMETHOD|BIRTH CONTROL METHOD||||WATT|||10^9 ORGANISMS|NOT DONE||NA|U|Y|1||38||OBSERVATION|1963-10-26||1966-11-13|||1971-02-01||1962-08-06
TRIAL STUDY 134XCP|RP|1381458A-D702-467D-ADCA-984EE7BD894D|1||||||MENOSTAT|MENOPAUSE STATUS||||UV2|||10^9 ORGANISMS/MG|NOT DONE||NA|Y|U|2||58||BASELINE|1965-09-24||1966-01-26|||1971-10-16||1970-04-24
TRIAL STUDY 134XCP|RP|1381458A-D702-467D-ADCA-984EE7BD894D|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||10^7 TCID 50/DOSE|||CAPFUL|NOT DONE||Y|Y|Y|2||58||BASELINE|1965-11-11||1962-10-21|||1967-08-16||1965-09-17
TRIAL STUDY 134XCP|RP|1381458A-D702-467D-ADCA-984EE7BD894D|1||||||PEELIND|PEELING INDICATOR||||BOLUS|||10^3 CFU/G|NOT DONE||N|N|NA|3||39||OBSERVATION|1961-12-03||1967-06-04|||1967-12-24||1968-05-08
TRIAL STUDY 134XCP|RP|1381458A-D702-467D-ADCA-984EE7BD894D|2||||||BRTHN|NUMBER OF BIRTHS||||KCAL|||MONTHS|NOT DONE||N|U|Y|3||39||RUN-IN|1969-02-26||1969-08-14|||1965-01-01||1963-12-31
TRIAL STUDY 134XCP|RP|1381458A-D702-467D-ADCA-984EE7BD894D|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||PHERESIS UNIT|||/MS|NOT DONE||NA|N|NA|4||88||TREATMENT|1960-12-06||1973-05-05|||1968-08-06||1967-11-01
TRIAL STUDY 134XCP|RP|1381458A-D702-467D-ADCA-984EE7BD894D|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||H*%|||UG/M2/H|NOT DONE||N|N|N|4||88||SCREENING|1970-08-06||1972-01-15|||1967-03-31||1969-09-18
TRIAL STUDY 134XCP|RP|1381458A-D702-467D-ADCA-984EE7BD894D|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||L/DAY|||GBQ/G|NOT DONE||NA|U|U|5||7||BASELINE|1971-03-31||1962-03-30|||1960-02-10||1972-06-06
TRIAL STUDY 134XCP|RP|1381458A-D702-467D-ADCA-984EE7BD894D|2||||||EDEMAIND|EDEMA INDICATOR||||MEQ/L|||/KG|NOT DONE||N|U|Y|5||7||INDUCTION TREATMENT|1963-04-12||1961-05-11|||1961-08-10||1973-05-14
TRIAL STUDY 134XCP|RP|04211DA3-CFD5-4750-9D61-C91FF7BC338A|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MEQ/G|||CI/ML|NOT DONE||NA|U|NA|1||38||INDUCTION TREATMENT|1962-04-09||1965-01-10|||1965-04-18||1960-10-19
TRIAL STUDY 134XCP|RP|04211DA3-CFD5-4750-9D61-C91FF7BC338A|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||UG/DOSE|||KG/M2|NOT DONE||U|NA|N|1||38||BASELINE|1969-05-20||1968-01-22|||1968-04-18||1961-02-26
TRIAL STUDY 134XCP|RP|04211DA3-CFD5-4750-9D61-C91FF7BC338A|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||L/DAY|||UG/ANIMAL|NOT DONE||U|NA|NA|2||58||INDUCTION TREATMENT|1964-10-12||1969-12-31|||1962-07-04||1965-05-15
TRIAL STUDY 134XCP|RP|04211DA3-CFD5-4750-9D61-C91FF7BC338A|2||||||ERYTHIND|ERYTHEMA INDICATOR||||ML/100G/MIN|||ML/CM|NOT DONE||NA|Y|N|2||58||TREATMENT|1966-09-23||1963-09-25|||1973-02-01||1961-03-15
TRIAL STUDY 134XCP|RP|04211DA3-CFD5-4750-9D61-C91FF7BC338A|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||/MM|||UG/M2/MIN|NOT DONE||N|Y|N|3||39||SCREENING|1968-03-18||1960-03-31|||1968-01-03||1972-02-27
TRIAL STUDY 134XCP|RP|04211DA3-CFD5-4750-9D61-C91FF7BC338A|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^6 ORGANISMS/G|||CARTRIDGE|NOT DONE||N|Y|N|3||39||OBSERVATION|1969-04-20||1961-11-21|||1964-08-21||1967-12-18
TRIAL STUDY 134XCP|RP|04211DA3-CFD5-4750-9D61-C91FF7BC338A|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||ABSORBANCE U/MIN|||BQ/KG|NOT DONE||U|NA|N|4||88||BLINDED TREATMENT|1966-08-01||1970-03-27|||1964-03-25||1960-03-27
TRIAL STUDY 134XCP|RP|04211DA3-CFD5-4750-9D61-C91FF7BC338A|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||NSEC|||UMOL/L/H|NOT DONE||N|U|NA|4||88||LONG-TERM FOLLOW-UP|1970-06-22||1969-08-10|||1966-05-14||1969-08-18
TRIAL STUDY 134XCP|RP|04211DA3-CFD5-4750-9D61-C91FF7BC338A|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||%|||MG/DAY|NOT DONE||Y|U|U|5||7||FOLLOW-UP|1967-07-05||1964-08-18|||1968-02-01||1961-10-12
TRIAL STUDY 134XCP|RP|04211DA3-CFD5-4750-9D61-C91FF7BC338A|2||||||BRTHN|NUMBER OF BIRTHS||||FMOL/L|||LOG EID 50/DOSE|NOT DONE||Y|N|U|5||7||FOLLOW-UP|1962-05-07||1963-04-21|||1968-08-20||1971-09-04
TRIAL STUDY 134XCP|RP|EF707A48-6FAD-47C0-913A-5CBCACA539E0|1||||||FUNDHT|FUNDAL HEIGHT||||PKAT/L|||MV/SEC|NOT DONE||NA|NA|Y|1||38||OBSERVATION|1962-09-06||1965-08-13|||1967-06-10||1971-04-21
TRIAL STUDY 134XCP|RP|EF707A48-6FAD-47C0-913A-5CBCACA539E0|2||||||PREGNN|NUMBER OF PREGNANCIES||||KALLIKREIN INHIBITOR UNIT|||NMOL BCE/MMOL|NOT DONE||N|NA|NA|1||38||TREATMENT|1965-04-10||1964-06-24|||1966-04-20||1971-05-22
TRIAL STUDY 134XCP|RP|EF707A48-6FAD-47C0-913A-5CBCACA539E0|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||BAR|||FOZ_BR|NOT DONE||U|N|N|2||58||WASHOUT|1972-06-02||1960-02-02|||1964-09-18||1966-10-27
TRIAL STUDY 134XCP|RP|EF707A48-6FAD-47C0-913A-5CBCACA539E0|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MMOL/S|||NCI|NOT DONE||N|Y|N|2||58||OBSERVATION|1967-08-04||1960-04-18|||1961-07-02||1962-01-10
TRIAL STUDY 134XCP|RP|EF707A48-6FAD-47C0-913A-5CBCACA539E0|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||UMOL/DL|||UMOL/KG/MIN|NOT DONE||NA|U|NA|3||39||OPEN LABEL TREATMENT|1971-02-04||1969-12-11|||1973-02-02||1964-02-11
TRIAL STUDY 134XCP|RP|EF707A48-6FAD-47C0-913A-5CBCACA539E0|2||||||EDEMAIND|EDEMA INDICATOR||||U/L|||K|NOT DONE||Y|U|U|3||39||RUN-IN|1960-08-13||1960-01-08|||1970-06-10||1970-12-17
TRIAL STUDY 134XCP|RP|EF707A48-6FAD-47C0-913A-5CBCACA539E0|1||||||MENOSTAT|MENOPAUSE STATUS||||PUFF|||NMOL BCE/MMOL|NOT DONE||Y|U|Y|4||88||RUN-IN|1962-05-07||1963-01-01|||1966-12-15||1961-05-12
TRIAL STUDY 134XCP|RP|EF707A48-6FAD-47C0-913A-5CBCACA539E0|2||||||DSCHGIND|DISCHARGE INDICATOR||||G/CAGE|||DDU|NOT DONE||U|N|U|4||88||LONG-TERM FOLLOW-UP|1963-07-13||1972-01-21|||1960-01-12||1963-08-03
TRIAL STUDY 134XCP|RP|EF707A48-6FAD-47C0-913A-5CBCACA539E0|1||||||GRAVIND|GRAVIDA INDICATOR||||STRIP|||GY/MIN|NOT DONE||N|Y|Y|5||7||TREATMENT|1971-06-24||1968-05-25|||1969-10-06||1960-04-27
TRIAL STUDY 134XCP|RP|EF707A48-6FAD-47C0-913A-5CBCACA539E0|2||||||PEELIND|PEELING INDICATOR||||LOG10 ELISA UNIT|||U/KG/DAY|NOT DONE||U|N|NA|5||7||OBSERVATION|1961-02-11||1965-01-27|||1962-04-23||1967-04-30
TRIAL STUDY 134XCP|RP|C896767E-2418-4226-A8AE-D875DA40F9FB|1||||||GRAVIND|GRAVIDA INDICATOR||||VOXEL|||ROENTGEN|NOT DONE||N|NA|NA|1||38||WASHOUT|1962-12-09||1962-09-06|||1968-01-24||1972-01-06
TRIAL STUDY 134XCP|RP|C896767E-2418-4226-A8AE-D875DA40F9FB|2||||||FUNDHT|FUNDAL HEIGHT||||CONTAINER|||/CMH2O|NOT DONE||NA|N|U|1||38||FOLLOW-UP|1971-03-23||1973-07-25|||1961-06-16||1965-04-27
TRIAL STUDY 134XCP|RP|C896767E-2418-4226-A8AE-D875DA40F9FB|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||MASK|||TSP|NOT DONE||NA|Y|N|2||58||BLINDED TREATMENT|1965-03-23||1972-05-23|||1965-12-02||1963-04-07
TRIAL STUDY 134XCP|RP|C896767E-2418-4226-A8AE-D875DA40F9FB|2||||||STILBIND|STILLBIRTH INDICATOR||||CD/M2|||PHERESIS UNIT|NOT DONE||NA|U|Y|2||58||WASHOUT|1963-12-24||1968-07-06|||1961-06-17||1973-06-03
TRIAL STUDY 134XCP|RP|C896767E-2418-4226-A8AE-D875DA40F9FB|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||UOSM|||ML/G/H|NOT DONE||N|U|N|3||39||INDUCTION TREATMENT|1971-10-11||1972-06-08|||1971-04-13||1967-02-11
TRIAL STUDY 134XCP|RP|C896767E-2418-4226-A8AE-D875DA40F9FB|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MG/KG/H|||KIT|NOT DONE||U|Y|NA|3||39||RUN-IN|1971-05-15||1970-04-04|||1968-08-21||1972-07-21
TRIAL STUDY 134XCP|RP|C896767E-2418-4226-A8AE-D875DA40F9FB|1||||||FUNDHT|FUNDAL HEIGHT||||CIGAR|||UCI/KG|NOT DONE||Y|Y|Y|4||88||SCREENING|1961-05-31||1965-10-01|||1970-03-25||1972-09-12
TRIAL STUDY 134XCP|RP|C896767E-2418-4226-A8AE-D875DA40F9FB|2||||||MENFDUR|MENSES FLOW DURATION||||F|||M/SEC|NOT DONE||Y|Y|NA|4||88||CONTINUATION TREATMENT|1967-04-12||1968-11-08|||1967-12-26||1962-11-23
TRIAL STUDY 134XCP|RP|C896767E-2418-4226-A8AE-D875DA40F9FB|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||C|||STRIP|NOT DONE||U|NA|NA|5||7||FOLLOW-UP|1970-12-23||1970-06-22|||1964-02-08||1964-09-21
TRIAL STUDY 134XCP|RP|C896767E-2418-4226-A8AE-D875DA40F9FB|2||||||MENFDUR|MENSES FLOW DURATION||||PG/L|||NMOL/MOL|NOT DONE||NA|U|N|5||7||SCREENING|1965-12-09||1964-12-06|||1967-06-03||1968-06-08
TRIAL STUDY 134XCP|RP|666BC019-B828-4DB4-BD2F-973BA689C9E7|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||U/KG/MIN|||ENZYME U/L|NOT DONE||U|U|NA|1||38||INDUCTION TREATMENT|1962-05-26||1971-12-14|||1967-06-20||1963-10-04
TRIAL STUDY 134XCP|RP|666BC019-B828-4DB4-BD2F-973BA689C9E7|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||SPRAY|||BQ/ML|NOT DONE||NA|Y|N|1||38||CONTINUATION TREATMENT|1972-05-24||1968-01-23|||1973-01-28||1964-08-22
TRIAL STUDY 134XCP|RP|666BC019-B828-4DB4-BD2F-973BA689C9E7|1||||||PRGENDTC|DATE PREGNANCY ENDED||||FT|||SV|NOT DONE||Y|N|Y|2||58||INDUCTION TREATMENT|1960-06-10||1964-06-21|||1964-03-15||1968-09-24
TRIAL STUDY 134XCP|RP|666BC019-B828-4DB4-BD2F-973BA689C9E7|2||||||GRAVIND|GRAVIDA INDICATOR||||IU/KG/H|||YEARS|NOT DONE||NA|Y|N|2||58||OBSERVATION|1963-03-31||1963-10-07|||1972-11-26||1965-09-14
TRIAL STUDY 134XCP|RP|666BC019-B828-4DB4-BD2F-973BA689C9E7|1||||||PREGNN|NUMBER OF PREGNANCIES||||MS/MMHG|||10^7 TCID 50/DOSE|NOT DONE||N|NA|Y|3||39||BASELINE|1969-07-12||1968-04-12|||1961-01-03||1972-04-06
TRIAL STUDY 134XCP|RP|666BC019-B828-4DB4-BD2F-973BA689C9E7|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UMOL/MOL|||/5X10^4 WBC|NOT DONE||U|NA|Y|3||39||CONTINUATION TREATMENT|1964-11-04||1965-03-23|||1967-02-11||1971-02-11
TRIAL STUDY 134XCP|RP|666BC019-B828-4DB4-BD2F-973BA689C9E7|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MG/L FEU|||MMOL/MIN/KPA|NOT DONE||Y|N|NA|4||88||INDUCTION TREATMENT|1966-05-18||1960-12-13|||1972-06-20||1965-06-05
TRIAL STUDY 134XCP|RP|666BC019-B828-4DB4-BD2F-973BA689C9E7|2||||||RASHIND|RASH INDICATOR||||BQ/ML|||ANTI-XA IU/ML|NOT DONE||NA|N|Y|4||88||OPEN LABEL TREATMENT|1963-06-26||1970-12-25|||1965-09-21||1968-08-30
TRIAL STUDY 134XCP|RP|666BC019-B828-4DB4-BD2F-973BA689C9E7|1||||||ERYTHIND|ERYTHEMA INDICATOR||||SCOOPFUL|||10^6 U|NOT DONE||NA|U|U|5||7||BASELINE|1971-05-07||1972-06-07|||1962-09-13||1966-09-12
TRIAL STUDY 134XCP|RP|666BC019-B828-4DB4-BD2F-973BA689C9E7|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||CCID 50/ML|||MEQ/G|NOT DONE||U|Y|NA|5||7||FOLLOW-UP|1968-02-20||1967-06-23|||1964-04-17||1965-07-31
TRIAL STUDY 134XCP|RP|91282D87-4943-4527-8F33-27A5C153951C|1||||||MENOAGE|MENOPAUSE AGE||||ML*CMH2O|||GTT|NOT DONE||N|NA|NA|1||38||BASELINE|1961-06-10||1970-09-14|||1963-09-11||1962-10-20
TRIAL STUDY 134XCP|RP|91282D87-4943-4527-8F33-27A5C153951C|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MMOL2/L2|||ML/S|NOT DONE||Y|U|N|1||38||INDUCTION TREATMENT|1962-05-22||1972-03-26|||1968-10-22||1972-02-14
TRIAL STUDY 134XCP|RP|91282D87-4943-4527-8F33-27A5C153951C|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||BQ/KG|||MPS U|NOT DONE||N|U|Y|2||58||RUN-IN|1972-12-09||1970-12-12|||1969-10-18||1964-06-04
TRIAL STUDY 134XCP|RP|91282D87-4943-4527-8F33-27A5C153951C|2||||||DSCHGIND|DISCHARGE INDICATOR||||UG/L FEU|||JAR|NOT DONE||N|NA|NA|2||58||BLINDED TREATMENT|1969-11-18||1973-03-06|||1973-05-17||1973-05-22
TRIAL STUDY 134XCP|RP|91282D87-4943-4527-8F33-27A5C153951C|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||AMOL|||10^6/EJACULATE U|NOT DONE||U|Y|NA|3||39||OBSERVATION|1969-01-07||1962-07-06|||1966-05-31||1971-11-19
TRIAL STUDY 134XCP|RP|91282D87-4943-4527-8F33-27A5C153951C|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||YEARS|||UU/DL|NOT DONE||NA|N|N|3||39||LONG-TERM FOLLOW-UP|1966-01-30||1964-06-08|||1964-12-08||1964-02-07
TRIAL STUDY 134XCP|RP|91282D87-4943-4527-8F33-27A5C153951C|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||10^6 CFU/G|||CIGARETTE|NOT DONE||N|Y|U|4||88||BLINDED TREATMENT|1964-12-13||1960-10-17|||1967-01-03||1968-11-07
TRIAL STUDY 134XCP|RP|91282D87-4943-4527-8F33-27A5C153951C|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||G/M2|||COPIES/UG|NOT DONE||N|U|Y|4||88||FOLLOW-UP|1968-05-20||1971-06-05|||1966-02-18||1960-03-13
TRIAL STUDY 134XCP|RP|91282D87-4943-4527-8F33-27A5C153951C|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||AMOL|||BU|NOT DONE||U|N|Y|5||7||FOLLOW-UP|1963-11-11||1969-02-21|||1961-06-08||1968-06-11
TRIAL STUDY 134XCP|RP|91282D87-4943-4527-8F33-27A5C153951C|2||||||STILBIND|STILLBIRTH INDICATOR||||MM/2H|||U/ANIMAL|NOT DONE||N|N|Y|5||7||BLINDED TREATMENT|1973-04-25||1968-06-03|||1963-03-18||1960-07-16
TRIAL STUDY 134XCP|RP|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MMHG*MIN/L|||MMOL/S|NOT DONE||Y|NA|N|1||38||BLINDED TREATMENT|1960-10-02||1964-06-26|||1971-01-24||1960-10-28
TRIAL STUDY 134XCP|RP|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||MMOL|||U/10^12 RBC|NOT DONE||U|NA|N|1||38||OBSERVATION|1970-01-14||1961-09-04|||1968-06-14||1971-08-23
TRIAL STUDY 134XCP|RP|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|1||||||EDEMAIND|EDEMA INDICATOR||||MIN/DAY|||AG|NOT DONE||N|U|Y|2||58||TREATMENT|1971-02-01||1963-07-02|||1962-12-07||1970-01-31
TRIAL STUDY 134XCP|RP|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|2||||||DLVRMODE|MODE OF DELIVERY||||OD UNIT|||DPM/100MG|NOT DONE||Y|Y|N|2||58||RUN-IN|1968-06-22||1966-07-19|||1966-07-18||1963-12-22
TRIAL STUDY 134XCP|RP|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|1||||||ULCERIND|ULCER INDICATOR||||COAT|||ML/CM3/MIN|NOT DONE||NA|Y|NA|3||39||OPEN LABEL TREATMENT|1965-05-11||1969-05-30|||1966-05-21||1970-07-06
TRIAL STUDY 134XCP|RP|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||JAR|||MPL U|NOT DONE||N|NA|N|3||39||WASHOUT|1966-06-28||1965-05-28|||1965-06-19||1970-01-07
TRIAL STUDY 134XCP|RP|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|1||||||FUNDHT|FUNDAL HEIGHT||||L/S|||PNU/ML|NOT DONE||NA|Y|Y|4||88||OBSERVATION|1960-01-09||1966-10-31|||1973-06-21||1972-08-08
TRIAL STUDY 134XCP|RP|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|2||||||MASSIND|MASS INDICATOR||||UM2|||UKAT|NOT DONE||U|NA|Y|4||88||FOLLOW-UP|1963-07-15||1965-09-25|||1960-12-27||1973-04-19
TRIAL STUDY 134XCP|RP|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|1||||||ERYTHIND|ERYTHEMA INDICATOR||||HENRY|||MEQ/DL|NOT DONE||U|U|NA|5||7||LONG-TERM FOLLOW-UP|1969-04-27||1960-12-04|||1968-01-24||1973-02-03
TRIAL STUDY 134XCP|RP|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|2||||||INTP|INTERPRETATION||||CD*S/M2|||ATM|NOT DONE||U|U|Y|5||7||LONG-TERM FOLLOW-UP|1972-09-02||1960-06-06|||1964-03-18||1973-07-08
TRIAL STUDY 134XCP|RP|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|1||||||DLVRMODE|MODE OF DELIVERY||||G/CM2|||NKAT/L|NOT DONE||N|Y|NA|1||38||TREATMENT|1972-05-01||1965-04-11|||1967-04-19||1970-12-01
TRIAL STUDY 134XCP|RP|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|2||||||THICK|THICKNESS||||TITER|||NFIU|NOT DONE||NA|N|U|1||38||FOLLOW-UP|1965-02-19||1972-05-24|||1960-05-01||1965-04-05
TRIAL STUDY 134XCP|RP|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||/MM2|||ML/CAGE/WK|NOT DONE||NA|U|N|2||58||BASELINE|1967-06-30||1960-07-19|||1969-08-23||1970-02-12
TRIAL STUDY 134XCP|RP|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||/2500 WBC|||CMOL|NOT DONE||N|U|U|2||58||OPEN LABEL TREATMENT|1960-05-26||1969-04-09|||1960-07-27||1968-12-15
TRIAL STUDY 134XCP|RP|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|1||||||BCMETHOD|BIRTH CONTROL METHOD||||PMOL/G|||FT2|NOT DONE||NA|Y|N|3||39||LONG-TERM FOLLOW-UP|1966-02-11||1966-08-23|||1965-07-13||1961-12-09
TRIAL STUDY 134XCP|RP|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|2||||||PUSTIND|PUSTULE INDICATOR||||MG/KG/MIN|||DNA COPIES/UG|NOT DONE||N|NA|U|3||39||FOLLOW-UP|1965-03-15||1969-04-05|||1964-06-03||1964-12-01
TRIAL STUDY 134XCP|RP|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||ML/CM|||MMOL/S|NOT DONE||U|Y|N|4||88||BLINDED TREATMENT|1966-01-30||1960-08-02|||1963-03-18||1965-08-17
TRIAL STUDY 134XCP|RP|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MMOL/G|||MASK|NOT DONE||Y|U|NA|4||88||OBSERVATION|1972-07-24||1967-10-03|||1969-12-11||1962-12-23
TRIAL STUDY 134XCP|RP|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||U/M2/MIN|||ENZYME U/L|NOT DONE||Y|Y|Y|5||7||TREATMENT|1962-02-10||1966-07-19|||1965-12-19||1967-04-03
TRIAL STUDY 134XCP|RP|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||CARTRIDGE|||UG/KG|NOT DONE||N|NA|Y|5||7||WASHOUT|1964-06-15||1969-10-13|||1969-11-21||1961-12-16
TRIAL STUDY 134XCP|RP|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|1||||||BLISTIND|BLISTERING INDICATOR||||CI/UL|||TRACE|NOT DONE||Y|U|N|1||38||SCREENING|1973-06-02||1967-01-20|||1969-11-05||1965-12-09
TRIAL STUDY 134XCP|RP|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|2||||||INABOIND|INDUCED ABORTION INDICATOR||||LINEAR FT*LB|||MM/SEC|NOT DONE||Y|Y|NA|1||38||BLINDED TREATMENT|1962-08-16||1972-11-11|||1973-01-07||1972-11-04
TRIAL STUDY 134XCP|RP|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|1||||||PREGNN|NUMBER OF PREGNANCIES||||G/DAY|||LM|NOT DONE||U|Y|NA|2||58||CONTINUATION TREATMENT|1962-05-01||1967-01-29|||1973-04-19||1965-05-06
TRIAL STUDY 134XCP|RP|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||CM2|||ROENTGEN|NOT DONE||NA|N|NA|2||58||BLINDED TREATMENT|1967-02-07||1967-07-06|||1972-09-02||1971-07-09
TRIAL STUDY 134XCP|RP|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||NMOL BCE/NMOL|||KCAL|NOT DONE||N|U|NA|3||39||OBSERVATION|1964-08-01||1967-10-11|||1969-01-02||1964-05-25
TRIAL STUDY 134XCP|RP|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|2||||||DSCHGIND|DISCHARGE INDICATOR||||HENRY|||MEQ/MMOL|NOT DONE||NA|Y|Y|3||39||OPEN LABEL TREATMENT|1968-12-20||1966-10-12|||1968-11-18||1967-05-21
TRIAL STUDY 134XCP|RP|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||L/MIN/M2|||CGY|NOT DONE||U|N|NA|4||88||OPEN LABEL TREATMENT|1964-12-03||1971-08-30|||1964-09-04||1973-06-17
TRIAL STUDY 134XCP|RP|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||UV|||U|NOT DONE||NA|Y|Y|4||88||OPEN LABEL TREATMENT|1964-03-08||1968-02-02|||1968-05-28||1970-08-24
TRIAL STUDY 134XCP|RP|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MBQ|||ML/ANIMAL/DAY|NOT DONE||Y|Y|Y|5||7||TREATMENT|1962-02-10||1961-07-07|||1972-10-17||1961-11-10
TRIAL STUDY 134XCP|RP|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||ML/BREATH|||10^3 ORGANISMS/G|NOT DONE||NA|Y|N|5||7||LONG-TERM FOLLOW-UP|1963-10-18||1972-10-25|||1962-02-28||1971-09-30
TRIAL STUDY 134XCP|RP|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||GMFI|||ELISA UNIT/ML|NOT DONE||NA|U|U|1||38||TREATMENT|1969-05-25||1967-04-14|||1961-11-17||1972-08-26
TRIAL STUDY 134XCP|RP|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||CM/MIN|||VIAL|NOT DONE||N|N|Y|1||38||OPEN LABEL TREATMENT|1965-09-21||1963-03-16|||1972-12-04||1968-07-14
TRIAL STUDY 134XCP|RP|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||PMOL/G|||PNU/ML|NOT DONE||U|N|N|2||58||OPEN LABEL TREATMENT|1969-05-23||1964-04-14|||1962-05-07||1969-08-22
TRIAL STUDY 134XCP|RP|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||GBQ/G|||GY|NOT DONE||N|Y|N|2||58||FOLLOW-UP|1965-01-04||1966-05-12|||1968-02-04||1970-08-08
TRIAL STUDY 134XCP|RP|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||COPIES/UL|||ML/KG/H|NOT DONE||N|U|NA|3||39||SCREENING|1961-12-29||1961-12-18|||1971-06-21||1960-01-04
TRIAL STUDY 134XCP|RP|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UOSM|||10^6 CFU/ML|NOT DONE||Y|Y|U|3||39||OPEN LABEL TREATMENT|1970-11-28||1960-12-13|||1971-05-12||1960-06-21
TRIAL STUDY 134XCP|RP|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||U/M2/H|||CI/UG|NOT DONE||Y|Y|N|4||88||INDUCTION TREATMENT|1960-02-08||1971-03-03|||1960-12-17||1967-01-11
TRIAL STUDY 134XCP|RP|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MPS U|||PSEC|NOT DONE||Y|N|Y|4||88||FOLLOW-UP|1968-02-01||1962-05-27|||1960-05-08||1964-12-08
TRIAL STUDY 134XCP|RP|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|1||||||MENARAGE|MENARCHE AGE||||10^9 CFU/ML|||MHZ|NOT DONE||NA|Y|U|5||7||TREATMENT|1968-05-22||1966-02-14|||1969-03-02||1965-02-01
TRIAL STUDY 134XCP|RP|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||NGEQ/L|||UV|NOT DONE||NA|N|U|5||7||SCREENING|1963-09-27||1964-06-01|||1961-06-02||1973-05-19
TRIAL STUDY 134XCP|RP|0320460C-3770-486A-85EB-ECD133AE6EFA|1||||||ABORTN|NUMBER OF ABORTIONS||||ML/CAGE|||KG/M2|NOT DONE||U|U|Y|1||38||INDUCTION TREATMENT|1962-05-25||1966-02-17|||1969-07-01||1972-11-01
TRIAL STUDY 134XCP|RP|0320460C-3770-486A-85EB-ECD133AE6EFA|2||||||ABORTN|NUMBER OF ABORTIONS||||ML/MIN/1.73M2|||10^9 CFU/ML|NOT DONE||N|Y|N|1||38||RUN-IN|1972-11-14||1965-06-22|||1966-08-24||1967-02-17
TRIAL STUDY 134XCP|RP|0320460C-3770-486A-85EB-ECD133AE6EFA|1||||||RASHIND|RASH INDICATOR||||10^9 CFU|||ML/BREATH|NOT DONE||NA|N|N|2||58||CONTINUATION TREATMENT|1970-07-13||1969-08-11|||1970-09-01||1960-12-21
TRIAL STUDY 134XCP|RP|0320460C-3770-486A-85EB-ECD133AE6EFA|2||||||INTP|INTERPRETATION||||UCI/KG|||KG/L|NOT DONE||NA|Y|Y|2||58||FOLLOW-UP|1961-01-17||1966-11-20|||1973-04-21||1964-07-14
TRIAL STUDY 134XCP|RP|0320460C-3770-486A-85EB-ECD133AE6EFA|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||U.CARR|||CCID 50/ML|NOT DONE||U|U|U|3||39||RUN-IN|1972-05-25||1972-11-17|||1963-10-16||1972-08-01
TRIAL STUDY 134XCP|RP|0320460C-3770-486A-85EB-ECD133AE6EFA|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||10^7 TCID 50/DOSE|||MG/MIN|NOT DONE||N|NA|U|3||39||SCREENING|1968-11-15||1970-09-23|||1973-08-07||1966-09-13
TRIAL STUDY 134XCP|RP|0320460C-3770-486A-85EB-ECD133AE6EFA|1||||||MENOAGE|MENOPAUSE AGE||||MILE|||OZ EQ|NOT DONE||Y|N|NA|4||88||SCREENING|1969-12-14||1962-11-10|||1971-01-18||1967-12-08
TRIAL STUDY 134XCP|RP|0320460C-3770-486A-85EB-ECD133AE6EFA|2||||||MENOSTAT|MENOPAUSE STATUS||||U/M2/DAY|||VG/ML|NOT DONE||Y|NA|Y|4||88||RUN-IN|1964-03-11||1961-03-20|||1969-05-16||1963-12-13
TRIAL STUDY 134XCP|RP|0320460C-3770-486A-85EB-ECD133AE6EFA|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||PFU/ANIMAL|||DPM/ML|NOT DONE||Y|Y|U|5||7||OBSERVATION|1962-11-06||1965-04-22|||1965-10-12||1967-06-07
TRIAL STUDY 134XCP|RP|0320460C-3770-486A-85EB-ECD133AE6EFA|2||||||PREGNN|NUMBER OF PREGNANCIES||||UG/MOL|||U/ANIMAL|NOT DONE||Y|U|Y|5||7||TREATMENT|1964-11-16||1972-07-12|||1965-07-17||1962-01-02
TRIAL STUDY 134XCP|RP|810B0B08-9236-41EC-8879-924661FA224E|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||1/(S*KPA)|||ML/ANIMAL/WK|NOT DONE||N|N|U|1||38||FOLLOW-UP|1973-05-20||1971-11-14|||1962-01-09||1964-02-01
TRIAL STUDY 134XCP|RP|810B0B08-9236-41EC-8879-924661FA224E|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ML*CMH2O|||ML/ANIMAL|NOT DONE||N|U|U|1||38||BASELINE|1962-12-21||1969-12-11|||1971-11-24||1964-12-21
TRIAL STUDY 134XCP|RP|810B0B08-9236-41EC-8879-924661FA224E|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||AFU|||ARBITRARY U|NOT DONE||NA|N|NA|2||58||LONG-TERM FOLLOW-UP|1960-12-17||1962-11-10|||1965-07-30||1971-11-28
TRIAL STUDY 134XCP|RP|810B0B08-9236-41EC-8879-924661FA224E|2||||||DSCHGIND|DISCHARGE INDICATOR||||NG/DAY|||10^9 ORGANISMS/ML|NOT DONE||N|U|NA|2||58||OPEN LABEL TREATMENT|1969-02-12||1965-05-25|||1965-11-10||1964-08-30
TRIAL STUDY 134XCP|RP|810B0B08-9236-41EC-8879-924661FA224E|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||LOG10 PFU|||KS|NOT DONE||Y|U|U|3||39||FOLLOW-UP|1967-11-08||1966-06-22|||1963-01-21||1961-05-27
TRIAL STUDY 134XCP|RP|810B0B08-9236-41EC-8879-924661FA224E|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||PMOL/DAY|||GRAIN|NOT DONE||Y|U|N|3||39||CONTINUATION TREATMENT|1971-01-14||1961-05-26|||1962-11-03||1967-11-06
TRIAL STUDY 134XCP|RP|810B0B08-9236-41EC-8879-924661FA224E|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||KG|||UMOL/L/MIN|NOT DONE||Y|Y|U|4||88||OPEN LABEL TREATMENT|1968-08-27||1971-01-18|||1968-08-02||1966-11-18
TRIAL STUDY 134XCP|RP|810B0B08-9236-41EC-8879-924661FA224E|2||||||MENOAGE|MENOPAUSE AGE||||DPM/MG|||ML/DAY|NOT DONE||U|Y|N|4||88||LONG-TERM FOLLOW-UP|1965-12-11||1973-06-03|||1966-11-03||1967-10-04
TRIAL STUDY 134XCP|RP|810B0B08-9236-41EC-8879-924661FA224E|1||||||DSCHGIND|DISCHARGE INDICATOR||||G|||MG/MOL|NOT DONE||U|U|U|5||7||RUN-IN|1960-07-12||1960-04-03|||1973-03-23||1973-05-10
TRIAL STUDY 134XCP|RP|810B0B08-9236-41EC-8879-924661FA224E|2||||||BCMETHOD|BIRTH CONTROL METHOD||||AMOL|||ML/G/MIN|NOT DONE||U|Y|Y|5||7||SCREENING|1964-07-28||1970-05-29|||1972-03-22||1960-04-06
TRIAL STUDY 134XCP|RP|BA3B0D91-DC95-4916-8ACA-71451447BE81|1||||||PUSTIND|PUSTULE INDICATOR||||TSP EQ|||SIEMENS|NOT DONE||Y|U|U|1||38||LONG-TERM FOLLOW-UP|1973-08-11||1969-08-28|||1963-07-02||1968-07-15
TRIAL STUDY 134XCP|RP|BA3B0D91-DC95-4916-8ACA-71451447BE81|2||||||FUNDHT|FUNDAL HEIGHT||||ANTI-XA IU/ML|||GPL U|NOT DONE||Y|N|NA|1||38||INDUCTION TREATMENT|1964-10-19||1963-03-13|||1964-09-11||1966-05-02
TRIAL STUDY 134XCP|RP|BA3B0D91-DC95-4916-8ACA-71451447BE81|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||OHM|||10^6 ORGANISMS/G|NOT DONE||Y|NA|N|2||58||CONTINUATION TREATMENT|1963-12-13||1961-05-20|||1965-07-28||1971-01-22
TRIAL STUDY 134XCP|RP|BA3B0D91-DC95-4916-8ACA-71451447BE81|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||DPM/MG|||DNA COPIES/ML|NOT DONE||Y|NA|NA|2||58||WASHOUT|1964-10-20||1970-04-23|||1970-04-09||1970-11-12
TRIAL STUDY 134XCP|RP|BA3B0D91-DC95-4916-8ACA-71451447BE81|1||||||PREGIND|PREGNANT INDICATOR||||FG|||KM/H|NOT DONE||U|N|Y|3||39||TREATMENT|1970-09-22||1963-07-17|||1961-10-08||1969-11-23
TRIAL STUDY 134XCP|RP|BA3B0D91-DC95-4916-8ACA-71451447BE81|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||PIPE|||ANTI-XA IU|NOT DONE||Y|Y|U|3||39||CONTINUATION TREATMENT|1969-12-10||1969-07-18|||1971-09-16||1962-06-02
TRIAL STUDY 134XCP|RP|BA3B0D91-DC95-4916-8ACA-71451447BE81|1||||||THICK|THICKNESS||||PPM|||ML*CMH2O|NOT DONE||N|Y|Y|4||88||RUN-IN|1965-07-29||1964-10-13|||1960-05-03||1967-06-13
TRIAL STUDY 134XCP|RP|BA3B0D91-DC95-4916-8ACA-71451447BE81|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||DAYS/WK|||SQU/ML|NOT DONE||Y|Y|N|4||88||WASHOUT|1968-12-17||1973-01-27|||1964-01-11||1968-08-04
TRIAL STUDY 134XCP|RP|BA3B0D91-DC95-4916-8ACA-71451447BE81|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MPA|||NGEQ/L|NOT DONE||N|N|NA|5||7||LONG-TERM FOLLOW-UP|1972-12-16||1961-09-26|||1970-09-23||1961-03-16
TRIAL STUDY 134XCP|RP|BA3B0D91-DC95-4916-8ACA-71451447BE81|2||||||EDEMAIND|EDEMA INDICATOR||||FEU|||USP U|NOT DONE||NA|Y|NA|5||7||BLINDED TREATMENT|1961-04-05||1962-10-01|||1973-06-15||1972-08-30
TRIAL STUDY 134XCP|RP|DE385129-5FB9-43C3-9FB1-005886674C9B|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||PMOL/DAY|||MMOL/S|NOT DONE||N|Y|Y|1||38||WASHOUT|1968-09-20||1971-02-01|||1960-09-02||1971-10-15
TRIAL STUDY 134XCP|RP|DE385129-5FB9-43C3-9FB1-005886674C9B|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||SQU/ML|||AU/ML|NOT DONE||U|U|Y|1||38||BLINDED TREATMENT|1960-03-08||1970-02-22|||1969-09-15||1969-06-15
TRIAL STUDY 134XCP|RP|DE385129-5FB9-43C3-9FB1-005886674C9B|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MEQ/DL|||FOZ_US|NOT DONE||Y|NA|NA|2||58||BASELINE|1962-08-05||1969-04-03|||1970-01-11||1971-10-29
TRIAL STUDY 134XCP|RP|DE385129-5FB9-43C3-9FB1-005886674C9B|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||ARBITRARY U|||BU|NOT DONE||U|U|Y|2||58||OPEN LABEL TREATMENT|1972-02-20||1970-08-21|||1965-09-12||1969-02-27
TRIAL STUDY 134XCP|RP|DE385129-5FB9-43C3-9FB1-005886674C9B|1||||||RASHIND|RASH INDICATOR||||CMOL|||MG/KG/H|NOT DONE||U|NA|NA|3||39||BLINDED TREATMENT|1969-12-16||1960-03-03|||1970-12-25||1965-06-28
TRIAL STUDY 134XCP|RP|DE385129-5FB9-43C3-9FB1-005886674C9B|2||||||MASSIND|MASS INDICATOR||||IU/DL|||PG|NOT DONE||NA|NA|U|3||39||OBSERVATION|1960-04-13||1960-02-24|||1963-04-13||1963-09-05
TRIAL STUDY 134XCP|RP|DE385129-5FB9-43C3-9FB1-005886674C9B|1||||||ERYTHIND|ERYTHEMA INDICATOR||||TESLA|||CMOL|NOT DONE||U|U|Y|4||88||OBSERVATION|1966-05-06||1967-10-09|||1969-12-11||1968-10-21
TRIAL STUDY 134XCP|RP|DE385129-5FB9-43C3-9FB1-005886674C9B|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||COPIES/ML|||NGEQ/L|NOT DONE||N|NA|Y|4||88||WASHOUT|1963-07-28||1970-10-19|||1971-03-28||1962-02-17
TRIAL STUDY 134XCP|RP|DE385129-5FB9-43C3-9FB1-005886674C9B|1||||||STILBIND|STILLBIRTH INDICATOR||||EID 50/ML|||CUP EQ|NOT DONE||Y|U|NA|5||7||SCREENING|1967-12-17||1961-04-23|||1965-07-24||1971-05-14
TRIAL STUDY 134XCP|RP|DE385129-5FB9-43C3-9FB1-005886674C9B|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MGEQ|||PKAT|NOT DONE||N|N|NA|5||7||LONG-TERM FOLLOW-UP|1960-11-13||1963-09-15|||1960-06-12||1965-12-10
TRIAL STUDY 134XCP|RP|8AE8077F-A13C-4593-B012-213A5EBE0A1D|1||||||PUSTIND|PUSTULE INDICATOR||||SBE/ML|||BAU/ML|NOT DONE||N|NA|N|1||38||SCREENING|1971-04-18||1963-05-21|||1971-06-22||1963-03-05
TRIAL STUDY 134XCP|RP|8AE8077F-A13C-4593-B012-213A5EBE0A1D|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||CM|||KG/CM|NOT DONE||Y|NA|Y|1||38||WASHOUT|1964-09-05||1972-06-06|||1972-03-22||1962-12-26
TRIAL STUDY 134XCP|RP|8AE8077F-A13C-4593-B012-213A5EBE0A1D|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||/CMH2O|||UM/S|NOT DONE||NA|N|NA|2||58||OPEN LABEL TREATMENT|1972-05-13||1962-12-22|||1968-05-31||1971-11-18
TRIAL STUDY 134XCP|RP|8AE8077F-A13C-4593-B012-213A5EBE0A1D|2||||||TNDRIND|TENDERNESS INDICATOR||||NKAT/L|||UMOL/L|NOT DONE||N|NA|U|2||58||TREATMENT|1961-08-22||1972-07-22|||1967-11-30||1971-08-22
TRIAL STUDY 134XCP|RP|8AE8077F-A13C-4593-B012-213A5EBE0A1D|1||||||PREGST|PREGNANT DURING THE STUDY||||U/G/MIN|||ABSORBANCE U|NOT DONE||Y|N|U|3||39||SCREENING|1972-12-05||1964-06-27|||1971-05-27||1961-12-04
TRIAL STUDY 134XCP|RP|8AE8077F-A13C-4593-B012-213A5EBE0A1D|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||BQ/G|||U/CL|NOT DONE||NA|NA|U|3||39||CONTINUATION TREATMENT|1968-01-11||1960-02-07|||1969-02-14||1966-04-24
TRIAL STUDY 134XCP|RP|8AE8077F-A13C-4593-B012-213A5EBE0A1D|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||PHERESIS UNIT|||100 IU/ML|NOT DONE||U|U|NA|4||88||LONG-TERM FOLLOW-UP|1969-09-01||1962-06-06|||1971-12-07||1971-11-15
TRIAL STUDY 134XCP|RP|8AE8077F-A13C-4593-B012-213A5EBE0A1D|2||||||BCMETHOD|BIRTH CONTROL METHOD||||ENZYME U/L|||MIN*MG/ML|NOT DONE||Y|Y|Y|4||88||TREATMENT|1962-07-18||1967-04-29|||1962-03-21||1969-04-12
TRIAL STUDY 134XCP|RP|8AE8077F-A13C-4593-B012-213A5EBE0A1D|1||||||BCMETHOD|BIRTH CONTROL METHOD||||BAG|||ML/BEAT|NOT DONE||U|U|U|5||7||INDUCTION TREATMENT|1967-07-03||1969-01-09|||1968-01-02||1963-08-26
TRIAL STUDY 134XCP|RP|8AE8077F-A13C-4593-B012-213A5EBE0A1D|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||U/KG/H|||ML/DOSE|NOT DONE||Y|Y|N|5||7||OBSERVATION|1960-10-18||1962-08-23|||1966-06-15||1966-11-14
TRIAL STUDY 134XCP|RP|72FCE18B-B3D6-45AC-993F-9883E4D11313|1||||||MASSIND|MASS INDICATOR||||CI/ML|||10^6 ORGANISMS/MG|NOT DONE||NA|NA|U|1||38||INDUCTION TREATMENT|1966-11-02||1972-01-01|||1962-06-15||1963-01-18
TRIAL STUDY 134XCP|RP|72FCE18B-B3D6-45AC-993F-9883E4D11313|2||||||PUSTIND|PUSTULE INDICATOR||||ML/CM|||NMOL/DAY|NOT DONE||Y|U|N|1||38||OPEN LABEL TREATMENT|1961-09-20||1969-04-01|||1968-01-09||1969-09-30
TRIAL STUDY 134XCP|RP|72FCE18B-B3D6-45AC-993F-9883E4D11313|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||SIEMENS|||10^5/HPF|NOT DONE||N|U|Y|2||58||INDUCTION TREATMENT|1964-11-09||1972-09-09|||1967-01-20||1964-09-08
TRIAL STUDY 134XCP|RP|72FCE18B-B3D6-45AC-993F-9883E4D11313|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||1/(S*KPA)|||OZ EQ|NOT DONE||U|Y|U|2||58||BLINDED TREATMENT|1960-02-20||1963-09-28|||1965-05-13||1963-10-03
TRIAL STUDY 134XCP|RP|72FCE18B-B3D6-45AC-993F-9883E4D11313|1||||||PEELIND|PEELING INDICATOR||||10^9/DOSE|||ABSORBANCE U/MIN|NOT DONE||U|U|N|3||39||FOLLOW-UP|1964-02-18||1961-06-22|||1971-11-19||1970-11-19
TRIAL STUDY 134XCP|RP|72FCE18B-B3D6-45AC-993F-9883E4D11313|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||CMH2O*S/ML|||BREATHS/30S|NOT DONE||U|Y|NA|3||39||RUN-IN|1964-08-21||1967-01-27|||1965-06-04||1966-07-08
TRIAL STUDY 134XCP|RP|72FCE18B-B3D6-45AC-993F-9883E4D11313|1||||||FUNDHT|FUNDAL HEIGHT||||OSM|||UG/MOL|NOT DONE||U|NA|Y|4||88||BLINDED TREATMENT|1960-04-24||1971-07-25|||1970-12-05||1966-04-11
TRIAL STUDY 134XCP|RP|72FCE18B-B3D6-45AC-993F-9883E4D11313|2||||||BRTHN|NUMBER OF BIRTHS||||NFIU|||MG/MIN|NOT DONE||Y|N|U|4||88||RUN-IN|1962-02-19||1968-09-25|||1967-01-24||1962-03-31
TRIAL STUDY 134XCP|RP|72FCE18B-B3D6-45AC-993F-9883E4D11313|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||DAGU/ML|||G/DL|NOT DONE||NA|Y|N|5||7||FOLLOW-UP|1967-06-28||1961-05-23|||1968-06-01||1960-08-28
TRIAL STUDY 134XCP|RP|72FCE18B-B3D6-45AC-993F-9883E4D11313|2||||||THICK|THICKNESS||||10^11/L|||PACK YEAR|NOT DONE||Y|N|U|5||7||TREATMENT|1962-08-07||1968-02-23|||1971-01-18||1965-05-19
TRIAL STUDY 134XCP|RP|1123F894-0821-41DF-9C28-ED6BC4A7098C|1||||||BLISTIND|BLISTERING INDICATOR||||NL|||ANTI-XA IU|NOT DONE||U|NA|N|1||38||TREATMENT|1970-07-06||1970-07-25|||1961-11-07||1965-10-15
TRIAL STUDY 134XCP|RP|1123F894-0821-41DF-9C28-ED6BC4A7098C|2||||||ULCERIND|ULCER INDICATOR||||KG/M2|||MG/L|NOT DONE||U|U|Y|1||38||FOLLOW-UP|1971-01-27||1964-03-01|||1972-02-10||1969-04-13
TRIAL STUDY 134XCP|RP|1123F894-0821-41DF-9C28-ED6BC4A7098C|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MEQ/L|||U/10^12 RBC|NOT DONE||NA|U|Y|2||58||OPEN LABEL TREATMENT|1972-09-02||1962-10-04|||1966-04-17||1972-09-25
TRIAL STUDY 134XCP|RP|1123F894-0821-41DF-9C28-ED6BC4A7098C|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ML/S/M2|||TSP EQ|NOT DONE||N|U|NA|2||58||BASELINE|1961-09-15||1973-07-06|||1971-07-01||1965-04-24
TRIAL STUDY 134XCP|RP|1123F894-0821-41DF-9C28-ED6BC4A7098C|1||||||DLVRMODE|MODE OF DELIVERY||||MV*MIN|||ENZYME U/L|NOT DONE||N|N|NA|3||39||OPEN LABEL TREATMENT|1971-10-12||1964-07-11|||1968-05-28||1965-12-22
TRIAL STUDY 134XCP|RP|1123F894-0821-41DF-9C28-ED6BC4A7098C|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||U/10^12 RBC|||ML/M2/MIN|NOT DONE||Y|U|NA|3||39||TREATMENT|1973-02-21||1969-03-24|||1972-08-10||1968-03-04
TRIAL STUDY 134XCP|RP|1123F894-0821-41DF-9C28-ED6BC4A7098C|1||||||FUNDHT|FUNDAL HEIGHT||||UIU/L|||UG/L DDU|NOT DONE||N|N|N|4||88||CONTINUATION TREATMENT|1967-11-23||1970-09-24|||1972-02-13||1972-09-17
TRIAL STUDY 134XCP|RP|1123F894-0821-41DF-9C28-ED6BC4A7098C|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||NMOL/MOL|||PMOL/L/H|NOT DONE||N|NA|NA|4||88||FOLLOW-UP|1970-06-12||1967-02-16|||1966-03-11||1970-04-05
TRIAL STUDY 134XCP|RP|1123F894-0821-41DF-9C28-ED6BC4A7098C|1||||||MENARAGE|MENARCHE AGE||||CYLINDER|||LOG10 TCID 50/ML|NOT DONE||NA|NA|Y|5||7||OBSERVATION|1970-10-06||1964-04-01|||1970-06-03||1969-06-05
TRIAL STUDY 134XCP|RP|1123F894-0821-41DF-9C28-ED6BC4A7098C|2||||||PEELIND|PEELING INDICATOR||||UU/DL|||OD UNIT|NOT DONE||N|Y|N|5||7||SCREENING|1962-08-22||1973-02-07|||1960-03-17||1965-05-23
TRIAL STUDY 134XCP|RP|42DD827A-E788-4E61-8E9F-421136A16166|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MBQ/UL|||FMOL/L|NOT DONE||N|U|U|1||38||CONTINUATION TREATMENT|1960-11-02||1967-10-07|||1968-10-16||1969-03-22
TRIAL STUDY 134XCP|RP|42DD827A-E788-4E61-8E9F-421136A16166|2||||||TNDRIND|TENDERNESS INDICATOR||||NKAT/G HB|||NMOL BCE/L|NOT DONE||N|N|U|1||38||RUN-IN|1963-10-22||1964-04-24|||1969-04-14||1972-01-01
TRIAL STUDY 134XCP|RP|42DD827A-E788-4E61-8E9F-421136A16166|1||||||TNDRIND|TENDERNESS INDICATOR||||/2500 WBC|||QUANTITY SUFFICIENT|NOT DONE||Y|U|U|2||58||OPEN LABEL TREATMENT|1972-05-06||1973-08-01|||1967-10-23||1967-06-12
TRIAL STUDY 134XCP|RP|42DD827A-E788-4E61-8E9F-421136A16166|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||LOG10 ELISA UNIT/DOSE|||MMOL/MIN/KPA/L|NOT DONE||U|NA|U|2||58||BLINDED TREATMENT|1967-04-30||1968-09-27|||1966-10-22||1969-01-27
TRIAL STUDY 134XCP|RP|42DD827A-E788-4E61-8E9F-421136A16166|1||||||TNDRIND|TENDERNESS INDICATOR||||DNA COPIES/ML|||MET|NOT DONE||N|Y|NA|3||39||BLINDED TREATMENT|1961-01-28||1963-06-19|||1968-06-12||1966-03-17
TRIAL STUDY 134XCP|RP|42DD827A-E788-4E61-8E9F-421136A16166|2||||||ABORTN|NUMBER OF ABORTIONS||||V/V|||G/DL|NOT DONE||U|N|NA|3||39||LONG-TERM FOLLOW-UP|1969-07-30||1963-07-20|||1961-11-18||1960-11-21
TRIAL STUDY 134XCP|RP|42DD827A-E788-4E61-8E9F-421136A16166|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||U/DL|||U/KG/MIN|NOT DONE||NA|Y|Y|4||88||FOLLOW-UP|1967-03-06||1973-03-23|||1970-11-01||1969-07-18
TRIAL STUDY 134XCP|RP|42DD827A-E788-4E61-8E9F-421136A16166|2||||||STILBIND|STILLBIRTH INDICATOR||||DAGU|||KUSP|NOT DONE||N|Y|NA|4||88||SCREENING|1972-10-29||1971-07-01|||1964-10-18||1961-06-21
TRIAL STUDY 134XCP|RP|42DD827A-E788-4E61-8E9F-421136A16166|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MET*H|||LOZENGE|NOT DONE||NA|N|U|5||7||TREATMENT|1962-11-03||1970-09-30|||1969-07-25||1963-03-30
TRIAL STUDY 134XCP|RP|42DD827A-E788-4E61-8E9F-421136A16166|2||||||BRTHN|NUMBER OF BIRTHS||||PT_US|||10^6 CFU|NOT DONE||NA|NA|N|5||7||RUN-IN|1963-10-13||1967-11-02|||1964-11-24||1967-01-20
TRIAL STUDY 134XCP|RP|CC1E2338-4454-4CBA-8848-0B994C459F05|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||INHALATION|||FG|NOT DONE||NA|NA|Y|1||38||OPEN LABEL TREATMENT|1965-04-03||1971-09-08|||1963-12-30||1965-10-21
TRIAL STUDY 134XCP|RP|CC1E2338-4454-4CBA-8848-0B994C459F05|2||||||STILBIND|STILLBIRTH INDICATOR||||ML/H|||/HPF|NOT DONE||U|Y|Y|1||38||LONG-TERM FOLLOW-UP|1971-10-12||1964-01-23|||1960-05-17||1960-04-30
TRIAL STUDY 134XCP|RP|CC1E2338-4454-4CBA-8848-0B994C459F05|1||||||ERYTHIND|ERYTHEMA INDICATOR||||GPELISA UNIT/ML|||DL|NOT DONE||Y|U|Y|2||58||CONTINUATION TREATMENT|1966-07-06||1970-02-14|||1966-09-15||1961-07-04
TRIAL STUDY 134XCP|RP|CC1E2338-4454-4CBA-8848-0B994C459F05|2||||||MENOAGE|MENOPAUSE AGE||||UMOL/L|||ML|NOT DONE||NA|N|U|2||58||SCREENING|1960-05-15||1971-11-03|||1963-07-26||1968-05-02
TRIAL STUDY 134XCP|RP|CC1E2338-4454-4CBA-8848-0B994C459F05|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UCI/L|||S*KPA|NOT DONE||NA|N|Y|3||39||BASELINE|1971-12-27||1972-12-11|||1969-02-16||1972-08-07
TRIAL STUDY 134XCP|RP|CC1E2338-4454-4CBA-8848-0B994C459F05|2||||||EDEMAIND|EDEMA INDICATOR||||UMOL/L/MIN|||100 IU/ML|NOT DONE||NA|NA|U|3||39||LONG-TERM FOLLOW-UP|1961-01-09||1960-10-30|||1967-02-03||1968-08-02
TRIAL STUDY 134XCP|RP|CC1E2338-4454-4CBA-8848-0B994C459F05|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||PSI|||U/M2/H|NOT DONE||N|Y|N|4||88||WASHOUT|1968-12-23||1972-12-17|||1961-05-16||1971-02-22
TRIAL STUDY 134XCP|RP|CC1E2338-4454-4CBA-8848-0B994C459F05|2||||||MASSIND|MASS INDICATOR||||IU/DL|||SBE/ML|NOT DONE||NA|U|Y|4||88||INDUCTION TREATMENT|1961-08-05||1971-09-11|||1966-07-19||1971-05-28
TRIAL STUDY 134XCP|RP|CC1E2338-4454-4CBA-8848-0B994C459F05|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||PHERESIS UNIT|||C|NOT DONE||Y|NA|Y|5||7||SCREENING|1970-03-31||1968-12-28|||1964-07-11||1967-10-30
TRIAL STUDY 134XCP|RP|CC1E2338-4454-4CBA-8848-0B994C459F05|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||PHERESIS UNIT|||CG|NOT DONE||U|U|U|5||7||WASHOUT|1968-09-21||1963-09-10|||1960-07-21||1973-05-20
TRIAL STUDY 134XCP|RP|ED04E60D-256A-4DB9-9290-4EFD0602A130|1||||||MENOSTAT|MENOPAUSE STATUS||||MET*H|||M/SEC|NOT DONE||U|NA|U|1||38||FOLLOW-UP|1970-07-04||1960-02-26|||1973-06-03||1967-10-18
TRIAL STUDY 134XCP|RP|ED04E60D-256A-4DB9-9290-4EFD0602A130|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||RATIO|||MOL/MOL|NOT DONE||Y|U|N|1||38||WASHOUT|1969-06-28||1970-04-23|||1968-04-18||1967-06-01
TRIAL STUDY 134XCP|RP|ED04E60D-256A-4DB9-9290-4EFD0602A130|1||||||MENOAGE|MENOPAUSE AGE||||LOG10 CFU/G|||CMHG|NOT DONE||NA|NA|U|2||58||BASELINE|1966-05-14||1964-10-02|||1960-05-16||1965-11-07
TRIAL STUDY 134XCP|RP|ED04E60D-256A-4DB9-9290-4EFD0602A130|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||UM|||BQ/MG|NOT DONE||N|U|N|2||58||SCREENING|1968-02-19||1971-09-03|||1966-10-07||1972-03-28
TRIAL STUDY 134XCP|RP|ED04E60D-256A-4DB9-9290-4EFD0602A130|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||UL/DOSE|||GENEQ/ML|NOT DONE||U|N|Y|3||39||LONG-TERM FOLLOW-UP|1968-04-26||1969-01-29|||1971-10-21||1973-04-08
TRIAL STUDY 134XCP|RP|ED04E60D-256A-4DB9-9290-4EFD0602A130|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||10^3 ORGANISMS/G|||MBP|NOT DONE||NA|U|N|3||39||INDUCTION TREATMENT|1967-10-21||1963-06-09|||1972-07-21||1971-07-24
TRIAL STUDY 134XCP|RP|ED04E60D-256A-4DB9-9290-4EFD0602A130|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||UL/DOSE|||PT_US|NOT DONE||U|NA|U|4||88||OPEN LABEL TREATMENT|1966-12-08||1971-06-23|||1968-02-26||1967-02-10
TRIAL STUDY 134XCP|RP|ED04E60D-256A-4DB9-9290-4EFD0602A130|2||||||PUSTIND|PUSTULE INDICATOR||||ML/G/H|||10^6/G|NOT DONE||U|U|Y|4||88||INDUCTION TREATMENT|1973-01-06||1968-06-15|||1969-10-03||1960-10-28
TRIAL STUDY 134XCP|RP|ED04E60D-256A-4DB9-9290-4EFD0602A130|1||||||TNDRIND|TENDERNESS INDICATOR||||AMP|||MEQ/UG|NOT DONE||Y|N|Y|5||7||CONTINUATION TREATMENT|1971-01-07||1960-12-30|||1972-06-19||1965-07-07
TRIAL STUDY 134XCP|RP|ED04E60D-256A-4DB9-9290-4EFD0602A130|2||||||PREGST|PREGNANT DURING THE STUDY||||G/KG|||UG|NOT DONE||Y|N|U|5||7||FOLLOW-UP|1964-04-22||1961-06-17|||1967-03-26||1966-09-04
TRIAL STUDY 134XCP|RP|C70F82F6-3280-429D-9657-CDFBA6B7F626|1||||||PRGENDTC|DATE PREGNANCY ENDED||||LX|||UL/KG/DAY|NOT DONE||N|U|N|1||38||INDUCTION TREATMENT|1969-01-03||1965-12-22|||1965-06-19||1970-11-03
TRIAL STUDY 134XCP|RP|C70F82F6-3280-429D-9657-CDFBA6B7F626|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||VP/ML|||G/DL|NOT DONE||Y|N|Y|1||38||FOLLOW-UP|1965-08-14||1967-07-13|||1971-05-30||1962-08-09
TRIAL STUDY 134XCP|RP|C70F82F6-3280-429D-9657-CDFBA6B7F626|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MET*H|||UM2|NOT DONE||NA|N|Y|2||58||SCREENING|1965-08-27||1969-02-10|||1961-08-13||1972-04-05
TRIAL STUDY 134XCP|RP|C70F82F6-3280-429D-9657-CDFBA6B7F626|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||ML/ANIMAL/DAY|||ML/CM3/MIN|NOT DONE||Y|U|N|2||58||OBSERVATION|1968-07-06||1967-06-20|||1969-07-05||1960-07-31
TRIAL STUDY 134XCP|RP|C70F82F6-3280-429D-9657-CDFBA6B7F626|1||||||PUSTIND|PUSTULE INDICATOR||||M|||/200 HPFS|NOT DONE||Y|N|NA|3||39||RUN-IN|1961-03-18||1962-07-22|||1964-06-05||1970-05-13
TRIAL STUDY 134XCP|RP|C70F82F6-3280-429D-9657-CDFBA6B7F626|2||||||STILBIND|STILLBIRTH INDICATOR||||AU/ML|||ML/DL|NOT DONE||N|NA|N|3||39||INDUCTION TREATMENT|1962-12-29||1973-08-09|||1969-10-06||1967-09-16
TRIAL STUDY 134XCP|RP|C70F82F6-3280-429D-9657-CDFBA6B7F626|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||% INHIBITION|||PACK|NOT DONE||Y|U|Y|4||88||FOLLOW-UP|1966-07-30||1970-03-08|||1962-11-12||1969-03-25
TRIAL STUDY 134XCP|RP|C70F82F6-3280-429D-9657-CDFBA6B7F626|2||||||PEELIND|PEELING INDICATOR||||/MM2|||DIOPTER|NOT DONE||N|Y|Y|4||88||RUN-IN|1969-08-12||1963-06-30|||1963-04-19||1962-06-29
TRIAL STUDY 134XCP|RP|C70F82F6-3280-429D-9657-CDFBA6B7F626|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||G/M2/DAY|||APL U/ML|NOT DONE||NA|U|N|5||7||BLINDED TREATMENT|1969-02-23||1970-04-19|||1969-06-07||1971-12-31
TRIAL STUDY 134XCP|RP|C70F82F6-3280-429D-9657-CDFBA6B7F626|2||||||INTP|INTERPRETATION||||V/SEC|||UL|NOT DONE||Y|N|Y|5||7||FOLLOW-UP|1962-05-15||1970-09-30|||1971-03-19||1973-06-13
TRIAL STUDY 134XCP|RP|D735D137-2C27-4F27-BA18-9A0F7FF0B145|1||||||PUSTIND|PUSTULE INDICATOR||||UL/DOSE|||MG|NOT DONE||NA|N|U|1||38||SCREENING|1964-04-19||1972-06-02|||1961-03-20||1965-03-05
TRIAL STUDY 134XCP|RP|D735D137-2C27-4F27-BA18-9A0F7FF0B145|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||CY/CM|||ML/SEC/1.73M2|NOT DONE||Y|U|U|1||38||TREATMENT|1968-05-04||1965-11-16|||1971-09-04||1973-04-01
TRIAL STUDY 134XCP|RP|D735D137-2C27-4F27-BA18-9A0F7FF0B145|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||ML/H|||ML/M2|NOT DONE||U|U|Y|2||58||SCREENING|1968-07-03||1969-08-13|||1964-08-04||1961-02-20
TRIAL STUDY 134XCP|RP|D735D137-2C27-4F27-BA18-9A0F7FF0B145|2||||||PRGENDTC|DATE PREGNANCY ENDED||||MG/KG/MIN|||ANTIBODY UNIT|NOT DONE||U|NA|Y|2||58||LONG-TERM FOLLOW-UP|1963-12-31||1960-06-04|||1960-08-22||1973-04-02
TRIAL STUDY 134XCP|RP|D735D137-2C27-4F27-BA18-9A0F7FF0B145|1||||||MENOSTAT|MENOPAUSE STATUS||||FOZ_US|||EQ|NOT DONE||Y|N|NA|3||39||TREATMENT|1969-01-01||1969-07-23|||1963-04-22||1963-12-26
TRIAL STUDY 134XCP|RP|D735D137-2C27-4F27-BA18-9A0F7FF0B145|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||DAGU|||VG/KG|NOT DONE||NA|N|U|3||39||WASHOUT|1970-09-05||1965-04-23|||1969-10-05||1972-05-01
TRIAL STUDY 134XCP|RP|D735D137-2C27-4F27-BA18-9A0F7FF0B145|1||||||EDEMAIND|EDEMA INDICATOR||||JDF UNIT|||G/ANIMAL/WK|NOT DONE||N|U|U|4||88||CONTINUATION TREATMENT|1968-02-21||1961-02-25|||1963-10-23||1964-08-30
TRIAL STUDY 134XCP|RP|D735D137-2C27-4F27-BA18-9A0F7FF0B145|2||||||MENOAGE|MENOPAUSE AGE||||MMOL/L|||NMOL/L/H|NOT DONE||Y|U|NA|4||88||CONTINUATION TREATMENT|1961-07-07||1965-06-23|||1972-10-03||1963-12-01
TRIAL STUDY 134XCP|RP|D735D137-2C27-4F27-BA18-9A0F7FF0B145|1||||||MENOSTAT|MENOPAUSE STATUS||||DPM/ML|||ML/MIN|NOT DONE||N|N|U|5||7||BLINDED TREATMENT|1968-10-02||1961-10-18|||1960-12-17||1968-12-04
TRIAL STUDY 134XCP|RP|D735D137-2C27-4F27-BA18-9A0F7FF0B145|2||||||MENARAGE|MENARCHE AGE||||USEC|||OSM|NOT DONE||U|NA|Y|5||7||BASELINE|1966-05-21||1970-10-20|||1966-12-25||1965-07-04
TRIAL STUDY 134XCP|RP|B00194E0-0E85-46DD-86C3-CD9048535986|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UGEQ|||NKAT/L|NOT DONE||Y|N|Y|1||38||WASHOUT|1973-07-04||1973-08-26|||1962-06-12||1969-10-24
TRIAL STUDY 134XCP|RP|B00194E0-0E85-46DD-86C3-CD9048535986|2||||||TNDRIND|TENDERNESS INDICATOR||||AMPULE|||IN|NOT DONE||N|N|Y|1||38||INDUCTION TREATMENT|1971-12-26||1963-06-27|||1966-02-26||1972-03-25
TRIAL STUDY 134XCP|RP|B00194E0-0E85-46DD-86C3-CD9048535986|1||||||ERYTHIND|ERYTHEMA INDICATOR||||10^3 ORGANISMS/G|||ML/BEAT|NOT DONE||N|N|N|2||58||TREATMENT|1968-05-04||1961-05-10|||1962-12-03||1971-03-25
TRIAL STUDY 134XCP|RP|B00194E0-0E85-46DD-86C3-CD9048535986|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||TUBERCULIN UNIT/ML|||BOWL|NOT DONE||Y|Y|Y|2||58||WASHOUT|1964-05-22||1965-02-10|||1971-10-05||1965-11-21
TRIAL STUDY 134XCP|RP|B00194E0-0E85-46DD-86C3-CD9048535986|1||||||INABOIND|INDUCED ABORTION INDICATOR||||UU/DL|||CMOL|NOT DONE||Y|Y|NA|3||39||BLINDED TREATMENT|1962-12-02||1964-04-25|||1967-08-05||1969-07-22
TRIAL STUDY 134XCP|RP|B00194E0-0E85-46DD-86C3-CD9048535986|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||SPRAY|||TITER|NOT DONE||N|U|U|3||39||SCREENING|1960-05-16||1965-09-13|||1965-08-12||1970-09-05
TRIAL STUDY 134XCP|RP|B00194E0-0E85-46DD-86C3-CD9048535986|1||||||EDEMAIND|EDEMA INDICATOR||||JDF UNIT|||SYRINGE|NOT DONE||Y|N|NA|4||88||FOLLOW-UP|1962-08-18||1960-04-14|||1963-10-13||1964-01-21
TRIAL STUDY 134XCP|RP|B00194E0-0E85-46DD-86C3-CD9048535986|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||ML/CM|||SCM|NOT DONE||NA|U|N|4||88||RUN-IN|1960-12-11||1971-09-26|||1973-04-03||1961-10-21
TRIAL STUDY 134XCP|RP|B00194E0-0E85-46DD-86C3-CD9048535986|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||ML*CMH2O|||PMOL/10^10 CELLS|NOT DONE||Y|N|U|5||7||OPEN LABEL TREATMENT|1969-10-07||1970-02-06|||1972-09-19||1963-08-17
TRIAL STUDY 134XCP|RP|B00194E0-0E85-46DD-86C3-CD9048535986|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MIN/DAY|||JOULE|NOT DONE||Y|NA|U|5||7||CONTINUATION TREATMENT|1965-04-09||1972-11-11|||1961-04-16||1962-06-24
TRIAL STUDY 134XCP|RP|B4F372E9-C461-414A-95B4-93CA0221D396|1||||||EDEMAIND|EDEMA INDICATOR||||10^6 ORGANISMS/MG|||SFC/10^6 PBMC|NOT DONE||U|U|N|1||38||WASHOUT|1966-09-02||1964-01-09|||1962-01-08||1963-08-01
TRIAL STUDY 134XCP|RP|B4F372E9-C461-414A-95B4-93CA0221D396|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||S^-1(%O2)^-1|||10^6 ORGANISMS/MG|NOT DONE||NA|U|U|1||38||SCREENING|1965-01-14||1970-08-29|||1971-03-26||1966-02-16
TRIAL STUDY 134XCP|RP|B4F372E9-C461-414A-95B4-93CA0221D396|1||||||ULCERIND|ULCER INDICATOR||||GPL U/ML|||MIN/DAY|NOT DONE||NA|NA|NA|2||58||FOLLOW-UP|1963-10-08||1970-05-08|||1972-11-04||1961-09-22
TRIAL STUDY 134XCP|RP|B4F372E9-C461-414A-95B4-93CA0221D396|2||||||TNDRIND|TENDERNESS INDICATOR||||MU/L|||G/M2/DAY|NOT DONE||U|U|NA|2||58||CONTINUATION TREATMENT|1961-03-06||1966-05-02|||1962-05-25||1969-08-23
TRIAL STUDY 134XCP|RP|B4F372E9-C461-414A-95B4-93CA0221D396|1||||||PUSTIND|PUSTULE INDICATOR||||DPM/MG|||MMAL|NOT DONE||NA|N|N|3||39||OPEN LABEL TREATMENT|1963-07-25||1969-09-15|||1973-06-06||1968-09-03
TRIAL STUDY 134XCP|RP|B4F372E9-C461-414A-95B4-93CA0221D396|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||10^12/L|||ML/DAY|NOT DONE||N|NA|N|3||39||BASELINE|1963-06-23||1963-04-07|||1965-05-04||1973-07-02
TRIAL STUDY 134XCP|RP|B4F372E9-C461-414A-95B4-93CA0221D396|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||HENRY|||YEARS|NOT DONE||Y|Y|NA|4||88||BASELINE|1973-08-05||1972-08-12|||1971-10-19||1971-10-29
TRIAL STUDY 134XCP|RP|B4F372E9-C461-414A-95B4-93CA0221D396|2||||||RASHIND|RASH INDICATOR||||MOL/G|||L/S/KPA|NOT DONE||NA|U|Y|4||88||BASELINE|1969-11-14||1968-03-13|||1972-02-25||1964-05-09
TRIAL STUDY 134XCP|RP|B4F372E9-C461-414A-95B4-93CA0221D396|1||||||PEELIND|PEELING INDICATOR||||MM3/MM2/YEAR|||MJOULE/CM2|NOT DONE||NA|U|N|5||7||OPEN LABEL TREATMENT|1967-05-04||1971-12-18|||1970-02-12||1969-02-14
TRIAL STUDY 134XCP|RP|B4F372E9-C461-414A-95B4-93CA0221D396|2||||||STILBIND|STILLBIRTH INDICATOR||||BREATHS/MIN|||MEQ/DL|NOT DONE||NA|NA|Y|5||7||CONTINUATION TREATMENT|1964-07-28||1964-04-23|||1973-01-13||1973-08-24
TRIAL STUDY 134XCP|RP|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|1||||||MENARAGE|MENARCHE AGE||||MM3/MM2/YEAR|||CAPFUL|NOT DONE||N|U|Y|1||38||FOLLOW-UP|1968-08-14||1961-12-30|||1964-10-03||1969-09-16
TRIAL STUDY 134XCP|RP|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||PATCH|||DAGU|NOT DONE||N|Y|NA|1||38||LONG-TERM FOLLOW-UP|1972-04-08||1963-02-02|||1971-04-22||1962-09-20
TRIAL STUDY 134XCP|RP|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|1||||||TNDRIND|TENDERNESS INDICATOR||||UL|||UG/MOL|NOT DONE||Y|U|U|2||58||CONTINUATION TREATMENT|1962-02-03||1972-02-25|||1970-02-10||1962-02-15
TRIAL STUDY 134XCP|RP|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||EQ|||KIU|NOT DONE||Y|U|Y|2||58||BLINDED TREATMENT|1971-11-27||1962-11-08|||1964-12-21||1972-10-15
TRIAL STUDY 134XCP|RP|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|1||||||PREGIND|PREGNANT INDICATOR||||ELISA UNIT|||PT_US|NOT DONE||U|U|U|3||39||OBSERVATION|1964-04-13||1966-10-11|||1970-09-02||1960-08-28
TRIAL STUDY 134XCP|RP|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||/100 WBC|||WEBER|NOT DONE||U|NA|N|3||39||RUN-IN|1965-02-10||1967-01-23|||1965-11-28||1961-03-13
TRIAL STUDY 134XCP|RP|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MU/L|||NMOL/MOL|NOT DONE||NA|NA|Y|4||88||OBSERVATION|1973-07-09||1968-08-19|||1968-05-07||1968-05-17
TRIAL STUDY 134XCP|RP|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||NMOL BCE/L|||FT2|NOT DONE||NA|N|NA|4||88||BLINDED TREATMENT|1972-10-30||1965-10-02|||1960-05-09||1967-12-23
TRIAL STUDY 134XCP|RP|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||FRAMES/S|||DAGU|NOT DONE||N|N|N|5||7||FOLLOW-UP|1973-04-30||1960-11-25|||1966-07-26||1971-07-25
TRIAL STUDY 134XCP|RP|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MET*H|||LOG10 TCID 50/ML|NOT DONE||Y|Y|U|5||7||OBSERVATION|1971-07-19||1964-12-07|||1967-07-22||1961-04-18
TRIAL STUDY 134XCP|RP|E43169E4-8B57-47D7-9C91-D42E40DD579B|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||10^6 RNA COPIES/ML|||M3|NOT DONE||Y|N|Y|1||38||TREATMENT|1966-02-28||1969-12-26|||1963-11-28||1967-07-06
TRIAL STUDY 134XCP|RP|E43169E4-8B57-47D7-9C91-D42E40DD579B|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||10^11/L|||POUCH|NOT DONE||U|N|N|1||38||WASHOUT|1963-07-17||1967-07-01|||1965-01-03||1960-02-13
TRIAL STUDY 134XCP|RP|E43169E4-8B57-47D7-9C91-D42E40DD579B|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||NCI|||UG/KG/DAY|NOT DONE||NA|NA|N|2||58||OPEN LABEL TREATMENT|1964-12-14||1966-04-14|||1973-08-04||1961-02-01
TRIAL STUDY 134XCP|RP|E43169E4-8B57-47D7-9C91-D42E40DD579B|2||||||GRAVIND|GRAVIDA INDICATOR||||PA|||IMPLANT|NOT DONE||U|Y|NA|2||58||INDUCTION TREATMENT|1965-09-17||1969-12-04|||1960-12-29||1962-04-06
TRIAL STUDY 134XCP|RP|E43169E4-8B57-47D7-9C91-D42E40DD579B|1||||||THICK|THICKNESS||||NKAT|||LOG10 CCID 50/DOSE|NOT DONE||N|NA|U|3||39||BASELINE|1968-11-20||1966-08-27|||1969-05-27||1971-01-08
TRIAL STUDY 134XCP|RP|E43169E4-8B57-47D7-9C91-D42E40DD579B|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||ML/MIN/MMHG|||MMOL/MIN/KPA/L|NOT DONE||N|N|Y|3||39||INDUCTION TREATMENT|1964-10-26||1964-07-01|||1967-12-19||1973-05-13
TRIAL STUDY 134XCP|RP|E43169E4-8B57-47D7-9C91-D42E40DD579B|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||TUBERCULIN UNIT|||LOG10 TCID 50/DOSE|NOT DONE||N|U|U|4||88||FOLLOW-UP|1972-07-28||1970-12-27|||1972-05-22||1962-02-20
TRIAL STUDY 134XCP|RP|E43169E4-8B57-47D7-9C91-D42E40DD579B|2||||||PEELIND|PEELING INDICATOR||||U/KG/H|||KV|NOT DONE||Y|U|N|4||88||TREATMENT|1963-11-19||1963-10-05|||1970-08-05||1964-06-17
TRIAL STUDY 134XCP|RP|E43169E4-8B57-47D7-9C91-D42E40DD579B|1||||||DSCHGIND|DISCHARGE INDICATOR||||POINT|||CAL|NOT DONE||N|N|N|5||7||RUN-IN|1970-10-21||1963-09-25|||1965-07-27||1963-11-23
TRIAL STUDY 134XCP|RP|E43169E4-8B57-47D7-9C91-D42E40DD579B|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||NMOL/L/H|||DRUM|NOT DONE||Y|Y|U|5||7||SCREENING|1961-05-30||1960-07-15|||1962-09-12||1968-08-09
TRIAL STUDY 134XCP|RP|066393EE-D112-41DD-AF8F-65EF57A4415B|1||||||PREGIND|PREGNANT INDICATOR||||10^6 COPIES/ML|||MG/KG/DAY|NOT DONE||U|U|N|1||38||TREATMENT|1967-03-15||1966-07-16|||1972-06-26||1966-08-24
TRIAL STUDY 134XCP|RP|066393EE-D112-41DD-AF8F-65EF57A4415B|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||TROCHE|||BAR|NOT DONE||NA|NA|N|1||38||OBSERVATION|1968-11-14||1961-04-01|||1973-04-19||1967-06-02
TRIAL STUDY 134XCP|RP|066393EE-D112-41DD-AF8F-65EF57A4415B|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MEQ/ML|||DAGU/ML|NOT DONE||U|NA|U|2||58||TREATMENT|1971-06-13||1967-07-08|||1966-03-25||1960-04-04
TRIAL STUDY 134XCP|RP|066393EE-D112-41DD-AF8F-65EF57A4415B|2||||||PREGNN|NUMBER OF PREGNANCIES||||CI/L|||TUBERCULIN UNIT|NOT DONE||U|NA|Y|2||58||LONG-TERM FOLLOW-UP|1968-06-03||1966-02-16|||1961-01-20||1969-02-06
TRIAL STUDY 134XCP|RP|066393EE-D112-41DD-AF8F-65EF57A4415B|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||CAN|||/MIN|NOT DONE||Y|U|NA|3||39||TREATMENT|1969-04-08||1963-08-21|||1967-05-23||1971-10-23
TRIAL STUDY 134XCP|RP|066393EE-D112-41DD-AF8F-65EF57A4415B|2||||||MENOAGE|MENOPAUSE AGE||||GENEQ/ML|||CM/MIN|NOT DONE||N|U|N|3||39||SCREENING|1971-02-16||1971-06-07|||1962-02-09||1970-03-15
TRIAL STUDY 134XCP|RP|066393EE-D112-41DD-AF8F-65EF57A4415B|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||BU/ML|||MEQ/G|NOT DONE||NA|U|Y|4||88||CONTINUATION TREATMENT|1966-12-08||1961-11-20|||1966-02-04||1969-06-24
TRIAL STUDY 134XCP|RP|066393EE-D112-41DD-AF8F-65EF57A4415B|2||||||EDEMAIND|EDEMA INDICATOR||||DIOPTER|||AU/ML|NOT DONE||NA|N|U|4||88||LONG-TERM FOLLOW-UP|1964-03-10||1965-09-12|||1969-03-05||1960-08-28
TRIAL STUDY 134XCP|RP|066393EE-D112-41DD-AF8F-65EF57A4415B|1||||||ERYTHIND|ERYTHEMA INDICATOR||||CIGAR|||GY/MIN|NOT DONE||U|N|Y|5||7||OPEN LABEL TREATMENT|1968-04-21||1970-04-21|||1969-04-06||1966-04-17
TRIAL STUDY 134XCP|RP|066393EE-D112-41DD-AF8F-65EF57A4415B|2||||||MENOSTAT|MENOPAUSE STATUS||||BOWL|||/10^3|NOT DONE||N|Y|N|5||7||BASELINE|1963-02-12||1960-02-08|||1964-11-19||1964-10-26
TRIAL STUDY 134XCP|RP|573C9228-D341-491C-9D66-0D0435E2C631|1||||||DLVRMODE|MODE OF DELIVERY||||MESF|||LENS|NOT DONE||U|Y|Y|1||38||OPEN LABEL TREATMENT|1968-03-24||1970-04-02|||1970-08-15||1971-02-27
TRIAL STUDY 134XCP|RP|573C9228-D341-491C-9D66-0D0435E2C631|2||||||ULCERIND|ULCER INDICATOR||||SFC/10^6 PBMC|||LX|NOT DONE||Y|NA|U|1||38||OBSERVATION|1970-08-04||1963-08-18|||1967-09-15||1966-10-18
TRIAL STUDY 134XCP|RP|573C9228-D341-491C-9D66-0D0435E2C631|1||||||MASSIND|MASS INDICATOR||||%/MIN|||U/KG/DAY|NOT DONE||Y|Y|U|2||58||TREATMENT|1972-06-14||1961-09-24|||1965-02-02||1962-05-10
TRIAL STUDY 134XCP|RP|573C9228-D341-491C-9D66-0D0435E2C631|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MV*MIN|||ML/G/DAY|NOT DONE||Y|U|NA|2||58||WASHOUT|1966-05-10||1969-03-01|||1961-06-29||1961-11-20
TRIAL STUDY 134XCP|RP|573C9228-D341-491C-9D66-0D0435E2C631|1||||||EDEMAIND|EDEMA INDICATOR||||MG/KG|||WAFER|NOT DONE||N|NA|NA|3||39||TREATMENT|1961-01-06||1973-01-08|||1972-07-27||1964-12-30
TRIAL STUDY 134XCP|RP|573C9228-D341-491C-9D66-0D0435E2C631|2||||||ULCERIND|ULCER INDICATOR||||10^3 ORGANISMS/ML|||MG/M2/MIN|NOT DONE||Y|U|NA|3||39||INDUCTION TREATMENT|1968-03-26||1973-04-30|||1965-04-04||1964-06-14
TRIAL STUDY 134XCP|RP|573C9228-D341-491C-9D66-0D0435E2C631|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UMOL/H/MMOL|||U/DL|NOT DONE||N|N|Y|4||88||INDUCTION TREATMENT|1965-06-11||1969-09-01|||1967-04-27||1972-12-18
TRIAL STUDY 134XCP|RP|573C9228-D341-491C-9D66-0D0435E2C631|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||PG/CELL|||COPIES/UL|NOT DONE||U|N|N|4||88||WASHOUT|1969-03-13||1972-07-08|||1971-04-08||1969-01-23
TRIAL STUDY 134XCP|RP|573C9228-D341-491C-9D66-0D0435E2C631|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||FT3|||CAL|NOT DONE||U|N|NA|5||7||OBSERVATION|1963-01-02||1968-01-09|||1963-11-03||1970-05-17
TRIAL STUDY 134XCP|RP|573C9228-D341-491C-9D66-0D0435E2C631|2||||||TNDRIND|TENDERNESS INDICATOR||||UV|||MJOULE/CM2|NOT DONE||N|U|NA|5||7||FOLLOW-UP|1967-08-17||1965-07-02|||1965-01-29||1961-01-10
TRIAL STUDY 134XCP|RP|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||FT|||CI/MG|NOT DONE||NA|Y|Y|1||38||INDUCTION TREATMENT|1960-07-07||1972-04-28|||1964-02-08||1965-07-29
TRIAL STUDY 134XCP|RP|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||USP U|||MCI/L|NOT DONE||N|N|U|1||38||FOLLOW-UP|1971-02-19||1964-05-30|||1966-08-20||1960-12-08
TRIAL STUDY 134XCP|RP|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||10^9 ORGANISMS|||BAU|NOT DONE||U|Y|Y|2||58||INDUCTION TREATMENT|1973-08-14||1972-05-01|||1961-01-28||1969-10-08
TRIAL STUDY 134XCP|RP|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||10^3 ORGANISMS/ML|||UG/KG/H|NOT DONE||N|N|NA|2||58||INDUCTION TREATMENT|1967-02-19||1966-02-07|||1966-04-06||1964-08-10
TRIAL STUDY 134XCP|RP|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||BQ/ML|||CCID 50/ML|NOT DONE||Y|NA|U|3||39||RUN-IN|1963-07-02||1965-09-03|||1968-12-07||1964-12-07
TRIAL STUDY 134XCP|RP|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|2||||||FUNDHT|FUNDAL HEIGHT||||PPTR|||CM2|NOT DONE||N|Y|NA|3||39||RUN-IN|1961-02-27||1960-11-26|||1961-01-11||1965-10-18
TRIAL STUDY 134XCP|RP|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|1||||||PRGENDTC|DATE PREGNANCY ENDED||||RPM|||F|NOT DONE||N|N|U|4||88||BLINDED TREATMENT|1961-11-15||1962-04-13|||1963-01-17||1961-05-23
TRIAL STUDY 134XCP|RP|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||LOG10 CFU/G|||ABSORBANCE U/ML|NOT DONE||Y|NA|U|4||88||SCREENING|1964-10-18||1963-06-01|||1967-11-21||1965-07-05
TRIAL STUDY 134XCP|RP|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MCI|||10^4 CFU|NOT DONE||U|NA|NA|5||7||CONTINUATION TREATMENT|1972-08-01||1961-01-04|||1967-03-04||1962-04-04
TRIAL STUDY 134XCP|RP|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||10^8/L|||L/S/KPA|NOT DONE||NA|NA|Y|5||7||OPEN LABEL TREATMENT|1966-07-12||1967-05-14|||1973-08-30||1970-10-05
TRIAL STUDY 134XCP|RP|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ANTI-XA IU|||MPA|NOT DONE||Y|Y|U|1||38||INDUCTION TREATMENT|1960-05-11||1970-12-22|||1967-09-13||1963-10-11
TRIAL STUDY 134XCP|RP|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||KBQ/UL|||U/DL|NOT DONE||NA|N|Y|1||38||CONTINUATION TREATMENT|1960-02-25||1962-08-09|||1961-08-28||1961-05-30
TRIAL STUDY 134XCP|RP|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|1||||||PRGENDTC|DATE PREGNANCY ENDED||||OZ EQ|||UG|NOT DONE||N|U|Y|2||58||OBSERVATION|1972-10-16||1962-04-08|||1969-02-09||1962-02-10
TRIAL STUDY 134XCP|RP|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||DL|||10^6 CFU|NOT DONE||Y|Y|N|2||58||FOLLOW-UP|1966-06-11||1961-05-27|||1971-06-22||1960-11-09
TRIAL STUDY 134XCP|RP|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||KG/M2|||P|NOT DONE||U|Y|N|3||39||FOLLOW-UP|1964-08-29||1960-05-09|||1965-04-16||1973-05-29
TRIAL STUDY 134XCP|RP|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|2||||||DLVRMODE|MODE OF DELIVERY||||PPTR|||PT_BR|NOT DONE||Y|Y|NA|3||39||OPEN LABEL TREATMENT|1972-12-22||1960-07-02|||1968-04-04||1961-11-24
TRIAL STUDY 134XCP|RP|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||IU/G HB|||DPM/100MG|NOT DONE||NA|U|Y|4||88||CONTINUATION TREATMENT|1970-12-20||1963-03-25|||1960-03-18||1964-07-20
TRIAL STUDY 134XCP|RP|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|2||||||MENFDUR|MENSES FLOW DURATION||||CY/CM|||ML/SEC/1.73M2|NOT DONE||NA|N|NA|4||88||TREATMENT|1963-04-01||1966-05-04|||1967-03-09||1972-05-19
TRIAL STUDY 134XCP|RP|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|1||||||RASHIND|RASH INDICATOR||||ARBITRARY U|||FT2|NOT DONE||Y|U|Y|5||7||BLINDED TREATMENT|1962-04-21||1970-11-06|||1970-04-28||1970-04-02
TRIAL STUDY 134XCP|RP|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|2||||||ABORTN|NUMBER OF ABORTIONS||||FMOL/L/SEC|||ML/M2/DAY|NOT DONE||Y|Y|Y|5||7||OBSERVATION|1971-02-18||1967-01-31|||1966-02-17||1967-06-16
TRIAL STUDY 134XCP|RP|61C75130-5C1A-4B8D-804C-92D3288B55D2|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||G/KG|||PMOL/DAY|NOT DONE||NA|N|U|1||38||OPEN LABEL TREATMENT|1968-09-15||1960-07-24|||1968-03-10||1964-05-06
TRIAL STUDY 134XCP|RP|61C75130-5C1A-4B8D-804C-92D3288B55D2|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MU/G|||M/SEC|NOT DONE||NA|N|Y|1||38||WASHOUT|1966-01-03||1965-08-21|||1970-12-10||1971-08-14
TRIAL STUDY 134XCP|RP|61C75130-5C1A-4B8D-804C-92D3288B55D2|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||U/KG|||MG/ML/MIN|NOT DONE||NA|Y|N|2||58||INDUCTION TREATMENT|1962-03-28||1963-01-04|||1970-09-10||1965-09-05
TRIAL STUDY 134XCP|RP|61C75130-5C1A-4B8D-804C-92D3288B55D2|2||||||MENOSTAT|MENOPAUSE STATUS||||KCAL/DAY|||YD|NOT DONE||NA|U|Y|2||58||BASELINE|1960-04-27||1963-07-19|||1968-10-29||1972-06-18
TRIAL STUDY 134XCP|RP|61C75130-5C1A-4B8D-804C-92D3288B55D2|1||||||PEELIND|PEELING INDICATOR||||MM/MIN|||AG|NOT DONE||U|U|NA|3||39||RUN-IN|1967-01-17||1971-03-09|||1963-07-17||1960-12-03
TRIAL STUDY 134XCP|RP|61C75130-5C1A-4B8D-804C-92D3288B55D2|2||||||MENFDUR|MENSES FLOW DURATION||||ML/BEAT|||UG/DOSE|NOT DONE||Y|U|U|3||39||WASHOUT|1960-12-01||1970-07-18|||1968-10-30||1972-11-09
TRIAL STUDY 134XCP|RP|61C75130-5C1A-4B8D-804C-92D3288B55D2|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||U/M2|||PACK YEAR|NOT DONE||U|Y|Y|4||88||WASHOUT|1962-12-26||1968-11-05|||1972-03-05||1961-03-09
TRIAL STUDY 134XCP|RP|61C75130-5C1A-4B8D-804C-92D3288B55D2|2||||||MASSIND|MASS INDICATOR||||PPM|||DAGU/ML|NOT DONE||N|N|NA|4||88||TREATMENT|1960-01-17||1971-02-06|||1960-11-21||1971-11-29
TRIAL STUDY 134XCP|RP|61C75130-5C1A-4B8D-804C-92D3288B55D2|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UG/G/DAY|||G/M2|NOT DONE||U|NA|NA|5||7||SCREENING|1968-08-20||1973-05-20|||1970-07-11||1960-04-02
TRIAL STUDY 134XCP|RP|61C75130-5C1A-4B8D-804C-92D3288B55D2|2||||||BRTHN|NUMBER OF BIRTHS||||ML/KG/DAY|||10^3 CFU|NOT DONE||NA|Y|N|5||7||OBSERVATION|1963-07-03||1968-03-12|||1963-05-25||1963-01-14
TRIAL STUDY 134XCP|RP|90AFB57A-125C-4C08-AE92-061F66FC2DAC|1||||||FUNDHT|FUNDAL HEIGHT||||NU/CL|||/HPF|NOT DONE||NA|NA|NA|1||38||OBSERVATION|1961-04-06||1973-04-14|||1971-12-26||1972-03-30
TRIAL STUDY 134XCP|RP|90AFB57A-125C-4C08-AE92-061F66FC2DAC|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MMOL/MOL|||CD/M2|NOT DONE||N|U|Y|1||38||WASHOUT|1964-11-20||1961-03-22|||1966-02-01||1971-10-27
TRIAL STUDY 134XCP|RP|90AFB57A-125C-4C08-AE92-061F66FC2DAC|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||AMU|||LOG10 CFU/ML|NOT DONE||N|Y|N|2||58||CONTINUATION TREATMENT|1963-10-14||1964-11-13|||1967-12-15||1972-07-26
TRIAL STUDY 134XCP|RP|90AFB57A-125C-4C08-AE92-061F66FC2DAC|2||||||MENFDUR|MENSES FLOW DURATION||||10^3/HPF|||WEBER|NOT DONE||U|NA|Y|2||58||OPEN LABEL TREATMENT|1969-09-09||1960-08-13|||1971-03-03||1972-02-19
TRIAL STUDY 134XCP|RP|90AFB57A-125C-4C08-AE92-061F66FC2DAC|1||||||PREGST|PREGNANT DURING THE STUDY||||KBQ/UL|||GPELISA UNIT/ML|NOT DONE||NA|Y|U|3||39||OPEN LABEL TREATMENT|1968-05-11||1966-11-11|||1968-09-30||1967-08-19
TRIAL STUDY 134XCP|RP|90AFB57A-125C-4C08-AE92-061F66FC2DAC|2||||||ERYTHIND|ERYTHEMA INDICATOR||||10^5/HPF|||MIN|NOT DONE||U|Y|U|3||39||LONG-TERM FOLLOW-UP|1971-04-18||1965-05-19|||1973-08-25||1969-10-26
TRIAL STUDY 134XCP|RP|90AFB57A-125C-4C08-AE92-061F66FC2DAC|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||HENRY|||H*%|NOT DONE||NA|Y|U|4||88||RUN-IN|1972-05-12||1966-06-05|||1963-03-20||1965-06-14
TRIAL STUDY 134XCP|RP|90AFB57A-125C-4C08-AE92-061F66FC2DAC|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MG/H|||MET*H|NOT DONE||U|NA|N|4||88||CONTINUATION TREATMENT|1962-05-06||1967-06-12|||1963-05-07||1973-05-05
TRIAL STUDY 134XCP|RP|90AFB57A-125C-4C08-AE92-061F66FC2DAC|1||||||TNDRIND|TENDERNESS INDICATOR||||ML/MMHG|||FIU|NOT DONE||Y|NA|NA|5||7||BLINDED TREATMENT|1964-11-20||1973-07-24|||1965-03-13||1966-04-06
TRIAL STUDY 134XCP|RP|90AFB57A-125C-4C08-AE92-061F66FC2DAC|2||||||BLISTIND|BLISTERING INDICATOR||||BQ/L|||G/U|NOT DONE||N|N|N|5||7||BLINDED TREATMENT|1968-12-17||1963-03-04|||1973-02-25||1967-01-14
TRIAL STUDY 134XCP|RP|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|1||||||MENOAGE|MENOPAUSE AGE||||ML/KG/H|||G/DAY|NOT DONE||U|U|NA|1||38||OPEN LABEL TREATMENT|1970-09-29||1972-01-21|||1968-06-13||1961-10-29
TRIAL STUDY 134XCP|RP|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|2||||||BRTHN|NUMBER OF BIRTHS||||ML/ANIMAL|||KPA/L/SEC|NOT DONE||Y|U|NA|1||38||SCREENING|1966-03-11||1966-12-21|||1972-04-22||1967-09-22
TRIAL STUDY 134XCP|RP|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MG2/DL2|||UGEQ|NOT DONE||Y|U|Y|2||58||INDUCTION TREATMENT|1961-04-02||1962-06-29|||1967-10-18||1972-04-16
TRIAL STUDY 134XCP|RP|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||NMOL/MOL|||BQ/MG|NOT DONE||U|Y|NA|2||58||OBSERVATION|1971-01-10||1968-09-25|||1970-08-25||1970-10-27
TRIAL STUDY 134XCP|RP|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||BU|||10^6/EJACULATE U|NOT DONE||Y|NA|NA|3||39||TREATMENT|1963-03-19||1965-07-02|||1969-09-28||1972-06-27
TRIAL STUDY 134XCP|RP|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|2||||||BCMETHOD|BIRTH CONTROL METHOD||||10^3 CFU/ML|||MOSM|NOT DONE||U|N|N|3||39||CONTINUATION TREATMENT|1973-01-26||1972-04-17|||1972-06-22||1971-08-08
TRIAL STUDY 134XCP|RP|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|1||||||MENOSTAT|MENOPAUSE STATUS||||10^6 COPIES/ML|||DPM/MG|NOT DONE||U|NA|N|4||88||OBSERVATION|1972-07-02||1967-11-26|||1968-06-11||1961-10-12
TRIAL STUDY 134XCP|RP|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||YD|||OI50|NOT DONE||Y|NA|Y|4||88||SCREENING|1960-06-05||1965-10-24|||1964-02-21||1960-08-18
TRIAL STUDY 134XCP|RP|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||KHZ|||IU/ML|NOT DONE||NA|U|Y|5||7||BLINDED TREATMENT|1969-12-03||1960-07-10|||1963-03-04||1973-05-31
TRIAL STUDY 134XCP|RP|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|2||||||PREGIND|PREGNANT INDICATOR||||DROP|||MMU/ML|NOT DONE||Y|Y|N|5||7||BASELINE|1960-02-25||1961-04-24|||1973-05-01||1967-08-22
TRIAL STUDY 134XCP|RP|01A42FAE-1EE2-4203-A62E-E368F31434F7|1||||||ERYTHIND|ERYTHEMA INDICATOR||||/WK|||MMU/ML|NOT DONE||NA|Y|NA|1||38||OBSERVATION|1964-12-17||1968-10-21|||1967-02-01||1961-03-21
TRIAL STUDY 134XCP|RP|01A42FAE-1EE2-4203-A62E-E368F31434F7|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^3 COPIES/ML|||CI/ML|NOT DONE||N|U|U|1||38||OPEN LABEL TREATMENT|1972-04-16||1968-02-10|||1961-08-11||1963-09-17
TRIAL STUDY 134XCP|RP|01A42FAE-1EE2-4203-A62E-E368F31434F7|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MMHG|||DAYS|NOT DONE||N|NA|Y|2||58||INDUCTION TREATMENT|1972-09-13||1961-09-30|||1964-08-20||1970-08-16
TRIAL STUDY 134XCP|RP|01A42FAE-1EE2-4203-A62E-E368F31434F7|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||PPTH|||MG/KG|NOT DONE||Y|Y|Y|2||58||BASELINE|1961-07-05||1965-07-15|||1960-03-06||1965-01-05
TRIAL STUDY 134XCP|RP|01A42FAE-1EE2-4203-A62E-E368F31434F7|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||ECL UNIT|||U/KG|NOT DONE||NA|N|N|3||39||WASHOUT|1966-12-26||1960-09-13|||1966-01-13||1968-04-25
TRIAL STUDY 134XCP|RP|01A42FAE-1EE2-4203-A62E-E368F31434F7|2||||||FUNDHT|FUNDAL HEIGHT||||NMOL/G|||FMOL/L|NOT DONE||U|NA|N|3||39||TREATMENT|1964-12-10||1970-12-21|||1971-03-12||1971-12-11
TRIAL STUDY 134XCP|RP|01A42FAE-1EE2-4203-A62E-E368F31434F7|1||||||PEELIND|PEELING INDICATOR||||MET*H|||H/WK|NOT DONE||Y|NA|U|4||88||OPEN LABEL TREATMENT|1962-06-05||1969-10-13|||1962-02-28||1967-08-27
TRIAL STUDY 134XCP|RP|01A42FAE-1EE2-4203-A62E-E368F31434F7|2||||||BCMETHOD|BIRTH CONTROL METHOD||||LOG10 PFU/ML|||M3|NOT DONE||U|U|NA|4||88||CONTINUATION TREATMENT|1960-03-22||1962-12-07|||1967-06-20||1962-04-12
TRIAL STUDY 134XCP|RP|01A42FAE-1EE2-4203-A62E-E368F31434F7|1||||||INABOIND|INDUCED ABORTION INDICATOR||||SACHET|||10^9/G|NOT DONE||NA|U|Y|5||7||CONTINUATION TREATMENT|1967-01-08||1964-12-02|||1967-06-24||1971-09-12
TRIAL STUDY 134XCP|RP|01A42FAE-1EE2-4203-A62E-E368F31434F7|2||||||MENOAGE|MENOPAUSE AGE||||M|||MIU/L|NOT DONE||Y|N|Y|5||7||SCREENING|1964-02-26||1962-07-05|||1960-11-22||1964-03-03
TRIAL STUDY 134XCP|RP|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|1||||||MENOAGE|MENOPAUSE AGE||||UMOL|||MONTHS|NOT DONE||U|Y|Y|1||38||WASHOUT|1967-05-09||1960-03-18|||1966-05-19||1968-11-26
TRIAL STUDY 134XCP|RP|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||BQ|||ENZYME U/G HB|NOT DONE||U|Y|NA|1||38||INDUCTION TREATMENT|1960-12-18||1971-02-26|||1972-09-07||1971-12-27
TRIAL STUDY 134XCP|RP|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||ML/CAGE/WK|||FIU|NOT DONE||N|Y|NA|2||58||INDUCTION TREATMENT|1972-07-23||1965-08-07|||1971-07-17||1960-02-14
TRIAL STUDY 134XCP|RP|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||DNA COPIES/UG|||ML/100G/MIN|NOT DONE||N|U|N|2||58||INDUCTION TREATMENT|1971-05-31||1966-02-11|||1961-04-27||1962-03-11
TRIAL STUDY 134XCP|RP|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||DB|||10^12 IU/L|NOT DONE||N|N|NA|3||39||BLINDED TREATMENT|1965-09-01||1966-06-23|||1970-05-08||1966-11-10
TRIAL STUDY 134XCP|RP|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||LINEAR FT*LB|||U/G/H|NOT DONE||N|U|Y|3||39||CONTINUATION TREATMENT|1964-02-16||1968-10-27|||1960-04-24||1971-04-23
TRIAL STUDY 134XCP|RP|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||KEV|||/MS|NOT DONE||NA|U|Y|4||88||INDUCTION TREATMENT|1966-09-04||1972-06-18|||1973-04-07||1962-09-28
TRIAL STUDY 134XCP|RP|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||BQ/G|||KG/CM2|NOT DONE||Y|U|Y|4||88||OBSERVATION|1960-06-07||1961-03-17|||1965-01-13||1968-11-24
TRIAL STUDY 134XCP|RP|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||UM|||CG|NOT DONE||NA|NA|U|5||7||LONG-TERM FOLLOW-UP|1965-03-01||1966-07-04|||1966-06-19||1969-08-09
TRIAL STUDY 134XCP|RP|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^4/HPF|||COULOMB|NOT DONE||N|U|U|5||7||RUN-IN|1973-02-14||1967-04-30|||1967-01-03||1970-09-28
TRIAL STUDY 134XCP|RP|92232C8B-0D28-4E2A-AA56-BA938429CCBF|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||NMOL/L/MIN|||MONTHS|NOT DONE||U|NA|NA|1||38||RUN-IN|1965-03-09||1967-05-26|||1970-02-06||1972-05-17
TRIAL STUDY 134XCP|RP|92232C8B-0D28-4E2A-AA56-BA938429CCBF|2||||||ULCERIND|ULCER INDICATOR||||ML/MMHG|||M2|NOT DONE||NA|Y|Y|1||38||INDUCTION TREATMENT|1961-06-06||1963-06-01|||1966-02-28||1970-11-11
TRIAL STUDY 134XCP|RP|92232C8B-0D28-4E2A-AA56-BA938429CCBF|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MBQ/UL|||MG/DOSE|NOT DONE||N|N|NA|2||58||OBSERVATION|1972-06-01||1970-02-10|||1967-04-04||1962-05-27
TRIAL STUDY 134XCP|RP|92232C8B-0D28-4E2A-AA56-BA938429CCBF|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||NEBULE|||PACK YEAR|NOT DONE||NA|Y|U|2||58||CONTINUATION TREATMENT|1962-04-02||1960-09-02|||1964-07-09||1963-12-04
TRIAL STUDY 134XCP|RP|92232C8B-0D28-4E2A-AA56-BA938429CCBF|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||YD|||CAL|NOT DONE||U|N|N|3||39||LONG-TERM FOLLOW-UP|1965-10-16||1963-09-06|||1968-12-18||1967-08-26
TRIAL STUDY 134XCP|RP|92232C8B-0D28-4E2A-AA56-BA938429CCBF|2||||||BLISTIND|BLISTERING INDICATOR||||KG|||NMOL/DAY|NOT DONE||Y|U|U|3||39||WASHOUT|1965-08-14||1961-09-28|||1972-07-26||1969-06-21
TRIAL STUDY 134XCP|RP|92232C8B-0D28-4E2A-AA56-BA938429CCBF|1||||||EDEMAIND|EDEMA INDICATOR||||10^6 RNA COPIES/ML|||UG/G/MIN|NOT DONE||U|N|Y|4||88||CONTINUATION TREATMENT|1968-08-03||1970-12-18|||1960-02-03||1963-12-16
TRIAL STUDY 134XCP|RP|92232C8B-0D28-4E2A-AA56-BA938429CCBF|2||||||EDEMAIND|EDEMA INDICATOR||||IU/MG|||10^3 CFU/G|NOT DONE||NA|Y|NA|4||88||WASHOUT|1967-01-02||1968-09-04|||1960-07-07||1969-09-14
TRIAL STUDY 134XCP|RP|92232C8B-0D28-4E2A-AA56-BA938429CCBF|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UOSM|||DEG/MM|NOT DONE||Y|NA|U|5||7||OPEN LABEL TREATMENT|1973-05-20||1966-08-20|||1961-06-02||1964-07-24
TRIAL STUDY 134XCP|RP|92232C8B-0D28-4E2A-AA56-BA938429CCBF|2||||||PEELIND|PEELING INDICATOR||||UV|||CGY|NOT DONE||NA|Y|U|5||7||INDUCTION TREATMENT|1962-01-09||1970-07-15|||1971-08-19||1963-07-01
TRIAL STUDY 134XCP|RP|F4F12AAA-E825-45D7-B414-A06F2D20381A|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||RFU|||KG|NOT DONE||N|N|NA|1||38||BLINDED TREATMENT|1963-09-23||1965-11-08|||1967-03-10||1963-04-04
TRIAL STUDY 134XCP|RP|F4F12AAA-E825-45D7-B414-A06F2D20381A|2||||||GRAVIND|GRAVIDA INDICATOR||||UMOL/L/SEC|||USP U|NOT DONE||U|Y|NA|1||38||RUN-IN|1969-04-13||1968-09-24|||1968-03-09||1966-05-02
TRIAL STUDY 134XCP|RP|F4F12AAA-E825-45D7-B414-A06F2D20381A|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||PMOL/DL|||MMHG/L/MIN|NOT DONE||Y|N|NA|2||58||BASELINE|1964-01-28||1973-07-16|||1972-11-06||1971-03-16
TRIAL STUDY 134XCP|RP|F4F12AAA-E825-45D7-B414-A06F2D20381A|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||10^9 ORGANISMS/ML|||MMOL2/L2|NOT DONE||Y|N|Y|2||58||SCREENING|1960-05-13||1971-04-16|||1970-06-09||1965-04-13
TRIAL STUDY 134XCP|RP|F4F12AAA-E825-45D7-B414-A06F2D20381A|1||||||GRAVIND|GRAVIDA INDICATOR||||CD/M2|||PM|NOT DONE||Y|N|U|3||39||BLINDED TREATMENT|1964-09-05||1971-03-14|||1961-09-03||1968-01-31
TRIAL STUDY 134XCP|RP|F4F12AAA-E825-45D7-B414-A06F2D20381A|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||YEARS|||NMOL/L|NOT DONE||Y|U|U|3||39||SCREENING|1963-10-06||1963-03-22|||1961-03-19||1961-06-20
TRIAL STUDY 134XCP|RP|F4F12AAA-E825-45D7-B414-A06F2D20381A|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||BQ/G|||MMAL|NOT DONE||Y|NA|NA|4||88||WASHOUT|1968-04-28||1964-09-21|||1965-05-16||1965-12-15
TRIAL STUDY 134XCP|RP|F4F12AAA-E825-45D7-B414-A06F2D20381A|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||1/(S*KPA)|||ML/ANIMAL|NOT DONE||N|Y|Y|4||88||OPEN LABEL TREATMENT|1961-06-24||1971-05-06|||1963-04-07||1966-08-30
TRIAL STUDY 134XCP|RP|F4F12AAA-E825-45D7-B414-A06F2D20381A|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||U/ANIMAL|||MG/KG/H|NOT DONE||N|NA|Y|5||7||FOLLOW-UP|1971-12-16||1969-01-10|||1963-10-30||1965-07-31
TRIAL STUDY 134XCP|RP|F4F12AAA-E825-45D7-B414-A06F2D20381A|2||||||MASSIND|MASS INDICATOR||||ML/CAGE/DAY|||/CMH2O|NOT DONE||NA|N|U|5||7||TREATMENT|1966-05-15||1961-10-12|||1972-06-23||1963-01-24
TRIAL STUDY 134XCP|RP|6CF611F2-686E-4AE9-B491-32157710F46D|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||RPM|||CI/KG|NOT DONE||Y|NA|NA|1||38||TREATMENT|1969-03-10||1970-02-25|||1966-02-07||1963-08-19
TRIAL STUDY 134XCP|RP|6CF611F2-686E-4AE9-B491-32157710F46D|2||||||FUNDHT|FUNDAL HEIGHT||||NMOL/KG/DAY|||V/SEC|NOT DONE||U|NA|N|1||38||FOLLOW-UP|1962-11-07||1961-09-21|||1968-11-26||1968-09-12
TRIAL STUDY 134XCP|RP|6CF611F2-686E-4AE9-B491-32157710F46D|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UV*SEC|||/MM|NOT DONE||N|NA|NA|2||58||LONG-TERM FOLLOW-UP|1963-04-03||1970-07-20|||1968-03-22||1972-06-21
TRIAL STUDY 134XCP|RP|6CF611F2-686E-4AE9-B491-32157710F46D|2||||||THICK|THICKNESS||||M|||U/10^12 RBC|NOT DONE||U|NA|N|2||58||WASHOUT|1962-10-14||1967-01-30|||1970-05-23||1961-05-03
TRIAL STUDY 134XCP|RP|6CF611F2-686E-4AE9-B491-32157710F46D|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||LOG10 CFU/ML|||MG/ML/MIN|NOT DONE||U|U|U|3||39||LONG-TERM FOLLOW-UP|1963-11-01||1964-04-16|||1966-12-14||1962-05-09
TRIAL STUDY 134XCP|RP|6CF611F2-686E-4AE9-B491-32157710F46D|2||||||BLISTIND|BLISTERING INDICATOR||||MGEQ|||BREATHS/MIN|NOT DONE||Y|Y|N|3||39||OPEN LABEL TREATMENT|1965-04-25||1970-12-03|||1973-01-18||1967-11-14
TRIAL STUDY 134XCP|RP|6CF611F2-686E-4AE9-B491-32157710F46D|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^9 ORGANISMS|||/MONTH|NOT DONE||Y|N|N|4||88||FOLLOW-UP|1965-08-23||1968-05-01|||1965-11-15||1966-12-26
TRIAL STUDY 134XCP|RP|6CF611F2-686E-4AE9-B491-32157710F46D|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||FT2|||TSP EQ|NOT DONE||Y|N|N|4||88||CONTINUATION TREATMENT|1968-04-16||1963-08-21|||1966-11-22||1965-12-05
TRIAL STUDY 134XCP|RP|6CF611F2-686E-4AE9-B491-32157710F46D|1||||||INTP|INTERPRETATION||||CI/UL|||MMOL/L|NOT DONE||U|U|NA|5||7||BLINDED TREATMENT|1962-06-11||1960-09-24|||1968-11-04||1972-11-03
TRIAL STUDY 134XCP|RP|6CF611F2-686E-4AE9-B491-32157710F46D|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MOSM/L|||MMU/ML|NOT DONE||Y|U|NA|5||7||SCREENING|1964-10-17||1965-05-03|||1973-07-31||1967-05-08
TRIAL STUDY 134XCP|RP|417DBC64-7BF9-4EB8-A14B-C5F63541F826|1||||||MENARAGE|MENARCHE AGE||||MG/CM2|||MV/SEC|NOT DONE||NA|U|Y|1||38||FOLLOW-UP|1970-09-21||1964-04-16|||1972-09-02||1970-09-12
TRIAL STUDY 134XCP|RP|417DBC64-7BF9-4EB8-A14B-C5F63541F826|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||G/CAGE/DAY|||DPM/ML|NOT DONE||Y|N|Y|1||38||OBSERVATION|1971-03-13||1963-12-06|||1969-03-24||1961-08-30
TRIAL STUDY 134XCP|RP|417DBC64-7BF9-4EB8-A14B-C5F63541F826|1||||||PEELIND|PEELING INDICATOR||||FRACTION OF 1|||UV|NOT DONE||Y|U|U|2||58||FOLLOW-UP|1967-11-10||1962-02-27|||1961-05-17||1961-06-03
TRIAL STUDY 134XCP|RP|417DBC64-7BF9-4EB8-A14B-C5F63541F826|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||LOG10 CCID 50/DOSE|||MPS U|NOT DONE||N|Y|NA|2||58||BLINDED TREATMENT|1970-04-17||1964-09-20|||1964-10-31||1968-12-20
TRIAL STUDY 134XCP|RP|417DBC64-7BF9-4EB8-A14B-C5F63541F826|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||BQ|||MG/ML/MIN|NOT DONE||N|U|Y|3||39||OBSERVATION|1968-08-12||1968-09-25|||1970-11-23||1963-03-21
TRIAL STUDY 134XCP|RP|417DBC64-7BF9-4EB8-A14B-C5F63541F826|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||H/WK|||IU/DL|NOT DONE||Y|Y|Y|3||39||OBSERVATION|1971-01-03||1967-09-22|||1962-09-26||1969-12-28
TRIAL STUDY 134XCP|RP|417DBC64-7BF9-4EB8-A14B-C5F63541F826|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||NEBULE|||ML/(MIN*100ML)|NOT DONE||Y|U|N|4||88||WASHOUT|1969-12-16||1961-07-10|||1969-02-25||1969-10-25
TRIAL STUDY 134XCP|RP|417DBC64-7BF9-4EB8-A14B-C5F63541F826|2||||||BRTHN|NUMBER OF BIRTHS||||10^3/HPF|||MM/2H|NOT DONE||NA|Y|NA|4||88||INDUCTION TREATMENT|1964-12-18||1970-08-04|||1973-09-01||1960-02-08
TRIAL STUDY 134XCP|RP|417DBC64-7BF9-4EB8-A14B-C5F63541F826|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||KN/CM2|||BQ/UL|NOT DONE||N|N|U|5||7||FOLLOW-UP|1966-09-01||1973-02-12|||1962-10-05||1960-09-15
TRIAL STUDY 134XCP|RP|417DBC64-7BF9-4EB8-A14B-C5F63541F826|2||||||PEELIND|PEELING INDICATOR||||MMHG*MIN/L|||DAYS/WK|NOT DONE||NA|U|N|5||7||BASELINE|1966-07-23||1972-09-26|||1964-07-01||1964-05-31
TRIAL STUDY 134XCP|RP|C3EF644E-25DC-4E0D-9073-735AED77EFAF|1||||||PREGST|PREGNANT DURING THE STUDY||||L/H/M2|||CD|NOT DONE||NA|NA|U|1||38||RUN-IN|1964-11-02||1968-03-20|||1970-08-14||1966-11-02
TRIAL STUDY 134XCP|RP|C3EF644E-25DC-4E0D-9073-735AED77EFAF|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||KAT|||SPRAY|NOT DONE||Y|Y|NA|1||38||WASHOUT|1967-11-15||1969-10-06|||1963-09-24||1961-03-03
TRIAL STUDY 134XCP|RP|C3EF644E-25DC-4E0D-9073-735AED77EFAF|1||||||ERYTHIND|ERYTHEMA INDICATOR||||10^4 CFU/ML|||OD UNIT|NOT DONE||NA|Y|N|2||58||OBSERVATION|1963-03-16||1969-04-25|||1967-07-01||1973-08-02
TRIAL STUDY 134XCP|RP|C3EF644E-25DC-4E0D-9073-735AED77EFAF|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||STEPS/MIN|||MKAT|NOT DONE||NA|N|N|2||58||TREATMENT|1973-07-21||1962-09-04|||1971-12-23||1971-11-03
TRIAL STUDY 134XCP|RP|C3EF644E-25DC-4E0D-9073-735AED77EFAF|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||GBQ/G|||MMOL/L|NOT DONE||U|N|NA|3||39||BASELINE|1967-08-24||1969-05-18|||1972-07-11||1967-12-01
TRIAL STUDY 134XCP|RP|C3EF644E-25DC-4E0D-9073-735AED77EFAF|2||||||MENFDUR|MENSES FLOW DURATION||||%/S|||NMOL|NOT DONE||N|N|NA|3||39||FOLLOW-UP|1962-01-11||1960-08-05|||1971-07-22||1971-02-13
TRIAL STUDY 134XCP|RP|C3EF644E-25DC-4E0D-9073-735AED77EFAF|1||||||FUNDHT|FUNDAL HEIGHT||||U.CARR|||U/M2/DAY|NOT DONE||U|NA|U|4||88||WASHOUT|1968-07-10||1965-09-21|||1967-06-19||1972-07-03
TRIAL STUDY 134XCP|RP|C3EF644E-25DC-4E0D-9073-735AED77EFAF|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^6 COPIES/ML|||CD*S/M2|NOT DONE||NA|U|NA|4||88||CONTINUATION TREATMENT|1962-10-09||1965-11-22|||1964-02-22||1961-02-24
TRIAL STUDY 134XCP|RP|C3EF644E-25DC-4E0D-9073-735AED77EFAF|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UMOL/H/MMOL|||UL/KG/DAY|NOT DONE||U|NA|U|5||7||WASHOUT|1965-07-19||1966-02-12|||1967-03-08||1970-10-09
TRIAL STUDY 134XCP|RP|C3EF644E-25DC-4E0D-9073-735AED77EFAF|2||||||MASSIND|MASS INDICATOR||||MS/MMHG|||NFIU|NOT DONE||U|NA|NA|5||7||BASELINE|1965-12-20||1961-04-28|||1970-04-10||1964-03-23
TRIAL STUDY 134XCP|RP|CAE5F41C-0560-4782-BA27-E314BF7E66B6|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||BE/ML|||BAG|NOT DONE||N|Y|NA|1||38||CONTINUATION TREATMENT|1966-11-04||1973-04-23|||1969-03-01||1969-12-14
TRIAL STUDY 134XCP|RP|CAE5F41C-0560-4782-BA27-E314BF7E66B6|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||PPM|||K|NOT DONE||Y|NA|NA|1||38||CONTINUATION TREATMENT|1971-01-22||1971-05-02|||1963-09-23||1965-04-09
TRIAL STUDY 134XCP|RP|CAE5F41C-0560-4782-BA27-E314BF7E66B6|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||10^7 TCID 50/DOSE|||/100 WBC|NOT DONE||N|U|U|2||58||OBSERVATION|1969-11-20||1964-09-13|||1968-01-25||1969-11-19
TRIAL STUDY 134XCP|RP|CAE5F41C-0560-4782-BA27-E314BF7E66B6|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||FRAMES/S|||MPL U/ML|NOT DONE||Y|NA|U|2||58||BLINDED TREATMENT|1972-08-09||1969-09-17|||1972-02-15||1970-06-23
TRIAL STUDY 134XCP|RP|CAE5F41C-0560-4782-BA27-E314BF7E66B6|1||||||PREGIND|PREGNANT INDICATOR||||U/G/MIN|||UL/KG/DAY|NOT DONE||U|N|Y|3||39||OBSERVATION|1960-07-10||1969-05-07|||1965-03-23||1961-08-01
TRIAL STUDY 134XCP|RP|CAE5F41C-0560-4782-BA27-E314BF7E66B6|2||||||PREGST|PREGNANT DURING THE STUDY||||EJACULATE U|||MM/SEC|NOT DONE||NA|Y|U|3||39||INDUCTION TREATMENT|1969-06-01||1965-07-07|||1970-12-11||1967-06-23
TRIAL STUDY 134XCP|RP|CAE5F41C-0560-4782-BA27-E314BF7E66B6|1||||||PREGNN|NUMBER OF PREGNANCIES||||MOL/DAY|||NKAT/G HB|NOT DONE||Y|N|U|4||88||SCREENING|1973-06-12||1968-11-21|||1966-06-26||1968-01-10
TRIAL STUDY 134XCP|RP|CAE5F41C-0560-4782-BA27-E314BF7E66B6|2||||||PEELIND|PEELING INDICATOR||||UG/L DDU|||10^3 ORGANISMS/ML|NOT DONE||U|U|Y|4||88||OPEN LABEL TREATMENT|1967-11-28||1961-08-15|||1967-12-22||1964-12-30
TRIAL STUDY 134XCP|RP|CAE5F41C-0560-4782-BA27-E314BF7E66B6|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||WEBER|||UG/G/H|NOT DONE||NA|N|NA|5||7||TREATMENT|1962-03-23||1971-09-27|||1973-08-16||1966-02-22
TRIAL STUDY 134XCP|RP|CAE5F41C-0560-4782-BA27-E314BF7E66B6|2||||||MENOAGE|MENOPAUSE AGE||||H*%|||CM/MIN|NOT DONE||NA|N|NA|5||7||INDUCTION TREATMENT|1961-01-07||1960-06-05|||1971-08-20||1973-03-12
TRIAL STUDY 134XCP|RP|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||NMOL BCE/NMOL|||MG/KG/MIN|NOT DONE||U|N|NA|1||38||TREATMENT|1960-12-04||1965-01-29|||1962-06-29||1965-07-25
TRIAL STUDY 134XCP|RP|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|2||||||ABORTN|NUMBER OF ABORTIONS||||G/G|||NKAT/L|NOT DONE||U|NA|U|1||38||CONTINUATION TREATMENT|1971-03-09||1971-03-09|||1970-12-26||1966-02-08
TRIAL STUDY 134XCP|RP|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|1||||||BRTHN|NUMBER OF BIRTHS||||P|||AMU|NOT DONE||U|U|U|2||58||FOLLOW-UP|1972-09-08||1960-11-13|||1962-10-26||1972-08-27
TRIAL STUDY 134XCP|RP|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|2||||||DSCHGIND|DISCHARGE INDICATOR||||MS/MMHG|||NSEC|NOT DONE||U|U|U|2||58||BASELINE|1973-05-11||1970-10-28|||1972-09-05||1968-08-12
TRIAL STUDY 134XCP|RP|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|1||||||MASSIND|MASS INDICATOR||||MEQ|||LM|NOT DONE||NA|Y|N|3||39||BASELINE|1965-11-12||1961-09-18|||1962-02-15||1966-09-08
TRIAL STUDY 134XCP|RP|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||KCAL|||U|NOT DONE||Y|N|U|3||39||OPEN LABEL TREATMENT|1971-07-14||1963-03-20|||1966-08-30||1969-03-11
TRIAL STUDY 134XCP|RP|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||NMOL/MOL|||G/G/DAY|NOT DONE||U|N|U|4||88||OBSERVATION|1969-09-08||1966-07-16|||1960-06-29||1961-09-01
TRIAL STUDY 134XCP|RP|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|2||||||BRTHN|NUMBER OF BIRTHS||||MG/KG|||U/ML|NOT DONE||U|U|Y|4||88||BLINDED TREATMENT|1966-05-07||1972-04-09|||1966-04-20||1972-12-12
TRIAL STUDY 134XCP|RP|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|1||||||EDEMAIND|EDEMA INDICATOR||||CMH2O*S/ML|||PA|NOT DONE||NA|Y|NA|5||7||LONG-TERM FOLLOW-UP|1967-04-05||1966-12-07|||1970-08-17||1967-02-19
TRIAL STUDY 134XCP|RP|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|2||||||BLISTIND|BLISTERING INDICATOR||||G/ANIMAL/WK|||/MM|NOT DONE||N|U|N|5||7||RUN-IN|1965-01-16||1967-12-05|||1972-05-27||1970-05-08
TRIAL STUDY 134XCP|RP|F34E7DCC-8637-463D-88E6-28AEBF495E9B|1||||||ULCERIND|ULCER INDICATOR||||MMHG|||SQU/ML|NOT DONE||U|Y|Y|1||38||BLINDED TREATMENT|1963-02-08||1960-05-19|||1969-11-29||1973-01-08
TRIAL STUDY 134XCP|RP|F34E7DCC-8637-463D-88E6-28AEBF495E9B|2||||||DSCHGIND|DISCHARGE INDICATOR||||MG/ML/DAY|||BAG|NOT DONE||N|U|Y|1||38||OBSERVATION|1962-11-05||1966-11-13|||1970-10-27||1965-01-22
TRIAL STUDY 134XCP|RP|F34E7DCC-8637-463D-88E6-28AEBF495E9B|1||||||RASHIND|RASH INDICATOR||||ANTI-XA IU|||BAU/ML|NOT DONE||U|N|U|2||58||FOLLOW-UP|1960-08-13||1971-12-04|||1968-01-12||1962-10-28
TRIAL STUDY 134XCP|RP|F34E7DCC-8637-463D-88E6-28AEBF495E9B|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||UM/DAY|||ML/BREATH|NOT DONE||Y|N|NA|2||58||RUN-IN|1969-07-02||1971-01-24|||1965-01-28||1966-10-04
TRIAL STUDY 134XCP|RP|F34E7DCC-8637-463D-88E6-28AEBF495E9B|1||||||ULCERIND|ULCER INDICATOR||||UV|||WEEKS|NOT DONE||Y|N|NA|3||39||BLINDED TREATMENT|1963-12-20||1962-01-20|||1968-06-04||1960-03-15
TRIAL STUDY 134XCP|RP|F34E7DCC-8637-463D-88E6-28AEBF495E9B|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MONTHS|||CI/KG|NOT DONE||U|U|NA|3||39||FOLLOW-UP|1962-09-29||1965-08-19|||1960-11-29||1960-07-23
TRIAL STUDY 134XCP|RP|F34E7DCC-8637-463D-88E6-28AEBF495E9B|1||||||DLVRMODE|MODE OF DELIVERY||||UGEQ|||ML|NOT DONE||N|N|NA|4||88||FOLLOW-UP|1963-11-28||1969-12-17|||1962-02-08||1961-12-07
TRIAL STUDY 134XCP|RP|F34E7DCC-8637-463D-88E6-28AEBF495E9B|2||||||DSCHGIND|DISCHARGE INDICATOR||||UG/CM2|||ENZYME U/G HB|NOT DONE||Y|NA|N|4||88||LONG-TERM FOLLOW-UP|1967-03-25||1973-09-06|||1962-06-19||1964-09-19
TRIAL STUDY 134XCP|RP|F34E7DCC-8637-463D-88E6-28AEBF495E9B|1||||||PREGST|PREGNANT DURING THE STUDY||||PA|||PMOL/L/H|NOT DONE||U|U|U|5||7||SCREENING|1962-09-30||1970-03-09|||1973-01-16||1968-02-24
TRIAL STUDY 134XCP|RP|F34E7DCC-8637-463D-88E6-28AEBF495E9B|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||TABLET|||CCID 50/DOSE|NOT DONE||Y|NA|N|5||7||FOLLOW-UP|1967-05-27||1970-07-30|||1961-10-30||1964-11-12
TRIAL STUDY 134XCP|RP|69530FE0-6896-4585-8B20-29AE90DB91F5|1||||||MENOSTAT|MENOPAUSE STATUS||||LOG10 IU/ML|||G/L|NOT DONE||U|U|N|1||38||CONTINUATION TREATMENT|1968-11-15||1961-08-25|||1973-07-11||1968-12-31
TRIAL STUDY 134XCP|RP|69530FE0-6896-4585-8B20-29AE90DB91F5|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MOSM|||MEQ/DL|NOT DONE||NA|NA|NA|1||38||RUN-IN|1966-04-11||1965-08-02|||1965-10-12||1962-12-28
TRIAL STUDY 134XCP|RP|69530FE0-6896-4585-8B20-29AE90DB91F5|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||BQ/MG|||NGEQ/L|NOT DONE||U|N|U|2||58||CONTINUATION TREATMENT|1973-08-12||1964-01-11|||1964-05-27||1962-12-26
TRIAL STUDY 134XCP|RP|69530FE0-6896-4585-8B20-29AE90DB91F5|2||||||PREGST|PREGNANT DURING THE STUDY||||ML/M2/MIN|||LENS|NOT DONE||NA|Y|NA|2||58||SCREENING|1972-08-22||1960-11-10|||1968-04-21||1963-10-24
TRIAL STUDY 134XCP|RP|69530FE0-6896-4585-8B20-29AE90DB91F5|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||GY/MIN|||AMOL|NOT DONE||NA|N|N|3||39||BLINDED TREATMENT|1967-10-17||1964-01-13|||1962-04-02||1970-02-28
TRIAL STUDY 134XCP|RP|69530FE0-6896-4585-8B20-29AE90DB91F5|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||G/U|||MEQ/KG|NOT DONE||Y|N|NA|3||39||LONG-TERM FOLLOW-UP|1963-07-08||1962-02-07|||1963-02-02||1968-06-19
TRIAL STUDY 134XCP|RP|69530FE0-6896-4585-8B20-29AE90DB91F5|1||||||MASSIND|MASS INDICATOR||||CGY|||UIU/L|NOT DONE||N|U|N|4||88||SCREENING|1961-01-30||1960-02-12|||1969-10-15||1961-10-26
TRIAL STUDY 134XCP|RP|69530FE0-6896-4585-8B20-29AE90DB91F5|2||||||MENARAGE|MENARCHE AGE||||UG/MIN|||SEC|NOT DONE||NA|NA|Y|4||88||SCREENING|1969-04-25||1961-10-29|||1962-03-16||1961-12-25
TRIAL STUDY 134XCP|RP|69530FE0-6896-4585-8B20-29AE90DB91F5|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||G/CAGE/DAY|||UG/M2|NOT DONE||Y|N|U|5||7||SCREENING|1964-10-07||1961-02-06|||1964-02-26||1961-05-24
TRIAL STUDY 134XCP|RP|69530FE0-6896-4585-8B20-29AE90DB91F5|2||||||ABORTN|NUMBER OF ABORTIONS||||/4.0 ML|||UM2|NOT DONE||NA|U|U|5||7||RUN-IN|1962-08-24||1968-02-28|||1971-02-16||1971-05-30
TRIAL STUDY 134XCP|RP|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MG/DL|||TSP|NOT DONE||NA|NA|U|1||38||OBSERVATION|1960-02-01||1960-02-27|||1961-11-21||1970-07-31
TRIAL STUDY 134XCP|RP|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MG/KG|||SCM|NOT DONE||U|NA|U|1||38||BLINDED TREATMENT|1970-01-15||1961-12-09|||1970-04-30||1963-04-03
TRIAL STUDY 134XCP|RP|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||ML/SEC/1.73M2|||GBQ/MG|NOT DONE||N|U|NA|2||58||FOLLOW-UP|1969-08-03||1969-06-20|||1962-01-04||1960-05-09
TRIAL STUDY 134XCP|RP|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||/10^4|||KG/M2|NOT DONE||Y|U|U|2||58||BLINDED TREATMENT|1971-12-09||1966-12-06|||1964-03-16||1964-04-09
TRIAL STUDY 134XCP|RP|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|1||||||MENARAGE|MENARCHE AGE||||10^7 CFU|||10^3 RNA COPIES/ML|NOT DONE||U|NA|NA|3||39||OBSERVATION|1969-01-30||1969-09-05|||1962-04-21||1966-07-18
TRIAL STUDY 134XCP|RP|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|2||||||MENOAGE|MENOPAUSE AGE||||BQ|||FMOL/L|NOT DONE||Y|Y|N|3||39||INDUCTION TREATMENT|1966-03-25||1971-06-13|||1966-09-17||1967-11-21
TRIAL STUDY 134XCP|RP|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||10^3 ORGANISMS/ML|||AFU|NOT DONE||NA|NA|N|4||88||LONG-TERM FOLLOW-UP|1961-09-09||1971-08-05|||1966-05-06||1971-07-30
TRIAL STUDY 134XCP|RP|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||/MONTH|||10^7 CFU|NOT DONE||NA|Y|Y|4||88||WASHOUT|1968-08-07||1960-09-14|||1968-06-20||1969-06-25
TRIAL STUDY 134XCP|RP|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||GPL U/ML|||ML/DAY|NOT DONE||NA|NA|NA|5||7||INDUCTION TREATMENT|1961-09-14||1971-07-11|||1968-10-08||1960-03-09
TRIAL STUDY 134XCP|RP|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|2||||||GRAVIND|GRAVIDA INDICATOR||||PMOL/G|||/10^5|NOT DONE||Y|Y|Y|5||7||CONTINUATION TREATMENT|1971-09-22||1972-03-20|||1973-04-11||1963-03-06
TRIAL STUDY 134XCP|RP|F1EF928C-B819-4620-8991-ABDC4E182217|1||||||TNDRIND|TENDERNESS INDICATOR||||RFU|||LOZENGE|NOT DONE||U|Y|NA|1||38||OPEN LABEL TREATMENT|1961-02-19||1963-05-26|||1970-12-17||1967-10-17
TRIAL STUDY 134XCP|RP|F1EF928C-B819-4620-8991-ABDC4E182217|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||FL|||ML/G/MIN|NOT DONE||N|NA|Y|1||38||LONG-TERM FOLLOW-UP|1965-09-03||1962-07-08|||1969-02-02||1960-03-15
TRIAL STUDY 134XCP|RP|F1EF928C-B819-4620-8991-ABDC4E182217|1||||||MENARAGE|MENARCHE AGE||||10^3 COPIES/ML|||H*%|NOT DONE||N|N|U|2||58||BASELINE|1970-07-20||1973-08-10|||1964-12-06||1972-02-01
TRIAL STUDY 134XCP|RP|F1EF928C-B819-4620-8991-ABDC4E182217|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||BOX|||BISCUIT|NOT DONE||NA|Y|U|2||58||OPEN LABEL TREATMENT|1970-01-07||1969-04-14|||1972-07-26||1961-10-28
TRIAL STUDY 134XCP|RP|F1EF928C-B819-4620-8991-ABDC4E182217|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||BEAM BREAKS|||MHZ|NOT DONE||Y|U|NA|3||39||OBSERVATION|1964-08-31||1973-06-03|||1963-06-21||1963-04-23
TRIAL STUDY 134XCP|RP|F1EF928C-B819-4620-8991-ABDC4E182217|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MPL U|||PSEC|NOT DONE||Y|Y|N|3||39||BLINDED TREATMENT|1967-12-21||1965-07-07|||1972-11-18||1962-08-27
TRIAL STUDY 134XCP|RP|F1EF928C-B819-4620-8991-ABDC4E182217|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||PIXELS/IN|||CIGARETTE|NOT DONE||U|Y|Y|4||88||WASHOUT|1962-09-10||1963-05-19|||1960-01-13||1968-05-28
TRIAL STUDY 134XCP|RP|F1EF928C-B819-4620-8991-ABDC4E182217|2||||||PRGENDTC|DATE PREGNANCY ENDED||||PMOL/DL|||TBSP|NOT DONE||N|NA|N|4||88||INDUCTION TREATMENT|1963-08-25||1961-11-29|||1968-07-24||1966-09-30
TRIAL STUDY 134XCP|RP|F1EF928C-B819-4620-8991-ABDC4E182217|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||PA|||MG/G/H|NOT DONE||NA|NA|NA|5||7||CONTINUATION TREATMENT|1963-07-13||1964-11-30|||1963-03-17||1961-04-29
TRIAL STUDY 134XCP|RP|F1EF928C-B819-4620-8991-ABDC4E182217|2||||||DSCHGIND|DISCHARGE INDICATOR||||DNA COPIES/UG|||MEQ/MMOL|NOT DONE||U|U|NA|5||7||RUN-IN|1961-07-28||1966-03-06|||1973-06-07||1962-05-14
TRIAL STUDY 134XCP|RP|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MMHG*MIN/L|||U/ML|NOT DONE||NA|NA|N|1||38||OPEN LABEL TREATMENT|1962-05-21||1970-07-24|||1967-07-16||1961-06-13
TRIAL STUDY 134XCP|RP|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|2||||||PRGENDTC|DATE PREGNANCY ENDED||||UMOL/MIN|||G/KG|NOT DONE||Y|N|Y|1||38||OBSERVATION|1966-07-05||1972-05-09|||1963-12-11||1962-12-09
TRIAL STUDY 134XCP|RP|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|1||||||MENFDUR|MENSES FLOW DURATION||||LOG10 CFU/ML|||TSP EQ|NOT DONE||NA|Y|N|2||58||SCREENING|1965-12-21||1961-12-23|||1961-04-27||1960-05-16
TRIAL STUDY 134XCP|RP|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||HOURS|||BAG|NOT DONE||N|Y|N|2||58||TREATMENT|1964-07-04||1960-08-09|||1969-06-28||1960-01-18
TRIAL STUDY 134XCP|RP|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MILE|||BEATS/MIN|NOT DONE||NA|NA|Y|3||39||SCREENING|1963-09-17||1962-10-14|||1962-03-19||1961-10-22
TRIAL STUDY 134XCP|RP|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ML/M2/DAY|||U/KG/MIN|NOT DONE||Y|N|U|3||39||WASHOUT|1970-02-12||1961-03-27|||1967-08-10||1960-08-17
TRIAL STUDY 134XCP|RP|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UG/M2/H|||10^3/L|NOT DONE||N|Y|N|4||88||RUN-IN|1965-06-05||1967-12-20|||1963-11-28||1968-07-25
TRIAL STUDY 134XCP|RP|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|2||||||BLISTIND|BLISTERING INDICATOR||||MG/ML/MIN|||IU/L|NOT DONE||U|NA|Y|4||88||RUN-IN|1963-01-27||1963-01-01|||1960-02-04||1973-08-08
TRIAL STUDY 134XCP|RP|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||CAPLET|||OD UNIT|NOT DONE||U|U|U|5||7||BLINDED TREATMENT|1970-04-12||1969-03-07|||1971-03-06||1965-06-04
TRIAL STUDY 134XCP|RP|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|2||||||MENOAGE|MENOPAUSE AGE||||WAFER|||OZ|NOT DONE||U|Y|U|5||7||OPEN LABEL TREATMENT|1963-12-09||1961-09-11|||1967-09-20||1967-03-12
TRIAL STUDY 134XCP|RP|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|1||||||RASHIND|RASH INDICATOR||||HZ/S|||ML/G/DAY|NOT DONE||N|U|U|1||38||BASELINE|1972-04-08||1965-09-04|||1969-10-08||1973-07-06
TRIAL STUDY 134XCP|RP|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||GAUSS|||G|NOT DONE||NA|NA|N|1||38||WASHOUT|1968-04-17||1961-10-16|||1967-06-29||1965-02-04
TRIAL STUDY 134XCP|RP|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||LOG10 CCID 50/DOSE|||UG/KG/H|NOT DONE||NA|N|N|2||58||BLINDED TREATMENT|1969-10-15||1972-08-14|||1968-09-14||1960-01-10
TRIAL STUDY 134XCP|RP|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MMOL/G|||SACHET|NOT DONE||U|U|NA|2||58||RUN-IN|1969-03-06||1963-12-29|||1967-03-01||1968-02-19
TRIAL STUDY 134XCP|RP|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||CUP|||KPA|NOT DONE||NA|NA|NA|3||39||WASHOUT|1961-06-29||1967-08-11|||1969-05-01||1967-03-07
TRIAL STUDY 134XCP|RP|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|2||||||BRTHN|NUMBER OF BIRTHS||||BQ/KG|||10^3/HPF|NOT DONE||Y|NA|NA|3||39||LONG-TERM FOLLOW-UP|1969-05-11||1962-10-28|||1961-05-13||1973-07-06
TRIAL STUDY 134XCP|RP|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|1||||||RASHIND|RASH INDICATOR||||DAMOL/L|||HOUNSFIELD UNIT|NOT DONE||Y|Y|NA|4||88||INDUCTION TREATMENT|1967-08-31||1964-06-30|||1967-11-01||1966-12-26
TRIAL STUDY 134XCP|RP|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||10^6 ORGANISMS/MG|||BQ/UG|NOT DONE||NA|N|U|4||88||OBSERVATION|1969-09-10||1963-10-13|||1965-01-18||1960-12-23
TRIAL STUDY 134XCP|RP|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||PHERESIS UNIT|||MM3/MM2/YEAR|NOT DONE||NA|NA|Y|5||7||FOLLOW-UP|1966-11-05||1972-02-25|||1963-03-20||1965-11-14
TRIAL STUDY 134XCP|RP|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||H*%|||IU/L|NOT DONE||Y|N|N|5||7||WASHOUT|1971-04-19||1965-02-07|||1966-11-30||1966-10-23
TRIAL STUDY 134XCP|RP|27D5690D-BCB3-4FEC-988C-666C29D5239A|1||||||FUNDHT|FUNDAL HEIGHT||||APPLICATION|||U.CARR|NOT DONE||N|Y|U|1||38||CONTINUATION TREATMENT|1962-12-06||1964-09-13|||1972-04-28||1970-07-19
TRIAL STUDY 134XCP|RP|27D5690D-BCB3-4FEC-988C-666C29D5239A|2||||||DLVRMODE|MODE OF DELIVERY||||CD*S/M2|||10^4 CFU/ML|NOT DONE||NA|Y|U|1||38||WASHOUT|1968-10-24||1960-01-18|||1961-06-04||1961-03-21
TRIAL STUDY 134XCP|RP|27D5690D-BCB3-4FEC-988C-666C29D5239A|1||||||STILBIND|STILLBIRTH INDICATOR||||DISK|||DB|NOT DONE||U|Y|N|2||58||LONG-TERM FOLLOW-UP|1960-04-10||1961-02-18|||1968-02-27||1971-12-01
TRIAL STUDY 134XCP|RP|27D5690D-BCB3-4FEC-988C-666C29D5239A|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||BREATHS/MIN|||10^6 CFU/G|NOT DONE||U|N|Y|2||58||TREATMENT|1972-01-29||1968-09-25|||1964-04-05||1966-02-26
TRIAL STUDY 134XCP|RP|27D5690D-BCB3-4FEC-988C-666C29D5239A|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UM/DAY|||S*KPA|NOT DONE||U|N|Y|3||39||BASELINE|1963-10-23||1969-03-06|||1966-09-20||1967-02-11
TRIAL STUDY 134XCP|RP|27D5690D-BCB3-4FEC-988C-666C29D5239A|2||||||THICK|THICKNESS||||LOG10 TCID 50/UL|||FT3|NOT DONE||NA|NA|Y|3||39||LONG-TERM FOLLOW-UP|1965-06-27||1966-03-06|||1967-05-13||1960-11-09
TRIAL STUDY 134XCP|RP|27D5690D-BCB3-4FEC-988C-666C29D5239A|1||||||DLVRMODE|MODE OF DELIVERY||||LOG10 CCID 50/DOSE|||10^6/G|NOT DONE||Y|Y|Y|4||88||BASELINE|1961-05-01||1962-01-31|||1971-07-27||1962-11-07
TRIAL STUDY 134XCP|RP|27D5690D-BCB3-4FEC-988C-666C29D5239A|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MMOL|||U|NOT DONE||U|U|NA|4||88||CONTINUATION TREATMENT|1969-07-15||1973-02-05|||1972-01-02||1967-10-22
TRIAL STUDY 134XCP|RP|27D5690D-BCB3-4FEC-988C-666C29D5239A|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||CMH2O*S2/ML|||PMOL/G|NOT DONE||U|N|N|5||7||TREATMENT|1963-11-12||1966-12-14|||1973-05-23||1961-03-24
TRIAL STUDY 134XCP|RP|27D5690D-BCB3-4FEC-988C-666C29D5239A|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^11/L|||CMOL/L|NOT DONE||N|N|U|5||7||BLINDED TREATMENT|1963-07-31||1963-06-02|||1968-06-14||1969-01-08
TRIAL STUDY 134XCP|RP|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|1||||||MENARAGE|MENARCHE AGE||||WEBER|||MG/ML/MIN|NOT DONE||NA|Y|U|1||38||LONG-TERM FOLLOW-UP|1963-05-21||1964-08-04|||1963-09-12||1965-06-12
TRIAL STUDY 134XCP|RP|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|2||||||ERYTHIND|ERYTHEMA INDICATOR||||L/DAY|||MMHG/SEC|NOT DONE||U|N|U|1||38||CONTINUATION TREATMENT|1967-10-07||1962-05-08|||1964-02-03||1972-03-24
TRIAL STUDY 134XCP|RP|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|1||||||PEELIND|PEELING INDICATOR||||NL|||G/ANIMAL|NOT DONE||U|NA|U|2||58||WASHOUT|1968-12-02||1970-02-16|||1966-05-04||1961-10-29
TRIAL STUDY 134XCP|RP|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|2||||||BCMETHOD|BIRTH CONTROL METHOD||||MOL/MOL|||JOULE|NOT DONE||NA|NA|N|2||58||WASHOUT|1964-08-26||1972-08-20|||1970-06-01||1970-07-13
TRIAL STUDY 134XCP|RP|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||M|||FFU|NOT DONE||U|Y|N|3||39||WASHOUT|1972-04-27||1964-07-21|||1967-01-03||1970-09-12
TRIAL STUDY 134XCP|RP|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^6 IU/ML|||C|NOT DONE||N|NA|NA|3||39||WASHOUT|1961-09-10||1964-04-16|||1960-12-31||1970-08-31
TRIAL STUDY 134XCP|RP|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|1||||||ABORTN|NUMBER OF ABORTIONS||||U/CL|||CUP|NOT DONE||NA|Y|U|4||88||RUN-IN|1972-11-29||1962-10-01|||1965-01-05||1963-04-28
TRIAL STUDY 134XCP|RP|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||M/SEC|||U/M2/MIN|NOT DONE||U|N|N|4||88||OPEN LABEL TREATMENT|1966-02-02||1970-07-16|||1967-03-14||1971-04-11
TRIAL STUDY 134XCP|RP|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|1||||||MASSIND|MASS INDICATOR||||U/M2/DAY|||U/KG/DAY|NOT DONE||N|Y|U|5||7||WASHOUT|1960-04-24||1964-11-24|||1966-06-28||1972-10-13
TRIAL STUDY 134XCP|RP|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|2||||||BLISTIND|BLISTERING INDICATOR||||ML/SEC/1.73M2|||JAR|NOT DONE||N|NA|U|5||7||SCREENING|1962-11-16||1970-01-21|||1960-08-31||1966-05-08
TRIAL STUDY 134XCP|RP|8E25F21F-A565-40CB-B0D7-6CC496171293|1||||||THICK|THICKNESS||||CG|||IU/L|NOT DONE||NA|NA|U|1||38||INDUCTION TREATMENT|1968-05-26||1969-09-03|||1965-08-06||1970-06-09
TRIAL STUDY 134XCP|RP|8E25F21F-A565-40CB-B0D7-6CC496171293|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||NMOL|||CCID 50/DOSE|NOT DONE||U|NA|NA|1||38||INDUCTION TREATMENT|1961-03-03||1967-11-18|||1966-10-10||1964-03-17
TRIAL STUDY 134XCP|RP|8E25F21F-A565-40CB-B0D7-6CC496171293|1||||||PREGNN|NUMBER OF PREGNANCIES||||ML/MIN/1.73M2|||10^7 PFU|NOT DONE||U|NA|NA|2||58||WASHOUT|1969-03-03||1968-09-22|||1973-05-10||1965-11-01
TRIAL STUDY 134XCP|RP|8E25F21F-A565-40CB-B0D7-6CC496171293|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MM3/MM2/YEAR|||LOG10 CCID 50/DOSE|NOT DONE||N|NA|U|2||58||TREATMENT|1970-06-25||1972-07-14|||1965-11-10||1972-09-18
TRIAL STUDY 134XCP|RP|8E25F21F-A565-40CB-B0D7-6CC496171293|1||||||INTP|INTERPRETATION||||MV2/HZ|||G/CAGE|NOT DONE||Y|Y|N|3||39||OBSERVATION|1973-08-18||1964-03-11|||1970-11-25||1967-12-22
TRIAL STUDY 134XCP|RP|8E25F21F-A565-40CB-B0D7-6CC496171293|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||F|||U/G|NOT DONE||N|N|Y|3||39||BASELINE|1970-08-25||1969-01-07|||1972-09-04||1967-04-13
TRIAL STUDY 134XCP|RP|8E25F21F-A565-40CB-B0D7-6CC496171293|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||PIXELS/CM|||10^9 CFU/G|NOT DONE||Y|NA|U|4||88||SCREENING|1962-11-26||1968-08-06|||1973-07-01||1968-10-18
TRIAL STUDY 134XCP|RP|8E25F21F-A565-40CB-B0D7-6CC496171293|2||||||PRGENDTC|DATE PREGNANCY ENDED||||G/ANIMAL|||MMOL/MIN/KPA/L|NOT DONE||U|NA|U|4||88||OBSERVATION|1971-05-14||1972-08-26|||1962-12-25||1966-07-19
TRIAL STUDY 134XCP|RP|8E25F21F-A565-40CB-B0D7-6CC496171293|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MANSON U/ML|||MCI/KG|NOT DONE||N|N|NA|5||7||SCREENING|1970-09-12||1966-10-27|||1960-03-29||1971-04-02
TRIAL STUDY 134XCP|RP|8E25F21F-A565-40CB-B0D7-6CC496171293|2||||||MENARAGE|MENARCHE AGE||||DAGU|||NMOL/ML/MIN|NOT DONE||N|N|U|5||7||OBSERVATION|1971-11-02||1969-02-20|||1972-11-18||1962-11-12
TRIAL STUDY 134XCP|RP|8CDD2247-485D-495C-9186-FF4CA3FFC32E|1||||||MENFDUR|MENSES FLOW DURATION||||UMOL/L/MIN|||GPL U/ML|NOT DONE||N|NA|NA|1||38||OBSERVATION|1963-10-13||1969-06-05|||1962-12-29||1973-05-02
TRIAL STUDY 134XCP|RP|8CDD2247-485D-495C-9186-FF4CA3FFC32E|2||||||STILBIND|STILLBIRTH INDICATOR||||ML/MIN/MMHG|||STEPS|NOT DONE||U|N|Y|1||38||INDUCTION TREATMENT|1968-06-02||1969-06-21|||1970-02-11||1962-12-05
TRIAL STUDY 134XCP|RP|8CDD2247-485D-495C-9186-FF4CA3FFC32E|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||/7.5 ML|||AFU|NOT DONE||N|Y|N|2||58||OPEN LABEL TREATMENT|1960-06-18||1972-08-15|||1966-07-23||1964-01-23
TRIAL STUDY 134XCP|RP|8CDD2247-485D-495C-9186-FF4CA3FFC32E|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^3 DNA COPIES/ML|||LOG10 TCID 50/DOSE|NOT DONE||NA|NA|NA|2||58||OPEN LABEL TREATMENT|1971-01-21||1961-08-10|||1963-03-05||1972-02-09
TRIAL STUDY 134XCP|RP|8CDD2247-485D-495C-9186-FF4CA3FFC32E|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^3 ORGANISMS/ML|||SACHET|NOT DONE||Y|U|Y|3||39||BLINDED TREATMENT|1961-10-14||1970-10-18|||1968-04-03||1971-01-31
TRIAL STUDY 134XCP|RP|8CDD2247-485D-495C-9186-FF4CA3FFC32E|2||||||MENARAGE|MENARCHE AGE||||/MIN|||UMOL/DL|NOT DONE||Y|NA|Y|3||39||FOLLOW-UP|1973-04-18||1961-11-03|||1967-07-30||1968-11-03
TRIAL STUDY 134XCP|RP|8CDD2247-485D-495C-9186-FF4CA3FFC32E|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||LOG10 TCID 50/DOSE|||APL U/ML|NOT DONE||NA|N|U|4||88||CONTINUATION TREATMENT|1960-08-01||1968-02-05|||1969-02-28||1973-07-18
TRIAL STUDY 134XCP|RP|8CDD2247-485D-495C-9186-FF4CA3FFC32E|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MEQ/L|||DPM|NOT DONE||U|Y|NA|4||88||BLINDED TREATMENT|1960-10-22||1967-02-07|||1961-09-28||1961-02-05
TRIAL STUDY 134XCP|RP|8CDD2247-485D-495C-9186-FF4CA3FFC32E|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||/10^4|||ELISA UNIT/DOSE|NOT DONE||N|NA|N|5||7||RUN-IN|1961-02-01||1961-06-15|||1970-04-08||1966-04-22
TRIAL STUDY 134XCP|RP|8CDD2247-485D-495C-9186-FF4CA3FFC32E|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||/LPF|||CL|NOT DONE||U|N|N|5||7||LONG-TERM FOLLOW-UP|1971-10-24||1968-08-15|||1968-12-07||1966-05-23
TRIAL STUDY 134XCP|RP|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|1||||||PEELIND|PEELING INDICATOR||||PHERESIS UNIT|||ENZYME U/G HB|NOT DONE||N|N|U|1||38||LONG-TERM FOLLOW-UP|1960-11-17||1972-06-07|||1962-06-16||1960-05-27
TRIAL STUDY 134XCP|RP|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||KHZ|||G/L|NOT DONE||U|U|Y|1||38||BASELINE|1962-05-07||1960-02-04|||1960-08-11||1971-01-18
TRIAL STUDY 134XCP|RP|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|1||||||PREGST|PREGNANT DURING THE STUDY||||PPTH|||10^6 ORGANISMS/MG|NOT DONE||N|NA|Y|2||58||OPEN LABEL TREATMENT|1972-08-06||1969-01-21|||1967-02-27||1961-06-16
TRIAL STUDY 134XCP|RP|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||UMOL/MG/MIN|||SBE/ML|NOT DONE||NA|N|Y|2||58||RUN-IN|1969-01-29||1969-10-06|||1961-09-26||1963-03-21
TRIAL STUDY 134XCP|RP|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|1||||||INABOIND|INDUCED ABORTION INDICATOR||||U/G HB|||10^6 CFU/G|NOT DONE||U|U|NA|3||39||RUN-IN|1969-08-28||1967-06-26|||1968-04-04||1966-02-23
TRIAL STUDY 134XCP|RP|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|2||||||PREGNN|NUMBER OF PREGNANCIES||||VIRTUAL PIXEL|||UG/ML/H|NOT DONE||Y|Y|U|3||39||LONG-TERM FOLLOW-UP|1966-08-11||1966-03-01|||1960-08-23||1971-08-12
TRIAL STUDY 134XCP|RP|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||%(W/W)|||MG/ANIMAL|NOT DONE||U|Y|Y|4||88||TREATMENT|1966-07-17||1971-05-28|||1964-10-23||1967-10-11
TRIAL STUDY 134XCP|RP|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|2||||||BRTHN|NUMBER OF BIRTHS||||ML/G/DAY|||10^6/G|NOT DONE||N|Y|Y|4||88||RUN-IN|1973-04-06||1970-04-17|||1963-03-26||1972-09-19
TRIAL STUDY 134XCP|RP|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|1||||||PUSTIND|PUSTULE INDICATOR||||PIXELS/CM|||NEWTON|NOT DONE||N|U|NA|5||7||INDUCTION TREATMENT|1971-05-26||1970-08-29|||1973-06-07||1972-07-31
TRIAL STUDY 134XCP|RP|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||CCID 50/DOSE|||UG/DAY|NOT DONE||N|N|NA|5||7||RUN-IN|1965-01-21||1971-10-16|||1970-03-03||1960-02-16
TRIAL STUDY 134XCP|RP|C004A8EB-220F-4FC5-A150-B5159DCA84D9|1||||||THICK|THICKNESS||||PT_US|||KCAL/DAY|NOT DONE||U|Y|N|1||38||CONTINUATION TREATMENT|1963-02-17||1971-12-18|||1970-07-14||1969-05-02
TRIAL STUDY 134XCP|RP|C004A8EB-220F-4FC5-A150-B5159DCA84D9|2||||||PREGIND|PREGNANT INDICATOR||||DPM/MG|||FIU|NOT DONE||N|N|NA|1||38||RUN-IN|1967-09-03||1963-02-09|||1969-04-01||1964-01-28
TRIAL STUDY 134XCP|RP|C004A8EB-220F-4FC5-A150-B5159DCA84D9|1||||||PEELIND|PEELING INDICATOR||||NMOL/KG/DAY|||MG/KG/H|NOT DONE||Y|Y|Y|2||58||BLINDED TREATMENT|1961-06-01||1969-09-20|||1960-05-06||1962-12-26
TRIAL STUDY 134XCP|RP|C004A8EB-220F-4FC5-A150-B5159DCA84D9|2||||||FUNDHT|FUNDAL HEIGHT||||MMOL/MOL|||AMU|NOT DONE||NA|NA|Y|2||58||BASELINE|1973-03-27||1967-10-06|||1966-01-07||1962-09-07
TRIAL STUDY 134XCP|RP|C004A8EB-220F-4FC5-A150-B5159DCA84D9|1||||||GRAVIND|GRAVIDA INDICATOR||||PACKAGE|||MONTHS|NOT DONE||NA|N|NA|3||39||RUN-IN|1973-06-14||1964-02-05|||1960-09-13||1962-10-01
TRIAL STUDY 134XCP|RP|C004A8EB-220F-4FC5-A150-B5159DCA84D9|2||||||DLVRMODE|MODE OF DELIVERY||||BEATS/MIN|||EJACULATE U|NOT DONE||N|N|N|3||39||INDUCTION TREATMENT|1972-09-29||1966-01-10|||1965-07-11||1961-01-04
TRIAL STUDY 134XCP|RP|C004A8EB-220F-4FC5-A150-B5159DCA84D9|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UMOL|||DPM/MG|NOT DONE||NA|N|Y|4||88||OPEN LABEL TREATMENT|1965-09-16||1963-07-19|||1973-07-15||1970-11-18
TRIAL STUDY 134XCP|RP|C004A8EB-220F-4FC5-A150-B5159DCA84D9|2||||||EDEMAIND|EDEMA INDICATOR||||KHZ|||ML/ANIMAL/DAY|NOT DONE||Y|NA|NA|4||88||BASELINE|1966-10-23||1965-01-10|||1960-10-04||1963-07-06
TRIAL STUDY 134XCP|RP|C004A8EB-220F-4FC5-A150-B5159DCA84D9|1||||||BCMETHOD|BIRTH CONTROL METHOD||||LOG10 COPIES/ML|||HOMEOPATHIC DILUTION|NOT DONE||Y|NA|NA|5||7||LONG-TERM FOLLOW-UP|1966-11-17||1968-06-13|||1970-09-27||1973-04-10
TRIAL STUDY 134XCP|RP|C004A8EB-220F-4FC5-A150-B5159DCA84D9|2||||||BLISTIND|BLISTERING INDICATOR||||COPIES/UL|||NG/MOL|NOT DONE||NA|NA|Y|5||7||RUN-IN|1970-10-06||1965-03-23|||1967-01-02||1968-05-02
TRIAL STUDY 134XCP|RP|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||VP/ML|||PT_BR|NOT DONE||U|NA|N|1||38||RUN-IN|1969-05-09||1963-01-24|||1972-07-04||1970-10-03
TRIAL STUDY 134XCP|RP|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||LINEAR FT*LB|||MG/MIN|NOT DONE||NA|N|N|1||38||BASELINE|1971-02-23||1965-10-14|||1963-09-17||1962-09-22
TRIAL STUDY 134XCP|RP|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|1||||||MENOAGE|MENOPAUSE AGE||||KG/M2|||APL U/ML|NOT DONE||U|U|N|2||58||LONG-TERM FOLLOW-UP|1969-04-01||1972-06-30|||1970-07-28||1960-06-22
TRIAL STUDY 134XCP|RP|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||NKAT/L|||GPL U/ML|NOT DONE||NA|NA|Y|2||58||OBSERVATION|1963-05-24||1969-02-21|||1969-07-02||1971-07-04
TRIAL STUDY 134XCP|RP|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||PG|||MPL U/ML|NOT DONE||N|N|Y|3||39||FOLLOW-UP|1960-03-21||1964-05-28|||1961-11-07||1961-12-07
TRIAL STUDY 134XCP|RP|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|2||||||BLISTIND|BLISTERING INDICATOR||||/4.0 ML|||CG|NOT DONE||U|NA|NA|3||39||BLINDED TREATMENT|1966-10-17||1963-08-01|||1962-11-07||1967-11-11
TRIAL STUDY 134XCP|RP|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|1||||||PUSTIND|PUSTULE INDICATOR||||/500 WBC|||/10^3|NOT DONE||U|N|NA|4||88||OBSERVATION|1963-02-11||1961-02-08|||1966-09-25||1963-06-13
TRIAL STUDY 134XCP|RP|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||/MONTH|||SUPPOSITORY|NOT DONE||N|N|N|4||88||SCREENING|1964-04-15||1963-09-15|||1960-02-29||1965-09-17
TRIAL STUDY 134XCP|RP|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|1||||||EDEMAIND|EDEMA INDICATOR||||NKAT/G HB|||G/L|NOT DONE||N|NA|Y|5||7||OBSERVATION|1960-03-10||1966-12-07|||1970-11-17||1968-09-05
TRIAL STUDY 134XCP|RP|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||BQ/UL|||MG/G/MIN|NOT DONE||U|U|NA|5||7||CONTINUATION TREATMENT|1964-07-23||1962-09-09|||1962-05-12||1969-09-18
TRIAL STUDY 134XCP|RP|AE127EDD-D708-4B1A-95F7-176A541A9584|1||||||MENFDUR|MENSES FLOW DURATION||||MM3/MM2/YEAR|||ML/MMHG|NOT DONE||U|N|Y|1||38||OPEN LABEL TREATMENT|1966-09-10||1963-12-03|||1969-01-15||1961-08-06
TRIAL STUDY 134XCP|RP|AE127EDD-D708-4B1A-95F7-176A541A9584|2||||||FUNDHT|FUNDAL HEIGHT||||10^3/HPF|||SPRAY|NOT DONE||NA|NA|Y|1||38||LONG-TERM FOLLOW-UP|1963-04-07||1960-11-27|||1961-01-11||1965-09-19
TRIAL STUDY 134XCP|RP|AE127EDD-D708-4B1A-95F7-176A541A9584|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||BQ/UL|||NG|NOT DONE||NA|NA|Y|2||58||LONG-TERM FOLLOW-UP|1965-01-26||1964-03-27|||1969-02-01||1969-03-04
TRIAL STUDY 134XCP|RP|AE127EDD-D708-4B1A-95F7-176A541A9584|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||PLUG|||100 IU/ML|NOT DONE||NA|U|N|2||58||CONTINUATION TREATMENT|1960-02-21||1966-07-29|||1961-07-11||1972-04-25
TRIAL STUDY 134XCP|RP|AE127EDD-D708-4B1A-95F7-176A541A9584|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||SEC|||10^6/EJACULATE U|NOT DONE||NA|NA|U|3||39||OPEN LABEL TREATMENT|1963-05-10||1964-09-22|||1967-10-30||1967-09-28
TRIAL STUDY 134XCP|RP|AE127EDD-D708-4B1A-95F7-176A541A9584|2||||||MENARAGE|MENARCHE AGE||||UV*SEC|||MG/KG/MIN|NOT DONE||U|NA|U|3||39||SCREENING|1971-07-15||1962-08-11|||1969-02-16||1967-05-31
TRIAL STUDY 134XCP|RP|AE127EDD-D708-4B1A-95F7-176A541A9584|1||||||BLISTIND|BLISTERING INDICATOR||||FMOL/G|||NMOL/L/H|NOT DONE||Y|Y|U|4||88||SCREENING|1960-07-20||1970-03-15|||1972-05-05||1962-01-17
TRIAL STUDY 134XCP|RP|AE127EDD-D708-4B1A-95F7-176A541A9584|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MG/M2/H|||/WK|NOT DONE||N|NA|U|4||88||BLINDED TREATMENT|1969-05-10||1969-09-30|||1971-06-09||1963-02-17
TRIAL STUDY 134XCP|RP|AE127EDD-D708-4B1A-95F7-176A541A9584|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||WAFER|||IN2|NOT DONE||N|Y|Y|5||7||BASELINE|1965-11-06||1964-02-17|||1968-05-17||1970-09-09
TRIAL STUDY 134XCP|RP|AE127EDD-D708-4B1A-95F7-176A541A9584|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UG/KG/H|||NKAT/L|NOT DONE||NA|U|N|5||7||RUN-IN|1971-07-07||1972-05-02|||1969-09-11||1960-06-16
TRIAL STUDY 134XCP|RP|F642D4A0-A67F-4A10-BB21-E4644E963D45|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||/H|||AMFI|NOT DONE||N|NA|N|1||38||RUN-IN|1960-08-15||1971-05-25|||1973-03-30||1962-06-17
TRIAL STUDY 134XCP|RP|F642D4A0-A67F-4A10-BB21-E4644E963D45|2||||||GRAVIND|GRAVIDA INDICATOR||||G/ANIMAL/WK|||LOG10 ELISA UNIT/DOSE|NOT DONE||N|Y|NA|1||38||SCREENING|1973-01-02||1965-08-01|||1965-09-06||1960-11-09
TRIAL STUDY 134XCP|RP|F642D4A0-A67F-4A10-BB21-E4644E963D45|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||PRESSOR UNITS|||MEQ/MMOL|NOT DONE||U|Y|NA|2||58||OPEN LABEL TREATMENT|1966-03-21||1968-08-08|||1962-05-23||1969-04-11
TRIAL STUDY 134XCP|RP|F642D4A0-A67F-4A10-BB21-E4644E963D45|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MBQ/UL|||MG/L FEU|NOT DONE||NA|Y|N|2||58||SCREENING|1960-01-08||1967-05-22|||1970-08-26||1961-06-07
TRIAL STUDY 134XCP|RP|F642D4A0-A67F-4A10-BB21-E4644E963D45|1||||||PEELIND|PEELING INDICATOR||||BOX|||TORR|NOT DONE||N|NA|N|3||39||FOLLOW-UP|1963-01-27||1960-08-02|||1969-10-24||1970-07-19
TRIAL STUDY 134XCP|RP|F642D4A0-A67F-4A10-BB21-E4644E963D45|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||PFU/ML|||MEQ/KG|NOT DONE||Y|NA|N|3||39||FOLLOW-UP|1968-02-25||1963-12-09|||1965-12-29||1972-01-04
TRIAL STUDY 134XCP|RP|F642D4A0-A67F-4A10-BB21-E4644E963D45|1||||||INABOIND|INDUCED ABORTION INDICATOR||||H/WK|||10^9 CFU|NOT DONE||N|Y|N|4||88||LONG-TERM FOLLOW-UP|1972-11-16||1969-07-30|||1972-02-09||1960-04-13
TRIAL STUDY 134XCP|RP|F642D4A0-A67F-4A10-BB21-E4644E963D45|2||||||BLISTIND|BLISTERING INDICATOR||||MG/M2/DAY|||10^9/DOSE|NOT DONE||U|Y|NA|4||88||CONTINUATION TREATMENT|1964-11-05||1966-05-19|||1967-07-26||1966-06-04
TRIAL STUDY 134XCP|RP|F642D4A0-A67F-4A10-BB21-E4644E963D45|1||||||ABORTN|NUMBER OF ABORTIONS||||KHZ|||U/KG/MIN|NOT DONE||U|Y|NA|5||7||WASHOUT|1965-11-06||1972-08-24|||1963-12-06||1964-10-31
TRIAL STUDY 134XCP|RP|F642D4A0-A67F-4A10-BB21-E4644E963D45|2||||||ABORTN|NUMBER OF ABORTIONS||||DEG/S|||MG2/DL2|NOT DONE||N|Y|N|5||7||TREATMENT|1971-10-01||1965-11-28|||1971-02-16||1973-06-19
TRIAL STUDY 134XCP|RP|933A6DFF-D519-46F4-AB52-78E6A898E4A1|1||||||DSCHGIND|DISCHARGE INDICATOR||||BEAM BREAKS|||UMOL/DAY|NOT DONE||NA|U|N|1||38||BASELINE|1973-03-25||1960-09-07|||1972-05-04||1969-11-15
TRIAL STUDY 134XCP|RP|933A6DFF-D519-46F4-AB52-78E6A898E4A1|2||||||PREGIND|PREGNANT INDICATOR||||BLOCKS|||L/MIN|NOT DONE||NA|N|NA|1||38||LONG-TERM FOLLOW-UP|1962-06-08||1962-10-26|||1961-03-17||1964-08-15
TRIAL STUDY 134XCP|RP|933A6DFF-D519-46F4-AB52-78E6A898E4A1|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||/MBP|||TSP EQ|NOT DONE||Y|N|NA|2||58||LONG-TERM FOLLOW-UP|1964-06-22||1961-09-08|||1969-08-24||1966-09-01
TRIAL STUDY 134XCP|RP|933A6DFF-D519-46F4-AB52-78E6A898E4A1|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||GY|||V/V|NOT DONE||Y|NA|Y|2||58||BASELINE|1965-02-27||1964-03-09|||1964-05-16||1973-04-27
TRIAL STUDY 134XCP|RP|933A6DFF-D519-46F4-AB52-78E6A898E4A1|1||||||TNDRIND|TENDERNESS INDICATOR||||PMOL/L|||SCM|NOT DONE||Y|NA|U|3||39||OPEN LABEL TREATMENT|1967-10-14||1970-08-24|||1962-06-29||1964-11-02
TRIAL STUDY 134XCP|RP|933A6DFF-D519-46F4-AB52-78E6A898E4A1|2||||||PREGNN|NUMBER OF PREGNANCIES||||G/CAGE/DAY|||ELISA UNIT/ML|NOT DONE||N|Y|Y|3||39||INDUCTION TREATMENT|1964-12-12||1962-08-04|||1970-10-25||1973-05-06
TRIAL STUDY 134XCP|RP|933A6DFF-D519-46F4-AB52-78E6A898E4A1|1||||||PREGNN|NUMBER OF PREGNANCIES||||G/KG/DAY|||GLOBULE|NOT DONE||U|N|Y|4||88||BLINDED TREATMENT|1970-07-20||1962-09-12|||1961-12-24||1969-01-12
TRIAL STUDY 134XCP|RP|933A6DFF-D519-46F4-AB52-78E6A898E4A1|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/MM|||ML/G/MIN|NOT DONE||NA|N|Y|4||88||TREATMENT|1960-10-27||1964-05-09|||1962-10-07||1966-06-21
TRIAL STUDY 134XCP|RP|933A6DFF-D519-46F4-AB52-78E6A898E4A1|1||||||BCMETHOD|BIRTH CONTROL METHOD||||ML/ANIMAL|||GBQ/G|NOT DONE||U|N|U|5||7||OBSERVATION|1971-03-08||1966-11-21|||1970-04-29||1962-04-29
TRIAL STUDY 134XCP|RP|933A6DFF-D519-46F4-AB52-78E6A898E4A1|2||||||BCMETHOD|BIRTH CONTROL METHOD||||CYCLE/MIN|||NKAT|NOT DONE||NA|U|NA|5||7||LONG-TERM FOLLOW-UP|1965-07-11||1968-11-01|||1969-01-20||1968-06-04
TRIAL STUDY 134XCP|RP|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||TESLA|||AU/ML|NOT DONE||Y|NA|U|1||38||FOLLOW-UP|1969-04-09||1962-10-06|||1970-02-27||1961-07-29
TRIAL STUDY 134XCP|RP|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|2||||||DLVRMODE|MODE OF DELIVERY||||IN|||LOG10 TCID 50/ML|NOT DONE||NA|Y|Y|1||38||BASELINE|1961-08-09||1965-11-18|||1971-01-20||1969-11-22
TRIAL STUDY 134XCP|RP|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|1||||||MASSIND|MASS INDICATOR||||G/CAGE/DAY|||G/ANIMAL/WK|NOT DONE||Y|U|Y|2||58||CONTINUATION TREATMENT|1964-12-31||1963-09-14|||1966-06-27||1968-10-04
TRIAL STUDY 134XCP|RP|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||ML/DAY|||L/MIN/M2|NOT DONE||Y|Y|N|2||58||RUN-IN|1961-03-17||1960-01-29|||1972-12-25||1972-08-22
TRIAL STUDY 134XCP|RP|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|1||||||BLISTIND|BLISTERING INDICATOR||||HZ|||10^6 CFU/ML|NOT DONE||NA|U|U|3||39||SCREENING|1973-05-29||1967-05-24|||1972-07-15||1960-09-08
TRIAL STUDY 134XCP|RP|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|2||||||DLVRMODE|MODE OF DELIVERY||||UM|||NFIU|NOT DONE||N|Y|NA|3||39||OPEN LABEL TREATMENT|1971-06-10||1961-06-22|||1970-12-04||1968-03-30
TRIAL STUDY 134XCP|RP|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MG/DOSE|||COPIES/UG|NOT DONE||U|Y|N|4||88||CONTINUATION TREATMENT|1962-04-26||1972-02-06|||1965-09-11||1962-12-05
TRIAL STUDY 134XCP|RP|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|2||||||RASHIND|RASH INDICATOR||||TSP EQ|||ML/CAGE/WK|NOT DONE||Y|NA|NA|4||88||OPEN LABEL TREATMENT|1965-05-11||1962-01-21|||1970-03-25||1965-08-15
TRIAL STUDY 134XCP|RP|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|1||||||MENOSTAT|MENOPAUSE STATUS||||/VF|||NMOL/L/MIN|NOT DONE||U|N|NA|5||7||WASHOUT|1965-11-26||1972-01-18|||1961-06-21||1969-04-03
TRIAL STUDY 134XCP|RP|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MEQ/L|||S*KPA|NOT DONE||NA|N|N|5||7||CONTINUATION TREATMENT|1962-12-10||1960-04-30|||1965-11-21||1960-01-12
TRIAL STUDY 134XCP|RP|38E177D4-1A58-4E78-90B7-85F76BF66826|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||ML/ANIMAL/DAY|||ML/M2/H|NOT DONE||N|U|Y|1||38||RUN-IN|1970-06-14||1973-03-20|||1967-01-08||1961-04-08
TRIAL STUDY 134XCP|RP|38E177D4-1A58-4E78-90B7-85F76BF66826|2||||||STILBIND|STILLBIRTH INDICATOR||||ML/MIN/MMHG|||DISK|NOT DONE||Y|N|NA|1||38||TREATMENT|1965-04-13||1965-12-12|||1971-07-24||1965-06-14
TRIAL STUDY 134XCP|RP|38E177D4-1A58-4E78-90B7-85F76BF66826|1||||||PRGENDTC|DATE PREGNANCY ENDED||||MONTHS|||ML/ANIMAL/DAY|NOT DONE||NA|N|N|2||58||INDUCTION TREATMENT|1965-04-05||1961-07-30|||1972-06-19||1971-06-04
TRIAL STUDY 134XCP|RP|38E177D4-1A58-4E78-90B7-85F76BF66826|2||||||STILBIND|STILLBIRTH INDICATOR||||RATIO|||KCAL|NOT DONE||Y|U|N|2||58||TREATMENT|1967-03-08||1967-02-01|||1969-02-17||1967-10-09
TRIAL STUDY 134XCP|RP|38E177D4-1A58-4E78-90B7-85F76BF66826|1||||||STILBIND|STILLBIRTH INDICATOR||||MOSM/L|||MCI/L|NOT DONE||U|NA|N|3||39||WASHOUT|1971-09-17||1968-05-31|||1960-10-16||1969-02-23
TRIAL STUDY 134XCP|RP|38E177D4-1A58-4E78-90B7-85F76BF66826|2||||||ABORTN|NUMBER OF ABORTIONS||||PACK|||PG/L|NOT DONE||N|Y|Y|3||39||INDUCTION TREATMENT|1961-09-02||1964-07-21|||1970-08-07||1969-10-04
TRIAL STUDY 134XCP|RP|38E177D4-1A58-4E78-90B7-85F76BF66826|1||||||PRGENDTC|DATE PREGNANCY ENDED||||/7.5 ML|||GRAIN|NOT DONE||Y|NA|Y|4||88||OBSERVATION|1966-04-02||1967-01-16|||1960-08-14||1973-01-26
TRIAL STUDY 134XCP|RP|38E177D4-1A58-4E78-90B7-85F76BF66826|2||||||ULCERIND|ULCER INDICATOR||||UG/KG/DAY|||NMOL/ML/MIN|NOT DONE||N|NA|Y|4||88||OBSERVATION|1963-01-10||1972-05-30|||1966-01-30||1964-09-18
TRIAL STUDY 134XCP|RP|38E177D4-1A58-4E78-90B7-85F76BF66826|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MAMP|||ANTI-XA IU|NOT DONE||N|NA|U|5||7||TREATMENT|1963-11-16||1962-05-16|||1966-08-05||1962-04-28
TRIAL STUDY 134XCP|RP|38E177D4-1A58-4E78-90B7-85F76BF66826|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MG/KG/DAY|||10^9 ORGANISMS/ML|NOT DONE||NA|U|N|5||7||CONTINUATION TREATMENT|1966-03-17||1969-10-17|||1970-08-26||1961-08-16
TRIAL STUDY 134XCP|RP|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||CMHG|||MOSM/L|NOT DONE||NA|NA|N|1||38||WASHOUT|1963-02-27||1965-10-22|||1967-03-11||1971-08-16
TRIAL STUDY 134XCP|RP|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|2||||||MENFDUR|MENSES FLOW DURATION||||UG/M2|||PFU/ANIMAL|NOT DONE||NA|Y|U|1||38||SCREENING|1966-06-03||1972-04-08|||1967-10-24||1971-08-08
TRIAL STUDY 134XCP|RP|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|1||||||EDEMAIND|EDEMA INDICATOR||||MMHG/SEC|||PG|NOT DONE||U|Y|N|2||58||FOLLOW-UP|1962-04-20||1964-10-22|||1971-07-25||1972-04-30
TRIAL STUDY 134XCP|RP|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|2||||||TNDRIND|TENDERNESS INDICATOR||||U/G/H|||AMP|NOT DONE||Y|Y|Y|2||58||SCREENING|1970-01-06||1965-10-16|||1963-10-07||1973-07-03
TRIAL STUDY 134XCP|RP|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||G/KG/DAY|||NG|NOT DONE||NA|U|U|3||39||TREATMENT|1963-09-03||1967-11-10|||1967-10-04||1972-05-14
TRIAL STUDY 134XCP|RP|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||UIU/L|||MG/CM2|NOT DONE||N|NA|NA|3||39||FOLLOW-UP|1960-08-07||1960-02-21|||1968-01-01||1962-01-09
TRIAL STUDY 134XCP|RP|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||PPTR|||P|NOT DONE||Y|NA|U|4||88||OBSERVATION|1973-02-28||1967-05-19|||1960-01-26||1962-04-24
TRIAL STUDY 134XCP|RP|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|2||||||BLISTIND|BLISTERING INDICATOR||||FOZ_US|||ML/KG/MIN|NOT DONE||N|NA|Y|4||88||INDUCTION TREATMENT|1969-04-26||1966-11-11|||1964-08-31||1967-05-04
TRIAL STUDY 134XCP|RP|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|1||||||TNDRIND|TENDERNESS INDICATOR||||ML*CMH2O|||10^3 CFU/G|NOT DONE||NA|N|U|5||7||CONTINUATION TREATMENT|1963-11-11||1973-04-03|||1960-07-18||1969-09-04
TRIAL STUDY 134XCP|RP|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|2||||||ULCERIND|ULCER INDICATOR||||IU/MMOL|||KEV|NOT DONE||U|N|U|5||7||BLINDED TREATMENT|1972-03-15||1967-06-21|||1968-02-17||1967-07-15
TRIAL STUDY 134XCP|RP|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||UMOL/KG/MIN|||10^9/DOSE|NOT DONE||N|NA|U|1||38||FOLLOW-UP|1970-10-12||1962-10-13|||1969-09-15||1964-12-03
TRIAL STUDY 134XCP|RP|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|2||||||DLVRMODE|MODE OF DELIVERY||||AMOL|||10^9 ORGANISMS|NOT DONE||Y|Y|Y|1||38||OBSERVATION|1968-02-06||1971-04-09|||1964-05-19||1971-12-06
TRIAL STUDY 134XCP|RP|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||G/DAY|||FT|NOT DONE||N|N|NA|2||58||FOLLOW-UP|1962-04-01||1962-06-24|||1973-07-21||1963-12-21
TRIAL STUDY 134XCP|RP|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|2||||||ERYTHIND|ERYTHEMA INDICATOR||||GPS U|||DPM/100MG|NOT DONE||U|NA|U|2||58||RUN-IN|1972-12-03||1968-02-19|||1969-10-04||1968-10-10
TRIAL STUDY 134XCP|RP|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|1||||||MENFDUR|MENSES FLOW DURATION||||IMPLANT|||KM/H|NOT DONE||NA|NA|N|3||39||SCREENING|1966-09-27||1970-11-27|||1966-04-26||1970-07-16
TRIAL STUDY 134XCP|RP|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MEQ/UL|||MET*MIN|NOT DONE||N|Y|Y|3||39||CONTINUATION TREATMENT|1963-01-13||1961-08-19|||1964-09-27||1962-11-23
TRIAL STUDY 134XCP|RP|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MET|||MG/KG/WEEK|NOT DONE||NA|Y|Y|4||88||OBSERVATION|1964-03-05||1962-10-20|||1964-04-30||1971-07-27
TRIAL STUDY 134XCP|RP|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||10^7 PFU|||FIU|NOT DONE||N|N|NA|4||88||CONTINUATION TREATMENT|1972-01-17||1967-01-08|||1967-07-16||1966-04-03
TRIAL STUDY 134XCP|RP|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||10^3 ORGANISMS/G|||G/CAGE|NOT DONE||U|N|U|5||7||FOLLOW-UP|1963-10-14||1969-02-25|||1966-06-14||1963-01-21
TRIAL STUDY 134XCP|RP|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|2||||||ERYTHIND|ERYTHEMA INDICATOR||||CONTAINER|||MIN/DAY|NOT DONE||U|Y|N|5||7||OBSERVATION|1961-08-25||1967-12-03|||1966-04-25||1965-03-24
TRIAL STUDY 134XCP|RP|50CFC814-7135-4356-BAC2-3F975B9F6AE3|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ABSORBANCE U/MIN|||VOXEL|NOT DONE||Y|Y|U|1||38||RUN-IN|1969-01-29||1965-12-08|||1966-12-10||1961-07-03
TRIAL STUDY 134XCP|RP|50CFC814-7135-4356-BAC2-3F975B9F6AE3|2||||||INABOIND|INDUCED ABORTION INDICATOR||||FARAD|||UG/KG/H|NOT DONE||Y|NA|N|1||38||LONG-TERM FOLLOW-UP|1972-04-17||1961-09-23|||1971-01-14||1969-02-04
TRIAL STUDY 134XCP|RP|50CFC814-7135-4356-BAC2-3F975B9F6AE3|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/100 WBC|||HR/DAY|NOT DONE||U|U|Y|2||58||RUN-IN|1963-10-04||1963-12-28|||1965-12-12||1967-12-02
TRIAL STUDY 134XCP|RP|50CFC814-7135-4356-BAC2-3F975B9F6AE3|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||/MONTH|||UG/KG/DAY|NOT DONE||N|NA|NA|2||58||OBSERVATION|1971-02-07||1972-07-21|||1961-05-02||1969-12-27
TRIAL STUDY 134XCP|RP|50CFC814-7135-4356-BAC2-3F975B9F6AE3|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MEQ/MMOL|||PT_BR|NOT DONE||NA|Y|N|3||39||BLINDED TREATMENT|1967-09-29||1972-06-23|||1964-06-23||1971-08-09
TRIAL STUDY 134XCP|RP|50CFC814-7135-4356-BAC2-3F975B9F6AE3|2||||||GRAVIND|GRAVIDA INDICATOR||||PACK YEAR|||ML/MMHG|NOT DONE||U|N|N|3||39||FOLLOW-UP|1960-02-09||1964-10-04|||1965-06-09||1969-05-04
TRIAL STUDY 134XCP|RP|50CFC814-7135-4356-BAC2-3F975B9F6AE3|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||LOG10 ELISA UNIT|||PATCH|NOT DONE||Y|N|U|4||88||BLINDED TREATMENT|1962-01-26||1965-10-26|||1964-09-21||1963-07-02
TRIAL STUDY 134XCP|RP|50CFC814-7135-4356-BAC2-3F975B9F6AE3|2||||||STILBIND|STILLBIRTH INDICATOR||||PL|||LENS|NOT DONE||N|Y|Y|4||88||INDUCTION TREATMENT|1969-03-30||1970-11-08|||1963-04-29||1964-08-09
TRIAL STUDY 134XCP|RP|50CFC814-7135-4356-BAC2-3F975B9F6AE3|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||CMH2O*S/ML|||NCI|NOT DONE||U|NA|U|5||7||OPEN LABEL TREATMENT|1972-03-05||1969-10-20|||1969-12-13||1966-07-03
TRIAL STUDY 134XCP|RP|50CFC814-7135-4356-BAC2-3F975B9F6AE3|2||||||RASHIND|RASH INDICATOR||||UOSM|||DAGU/ML|NOT DONE||U|N|NA|5||7||BLINDED TREATMENT|1970-03-09||1960-02-01|||1962-05-18||1973-04-01
TRIAL STUDY 134XCP|RP|8A639816-D878-4FD7-AF28-CF9EA2236462|1||||||PREGIND|PREGNANT INDICATOR||||10^9/G|||MMHG/SEC|NOT DONE||U|NA|NA|1||38||OBSERVATION|1962-08-26||1962-03-17|||1963-09-17||1972-10-09
TRIAL STUDY 134XCP|RP|8A639816-D878-4FD7-AF28-CF9EA2236462|2||||||DSCHGIND|DISCHARGE INDICATOR||||U/MMOL|||UG/L DDU|NOT DONE||N|N|U|1||38||BLINDED TREATMENT|1969-01-30||1965-10-02|||1960-03-18||1960-01-28
TRIAL STUDY 134XCP|RP|8A639816-D878-4FD7-AF28-CF9EA2236462|1||||||ERYTHIND|ERYTHEMA INDICATOR||||%/S|||MIN/DAY|NOT DONE||Y|NA|Y|2||58||LONG-TERM FOLLOW-UP|1964-05-16||1972-09-07|||1966-01-02||1962-12-25
TRIAL STUDY 134XCP|RP|8A639816-D878-4FD7-AF28-CF9EA2236462|2||||||PREGNN|NUMBER OF PREGNANCIES||||U/M2/MIN|||MG/KG/MIN|NOT DONE||N|NA|N|2||58||FOLLOW-UP|1960-07-13||1971-09-27|||1970-01-15||1969-03-22
TRIAL STUDY 134XCP|RP|8A639816-D878-4FD7-AF28-CF9EA2236462|1||||||BCMETHOD|BIRTH CONTROL METHOD||||AMU|||BQ/UG|NOT DONE||Y|NA|Y|3||39||RUN-IN|1972-07-02||1969-03-30|||1970-04-20||1963-08-15
TRIAL STUDY 134XCP|RP|8A639816-D878-4FD7-AF28-CF9EA2236462|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||CCID 50/DOSE|||LOG10 IU/ML|NOT DONE||U|N|Y|3||39||OBSERVATION|1965-08-07||1973-08-17|||1969-08-23||1962-11-15
TRIAL STUDY 134XCP|RP|8A639816-D878-4FD7-AF28-CF9EA2236462|1||||||ULCERIND|ULCER INDICATOR||||PL|||PPM|NOT DONE||U|Y|N|4||88||LONG-TERM FOLLOW-UP|1970-03-23||1972-01-06|||1966-09-13||1971-05-21
TRIAL STUDY 134XCP|RP|8A639816-D878-4FD7-AF28-CF9EA2236462|2||||||MENFDUR|MENSES FLOW DURATION||||NMOL/L/H|||CAPSULE|NOT DONE||Y|U|NA|4||88||RUN-IN|1965-11-21||1972-11-10|||1962-01-27||1963-01-06
TRIAL STUDY 134XCP|RP|8A639816-D878-4FD7-AF28-CF9EA2236462|1||||||EDEMAIND|EDEMA INDICATOR||||10^8/L|||/2500 WBC|NOT DONE||Y|U|U|5||7||OPEN LABEL TREATMENT|1961-03-30||1968-08-20|||1973-05-19||1968-08-27
TRIAL STUDY 134XCP|RP|8A639816-D878-4FD7-AF28-CF9EA2236462|2||||||FUNDHT|FUNDAL HEIGHT||||MG/MIN|||COPIES/ML|NOT DONE||NA|Y|NA|5||7||RUN-IN|1964-06-10||1972-07-17|||1967-03-28||1963-11-21
TRIAL STUDY 134XCP|RP|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|1||||||PRGENDTC|DATE PREGNANCY ENDED||||DAGU/ML|||PNU/ML|NOT DONE||Y|NA|N|1||38||BASELINE|1967-10-09||1969-04-22|||1963-06-04||1972-07-25
TRIAL STUDY 134XCP|RP|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||PMOL/L/H|||/500 WBC|NOT DONE||N|Y|U|1||38||INDUCTION TREATMENT|1968-05-05||1973-02-17|||1971-10-21||1965-04-11
TRIAL STUDY 134XCP|RP|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MOL/G|||NMOL/G|NOT DONE||U|N|N|2||58||FOLLOW-UP|1972-12-18||1966-07-16|||1969-12-30||1970-01-28
TRIAL STUDY 134XCP|RP|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|2||||||PREGST|PREGNANT DURING THE STUDY||||MMOL/MIN/KPA|||NM|NOT DONE||Y|NA|NA|2||58||OBSERVATION|1963-01-24||1962-12-18|||1972-05-18||1964-04-21
TRIAL STUDY 134XCP|RP|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||G/ANIMAL/DAY|||OZ EQ|NOT DONE||U|N|N|3||39||RUN-IN|1964-04-17||1967-11-27|||1967-07-16||1966-07-16
TRIAL STUDY 134XCP|RP|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||NMOL|||MAMP|NOT DONE||Y|NA|U|3||39||BLINDED TREATMENT|1962-06-02||1964-08-27|||1971-05-15||1972-12-16
TRIAL STUDY 134XCP|RP|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||/MM|||DRAM|NOT DONE||Y|NA|N|4||88||LONG-TERM FOLLOW-UP|1961-10-07||1960-09-03|||1965-02-19||1963-03-21
TRIAL STUDY 134XCP|RP|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|2||||||PREGNN|NUMBER OF PREGNANCIES||||MG/M2/MIN|||NCI|NOT DONE||N|NA|N|4||88||OBSERVATION|1971-04-21||1964-03-13|||1967-08-22||1967-03-04
TRIAL STUDY 134XCP|RP|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|1||||||PREGNN|NUMBER OF PREGNANCIES||||MG/CM2|||ENZYME U/M2|NOT DONE||Y|Y|NA|5||7||OBSERVATION|1963-07-15||1960-06-28|||1970-03-20||1961-12-07
TRIAL STUDY 134XCP|RP|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||VP/ML|||MG/M2/MIN|NOT DONE||U|N|N|5||7||WASHOUT|1961-02-22||1960-08-28|||1972-05-26||1960-02-24
TRIAL STUDY 134XCP|RP|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|1||||||PREGNN|NUMBER OF PREGNANCIES||||U/G/H|||MMOL/MIN/KPA|NOT DONE||U|U|U|1||38||CONTINUATION TREATMENT|1969-09-27||1967-12-28|||1961-11-05||1965-11-14
TRIAL STUDY 134XCP|RP|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||PPB|||OZ EQ|NOT DONE||Y|U|Y|1||38||TREATMENT|1971-02-28||1966-06-03|||1970-07-28||1969-12-27
TRIAL STUDY 134XCP|RP|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||/10^4|||RPM|NOT DONE||U|N|N|2||58||OBSERVATION|1961-03-21||1970-10-19|||1960-08-04||1962-07-08
TRIAL STUDY 134XCP|RP|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|2||||||TNDRIND|TENDERNESS INDICATOR||||OI50|||U/G|NOT DONE||NA|N|NA|2||58||WASHOUT|1971-11-19||1972-05-02|||1963-03-21||1963-11-05
TRIAL STUDY 134XCP|RP|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|1||||||RASHIND|RASH INDICATOR||||SUPPOSITORY|||UG/L DDU|NOT DONE||N|N|U|3||39||FOLLOW-UP|1969-02-25||1969-08-14|||1973-06-04||1962-11-19
TRIAL STUDY 134XCP|RP|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||KBQ/UL|||MG|NOT DONE||N|NA|Y|3||39||OBSERVATION|1970-04-07||1972-02-05|||1970-11-16||1961-09-19
TRIAL STUDY 134XCP|RP|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|1||||||BLISTIND|BLISTERING INDICATOR||||PFU|||CD/M2|NOT DONE||NA|NA|Y|4||88||RUN-IN|1961-12-10||1972-05-08|||1963-02-17||1971-02-24
TRIAL STUDY 134XCP|RP|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||CM/MIN|||U/G/MIN|NOT DONE||NA|NA|NA|4||88||OBSERVATION|1965-02-18||1972-04-23|||1967-10-31||1973-07-05
TRIAL STUDY 134XCP|RP|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|1||||||MENOAGE|MENOPAUSE AGE||||UG/DAY|||FMOL|NOT DONE||NA|N|Y|5||7||OBSERVATION|1970-05-03||1964-03-06|||1967-06-12||1973-02-16
TRIAL STUDY 134XCP|RP|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MG/DOSE|||/10^5|NOT DONE||NA|U|Y|5||7||SCREENING|1960-03-15||1964-12-12|||1963-05-13||1970-09-10
TRIAL STUDY 134XCP|RP|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||U/G/H|||POINT|NOT DONE||N|N|N|1||38||WASHOUT|1966-04-26||1965-01-28|||1968-05-19||1963-02-19
TRIAL STUDY 134XCP|RP|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|2||||||FUNDHT|FUNDAL HEIGHT||||BQ/UL|||CCID 50/DOSE|NOT DONE||N|Y|Y|1||38||TREATMENT|1971-11-13||1962-12-22|||1972-07-19||1972-06-07
TRIAL STUDY 134XCP|RP|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|1||||||RASHIND|RASH INDICATOR||||UG/CM2|||NMOL BCE/MMOL|NOT DONE||N|U|N|2||58||OPEN LABEL TREATMENT|1970-12-20||1966-03-30|||1965-10-07||1962-06-29
TRIAL STUDY 134XCP|RP|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|2||||||ULCERIND|ULCER INDICATOR||||CUP|||GMFI|NOT DONE||U|U|Y|2||58||RUN-IN|1960-02-10||1970-01-22|||1962-06-30||1967-02-07
TRIAL STUDY 134XCP|RP|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|1||||||ULCERIND|ULCER INDICATOR||||MET*H|||MET*H|NOT DONE||N|Y|NA|3||39||FOLLOW-UP|1970-01-14||1963-06-13|||1970-02-20||1969-09-23
TRIAL STUDY 134XCP|RP|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||U/G HB|||ML/M2|NOT DONE||Y|U|N|3||39||FOLLOW-UP|1969-12-11||1966-01-14|||1973-02-05||1973-05-20
TRIAL STUDY 134XCP|RP|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|1||||||GRAVIND|GRAVIDA INDICATOR||||MHZ|||MG|NOT DONE||NA|N|N|4||88||RUN-IN|1961-07-24||1966-04-10|||1960-09-17||1972-03-10
TRIAL STUDY 134XCP|RP|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||TUBERCULIN UNIT/ML|||F|NOT DONE||U|N|N|4||88||LONG-TERM FOLLOW-UP|1968-07-21||1970-04-15|||1971-03-28||1966-08-01
TRIAL STUDY 134XCP|RP|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|1||||||STILBIND|STILLBIRTH INDICATOR||||SIEMENS|||NMOL BCE/MMOL|NOT DONE||NA|N|N|5||7||OBSERVATION|1966-07-24||1969-08-08|||1973-01-28||1973-07-27
TRIAL STUDY 134XCP|RP|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||ML/CM H2O|||U/M2|NOT DONE||Y|N|Y|5||7||LONG-TERM FOLLOW-UP|1965-03-15||1963-03-29|||1972-06-18||1962-03-24
TRIAL STUDY 134XCP|RP|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MIN/DAY|||TORR|NOT DONE||U|N|NA|1||38||BASELINE|1973-05-30||1973-04-05|||1965-07-12||1965-02-26
TRIAL STUDY 134XCP|RP|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|2||||||BCMETHOD|BIRTH CONTROL METHOD||||LOG10 TCID 50/ML|||1/(S*KPA)|NOT DONE||NA|NA|N|1||38||RUN-IN|1961-09-07||1967-12-12|||1969-07-22||1968-10-21
TRIAL STUDY 134XCP|RP|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|1||||||MENOSTAT|MENOPAUSE STATUS||||/2000 RBC|||IU/DAY|NOT DONE||NA|N|N|2||58||TREATMENT|1971-10-05||1962-06-03|||1963-03-04||1961-07-05
TRIAL STUDY 134XCP|RP|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||/LPF|||S^-1(%O2)^-1|NOT DONE||Y|U|U|2||58||LONG-TERM FOLLOW-UP|1961-05-02||1971-05-27|||1970-05-10||1963-01-03
TRIAL STUDY 134XCP|RP|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|1||||||FUNDHT|FUNDAL HEIGHT||||FL|||ML/ANIMAL|NOT DONE||NA|U|U|3||39||OBSERVATION|1972-01-28||1964-01-09|||1967-10-11||1971-06-27
TRIAL STUDY 134XCP|RP|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|2||||||BLISTIND|BLISTERING INDICATOR||||JAR|||LB|NOT DONE||NA|NA|N|3||39||RUN-IN|1963-02-23||1964-04-29|||1961-02-28||1963-03-12
TRIAL STUDY 134XCP|RP|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|1||||||DLVRMODE|MODE OF DELIVERY||||M|||UL/KG/DAY|NOT DONE||Y|NA|Y|4||88||SCREENING|1965-10-27||1970-09-23|||1963-07-16||1966-04-04
TRIAL STUDY 134XCP|RP|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UG/H|||MV*MIN|NOT DONE||N|U|Y|4||88||OBSERVATION|1965-12-18||1963-01-24|||1960-05-17||1972-06-02
TRIAL STUDY 134XCP|RP|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|1||||||GRAVIND|GRAVIDA INDICATOR||||MG/KG/DOSE|||LOG10 CFU/ML|NOT DONE||U|NA|U|5||7||OPEN LABEL TREATMENT|1965-06-18||1963-06-12|||1973-03-14||1968-09-28
TRIAL STUDY 134XCP|RP|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|2||||||PUSTIND|PUSTULE INDICATOR||||TSP EQ|||10^6 U|NOT DONE||Y|U|NA|5||7||TREATMENT|1967-07-01||1971-09-26|||1966-10-18||1970-07-30
TRIAL STUDY 134XCP|RP|30419F44-B519-488C-A505-F23D88A46024|1||||||MENARAGE|MENARCHE AGE||||L/KG|||10^4 CFU|NOT DONE||U|Y|N|1||38||CONTINUATION TREATMENT|1961-09-29||1972-10-30|||1971-08-04||1967-03-20
TRIAL STUDY 134XCP|RP|30419F44-B519-488C-A505-F23D88A46024|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||ML/G/DAY|||DIOPTER|NOT DONE||Y|U|N|1||38||RUN-IN|1965-12-04||1967-11-07|||1969-03-10||1965-12-28
TRIAL STUDY 134XCP|RP|30419F44-B519-488C-A505-F23D88A46024|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MG/ML/MIN|||PIXELS/CM|NOT DONE||U|NA|N|2||58||LONG-TERM FOLLOW-UP|1961-02-27||1962-03-17|||1964-12-23||1960-12-23
TRIAL STUDY 134XCP|RP|30419F44-B519-488C-A505-F23D88A46024|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||CD*S/M2|||CUP EQ|NOT DONE||Y|Y|U|2||58||CONTINUATION TREATMENT|1970-11-23||1963-10-23|||1961-08-27||1963-10-07
TRIAL STUDY 134XCP|RP|30419F44-B519-488C-A505-F23D88A46024|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||PATCH|||ML/CM|NOT DONE||U|Y|N|3||39||WASHOUT|1972-07-17||1965-07-17|||1966-02-09||1967-06-02
TRIAL STUDY 134XCP|RP|30419F44-B519-488C-A505-F23D88A46024|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||KAT|||ML/CM|NOT DONE||U|Y|U|3||39||SCREENING|1963-07-10||1963-07-27|||1960-10-11||1973-01-04
TRIAL STUDY 134XCP|RP|30419F44-B519-488C-A505-F23D88A46024|1||||||BRTHN|NUMBER OF BIRTHS||||MG/ML/DAY|||10^9/DOSE|NOT DONE||Y|N|U|4||88||RUN-IN|1972-04-01||1962-06-13|||1970-06-06||1968-09-01
TRIAL STUDY 134XCP|RP|30419F44-B519-488C-A505-F23D88A46024|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||DIP|||JAR|NOT DONE||Y|Y|NA|4||88||OBSERVATION|1962-10-12||1966-03-31|||1966-03-03||1967-09-10
TRIAL STUDY 134XCP|RP|30419F44-B519-488C-A505-F23D88A46024|1||||||MASSIND|MASS INDICATOR||||CI/UL|||NMOL/G|NOT DONE||NA|Y|Y|5||7||BASELINE|1965-12-28||1971-05-01|||1962-11-10||1965-10-04
TRIAL STUDY 134XCP|RP|30419F44-B519-488C-A505-F23D88A46024|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||MCI|||MM/H|NOT DONE||N|U|U|5||7||LONG-TERM FOLLOW-UP|1971-12-05||1967-11-08|||1973-08-16||1965-12-18
TRIAL STUDY 134XCP|RP|2AF06F66-5E51-4AC9-AF62-A34329724F7D|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||PL|||UGEQ|NOT DONE||N|U|U|1||38||FOLLOW-UP|1963-12-08||1965-11-23|||1972-01-20||1961-11-05
TRIAL STUDY 134XCP|RP|2AF06F66-5E51-4AC9-AF62-A34329724F7D|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MV2/HZ|||LOG10 ELISA UNIT|NOT DONE||N|NA|Y|1||38||BASELINE|1971-03-29||1966-11-17|||1966-10-23||1960-03-20
TRIAL STUDY 134XCP|RP|2AF06F66-5E51-4AC9-AF62-A34329724F7D|1||||||FUNDHT|FUNDAL HEIGHT||||ML/MIN/1.73M2|||MV2/HZ|NOT DONE||N|NA|U|2||58||BLINDED TREATMENT|1968-08-14||1967-01-28|||1964-06-14||1963-08-12
TRIAL STUDY 134XCP|RP|2AF06F66-5E51-4AC9-AF62-A34329724F7D|2||||||PUSTIND|PUSTULE INDICATOR||||/WK|||HOMEOPATHIC DILUTION|NOT DONE||Y|NA|Y|2||58||LONG-TERM FOLLOW-UP|1960-11-02||1968-04-10|||1972-09-14||1972-08-20
TRIAL STUDY 134XCP|RP|2AF06F66-5E51-4AC9-AF62-A34329724F7D|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||CY/CM|||SPRAY|NOT DONE||N|U|N|3||39||INDUCTION TREATMENT|1966-08-22||1970-08-26|||1960-09-06||1971-02-13
TRIAL STUDY 134XCP|RP|2AF06F66-5E51-4AC9-AF62-A34329724F7D|2||||||INABOIND|INDUCED ABORTION INDICATOR||||TSP|||PMOL/10^10 CELLS|NOT DONE||NA|Y|NA|3||39||BASELINE|1970-01-16||1967-03-27|||1973-04-06||1973-09-06
TRIAL STUDY 134XCP|RP|2AF06F66-5E51-4AC9-AF62-A34329724F7D|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||ML/S|||ML/M2/DAY|NOT DONE||N|N|Y|4||88||CONTINUATION TREATMENT|1968-09-06||1972-03-01|||1962-11-08||1969-02-13
TRIAL STUDY 134XCP|RP|2AF06F66-5E51-4AC9-AF62-A34329724F7D|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||MDFI|||ML/S|NOT DONE||Y|Y|Y|4||88||CONTINUATION TREATMENT|1963-06-23||1968-08-13|||1960-01-01||1971-06-08
TRIAL STUDY 134XCP|RP|2AF06F66-5E51-4AC9-AF62-A34329724F7D|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||DPM/100MG|||DPM|NOT DONE||U|U|NA|5||7||CONTINUATION TREATMENT|1970-01-21||1966-05-18|||1965-03-18||1973-06-18
TRIAL STUDY 134XCP|RP|2AF06F66-5E51-4AC9-AF62-A34329724F7D|2||||||MENFDUR|MENSES FLOW DURATION||||ENZYME U/G HB|||G/DAY|NOT DONE||N|NA|Y|5||7||INDUCTION TREATMENT|1964-04-12||1971-06-23|||1962-03-24||1963-05-05
TRIAL STUDY 134XCP|RP|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MG/KG/WEEK|||ENZYME U|NOT DONE||NA|N|N|1||38||OBSERVATION|1966-07-16||1972-09-26|||1961-09-14||1969-02-19
TRIAL STUDY 134XCP|RP|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|2||||||PEELIND|PEELING INDICATOR||||CUP EQ|||/7.5 ML|NOT DONE||Y|Y|N|1||38||SCREENING|1969-08-04||1960-03-19|||1966-10-16||1971-11-17
TRIAL STUDY 134XCP|RP|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|1||||||PREGNN|NUMBER OF PREGNANCIES||||ENZYME U/L|||U/MG|NOT DONE||NA|U|U|2||58||OBSERVATION|1965-03-29||1960-05-04|||1961-10-16||1967-05-04
TRIAL STUDY 134XCP|RP|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||V/V|||GPL U|NOT DONE||N|U|NA|2||58||BASELINE|1960-02-07||1967-01-07|||1966-06-08||1966-09-10
TRIAL STUDY 134XCP|RP|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||ARBITRARY U|||G/KG|NOT DONE||NA|NA|Y|3||39||BASELINE|1973-08-10||1970-10-29|||1970-08-27||1960-11-13
TRIAL STUDY 134XCP|RP|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|2||||||MENARAGE|MENARCHE AGE||||NMOL BCE/MMOL|||COPIES/UG|NOT DONE||NA|NA|N|3||39||OPEN LABEL TREATMENT|1972-03-28||1971-01-30|||1965-03-26||1964-02-15
TRIAL STUDY 134XCP|RP|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|1||||||MENARAGE|MENARCHE AGE||||%(V/V)|||CMOL/L|NOT DONE||NA|Y|N|4||88||RUN-IN|1972-07-03||1963-12-02|||1963-12-26||1964-05-29
TRIAL STUDY 134XCP|RP|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|2||||||BCMETHOD|BIRTH CONTROL METHOD||||10^6/HPF|||10^10/L|NOT DONE||Y|U|U|4||88||RUN-IN|1962-11-27||1964-08-13|||1971-10-04||1960-08-25
TRIAL STUDY 134XCP|RP|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|1||||||GRAVIND|GRAVIDA INDICATOR||||CAN|||SCM|NOT DONE||Y|Y|U|5||7||INDUCTION TREATMENT|1968-08-19||1961-04-02|||1968-06-15||1971-04-21
TRIAL STUDY 134XCP|RP|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||10^6 CFU|||10^3 CFU|NOT DONE||NA|Y|N|5||7||FOLLOW-UP|1972-09-17||1961-02-04|||1962-10-02||1967-07-14
TRIAL STUDY 134XCP|RP|94F4C997-3114-4444-BF89-E762226AAC89|1||||||MENOAGE|MENOPAUSE AGE||||UG/L/H|||UM/S|NOT DONE||N|NA|NA|1||38||SCREENING|1963-04-15||1965-07-29|||1970-04-10||1964-11-03
TRIAL STUDY 134XCP|RP|94F4C997-3114-4444-BF89-E762226AAC89|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||KEV|||G/ANIMAL|NOT DONE||U|U|NA|1||38||RUN-IN|1972-01-16||1965-09-20|||1964-12-08||1966-06-07
TRIAL STUDY 134XCP|RP|94F4C997-3114-4444-BF89-E762226AAC89|1||||||MENARAGE|MENARCHE AGE||||%(V/V)|||COPIES/UL|NOT DONE||Y|N|N|2||58||BASELINE|1964-11-15||1961-03-28|||1966-07-28||1968-03-31
TRIAL STUDY 134XCP|RP|94F4C997-3114-4444-BF89-E762226AAC89|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MM2|||U|NOT DONE||N|U|NA|2||58||RUN-IN|1972-11-12||1972-03-08|||1966-07-27||1966-11-22
TRIAL STUDY 134XCP|RP|94F4C997-3114-4444-BF89-E762226AAC89|1||||||EDEMAIND|EDEMA INDICATOR||||MG/KG/DAY|||FOZ_US|NOT DONE||N|Y|Y|3||39||RUN-IN|1964-08-20||1961-10-03|||1969-12-09||1973-02-08
TRIAL STUDY 134XCP|RP|94F4C997-3114-4444-BF89-E762226AAC89|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MPH|||MM/H|NOT DONE||NA|N|N|3||39||BASELINE|1961-10-13||1972-11-17|||1965-08-25||1961-12-29
TRIAL STUDY 134XCP|RP|94F4C997-3114-4444-BF89-E762226AAC89|1||||||PUSTIND|PUSTULE INDICATOR||||PFU/ANIMAL|||UG/L FEU|NOT DONE||N|NA|Y|4||88||BASELINE|1968-11-07||1961-11-11|||1973-03-25||1962-02-02
TRIAL STUDY 134XCP|RP|94F4C997-3114-4444-BF89-E762226AAC89|2||||||BLISTIND|BLISTERING INDICATOR||||MIN/DAY|||CMOL/L|NOT DONE||U|N|NA|4||88||CONTINUATION TREATMENT|1961-12-16||1971-04-03|||1968-03-13||1966-11-11
TRIAL STUDY 134XCP|RP|94F4C997-3114-4444-BF89-E762226AAC89|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||UG/KG|||APL U|NOT DONE||Y|N|N|5||7||WASHOUT|1967-10-14||1967-05-16|||1973-06-22||1968-10-02
TRIAL STUDY 134XCP|RP|94F4C997-3114-4444-BF89-E762226AAC89|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||M/SEC|||AG|NOT DONE||NA|Y|NA|5||7||WASHOUT|1972-09-15||1972-12-21|||1965-02-02||1964-10-11
TRIAL STUDY 134XCP|RP|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|1||||||MENFDUR|MENSES FLOW DURATION||||10^8 PFU|||MNFI|NOT DONE||U|N|NA|1||38||OPEN LABEL TREATMENT|1970-09-07||1964-06-11|||1970-03-24||1966-12-09
TRIAL STUDY 134XCP|RP|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||/MS|||KG/M2|NOT DONE||NA|NA|Y|1||38||RUN-IN|1967-01-25||1969-03-31|||1964-10-29||1964-11-04
TRIAL STUDY 134XCP|RP|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||PFU|||KIT|NOT DONE||N|N|Y|2||58||LONG-TERM FOLLOW-UP|1968-05-29||1970-03-17|||1971-02-14||1964-11-06
TRIAL STUDY 134XCP|RP|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|2||||||BCMETHOD|BIRTH CONTROL METHOD||||MM/2H|||UG/G/H|NOT DONE||N|NA|NA|2||58||RUN-IN|1971-07-01||1962-08-10|||1963-07-11||1967-08-10
TRIAL STUDY 134XCP|RP|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||10^7 CFU|||PIPE|NOT DONE||Y|N|NA|3||39||FOLLOW-UP|1962-07-31||1960-03-30|||1962-10-20||1961-03-19
TRIAL STUDY 134XCP|RP|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||L/DAY|||BQ|NOT DONE||N|NA|N|3||39||WASHOUT|1969-11-23||1971-05-17|||1972-11-19||1970-12-22
TRIAL STUDY 134XCP|RP|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||KEV|||DPM|NOT DONE||Y|U|Y|4||88||SCREENING|1970-05-16||1962-11-21|||1966-02-23||1966-07-02
TRIAL STUDY 134XCP|RP|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|2||||||BRTHN|NUMBER OF BIRTHS||||ML*CMH2O|||KDA|NOT DONE||NA|N|N|4||88||OBSERVATION|1960-08-15||1972-04-30|||1962-03-05||1967-02-07
TRIAL STUDY 134XCP|RP|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MEQ/DAY|||NMOL/G|NOT DONE||U|N|U|5||7||WASHOUT|1960-05-11||1966-11-18|||1961-04-25||1966-07-21
TRIAL STUDY 134XCP|RP|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||/200 HPFS|||/10^5|NOT DONE||Y|N|NA|5||7||SCREENING|1972-08-12||1973-07-04|||1972-05-23||1963-02-03
TRIAL STUDY 134XCP|RP|D20DE6F0-DA30-4453-8F80-61093BF046A6|1||||||FUNDHT|FUNDAL HEIGHT||||NSEC|||EVENTS|NOT DONE||Y|N|NA|1||38||LONG-TERM FOLLOW-UP|1971-11-07||1972-01-29|||1962-09-22||1972-11-12
TRIAL STUDY 134XCP|RP|D20DE6F0-DA30-4453-8F80-61093BF046A6|2||||||PUSTIND|PUSTULE INDICATOR||||BQ/MG|||U/G/DAY|NOT DONE||Y|U|Y|1||38||INDUCTION TREATMENT|1961-10-02||1960-05-04|||1972-06-18||1963-04-08
TRIAL STUDY 134XCP|RP|D20DE6F0-DA30-4453-8F80-61093BF046A6|1||||||INTP|INTERPRETATION||||HOMEOPATHIC DILUTION|||MPS U|NOT DONE||NA|U|U|2||58||INDUCTION TREATMENT|1960-04-13||1972-03-02|||1967-03-08||1969-05-15
TRIAL STUDY 134XCP|RP|D20DE6F0-DA30-4453-8F80-61093BF046A6|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||IU/MMOL|||G/KG/DAY|NOT DONE||NA|U|NA|2||58||FOLLOW-UP|1964-03-29||1966-08-29|||1972-07-20||1962-05-02
TRIAL STUDY 134XCP|RP|D20DE6F0-DA30-4453-8F80-61093BF046A6|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MANSON U/ML|||S/H|NOT DONE||N|U|U|3||39||BASELINE|1961-03-02||1970-02-02|||1971-03-13||1967-03-13
TRIAL STUDY 134XCP|RP|D20DE6F0-DA30-4453-8F80-61093BF046A6|2||||||FUNDHT|FUNDAL HEIGHT||||NMOL/L|||MM/2H|NOT DONE||N|NA|Y|3||39||BLINDED TREATMENT|1965-04-17||1968-03-15|||1968-03-23||1966-07-23
TRIAL STUDY 134XCP|RP|D20DE6F0-DA30-4453-8F80-61093BF046A6|1||||||INTP|INTERPRETATION||||LM|||10^5/L|NOT DONE||Y|NA|Y|4||88||LONG-TERM FOLLOW-UP|1962-07-15||1961-05-29|||1960-09-16||1961-02-15
TRIAL STUDY 134XCP|RP|D20DE6F0-DA30-4453-8F80-61093BF046A6|2||||||PUSTIND|PUSTULE INDICATOR||||PA|||VG/ML|NOT DONE||U|Y|Y|4||88||TREATMENT|1965-11-07||1962-05-02|||1969-11-08||1972-02-11
TRIAL STUDY 134XCP|RP|D20DE6F0-DA30-4453-8F80-61093BF046A6|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||%/S|||MG/ANIMAL|NOT DONE||N|U|U|5||7||OPEN LABEL TREATMENT|1970-01-18||1961-07-12|||1967-09-28||1966-01-17
TRIAL STUDY 134XCP|RP|D20DE6F0-DA30-4453-8F80-61093BF046A6|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||U/L|||EJACULATE U|NOT DONE||N|Y|Y|5||7||OPEN LABEL TREATMENT|1971-09-14||1969-11-23|||1971-03-27||1968-06-22
TRIAL STUDY 134XCP|RP|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||EID 50/DOSE|||ML/KG|NOT DONE||N|U|N|1||38||LONG-TERM FOLLOW-UP|1973-07-20||1967-09-01|||1960-11-21||1968-01-28
TRIAL STUDY 134XCP|RP|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||GBQ/MG|||U/ML|NOT DONE||U|NA|Y|1||38||RUN-IN|1967-11-23||1965-11-06|||1962-06-24||1966-05-11
TRIAL STUDY 134XCP|RP|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||PG/L|||KAT|NOT DONE||NA|U|Y|2||58||OPEN LABEL TREATMENT|1965-04-17||1973-08-06|||1972-01-02||1970-06-06
TRIAL STUDY 134XCP|RP|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||CG|||GPL U|NOT DONE||Y|NA|NA|2||58||RUN-IN|1972-07-18||1972-12-25|||1967-03-03||1962-02-01
TRIAL STUDY 134XCP|RP|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||RPM|||CCID 50/ML|NOT DONE||Y|NA|Y|3||39||CONTINUATION TREATMENT|1970-05-05||1964-02-10|||1963-07-11||1966-12-31
TRIAL STUDY 134XCP|RP|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||POUCH|||CCID 50/DOSE|NOT DONE||Y|Y|Y|3||39||RUN-IN|1970-02-07||1961-03-12|||1973-07-18||1963-03-28
TRIAL STUDY 134XCP|RP|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|1||||||INABOIND|INDUCED ABORTION INDICATOR||||ML/M2/H|||BEATS/MIN|NOT DONE||U|NA|U|4||88||OPEN LABEL TREATMENT|1967-03-08||1968-04-18|||1964-12-03||1969-10-08
TRIAL STUDY 134XCP|RP|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||KG/L|||M/SEC2|NOT DONE||U|U|Y|4||88||BLINDED TREATMENT|1964-02-24||1966-07-14|||1966-06-17||1971-07-25
TRIAL STUDY 134XCP|RP|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|1||||||PREGST|PREGNANT DURING THE STUDY||||TSP EQ|||NMOL/L|NOT DONE||N|Y|Y|5||7||WASHOUT|1971-06-16||1970-01-05|||1971-03-19||1966-06-20
TRIAL STUDY 134XCP|RP|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|2||||||ULCERIND|ULCER INDICATOR||||10^6/G|||NMOL BCE/MMOL|NOT DONE||U|Y|NA|5||7||OPEN LABEL TREATMENT|1961-10-01||1971-11-15|||1968-05-01||1969-02-18
TRIAL STUDY 134XCP|RP|F20939CF-C668-4514-A2CF-63723560FA46|1||||||MENARAGE|MENARCHE AGE||||LOG10 CFU/ML|||PLUG|NOT DONE||U|U|Y|1||38||FOLLOW-UP|1965-11-18||1973-02-15|||1964-08-21||1966-04-21
TRIAL STUDY 134XCP|RP|F20939CF-C668-4514-A2CF-63723560FA46|2||||||MASSIND|MASS INDICATOR||||U/ML|||FMOL/G|NOT DONE||U|U|NA|1||38||BLINDED TREATMENT|1970-01-30||1962-05-03|||1972-05-15||1966-08-29
TRIAL STUDY 134XCP|RP|F20939CF-C668-4514-A2CF-63723560FA46|1||||||ERYTHIND|ERYTHEMA INDICATOR||||/500 WBC|||ENZYME U|NOT DONE||NA|Y|U|2||58||BASELINE|1973-03-08||1971-01-05|||1972-09-30||1961-07-21
TRIAL STUDY 134XCP|RP|F20939CF-C668-4514-A2CF-63723560FA46|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MV*MIN|||EJACULATE U|NOT DONE||N|U|N|2||58||CONTINUATION TREATMENT|1969-03-08||1961-05-05|||1963-04-01||1963-12-08
TRIAL STUDY 134XCP|RP|F20939CF-C668-4514-A2CF-63723560FA46|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||/MIN|||10^3 CFU/ML|NOT DONE||NA|NA|N|3||39||OPEN LABEL TREATMENT|1961-02-06||1967-02-09|||1965-11-17||1960-03-24
TRIAL STUDY 134XCP|RP|F20939CF-C668-4514-A2CF-63723560FA46|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MAC50|||TROCHE|NOT DONE||NA|Y|NA|3||39||OPEN LABEL TREATMENT|1970-06-03||1969-09-20|||1961-09-11||1970-08-25
TRIAL STUDY 134XCP|RP|F20939CF-C668-4514-A2CF-63723560FA46|1||||||RASHIND|RASH INDICATOR||||MIN/DAY|||P|NOT DONE||NA|U|NA|4||88||CONTINUATION TREATMENT|1964-06-06||1965-04-09|||1971-11-06||1963-12-08
TRIAL STUDY 134XCP|RP|F20939CF-C668-4514-A2CF-63723560FA46|2||||||GRAVIND|GRAVIDA INDICATOR||||10^9 ORGANISMS|||VP/DOSE|NOT DONE||NA|Y|NA|4||88||BASELINE|1970-10-01||1965-08-12|||1969-01-31||1963-10-21
TRIAL STUDY 134XCP|RP|F20939CF-C668-4514-A2CF-63723560FA46|1||||||PREGIND|PREGNANT INDICATOR||||MOL/L|||BOLUS|NOT DONE||Y|U|U|5||7||BLINDED TREATMENT|1963-09-18||1972-09-14|||1971-05-21||1971-07-24
TRIAL STUDY 134XCP|RP|F20939CF-C668-4514-A2CF-63723560FA46|2||||||EDEMAIND|EDEMA INDICATOR||||TESLA|||MU/G|NOT DONE||U|Y|N|5||7||WASHOUT|1962-08-15||1962-05-01|||1964-12-21||1966-08-30
TRIAL STUDY 134XCP|RP|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||UIU/L|||10^6/HPF|NOT DONE||NA|NA|Y|1||38||CONTINUATION TREATMENT|1961-10-14||1972-03-10|||1964-03-09||1971-05-28
TRIAL STUDY 134XCP|RP|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|2||||||RASHIND|RASH INDICATOR||||BE/ML|||MOL/MG|NOT DONE||Y|Y|N|1||38||OBSERVATION|1960-10-30||1971-04-11|||1970-05-11||1969-10-23
TRIAL STUDY 134XCP|RP|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||UM2|||BQ/UL|NOT DONE||U|NA|NA|2||58||BLINDED TREATMENT|1964-12-14||1971-12-23|||1972-06-29||1966-06-12
TRIAL STUDY 134XCP|RP|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|2||||||MENOSTAT|MENOPAUSE STATUS||||MIN/DAY|||CYCLE/MIN|NOT DONE||N|Y|Y|2||58||OBSERVATION|1965-07-19||1960-03-06|||1972-03-09||1965-10-15
TRIAL STUDY 134XCP|RP|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|1||||||BCMETHOD|BIRTH CONTROL METHOD||||NEEDLE GAUGE|||UMOL/MIN|NOT DONE||U|NA|N|3||39||SCREENING|1971-10-29||1972-12-26|||1967-07-14||1971-11-03
TRIAL STUDY 134XCP|RP|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|2||||||INTP|INTERPRETATION||||G/CAGE/WK|||GBQ|NOT DONE||U|N|N|3||39||OBSERVATION|1963-12-08||1964-05-09|||1964-01-23||1967-09-03
TRIAL STUDY 134XCP|RP|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|1||||||MENARAGE|MENARCHE AGE||||KBQ|||10^7 TCID 50/DOSE|NOT DONE||U|Y|NA|4||88||OBSERVATION|1973-02-21||1963-05-27|||1967-08-23||1965-09-09
TRIAL STUDY 134XCP|RP|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||MG/G/MIN|||OSM|NOT DONE||N|N|U|4||88||INDUCTION TREATMENT|1963-05-19||1960-06-27|||1972-06-28||1960-03-01
TRIAL STUDY 134XCP|RP|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||ML/CAGE/DAY|||ELISA UNIT/ML|NOT DONE||NA|N|Y|5||7||OPEN LABEL TREATMENT|1969-10-01||1960-11-18|||1967-10-25||1973-05-04
TRIAL STUDY 134XCP|RP|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|2||||||PREGNN|NUMBER OF PREGNANCIES||||NGEQ/L|||NFIU|NOT DONE||N|NA|Y|5||7||TREATMENT|1967-04-11||1960-02-08|||1962-11-16||1965-04-13
TRIAL STUDY 134XCP|RP|9A60A414-54A0-4A7F-84EE-FCB8246D2477|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||PMOL/L/H|||SBE/ML|NOT DONE||NA|N|N|1||38||LONG-TERM FOLLOW-UP|1961-12-13||1967-06-10|||1961-06-13||1963-07-18
TRIAL STUDY 134XCP|RP|9A60A414-54A0-4A7F-84EE-FCB8246D2477|2||||||PRGENDTC|DATE PREGNANCY ENDED||||PACK|||U/ML|NOT DONE||N|Y|Y|1||38||OPEN LABEL TREATMENT|1970-01-25||1967-12-20|||1971-03-08||1966-12-10
TRIAL STUDY 134XCP|RP|9A60A414-54A0-4A7F-84EE-FCB8246D2477|1||||||PEELIND|PEELING INDICATOR||||ML*CMH2O|||KG|NOT DONE||U|NA|NA|2||58||FOLLOW-UP|1960-01-13||1969-07-31|||1973-07-28||1960-04-03
TRIAL STUDY 134XCP|RP|9A60A414-54A0-4A7F-84EE-FCB8246D2477|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||FT2|||FINGERTIP UNIT|NOT DONE||NA|Y|U|2||58||WASHOUT|1968-02-05||1972-02-22|||1964-02-07||1962-12-16
TRIAL STUDY 134XCP|RP|9A60A414-54A0-4A7F-84EE-FCB8246D2477|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MOL/MOL|||UG/G/DAY|NOT DONE||Y|NA|U|3||39||BLINDED TREATMENT|1965-07-07||1972-05-07|||1973-01-06||1961-09-01
TRIAL STUDY 134XCP|RP|9A60A414-54A0-4A7F-84EE-FCB8246D2477|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^6 ORGANISMS/ML|||UG/DAY|NOT DONE||U|Y|Y|3||39||OBSERVATION|1963-02-04||1960-11-09|||1972-06-29||1969-05-18
TRIAL STUDY 134XCP|RP|9A60A414-54A0-4A7F-84EE-FCB8246D2477|1||||||MENOSTAT|MENOPAUSE STATUS||||NGEQ/L|||MOL/MOL|NOT DONE||U|NA|N|4||88||TREATMENT|1963-06-17||1970-11-18|||1967-09-04||1962-02-24
TRIAL STUDY 134XCP|RP|9A60A414-54A0-4A7F-84EE-FCB8246D2477|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||HPA|||BLOCKS|NOT DONE||N|Y|NA|4||88||OPEN LABEL TREATMENT|1970-12-31||1966-09-19|||1972-08-25||1960-08-14
TRIAL STUDY 134XCP|RP|9A60A414-54A0-4A7F-84EE-FCB8246D2477|1||||||INABOIND|INDUCED ABORTION INDICATOR||||IU/MMOL|||10^6 IU|NOT DONE||U|NA|N|5||7||WASHOUT|1968-12-29||1960-07-17|||1961-03-09||1967-02-22
TRIAL STUDY 134XCP|RP|9A60A414-54A0-4A7F-84EE-FCB8246D2477|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ANTI-XA IU|||%(V/V)|NOT DONE||N|U|U|5||7||BLINDED TREATMENT|1960-08-07||1963-05-14|||1967-06-02||1971-11-13
TRIAL STUDY 134XCP|RP|8D546F1C-E719-4C03-A66A-9916EFF2A144|1||||||PUSTIND|PUSTULE INDICATOR||||SUPPOSITORY|||SCM|NOT DONE||N|NA|U|1||38||INDUCTION TREATMENT|1961-05-17||1966-03-30|||1965-05-12||1961-07-01
TRIAL STUDY 134XCP|RP|8D546F1C-E719-4C03-A66A-9916EFF2A144|2||||||BCMETHOD|BIRTH CONTROL METHOD||||HOUNSFIELD UNIT|||ELISA UNIT|NOT DONE||N|N|Y|1||38||BASELINE|1963-05-30||1966-11-07|||1973-06-26||1965-03-09
TRIAL STUDY 134XCP|RP|8D546F1C-E719-4C03-A66A-9916EFF2A144|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||EU|||CM/MIN|NOT DONE||NA|Y|NA|2||58||OPEN LABEL TREATMENT|1964-05-29||1966-01-06|||1962-04-25||1970-11-21
TRIAL STUDY 134XCP|RP|8D546F1C-E719-4C03-A66A-9916EFF2A144|2||||||ABORTN|NUMBER OF ABORTIONS||||CUP EQ|||MESF|NOT DONE||Y|U|NA|2||58||SCREENING|1962-09-08||1965-11-06|||1968-03-30||1967-06-07
TRIAL STUDY 134XCP|RP|8D546F1C-E719-4C03-A66A-9916EFF2A144|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||CMH2O/ML|||MV|NOT DONE||N|NA|N|3||39||FOLLOW-UP|1970-11-06||1960-08-11|||1961-05-23||1961-01-04
TRIAL STUDY 134XCP|RP|8D546F1C-E719-4C03-A66A-9916EFF2A144|2||||||GRAVIND|GRAVIDA INDICATOR||||PMOL/DL|||ML/KG/DAY|NOT DONE||N|U|N|3||39||TREATMENT|1966-12-23||1966-05-11|||1963-03-29||1969-10-13
TRIAL STUDY 134XCP|RP|8D546F1C-E719-4C03-A66A-9916EFF2A144|1||||||PRGENDTC|DATE PREGNANCY ENDED||||10^9/G|||EU|NOT DONE||N|U|N|4||88||RUN-IN|1966-12-14||1963-08-21|||1971-10-18||1961-07-07
TRIAL STUDY 134XCP|RP|8D546F1C-E719-4C03-A66A-9916EFF2A144|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||OHM|||MAC50|NOT DONE||NA|NA|Y|4||88||WASHOUT|1970-04-30||1969-03-14|||1965-01-09||1969-04-27
TRIAL STUDY 134XCP|RP|8D546F1C-E719-4C03-A66A-9916EFF2A144|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UCI/KG|||MG/KG|NOT DONE||N|Y|Y|5||7||OBSERVATION|1962-12-28||1960-11-16|||1964-10-26||1961-07-12
TRIAL STUDY 134XCP|RP|8D546F1C-E719-4C03-A66A-9916EFF2A144|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||UL/KG/DAY|||G/M2/DAY|NOT DONE||Y|U|U|5||7||BLINDED TREATMENT|1964-06-25||1970-03-09|||1964-05-07||1967-05-30
TRIAL STUDY 134XCP|RP|B998085D-F227-46C8-B2D8-37E97BA799D2|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||DEG/S|||U/M2/DAY|NOT DONE||Y|N|N|1||38||RUN-IN|1970-12-27||1964-02-15|||1971-07-21||1969-08-31
TRIAL STUDY 134XCP|RP|B998085D-F227-46C8-B2D8-37E97BA799D2|2||||||INTP|INTERPRETATION||||CFU/ML|||MOL/ML|NOT DONE||N|N|N|1||38||FOLLOW-UP|1962-04-11||1966-09-01|||1967-05-28||1971-09-15
TRIAL STUDY 134XCP|RP|B998085D-F227-46C8-B2D8-37E97BA799D2|1||||||PREGIND|PREGNANT INDICATOR||||MMAL|||MMOL|NOT DONE||N|U|U|2||58||BLINDED TREATMENT|1962-04-10||1964-09-22|||1968-01-23||1964-03-06
TRIAL STUDY 134XCP|RP|B998085D-F227-46C8-B2D8-37E97BA799D2|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||CGY|||MBP|NOT DONE||NA|Y|U|2||58||BLINDED TREATMENT|1964-06-17||1965-06-17|||1969-03-06||1972-04-23
TRIAL STUDY 134XCP|RP|B998085D-F227-46C8-B2D8-37E97BA799D2|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||10^6 RNA COPIES/ML|||MEQ|NOT DONE||U|Y|NA|3||39||BASELINE|1968-02-20||1968-08-22|||1963-05-09||1964-05-31
TRIAL STUDY 134XCP|RP|B998085D-F227-46C8-B2D8-37E97BA799D2|2||||||PRGENDTC|DATE PREGNANCY ENDED||||CI/MG|||10^4/HPF|NOT DONE||N|NA|U|3||39||BASELINE|1961-01-18||1964-12-06|||1971-12-09||1961-06-04
TRIAL STUDY 134XCP|RP|B998085D-F227-46C8-B2D8-37E97BA799D2|1||||||TNDRIND|TENDERNESS INDICATOR||||KIT|||UG|NOT DONE||U|U|U|4||88||TREATMENT|1965-06-02||1965-01-29|||1960-01-09||1963-10-20
TRIAL STUDY 134XCP|RP|B998085D-F227-46C8-B2D8-37E97BA799D2|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||M/SEC|||FRACTION OF 1|NOT DONE||N|NA|Y|4||88||INDUCTION TREATMENT|1963-04-23||1968-05-03|||1968-04-09||1971-10-09
TRIAL STUDY 134XCP|RP|B998085D-F227-46C8-B2D8-37E97BA799D2|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MG/MOL|||SACHET|NOT DONE||U|NA|N|5||7||WASHOUT|1964-07-22||1965-08-27|||1971-08-11||1964-10-14
TRIAL STUDY 134XCP|RP|B998085D-F227-46C8-B2D8-37E97BA799D2|2||||||ULCERIND|ULCER INDICATOR||||MMOL/DAY|||HENRY|NOT DONE||N|NA|U|5||7||FOLLOW-UP|1969-11-17||1967-05-30|||1973-05-12||1969-07-02
TRIAL STUDY 134XCP|RP|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||KIT|||LM|NOT DONE||N|N|U|1||38||SCREENING|1964-09-27||1971-01-21|||1967-03-17||1966-11-02
TRIAL STUDY 134XCP|RP|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|2||||||PREGNN|NUMBER OF PREGNANCIES||||UMOL/KG/MIN|||STEPS/MIN|NOT DONE||NA|U|U|1||38||FOLLOW-UP|1966-02-05||1964-03-21|||1973-04-14||1973-05-04
TRIAL STUDY 134XCP|RP|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||U/KG|||10^6 CFU|NOT DONE||Y|N|NA|2||58||BLINDED TREATMENT|1971-11-07||1964-01-05|||1964-09-21||1962-11-10
TRIAL STUDY 134XCP|RP|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||G/CM2|||PL|NOT DONE||Y|Y|NA|2||58||BLINDED TREATMENT|1970-01-20||1961-03-23|||1970-11-06||1965-06-06
TRIAL STUDY 134XCP|RP|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|1||||||MENFDUR|MENSES FLOW DURATION||||MM2|||MM2|NOT DONE||NA|Y|Y|3||39||OBSERVATION|1973-01-12||1960-02-04|||1966-10-01||1968-01-04
TRIAL STUDY 134XCP|RP|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|2||||||MENOAGE|MENOPAUSE AGE||||IU/ML|||L/L|NOT DONE||NA|N|NA|3||39||CONTINUATION TREATMENT|1964-03-20||1967-07-29|||1961-02-23||1963-05-22
TRIAL STUDY 134XCP|RP|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||ANTIBODY UNIT|||C|NOT DONE||Y|N|N|4||88||LONG-TERM FOLLOW-UP|1967-07-07||1965-12-29|||1970-03-22||1968-12-04
TRIAL STUDY 134XCP|RP|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||GENEQ|||GMFI|NOT DONE||N|NA|N|4||88||BASELINE|1967-09-25||1969-10-13|||1963-09-04||1962-09-10
TRIAL STUDY 134XCP|RP|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|1||||||ULCERIND|ULCER INDICATOR||||LOG10 CCID 50/DOSE|||UG/M2|NOT DONE||NA|N|N|5||7||CONTINUATION TREATMENT|1969-01-08||1971-06-26|||1960-12-24||1960-10-02
TRIAL STUDY 134XCP|RP|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||EID 50/DOSE|||MM/H|NOT DONE||NA|Y|Y|5||7||RUN-IN|1967-07-06||1970-10-29|||1965-06-05||1973-04-29
TRIAL STUDY 134XCP|RP|537CE647-EA58-430C-B37B-F56BF20B5AF0|1||||||MENFDUR|MENSES FLOW DURATION||||MV2/HZ|||STEPS|NOT DONE||N|N|N|1||38||TREATMENT|1973-08-18||1968-08-06|||1973-02-09||1968-11-10
TRIAL STUDY 134XCP|RP|537CE647-EA58-430C-B37B-F56BF20B5AF0|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||SFC/10^6 PBMC|||UG/MIN|NOT DONE||Y|U|U|1||38||INDUCTION TREATMENT|1971-02-26||1965-07-26|||1969-07-25||1966-09-13
TRIAL STUDY 134XCP|RP|537CE647-EA58-430C-B37B-F56BF20B5AF0|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||GY|||NKAT|NOT DONE||U|Y|Y|2||58||RUN-IN|1971-03-27||1960-06-04|||1960-04-23||1970-03-10
TRIAL STUDY 134XCP|RP|537CE647-EA58-430C-B37B-F56BF20B5AF0|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||10^8/L|||OSM|NOT DONE||Y|U|Y|2||58||OPEN LABEL TREATMENT|1969-04-26||1968-08-19|||1962-09-13||1964-06-02
TRIAL STUDY 134XCP|RP|537CE647-EA58-430C-B37B-F56BF20B5AF0|1||||||PREGIND|PREGNANT INDICATOR||||NKAT/G HB|||KN/CM2|NOT DONE||Y|N|NA|3||39||FOLLOW-UP|1973-07-18||1970-09-13|||1971-12-31||1962-09-22
TRIAL STUDY 134XCP|RP|537CE647-EA58-430C-B37B-F56BF20B5AF0|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||1/(S*KPA)|||G/G|NOT DONE||NA|N|U|3||39||FOLLOW-UP|1971-05-29||1963-11-16|||1971-10-16||1968-12-12
TRIAL STUDY 134XCP|RP|537CE647-EA58-430C-B37B-F56BF20B5AF0|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||LM|||10^9 ORGANISMS|NOT DONE||Y|N|NA|4||88||OBSERVATION|1960-11-07||1973-05-17|||1972-02-18||1965-04-29
TRIAL STUDY 134XCP|RP|537CE647-EA58-430C-B37B-F56BF20B5AF0|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||U/KG/H|||MEQ/G|NOT DONE||U|Y|N|4||88||CONTINUATION TREATMENT|1969-08-20||1968-10-25|||1963-01-24||1960-10-20
TRIAL STUDY 134XCP|RP|537CE647-EA58-430C-B37B-F56BF20B5AF0|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||APL U|||P|NOT DONE||U|U|N|5||7||INDUCTION TREATMENT|1961-10-21||1961-11-18|||1963-11-03||1972-02-29
TRIAL STUDY 134XCP|RP|537CE647-EA58-430C-B37B-F56BF20B5AF0|2||||||BCMETHOD|BIRTH CONTROL METHOD||||UG/MIN|||DNA COPIES/UG|NOT DONE||U|U|U|5||7||OPEN LABEL TREATMENT|1963-02-23||1972-02-04|||1965-08-28||1961-08-07
TRIAL STUDY 134XCP|RP|3464201C-9704-40B6-B3B3-2BADE02BD58F|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||KPA|||APS U|NOT DONE||N|NA|N|1||38||FOLLOW-UP|1969-08-10||1972-07-01|||1967-05-15||1971-04-18
TRIAL STUDY 134XCP|RP|3464201C-9704-40B6-B3B3-2BADE02BD58F|2||||||FUNDHT|FUNDAL HEIGHT||||FOZ_US|||ML/CM|NOT DONE||N|Y|Y|1||38||OBSERVATION|1961-12-02||1965-08-24|||1972-04-13||1963-06-12
TRIAL STUDY 134XCP|RP|3464201C-9704-40B6-B3B3-2BADE02BD58F|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||FT|||PKAT|NOT DONE||N|U|N|2||58||BASELINE|1972-06-15||1973-06-21|||1966-02-02||1966-05-10
TRIAL STUDY 134XCP|RP|3464201C-9704-40B6-B3B3-2BADE02BD58F|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||/MM|||MMOL/DAY|NOT DONE||NA|NA|Y|2||58||RUN-IN|1964-08-11||1966-02-05|||1972-01-27||1964-03-22
TRIAL STUDY 134XCP|RP|3464201C-9704-40B6-B3B3-2BADE02BD58F|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ML*CMH2O|||DRUM|NOT DONE||N|U|N|3||39||BLINDED TREATMENT|1961-03-02||1970-07-10|||1961-05-05||1963-06-11
TRIAL STUDY 134XCP|RP|3464201C-9704-40B6-B3B3-2BADE02BD58F|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||CM|||PHERESIS UNIT|NOT DONE||N|NA|U|3||39||INDUCTION TREATMENT|1968-06-27||1963-03-27|||1972-04-24||1970-02-02
TRIAL STUDY 134XCP|RP|3464201C-9704-40B6-B3B3-2BADE02BD58F|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UG/L|||CL|NOT DONE||N|U|U|4||88||RUN-IN|1965-03-14||1972-06-01|||1960-07-24||1972-06-12
TRIAL STUDY 134XCP|RP|3464201C-9704-40B6-B3B3-2BADE02BD58F|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||ML/100G/MIN|||10^9 ORGANISMS/ML|NOT DONE||N|U|U|4||88||BLINDED TREATMENT|1964-01-22||1967-04-22|||1968-06-05||1964-04-27
TRIAL STUDY 134XCP|RP|3464201C-9704-40B6-B3B3-2BADE02BD58F|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||UG/KG/DAY|||MV*MIN|NOT DONE||U|NA|U|5||7||RUN-IN|1966-05-04||1972-01-07|||1963-12-17||1966-03-10
TRIAL STUDY 134XCP|RP|3464201C-9704-40B6-B3B3-2BADE02BD58F|2||||||INABOIND|INDUCED ABORTION INDICATOR||||KA_U/DL|||ELISA UNIT/ML|NOT DONE||Y|U|NA|5||7||FOLLOW-UP|1973-09-07||1966-08-11|||1963-04-04||1972-11-17
TRIAL STUDY 134XCP|RP|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|1||||||DSCHGIND|DISCHARGE INDICATOR||||GRAVITATIONAL UNIT|||VG/KG|NOT DONE||U|Y|NA|1||38||INDUCTION TREATMENT|1970-05-11||1967-03-26|||1965-07-02||1967-12-07
TRIAL STUDY 134XCP|RP|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||RATIO|||MV|NOT DONE||Y|U|NA|1||38||BLINDED TREATMENT|1962-11-17||1966-01-28|||1973-03-23||1965-01-15
TRIAL STUDY 134XCP|RP|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|1||||||BRTHN|NUMBER OF BIRTHS||||CFU/ML|||LOG10 TCID 50/DOSE|NOT DONE||Y|Y|NA|2||58||LONG-TERM FOLLOW-UP|1964-06-17||1966-08-28|||1960-06-11||1966-06-28
TRIAL STUDY 134XCP|RP|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MV2/HZ|||KPA/L/SEC|NOT DONE||NA|U|Y|2||58||RUN-IN|1971-09-12||1970-02-02|||1973-04-21||1966-11-07
TRIAL STUDY 134XCP|RP|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|1||||||MASSIND|MASS INDICATOR||||FT3|||DAYS|NOT DONE||NA|Y|U|3||39||BLINDED TREATMENT|1960-06-08||1965-02-18|||1965-11-25||1964-05-02
TRIAL STUDY 134XCP|RP|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||U/DL|||ATM|NOT DONE||U|NA|NA|3||39||BASELINE|1971-05-09||1968-04-07|||1960-06-21||1969-07-29
TRIAL STUDY 134XCP|RP|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|1||||||PREGNN|NUMBER OF PREGNANCIES||||L/DAY|||NCI|NOT DONE||NA|Y|U|4||88||LONG-TERM FOLLOW-UP|1971-11-02||1962-05-29|||1970-10-17||1969-01-07
TRIAL STUDY 134XCP|RP|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|2||||||GRAVIND|GRAVIDA INDICATOR||||MEQ/L|||IN2|NOT DONE||NA|N|N|4||88||LONG-TERM FOLLOW-UP|1971-01-04||1960-04-06|||1960-10-19||1969-09-27
TRIAL STUDY 134XCP|RP|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||NKAT/G HB|||10^9/DOSE|NOT DONE||U|Y|U|5||7||RUN-IN|1967-11-21||1963-08-31|||1961-06-09||1961-10-18
TRIAL STUDY 134XCP|RP|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|2||||||MENARAGE|MENARCHE AGE||||NG/L|||K|NOT DONE||U|N|N|5||7||INDUCTION TREATMENT|1963-10-02||1967-06-20|||1964-01-04||1961-06-30
TRIAL STUDY 134XCP|RP|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|1||||||MENFDUR|MENSES FLOW DURATION||||KPA/L/SEC|||ML/MIN/1.73M2|NOT DONE||Y|U|Y|1||38||CONTINUATION TREATMENT|1960-06-05||1962-02-27|||1965-07-27||1973-05-12
TRIAL STUDY 134XCP|RP|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MOL/MOL|||GPS U|NOT DONE||U|NA|U|1||38||TREATMENT|1969-02-01||1972-06-04|||1969-01-28||1973-05-03
TRIAL STUDY 134XCP|RP|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||FT3|||MMOL/G|NOT DONE||NA|Y|NA|2||58||FOLLOW-UP|1969-03-17||1971-07-16|||1970-12-08||1967-06-11
TRIAL STUDY 134XCP|RP|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||MOL/G|||S*KPA|NOT DONE||N|Y|NA|2||58||TREATMENT|1964-03-07||1965-11-28|||1971-03-10||1973-06-02
TRIAL STUDY 134XCP|RP|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|1||||||BLISTIND|BLISTERING INDICATOR||||ML/KG/H|||LOG10 CCID 50/DOSE|NOT DONE||N|NA|Y|3||39||OBSERVATION|1973-03-21||1964-09-11|||1973-06-21||1972-10-29
TRIAL STUDY 134XCP|RP|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||COPIES/UL|||10^3 ORGANISMS/ML|NOT DONE||U|NA|N|3||39||BASELINE|1965-04-05||1960-07-29|||1970-05-01||1970-12-17
TRIAL STUDY 134XCP|RP|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||%/MIN|||/40 HPFS|NOT DONE||Y|U|NA|4||88||OBSERVATION|1964-06-28||1964-06-15|||1964-11-17||1972-06-07
TRIAL STUDY 134XCP|RP|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|2||||||STILBIND|STILLBIRTH INDICATOR||||ML/DAY|||10^6 IU|NOT DONE||N|NA|Y|4||88||TREATMENT|1969-07-04||1967-10-25|||1965-10-02||1972-12-04
TRIAL STUDY 134XCP|RP|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||YEARS|||UL/KG/DAY|NOT DONE||NA|U|N|5||7||LONG-TERM FOLLOW-UP|1968-12-06||1963-06-04|||1964-01-02||1960-07-25
TRIAL STUDY 134XCP|RP|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||10^9 ORGANISMS/G|||ANTIBODY UNIT|NOT DONE||N|N|U|5||7||SCREENING|1965-07-10||1968-09-30|||1960-02-18||1967-02-01
TRIAL STUDY 134XCP|RP|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|1||||||BLISTIND|BLISTERING INDICATOR||||WAFER|||10^12/L|NOT DONE||Y|Y|NA|1||38||TREATMENT|1960-01-16||1963-07-30|||1966-04-26||1960-03-12
TRIAL STUDY 134XCP|RP|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|2||||||ULCERIND|ULCER INDICATOR||||DPM/100MG|||FRAMES/S|NOT DONE||NA|Y|NA|1||38||FOLLOW-UP|1970-07-24||1961-09-10|||1966-02-21||1964-09-02
TRIAL STUDY 134XCP|RP|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||DISK|||RAD|NOT DONE||NA|U|Y|2||58||WASHOUT|1961-02-24||1963-05-12|||1971-03-04||1967-10-09
TRIAL STUDY 134XCP|RP|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||TSP EQ|||DNA COPIES/UG|NOT DONE||N|N|NA|2||58||FOLLOW-UP|1969-06-17||1968-02-16|||1973-07-13||1969-06-04
TRIAL STUDY 134XCP|RP|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||CPM|||10^4/HPF|NOT DONE||NA|U|Y|3||39||OBSERVATION|1965-11-25||1960-03-05|||1965-08-04||1964-01-10
TRIAL STUDY 134XCP|RP|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|2||||||PRGENDTC|DATE PREGNANCY ENDED||||/7.5 ML|||FOZ_BR|NOT DONE||Y|NA|N|3||39||TREATMENT|1964-12-01||1965-02-12|||1973-05-21||1972-03-02
TRIAL STUDY 134XCP|RP|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||VIRTUAL PIXEL|||EIA UNIT|NOT DONE||NA|N|U|4||88||LONG-TERM FOLLOW-UP|1965-07-22||1963-03-30|||1966-04-20||1967-08-31
TRIAL STUDY 134XCP|RP|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|2||||||BLISTIND|BLISTERING INDICATOR||||HOUNSFIELD UNIT|||CONTAINER|NOT DONE||U|Y|N|4||88||FOLLOW-UP|1964-12-12||1960-11-15|||1967-11-09||1969-12-10
TRIAL STUDY 134XCP|RP|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||PPB|||UEQ/L|NOT DONE||U|U|U|5||7||BLINDED TREATMENT|1963-12-26||1971-08-28|||1968-08-28||1962-08-10
TRIAL STUDY 134XCP|RP|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||CG|||UG/M2|NOT DONE||Y|Y|U|5||7||CONTINUATION TREATMENT|1961-06-21||1967-05-02|||1964-10-23||1965-09-02
TRIAL STUDY 134XCP|RP|11A6144A-895B-4143-85D2-69952C6D452C|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||U/G/DAY|||CI/G|NOT DONE||NA|N|N|1||38||TREATMENT|1970-12-06||1972-02-08|||1963-10-26||1962-12-13
TRIAL STUDY 134XCP|RP|11A6144A-895B-4143-85D2-69952C6D452C|2||||||PEELIND|PEELING INDICATOR||||BEAM BREAKS|||AMU|NOT DONE||N|U|Y|1||38||OPEN LABEL TREATMENT|1973-01-08||1971-02-04|||1962-04-04||1965-04-17
TRIAL STUDY 134XCP|RP|11A6144A-895B-4143-85D2-69952C6D452C|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||ML/SEC/1.73M2|||TBSP|NOT DONE||NA|Y|NA|2||58||LONG-TERM FOLLOW-UP|1964-04-22||1967-01-24|||1962-07-11||1968-02-01
TRIAL STUDY 134XCP|RP|11A6144A-895B-4143-85D2-69952C6D452C|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||DAMOL/L|||GAUSS|NOT DONE||NA|Y|NA|2||58||CONTINUATION TREATMENT|1967-05-12||1965-09-10|||1965-07-28||1960-07-14
TRIAL STUDY 134XCP|RP|11A6144A-895B-4143-85D2-69952C6D452C|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||GENEQ|||AFU|NOT DONE||U|N|Y|3||39||FOLLOW-UP|1964-02-27||1966-04-07|||1965-12-24||1972-09-23
TRIAL STUDY 134XCP|RP|11A6144A-895B-4143-85D2-69952C6D452C|2||||||PREGIND|PREGNANT INDICATOR||||10^9/G|||% INHIBITION|NOT DONE||U|NA|NA|3||39||OPEN LABEL TREATMENT|1963-04-24||1971-11-15|||1967-05-08||1960-05-24
TRIAL STUDY 134XCP|RP|11A6144A-895B-4143-85D2-69952C6D452C|1||||||GRAVIND|GRAVIDA INDICATOR||||UMOL/DL|||10^7 PFU|NOT DONE||N|Y|Y|4||88||WASHOUT|1961-06-07||1968-05-02|||1965-12-05||1963-12-03
TRIAL STUDY 134XCP|RP|11A6144A-895B-4143-85D2-69952C6D452C|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MOSM/L|||NEEDLE GAUGE|NOT DONE||NA|N|N|4||88||OPEN LABEL TREATMENT|1962-04-05||1972-06-11|||1965-07-10||1961-07-31
TRIAL STUDY 134XCP|RP|11A6144A-895B-4143-85D2-69952C6D452C|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||BQ/L|||SQU/ML|NOT DONE||NA|NA|N|5||7||BASELINE|1961-06-18||1963-02-27|||1962-06-06||1972-11-18
TRIAL STUDY 134XCP|RP|11A6144A-895B-4143-85D2-69952C6D452C|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||ML/KG/DAY|||NEWTON|NOT DONE||Y|N|U|5||7||CONTINUATION TREATMENT|1967-12-26||1963-01-13|||1967-08-22||1962-06-03
TRIAL STUDY 134XCP|RP|8958D35E-F685-4542-AE01-625133F1EF7D|1||||||ERYTHIND|ERYTHEMA INDICATOR||||BQ/ML|||MJOULE/CM2|NOT DONE||N|NA|NA|1||38||OBSERVATION|1973-01-16||1965-01-15|||1967-08-09||1968-09-20
TRIAL STUDY 134XCP|RP|8958D35E-F685-4542-AE01-625133F1EF7D|2||||||BRTHN|NUMBER OF BIRTHS||||10^6 IU/ML|||MG/L FEU|NOT DONE||N|U|N|1||38||LONG-TERM FOLLOW-UP|1962-11-30||1960-02-13|||1967-09-12||1968-02-07
TRIAL STUDY 134XCP|RP|8958D35E-F685-4542-AE01-625133F1EF7D|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||DYN|||LOG10 COPIES/ML|NOT DONE||NA|U|NA|2||58||BLINDED TREATMENT|1966-11-08||1969-10-20|||1967-07-10||1969-05-25
TRIAL STUDY 134XCP|RP|8958D35E-F685-4542-AE01-625133F1EF7D|2||||||DLVRMODE|MODE OF DELIVERY||||KBQ/UL|||TUBERCULIN UNIT|NOT DONE||NA|U|N|2||58||TREATMENT|1961-08-06||1972-09-24|||1961-04-12||1967-06-07
TRIAL STUDY 134XCP|RP|8958D35E-F685-4542-AE01-625133F1EF7D|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||SUPPOSITORY|||U/G HB|NOT DONE||N|N|Y|3||39||OPEN LABEL TREATMENT|1962-10-11||1968-01-25|||1971-10-07||1972-03-31
TRIAL STUDY 134XCP|RP|8958D35E-F685-4542-AE01-625133F1EF7D|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||ROENTGEN|||UG/KG/H|NOT DONE||U|Y|NA|3||39||LONG-TERM FOLLOW-UP|1968-05-26||1961-09-16|||1970-01-27||1966-01-13
TRIAL STUDY 134XCP|RP|8958D35E-F685-4542-AE01-625133F1EF7D|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^6 COPIES/ML|||MEQ/ML|NOT DONE||NA|Y|NA|4||88||BASELINE|1966-08-16||1971-02-17|||1972-09-27||1968-05-06
TRIAL STUDY 134XCP|RP|8958D35E-F685-4542-AE01-625133F1EF7D|2||||||PREGST|PREGNANT DURING THE STUDY||||ML/MIN/1.73M2|||MV2/HZ|NOT DONE||N|U|U|4||88||FOLLOW-UP|1960-05-22||1961-09-07|||1966-08-07||1963-01-01
TRIAL STUDY 134XCP|RP|8958D35E-F685-4542-AE01-625133F1EF7D|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||APL U|||DPM/100MG|NOT DONE||NA|U|N|5||7||FOLLOW-UP|1961-10-18||1965-11-30|||1970-10-19||1970-11-19
TRIAL STUDY 134XCP|RP|8958D35E-F685-4542-AE01-625133F1EF7D|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||/100 HPFS|||PPTR|NOT DONE||N|NA|NA|5||7||OBSERVATION|1969-12-08||1967-08-31|||1969-07-07||1969-02-16
TRIAL STUDY 134XCP|RP|00982640-C826-4CD4-B927-A311227E63CC|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||DAMOL/L|||MOSM/L|NOT DONE||Y|NA|Y|1||38||BLINDED TREATMENT|1968-08-31||1971-06-23|||1967-04-19||1961-07-15
TRIAL STUDY 134XCP|RP|00982640-C826-4CD4-B927-A311227E63CC|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^9 CFU|||UMOL/L/SEC|NOT DONE||Y|Y|Y|1||38||OBSERVATION|1972-12-06||1964-12-06|||1965-07-04||1968-07-26
TRIAL STUDY 134XCP|RP|00982640-C826-4CD4-B927-A311227E63CC|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MNFI|||UV*SEC|NOT DONE||U|U|NA|2||58||LONG-TERM FOLLOW-UP|1972-02-26||1965-09-11|||1963-08-18||1965-05-23
TRIAL STUDY 134XCP|RP|00982640-C826-4CD4-B927-A311227E63CC|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||ANTI-XA IU|||MV/SEC|NOT DONE||N|Y|U|2||58||INDUCTION TREATMENT|1968-05-16||1969-10-10|||1970-08-14||1970-03-30
TRIAL STUDY 134XCP|RP|00982640-C826-4CD4-B927-A311227E63CC|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MPL U|||MET*H|NOT DONE||U|Y|N|3||39||OPEN LABEL TREATMENT|1960-02-19||1965-09-23|||1967-09-08||1968-03-05
TRIAL STUDY 134XCP|RP|00982640-C826-4CD4-B927-A311227E63CC|2||||||INTP|INTERPRETATION||||RATIO|||FMOL|NOT DONE||Y|Y|NA|3||39||BASELINE|1961-01-15||1967-07-18|||1962-09-23||1972-04-22
TRIAL STUDY 134XCP|RP|00982640-C826-4CD4-B927-A311227E63CC|1||||||INABOIND|INDUCED ABORTION INDICATOR||||CONTAINER|||MGEQ|NOT DONE||Y|Y|NA|4||88||BASELINE|1960-02-26||1962-11-28|||1968-04-30||1967-08-23
TRIAL STUDY 134XCP|RP|00982640-C826-4CD4-B927-A311227E63CC|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||UG/CM2|||/10^3|NOT DONE||Y|Y|NA|4||88||BLINDED TREATMENT|1972-02-03||1967-10-29|||1964-04-02||1969-07-03
TRIAL STUDY 134XCP|RP|00982640-C826-4CD4-B927-A311227E63CC|1||||||MENARAGE|MENARCHE AGE||||WATT|||UU/DL|NOT DONE||Y|N|NA|5||7||SCREENING|1971-06-25||1973-04-18|||1960-07-18||1962-03-09
TRIAL STUDY 134XCP|RP|00982640-C826-4CD4-B927-A311227E63CC|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UG/L FEU|||DRAM|NOT DONE||U|U|NA|5||7||TREATMENT|1962-11-26||1963-07-08|||1966-03-18||1973-05-26
TRIAL STUDY 134XCP|RP|C213CAA8-2FAC-402C-A19E-11A60708A71A|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||IU/KG/H|||BAG|NOT DONE||Y|U|Y|1||38||TREATMENT|1960-09-11||1968-08-08|||1969-11-24||1965-10-23
TRIAL STUDY 134XCP|RP|C213CAA8-2FAC-402C-A19E-11A60708A71A|2||||||PREGST|PREGNANT DURING THE STUDY||||VOXEL|||BQ/MG|NOT DONE||Y|Y|N|1||38||WASHOUT|1965-01-22||1968-04-26|||1966-03-08||1968-04-09
TRIAL STUDY 134XCP|RP|C213CAA8-2FAC-402C-A19E-11A60708A71A|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||KCAL/DAY|||GY/H|NOT DONE||Y|Y|NA|2||58||TREATMENT|1961-02-05||1961-05-03|||1961-09-17||1965-10-19
TRIAL STUDY 134XCP|RP|C213CAA8-2FAC-402C-A19E-11A60708A71A|2||||||PREGIND|PREGNANT INDICATOR||||10^9 ORGANISMS/ML|||ML/S|NOT DONE||Y|U|U|2||58||SCREENING|1960-01-27||1966-08-01|||1970-05-14||1971-08-26
TRIAL STUDY 134XCP|RP|C213CAA8-2FAC-402C-A19E-11A60708A71A|1||||||MENOSTAT|MENOPAUSE STATUS||||CMH2O/ML|||CCID 50/ML|NOT DONE||Y|U|NA|3||39||SCREENING|1960-02-15||1963-02-21|||1967-01-29||1963-10-19
TRIAL STUDY 134XCP|RP|C213CAA8-2FAC-402C-A19E-11A60708A71A|2||||||TNDRIND|TENDERNESS INDICATOR||||PATCH|||MG/L|NOT DONE||N|U|U|3||39||BLINDED TREATMENT|1969-11-23||1970-07-20|||1971-02-04||1964-01-13
TRIAL STUDY 134XCP|RP|C213CAA8-2FAC-402C-A19E-11A60708A71A|1||||||ULCERIND|ULCER INDICATOR||||CMH2O/ML|||ROENTGEN|NOT DONE||Y|U|NA|4||88||OPEN LABEL TREATMENT|1968-02-08||1971-07-21|||1961-09-24||1969-06-09
TRIAL STUDY 134XCP|RP|C213CAA8-2FAC-402C-A19E-11A60708A71A|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||LOG10 TCID 50/UL|||DEG|NOT DONE||Y|N|U|4||88||TREATMENT|1962-05-19||1971-09-13|||1962-07-27||1971-12-05
TRIAL STUDY 134XCP|RP|C213CAA8-2FAC-402C-A19E-11A60708A71A|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UMOL/L/MIN|||/500 WBC|NOT DONE||NA|U|U|5||7||WASHOUT|1963-01-09||1967-07-23|||1966-10-14||1972-11-10
TRIAL STUDY 134XCP|RP|C213CAA8-2FAC-402C-A19E-11A60708A71A|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UM2|||MOL/MG|NOT DONE||Y|Y|U|5||7||RUN-IN|1966-09-29||1962-10-04|||1969-01-19||1966-09-18
TRIAL STUDY 134XCP|RP|F0559682-CD36-4ED0-8082-A54D40305512|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||DL|||IMPLANT|NOT DONE||NA|U|Y|1||38||OBSERVATION|1971-11-01||1963-03-09|||1964-07-30||1963-06-10
TRIAL STUDY 134XCP|RP|F0559682-CD36-4ED0-8082-A54D40305512|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||LOG10 CFU/G|||CMH2O/ML|NOT DONE||Y|U|N|1||38||FOLLOW-UP|1973-04-27||1967-02-12|||1969-06-25||1961-03-10
TRIAL STUDY 134XCP|RP|F0559682-CD36-4ED0-8082-A54D40305512|1||||||GRAVIND|GRAVIDA INDICATOR||||/CMH2O|||10^3 RNA COPIES/ML|NOT DONE||U|Y|U|2||58||WASHOUT|1967-07-20||1963-07-14|||1971-10-02||1970-08-27
TRIAL STUDY 134XCP|RP|F0559682-CD36-4ED0-8082-A54D40305512|2||||||PREGST|PREGNANT DURING THE STUDY||||NU/CL|||FT2|NOT DONE||N|U|Y|2||58||OBSERVATION|1961-12-21||1960-08-23|||1964-08-29||1963-12-14
TRIAL STUDY 134XCP|RP|F0559682-CD36-4ED0-8082-A54D40305512|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^3 CFU/ML|||MG/MIN|NOT DONE||U|NA|Y|3||39||TREATMENT|1960-10-09||1969-10-18|||1965-12-15||1972-03-05
TRIAL STUDY 134XCP|RP|F0559682-CD36-4ED0-8082-A54D40305512|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||LOG10 PFU|||MOL/MG|NOT DONE||NA|N|NA|3||39||INDUCTION TREATMENT|1968-12-21||1963-08-13|||1971-11-25||1967-03-14
TRIAL STUDY 134XCP|RP|F0559682-CD36-4ED0-8082-A54D40305512|1||||||INTP|INTERPRETATION||||DEG/S|||MOL/G|NOT DONE||N|Y|NA|4||88||LONG-TERM FOLLOW-UP|1971-03-11||1960-06-16|||1970-05-26||1971-04-30
TRIAL STUDY 134XCP|RP|F0559682-CD36-4ED0-8082-A54D40305512|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||LOG EID 50/DOSE|||BQ/UG|NOT DONE||U|U|Y|4||88||RUN-IN|1972-06-03||1960-11-07|||1967-04-17||1962-03-17
TRIAL STUDY 134XCP|RP|F0559682-CD36-4ED0-8082-A54D40305512|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||OZ|||KALLIKREIN INHIBITOR UNIT|NOT DONE||NA|N|U|5||7||LONG-TERM FOLLOW-UP|1970-07-30||1962-01-20|||1964-05-22||1960-02-28
TRIAL STUDY 134XCP|RP|F0559682-CD36-4ED0-8082-A54D40305512|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||F|||BE/ML|NOT DONE||N|Y|N|5||7||INDUCTION TREATMENT|1966-11-07||1965-05-30|||1967-08-01||1972-11-16
TRIAL STUDY 134XCP|RP|C004A4D5-DBD0-4967-9597-8C1653AB8298|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||U/M2/DAY|||LOZENGE|NOT DONE||N|U|U|1||38||OPEN LABEL TREATMENT|1969-09-07||1963-02-14|||1971-11-20||1971-02-04
TRIAL STUDY 134XCP|RP|C004A4D5-DBD0-4967-9597-8C1653AB8298|2||||||INTP|INTERPRETATION||||ELISA UNIT/ML|||MAC50|NOT DONE||Y|U|N|1||38||WASHOUT|1960-11-08||1960-09-08|||1961-09-08||1968-01-03
TRIAL STUDY 134XCP|RP|C004A4D5-DBD0-4967-9597-8C1653AB8298|1||||||EDEMAIND|EDEMA INDICATOR||||ML/(MIN*100ML)|||MPA|NOT DONE||NA|N|Y|2||58||INDUCTION TREATMENT|1968-06-07||1971-11-13|||1970-02-26||1973-09-08
TRIAL STUDY 134XCP|RP|C004A4D5-DBD0-4967-9597-8C1653AB8298|2||||||EDEMAIND|EDEMA INDICATOR||||U/G/H|||MG/DL|NOT DONE||U|Y|NA|2||58||CONTINUATION TREATMENT|1961-05-26||1963-06-17|||1962-09-23||1966-03-27
TRIAL STUDY 134XCP|RP|C004A4D5-DBD0-4967-9597-8C1653AB8298|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||ATM|||TCID 50/DOSE|NOT DONE||Y|Y|U|3||39||BASELINE|1970-08-24||1972-12-11|||1968-08-05||1961-08-07
TRIAL STUDY 134XCP|RP|C004A4D5-DBD0-4967-9597-8C1653AB8298|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||KHZ|||LOG10 TCID 50/ML|NOT DONE||NA|N|N|3||39||TREATMENT|1968-01-27||1962-05-20|||1961-01-04||1971-10-14
TRIAL STUDY 134XCP|RP|C004A4D5-DBD0-4967-9597-8C1653AB8298|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||10^6 IU/ML|||VP/ML|NOT DONE||N|N|N|4||88||RUN-IN|1972-03-30||1969-02-23|||1972-05-19||1966-03-30
TRIAL STUDY 134XCP|RP|C004A4D5-DBD0-4967-9597-8C1653AB8298|2||||||MENOSTAT|MENOPAUSE STATUS||||TESLA|||MV/SEC|NOT DONE||N|U|U|4||88||OBSERVATION|1969-01-24||1960-09-20|||1973-04-30||1961-12-20
TRIAL STUDY 134XCP|RP|C004A4D5-DBD0-4967-9597-8C1653AB8298|1||||||PREGNN|NUMBER OF PREGNANCIES||||H/WK|||/H|NOT DONE||U|N|Y|5||7||INDUCTION TREATMENT|1961-04-23||1964-04-08|||1967-05-23||1966-04-28
TRIAL STUDY 134XCP|RP|C004A4D5-DBD0-4967-9597-8C1653AB8298|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||PMOL|||KPA/L/SEC|NOT DONE||N|U|U|5||7||FOLLOW-UP|1962-04-12||1965-06-24|||1967-04-09||1965-01-06
TRIAL STUDY 134XCP|RP|ABB838A1-2387-471E-8F50-1F48205BC8EE|1||||||MENOAGE|MENOPAUSE AGE||||DAGU/ML|||FOZ_US|NOT DONE||U|U|Y|1||38||INDUCTION TREATMENT|1968-11-05||1971-12-03|||1964-07-02||1972-10-30
TRIAL STUDY 134XCP|RP|ABB838A1-2387-471E-8F50-1F48205BC8EE|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||10^9 CFU/ML|||PMOL/DL|NOT DONE||N|NA|Y|1||38||RUN-IN|1970-06-13||1971-03-14|||1971-05-22||1971-08-03
TRIAL STUDY 134XCP|RP|ABB838A1-2387-471E-8F50-1F48205BC8EE|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||COAT|||USP U|NOT DONE||NA|N|N|2||58||LONG-TERM FOLLOW-UP|1966-12-16||1968-06-28|||1965-10-27||1963-08-19
TRIAL STUDY 134XCP|RP|ABB838A1-2387-471E-8F50-1F48205BC8EE|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UMOL|||UG/MOL|NOT DONE||N|U|U|2||58||OBSERVATION|1963-12-23||1962-03-01|||1973-02-21||1968-03-26
TRIAL STUDY 134XCP|RP|ABB838A1-2387-471E-8F50-1F48205BC8EE|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||FRAMES/S|||UG/M2/H|NOT DONE||N|U|U|3||39||RUN-IN|1965-03-19||1961-12-19|||1969-02-28||1962-10-21
TRIAL STUDY 134XCP|RP|ABB838A1-2387-471E-8F50-1F48205BC8EE|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||G/G|||KPA/L/SEC|NOT DONE||U|NA|U|3||39||RUN-IN|1972-11-03||1969-06-21|||1968-01-29||1969-11-14
TRIAL STUDY 134XCP|RP|ABB838A1-2387-471E-8F50-1F48205BC8EE|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MG/KG/MIN|||10^9 ORGANISMS/ML|NOT DONE||NA|U|N|4||88||OPEN LABEL TREATMENT|1961-02-04||1962-04-05|||1967-07-25||1966-11-14
TRIAL STUDY 134XCP|RP|ABB838A1-2387-471E-8F50-1F48205BC8EE|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MM/H|||MMOL|NOT DONE||Y|Y|N|4||88||CONTINUATION TREATMENT|1969-07-23||1965-09-08|||1970-04-26||1968-10-17
TRIAL STUDY 134XCP|RP|ABB838A1-2387-471E-8F50-1F48205BC8EE|1||||||PREGNN|NUMBER OF PREGNANCIES||||H*%|||MMOL/L|NOT DONE||Y|NA|NA|5||7||SCREENING|1964-10-04||1964-10-29|||1968-09-05||1967-01-08
TRIAL STUDY 134XCP|RP|ABB838A1-2387-471E-8F50-1F48205BC8EE|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||FOZ_BR|||UIU/DL|NOT DONE||U|N|Y|5||7||TREATMENT|1973-01-05||1971-03-27|||1965-09-16||1962-07-11
TRIAL STUDY 134XCP|RP|88126417-8564-4659-AA60-63642067113D|1||||||GRAVIND|GRAVIDA INDICATOR||||U/KG/H|||IU/DAY|NOT DONE||N|Y|N|1||38||OPEN LABEL TREATMENT|1966-03-13||1965-08-14|||1966-04-17||1970-03-16
TRIAL STUDY 134XCP|RP|88126417-8564-4659-AA60-63642067113D|2||||||ERYTHIND|ERYTHEMA INDICATOR||||MMOL/MOL|||DEG/MM|NOT DONE||N|N|Y|1||38||SCREENING|1962-05-23||1967-12-07|||1960-03-24||1965-06-20
TRIAL STUDY 134XCP|RP|88126417-8564-4659-AA60-63642067113D|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||UM|||/200 HPFS|NOT DONE||N|Y|N|2||58||BLINDED TREATMENT|1962-12-12||1969-06-30|||1960-08-29||1969-11-06
TRIAL STUDY 134XCP|RP|88126417-8564-4659-AA60-63642067113D|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||PRESSOR UNITS|||KS|NOT DONE||NA|N|Y|2||58||BASELINE|1963-02-17||1971-09-17|||1969-01-02||1970-10-22
TRIAL STUDY 134XCP|RP|88126417-8564-4659-AA60-63642067113D|1||||||FUNDHT|FUNDAL HEIGHT||||NMOL BCE/NMOL|||STEPS|NOT DONE||NA|U|U|3||39||CONTINUATION TREATMENT|1964-04-02||1969-03-20|||1961-09-15||1963-06-26
TRIAL STUDY 134XCP|RP|88126417-8564-4659-AA60-63642067113D|2||||||FUNDHT|FUNDAL HEIGHT||||UG/G/H|||IN2|NOT DONE||Y|U|Y|3||39||TREATMENT|1963-02-08||1971-11-23|||1960-05-20||1973-02-27
TRIAL STUDY 134XCP|RP|88126417-8564-4659-AA60-63642067113D|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||LX|||ABSORBANCE U/ML|NOT DONE||NA|U|NA|4||88||SCREENING|1962-03-30||1963-04-02|||1966-04-23||1971-07-21
TRIAL STUDY 134XCP|RP|88126417-8564-4659-AA60-63642067113D|2||||||INABOIND|INDUCED ABORTION INDICATOR||||FIU|||L/H/M2|NOT DONE||U|Y|Y|4||88||OBSERVATION|1967-12-02||1963-03-12|||1960-06-03||1963-09-06
TRIAL STUDY 134XCP|RP|88126417-8564-4659-AA60-63642067113D|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ML/KG/DAY|||BQ/UL|NOT DONE||Y|NA|Y|5||7||BASELINE|1970-01-24||1970-10-19|||1971-07-08||1960-08-04
TRIAL STUDY 134XCP|RP|88126417-8564-4659-AA60-63642067113D|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||ML/M2|||IU/DAY|NOT DONE||N|N|Y|5||7||TREATMENT|1967-04-17||1960-10-23|||1962-10-31||1965-07-12
TRIAL STUDY 134XCP|RP|6ADA444E-F1B4-4E59-9F2D-26DC78845397|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||PA|||MEQ/UG|NOT DONE||NA|Y|N|1||38||FOLLOW-UP|1969-09-14||1971-05-01|||1963-04-01||1968-05-17
TRIAL STUDY 134XCP|RP|6ADA444E-F1B4-4E59-9F2D-26DC78845397|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||CM|||ML/G/DAY|NOT DONE||U|Y|NA|1||38||FOLLOW-UP|1972-10-26||1972-04-07|||1966-08-20||1968-05-19
TRIAL STUDY 134XCP|RP|6ADA444E-F1B4-4E59-9F2D-26DC78845397|1||||||BLISTIND|BLISTERING INDICATOR||||OI50|||/MS|NOT DONE||NA|U|Y|2||58||BLINDED TREATMENT|1967-02-22||1969-06-04|||1962-01-01||1972-01-16
TRIAL STUDY 134XCP|RP|6ADA444E-F1B4-4E59-9F2D-26DC78845397|2||||||MENOSTAT|MENOPAUSE STATUS||||PG/DL|||S/H|NOT DONE||Y|U|N|2||58||BASELINE|1963-01-17||1970-08-20|||1971-10-23||1972-10-21
TRIAL STUDY 134XCP|RP|6ADA444E-F1B4-4E59-9F2D-26DC78845397|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||GBQ/MG|||U/MMOL|NOT DONE||NA|U|Y|3||39||RUN-IN|1969-11-22||1969-05-23|||1966-11-17||1970-05-26
TRIAL STUDY 134XCP|RP|6ADA444E-F1B4-4E59-9F2D-26DC78845397|2||||||MENARAGE|MENARCHE AGE||||DAGU/ML|||10^9 ORGANISMS/G|NOT DONE||U|U|U|3||39||WASHOUT|1960-06-10||1969-06-18|||1967-12-12||1966-06-14
TRIAL STUDY 134XCP|RP|6ADA444E-F1B4-4E59-9F2D-26DC78845397|1||||||PUSTIND|PUSTULE INDICATOR||||GENEQ|||LOG10 IU/ML|NOT DONE||N|Y|U|4||88||SCREENING|1969-04-20||1965-07-03|||1971-01-29||1965-08-31
TRIAL STUDY 134XCP|RP|6ADA444E-F1B4-4E59-9F2D-26DC78845397|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||U|||V|NOT DONE||N|N|Y|4||88||OPEN LABEL TREATMENT|1962-12-25||1966-11-11|||1968-07-01||1969-03-14
TRIAL STUDY 134XCP|RP|6ADA444E-F1B4-4E59-9F2D-26DC78845397|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||M|||CI/ML|NOT DONE||NA|N|NA|5||7||BLINDED TREATMENT|1963-07-09||1972-12-03|||1967-12-31||1966-01-12
TRIAL STUDY 134XCP|RP|6ADA444E-F1B4-4E59-9F2D-26DC78845397|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||CM/S|||G/ANIMAL/DAY|NOT DONE||N|Y|Y|5||7||CONTINUATION TREATMENT|1962-12-01||1970-02-11|||1968-09-25||1965-12-17
TRIAL STUDY 134XCP|RP|85060A90-92F7-4440-AD1C-62A70C2FD5CB|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||M2|||SQU/ML|NOT DONE||U|NA|Y|1||38||INDUCTION TREATMENT|1964-01-27||1960-08-14|||1971-08-25||1972-08-04
TRIAL STUDY 134XCP|RP|85060A90-92F7-4440-AD1C-62A70C2FD5CB|2||||||EDEMAIND|EDEMA INDICATOR||||PRESSOR UNITS|||RFU|NOT DONE||U|NA|U|1||38||OPEN LABEL TREATMENT|1960-08-06||1965-12-26|||1968-11-04||1964-07-31
TRIAL STUDY 134XCP|RP|85060A90-92F7-4440-AD1C-62A70C2FD5CB|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||NMOL/KG/DAY|||PMOL/DAY|NOT DONE||NA|U|Y|2||58||SCREENING|1970-06-22||1967-08-11|||1966-07-14||1963-08-02
TRIAL STUDY 134XCP|RP|85060A90-92F7-4440-AD1C-62A70C2FD5CB|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||CI/L|||BQ/KG|NOT DONE||U|U|U|2||58||CONTINUATION TREATMENT|1968-07-28||1967-02-27|||1967-03-30||1967-07-04
TRIAL STUDY 134XCP|RP|85060A90-92F7-4440-AD1C-62A70C2FD5CB|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||UEQ|||M|NOT DONE||N|Y|N|3||39||INDUCTION TREATMENT|1960-07-31||1972-07-24|||1966-06-13||1960-05-11
TRIAL STUDY 134XCP|RP|85060A90-92F7-4440-AD1C-62A70C2FD5CB|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||COPIES/UL|||10^3 ORGANISMS/ML|NOT DONE||Y|U|Y|3||39||TREATMENT|1962-08-30||1970-09-05|||1971-04-06||1969-01-23
TRIAL STUDY 134XCP|RP|85060A90-92F7-4440-AD1C-62A70C2FD5CB|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UOSM|||10^6 IU|NOT DONE||Y|N|NA|4||88||WASHOUT|1968-06-25||1973-05-22|||1970-01-07||1969-03-20
TRIAL STUDY 134XCP|RP|85060A90-92F7-4440-AD1C-62A70C2FD5CB|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MBQ|||AMOL|NOT DONE||Y|NA|N|4||88||RUN-IN|1963-12-09||1970-03-12|||1970-06-16||1972-06-24
TRIAL STUDY 134XCP|RP|85060A90-92F7-4440-AD1C-62A70C2FD5CB|1||||||MENOAGE|MENOPAUSE AGE||||MG/M2|||10^8 PFU|NOT DONE||U|U|U|5||7||CONTINUATION TREATMENT|1961-03-24||1969-09-14|||1970-03-03||1971-10-19
TRIAL STUDY 134XCP|RP|85060A90-92F7-4440-AD1C-62A70C2FD5CB|2||||||THICK|THICKNESS||||OHM|||10^8 PFU|NOT DONE||U|U|N|5||7||CONTINUATION TREATMENT|1965-01-04||1964-02-13|||1966-05-10||1962-07-03
TRIAL STUDY 134XCP|RP|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||PA|||UMOL/L/MIN|NOT DONE||Y|NA|N|1||38||FOLLOW-UP|1968-06-07||1963-12-28|||1971-05-30||1962-07-18
TRIAL STUDY 134XCP|RP|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|2||||||INABOIND|INDUCED ABORTION INDICATOR||||NMOL BCE/MMOL|||G/KG|NOT DONE||Y|N|Y|1||38||WASHOUT|1965-03-10||1970-07-22|||1963-08-26||1961-06-19
TRIAL STUDY 134XCP|RP|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||KG/CM2|||NMOL/DAY|NOT DONE||N|NA|Y|2||58||TREATMENT|1971-05-20||1972-02-26|||1963-07-24||1967-05-03
TRIAL STUDY 134XCP|RP|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|2||||||GRAVIND|GRAVIDA INDICATOR||||AMOL|||ML/SEC/1.73M2|NOT DONE||Y|NA|NA|2||58||BASELINE|1961-08-15||1971-11-24|||1963-05-22||1966-11-19
TRIAL STUDY 134XCP|RP|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UKAT/L|||AMFI|NOT DONE||U|N|N|3||39||SCREENING|1968-01-12||1965-07-09|||1972-01-01||1967-06-15
TRIAL STUDY 134XCP|RP|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||PL|||G/CAGE|NOT DONE||U|Y|Y|3||39||BLINDED TREATMENT|1970-04-25||1966-05-06|||1966-01-29||1962-04-15
TRIAL STUDY 134XCP|RP|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MV2/HZ|||KN/CM2|NOT DONE||Y|Y|NA|4||88||SCREENING|1961-01-28||1969-09-05|||1969-06-23||1965-04-28
TRIAL STUDY 134XCP|RP|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|2||||||BRTHN|NUMBER OF BIRTHS||||MONTHS|||ML/KG/H|NOT DONE||NA|N|Y|4||88||CONTINUATION TREATMENT|1963-01-11||1970-03-30|||1961-02-27||1973-06-25
TRIAL STUDY 134XCP|RP|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MMHG|||BE/ML|NOT DONE||Y|U|NA|5||7||TREATMENT|1971-07-16||1962-07-05|||1967-11-06||1973-05-04
TRIAL STUDY 134XCP|RP|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MV|||MEQ/MMOL|NOT DONE||Y|Y|NA|5||7||LONG-TERM FOLLOW-UP|1963-07-02||1963-04-29|||1964-04-07||1967-11-23
TRIAL STUDY 134XCP|RP|170052E6-031C-48EF-9CE4-CA84ED6B77FF|1||||||FUNDHT|FUNDAL HEIGHT||||LOG EID 50/DOSE|||PIXELS/CM|NOT DONE||N|N|Y|1||38||RUN-IN|1971-12-23||1964-11-22|||1970-02-26||1968-11-20
TRIAL STUDY 134XCP|RP|170052E6-031C-48EF-9CE4-CA84ED6B77FF|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MEQ/L|||MEQ/KG|NOT DONE||NA|N|U|1||38||TREATMENT|1966-11-27||1970-09-06|||1965-09-12||1972-10-05
TRIAL STUDY 134XCP|RP|170052E6-031C-48EF-9CE4-CA84ED6B77FF|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||HEP|||UG/DAY|NOT DONE||U|N|N|2||58||TREATMENT|1966-02-26||1969-07-26|||1969-06-21||1960-04-07
TRIAL STUDY 134XCP|RP|170052E6-031C-48EF-9CE4-CA84ED6B77FF|2||||||MASSIND|MASS INDICATOR||||L/MIN/M2|||G/L|NOT DONE||N|U|Y|2||58||INDUCTION TREATMENT|1963-06-14||1966-10-31|||1962-12-29||1962-11-07
TRIAL STUDY 134XCP|RP|170052E6-031C-48EF-9CE4-CA84ED6B77FF|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||OI50|||PMOL/DL|NOT DONE||NA|N|NA|3||39||FOLLOW-UP|1960-11-11||1965-09-19|||1969-07-02||1963-01-03
TRIAL STUDY 134XCP|RP|170052E6-031C-48EF-9CE4-CA84ED6B77FF|2||||||MENARAGE|MENARCHE AGE||||MASK|||PMOL/DL|NOT DONE||NA|N|U|3||39||SCREENING|1965-09-19||1962-12-26|||1966-02-24||1966-08-09
TRIAL STUDY 134XCP|RP|170052E6-031C-48EF-9CE4-CA84ED6B77FF|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^6 CFU/G|||U/G/DAY|NOT DONE||U|Y|NA|4||88||FOLLOW-UP|1969-10-31||1962-05-16|||1966-05-03||1968-12-28
TRIAL STUDY 134XCP|RP|170052E6-031C-48EF-9CE4-CA84ED6B77FF|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||DPM/ML|||GMFI|NOT DONE||N|Y|N|4||88||CONTINUATION TREATMENT|1962-07-27||1971-03-02|||1962-01-12||1966-11-27
TRIAL STUDY 134XCP|RP|170052E6-031C-48EF-9CE4-CA84ED6B77FF|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MG/KG/MIN|||10^6/EJACULATE U|NOT DONE||NA|Y|NA|5||7||WASHOUT|1969-09-03||1967-04-16|||1966-05-23||1965-07-18
TRIAL STUDY 134XCP|RP|170052E6-031C-48EF-9CE4-CA84ED6B77FF|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||SACHET|||GAUSS|NOT DONE||Y|NA|U|5||7||FOLLOW-UP|1962-04-24||1962-02-07|||1970-01-29||1970-09-26
TRIAL STUDY 134XCP|RP|D3F628DE-8358-4C2C-B474-763E48719E5E|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||PKAT/L|||MG/L FEU|NOT DONE||NA|U|N|1||38||CONTINUATION TREATMENT|1972-06-28||1965-11-03|||1968-07-12||1970-10-20
TRIAL STUDY 134XCP|RP|D3F628DE-8358-4C2C-B474-763E48719E5E|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MG/M2/DAY|||MKAT|NOT DONE||N|Y|U|1||38||RUN-IN|1961-08-11||1971-11-28|||1970-01-25||1963-12-01
TRIAL STUDY 134XCP|RP|D3F628DE-8358-4C2C-B474-763E48719E5E|1||||||DSCHGIND|DISCHARGE INDICATOR||||TUBE|||TROCHE|NOT DONE||Y|NA|Y|2||58||RUN-IN|1961-04-30||1964-05-17|||1966-11-29||1965-08-09
TRIAL STUDY 134XCP|RP|D3F628DE-8358-4C2C-B474-763E48719E5E|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||TUBERCULIN UNIT/ML|||NEWTON|NOT DONE||U|Y|U|2||58||WASHOUT|1962-01-05||1970-04-28|||1972-03-08||1965-01-14
TRIAL STUDY 134XCP|RP|D3F628DE-8358-4C2C-B474-763E48719E5E|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||KIU|||ABSORBANCE U|NOT DONE||Y|Y|U|3||39||WASHOUT|1960-02-14||1968-12-27|||1967-08-03||1970-01-23
TRIAL STUDY 134XCP|RP|D3F628DE-8358-4C2C-B474-763E48719E5E|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||FINGERTIP UNIT|||NMOL|NOT DONE||Y|NA|NA|3||39||INDUCTION TREATMENT|1970-03-01||1961-06-22|||1962-04-27||1966-05-20
TRIAL STUDY 134XCP|RP|D3F628DE-8358-4C2C-B474-763E48719E5E|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||LX|||LOG10 TCID 50/UL|NOT DONE||Y|NA|N|4||88||BASELINE|1966-12-07||1969-04-06|||1970-07-29||1967-03-01
TRIAL STUDY 134XCP|RP|D3F628DE-8358-4C2C-B474-763E48719E5E|2||||||PREGNN|NUMBER OF PREGNANCIES||||10^6 CFU/ML|||MG/KG/DOSE|NOT DONE||NA|NA|N|4||88||SCREENING|1972-11-15||1970-01-28|||1971-04-27||1965-05-20
TRIAL STUDY 134XCP|RP|D3F628DE-8358-4C2C-B474-763E48719E5E|1||||||GRAVIND|GRAVIDA INDICATOR||||MASK|||SCM|NOT DONE||Y|N|N|5||7||FOLLOW-UP|1973-04-10||1964-04-19|||1966-09-14||1963-09-22
TRIAL STUDY 134XCP|RP|D3F628DE-8358-4C2C-B474-763E48719E5E|2||||||EDEMAIND|EDEMA INDICATOR||||HOURS|||MS2|NOT DONE||NA|U|U|5||7||TREATMENT|1962-05-26||1964-05-30|||1965-12-21||1964-01-09
TRIAL STUDY 134XCP|RP|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||CCID 50/ML|||BISCUIT|NOT DONE||N|N|U|1||38||WASHOUT|1972-03-01||1965-03-31|||1966-04-08||1973-02-20
TRIAL STUDY 134XCP|RP|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||CMHG|||MCI/L|NOT DONE||N|N|N|1||38||LONG-TERM FOLLOW-UP|1968-07-21||1960-12-03|||1963-08-21||1972-07-20
TRIAL STUDY 134XCP|RP|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||/H|||UU/DL|NOT DONE||NA|U|Y|2||58||OPEN LABEL TREATMENT|1972-07-29||1972-01-06|||1969-01-02||1971-06-16
TRIAL STUDY 134XCP|RP|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||CYCLE/MIN|||FMOL|NOT DONE||N|NA|NA|2||58||FOLLOW-UP|1968-01-30||1961-02-07|||1964-02-10||1961-10-16
TRIAL STUDY 134XCP|RP|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||UG/MOL|||%/S|NOT DONE||Y|U|N|3||39||BASELINE|1964-10-26||1961-03-25|||1966-04-21||1960-03-30
TRIAL STUDY 134XCP|RP|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MU|||LOG10 ELISA UNIT|NOT DONE||U|N|Y|3||39||SCREENING|1960-05-28||1970-08-22|||1966-04-08||1967-07-12
TRIAL STUDY 134XCP|RP|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|1||||||ERYTHIND|ERYTHEMA INDICATOR||||CI/MG|||ML/M2|NOT DONE||Y|Y|N|4||88||LONG-TERM FOLLOW-UP|1972-09-01||1963-02-21|||1971-04-26||1960-12-31
TRIAL STUDY 134XCP|RP|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|2||||||INABOIND|INDUCED ABORTION INDICATOR||||10^6 U|||MSEC|NOT DONE||U|Y|U|4||88||TREATMENT|1965-05-26||1964-11-18|||1970-04-18||1964-03-26
TRIAL STUDY 134XCP|RP|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||PFU/ML|||10^6/G|NOT DONE||Y|N|N|5||7||INDUCTION TREATMENT|1963-11-23||1972-01-14|||1961-03-28||1968-06-22
TRIAL STUDY 134XCP|RP|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||TBSP|||MPS U|NOT DONE||N|N|U|5||7||BASELINE|1963-06-27||1966-09-24|||1972-12-24||1969-08-23
TRIAL STUDY 134XCP|RP|4395486D-C521-4478-9442-68CF0344C6FB|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||KBQ|||BLOCKS|NOT DONE||N|NA|N|1||38||LONG-TERM FOLLOW-UP|1969-03-25||1969-09-01|||1968-10-06||1971-03-19
TRIAL STUDY 134XCP|RP|4395486D-C521-4478-9442-68CF0344C6FB|2||||||FUNDHT|FUNDAL HEIGHT||||PA|||DAGU/ML|NOT DONE||N|N|U|1||38||CONTINUATION TREATMENT|1962-05-01||1964-07-04|||1964-11-26||1972-06-11
TRIAL STUDY 134XCP|RP|4395486D-C521-4478-9442-68CF0344C6FB|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||NL|||UIU/L|NOT DONE||NA|Y|NA|2||58||WASHOUT|1970-08-30||1963-06-10|||1962-05-31||1968-05-20
TRIAL STUDY 134XCP|RP|4395486D-C521-4478-9442-68CF0344C6FB|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||PELLET|||ML/G/H|NOT DONE||U|Y|U|2||58||FOLLOW-UP|1973-01-29||1969-05-03|||1963-06-14||1968-06-03
TRIAL STUDY 134XCP|RP|4395486D-C521-4478-9442-68CF0344C6FB|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||FT|||NG/DAY|NOT DONE||Y|U|U|3||39||OPEN LABEL TREATMENT|1961-05-10||1970-12-02|||1961-09-05||1971-05-05
TRIAL STUDY 134XCP|RP|4395486D-C521-4478-9442-68CF0344C6FB|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||TABLET|||COPIES/ML|NOT DONE||U|U|N|3||39||INDUCTION TREATMENT|1965-06-02||1971-11-08|||1960-01-02||1966-12-06
TRIAL STUDY 134XCP|RP|4395486D-C521-4478-9442-68CF0344C6FB|1||||||ULCERIND|ULCER INDICATOR||||U/M2/MIN|||10^9 ORGANISMS/ML|NOT DONE||NA|NA|Y|4||88||TREATMENT|1966-12-11||1965-03-29|||1966-11-03||1961-02-13
TRIAL STUDY 134XCP|RP|4395486D-C521-4478-9442-68CF0344C6FB|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MET*H|||OI50|NOT DONE||N|Y|N|4||88||WASHOUT|1966-01-24||1961-03-24|||1960-12-02||1968-12-22
TRIAL STUDY 134XCP|RP|4395486D-C521-4478-9442-68CF0344C6FB|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||G/MOL|||MNFI|NOT DONE||NA|N|NA|5||7||CONTINUATION TREATMENT|1966-02-03||1973-04-29|||1965-09-23||1964-03-01
TRIAL STUDY 134XCP|RP|4395486D-C521-4478-9442-68CF0344C6FB|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||CM/S|||UG/MIN|NOT DONE||U|Y|N|5||7||RUN-IN|1973-07-02||1967-12-31|||1973-07-24||1968-03-22
TRIAL STUDY 134XCP|RP|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||VG/ML|||EQ|NOT DONE||NA|N|U|1||38||RUN-IN|1971-03-27||1963-10-15|||1967-01-24||1969-07-08
TRIAL STUDY 134XCP|RP|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||FOZ_US|||MCI/L|NOT DONE||NA|NA|U|1||38||WASHOUT|1965-02-11||1962-04-14|||1965-02-12||1960-01-28
TRIAL STUDY 134XCP|RP|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|1||||||PEELIND|PEELING INDICATOR||||OI50|||G/KG/DAY|NOT DONE||Y|U|N|2||58||RUN-IN|1964-08-04||1971-04-23|||1960-10-12||1970-10-11
TRIAL STUDY 134XCP|RP|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||FARAD|||NFIU|NOT DONE||Y|Y|N|2||58||BASELINE|1962-12-09||1961-04-05|||1972-03-21||1965-10-01
TRIAL STUDY 134XCP|RP|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||VG/KG|||BEAM BREAKS|NOT DONE||Y|Y|U|3||39||WASHOUT|1972-12-06||1964-10-05|||1973-01-23||1961-05-11
TRIAL STUDY 134XCP|RP|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|2||||||DLVRMODE|MODE OF DELIVERY||||U/G HB|||PIXEL|NOT DONE||NA|N|N|3||39||WASHOUT|1972-09-07||1964-06-03|||1960-08-16||1970-04-10
TRIAL STUDY 134XCP|RP|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||DEG/S|||LOG EID 50/DOSE|NOT DONE||U|NA|Y|4||88||RUN-IN|1965-01-05||1965-09-18|||1962-03-01||1961-10-06
TRIAL STUDY 134XCP|RP|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|2||||||BLISTIND|BLISTERING INDICATOR||||CCID 50/DOSE|||10^9 CFU/G|NOT DONE||Y|U|NA|4||88||SCREENING|1961-05-09||1961-08-23|||1965-10-22||1966-01-26
TRIAL STUDY 134XCP|RP|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|1||||||MENFDUR|MENSES FLOW DURATION||||TRACE|||MGEQ|NOT DONE||N|U|U|5||7||LONG-TERM FOLLOW-UP|1960-05-04||1961-05-20|||1961-01-02||1965-07-01
TRIAL STUDY 134XCP|RP|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|2||||||BLISTIND|BLISTERING INDICATOR||||DRAM|||IU|NOT DONE||U|Y|N|5||7||RUN-IN|1966-01-09||1964-09-07|||1966-07-01||1966-11-29
TRIAL STUDY 134XCP|RP|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MU/L|||KALLIKREIN INHIBITOR UNIT|NOT DONE||Y|Y|NA|1||38||SCREENING|1968-06-28||1964-08-28|||1962-05-04||1970-10-14
TRIAL STUDY 134XCP|RP|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|2||||||STILBIND|STILLBIRTH INDICATOR||||MSEC|||BU|NOT DONE||Y|N|Y|1||38||OBSERVATION|1967-02-11||1965-10-07|||1970-12-29||1973-08-28
TRIAL STUDY 134XCP|RP|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|1||||||BRTHN|NUMBER OF BIRTHS||||UMOL/DAY|||10^6 ORGANISMS|NOT DONE||U|N|NA|2||58||SCREENING|1966-12-04||1972-11-28|||1966-08-11||1967-12-17
TRIAL STUDY 134XCP|RP|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|2||||||INABOIND|INDUCED ABORTION INDICATOR||||GPS U|||NMOL/DAY|NOT DONE||Y|Y|Y|2||58||WASHOUT|1971-05-31||1971-10-06|||1967-10-13||1966-02-08
TRIAL STUDY 134XCP|RP|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|1||||||FUNDHT|FUNDAL HEIGHT||||NMOL/DAY|||LX|NOT DONE||U|N|U|3||39||WASHOUT|1966-12-22||1973-06-27|||1965-04-16||1969-12-05
TRIAL STUDY 134XCP|RP|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|2||||||PREGNN|NUMBER OF PREGNANCIES||||10^6 ORGANISMS/ML|||HZ/S|NOT DONE||N|N|U|3||39||FOLLOW-UP|1960-12-05||1965-08-02|||1968-01-13||1964-06-27
TRIAL STUDY 134XCP|RP|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MAMP|||UG/KG/H|NOT DONE||NA|N|Y|4||88||OBSERVATION|1969-08-30||1967-01-21|||1961-10-20||1972-02-25
TRIAL STUDY 134XCP|RP|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||DROP|||/LPF|NOT DONE||N|NA|U|4||88||BASELINE|1969-02-02||1967-07-13|||1960-06-28||1963-12-01
TRIAL STUDY 134XCP|RP|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|1||||||TNDRIND|TENDERNESS INDICATOR||||G/L|||CYCLE/MIN|NOT DONE||Y|Y|Y|5||7||SCREENING|1960-06-03||1961-11-29|||1965-04-30||1962-10-06
TRIAL STUDY 134XCP|RP|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|2||||||PREGST|PREGNANT DURING THE STUDY||||SYRINGE|||UM|NOT DONE||N|U|N|5||7||BLINDED TREATMENT|1963-07-17||1971-03-28|||1960-03-17||1965-06-09
TRIAL STUDY 134XCP|RP|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|1||||||STILBIND|STILLBIRTH INDICATOR||||10^6/HPF|||RPM|NOT DONE||N|Y|Y|1||38||OPEN LABEL TREATMENT|1963-09-03||1963-09-27|||1973-08-29||1972-08-23
TRIAL STUDY 134XCP|RP|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||KIU|||MG/H|NOT DONE||U|NA|NA|1||38||BASELINE|1965-01-29||1972-08-09|||1968-04-30||1970-01-26
TRIAL STUDY 134XCP|RP|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||CFU/G|||PATCH|NOT DONE||NA|NA|N|2||58||CONTINUATION TREATMENT|1972-10-06||1971-04-25|||1965-02-03||1970-07-16
TRIAL STUDY 134XCP|RP|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|2||||||FUNDHT|FUNDAL HEIGHT||||UG/KG|||CGY|NOT DONE||U|Y|Y|2||58||OPEN LABEL TREATMENT|1968-09-09||1965-10-11|||1972-06-27||1961-11-25
TRIAL STUDY 134XCP|RP|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||CCID 50/DOSE|||UM|NOT DONE||N|NA|U|3||39||FOLLOW-UP|1964-01-10||1967-05-23|||1969-08-03||1970-04-24
TRIAL STUDY 134XCP|RP|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||TSP EQ|||MMOL/MOL|NOT DONE||U|U|NA|3||39||TREATMENT|1963-06-27||1964-07-24|||1965-12-12||1973-05-20
TRIAL STUDY 134XCP|RP|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|1||||||STILBIND|STILLBIRTH INDICATOR||||KG/L|||AMOL|NOT DONE||NA|Y|N|4||88||CONTINUATION TREATMENT|1971-05-03||1965-03-10|||1972-03-28||1965-08-17
TRIAL STUDY 134XCP|RP|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|2||||||BRTHN|NUMBER OF BIRTHS||||10^6 CFU/G|||VP/ML|NOT DONE||U|Y|U|4||88||OBSERVATION|1961-08-14||1972-04-04|||1964-09-04||1966-01-25
TRIAL STUDY 134XCP|RP|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|1||||||BRTHN|NUMBER OF BIRTHS||||NSEC|||ML/G/H|NOT DONE||N|N|U|5||7||LONG-TERM FOLLOW-UP|1971-11-25||1968-01-28|||1963-12-23||1961-05-03
TRIAL STUDY 134XCP|RP|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|2||||||BCMETHOD|BIRTH CONTROL METHOD||||MHZ|||MGEQ|NOT DONE||U|U|Y|5||7||LONG-TERM FOLLOW-UP|1972-06-06||1969-09-02|||1967-07-17||1961-10-23
TRIAL STUDY 134XCP|RP|19394300-46A6-484F-AE02-50BDD39096E3|1||||||DSCHGIND|DISCHARGE INDICATOR||||JDF UNIT|||TORR|NOT DONE||N|N|N|1||38||OPEN LABEL TREATMENT|1967-05-15||1972-02-28|||1968-11-27||1966-10-29
TRIAL STUDY 134XCP|RP|19394300-46A6-484F-AE02-50BDD39096E3|2||||||STILBIND|STILLBIRTH INDICATOR||||FG|||BQ/G|NOT DONE||Y|N|N|1||38||CONTINUATION TREATMENT|1961-09-25||1972-08-01|||1971-01-06||1968-10-03
TRIAL STUDY 134XCP|RP|19394300-46A6-484F-AE02-50BDD39096E3|1||||||GRAVIND|GRAVIDA INDICATOR||||MOSM|||FEU|NOT DONE||N|Y|Y|2||58||OPEN LABEL TREATMENT|1964-04-14||1967-05-06|||1967-08-26||1964-04-21
TRIAL STUDY 134XCP|RP|19394300-46A6-484F-AE02-50BDD39096E3|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||ML/CAGE/DAY|||POINT|NOT DONE||N|Y|U|2||58||SCREENING|1966-08-12||1969-01-03|||1969-02-18||1960-01-05
TRIAL STUDY 134XCP|RP|19394300-46A6-484F-AE02-50BDD39096E3|1||||||PREGNN|NUMBER OF PREGNANCIES||||L/H|||ML/100G/MIN|NOT DONE||Y|NA|N|3||39||OBSERVATION|1972-12-10||1965-12-14|||1963-05-13||1972-08-27
TRIAL STUDY 134XCP|RP|19394300-46A6-484F-AE02-50BDD39096E3|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||USEC|||MG2/DL2|NOT DONE||U|NA|Y|3||39||TREATMENT|1964-08-14||1972-02-25|||1970-12-12||1970-06-23
TRIAL STUDY 134XCP|RP|19394300-46A6-484F-AE02-50BDD39096E3|1||||||EDEMAIND|EDEMA INDICATOR||||MJOULE/CM2|||UG/L FEU|NOT DONE||N|NA|NA|4||88||TREATMENT|1963-08-24||1971-07-13|||1964-11-29||1972-04-25
TRIAL STUDY 134XCP|RP|19394300-46A6-484F-AE02-50BDD39096E3|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||CI|||GBQ/G|NOT DONE||N|N|Y|4||88||FOLLOW-UP|1963-11-14||1973-07-02|||1970-10-28||1967-08-28
TRIAL STUDY 134XCP|RP|19394300-46A6-484F-AE02-50BDD39096E3|1||||||STILBIND|STILLBIRTH INDICATOR||||TUBE|||SUPPOSITORY|NOT DONE||N|N|Y|5||7||INDUCTION TREATMENT|1972-09-03||1961-06-07|||1968-05-13||1961-07-18
TRIAL STUDY 134XCP|RP|19394300-46A6-484F-AE02-50BDD39096E3|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||PMOL/G|||KV|NOT DONE||Y|U|N|5||7||OBSERVATION|1961-08-07||1970-02-18|||1970-11-21||1962-12-28
TRIAL STUDY 134XCP|RP|8C89BD60-3504-4F8B-8F33-7F0C949DB407|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MG/H|||U/G/DAY|NOT DONE||N|N|Y|1||38||BASELINE|1968-11-01||1960-05-28|||1962-02-11||1969-05-18
TRIAL STUDY 134XCP|RP|8C89BD60-3504-4F8B-8F33-7F0C949DB407|2||||||PEELIND|PEELING INDICATOR||||CAPLET|||/MONTH|NOT DONE||N|Y|N|1||38||SCREENING|1968-12-13||1962-03-19|||1969-05-17||1963-12-31
TRIAL STUDY 134XCP|RP|8C89BD60-3504-4F8B-8F33-7F0C949DB407|1||||||MASSIND|MASS INDICATOR||||MM/SEC|||UOSM|NOT DONE||Y|NA|Y|2||58||OBSERVATION|1960-02-01||1968-04-10|||1960-08-27||1965-10-23
TRIAL STUDY 134XCP|RP|8C89BD60-3504-4F8B-8F33-7F0C949DB407|2||||||TNDRIND|TENDERNESS INDICATOR||||NMOL/L/H|||DRUM|NOT DONE||NA|N|Y|2||58||INDUCTION TREATMENT|1963-01-05||1964-07-11|||1970-08-26||1972-10-17
TRIAL STUDY 134XCP|RP|8C89BD60-3504-4F8B-8F33-7F0C949DB407|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||KG/L|||KUSP|NOT DONE||U|NA|N|3||39||BLINDED TREATMENT|1965-07-17||1972-07-20|||1968-03-23||1972-05-29
TRIAL STUDY 134XCP|RP|8C89BD60-3504-4F8B-8F33-7F0C949DB407|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MIU/L|||IN|NOT DONE||N|U|U|3||39||LONG-TERM FOLLOW-UP|1969-09-23||1964-09-24|||1965-01-31||1971-05-23
TRIAL STUDY 134XCP|RP|8C89BD60-3504-4F8B-8F33-7F0C949DB407|1||||||PREGNN|NUMBER OF PREGNANCIES||||LOG10 TCID 50/ML|||10^9 CFU/ML|NOT DONE||Y|Y|N|4||88||CONTINUATION TREATMENT|1965-05-09||1971-10-15|||1971-07-06||1966-11-12
TRIAL STUDY 134XCP|RP|8C89BD60-3504-4F8B-8F33-7F0C949DB407|2||||||GRAVIND|GRAVIDA INDICATOR||||ML/CM H2O|||NEEDLE GAUGE|NOT DONE||N|U|Y|4||88||RUN-IN|1966-06-24||1968-10-24|||1963-09-10||1973-01-31
TRIAL STUDY 134XCP|RP|8C89BD60-3504-4F8B-8F33-7F0C949DB407|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||10^9 ORGANISMS/G|||MESF|NOT DONE||NA|Y|Y|5||7||CONTINUATION TREATMENT|1961-12-15||1963-04-27|||1968-08-06||1971-02-06
TRIAL STUDY 134XCP|RP|8C89BD60-3504-4F8B-8F33-7F0C949DB407|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||UIU/L|||TSP|NOT DONE||Y|Y|U|5||7||LONG-TERM FOLLOW-UP|1965-09-28||1972-07-13|||1960-08-18||1967-11-02
TRIAL STUDY 134XCP|RP|4746A481-011E-4376-9D2F-5E57F560A6DE|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MMAL|||PHERESIS UNIT|NOT DONE||U|U|U|1||38||SCREENING|1966-06-06||1970-06-30|||1966-05-03||1965-10-11
TRIAL STUDY 134XCP|RP|4746A481-011E-4376-9D2F-5E57F560A6DE|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||SHOCK WAVE|||AG|NOT DONE||NA|U|U|1||38||LONG-TERM FOLLOW-UP|1973-05-16||1967-11-29|||1960-11-13||1962-09-09
TRIAL STUDY 134XCP|RP|4746A481-011E-4376-9D2F-5E57F560A6DE|1||||||PEELIND|PEELING INDICATOR||||LOZENGE|||10^9 CFU/ML|NOT DONE||Y|U|Y|2||58||FOLLOW-UP|1967-09-02||1968-12-08|||1967-07-16||1962-04-17
TRIAL STUDY 134XCP|RP|4746A481-011E-4376-9D2F-5E57F560A6DE|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MPA|||ML/S|NOT DONE||N|U|N|2||58||SCREENING|1963-09-20||1962-05-28|||1962-08-14||1968-08-17
TRIAL STUDY 134XCP|RP|4746A481-011E-4376-9D2F-5E57F560A6DE|1||||||ERYTHIND|ERYTHEMA INDICATOR||||MMHG/SEC|||GAUSS|NOT DONE||Y|N|NA|3||39||OBSERVATION|1963-07-04||1964-10-10|||1962-09-02||1966-11-15
TRIAL STUDY 134XCP|RP|4746A481-011E-4376-9D2F-5E57F560A6DE|2||||||INABOIND|INDUCED ABORTION INDICATOR||||DPM/0.5 ML|||DEG/MM|NOT DONE||NA|NA|Y|3||39||SCREENING|1969-09-09||1972-11-11|||1968-04-09||1963-11-17
TRIAL STUDY 134XCP|RP|4746A481-011E-4376-9D2F-5E57F560A6DE|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||V|||ML/SEC/1.73M2|NOT DONE||Y|U|Y|4||88||TREATMENT|1969-08-26||1963-11-29|||1967-01-15||1971-03-30
TRIAL STUDY 134XCP|RP|4746A481-011E-4376-9D2F-5E57F560A6DE|2||||||THICK|THICKNESS||||CM|||UV|NOT DONE||Y|U|N|4||88||TREATMENT|1964-12-23||1971-10-29|||1971-05-11||1973-08-17
TRIAL STUDY 134XCP|RP|4746A481-011E-4376-9D2F-5E57F560A6DE|1||||||MENOSTAT|MENOPAUSE STATUS||||S/H|||/SEC|NOT DONE||N|NA|U|5||7||INDUCTION TREATMENT|1961-04-26||1971-08-28|||1963-07-03||1964-06-29
TRIAL STUDY 134XCP|RP|4746A481-011E-4376-9D2F-5E57F560A6DE|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||10^3 DNA COPIES/ML|||KG|NOT DONE||NA|NA|NA|5||7||SCREENING|1962-10-16||1963-07-25|||1964-06-21||1968-10-01
TRIAL STUDY 134XCP|RP|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|1||||||BLISTIND|BLISTERING INDICATOR||||KG/CM|||JOULE|NOT DONE||Y|N|N|1||38||OBSERVATION|1971-01-24||1961-03-19|||1962-09-15||1972-09-09
TRIAL STUDY 134XCP|RP|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||UMOL/DL|||M2|NOT DONE||N|U|Y|1||38||FOLLOW-UP|1968-08-26||1971-08-11|||1971-08-08||1963-08-10
TRIAL STUDY 134XCP|RP|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|1||||||PREGNN|NUMBER OF PREGNANCIES||||MBQ/UL|||MEQ/G|NOT DONE||NA|U|U|2||58||OPEN LABEL TREATMENT|1961-08-04||1965-06-07|||1970-06-21||1969-02-17
TRIAL STUDY 134XCP|RP|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|2||||||PUSTIND|PUSTULE INDICATOR||||MG/DOSE|||HOURS|NOT DONE||Y|Y|N|2||58||BLINDED TREATMENT|1963-11-09||1963-06-05|||1967-12-22||1966-02-15
TRIAL STUDY 134XCP|RP|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||CL|||MG/KG|NOT DONE||N|NA|NA|3||39||CONTINUATION TREATMENT|1971-12-27||1969-10-21|||1972-03-19||1971-01-02
TRIAL STUDY 134XCP|RP|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|2||||||INABOIND|INDUCED ABORTION INDICATOR||||H*%|||IN|NOT DONE||U|NA|U|3||39||TREATMENT|1965-07-22||1970-05-09|||1960-01-22||1962-06-14
TRIAL STUDY 134XCP|RP|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||RPM|||DAYS/MONTH|NOT DONE||NA|U|Y|4||88||INDUCTION TREATMENT|1970-11-06||1969-01-12|||1967-04-06||1970-02-06
TRIAL STUDY 134XCP|RP|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||BQ/G|||EQ|NOT DONE||NA|N|Y|4||88||BLINDED TREATMENT|1968-05-09||1967-04-15|||1969-01-23||1965-12-07
TRIAL STUDY 134XCP|RP|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|1||||||BLISTIND|BLISTERING INDICATOR||||UMOL/MOL|||10^9 CFU/ML|NOT DONE||NA|Y|Y|5||7||TREATMENT|1968-06-08||1961-01-31|||1973-06-03||1968-12-08
TRIAL STUDY 134XCP|RP|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|2||||||ABORTN|NUMBER OF ABORTIONS||||P|||UG/KG|NOT DONE||N|U|NA|5||7||SCREENING|1964-02-23||1969-12-07|||1966-01-28||1960-02-04
TRIAL STUDY 134XCP|RP|04F5220E-7A8C-4982-9379-496306612E33|1||||||STILBIND|STILLBIRTH INDICATOR||||ML/(MIN*100ML)|||DAGU/ML|NOT DONE||Y|N|Y|1||38||OBSERVATION|1961-10-19||1961-09-18|||1972-12-22||1968-04-11
TRIAL STUDY 134XCP|RP|04F5220E-7A8C-4982-9379-496306612E33|2||||||DSCHGIND|DISCHARGE INDICATOR||||MMHG/SEC|||UMOL/MIN|NOT DONE||Y|NA|N|1||38||TREATMENT|1969-08-31||1970-12-30|||1964-07-13||1963-12-01
TRIAL STUDY 134XCP|RP|04F5220E-7A8C-4982-9379-496306612E33|1||||||FUNDHT|FUNDAL HEIGHT||||G/ANIMAL/WK|||GRAVITATIONAL UNIT|NOT DONE||N|NA|Y|2||58||LONG-TERM FOLLOW-UP|1968-01-09||1968-11-10|||1971-10-04||1967-03-15
TRIAL STUDY 134XCP|RP|04F5220E-7A8C-4982-9379-496306612E33|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||L/MIN/M2|||PSI|NOT DONE||Y|NA|N|2||58||LONG-TERM FOLLOW-UP|1964-01-02||1969-10-29|||1961-04-19||1969-02-15
TRIAL STUDY 134XCP|RP|04F5220E-7A8C-4982-9379-496306612E33|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||APL U/ML|||ML/KG/MIN|NOT DONE||Y|Y|NA|3||39||INDUCTION TREATMENT|1969-07-15||1964-06-01|||1972-09-19||1961-02-02
TRIAL STUDY 134XCP|RP|04F5220E-7A8C-4982-9379-496306612E33|2||||||MENOAGE|MENOPAUSE AGE||||MIN/DAY|||CAL|NOT DONE||U|N|NA|3||39||FOLLOW-UP|1971-08-08||1963-10-06|||1961-11-04||1973-05-09
TRIAL STUDY 134XCP|RP|04F5220E-7A8C-4982-9379-496306612E33|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||BOTTLE|||GBQ/UG|NOT DONE||NA|NA|U|4||88||BLINDED TREATMENT|1964-02-14||1969-02-21|||1970-11-15||1969-11-14
TRIAL STUDY 134XCP|RP|04F5220E-7A8C-4982-9379-496306612E33|2||||||PEELIND|PEELING INDICATOR||||NMOL/DAY|||MMOL/MIN/KPA/L|NOT DONE||U|NA|Y|4||88||SCREENING|1961-11-21||1972-02-05|||1965-09-21||1967-02-07
TRIAL STUDY 134XCP|RP|04F5220E-7A8C-4982-9379-496306612E33|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||KS|||UMOL|NOT DONE||NA|U|Y|5||7||BASELINE|1968-02-25||1965-09-19|||1966-05-19||1963-10-31
TRIAL STUDY 134XCP|RP|04F5220E-7A8C-4982-9379-496306612E33|2||||||ABORTN|NUMBER OF ABORTIONS||||HZ/S|||HR/DAY|NOT DONE||NA|U|Y|5||7||RUN-IN|1971-04-22||1964-07-16|||1970-08-14||1969-03-20
TRIAL STUDY 134XCP|RP|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|1||||||THICK|THICKNESS||||PG/DL|||10^7/L|NOT DONE||NA|Y|Y|1||38||TREATMENT|1971-08-28||1969-10-06|||1968-03-06||1965-06-27
TRIAL STUDY 134XCP|RP|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||UG/CM2|||DAMOL/L|NOT DONE||Y|U|Y|1||38||LONG-TERM FOLLOW-UP|1963-11-24||1962-01-27|||1971-07-23||1962-07-05
TRIAL STUDY 134XCP|RP|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/100 HPFS|||MBP|NOT DONE||Y|N|NA|2||58||BASELINE|1972-07-03||1970-10-15|||1967-04-02||1964-10-22
TRIAL STUDY 134XCP|RP|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||MG/H|||/DAY|NOT DONE||U|NA|NA|2||58||CONTINUATION TREATMENT|1972-10-24||1963-08-23|||1963-06-04||1972-09-11
TRIAL STUDY 134XCP|RP|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|1||||||RASHIND|RASH INDICATOR||||MG/KG/DAY|||UMOL/MG/MIN|NOT DONE||N|NA|U|3||39||SCREENING|1961-02-15||1970-10-15|||1972-03-14||1971-01-24
TRIAL STUDY 134XCP|RP|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||UG/DL|||U/KG/H|NOT DONE||NA|Y|NA|3||39||OBSERVATION|1969-01-23||1960-06-27|||1961-07-18||1967-12-01
TRIAL STUDY 134XCP|RP|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|1||||||PUSTIND|PUSTULE INDICATOR||||10^9 ORGANISMS/ML|||G/G|NOT DONE||U|NA|U|4||88||OBSERVATION|1964-05-20||1971-04-25|||1969-06-27||1973-01-27
TRIAL STUDY 134XCP|RP|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MG/KG/WEEK|||V/V|NOT DONE||NA|Y|Y|4||88||OBSERVATION|1963-12-26||1965-07-28|||1963-04-17||1966-03-10
TRIAL STUDY 134XCP|RP|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||U/M2|||DRUM|NOT DONE||N|NA|Y|5||7||BLINDED TREATMENT|1964-12-02||1962-01-26|||1971-11-17||1966-10-11
TRIAL STUDY 134XCP|RP|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||U/G HB|||ANTI-XA IU|NOT DONE||N|NA|U|5||7||FOLLOW-UP|1971-12-05||1972-11-20|||1960-01-01||1965-11-03
TRIAL STUDY 134XCP|RP|73BDFAA2-6260-4E1D-8039-7523F0C52873|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||PIPE|||UL/ML|NOT DONE||U|Y|Y|1||38||OPEN LABEL TREATMENT|1965-11-10||1969-07-25|||1970-02-12||1969-06-20
TRIAL STUDY 134XCP|RP|73BDFAA2-6260-4E1D-8039-7523F0C52873|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MMAL|||NMOL/L|NOT DONE||NA|NA|NA|1||38||LONG-TERM FOLLOW-UP|1969-02-14||1969-04-24|||1972-12-24||1972-08-20
TRIAL STUDY 134XCP|RP|73BDFAA2-6260-4E1D-8039-7523F0C52873|1||||||INABOIND|INDUCED ABORTION INDICATOR||||10^6/HPF|||MV*MIN|NOT DONE||U|U|U|2||58||OBSERVATION|1966-04-08||1966-11-23|||1964-12-01||1964-08-20
TRIAL STUDY 134XCP|RP|73BDFAA2-6260-4E1D-8039-7523F0C52873|2||||||RASHIND|RASH INDICATOR||||UMOL/L/MIN|||MMHG|NOT DONE||NA|N|U|2||58||OBSERVATION|1972-06-29||1961-02-20|||1969-12-05||1967-03-15
TRIAL STUDY 134XCP|RP|73BDFAA2-6260-4E1D-8039-7523F0C52873|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||PFU|||KDA|NOT DONE||N|N|Y|3||39||CONTINUATION TREATMENT|1969-09-15||1963-04-28|||1963-07-21||1964-04-22
TRIAL STUDY 134XCP|RP|73BDFAA2-6260-4E1D-8039-7523F0C52873|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MDFI|||10^7 TCID 50/DOSE|NOT DONE||N|Y|N|3||39||RUN-IN|1966-08-08||1973-04-25|||1962-12-24||1966-10-31
TRIAL STUDY 134XCP|RP|73BDFAA2-6260-4E1D-8039-7523F0C52873|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||PT_US|||WATT|NOT DONE||N|NA|NA|4||88||CONTINUATION TREATMENT|1973-04-09||1963-01-05|||1962-10-30||1967-12-07
TRIAL STUDY 134XCP|RP|73BDFAA2-6260-4E1D-8039-7523F0C52873|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||ML/DOSE|||U|NOT DONE||NA|N|U|4||88||LONG-TERM FOLLOW-UP|1960-12-13||1969-05-20|||1969-07-30||1973-03-24
TRIAL STUDY 134XCP|RP|73BDFAA2-6260-4E1D-8039-7523F0C52873|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||PG/CELL|||AMOL|NOT DONE||NA|U|NA|5||7||OPEN LABEL TREATMENT|1966-04-17||1962-09-19|||1964-02-17||1972-05-10
TRIAL STUDY 134XCP|RP|73BDFAA2-6260-4E1D-8039-7523F0C52873|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||JAR|||PMOL/L/H|NOT DONE||Y|NA|U|5||7||BLINDED TREATMENT|1964-02-02||1969-05-01|||1969-09-25||1962-05-26
TRIAL STUDY 134XCP|RP|147C2E77-A2C5-4219-9BB5-D209813E563B|1||||||ULCERIND|ULCER INDICATOR||||MMU/ML|||DAMOL/L|NOT DONE||U|N|Y|1||38||OPEN LABEL TREATMENT|1966-10-31||1963-12-20|||1962-01-29||1960-05-07
TRIAL STUDY 134XCP|RP|147C2E77-A2C5-4219-9BB5-D209813E563B|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||OZ EQ|||MG/MIN|NOT DONE||N|U|NA|1||38||FOLLOW-UP|1961-07-14||1961-11-18|||1971-09-10||1962-05-15
TRIAL STUDY 134XCP|RP|147C2E77-A2C5-4219-9BB5-D209813E563B|1||||||DSCHGIND|DISCHARGE INDICATOR||||ARBITRARY U|||PSEC|NOT DONE||Y|Y|N|2||58||RUN-IN|1973-07-15||1961-08-29|||1970-08-04||1971-02-11
TRIAL STUDY 134XCP|RP|147C2E77-A2C5-4219-9BB5-D209813E563B|2||||||MENOAGE|MENOPAUSE AGE||||NMOL/MOL|||MU/L|NOT DONE||N|Y|U|2||58||CONTINUATION TREATMENT|1972-11-14||1969-09-13|||1960-06-10||1961-02-02
TRIAL STUDY 134XCP|RP|147C2E77-A2C5-4219-9BB5-D209813E563B|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||LOG10 TCID 50/DOSE|||PG/DL|NOT DONE||NA|Y|NA|3||39||TREATMENT|1969-12-25||1961-04-18|||1961-04-11||1969-09-21
TRIAL STUDY 134XCP|RP|147C2E77-A2C5-4219-9BB5-D209813E563B|2||||||BCMETHOD|BIRTH CONTROL METHOD||||DAYS/MONTH|||10^4 CFU/ML|NOT DONE||Y|N|U|3||39||INDUCTION TREATMENT|1964-01-21||1962-06-07|||1967-07-27||1971-03-11
TRIAL STUDY 134XCP|RP|147C2E77-A2C5-4219-9BB5-D209813E563B|1||||||PREGNN|NUMBER OF PREGNANCIES||||AGU/ML|||UGEQ/L|NOT DONE||N|U|Y|4||88||SCREENING|1970-09-24||1970-09-26|||1963-07-07||1960-05-21
TRIAL STUDY 134XCP|RP|147C2E77-A2C5-4219-9BB5-D209813E563B|2||||||ULCERIND|ULCER INDICATOR||||ML/ANIMAL/DAY|||PACKAGE|NOT DONE||N|Y|NA|4||88||BLINDED TREATMENT|1973-04-20||1970-10-25|||1969-12-19||1965-07-08
TRIAL STUDY 134XCP|RP|147C2E77-A2C5-4219-9BB5-D209813E563B|1||||||DSCHGIND|DISCHARGE INDICATOR||||10^3/L|||CAL|NOT DONE||N|NA|Y|5||7||OBSERVATION|1967-03-14||1968-01-10|||1966-08-14||1973-02-15
TRIAL STUDY 134XCP|RP|147C2E77-A2C5-4219-9BB5-D209813E563B|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||EQ|||MEQ/KG|NOT DONE||NA|N|Y|5||7||FOLLOW-UP|1969-08-20||1972-06-19|||1966-08-18||1970-03-13
TRIAL STUDY 134XCP|RP|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||DISK|||KM|NOT DONE||N|U|N|1||38||INDUCTION TREATMENT|1969-01-27||1970-09-27|||1971-04-03||1968-06-27
TRIAL STUDY 134XCP|RP|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||TSP|||CMOL/L|NOT DONE||Y|U|U|1||38||SCREENING|1962-01-11||1968-12-31|||1970-06-05||1964-02-20
TRIAL STUDY 134XCP|RP|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|1||||||PRGENDTC|DATE PREGNANCY ENDED||||/DAY|||PSEC|NOT DONE||U|U|Y|2||58||WASHOUT|1969-10-02||1968-07-31|||1962-09-16||1961-03-15
TRIAL STUDY 134XCP|RP|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||DIP|||APL U|NOT DONE||U|U|NA|2||58||OBSERVATION|1966-03-29||1968-03-22|||1961-01-11||1966-02-25
TRIAL STUDY 134XCP|RP|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/MIN|||MG/KG/DOSE|NOT DONE||U|Y|U|3||39||LONG-TERM FOLLOW-UP|1961-02-20||1971-01-20|||1963-08-18||1973-01-18
TRIAL STUDY 134XCP|RP|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|2||||||EDEMAIND|EDEMA INDICATOR||||KPA|||/10^3|NOT DONE||N|Y|NA|3||39||WASHOUT|1963-07-28||1968-08-20|||1964-09-29||1970-08-30
TRIAL STUDY 134XCP|RP|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||KG/MOL|||AU/ML|NOT DONE||Y|U|NA|4||88||TREATMENT|1966-06-22||1964-03-27|||1971-01-30||1971-05-05
TRIAL STUDY 134XCP|RP|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|2||||||PEELIND|PEELING INDICATOR||||10^10/L|||AMOL|NOT DONE||NA|N|Y|4||88||OBSERVATION|1967-09-17||1968-02-04|||1970-11-14||1969-06-11
TRIAL STUDY 134XCP|RP|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|1||||||MENFDUR|MENSES FLOW DURATION||||10^4/HPF|||MM3/MM2/YEAR|NOT DONE||NA|U|N|5||7||CONTINUATION TREATMENT|1964-05-26||1963-04-25|||1970-11-29||1960-04-01
TRIAL STUDY 134XCP|RP|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|2||||||ULCERIND|ULCER INDICATOR||||USP U|||NMOL/L/H|NOT DONE||N|Y|N|5||7||FOLLOW-UP|1963-11-05||1962-01-09|||1963-12-04||1963-04-09
TRIAL STUDY 134XCP|RP|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||OZ|||NMOL/DAY|NOT DONE||NA|U|U|1||38||CONTINUATION TREATMENT|1966-03-26||1963-10-06|||1961-08-23||1963-08-29
TRIAL STUDY 134XCP|RP|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|2||||||BRTHN|NUMBER OF BIRTHS||||MV|||U/KG|NOT DONE||Y|U|NA|1||38||OPEN LABEL TREATMENT|1960-05-24||1961-09-08|||1971-10-17||1963-06-02
TRIAL STUDY 134XCP|RP|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|1||||||TNDRIND|TENDERNESS INDICATOR||||SHOCK WAVE|||100 IU/ML|NOT DONE||NA|U|NA|2||58||SCREENING|1963-08-17||1970-07-19|||1968-04-28||1969-11-01
TRIAL STUDY 134XCP|RP|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|2||||||TNDRIND|TENDERNESS INDICATOR||||FINGERTIP UNIT|||UKAT|NOT DONE||U|Y|NA|2||58||SCREENING|1965-05-16||1964-01-10|||1967-09-16||1961-03-31
TRIAL STUDY 134XCP|RP|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MV/SEC|||10^6 CFU|NOT DONE||U|Y|N|3||39||WASHOUT|1967-01-20||1971-11-14|||1965-05-29||1961-10-19
TRIAL STUDY 134XCP|RP|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|2||||||TNDRIND|TENDERNESS INDICATOR||||MPH|||MGEQ|NOT DONE||N|N|NA|3||39||FOLLOW-UP|1965-05-12||1967-03-04|||1971-05-11||1970-04-13
TRIAL STUDY 134XCP|RP|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||IU/MMOL|||ML/KG/MIN|NOT DONE||NA|U|N|4||88||RUN-IN|1962-12-29||1961-11-03|||1966-05-22||1973-02-23
TRIAL STUDY 134XCP|RP|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|2||||||ULCERIND|ULCER INDICATOR||||PL|||TRANSDUCING UNIT|NOT DONE||NA|Y|NA|4||88||INDUCTION TREATMENT|1973-07-03||1961-12-30|||1965-01-29||1969-06-19
TRIAL STUDY 134XCP|RP|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|1||||||TNDRIND|TENDERNESS INDICATOR||||10^6/HPF|||L/L|NOT DONE||U|N|U|5||7||CONTINUATION TREATMENT|1971-07-16||1961-02-21|||1971-02-15||1968-09-06
TRIAL STUDY 134XCP|RP|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|2||||||TNDRIND|TENDERNESS INDICATOR||||GLOBULE|||EVENTS|NOT DONE||Y|Y|N|5||7||RUN-IN|1966-02-25||1970-08-06|||1973-03-11||1971-04-04
TRIAL STUDY 134XCP|RP|25E17A89-8A2F-4870-B076-1D32634F5620|1||||||RASHIND|RASH INDICATOR||||COPIES/UG|||NG/DL|NOT DONE||Y|Y|Y|1||38||SCREENING|1968-09-12||1964-06-22|||1968-05-10||1961-12-10
TRIAL STUDY 134XCP|RP|25E17A89-8A2F-4870-B076-1D32634F5620|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||10^4/HPF|||NGEQ/L|NOT DONE||Y|U|NA|1||38||CONTINUATION TREATMENT|1969-04-16||1966-08-22|||1965-06-02||1971-11-28
TRIAL STUDY 134XCP|RP|25E17A89-8A2F-4870-B076-1D32634F5620|1||||||PEELIND|PEELING INDICATOR||||10^7 CFU/ML|||PG/DL|NOT DONE||U|NA|U|2||58||CONTINUATION TREATMENT|1960-04-16||1966-06-28|||1961-01-30||1973-06-15
TRIAL STUDY 134XCP|RP|25E17A89-8A2F-4870-B076-1D32634F5620|2||||||EDEMAIND|EDEMA INDICATOR||||LOG10 ELISA UNIT|||/KG|NOT DONE||U|NA|NA|2||58||BLINDED TREATMENT|1968-06-07||1968-02-27|||1961-02-06||1968-10-08
TRIAL STUDY 134XCP|RP|25E17A89-8A2F-4870-B076-1D32634F5620|1||||||MENFDUR|MENSES FLOW DURATION||||ML/KG|||WEBER|NOT DONE||N|NA|U|3||39||WASHOUT|1973-05-28||1967-06-17|||1963-06-04||1964-09-04
TRIAL STUDY 134XCP|RP|25E17A89-8A2F-4870-B076-1D32634F5620|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||AGU/ML|||10^3 CFU/G|NOT DONE||NA|NA|Y|3||39||CONTINUATION TREATMENT|1970-10-24||1964-04-19|||1971-10-02||1966-03-09
TRIAL STUDY 134XCP|RP|25E17A89-8A2F-4870-B076-1D32634F5620|1||||||ABORTN|NUMBER OF ABORTIONS||||VIRTUAL PIXEL|||ML/G/MIN|NOT DONE||Y|N|NA|4||88||SCREENING|1968-09-03||1963-03-29|||1968-12-30||1970-09-10
TRIAL STUDY 134XCP|RP|25E17A89-8A2F-4870-B076-1D32634F5620|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MMOL/DAY|||AMOL|NOT DONE||NA|U|Y|4||88||WASHOUT|1967-01-02||1969-12-29|||1964-03-13||1967-09-09
TRIAL STUDY 134XCP|RP|25E17A89-8A2F-4870-B076-1D32634F5620|1||||||THICK|THICKNESS||||10^6/EJACULATE U|||DL|NOT DONE||N|N|Y|5||7||CONTINUATION TREATMENT|1966-02-11||1967-12-08|||1967-08-08||1963-06-14
TRIAL STUDY 134XCP|RP|25E17A89-8A2F-4870-B076-1D32634F5620|2||||||RASHIND|RASH INDICATOR||||VP/DOSE|||GPL U/ML|NOT DONE||Y|Y|Y|5||7||FOLLOW-UP|1967-04-23||1967-05-23|||1970-05-29||1968-09-08
TRIAL STUDY 134XCP|RP|B7B67C06-0802-4E69-A5A1-469213BE7E48|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||10^6/L|||KBQ|NOT DONE||NA|N|NA|1||38||OPEN LABEL TREATMENT|1972-11-09||1962-11-07|||1961-02-07||1966-04-14
TRIAL STUDY 134XCP|RP|B7B67C06-0802-4E69-A5A1-469213BE7E48|2||||||MENOSTAT|MENOPAUSE STATUS||||CD/M2|||U/G/H|NOT DONE||N|Y|N|1||38||BASELINE|1973-08-05||1968-12-27|||1973-07-05||1964-04-04
TRIAL STUDY 134XCP|RP|B7B67C06-0802-4E69-A5A1-469213BE7E48|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MOL/L|||ANTI-XA IU|NOT DONE||N|NA|Y|2||58||TREATMENT|1966-06-11||1970-04-19|||1970-08-11||1972-02-26
TRIAL STUDY 134XCP|RP|B7B67C06-0802-4E69-A5A1-469213BE7E48|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||RING|||KPA/L/SEC|NOT DONE||NA|U|U|2||58||BASELINE|1968-03-26||1962-12-11|||1960-02-01||1968-02-21
TRIAL STUDY 134XCP|RP|B7B67C06-0802-4E69-A5A1-469213BE7E48|1||||||PUSTIND|PUSTULE INDICATOR||||U/G|||MG/ML/MIN|NOT DONE||U|Y|N|3||39||CONTINUATION TREATMENT|1962-06-24||1960-10-29|||1961-02-07||1970-01-16
TRIAL STUDY 134XCP|RP|B7B67C06-0802-4E69-A5A1-469213BE7E48|2||||||ULCERIND|ULCER INDICATOR||||UKAT|||10^3 CFU/G|NOT DONE||Y|Y|Y|3||39||BASELINE|1966-09-21||1963-07-19|||1972-07-15||1968-03-10
TRIAL STUDY 134XCP|RP|B7B67C06-0802-4E69-A5A1-469213BE7E48|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||BP|||MEQ|NOT DONE||U|NA|U|4||88||OPEN LABEL TREATMENT|1972-09-05||1970-04-15|||1971-01-20||1969-08-27
TRIAL STUDY 134XCP|RP|B7B67C06-0802-4E69-A5A1-469213BE7E48|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||CP|||EU|NOT DONE||Y|Y|U|4||88||FOLLOW-UP|1970-05-10||1971-08-17|||1973-02-08||1972-09-25
TRIAL STUDY 134XCP|RP|B7B67C06-0802-4E69-A5A1-469213BE7E48|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||DDU|||VG/ML|NOT DONE||U|NA|U|5||7||INDUCTION TREATMENT|1961-07-12||1962-10-18|||1968-07-25||1973-08-11
TRIAL STUDY 134XCP|RP|B7B67C06-0802-4E69-A5A1-469213BE7E48|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||NEBULE|||FMOL/L|NOT DONE||NA|NA|NA|5||7||OPEN LABEL TREATMENT|1962-03-02||1960-11-19|||1962-05-21||1971-09-14
TRIAL STUDY 134XCP|RP|626E3EA7-423B-434F-89E4-CA076A39B8DB|1||||||FUNDHT|FUNDAL HEIGHT||||EVENTS|||S^-1(%O2)^-1|NOT DONE||Y|U|Y|1||38||OPEN LABEL TREATMENT|1966-06-16||1970-06-30|||1964-06-25||1961-08-16
TRIAL STUDY 134XCP|RP|626E3EA7-423B-434F-89E4-CA076A39B8DB|2||||||PREGNN|NUMBER OF PREGNANCIES||||ANTI-XA IU|||S*KPA|NOT DONE||NA|N|U|1||38||OBSERVATION|1965-07-18||1966-08-13|||1963-03-19||1971-10-22
TRIAL STUDY 134XCP|RP|626E3EA7-423B-434F-89E4-CA076A39B8DB|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MGEQ|||UIU/L|NOT DONE||N|U|NA|2||58||OPEN LABEL TREATMENT|1968-11-17||1971-01-10|||1966-09-28||1961-06-20
TRIAL STUDY 134XCP|RP|626E3EA7-423B-434F-89E4-CA076A39B8DB|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ML/KG/H|||10^9 ORGANISMS|NOT DONE||N|NA|NA|2||58||WASHOUT|1964-09-06||1973-04-18|||1964-12-23||1960-04-29
TRIAL STUDY 134XCP|RP|626E3EA7-423B-434F-89E4-CA076A39B8DB|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^4 CFU|||PFU/ML|NOT DONE||N|U|U|3||39||LONG-TERM FOLLOW-UP|1963-11-18||1961-01-21|||1967-09-14||1970-09-29
TRIAL STUDY 134XCP|RP|626E3EA7-423B-434F-89E4-CA076A39B8DB|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||NCI|||RNA COPIES/ML|NOT DONE||U|U|Y|3||39||BASELINE|1969-02-23||1969-10-02|||1968-11-20||1971-02-12
TRIAL STUDY 134XCP|RP|626E3EA7-423B-434F-89E4-CA076A39B8DB|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||G|||NCI|NOT DONE||NA|Y|Y|4||88||OPEN LABEL TREATMENT|1962-06-27||1963-03-16|||1970-08-20||1963-02-13
TRIAL STUDY 134XCP|RP|626E3EA7-423B-434F-89E4-CA076A39B8DB|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||/7.5 ML|||CCID 50/ML|NOT DONE||Y|N|Y|4||88||BLINDED TREATMENT|1965-02-21||1961-01-31|||1967-04-06||1969-10-05
TRIAL STUDY 134XCP|RP|626E3EA7-423B-434F-89E4-CA076A39B8DB|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||M/SEC2|||SPRAY|NOT DONE||N|Y|Y|5||7||SCREENING|1966-01-07||1965-08-30|||1967-06-18||1968-01-05
TRIAL STUDY 134XCP|RP|626E3EA7-423B-434F-89E4-CA076A39B8DB|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||PSEC|||VG/KG|NOT DONE||U|Y|N|5||7||OBSERVATION|1970-02-27||1967-07-31|||1961-09-12||1966-01-26
TRIAL STUDY 134XCP|RP|98ED3A38-1E74-470E-BF45-0D1E905BEF36|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||LOG10 CFU/ML|||KIT|NOT DONE||U|Y|NA|1||38||OBSERVATION|1960-07-31||1962-02-20|||1971-03-13||1972-06-29
TRIAL STUDY 134XCP|RP|98ED3A38-1E74-470E-BF45-0D1E905BEF36|2||||||INTP|INTERPRETATION||||L/MIN/M2|||L/S/KPA|NOT DONE||U|Y|NA|1||38||OPEN LABEL TREATMENT|1963-11-24||1967-03-01|||1965-01-07||1964-01-26
TRIAL STUDY 134XCP|RP|98ED3A38-1E74-470E-BF45-0D1E905BEF36|1||||||PRGENDTC|DATE PREGNANCY ENDED||||MOL/ML|||BQ/ML|NOT DONE||N|U|U|2||58||RUN-IN|1963-06-11||1973-02-15|||1971-05-01||1961-06-30
TRIAL STUDY 134XCP|RP|98ED3A38-1E74-470E-BF45-0D1E905BEF36|2||||||BLISTIND|BLISTERING INDICATOR||||RFU|||MAC50|NOT DONE||U|N|U|2||58||WASHOUT|1972-03-11||1972-04-14|||1973-05-11||1965-12-29
TRIAL STUDY 134XCP|RP|98ED3A38-1E74-470E-BF45-0D1E905BEF36|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UG/ANIMAL|||UGEQ/L|NOT DONE||U|Y|NA|3||39||SCREENING|1972-05-28||1968-06-13|||1961-12-16||1962-07-11
TRIAL STUDY 134XCP|RP|98ED3A38-1E74-470E-BF45-0D1E905BEF36|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||NU/CL|||NEEDLE GAUGE|NOT DONE||NA|N|NA|3||39||OPEN LABEL TREATMENT|1962-10-22||1960-12-15|||1964-02-16||1964-05-31
TRIAL STUDY 134XCP|RP|98ED3A38-1E74-470E-BF45-0D1E905BEF36|1||||||INABOIND|INDUCED ABORTION INDICATOR||||/7.5 ML|||RPM|NOT DONE||N|N|NA|4||88||RUN-IN|1960-10-12||1966-02-22|||1970-11-03||1973-02-06
TRIAL STUDY 134XCP|RP|98ED3A38-1E74-470E-BF45-0D1E905BEF36|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||COULOMB|||/100 HPFS|NOT DONE||Y|N|NA|4||88||OPEN LABEL TREATMENT|1970-04-26||1969-09-29|||1962-04-23||1968-03-17
TRIAL STUDY 134XCP|RP|98ED3A38-1E74-470E-BF45-0D1E905BEF36|1||||||TNDRIND|TENDERNESS INDICATOR||||NG/L|||DB|NOT DONE||NA|U|Y|5||7||BLINDED TREATMENT|1973-09-04||1965-07-31|||1973-04-01||1972-04-24
TRIAL STUDY 134XCP|RP|98ED3A38-1E74-470E-BF45-0D1E905BEF36|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||NEWTON|||KIU|NOT DONE||Y|N|Y|5||7||BLINDED TREATMENT|1969-12-25||1964-09-02|||1969-03-11||1972-01-15
TRIAL STUDY 134XCP|RP|99DF7819-987E-4E55-89FD-FF49E7C02A5A|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||L/H|||CI/G|NOT DONE||NA|U|NA|1||38||WASHOUT|1966-12-15||1968-03-22|||1973-01-01||1969-09-29
TRIAL STUDY 134XCP|RP|99DF7819-987E-4E55-89FD-FF49E7C02A5A|2||||||MASSIND|MASS INDICATOR||||UL/DOSE|||NG/DL|NOT DONE||Y|U|N|1||38||OPEN LABEL TREATMENT|1961-01-19||1962-03-01|||1967-01-13||1973-03-19
TRIAL STUDY 134XCP|RP|99DF7819-987E-4E55-89FD-FF49E7C02A5A|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||10^6/G|||MOL|NOT DONE||U|N|NA|2||58||WASHOUT|1961-11-10||1963-06-24|||1965-01-03||1965-05-03
TRIAL STUDY 134XCP|RP|99DF7819-987E-4E55-89FD-FF49E7C02A5A|2||||||PREGIND|PREGNANT INDICATOR||||/SEC|||ANSON U|NOT DONE||N|U|N|2||58||CONTINUATION TREATMENT|1962-12-27||1967-08-27|||1973-02-05||1972-05-06
TRIAL STUDY 134XCP|RP|99DF7819-987E-4E55-89FD-FF49E7C02A5A|1||||||RASHIND|RASH INDICATOR||||IU/G HB|||10^3 ORGANISMS|NOT DONE||NA|N|U|3||39||BLINDED TREATMENT|1966-12-22||1967-01-11|||1961-04-06||1966-12-24
TRIAL STUDY 134XCP|RP|99DF7819-987E-4E55-89FD-FF49E7C02A5A|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||YD|||/SEC|NOT DONE||N|Y|NA|3||39||RUN-IN|1966-11-12||1961-12-06|||1968-02-27||1973-04-08
TRIAL STUDY 134XCP|RP|99DF7819-987E-4E55-89FD-FF49E7C02A5A|1||||||DSCHGIND|DISCHARGE INDICATOR||||PELLET|||MET|NOT DONE||NA|N|U|4||88||BLINDED TREATMENT|1967-06-11||1961-03-10|||1967-08-05||1962-01-29
TRIAL STUDY 134XCP|RP|99DF7819-987E-4E55-89FD-FF49E7C02A5A|2||||||PREGNN|NUMBER OF PREGNANCIES||||CAPLET|||CYCLE/MIN|NOT DONE||NA|NA|NA|4||88||OPEN LABEL TREATMENT|1972-07-23||1960-05-23|||1965-06-07||1972-02-11
TRIAL STUDY 134XCP|RP|99DF7819-987E-4E55-89FD-FF49E7C02A5A|1||||||STILBIND|STILLBIRTH INDICATOR||||G/ANIMAL/DAY|||U/KG/H|NOT DONE||U|Y|Y|5||7||WASHOUT|1972-07-22||1960-10-21|||1971-06-13||1971-07-27
TRIAL STUDY 134XCP|RP|99DF7819-987E-4E55-89FD-FF49E7C02A5A|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||POINT|||MEQ|NOT DONE||NA|U|Y|5||7||BLINDED TREATMENT|1967-02-03||1970-06-24|||1968-01-21||1961-03-02
TRIAL STUDY 134XCP|RP|05481BE7-9309-4356-B46E-9C2525D2C54E|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||L/H|||MPL U|NOT DONE||Y|U|NA|1||38||LONG-TERM FOLLOW-UP|1973-03-26||1963-07-02|||1967-03-29||1963-11-08
TRIAL STUDY 134XCP|RP|05481BE7-9309-4356-B46E-9C2525D2C54E|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||/100 WBC|||/H|NOT DONE||NA|U|Y|1||38||WASHOUT|1968-09-20||1969-09-14|||1972-12-25||1973-06-06
TRIAL STUDY 134XCP|RP|05481BE7-9309-4356-B46E-9C2525D2C54E|1||||||DSCHGIND|DISCHARGE INDICATOR||||MDFI|||MEQ/DL|NOT DONE||NA|NA|Y|2||58||OBSERVATION|1965-03-08||1966-03-28|||1961-07-28||1972-05-19
TRIAL STUDY 134XCP|RP|05481BE7-9309-4356-B46E-9C2525D2C54E|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||SUPPOSITORY|||HEP|NOT DONE||N|NA|U|2||58||TREATMENT|1969-10-12||1972-05-26|||1960-10-05||1962-10-12
TRIAL STUDY 134XCP|RP|05481BE7-9309-4356-B46E-9C2525D2C54E|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||PA|||/5X10^4 WBC|NOT DONE||U|NA|U|3||39||OPEN LABEL TREATMENT|1969-04-28||1968-06-15|||1968-11-16||1963-09-08
TRIAL STUDY 134XCP|RP|05481BE7-9309-4356-B46E-9C2525D2C54E|2||||||PEELIND|PEELING INDICATOR||||CUP EQ|||BAU/ML|NOT DONE||U|Y|Y|3||39||OPEN LABEL TREATMENT|1967-04-15||1960-11-21|||1971-01-29||1966-06-03
TRIAL STUDY 134XCP|RP|05481BE7-9309-4356-B46E-9C2525D2C54E|1||||||GRAVIND|GRAVIDA INDICATOR||||10^9 CFU/ML|||GY|NOT DONE||U|NA|N|4||88||OBSERVATION|1968-03-01||1967-03-15|||1966-08-27||1960-05-29
TRIAL STUDY 134XCP|RP|05481BE7-9309-4356-B46E-9C2525D2C54E|2||||||PREGST|PREGNANT DURING THE STUDY||||ANTIBODY UNIT|||BQ/MG|NOT DONE||NA|U|Y|4||88||BLINDED TREATMENT|1961-11-03||1967-08-27|||1965-06-29||1962-02-26
TRIAL STUDY 134XCP|RP|05481BE7-9309-4356-B46E-9C2525D2C54E|1||||||PREGIND|PREGNANT INDICATOR||||PG/CELL|||DAYS|NOT DONE||NA|U|Y|5||7||FOLLOW-UP|1960-12-10||1965-07-15|||1969-06-12||1966-11-11
TRIAL STUDY 134XCP|RP|05481BE7-9309-4356-B46E-9C2525D2C54E|2||||||MENFDUR|MENSES FLOW DURATION||||UU/L|||TUBERCULIN UNIT|NOT DONE||U|N|NA|5||7||OPEN LABEL TREATMENT|1961-12-13||1966-01-27|||1960-06-04||1970-04-27
TRIAL STUDY 134XCP|RP|2F49D512-0A23-4D2D-959B-A1756991E817|1||||||STILBIND|STILLBIRTH INDICATOR||||OHM|||DMOL|NOT DONE||U|N|NA|1||38||TREATMENT|1962-02-27||1969-09-15|||1969-04-27||1973-04-14
TRIAL STUDY 134XCP|RP|2F49D512-0A23-4D2D-959B-A1756991E817|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||UG/ML/H|||ML/CAGE/DAY|NOT DONE||NA|NA|NA|1||38||OBSERVATION|1962-12-24||1969-10-05|||1971-05-24||1968-06-16
TRIAL STUDY 134XCP|RP|2F49D512-0A23-4D2D-959B-A1756991E817|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||CUP|||/10^3|NOT DONE||U|U|N|2||58||INDUCTION TREATMENT|1968-07-07||1967-02-02|||1966-03-19||1961-07-05
TRIAL STUDY 134XCP|RP|2F49D512-0A23-4D2D-959B-A1756991E817|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ML/M2/DAY|||ML/SEC/1.73M2|NOT DONE||NA|N|N|2||58||INDUCTION TREATMENT|1972-03-15||1971-11-23|||1965-07-21||1962-11-30
TRIAL STUDY 134XCP|RP|2F49D512-0A23-4D2D-959B-A1756991E817|1||||||PREGIND|PREGNANT INDICATOR||||CM/S|||10^6 COPIES/ML|NOT DONE||Y|U|Y|3||39||SCREENING|1966-01-16||1968-09-06|||1965-05-09||1963-12-02
TRIAL STUDY 134XCP|RP|2F49D512-0A23-4D2D-959B-A1756991E817|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||DRAM|||SFC/10^6 PBMC|NOT DONE||Y|Y|U|3||39||SCREENING|1962-03-15||1972-07-08|||1966-08-21||1972-06-23
TRIAL STUDY 134XCP|RP|2F49D512-0A23-4D2D-959B-A1756991E817|1||||||PREGST|PREGNANT DURING THE STUDY||||NMOL/L|||PPTH|NOT DONE||U|N|NA|4||88||INDUCTION TREATMENT|1971-03-05||1968-09-29|||1972-10-13||1965-04-28
TRIAL STUDY 134XCP|RP|2F49D512-0A23-4D2D-959B-A1756991E817|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||HOMEOPATHIC DILUTION|||CL|NOT DONE||NA|N|Y|4||88||BLINDED TREATMENT|1967-11-15||1967-01-31|||1971-07-26||1967-01-18
TRIAL STUDY 134XCP|RP|2F49D512-0A23-4D2D-959B-A1756991E817|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||/MM2|||10^9/L|NOT DONE||U|Y|Y|5||7||BASELINE|1969-04-08||1973-02-14|||1968-08-15||1967-09-17
TRIAL STUDY 134XCP|RP|2F49D512-0A23-4D2D-959B-A1756991E817|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MOL|||H/WK|NOT DONE||Y|N|Y|5||7||TREATMENT|1969-03-24||1960-03-11|||1965-11-21||1970-03-12
TRIAL STUDY 134XCP|RP|E884C56C-1612-49CC-A594-B65E7B354842|1||||||BLISTIND|BLISTERING INDICATOR||||ECL UNIT|||BAU/ML|NOT DONE||Y|NA|NA|1||38||WASHOUT|1968-10-19||1967-04-07|||1972-11-18||1962-01-14
TRIAL STUDY 134XCP|RP|E884C56C-1612-49CC-A594-B65E7B354842|2||||||MENOAGE|MENOPAUSE AGE||||BQ/L|||ML/S|NOT DONE||N|Y|N|1||38||OBSERVATION|1967-10-30||1972-03-13|||1967-11-29||1962-08-20
TRIAL STUDY 134XCP|RP|E884C56C-1612-49CC-A594-B65E7B354842|1||||||PREGNN|NUMBER OF PREGNANCIES||||ANSON U|||UG/L FEU|NOT DONE||U|U|N|2||58||RUN-IN|1969-08-18||1963-08-23|||1960-05-02||1963-07-08
TRIAL STUDY 134XCP|RP|E884C56C-1612-49CC-A594-B65E7B354842|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^5/L|||MG2/DL2|NOT DONE||U|Y|NA|2||58||BASELINE|1963-07-11||1961-03-09|||1960-04-01||1966-01-21
TRIAL STUDY 134XCP|RP|E884C56C-1612-49CC-A594-B65E7B354842|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||PSEC|||PSI|NOT DONE||N|U|U|3||39||FOLLOW-UP|1972-09-14||1962-07-13|||1962-04-26||1967-11-25
TRIAL STUDY 134XCP|RP|E884C56C-1612-49CC-A594-B65E7B354842|2||||||EDEMAIND|EDEMA INDICATOR||||/2000 RBC|||BQ/UL|NOT DONE||U|U|N|3||39||BASELINE|1961-04-03||1968-12-28|||1965-10-11||1971-08-10
TRIAL STUDY 134XCP|RP|E884C56C-1612-49CC-A594-B65E7B354842|1||||||MASSIND|MASS INDICATOR||||ML/MIN|||UMOL/MG/MIN|NOT DONE||U|U|Y|4||88||CONTINUATION TREATMENT|1967-01-12||1968-08-08|||1962-03-27||1972-03-05
TRIAL STUDY 134XCP|RP|E884C56C-1612-49CC-A594-B65E7B354842|2||||||THICK|THICKNESS||||10^6 DNA COPIES/ML|||SHOCK WAVE|NOT DONE||U|Y|NA|4||88||FOLLOW-UP|1965-05-10||1971-03-31|||1968-03-11||1967-07-14
TRIAL STUDY 134XCP|RP|E884C56C-1612-49CC-A594-B65E7B354842|1||||||PREGST|PREGNANT DURING THE STUDY||||VG/DOSE|||10^7 TCID 50/DOSE|NOT DONE||U|U|U|5||7||INDUCTION TREATMENT|1966-08-08||1962-08-23|||1970-04-05||1972-01-17
TRIAL STUDY 134XCP|RP|E884C56C-1612-49CC-A594-B65E7B354842|2||||||PUSTIND|PUSTULE INDICATOR||||VG/KG|||F|NOT DONE||NA|N|N|5||7||SCREENING|1971-09-10||1960-10-20|||1962-07-13||1966-12-25
TRIAL STUDY 134XCP|RP|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||ML/DAY|||DEG|NOT DONE||N|N|Y|1||38||BLINDED TREATMENT|1967-10-05||1967-05-12|||1963-03-24||1967-10-26
TRIAL STUDY 134XCP|RP|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||PL|||USP U|NOT DONE||NA|U|N|1||38||WASHOUT|1965-06-04||1971-11-15|||1967-01-12||1965-01-17
TRIAL STUDY 134XCP|RP|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||POUCH|||L/H|NOT DONE||NA|NA|N|2||58||TREATMENT|1972-09-24||1965-02-19|||1960-08-08||1961-01-22
TRIAL STUDY 134XCP|RP|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||U/MG|||ELISA UNIT/DOSE|NOT DONE||N|N|Y|2||58||SCREENING|1966-08-06||1964-11-25|||1972-01-02||1962-07-17
TRIAL STUDY 134XCP|RP|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|1||||||ULCERIND|ULCER INDICATOR||||CYCLE/MIN|||ML/CAGE/DAY|NOT DONE||Y|U|Y|3||39||RUN-IN|1967-07-17||1973-01-25|||1965-08-29||1966-05-02
TRIAL STUDY 134XCP|RP|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|2||||||BRTHN|NUMBER OF BIRTHS||||CI/KG|||BAU|NOT DONE||U|NA|Y|3||39||SCREENING|1972-05-30||1971-03-14|||1964-04-24||1970-12-11
TRIAL STUDY 134XCP|RP|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||ML/KG/DAY|||NMOL/L/MIN|NOT DONE||Y|NA|NA|4||88||OPEN LABEL TREATMENT|1962-05-11||1968-10-11|||1967-09-09||1971-12-11
TRIAL STUDY 134XCP|RP|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||BREATHS/MIN|||NL|NOT DONE||NA|N|N|4||88||SCREENING|1972-04-10||1960-11-21|||1962-11-12||1969-01-02
TRIAL STUDY 134XCP|RP|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||FMOL/L|||CYCLE/MIN|NOT DONE||Y|U|NA|5||7||SCREENING|1970-01-29||1966-10-19|||1963-01-22||1970-09-29
TRIAL STUDY 134XCP|RP|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||APPLICATION|||L/S|NOT DONE||NA|Y|Y|5||7||WASHOUT|1967-11-22||1965-03-10|||1962-10-21||1965-04-15
TRIAL STUDY 134XCP|RP|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||GTT|||MG/L FEU|NOT DONE||U|N|N|1||38||CONTINUATION TREATMENT|1968-09-28||1961-03-03|||1969-01-12||1961-09-08
TRIAL STUDY 134XCP|RP|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||FINGERTIP UNIT|||KG/CM2|NOT DONE||N|Y|NA|1||38||FOLLOW-UP|1961-08-22||1963-01-13|||1967-07-26||1962-10-05
TRIAL STUDY 134XCP|RP|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||MG/KG/WEEK|||NMOL/L/H|NOT DONE||U|NA|Y|2||58||LONG-TERM FOLLOW-UP|1972-12-31||1964-04-02|||1965-07-15||1972-10-05
TRIAL STUDY 134XCP|RP|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|2||||||MENOSTAT|MENOPAUSE STATUS||||TRANSDUCING UNIT/ML|||ENZYME U/L|NOT DONE||U|Y|Y|2||58||CONTINUATION TREATMENT|1969-06-09||1971-09-25|||1960-06-20||1960-10-20
TRIAL STUDY 134XCP|RP|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/CAGE/WK|||FT|NOT DONE||Y|N|N|3||39||LONG-TERM FOLLOW-UP|1970-11-27||1965-12-03|||1973-09-02||1961-11-07
TRIAL STUDY 134XCP|RP|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|2||||||PREGNN|NUMBER OF PREGNANCIES||||UGEQ|||EID 50/DOSE|NOT DONE||U|Y|NA|3||39||BLINDED TREATMENT|1962-03-12||1962-10-14|||1964-06-17||1966-07-24
TRIAL STUDY 134XCP|RP|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|1||||||EDEMAIND|EDEMA INDICATOR||||GBQ/G|||GTT|NOT DONE||Y|NA|Y|4||88||INDUCTION TREATMENT|1961-05-22||1964-03-09|||1968-12-22||1968-03-06
TRIAL STUDY 134XCP|RP|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MEQ|||MEQ/L|NOT DONE||Y|N|N|4||88||BLINDED TREATMENT|1970-05-09||1966-10-18|||1962-01-15||1968-08-07
TRIAL STUDY 134XCP|RP|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|1||||||ABORTN|NUMBER OF ABORTIONS||||%(V/V)|||MCI/L|NOT DONE||Y|Y|N|5||7||INDUCTION TREATMENT|1973-05-10||1962-04-07|||1960-09-12||1972-06-23
TRIAL STUDY 134XCP|RP|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ML/MIN|||SFC/10^6 PBMC|NOT DONE||U|NA|U|5||7||BASELINE|1967-05-08||1967-04-08|||1965-01-14||1961-07-29
TRIAL STUDY 134XCP|RP|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|1||||||PRGENDTC|DATE PREGNANCY ENDED||||UG/M2/DAY|||S^-1(%O2)^-1|NOT DONE||NA|Y|Y|1||38||SCREENING|1962-05-01||1962-12-26|||1968-10-12||1969-06-11
TRIAL STUDY 134XCP|RP|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|2||||||BLISTIND|BLISTERING INDICATOR||||IMPLANT|||MBQ|NOT DONE||U|Y|NA|1||38||BASELINE|1966-03-26||1962-06-18|||1963-02-16||1970-09-05
TRIAL STUDY 134XCP|RP|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||U/M2|||IU/ML|NOT DONE||Y|U|Y|2||58||SCREENING|1966-06-23||1971-03-09|||1968-12-17||1971-04-28
TRIAL STUDY 134XCP|RP|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||INHALATION|||MEQ/KG|NOT DONE||NA|N|Y|2||58||RUN-IN|1970-01-27||1963-07-31|||1970-01-28||1972-02-28
TRIAL STUDY 134XCP|RP|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||PATCH|||FG|NOT DONE||N|Y|Y|3||39||FOLLOW-UP|1971-03-30||1961-09-13|||1969-03-06||1961-09-27
TRIAL STUDY 134XCP|RP|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|2||||||ABORTN|NUMBER OF ABORTIONS||||10^6 ORGANISMS/G|||G/M2/DAY|NOT DONE||Y|U|U|3||39||BLINDED TREATMENT|1961-10-04||1969-08-16|||1965-03-26||1966-09-25
TRIAL STUDY 134XCP|RP|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||KALLIKREIN INHIBITOR UNIT|||OSM|NOT DONE||Y|N|N|4||88||BLINDED TREATMENT|1966-06-25||1965-11-20|||1972-12-25||1969-02-03
TRIAL STUDY 134XCP|RP|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|2||||||MENFDUR|MENSES FLOW DURATION||||/200 HPFS|||/MS|NOT DONE||NA|U|Y|4||88||RUN-IN|1969-08-05||1962-09-23|||1965-07-01||1962-03-23
TRIAL STUDY 134XCP|RP|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||/HPF|||10^7 PFU|NOT DONE||U|N|N|5||7||OBSERVATION|1964-06-21||1966-12-02|||1965-05-23||1962-10-30
TRIAL STUDY 134XCP|RP|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||ML/ANIMAL/DAY|||MMOL/G|NOT DONE||Y|N|NA|5||7||INDUCTION TREATMENT|1970-10-09||1971-09-23|||1965-01-20||1965-12-30
TRIAL STUDY 134XCP|RP|0B140787-9458-4F66-B7E9-1FAFF239085E|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||U/ANIMAL|||10^6 DNA COPIES/ML|NOT DONE||Y|U|U|1||38||TREATMENT|1963-07-14||1969-08-01|||1963-01-04||1964-07-23
TRIAL STUDY 134XCP|RP|0B140787-9458-4F66-B7E9-1FAFF239085E|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||LB|||HENRY|NOT DONE||U|N|N|1||38||OPEN LABEL TREATMENT|1966-01-20||1971-07-01|||1970-10-01||1971-04-18
TRIAL STUDY 134XCP|RP|0B140787-9458-4F66-B7E9-1FAFF239085E|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||BQ/ML|||RFU|NOT DONE||Y|NA|N|2||58||SCREENING|1973-07-27||1971-02-18|||1961-06-05||1961-01-12
TRIAL STUDY 134XCP|RP|0B140787-9458-4F66-B7E9-1FAFF239085E|2||||||BCMETHOD|BIRTH CONTROL METHOD||||UMOL/L/H|||DRAM|NOT DONE||Y|NA|Y|2||58||OPEN LABEL TREATMENT|1964-07-15||1964-08-27|||1961-06-14||1961-04-06
TRIAL STUDY 134XCP|RP|0B140787-9458-4F66-B7E9-1FAFF239085E|1||||||PUSTIND|PUSTULE INDICATOR||||USEC|||NG/MOL|NOT DONE||NA|U|NA|3||39||CONTINUATION TREATMENT|1969-04-13||1962-06-12|||1965-09-08||1971-04-06
TRIAL STUDY 134XCP|RP|0B140787-9458-4F66-B7E9-1FAFF239085E|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||QUANTITY SUFFICIENT|||CM2|NOT DONE||U|U|N|3||39||CONTINUATION TREATMENT|1966-02-04||1969-03-14|||1967-02-18||1971-10-16
TRIAL STUDY 134XCP|RP|0B140787-9458-4F66-B7E9-1FAFF239085E|1||||||FUNDHT|FUNDAL HEIGHT||||ENZYME U/M2|||/10^4|NOT DONE||N|N|NA|4||88||BASELINE|1967-05-24||1964-12-09|||1963-04-30||1965-10-30
TRIAL STUDY 134XCP|RP|0B140787-9458-4F66-B7E9-1FAFF239085E|2||||||MENARAGE|MENARCHE AGE||||UCI/KG|||CFU/ML|NOT DONE||Y|U|NA|4||88||CONTINUATION TREATMENT|1963-01-16||1970-06-27|||1962-12-09||1962-07-02
TRIAL STUDY 134XCP|RP|0B140787-9458-4F66-B7E9-1FAFF239085E|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||NG/DAY|||DDU|NOT DONE||NA|Y|NA|5||7||CONTINUATION TREATMENT|1968-10-01||1970-01-26|||1963-01-25||1961-05-15
TRIAL STUDY 134XCP|RP|0B140787-9458-4F66-B7E9-1FAFF239085E|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||ECL UNIT|||CIGAR|NOT DONE||NA|U|NA|5||7||BLINDED TREATMENT|1966-07-30||1962-12-22|||1960-08-09||1960-03-02
TRIAL STUDY 134XCP|RP|FB91BADF-308B-4F6A-90D0-032E93E20C4A|1||||||BLISTIND|BLISTERING INDICATOR||||GAUSS|||L/S|NOT DONE||N|Y|N|1||38||RUN-IN|1970-03-02||1960-07-26|||1964-01-23||1972-09-28
TRIAL STUDY 134XCP|RP|FB91BADF-308B-4F6A-90D0-032E93E20C4A|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||EIA UNIT|||NM|NOT DONE||U|NA|N|1||38||FOLLOW-UP|1972-12-11||1970-04-04|||1965-03-09||1969-05-27
TRIAL STUDY 134XCP|RP|FB91BADF-308B-4F6A-90D0-032E93E20C4A|1||||||BLISTIND|BLISTERING INDICATOR||||L/MIN/M2|||BOTTLE|NOT DONE||Y|Y|NA|2||58||BASELINE|1963-11-18||1969-10-10|||1966-11-25||1968-08-19
TRIAL STUDY 134XCP|RP|FB91BADF-308B-4F6A-90D0-032E93E20C4A|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||GBQ/G|||ML/DAY|NOT DONE||U|N|NA|2||58||INDUCTION TREATMENT|1970-06-16||1970-01-24|||1961-02-15||1973-09-01
TRIAL STUDY 134XCP|RP|FB91BADF-308B-4F6A-90D0-032E93E20C4A|1||||||INABOIND|INDUCED ABORTION INDICATOR||||S*KPA|||NMOL/KG/DAY|NOT DONE||NA|N|Y|3||39||OBSERVATION|1968-05-04||1960-06-12|||1966-08-29||1967-06-25
TRIAL STUDY 134XCP|RP|FB91BADF-308B-4F6A-90D0-032E93E20C4A|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||CMH2O/ML|||ML/CAGE/DAY|NOT DONE||Y|Y|NA|3||39||BLINDED TREATMENT|1964-10-24||1971-04-09|||1968-11-19||1972-01-13
TRIAL STUDY 134XCP|RP|FB91BADF-308B-4F6A-90D0-032E93E20C4A|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UU/L|||PMOL/G|NOT DONE||NA|Y|N|4||88||SCREENING|1961-07-20||1960-11-01|||1965-04-16||1963-02-18
TRIAL STUDY 134XCP|RP|FB91BADF-308B-4F6A-90D0-032E93E20C4A|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||EJACULATE U|||UGEQ|NOT DONE||NA|Y|Y|4||88||TREATMENT|1965-03-12||1972-06-23|||1963-07-26||1969-09-29
TRIAL STUDY 134XCP|RP|FB91BADF-308B-4F6A-90D0-032E93E20C4A|1||||||BLISTIND|BLISTERING INDICATOR||||UG/KG/H|||KG/CM2|NOT DONE||U|N|N|5||7||RUN-IN|1967-02-27||1968-06-25|||1964-07-02||1969-06-12
TRIAL STUDY 134XCP|RP|FB91BADF-308B-4F6A-90D0-032E93E20C4A|2||||||MENFDUR|MENSES FLOW DURATION||||BP|||TRANSDUCING UNIT|NOT DONE||N|U|Y|5||7||INDUCTION TREATMENT|1960-01-20||1972-03-25|||1967-09-11||1960-08-29
TRIAL STUDY 134XCP|RP|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|1||||||THICK|THICKNESS||||UV2|||UV2|NOT DONE||U|NA|U|1||38||OPEN LABEL TREATMENT|1960-08-18||1972-10-22|||1961-04-14||1965-02-09
TRIAL STUDY 134XCP|RP|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|2||||||THICK|THICKNESS||||KG/L|||UG/G/DAY|NOT DONE||U|U|Y|1||38||TREATMENT|1972-11-05||1972-11-20|||1971-02-26||1965-01-28
TRIAL STUDY 134XCP|RP|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|1||||||MENOSTAT|MENOPAUSE STATUS||||PUFF|||CAN|NOT DONE||Y|Y|NA|2||58||OBSERVATION|1964-09-20||1966-01-13|||1964-11-27||1968-02-04
TRIAL STUDY 134XCP|RP|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||ML/G/H|||10^6/EJACULATE U|NOT DONE||N|U|N|2||58||TREATMENT|1960-03-21||1966-05-26|||1971-09-28||1968-10-05
TRIAL STUDY 134XCP|RP|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||JDF UNIT|||MG/ANIMAL|NOT DONE||Y|U|NA|3||39||OPEN LABEL TREATMENT|1970-01-30||1966-01-29|||1966-11-02||1972-02-11
TRIAL STUDY 134XCP|RP|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||ML/DOSE|||10^7 CFU/ML|NOT DONE||Y|N|NA|3||39||LONG-TERM FOLLOW-UP|1969-10-04||1964-09-10|||1961-08-20||1973-06-04
TRIAL STUDY 134XCP|RP|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||%|||MGEQ|NOT DONE||NA|NA|Y|4||88||WASHOUT|1968-05-17||1966-11-02|||1964-09-05||1969-01-20
TRIAL STUDY 134XCP|RP|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|2||||||BCMETHOD|BIRTH CONTROL METHOD||||BAU|||AMPULE|NOT DONE||NA|NA|Y|4||88||BLINDED TREATMENT|1963-08-05||1967-06-27|||1967-02-07||1970-06-12
TRIAL STUDY 134XCP|RP|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|1||||||BRTHN|NUMBER OF BIRTHS||||MG/KG/H|||VG/KG|NOT DONE||Y|N|N|5||7||TREATMENT|1971-06-27||1968-06-21|||1970-01-31||1961-12-14
TRIAL STUDY 134XCP|RP|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||NMOL BCE/MMOL|||/WK|NOT DONE||N|Y|N|5||7||INDUCTION TREATMENT|1971-06-15||1963-03-10|||1972-11-18||1961-07-30
TRIAL STUDY 134XCP|RP|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||DL|||MV2/HZ|NOT DONE||U|N|NA|1||38||BASELINE|1972-05-01||1967-07-25|||1973-06-11||1970-11-02
TRIAL STUDY 134XCP|RP|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|2||||||DSCHGIND|DISCHARGE INDICATOR||||/VF|||MET*H|NOT DONE||N|U|Y|1||38||WASHOUT|1964-11-05||1961-06-01|||1969-11-20||1961-07-30
TRIAL STUDY 134XCP|RP|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MG/KG/DAY|||SQU/ML|NOT DONE||U|NA|U|2||58||BLINDED TREATMENT|1960-06-28||1965-02-19|||1973-01-31||1960-08-05
TRIAL STUDY 134XCP|RP|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||G/ANIMAL|||BEL|NOT DONE||U|NA|U|2||58||TREATMENT|1966-09-09||1968-04-13|||1971-08-30||1967-04-19
TRIAL STUDY 134XCP|RP|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|1||||||EDEMAIND|EDEMA INDICATOR||||UCI/KG|||PIPE|NOT DONE||NA|N|NA|3||39||BASELINE|1967-05-15||1961-06-27|||1965-04-06||1965-01-13
TRIAL STUDY 134XCP|RP|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||KCAL/DAY|||UG/G/DAY|NOT DONE||NA|NA|N|3||39||SCREENING|1965-10-30||1973-02-05|||1965-06-03||1960-10-24
TRIAL STUDY 134XCP|RP|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||G/CAGE|||G/U|NOT DONE||Y|U|U|4||88||TREATMENT|1963-02-27||1971-01-22|||1962-09-26||1970-07-08
TRIAL STUDY 134XCP|RP|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||/2000 RBC|||CMH2O*S/ML|NOT DONE||U|U|NA|4||88||LONG-TERM FOLLOW-UP|1960-07-03||1965-12-13|||1966-12-14||1967-06-05
TRIAL STUDY 134XCP|RP|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|1||||||MENFDUR|MENSES FLOW DURATION||||PPTR|||WEBER|NOT DONE||U|U|Y|5||7||FOLLOW-UP|1964-12-18||1964-10-12|||1966-09-12||1968-09-07
TRIAL STUDY 134XCP|RP|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||TABLET|||UMOL/DAY|NOT DONE||Y|U|N|5||7||OBSERVATION|1964-11-02||1960-03-28|||1961-09-26||1960-08-24
TRIAL STUDY 134XCP|RP|3B583022-3A2C-4387-80A5-035E3FD111BD|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MEQ|||UEQ/L|NOT DONE||NA|NA|N|1||38||INDUCTION TREATMENT|1962-01-19||1972-05-12|||1969-07-30||1973-05-25
TRIAL STUDY 134XCP|RP|3B583022-3A2C-4387-80A5-035E3FD111BD|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||G/L|||U/G HB|NOT DONE||N|Y|N|1||38||TREATMENT|1968-03-28||1960-11-25|||1960-01-18||1962-09-08
TRIAL STUDY 134XCP|RP|3B583022-3A2C-4387-80A5-035E3FD111BD|1||||||PREGIND|PREGNANT INDICATOR||||KDA|||10^6/HPF|NOT DONE||U|NA|N|2||58||LONG-TERM FOLLOW-UP|1968-09-01||1968-08-20|||1960-07-01||1969-05-06
TRIAL STUDY 134XCP|RP|3B583022-3A2C-4387-80A5-035E3FD111BD|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||BEL|||BU|NOT DONE||Y|N|NA|2||58||WASHOUT|1968-09-13||1960-06-08|||1964-03-25||1973-05-06
TRIAL STUDY 134XCP|RP|3B583022-3A2C-4387-80A5-035E3FD111BD|1||||||DSCHGIND|DISCHARGE INDICATOR||||SEC|||AMP|NOT DONE||NA|N|Y|3||39||BLINDED TREATMENT|1964-08-31||1961-08-27|||1970-01-28||1972-10-13
TRIAL STUDY 134XCP|RP|3B583022-3A2C-4387-80A5-035E3FD111BD|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||L/S/KPA|||CCID 50/DOSE|NOT DONE||Y|N|NA|3||39||RUN-IN|1967-02-10||1960-09-17|||1972-07-16||1969-05-18
TRIAL STUDY 134XCP|RP|3B583022-3A2C-4387-80A5-035E3FD111BD|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UMOL/L/MIN|||UG/ANIMAL|NOT DONE||NA|Y|NA|4||88||SCREENING|1967-03-05||1970-06-19|||1964-04-20||1967-04-12
TRIAL STUDY 134XCP|RP|3B583022-3A2C-4387-80A5-035E3FD111BD|2||||||THICK|THICKNESS||||U/KG/DAY|||PPM|NOT DONE||U|U|Y|4||88||BASELINE|1972-07-29||1967-09-09|||1960-06-09||1970-11-17
TRIAL STUDY 134XCP|RP|3B583022-3A2C-4387-80A5-035E3FD111BD|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||GMFI|||ML/G/H|NOT DONE||Y|Y|U|5||7||TREATMENT|1973-01-27||1965-02-11|||1970-02-26||1968-07-21
TRIAL STUDY 134XCP|RP|3B583022-3A2C-4387-80A5-035E3FD111BD|2||||||MENOAGE|MENOPAUSE AGE||||F|||NEBULE|NOT DONE||Y|Y|NA|5||7||RUN-IN|1973-01-10||1972-12-13|||1965-09-15||1962-05-19
TRIAL STUDY 134XCP|RP|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|1||||||BLISTIND|BLISTERING INDICATOR||||MMOL/S|||NGEQ/L|NOT DONE||U|Y|Y|1||38||RUN-IN|1960-09-17||1961-06-30|||1971-03-26||1972-11-05
TRIAL STUDY 134XCP|RP|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MSEC|||KIU|NOT DONE||Y|NA|U|1||38||FOLLOW-UP|1972-01-16||1973-01-10|||1973-07-22||1965-07-05
TRIAL STUDY 134XCP|RP|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||LOG10 TCID 50/ML|||AMFI|NOT DONE||U|U|Y|2||58||TREATMENT|1971-08-13||1967-11-03|||1964-06-12||1961-02-24
TRIAL STUDY 134XCP|RP|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|2||||||INTP|INTERPRETATION||||FG|||IMPLANT|NOT DONE||U|N|U|2||58||OBSERVATION|1972-12-01||1963-02-01|||1970-10-27||1965-11-12
TRIAL STUDY 134XCP|RP|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|1||||||THICK|THICKNESS||||LOG10 PFU|||10^7/L|NOT DONE||NA|NA|N|3||39||LONG-TERM FOLLOW-UP|1971-02-24||1960-08-18|||1960-11-12||1967-04-16
TRIAL STUDY 134XCP|RP|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|2||||||DLVRMODE|MODE OF DELIVERY||||MOL/ML|||MKAT|NOT DONE||N|U|N|3||39||OBSERVATION|1967-06-11||1962-06-18|||1965-12-12||1971-09-09
TRIAL STUDY 134XCP|RP|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||U/G/DAY|||TSP|NOT DONE||NA|NA|N|4||88||BASELINE|1972-09-11||1969-06-13|||1960-09-19||1968-01-20
TRIAL STUDY 134XCP|RP|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|2||||||PEELIND|PEELING INDICATOR||||WEEKS|||UMOL/L/H|NOT DONE||Y|NA|N|4||88||LONG-TERM FOLLOW-UP|1971-10-20||1961-04-17|||1968-09-28||1970-08-28
TRIAL STUDY 134XCP|RP|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||10^11/L|||ML/BREATH|NOT DONE||N|N|N|5||7||WASHOUT|1971-11-26||1960-12-28|||1966-07-11||1967-12-07
TRIAL STUDY 134XCP|RP|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MOL/MG|||BP|NOT DONE||NA|N|Y|5||7||TREATMENT|1967-08-07||1973-07-05|||1966-03-06||1969-03-26
TRIAL STUDY 134XCP|RP|B5370AC4-3185-48DC-B1BC-A00AE8496783|1||||||PREGST|PREGNANT DURING THE STUDY||||MILE|||MMOL/L|NOT DONE||Y|N|Y|1||38||WASHOUT|1970-03-31||1971-10-10|||1971-04-29||1969-01-08
TRIAL STUDY 134XCP|RP|B5370AC4-3185-48DC-B1BC-A00AE8496783|2||||||EDEMAIND|EDEMA INDICATOR||||ML/SEC/1.73M2|||ML/100G/MIN|NOT DONE||NA|N|NA|1||38||BASELINE|1965-05-10||1960-06-15|||1970-11-20||1971-11-09
TRIAL STUDY 134XCP|RP|B5370AC4-3185-48DC-B1BC-A00AE8496783|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UL/DOSE|||KCAL|NOT DONE||Y|N|N|2||58||CONTINUATION TREATMENT|1962-07-27||1973-02-23|||1971-07-23||1961-10-08
TRIAL STUDY 134XCP|RP|B5370AC4-3185-48DC-B1BC-A00AE8496783|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||PACKET|||CI|NOT DONE||N|U|Y|2||58||RUN-IN|1967-03-17||1971-06-14|||1972-05-05||1962-06-12
TRIAL STUDY 134XCP|RP|B5370AC4-3185-48DC-B1BC-A00AE8496783|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||IU/G|||%(W/W)|NOT DONE||NA|N|NA|3||39||BASELINE|1964-06-26||1961-12-25|||1962-05-23||1964-08-11
TRIAL STUDY 134XCP|RP|B5370AC4-3185-48DC-B1BC-A00AE8496783|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/G|||%(W/V)|NOT DONE||U|NA|NA|3||39||TREATMENT|1962-03-04||1966-11-26|||1970-02-02||1968-10-06
TRIAL STUDY 134XCP|RP|B5370AC4-3185-48DC-B1BC-A00AE8496783|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MMOL|||MBQ|NOT DONE||NA|Y|Y|4||88||OPEN LABEL TREATMENT|1972-06-15||1967-08-24|||1960-03-31||1966-03-12
TRIAL STUDY 134XCP|RP|B5370AC4-3185-48DC-B1BC-A00AE8496783|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||LINEAR FT*LB|||MG/L FEU|NOT DONE||NA|U|Y|4||88||SCREENING|1972-03-07||1966-06-01|||1971-01-27||1968-06-30
TRIAL STUDY 134XCP|RP|B5370AC4-3185-48DC-B1BC-A00AE8496783|1||||||BLISTIND|BLISTERING INDICATOR||||CAPLET|||PACKET|NOT DONE||Y|U|U|5||7||BLINDED TREATMENT|1969-04-23||1968-11-15|||1973-06-07||1966-03-24
TRIAL STUDY 134XCP|RP|B5370AC4-3185-48DC-B1BC-A00AE8496783|2||||||INTP|INTERPRETATION||||MU|||DEG/MM|NOT DONE||Y|NA|N|5||7||INDUCTION TREATMENT|1972-12-15||1969-01-15|||1973-05-17||1967-04-21
TRIAL STUDY 134XCP|RP|1112A903-1F2A-4583-BB9A-41DD206D5B4A|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||S*KPA|||BEATS/MIN|NOT DONE||NA|NA|Y|1||38||OPEN LABEL TREATMENT|1960-06-09||1973-01-26|||1970-08-02||1965-10-29
TRIAL STUDY 134XCP|RP|1112A903-1F2A-4583-BB9A-41DD206D5B4A|2||||||BCMETHOD|BIRTH CONTROL METHOD||||10^6 IU|||UMOL/DL|NOT DONE||U|Y|NA|1||38||LONG-TERM FOLLOW-UP|1964-08-23||1971-08-16|||1973-08-20||1961-01-23
TRIAL STUDY 134XCP|RP|1112A903-1F2A-4583-BB9A-41DD206D5B4A|1||||||BCMETHOD|BIRTH CONTROL METHOD||||FT2|||KEV|NOT DONE||Y|Y|Y|2||58||SCREENING|1964-02-12||1960-01-17|||1966-05-07||1970-10-16
TRIAL STUDY 134XCP|RP|1112A903-1F2A-4583-BB9A-41DD206D5B4A|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||FRACTION OF 1|||TSP|NOT DONE||Y|U|U|2||58||RUN-IN|1972-03-09||1969-08-27|||1967-07-06||1967-01-02
TRIAL STUDY 134XCP|RP|1112A903-1F2A-4583-BB9A-41DD206D5B4A|1||||||PEELIND|PEELING INDICATOR||||ML/SEC/1.73M2|||U/G/MIN|NOT DONE||N|U|U|3||39||OPEN LABEL TREATMENT|1966-11-01||1964-12-27|||1971-01-27||1968-01-22
TRIAL STUDY 134XCP|RP|1112A903-1F2A-4583-BB9A-41DD206D5B4A|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MS/MMHG|||USP U|NOT DONE||Y|U|NA|3||39||OPEN LABEL TREATMENT|1964-07-23||1970-02-24|||1963-09-23||1964-02-01
TRIAL STUDY 134XCP|RP|1112A903-1F2A-4583-BB9A-41DD206D5B4A|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UMOL/L/H|||PPTH|NOT DONE||NA|Y|N|4||88||INDUCTION TREATMENT|1967-01-06||1965-04-13|||1964-11-08||1972-06-21
TRIAL STUDY 134XCP|RP|1112A903-1F2A-4583-BB9A-41DD206D5B4A|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||PMOL/10^9 CELLS|||NMOL/L/MIN|NOT DONE||U|U|N|4||88||FOLLOW-UP|1963-01-11||1970-12-08|||1965-03-08||1960-08-02
TRIAL STUDY 134XCP|RP|1112A903-1F2A-4583-BB9A-41DD206D5B4A|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||NG/DL|||INHALATION|NOT DONE||U|Y|U|5||7||CONTINUATION TREATMENT|1973-07-21||1965-02-19|||1963-11-24||1962-10-26
TRIAL STUDY 134XCP|RP|1112A903-1F2A-4583-BB9A-41DD206D5B4A|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MANSON U/ML|||C|NOT DONE||NA|NA|U|5||7||FOLLOW-UP|1963-02-21||1965-01-17|||1964-11-22||1970-12-22
TRIAL STUDY 134XCP|RP|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||CI/UG|||BQ/MG|NOT DONE||N|Y|U|1||38||RUN-IN|1972-10-31||1961-10-01|||1971-09-17||1970-06-05
TRIAL STUDY 134XCP|RP|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|2||||||ULCERIND|ULCER INDICATOR||||UG/KG/MIN|||UL|NOT DONE||U|NA|U|1||38||INDUCTION TREATMENT|1962-06-17||1968-09-20|||1967-08-17||1969-01-23
TRIAL STUDY 134XCP|RP|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MM|||BOTTLE|NOT DONE||U|NA|NA|2||58||OPEN LABEL TREATMENT|1968-08-01||1972-04-04|||1970-06-10||1960-05-15
TRIAL STUDY 134XCP|RP|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|2||||||ULCERIND|ULCER INDICATOR||||ML/KG|||ML/M2|NOT DONE||N|U|NA|2||58||OPEN LABEL TREATMENT|1972-01-26||1964-12-04|||1968-06-12||1972-06-05
TRIAL STUDY 134XCP|RP|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|1||||||PUSTIND|PUSTULE INDICATOR||||UOSM|||UG/G/DAY|NOT DONE||Y|N|N|3||39||SCREENING|1967-11-21||1970-02-27|||1966-01-13||1969-06-23
TRIAL STUDY 134XCP|RP|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ABSORBANCE U/ML|||IU|NOT DONE||NA|Y|NA|3||39||RUN-IN|1963-10-25||1962-05-07|||1969-11-21||1964-05-29
TRIAL STUDY 134XCP|RP|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||NL|||MV|NOT DONE||NA|Y|Y|4||88||TREATMENT|1962-02-02||1960-11-08|||1962-02-02||1962-05-28
TRIAL STUDY 134XCP|RP|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|2||||||STILBIND|STILLBIRTH INDICATOR||||ML/G/MIN|||MGEQ|NOT DONE||NA|NA|Y|4||88||INDUCTION TREATMENT|1967-04-12||1966-05-09|||1971-05-03||1961-05-20
TRIAL STUDY 134XCP|RP|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MS/MMHG|||NMOL/MOL|NOT DONE||NA|N|U|5||7||FOLLOW-UP|1965-08-03||1969-08-14|||1968-08-31||1970-04-27
TRIAL STUDY 134XCP|RP|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||UM/S|||M2|NOT DONE||Y|NA|NA|5||7||BASELINE|1961-01-06||1970-03-05|||1972-05-03||1962-12-15
TRIAL STUDY 134XCP|RP|D09F047E-E380-453B-875D-FF3C8C5EA839|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MMHG*MIN/L|||PACK YEAR|NOT DONE||U|NA|N|1||38||WASHOUT|1967-12-05||1968-09-04|||1960-11-04||1965-12-24
TRIAL STUDY 134XCP|RP|D09F047E-E380-453B-875D-FF3C8C5EA839|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||NMOL|||ML/G/DAY|NOT DONE||N|N|NA|1||38||TREATMENT|1968-10-13||1963-03-20|||1967-01-29||1964-10-19
TRIAL STUDY 134XCP|RP|D09F047E-E380-453B-875D-FF3C8C5EA839|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||%(V/V)|||BQ/MG|NOT DONE||U|U|U|2||58||LONG-TERM FOLLOW-UP|1967-12-07||1960-12-02|||1962-02-03||1964-08-04
TRIAL STUDY 134XCP|RP|D09F047E-E380-453B-875D-FF3C8C5EA839|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||BQ/L|||ELISA UNIT/ML|NOT DONE||U|U|Y|2||58||LONG-TERM FOLLOW-UP|1967-12-22||1971-11-16|||1963-03-06||1966-03-13
TRIAL STUDY 134XCP|RP|D09F047E-E380-453B-875D-FF3C8C5EA839|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||PPTH|||RNA COPIES/ML|NOT DONE||U|U|N|3||39||WASHOUT|1969-06-15||1960-09-21|||1960-06-03||1962-05-26
TRIAL STUDY 134XCP|RP|D09F047E-E380-453B-875D-FF3C8C5EA839|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||PA|||ELISA UNIT|NOT DONE||U|NA|U|3||39||OPEN LABEL TREATMENT|1973-05-09||1963-07-04|||1961-06-30||1967-04-10
TRIAL STUDY 134XCP|RP|D09F047E-E380-453B-875D-FF3C8C5EA839|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||SFC/10^6 PBMC|||NKAT|NOT DONE||U|U|NA|4||88||CONTINUATION TREATMENT|1962-05-29||1973-06-13|||1971-11-22||1966-08-07
TRIAL STUDY 134XCP|RP|D09F047E-E380-453B-875D-FF3C8C5EA839|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||CM/MIN|||KG/CM2|NOT DONE||U|NA|NA|4||88||INDUCTION TREATMENT|1969-07-10||1971-02-01|||1964-12-29||1971-03-13
TRIAL STUDY 134XCP|RP|D09F047E-E380-453B-875D-FF3C8C5EA839|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UG/KG/H|||TESLA|NOT DONE||NA|Y|Y|5||7||INDUCTION TREATMENT|1972-01-10||1973-07-04|||1965-01-06||1969-01-26
TRIAL STUDY 134XCP|RP|D09F047E-E380-453B-875D-FF3C8C5EA839|2||||||DLVRMODE|MODE OF DELIVERY||||MG/G/H|||NMOL/ML/MIN|NOT DONE||Y|U|U|5||7||INDUCTION TREATMENT|1969-05-26||1961-02-25|||1964-02-26||1960-10-20
TRIAL STUDY 134XCP|RP|E1B16559-B9CA-4B14-A77A-4AD546EF5262|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||UMOL/L|||PM|NOT DONE||U|Y|N|1||38||BLINDED TREATMENT|1972-12-09||1970-01-07|||1972-05-09||1966-04-30
TRIAL STUDY 134XCP|RP|E1B16559-B9CA-4B14-A77A-4AD546EF5262|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||UG/M2|||ANTI-XA IU/ML|NOT DONE||NA|U|U|1||38||BLINDED TREATMENT|1972-05-29||1965-09-23|||1962-01-25||1965-11-19
TRIAL STUDY 134XCP|RP|E1B16559-B9CA-4B14-A77A-4AD546EF5262|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||U/10^12 RBC|||MOSM/KG|NOT DONE||Y|U|Y|2||58||LONG-TERM FOLLOW-UP|1969-08-02||1973-08-30|||1960-03-03||1965-09-28
TRIAL STUDY 134XCP|RP|E1B16559-B9CA-4B14-A77A-4AD546EF5262|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||DAGU|||AMFI|NOT DONE||NA|N|NA|2||58||TREATMENT|1963-04-29||1962-02-02|||1961-06-23||1960-12-29
TRIAL STUDY 134XCP|RP|E1B16559-B9CA-4B14-A77A-4AD546EF5262|1||||||EDEMAIND|EDEMA INDICATOR||||BQ/MG|||BP|NOT DONE||U|Y|NA|3||39||BLINDED TREATMENT|1968-04-25||1971-12-17|||1971-06-18||1966-08-22
TRIAL STUDY 134XCP|RP|E1B16559-B9CA-4B14-A77A-4AD546EF5262|2||||||PRGENDTC|DATE PREGNANCY ENDED||||PHERESIS UNIT|||DEG/S|NOT DONE||U|N|Y|3||39||WASHOUT|1963-03-28||1971-12-31|||1967-12-21||1962-11-27
TRIAL STUDY 134XCP|RP|E1B16559-B9CA-4B14-A77A-4AD546EF5262|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||GBQ|||MSEC|NOT DONE||N|U|Y|4||88||FOLLOW-UP|1962-06-21||1966-06-07|||1968-11-18||1965-09-14
TRIAL STUDY 134XCP|RP|E1B16559-B9CA-4B14-A77A-4AD546EF5262|2||||||PREGST|PREGNANT DURING THE STUDY||||IN2|||UG/M2/H|NOT DONE||N|N|U|4||88||WASHOUT|1970-01-24||1965-12-04|||1963-06-07||1966-10-15
TRIAL STUDY 134XCP|RP|E1B16559-B9CA-4B14-A77A-4AD546EF5262|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||G/KG/DAY|||ML/BREATH|NOT DONE||U|NA|Y|5||7||INDUCTION TREATMENT|1960-05-10||1961-07-29|||1970-09-20||1966-01-10
TRIAL STUDY 134XCP|RP|E1B16559-B9CA-4B14-A77A-4AD546EF5262|2||||||MENARAGE|MENARCHE AGE||||10^3 ORGANISMS|||TITER|NOT DONE||N|Y|Y|5||7||INDUCTION TREATMENT|1966-11-02||1965-09-11|||1960-04-10||1964-06-03
TRIAL STUDY 134XCP|RP|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|1||||||PREGST|PREGNANT DURING THE STUDY||||MG/KG|||DNA COPIES/ML|NOT DONE||NA|NA|N|1||38||WASHOUT|1964-03-14||1969-01-07|||1964-03-10||1962-03-23
TRIAL STUDY 134XCP|RP|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||USP U|||/2500 WBC|NOT DONE||N|N|Y|1||38||BLINDED TREATMENT|1969-12-25||1966-10-09|||1966-07-25||1962-03-30
TRIAL STUDY 134XCP|RP|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|1||||||BLISTIND|BLISTERING INDICATOR||||NCI|||10^3 ORGANISMS/G|NOT DONE||NA|NA|Y|2||58||WASHOUT|1969-02-03||1965-05-20|||1962-07-05||1972-11-02
TRIAL STUDY 134XCP|RP|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||G|||EP U|NOT DONE||Y|Y|N|2||58||WASHOUT|1967-01-20||1964-07-19|||1971-08-08||1971-09-17
TRIAL STUDY 134XCP|RP|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|1||||||DSCHGIND|DISCHARGE INDICATOR||||FRAMES/S|||RNA COPIES/ML|NOT DONE||NA|N|NA|3||39||TREATMENT|1966-04-04||1963-03-22|||1972-09-17||1962-10-13
TRIAL STUDY 134XCP|RP|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||APL U|||HOMEOPATHIC DILUTION|NOT DONE||NA|NA|Y|3||39||OPEN LABEL TREATMENT|1964-01-25||1963-02-11|||1973-03-30||1964-09-29
TRIAL STUDY 134XCP|RP|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|1||||||MASSIND|MASS INDICATOR||||10^6/L|||UMOL/MIN|NOT DONE||Y|U|Y|4||88||INDUCTION TREATMENT|1972-09-28||1970-09-06|||1969-07-14||1967-05-26
TRIAL STUDY 134XCP|RP|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||/40 HPFS|||UMOL/KG/MIN|NOT DONE||Y|N|U|4||88||OPEN LABEL TREATMENT|1965-07-01||1967-11-30|||1963-09-02||1965-05-02
TRIAL STUDY 134XCP|RP|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||APPLICATION|||CMH2O/ML|NOT DONE||N|NA|N|5||7||INDUCTION TREATMENT|1967-01-23||1960-11-26|||1968-04-28||1965-05-11
TRIAL STUDY 134XCP|RP|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||FEU|||P|NOT DONE||N|U|U|5||7||INDUCTION TREATMENT|1960-11-14||1961-05-03|||1967-07-14||1962-01-27
TRIAL STUDY 134XCP|RP|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|1||||||PREGIND|PREGNANT INDICATOR||||NEWTON|||MU|NOT DONE||Y|U|NA|1||38||FOLLOW-UP|1971-06-26||1970-02-19|||1972-02-15||1962-12-20
TRIAL STUDY 134XCP|RP|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|2||||||MENOSTAT|MENOPAUSE STATUS||||BAR|||NKAT/L|NOT DONE||N|U|U|1||38||SCREENING|1968-07-22||1966-01-17|||1968-10-10||1966-11-21
TRIAL STUDY 134XCP|RP|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UGEQ|||BU|NOT DONE||Y|U|NA|2||58||SCREENING|1962-03-27||1967-12-16|||1963-02-21||1968-10-14
TRIAL STUDY 134XCP|RP|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||SYRINGE|||G/ANIMAL/WK|NOT DONE||Y|Y|Y|2||58||FOLLOW-UP|1972-05-13||1968-01-13|||1967-12-14||1971-10-21
TRIAL STUDY 134XCP|RP|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|1||||||ULCERIND|ULCER INDICATOR||||10^3 CFU/G|||UL/DOSE|NOT DONE||NA|U|N|3||39||CONTINUATION TREATMENT|1963-11-29||1972-02-23|||1965-02-18||1967-09-05
TRIAL STUDY 134XCP|RP|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||TABLET|||FFU|NOT DONE||U|Y|Y|3||39||TREATMENT|1972-04-25||1962-03-01|||1967-08-03||1973-05-20
TRIAL STUDY 134XCP|RP|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MCI/KG|||APL U|NOT DONE||Y|U|N|4||88||SCREENING|1962-04-16||1966-10-31|||1964-11-01||1966-01-23
TRIAL STUDY 134XCP|RP|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||LOG10 TCID 50/ML|||OSM|NOT DONE||N|NA|U|4||88||FOLLOW-UP|1964-11-03||1970-02-10|||1972-01-03||1966-07-03
TRIAL STUDY 134XCP|RP|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||WATT|||LOG10 ELISA UNIT/DOSE|NOT DONE||U|U|U|5||7||OPEN LABEL TREATMENT|1972-01-08||1970-12-24|||1972-06-29||1961-05-16
TRIAL STUDY 134XCP|RP|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MG/ANIMAL|||BOWL|NOT DONE||U|NA|NA|5||7||TREATMENT|1971-12-17||1960-07-15|||1961-08-18||1964-04-08
TRIAL STUDY 134XCP|RP|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||DDU|||UG/M2/MIN|NOT DONE||Y|Y|N|1||38||SCREENING|1964-08-28||1968-11-09|||1972-03-26||1969-11-23
TRIAL STUDY 134XCP|RP|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||DRAM|||BISCUIT|NOT DONE||NA|U|Y|1||38||LONG-TERM FOLLOW-UP|1970-09-14||1964-12-31|||1960-04-19||1968-06-15
TRIAL STUDY 134XCP|RP|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|1||||||ULCERIND|ULCER INDICATOR||||%(V/V)|||NMOL BCE/L|NOT DONE||U|U|U|2||58||TREATMENT|1960-04-11||1973-02-04|||1960-01-29||1961-06-16
TRIAL STUDY 134XCP|RP|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|2||||||TNDRIND|TENDERNESS INDICATOR||||L/DAY|||DEG|NOT DONE||U|U|N|2||58||SCREENING|1969-06-30||1964-09-14|||1970-02-24||1964-07-19
TRIAL STUDY 134XCP|RP|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|1||||||BRTHN|NUMBER OF BIRTHS||||KN/CM2|||V|NOT DONE||NA|N|N|3||39||BASELINE|1972-04-13||1968-11-27|||1973-06-05||1964-08-09
TRIAL STUDY 134XCP|RP|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|2||||||BRTHN|NUMBER OF BIRTHS||||MET|||MILE|NOT DONE||NA|NA|NA|3||39||SCREENING|1969-01-28||1964-08-06|||1962-04-19||1960-07-17
TRIAL STUDY 134XCP|RP|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|1||||||MENFDUR|MENSES FLOW DURATION||||UCI/KG|||ML/DL|NOT DONE||Y|NA|N|4||88||OBSERVATION|1971-05-22||1961-06-18|||1965-10-10||1966-05-07
TRIAL STUDY 134XCP|RP|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|2||||||MENARAGE|MENARCHE AGE||||TRANSDUCING UNIT/ML|||%(W/W)|NOT DONE||NA|N|Y|4||88||OPEN LABEL TREATMENT|1964-02-26||1973-07-07|||1971-02-03||1971-12-25
TRIAL STUDY 134XCP|RP|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|1||||||PRGENDTC|DATE PREGNANCY ENDED||||PRESSOR UNITS|||MILE|NOT DONE||NA|NA|N|5||7||SCREENING|1965-07-11||1967-07-23|||1960-11-07||1973-01-28
TRIAL STUDY 134XCP|RP|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|2||||||THICK|THICKNESS||||DDU|||MCI/L|NOT DONE||N|Y|N|5||7||BLINDED TREATMENT|1963-07-26||1966-07-07|||1960-10-15||1963-01-26
TRIAL STUDY 134XCP|RP|44199000-F1B7-4187-9E5A-AA5F69E831C3|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||KPA|||NMOL|NOT DONE||Y|Y|N|1||38||BLINDED TREATMENT|1963-09-17||1967-03-19|||1968-01-25||1966-10-21
TRIAL STUDY 134XCP|RP|44199000-F1B7-4187-9E5A-AA5F69E831C3|2||||||BCMETHOD|BIRTH CONTROL METHOD||||MV2/HZ|||MMHG/SEC|NOT DONE||Y|N|N|1||38||OBSERVATION|1972-11-04||1967-03-10|||1965-07-30||1961-07-09
TRIAL STUDY 134XCP|RP|44199000-F1B7-4187-9E5A-AA5F69E831C3|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||U/ANIMAL|||CM|NOT DONE||Y|Y|Y|2||58||OBSERVATION|1972-09-23||1970-10-20|||1962-09-08||1972-03-30
TRIAL STUDY 134XCP|RP|44199000-F1B7-4187-9E5A-AA5F69E831C3|2||||||DLVRMODE|MODE OF DELIVERY||||PFU/ANIMAL|||10^9 ORGANISMS/MG|NOT DONE||Y|N|NA|2||58||TREATMENT|1961-02-24||1968-06-26|||1964-10-05||1970-01-07
TRIAL STUDY 134XCP|RP|44199000-F1B7-4187-9E5A-AA5F69E831C3|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||MOSM/L|||/HPF|NOT DONE||N|N|Y|3||39||RUN-IN|1965-12-21||1966-04-06|||1964-08-15||1966-09-13
TRIAL STUDY 134XCP|RP|44199000-F1B7-4187-9E5A-AA5F69E831C3|2||||||DLVRMODE|MODE OF DELIVERY||||CM2|||UL/ML|NOT DONE||N|N|N|3||39||WASHOUT|1970-02-07||1970-10-20|||1972-04-10||1963-04-01
TRIAL STUDY 134XCP|RP|44199000-F1B7-4187-9E5A-AA5F69E831C3|1||||||INTP|INTERPRETATION||||YEARS|||U/MG|NOT DONE||N|U|Y|4||88||OBSERVATION|1962-02-01||1972-01-11|||1960-11-15||1969-08-16
TRIAL STUDY 134XCP|RP|44199000-F1B7-4187-9E5A-AA5F69E831C3|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||KG/CM|||MGEQ|NOT DONE||Y|N|NA|4||88||RUN-IN|1963-08-07||1970-09-12|||1961-03-22||1964-02-03
TRIAL STUDY 134XCP|RP|44199000-F1B7-4187-9E5A-AA5F69E831C3|1||||||TNDRIND|TENDERNESS INDICATOR||||10^6 ORGANISMS/ML|||10^11/L|NOT DONE||NA|NA|NA|5||7||LONG-TERM FOLLOW-UP|1969-02-24||1965-10-05|||1967-10-05||1961-02-13
TRIAL STUDY 134XCP|RP|44199000-F1B7-4187-9E5A-AA5F69E831C3|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||CCID 50/DOSE|||TORR|NOT DONE||NA|Y|U|5||7||RUN-IN|1969-04-29||1968-02-01|||1961-10-31||1966-03-21
TRIAL STUDY 134XCP|RP|1D487F49-92DB-4132-BD95-1B8797594DE7|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^3 ORGANISMS/G|||KIT|NOT DONE||Y|Y|Y|1||38||RUN-IN|1969-10-08||1972-03-04|||1961-02-23||1960-01-22
TRIAL STUDY 134XCP|RP|1D487F49-92DB-4132-BD95-1B8797594DE7|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MOL/ML|||MMOL|NOT DONE||U|U|N|1||38||TREATMENT|1961-01-14||1963-08-03|||1971-12-30||1969-07-31
TRIAL STUDY 134XCP|RP|1D487F49-92DB-4132-BD95-1B8797594DE7|1||||||ULCERIND|ULCER INDICATOR||||G/U|||DRAM|NOT DONE||Y|N|N|2||58||BASELINE|1969-06-21||1963-01-02|||1962-10-11||1965-07-23
TRIAL STUDY 134XCP|RP|1D487F49-92DB-4132-BD95-1B8797594DE7|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UV|||10^6 ORGANISMS/G|NOT DONE||NA|N|NA|2||58||OBSERVATION|1968-06-11||1962-05-21|||1973-06-08||1961-09-06
TRIAL STUDY 134XCP|RP|1D487F49-92DB-4132-BD95-1B8797594DE7|1||||||DSCHGIND|DISCHARGE INDICATOR||||ML/CM|||100 IU/ML|NOT DONE||Y|Y|U|3||39||CONTINUATION TREATMENT|1963-07-20||1961-10-16|||1964-08-24||1960-04-29
TRIAL STUDY 134XCP|RP|1D487F49-92DB-4132-BD95-1B8797594DE7|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||/CMH2O|||NMOL|NOT DONE||NA|NA|NA|3||39||BASELINE|1965-10-10||1970-02-18|||1960-11-12||1972-08-17
TRIAL STUDY 134XCP|RP|1D487F49-92DB-4132-BD95-1B8797594DE7|1||||||DSCHGIND|DISCHARGE INDICATOR||||MDFI|||FFU|NOT DONE||U|Y|NA|4||88||WASHOUT|1968-07-11||1971-09-11|||1967-06-30||1970-05-31
TRIAL STUDY 134XCP|RP|1D487F49-92DB-4132-BD95-1B8797594DE7|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MMOL/MOL|||MMHG/SEC|NOT DONE||N|Y|NA|4||88||LONG-TERM FOLLOW-UP|1960-10-03||1966-12-04|||1961-05-24||1971-05-27
TRIAL STUDY 134XCP|RP|1D487F49-92DB-4132-BD95-1B8797594DE7|1||||||PEELIND|PEELING INDICATOR||||MEQ|||10^6 CFU/G|NOT DONE||Y|U|U|5||7||OBSERVATION|1970-06-21||1965-12-24|||1963-11-29||1962-07-24
TRIAL STUDY 134XCP|RP|1D487F49-92DB-4132-BD95-1B8797594DE7|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||OI50|||MG/CM2|NOT DONE||U|Y|N|5||7||WASHOUT|1970-05-18||1972-02-24|||1965-02-03||1970-07-20
TRIAL STUDY 134XCP|RP|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|1||||||STILBIND|STILLBIRTH INDICATOR||||DAGU|||LOG10 PFU/ML|NOT DONE||N|U|U|1||38||WASHOUT|1960-03-10||1965-01-21|||1960-07-10||1972-05-01
TRIAL STUDY 134XCP|RP|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||PMOL/DL|||10^6 ORGANISMS/G|NOT DONE||U|U|U|1||38||FOLLOW-UP|1961-09-28||1960-12-13|||1971-10-19||1966-03-21
TRIAL STUDY 134XCP|RP|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||AG|||MMOL/G|NOT DONE||Y|NA|Y|2||58||BLINDED TREATMENT|1970-06-14||1971-12-31|||1970-03-30||1970-07-24
TRIAL STUDY 134XCP|RP|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|2||||||DSCHGIND|DISCHARGE INDICATOR||||UIU/L|||UIU/DL|NOT DONE||N|N|Y|2||58||OBSERVATION|1964-09-03||1967-09-10|||1965-10-22||1962-01-31
TRIAL STUDY 134XCP|RP|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|1||||||EDEMAIND|EDEMA INDICATOR||||NMOL/L/MIN|||CM|NOT DONE||NA|N|NA|3||39||CONTINUATION TREATMENT|1970-04-17||1970-11-18|||1964-05-22||1965-02-12
TRIAL STUDY 134XCP|RP|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||KPA|||U/G/DAY|NOT DONE||NA|Y|N|3||39||OBSERVATION|1965-09-11||1970-05-17|||1960-05-11||1969-08-22
TRIAL STUDY 134XCP|RP|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|1||||||TNDRIND|TENDERNESS INDICATOR||||ML/MIN/MMHG|||NMOL/L|NOT DONE||N|N|N|4||88||RUN-IN|1964-07-24||1960-05-07|||1962-11-21||1964-08-19
TRIAL STUDY 134XCP|RP|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||COPIES/UG|||SBE/ML|NOT DONE||N|N|U|4||88||OBSERVATION|1966-06-30||1964-09-03|||1973-04-15||1967-01-11
TRIAL STUDY 134XCP|RP|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||G/ANIMAL|||L/DAY|NOT DONE||NA|N|Y|5||7||BLINDED TREATMENT|1962-11-10||1964-03-05|||1967-10-14||1969-05-31
TRIAL STUDY 134XCP|RP|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||PUFF|||G/KG|NOT DONE||NA|U|N|5||7||INDUCTION TREATMENT|1961-11-21||1960-12-29|||1964-11-11||1970-01-11
TRIAL STUDY 134XCP|RP|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|1||||||GRAVIND|GRAVIDA INDICATOR||||10^12/L|||MEQ/KG|NOT DONE||N|Y|NA|1||38||OBSERVATION|1968-01-15||1963-05-30|||1973-06-05||1961-04-29
TRIAL STUDY 134XCP|RP|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||ML/(MIN*100ML)|||OZ EQ|NOT DONE||Y|U|Y|1||38||OPEN LABEL TREATMENT|1968-07-27||1968-11-16|||1964-06-11||1964-04-30
TRIAL STUDY 134XCP|RP|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MMOL/L|||UMOL/DL|NOT DONE||Y|NA|NA|2||58||RUN-IN|1973-03-28||1972-07-28|||1967-05-26||1969-02-25
TRIAL STUDY 134XCP|RP|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|2||||||PREGIND|PREGNANT INDICATOR||||NG/DAY|||10^3 COPIES/ML|NOT DONE||NA|NA|Y|2||58||SCREENING|1961-06-21||1964-12-11|||1969-09-23||1961-02-05
TRIAL STUDY 134XCP|RP|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|1||||||PUSTIND|PUSTULE INDICATOR||||UCI/L|||ML/CAGE|NOT DONE||Y|Y|N|3||39||CONTINUATION TREATMENT|1971-06-06||1970-08-02|||1960-08-12||1970-12-26
TRIAL STUDY 134XCP|RP|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|2||||||PREGIND|PREGNANT INDICATOR||||MG/G/H|||YEARS|NOT DONE||U|NA|Y|3||39||TREATMENT|1970-09-30||1965-09-01|||1971-11-04||1960-03-15
TRIAL STUDY 134XCP|RP|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|1||||||MENOAGE|MENOPAUSE AGE||||STEPS/MIN|||KDA|NOT DONE||N|Y|NA|4||88||INDUCTION TREATMENT|1960-02-03||1960-04-02|||1971-11-13||1963-08-03
TRIAL STUDY 134XCP|RP|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||UG/MIN|||ENZYME U/L|NOT DONE||Y|N|NA|4||88||RUN-IN|1961-04-06||1964-01-21|||1966-01-15||1960-06-19
TRIAL STUDY 134XCP|RP|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||RPM|||UV2|NOT DONE||N|NA|U|5||7||TREATMENT|1966-06-17||1969-09-19|||1972-06-19||1967-11-01
TRIAL STUDY 134XCP|RP|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|2||||||TNDRIND|TENDERNESS INDICATOR||||PL|||USIEMENS|NOT DONE||N|N|U|5||7||CONTINUATION TREATMENT|1971-04-11||1971-12-25|||1961-02-08||1970-04-08
TRIAL STUDY 134XCP|RP|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|1||||||THICK|THICKNESS||||UG/L/H|||JAR|NOT DONE||U|U|Y|1||38||INDUCTION TREATMENT|1965-10-18||1965-09-08|||1970-07-16||1971-08-17
TRIAL STUDY 134XCP|RP|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MMU/ML|||10^9/G|NOT DONE||N|Y|U|1||38||FOLLOW-UP|1972-12-25||1972-12-28|||1968-05-08||1967-10-28
TRIAL STUDY 134XCP|RP|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||YEARS|||LOG10 TCID 50/UL|NOT DONE||N|NA|Y|2||58||WASHOUT|1969-11-16||1961-10-15|||1968-11-05||1964-02-15
TRIAL STUDY 134XCP|RP|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|2||||||DLVRMODE|MODE OF DELIVERY||||LB|||G/CM2|NOT DONE||U|Y|N|2||58||TREATMENT|1972-03-31||1969-03-31|||1965-02-27||1970-01-03
TRIAL STUDY 134XCP|RP|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||/2500 WBC|||SPRAY|NOT DONE||N|U|NA|3||39||FOLLOW-UP|1972-12-20||1972-09-07|||1966-02-06||1960-11-16
TRIAL STUDY 134XCP|RP|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|2||||||BLISTIND|BLISTERING INDICATOR||||MAMP|||G/CAGE/DAY|NOT DONE||NA|NA|N|3||39||OBSERVATION|1968-12-02||1970-03-05|||1973-07-20||1964-01-01
TRIAL STUDY 134XCP|RP|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||CFU/ML|||/4.0 ML|NOT DONE||NA|NA|U|4||88||TREATMENT|1963-05-14||1960-05-20|||1965-03-21||1970-07-26
TRIAL STUDY 134XCP|RP|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||LOG10 TCID 50/ML|||TSP|NOT DONE||U|NA|U|4||88||TREATMENT|1965-04-11||1961-10-08|||1970-08-05||1962-12-17
TRIAL STUDY 134XCP|RP|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UG/DL|||LOG10 TCID 50/UL|NOT DONE||NA|N|NA|5||7||RUN-IN|1967-07-17||1964-01-06|||1962-05-27||1969-02-04
TRIAL STUDY 134XCP|RP|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||UV2|||G/CAGE/DAY|NOT DONE||N|Y|NA|5||7||FOLLOW-UP|1963-01-31||1960-03-19|||1971-05-31||1964-01-22
TRIAL STUDY 134XCP|RP|33233744-4E16-437D-852B-B5F2CCC94B1A|1||||||BLISTIND|BLISTERING INDICATOR||||CCID 50/DOSE|||HOMEOPATHIC DILUTION|NOT DONE||U|Y|N|1||38||RUN-IN|1965-02-28||1960-08-13|||1966-05-21||1968-03-14
TRIAL STUDY 134XCP|RP|33233744-4E16-437D-852B-B5F2CCC94B1A|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MNFI|||ML/M2/DAY|NOT DONE||Y|U|U|1||38||CONTINUATION TREATMENT|1963-06-30||1969-06-03|||1972-07-05||1968-01-21
TRIAL STUDY 134XCP|RP|33233744-4E16-437D-852B-B5F2CCC94B1A|1||||||PUSTIND|PUSTULE INDICATOR||||CMHG|||MAC50|NOT DONE||Y|Y|N|2||58||INDUCTION TREATMENT|1971-10-30||1963-08-26|||1964-05-09||1973-03-17
TRIAL STUDY 134XCP|RP|33233744-4E16-437D-852B-B5F2CCC94B1A|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||LOG10 ELISA UNIT/DOSE|||U/KG/H|NOT DONE||U|U|U|2||58||FOLLOW-UP|1970-03-10||1962-07-10|||1971-10-27||1966-04-09
TRIAL STUDY 134XCP|RP|33233744-4E16-437D-852B-B5F2CCC94B1A|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||FMOL/L|||RAD|NOT DONE||NA|U|N|3||39||OPEN LABEL TREATMENT|1961-09-13||1964-03-06|||1972-01-25||1963-09-22
TRIAL STUDY 134XCP|RP|33233744-4E16-437D-852B-B5F2CCC94B1A|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MMOL/G|||10^3 DNA COPIES/ML|NOT DONE||Y|Y|NA|3||39||OBSERVATION|1966-12-26||1962-03-02|||1964-08-22||1971-11-26
TRIAL STUDY 134XCP|RP|33233744-4E16-437D-852B-B5F2CCC94B1A|1||||||PREGIND|PREGNANT INDICATOR||||RFU|||NMOL/L/MIN|NOT DONE||U|U|N|4||88||TREATMENT|1971-09-22||1968-07-31|||1963-12-10||1965-07-18
TRIAL STUDY 134XCP|RP|33233744-4E16-437D-852B-B5F2CCC94B1A|2||||||BRTHN|NUMBER OF BIRTHS||||CARTRIDGE|||MEQ/ML|NOT DONE||NA|Y|NA|4||88||FOLLOW-UP|1967-09-26||1969-03-12|||1965-05-01||1963-12-16
TRIAL STUDY 134XCP|RP|33233744-4E16-437D-852B-B5F2CCC94B1A|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||BP|||U|NOT DONE||NA|U|U|5||7||OBSERVATION|1961-09-22||1964-08-14|||1964-08-26||1960-12-02
TRIAL STUDY 134XCP|RP|33233744-4E16-437D-852B-B5F2CCC94B1A|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||G/DAY|||SQU/ML|NOT DONE||NA|NA|U|5||7||CONTINUATION TREATMENT|1971-09-01||1969-01-30|||1963-12-03||1971-04-14
TRIAL STUDY 134XCP|RP|B27DC754-F6E2-41E3-9804-0F92AE0006B4|1||||||PREGIND|PREGNANT INDICATOR||||PACKAGE|||NMOL/G|NOT DONE||U|Y|N|1||38||TREATMENT|1961-07-04||1960-02-03|||1961-04-14||1970-01-05
TRIAL STUDY 134XCP|RP|B27DC754-F6E2-41E3-9804-0F92AE0006B4|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||CD/M2|||UG/DL|NOT DONE||N|U|N|1||38||CONTINUATION TREATMENT|1962-12-23||1960-02-17|||1964-10-26||1973-01-01
TRIAL STUDY 134XCP|RP|B27DC754-F6E2-41E3-9804-0F92AE0006B4|1||||||TNDRIND|TENDERNESS INDICATOR||||JDF UNIT|||10^3 ORGANISMS/G|NOT DONE||N|N|NA|2||58||TREATMENT|1964-11-14||1961-07-25|||1968-07-15||1972-12-31
TRIAL STUDY 134XCP|RP|B27DC754-F6E2-41E3-9804-0F92AE0006B4|2||||||TNDRIND|TENDERNESS INDICATOR||||PIXELS/CM|||GPELISA UNIT/ML|NOT DONE||N|N|NA|2||58||LONG-TERM FOLLOW-UP|1966-02-01||1967-12-29|||1967-03-21||1972-05-05
TRIAL STUDY 134XCP|RP|B27DC754-F6E2-41E3-9804-0F92AE0006B4|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MG/ML/DAY|||ENZYME U/L|NOT DONE||Y|Y|Y|3||39||FOLLOW-UP|1962-08-07||1970-09-20|||1965-10-16||1971-06-22
TRIAL STUDY 134XCP|RP|B27DC754-F6E2-41E3-9804-0F92AE0006B4|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MG/KG/DOSE|||TUBERCULIN UNIT|NOT DONE||NA|NA|N|3||39||TREATMENT|1968-12-17||1965-01-01|||1963-03-13||1962-08-13
TRIAL STUDY 134XCP|RP|B27DC754-F6E2-41E3-9804-0F92AE0006B4|1||||||PREGIND|PREGNANT INDICATOR||||VP/DOSE|||RATIO|NOT DONE||NA|U|N|4||88||RUN-IN|1964-05-22||1969-01-17|||1968-12-14||1971-06-24
TRIAL STUDY 134XCP|RP|B27DC754-F6E2-41E3-9804-0F92AE0006B4|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||/MS|||PFU/ML|NOT DONE||Y|Y|U|4||88||OPEN LABEL TREATMENT|1969-03-09||1968-07-31|||1972-04-16||1970-07-26
TRIAL STUDY 134XCP|RP|B27DC754-F6E2-41E3-9804-0F92AE0006B4|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||MEQ/UG|||MG/DOSE|NOT DONE||N|U|U|5||7||WASHOUT|1960-03-13||1965-12-22|||1966-06-25||1967-07-14
TRIAL STUDY 134XCP|RP|B27DC754-F6E2-41E3-9804-0F92AE0006B4|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MGEQ|||OI50|NOT DONE||N|N|NA|5||7||TREATMENT|1965-09-01||1972-02-16|||1969-05-04||1968-07-05
TRIAL STUDY 134XCP|RP|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|1||||||PREGST|PREGNANT DURING THE STUDY||||GY/H|||JOULE|NOT DONE||N|Y|N|1||38||BASELINE|1968-05-19||1971-10-03|||1969-04-18||1972-04-12
TRIAL STUDY 134XCP|RP|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MMHG/L/MIN|||MMOL|NOT DONE||N|U|U|1||38||INDUCTION TREATMENT|1964-03-28||1965-07-30|||1967-02-19||1965-10-20
TRIAL STUDY 134XCP|RP|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||FOZ_BR|||MG/ML/MIN|NOT DONE||NA|NA|N|2||58||SCREENING|1962-11-07||1968-01-05|||1963-01-26||1967-08-16
TRIAL STUDY 134XCP|RP|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|2||||||PRGENDTC|DATE PREGNANCY ENDED||||UCI/L|||RATIO|NOT DONE||U|Y|U|2||58||OBSERVATION|1969-03-16||1971-07-10|||1973-04-25||1967-01-05
TRIAL STUDY 134XCP|RP|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|1||||||EDEMAIND|EDEMA INDICATOR||||VG/ML|||MG/DL|NOT DONE||N|Y|U|3||39||SCREENING|1971-11-24||1962-09-03|||1972-02-18||1965-12-07
TRIAL STUDY 134XCP|RP|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^6/L|||UL/ML|NOT DONE||Y|NA|NA|3||39||RUN-IN|1966-05-30||1961-12-14|||1971-07-31||1967-07-30
TRIAL STUDY 134XCP|RP|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|1||||||INTP|INTERPRETATION||||MG/KG|||UG/L FEU|NOT DONE||NA|U|Y|4||88||SCREENING|1966-02-19||1965-02-27|||1972-10-11||1966-01-31
TRIAL STUDY 134XCP|RP|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MU|||CG|NOT DONE||Y|Y|N|4||88||CONTINUATION TREATMENT|1963-07-28||1962-11-30|||1971-01-31||1969-06-14
TRIAL STUDY 134XCP|RP|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||10^6/HPF|||CM|NOT DONE||NA|N|N|5||7||CONTINUATION TREATMENT|1964-02-15||1966-02-18|||1968-07-11||1973-07-21
TRIAL STUDY 134XCP|RP|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UG/DAY|||PMOL/G|NOT DONE||Y|U|NA|5||7||FOLLOW-UP|1972-03-29||1961-09-09|||1964-12-27||1960-09-15
TRIAL STUDY 134XCP|RP|BDE843D8-2F69-4542-BC47-D52302FD4898|1||||||MENARAGE|MENARCHE AGE||||WEEKS|||LB|NOT DONE||Y|U|U|1||38||SCREENING|1968-08-28||1968-11-28|||1971-03-25||1964-07-15
TRIAL STUDY 134XCP|RP|BDE843D8-2F69-4542-BC47-D52302FD4898|2||||||MASSIND|MASS INDICATOR||||MOL/MOL|||CP|NOT DONE||N|Y|N|1||38||BASELINE|1967-02-27||1969-04-23|||1960-01-28||1963-02-24
TRIAL STUDY 134XCP|RP|BDE843D8-2F69-4542-BC47-D52302FD4898|1||||||STILBIND|STILLBIRTH INDICATOR||||MM2|||KG/L|NOT DONE||Y|Y|U|2||58||LONG-TERM FOLLOW-UP|1969-07-23||1967-10-06|||1969-07-29||1965-09-21
TRIAL STUDY 134XCP|RP|BDE843D8-2F69-4542-BC47-D52302FD4898|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||VIRTUAL PIXEL|||UG/CM2|NOT DONE||Y|NA|N|2||58||TREATMENT|1965-09-10||1963-09-05|||1971-04-10||1972-05-27
TRIAL STUDY 134XCP|RP|BDE843D8-2F69-4542-BC47-D52302FD4898|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||SBE/ML|||UM/DAY|NOT DONE||NA|Y|NA|3||39||SCREENING|1968-03-07||1964-07-20|||1967-03-28||1968-10-15
TRIAL STUDY 134XCP|RP|BDE843D8-2F69-4542-BC47-D52302FD4898|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MG|||NCI|NOT DONE||U|N|NA|3||39||WASHOUT|1960-06-13||1966-02-26|||1970-09-26||1965-09-07
TRIAL STUDY 134XCP|RP|BDE843D8-2F69-4542-BC47-D52302FD4898|1||||||PREGIND|PREGNANT INDICATOR||||KPA|||MG/DOSE|NOT DONE||N|Y|N|4||88||OBSERVATION|1972-12-01||1964-07-15|||1966-04-12||1962-07-05
TRIAL STUDY 134XCP|RP|BDE843D8-2F69-4542-BC47-D52302FD4898|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||DPM/ML|||10^3 CFU/ML|NOT DONE||Y|NA|NA|4||88||TREATMENT|1967-06-23||1964-01-27|||1965-08-31||1972-01-26
TRIAL STUDY 134XCP|RP|BDE843D8-2F69-4542-BC47-D52302FD4898|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||BQ/G|||ML/KG/MIN|NOT DONE||U|Y|NA|5||7||WASHOUT|1969-04-09||1960-03-29|||1964-02-05||1964-06-01
TRIAL STUDY 134XCP|RP|BDE843D8-2F69-4542-BC47-D52302FD4898|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||UM/S|||CCID 50/ML|NOT DONE||Y|Y|U|5||7||BLINDED TREATMENT|1972-07-29||1966-08-31|||1973-04-08||1970-07-03
TRIAL STUDY 134XCP|RP|A8C8CB0C-C575-414C-BF1C-846361DB03BC|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MG/G/MIN|||/MBP|NOT DONE||U|N|Y|1||38||BLINDED TREATMENT|1972-09-17||1970-02-28|||1971-11-29||1969-03-05
TRIAL STUDY 134XCP|RP|A8C8CB0C-C575-414C-BF1C-846361DB03BC|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||BEATS/MIN|||%/S|NOT DONE||Y|U|U|1||38||OBSERVATION|1961-09-25||1960-01-14|||1971-06-20||1969-10-24
TRIAL STUDY 134XCP|RP|A8C8CB0C-C575-414C-BF1C-846361DB03BC|1||||||RASHIND|RASH INDICATOR||||COPIES/ML|||TRANSDUCING UNIT/ML|NOT DONE||N|NA|U|2||58||WASHOUT|1962-10-14||1967-05-07|||1964-08-27||1961-10-31
TRIAL STUDY 134XCP|RP|A8C8CB0C-C575-414C-BF1C-846361DB03BC|2||||||ERYTHIND|ERYTHEMA INDICATOR||||L|||GAUSS|NOT DONE||N|U|U|2||58||LONG-TERM FOLLOW-UP|1971-01-19||1961-12-16|||1971-06-06||1965-05-23
TRIAL STUDY 134XCP|RP|A8C8CB0C-C575-414C-BF1C-846361DB03BC|1||||||MENOSTAT|MENOPAUSE STATUS||||ML/ANIMAL/WK|||UMOL/DAY|NOT DONE||NA|U|N|3||39||WASHOUT|1960-10-17||1964-08-25|||1960-09-23||1966-12-25
TRIAL STUDY 134XCP|RP|A8C8CB0C-C575-414C-BF1C-846361DB03BC|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||BLOCKS|||G/M2|NOT DONE||N|NA|U|3||39||BASELINE|1973-08-19||1973-01-23|||1962-09-25||1962-01-10
TRIAL STUDY 134XCP|RP|A8C8CB0C-C575-414C-BF1C-846361DB03BC|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||GTT|||KG|NOT DONE||N|U|NA|4||88||SCREENING|1961-10-10||1972-03-26|||1960-12-10||1968-09-25
TRIAL STUDY 134XCP|RP|A8C8CB0C-C575-414C-BF1C-846361DB03BC|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||CCID 50/DOSE|||RATIO|NOT DONE||NA|N|Y|4||88||CONTINUATION TREATMENT|1963-05-20||1972-10-30|||1970-02-21||1963-12-23
TRIAL STUDY 134XCP|RP|A8C8CB0C-C575-414C-BF1C-846361DB03BC|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MSEC|||MAMP|NOT DONE||Y|NA|Y|5||7||CONTINUATION TREATMENT|1972-12-30||1969-09-28|||1963-07-28||1966-05-27
TRIAL STUDY 134XCP|RP|A8C8CB0C-C575-414C-BF1C-846361DB03BC|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||LOG10 CCID 50/DOSE|||VP/DOSE|NOT DONE||U|U|N|5||7||OBSERVATION|1963-07-16||1968-02-24|||1973-03-23||1962-04-13
TRIAL STUDY 134XCP|RP|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|1||||||DSCHGIND|DISCHARGE INDICATOR||||ENZYME U/L|||/100 HPFS|NOT DONE||NA|U|Y|1||38||FOLLOW-UP|1972-04-12||1966-07-02|||1960-03-15||1971-02-10
TRIAL STUDY 134XCP|RP|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|2||||||MENOSTAT|MENOPAUSE STATUS||||10^6 CFU|||MMHG*MIN/L|NOT DONE||NA|NA|N|1||38||CONTINUATION TREATMENT|1973-07-11||1962-04-23|||1972-11-17||1972-10-02
TRIAL STUDY 134XCP|RP|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|1||||||RASHIND|RASH INDICATOR||||ENZYME U|||%(W/W)|NOT DONE||N|NA|Y|2||58||RUN-IN|1969-09-03||1964-05-23|||1964-08-19||1963-02-12
TRIAL STUDY 134XCP|RP|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|2||||||FUNDHT|FUNDAL HEIGHT||||MAC50|||AFU|NOT DONE||N|N|U|2||58||SCREENING|1972-07-28||1973-04-24|||1968-04-19||1972-01-30
TRIAL STUDY 134XCP|RP|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|1||||||STILBIND|STILLBIRTH INDICATOR||||PA|||UGEQ/L|NOT DONE||N|NA|U|3||39||TREATMENT|1964-04-08||1972-03-05|||1967-07-10||1966-02-11
TRIAL STUDY 134XCP|RP|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||DRUM|||HOMEOPATHIC DILUTION|NOT DONE||N|Y|NA|3||39||OBSERVATION|1971-09-15||1969-05-22|||1967-12-27||1963-04-10
TRIAL STUDY 134XCP|RP|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||PMOL/DL|||V/SEC|NOT DONE||Y|Y|Y|4||88||WASHOUT|1965-07-31||1963-03-18|||1960-09-21||1969-06-09
TRIAL STUDY 134XCP|RP|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UG/M2/H|||WAFER|NOT DONE||NA|U|U|4||88||CONTINUATION TREATMENT|1972-02-04||1972-12-22|||1962-11-25||1968-10-04
TRIAL STUDY 134XCP|RP|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|1||||||MASSIND|MASS INDICATOR||||BE/ML|||MGEQ|NOT DONE||N|Y|Y|5||7||BASELINE|1968-12-21||1973-06-19|||1973-01-17||1966-12-05
TRIAL STUDY 134XCP|RP|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||MILE|||UL/DOSE|NOT DONE||Y|N|U|5||7||OPEN LABEL TREATMENT|1972-12-30||1962-02-20|||1972-09-10||1966-12-26
TRIAL STUDY 134XCP|RP|86198851-0F45-45E0-A0CE-C50FEC078456|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||CAPFUL|||ML/M2/MIN|NOT DONE||U|U|U|1||38||TREATMENT|1970-12-27||1960-07-29|||1971-12-20||1961-12-15
TRIAL STUDY 134XCP|RP|86198851-0F45-45E0-A0CE-C50FEC078456|2||||||ERYTHIND|ERYTHEMA INDICATOR||||AMFI|||NEEDLE GAUGE|NOT DONE||U|NA|Y|1||38||TREATMENT|1962-10-16||1965-04-17|||1969-03-10||1960-09-10
TRIAL STUDY 134XCP|RP|86198851-0F45-45E0-A0CE-C50FEC078456|1||||||MENFDUR|MENSES FLOW DURATION||||L/H/M2|||10^11/L|NOT DONE||N|U|U|2||58||SCREENING|1966-08-15||1966-03-27|||1961-10-13||1965-05-29
TRIAL STUDY 134XCP|RP|86198851-0F45-45E0-A0CE-C50FEC078456|2||||||TNDRIND|TENDERNESS INDICATOR||||MG/M2/DAY|||CAL|NOT DONE||NA|Y|N|2||58||TREATMENT|1967-11-30||1968-05-27|||1963-04-21||1968-02-02
TRIAL STUDY 134XCP|RP|86198851-0F45-45E0-A0CE-C50FEC078456|1||||||ABORTN|NUMBER OF ABORTIONS||||ANSON U|||NCI|NOT DONE||NA|N|NA|3||39||CONTINUATION TREATMENT|1961-12-29||1965-11-05|||1960-11-02||1968-03-30
TRIAL STUDY 134XCP|RP|86198851-0F45-45E0-A0CE-C50FEC078456|2||||||ULCERIND|ULCER INDICATOR||||KIU|||NG|NOT DONE||N|U|Y|3||39||BLINDED TREATMENT|1968-03-16||1960-03-04|||1970-09-30||1965-07-27
TRIAL STUDY 134XCP|RP|86198851-0F45-45E0-A0CE-C50FEC078456|1||||||PRGENDTC|DATE PREGNANCY ENDED||||ML/MIN|||BQ/UG|NOT DONE||NA|N|N|4||88||TREATMENT|1962-09-26||1968-12-05|||1967-04-14||1964-07-17
TRIAL STUDY 134XCP|RP|86198851-0F45-45E0-A0CE-C50FEC078456|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||SIEMENS|||UMOL/DL|NOT DONE||Y|NA|NA|4||88||LONG-TERM FOLLOW-UP|1970-01-17||1971-01-26|||1970-10-11||1968-02-24
TRIAL STUDY 134XCP|RP|86198851-0F45-45E0-A0CE-C50FEC078456|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ML/(MIN*100ML)|||PIXELS/CM|NOT DONE||U|Y|N|5||7||TREATMENT|1970-10-11||1968-02-06|||1973-08-28||1971-04-08
TRIAL STUDY 134XCP|RP|86198851-0F45-45E0-A0CE-C50FEC078456|2||||||PUSTIND|PUSTULE INDICATOR||||CI/UL|||% INHIBITION|NOT DONE||N|Y|N|5||7||TREATMENT|1966-07-24||1963-07-20|||1972-08-15||1967-06-16
TRIAL STUDY 134XCP|RP|9CD28016-BED9-4159-9C1B-60821D74615B|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||H*%|||PFU/ANIMAL|NOT DONE||N|N|N|1||38||BLINDED TREATMENT|1962-04-12||1965-04-04|||1962-05-07||1963-07-11
TRIAL STUDY 134XCP|RP|9CD28016-BED9-4159-9C1B-60821D74615B|2||||||MASSIND|MASS INDICATOR||||LX|||MOSM/L|NOT DONE||U|N|N|1||38||CONTINUATION TREATMENT|1968-11-06||1970-07-10|||1972-09-15||1964-02-10
TRIAL STUDY 134XCP|RP|9CD28016-BED9-4159-9C1B-60821D74615B|1||||||PUSTIND|PUSTULE INDICATOR||||ML/KG/DAY|||MOL/L|NOT DONE||N|U|N|2||58||FOLLOW-UP|1965-02-23||1961-07-23|||1965-11-18||1967-05-16
TRIAL STUDY 134XCP|RP|9CD28016-BED9-4159-9C1B-60821D74615B|2||||||FUNDHT|FUNDAL HEIGHT||||ATM|||OHM|NOT DONE||N|NA|NA|2||58||OPEN LABEL TREATMENT|1965-08-10||1966-08-21|||1965-12-25||1962-07-17
TRIAL STUDY 134XCP|RP|9CD28016-BED9-4159-9C1B-60821D74615B|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||FEU|||MBP|NOT DONE||U|Y|NA|3||39||CONTINUATION TREATMENT|1964-01-06||1972-05-20|||1966-03-09||1964-11-01
TRIAL STUDY 134XCP|RP|9CD28016-BED9-4159-9C1B-60821D74615B|2||||||MENFDUR|MENSES FLOW DURATION||||NG/L|||UM|NOT DONE||U|N|NA|3||39||OPEN LABEL TREATMENT|1965-10-04||1970-06-28|||1965-04-19||1970-01-10
TRIAL STUDY 134XCP|RP|9CD28016-BED9-4159-9C1B-60821D74615B|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||U/G/MIN|||JAR|NOT DONE||N|U|Y|4||88||CONTINUATION TREATMENT|1964-10-13||1969-09-20|||1972-09-29||1969-05-03
TRIAL STUDY 134XCP|RP|9CD28016-BED9-4159-9C1B-60821D74615B|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||%(W/V)|||LOG10 TCID 50/DOSE|NOT DONE||Y|U|NA|4||88||TREATMENT|1973-02-27||1964-09-12|||1968-02-24||1962-12-11
TRIAL STUDY 134XCP|RP|9CD28016-BED9-4159-9C1B-60821D74615B|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MDFI|||ML/MIN/MMHG|NOT DONE||U|Y|Y|5||7||BLINDED TREATMENT|1971-01-30||1970-11-01|||1960-02-22||1967-03-19
TRIAL STUDY 134XCP|RP|9CD28016-BED9-4159-9C1B-60821D74615B|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||GENEQ|||LOG10 IU/ML|NOT DONE||Y|N|U|5||7||BASELINE|1969-01-14||1966-09-21|||1960-07-24||1971-04-10
TRIAL STUDY 134XCP|RP|BE578D25-C23E-416F-8A57-C901F7B58596|1||||||INABOIND|INDUCED ABORTION INDICATOR||||ML/MMHG|||%|NOT DONE||U|NA|NA|1||38||BASELINE|1970-12-05||1967-08-12|||1961-08-08||1967-02-14
TRIAL STUDY 134XCP|RP|BE578D25-C23E-416F-8A57-C901F7B58596|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||ABSORBANCE U/ML|||CPM|NOT DONE||NA|N|U|1||38||LONG-TERM FOLLOW-UP|1965-10-02||1971-12-25|||1967-11-10||1962-10-01
TRIAL STUDY 134XCP|RP|BE578D25-C23E-416F-8A57-C901F7B58596|1||||||ERYTHIND|ERYTHEMA INDICATOR||||MOSM/KG|||KHZ|NOT DONE||NA|NA|Y|2||58||LONG-TERM FOLLOW-UP|1972-03-08||1972-12-15|||1965-11-24||1970-07-25
TRIAL STUDY 134XCP|RP|BE578D25-C23E-416F-8A57-C901F7B58596|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||KUSP|||MMOL/DAY|NOT DONE||N|NA|U|2||58||FOLLOW-UP|1961-07-05||1963-07-02|||1969-04-02||1972-11-07
TRIAL STUDY 134XCP|RP|BE578D25-C23E-416F-8A57-C901F7B58596|1||||||MENOSTAT|MENOPAUSE STATUS||||BQ/G|||10^9 ORGANISMS/MG|NOT DONE||U|N|Y|3||39||LONG-TERM FOLLOW-UP|1965-08-19||1962-01-13|||1967-05-04||1966-10-01
TRIAL STUDY 134XCP|RP|BE578D25-C23E-416F-8A57-C901F7B58596|2||||||INABOIND|INDUCED ABORTION INDICATOR||||ELISA UNIT/ML|||DAYS/MONTH|NOT DONE||N|U|NA|3||39||INDUCTION TREATMENT|1970-05-20||1963-01-07|||1966-02-24||1971-10-26
TRIAL STUDY 134XCP|RP|BE578D25-C23E-416F-8A57-C901F7B58596|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||10^7 TCID 50/DOSE|||MPL U/ML|NOT DONE||Y|NA|Y|4||88||FOLLOW-UP|1966-09-17||1972-10-14|||1961-08-13||1971-07-11
TRIAL STUDY 134XCP|RP|BE578D25-C23E-416F-8A57-C901F7B58596|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||10^6/HPF|||TRANSDUCING UNIT/ML|NOT DONE||U|Y|NA|4||88||FOLLOW-UP|1970-01-20||1967-04-06|||1964-09-24||1970-01-29
TRIAL STUDY 134XCP|RP|BE578D25-C23E-416F-8A57-C901F7B58596|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^7 PFU|||OZ EQ|NOT DONE||Y|N|Y|5||7||BLINDED TREATMENT|1966-03-26||1962-08-06|||1973-05-09||1972-09-27
TRIAL STUDY 134XCP|RP|BE578D25-C23E-416F-8A57-C901F7B58596|2||||||THICK|THICKNESS||||MNFI|||DIP|NOT DONE||N|Y|Y|5||7||TREATMENT|1966-03-13||1964-12-19|||1963-05-11||1971-05-30
TRIAL STUDY 134XCP|RP|A60D5FE6-26BA-487D-98E0-5F464305924C|1||||||MENFDUR|MENSES FLOW DURATION||||MCI/L|||MCI|NOT DONE||NA|N|N|1||38||CONTINUATION TREATMENT|1970-05-20||1965-11-04|||1967-11-09||1967-10-28
TRIAL STUDY 134XCP|RP|A60D5FE6-26BA-487D-98E0-5F464305924C|2||||||MENFDUR|MENSES FLOW DURATION||||UKAT/L|||/HPF|NOT DONE||Y|Y|NA|1||38||RUN-IN|1964-11-02||1970-05-11|||1962-10-10||1964-09-11
TRIAL STUDY 134XCP|RP|A60D5FE6-26BA-487D-98E0-5F464305924C|1||||||PUSTIND|PUSTULE INDICATOR||||BP|||L|NOT DONE||N|U|Y|2||58||INDUCTION TREATMENT|1967-11-24||1965-12-08|||1973-02-24||1968-04-10
TRIAL STUDY 134XCP|RP|A60D5FE6-26BA-487D-98E0-5F464305924C|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||CMH2O*S2/ML|||UMOL/DAY|NOT DONE||U|Y|U|2||58||BLINDED TREATMENT|1964-04-18||1969-07-14|||1973-02-23||1969-05-01
TRIAL STUDY 134XCP|RP|A60D5FE6-26BA-487D-98E0-5F464305924C|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MOSM/KG|||UKAT/10^12 RBC|NOT DONE||NA|Y|Y|3||39||OBSERVATION|1970-05-30||1960-12-05|||1971-11-26||1969-09-28
TRIAL STUDY 134XCP|RP|A60D5FE6-26BA-487D-98E0-5F464305924C|2||||||MASSIND|MASS INDICATOR||||INHALATION|||HOMEOPATHIC DILUTION|NOT DONE||NA|U|Y|3||39||LONG-TERM FOLLOW-UP|1963-11-20||1966-12-30|||1973-02-23||1972-03-07
TRIAL STUDY 134XCP|RP|A60D5FE6-26BA-487D-98E0-5F464305924C|1||||||BCMETHOD|BIRTH CONTROL METHOD||||MM3/MM2/YEAR|||MEQ/DAY|NOT DONE||N|U|NA|4||88||OBSERVATION|1972-06-11||1968-07-09|||1961-02-27||1965-05-17
TRIAL STUDY 134XCP|RP|A60D5FE6-26BA-487D-98E0-5F464305924C|2||||||TNDRIND|TENDERNESS INDICATOR||||LB|||MHZ|NOT DONE||Y|U|NA|4||88||SCREENING|1966-02-16||1967-11-10|||1963-01-26||1969-01-02
TRIAL STUDY 134XCP|RP|A60D5FE6-26BA-487D-98E0-5F464305924C|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MAC50|||CAL|NOT DONE||Y|N|N|5||7||SCREENING|1960-06-27||1963-04-25|||1971-02-04||1969-11-06
TRIAL STUDY 134XCP|RP|A60D5FE6-26BA-487D-98E0-5F464305924C|2||||||MASSIND|MASS INDICATOR||||G/ANIMAL|||MIN*MG/ML|NOT DONE||N|NA|N|5||7||BASELINE|1973-02-23||1966-09-03|||1970-12-08||1962-06-02
TRIAL STUDY 134XCP|RP|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|1||||||ULCERIND|ULCER INDICATOR||||MG/M2/DAY|||HENRY|NOT DONE||NA|NA|U|1||38||BLINDED TREATMENT|1971-04-25||1971-02-06|||1969-05-24||1962-07-17
TRIAL STUDY 134XCP|RP|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MOL/L|||CI/L|NOT DONE||Y|U|U|1||38||INDUCTION TREATMENT|1961-12-05||1970-08-15|||1963-10-06||1967-08-29
TRIAL STUDY 134XCP|RP|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||L/S/KPA|||MCI/KG|NOT DONE||U|NA|U|2||58||RUN-IN|1962-03-07||1969-03-09|||1967-07-10||1973-08-09
TRIAL STUDY 134XCP|RP|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||PPM|||MM/MIN|NOT DONE||N|NA|U|2||58||SCREENING|1964-05-02||1972-07-12|||1961-07-04||1964-02-06
TRIAL STUDY 134XCP|RP|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||NMOL/G|||ENZYME U/L|NOT DONE||Y|Y|Y|3||39||LONG-TERM FOLLOW-UP|1967-09-27||1966-09-01|||1962-12-26||1963-10-20
TRIAL STUDY 134XCP|RP|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||FIU|||UGEQ|NOT DONE||NA|U|U|3||39||SCREENING|1965-01-21||1968-02-05|||1964-10-12||1971-04-13
TRIAL STUDY 134XCP|RP|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||DIP|||10^6 CFU|NOT DONE||Y|Y|U|4||88||OBSERVATION|1961-06-05||1971-04-09|||1971-07-14||1970-06-20
TRIAL STUDY 134XCP|RP|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||DRAM|||FFU|NOT DONE||NA|Y|NA|4||88||INDUCTION TREATMENT|1961-09-12||1970-01-22|||1970-02-01||1973-01-29
TRIAL STUDY 134XCP|RP|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|1||||||MASSIND|MASS INDICATOR||||APS U|||ANSON U|NOT DONE||Y|N|U|5||7||OBSERVATION|1960-01-28||1968-11-06|||1973-06-26||1964-03-17
TRIAL STUDY 134XCP|RP|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|2||||||BLISTIND|BLISTERING INDICATOR||||DPM/0.5 ML|||/MM2|NOT DONE||Y|NA|N|5||7||INDUCTION TREATMENT|1967-10-10||1969-04-27|||1960-10-07||1962-11-15
TRIAL STUDY 134XCP|RP|89739AE0-A8B9-44DE-970E-9D679ED58C4F|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||PIXELS/IN|||UMOL/KG/MIN|NOT DONE||U|NA|N|1||38||CONTINUATION TREATMENT|1960-01-11||1968-09-17|||1960-12-22||1968-04-12
TRIAL STUDY 134XCP|RP|89739AE0-A8B9-44DE-970E-9D679ED58C4F|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MHZ|||UMOL/L|NOT DONE||Y|U|U|1||38||INDUCTION TREATMENT|1970-09-06||1964-12-06|||1962-02-01||1969-07-13
TRIAL STUDY 134XCP|RP|89739AE0-A8B9-44DE-970E-9D679ED58C4F|1||||||PEELIND|PEELING INDICATOR||||BQ/MG|||EJACULATE U|NOT DONE||U|U|N|2||58||FOLLOW-UP|1960-11-20||1969-09-18|||1966-01-04||1960-03-08
TRIAL STUDY 134XCP|RP|89739AE0-A8B9-44DE-970E-9D679ED58C4F|2||||||PUSTIND|PUSTULE INDICATOR||||CPM|||PMOL/G|NOT DONE||U|N|Y|2||58||SCREENING|1960-05-11||1965-09-23|||1972-05-12||1967-02-22
TRIAL STUDY 134XCP|RP|89739AE0-A8B9-44DE-970E-9D679ED58C4F|1||||||PREGIND|PREGNANT INDICATOR||||U/ANIMAL|||MMOL/G|NOT DONE||NA|NA|NA|3||39||OBSERVATION|1968-11-25||1968-01-06|||1971-01-17||1968-07-10
TRIAL STUDY 134XCP|RP|89739AE0-A8B9-44DE-970E-9D679ED58C4F|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UG/CM2|||GBQ|NOT DONE||U|NA|NA|3||39||TREATMENT|1973-08-10||1968-01-20|||1972-03-20||1971-04-03
TRIAL STUDY 134XCP|RP|89739AE0-A8B9-44DE-970E-9D679ED58C4F|1||||||INTP|INTERPRETATION||||NMOL/L/MIN|||%(W/W)|NOT DONE||N|Y|NA|4||88||CONTINUATION TREATMENT|1968-11-17||1967-06-21|||1963-04-22||1963-07-10
TRIAL STUDY 134XCP|RP|89739AE0-A8B9-44DE-970E-9D679ED58C4F|2||||||ABORTN|NUMBER OF ABORTIONS||||GRAIN|||ML/ANIMAL|NOT DONE||N|U|Y|4||88||FOLLOW-UP|1972-12-28||1963-03-11|||1965-07-28||1970-02-10
TRIAL STUDY 134XCP|RP|89739AE0-A8B9-44DE-970E-9D679ED58C4F|1||||||EDEMAIND|EDEMA INDICATOR||||DPM/100MG|||LOG10 CFU/G|NOT DONE||N|U|Y|5||7||LONG-TERM FOLLOW-UP|1960-04-18||1965-05-08|||1963-07-12||1970-11-07
TRIAL STUDY 134XCP|RP|89739AE0-A8B9-44DE-970E-9D679ED58C4F|2||||||TNDRIND|TENDERNESS INDICATOR||||NKAT/L|||MM/MIN|NOT DONE||U|N|N|5||7||CONTINUATION TREATMENT|1970-09-25||1972-02-13|||1971-04-13||1970-08-02
TRIAL STUDY 134XCP|RP|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|1||||||TNDRIND|TENDERNESS INDICATOR||||NMOL BCE/MMOL|||NG/DAY|NOT DONE||N|Y|Y|1||38||RUN-IN|1960-03-09||1970-11-20|||1966-05-14||1965-07-03
TRIAL STUDY 134XCP|RP|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|2||||||PRGENDTC|DATE PREGNANCY ENDED||||10^7 TCID 50/DOSE|||FG|NOT DONE||U|N|N|1||38||OBSERVATION|1962-04-04||1969-05-25|||1965-09-19||1960-11-07
TRIAL STUDY 134XCP|RP|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||PACKAGE|||GENEQ|NOT DONE||Y|NA|U|2||58||OBSERVATION|1966-10-26||1961-02-05|||1971-03-07||1970-10-21
TRIAL STUDY 134XCP|RP|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||ML/S/M2|||V|NOT DONE||NA|N|N|2||58||TREATMENT|1963-04-09||1966-01-30|||1971-12-22||1963-09-03
TRIAL STUDY 134XCP|RP|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|1||||||MASSIND|MASS INDICATOR||||INHALATION|||MG|NOT DONE||U|U|N|3||39||BLINDED TREATMENT|1973-07-16||1969-01-06|||1961-03-03||1962-07-13
TRIAL STUDY 134XCP|RP|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||NMOL/G|||CARTRIDGE|NOT DONE||NA|U|U|3||39||SCREENING|1969-07-08||1969-01-02|||1967-12-03||1968-10-16
TRIAL STUDY 134XCP|RP|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||LOG10 TCID 50/DOSE|||AMU|NOT DONE||NA|N|NA|4||88||LONG-TERM FOLLOW-UP|1972-04-23||1969-02-16|||1973-05-10||1969-09-24
TRIAL STUDY 134XCP|RP|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||AMU|||MG/M2/DAY|NOT DONE||U|U|Y|4||88||CONTINUATION TREATMENT|1968-02-08||1961-02-07|||1967-10-03||1971-05-30
TRIAL STUDY 134XCP|RP|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MG/G/H|||ML/MMHG/MIN/L|NOT DONE||NA|N|N|5||7||INDUCTION TREATMENT|1963-11-25||1967-08-28|||1970-12-21||1965-05-22
TRIAL STUDY 134XCP|RP|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|2||||||ULCERIND|ULCER INDICATOR||||ELISA UNIT/DOSE|||MEQ/ML|NOT DONE||U|NA|NA|5||7||BLINDED TREATMENT|1962-02-18||1962-04-06|||1969-04-16||1963-11-05
TRIAL STUDY 134XCP|RP|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||PKAT|||LOG10 IU/ML|NOT DONE||Y|Y|U|1||38||INDUCTION TREATMENT|1970-05-30||1968-10-12|||1970-12-13||1973-08-15
TRIAL STUDY 134XCP|RP|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|2||||||DSCHGIND|DISCHARGE INDICATOR||||GENEQ/ML|||JDF UNIT|NOT DONE||U|N|U|1||38||RUN-IN|1962-05-30||1960-03-29|||1967-10-01||1961-03-30
TRIAL STUDY 134XCP|RP|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|1||||||PUSTIND|PUSTULE INDICATOR||||UG/CM2|||LOG10 TCID 50/UL|NOT DONE||N|Y|U|2||58||RUN-IN|1964-11-22||1962-01-08|||1963-07-21||1971-12-14
TRIAL STUDY 134XCP|RP|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|2||||||PREGST|PREGNANT DURING THE STUDY||||CL|||ML/CAGE/DAY|NOT DONE||N|Y|U|2||58||OBSERVATION|1972-08-03||1962-10-18|||1961-05-17||1970-11-17
TRIAL STUDY 134XCP|RP|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||APL U/ML|||VP/DOSE|NOT DONE||Y|U|U|3||39||WASHOUT|1969-02-24||1971-02-01|||1967-07-03||1968-03-06
TRIAL STUDY 134XCP|RP|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||NKAT/G HB|||MPL U|NOT DONE||Y|Y|Y|3||39||CONTINUATION TREATMENT|1964-10-26||1968-10-27|||1961-11-18||1972-05-04
TRIAL STUDY 134XCP|RP|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|1||||||ULCERIND|ULCER INDICATOR||||SHOCK WAVE|||DIOPTER|NOT DONE||Y|U|N|4||88||RUN-IN|1960-05-22||1970-04-29|||1961-06-25||1973-06-21
TRIAL STUDY 134XCP|RP|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|2||||||PREGIND|PREGNANT INDICATOR||||UG/H|||MBQ/UL|NOT DONE||NA|N|N|4||88||OBSERVATION|1965-07-04||1966-07-28|||1965-08-28||1966-06-07
TRIAL STUDY 134XCP|RP|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||HENRY|||UCI/KG|NOT DONE||U|N|U|5||7||BLINDED TREATMENT|1969-03-04||1963-10-19|||1973-06-14||1972-04-17
TRIAL STUDY 134XCP|RP|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UOSM|||NMOL/KG/DAY|NOT DONE||N|N|NA|5||7||SCREENING|1969-01-10||1971-09-08|||1973-08-25||1964-06-30
TRIAL STUDY 134XCP|RP|CED88848-769E-41C1-9ACD-99E45766D27B|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||/MBP|||LOG10 IU/ML|NOT DONE||Y|Y|NA|1||38||LONG-TERM FOLLOW-UP|1968-06-07||1968-02-28|||1972-11-01||1963-05-05
TRIAL STUDY 134XCP|RP|CED88848-769E-41C1-9ACD-99E45766D27B|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UG/MIN|||CM2|NOT DONE||NA|NA|N|1||38||RUN-IN|1965-04-11||1969-09-16|||1973-04-19||1961-09-03
TRIAL STUDY 134XCP|RP|CED88848-769E-41C1-9ACD-99E45766D27B|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||UV2|||AMPULE|NOT DONE||N|NA|NA|2||58||OPEN LABEL TREATMENT|1965-08-09||1963-12-25|||1970-01-26||1964-09-11
TRIAL STUDY 134XCP|RP|CED88848-769E-41C1-9ACD-99E45766D27B|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||G/L|||10^10/L|NOT DONE||Y|N|NA|2||58||LONG-TERM FOLLOW-UP|1960-03-24||1967-09-14|||1962-12-30||1961-02-25
TRIAL STUDY 134XCP|RP|CED88848-769E-41C1-9ACD-99E45766D27B|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||KV|||BQ/KG|NOT DONE||Y|Y|U|3||39||WASHOUT|1971-10-09||1965-05-27|||1963-08-26||1973-09-08
TRIAL STUDY 134XCP|RP|CED88848-769E-41C1-9ACD-99E45766D27B|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||MMU/ML|||COPIES/UL|NOT DONE||Y|U|Y|3||39||TREATMENT|1963-02-01||1960-05-05|||1964-05-03||1968-08-22
TRIAL STUDY 134XCP|RP|CED88848-769E-41C1-9ACD-99E45766D27B|1||||||THICK|THICKNESS||||MJOULE/CM2|||DEG/S|NOT DONE||NA|NA|Y|4||88||INDUCTION TREATMENT|1966-09-25||1962-06-09|||1965-05-07||1966-09-23
TRIAL STUDY 134XCP|RP|CED88848-769E-41C1-9ACD-99E45766D27B|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||KBQ/UL|||HENRY|NOT DONE||Y|Y|U|4||88||INDUCTION TREATMENT|1964-05-24||1969-04-19|||1968-12-28||1969-01-21
TRIAL STUDY 134XCP|RP|CED88848-769E-41C1-9ACD-99E45766D27B|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||CMH2O*S2/ML|||UL/ML|NOT DONE||N|U|U|5||7||FOLLOW-UP|1968-03-08||1968-09-29|||1964-08-30||1969-08-09
TRIAL STUDY 134XCP|RP|CED88848-769E-41C1-9ACD-99E45766D27B|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||/MS|||CAL|NOT DONE||NA|NA|NA|5||7||OBSERVATION|1973-05-10||1973-06-30|||1968-04-23||1967-08-29
TRIAL STUDY 134XCP|RP|E7958F8B-D987-4929-993A-8960EB30A309|1||||||BLISTIND|BLISTERING INDICATOR||||10^6 ORGANISMS/ML|||DEG/MM|NOT DONE||U|N|Y|1||38||RUN-IN|1970-03-09||1962-11-26|||1969-01-07||1961-03-26
TRIAL STUDY 134XCP|RP|E7958F8B-D987-4929-993A-8960EB30A309|2||||||DLVRMODE|MODE OF DELIVERY||||STRIP|||PFU|NOT DONE||U|U|NA|1||38||OPEN LABEL TREATMENT|1972-05-27||1973-08-07|||1968-12-27||1962-01-29
TRIAL STUDY 134XCP|RP|E7958F8B-D987-4929-993A-8960EB30A309|1||||||ERYTHIND|ERYTHEMA INDICATOR||||UGEQ|||MANSON U/ML|NOT DONE||NA|N|Y|2||58||BLINDED TREATMENT|1966-04-15||1960-09-16|||1973-02-13||1964-04-24
TRIAL STUDY 134XCP|RP|E7958F8B-D987-4929-993A-8960EB30A309|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||NMOL/DAY|||GTT|NOT DONE||Y|U|NA|2||58||BASELINE|1972-01-30||1967-02-12|||1961-04-15||1969-08-03
TRIAL STUDY 134XCP|RP|E7958F8B-D987-4929-993A-8960EB30A309|1||||||BCMETHOD|BIRTH CONTROL METHOD||||PPTR|||DL|NOT DONE||U|U|NA|3||39||SCREENING|1964-08-12||1968-06-21|||1973-06-27||1969-11-08
TRIAL STUDY 134XCP|RP|E7958F8B-D987-4929-993A-8960EB30A309|2||||||BLISTIND|BLISTERING INDICATOR||||UMOL/L/MIN|||G/DAY|NOT DONE||N|NA|N|3||39||TREATMENT|1961-01-26||1965-12-15|||1964-10-19||1972-03-19
TRIAL STUDY 134XCP|RP|E7958F8B-D987-4929-993A-8960EB30A309|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||G/CM2|||KG/M2|NOT DONE||NA|N|U|4||88||LONG-TERM FOLLOW-UP|1971-12-28||1960-06-16|||1966-04-24||1960-06-17
TRIAL STUDY 134XCP|RP|E7958F8B-D987-4929-993A-8960EB30A309|2||||||ABORTN|NUMBER OF ABORTIONS||||UG/M2/H|||USEC|NOT DONE||NA|N|N|4||88||SCREENING|1966-10-01||1961-03-20|||1968-01-20||1968-03-20
TRIAL STUDY 134XCP|RP|E7958F8B-D987-4929-993A-8960EB30A309|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||L/S/KPA|||DIP|NOT DONE||N|Y|NA|5||7||SCREENING|1970-05-09||1969-05-17|||1964-05-22||1963-03-27
TRIAL STUDY 134XCP|RP|E7958F8B-D987-4929-993A-8960EB30A309|2||||||GRAVIND|GRAVIDA INDICATOR||||CD/M2|||LINEAR FT*LB|NOT DONE||N|U|NA|5||7||INDUCTION TREATMENT|1968-04-22||1970-03-08|||1963-03-01||1969-10-25
TRIAL STUDY 134XCP|RP|A633D973-B611-4014-A43E-C8C2D21DBFC2|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||APL U|||NG/MOL|NOT DONE||U|N|Y|1||38||TREATMENT|1961-10-05||1967-12-14|||1968-02-08||1962-02-03
TRIAL STUDY 134XCP|RP|A633D973-B611-4014-A43E-C8C2D21DBFC2|2||||||MENFDUR|MENSES FLOW DURATION||||BEAM BREAKS|||/MM|NOT DONE||NA|NA|N|1||38||TREATMENT|1966-02-27||1967-09-18|||1960-02-09||1968-03-19
TRIAL STUDY 134XCP|RP|A633D973-B611-4014-A43E-C8C2D21DBFC2|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||UV2|||DEG2|NOT DONE||U|Y|Y|2||58||FOLLOW-UP|1967-08-30||1967-08-15|||1962-04-25||1968-02-06
TRIAL STUDY 134XCP|RP|A633D973-B611-4014-A43E-C8C2D21DBFC2|2||||||ERYTHIND|ERYTHEMA INDICATOR||||LB|||V/V|NOT DONE||Y|Y|NA|2||58||LONG-TERM FOLLOW-UP|1968-09-09||1971-08-17|||1971-07-13||1968-05-10
TRIAL STUDY 134XCP|RP|A633D973-B611-4014-A43E-C8C2D21DBFC2|1||||||PUSTIND|PUSTULE INDICATOR||||CD/M2|||MG/M2/DAY|NOT DONE||N|Y|NA|3||39||CONTINUATION TREATMENT|1967-03-06||1963-10-05|||1965-02-27||1967-08-12
TRIAL STUDY 134XCP|RP|A633D973-B611-4014-A43E-C8C2D21DBFC2|2||||||PEELIND|PEELING INDICATOR||||CFU/ML|||DAGU|NOT DONE||N|N|Y|3||39||CONTINUATION TREATMENT|1969-06-11||1963-11-13|||1961-11-24||1968-09-07
TRIAL STUDY 134XCP|RP|A633D973-B611-4014-A43E-C8C2D21DBFC2|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MG/ANIMAL|||CI/G|NOT DONE||NA|NA|Y|4||88||BASELINE|1970-08-15||1964-07-15|||1966-09-10||1973-06-27
TRIAL STUDY 134XCP|RP|A633D973-B611-4014-A43E-C8C2D21DBFC2|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UG/G/MIN|||BP|NOT DONE||Y|Y|Y|4||88||INDUCTION TREATMENT|1966-09-30||1965-06-10|||1973-06-09||1968-06-30
TRIAL STUDY 134XCP|RP|A633D973-B611-4014-A43E-C8C2D21DBFC2|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||CD|||LOG10 CCID 50/DOSE|NOT DONE||Y|NA|N|5||7||BLINDED TREATMENT|1968-05-11||1968-09-18|||1966-09-04||1963-11-18
TRIAL STUDY 134XCP|RP|A633D973-B611-4014-A43E-C8C2D21DBFC2|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||10^8/L|||PFU/ANIMAL|NOT DONE||U|Y|Y|5||7||OPEN LABEL TREATMENT|1960-12-04||1962-10-25|||1971-05-23||1961-02-15
TRIAL STUDY 134XCP|RP|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||CYLINDER|||ELISA UNIT/ML|NOT DONE||U|N|U|1||38||SCREENING|1966-02-06||1967-09-15|||1963-02-06||1962-10-08
TRIAL STUDY 134XCP|RP|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||CI/KG|||KHZ|NOT DONE||U|Y|U|1||38||OBSERVATION|1970-10-05||1968-11-16|||1967-09-30||1964-08-09
TRIAL STUDY 134XCP|RP|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||BAU|||UMOL/H/MMOL|NOT DONE||U|Y|N|2||58||CONTINUATION TREATMENT|1962-09-04||1972-10-06|||1968-11-13||1972-01-29
TRIAL STUDY 134XCP|RP|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||APPLICATION|||UG/M2/DAY|NOT DONE||U|U|U|2||58||OPEN LABEL TREATMENT|1962-06-10||1967-09-19|||1962-12-19||1968-08-29
TRIAL STUDY 134XCP|RP|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|1||||||ERYTHIND|ERYTHEMA INDICATOR||||PMOL/10^9 CELLS|||FG|NOT DONE||NA|U|Y|3||39||RUN-IN|1964-08-26||1960-12-21|||1969-01-01||1963-01-11
TRIAL STUDY 134XCP|RP|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||AU/ML|||HENRY|NOT DONE||Y|NA|N|3||39||BASELINE|1962-08-10||1960-08-15|||1967-08-09||1962-07-03
TRIAL STUDY 134XCP|RP|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|1||||||DLVRMODE|MODE OF DELIVERY||||G/ANIMAL|||MIN|NOT DONE||Y|U|N|4||88||OPEN LABEL TREATMENT|1963-11-15||1963-11-13|||1970-06-28||1968-12-13
TRIAL STUDY 134XCP|RP|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MOL/G|||IU/KG/H|NOT DONE||N|N|Y|4||88||OBSERVATION|1960-01-17||1962-04-27|||1970-06-18||1971-03-02
TRIAL STUDY 134XCP|RP|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|1||||||PREGST|PREGNANT DURING THE STUDY||||TORR|||CUP EQ|NOT DONE||N|NA|Y|5||7||WASHOUT|1961-07-29||1960-11-27|||1962-07-01||1960-02-05
TRIAL STUDY 134XCP|RP|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|2||||||RASHIND|RASH INDICATOR||||TUBERCULIN UNIT|||H*%|NOT DONE||U|Y|NA|5||7||BLINDED TREATMENT|1965-04-09||1960-06-02|||1961-01-06||1970-09-10
TRIAL STUDY 134XCP|RP|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MS/MMHG|||KN/CM2|NOT DONE||Y|N|U|1||38||OPEN LABEL TREATMENT|1966-11-21||1971-08-21|||1960-07-19||1968-02-21
TRIAL STUDY 134XCP|RP|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|2||||||MENARAGE|MENARCHE AGE||||/500 WBC|||MNFI|NOT DONE||NA|N|NA|1||38||WASHOUT|1967-07-15||1973-06-19|||1970-10-29||1962-01-02
TRIAL STUDY 134XCP|RP|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||POINT|||10^6 ORGANISMS/G|NOT DONE||N|N|NA|2||58||TREATMENT|1967-03-08||1964-02-12|||1968-02-20||1961-08-02
TRIAL STUDY 134XCP|RP|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|2||||||ULCERIND|ULCER INDICATOR||||NMOL/L|||BEATS/MIN|NOT DONE||NA|Y|N|2||58||OPEN LABEL TREATMENT|1961-06-18||1963-09-03|||1966-05-27||1963-08-17
TRIAL STUDY 134XCP|RP|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UG/G/DAY|||PFU/ANIMAL|NOT DONE||Y|N|NA|3||39||CONTINUATION TREATMENT|1969-10-18||1966-08-19|||1962-09-23||1969-05-28
TRIAL STUDY 134XCP|RP|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||CM2|||GBQ/UG|NOT DONE||NA|Y|N|3||39||INDUCTION TREATMENT|1960-04-28||1965-02-06|||1971-09-30||1970-02-26
TRIAL STUDY 134XCP|RP|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|1||||||MENFDUR|MENSES FLOW DURATION||||DPM/100MG|||INHALATION|NOT DONE||Y|Y|NA|4||88||RUN-IN|1969-08-20||1960-03-28|||1962-11-10||1961-07-20
TRIAL STUDY 134XCP|RP|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/G/DAY|||UG|NOT DONE||U|NA|Y|4||88||LONG-TERM FOLLOW-UP|1973-06-21||1961-12-10|||1973-03-02||1969-03-26
TRIAL STUDY 134XCP|RP|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||PA|||MMOL/G|NOT DONE||Y|NA|U|5||7||WASHOUT|1967-07-06||1968-12-24|||1970-04-01||1971-09-02
TRIAL STUDY 134XCP|RP|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UMOL/DL|||UMOL/MIN|NOT DONE||Y|N|Y|5||7||LONG-TERM FOLLOW-UP|1964-10-22||1969-09-10|||1961-06-08||1966-08-09
TRIAL STUDY 134XCP|RP|264AA652-A25E-43CE-A54F-6FEB54AB62F3|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||SFC/10^6 PBMC|||MG/DOSE|NOT DONE||U|N|N|1||38||SCREENING|1972-06-13||1963-09-02|||1960-12-26||1965-06-10
TRIAL STUDY 134XCP|RP|264AA652-A25E-43CE-A54F-6FEB54AB62F3|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||OSM|||PACK YEAR|NOT DONE||N|Y|N|1||38||RUN-IN|1963-01-08||1965-09-06|||1971-08-04||1972-06-01
TRIAL STUDY 134XCP|RP|264AA652-A25E-43CE-A54F-6FEB54AB62F3|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^7/L|||10^3 RNA COPIES/ML|NOT DONE||NA|Y|NA|2||58||OBSERVATION|1963-11-03||1971-12-12|||1965-03-29||1966-11-03
TRIAL STUDY 134XCP|RP|264AA652-A25E-43CE-A54F-6FEB54AB62F3|2||||||MASSIND|MASS INDICATOR||||/200 HPFS|||GENEQ|NOT DONE||Y|U|Y|2||58||WASHOUT|1972-12-08||1972-08-31|||1972-06-19||1970-06-09
TRIAL STUDY 134XCP|RP|264AA652-A25E-43CE-A54F-6FEB54AB62F3|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||PL|||/10^4|NOT DONE||Y|U|N|3||39||BASELINE|1967-10-03||1966-04-06|||1962-09-22||1960-06-19
TRIAL STUDY 134XCP|RP|264AA652-A25E-43CE-A54F-6FEB54AB62F3|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||ML/ANIMAL|||MESF|NOT DONE||U|Y|NA|3||39||TREATMENT|1967-06-08||1965-08-25|||1960-11-02||1973-01-10
TRIAL STUDY 134XCP|RP|264AA652-A25E-43CE-A54F-6FEB54AB62F3|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||KUSP|||MG/DOSE|NOT DONE||Y|Y|U|4||88||SCREENING|1963-04-10||1970-02-09|||1970-03-24||1967-07-06
TRIAL STUDY 134XCP|RP|264AA652-A25E-43CE-A54F-6FEB54AB62F3|2||||||TNDRIND|TENDERNESS INDICATOR||||UMOL/L|||L/H/M2|NOT DONE||N|NA|Y|4||88||LONG-TERM FOLLOW-UP|1966-11-30||1972-11-16|||1967-10-23||1970-12-08
TRIAL STUDY 134XCP|RP|264AA652-A25E-43CE-A54F-6FEB54AB62F3|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^6 CFU|||SQU/ML|NOT DONE||Y|Y|Y|5||7||BASELINE|1973-04-26||1971-11-24|||1970-08-04||1967-04-03
TRIAL STUDY 134XCP|RP|264AA652-A25E-43CE-A54F-6FEB54AB62F3|2||||||GRAVIND|GRAVIDA INDICATOR||||UL/KG/DAY|||MJOULE/CM2|NOT DONE||U|NA|Y|5||7||BLINDED TREATMENT|1962-05-15||1971-06-02|||1969-09-11||1963-04-05
TRIAL STUDY 134XCP|RP|4DE042DC-2F1E-425C-BA36-F64A3493CE76|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||F|||%/MIN|NOT DONE||N|U|Y|1||38||TREATMENT|1965-11-05||1960-06-14|||1969-01-01||1965-10-15
TRIAL STUDY 134XCP|RP|4DE042DC-2F1E-425C-BA36-F64A3493CE76|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||/10^5|||PA|NOT DONE||Y|NA|U|1||38||BASELINE|1967-04-20||1969-03-14|||1960-11-11||1972-01-16
TRIAL STUDY 134XCP|RP|4DE042DC-2F1E-425C-BA36-F64A3493CE76|1||||||PREGIND|PREGNANT INDICATOR||||/LPF|||% INHIBITION|NOT DONE||Y|N|NA|2||58||CONTINUATION TREATMENT|1972-11-16||1970-04-30|||1962-08-15||1963-09-13
TRIAL STUDY 134XCP|RP|4DE042DC-2F1E-425C-BA36-F64A3493CE76|2||||||MENARAGE|MENARCHE AGE||||MCI|||CGY|NOT DONE||N|Y|N|2||58||FOLLOW-UP|1962-06-20||1962-10-23|||1961-06-13||1973-03-23
TRIAL STUDY 134XCP|RP|4DE042DC-2F1E-425C-BA36-F64A3493CE76|1||||||GRAVIND|GRAVIDA INDICATOR||||UV*SEC|||IU/MG|NOT DONE||U|NA|U|3||39||BLINDED TREATMENT|1962-03-28||1961-09-28|||1962-01-11||1967-04-29
TRIAL STUDY 134XCP|RP|4DE042DC-2F1E-425C-BA36-F64A3493CE76|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UG/DOSE|||UEQ/L|NOT DONE||NA|Y|U|3||39||CONTINUATION TREATMENT|1972-04-15||1961-08-07|||1961-06-27||1971-02-10
TRIAL STUDY 134XCP|RP|4DE042DC-2F1E-425C-BA36-F64A3493CE76|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||IU/MMOL|||10^6/G|NOT DONE||N|U|Y|4||88||OBSERVATION|1973-03-08||1969-10-25|||1963-05-26||1960-04-08
TRIAL STUDY 134XCP|RP|4DE042DC-2F1E-425C-BA36-F64A3493CE76|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MOL/MG|||CI/L|NOT DONE||NA|U|N|4||88||CONTINUATION TREATMENT|1962-04-23||1963-03-09|||1967-11-03||1965-11-07
TRIAL STUDY 134XCP|RP|4DE042DC-2F1E-425C-BA36-F64A3493CE76|1||||||BCMETHOD|BIRTH CONTROL METHOD||||PELLET|||L/H|NOT DONE||Y|NA|U|5||7||INDUCTION TREATMENT|1972-02-14||1970-03-01|||1961-07-18||1965-12-04
TRIAL STUDY 134XCP|RP|4DE042DC-2F1E-425C-BA36-F64A3493CE76|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||BAR|||FEU|NOT DONE||Y|Y|NA|5||7||SCREENING|1966-07-01||1967-12-03|||1964-07-16||1963-03-24
TRIAL STUDY 134XCP|RP|872942E9-A575-4929-9B21-D30DE51B367B|1||||||TNDRIND|TENDERNESS INDICATOR||||MEQ/UG|||FRACTION OF 1|NOT DONE||N|NA|NA|1||38||INDUCTION TREATMENT|1962-09-07||1962-09-14|||1966-11-22||1971-08-19
TRIAL STUDY 134XCP|RP|872942E9-A575-4929-9B21-D30DE51B367B|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||DRUM|||MMOL/DAY|NOT DONE||U|Y|N|1||38||WASHOUT|1965-12-01||1960-09-06|||1960-03-22||1966-11-25
TRIAL STUDY 134XCP|RP|872942E9-A575-4929-9B21-D30DE51B367B|1||||||PREGST|PREGNANT DURING THE STUDY||||DEG|||HOURS|NOT DONE||Y|N|U|2||58||CONTINUATION TREATMENT|1965-10-02||1968-10-06|||1973-01-08||1960-12-26
TRIAL STUDY 134XCP|RP|872942E9-A575-4929-9B21-D30DE51B367B|2||||||PEELIND|PEELING INDICATOR||||DEG/MM|||MJOULE/CM2|NOT DONE||N|Y|NA|2||58||OBSERVATION|1966-03-03||1971-09-19|||1967-04-30||1969-07-10
TRIAL STUDY 134XCP|RP|872942E9-A575-4929-9B21-D30DE51B367B|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||LOG10 ELISA UNIT|||UCI/L|NOT DONE||U|U|Y|3||39||SCREENING|1962-05-02||1968-05-03|||1971-05-07||1963-07-07
TRIAL STUDY 134XCP|RP|872942E9-A575-4929-9B21-D30DE51B367B|2||||||MASSIND|MASS INDICATOR||||BU/ML|||KM/H|NOT DONE||U|NA|N|3||39||OBSERVATION|1961-12-26||1969-10-19|||1962-04-29||1961-03-04
TRIAL STUDY 134XCP|RP|872942E9-A575-4929-9B21-D30DE51B367B|1||||||ABORTN|NUMBER OF ABORTIONS||||GBQ/MG|||ANSON U|NOT DONE||U|NA|Y|4||88||OPEN LABEL TREATMENT|1965-10-25||1963-06-11|||1960-06-17||1971-09-10
TRIAL STUDY 134XCP|RP|872942E9-A575-4929-9B21-D30DE51B367B|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ML/CM H2O|||SPRAY|NOT DONE||NA|Y|U|4||88||LONG-TERM FOLLOW-UP|1968-04-22||1971-08-11|||1969-05-19||1966-06-29
TRIAL STUDY 134XCP|RP|872942E9-A575-4929-9B21-D30DE51B367B|1||||||PEELIND|PEELING INDICATOR||||ML/KG|||SCM|NOT DONE||U|NA|N|5||7||FOLLOW-UP|1963-05-19||1961-08-30|||1965-10-29||1961-05-16
TRIAL STUDY 134XCP|RP|872942E9-A575-4929-9B21-D30DE51B367B|2||||||DLVRMODE|MODE OF DELIVERY||||U/ANIMAL|||SUPPOSITORY|NOT DONE||N|NA|U|5||7||OPEN LABEL TREATMENT|1965-03-21||1966-03-24|||1972-07-25||1964-05-18
TRIAL STUDY 134XCP|RP|628822F3-4983-44F8-B98D-7A35AAFF2962|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||KDA|||ML/M2/MIN|NOT DONE||U|Y|Y|1||38||WASHOUT|1962-03-22||1970-04-12|||1966-07-09||1970-11-03
TRIAL STUDY 134XCP|RP|628822F3-4983-44F8-B98D-7A35AAFF2962|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MOL/ML|||TROCHE|NOT DONE||N|N|N|1||38||BLINDED TREATMENT|1970-05-26||1970-09-12|||1968-02-10||1969-04-24
TRIAL STUDY 134XCP|RP|628822F3-4983-44F8-B98D-7A35AAFF2962|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||CMH2O/ML|||MMHG/L/MIN|NOT DONE||Y|U|NA|2||58||TREATMENT|1969-01-09||1966-02-06|||1967-02-27||1969-12-10
TRIAL STUDY 134XCP|RP|628822F3-4983-44F8-B98D-7A35AAFF2962|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MMOL2/L2|||CM/S|NOT DONE||N|Y|Y|2||58||BLINDED TREATMENT|1969-11-23||1961-03-28|||1971-08-12||1971-06-24
TRIAL STUDY 134XCP|RP|628822F3-4983-44F8-B98D-7A35AAFF2962|1||||||ABORTN|NUMBER OF ABORTIONS||||UG/DL|||G/CAGE/WK|NOT DONE||U|NA|N|3||39||CONTINUATION TREATMENT|1973-03-18||1973-05-03|||1964-07-04||1973-03-15
TRIAL STUDY 134XCP|RP|628822F3-4983-44F8-B98D-7A35AAFF2962|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||M|||10^6 ORGANISMS/ML|NOT DONE||Y|Y|N|3||39||LONG-TERM FOLLOW-UP|1960-02-18||1961-04-04|||1970-12-08||1971-10-01
TRIAL STUDY 134XCP|RP|628822F3-4983-44F8-B98D-7A35AAFF2962|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||COULOMB|||G/KG/DAY|NOT DONE||N|U|N|4||88||FOLLOW-UP|1968-04-30||1965-12-31|||1970-12-28||1966-10-14
TRIAL STUDY 134XCP|RP|628822F3-4983-44F8-B98D-7A35AAFF2962|2||||||THICK|THICKNESS||||LOG10 ELISA UNIT|||ML/CAGE/DAY|NOT DONE||N|U|NA|4||88||CONTINUATION TREATMENT|1962-09-12||1968-06-26|||1966-11-05||1961-11-20
TRIAL STUDY 134XCP|RP|628822F3-4983-44F8-B98D-7A35AAFF2962|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^3 RNA COPIES/ML|||MOSM|NOT DONE||U|NA|Y|5||7||TREATMENT|1961-12-06||1972-12-22|||1973-01-07||1965-11-09
TRIAL STUDY 134XCP|RP|628822F3-4983-44F8-B98D-7A35AAFF2962|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||NMOL|||L/S|NOT DONE||U|N|NA|5||7||RUN-IN|1968-05-08||1966-11-16|||1968-08-31||1962-06-29
TRIAL STUDY 134XCP|RP|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|1||||||BRTHN|NUMBER OF BIRTHS||||/10^4|||ML/MIN/1.73M2|NOT DONE||Y|N|N|1||38||INDUCTION TREATMENT|1973-03-22||1969-11-26|||1962-10-14||1962-08-13
TRIAL STUDY 134XCP|RP|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||H*%|||10^6 ORGANISMS|NOT DONE||U|Y|Y|1||38||CONTINUATION TREATMENT|1967-11-28||1964-02-25|||1960-02-22||1972-12-27
TRIAL STUDY 134XCP|RP|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||ANTIBODY UNIT|||MIN*MG/ML|NOT DONE||U|U|NA|2||58||RUN-IN|1961-08-22||1968-09-13|||1963-09-17||1963-10-12
TRIAL STUDY 134XCP|RP|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||FMOL/L|||APL U/ML|NOT DONE||NA|Y|Y|2||58||LONG-TERM FOLLOW-UP|1966-10-24||1960-08-10|||1971-04-22||1965-08-29
TRIAL STUDY 134XCP|RP|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|1||||||STILBIND|STILLBIRTH INDICATOR||||ML/KG/MIN|||ML/MIN/1.73M2|NOT DONE||U|N|N|3||39||LONG-TERM FOLLOW-UP|1972-12-27||1968-12-21|||1972-01-27||1971-09-30
TRIAL STUDY 134XCP|RP|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|2||||||MENFDUR|MENSES FLOW DURATION||||CGY|||UL/KG/DAY|NOT DONE||Y|NA|NA|3||39||WASHOUT|1963-06-07||1967-06-29|||1963-10-21||1960-02-29
TRIAL STUDY 134XCP|RP|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MM3/MM2/YEAR|||OZ|NOT DONE||U|U|NA|4||88||OPEN LABEL TREATMENT|1965-04-16||1970-09-03|||1970-10-30||1971-05-29
TRIAL STUDY 134XCP|RP|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|2||||||EDEMAIND|EDEMA INDICATOR||||/MM|||VG/KG|NOT DONE||U|NA|U|4||88||INDUCTION TREATMENT|1966-12-31||1961-01-14|||1964-06-07||1969-05-19
TRIAL STUDY 134XCP|RP|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||BAU/ML|||EID 50/ML|NOT DONE||Y|Y|NA|5||7||LONG-TERM FOLLOW-UP|1965-07-12||1968-09-09|||1968-10-18||1969-01-09
TRIAL STUDY 134XCP|RP|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|2||||||MASSIND|MASS INDICATOR||||/10^5|||CMOL/L|NOT DONE||NA|N|N|5||7||LONG-TERM FOLLOW-UP|1962-10-23||1970-10-22|||1971-12-30||1969-03-11
TRIAL STUDY 134XCP|RP|6045DFAB-0734-4E6D-A492-34BD613EC783|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||ML/KG/DAY|||SUPPOSITORY|NOT DONE||N|NA|Y|1||38||TREATMENT|1960-06-29||1971-06-25|||1960-01-06||1973-03-05
TRIAL STUDY 134XCP|RP|6045DFAB-0734-4E6D-A492-34BD613EC783|2||||||MASSIND|MASS INDICATOR||||GPELISA UNIT/ML|||AGU/ML|NOT DONE||Y|N|NA|1||38||CONTINUATION TREATMENT|1972-08-10||1971-03-12|||1971-11-08||1961-04-17
TRIAL STUDY 134XCP|RP|6045DFAB-0734-4E6D-A492-34BD613EC783|1||||||DLVRMODE|MODE OF DELIVERY||||10^6/HPF|||10^9/G|NOT DONE||N|U|NA|2||58||SCREENING|1961-12-14||1971-09-17|||1962-12-24||1971-12-15
TRIAL STUDY 134XCP|RP|6045DFAB-0734-4E6D-A492-34BD613EC783|2||||||PREGNN|NUMBER OF PREGNANCIES||||MG/MIN|||PT_US|NOT DONE||U|NA|Y|2||58||RUN-IN|1967-12-23||1964-08-14|||1961-01-24||1970-11-04
TRIAL STUDY 134XCP|RP|6045DFAB-0734-4E6D-A492-34BD613EC783|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||PT_BR|||10^7 TCID 50/DOSE|NOT DONE||N|Y|N|3||39||BLINDED TREATMENT|1964-01-16||1967-12-26|||1961-02-12||1962-07-06
TRIAL STUDY 134XCP|RP|6045DFAB-0734-4E6D-A492-34BD613EC783|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||ML/CAGE/DAY|||SQU/ML|NOT DONE||N|NA|U|3||39||WASHOUT|1967-10-17||1960-11-14|||1961-02-06||1967-04-01
TRIAL STUDY 134XCP|RP|6045DFAB-0734-4E6D-A492-34BD613EC783|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||BQ/MG|||U/G/MIN|NOT DONE||U|NA|Y|4||88||LONG-TERM FOLLOW-UP|1964-03-28||1965-09-24|||1960-12-15||1968-08-03
TRIAL STUDY 134XCP|RP|6045DFAB-0734-4E6D-A492-34BD613EC783|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||10^8 PFU|||CUP|NOT DONE||N|N|Y|4||88||INDUCTION TREATMENT|1969-11-29||1969-10-23|||1969-12-08||1963-08-29
TRIAL STUDY 134XCP|RP|6045DFAB-0734-4E6D-A492-34BD613EC783|1||||||BCMETHOD|BIRTH CONTROL METHOD||||UKAT/L|||CG|NOT DONE||N|U|NA|5||7||BASELINE|1962-05-11||1969-09-16|||1973-04-03||1961-05-07
TRIAL STUDY 134XCP|RP|6045DFAB-0734-4E6D-A492-34BD613EC783|2||||||BRTHN|NUMBER OF BIRTHS||||MS2|||UG/KG/MIN|NOT DONE||Y|U|NA|5||7||SCREENING|1972-12-21||1963-02-08|||1967-04-26||1972-12-01
TRIAL STUDY 134XCP|RP|482F0519-E738-46DE-A5C4-4AC76B6E7011|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||LOG10 ELISA UNIT/DOSE|||GBQ/UG|NOT DONE||U|N|NA|1||38||FOLLOW-UP|1972-08-02||1973-04-29|||1960-04-20||1964-03-20
TRIAL STUDY 134XCP|RP|482F0519-E738-46DE-A5C4-4AC76B6E7011|2||||||INABOIND|INDUCED ABORTION INDICATOR||||CI|||FG|NOT DONE||U|U|U|1||38||OBSERVATION|1961-10-19||1967-07-20|||1968-12-14||1960-01-05
TRIAL STUDY 134XCP|RP|482F0519-E738-46DE-A5C4-4AC76B6E7011|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UMOL|||APPLICATION|NOT DONE||Y|Y|NA|2||58||INDUCTION TREATMENT|1969-11-06||1961-10-19|||1964-11-28||1972-05-26
TRIAL STUDY 134XCP|RP|482F0519-E738-46DE-A5C4-4AC76B6E7011|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/DAY|||MS2|NOT DONE||Y|N|N|2||58||FOLLOW-UP|1964-07-17||1971-08-03|||1968-08-19||1965-05-15
TRIAL STUDY 134XCP|RP|482F0519-E738-46DE-A5C4-4AC76B6E7011|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||CAPSULE|||G/L|NOT DONE||N|NA|U|3||39||BASELINE|1967-06-10||1967-01-23|||1969-09-12||1970-07-05
TRIAL STUDY 134XCP|RP|482F0519-E738-46DE-A5C4-4AC76B6E7011|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MCI/KG|||MM|NOT DONE||N|Y|NA|3||39||RUN-IN|1962-12-30||1967-03-04|||1966-06-23||1973-03-11
TRIAL STUDY 134XCP|RP|482F0519-E738-46DE-A5C4-4AC76B6E7011|1||||||MENARAGE|MENARCHE AGE||||CM|||TAMPON|NOT DONE||U|Y|Y|4||88||FOLLOW-UP|1973-04-05||1964-04-15|||1965-11-30||1972-11-29
TRIAL STUDY 134XCP|RP|482F0519-E738-46DE-A5C4-4AC76B6E7011|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MPL U/ML|||LOG10 CFU/ML|NOT DONE||N|N|NA|4||88||WASHOUT|1969-06-02||1972-05-19|||1964-04-29||1973-06-27
TRIAL STUDY 134XCP|RP|482F0519-E738-46DE-A5C4-4AC76B6E7011|1||||||MENFDUR|MENSES FLOW DURATION||||UM/S|||10^11/L|NOT DONE||Y|NA|Y|5||7||OPEN LABEL TREATMENT|1969-09-08||1965-12-02|||1972-09-03||1969-02-19
TRIAL STUDY 134XCP|RP|482F0519-E738-46DE-A5C4-4AC76B6E7011|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||APL U|||10^6 CFU/ML|NOT DONE||NA|U|NA|5||7||OPEN LABEL TREATMENT|1966-01-24||1971-05-07|||1971-08-18||1968-02-22
TRIAL STUDY 134XCP|RP|DFDD42F5-749C-4AF0-8351-780DB9614F61|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||ABSORBANCE U/ML|||/H|NOT DONE||U|U|U|1||38||OBSERVATION|1963-09-04||1964-02-12|||1967-06-29||1964-06-27
TRIAL STUDY 134XCP|RP|DFDD42F5-749C-4AF0-8351-780DB9614F61|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||CP|||UGEQ|NOT DONE||Y|Y|U|1||38||OPEN LABEL TREATMENT|1960-05-05||1961-01-01|||1965-01-19||1972-01-16
TRIAL STUDY 134XCP|RP|DFDD42F5-749C-4AF0-8351-780DB9614F61|1||||||RASHIND|RASH INDICATOR||||10^6 ORGANISMS/ML|||WEEKS|NOT DONE||Y|Y|Y|2||58||OPEN LABEL TREATMENT|1968-03-02||1964-10-16|||1960-11-27||1971-10-03
TRIAL STUDY 134XCP|RP|DFDD42F5-749C-4AF0-8351-780DB9614F61|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||PG/L|||HEP|NOT DONE||Y|Y|U|2||58||CONTINUATION TREATMENT|1966-10-04||1961-11-07|||1968-07-16||1962-09-23
TRIAL STUDY 134XCP|RP|DFDD42F5-749C-4AF0-8351-780DB9614F61|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||NEWTON|||ML/S/M2|NOT DONE||Y|NA|N|3||39||LONG-TERM FOLLOW-UP|1968-07-23||1966-05-14|||1970-07-01||1964-05-14
TRIAL STUDY 134XCP|RP|DFDD42F5-749C-4AF0-8351-780DB9614F61|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||10^3 ORGANISMS|||MPA|NOT DONE||U|NA|NA|3||39||FOLLOW-UP|1961-07-01||1961-03-21|||1960-04-03||1965-04-24
TRIAL STUDY 134XCP|RP|DFDD42F5-749C-4AF0-8351-780DB9614F61|1||||||MENOSTAT|MENOPAUSE STATUS||||GPELISA UNIT/ML|||UG/G/MIN|NOT DONE||NA|NA|Y|4||88||FOLLOW-UP|1971-10-25||1971-09-21|||1968-03-05||1972-04-18
TRIAL STUDY 134XCP|RP|DFDD42F5-749C-4AF0-8351-780DB9614F61|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||VG/ML|||AMPULE|NOT DONE||N|NA|NA|4||88||RUN-IN|1965-03-31||1968-02-08|||1968-12-02||1966-10-03
TRIAL STUDY 134XCP|RP|DFDD42F5-749C-4AF0-8351-780DB9614F61|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UKAT/L|||BQ|NOT DONE||U|U|U|5||7||BASELINE|1971-06-06||1973-07-09|||1962-02-18||1962-01-28
TRIAL STUDY 134XCP|RP|DFDD42F5-749C-4AF0-8351-780DB9614F61|2||||||RASHIND|RASH INDICATOR||||AMOL|||G/ANIMAL|NOT DONE||NA|NA|Y|5||7||RUN-IN|1967-11-12||1966-08-26|||1960-10-07||1967-10-30
TRIAL STUDY 134XCP|RP|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MG/KG/MIN|||UKAT|NOT DONE||U|N|N|1||38||TREATMENT|1965-12-14||1966-01-02|||1969-08-19||1962-07-30
TRIAL STUDY 134XCP|RP|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|2||||||ULCERIND|ULCER INDICATOR||||10^3 COPIES/ML|||APL U/ML|NOT DONE||Y|NA|NA|1||38||RUN-IN|1965-02-17||1973-07-31|||1973-07-02||1967-04-09
TRIAL STUDY 134XCP|RP|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||CI/UL|||MV*MIN|NOT DONE||NA|N|Y|2||58||CONTINUATION TREATMENT|1960-05-21||1960-09-07|||1967-04-22||1960-06-09
TRIAL STUDY 134XCP|RP|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|2||||||INABOIND|INDUCED ABORTION INDICATOR||||ML/S/M2|||CI/KG|NOT DONE||N|Y|Y|2||58||RUN-IN|1971-08-12||1970-11-28|||1961-01-13||1964-02-16
TRIAL STUDY 134XCP|RP|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|1||||||PUSTIND|PUSTULE INDICATOR||||V/SEC|||DAYS|NOT DONE||Y|N|N|3||39||FOLLOW-UP|1966-11-14||1962-02-18|||1971-09-07||1963-07-24
TRIAL STUDY 134XCP|RP|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||G/MOL|||10^4 CFU/ML|NOT DONE||Y|NA|Y|3||39||LONG-TERM FOLLOW-UP|1967-02-20||1968-11-06|||1968-12-03||1964-02-29
TRIAL STUDY 134XCP|RP|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||/KG|||DIP|NOT DONE||NA|U|U|4||88||BASELINE|1969-10-25||1968-03-07|||1962-09-09||1968-12-13
TRIAL STUDY 134XCP|RP|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|2||||||STILBIND|STILLBIRTH INDICATOR||||M/SEC|||LX|NOT DONE||Y|NA|U|4||88||RUN-IN|1969-01-25||1970-07-20|||1968-08-30||1960-12-02
TRIAL STUDY 134XCP|RP|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||UG/M2/H|||10^6 COPIES/ML|NOT DONE||NA|U|Y|5||7||LONG-TERM FOLLOW-UP|1967-09-23||1968-03-23|||1966-11-23||1971-05-04
TRIAL STUDY 134XCP|RP|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UV*SEC|||UG/M2/H|NOT DONE||U|NA|U|5||7||BASELINE|1969-06-09||1965-05-29|||1964-09-02||1961-12-18
TRIAL STUDY 134XCP|RP|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||APPLICATION|||EJACULATE U|NOT DONE||Y|NA|U|1||38||BLINDED TREATMENT|1972-01-14||1966-05-17|||1969-12-21||1965-05-13
TRIAL STUDY 134XCP|RP|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||BISCUIT|||HEP|NOT DONE||Y|NA|NA|1||38||RUN-IN|1969-04-05||1969-09-24|||1970-07-03||1968-12-12
TRIAL STUDY 134XCP|RP|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|1||||||STILBIND|STILLBIRTH INDICATOR||||GY/MIN|||MMOL/MIN/KPA|NOT DONE||Y|NA|NA|2||58||INDUCTION TREATMENT|1965-03-18||1968-11-14|||1969-01-23||1961-06-11
TRIAL STUDY 134XCP|RP|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||/MONTH|||SFC/10^6 PBMC|NOT DONE||U|U|N|2||58||OPEN LABEL TREATMENT|1972-04-11||1962-02-20|||1970-10-16||1963-04-09
TRIAL STUDY 134XCP|RP|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|1||||||INABOIND|INDUCED ABORTION INDICATOR||||COPIES/UL|||10^6 CFU/ML|NOT DONE||NA|N|Y|3||39||BLINDED TREATMENT|1966-08-11||1973-07-06|||1961-06-03||1961-09-13
TRIAL STUDY 134XCP|RP|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|2||||||DSCHGIND|DISCHARGE INDICATOR||||KAT|||PIXEL|NOT DONE||Y|N|U|3||39||BLINDED TREATMENT|1969-01-09||1965-07-28|||1971-08-26||1960-09-09
TRIAL STUDY 134XCP|RP|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MMOL/MIN/KPA/L|||UG/KG/MIN|NOT DONE||NA|NA|U|4||88||SCREENING|1968-05-01||1970-10-30|||1962-06-19||1961-05-10
TRIAL STUDY 134XCP|RP|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||UMOL/DAY|||APL U|NOT DONE||N|N|U|4||88||WASHOUT|1962-09-23||1969-09-13|||1962-04-23||1970-11-30
TRIAL STUDY 134XCP|RP|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|1||||||DSCHGIND|DISCHARGE INDICATOR||||PMOL/G|||UMOL/DAY|NOT DONE||U|U|U|5||7||BLINDED TREATMENT|1973-03-16||1971-05-06|||1969-01-17||1967-05-11
TRIAL STUDY 134XCP|RP|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||BQ/MG|||UG/G/H|NOT DONE||N|NA|NA|5||7||LONG-TERM FOLLOW-UP|1963-07-21||1969-11-03|||1965-01-11||1970-08-05
TRIAL STUDY 134XCP|RP|E0434C66-0F59-476F-9913-55766C4AED1B|1||||||RASHIND|RASH INDICATOR||||PFU/ANIMAL|||ML/CM|NOT DONE||Y|N|N|1||38||CONTINUATION TREATMENT|1971-08-20||1970-11-06|||1972-01-30||1961-12-31
TRIAL STUDY 134XCP|RP|E0434C66-0F59-476F-9913-55766C4AED1B|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||LM|||DNA COPIES/ML|NOT DONE||N|NA|N|1||38||OPEN LABEL TREATMENT|1961-02-24||1962-01-17|||1961-05-18||1968-06-21
TRIAL STUDY 134XCP|RP|E0434C66-0F59-476F-9913-55766C4AED1B|1||||||MENOAGE|MENOPAUSE AGE||||APPLICATION|||DYN|NOT DONE||U|NA|NA|2||58||OBSERVATION|1965-08-13||1972-02-26|||1969-02-21||1960-12-10
TRIAL STUDY 134XCP|RP|E0434C66-0F59-476F-9913-55766C4AED1B|2||||||MENARAGE|MENARCHE AGE||||10^11/L|||UMOL/H/MMOL|NOT DONE||N|N|NA|2||58||BASELINE|1968-09-21||1963-05-03|||1972-03-22||1969-04-07
TRIAL STUDY 134XCP|RP|E0434C66-0F59-476F-9913-55766C4AED1B|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||/MONTH|||RING|NOT DONE||NA|N|NA|3||39||BLINDED TREATMENT|1964-03-31||1961-01-07|||1969-11-17||1961-10-24
TRIAL STUDY 134XCP|RP|E0434C66-0F59-476F-9913-55766C4AED1B|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UG/KG/H|||CM2|NOT DONE||N|Y|NA|3||39||SCREENING|1963-04-22||1972-02-05|||1967-11-22||1970-06-22
TRIAL STUDY 134XCP|RP|E0434C66-0F59-476F-9913-55766C4AED1B|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||MONTHS|||10^9 ORGANISMS/G|NOT DONE||Y|Y|U|4||88||LONG-TERM FOLLOW-UP|1961-01-28||1968-11-22|||1969-11-06||1965-01-26
TRIAL STUDY 134XCP|RP|E0434C66-0F59-476F-9913-55766C4AED1B|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||KCAL/DAY|||L/KG|NOT DONE||N|N|N|4||88||RUN-IN|1962-02-10||1968-08-10|||1962-08-22||1963-01-01
TRIAL STUDY 134XCP|RP|E0434C66-0F59-476F-9913-55766C4AED1B|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PIXELS/CM|||10^6/G|NOT DONE||NA|N|U|5||7||OPEN LABEL TREATMENT|1965-05-20||1970-02-13|||1971-01-17||1970-12-04
TRIAL STUDY 134XCP|RP|E0434C66-0F59-476F-9913-55766C4AED1B|2||||||ABORTN|NUMBER OF ABORTIONS||||MG/DAY|||PIXELS/CM|NOT DONE||N|N|U|5||7||OBSERVATION|1965-01-15||1964-01-24|||1964-11-14||1960-08-22
TRIAL STUDY 134XCP|RP|60B57F98-61FF-4322-8084-7A536964F60A|1||||||PREGNN|NUMBER OF PREGNANCIES||||JAR|||C|NOT DONE||U|NA|Y|1||38||WASHOUT|1962-10-11||1968-02-13|||1966-12-30||1964-05-04
TRIAL STUDY 134XCP|RP|60B57F98-61FF-4322-8084-7A536964F60A|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UMOL/MOL|||IU/DAY|NOT DONE||U|NA|NA|1||38||BLINDED TREATMENT|1971-09-29||1966-04-29|||1971-10-21||1969-02-01
TRIAL STUDY 134XCP|RP|60B57F98-61FF-4322-8084-7A536964F60A|1||||||BRTHN|NUMBER OF BIRTHS||||L/L|||ELISA UNIT/DOSE|NOT DONE||Y|Y|NA|2||58||OPEN LABEL TREATMENT|1968-09-27||1972-05-24|||1972-09-04||1967-08-03
TRIAL STUDY 134XCP|RP|60B57F98-61FF-4322-8084-7A536964F60A|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||COPIES/UG|||PPTR|NOT DONE||N|U|NA|2||58||OBSERVATION|1961-09-02||1972-04-29|||1972-04-04||1969-07-31
TRIAL STUDY 134XCP|RP|60B57F98-61FF-4322-8084-7A536964F60A|1||||||PREGNN|NUMBER OF PREGNANCIES||||BOLUS|||UGEQ/L|NOT DONE||NA|N|N|3||39||LONG-TERM FOLLOW-UP|1960-04-10||1969-01-10|||1969-06-07||1963-11-13
TRIAL STUDY 134XCP|RP|60B57F98-61FF-4322-8084-7A536964F60A|2||||||RASHIND|RASH INDICATOR||||AGU/ML|||LOG10 PFU/ML|NOT DONE||N|U|Y|3||39||SCREENING|1970-05-26||1971-04-14|||1969-03-11||1966-07-16
TRIAL STUDY 134XCP|RP|60B57F98-61FF-4322-8084-7A536964F60A|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||FEU|||PKAT/L|NOT DONE||NA|N|N|4||88||TREATMENT|1960-04-20||1964-08-03|||1971-02-26||1960-05-17
TRIAL STUDY 134XCP|RP|60B57F98-61FF-4322-8084-7A536964F60A|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ELISA UNIT|||10^6 ORGANISMS/ML|NOT DONE||Y|U|Y|4||88||TREATMENT|1971-01-28||1968-05-23|||1965-11-18||1964-02-05
TRIAL STUDY 134XCP|RP|60B57F98-61FF-4322-8084-7A536964F60A|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||DAGU|||MET*MIN|NOT DONE||Y|U|Y|5||7||CONTINUATION TREATMENT|1966-03-17||1969-02-26|||1967-05-11||1960-05-01
TRIAL STUDY 134XCP|RP|60B57F98-61FF-4322-8084-7A536964F60A|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MEQ/L|||MBQ/UL|NOT DONE||NA|Y|Y|5||7||SCREENING|1970-10-02||1964-10-12|||1965-09-05||1966-04-17
TRIAL STUDY 134XCP|RP|C79CA198-24E2-4A76-8C32-F3AA973EA41E|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||NCI|||ML/CM|NOT DONE||U|N|NA|1||38||TREATMENT|1970-01-13||1971-08-24|||1961-12-03||1960-09-21
TRIAL STUDY 134XCP|RP|C79CA198-24E2-4A76-8C32-F3AA973EA41E|2||||||STILBIND|STILLBIRTH INDICATOR||||EU|||MG/ANIMAL|NOT DONE||N|NA|U|1||38||BLINDED TREATMENT|1968-11-22||1960-02-18|||1960-04-04||1965-10-13
TRIAL STUDY 134XCP|RP|C79CA198-24E2-4A76-8C32-F3AA973EA41E|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UG/L DDU|||ANSON U|NOT DONE||Y|NA|NA|2||58||BLINDED TREATMENT|1973-07-09||1963-09-30|||1962-07-19||1961-03-22
TRIAL STUDY 134XCP|RP|C79CA198-24E2-4A76-8C32-F3AA973EA41E|2||||||ERYTHIND|ERYTHEMA INDICATOR||||GBQ/G|||UG/MIN|NOT DONE||NA|Y|N|2||58||RUN-IN|1970-10-03||1966-02-27|||1971-07-21||1971-12-10
TRIAL STUDY 134XCP|RP|C79CA198-24E2-4A76-8C32-F3AA973EA41E|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||MU/G|||NM|NOT DONE||Y|Y|NA|3||39||SCREENING|1964-06-14||1967-10-22|||1970-03-22||1966-08-14
TRIAL STUDY 134XCP|RP|C79CA198-24E2-4A76-8C32-F3AA973EA41E|2||||||MENOAGE|MENOPAUSE AGE||||UG/G/MIN|||GY/MIN|NOT DONE||U|Y|Y|3||39||LONG-TERM FOLLOW-UP|1973-05-22||1969-03-16|||1970-05-24||1965-03-07
TRIAL STUDY 134XCP|RP|C79CA198-24E2-4A76-8C32-F3AA973EA41E|1||||||MENARAGE|MENARCHE AGE||||UU/L|||SBE/ML|NOT DONE||NA|N|N|4||88||WASHOUT|1962-07-25||1966-12-20|||1962-09-16||1969-01-16
TRIAL STUDY 134XCP|RP|C79CA198-24E2-4A76-8C32-F3AA973EA41E|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||LOG10 ELISA UNIT/DOSE|||ELISA UNIT|NOT DONE||N|U|N|4||88||OBSERVATION|1967-04-19||1969-10-16|||1966-05-25||1963-09-10
TRIAL STUDY 134XCP|RP|C79CA198-24E2-4A76-8C32-F3AA973EA41E|1||||||MENARAGE|MENARCHE AGE||||ANTI-XA IU|||FARAD|NOT DONE||U|Y|Y|5||7||RUN-IN|1965-11-24||1970-12-13|||1963-04-02||1973-02-21
TRIAL STUDY 134XCP|RP|C79CA198-24E2-4A76-8C32-F3AA973EA41E|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||UMOL/MOL|||CAPSULE|NOT DONE||N|NA|NA|5||7||INDUCTION TREATMENT|1960-07-25||1970-03-25|||1969-03-28||1971-10-26
TRIAL STUDY 134XCP|RP|D250194D-9BBD-40D3-A13B-BBCEB53DB450|1||||||THICK|THICKNESS||||CCID 50/ML|||PG/DL|NOT DONE||Y|NA|U|1||38||CONTINUATION TREATMENT|1962-01-10||1972-01-25|||1968-06-28||1962-03-24
TRIAL STUDY 134XCP|RP|D250194D-9BBD-40D3-A13B-BBCEB53DB450|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MCI|||CMOL|NOT DONE||U|Y|U|1||38||BASELINE|1968-08-10||1972-11-22|||1962-05-14||1963-10-25
TRIAL STUDY 134XCP|RP|D250194D-9BBD-40D3-A13B-BBCEB53DB450|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MM/MIN|||10^7 PFU|NOT DONE||NA|U|NA|2||58||BLINDED TREATMENT|1971-10-23||1971-07-07|||1967-01-21||1971-09-25
TRIAL STUDY 134XCP|RP|D250194D-9BBD-40D3-A13B-BBCEB53DB450|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||F|||U/G HB|NOT DONE||NA|Y|Y|2||58||SCREENING|1971-08-05||1972-01-04|||1970-09-22||1968-06-02
TRIAL STUDY 134XCP|RP|D250194D-9BBD-40D3-A13B-BBCEB53DB450|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||PFU/ANIMAL|||/MM|NOT DONE||Y|Y|N|3||39||RUN-IN|1968-05-23||1967-04-29|||1961-12-06||1962-11-22
TRIAL STUDY 134XCP|RP|D250194D-9BBD-40D3-A13B-BBCEB53DB450|2||||||PREGIND|PREGNANT INDICATOR||||/HPF|||ELISA UNIT|NOT DONE||U|Y|U|3||39||INDUCTION TREATMENT|1970-06-26||1960-05-17|||1963-01-22||1971-11-09
TRIAL STUDY 134XCP|RP|D250194D-9BBD-40D3-A13B-BBCEB53DB450|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||IU|||BQ|NOT DONE||N|U|NA|4||88||FOLLOW-UP|1961-07-30||1969-12-03|||1973-07-17||1960-08-07
TRIAL STUDY 134XCP|RP|D250194D-9BBD-40D3-A13B-BBCEB53DB450|2||||||DLVRMODE|MODE OF DELIVERY||||MN|||PG|NOT DONE||NA|Y|N|4||88||BLINDED TREATMENT|1972-06-24||1967-05-23|||1972-07-01||1971-04-21
TRIAL STUDY 134XCP|RP|D250194D-9BBD-40D3-A13B-BBCEB53DB450|1||||||MENFDUR|MENSES FLOW DURATION||||UV2|||FMOL/L/SEC|NOT DONE||U|Y|NA|5||7||WASHOUT|1964-02-17||1961-12-19|||1972-12-10||1966-10-25
TRIAL STUDY 134XCP|RP|D250194D-9BBD-40D3-A13B-BBCEB53DB450|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||DAMOL/L|||PM|NOT DONE||U|NA|NA|5||7||WASHOUT|1967-10-22||1969-07-01|||1961-01-01||1966-08-22
TRIAL STUDY 134XCP|RP|369AE0AF-8693-4363-9A6E-CD30567BD614|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||G/CAGE/DAY|||U/G/DAY|NOT DONE||U|N|N|1||38||INDUCTION TREATMENT|1967-02-19||1967-02-21|||1962-10-28||1971-05-21
TRIAL STUDY 134XCP|RP|369AE0AF-8693-4363-9A6E-CD30567BD614|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||CUP|||MU/L|NOT DONE||NA|Y|Y|1||38||BASELINE|1972-08-06||1965-05-21|||1960-10-16||1968-06-23
TRIAL STUDY 134XCP|RP|369AE0AF-8693-4363-9A6E-CD30567BD614|1||||||BLISTIND|BLISTERING INDICATOR||||PG/DL|||PFU/DOSE|NOT DONE||N|U|NA|2||58||BLINDED TREATMENT|1962-02-06||1968-02-11|||1962-10-07||1969-04-06
TRIAL STUDY 134XCP|RP|369AE0AF-8693-4363-9A6E-CD30567BD614|2||||||BLISTIND|BLISTERING INDICATOR||||DAYS/WK|||G/CM2|NOT DONE||NA|Y|U|2||58||RUN-IN|1960-11-22||1963-06-05|||1965-12-17||1964-03-05
TRIAL STUDY 134XCP|RP|369AE0AF-8693-4363-9A6E-CD30567BD614|1||||||MENOAGE|MENOPAUSE AGE||||FMOL/G|||U/M2|NOT DONE||N|Y|NA|3||39||OBSERVATION|1970-08-13||1968-02-27|||1968-07-26||1961-08-20
TRIAL STUDY 134XCP|RP|369AE0AF-8693-4363-9A6E-CD30567BD614|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||KUSP|||PRESSOR UNITS|NOT DONE||Y|Y|NA|3||39||RUN-IN|1970-10-21||1966-03-25|||1963-01-31||1967-10-24
TRIAL STUDY 134XCP|RP|369AE0AF-8693-4363-9A6E-CD30567BD614|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||10^6 DNA COPIES/ML|||ML/M2/DAY|NOT DONE||N|N|Y|4||88||TREATMENT|1970-02-27||1966-11-16|||1972-04-21||1966-09-27
TRIAL STUDY 134XCP|RP|369AE0AF-8693-4363-9A6E-CD30567BD614|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||LINEAR FT*LB|||CGY|NOT DONE||N|U|Y|4||88||WASHOUT|1970-12-10||1964-10-09|||1966-03-23||1967-07-07
TRIAL STUDY 134XCP|RP|369AE0AF-8693-4363-9A6E-CD30567BD614|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||NL|||PG|NOT DONE||Y|N|N|5||7||TREATMENT|1965-12-18||1966-08-01|||1972-03-18||1967-05-10
TRIAL STUDY 134XCP|RP|369AE0AF-8693-4363-9A6E-CD30567BD614|2||||||MENFDUR|MENSES FLOW DURATION||||CYLINDER|||CI/UL|NOT DONE||Y|NA|N|5||7||SCREENING|1963-10-19||1961-09-21|||1969-05-15||1970-03-16
TRIAL STUDY 134XCP|RP|4497DB94-5B91-4169-9D73-73EE5C1D9B76|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||BAU/ML|||MG/KG/WEEK|NOT DONE||Y|U|N|1||38||OPEN LABEL TREATMENT|1963-11-29||1966-04-12|||1962-08-29||1961-09-03
TRIAL STUDY 134XCP|RP|4497DB94-5B91-4169-9D73-73EE5C1D9B76|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MMOL/MIN/KPA|||TRACE|NOT DONE||U|U|N|1||38||LONG-TERM FOLLOW-UP|1971-12-08||1960-10-26|||1972-03-09||1973-07-20
TRIAL STUDY 134XCP|RP|4497DB94-5B91-4169-9D73-73EE5C1D9B76|1||||||BLISTIND|BLISTERING INDICATOR||||K|||PACK|NOT DONE||N|U|N|2||58||INDUCTION TREATMENT|1965-10-10||1962-06-15|||1971-06-09||1969-08-13
TRIAL STUDY 134XCP|RP|4497DB94-5B91-4169-9D73-73EE5C1D9B76|2||||||PEELIND|PEELING INDICATOR||||SPRAY|||MOL|NOT DONE||U|U|Y|2||58||FOLLOW-UP|1971-02-25||1963-07-13|||1969-03-06||1971-10-11
TRIAL STUDY 134XCP|RP|4497DB94-5B91-4169-9D73-73EE5C1D9B76|1||||||BCMETHOD|BIRTH CONTROL METHOD||||PMOL/DAY|||PPB|NOT DONE||U|N|N|3||39||INDUCTION TREATMENT|1970-08-18||1969-05-12|||1969-10-11||1969-10-02
TRIAL STUDY 134XCP|RP|4497DB94-5B91-4169-9D73-73EE5C1D9B76|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MESF|||MG|NOT DONE||NA|N|N|3||39||RUN-IN|1972-12-07||1970-11-09|||1965-07-19||1973-08-28
TRIAL STUDY 134XCP|RP|4497DB94-5B91-4169-9D73-73EE5C1D9B76|1||||||ERYTHIND|ERYTHEMA INDICATOR||||BOLUS|||DEG2|NOT DONE||NA|N|N|4||88||OPEN LABEL TREATMENT|1971-08-06||1970-08-02|||1971-03-27||1961-01-30
TRIAL STUDY 134XCP|RP|4497DB94-5B91-4169-9D73-73EE5C1D9B76|2||||||PRGENDTC|DATE PREGNANCY ENDED||||U/10^12 RBC|||L/H|NOT DONE||U|Y|Y|4||88||WASHOUT|1971-03-18||1963-03-02|||1965-08-25||1972-08-17
TRIAL STUDY 134XCP|RP|4497DB94-5B91-4169-9D73-73EE5C1D9B76|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||KHZ|||MPS U|NOT DONE||N|N|N|5||7||CONTINUATION TREATMENT|1963-10-15||1963-07-06|||1968-07-22||1963-10-31
TRIAL STUDY 134XCP|RP|4497DB94-5B91-4169-9D73-73EE5C1D9B76|2||||||MENARAGE|MENARCHE AGE||||BOTTLE|||PMOL/DAY|NOT DONE||NA|NA|U|5||7||TREATMENT|1973-05-03||1970-08-21|||1961-12-14||1962-05-18
TRIAL STUDY 134XCP|RP|487D7E2D-6E7E-4A5E-ADC7-72B888746263|1||||||BRTHN|NUMBER OF BIRTHS||||DRINK|||KG/CM|NOT DONE||NA|U|Y|1||38||FOLLOW-UP|1968-11-28||1960-10-20|||1972-07-31||1964-07-25
TRIAL STUDY 134XCP|RP|487D7E2D-6E7E-4A5E-ADC7-72B888746263|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||PMOL/DL|||MG/M2/DAY|NOT DONE||U|NA|NA|1||38||OPEN LABEL TREATMENT|1966-03-05||1970-12-12|||1971-03-23||1967-08-23
TRIAL STUDY 134XCP|RP|487D7E2D-6E7E-4A5E-ADC7-72B888746263|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||GPELISA UNIT/ML|||GRAVITATIONAL UNIT|NOT DONE||NA|N|NA|2||58||LONG-TERM FOLLOW-UP|1970-03-03||1971-08-13|||1969-09-10||1960-08-10
TRIAL STUDY 134XCP|RP|487D7E2D-6E7E-4A5E-ADC7-72B888746263|2||||||DSCHGIND|DISCHARGE INDICATOR||||10^8 PFU|||PKAT|NOT DONE||N|NA|NA|2||58||TREATMENT|1967-03-30||1969-06-28|||1965-10-27||1966-07-18
TRIAL STUDY 134XCP|RP|487D7E2D-6E7E-4A5E-ADC7-72B888746263|1||||||PREGST|PREGNANT DURING THE STUDY||||10^9 ORGANISMS/ML|||POINT|NOT DONE||U|N|NA|3||39||BLINDED TREATMENT|1970-04-03||1966-06-28|||1968-07-18||1960-08-30
TRIAL STUDY 134XCP|RP|487D7E2D-6E7E-4A5E-ADC7-72B888746263|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||INHALATION|||IU/DAY|NOT DONE||NA|N|N|3||39||LONG-TERM FOLLOW-UP|1972-09-25||1972-08-30|||1960-07-30||1963-02-17
TRIAL STUDY 134XCP|RP|487D7E2D-6E7E-4A5E-ADC7-72B888746263|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||U/G/DAY|||VOXEL|NOT DONE||U|NA|Y|4||88||LONG-TERM FOLLOW-UP|1966-12-08||1967-01-29|||1962-05-07||1972-11-14
TRIAL STUDY 134XCP|RP|487D7E2D-6E7E-4A5E-ADC7-72B888746263|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||DRUM|||PMOL/L|NOT DONE||U|U|U|4||88||CONTINUATION TREATMENT|1961-07-13||1972-08-17|||1968-03-03||1961-04-21
TRIAL STUDY 134XCP|RP|487D7E2D-6E7E-4A5E-ADC7-72B888746263|1||||||BRTHN|NUMBER OF BIRTHS||||10^3 ORGANISMS|||UOSM|NOT DONE||NA|Y|Y|5||7||OBSERVATION|1963-12-15||1968-04-22|||1963-08-19||1963-11-02
TRIAL STUDY 134XCP|RP|487D7E2D-6E7E-4A5E-ADC7-72B888746263|2||||||MASSIND|MASS INDICATOR||||G|||OHM|NOT DONE||U|U|U|5||7||BLINDED TREATMENT|1962-12-02||1969-06-03|||1972-01-26||1970-09-15
TRIAL STUDY 134XCP|RP|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||EP U|||IU/DAY|NOT DONE||Y|Y|Y|1||38||LONG-TERM FOLLOW-UP|1962-01-09||1971-02-05|||1972-01-02||1966-07-18
TRIAL STUDY 134XCP|RP|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||BQ/L|||MV|NOT DONE||Y|NA|NA|1||38||WASHOUT|1966-11-23||1968-11-28|||1962-04-02||1967-08-19
TRIAL STUDY 134XCP|RP|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|1||||||PEELIND|PEELING INDICATOR||||ELISA UNIT/ML|||K|NOT DONE||N|U|N|2||58||RUN-IN|1973-07-26||1971-04-02|||1967-09-11||1965-03-28
TRIAL STUDY 134XCP|RP|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||OD UNIT|||DAYS/MONTH|NOT DONE||N|U|U|2||58||LONG-TERM FOLLOW-UP|1960-05-13||1965-11-02|||1966-04-19||1969-10-20
TRIAL STUDY 134XCP|RP|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||PACKET|||EIA UNIT|NOT DONE||Y|U|N|3||39||OPEN LABEL TREATMENT|1967-03-21||1970-07-03|||1970-08-03||1964-04-09
TRIAL STUDY 134XCP|RP|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||ML/DL|||MG/ANIMAL|NOT DONE||N|U|NA|3||39||BASELINE|1971-09-11||1969-11-08|||1962-03-09||1969-04-23
TRIAL STUDY 134XCP|RP|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|1||||||BLISTIND|BLISTERING INDICATOR||||MAC50|||PA|NOT DONE||N|NA|U|4||88||WASHOUT|1961-09-09||1965-11-04|||1971-05-19||1961-03-11
TRIAL STUDY 134XCP|RP|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|2||||||PREGIND|PREGNANT INDICATOR||||DRINK|||/SEC|NOT DONE||NA|NA|U|4||88||INDUCTION TREATMENT|1972-06-30||1970-06-29|||1969-01-08||1964-10-24
TRIAL STUDY 134XCP|RP|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|1||||||INABOIND|INDUCED ABORTION INDICATOR||||IN|||TABLET|NOT DONE||N|N|N|5||7||FOLLOW-UP|1961-02-24||1967-03-17|||1972-06-30||1971-12-22
TRIAL STUDY 134XCP|RP|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|2||||||MASSIND|MASS INDICATOR||||PRESSOR UNITS|||UMOL/L/SEC|NOT DONE||Y|U|U|5||7||OBSERVATION|1969-07-16||1960-09-13|||1962-09-18||1970-02-10
TRIAL STUDY 134XCP|RP|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|1||||||EDEMAIND|EDEMA INDICATOR||||BU/ML|||HOMEOPATHIC DILUTION|NOT DONE||Y|N|Y|1||38||INDUCTION TREATMENT|1964-08-22||1971-11-01|||1967-03-01||1969-04-08
TRIAL STUDY 134XCP|RP|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/DAY|||MG/MOL|NOT DONE||U|NA|U|1||38||TREATMENT|1970-07-28||1970-07-03|||1960-09-25||1960-06-24
TRIAL STUDY 134XCP|RP|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UU/L|||G/MOL|NOT DONE||U|Y|U|2||58||BASELINE|1965-05-28||1971-07-16|||1963-02-05||1968-04-29
TRIAL STUDY 134XCP|RP|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||TUBE|||MMOL2/L2|NOT DONE||U|NA|NA|2||58||WASHOUT|1970-06-14||1971-04-08|||1962-11-05||1965-09-07
TRIAL STUDY 134XCP|RP|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||AMPULE|||NMOL BCE/MMOL|NOT DONE||N|NA|U|3||39||SCREENING|1966-10-06||1973-06-14|||1964-03-25||1966-04-04
TRIAL STUDY 134XCP|RP|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|2||||||MENOAGE|MENOPAUSE AGE||||MEQ/KG|||MU/L|NOT DONE||Y|Y|U|3||39||SCREENING|1970-10-24||1973-04-27|||1962-10-15||1969-09-23
TRIAL STUDY 134XCP|RP|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|1||||||RASHIND|RASH INDICATOR||||CUP EQ|||MV2/HZ|NOT DONE||Y|U|N|4||88||FOLLOW-UP|1970-02-21||1972-07-14|||1966-10-31||1968-05-28
TRIAL STUDY 134XCP|RP|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||G/KG|||PMOL/10^9 CELLS|NOT DONE||NA|Y|NA|4||88||OPEN LABEL TREATMENT|1964-02-09||1973-06-01|||1961-05-07||1961-07-10
TRIAL STUDY 134XCP|RP|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|1||||||FUNDHT|FUNDAL HEIGHT||||10^9 ORGANISMS/G|||MMOL/MOL|NOT DONE||N|N|Y|5||7||RUN-IN|1972-09-13||1965-07-15|||1962-04-15||1961-10-19
TRIAL STUDY 134XCP|RP|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|2||||||RASHIND|RASH INDICATOR||||UG/DAY|||FMOL/L|NOT DONE||N|NA|U|5||7||SCREENING|1962-08-01||1967-03-20|||1973-01-27||1969-04-10
TRIAL STUDY 134XCP|RP|8BF6E538-2F39-48E4-B115-AE1693843BBC|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||BQ/UL|||10^4 CFU|NOT DONE||Y|NA|NA|1||38||LONG-TERM FOLLOW-UP|1960-09-22||1960-12-07|||1966-07-04||1964-11-23
TRIAL STUDY 134XCP|RP|8BF6E538-2F39-48E4-B115-AE1693843BBC|2||||||BCMETHOD|BIRTH CONTROL METHOD||||MIU/L|||BQ/KG|NOT DONE||U|Y|N|1||38||BASELINE|1962-08-12||1963-07-18|||1972-05-18||1963-03-04
TRIAL STUDY 134XCP|RP|8BF6E538-2F39-48E4-B115-AE1693843BBC|1||||||MENOSTAT|MENOPAUSE STATUS||||TSP|||KIT|NOT DONE||Y|Y|NA|2||58||OPEN LABEL TREATMENT|1960-08-20||1973-01-12|||1962-01-28||1960-04-28
TRIAL STUDY 134XCP|RP|8BF6E538-2F39-48E4-B115-AE1693843BBC|2||||||BCMETHOD|BIRTH CONTROL METHOD||||MSEC|||SACHET|NOT DONE||U|NA|N|2||58||INDUCTION TREATMENT|1961-01-12||1963-06-18|||1966-12-16||1966-11-08
TRIAL STUDY 134XCP|RP|8BF6E538-2F39-48E4-B115-AE1693843BBC|1||||||INTP|INTERPRETATION||||KIT|||UCI|NOT DONE||Y|N|U|3||39||OBSERVATION|1961-03-30||1971-04-30|||1963-08-05||1967-01-21
TRIAL STUDY 134XCP|RP|8BF6E538-2F39-48E4-B115-AE1693843BBC|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||TROCHE|||PA|NOT DONE||Y|U|Y|3||39||BLINDED TREATMENT|1971-11-01||1972-03-15|||1972-01-15||1968-11-16
TRIAL STUDY 134XCP|RP|8BF6E538-2F39-48E4-B115-AE1693843BBC|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||WEBER|||PMOL/G|NOT DONE||Y|Y|Y|4||88||CONTINUATION TREATMENT|1960-02-08||1962-09-18|||1967-09-04||1969-02-28
TRIAL STUDY 134XCP|RP|8BF6E538-2F39-48E4-B115-AE1693843BBC|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||BP|||TUBERCULIN UNIT/ML|NOT DONE||U|N|NA|4||88||RUN-IN|1972-07-03||1973-05-04|||1971-07-12||1964-09-16
TRIAL STUDY 134XCP|RP|8BF6E538-2F39-48E4-B115-AE1693843BBC|1||||||FUNDHT|FUNDAL HEIGHT||||10^3 ORGANISMS/ML|||FMOL|NOT DONE||U|N|NA|5||7||TREATMENT|1968-01-29||1971-04-13|||1970-03-27||1963-12-07
TRIAL STUDY 134XCP|RP|8BF6E538-2F39-48E4-B115-AE1693843BBC|2||||||THICK|THICKNESS||||V|||DRAM|NOT DONE||U|NA|NA|5||7||OPEN LABEL TREATMENT|1973-02-27||1965-12-22|||1972-11-26||1973-04-12
TRIAL STUDY 134XCP|RP|57F001BC-36EB-44AF-9487-373FA31B7311|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||WATT|||TAMPON|NOT DONE||N|Y|N|1||38||RUN-IN|1964-04-26||1968-11-20|||1965-11-10||1963-02-09
TRIAL STUDY 134XCP|RP|57F001BC-36EB-44AF-9487-373FA31B7311|2||||||DSCHGIND|DISCHARGE INDICATOR||||G/ANIMAL/WK|||G/ANIMAL/WK|NOT DONE||N|U|N|1||38||TREATMENT|1970-10-04||1963-05-03|||1970-06-26||1965-04-11
TRIAL STUDY 134XCP|RP|57F001BC-36EB-44AF-9487-373FA31B7311|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||AMU|||MG/L|NOT DONE||N|N|Y|2||58||CONTINUATION TREATMENT|1961-09-23||1961-03-11|||1963-12-24||1968-08-30
TRIAL STUDY 134XCP|RP|57F001BC-36EB-44AF-9487-373FA31B7311|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||TROCHE|||GBQ/UG|NOT DONE||Y|Y|U|2||58||RUN-IN|1962-04-19||1966-04-12|||1970-03-17||1960-04-24
TRIAL STUDY 134XCP|RP|57F001BC-36EB-44AF-9487-373FA31B7311|1||||||PEELIND|PEELING INDICATOR||||ATM|||CMOL|NOT DONE||NA|U|Y|3||39||INDUCTION TREATMENT|1967-11-30||1970-12-14|||1960-08-01||1967-06-23
TRIAL STUDY 134XCP|RP|57F001BC-36EB-44AF-9487-373FA31B7311|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||PFU/DOSE|||10^3 ORGANISMS|NOT DONE||U|N|N|3||39||OBSERVATION|1968-06-01||1960-02-06|||1966-06-20||1965-06-19
TRIAL STUDY 134XCP|RP|57F001BC-36EB-44AF-9487-373FA31B7311|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||PACK|||U/G/MIN|NOT DONE||NA|NA|NA|4||88||BASELINE|1961-11-22||1961-06-14|||1966-11-23||1963-09-10
TRIAL STUDY 134XCP|RP|57F001BC-36EB-44AF-9487-373FA31B7311|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||/10^4|||UMOL/MG/MIN|NOT DONE||U|N|NA|4||88||WASHOUT|1972-10-04||1969-07-14|||1969-12-08||1968-03-19
TRIAL STUDY 134XCP|RP|57F001BC-36EB-44AF-9487-373FA31B7311|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||DAGU/ML|||S*KPA|NOT DONE||NA|NA|Y|5||7||BLINDED TREATMENT|1970-03-11||1961-10-31|||1967-06-07||1973-06-12
TRIAL STUDY 134XCP|RP|57F001BC-36EB-44AF-9487-373FA31B7311|2||||||PREGST|PREGNANT DURING THE STUDY||||U/M2|||GTT|NOT DONE||N|Y|N|5||7||TREATMENT|1968-05-02||1965-04-03|||1961-03-24||1968-08-19
TRIAL STUDY 134XCP|RP|3FBDC961-EB02-4B28-8672-2A0A0A33529E|1||||||STILBIND|STILLBIRTH INDICATOR||||UMOL/MIN|||KEV|NOT DONE||N|U|N|1||38||FOLLOW-UP|1970-01-02||1961-09-13|||1964-07-17||1972-08-14
TRIAL STUDY 134XCP|RP|3FBDC961-EB02-4B28-8672-2A0A0A33529E|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||10^6 DNA COPIES/ML|||PIXELS/IN|NOT DONE||N|N|U|1||38||BASELINE|1962-09-15||1966-01-23|||1964-12-08||1970-09-28
TRIAL STUDY 134XCP|RP|3FBDC961-EB02-4B28-8672-2A0A0A33529E|1||||||PREGIND|PREGNANT INDICATOR||||STEPS/MIN|||MMHG/L/MIN|NOT DONE||Y|N|U|2||58||LONG-TERM FOLLOW-UP|1967-12-27||1962-12-07|||1966-03-09||1963-09-05
TRIAL STUDY 134XCP|RP|3FBDC961-EB02-4B28-8672-2A0A0A33529E|2||||||DSCHGIND|DISCHARGE INDICATOR||||LM|||UG/ML/H|NOT DONE||N|NA|U|2||58||BASELINE|1965-08-30||1961-10-04|||1962-05-08||1972-10-12
TRIAL STUDY 134XCP|RP|3FBDC961-EB02-4B28-8672-2A0A0A33529E|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||GY/MIN|||10^9/L|NOT DONE||NA|U|Y|3||39||CONTINUATION TREATMENT|1970-05-10||1968-04-24|||1960-02-27||1971-04-21
TRIAL STUDY 134XCP|RP|3FBDC961-EB02-4B28-8672-2A0A0A33529E|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||DPM/MG|||U/M2/MIN|NOT DONE||Y|U|NA|3||39||TREATMENT|1964-01-08||1966-06-02|||1971-08-30||1960-03-17
TRIAL STUDY 134XCP|RP|3FBDC961-EB02-4B28-8672-2A0A0A33529E|1||||||TNDRIND|TENDERNESS INDICATOR||||MG/ANIMAL|||PPTH|NOT DONE||NA|N|NA|4||88||CONTINUATION TREATMENT|1967-06-19||1972-09-06|||1970-08-27||1969-04-29
TRIAL STUDY 134XCP|RP|3FBDC961-EB02-4B28-8672-2A0A0A33529E|2||||||MASSIND|MASS INDICATOR||||MG/CM2|||MV*MIN|NOT DONE||U|N|NA|4||88||BASELINE|1972-01-29||1963-10-24|||1970-12-20||1965-04-21
TRIAL STUDY 134XCP|RP|3FBDC961-EB02-4B28-8672-2A0A0A33529E|1||||||INABOIND|INDUCED ABORTION INDICATOR||||UMOL/KG/MIN|||IU/MMOL|NOT DONE||Y|NA|NA|5||7||BASELINE|1967-05-02||1968-02-16|||1968-08-30||1960-06-04
TRIAL STUDY 134XCP|RP|3FBDC961-EB02-4B28-8672-2A0A0A33529E|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||10^6 U|||NMOL BCE/L|NOT DONE||U|Y|N|5||7||BLINDED TREATMENT|1965-03-23||1969-11-15|||1968-02-04||1961-04-16
TRIAL STUDY 134XCP|RP|1B524FC4-365B-4A16-A4D7-ED818C6E6086|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||TCID 50/DOSE|||CAPFUL|NOT DONE||N|NA|N|1||38||WASHOUT|1968-07-15||1963-02-17|||1969-09-20||1965-02-27
TRIAL STUDY 134XCP|RP|1B524FC4-365B-4A16-A4D7-ED818C6E6086|2||||||MENOAGE|MENOPAUSE AGE||||10^6 IU|||HPA|NOT DONE||Y|N|N|1||38||SCREENING|1968-02-24||1963-07-29|||1972-03-05||1966-04-05
TRIAL STUDY 134XCP|RP|1B524FC4-365B-4A16-A4D7-ED818C6E6086|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||UMOL/MIN|||MILE|NOT DONE||N|N|U|2||58||SCREENING|1968-10-26||1973-08-02|||1969-02-17||1972-04-15
TRIAL STUDY 134XCP|RP|1B524FC4-365B-4A16-A4D7-ED818C6E6086|2||||||PREGIND|PREGNANT INDICATOR||||MEQ/ML|||/VF|NOT DONE||Y|NA|NA|2||58||INDUCTION TREATMENT|1969-12-17||1972-08-14|||1960-07-29||1969-08-03
TRIAL STUDY 134XCP|RP|1B524FC4-365B-4A16-A4D7-ED818C6E6086|1||||||BCMETHOD|BIRTH CONTROL METHOD||||ENZYME U/M2|||MASK|NOT DONE||N|NA|NA|3||39||BASELINE|1967-05-14||1966-07-28|||1963-03-31||1963-05-18
TRIAL STUDY 134XCP|RP|1B524FC4-365B-4A16-A4D7-ED818C6E6086|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||AG|||HR/DAY|NOT DONE||NA|N|NA|3||39||OBSERVATION|1965-01-11||1966-11-15|||1967-10-26||1969-04-07
TRIAL STUDY 134XCP|RP|1B524FC4-365B-4A16-A4D7-ED818C6E6086|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||ML/MIN|||BQ/G|NOT DONE||N|N|Y|4||88||BLINDED TREATMENT|1963-10-25||1964-05-31|||1961-12-12||1972-06-13
TRIAL STUDY 134XCP|RP|1B524FC4-365B-4A16-A4D7-ED818C6E6086|2||||||RASHIND|RASH INDICATOR||||MG/CM2|||UMOL/MIN|NOT DONE||N|U|N|4||88||WASHOUT|1961-04-22||1973-06-24|||1970-02-19||1971-07-08
TRIAL STUDY 134XCP|RP|1B524FC4-365B-4A16-A4D7-ED818C6E6086|1||||||PRGENDTC|DATE PREGNANCY ENDED||||UL/DOSE|||/MS|NOT DONE||N|NA|U|5||7||CONTINUATION TREATMENT|1963-08-03||1972-03-23|||1968-05-25||1962-02-12
TRIAL STUDY 134XCP|RP|1B524FC4-365B-4A16-A4D7-ED818C6E6086|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||DYN|||KIU|NOT DONE||N|N|Y|5||7||OBSERVATION|1967-12-23||1972-07-02|||1960-06-20||1973-06-11
TRIAL STUDY 134XCP|RP|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||S/H|||PUFF|NOT DONE||NA|NA|Y|1||38||WASHOUT|1962-07-16||1964-07-03|||1973-04-06||1963-09-18
TRIAL STUDY 134XCP|RP|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||NMOL/L/H|||CY/CM|NOT DONE||Y|NA|N|1||38||INDUCTION TREATMENT|1971-07-02||1964-11-20|||1972-08-18||1962-07-26
TRIAL STUDY 134XCP|RP|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||BU|||PFU|NOT DONE||NA|Y|U|2||58||BLINDED TREATMENT|1972-11-13||1961-05-01|||1960-08-19||1960-03-20
TRIAL STUDY 134XCP|RP|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||ML/M2/DAY|||KG/CM|NOT DONE||Y|N|NA|2||58||SCREENING|1969-01-30||1970-04-04|||1970-11-04||1971-07-30
TRIAL STUDY 134XCP|RP|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|1||||||INTP|INTERPRETATION||||SIEMENS|||CIGAR|NOT DONE||Y|N|NA|3||39||LONG-TERM FOLLOW-UP|1963-05-10||1968-08-26|||1963-06-25||1967-12-25
TRIAL STUDY 134XCP|RP|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||ANTIBODY UNIT|||10^6 ORGANISMS/G|NOT DONE||NA|N|NA|3||39||BLINDED TREATMENT|1972-08-24||1969-10-12|||1971-04-14||1970-03-12
TRIAL STUDY 134XCP|RP|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^3 COPIES/ML|||ML/CM3/MIN|NOT DONE||N|U|NA|4||88||TREATMENT|1968-01-23||1963-02-01|||1966-08-21||1963-06-28
TRIAL STUDY 134XCP|RP|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||LOG10 TCID 50/DOSE|||TABLET|NOT DONE||Y|Y|N|4||88||LONG-TERM FOLLOW-UP|1962-10-26||1966-06-19|||1969-09-25||1972-05-12
TRIAL STUDY 134XCP|RP|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|1||||||BLISTIND|BLISTERING INDICATOR||||/MIN|||DEG/S|NOT DONE||Y|N|U|5||7||SCREENING|1970-03-02||1962-11-28|||1966-01-17||1970-11-19
TRIAL STUDY 134XCP|RP|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|2||||||TNDRIND|TENDERNESS INDICATOR||||GTT|||UEQ/L|NOT DONE||N|U|NA|5||7||BASELINE|1962-09-30||1966-09-24|||1971-01-30||1971-09-07
TRIAL STUDY 134XCP|RP|27671577-2C6D-429F-BED9-0EDAB15CCB33|1||||||MENARAGE|MENARCHE AGE||||LOG10 CCID 50/DOSE|||LM|NOT DONE||N|N|U|1||38||BASELINE|1961-03-14||1966-01-07|||1973-02-08||1969-09-21
TRIAL STUDY 134XCP|RP|27671577-2C6D-429F-BED9-0EDAB15CCB33|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||G/ANIMAL/WK|||10^7 TCID 50/DOSE|NOT DONE||U|U|N|1||38||RUN-IN|1969-04-28||1960-01-13|||1968-04-08||1965-08-07
TRIAL STUDY 134XCP|RP|27671577-2C6D-429F-BED9-0EDAB15CCB33|1||||||PREGST|PREGNANT DURING THE STUDY||||APL U|||CI/KG|NOT DONE||N|U|Y|2||58||OPEN LABEL TREATMENT|1964-08-23||1968-03-28|||1963-06-09||1962-08-07
TRIAL STUDY 134XCP|RP|27671577-2C6D-429F-BED9-0EDAB15CCB33|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ABSORBANCE U|||CAL|NOT DONE||NA|Y|Y|2||58||BLINDED TREATMENT|1972-04-05||1966-05-30|||1972-04-19||1961-11-20
TRIAL STUDY 134XCP|RP|27671577-2C6D-429F-BED9-0EDAB15CCB33|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||DISK|||NMOL BCE/NMOL|NOT DONE||NA|NA|U|3||39||LONG-TERM FOLLOW-UP|1969-03-08||1964-04-05|||1972-04-06||1968-10-13
TRIAL STUDY 134XCP|RP|27671577-2C6D-429F-BED9-0EDAB15CCB33|2||||||MENOSTAT|MENOPAUSE STATUS||||%(W/V)|||MKAT|NOT DONE||N|N|N|3||39||TREATMENT|1970-05-12||1970-10-02|||1961-01-03||1969-09-08
TRIAL STUDY 134XCP|RP|27671577-2C6D-429F-BED9-0EDAB15CCB33|1||||||MASSIND|MASS INDICATOR||||BOTTLE|||UMOL/L/H|NOT DONE||Y|U|NA|4||88||BLINDED TREATMENT|1968-04-21||1969-02-17|||1960-10-08||1960-12-18
TRIAL STUDY 134XCP|RP|27671577-2C6D-429F-BED9-0EDAB15CCB33|2||||||THICK|THICKNESS||||BOLUS|||KUSP|NOT DONE||U|NA|N|4||88||SCREENING|1966-11-09||1964-05-09|||1968-08-22||1971-03-13
TRIAL STUDY 134XCP|RP|27671577-2C6D-429F-BED9-0EDAB15CCB33|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||L/L|||BQ|NOT DONE||NA|U|NA|5||7||OPEN LABEL TREATMENT|1973-02-24||1965-03-14|||1963-12-25||1966-05-29
TRIAL STUDY 134XCP|RP|27671577-2C6D-429F-BED9-0EDAB15CCB33|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||GENEQ|||LOZENGE|NOT DONE||U|N|Y|5||7||CONTINUATION TREATMENT|1965-01-25||1973-05-07|||1972-04-07||1966-03-01
TRIAL STUDY 134XCP|RP|CD69750D-957B-405C-A397-AFA331D30535|1||||||THICK|THICKNESS||||MEQ/DAY|||UG/CM2|NOT DONE||NA|N|NA|1||38||RUN-IN|1971-02-07||1961-11-03|||1969-11-22||1967-12-05
TRIAL STUDY 134XCP|RP|CD69750D-957B-405C-A397-AFA331D30535|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||MEQ/DAY|||UV*SEC|NOT DONE||N|U|U|1||38||INDUCTION TREATMENT|1961-07-21||1960-08-21|||1969-04-21||1963-01-15
TRIAL STUDY 134XCP|RP|CD69750D-957B-405C-A397-AFA331D30535|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MEQ/UG|||AG|NOT DONE||N|U|U|2||58||FOLLOW-UP|1960-07-23||1973-05-15|||1972-10-29||1970-09-25
TRIAL STUDY 134XCP|RP|CD69750D-957B-405C-A397-AFA331D30535|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||USIEMENS|||SYRINGE|NOT DONE||Y|NA|U|2||58||LONG-TERM FOLLOW-UP|1973-05-16||1968-03-04|||1964-03-25||1965-01-14
TRIAL STUDY 134XCP|RP|CD69750D-957B-405C-A397-AFA331D30535|1||||||BRTHN|NUMBER OF BIRTHS||||MG/L FEU|||MIN*MG/ML|NOT DONE||NA|U|NA|3||39||OBSERVATION|1963-04-10||1972-05-17|||1966-07-06||1962-10-25
TRIAL STUDY 134XCP|RP|CD69750D-957B-405C-A397-AFA331D30535|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||VG/KG|||FIU|NOT DONE||Y|N|Y|3||39||LONG-TERM FOLLOW-UP|1961-07-16||1973-06-09|||1962-02-11||1971-01-01
TRIAL STUDY 134XCP|RP|CD69750D-957B-405C-A397-AFA331D30535|1||||||BLISTIND|BLISTERING INDICATOR||||ML/ANIMAL/DAY|||NG/DL|NOT DONE||N|Y|N|4||88||BASELINE|1966-08-08||1961-02-03|||1963-07-19||1973-08-20
TRIAL STUDY 134XCP|RP|CD69750D-957B-405C-A397-AFA331D30535|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||/CMH2O|||MS/MMHG|NOT DONE||U|U|U|4||88||FOLLOW-UP|1963-03-28||1973-02-23|||1967-06-21||1965-06-10
TRIAL STUDY 134XCP|RP|CD69750D-957B-405C-A397-AFA331D30535|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||KPA/L/SEC|||KDA|NOT DONE||Y|N|N|5||7||OBSERVATION|1965-10-15||1968-10-10|||1966-01-23||1969-01-31
TRIAL STUDY 134XCP|RP|CD69750D-957B-405C-A397-AFA331D30535|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||LX|||MAC50|NOT DONE||N|NA|U|5||7||RUN-IN|1965-01-04||1966-07-02|||1967-10-26||1972-07-22
TRIAL STUDY 134XCP|RP|5BFDDFC2-7D15-4B01-8140-62376D160EF0|1||||||INABOIND|INDUCED ABORTION INDICATOR||||STEPS/MIN|||GTT|NOT DONE||NA|Y|N|1||38||WASHOUT|1970-05-16||1961-04-21|||1971-11-30||1972-06-28
TRIAL STUDY 134XCP|RP|5BFDDFC2-7D15-4B01-8140-62376D160EF0|2||||||INTP|INTERPRETATION||||MOL/G|||M2|NOT DONE||N|NA|Y|1||38||BLINDED TREATMENT|1969-01-14||1962-02-08|||1965-11-23||1967-02-09
TRIAL STUDY 134XCP|RP|5BFDDFC2-7D15-4B01-8140-62376D160EF0|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||L/S/KPA|||MANSON U/ML|NOT DONE||N|NA|U|2||58||SCREENING|1969-06-14||1972-06-24|||1970-08-11||1969-03-17
TRIAL STUDY 134XCP|RP|5BFDDFC2-7D15-4B01-8140-62376D160EF0|2||||||PEELIND|PEELING INDICATOR||||EU|||L/MIN/M2|NOT DONE||N|Y|N|2||58||WASHOUT|1960-05-15||1962-12-25|||1962-12-16||1962-07-08
TRIAL STUDY 134XCP|RP|5BFDDFC2-7D15-4B01-8140-62376D160EF0|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||EQ|||/WK|NOT DONE||U|NA|U|3||39||SCREENING|1966-01-24||1973-05-09|||1969-11-26||1961-03-17
TRIAL STUDY 134XCP|RP|5BFDDFC2-7D15-4B01-8140-62376D160EF0|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||LOG10 ELISA UNIT|||JOULE|NOT DONE||Y|N|N|3||39||LONG-TERM FOLLOW-UP|1964-03-19||1968-01-16|||1969-06-06||1966-11-07
TRIAL STUDY 134XCP|RP|5BFDDFC2-7D15-4B01-8140-62376D160EF0|1||||||MENOAGE|MENOPAUSE AGE||||KIT|||PMOL/DAY|NOT DONE||Y|N|Y|4||88||INDUCTION TREATMENT|1970-08-04||1963-01-02|||1967-06-20||1962-02-07
TRIAL STUDY 134XCP|RP|5BFDDFC2-7D15-4B01-8140-62376D160EF0|2||||||TNDRIND|TENDERNESS INDICATOR||||10^6 CFU/G|||/10^4|NOT DONE||U|N|N|4||88||BLINDED TREATMENT|1967-01-15||1971-08-17|||1963-01-26||1964-02-18
TRIAL STUDY 134XCP|RP|5BFDDFC2-7D15-4B01-8140-62376D160EF0|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||G/U|||ML/BREATH|NOT DONE||Y|N|U|5||7||TREATMENT|1967-10-21||1962-10-20|||1960-08-26||1965-05-13
TRIAL STUDY 134XCP|RP|5BFDDFC2-7D15-4B01-8140-62376D160EF0|2||||||THICK|THICKNESS||||MET|||U/G/MIN|NOT DONE||N|Y|U|5||7||TREATMENT|1970-04-05||1962-11-22|||1969-01-09||1968-06-01
TRIAL STUDY 134XCP|RP|DEA8E573-2709-41F9-AB0D-8C39F5169B48|1||||||MENOSTAT|MENOPAUSE STATUS||||/4.0 ML|||LOG10 PFU|NOT DONE||Y|Y|Y|1||38||LONG-TERM FOLLOW-UP|1971-04-03||1967-09-11|||1960-01-29||1972-03-08
TRIAL STUDY 134XCP|RP|DEA8E573-2709-41F9-AB0D-8C39F5169B48|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^8 PFU|||10^6 DNA COPIES/ML|NOT DONE||NA|U|N|1||38||BASELINE|1966-09-04||1960-09-13|||1965-02-06||1962-01-17
TRIAL STUDY 134XCP|RP|DEA8E573-2709-41F9-AB0D-8C39F5169B48|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||SUPPOSITORY|||PMOL/10^10 CELLS|NOT DONE||Y|NA|N|2||58||TREATMENT|1970-10-27||1969-07-12|||1960-02-14||1972-03-07
TRIAL STUDY 134XCP|RP|DEA8E573-2709-41F9-AB0D-8C39F5169B48|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||10^9/DOSE|||SACHET|NOT DONE||Y|NA|NA|2||58||BLINDED TREATMENT|1969-05-01||1969-10-28|||1969-06-16||1967-05-17
TRIAL STUDY 134XCP|RP|DEA8E573-2709-41F9-AB0D-8C39F5169B48|1||||||PEELIND|PEELING INDICATOR||||MPL U/ML|||UKAT/L|NOT DONE||U|NA|N|3||39||INDUCTION TREATMENT|1961-03-30||1962-03-19|||1973-03-25||1965-01-17
TRIAL STUDY 134XCP|RP|DEA8E573-2709-41F9-AB0D-8C39F5169B48|2||||||ULCERIND|ULCER INDICATOR||||10^7/L|||G/G/DAY|NOT DONE||NA|NA|U|3||39||BASELINE|1970-02-13||1967-11-25|||1967-07-17||1966-06-06
TRIAL STUDY 134XCP|RP|DEA8E573-2709-41F9-AB0D-8C39F5169B48|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MMHG/L/MIN|||DAYS/WK|NOT DONE||N|U|Y|4||88||SCREENING|1966-06-30||1962-04-19|||1964-06-25||1966-11-24
TRIAL STUDY 134XCP|RP|DEA8E573-2709-41F9-AB0D-8C39F5169B48|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||IU/G|||MMOL/G|NOT DONE||N|U|U|4||88||CONTINUATION TREATMENT|1967-05-22||1961-04-09|||1967-03-15||1961-10-30
TRIAL STUDY 134XCP|RP|DEA8E573-2709-41F9-AB0D-8C39F5169B48|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||LOG10 PFU|||MCI/L|NOT DONE||Y|N|Y|5||7||FOLLOW-UP|1961-05-02||1964-12-22|||1965-01-18||1962-12-13
TRIAL STUDY 134XCP|RP|DEA8E573-2709-41F9-AB0D-8C39F5169B48|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||UG/L DDU|||BAU|NOT DONE||U|Y|NA|5||7||LONG-TERM FOLLOW-UP|1965-03-24||1963-02-11|||1961-08-13||1961-12-16
TRIAL STUDY 134XCP|RP|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/DAY|||UG/G/H|NOT DONE||Y|U|NA|1||38||TREATMENT|1969-10-30||1972-07-25|||1962-09-14||1961-03-06
TRIAL STUDY 134XCP|RP|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|2||||||TNDRIND|TENDERNESS INDICATOR||||BREATHS/30S|||/40 HPFS|NOT DONE||NA|Y|Y|1||38||INDUCTION TREATMENT|1970-08-22||1969-01-31|||1971-01-18||1962-07-12
TRIAL STUDY 134XCP|RP|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|1||||||TNDRIND|TENDERNESS INDICATOR||||JAR|||10^8 PFU|NOT DONE||Y|U|N|2||58||OBSERVATION|1964-09-11||1962-03-14|||1964-11-17||1971-11-01
TRIAL STUDY 134XCP|RP|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|2||||||FUNDHT|FUNDAL HEIGHT||||LOZENGE|||LB|NOT DONE||N|U|U|2||58||FOLLOW-UP|1971-07-17||1967-07-21|||1971-07-11||1966-02-22
TRIAL STUDY 134XCP|RP|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||OZ EQ|||UM/S|NOT DONE||N|U|U|3||39||OPEN LABEL TREATMENT|1967-02-04||1972-09-26|||1960-07-05||1965-07-19
TRIAL STUDY 134XCP|RP|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|2||||||RASHIND|RASH INDICATOR||||NGEQ/L|||ML/M2|NOT DONE||U|U|N|3||39||FOLLOW-UP|1973-06-09||1965-07-31|||1969-05-29||1965-02-20
TRIAL STUDY 134XCP|RP|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|1||||||GRAVIND|GRAVIDA INDICATOR||||MV2/HZ|||U|NOT DONE||NA|U|U|4||88||BASELINE|1971-10-06||1972-01-22|||1965-11-04||1965-07-12
TRIAL STUDY 134XCP|RP|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|2||||||MENFDUR|MENSES FLOW DURATION||||DAYS|||KHZ|NOT DONE||NA|Y|N|4||88||BASELINE|1962-04-25||1962-06-02|||1965-09-17||1968-07-24
TRIAL STUDY 134XCP|RP|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|1||||||RASHIND|RASH INDICATOR||||UG/M2|||MV/SEC|NOT DONE||Y|N|N|5||7||CONTINUATION TREATMENT|1964-10-08||1963-01-05|||1970-12-25||1970-07-06
TRIAL STUDY 134XCP|RP|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|2||||||PRGENDTC|DATE PREGNANCY ENDED||||UMOL|||SUPPOSITORY|NOT DONE||Y|NA|N|5||7||LONG-TERM FOLLOW-UP|1961-05-28||1967-10-26|||1967-11-14||1966-06-08
TRIAL STUDY 134XCP|RP|77CF8795-CFF5-40C6-A811-624972806A38|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||JAR|||KG/MOL|NOT DONE||Y|NA|NA|1||38||CONTINUATION TREATMENT|1967-08-10||1960-10-24|||1966-09-19||1960-07-20
TRIAL STUDY 134XCP|RP|77CF8795-CFF5-40C6-A811-624972806A38|2||||||MENARAGE|MENARCHE AGE||||G/G|||PLUG|NOT DONE||NA|NA|NA|1||38||OBSERVATION|1973-04-15||1963-04-09|||1962-10-04||1973-03-30
TRIAL STUDY 134XCP|RP|77CF8795-CFF5-40C6-A811-624972806A38|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||BOTTLE|||LX|NOT DONE||NA|NA|N|2||58||OPEN LABEL TREATMENT|1970-08-11||1968-01-11|||1965-10-22||1962-04-23
TRIAL STUDY 134XCP|RP|77CF8795-CFF5-40C6-A811-624972806A38|2||||||ERYTHIND|ERYTHEMA INDICATOR||||GENEQ|||BE/ML|NOT DONE||NA|NA|N|2||58||SCREENING|1962-11-12||1961-03-21|||1969-10-18||1966-10-08
TRIAL STUDY 134XCP|RP|77CF8795-CFF5-40C6-A811-624972806A38|1||||||TNDRIND|TENDERNESS INDICATOR||||G/CAGE|||LM|NOT DONE||Y|U|Y|3||39||INDUCTION TREATMENT|1965-03-29||1973-08-19|||1969-03-21||1972-01-01
TRIAL STUDY 134XCP|RP|77CF8795-CFF5-40C6-A811-624972806A38|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||TUBERCULIN UNIT/ML|||DAGU|NOT DONE||Y|U|Y|3||39||SCREENING|1967-07-15||1961-11-05|||1965-01-26||1972-04-03
TRIAL STUDY 134XCP|RP|77CF8795-CFF5-40C6-A811-624972806A38|1||||||MENOAGE|MENOPAUSE AGE||||MEQ/UL|||NMOL|NOT DONE||N|N|Y|4||88||WASHOUT|1973-01-12||1966-10-24|||1965-03-12||1965-06-17
TRIAL STUDY 134XCP|RP|77CF8795-CFF5-40C6-A811-624972806A38|2||||||PREGIND|PREGNANT INDICATOR||||BQ/MG|||U/G HB|NOT DONE||NA|NA|NA|4||88||BASELINE|1964-08-03||1973-05-07|||1968-02-24||1969-05-12
TRIAL STUDY 134XCP|RP|77CF8795-CFF5-40C6-A811-624972806A38|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||10^9 CFU/ML|||CI/UG|NOT DONE||U|Y|U|5||7||CONTINUATION TREATMENT|1967-06-09||1963-12-31|||1961-08-23||1961-02-01
TRIAL STUDY 134XCP|RP|77CF8795-CFF5-40C6-A811-624972806A38|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||ANSON U|||10^4/HPF|NOT DONE||N|NA|U|5||7||WASHOUT|1969-11-25||1963-12-27|||1961-02-05||1965-07-24
TRIAL STUDY 134XCP|RP|D43B827C-D393-41D4-81C5-AACB1A7673A1|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||UMOL/L/H|||BOLUS|NOT DONE||N|NA|U|1||38||WASHOUT|1972-03-08||1970-03-29|||1960-12-28||1971-09-03
TRIAL STUDY 134XCP|RP|D43B827C-D393-41D4-81C5-AACB1A7673A1|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||KG/CM2|||UU/DL|NOT DONE||Y|N|U|1||38||OPEN LABEL TREATMENT|1973-04-02||1972-08-13|||1969-11-25||1969-09-22
TRIAL STUDY 134XCP|RP|D43B827C-D393-41D4-81C5-AACB1A7673A1|1||||||MASSIND|MASS INDICATOR||||NMOL/G|||MG/M2/DAY|NOT DONE||Y|Y|Y|2||58||WASHOUT|1970-11-29||1968-12-05|||1963-03-17||1967-01-16
TRIAL STUDY 134XCP|RP|D43B827C-D393-41D4-81C5-AACB1A7673A1|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MM/2H|||HPA|NOT DONE||Y|U|Y|2||58||SCREENING|1964-09-02||1972-11-29|||1966-08-09||1970-11-05
TRIAL STUDY 134XCP|RP|D43B827C-D393-41D4-81C5-AACB1A7673A1|1||||||BLISTIND|BLISTERING INDICATOR||||UL|||MPS U|NOT DONE||N|N|Y|3||39||OPEN LABEL TREATMENT|1970-01-11||1972-03-15|||1966-10-08||1968-08-19
TRIAL STUDY 134XCP|RP|D43B827C-D393-41D4-81C5-AACB1A7673A1|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||BU/ML|||MV2/HZ|NOT DONE||N|N|N|3||39||FOLLOW-UP|1971-12-24||1973-05-02|||1968-08-24||1960-10-22
TRIAL STUDY 134XCP|RP|D43B827C-D393-41D4-81C5-AACB1A7673A1|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||10^7 PFU|||HPA|NOT DONE||U|NA|U|4||88||OBSERVATION|1973-01-30||1965-01-24|||1971-10-28||1964-08-16
TRIAL STUDY 134XCP|RP|D43B827C-D393-41D4-81C5-AACB1A7673A1|2||||||TNDRIND|TENDERNESS INDICATOR||||/200 HPFS|||MG/M2|NOT DONE||N|NA|N|4||88||SCREENING|1960-10-07||1960-12-07|||1971-03-11||1964-11-10
TRIAL STUDY 134XCP|RP|D43B827C-D393-41D4-81C5-AACB1A7673A1|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||UMOL/KG/MIN|||H*%|NOT DONE||NA|N|Y|5||7||LONG-TERM FOLLOW-UP|1972-04-30||1964-05-27|||1965-06-26||1962-01-07
TRIAL STUDY 134XCP|RP|D43B827C-D393-41D4-81C5-AACB1A7673A1|2||||||BCMETHOD|BIRTH CONTROL METHOD||||EU|||10^4 CFU|NOT DONE||Y|U|NA|5||7||LONG-TERM FOLLOW-UP|1961-02-20||1966-07-10|||1962-03-24||1969-06-25
TRIAL STUDY 134XCP|RP|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||VOXEL|||UG/L/H|NOT DONE||Y|Y|U|1||38||FOLLOW-UP|1962-07-06||1968-08-16|||1969-07-17||1971-12-02
TRIAL STUDY 134XCP|RP|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||CMOL/L|||CMH2O*S2/ML|NOT DONE||U|N|NA|1||38||BLINDED TREATMENT|1966-07-27||1965-11-30|||1967-06-27||1969-11-14
TRIAL STUDY 134XCP|RP|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|1||||||BCMETHOD|BIRTH CONTROL METHOD||||10^6 CFU/G|||LM|NOT DONE||U|NA|N|2||58||TREATMENT|1968-04-19||1966-04-09|||1970-03-07||1965-05-19
TRIAL STUDY 134XCP|RP|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MPL U|||ML/MIN|NOT DONE||Y|Y|NA|2||58||TREATMENT|1971-03-22||1965-07-16|||1966-10-22||1971-10-02
TRIAL STUDY 134XCP|RP|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||BQ/KG|||10^3/L|NOT DONE||NA|Y|N|3||39||RUN-IN|1968-07-11||1973-02-25|||1960-05-17||1965-09-23
TRIAL STUDY 134XCP|RP|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||TSP|||10^6 ORGANISMS/MG|NOT DONE||Y|N|N|3||39||BASELINE|1970-09-07||1969-06-08|||1962-04-02||1970-10-10
TRIAL STUDY 134XCP|RP|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MG/G/H|||CM H2O|NOT DONE||NA|U|N|4||88||LONG-TERM FOLLOW-UP|1962-06-21||1970-03-30|||1961-11-19||1962-05-12
TRIAL STUDY 134XCP|RP|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|2||||||DSCHGIND|DISCHARGE INDICATOR||||UCI/L|||MOL/L|NOT DONE||U|N|U|4||88||CONTINUATION TREATMENT|1969-09-06||1972-06-22|||1960-05-09||1970-03-24
TRIAL STUDY 134XCP|RP|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|1||||||MENOSTAT|MENOPAUSE STATUS||||BQ/KG|||S/H|NOT DONE||NA|NA|U|5||7||FOLLOW-UP|1964-01-16||1964-08-09|||1964-04-04||1969-11-18
TRIAL STUDY 134XCP|RP|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||L/L|||DAYS/MONTH|NOT DONE||U|U|U|5||7||CONTINUATION TREATMENT|1971-12-18||1960-02-06|||1970-08-14||1965-04-25
TRIAL STUDY 134XCP|RP|0671FB62-42B8-4882-93ED-0E11CFE07DE9|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||U/G|||MONTHS|NOT DONE||NA|U|NA|1||38||INDUCTION TREATMENT|1960-06-19||1965-01-02|||1968-01-22||1968-02-14
TRIAL STUDY 134XCP|RP|0671FB62-42B8-4882-93ED-0E11CFE07DE9|2||||||THICK|THICKNESS||||10^9/DOSE|||TABLET|NOT DONE||NA|N|N|1||38||TREATMENT|1963-07-10||1967-02-15|||1966-02-22||1962-08-17
TRIAL STUDY 134XCP|RP|0671FB62-42B8-4882-93ED-0E11CFE07DE9|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||G/ANIMAL/DAY|||UM2|NOT DONE||U|U|N|2||58||WASHOUT|1967-06-15||1964-10-09|||1965-12-18||1962-07-24
TRIAL STUDY 134XCP|RP|0671FB62-42B8-4882-93ED-0E11CFE07DE9|2||||||BCMETHOD|BIRTH CONTROL METHOD||||NMOL BCE/MMOL|||ML/H|NOT DONE||NA|Y|U|2||58||FOLLOW-UP|1962-03-31||1968-03-19|||1969-01-21||1961-03-29
TRIAL STUDY 134XCP|RP|0671FB62-42B8-4882-93ED-0E11CFE07DE9|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||UG/KG/DAY|||UG/M2/MIN|NOT DONE||N|N|U|3||39||RUN-IN|1961-07-31||1961-04-10|||1970-10-21||1964-08-19
TRIAL STUDY 134XCP|RP|0671FB62-42B8-4882-93ED-0E11CFE07DE9|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||/100 HPFS|||CUP EQ|NOT DONE||NA|Y|Y|3||39||OBSERVATION|1970-02-04||1966-09-06|||1972-02-29||1972-12-23
TRIAL STUDY 134XCP|RP|0671FB62-42B8-4882-93ED-0E11CFE07DE9|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||U/L|||MSEC|NOT DONE||N|U|NA|4||88||OBSERVATION|1972-04-26||1968-06-04|||1961-02-23||1961-09-29
TRIAL STUDY 134XCP|RP|0671FB62-42B8-4882-93ED-0E11CFE07DE9|2||||||PREGST|PREGNANT DURING THE STUDY||||10^5/HPF|||%(W/W)|NOT DONE||Y|U|N|4||88||RUN-IN|1970-05-28||1962-08-06|||1961-09-01||1971-04-06
TRIAL STUDY 134XCP|RP|0671FB62-42B8-4882-93ED-0E11CFE07DE9|1||||||EDEMAIND|EDEMA INDICATOR||||BE/ML|||FOZ_US|NOT DONE||U|NA|U|5||7||LONG-TERM FOLLOW-UP|1968-05-14||1965-12-27|||1972-04-22||1963-01-27
TRIAL STUDY 134XCP|RP|0671FB62-42B8-4882-93ED-0E11CFE07DE9|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||KG/MOL|||G/KG/DAY|NOT DONE||N|N|U|5||7||BASELINE|1964-05-18||1973-08-08|||1968-03-17||1963-06-01
TRIAL STUDY 134XCP|RP|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||PMOL/10^9 CELLS|||MG/L|NOT DONE||Y|Y|N|1||38||SCREENING|1966-06-06||1973-07-22|||1968-06-28||1968-01-08
TRIAL STUDY 134XCP|RP|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||FMOL/L/SEC|||DEG|NOT DONE||N|Y|U|1||38||SCREENING|1968-12-03||1971-10-02|||1962-08-12||1962-03-12
TRIAL STUDY 134XCP|RP|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|1||||||PRGENDTC|DATE PREGNANCY ENDED||||MG/H|||BQ/ML|NOT DONE||Y|NA|Y|2||58||OBSERVATION|1969-11-08||1962-08-25|||1963-10-11||1966-06-14
TRIAL STUDY 134XCP|RP|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MG/G/H|||ANSON U|NOT DONE||N|NA|Y|2||58||OPEN LABEL TREATMENT|1963-11-24||1962-12-02|||1964-05-23||1962-05-25
TRIAL STUDY 134XCP|RP|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|1||||||DSCHGIND|DISCHARGE INDICATOR||||/10^3|||SBE/ML|NOT DONE||U|U|U|3||39||OPEN LABEL TREATMENT|1972-06-24||1971-09-12|||1968-01-04||1970-05-03
TRIAL STUDY 134XCP|RP|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||NSEC|||CI/L|NOT DONE||Y|Y|N|3||39||TREATMENT|1963-12-06||1965-01-17|||1963-03-02||1961-06-29
TRIAL STUDY 134XCP|RP|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||KS|||LOG10 TCID 50/DOSE|NOT DONE||NA|U|U|4||88||SCREENING|1968-04-17||1967-05-29|||1968-07-30||1964-04-02
TRIAL STUDY 134XCP|RP|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|2||||||BRTHN|NUMBER OF BIRTHS||||OSM|||LOG10 CCID 50/DOSE|NOT DONE||Y|U|N|4||88||RUN-IN|1964-09-21||1965-08-04|||1972-12-27||1964-10-24
TRIAL STUDY 134XCP|RP|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|1||||||FUNDHT|FUNDAL HEIGHT||||MEQ/G|||UMOL/L/MIN|NOT DONE||U|NA|Y|5||7||RUN-IN|1967-10-01||1964-10-21|||1968-03-14||1968-02-16
TRIAL STUDY 134XCP|RP|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|2||||||PEELIND|PEELING INDICATOR||||OI50|||/DAY|NOT DONE||U|Y|U|5||7||BASELINE|1973-04-06||1963-05-13|||1962-03-25||1971-10-28
TRIAL STUDY 134XCP|RP|E9161164-3B91-4855-AFBA-12C6BD93F95F|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||NEWTON|||KEV|NOT DONE||U|Y|U|1||38||OPEN LABEL TREATMENT|1966-07-02||1968-02-20|||1967-06-19||1968-11-16
TRIAL STUDY 134XCP|RP|E9161164-3B91-4855-AFBA-12C6BD93F95F|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MG/G/MIN|||/5X10^4 WBC|NOT DONE||NA|NA|NA|1||38||FOLLOW-UP|1970-01-25||1966-01-14|||1967-12-20||1961-04-16
TRIAL STUDY 134XCP|RP|E9161164-3B91-4855-AFBA-12C6BD93F95F|1||||||PUSTIND|PUSTULE INDICATOR||||NEEDLE GAUGE|||MGEQ|NOT DONE||N|U|NA|2||58||SCREENING|1972-06-26||1972-12-15|||1971-02-23||1965-08-12
TRIAL STUDY 134XCP|RP|E9161164-3B91-4855-AFBA-12C6BD93F95F|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||IU/MMOL|||TORR|NOT DONE||Y|U|U|2||58||CONTINUATION TREATMENT|1967-02-27||1963-04-15|||1969-11-08||1960-11-17
TRIAL STUDY 134XCP|RP|E9161164-3B91-4855-AFBA-12C6BD93F95F|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||10^3 RNA COPIES/ML|||UM|NOT DONE||U|Y|N|3||39||TREATMENT|1966-08-01||1960-10-16|||1963-07-02||1961-05-30
TRIAL STUDY 134XCP|RP|E9161164-3B91-4855-AFBA-12C6BD93F95F|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^6 ORGANISMS/MG|||ELISA UNIT/DOSE|NOT DONE||NA|NA|N|3||39||CONTINUATION TREATMENT|1960-06-03||1970-10-26|||1962-05-01||1969-06-20
TRIAL STUDY 134XCP|RP|E9161164-3B91-4855-AFBA-12C6BD93F95F|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||UG|||NMOL/MOL|NOT DONE||Y|Y|N|4||88||LONG-TERM FOLLOW-UP|1970-12-02||1967-05-19|||1965-09-30||1973-07-23
TRIAL STUDY 134XCP|RP|E9161164-3B91-4855-AFBA-12C6BD93F95F|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UCI/L|||DL|NOT DONE||U|Y|Y|4||88||BASELINE|1967-06-30||1962-07-05|||1965-11-01||1963-11-21
TRIAL STUDY 134XCP|RP|E9161164-3B91-4855-AFBA-12C6BD93F95F|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||COAT|||MEQ/DL|NOT DONE||U|NA|Y|5||7||OBSERVATION|1967-05-13||1965-01-21|||1967-09-02||1960-08-06
TRIAL STUDY 134XCP|RP|E9161164-3B91-4855-AFBA-12C6BD93F95F|2||||||PREGIND|PREGNANT INDICATOR||||MMOL/S|||100 IU/ML|NOT DONE||NA|Y|U|5||7||BLINDED TREATMENT|1973-01-05||1963-02-13|||1962-11-04||1970-11-25
TRIAL STUDY 134XCP|RP|FBB66C13-05F5-4337-B34A-9900EB5F50F3|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||INHALATION|||ANSON U|NOT DONE||NA|N|Y|1||38||OBSERVATION|1961-08-17||1972-03-21|||1972-10-09||1962-09-11
TRIAL STUDY 134XCP|RP|FBB66C13-05F5-4337-B34A-9900EB5F50F3|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||GBQ/MG|||KUSP|NOT DONE||U|N|NA|1||38||SCREENING|1966-09-29||1966-03-30|||1968-04-19||1966-06-21
TRIAL STUDY 134XCP|RP|FBB66C13-05F5-4337-B34A-9900EB5F50F3|1||||||PUSTIND|PUSTULE INDICATOR||||UMOL/L/SEC|||CAL|NOT DONE||Y|NA|U|2||58||FOLLOW-UP|1967-09-08||1969-10-19|||1964-05-05||1971-03-08
TRIAL STUDY 134XCP|RP|FBB66C13-05F5-4337-B34A-9900EB5F50F3|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||G/DAY|||FMOL/G|NOT DONE||Y|Y|Y|2||58||TREATMENT|1960-02-17||1962-12-26|||1966-06-10||1963-08-20
TRIAL STUDY 134XCP|RP|FBB66C13-05F5-4337-B34A-9900EB5F50F3|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||NMOL BCE/NMOL|||PPB|NOT DONE||Y|Y|Y|3||39||CONTINUATION TREATMENT|1965-01-11||1963-09-08|||1960-12-01||1967-04-24
TRIAL STUDY 134XCP|RP|FBB66C13-05F5-4337-B34A-9900EB5F50F3|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||TSP EQ|||10^6 ORGANISMS|NOT DONE||Y|NA|Y|3||39||SCREENING|1960-01-17||1961-08-19|||1971-04-18||1963-02-22
TRIAL STUDY 134XCP|RP|FBB66C13-05F5-4337-B34A-9900EB5F50F3|1||||||ULCERIND|ULCER INDICATOR||||APL U/ML|||UCI|NOT DONE||Y|N|Y|4||88||LONG-TERM FOLLOW-UP|1969-06-29||1969-02-22|||1961-06-29||1972-09-18
TRIAL STUDY 134XCP|RP|FBB66C13-05F5-4337-B34A-9900EB5F50F3|2||||||FUNDHT|FUNDAL HEIGHT||||MMOL|||MV2/HZ|NOT DONE||N|N|N|4||88||BLINDED TREATMENT|1971-01-31||1962-09-09|||1961-02-05||1961-03-17
TRIAL STUDY 134XCP|RP|FBB66C13-05F5-4337-B34A-9900EB5F50F3|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||CI/UG|||MEQ/UG|NOT DONE||NA|N|Y|5||7||SCREENING|1963-04-30||1966-10-07|||1962-06-29||1966-12-28
TRIAL STUDY 134XCP|RP|FBB66C13-05F5-4337-B34A-9900EB5F50F3|2||||||DLVRMODE|MODE OF DELIVERY||||NMOL/DAY|||FFU|NOT DONE||Y|N|NA|5||7||OBSERVATION|1971-09-23||1971-06-01|||1965-02-06||1968-02-21
TRIAL STUDY 134XCP|RP|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||NG/DAY|||MG/KG|NOT DONE||NA|U|U|1||38||BASELINE|1968-02-02||1968-05-27|||1966-11-28||1962-03-04
TRIAL STUDY 134XCP|RP|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||U|||G/G|NOT DONE||N|U|N|1||38||BASELINE|1960-03-25||1968-01-31|||1964-02-10||1961-01-06
TRIAL STUDY 134XCP|RP|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|1||||||INTP|INTERPRETATION||||CFU/G|||U/M2/MIN|NOT DONE||N|NA|NA|2||58||CONTINUATION TREATMENT|1971-03-09||1970-08-28|||1960-07-13||1969-02-23
TRIAL STUDY 134XCP|RP|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||BAR|||CCID 50/ML|NOT DONE||N|U|N|2||58||OPEN LABEL TREATMENT|1964-03-21||1960-10-13|||1963-02-04||1971-11-24
TRIAL STUDY 134XCP|RP|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^4 CFU/ML|||KS|NOT DONE||Y|Y|NA|3||39||CONTINUATION TREATMENT|1967-12-13||1962-05-18|||1964-08-11||1961-10-06
TRIAL STUDY 134XCP|RP|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||AG|||SUPPOSITORY|NOT DONE||Y|N|U|3||39||FOLLOW-UP|1961-11-11||1962-09-04|||1973-03-16||1963-12-22
TRIAL STUDY 134XCP|RP|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||DROP|||M|NOT DONE||NA|U|Y|4||88||OBSERVATION|1965-06-16||1962-09-28|||1962-10-09||1972-03-28
TRIAL STUDY 134XCP|RP|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||/500 WBC|||NG/MOL|NOT DONE||Y|NA|Y|4||88||INDUCTION TREATMENT|1966-12-12||1967-04-24|||1964-04-21||1969-05-27
TRIAL STUDY 134XCP|RP|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|1||||||MASSIND|MASS INDICATOR||||G/CM2|||DRUM|NOT DONE||N|Y|U|5||7||BLINDED TREATMENT|1960-03-16||1962-07-31|||1963-10-12||1960-06-16
TRIAL STUDY 134XCP|RP|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MMHG/L/MIN|||MEQ/DL|NOT DONE||U|N|NA|5||7||CONTINUATION TREATMENT|1964-02-12||1969-08-08|||1964-05-22||1961-12-05
TRIAL STUDY 134XCP|RP|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||USEC|||LOG10 TCID 50/UL|NOT DONE||N|Y|U|1||38||OBSERVATION|1972-09-12||1971-12-11|||1969-06-03||1966-10-31
TRIAL STUDY 134XCP|RP|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|2||||||FUNDHT|FUNDAL HEIGHT||||NU/CL|||LOG10 PFU|NOT DONE||NA|U|Y|1||38||TREATMENT|1961-10-02||1963-08-28|||1971-03-19||1972-06-21
TRIAL STUDY 134XCP|RP|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|1||||||INTP|INTERPRETATION||||10^3 ORGANISMS/G|||KM|NOT DONE||NA|Y|Y|2||58||BASELINE|1970-02-25||1965-12-13|||1968-11-24||1966-03-13
TRIAL STUDY 134XCP|RP|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||UG/ANIMAL|||10^12 IU/L|NOT DONE||NA|U|U|2||58||FOLLOW-UP|1968-08-02||1966-04-28|||1963-08-03||1965-02-11
TRIAL STUDY 134XCP|RP|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||DPM/ML|||/100 HPFS|NOT DONE||N|U|N|3||39||BASELINE|1968-03-06||1964-07-05|||1961-10-10||1971-05-20
TRIAL STUDY 134XCP|RP|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|2||||||GRAVIND|GRAVIDA INDICATOR||||ENZYME U|||MM2|NOT DONE||U|NA|NA|3||39||TREATMENT|1962-10-09||1960-12-22|||1966-03-02||1963-04-17
TRIAL STUDY 134XCP|RP|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|1||||||ERYTHIND|ERYTHEMA INDICATOR||||VG/ML|||CI/MG|NOT DONE||Y|NA|U|4||88||OBSERVATION|1964-09-02||1968-01-17|||1963-11-20||1970-02-17
TRIAL STUDY 134XCP|RP|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|2||||||INTP|INTERPRETATION||||LOG10 CFU/ML|||/2000 RBC|NOT DONE||NA|U|NA|4||88||TREATMENT|1964-01-17||1970-11-07|||1960-05-17||1964-11-30
TRIAL STUDY 134XCP|RP|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|1||||||PREGST|PREGNANT DURING THE STUDY||||NKAT/L|||GAUSS|NOT DONE||N|N|Y|5||7||TREATMENT|1960-06-22||1967-02-14|||1966-07-07||1970-07-21
TRIAL STUDY 134XCP|RP|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||GTT|||U/L|NOT DONE||N|NA|U|5||7||WASHOUT|1973-02-19||1963-01-13|||1966-06-22||1964-12-23
TRIAL STUDY 134XCP|RP|21223189-5527-4B3F-AFD5-21F77AC0DEBE|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||G/ANIMAL/WK|||10^10/L|NOT DONE||NA|N|NA|1||38||SCREENING|1964-05-02||1964-07-27|||1970-07-07||1967-09-11
TRIAL STUDY 134XCP|RP|21223189-5527-4B3F-AFD5-21F77AC0DEBE|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||CD|||CI/MG|NOT DONE||N|NA|U|1||38||BLINDED TREATMENT|1965-11-07||1971-11-23|||1964-02-26||1972-09-18
TRIAL STUDY 134XCP|RP|21223189-5527-4B3F-AFD5-21F77AC0DEBE|1||||||RASHIND|RASH INDICATOR||||CD/M2|||M|NOT DONE||NA|N|NA|2||58||TREATMENT|1971-10-04||1968-06-07|||1965-03-24||1972-10-31
TRIAL STUDY 134XCP|RP|21223189-5527-4B3F-AFD5-21F77AC0DEBE|2||||||PREGNN|NUMBER OF PREGNANCIES||||10^4 CFU|||MV|NOT DONE||Y|NA|N|2||58||CONTINUATION TREATMENT|1969-08-03||1960-01-31|||1971-01-27||1970-04-07
TRIAL STUDY 134XCP|RP|21223189-5527-4B3F-AFD5-21F77AC0DEBE|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||ML/ANIMAL/DAY|||JAR|NOT DONE||Y|U|NA|3||39||CONTINUATION TREATMENT|1968-05-29||1964-06-21|||1973-05-30||1971-02-09
TRIAL STUDY 134XCP|RP|21223189-5527-4B3F-AFD5-21F77AC0DEBE|2||||||BLISTIND|BLISTERING INDICATOR||||/HPF|||SV|NOT DONE||Y|Y|N|3||39||TREATMENT|1971-03-26||1965-09-16|||1973-08-10||1962-01-22
TRIAL STUDY 134XCP|RP|21223189-5527-4B3F-AFD5-21F77AC0DEBE|1||||||EDEMAIND|EDEMA INDICATOR||||DAYS|||ML/G/MIN|NOT DONE||N|N|U|4||88||CONTINUATION TREATMENT|1969-08-09||1970-09-18|||1961-12-20||1968-01-24
TRIAL STUDY 134XCP|RP|21223189-5527-4B3F-AFD5-21F77AC0DEBE|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||VIAL|||SBE/ML|NOT DONE||N|N|Y|4||88||BASELINE|1972-07-15||1961-12-11|||1972-06-28||1965-07-31
TRIAL STUDY 134XCP|RP|21223189-5527-4B3F-AFD5-21F77AC0DEBE|1||||||THICK|THICKNESS||||MEQ/DL|||10^3 CFU/ML|NOT DONE||Y|NA|U|5||7||BLINDED TREATMENT|1962-03-20||1963-09-10|||1971-05-06||1968-07-02
TRIAL STUDY 134XCP|RP|21223189-5527-4B3F-AFD5-21F77AC0DEBE|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||U/M2/MIN|||NFIU|NOT DONE||NA|U|NA|5||7||CONTINUATION TREATMENT|1972-02-29||1965-08-19|||1963-03-06||1963-06-09
TRIAL STUDY 134XCP|RP|CA6ECC17-3E3B-435C-A485-8612C267E52B|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||K|||USP U|NOT DONE||U|NA|NA|1||38||WASHOUT|1968-04-09||1965-01-20|||1961-01-25||1970-03-12
TRIAL STUDY 134XCP|RP|CA6ECC17-3E3B-435C-A485-8612C267E52B|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||KPA|||GBQ|NOT DONE||NA|Y|NA|1||38||OBSERVATION|1972-08-14||1964-05-24|||1961-07-31||1966-09-19
TRIAL STUDY 134XCP|RP|CA6ECC17-3E3B-435C-A485-8612C267E52B|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||10^6 U|||DB|NOT DONE||Y|NA|N|2||58||INDUCTION TREATMENT|1966-12-08||1972-12-29|||1971-02-03||1973-06-25
TRIAL STUDY 134XCP|RP|CA6ECC17-3E3B-435C-A485-8612C267E52B|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||UG/M2/H|||CAL|NOT DONE||U|Y|N|2||58||INDUCTION TREATMENT|1968-12-03||1961-05-22|||1967-09-25||1971-09-27
TRIAL STUDY 134XCP|RP|CA6ECC17-3E3B-435C-A485-8612C267E52B|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MG/G/H|||LOG10 CCID 50/DOSE|NOT DONE||Y|N|U|3||39||INDUCTION TREATMENT|1969-04-26||1967-12-05|||1967-06-13||1968-03-03
TRIAL STUDY 134XCP|RP|CA6ECC17-3E3B-435C-A485-8612C267E52B|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||KPA|||L/S|NOT DONE||U|NA|U|3||39||OPEN LABEL TREATMENT|1971-02-11||1966-08-16|||1967-02-26||1972-04-06
TRIAL STUDY 134XCP|RP|CA6ECC17-3E3B-435C-A485-8612C267E52B|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^3/L|||AFU|NOT DONE||N|N|Y|4||88||RUN-IN|1962-01-19||1969-10-09|||1963-05-19||1961-10-01
TRIAL STUDY 134XCP|RP|CA6ECC17-3E3B-435C-A485-8612C267E52B|2||||||MASSIND|MASS INDICATOR||||UMOL/MIN|||IU/DAY|NOT DONE||NA|NA|U|4||88||INDUCTION TREATMENT|1966-01-17||1971-07-15|||1971-08-22||1961-06-30
TRIAL STUDY 134XCP|RP|CA6ECC17-3E3B-435C-A485-8612C267E52B|1||||||PRGENDTC|DATE PREGNANCY ENDED||||M3|||/MM2|NOT DONE||U|N|N|5||7||CONTINUATION TREATMENT|1965-10-17||1965-02-11|||1969-10-24||1960-11-16
TRIAL STUDY 134XCP|RP|CA6ECC17-3E3B-435C-A485-8612C267E52B|2||||||PREGIND|PREGNANT INDICATOR||||GENEQ|||MIN*MG/ML|NOT DONE||NA|NA|NA|5||7||RUN-IN|1972-07-20||1961-12-05|||1964-02-06||1962-07-18
TRIAL STUDY 134XCP|RP|BCB41507-87B3-4773-B1E5-AE039853DED0|1||||||BLISTIND|BLISTERING INDICATOR||||CM/MIN|||MCI/L|NOT DONE||NA|NA|Y|1||38||OBSERVATION|1965-01-13||1962-11-27|||1971-06-13||1970-01-30
TRIAL STUDY 134XCP|RP|BCB41507-87B3-4773-B1E5-AE039853DED0|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||/HPF|||TSP|NOT DONE||Y|U|U|1||38||TREATMENT|1966-02-19||1963-05-24|||1968-01-23||1968-12-31
TRIAL STUDY 134XCP|RP|BCB41507-87B3-4773-B1E5-AE039853DED0|1||||||MASSIND|MASS INDICATOR||||BOTTLE|||L/KG|NOT DONE||NA|U|NA|2||58||FOLLOW-UP|1971-03-08||1960-03-24|||1960-02-23||1968-05-17
TRIAL STUDY 134XCP|RP|BCB41507-87B3-4773-B1E5-AE039853DED0|2||||||PRGENDTC|DATE PREGNANCY ENDED||||NKAT/G HB|||AMPULE|NOT DONE||NA|Y|U|2||58||WASHOUT|1970-02-04||1966-03-09|||1962-04-16||1970-05-20
TRIAL STUDY 134XCP|RP|BCB41507-87B3-4773-B1E5-AE039853DED0|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||ML/S|||NMOL/L/H|NOT DONE||N|U|Y|3||39||WASHOUT|1969-08-26||1960-03-14|||1961-08-02||1961-07-30
TRIAL STUDY 134XCP|RP|BCB41507-87B3-4773-B1E5-AE039853DED0|2||||||THICK|THICKNESS||||GY/H|||CMOL|NOT DONE||N|U|Y|3||39||BASELINE|1963-05-06||1969-11-03|||1963-01-21||1971-02-19
TRIAL STUDY 134XCP|RP|BCB41507-87B3-4773-B1E5-AE039853DED0|1||||||GRAVIND|GRAVIDA INDICATOR||||ML/G/DAY|||MG/H|NOT DONE||Y|Y|U|4||88||FOLLOW-UP|1969-08-18||1964-06-20|||1968-07-17||1966-04-26
TRIAL STUDY 134XCP|RP|BCB41507-87B3-4773-B1E5-AE039853DED0|2||||||PREGIND|PREGNANT INDICATOR||||BQ/KG|||CIGARETTE|NOT DONE||U|NA|Y|4||88||INDUCTION TREATMENT|1967-05-11||1969-05-31|||1967-09-21||1960-06-18
TRIAL STUDY 134XCP|RP|BCB41507-87B3-4773-B1E5-AE039853DED0|1||||||ULCERIND|ULCER INDICATOR||||/10^4|||KUSP|NOT DONE||U|Y|Y|5||7||CONTINUATION TREATMENT|1968-12-08||1970-05-31|||1969-06-09||1971-01-24
TRIAL STUDY 134XCP|RP|BCB41507-87B3-4773-B1E5-AE039853DED0|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||G/G/DAY|||C|NOT DONE||Y|Y|Y|5||7||SCREENING|1965-11-20||1966-01-02|||1970-08-18||1964-05-31
TRIAL STUDY 134XCP|RP|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|1||||||DLVRMODE|MODE OF DELIVERY||||HOUNSFIELD UNIT|||/CMH2O|NOT DONE||U|N|U|1||38||LONG-TERM FOLLOW-UP|1962-05-25||1969-10-10|||1961-11-28||1962-03-07
TRIAL STUDY 134XCP|RP|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||10^6/HPF|||PL|NOT DONE||Y|U|N|1||38||TREATMENT|1966-01-06||1970-02-08|||1966-06-04||1966-10-14
TRIAL STUDY 134XCP|RP|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||CG|||U/KG/MIN|NOT DONE||U|NA|U|2||58||SCREENING|1967-07-28||1964-05-25|||1962-09-27||1965-05-13
TRIAL STUDY 134XCP|RP|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||/CMH2O|||10^3 DNA COPIES/ML|NOT DONE||N|NA|U|2||58||WASHOUT|1961-09-16||1971-09-27|||1970-12-12||1972-11-03
TRIAL STUDY 134XCP|RP|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ML/DOSE|||BQ/MG|NOT DONE||NA|Y|U|3||39||LONG-TERM FOLLOW-UP|1966-02-08||1963-11-18|||1970-06-28||1963-02-22
TRIAL STUDY 134XCP|RP|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|2||||||GRAVIND|GRAVIDA INDICATOR||||RNA COPIES/ML|||10^6 IU/ML|NOT DONE||NA|NA|U|3||39||WASHOUT|1970-04-18||1970-07-15|||1970-06-25||1965-08-24
TRIAL STUDY 134XCP|RP|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||BAU|||10^6 ORGANISMS/ML|NOT DONE||NA|NA|U|4||88||BLINDED TREATMENT|1967-02-26||1972-03-09|||1970-02-05||1960-06-12
TRIAL STUDY 134XCP|RP|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||10^4 CFU/ML|||S^-1(%O2)^-1|NOT DONE||Y|NA|U|4||88||OBSERVATION|1966-05-05||1963-07-29|||1965-03-31||1973-03-07
TRIAL STUDY 134XCP|RP|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||U/M2/H|||L/S|NOT DONE||Y|Y|N|5||7||BASELINE|1971-01-31||1964-10-23|||1960-09-24||1968-08-03
TRIAL STUDY 134XCP|RP|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||/10^3|||CAPLET|NOT DONE||NA|Y|Y|5||7||LONG-TERM FOLLOW-UP|1963-10-29||1967-02-19|||1968-08-29||1967-02-21
TRIAL STUDY 134XCP|RP|EC726B09-0B0F-4933-94F4-8941DF68EDE6|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||CD/M2|||IMPLANT|NOT DONE||NA|Y|Y|1||38||SCREENING|1964-02-17||1972-03-16|||1967-07-08||1962-04-11
TRIAL STUDY 134XCP|RP|EC726B09-0B0F-4933-94F4-8941DF68EDE6|2||||||ULCERIND|ULCER INDICATOR||||TABLET|||PLUG|NOT DONE||N|N|NA|1||38||INDUCTION TREATMENT|1968-05-16||1961-09-06|||1964-01-18||1961-08-12
TRIAL STUDY 134XCP|RP|EC726B09-0B0F-4933-94F4-8941DF68EDE6|1||||||ABORTN|NUMBER OF ABORTIONS||||/5X10^4 WBC|||MM3/MM2/YEAR|NOT DONE||Y|N|Y|2||58||OBSERVATION|1967-04-14||1970-08-10|||1963-05-22||1965-12-14
TRIAL STUDY 134XCP|RP|EC726B09-0B0F-4933-94F4-8941DF68EDE6|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||MMOL/MIN/KPA/L|||U.CARR|NOT DONE||Y|U|NA|2||58||WASHOUT|1972-03-28||1969-02-08|||1966-01-11||1964-05-28
TRIAL STUDY 134XCP|RP|EC726B09-0B0F-4933-94F4-8941DF68EDE6|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||/DAY|||CI/L|NOT DONE||NA|NA|N|3||39||OBSERVATION|1968-10-19||1972-04-19|||1960-07-07||1960-03-27
TRIAL STUDY 134XCP|RP|EC726B09-0B0F-4933-94F4-8941DF68EDE6|2||||||THICK|THICKNESS||||UMOL/L|||BAU/ML|NOT DONE||U|U|N|3||39||CONTINUATION TREATMENT|1966-03-14||1961-10-19|||1970-07-28||1969-04-09
TRIAL STUDY 134XCP|RP|EC726B09-0B0F-4933-94F4-8941DF68EDE6|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MEQ/G|||UG/L DDU|NOT DONE||Y|Y|Y|4||88||FOLLOW-UP|1966-05-30||1968-11-18|||1963-12-14||1968-04-12
TRIAL STUDY 134XCP|RP|EC726B09-0B0F-4933-94F4-8941DF68EDE6|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MEQ/L|||CM H2O|NOT DONE||N|Y|N|4||88||TREATMENT|1969-12-02||1962-01-17|||1966-09-26||1968-05-19
TRIAL STUDY 134XCP|RP|EC726B09-0B0F-4933-94F4-8941DF68EDE6|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||TRANSDUCING UNIT/ML|||U/G|NOT DONE||Y|U|N|5||7||WASHOUT|1963-03-15||1961-11-24|||1971-05-21||1964-05-05
TRIAL STUDY 134XCP|RP|EC726B09-0B0F-4933-94F4-8941DF68EDE6|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MM/MIN|||TORR|NOT DONE||Y|Y|U|5||7||RUN-IN|1969-02-13||1971-02-06|||1968-05-19||1970-06-24
TRIAL STUDY 134XCP|RP|9F703096-9152-422E-AEAB-AD22F00863ED|1||||||MASSIND|MASS INDICATOR||||S^-1(%O2)^-1|||%|NOT DONE||NA|U|U|1||38||INDUCTION TREATMENT|1963-04-24||1965-03-04|||1969-06-30||1963-06-13
TRIAL STUDY 134XCP|RP|9F703096-9152-422E-AEAB-AD22F00863ED|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||KEV|||U/KG|NOT DONE||U|U|N|1||38||FOLLOW-UP|1965-08-26||1961-05-31|||1961-07-02||1968-05-14
TRIAL STUDY 134XCP|RP|9F703096-9152-422E-AEAB-AD22F00863ED|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^9 CFU|||10^12 IU/L|NOT DONE||N|N|Y|2||58||INDUCTION TREATMENT|1969-01-20||1965-11-06|||1966-12-17||1966-12-20
TRIAL STUDY 134XCP|RP|9F703096-9152-422E-AEAB-AD22F00863ED|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MET|||MAMP|NOT DONE||Y|N|Y|2||58||WASHOUT|1970-05-22||1963-10-16|||1973-02-09||1965-07-09
TRIAL STUDY 134XCP|RP|9F703096-9152-422E-AEAB-AD22F00863ED|1||||||RASHIND|RASH INDICATOR||||MEQ/DL|||10^6 ORGANISMS/MG|NOT DONE||NA|NA|Y|3||39||OBSERVATION|1972-06-01||1971-10-26|||1971-01-27||1960-05-05
TRIAL STUDY 134XCP|RP|9F703096-9152-422E-AEAB-AD22F00863ED|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^4/L|||CY/CM|NOT DONE||N|Y|N|3||39||TREATMENT|1965-03-19||1969-03-28|||1966-08-15||1961-08-29
TRIAL STUDY 134XCP|RP|9F703096-9152-422E-AEAB-AD22F00863ED|1||||||ERYTHIND|ERYTHEMA INDICATOR||||KIT|||OZ|NOT DONE||N|N|Y|4||88||INDUCTION TREATMENT|1963-07-19||1964-06-19|||1967-11-27||1960-07-18
TRIAL STUDY 134XCP|RP|9F703096-9152-422E-AEAB-AD22F00863ED|2||||||INTP|INTERPRETATION||||MOL/L|||MEQ/MMOL|NOT DONE||N|U|N|4||88||LONG-TERM FOLLOW-UP|1962-11-27||1970-06-18|||1964-11-06||1963-02-15
TRIAL STUDY 134XCP|RP|9F703096-9152-422E-AEAB-AD22F00863ED|1||||||ULCERIND|ULCER INDICATOR||||100 IU/ML|||SBE/ML|NOT DONE||N|U|Y|5||7||INDUCTION TREATMENT|1960-07-13||1961-07-16|||1970-05-07||1972-07-13
TRIAL STUDY 134XCP|RP|9F703096-9152-422E-AEAB-AD22F00863ED|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UG/G/H|||/HPF|NOT DONE||U|U|N|5||7||WASHOUT|1961-06-09||1961-02-04|||1965-06-27||1963-06-14
TRIAL STUDY 134XCP|RP|57455593-8872-4B17-8B3F-8A02FE855290|1||||||ABORTN|NUMBER OF ABORTIONS||||LOG EID 50/DOSE|||LOG10 PFU/ML|NOT DONE||U|Y|U|1||38||BASELINE|1960-04-26||1968-11-15|||1964-02-04||1968-08-06
TRIAL STUDY 134XCP|RP|57455593-8872-4B17-8B3F-8A02FE855290|2||||||DLVRMODE|MODE OF DELIVERY||||CFU/G|||KEV|NOT DONE||U|Y|N|1||38||BLINDED TREATMENT|1973-07-08||1966-03-19|||1971-10-03||1970-03-14
TRIAL STUDY 134XCP|RP|57455593-8872-4B17-8B3F-8A02FE855290|1||||||FUNDHT|FUNDAL HEIGHT||||MIU/L|||FRACTION OF 1|NOT DONE||Y|N|N|2||58||CONTINUATION TREATMENT|1966-07-13||1967-05-04|||1963-03-04||1960-08-18
TRIAL STUDY 134XCP|RP|57455593-8872-4B17-8B3F-8A02FE855290|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||U/M2/MIN|||ML/SEC/1.73M2|NOT DONE||Y|Y|Y|2||58||BASELINE|1962-09-28||1960-11-25|||1966-01-17||1970-06-01
TRIAL STUDY 134XCP|RP|57455593-8872-4B17-8B3F-8A02FE855290|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||BQ/UL|||G/L|NOT DONE||N|U|NA|3||39||OBSERVATION|1964-01-02||1968-10-01|||1971-10-13||1962-05-20
TRIAL STUDY 134XCP|RP|57455593-8872-4B17-8B3F-8A02FE855290|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MEQ|||10^6 ORGANISMS|NOT DONE||U|N|NA|3||39||BLINDED TREATMENT|1965-09-21||1971-12-28|||1972-08-19||1961-08-04
TRIAL STUDY 134XCP|RP|57455593-8872-4B17-8B3F-8A02FE855290|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||G/CM2|||MG/ANIMAL|NOT DONE||Y|Y|U|4||88||RUN-IN|1968-02-23||1961-09-28|||1961-06-18||1961-02-01
TRIAL STUDY 134XCP|RP|57455593-8872-4B17-8B3F-8A02FE855290|2||||||PREGIND|PREGNANT INDICATOR||||KS|||/4.0 ML|NOT DONE||Y|N|NA|4||88||LONG-TERM FOLLOW-UP|1961-02-24||1970-06-20|||1970-02-09||1960-07-30
TRIAL STUDY 134XCP|RP|57455593-8872-4B17-8B3F-8A02FE855290|1||||||FUNDHT|FUNDAL HEIGHT||||G/KG|||MIU/L|NOT DONE||NA|Y|U|5||7||CONTINUATION TREATMENT|1972-03-02||1962-02-17|||1961-09-28||1971-05-29
TRIAL STUDY 134XCP|RP|57455593-8872-4B17-8B3F-8A02FE855290|2||||||MENARAGE|MENARCHE AGE||||SEC|||UCI/L|NOT DONE||N|Y|NA|5||7||CONTINUATION TREATMENT|1969-07-13||1972-07-06|||1965-06-16||1962-07-22
TRIAL STUDY 134XCP|RP|97F58005-7367-49DC-967B-FAD681B55DF8|1||||||MENARAGE|MENARCHE AGE||||MMOL/DAY|||NL|NOT DONE||N|Y|NA|1||38||FOLLOW-UP|1972-11-14||1970-06-11|||1971-03-30||1973-05-10
TRIAL STUDY 134XCP|RP|97F58005-7367-49DC-967B-FAD681B55DF8|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UMOL/L/SEC|||U.CARR|NOT DONE||U|N|Y|1||38||BLINDED TREATMENT|1960-08-12||1967-08-15|||1971-10-09||1970-12-05
TRIAL STUDY 134XCP|RP|97F58005-7367-49DC-967B-FAD681B55DF8|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MEQ/ML|||ML/BEAT|NOT DONE||Y|U|U|2||58||INDUCTION TREATMENT|1962-02-13||1972-09-28|||1965-01-01||1968-11-26
TRIAL STUDY 134XCP|RP|97F58005-7367-49DC-967B-FAD681B55DF8|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MEQ/DL|||UKAT/L|NOT DONE||U|N|N|2||58||FOLLOW-UP|1961-06-06||1968-06-06|||1966-02-01||1973-06-09
TRIAL STUDY 134XCP|RP|97F58005-7367-49DC-967B-FAD681B55DF8|1||||||PRGENDTC|DATE PREGNANCY ENDED||||UG/MOL|||10^3 ORGANISMS/G|NOT DONE||N|N|N|3||39||LONG-TERM FOLLOW-UP|1968-04-11||1960-08-27|||1969-03-20||1972-04-28
TRIAL STUDY 134XCP|RP|97F58005-7367-49DC-967B-FAD681B55DF8|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||LOG10 ELISA UNIT/DOSE|||UG/M2/H|NOT DONE||Y|U|Y|3||39||TREATMENT|1963-07-05||1967-04-08|||1967-08-31||1972-12-29
TRIAL STUDY 134XCP|RP|97F58005-7367-49DC-967B-FAD681B55DF8|1||||||MENARAGE|MENARCHE AGE||||NMOL/ML/MIN|||KV|NOT DONE||Y|NA|Y|4||88||OBSERVATION|1965-08-08||1967-01-25|||1968-01-17||1970-03-13
TRIAL STUDY 134XCP|RP|97F58005-7367-49DC-967B-FAD681B55DF8|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||PMOL/DAY|||G/CAGE/WK|NOT DONE||Y|U|NA|4||88||WASHOUT|1972-07-14||1966-02-28|||1964-01-18||1968-02-29
TRIAL STUDY 134XCP|RP|97F58005-7367-49DC-967B-FAD681B55DF8|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||U/MMOL|||LOG10 IU/ML|NOT DONE||NA|N|NA|5||7||LONG-TERM FOLLOW-UP|1961-06-17||1961-08-12|||1962-07-11||1973-08-18
TRIAL STUDY 134XCP|RP|97F58005-7367-49DC-967B-FAD681B55DF8|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||IU/KG|||ML/M2/H|NOT DONE||NA|U|NA|5||7||INDUCTION TREATMENT|1962-08-28||1971-12-25|||1962-11-30||1972-09-07
TRIAL STUDY 134XCP|RP|83AC0828-3C22-4F7C-9D22-F044BB5B630D|1||||||EDEMAIND|EDEMA INDICATOR||||MG/DOSE|||MEQ/UG|NOT DONE||N|U|Y|1||38||RUN-IN|1965-03-01||1971-06-08|||1967-09-06||1963-10-20
TRIAL STUDY 134XCP|RP|83AC0828-3C22-4F7C-9D22-F044BB5B630D|2||||||ERYTHIND|ERYTHEMA INDICATOR||||MPH|||M/SEC|NOT DONE||Y|N|U|1||38||SCREENING|1966-12-27||1960-07-27|||1973-03-20||1960-07-10
TRIAL STUDY 134XCP|RP|83AC0828-3C22-4F7C-9D22-F044BB5B630D|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||ML/M2/DAY|||CUP|NOT DONE||Y|Y|N|2||58||OPEN LABEL TREATMENT|1966-01-28||1960-10-21|||1967-09-23||1964-06-07
TRIAL STUDY 134XCP|RP|83AC0828-3C22-4F7C-9D22-F044BB5B630D|2||||||MENARAGE|MENARCHE AGE||||KUSP|||RATIO|NOT DONE||U|N|N|2||58||FOLLOW-UP|1965-12-14||1960-01-23|||1968-08-04||1969-07-19
TRIAL STUDY 134XCP|RP|83AC0828-3C22-4F7C-9D22-F044BB5B630D|1||||||RASHIND|RASH INDICATOR||||NKAT/L|||ML/MIN|NOT DONE||NA|NA|Y|3||39||INDUCTION TREATMENT|1967-09-04||1960-03-15|||1968-02-06||1967-10-21
TRIAL STUDY 134XCP|RP|83AC0828-3C22-4F7C-9D22-F044BB5B630D|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MNFI|||CMH2O*S2/ML|NOT DONE||N|U|NA|3||39||LONG-TERM FOLLOW-UP|1968-01-17||1965-08-02|||1967-02-08||1972-11-09
TRIAL STUDY 134XCP|RP|83AC0828-3C22-4F7C-9D22-F044BB5B630D|1||||||BCMETHOD|BIRTH CONTROL METHOD||||MV/SEC|||ML/S/M2|NOT DONE||U|NA|N|4||88||INDUCTION TREATMENT|1972-11-18||1970-03-21|||1968-11-14||1965-09-16
TRIAL STUDY 134XCP|RP|83AC0828-3C22-4F7C-9D22-F044BB5B630D|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||EQ|||%/MIN|NOT DONE||Y|NA|N|4||88||CONTINUATION TREATMENT|1968-03-24||1972-04-25|||1961-10-08||1963-07-22
TRIAL STUDY 134XCP|RP|83AC0828-3C22-4F7C-9D22-F044BB5B630D|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MU/L|||NL|NOT DONE||Y|U|U|5||7||BASELINE|1970-06-08||1966-01-01|||1961-12-27||1970-10-13
TRIAL STUDY 134XCP|RP|83AC0828-3C22-4F7C-9D22-F044BB5B630D|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||ML/DL|||DAYS/MONTH|NOT DONE||U|U|N|5||7||BLINDED TREATMENT|1972-12-29||1964-05-30|||1971-12-16||1965-04-04
TRIAL STUDY 134XCP|RP|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||ML/SEC/1.73M2|||UGEQ/L|NOT DONE||NA|U|U|1||38||OPEN LABEL TREATMENT|1967-03-19||1969-03-19|||1973-07-20||1961-12-19
TRIAL STUDY 134XCP|RP|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||SCOOPFUL|||DAYS|NOT DONE||N|NA|U|1||38||LONG-TERM FOLLOW-UP|1972-06-10||1969-05-18|||1960-02-07||1969-09-26
TRIAL STUDY 134XCP|RP|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|1||||||GRAVIND|GRAVIDA INDICATOR||||SFC/10^6 PBMC|||UMOL/KG/MIN|NOT DONE||U|N|NA|2||58||RUN-IN|1972-08-19||1969-01-17|||1971-07-05||1960-12-31
TRIAL STUDY 134XCP|RP|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|2||||||MENFDUR|MENSES FLOW DURATION||||UMOL/MOL|||MBQ|NOT DONE||Y|N|NA|2||58||INDUCTION TREATMENT|1968-02-06||1962-08-16|||1966-10-14||1968-01-18
TRIAL STUDY 134XCP|RP|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||ML/MIN/1.73M2|||MET|NOT DONE||U|N|NA|3||39||INDUCTION TREATMENT|1961-09-05||1968-11-08|||1969-03-14||1971-11-24
TRIAL STUDY 134XCP|RP|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|2||||||GRAVIND|GRAVIDA INDICATOR||||MU/G|||/100 WBC|NOT DONE||U|U|NA|3||39||BLINDED TREATMENT|1962-01-06||1961-06-15|||1967-08-15||1961-08-19
TRIAL STUDY 134XCP|RP|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||/MBP|||10^6 CFU|NOT DONE||N|N|NA|4||88||BLINDED TREATMENT|1965-11-05||1960-11-30|||1960-01-08||1970-01-14
TRIAL STUDY 134XCP|RP|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MDFI|||COPIES/UG|NOT DONE||U|Y|NA|4||88||CONTINUATION TREATMENT|1964-10-31||1962-10-25|||1962-12-06||1970-04-08
TRIAL STUDY 134XCP|RP|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|1||||||ULCERIND|ULCER INDICATOR||||MCI/KG|||/HPF|NOT DONE||NA|U|U|5||7||RUN-IN|1967-06-14||1960-02-02|||1966-06-17||1972-05-08
TRIAL STUDY 134XCP|RP|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||NG/DAY|||PA|NOT DONE||U|N|U|5||7||BASELINE|1969-04-02||1973-09-05|||1962-02-24||1960-03-22
TRIAL STUDY 134XCP|RP|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|1||||||INTP|INTERPRETATION||||MG/DL|||PPTR|NOT DONE||U|Y|NA|1||38||WASHOUT|1967-12-08||1973-07-26|||1962-09-18||1969-04-10
TRIAL STUDY 134XCP|RP|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||SACHET|||MMOL/L|NOT DONE||Y|Y|U|1||38||OBSERVATION|1965-06-04||1971-05-29|||1969-03-01||1968-06-10
TRIAL STUDY 134XCP|RP|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|1||||||PRGENDTC|DATE PREGNANCY ENDED||||CD|||MEQ/KG|NOT DONE||Y|U|Y|2||58||BASELINE|1960-12-19||1968-04-20|||1969-11-07||1964-11-23
TRIAL STUDY 134XCP|RP|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|2||||||INABOIND|INDUCED ABORTION INDICATOR||||NG/MOL|||ML/CM3/MIN|NOT DONE||Y|Y|U|2||58||INDUCTION TREATMENT|1970-03-24||1971-04-17|||1962-10-26||1965-08-29
TRIAL STUDY 134XCP|RP|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|1||||||DLVRMODE|MODE OF DELIVERY||||NKAT|||HOMEOPATHIC DILUTION|NOT DONE||U|U|U|3||39||CONTINUATION TREATMENT|1971-08-04||1965-12-15|||1968-07-10||1973-01-07
TRIAL STUDY 134XCP|RP|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|2||||||PREGNN|NUMBER OF PREGNANCIES||||PFU|||CIGAR|NOT DONE||N|Y|NA|3||39||TREATMENT|1971-06-17||1972-02-14|||1968-10-22||1971-11-13
TRIAL STUDY 134XCP|RP|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|1||||||PEELIND|PEELING INDICATOR||||CMOL|||AMU|NOT DONE||NA|Y|NA|4||88||CONTINUATION TREATMENT|1967-06-12||1972-02-04|||1962-09-14||1961-10-13
TRIAL STUDY 134XCP|RP|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|2||||||ULCERIND|ULCER INDICATOR||||ML/DOSE|||TRANSDUCING UNIT/ML|NOT DONE||Y|N|NA|4||88||BLINDED TREATMENT|1961-10-23||1973-05-10|||1972-12-31||1963-04-06
TRIAL STUDY 134XCP|RP|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|1||||||PRGENDTC|DATE PREGNANCY ENDED||||F|||UKAT/L|NOT DONE||U|U|NA|5||7||FOLLOW-UP|1971-09-25||1963-07-23|||1962-02-23||1965-08-01
TRIAL STUDY 134XCP|RP|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|2||||||DLVRMODE|MODE OF DELIVERY||||LB|||/KG|NOT DONE||U|U|N|5||7||FOLLOW-UP|1966-03-02||1970-10-08|||1964-07-28||1963-09-12
TRIAL STUDY 134XCP|RP|B386B813-1175-4421-9C86-F9AB597877FA|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||LENS|||ML/M2/DAY|NOT DONE||U|U|U|1||38||BLINDED TREATMENT|1962-06-20||1962-06-05|||1963-01-16||1969-09-03
TRIAL STUDY 134XCP|RP|B386B813-1175-4421-9C86-F9AB597877FA|2||||||MENARAGE|MENARCHE AGE||||/200 HPFS|||MOL/G|NOT DONE||Y|Y|U|1||38||FOLLOW-UP|1972-12-12||1961-06-20|||1968-09-09||1962-12-29
TRIAL STUDY 134XCP|RP|B386B813-1175-4421-9C86-F9AB597877FA|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||DB|||HPA|NOT DONE||Y|U|U|2||58||OBSERVATION|1970-05-14||1963-06-13|||1962-08-12||1969-10-26
TRIAL STUDY 134XCP|RP|B386B813-1175-4421-9C86-F9AB597877FA|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||GRAVITATIONAL UNIT|||MET*MIN|NOT DONE||NA|U|U|2||58||INDUCTION TREATMENT|1968-01-15||1971-07-20|||1968-09-15||1964-02-22
TRIAL STUDY 134XCP|RP|B386B813-1175-4421-9C86-F9AB597877FA|1||||||PUSTIND|PUSTULE INDICATOR||||PNU/ML|||CGY|NOT DONE||U|NA|N|3||39||CONTINUATION TREATMENT|1972-02-05||1960-07-30|||1972-06-27||1963-01-21
TRIAL STUDY 134XCP|RP|B386B813-1175-4421-9C86-F9AB597877FA|2||||||PREGIND|PREGNANT INDICATOR||||10^3 RNA COPIES/ML|||CMOL|NOT DONE||NA|Y|Y|3||39||INDUCTION TREATMENT|1962-07-07||1962-10-06|||1971-07-01||1967-11-05
TRIAL STUDY 134XCP|RP|B386B813-1175-4421-9C86-F9AB597877FA|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MOL/MG|||WEEKS|NOT DONE||NA|U|N|4||88||WASHOUT|1962-01-19||1964-03-28|||1973-04-15||1969-06-21
TRIAL STUDY 134XCP|RP|B386B813-1175-4421-9C86-F9AB597877FA|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||U/M2/MIN|||BAU|NOT DONE||N|N|N|4||88||WASHOUT|1960-02-27||1971-06-06|||1966-10-19||1969-12-05
TRIAL STUDY 134XCP|RP|B386B813-1175-4421-9C86-F9AB597877FA|1||||||MENARAGE|MENARCHE AGE||||10^4 CFU/ML|||MEQ/DAY|NOT DONE||N|NA|Y|5||7||RUN-IN|1973-02-08||1973-08-07|||1966-07-07||1968-12-10
TRIAL STUDY 134XCP|RP|B386B813-1175-4421-9C86-F9AB597877FA|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||%|||NG/L|NOT DONE||NA|NA|N|5||7||OBSERVATION|1963-03-14||1969-12-12|||1966-03-06||1966-08-16
TRIAL STUDY 134XCP|RP|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|1||||||ERYTHIND|ERYTHEMA INDICATOR||||KPA|||PIXEL|NOT DONE||U|Y|NA|1||38||INDUCTION TREATMENT|1972-08-31||1970-07-24|||1970-02-18||1965-02-12
TRIAL STUDY 134XCP|RP|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||FL|||PMOL/10^10 CELLS|NOT DONE||NA|NA|N|1||38||BASELINE|1970-05-14||1964-04-03|||1970-12-20||1971-04-25
TRIAL STUDY 134XCP|RP|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||STEPS/MIN|||FT2|NOT DONE||N|U|U|2||58||RUN-IN|1963-05-16||1966-07-07|||1960-06-27||1962-02-26
TRIAL STUDY 134XCP|RP|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UM/S|||/H|NOT DONE||Y|Y|Y|2||58||LONG-TERM FOLLOW-UP|1973-08-14||1961-05-24|||1963-04-18||1963-09-30
TRIAL STUDY 134XCP|RP|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|1||||||ERYTHIND|ERYTHEMA INDICATOR||||GBQ/MG|||10^6/EJACULATE U|NOT DONE||Y|NA|N|3||39||RUN-IN|1961-10-02||1966-08-24|||1964-11-05||1972-03-09
TRIAL STUDY 134XCP|RP|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|2||||||INTP|INTERPRETATION||||PIXELS/CM|||NM|NOT DONE||N|Y|U|3||39||LONG-TERM FOLLOW-UP|1966-04-14||1966-04-04|||1970-04-07||1973-06-23
TRIAL STUDY 134XCP|RP|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||NEBULE|||LM|NOT DONE||Y|NA|N|4||88||CONTINUATION TREATMENT|1973-04-14||1967-09-09|||1967-10-26||1971-01-28
TRIAL STUDY 134XCP|RP|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||SIEMENS|||MS/MMHG|NOT DONE||NA|Y|U|4||88||FOLLOW-UP|1973-03-26||1972-09-20|||1960-05-05||1973-04-18
TRIAL STUDY 134XCP|RP|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|1||||||EDEMAIND|EDEMA INDICATOR||||MGEQ|||IMPLANT|NOT DONE||U|NA|NA|5||7||RUN-IN|1973-02-17||1970-09-20|||1964-08-08||1969-06-11
TRIAL STUDY 134XCP|RP|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||S/H|||CP|NOT DONE||Y|Y|NA|5||7||FOLLOW-UP|1960-11-23||1967-08-14|||1966-08-27||1968-04-07
TRIAL STUDY 134XCP|RP|7B33775D-1DFF-49A6-820E-7981F5C16AFF|1||||||PREGNN|NUMBER OF PREGNANCIES||||BISCUIT|||DYN|NOT DONE||Y|U|U|1||38||BASELINE|1966-08-01||1970-05-27|||1970-12-23||1970-06-23
TRIAL STUDY 134XCP|RP|7B33775D-1DFF-49A6-820E-7981F5C16AFF|2||||||BRTHN|NUMBER OF BIRTHS||||ML/BREATH|||NMOL BCE/L|NOT DONE||NA|N|N|1||38||OBSERVATION|1969-03-30||1970-03-25|||1963-05-30||1962-09-11
TRIAL STUDY 134XCP|RP|7B33775D-1DFF-49A6-820E-7981F5C16AFF|1||||||FUNDHT|FUNDAL HEIGHT||||LOG EID 50/DOSE|||MMOL/MOL|NOT DONE||NA|NA|Y|2||58||INDUCTION TREATMENT|1970-02-13||1960-03-15|||1965-07-13||1970-12-12
TRIAL STUDY 134XCP|RP|7B33775D-1DFF-49A6-820E-7981F5C16AFF|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||OI50|||RAD|NOT DONE||Y|Y|U|2||58||CONTINUATION TREATMENT|1964-01-24||1966-10-04|||1973-07-17||1965-03-11
TRIAL STUDY 134XCP|RP|7B33775D-1DFF-49A6-820E-7981F5C16AFF|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||GMFI|||FMOL|NOT DONE||NA|U|NA|3||39||BASELINE|1973-07-22||1973-07-06|||1968-10-04||1968-07-13
TRIAL STUDY 134XCP|RP|7B33775D-1DFF-49A6-820E-7981F5C16AFF|2||||||MENFDUR|MENSES FLOW DURATION||||MMHG*MIN/L|||MMAL|NOT DONE||N|N|NA|3||39||OPEN LABEL TREATMENT|1963-06-27||1960-11-16|||1964-04-11||1962-06-18
TRIAL STUDY 134XCP|RP|7B33775D-1DFF-49A6-820E-7981F5C16AFF|1||||||MENOSTAT|MENOPAUSE STATUS||||COAT|||CY/CM|NOT DONE||Y|Y|NA|4||88||WASHOUT|1961-03-29||1965-12-02|||1972-12-10||1967-10-13
TRIAL STUDY 134XCP|RP|7B33775D-1DFF-49A6-820E-7981F5C16AFF|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||CYCLE/MIN|||10^3 COPIES/ML|NOT DONE||N|NA|NA|4||88||TREATMENT|1970-06-25||1961-02-25|||1961-01-01||1967-05-14
TRIAL STUDY 134XCP|RP|7B33775D-1DFF-49A6-820E-7981F5C16AFF|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||KDA|||HPA|NOT DONE||NA|NA|Y|5||7||CONTINUATION TREATMENT|1960-11-14||1960-10-19|||1963-05-31||1973-06-14
TRIAL STUDY 134XCP|RP|7B33775D-1DFF-49A6-820E-7981F5C16AFF|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||UG/M2/MIN|||MOL/DAY|NOT DONE||U|Y|N|5||7||CONTINUATION TREATMENT|1971-05-28||1963-07-03|||1971-01-24||1962-12-30
TRIAL STUDY 134XCP|RP|DC48DD03-B87E-422D-A2EE-D87342260E19|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||CM|||NKAT/G HB|NOT DONE||Y|Y|Y|1||38||SCREENING|1960-06-26||1966-10-07|||1968-05-03||1972-09-04
TRIAL STUDY 134XCP|RP|DC48DD03-B87E-422D-A2EE-D87342260E19|2||||||MENFDUR|MENSES FLOW DURATION||||MASK|||MM|NOT DONE||NA|N|N|1||38||OPEN LABEL TREATMENT|1960-10-17||1964-07-05|||1960-03-09||1970-07-22
TRIAL STUDY 134XCP|RP|DC48DD03-B87E-422D-A2EE-D87342260E19|1||||||MENOSTAT|MENOPAUSE STATUS||||TSP EQ|||KUSP|NOT DONE||NA|N|U|2||58||CONTINUATION TREATMENT|1973-04-29||1965-04-14|||1973-07-11||1969-12-30
TRIAL STUDY 134XCP|RP|DC48DD03-B87E-422D-A2EE-D87342260E19|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||DPM/100MG|||10^3 CFU/ML|NOT DONE||NA|N|N|2||58||OBSERVATION|1969-07-11||1972-10-13|||1964-08-11||1960-03-11
TRIAL STUDY 134XCP|RP|DC48DD03-B87E-422D-A2EE-D87342260E19|1||||||BCMETHOD|BIRTH CONTROL METHOD||||LOG10 COPIES/ML|||G/MOL|NOT DONE||N|NA|Y|3||39||OPEN LABEL TREATMENT|1967-07-17||1961-01-17|||1971-09-17||1970-06-12
TRIAL STUDY 134XCP|RP|DC48DD03-B87E-422D-A2EE-D87342260E19|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UM/DAY|||GRAVITATIONAL UNIT|NOT DONE||N|Y|U|3||39||OPEN LABEL TREATMENT|1961-12-13||1973-08-13|||1972-11-04||1961-10-03
TRIAL STUDY 134XCP|RP|DC48DD03-B87E-422D-A2EE-D87342260E19|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||LOG10 CFU/G|||OSM|NOT DONE||NA|Y|NA|4||88||SCREENING|1962-12-16||1965-01-26|||1972-10-07||1960-01-13
TRIAL STUDY 134XCP|RP|DC48DD03-B87E-422D-A2EE-D87342260E19|2||||||ERYTHIND|ERYTHEMA INDICATOR||||MMOL/DAY|||10^7 CFU|NOT DONE||U|U|U|4||88||TREATMENT|1966-01-06||1960-01-17|||1965-05-06||1964-07-23
TRIAL STUDY 134XCP|RP|DC48DD03-B87E-422D-A2EE-D87342260E19|1||||||ERYTHIND|ERYTHEMA INDICATOR||||L|||MIU/L|NOT DONE||U|U|NA|5||7||BASELINE|1961-12-20||1961-10-18|||1962-06-02||1962-05-09
TRIAL STUDY 134XCP|RP|DC48DD03-B87E-422D-A2EE-D87342260E19|2||||||ABORTN|NUMBER OF ABORTIONS||||S/H|||F|NOT DONE||Y|U|NA|5||7||OBSERVATION|1963-02-28||1960-10-29|||1970-08-02||1971-02-04
TRIAL STUDY 134XCP|RP|2E084441-61A3-4B8B-9050-A5D7B38CA978|1||||||MENFDUR|MENSES FLOW DURATION||||%|||UV2|NOT DONE||U|Y|NA|1||38||BLINDED TREATMENT|1964-12-06||1973-08-06|||1970-10-07||1970-12-23
TRIAL STUDY 134XCP|RP|2E084441-61A3-4B8B-9050-A5D7B38CA978|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||ML/CAGE/DAY|||DAYS/WK|NOT DONE||NA|Y|Y|1||38||RUN-IN|1964-07-12||1968-12-27|||1960-05-10||1966-11-14
TRIAL STUDY 134XCP|RP|2E084441-61A3-4B8B-9050-A5D7B38CA978|1||||||MENARAGE|MENARCHE AGE||||FARAD|||CMH2O*S2/ML|NOT DONE||U|NA|Y|2||58||SCREENING|1972-10-27||1968-08-07|||1960-09-18||1963-06-18
TRIAL STUDY 134XCP|RP|2E084441-61A3-4B8B-9050-A5D7B38CA978|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||TROCHE|||NMOL/L/H|NOT DONE||U|Y|U|2||58||FOLLOW-UP|1962-10-30||1969-12-13|||1961-06-26||1973-01-24
TRIAL STUDY 134XCP|RP|2E084441-61A3-4B8B-9050-A5D7B38CA978|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MMOL/DAY|||MU/L|NOT DONE||U|N|U|3||39||FOLLOW-UP|1973-03-27||1963-08-18|||1961-03-20||1964-01-05
TRIAL STUDY 134XCP|RP|2E084441-61A3-4B8B-9050-A5D7B38CA978|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UMOL/L/SEC|||ML/100G/MIN|NOT DONE||NA|NA|Y|3||39||INDUCTION TREATMENT|1973-02-11||1973-04-09|||1972-01-21||1967-09-28
TRIAL STUDY 134XCP|RP|2E084441-61A3-4B8B-9050-A5D7B38CA978|1||||||PRGENDTC|DATE PREGNANCY ENDED||||FL|||KG/L|NOT DONE||Y|U|N|4||88||TREATMENT|1968-06-16||1970-08-22|||1964-01-02||1968-03-19
TRIAL STUDY 134XCP|RP|2E084441-61A3-4B8B-9050-A5D7B38CA978|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||RFU|||/LSQN|NOT DONE||N|U|Y|4||88||TREATMENT|1964-02-24||1962-07-22|||1960-03-11||1963-02-23
TRIAL STUDY 134XCP|RP|2E084441-61A3-4B8B-9050-A5D7B38CA978|1||||||PRGENDTC|DATE PREGNANCY ENDED||||KG/CM2|||10^3 CFU|NOT DONE||Y|N|N|5||7||CONTINUATION TREATMENT|1962-07-04||1967-09-20|||1971-09-16||1963-10-09
TRIAL STUDY 134XCP|RP|2E084441-61A3-4B8B-9050-A5D7B38CA978|2||||||MENFDUR|MENSES FLOW DURATION||||MAMP|||CS|NOT DONE||N|NA|U|5||7||SCREENING|1967-11-15||1964-09-30|||1961-03-27||1971-02-14
TRIAL STUDY 134XCP|RP|601D563B-AA21-4859-A87E-B2068C1E3F53|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||10^3 DNA COPIES/ML|||PELLET|NOT DONE||N|Y|N|1||38||INDUCTION TREATMENT|1966-02-01||1962-03-27|||1964-05-13||1973-07-31
TRIAL STUDY 134XCP|RP|601D563B-AA21-4859-A87E-B2068C1E3F53|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/2000 RBC|||BP|NOT DONE||U|NA|U|1||38||INDUCTION TREATMENT|1969-02-13||1966-05-25|||1965-03-12||1970-01-15
TRIAL STUDY 134XCP|RP|601D563B-AA21-4859-A87E-B2068C1E3F53|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||UG/DAY|||M/SEC2|NOT DONE||U|N|N|2||58||CONTINUATION TREATMENT|1964-09-05||1967-07-22|||1961-08-17||1973-09-05
TRIAL STUDY 134XCP|RP|601D563B-AA21-4859-A87E-B2068C1E3F53|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||IU/G HB|||WAFER|NOT DONE||Y|N|N|2||58||WASHOUT|1960-10-24||1960-07-01|||1965-09-05||1965-06-21
TRIAL STUDY 134XCP|RP|601D563B-AA21-4859-A87E-B2068C1E3F53|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||UG/M2/H|||MET*MIN|NOT DONE||U|NA|Y|3||39||RUN-IN|1968-03-05||1963-05-30|||1960-01-25||1972-06-01
TRIAL STUDY 134XCP|RP|601D563B-AA21-4859-A87E-B2068C1E3F53|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||HR/DAY|||MOL/MOL|NOT DONE||U|U|U|3||39||RUN-IN|1972-09-12||1961-01-18|||1968-10-05||1964-09-30
TRIAL STUDY 134XCP|RP|601D563B-AA21-4859-A87E-B2068C1E3F53|1||||||MENOSTAT|MENOPAUSE STATUS||||MMAL|||HEP|NOT DONE||Y|Y|Y|4||88||CONTINUATION TREATMENT|1967-01-06||1962-01-20|||1965-07-08||1966-02-25
TRIAL STUDY 134XCP|RP|601D563B-AA21-4859-A87E-B2068C1E3F53|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||BP|||UKAT/L|NOT DONE||Y|U|Y|4||88||SCREENING|1968-03-17||1968-07-25|||1964-02-29||1971-02-12
TRIAL STUDY 134XCP|RP|601D563B-AA21-4859-A87E-B2068C1E3F53|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||VIAL|||10^6 DNA COPIES/ML|NOT DONE||U|Y|Y|5||7||SCREENING|1970-05-06||1972-04-08|||1960-08-27||1966-07-07
TRIAL STUDY 134XCP|RP|601D563B-AA21-4859-A87E-B2068C1E3F53|2||||||INABOIND|INDUCED ABORTION INDICATOR||||EID 50/DOSE|||M/SEC2|NOT DONE||N|N|N|5||7||LONG-TERM FOLLOW-UP|1972-08-15||1973-02-11|||1963-10-12||1964-04-07
TRIAL STUDY 134XCP|RP|D8FE5979-24C7-478F-8612-0102F28F5ADE|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||U/G HB|||DROP|NOT DONE||NA|U|Y|1||38||OBSERVATION|1963-05-13||1972-11-18|||1961-03-03||1963-06-19
TRIAL STUDY 134XCP|RP|D8FE5979-24C7-478F-8612-0102F28F5ADE|2||||||PRGENDTC|DATE PREGNANCY ENDED||||ML/G/MIN|||G/CAGE|NOT DONE||Y|N|NA|1||38||SCREENING|1963-03-16||1965-05-18|||1967-12-22||1960-11-03
TRIAL STUDY 134XCP|RP|D8FE5979-24C7-478F-8612-0102F28F5ADE|1||||||BLISTIND|BLISTERING INDICATOR||||EQ|||ELISA UNIT/ML|NOT DONE||Y|NA|N|2||58||BLINDED TREATMENT|1973-07-08||1960-11-10|||1963-02-09||1965-02-16
TRIAL STUDY 134XCP|RP|D8FE5979-24C7-478F-8612-0102F28F5ADE|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||G/G|||MV2/HZ|NOT DONE||U|Y|Y|2||58||OPEN LABEL TREATMENT|1961-09-05||1961-04-15|||1962-02-07||1973-05-20
TRIAL STUDY 134XCP|RP|D8FE5979-24C7-478F-8612-0102F28F5ADE|1||||||PUSTIND|PUSTULE INDICATOR||||SCM|||H*%|NOT DONE||U|N|NA|3||39||WASHOUT|1962-07-22||1966-06-30|||1963-04-01||1970-09-25
TRIAL STUDY 134XCP|RP|D8FE5979-24C7-478F-8612-0102F28F5ADE|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||KN/CM2|||U/ANIMAL|NOT DONE||Y|Y|U|3||39||BLINDED TREATMENT|1970-12-06||1963-05-17|||1973-02-18||1960-09-14
TRIAL STUDY 134XCP|RP|D8FE5979-24C7-478F-8612-0102F28F5ADE|1||||||DSCHGIND|DISCHARGE INDICATOR||||/2500 WBC|||MPS U|NOT DONE||NA|Y|U|4||88||FOLLOW-UP|1965-08-12||1970-10-01|||1964-06-03||1968-01-09
TRIAL STUDY 134XCP|RP|D8FE5979-24C7-478F-8612-0102F28F5ADE|2||||||PREGIND|PREGNANT INDICATOR||||NGEQ/L|||BOX|NOT DONE||NA|N|N|4||88||WASHOUT|1960-08-30||1963-03-28|||1961-03-12||1964-04-26
TRIAL STUDY 134XCP|RP|D8FE5979-24C7-478F-8612-0102F28F5ADE|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ML/KG/MIN|||IU/L|NOT DONE||U|NA|NA|5||7||INDUCTION TREATMENT|1972-05-31||1971-04-29|||1960-03-01||1962-09-13
TRIAL STUDY 134XCP|RP|D8FE5979-24C7-478F-8612-0102F28F5ADE|2||||||MENARAGE|MENARCHE AGE||||NM|||MOSM/L|NOT DONE||Y|Y|N|5||7||RUN-IN|1962-09-23||1961-07-14|||1962-07-17||1960-07-06
TRIAL STUDY 134XCP|RP|D275315F-D3C5-4260-8BD6-37DDB67262B0|1||||||PEELIND|PEELING INDICATOR||||PKAT|||FEU|NOT DONE||NA|U|NA|1||38||LONG-TERM FOLLOW-UP|1967-05-31||1966-07-22|||1963-01-28||1961-09-17
TRIAL STUDY 134XCP|RP|D275315F-D3C5-4260-8BD6-37DDB67262B0|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||EIA UNIT|||SIEMENS|NOT DONE||N|N|N|1||38||OPEN LABEL TREATMENT|1962-02-20||1970-10-01|||1964-05-12||1965-07-09
TRIAL STUDY 134XCP|RP|D275315F-D3C5-4260-8BD6-37DDB67262B0|1||||||MASSIND|MASS INDICATOR||||MG/KG/H|||U/G|NOT DONE||N|NA|Y|2||58||LONG-TERM FOLLOW-UP|1961-05-28||1964-12-21|||1970-08-27||1960-08-13
TRIAL STUDY 134XCP|RP|D275315F-D3C5-4260-8BD6-37DDB67262B0|2||||||PEELIND|PEELING INDICATOR||||MEQ/DL|||HENRY|NOT DONE||N|Y|U|2||58||SCREENING|1971-01-23||1964-08-19|||1972-10-27||1962-08-07
TRIAL STUDY 134XCP|RP|D275315F-D3C5-4260-8BD6-37DDB67262B0|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||NMOL/MOL|||10^6 ORGANISMS/ML|NOT DONE||U|U|Y|3||39||BASELINE|1961-03-29||1965-09-16|||1973-03-28||1970-08-18
TRIAL STUDY 134XCP|RP|D275315F-D3C5-4260-8BD6-37DDB67262B0|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||NM|||DPM|NOT DONE||U|Y|N|3||39||WASHOUT|1972-07-07||1970-06-01|||1970-05-04||1960-03-07
TRIAL STUDY 134XCP|RP|D275315F-D3C5-4260-8BD6-37DDB67262B0|1||||||PREGIND|PREGNANT INDICATOR||||PKAT|||PMOL/10^9 CELLS|NOT DONE||NA|Y|U|4||88||WASHOUT|1973-03-12||1967-03-04|||1972-09-07||1970-08-20
TRIAL STUDY 134XCP|RP|D275315F-D3C5-4260-8BD6-37DDB67262B0|2||||||MENARAGE|MENARCHE AGE||||UMOL/MOL|||EU|NOT DONE||U|Y|U|4||88||WASHOUT|1970-02-12||1971-07-08|||1973-08-04||1971-04-12
TRIAL STUDY 134XCP|RP|D275315F-D3C5-4260-8BD6-37DDB67262B0|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||AMP|||/LPF|NOT DONE||NA|N|Y|5||7||INDUCTION TREATMENT|1968-10-25||1972-04-23|||1965-11-26||1969-10-26
TRIAL STUDY 134XCP|RP|D275315F-D3C5-4260-8BD6-37DDB67262B0|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||UV|||MV/SEC|NOT DONE||Y|U|Y|5||7||CONTINUATION TREATMENT|1968-10-07||1965-02-19|||1965-11-12||1965-01-16
TRIAL STUDY 134XCP|RP|34127CD2-378B-4335-AD4B-F305D0A21AF4|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||SIEMENS|||NMOL|NOT DONE||U|U|U|1||38||WASHOUT|1962-02-26||1966-10-01|||1968-11-19||1964-08-14
TRIAL STUDY 134XCP|RP|34127CD2-378B-4335-AD4B-F305D0A21AF4|2||||||BLISTIND|BLISTERING INDICATOR||||10^6 IU|||MOL|NOT DONE||Y|N|NA|1||38||OBSERVATION|1961-03-27||1969-04-07|||1971-03-13||1963-09-10
TRIAL STUDY 134XCP|RP|34127CD2-378B-4335-AD4B-F305D0A21AF4|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||G/ANIMAL/DAY|||FIU|NOT DONE||NA|Y|Y|2||58||OPEN LABEL TREATMENT|1964-09-16||1962-04-03|||1966-09-20||1973-04-18
TRIAL STUDY 134XCP|RP|34127CD2-378B-4335-AD4B-F305D0A21AF4|2||||||EDEMAIND|EDEMA INDICATOR||||P|||KV|NOT DONE||N|N|N|2||58||FOLLOW-UP|1965-11-13||1963-12-05|||1973-08-16||1962-12-22
TRIAL STUDY 134XCP|RP|34127CD2-378B-4335-AD4B-F305D0A21AF4|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||DAMOL/L|||10^9 ORGANISMS|NOT DONE||N|Y|N|3||39||OPEN LABEL TREATMENT|1967-07-06||1965-04-13|||1963-07-23||1966-09-25
TRIAL STUDY 134XCP|RP|34127CD2-378B-4335-AD4B-F305D0A21AF4|2||||||GRAVIND|GRAVIDA INDICATOR||||MIN*MG/ML|||/WK|NOT DONE||U|N|U|3||39||LONG-TERM FOLLOW-UP|1963-04-15||1965-06-10|||1967-04-01||1962-12-13
TRIAL STUDY 134XCP|RP|34127CD2-378B-4335-AD4B-F305D0A21AF4|1||||||RASHIND|RASH INDICATOR||||SYRINGE|||PACKAGE|NOT DONE||Y|NA|Y|4||88||FOLLOW-UP|1961-08-14||1964-12-23|||1963-11-13||1972-09-15
TRIAL STUDY 134XCP|RP|34127CD2-378B-4335-AD4B-F305D0A21AF4|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||LOG10 ELISA UNIT|||10^4/HPF|NOT DONE||Y|Y|U|4||88||CONTINUATION TREATMENT|1965-08-08||1960-07-10|||1966-12-27||1972-01-08
TRIAL STUDY 134XCP|RP|34127CD2-378B-4335-AD4B-F305D0A21AF4|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UG/CM2|||MG/ML/MIN|NOT DONE||NA|NA|NA|5||7||SCREENING|1960-08-07||1962-06-28|||1962-01-30||1971-01-26
TRIAL STUDY 134XCP|RP|34127CD2-378B-4335-AD4B-F305D0A21AF4|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||GENEQ|||BOLUS|NOT DONE||NA|Y|N|5||7||LONG-TERM FOLLOW-UP|1968-04-22||1962-06-01|||1969-09-25||1972-09-27
TRIAL STUDY 134XCP|RP|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||G/CAGE|||BOTTLE|NOT DONE||N|U|N|1||38||BLINDED TREATMENT|1968-12-01||1962-12-03|||1964-12-06||1963-12-15
TRIAL STUDY 134XCP|RP|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||HZ/S|||IU/G HB|NOT DONE||U|N|U|1||38||OBSERVATION|1966-02-23||1961-04-14|||1963-03-02||1972-06-14
TRIAL STUDY 134XCP|RP|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||NG/L|||ML/KG/H|NOT DONE||NA|Y|Y|2||58||OBSERVATION|1965-07-17||1970-10-02|||1969-10-29||1961-10-31
TRIAL STUDY 134XCP|RP|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||10^9 CFU|||PACKAGE|NOT DONE||NA|N|NA|2||58||RUN-IN|1965-04-29||1960-07-25|||1961-02-10||1968-04-14
TRIAL STUDY 134XCP|RP|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|1||||||THICK|THICKNESS||||M/SEC2|||EID 50/ML|NOT DONE||U|Y|Y|3||39||OBSERVATION|1971-12-31||1967-02-28|||1973-04-25||1962-12-28
TRIAL STUDY 134XCP|RP|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||PSI|||FT3|NOT DONE||U|N|U|3||39||LONG-TERM FOLLOW-UP|1968-09-05||1965-04-24|||1972-02-02||1970-01-19
TRIAL STUDY 134XCP|RP|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||EID 50/ML|||U/MG|NOT DONE||NA|N|U|4||88||BASELINE|1973-01-30||1971-05-12|||1960-11-03||1965-04-05
TRIAL STUDY 134XCP|RP|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|2||||||PREGST|PREGNANT DURING THE STUDY||||BQ|||KIT|NOT DONE||Y|N|N|4||88||BLINDED TREATMENT|1971-06-07||1963-04-03|||1967-07-19||1973-02-07
TRIAL STUDY 134XCP|RP|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|1||||||STILBIND|STILLBIRTH INDICATOR||||SEC|||PIXEL|NOT DONE||NA|Y|U|5||7||RUN-IN|1965-01-14||1963-10-18|||1965-02-22||1966-10-29
TRIAL STUDY 134XCP|RP|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||FMOL/L/SEC|||KHZ|NOT DONE||NA|N|Y|5||7||RUN-IN|1961-08-24||1960-03-10|||1962-12-11||1969-06-30
TRIAL STUDY 134XCP|RP|6EE04A90-681B-439E-9783-04B40A4AF240|1||||||BCMETHOD|BIRTH CONTROL METHOD||||CI/MG|||APL U|NOT DONE||NA|N|N|1||38||LONG-TERM FOLLOW-UP|1961-11-30||1966-05-30|||1961-12-06||1960-11-19
TRIAL STUDY 134XCP|RP|6EE04A90-681B-439E-9783-04B40A4AF240|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ML/BEAT|||UL/ML|NOT DONE||NA|U|NA|1||38||BLINDED TREATMENT|1964-05-11||1963-07-25|||1966-01-02||1972-09-24
TRIAL STUDY 134XCP|RP|6EE04A90-681B-439E-9783-04B40A4AF240|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||HPA|||DDU|NOT DONE||Y|NA|U|2||58||OBSERVATION|1961-04-02||1965-01-22|||1970-11-07||1970-04-11
TRIAL STUDY 134XCP|RP|6EE04A90-681B-439E-9783-04B40A4AF240|2||||||PREGNN|NUMBER OF PREGNANCIES||||UMOL/KG/MIN|||CMOL|NOT DONE||NA|Y|NA|2||58||SCREENING|1960-08-07||1972-05-29|||1973-04-29||1963-12-04
TRIAL STUDY 134XCP|RP|6EE04A90-681B-439E-9783-04B40A4AF240|1||||||PREGNN|NUMBER OF PREGNANCIES||||10^6 IU/ML|||VIAL|NOT DONE||U|NA|NA|3||39||LONG-TERM FOLLOW-UP|1964-01-07||1963-04-21|||1971-06-03||1973-07-21
TRIAL STUDY 134XCP|RP|6EE04A90-681B-439E-9783-04B40A4AF240|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||/MM2|||MV|NOT DONE||Y|U|NA|3||39||CONTINUATION TREATMENT|1963-12-24||1967-07-01|||1970-11-22||1964-07-15
TRIAL STUDY 134XCP|RP|6EE04A90-681B-439E-9783-04B40A4AF240|1||||||BLISTIND|BLISTERING INDICATOR||||U/G|||KHZ|NOT DONE||U|Y|N|4||88||WASHOUT|1968-01-04||1963-05-31|||1962-12-22||1966-10-01
TRIAL STUDY 134XCP|RP|6EE04A90-681B-439E-9783-04B40A4AF240|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||UEQ|||KA_U/DL|NOT DONE||U|U|N|4||88||BLINDED TREATMENT|1972-07-08||1965-12-24|||1971-06-27||1962-05-15
TRIAL STUDY 134XCP|RP|6EE04A90-681B-439E-9783-04B40A4AF240|1||||||MASSIND|MASS INDICATOR||||AMFI|||MOSM/L|NOT DONE||N|NA|NA|5||7||OPEN LABEL TREATMENT|1968-10-12||1966-07-24|||1971-03-17||1970-05-04
TRIAL STUDY 134XCP|RP|6EE04A90-681B-439E-9783-04B40A4AF240|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||UG/DAY|||%|NOT DONE||NA|U|N|5||7||OBSERVATION|1968-04-16||1967-02-26|||1966-08-31||1967-03-06
TRIAL STUDY 134XCP|RP|A5C0B034-1226-40EE-87E3-D46A7342B550|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MPA|||MEQ/ML|NOT DONE||U|N|NA|1||38||OBSERVATION|1962-02-20||1968-11-26|||1973-03-28||1967-12-17
TRIAL STUDY 134XCP|RP|A5C0B034-1226-40EE-87E3-D46A7342B550|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||/MM|||G/M2/DAY|NOT DONE||U|U|U|1||38||INDUCTION TREATMENT|1971-06-16||1965-03-21|||1962-04-22||1970-04-07
TRIAL STUDY 134XCP|RP|A5C0B034-1226-40EE-87E3-D46A7342B550|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^6 IU/ML|||SV|NOT DONE||Y|NA|N|2||58||OPEN LABEL TREATMENT|1963-03-16||1972-10-30|||1967-11-12||1962-02-20
TRIAL STUDY 134XCP|RP|A5C0B034-1226-40EE-87E3-D46A7342B550|2||||||THICK|THICKNESS||||LOZENGE|||10^6 ORGANISMS/ML|NOT DONE||N|NA|N|2||58||LONG-TERM FOLLOW-UP|1962-05-10||1964-12-19|||1966-11-03||1971-11-05
TRIAL STUDY 134XCP|RP|A5C0B034-1226-40EE-87E3-D46A7342B550|1||||||INTP|INTERPRETATION||||AG|||NKAT/L|NOT DONE||Y|Y|U|3||39||WASHOUT|1965-07-28||1969-07-18|||1961-11-08||1971-10-27
TRIAL STUDY 134XCP|RP|A5C0B034-1226-40EE-87E3-D46A7342B550|2||||||MENOAGE|MENOPAUSE AGE||||FG|||LOG10 IU/ML|NOT DONE||NA|Y|U|3||39||INDUCTION TREATMENT|1968-08-31||1973-07-21|||1960-06-30||1965-11-19
TRIAL STUDY 134XCP|RP|A5C0B034-1226-40EE-87E3-D46A7342B550|1||||||THICK|THICKNESS||||KG/M2|||/100 HPFS|NOT DONE||NA|U|N|4||88||INDUCTION TREATMENT|1967-06-29||1967-10-02|||1972-05-31||1967-04-08
TRIAL STUDY 134XCP|RP|A5C0B034-1226-40EE-87E3-D46A7342B550|2||||||MENOAGE|MENOPAUSE AGE||||MG/M2/DAY|||UEQ/L|NOT DONE||U|Y|NA|4||88||OBSERVATION|1963-04-30||1968-10-01|||1961-10-19||1963-06-04
TRIAL STUDY 134XCP|RP|A5C0B034-1226-40EE-87E3-D46A7342B550|1||||||BLISTIND|BLISTERING INDICATOR||||GENEQ|||MCI/KG|NOT DONE||U|Y|U|5||7||BLINDED TREATMENT|1960-09-07||1967-11-05|||1960-10-03||1964-05-03
TRIAL STUDY 134XCP|RP|A5C0B034-1226-40EE-87E3-D46A7342B550|2||||||RASHIND|RASH INDICATOR||||CI/UL|||CI/G|NOT DONE||U|N|NA|5||7||CONTINUATION TREATMENT|1961-06-01||1961-08-23|||1964-02-22||1964-01-05
TRIAL STUDY 134XCP|RP|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||IU/MMOL|||/HPF|NOT DONE||Y|NA|U|1||38||RUN-IN|1961-06-28||1966-01-21|||1973-05-05||1965-01-24
TRIAL STUDY 134XCP|RP|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||PELLET|||UMOL/L/H|NOT DONE||N|N|U|1||38||BLINDED TREATMENT|1964-09-17||1971-09-15|||1963-02-28||1969-02-21
TRIAL STUDY 134XCP|RP|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MOL/MG|||DAGU|NOT DONE||N|NA|U|2||58||INDUCTION TREATMENT|1970-01-23||1973-01-08|||1970-05-24||1962-08-26
TRIAL STUDY 134XCP|RP|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|2||||||PRGENDTC|DATE PREGNANCY ENDED||||MG2/DL2|||10^7 PFU|NOT DONE||Y|U|Y|2||58||BASELINE|1971-03-22||1972-05-30|||1960-02-01||1965-10-03
TRIAL STUDY 134XCP|RP|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|1||||||MENARAGE|MENARCHE AGE||||U/G|||UIU/L|NOT DONE||NA|N|N|3||39||LONG-TERM FOLLOW-UP|1971-10-26||1970-03-23|||1970-03-15||1967-10-19
TRIAL STUDY 134XCP|RP|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||BEAM BREAKS|||HEP|NOT DONE||U|NA|U|3||39||FOLLOW-UP|1960-06-15||1962-04-06|||1972-01-03||1962-12-03
TRIAL STUDY 134XCP|RP|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||10^3/HPF|||KIT|NOT DONE||N|N|N|4||88||TREATMENT|1971-11-24||1967-11-18|||1972-07-02||1960-11-17
TRIAL STUDY 134XCP|RP|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|2||||||MENOAGE|MENOPAUSE AGE||||MOSM|||GPL U/ML|NOT DONE||NA|U|N|4||88||LONG-TERM FOLLOW-UP|1966-12-13||1964-08-03|||1960-05-15||1965-08-29
TRIAL STUDY 134XCP|RP|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|1||||||MENOSTAT|MENOPAUSE STATUS||||CONTAINER|||QUANTITY SUFFICIENT|NOT DONE||NA|U|NA|5||7||INDUCTION TREATMENT|1973-03-15||1961-05-01|||1960-01-28||1967-02-13
TRIAL STUDY 134XCP|RP|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/G/DAY|||IU/MG|NOT DONE||NA|N|NA|5||7||LONG-TERM FOLLOW-UP|1966-03-13||1964-09-17|||1960-06-18||1970-06-08
TRIAL STUDY 134XCP|RP|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||TORR|||ML/G/MIN|NOT DONE||U|U|Y|1||38||CONTINUATION TREATMENT|1972-02-02||1962-05-01|||1968-11-20||1967-02-08
TRIAL STUDY 134XCP|RP|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|2||||||EDEMAIND|EDEMA INDICATOR||||CMHG|||WATT|NOT DONE||Y|N|Y|1||38||RUN-IN|1965-03-12||1961-05-30|||1972-06-21||1964-05-22
TRIAL STUDY 134XCP|RP|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MG/KG/DAY|||DNA COPIES/ML|NOT DONE||NA|U|N|2||58||OPEN LABEL TREATMENT|1969-07-17||1973-06-07|||1961-08-29||1973-08-21
TRIAL STUDY 134XCP|RP|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MESF|||FMOL|NOT DONE||N|N|U|2||58||OPEN LABEL TREATMENT|1966-03-25||1962-07-07|||1964-07-22||1963-01-05
TRIAL STUDY 134XCP|RP|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MG/MIN|||GENEQ|NOT DONE||NA|N|NA|3||39||LONG-TERM FOLLOW-UP|1963-11-02||1972-04-10|||1970-08-28||1971-04-23
TRIAL STUDY 134XCP|RP|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|2||||||DSCHGIND|DISCHARGE INDICATOR||||AMU|||TCID 50/DOSE|NOT DONE||Y|N|Y|3||39||FOLLOW-UP|1968-04-30||1972-09-07|||1968-08-19||1968-03-24
TRIAL STUDY 134XCP|RP|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|1||||||INABOIND|INDUCED ABORTION INDICATOR||||NSEC|||NGEQ/L|NOT DONE||Y|NA|N|4||88||OPEN LABEL TREATMENT|1972-04-29||1970-08-09|||1969-03-09||1971-03-25
TRIAL STUDY 134XCP|RP|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|2||||||THICK|THICKNESS||||KG/CM|||10^7 CFU|NOT DONE||Y|N|N|4||88||CONTINUATION TREATMENT|1971-06-13||1963-02-24|||1966-05-17||1965-05-26
TRIAL STUDY 134XCP|RP|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||CAPFUL|||CM/MIN|NOT DONE||Y|Y|U|5||7||LONG-TERM FOLLOW-UP|1961-04-06||1970-07-03|||1967-02-15||1969-11-11
TRIAL STUDY 134XCP|RP|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|2||||||DSCHGIND|DISCHARGE INDICATOR||||MBQ|||/40 HPFS|NOT DONE||U|Y|NA|5||7||SCREENING|1962-03-16||1972-03-15|||1960-05-17||1961-03-16
TRIAL STUDY 134XCP|RP|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|1||||||BCMETHOD|BIRTH CONTROL METHOD||||MBP|||DEG/MM|NOT DONE||U|Y|U|1||38||FOLLOW-UP|1969-04-07||1970-02-06|||1965-01-27||1973-07-12
TRIAL STUDY 134XCP|RP|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MG/G/MIN|||NU/CL|NOT DONE||N|Y|U|1||38||INDUCTION TREATMENT|1961-06-25||1963-09-14|||1963-03-02||1963-08-12
TRIAL STUDY 134XCP|RP|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||OZ|||MMHG|NOT DONE||NA|N|Y|2||58||LONG-TERM FOLLOW-UP|1968-08-21||1963-02-07|||1965-06-09||1968-12-25
TRIAL STUDY 134XCP|RP|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||ML/MIN|||GPS U|NOT DONE||NA|Y|N|2||58||OBSERVATION|1969-08-31||1960-11-03|||1970-10-28||1961-09-10
TRIAL STUDY 134XCP|RP|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|1||||||THICK|THICKNESS||||MDFI|||IU|NOT DONE||Y|Y|NA|3||39||SCREENING|1962-12-20||1972-11-15|||1963-08-25||1972-07-19
TRIAL STUDY 134XCP|RP|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||DDU|||ML/CAGE/DAY|NOT DONE||Y|N|Y|3||39||RUN-IN|1971-02-11||1969-02-07|||1961-08-15||1967-03-22
TRIAL STUDY 134XCP|RP|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|1||||||PUSTIND|PUSTULE INDICATOR||||KV|||NSEC|NOT DONE||U|NA|NA|4||88||SCREENING|1968-05-10||1971-11-15|||1970-06-17||1966-03-06
TRIAL STUDY 134XCP|RP|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|2||||||MENARAGE|MENARCHE AGE||||KS|||ML/DOSE|NOT DONE||NA|NA|NA|4||88||BLINDED TREATMENT|1972-02-21||1961-08-12|||1968-03-19||1970-07-27
TRIAL STUDY 134XCP|RP|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|1||||||GRAVIND|GRAVIDA INDICATOR||||MEQ/UL|||UG/DOSE|NOT DONE||U|NA|U|5||7||TREATMENT|1967-11-01||1971-12-18|||1964-07-12||1972-09-12
TRIAL STUDY 134XCP|RP|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^4/L|||EP U|NOT DONE||NA|Y|U|5||7||LONG-TERM FOLLOW-UP|1968-01-23||1971-01-19|||1967-06-21||1965-01-25
TRIAL STUDY 134XCP|RP|D58A8C37-6659-4B00-8BED-256E8754F93C|1||||||FUNDHT|FUNDAL HEIGHT||||MMOL2/L2|||10^8/L|NOT DONE||NA|NA|N|1||38||SCREENING|1966-01-18||1966-03-15|||1963-08-09||1967-09-18
TRIAL STUDY 134XCP|RP|D58A8C37-6659-4B00-8BED-256E8754F93C|2||||||PEELIND|PEELING INDICATOR||||P|||EVENTS|NOT DONE||NA|Y|Y|1||38||INDUCTION TREATMENT|1963-11-18||1973-09-08|||1967-01-15||1971-04-27
TRIAL STUDY 134XCP|RP|D58A8C37-6659-4B00-8BED-256E8754F93C|1||||||STILBIND|STILLBIRTH INDICATOR||||P|||TCID 50/DOSE|NOT DONE||U|Y|N|2||58||FOLLOW-UP|1968-11-30||1966-03-02|||1960-05-17||1964-05-10
TRIAL STUDY 134XCP|RP|D58A8C37-6659-4B00-8BED-256E8754F93C|2||||||EDEMAIND|EDEMA INDICATOR||||DEG2|||BOLUS|NOT DONE||N|N|NA|2||58||WASHOUT|1960-06-11||1961-06-06|||1961-05-16||1963-02-04
TRIAL STUDY 134XCP|RP|D58A8C37-6659-4B00-8BED-256E8754F93C|1||||||MENFDUR|MENSES FLOW DURATION||||UCI/L|||IMPLANT|NOT DONE||Y|Y|Y|3||39||FOLLOW-UP|1969-09-11||1968-12-12|||1973-03-26||1968-06-02
TRIAL STUDY 134XCP|RP|D58A8C37-6659-4B00-8BED-256E8754F93C|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||/LSQN|||CAN|NOT DONE||U|U|N|3||39||CONTINUATION TREATMENT|1965-05-01||1963-03-13|||1963-04-27||1964-06-05
TRIAL STUDY 134XCP|RP|D58A8C37-6659-4B00-8BED-256E8754F93C|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||/HPF|||EJACULATE U|NOT DONE||U|N|NA|4||88||WASHOUT|1966-11-13||1961-12-19|||1970-07-07||1973-01-26
TRIAL STUDY 134XCP|RP|D58A8C37-6659-4B00-8BED-256E8754F93C|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||DAYS/WK|||CD*S/M2|NOT DONE||U|U|Y|4||88||SCREENING|1971-09-08||1970-03-08|||1973-07-31||1966-06-09
TRIAL STUDY 134XCP|RP|D58A8C37-6659-4B00-8BED-256E8754F93C|1||||||ULCERIND|ULCER INDICATOR||||MU/L|||NL|NOT DONE||N|Y|NA|5||7||WASHOUT|1960-05-10||1963-11-11|||1973-05-02||1970-07-14
TRIAL STUDY 134XCP|RP|D58A8C37-6659-4B00-8BED-256E8754F93C|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MG/G/H|||M|NOT DONE||U|Y|N|5||7||OBSERVATION|1965-11-14||1969-09-27|||1967-05-26||1960-04-25
TRIAL STUDY 134XCP|RP|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MG/H|||ML/M2/MIN|NOT DONE||N|NA|N|1||38||BASELINE|1964-02-03||1967-05-24|||1966-09-30||1960-10-10
TRIAL STUDY 134XCP|RP|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||U/M2|||FT3|NOT DONE||NA|U|NA|1||38||SCREENING|1965-09-05||1968-01-09|||1961-06-26||1972-08-31
TRIAL STUDY 134XCP|RP|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MPS U|||ML/M2/DAY|NOT DONE||NA|Y|NA|2||58||OPEN LABEL TREATMENT|1965-02-23||1964-06-26|||1968-05-11||1971-09-25
TRIAL STUDY 134XCP|RP|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||TABLET|||MASK|NOT DONE||U|U|N|2||58||TREATMENT|1968-03-27||1961-10-16|||1966-05-18||1967-12-24
TRIAL STUDY 134XCP|RP|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|1||||||MENARAGE|MENARCHE AGE||||KBQ/UL|||GBQ|NOT DONE||NA|NA|Y|3||39||TREATMENT|1969-01-19||1970-10-28|||1971-01-22||1967-07-19
TRIAL STUDY 134XCP|RP|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||MOL/ML|||DEG2|NOT DONE||Y|U|NA|3||39||TREATMENT|1972-08-30||1964-08-20|||1960-11-02||1971-07-01
TRIAL STUDY 134XCP|RP|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||DPM/0.5 ML|||MMHG/L/MIN|NOT DONE||U|Y|Y|4||88||OBSERVATION|1970-10-11||1961-03-23|||1963-05-27||1961-03-02
TRIAL STUDY 134XCP|RP|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||/MS|||ML/ANIMAL/WK|NOT DONE||N|N|U|4||88||BASELINE|1966-03-27||1963-03-17|||1961-06-05||1962-12-06
TRIAL STUDY 134XCP|RP|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||AG|||KG/MOL|NOT DONE||NA|NA|NA|5||7||SCREENING|1960-09-29||1964-11-24|||1973-01-27||1965-10-23
TRIAL STUDY 134XCP|RP|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|2||||||STILBIND|STILLBIRTH INDICATOR||||ML/M2/H|||MG/M2/DAY|NOT DONE||U|NA|Y|5||7||BLINDED TREATMENT|1965-09-04||1970-04-18|||1969-09-22||1968-12-09
TRIAL STUDY 134XCP|RP|5440F45F-C220-46E7-8354-6AF34A003E5E|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^9 ORGANISMS/G|||10^4 CFU/ML|NOT DONE||NA|U|Y|1||38||BASELINE|1961-09-26||1963-08-19|||1965-05-01||1970-08-09
TRIAL STUDY 134XCP|RP|5440F45F-C220-46E7-8354-6AF34A003E5E|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||VP/DOSE|||KIU|NOT DONE||Y|U|NA|1||38||OPEN LABEL TREATMENT|1972-08-08||1969-10-07|||1965-08-27||1963-04-05
TRIAL STUDY 134XCP|RP|5440F45F-C220-46E7-8354-6AF34A003E5E|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UM/S|||BU/ML|NOT DONE||U|N|Y|2||58||BASELINE|1963-12-31||1968-08-02|||1971-04-02||1965-05-05
TRIAL STUDY 134XCP|RP|5440F45F-C220-46E7-8354-6AF34A003E5E|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||DPM/MG|||UMOL/L/H|NOT DONE||Y|N|NA|2||58||OBSERVATION|1964-10-09||1970-10-18|||1965-02-11||1960-01-14
TRIAL STUDY 134XCP|RP|5440F45F-C220-46E7-8354-6AF34A003E5E|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MEQ/MMOL|||RPM|NOT DONE||U|U|U|3||39||SCREENING|1962-04-29||1961-12-01|||1965-12-06||1973-06-06
TRIAL STUDY 134XCP|RP|5440F45F-C220-46E7-8354-6AF34A003E5E|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MG|||MG/M2/H|NOT DONE||U|Y|N|3||39||LONG-TERM FOLLOW-UP|1971-09-30||1967-02-27|||1965-12-16||1962-03-08
TRIAL STUDY 134XCP|RP|5440F45F-C220-46E7-8354-6AF34A003E5E|1||||||STILBIND|STILLBIRTH INDICATOR||||G/DAY|||MG/CM2|NOT DONE||NA|N|NA|4||88||LONG-TERM FOLLOW-UP|1965-03-08||1965-04-15|||1972-11-02||1962-12-28
TRIAL STUDY 134XCP|RP|5440F45F-C220-46E7-8354-6AF34A003E5E|2||||||MASSIND|MASS INDICATOR||||BU/ML|||/KG|NOT DONE||Y|Y|N|4||88||TREATMENT|1962-06-06||1960-03-10|||1969-06-25||1963-04-12
TRIAL STUDY 134XCP|RP|5440F45F-C220-46E7-8354-6AF34A003E5E|1||||||PREGIND|PREGNANT INDICATOR||||PACKET|||MU|NOT DONE||N|U|N|5||7||LONG-TERM FOLLOW-UP|1973-02-02||1971-06-13|||1962-08-04||1963-09-03
TRIAL STUDY 134XCP|RP|5440F45F-C220-46E7-8354-6AF34A003E5E|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||PSI|||ANTI-XA IU|NOT DONE||NA|U|Y|5||7||TREATMENT|1969-05-09||1968-12-22|||1968-01-07||1972-06-25
TRIAL STUDY 134XCP|RP|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|1||||||STILBIND|STILLBIRTH INDICATOR||||M/SEC|||PUFF|NOT DONE||NA|NA|NA|1||38||RUN-IN|1971-05-19||1967-11-29|||1968-01-03||1968-08-04
TRIAL STUDY 134XCP|RP|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|2||||||BRTHN|NUMBER OF BIRTHS||||PA|||PMOL/G|NOT DONE||NA|U|Y|1||38||BLINDED TREATMENT|1971-11-20||1972-12-28|||1969-05-20||1961-07-28
TRIAL STUDY 134XCP|RP|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|1||||||FUNDHT|FUNDAL HEIGHT||||HOMEOPATHIC DILUTION|||10^3/L|NOT DONE||N|U|U|2||58||WASHOUT|1970-03-14||1964-03-08|||1969-09-04||1966-08-07
TRIAL STUDY 134XCP|RP|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||10^3/HPF|||MG/KG/WEEK|NOT DONE||Y|U|N|2||58||OPEN LABEL TREATMENT|1968-07-01||1968-05-04|||1963-08-14||1968-10-22
TRIAL STUDY 134XCP|RP|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|1||||||PEELIND|PEELING INDICATOR||||KCAL/DAY|||/100 HPFS|NOT DONE||N|NA|N|3||39||FOLLOW-UP|1966-04-06||1969-09-21|||1963-04-14||1966-11-17
TRIAL STUDY 134XCP|RP|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|2||||||BRTHN|NUMBER OF BIRTHS||||RPM|||KIT|NOT DONE||U|Y|U|3||39||BASELINE|1969-12-05||1969-01-11|||1967-05-16||1972-09-13
TRIAL STUDY 134XCP|RP|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|1||||||INTP|INTERPRETATION||||UCI/L|||MEQ/MMOL|NOT DONE||U|U|Y|4||88||INDUCTION TREATMENT|1971-12-26||1972-01-02|||1972-03-24||1960-02-20
TRIAL STUDY 134XCP|RP|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MEQ|||UKAT/10^12 RBC|NOT DONE||U|U|NA|4||88||BASELINE|1965-12-04||1965-01-08|||1970-09-15||1963-01-18
TRIAL STUDY 134XCP|RP|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|1||||||FUNDHT|FUNDAL HEIGHT||||CAPLET|||COULOMB|NOT DONE||NA|U|U|5||7||INDUCTION TREATMENT|1965-08-23||1972-03-12|||1962-06-12||1973-03-09
TRIAL STUDY 134XCP|RP|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MM2|||MG/DL|NOT DONE||U|N|N|5||7||OBSERVATION|1960-09-25||1967-08-07|||1964-02-14||1971-12-01
TRIAL STUDY 134XCP|RP|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|1||||||DLVRMODE|MODE OF DELIVERY||||U/ML|||SHOCK WAVE|NOT DONE||U|U|U|1||38||TREATMENT|1973-05-06||1966-03-02|||1968-10-09||1962-10-31
TRIAL STUDY 134XCP|RP|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|2||||||DSCHGIND|DISCHARGE INDICATOR||||LX|||MEQ/DL|NOT DONE||Y|NA|Y|1||38||WASHOUT|1964-09-25||1964-10-31|||1970-12-19||1970-04-24
TRIAL STUDY 134XCP|RP|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PMOL/G|||CFU/ML|NOT DONE||Y|U|NA|2||58||WASHOUT|1966-12-30||1967-08-07|||1963-11-06||1960-03-26
TRIAL STUDY 134XCP|RP|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||OSM|||PIXELS/CM|NOT DONE||NA|NA|N|2||58||OBSERVATION|1968-07-21||1967-10-29|||1970-10-20||1971-08-30
TRIAL STUDY 134XCP|RP|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|1||||||DLVRMODE|MODE OF DELIVERY||||PA|||ML/BREATH|NOT DONE||U|N|U|3||39||LONG-TERM FOLLOW-UP|1967-10-06||1971-06-06|||1965-03-25||1965-08-30
TRIAL STUDY 134XCP|RP|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|2||||||PREGIND|PREGNANT INDICATOR||||HOMEOPATHIC DILUTION|||LX|NOT DONE||U|Y|N|3||39||TREATMENT|1960-09-02||1967-01-12|||1973-03-08||1970-10-28
TRIAL STUDY 134XCP|RP|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|1||||||BCMETHOD|BIRTH CONTROL METHOD||||NMOL/ML/MIN|||GPL U/ML|NOT DONE||NA|N|Y|4||88||CONTINUATION TREATMENT|1960-12-19||1962-07-16|||1964-03-12||1969-09-13
TRIAL STUDY 134XCP|RP|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/DAY|||DIP|NOT DONE||Y|Y|Y|4||88||OPEN LABEL TREATMENT|1967-12-28||1970-05-28|||1961-06-02||1970-01-14
TRIAL STUDY 134XCP|RP|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||U/KG/MIN|||HR/DAY|NOT DONE||N|Y|U|5||7||TREATMENT|1972-11-10||1973-04-19|||1964-12-06||1963-08-15
TRIAL STUDY 134XCP|RP|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MPL U/ML|||KG/CM2|NOT DONE||NA|NA|U|5||7||TREATMENT|1973-09-05||1971-06-11|||1965-03-12||1970-06-02
TRIAL STUDY 134XCP|RP|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^9 ORGANISMS/ML|||U/KG|NOT DONE||N|U|NA|1||38||CONTINUATION TREATMENT|1961-06-10||1968-09-13|||1966-04-13||1962-09-02
TRIAL STUDY 134XCP|RP|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||GENEQ/ML|||UMOL/L/MIN|NOT DONE||U|U|Y|1||38||SCREENING|1967-12-29||1968-05-23|||1964-05-14||1960-10-09
TRIAL STUDY 134XCP|RP|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||CM/S|||GPL U/ML|NOT DONE||U|U|NA|2||58||LONG-TERM FOLLOW-UP|1973-08-03||1961-05-09|||1973-02-09||1969-11-23
TRIAL STUDY 134XCP|RP|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|2||||||PRGENDTC|DATE PREGNANCY ENDED||||HR/DAY|||10^3/L|NOT DONE||N|N|Y|2||58||SCREENING|1963-02-02||1962-11-17|||1972-12-31||1968-09-23
TRIAL STUDY 134XCP|RP|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||BOTTLE|||/H|NOT DONE||U|NA|U|3||39||WASHOUT|1965-02-08||1962-09-03|||1968-06-21||1966-04-16
TRIAL STUDY 134XCP|RP|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ML/MIN/1.73M2|||ENZYME U/G HB|NOT DONE||Y|NA|NA|3||39||INDUCTION TREATMENT|1968-04-24||1968-01-05|||1968-11-03||1971-06-17
TRIAL STUDY 134XCP|RP|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|1||||||FUNDHT|FUNDAL HEIGHT||||DAMOL/L|||MHZ|NOT DONE||U|N|N|4||88||SCREENING|1968-11-12||1971-07-12|||1966-05-07||1963-01-04
TRIAL STUDY 134XCP|RP|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||/HPF|||L/MIN/M2|NOT DONE||U|Y|N|4||88||BASELINE|1964-10-28||1967-05-22|||1968-03-30||1973-07-18
TRIAL STUDY 134XCP|RP|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MG/DOSE|||IU/KG|NOT DONE||U|NA|N|5||7||INDUCTION TREATMENT|1967-12-21||1967-05-07|||1967-05-03||1964-08-08
TRIAL STUDY 134XCP|RP|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||U/ANIMAL|||MG/KG/H|NOT DONE||Y|NA|NA|5||7||BASELINE|1962-09-04||1971-02-10|||1965-06-13||1965-12-31
TRIAL STUDY 134XCP|RP|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||HPA|||PFU|NOT DONE||Y|Y|N|1||38||TREATMENT|1965-05-16||1969-10-03|||1971-01-21||1969-12-18
TRIAL STUDY 134XCP|RP|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||KM/H|||UL/KG/DAY|NOT DONE||NA|Y|U|1||38||CONTINUATION TREATMENT|1969-02-19||1967-05-31|||1969-04-04||1968-07-28
TRIAL STUDY 134XCP|RP|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||/500 WBC|||KS|NOT DONE||Y|N|U|2||58||RUN-IN|1967-11-03||1967-03-13|||1960-06-18||1965-07-18
TRIAL STUDY 134XCP|RP|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|2||||||STILBIND|STILLBIRTH INDICATOR||||MG/M2/DAY|||NL|NOT DONE||Y|N|NA|2||58||TREATMENT|1972-11-27||1971-12-09|||1967-12-04||1962-06-09
TRIAL STUDY 134XCP|RP|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|1||||||PUSTIND|PUSTULE INDICATOR||||KG/M2|||MG/M2/MIN|NOT DONE||U|Y|NA|3||39||RUN-IN|1973-03-10||1973-04-01|||1964-12-01||1963-07-07
TRIAL STUDY 134XCP|RP|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||CUP|||IMPLANT|NOT DONE||U|N|Y|3||39||BLINDED TREATMENT|1971-12-10||1960-08-22|||1971-02-09||1968-04-21
TRIAL STUDY 134XCP|RP|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||ML/SEC/1.73M2|||CAL|NOT DONE||Y|Y|U|4||88||BLINDED TREATMENT|1971-09-22||1962-01-29|||1968-03-17||1961-08-24
TRIAL STUDY 134XCP|RP|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||U/KG|||ELISA UNIT/ML|NOT DONE||N|Y|Y|4||88||SCREENING|1972-04-12||1967-12-19|||1971-02-15||1961-09-22
TRIAL STUDY 134XCP|RP|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|1||||||BCMETHOD|BIRTH CONTROL METHOD||||ROENTGEN|||MS2|NOT DONE||U|U|Y|5||7||RUN-IN|1972-05-12||1969-11-05|||1963-05-05||1961-12-19
TRIAL STUDY 134XCP|RP|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|2||||||RASHIND|RASH INDICATOR||||SFC/10^6 PBMC|||MG/L FEU|NOT DONE||NA|Y|Y|5||7||TREATMENT|1964-05-05||1961-05-05|||1963-08-13||1971-06-07
TRIAL STUDY 134XCP|RP|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|1||||||ABORTN|NUMBER OF ABORTIONS||||S*KPA|||MPA|NOT DONE||U|N|N|1||38||RUN-IN|1965-06-26||1965-02-26|||1960-12-13||1965-04-22
TRIAL STUDY 134XCP|RP|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UG/DL|||ML/H|NOT DONE||Y|NA|NA|1||38||BASELINE|1965-12-14||1967-10-14|||1964-10-23||1965-04-29
TRIAL STUDY 134XCP|RP|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|1||||||MENARAGE|MENARCHE AGE||||UG/DOSE|||AG|NOT DONE||N|Y|U|2||58||OBSERVATION|1966-02-25||1968-05-19|||1968-03-23||1968-05-15
TRIAL STUDY 134XCP|RP|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||TSP EQ|||ML/CAGE/DAY|NOT DONE||NA|N|U|2||58||OPEN LABEL TREATMENT|1962-05-22||1962-04-28|||1965-08-27||1963-08-03
TRIAL STUDY 134XCP|RP|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|1||||||PREGIND|PREGNANT INDICATOR||||FINGERTIP UNIT|||ML/G/MIN|NOT DONE||U|N|N|3||39||OPEN LABEL TREATMENT|1962-03-15||1966-10-05|||1968-01-12||1971-04-21
TRIAL STUDY 134XCP|RP|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||PFU/DOSE|||ELISA UNIT/DOSE|NOT DONE||U|U|N|3||39||WASHOUT|1963-03-07||1965-06-08|||1960-05-26||1968-10-03
TRIAL STUDY 134XCP|RP|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|1||||||PREGIND|PREGNANT INDICATOR||||U/M2|||ENZYME U/G HB|NOT DONE||NA|U|N|4||88||FOLLOW-UP|1968-09-20||1970-02-14|||1966-07-09||1973-03-21
TRIAL STUDY 134XCP|RP|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|2||||||PUSTIND|PUSTULE INDICATOR||||EQ|||DMOL|NOT DONE||Y|Y|N|4||88||INDUCTION TREATMENT|1964-09-10||1961-06-12|||1963-03-10||1961-11-29
TRIAL STUDY 134XCP|RP|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||FEU|||V/V|NOT DONE||Y|Y|NA|5||7||OPEN LABEL TREATMENT|1970-09-07||1968-11-22|||1961-04-03||1962-07-16
TRIAL STUDY 134XCP|RP|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||BEL|||U/G/H|NOT DONE||Y|U|NA|5||7||INDUCTION TREATMENT|1962-10-08||1960-04-10|||1967-06-09||1967-09-18
TRIAL STUDY 134XCP|RP|1E9C7E41-8565-4C60-9EEB-814914081596|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PG/L|||VG/ML|NOT DONE||U|N|Y|1||38||BASELINE|1971-02-24||1960-09-30|||1963-05-04||1963-06-28
TRIAL STUDY 134XCP|RP|1E9C7E41-8565-4C60-9EEB-814914081596|2||||||THICK|THICKNESS||||U/G/MIN|||CI/UG|NOT DONE||Y|NA|N|1||38||SCREENING|1970-12-17||1966-06-05|||1969-12-26||1972-07-21
TRIAL STUDY 134XCP|RP|1E9C7E41-8565-4C60-9EEB-814914081596|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||USP U|||MOL/MOL|NOT DONE||N|Y|NA|2||58||CONTINUATION TREATMENT|1960-10-14||1971-05-02|||1971-09-05||1972-07-18
TRIAL STUDY 134XCP|RP|1E9C7E41-8565-4C60-9EEB-814914081596|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MCI/KG|||DEG|NOT DONE||N|N|N|2||58||CONTINUATION TREATMENT|1961-02-22||1967-01-07|||1965-02-18||1970-09-19
TRIAL STUDY 134XCP|RP|1E9C7E41-8565-4C60-9EEB-814914081596|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||AMFI|||ML*CMH2O|NOT DONE||Y|N|N|3||39||LONG-TERM FOLLOW-UP|1961-12-07||1971-12-28|||1964-12-09||1962-02-03
TRIAL STUDY 134XCP|RP|1E9C7E41-8565-4C60-9EEB-814914081596|2||||||MENARAGE|MENARCHE AGE||||IN|||DEG2|NOT DONE||NA|NA|NA|3||39||SCREENING|1972-05-29||1965-03-02|||1972-04-03||1961-09-13
TRIAL STUDY 134XCP|RP|1E9C7E41-8565-4C60-9EEB-814914081596|1||||||EDEMAIND|EDEMA INDICATOR||||/2500 WBC|||ML/CM|NOT DONE||N|N|N|4||88||BLINDED TREATMENT|1963-09-12||1961-09-19|||1971-03-11||1962-07-17
TRIAL STUDY 134XCP|RP|1E9C7E41-8565-4C60-9EEB-814914081596|2||||||PREGIND|PREGNANT INDICATOR||||COPIES/UG|||PACKET|NOT DONE||U|N|Y|4||88||OBSERVATION|1966-10-08||1962-06-12|||1964-03-28||1962-07-14
TRIAL STUDY 134XCP|RP|1E9C7E41-8565-4C60-9EEB-814914081596|1||||||ERYTHIND|ERYTHEMA INDICATOR||||COPIES/UG|||/SEC|NOT DONE||Y|N|NA|5||7||TREATMENT|1967-05-02||1970-11-06|||1967-03-02||1965-10-20
TRIAL STUDY 134XCP|RP|1E9C7E41-8565-4C60-9EEB-814914081596|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ANSON U|||/40 HPFS|NOT DONE||NA|NA|NA|5||7||FOLLOW-UP|1967-07-08||1961-10-11|||1973-04-19||1964-12-29
TRIAL STUDY 134XCP|RP|D7A008CF-5990-4D74-934A-A4DD3180EBD4|1||||||GRAVIND|GRAVIDA INDICATOR||||PNU/ML|||MV/SEC|NOT DONE||NA|Y|Y|1||38||LONG-TERM FOLLOW-UP|1970-08-26||1960-07-17|||1973-06-04||1970-05-28
TRIAL STUDY 134XCP|RP|D7A008CF-5990-4D74-934A-A4DD3180EBD4|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||DRUM|||MMOL/G|NOT DONE||NA|Y|Y|1||38||WASHOUT|1961-01-06||1972-10-23|||1969-04-17||1969-07-11
TRIAL STUDY 134XCP|RP|D7A008CF-5990-4D74-934A-A4DD3180EBD4|1||||||MENOSTAT|MENOPAUSE STATUS||||UV2|||DPM/0.5 ML|NOT DONE||Y|N|Y|2||58||LONG-TERM FOLLOW-UP|1971-09-04||1969-09-08|||1969-05-21||1970-10-04
TRIAL STUDY 134XCP|RP|D7A008CF-5990-4D74-934A-A4DD3180EBD4|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||NG/MOL|||CI/L|NOT DONE||U|NA|Y|2||58||LONG-TERM FOLLOW-UP|1968-12-06||1967-12-25|||1963-08-16||1960-05-10
TRIAL STUDY 134XCP|RP|D7A008CF-5990-4D74-934A-A4DD3180EBD4|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||NEBULE|||/MS|NOT DONE||NA|NA|N|3||39||RUN-IN|1964-12-04||1973-04-22|||1970-09-30||1970-04-15
TRIAL STUDY 134XCP|RP|D7A008CF-5990-4D74-934A-A4DD3180EBD4|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MG/ML/DAY|||DAYS/WK|NOT DONE||NA|N|N|3||39||OBSERVATION|1973-06-17||1961-04-30|||1964-07-11||1972-12-20
TRIAL STUDY 134XCP|RP|D7A008CF-5990-4D74-934A-A4DD3180EBD4|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MM3/MM2/YEAR|||MEQ/DL|NOT DONE||NA|U|U|4||88||LONG-TERM FOLLOW-UP|1964-03-16||1963-03-23|||1962-01-29||1973-06-09
TRIAL STUDY 134XCP|RP|D7A008CF-5990-4D74-934A-A4DD3180EBD4|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||/SEC|||APL U|NOT DONE||U|NA|N|4||88||LONG-TERM FOLLOW-UP|1972-08-07||1971-10-23|||1962-05-28||1967-05-01
TRIAL STUDY 134XCP|RP|D7A008CF-5990-4D74-934A-A4DD3180EBD4|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||10^6 COPIES/ML|||MM/2H|NOT DONE||NA|N|U|5||7||CONTINUATION TREATMENT|1969-09-10||1968-03-25|||1968-01-18||1970-08-01
TRIAL STUDY 134XCP|RP|D7A008CF-5990-4D74-934A-A4DD3180EBD4|2||||||INTP|INTERPRETATION||||BAU/ML|||MS2|NOT DONE||U|NA|NA|5||7||OPEN LABEL TREATMENT|1970-03-03||1963-09-01|||1972-04-13||1964-02-14
TRIAL STUDY 134XCP|RP|C168FA23-40EE-46D8-9A56-8B80490A0EFB|1||||||PUSTIND|PUSTULE INDICATOR||||CYCLE/MIN|||U/M2/H|NOT DONE||N|N|NA|1||38||RUN-IN|1971-01-07||1970-09-05|||1963-11-07||1972-05-14
TRIAL STUDY 134XCP|RP|C168FA23-40EE-46D8-9A56-8B80490A0EFB|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||P|||ML/S/M2|NOT DONE||NA|U|Y|1||38||SCREENING|1971-01-18||1961-12-03|||1966-10-13||1968-10-26
TRIAL STUDY 134XCP|RP|C168FA23-40EE-46D8-9A56-8B80490A0EFB|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||NMOL/KG/DAY|||MM/MIN|NOT DONE||N|NA|NA|2||58||SCREENING|1967-02-25||1967-01-22|||1965-02-09||1963-02-14
TRIAL STUDY 134XCP|RP|C168FA23-40EE-46D8-9A56-8B80490A0EFB|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||DAYS/MONTH|||VG/KG|NOT DONE||Y|NA|Y|2||58||SCREENING|1972-06-03||1962-10-20|||1964-09-02||1967-10-20
TRIAL STUDY 134XCP|RP|C168FA23-40EE-46D8-9A56-8B80490A0EFB|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||FL|||MG/DL|NOT DONE||N|Y|U|3||39||CONTINUATION TREATMENT|1962-10-01||1967-01-01|||1971-04-13||1973-02-16
TRIAL STUDY 134XCP|RP|C168FA23-40EE-46D8-9A56-8B80490A0EFB|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MKAT|||ML/SEC/1.73M2|NOT DONE||Y|N|Y|3||39||INDUCTION TREATMENT|1973-04-03||1963-08-30|||1970-12-15||1967-06-09
TRIAL STUDY 134XCP|RP|C168FA23-40EE-46D8-9A56-8B80490A0EFB|1||||||MASSIND|MASS INDICATOR||||% INHIBITION|||/500 WBC|NOT DONE||Y|NA|Y|4||88||OBSERVATION|1966-03-24||1961-01-26|||1962-04-28||1970-04-24
TRIAL STUDY 134XCP|RP|C168FA23-40EE-46D8-9A56-8B80490A0EFB|2||||||INTP|INTERPRETATION||||MAMP|||ROENTGEN|NOT DONE||NA|Y|Y|4||88||OPEN LABEL TREATMENT|1963-02-22||1970-03-29|||1973-09-03||1968-06-23
TRIAL STUDY 134XCP|RP|C168FA23-40EE-46D8-9A56-8B80490A0EFB|1||||||FUNDHT|FUNDAL HEIGHT||||KAT|||U/DL|NOT DONE||N|Y|N|5||7||BLINDED TREATMENT|1969-01-03||1973-04-30|||1960-11-05||1966-11-21
TRIAL STUDY 134XCP|RP|C168FA23-40EE-46D8-9A56-8B80490A0EFB|2||||||ERYTHIND|ERYTHEMA INDICATOR||||G|||BOWL|NOT DONE||N|Y|Y|5||7||TREATMENT|1973-03-29||1968-06-11|||1960-03-01||1969-07-25
TRIAL STUDY 134XCP|RP|215E4E69-70C3-493C-9D67-F717363E8138|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||ELISA UNIT/ML|||FT3|NOT DONE||N|NA|Y|1||38||OBSERVATION|1969-02-11||1967-01-25|||1971-12-03||1972-06-12
TRIAL STUDY 134XCP|RP|215E4E69-70C3-493C-9D67-F717363E8138|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||ANTIBODY UNIT|||UG/KG|NOT DONE||NA|NA|U|1||38||CONTINUATION TREATMENT|1964-09-04||1973-06-25|||1969-11-10||1961-01-09
TRIAL STUDY 134XCP|RP|215E4E69-70C3-493C-9D67-F717363E8138|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MG/DAY|||10^5/HPF|NOT DONE||U|NA|NA|2||58||OBSERVATION|1967-11-28||1970-12-08|||1966-01-10||1968-07-15
TRIAL STUDY 134XCP|RP|215E4E69-70C3-493C-9D67-F717363E8138|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||TRANSDUCING UNIT|||MMOL/MIN/KPA|NOT DONE||U|N|NA|2||58||FOLLOW-UP|1972-02-15||1972-08-14|||1965-04-12||1972-04-06
TRIAL STUDY 134XCP|RP|215E4E69-70C3-493C-9D67-F717363E8138|1||||||ERYTHIND|ERYTHEMA INDICATOR||||MG/M2|||KDA|NOT DONE||Y|U|U|3||39||SCREENING|1972-11-13||1972-06-12|||1964-06-25||1968-05-13
TRIAL STUDY 134XCP|RP|215E4E69-70C3-493C-9D67-F717363E8138|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MU|||FL|NOT DONE||NA|NA|Y|3||39||BASELINE|1963-11-15||1968-11-15|||1962-12-01||1968-07-18
TRIAL STUDY 134XCP|RP|215E4E69-70C3-493C-9D67-F717363E8138|1||||||THICK|THICKNESS||||UM|||KUSP|NOT DONE||U|NA|N|4||88||OBSERVATION|1968-06-11||1971-01-09|||1964-08-19||1971-09-09
TRIAL STUDY 134XCP|RP|215E4E69-70C3-493C-9D67-F717363E8138|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||EIA UNIT|||/100 HPFS|NOT DONE||NA|N|N|4||88||CONTINUATION TREATMENT|1971-12-19||1969-08-26|||1972-03-25||1962-12-04
TRIAL STUDY 134XCP|RP|215E4E69-70C3-493C-9D67-F717363E8138|1||||||DSCHGIND|DISCHARGE INDICATOR||||MEQ|||PA|NOT DONE||NA|N|U|5||7||BLINDED TREATMENT|1969-09-14||1968-08-08|||1960-11-01||1962-09-24
TRIAL STUDY 134XCP|RP|215E4E69-70C3-493C-9D67-F717363E8138|2||||||DSCHGIND|DISCHARGE INDICATOR||||M/SEC2|||HZ|NOT DONE||NA|U|NA|5||7||LONG-TERM FOLLOW-UP|1968-07-10||1970-03-06|||1962-06-18||1964-08-24
TRIAL STUDY 134XCP|RP|962CD4CA-AF22-42FB-ADB5-85F76850CA81|1||||||BRTHN|NUMBER OF BIRTHS||||SACHET|||OZ|NOT DONE||U|N|Y|1||38||WASHOUT|1961-01-19||1969-04-11|||1965-08-03||1972-05-10
TRIAL STUDY 134XCP|RP|962CD4CA-AF22-42FB-ADB5-85F76850CA81|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||IU/L|||DDU|NOT DONE||NA|Y|U|1||38||BASELINE|1962-01-23||1973-03-04|||1967-05-24||1963-11-18
TRIAL STUDY 134XCP|RP|962CD4CA-AF22-42FB-ADB5-85F76850CA81|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MMHG/SEC|||CAPSULE|NOT DONE||NA|NA|N|2||58||CONTINUATION TREATMENT|1960-03-14||1966-12-23|||1961-05-30||1961-04-12
TRIAL STUDY 134XCP|RP|962CD4CA-AF22-42FB-ADB5-85F76850CA81|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||UV|||MIU/L|NOT DONE||U|NA|Y|2||58||LONG-TERM FOLLOW-UP|1962-07-01||1966-07-20|||1972-12-15||1972-02-22
TRIAL STUDY 134XCP|RP|962CD4CA-AF22-42FB-ADB5-85F76850CA81|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||EID 50/ML|||10^3 ORGANISMS/G|NOT DONE||N|NA|NA|3||39||TREATMENT|1961-10-03||1972-01-14|||1963-12-11||1966-12-19
TRIAL STUDY 134XCP|RP|962CD4CA-AF22-42FB-ADB5-85F76850CA81|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||BQ/UL|||L/MIN/M2|NOT DONE||N|NA|NA|3||39||INDUCTION TREATMENT|1966-04-13||1972-12-05|||1965-06-15||1963-04-17
TRIAL STUDY 134XCP|RP|962CD4CA-AF22-42FB-ADB5-85F76850CA81|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||UG/KG/DAY|||EVENTS|NOT DONE||U|NA|N|4||88||CONTINUATION TREATMENT|1973-04-22||1972-02-11|||1960-07-22||1963-01-15
TRIAL STUDY 134XCP|RP|962CD4CA-AF22-42FB-ADB5-85F76850CA81|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||TSP EQ|||CM2|NOT DONE||U|Y|U|4||88||CONTINUATION TREATMENT|1967-06-15||1962-03-22|||1962-06-05||1969-08-19
TRIAL STUDY 134XCP|RP|962CD4CA-AF22-42FB-ADB5-85F76850CA81|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||TRANSDUCING UNIT|||APL U/ML|NOT DONE||N|NA|Y|5||7||BLINDED TREATMENT|1964-01-16||1971-06-20|||1966-10-15||1961-05-16
TRIAL STUDY 134XCP|RP|962CD4CA-AF22-42FB-ADB5-85F76850CA81|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||CI/UL|||L/H|NOT DONE||U|U|NA|5||7||INDUCTION TREATMENT|1963-06-03||1970-08-26|||1971-01-29||1961-06-04
TRIAL STUDY 134XCP|RP|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|1||||||MASSIND|MASS INDICATOR||||IN2|||CI/MG|NOT DONE||NA|NA|N|1||38||WASHOUT|1964-12-05||1969-01-16|||1965-07-30||1973-07-30
TRIAL STUDY 134XCP|RP|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|2||||||PREGIND|PREGNANT INDICATOR||||MIN/DAY|||MG/H|NOT DONE||Y|U|NA|1||38||OPEN LABEL TREATMENT|1961-06-28||1965-08-17|||1967-04-28||1968-12-10
TRIAL STUDY 134XCP|RP|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||ML/G/MIN|||KCAL/DAY|NOT DONE||Y|N|U|2||58||TREATMENT|1963-04-27||1962-03-29|||1960-11-04||1973-05-19
TRIAL STUDY 134XCP|RP|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||FMOL/L/SEC|||UMOL/MIN|NOT DONE||N|U|NA|2||58||OBSERVATION|1966-06-02||1961-09-01|||1970-08-23||1964-02-20
TRIAL STUDY 134XCP|RP|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|1||||||TNDRIND|TENDERNESS INDICATOR||||MEQ/KG|||DEG/S|NOT DONE||NA|NA|Y|3||39||FOLLOW-UP|1967-09-07||1963-02-14|||1960-09-06||1972-07-23
TRIAL STUDY 134XCP|RP|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|2||||||ABORTN|NUMBER OF ABORTIONS||||NFIU|||ELISA UNIT/ML|NOT DONE||NA|Y|Y|3||39||RUN-IN|1971-09-14||1960-08-18|||1962-05-02||1971-03-22
TRIAL STUDY 134XCP|RP|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|1||||||PREGNN|NUMBER OF PREGNANCIES||||KG|||G/CAGE/WK|NOT DONE||Y|Y|N|4||88||SCREENING|1964-09-01||1961-06-17|||1968-12-14||1962-04-30
TRIAL STUDY 134XCP|RP|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|2||||||RASHIND|RASH INDICATOR||||ABSORBANCE U/MIN|||MEQ|NOT DONE||N|Y|NA|4||88||INDUCTION TREATMENT|1960-03-26||1970-08-13|||1970-06-30||1966-04-24
TRIAL STUDY 134XCP|RP|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|1||||||STILBIND|STILLBIRTH INDICATOR||||FT3|||DAMOL/L|NOT DONE||N|Y|U|5||7||BLINDED TREATMENT|1973-02-24||1973-02-13|||1970-02-05||1968-03-10
TRIAL STUDY 134XCP|RP|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|2||||||ABORTN|NUMBER OF ABORTIONS||||GPL U|||AMU|NOT DONE||Y|U|NA|5||7||CONTINUATION TREATMENT|1970-01-12||1970-03-14|||1964-08-21||1967-10-25
TRIAL STUDY 134XCP|RP|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MEQ/ML|||ML/CAGE/WK|NOT DONE||Y|NA|NA|1||38||BASELINE|1972-09-18||1970-08-31|||1965-12-20||1967-02-11
TRIAL STUDY 134XCP|RP|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|2||||||PREGNN|NUMBER OF PREGNANCIES||||UG/MOL|||TUBERCULIN UNIT/ML|NOT DONE||N|Y|U|1||38||RUN-IN|1967-02-24||1969-09-24|||1960-01-06||1966-02-16
TRIAL STUDY 134XCP|RP|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|1||||||GRAVIND|GRAVIDA INDICATOR||||KG/CM2|||/10^4|NOT DONE||NA|U|Y|2||58||OBSERVATION|1966-10-02||1962-08-06|||1966-01-19||1964-07-25
TRIAL STUDY 134XCP|RP|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|2||||||TNDRIND|TENDERNESS INDICATOR||||/MS|||K|NOT DONE||N|U|U|2||58||OBSERVATION|1963-01-24||1960-12-24|||1962-12-01||1971-09-28
TRIAL STUDY 134XCP|RP|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MG/M2/H|||MMOL/S|NOT DONE||U|Y|N|3||39||INDUCTION TREATMENT|1962-08-25||1968-11-13|||1964-02-22||1964-08-24
TRIAL STUDY 134XCP|RP|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||PA|||COULOMB|NOT DONE||N|Y|N|3||39||OPEN LABEL TREATMENT|1960-11-30||1971-07-06|||1961-11-22||1969-09-12
TRIAL STUDY 134XCP|RP|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||NKAT|||GBQ|NOT DONE||Y|NA|Y|4||88||BLINDED TREATMENT|1966-04-01||1963-03-03|||1969-08-23||1965-06-18
TRIAL STUDY 134XCP|RP|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||NMOL|||UV|NOT DONE||U|NA|N|4||88||OPEN LABEL TREATMENT|1967-04-29||1972-09-21|||1964-06-06||1969-01-23
TRIAL STUDY 134XCP|RP|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ELISA UNIT/DOSE|||U/G/MIN|NOT DONE||Y|N|N|5||7||SCREENING|1965-11-17||1968-11-28|||1965-12-18||1965-04-06
TRIAL STUDY 134XCP|RP|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||CYLINDER|||M2|NOT DONE||Y|NA|NA|5||7||SCREENING|1973-01-16||1967-04-09|||1967-01-25||1961-09-09
TRIAL STUDY 134XCP|RP|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UG/KG|||HOURS|NOT DONE||N|Y|U|1||38||LONG-TERM FOLLOW-UP|1972-02-23||1963-12-12|||1964-08-03||1963-10-02
TRIAL STUDY 134XCP|RP|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ANTI-XA IU/ML|||10^6 ORGANISMS|NOT DONE||N|NA|N|1||38||BASELINE|1963-07-10||1960-07-26|||1964-07-13||1966-08-03
TRIAL STUDY 134XCP|RP|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||NMOL/ML/MIN|||GBQ/MG|NOT DONE||NA|NA|N|2||58||RUN-IN|1967-06-11||1965-08-16|||1973-01-10||1970-05-21
TRIAL STUDY 134XCP|RP|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||C|||L/DAY|NOT DONE||N|Y|U|2||58||INDUCTION TREATMENT|1961-04-24||1970-03-25|||1968-10-21||1966-11-04
TRIAL STUDY 134XCP|RP|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ML/M2|||UCI/KG|NOT DONE||N|NA|NA|3||39||INDUCTION TREATMENT|1963-10-03||1962-05-06|||1964-11-05||1965-03-12
TRIAL STUDY 134XCP|RP|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||ML/DL|||NG/DL|NOT DONE||NA|Y|U|3||39||FOLLOW-UP|1968-07-17||1972-08-07|||1966-04-10||1969-01-17
TRIAL STUDY 134XCP|RP|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||PFU/DOSE|||ML/SEC/1.73M2|NOT DONE||N|U|U|4||88||RUN-IN|1967-08-17||1966-03-04|||1969-05-06||1965-11-08
TRIAL STUDY 134XCP|RP|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||IU/MMOL|||10^6 IU|NOT DONE||N|Y|U|4||88||BASELINE|1969-02-05||1967-03-18|||1963-07-02||1965-06-22
TRIAL STUDY 134XCP|RP|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|1||||||PREGIND|PREGNANT INDICATOR||||IU|||ML/KG/DAY|NOT DONE||N|Y|NA|5||7||OBSERVATION|1968-05-30||1969-09-27|||1971-03-22||1972-08-17
TRIAL STUDY 134XCP|RP|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||LINEAR FT*LB|||G/M2/DAY|NOT DONE||N|N|U|5||7||BLINDED TREATMENT|1961-06-05||1964-01-04|||1965-10-21||1968-04-29
TRIAL STUDY 134XCP|RP|4A5A02C2-F875-4146-B58D-9E0E4F00527D|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||CM H2O|||/2500 WBC|NOT DONE||Y|Y|NA|1||38||LONG-TERM FOLLOW-UP|1960-06-16||1968-02-10|||1971-07-12||1961-08-20
TRIAL STUDY 134XCP|RP|4A5A02C2-F875-4146-B58D-9E0E4F00527D|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||LOG10 CCID 50/DOSE|||10^4/HPF|NOT DONE||NA|NA|NA|1||38||RUN-IN|1969-03-25||1971-12-01|||1968-03-22||1968-04-02
TRIAL STUDY 134XCP|RP|4A5A02C2-F875-4146-B58D-9E0E4F00527D|1||||||PREGIND|PREGNANT INDICATOR||||ML/DOSE|||OHM|NOT DONE||Y|N|NA|2||58||OBSERVATION|1970-07-14||1966-02-15|||1964-07-14||1963-11-21
TRIAL STUDY 134XCP|RP|4A5A02C2-F875-4146-B58D-9E0E4F00527D|2||||||PREGNN|NUMBER OF PREGNANCIES||||UOSM|||10^4/L|NOT DONE||NA|Y|U|2||58||TREATMENT|1966-05-26||1970-01-12|||1968-03-30||1972-02-29
TRIAL STUDY 134XCP|RP|4A5A02C2-F875-4146-B58D-9E0E4F00527D|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||SHOCK WAVE|||MG/G/MIN|NOT DONE||NA|Y|NA|3||39||OBSERVATION|1970-06-27||1961-03-21|||1960-04-11||1965-06-21
TRIAL STUDY 134XCP|RP|4A5A02C2-F875-4146-B58D-9E0E4F00527D|2||||||MENFDUR|MENSES FLOW DURATION||||LOG EID 50/DOSE|||TROCHE|NOT DONE||Y|U|Y|3||39||INDUCTION TREATMENT|1960-07-24||1973-01-26|||1967-10-11||1965-04-12
TRIAL STUDY 134XCP|RP|4A5A02C2-F875-4146-B58D-9E0E4F00527D|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||FMOL/G|||10^4/HPF|NOT DONE||NA|Y|Y|4||88||INDUCTION TREATMENT|1966-07-17||1966-04-10|||1968-03-31||1966-07-23
TRIAL STUDY 134XCP|RP|4A5A02C2-F875-4146-B58D-9E0E4F00527D|2||||||RASHIND|RASH INDICATOR||||BAG|||10^6 U|NOT DONE||Y|Y|Y|4||88||WASHOUT|1970-07-24||1969-03-20|||1967-08-31||1967-08-11
TRIAL STUDY 134XCP|RP|4A5A02C2-F875-4146-B58D-9E0E4F00527D|1||||||BRTHN|NUMBER OF BIRTHS||||CMOL|||NG/MOL|NOT DONE||N|Y|N|5||7||INDUCTION TREATMENT|1968-09-30||1968-09-28|||1966-05-05||1973-06-09
TRIAL STUDY 134XCP|RP|4A5A02C2-F875-4146-B58D-9E0E4F00527D|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||G/KG/DAY|||KG/CM2|NOT DONE||U|NA|Y|5||7||INDUCTION TREATMENT|1967-09-22||1971-06-18|||1966-02-16||1970-10-10
TRIAL STUDY 134XCP|RP|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||KS|||GBQ/UG|NOT DONE||Y|N|N|1||38||RUN-IN|1970-04-28||1971-03-24|||1961-06-08||1966-05-02
TRIAL STUDY 134XCP|RP|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||PIXEL|||KM/H|NOT DONE||N|U|N|1||38||INDUCTION TREATMENT|1973-04-27||1969-12-11|||1973-07-10||1966-09-05
TRIAL STUDY 134XCP|RP|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|1||||||STILBIND|STILLBIRTH INDICATOR||||CL|||UCI/L|NOT DONE||U|NA|Y|2||58||BASELINE|1962-11-29||1967-04-21|||1965-09-11||1970-01-03
TRIAL STUDY 134XCP|RP|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|2||||||PEELIND|PEELING INDICATOR||||MGEQ|||EP U|NOT DONE||NA|NA|Y|2||58||OBSERVATION|1962-05-22||1970-02-26|||1973-01-03||1968-05-04
TRIAL STUDY 134XCP|RP|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^3 ORGANISMS|||TAMPON|NOT DONE||Y|N|Y|3||39||LONG-TERM FOLLOW-UP|1960-07-23||1961-08-22|||1960-06-20||1971-08-10
TRIAL STUDY 134XCP|RP|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|2||||||MENFDUR|MENSES FLOW DURATION||||M/SEC2|||/500 WBC|NOT DONE||U|U|NA|3||39||WASHOUT|1971-01-27||1963-08-20|||1965-02-19||1973-04-23
TRIAL STUDY 134XCP|RP|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|1||||||ULCERIND|ULCER INDICATOR||||DIOPTER|||ECL UNIT|NOT DONE||N|N|Y|4||88||INDUCTION TREATMENT|1971-11-27||1966-01-23|||1969-12-24||1961-08-07
TRIAL STUDY 134XCP|RP|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||10^9 CFU/ML|||10^9 CFU/ML|NOT DONE||U|N|NA|4||88||TREATMENT|1963-08-10||1961-03-10|||1970-03-06||1963-12-22
TRIAL STUDY 134XCP|RP|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MG/ML/MIN|||UG/ANIMAL|NOT DONE||U|U|U|5||7||FOLLOW-UP|1960-01-19||1961-05-17|||1962-03-17||1973-02-12
TRIAL STUDY 134XCP|RP|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|2||||||BRTHN|NUMBER OF BIRTHS||||10^6 CFU|||PSEC|NOT DONE||Y|N|N|5||7||LONG-TERM FOLLOW-UP|1963-01-15||1967-12-05|||1972-08-15||1972-02-08
TRIAL STUDY 134XCP|RP|859D9297-58D0-4740-899D-E7BEC931D419|1||||||RASHIND|RASH INDICATOR||||KALLIKREIN INHIBITOR UNIT|||BAR|NOT DONE||N|N|U|1||38||FOLLOW-UP|1960-04-22||1961-09-23|||1966-11-20||1966-07-29
TRIAL STUDY 134XCP|RP|859D9297-58D0-4740-899D-E7BEC931D419|2||||||DLVRMODE|MODE OF DELIVERY||||KBQ|||PFU/DOSE|NOT DONE||Y|N|NA|1||38||BLINDED TREATMENT|1964-12-08||1960-01-27|||1967-01-31||1962-10-23
TRIAL STUDY 134XCP|RP|859D9297-58D0-4740-899D-E7BEC931D419|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UMOL|||FOZ_BR|NOT DONE||U|U|Y|2||58||TREATMENT|1963-02-10||1971-07-24|||1960-08-18||1968-10-01
TRIAL STUDY 134XCP|RP|859D9297-58D0-4740-899D-E7BEC931D419|2||||||ABORTN|NUMBER OF ABORTIONS||||AMPULE|||MPA|NOT DONE||N|NA|NA|2||58||BASELINE|1971-10-10||1969-01-25|||1965-10-04||1972-09-05
TRIAL STUDY 134XCP|RP|859D9297-58D0-4740-899D-E7BEC931D419|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||TABLET|||HPA|NOT DONE||NA|NA|U|3||39||CONTINUATION TREATMENT|1964-09-20||1967-07-01|||1969-09-23||1971-06-21
TRIAL STUDY 134XCP|RP|859D9297-58D0-4740-899D-E7BEC931D419|2||||||MENARAGE|MENARCHE AGE||||NG/L|||UG/M2|NOT DONE||U|NA|Y|3||39||TREATMENT|1968-12-14||1967-07-13|||1960-12-26||1961-01-04
TRIAL STUDY 134XCP|RP|859D9297-58D0-4740-899D-E7BEC931D419|1||||||PREGNN|NUMBER OF PREGNANCIES||||% INHIBITION|||VIRTUAL PIXEL|NOT DONE||Y|Y|NA|4||88||FOLLOW-UP|1964-03-27||1962-02-28|||1960-11-06||1966-02-26
TRIAL STUDY 134XCP|RP|859D9297-58D0-4740-899D-E7BEC931D419|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||HOUNSFIELD UNIT|||TUBE|NOT DONE||Y|NA|NA|4||88||FOLLOW-UP|1971-11-09||1969-11-08|||1967-03-23||1972-04-23
TRIAL STUDY 134XCP|RP|859D9297-58D0-4740-899D-E7BEC931D419|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||UG/M2/DAY|||10^3 RNA COPIES/ML|NOT DONE||Y|N|NA|5||7||BASELINE|1967-02-15||1966-09-02|||1972-04-05||1971-03-28
TRIAL STUDY 134XCP|RP|859D9297-58D0-4740-899D-E7BEC931D419|2||||||PREGIND|PREGNANT INDICATOR||||TUBERCULIN UNIT/ML|||BQ/MG|NOT DONE||NA|NA|U|5||7||SCREENING|1965-06-06||1972-09-07|||1968-02-20||1961-12-07
TRIAL STUDY 134XCP|RP|A1E34C29-91C2-4C2B-942E-84CD6A10A056|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MG/MOL|||MPS U|NOT DONE||U|NA|N|1||38||WASHOUT|1970-11-01||1961-12-28|||1961-02-18||1967-09-21
TRIAL STUDY 134XCP|RP|A1E34C29-91C2-4C2B-942E-84CD6A10A056|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^6 U|||PRESSOR UNITS|NOT DONE||Y|U|Y|1||38||RUN-IN|1964-02-12||1961-06-26|||1968-01-22||1967-09-05
TRIAL STUDY 134XCP|RP|A1E34C29-91C2-4C2B-942E-84CD6A10A056|1||||||TNDRIND|TENDERNESS INDICATOR||||SCOOPFUL|||OZ EQ|NOT DONE||N|Y|NA|2||58||OBSERVATION|1960-04-22||1968-03-16|||1962-10-08||1965-08-26
TRIAL STUDY 134XCP|RP|A1E34C29-91C2-4C2B-942E-84CD6A10A056|2||||||THICK|THICKNESS||||MPH|||BOTTLE|NOT DONE||N|NA|U|2||58||CONTINUATION TREATMENT|1969-08-13||1960-02-17|||1965-09-15||1969-02-10
TRIAL STUDY 134XCP|RP|A1E34C29-91C2-4C2B-942E-84CD6A10A056|1||||||BCMETHOD|BIRTH CONTROL METHOD||||OZ EQ|||CM2|NOT DONE||Y|NA|NA|3||39||OBSERVATION|1962-11-29||1964-06-15|||1973-05-14||1964-07-16
TRIAL STUDY 134XCP|RP|A1E34C29-91C2-4C2B-942E-84CD6A10A056|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||UG/L/H|||IMPLANT|NOT DONE||NA|U|N|3||39||LONG-TERM FOLLOW-UP|1967-04-15||1966-09-12|||1960-04-11||1969-01-04
TRIAL STUDY 134XCP|RP|A1E34C29-91C2-4C2B-942E-84CD6A10A056|1||||||MENFDUR|MENSES FLOW DURATION||||DNA COPIES/UG|||VIRTUAL PIXEL|NOT DONE||U|Y|U|4||88||SCREENING|1968-09-09||1970-11-04|||1968-03-19||1967-03-09
TRIAL STUDY 134XCP|RP|A1E34C29-91C2-4C2B-942E-84CD6A10A056|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||10^6 CFU/G|||CPM|NOT DONE||N|NA|Y|4||88||BASELINE|1973-05-26||1962-09-15|||1972-12-19||1962-01-02
TRIAL STUDY 134XCP|RP|A1E34C29-91C2-4C2B-942E-84CD6A10A056|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||ML|||/DAY|NOT DONE||Y|Y|NA|5||7||BASELINE|1960-01-15||1967-12-03|||1970-03-18||1963-01-30
TRIAL STUDY 134XCP|RP|A1E34C29-91C2-4C2B-942E-84CD6A10A056|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||G/CAGE/WK|||CD/M2|NOT DONE||Y|NA|N|5||7||OBSERVATION|1968-02-18||1960-07-25|||1971-11-07||1965-04-26
TRIAL STUDY 134XCP|RP|4E5FF284-E15A-421D-BC13-94655EEFE540|1||||||BCMETHOD|BIRTH CONTROL METHOD||||DPM/MG|||MEQ/MMOL|NOT DONE||Y|N|N|1||38||FOLLOW-UP|1972-12-23||1971-06-12|||1960-10-11||1968-10-31
TRIAL STUDY 134XCP|RP|4E5FF284-E15A-421D-BC13-94655EEFE540|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||OZ EQ|||FRACTION OF 1|NOT DONE||NA|Y|N|1||38||INDUCTION TREATMENT|1971-05-15||1967-07-02|||1964-10-21||1968-12-07
TRIAL STUDY 134XCP|RP|4E5FF284-E15A-421D-BC13-94655EEFE540|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||ABSORBANCE U/ML|||UMOL/KG/MIN|NOT DONE||NA|Y|U|2||58||WASHOUT|1971-03-25||1965-10-10|||1967-07-11||1968-11-13
TRIAL STUDY 134XCP|RP|4E5FF284-E15A-421D-BC13-94655EEFE540|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MG/KG/WEEK|||AGU/ML|NOT DONE||N|Y|NA|2||58||RUN-IN|1972-11-27||1961-06-03|||1971-04-28||1965-08-11
TRIAL STUDY 134XCP|RP|4E5FF284-E15A-421D-BC13-94655EEFE540|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||ABSORBANCE U|||GBQ/G|NOT DONE||NA|N|U|3||39||OPEN LABEL TREATMENT|1964-11-29||1961-05-30|||1969-08-09||1973-03-24
TRIAL STUDY 134XCP|RP|4E5FF284-E15A-421D-BC13-94655EEFE540|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||ELISA UNIT/ML|||SCM|NOT DONE||Y|NA|U|3||39||CONTINUATION TREATMENT|1972-03-30||1967-11-04|||1963-12-20||1966-06-04
TRIAL STUDY 134XCP|RP|4E5FF284-E15A-421D-BC13-94655EEFE540|1||||||FUNDHT|FUNDAL HEIGHT||||MG/H|||PPB|NOT DONE||NA|Y|NA|4||88||BASELINE|1967-12-27||1967-02-05|||1965-11-01||1969-06-06
TRIAL STUDY 134XCP|RP|4E5FF284-E15A-421D-BC13-94655EEFE540|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^9 ORGANISMS/G|||BLOCKS|NOT DONE||Y|NA|NA|4||88||BLINDED TREATMENT|1961-11-28||1969-06-15|||1969-05-31||1967-02-23
TRIAL STUDY 134XCP|RP|4E5FF284-E15A-421D-BC13-94655EEFE540|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||MAMP|||L/KG|NOT DONE||U|NA|U|5||7||OPEN LABEL TREATMENT|1962-04-12||1967-12-04|||1971-01-21||1970-06-02
TRIAL STUDY 134XCP|RP|4E5FF284-E15A-421D-BC13-94655EEFE540|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||CL|||UG/G/MIN|NOT DONE||Y|N|NA|5||7||OPEN LABEL TREATMENT|1970-04-09||1960-05-20|||1960-01-22||1968-04-21
TRIAL STUDY 134XCP|RP|30BAB760-662A-41DF-9599-CBE0BC3A57D9|1||||||MENFDUR|MENSES FLOW DURATION||||APL U|||USIEMENS|NOT DONE||NA|Y|NA|1||38||OPEN LABEL TREATMENT|1963-12-06||1962-08-11|||1970-08-25||1970-11-19
TRIAL STUDY 134XCP|RP|30BAB760-662A-41DF-9599-CBE0BC3A57D9|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||EID 50/DOSE|||10^3 ORGANISMS/ML|NOT DONE||U|U|U|1||38||LONG-TERM FOLLOW-UP|1967-05-08||1969-02-11|||1963-01-19||1969-09-20
TRIAL STUDY 134XCP|RP|30BAB760-662A-41DF-9599-CBE0BC3A57D9|1||||||MENOSTAT|MENOPAUSE STATUS||||MAMP|||10^9 ORGANISMS|NOT DONE||U|Y|NA|2||58||OBSERVATION|1963-09-07||1972-06-01|||1968-09-05||1967-12-11
TRIAL STUDY 134XCP|RP|30BAB760-662A-41DF-9599-CBE0BC3A57D9|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||UMOL/MOL|||BQ/MG|NOT DONE||N|N|NA|2||58||CONTINUATION TREATMENT|1966-06-15||1967-09-01|||1966-04-03||1960-07-22
TRIAL STUDY 134XCP|RP|30BAB760-662A-41DF-9599-CBE0BC3A57D9|1||||||GRAVIND|GRAVIDA INDICATOR||||L/H|||10^6 COPIES/ML|NOT DONE||NA|U|NA|3||39||OPEN LABEL TREATMENT|1970-07-16||1971-09-10|||1962-04-10||1972-08-01
TRIAL STUDY 134XCP|RP|30BAB760-662A-41DF-9599-CBE0BC3A57D9|2||||||BRTHN|NUMBER OF BIRTHS||||ML*CMH2O|||MPL U|NOT DONE||N|Y|Y|3||39||CONTINUATION TREATMENT|1968-03-08||1960-01-06|||1964-03-20||1961-04-29
TRIAL STUDY 134XCP|RP|30BAB760-662A-41DF-9599-CBE0BC3A57D9|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||KG/MOL|||IN2|NOT DONE||N|Y|NA|4||88||FOLLOW-UP|1966-03-10||1967-09-16|||1969-01-27||1961-01-12
TRIAL STUDY 134XCP|RP|30BAB760-662A-41DF-9599-CBE0BC3A57D9|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||%|||UG/ML/H|NOT DONE||N|N|Y|4||88||BLINDED TREATMENT|1972-02-08||1971-03-16|||1972-04-05||1966-03-25
TRIAL STUDY 134XCP|RP|30BAB760-662A-41DF-9599-CBE0BC3A57D9|1||||||BRTHN|NUMBER OF BIRTHS||||SYRINGE|||UL/DOSE|NOT DONE||NA|NA|U|5||7||RUN-IN|1966-07-05||1968-10-11|||1971-05-10||1965-03-04
TRIAL STUDY 134XCP|RP|30BAB760-662A-41DF-9599-CBE0BC3A57D9|2||||||PEELIND|PEELING INDICATOR||||FEU|||DRUM|NOT DONE||NA|NA|Y|5||7||WASHOUT|1963-10-20||1962-03-05|||1967-03-21||1960-03-07
TRIAL STUDY 134XCP|RP|8747C2AB-18EB-430B-8E89-CF9183DBF322|1||||||MENOAGE|MENOPAUSE AGE||||NKAT/L|||NSEC|NOT DONE||U|NA|U|1||38||INDUCTION TREATMENT|1965-01-20||1971-06-30|||1966-02-05||1967-02-08
TRIAL STUDY 134XCP|RP|8747C2AB-18EB-430B-8E89-CF9183DBF322|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||LM|||U.CARR|NOT DONE||U|Y|NA|1||38||WASHOUT|1964-09-21||1972-04-09|||1967-08-06||1961-06-22
TRIAL STUDY 134XCP|RP|8747C2AB-18EB-430B-8E89-CF9183DBF322|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||/2500 WBC|||FMOL|NOT DONE||U|NA|U|2||58||OPEN LABEL TREATMENT|1967-02-01||1970-04-17|||1966-06-27||1961-08-27
TRIAL STUDY 134XCP|RP|8747C2AB-18EB-430B-8E89-CF9183DBF322|2||||||STILBIND|STILLBIRTH INDICATOR||||MV*MIN|||FMOL/L|NOT DONE||U|NA|N|2||58||TREATMENT|1962-07-13||1971-10-26|||1965-11-29||1968-01-22
TRIAL STUDY 134XCP|RP|8747C2AB-18EB-430B-8E89-CF9183DBF322|1||||||GRAVIND|GRAVIDA INDICATOR||||G/G/DAY|||BU|NOT DONE||N|N|N|3||39||INDUCTION TREATMENT|1962-08-27||1962-11-22|||1971-03-17||1968-05-06
TRIAL STUDY 134XCP|RP|8747C2AB-18EB-430B-8E89-CF9183DBF322|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||WATT|||U/10^12 RBC|NOT DONE||N|U|NA|3||39||FOLLOW-UP|1966-07-12||1965-01-24|||1972-09-07||1965-08-31
TRIAL STUDY 134XCP|RP|8747C2AB-18EB-430B-8E89-CF9183DBF322|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||EP U|||FARAD|NOT DONE||U|Y|U|4||88||OPEN LABEL TREATMENT|1971-06-25||1961-08-13|||1968-07-12||1965-05-11
TRIAL STUDY 134XCP|RP|8747C2AB-18EB-430B-8E89-CF9183DBF322|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PPTH|||UG/L|NOT DONE||N|N|U|4||88||OBSERVATION|1973-04-01||1965-02-03|||1972-04-21||1968-08-27
TRIAL STUDY 134XCP|RP|8747C2AB-18EB-430B-8E89-CF9183DBF322|1||||||FUNDHT|FUNDAL HEIGHT||||G/L|||G/G|NOT DONE||U|Y|U|5||7||SCREENING|1970-03-05||1972-06-17|||1960-10-07||1964-09-05
TRIAL STUDY 134XCP|RP|8747C2AB-18EB-430B-8E89-CF9183DBF322|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||UL|||MEQ/UG|NOT DONE||Y|Y|N|5||7||FOLLOW-UP|1963-03-14||1961-09-01|||1969-08-25||1960-10-07
TRIAL STUDY 134XCP|RP|5A0FF15D-E779-47BA-8D3C-247A0FA57854|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||CP|||MMAL|NOT DONE||NA|U|NA|1||38||LONG-TERM FOLLOW-UP|1971-03-20||1967-07-22|||1968-05-10||1965-12-11
TRIAL STUDY 134XCP|RP|5A0FF15D-E779-47BA-8D3C-247A0FA57854|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||NMOL/KG/DAY|||NMOL BCE/L|NOT DONE||N|U|N|1||38||FOLLOW-UP|1973-04-29||1966-01-24|||1971-02-01||1970-01-26
TRIAL STUDY 134XCP|RP|5A0FF15D-E779-47BA-8D3C-247A0FA57854|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||IN|||MG/ML/MIN|NOT DONE||N|NA|NA|2||58||CONTINUATION TREATMENT|1961-05-14||1964-11-29|||1968-05-11||1968-07-20
TRIAL STUDY 134XCP|RP|5A0FF15D-E779-47BA-8D3C-247A0FA57854|2||||||ABORTN|NUMBER OF ABORTIONS||||OSM|||MHZ|NOT DONE||U|U|U|2||58||RUN-IN|1964-10-12||1965-08-22|||1968-08-31||1970-03-24
TRIAL STUDY 134XCP|RP|5A0FF15D-E779-47BA-8D3C-247A0FA57854|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||HEP|||MGEQ|NOT DONE||NA|Y|U|3||39||SCREENING|1965-12-22||1970-04-30|||1965-08-23||1960-07-30
TRIAL STUDY 134XCP|RP|5A0FF15D-E779-47BA-8D3C-247A0FA57854|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MOL/DAY|||MPH|NOT DONE||NA|NA|NA|3||39||BLINDED TREATMENT|1969-01-31||1960-01-12|||1965-11-13||1967-05-21
TRIAL STUDY 134XCP|RP|5A0FF15D-E779-47BA-8D3C-247A0FA57854|1||||||BLISTIND|BLISTERING INDICATOR||||NG/DAY|||%(V/V)|NOT DONE||U|NA|NA|4||88||RUN-IN|1972-10-27||1967-10-24|||1965-07-30||1970-02-03
TRIAL STUDY 134XCP|RP|5A0FF15D-E779-47BA-8D3C-247A0FA57854|2||||||ULCERIND|ULCER INDICATOR||||10^9 CFU/G|||UG/KG/MIN|NOT DONE||Y|Y|N|4||88||SCREENING|1964-12-12||1972-12-27|||1971-01-30||1963-06-15
TRIAL STUDY 134XCP|RP|5A0FF15D-E779-47BA-8D3C-247A0FA57854|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MOL/L|||L/S|NOT DONE||U|NA|NA|5||7||LONG-TERM FOLLOW-UP|1971-03-07||1973-06-02|||1962-01-05||1962-07-09
TRIAL STUDY 134XCP|RP|5A0FF15D-E779-47BA-8D3C-247A0FA57854|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||10^3 DNA COPIES/ML|||FT|NOT DONE||NA|NA|N|5||7||WASHOUT|1972-09-12||1962-08-09|||1968-01-02||1966-06-05
TRIAL STUDY 134XCP|RP|73260E60-6ADB-44DA-9A45-776B91F8B453|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||G/MOL|||PHERESIS UNIT|NOT DONE||NA|NA|N|1||38||BLINDED TREATMENT|1960-02-13||1960-02-23|||1965-03-03||1964-08-11
TRIAL STUDY 134XCP|RP|73260E60-6ADB-44DA-9A45-776B91F8B453|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||ML/CM|||DRINK|NOT DONE||NA|NA|Y|1||38||TREATMENT|1971-05-17||1963-07-04|||1972-01-10||1967-03-12
TRIAL STUDY 134XCP|RP|73260E60-6ADB-44DA-9A45-776B91F8B453|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||10^3 RNA COPIES/ML|||CFU/ML|NOT DONE||N|N|U|2||58||WASHOUT|1970-02-10||1968-08-17|||1964-07-05||1961-04-28
TRIAL STUDY 134XCP|RP|73260E60-6ADB-44DA-9A45-776B91F8B453|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||ANSON U|||/2000 RBC|NOT DONE||N|NA|Y|2||58||OPEN LABEL TREATMENT|1970-06-10||1969-06-09|||1968-07-13||1963-04-23
TRIAL STUDY 134XCP|RP|73260E60-6ADB-44DA-9A45-776B91F8B453|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||UMOL/KG/MIN|||HZ/S|NOT DONE||U|NA|Y|3||39||CONTINUATION TREATMENT|1967-06-25||1973-02-15|||1965-11-28||1973-03-19
TRIAL STUDY 134XCP|RP|73260E60-6ADB-44DA-9A45-776B91F8B453|2||||||EDEMAIND|EDEMA INDICATOR||||KV|||10^9 CFU/G|NOT DONE||NA|U|N|3||39||OPEN LABEL TREATMENT|1969-10-14||1964-09-25|||1973-06-30||1966-07-02
TRIAL STUDY 134XCP|RP|73260E60-6ADB-44DA-9A45-776B91F8B453|1||||||STILBIND|STILLBIRTH INDICATOR||||NKAT|||FMOL/L/SEC|NOT DONE||NA|N|N|4||88||CONTINUATION TREATMENT|1973-08-10||1971-07-19|||1965-01-29||1972-05-27
TRIAL STUDY 134XCP|RP|73260E60-6ADB-44DA-9A45-776B91F8B453|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||FT|||COPIES/UL|NOT DONE||NA|NA|Y|4||88||LONG-TERM FOLLOW-UP|1968-07-19||1964-07-07|||1961-02-16||1967-02-24
TRIAL STUDY 134XCP|RP|73260E60-6ADB-44DA-9A45-776B91F8B453|1||||||PUSTIND|PUSTULE INDICATOR||||% INHIBITION|||DIOPTER|NOT DONE||U|U|N|5||7||CONTINUATION TREATMENT|1965-05-05||1960-07-27|||1971-07-23||1965-10-24
TRIAL STUDY 134XCP|RP|73260E60-6ADB-44DA-9A45-776B91F8B453|2||||||GRAVIND|GRAVIDA INDICATOR||||PL|||NMOL BCE/L|NOT DONE||U|Y|N|5||7||CONTINUATION TREATMENT|1960-10-28||1973-07-17|||1964-07-20||1971-06-14
TRIAL STUDY 134XCP|RP|7B64252E-9A08-4177-BFA9-45B0C0E53097|1||||||ERYTHIND|ERYTHEMA INDICATOR||||DNA COPIES/UG|||SQU/ML|NOT DONE||NA|N|U|1||38||OPEN LABEL TREATMENT|1961-12-24||1965-03-27|||1960-02-02||1961-03-18
TRIAL STUDY 134XCP|RP|7B64252E-9A08-4177-BFA9-45B0C0E53097|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||100 IU/ML|||PMOL/10^10 CELLS|NOT DONE||Y|Y|NA|1||38||SCREENING|1961-08-29||1970-11-07|||1969-08-23||1972-01-10
TRIAL STUDY 134XCP|RP|7B64252E-9A08-4177-BFA9-45B0C0E53097|1||||||DSCHGIND|DISCHARGE INDICATOR||||IU/G HB|||PIXELS/CM|NOT DONE||NA|U|NA|2||58||SCREENING|1972-10-13||1960-05-22|||1967-05-19||1963-08-06
TRIAL STUDY 134XCP|RP|7B64252E-9A08-4177-BFA9-45B0C0E53097|2||||||MENOAGE|MENOPAUSE AGE||||MBQ|||SUPPOSITORY|NOT DONE||U|N|Y|2||58||LONG-TERM FOLLOW-UP|1966-10-21||1967-04-26|||1965-11-08||1962-06-27
TRIAL STUDY 134XCP|RP|7B64252E-9A08-4177-BFA9-45B0C0E53097|1||||||ULCERIND|ULCER INDICATOR||||ML/G/MIN|||U/G/H|NOT DONE||NA|U|U|3||39||BLINDED TREATMENT|1960-08-07||1962-12-07|||1962-02-04||1964-09-28
TRIAL STUDY 134XCP|RP|7B64252E-9A08-4177-BFA9-45B0C0E53097|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^3 CFU/ML|||AMFI|NOT DONE||Y|N|U|3||39||WASHOUT|1968-09-15||1963-10-16|||1972-12-28||1960-06-02
TRIAL STUDY 134XCP|RP|7B64252E-9A08-4177-BFA9-45B0C0E53097|1||||||MENARAGE|MENARCHE AGE||||COAT|||10^6 U|NOT DONE||NA|Y|U|4||88||CONTINUATION TREATMENT|1966-07-07||1964-12-20|||1968-07-07||1960-10-22
TRIAL STUDY 134XCP|RP|7B64252E-9A08-4177-BFA9-45B0C0E53097|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UIU/DL|||ML/M2/H|NOT DONE||U|Y|Y|4||88||WASHOUT|1967-01-08||1972-06-08|||1971-07-04||1961-10-24
TRIAL STUDY 134XCP|RP|7B64252E-9A08-4177-BFA9-45B0C0E53097|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||10^3 CFU/G|||10^3 ORGANISMS/G|NOT DONE||N|U|N|5||7||BASELINE|1965-03-09||1963-02-02|||1972-01-21||1972-06-01
TRIAL STUDY 134XCP|RP|7B64252E-9A08-4177-BFA9-45B0C0E53097|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^7/L|||EJACULATE U|NOT DONE||N|U|Y|5||7||TREATMENT|1964-09-11||1972-11-15|||1964-04-25||1961-09-24
TRIAL STUDY 134XCP|RP|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|1||||||MASSIND|MASS INDICATOR||||VG/DOSE|||UMOL/KG/MIN|NOT DONE||N|U|Y|1||38||SCREENING|1963-11-21||1968-11-22|||1961-04-24||1972-01-20
TRIAL STUDY 134XCP|RP|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|2||||||FUNDHT|FUNDAL HEIGHT||||ML/CM H2O|||KEV|NOT DONE||U|U|Y|1||38||WASHOUT|1972-05-13||1964-06-09|||1969-10-21||1969-01-29
TRIAL STUDY 134XCP|RP|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||DAGU|||AGU/ML|NOT DONE||Y|U|NA|2||58||BASELINE|1969-07-28||1971-10-06|||1965-11-21||1971-12-05
TRIAL STUDY 134XCP|RP|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|2||||||FUNDHT|FUNDAL HEIGHT||||L/KG|||NG/MOL|NOT DONE||Y|N|U|2||58||OBSERVATION|1968-12-17||1967-09-13|||1965-12-25||1966-12-11
TRIAL STUDY 134XCP|RP|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|1||||||BLISTIND|BLISTERING INDICATOR||||UMOL/DAY|||FT|NOT DONE||N|Y|N|3||39||CONTINUATION TREATMENT|1963-01-06||1963-05-14|||1965-02-28||1968-11-13
TRIAL STUDY 134XCP|RP|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||BEAM BREAKS|||U/L|NOT DONE||Y|NA|Y|3||39||WASHOUT|1969-12-13||1972-11-16|||1962-10-16||1964-12-25
TRIAL STUDY 134XCP|RP|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|1||||||ULCERIND|ULCER INDICATOR||||10^11/L|||MG/KG/WEEK|NOT DONE||N|Y|Y|4||88||TREATMENT|1963-11-21||1962-03-19|||1963-03-04||1962-07-04
TRIAL STUDY 134XCP|RP|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||10^9/DOSE|||10^6 ORGANISMS/ML|NOT DONE||Y|NA|N|4||88||INDUCTION TREATMENT|1960-01-26||1973-05-28|||1960-04-06||1963-02-12
TRIAL STUDY 134XCP|RP|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MG/M2/MIN|||CIGARETTE|NOT DONE||NA|NA|Y|5||7||BLINDED TREATMENT|1969-04-21||1967-10-22|||1972-02-23||1968-04-15
TRIAL STUDY 134XCP|RP|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||10^7 TCID 50/DOSE|||CIGARETTE|NOT DONE||NA|Y|N|5||7||BASELINE|1964-10-31||1962-08-25|||1969-06-16||1973-01-27
TRIAL STUDY 134XCP|RP|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|1||||||PRGENDTC|DATE PREGNANCY ENDED||||MG/MOL|||MMAL|NOT DONE||NA|NA|Y|1||38||WASHOUT|1970-08-09||1973-05-08|||1966-04-18||1972-08-03
TRIAL STUDY 134XCP|RP|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|2||||||BCMETHOD|BIRTH CONTROL METHOD||||RFU|||ELISA UNIT|NOT DONE||U|N|NA|1||38||SCREENING|1967-04-17||1967-03-20|||1973-01-25||1960-05-27
TRIAL STUDY 134XCP|RP|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||LOG10 IU/ML|||PMOL/10^10 CELLS|NOT DONE||U|N|U|2||58||OPEN LABEL TREATMENT|1965-02-08||1961-02-03|||1963-03-27||1960-04-15
TRIAL STUDY 134XCP|RP|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MEQ/L|||MMOL/MIN/KPA/L|NOT DONE||N|U|NA|2||58||TREATMENT|1965-07-24||1965-10-19|||1967-04-24||1972-05-10
TRIAL STUDY 134XCP|RP|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MAMP|||U/MG|NOT DONE||Y|U|U|3||39||FOLLOW-UP|1961-09-07||1969-10-08|||1973-05-11||1961-04-13
TRIAL STUDY 134XCP|RP|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|2||||||PREGIND|PREGNANT INDICATOR||||BQ/G|||NMOL/L|NOT DONE||NA|Y|U|3||39||RUN-IN|1961-07-10||1971-08-08|||1972-03-01||1970-12-20
TRIAL STUDY 134XCP|RP|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|1||||||MENFDUR|MENSES FLOW DURATION||||BLOCKS|||BQ/UG|NOT DONE||N|NA|Y|4||88||INDUCTION TREATMENT|1963-09-13||1972-02-03|||1968-03-06||1962-03-06
TRIAL STUDY 134XCP|RP|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||VIAL|||%/S|NOT DONE||NA|U|Y|4||88||RUN-IN|1967-09-15||1968-07-12|||1970-04-06||1969-10-05
TRIAL STUDY 134XCP|RP|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|1||||||MENOSTAT|MENOPAUSE STATUS||||U/DL|||GBQ/G|NOT DONE||N|Y|U|5||7||OPEN LABEL TREATMENT|1963-04-27||1960-06-24|||1971-07-30||1961-09-23
TRIAL STUDY 134XCP|RP|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MSEC|||/HPF|NOT DONE||Y|N|U|5||7||FOLLOW-UP|1960-09-21||1968-07-05|||1964-12-16||1966-05-01
TRIAL STUDY 134XCP|RP|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||ELISA UNIT|||UG/KG|NOT DONE||U|NA|NA|1||38||CONTINUATION TREATMENT|1965-12-03||1965-01-04|||1967-07-11||1960-08-09
TRIAL STUDY 134XCP|RP|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||GLOBULE|||CYCLE/MIN|NOT DONE||Y|U|N|1||38||BASELINE|1966-08-18||1963-07-06|||1969-11-12||1966-03-14
TRIAL STUDY 134XCP|RP|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|1||||||STILBIND|STILLBIRTH INDICATOR||||COULOMB|||RATIO|NOT DONE||U|N|NA|2||58||BLINDED TREATMENT|1966-08-19||1964-04-13|||1971-03-04||1972-02-28
TRIAL STUDY 134XCP|RP|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|2||||||PREGIND|PREGNANT INDICATOR||||G/CAGE|||MU/L|NOT DONE||U|Y|U|2||58||TREATMENT|1972-12-01||1964-07-27|||1962-12-22||1972-12-14
TRIAL STUDY 134XCP|RP|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||BQ/KG|||PMOL/L/H|NOT DONE||Y|Y|N|3||39||OPEN LABEL TREATMENT|1964-10-12||1962-10-24|||1966-11-06||1970-12-01
TRIAL STUDY 134XCP|RP|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||BQ/KG|||IN2|NOT DONE||NA|U|Y|3||39||OPEN LABEL TREATMENT|1962-04-13||1967-06-23|||1960-03-02||1972-06-12
TRIAL STUDY 134XCP|RP|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UGEQ/L|||ENZYME U/G HB|NOT DONE||N|U|NA|4||88||TREATMENT|1973-04-17||1965-01-17|||1973-04-22||1967-03-18
TRIAL STUDY 134XCP|RP|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||/100 HPFS|||CD|NOT DONE||N|Y|NA|4||88||FOLLOW-UP|1964-02-06||1968-10-14|||1961-09-12||1970-09-09
TRIAL STUDY 134XCP|RP|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|1||||||STILBIND|STILLBIRTH INDICATOR||||% INHIBITION|||/MS|NOT DONE||U|U|NA|5||7||SCREENING|1969-12-29||1968-12-28|||1965-07-30||1968-10-21
TRIAL STUDY 134XCP|RP|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||PMOL/L/H|||MG/M2/H|NOT DONE||Y|U|N|5||7||CONTINUATION TREATMENT|1962-05-27||1969-02-05|||1969-10-08||1964-02-02
TRIAL STUDY 134XCP|RP|1B0EE182-6729-4333-BB9B-5561CAB31D26|1||||||STILBIND|STILLBIRTH INDICATOR||||CI/L|||CI/KG|NOT DONE||U|N|NA|1||38||TREATMENT|1969-03-15||1965-08-19|||1969-11-29||1970-09-25
TRIAL STUDY 134XCP|RP|1B0EE182-6729-4333-BB9B-5561CAB31D26|2||||||INTP|INTERPRETATION||||10^7/L|||SPRAY|NOT DONE||NA|NA|U|1||38||FOLLOW-UP|1965-12-30||1970-04-28|||1972-04-03||1973-08-19
TRIAL STUDY 134XCP|RP|1B0EE182-6729-4333-BB9B-5561CAB31D26|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^10/L|||MET|NOT DONE||Y|U|Y|2||58||BLINDED TREATMENT|1962-01-27||1965-05-27|||1960-09-28||1969-06-01
TRIAL STUDY 134XCP|RP|1B0EE182-6729-4333-BB9B-5561CAB31D26|2||||||MASSIND|MASS INDICATOR||||M|||GY/H|NOT DONE||N|U|N|2||58||LONG-TERM FOLLOW-UP|1968-05-22||1972-05-06|||1970-01-28||1965-01-17
TRIAL STUDY 134XCP|RP|1B0EE182-6729-4333-BB9B-5561CAB31D26|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||AMOL|||UG/L|NOT DONE||N|N|N|3||39||OBSERVATION|1964-05-23||1961-01-02|||1965-09-02||1961-06-15
TRIAL STUDY 134XCP|RP|1B0EE182-6729-4333-BB9B-5561CAB31D26|2||||||PREGNN|NUMBER OF PREGNANCIES||||MG/ML/DAY|||MOL/MG|NOT DONE||NA|N|N|3||39||LONG-TERM FOLLOW-UP|1967-02-08||1960-04-14|||1970-09-03||1968-02-20
TRIAL STUDY 134XCP|RP|1B0EE182-6729-4333-BB9B-5561CAB31D26|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||TCID 50/DOSE|||MBQ/UL|NOT DONE||NA|U|NA|4||88||TREATMENT|1967-09-10||1968-10-03|||1964-11-29||1971-10-24
TRIAL STUDY 134XCP|RP|1B0EE182-6729-4333-BB9B-5561CAB31D26|2||||||ABORTN|NUMBER OF ABORTIONS||||MM3/MM2/YEAR|||PG/L|NOT DONE||U|Y|U|4||88||WASHOUT|1963-12-01||1971-04-10|||1966-01-19||1968-01-21
TRIAL STUDY 134XCP|RP|1B0EE182-6729-4333-BB9B-5561CAB31D26|1||||||RASHIND|RASH INDICATOR||||UG|||LOG10 PFU/ML|NOT DONE||U|U|U|5||7||INDUCTION TREATMENT|1964-09-29||1960-11-20|||1963-09-19||1961-08-22
TRIAL STUDY 134XCP|RP|1B0EE182-6729-4333-BB9B-5561CAB31D26|2||||||RASHIND|RASH INDICATOR||||DEG2|||M2|NOT DONE||U|Y|Y|5||7||BLINDED TREATMENT|1972-05-18||1971-04-20|||1973-04-29||1960-11-04
TRIAL STUDY 134XCP|RP|1F3AD620-4B16-4EFF-8F5A-45105841BE02|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MG|||IN2|NOT DONE||U|U|Y|1||38||RUN-IN|1962-01-13||1960-12-22|||1972-03-07||1960-11-06
TRIAL STUDY 134XCP|RP|1F3AD620-4B16-4EFF-8F5A-45105841BE02|2||||||THICK|THICKNESS||||MV/SEC|||GRAIN|NOT DONE||N|N|N|1||38||CONTINUATION TREATMENT|1969-07-05||1970-07-02|||1965-02-11||1972-04-08
TRIAL STUDY 134XCP|RP|1F3AD620-4B16-4EFF-8F5A-45105841BE02|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||FIU|||ML/BREATH|NOT DONE||NA|U|Y|2||58||INDUCTION TREATMENT|1967-01-15||1971-02-05|||1960-08-10||1972-07-08
TRIAL STUDY 134XCP|RP|1F3AD620-4B16-4EFF-8F5A-45105841BE02|2||||||EDEMAIND|EDEMA INDICATOR||||MG/ML/DAY|||MMU/ML|NOT DONE||Y|NA|Y|2||58||OBSERVATION|1973-03-27||1973-04-02|||1968-08-07||1973-04-24
TRIAL STUDY 134XCP|RP|1F3AD620-4B16-4EFF-8F5A-45105841BE02|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||RFU|||G/ANIMAL/DAY|NOT DONE||U|Y|Y|3||39||WASHOUT|1972-01-30||1963-03-20|||1968-08-02||1966-09-04
TRIAL STUDY 134XCP|RP|1F3AD620-4B16-4EFF-8F5A-45105841BE02|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MG/MOL|||MBQ|NOT DONE||N|U|NA|3||39||SCREENING|1968-04-14||1970-02-19|||1963-10-16||1964-07-13
TRIAL STUDY 134XCP|RP|1F3AD620-4B16-4EFF-8F5A-45105841BE02|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||POUCH|||NG/L|NOT DONE||Y|N|NA|4||88||FOLLOW-UP|1970-07-21||1968-12-22|||1965-08-01||1964-05-18
TRIAL STUDY 134XCP|RP|1F3AD620-4B16-4EFF-8F5A-45105841BE02|2||||||FUNDHT|FUNDAL HEIGHT||||CI/UG|||10^5/L|NOT DONE||Y|NA|NA|4||88||OBSERVATION|1960-09-19||1967-07-16|||1964-04-25||1967-04-13
TRIAL STUDY 134XCP|RP|1F3AD620-4B16-4EFF-8F5A-45105841BE02|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||MIU/L|||MV2/HZ|NOT DONE||Y|U|U|5||7||RUN-IN|1966-01-07||1967-02-22|||1967-04-12||1961-06-17
TRIAL STUDY 134XCP|RP|1F3AD620-4B16-4EFF-8F5A-45105841BE02|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||V/SEC|||PIXELS/IN|NOT DONE||N|U|NA|5||7||RUN-IN|1963-12-30||1965-03-21|||1963-04-04||1972-12-01
TRIAL STUDY 134XCP|RP|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MIN*MG/ML|||%(V/V)|NOT DONE||U|NA|N|1||38||OBSERVATION|1963-11-18||1962-06-23|||1963-12-20||1962-04-02
TRIAL STUDY 134XCP|RP|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MMOL/KG|||U/G/MIN|NOT DONE||N|U|U|1||38||BASELINE|1962-09-24||1972-10-05|||1969-12-24||1966-05-12
TRIAL STUDY 134XCP|RP|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MG/M2/DAY|||10^8/L|NOT DONE||NA|U|Y|2||58||BLINDED TREATMENT|1968-03-04||1966-02-03|||1964-03-28||1973-05-15
TRIAL STUDY 134XCP|RP|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|2||||||PUSTIND|PUSTULE INDICATOR||||U/G/DAY|||ML/MMHG|NOT DONE||NA|NA|U|2||58||CONTINUATION TREATMENT|1972-09-18||1969-12-16|||1966-05-04||1965-06-01
TRIAL STUDY 134XCP|RP|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MSEC|||MM3/MM2/YEAR|NOT DONE||U|Y|Y|3||39||OPEN LABEL TREATMENT|1973-08-18||1964-02-24|||1964-10-02||1966-10-21
TRIAL STUDY 134XCP|RP|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||GAUSS|||SCM|NOT DONE||Y|U|U|3||39||TREATMENT|1965-09-07||1968-07-13|||1967-02-27||1962-08-16
TRIAL STUDY 134XCP|RP|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||10^6 CFU/ML|||/100 WBC|NOT DONE||NA|NA|NA|4||88||BASELINE|1972-11-05||1962-03-22|||1961-06-01||1968-02-01
TRIAL STUDY 134XCP|RP|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|2||||||PRGENDTC|DATE PREGNANCY ENDED||||10^7 TCID 50/DOSE|||KG/M2|NOT DONE||N|NA|U|4||88||OBSERVATION|1961-04-10||1968-06-30|||1970-09-16||1965-07-08
TRIAL STUDY 134XCP|RP|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|1||||||BRTHN|NUMBER OF BIRTHS||||10^8/L|||CI/ML|NOT DONE||Y|Y|NA|5||7||LONG-TERM FOLLOW-UP|1960-09-24||1960-07-28|||1964-09-07||1972-08-17
TRIAL STUDY 134XCP|RP|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|2||||||PEELIND|PEELING INDICATOR||||10^9 CFU/G|||DL|NOT DONE||U|N|N|5||7||OBSERVATION|1961-04-01||1971-03-01|||1960-12-08||1964-10-05
TRIAL STUDY 134XCP|RP|152147B0-6EAD-4124-8E1A-BD7707850B60|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MMHG|||TSP EQ|NOT DONE||U|Y|N|1||38||BLINDED TREATMENT|1969-10-07||1961-09-04|||1967-03-01||1968-08-22
TRIAL STUDY 134XCP|RP|152147B0-6EAD-4124-8E1A-BD7707850B60|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||FARAD|||IU/DL|NOT DONE||NA|N|U|1||38||OBSERVATION|1967-10-25||1962-02-27|||1972-02-22||1963-03-26
TRIAL STUDY 134XCP|RP|152147B0-6EAD-4124-8E1A-BD7707850B60|1||||||MENFDUR|MENSES FLOW DURATION||||G/L|||10^9 ORGANISMS/G|NOT DONE||U|U|N|2||58||INDUCTION TREATMENT|1972-07-02||1967-10-13|||1972-06-18||1960-06-13
TRIAL STUDY 134XCP|RP|152147B0-6EAD-4124-8E1A-BD7707850B60|2||||||PRGENDTC|DATE PREGNANCY ENDED||||KV|||TSP EQ|NOT DONE||NA|NA|N|2||58||LONG-TERM FOLLOW-UP|1964-11-15||1968-04-13|||1972-04-27||1972-05-17
TRIAL STUDY 134XCP|RP|152147B0-6EAD-4124-8E1A-BD7707850B60|1||||||TNDRIND|TENDERNESS INDICATOR||||MBQ|||ML/KG/MIN|NOT DONE||N|Y|N|3||39||INDUCTION TREATMENT|1964-01-08||1969-01-30|||1961-05-17||1960-08-12
TRIAL STUDY 134XCP|RP|152147B0-6EAD-4124-8E1A-BD7707850B60|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MG/KG/MIN|||ABSORBANCE U/MIN|NOT DONE||U|NA|NA|3||39||INDUCTION TREATMENT|1972-07-14||1964-09-05|||1963-11-03||1965-03-18
TRIAL STUDY 134XCP|RP|152147B0-6EAD-4124-8E1A-BD7707850B60|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MCI|||10^7 PFU|NOT DONE||NA|N|U|4||88||SCREENING|1962-05-21||1973-01-04|||1962-01-02||1967-07-03
TRIAL STUDY 134XCP|RP|152147B0-6EAD-4124-8E1A-BD7707850B60|2||||||TNDRIND|TENDERNESS INDICATOR||||UG/L FEU|||HZ/S|NOT DONE||Y|NA|NA|4||88||OBSERVATION|1961-08-26||1963-01-30|||1968-10-10||1969-09-01
TRIAL STUDY 134XCP|RP|152147B0-6EAD-4124-8E1A-BD7707850B60|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||BQ/ML|||GY/MIN|NOT DONE||N|N|NA|5||7||CONTINUATION TREATMENT|1963-12-22||1967-10-24|||1966-05-20||1964-07-10
TRIAL STUDY 134XCP|RP|152147B0-6EAD-4124-8E1A-BD7707850B60|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||PMOL/DAY|||CY/CM|NOT DONE||N|U|N|5||7||OBSERVATION|1969-02-18||1968-01-23|||1969-11-14||1962-03-16
TRIAL STUDY 134XCP|RP|3CCF019C-5663-4670-B2D1-EC01D6B58D06|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||S^-1(%O2)^-1|||EQ|NOT DONE||NA|Y|N|1||38||OBSERVATION|1960-12-18||1968-09-04|||1964-03-05||1970-04-11
TRIAL STUDY 134XCP|RP|3CCF019C-5663-4670-B2D1-EC01D6B58D06|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||UG/G/DAY|||M2|NOT DONE||NA|U|U|1||38||BASELINE|1963-12-25||1962-08-26|||1966-11-25||1970-12-29
TRIAL STUDY 134XCP|RP|3CCF019C-5663-4670-B2D1-EC01D6B58D06|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||FOZ_US|||BEAM BREAKS|NOT DONE||N|U|U|2||58||OBSERVATION|1963-05-13||1964-03-09|||1968-10-18||1968-12-11
TRIAL STUDY 134XCP|RP|3CCF019C-5663-4670-B2D1-EC01D6B58D06|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||DEG/MM|||ML/DAY|NOT DONE||Y|NA|U|2||58||OBSERVATION|1971-12-14||1961-09-03|||1960-11-12||1969-03-07
TRIAL STUDY 134XCP|RP|3CCF019C-5663-4670-B2D1-EC01D6B58D06|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||L/H|||10^9 CFU/G|NOT DONE||NA|N|Y|3||39||FOLLOW-UP|1970-06-27||1972-10-05|||1962-02-19||1972-08-24
TRIAL STUDY 134XCP|RP|3CCF019C-5663-4670-B2D1-EC01D6B58D06|2||||||INABOIND|INDUCED ABORTION INDICATOR||||G/M2/DAY|||U/M2/DAY|NOT DONE||U|N|N|3||39||CONTINUATION TREATMENT|1972-01-30||1966-12-09|||1966-08-16||1964-02-19
TRIAL STUDY 134XCP|RP|3CCF019C-5663-4670-B2D1-EC01D6B58D06|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||BOX|||ML/CAGE|NOT DONE||N|Y|NA|4||88||OPEN LABEL TREATMENT|1965-05-26||1966-06-07|||1966-01-15||1972-12-22
TRIAL STUDY 134XCP|RP|3CCF019C-5663-4670-B2D1-EC01D6B58D06|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||INHALATION|||IU/ML|NOT DONE||U|Y|Y|4||88||RUN-IN|1973-01-28||1973-01-23|||1963-05-17||1960-10-05
TRIAL STUDY 134XCP|RP|3CCF019C-5663-4670-B2D1-EC01D6B58D06|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ANSON U|||PPTH|NOT DONE||N|Y|U|5||7||LONG-TERM FOLLOW-UP|1960-08-19||1973-02-19|||1969-11-24||1960-09-03
TRIAL STUDY 134XCP|RP|3CCF019C-5663-4670-B2D1-EC01D6B58D06|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||CP|||UG/KG/DAY|NOT DONE||U|N|N|5||7||INDUCTION TREATMENT|1962-04-04||1967-08-27|||1963-12-13||1960-02-06
TRIAL STUDY 134XCP|RP|6599D082-A8A0-412D-BBDF-CD786C581905|1||||||ERYTHIND|ERYTHEMA INDICATOR||||LOG10 CFU/G|||CI/MG|NOT DONE||Y|Y|N|1||38||SCREENING|1964-06-08||1969-05-26|||1961-12-31||1964-03-31
TRIAL STUDY 134XCP|RP|6599D082-A8A0-412D-BBDF-CD786C581905|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||IU/KG|||10^3 ORGANISMS/G|NOT DONE||U|U|Y|1||38||OBSERVATION|1973-04-20||1971-11-19|||1971-11-29||1968-05-24
TRIAL STUDY 134XCP|RP|6599D082-A8A0-412D-BBDF-CD786C581905|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||SYRINGE|||APL U/ML|NOT DONE||U|Y|N|2||58||LONG-TERM FOLLOW-UP|1962-10-08||1965-09-16|||1966-01-19||1967-07-22
TRIAL STUDY 134XCP|RP|6599D082-A8A0-412D-BBDF-CD786C581905|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||/MBP|||NKAT/G HB|NOT DONE||U|Y|U|2||58||CONTINUATION TREATMENT|1972-02-04||1969-08-07|||1965-11-01||1968-09-11
TRIAL STUDY 134XCP|RP|6599D082-A8A0-412D-BBDF-CD786C581905|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||UMOL/MIN|||DROP|NOT DONE||Y|NA|N|3||39||WASHOUT|1961-05-29||1968-03-08|||1962-05-05||1961-12-07
TRIAL STUDY 134XCP|RP|6599D082-A8A0-412D-BBDF-CD786C581905|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MG/KG|||BLOCKS|NOT DONE||U|U|U|3||39||TREATMENT|1967-11-04||1969-11-02|||1971-09-18||1969-10-24
TRIAL STUDY 134XCP|RP|6599D082-A8A0-412D-BBDF-CD786C581905|1||||||STILBIND|STILLBIRTH INDICATOR||||LOG10 ELISA UNIT/DOSE|||AMU|NOT DONE||N|NA|NA|4||88||BASELINE|1969-01-10||1968-01-05|||1968-10-05||1964-09-04
TRIAL STUDY 134XCP|RP|6599D082-A8A0-412D-BBDF-CD786C581905|2||||||BCMETHOD|BIRTH CONTROL METHOD||||UG/G/MIN|||FG|NOT DONE||Y|NA|U|4||88||RUN-IN|1963-02-26||1965-11-01|||1964-11-03||1967-12-05
TRIAL STUDY 134XCP|RP|6599D082-A8A0-412D-BBDF-CD786C581905|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MESF|||YEARS|NOT DONE||U|NA|Y|5||7||OBSERVATION|1961-04-30||1962-05-09|||1971-09-28||1968-09-05
TRIAL STUDY 134XCP|RP|6599D082-A8A0-412D-BBDF-CD786C581905|2||||||RASHIND|RASH INDICATOR||||UG/G/MIN|||AMOL|NOT DONE||N|U|U|5||7||RUN-IN|1961-08-15||1970-03-18|||1962-12-11||1972-03-11
TRIAL STUDY 134XCP|RP|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|1||||||BLISTIND|BLISTERING INDICATOR||||10^7 TCID 50/DOSE|||MPA|NOT DONE||Y|U|N|1||38||WASHOUT|1967-02-19||1971-12-09|||1970-05-05||1967-09-12
TRIAL STUDY 134XCP|RP|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||10^9 ORGANISMS|||IU/MG|NOT DONE||N|NA|NA|1||38||OPEN LABEL TREATMENT|1971-10-26||1963-02-27|||1960-04-10||1964-12-04
TRIAL STUDY 134XCP|RP|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||LOG10 ELISA UNIT|||MCI|NOT DONE||Y|NA|Y|2||58||LONG-TERM FOLLOW-UP|1965-11-28||1966-06-02|||1968-12-10||1966-03-23
TRIAL STUDY 134XCP|RP|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MMOL|||L/H/M2|NOT DONE||N|Y|N|2||58||LONG-TERM FOLLOW-UP|1961-05-22||1966-08-31|||1961-07-13||1968-04-13
TRIAL STUDY 134XCP|RP|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||LX|||BEAM BREAKS|NOT DONE||Y|N|NA|3||39||WASHOUT|1965-05-03||1967-11-20|||1964-01-01||1973-08-19
TRIAL STUDY 134XCP|RP|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|2||||||MENOAGE|MENOPAUSE AGE||||MCI/KG|||U/M2/H|NOT DONE||NA|N|N|3||39||WASHOUT|1967-12-30||1971-12-06|||1961-03-22||1969-11-06
TRIAL STUDY 134XCP|RP|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|1||||||INTP|INTERPRETATION||||FINGERTIP UNIT|||MOL/G|NOT DONE||U|NA|U|4||88||BASELINE|1972-05-06||1965-10-27|||1973-03-19||1966-11-01
TRIAL STUDY 134XCP|RP|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MIN|||WEEKS|NOT DONE||Y|Y|NA|4||88||BLINDED TREATMENT|1966-08-16||1966-08-06|||1969-04-14||1972-04-26
TRIAL STUDY 134XCP|RP|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||P|||KG/M2|NOT DONE||NA|N|U|5||7||WASHOUT|1971-11-29||1964-03-25|||1971-02-11||1962-03-10
TRIAL STUDY 134XCP|RP|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|2||||||BLISTIND|BLISTERING INDICATOR||||CCID 50/DOSE|||NFIU|NOT DONE||Y|N|NA|5||7||OBSERVATION|1961-08-03||1965-02-21|||1966-10-12||1966-02-13
TRIAL STUDY 134XCP|RP|AAC3113C-793D-43F4-87E9-111246E03003|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||NMOL/G|||CAPLET|NOT DONE||NA|U|Y|1||38||CONTINUATION TREATMENT|1966-05-25||1972-01-25|||1970-08-24||1966-05-15
TRIAL STUDY 134XCP|RP|AAC3113C-793D-43F4-87E9-111246E03003|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||LOG10 CFU/ML|||MG/M2/H|NOT DONE||NA|Y|N|1||38||RUN-IN|1964-04-18||1960-08-07|||1968-09-08||1969-07-06
TRIAL STUDY 134XCP|RP|AAC3113C-793D-43F4-87E9-111246E03003|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||UMOL/KG/MIN|||PT_US|NOT DONE||N|NA|N|2||58||BASELINE|1973-08-03||1960-10-15|||1961-08-11||1964-06-19
TRIAL STUDY 134XCP|RP|AAC3113C-793D-43F4-87E9-111246E03003|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||MM/H|||ML/DAY|NOT DONE||N|Y|Y|2||58||OBSERVATION|1973-01-29||1972-01-01|||1971-07-03||1971-09-09
TRIAL STUDY 134XCP|RP|AAC3113C-793D-43F4-87E9-111246E03003|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||TABLET|||CG|NOT DONE||Y|N|N|3||39||INDUCTION TREATMENT|1966-02-23||1963-11-21|||1964-04-29||1970-11-04
TRIAL STUDY 134XCP|RP|AAC3113C-793D-43F4-87E9-111246E03003|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^6 IU/ML|||MG/CM2|NOT DONE||U|N|NA|3||39||OPEN LABEL TREATMENT|1973-05-07||1964-06-19|||1973-01-26||1972-05-24
TRIAL STUDY 134XCP|RP|AAC3113C-793D-43F4-87E9-111246E03003|1||||||DSCHGIND|DISCHARGE INDICATOR||||UM/S|||MG/ANIMAL|NOT DONE||NA|U|Y|4||88||CONTINUATION TREATMENT|1970-01-22||1972-03-10|||1968-06-14||1973-08-22
TRIAL STUDY 134XCP|RP|AAC3113C-793D-43F4-87E9-111246E03003|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||/5X10^4 WBC|||CI/G|NOT DONE||Y|NA|N|4||88||BLINDED TREATMENT|1969-05-07||1968-11-25|||1970-05-22||1962-10-11
TRIAL STUDY 134XCP|RP|AAC3113C-793D-43F4-87E9-111246E03003|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||U/G/H|||%/S|NOT DONE||U|U|U|5||7||BASELINE|1960-06-27||1970-12-21|||1968-03-30||1966-05-18
TRIAL STUDY 134XCP|RP|AAC3113C-793D-43F4-87E9-111246E03003|2||||||PREGNN|NUMBER OF PREGNANCIES||||DEG|||MEQ|NOT DONE||Y|Y|NA|5||7||FOLLOW-UP|1963-05-08||1962-08-07|||1973-02-15||1966-05-12
TRIAL STUDY 134XCP|RP|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||KHZ|||GBQ/UG|NOT DONE||NA|Y|Y|1||38||RUN-IN|1973-09-04||1967-09-16|||1964-11-09||1968-09-12
TRIAL STUDY 134XCP|RP|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||NKAT/G HB|||MV|NOT DONE||NA|NA|U|1||38||INDUCTION TREATMENT|1964-02-12||1962-04-26|||1963-07-11||1966-08-24
TRIAL STUDY 134XCP|RP|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|1||||||DLVRMODE|MODE OF DELIVERY||||BREATHS/30S|||RATIO|NOT DONE||N|NA|N|2||58||SCREENING|1970-09-29||1960-09-24|||1969-12-09||1964-03-18
TRIAL STUDY 134XCP|RP|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|2||||||PRGENDTC|DATE PREGNANCY ENDED||||CYCLE/MIN|||KS|NOT DONE||Y|N|NA|2||58||FOLLOW-UP|1966-11-20||1962-02-20|||1968-02-04||1966-09-11
TRIAL STUDY 134XCP|RP|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PA|||GENEQ|NOT DONE||Y|N|NA|3||39||BASELINE|1972-06-20||1961-11-12|||1972-07-21||1962-06-11
TRIAL STUDY 134XCP|RP|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||ML/MIN|||MM|NOT DONE||U|N|Y|3||39||BASELINE|1967-06-21||1970-12-13|||1969-11-20||1972-03-19
TRIAL STUDY 134XCP|RP|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||PFU/DOSE|||10^9/DOSE|NOT DONE||N|NA|Y|4||88||TREATMENT|1963-02-17||1963-12-01|||1965-09-05||1962-11-27
TRIAL STUDY 134XCP|RP|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|2||||||PREGNN|NUMBER OF PREGNANCIES||||M3|||/VF|NOT DONE||Y|Y|NA|4||88||BLINDED TREATMENT|1971-07-14||1970-03-02|||1964-02-07||1964-05-17
TRIAL STUDY 134XCP|RP|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|1||||||ULCERIND|ULCER INDICATOR||||MPA|||MOL|NOT DONE||NA|N|Y|5||7||CONTINUATION TREATMENT|1960-01-05||1969-06-16|||1971-04-07||1967-07-16
TRIAL STUDY 134XCP|RP|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|2||||||STILBIND|STILLBIRTH INDICATOR||||10^9 CFU/G|||G/G/DAY|NOT DONE||N|Y|U|5||7||FOLLOW-UP|1963-09-23||1964-01-20|||1963-10-20||1965-08-17
TRIAL STUDY 134XCP|RP|941A9CF9-872C-42CF-A409-129BE5A88520|1||||||RASHIND|RASH INDICATOR||||CMH2O*S/ML|||DAGU|NOT DONE||U|N|U|1||38||WASHOUT|1967-02-28||1968-04-20|||1969-03-06||1968-03-17
TRIAL STUDY 134XCP|RP|941A9CF9-872C-42CF-A409-129BE5A88520|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||RATIO|||AFU|NOT DONE||N|N|NA|1||38||TREATMENT|1972-12-19||1964-07-05|||1960-11-01||1970-12-13
TRIAL STUDY 134XCP|RP|941A9CF9-872C-42CF-A409-129BE5A88520|1||||||DSCHGIND|DISCHARGE INDICATOR||||1/(S*KPA)|||V|NOT DONE||N|Y|NA|2||58||OBSERVATION|1966-06-26||1970-06-03|||1967-08-18||1966-02-11
TRIAL STUDY 134XCP|RP|941A9CF9-872C-42CF-A409-129BE5A88520|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||CM/MIN|||UG/H|NOT DONE||Y|U|U|2||58||INDUCTION TREATMENT|1967-06-17||1964-05-27|||1971-07-09||1960-03-17
TRIAL STUDY 134XCP|RP|941A9CF9-872C-42CF-A409-129BE5A88520|1||||||PREGIND|PREGNANT INDICATOR||||S*KPA|||MMHG*MIN/L|NOT DONE||Y|Y|U|3||39||SCREENING|1971-06-22||1966-10-10|||1964-02-29||1973-07-28
TRIAL STUDY 134XCP|RP|941A9CF9-872C-42CF-A409-129BE5A88520|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||GY|||USEC|NOT DONE||U|U|Y|3||39||WASHOUT|1969-05-10||1971-05-06|||1968-01-30||1962-02-14
TRIAL STUDY 134XCP|RP|941A9CF9-872C-42CF-A409-129BE5A88520|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||U/M2/DAY|||STEPS|NOT DONE||U|U|U|4||88||BLINDED TREATMENT|1971-09-15||1962-09-19|||1971-12-28||1961-04-05
TRIAL STUDY 134XCP|RP|941A9CF9-872C-42CF-A409-129BE5A88520|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||VIRTUAL PIXEL|||VG/DOSE|NOT DONE||NA|Y|N|4||88||OBSERVATION|1964-09-17||1969-02-03|||1968-08-04||1964-03-11
TRIAL STUDY 134XCP|RP|941A9CF9-872C-42CF-A409-129BE5A88520|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||CI/UL|||UG/M2/H|NOT DONE||N|N|Y|5||7||WASHOUT|1963-01-09||1969-04-30|||1963-07-20||1962-09-04
TRIAL STUDY 134XCP|RP|941A9CF9-872C-42CF-A409-129BE5A88520|2||||||MENFDUR|MENSES FLOW DURATION||||MG/L|||UL|NOT DONE||NA|Y|NA|5||7||FOLLOW-UP|1963-10-04||1960-08-29|||1970-06-02||1965-05-04
TRIAL STUDY 134XCP|RP|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||UMOL/L|||LOG10 CFU/G|NOT DONE||NA|Y|U|1||38||WASHOUT|1965-12-13||1961-03-02|||1962-07-12||1960-04-23
TRIAL STUDY 134XCP|RP|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||100 IU/ML|||NMOL/ML/MIN|NOT DONE||Y|N|Y|1||38||LONG-TERM FOLLOW-UP|1971-02-14||1967-10-15|||1964-02-20||1963-07-10
TRIAL STUDY 134XCP|RP|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||PFU/ANIMAL|||BAU|NOT DONE||U|Y|N|2||58||BLINDED TREATMENT|1970-06-29||1967-04-08|||1972-06-01||1962-10-20
TRIAL STUDY 134XCP|RP|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MG/G/MIN|||KUSP|NOT DONE||NA|U|NA|2||58||INDUCTION TREATMENT|1968-10-25||1962-09-19|||1967-09-15||1969-10-12
TRIAL STUDY 134XCP|RP|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||L/MIN/M2|||PMOL/DAY|NOT DONE||NA|NA|N|3||39||TREATMENT|1961-01-18||1962-02-07|||1971-05-13||1962-10-16
TRIAL STUDY 134XCP|RP|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UG/L|||MG/ML/MIN|NOT DONE||N|N|N|3||39||FOLLOW-UP|1961-02-01||1963-08-12|||1967-04-20||1970-05-26
TRIAL STUDY 134XCP|RP|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|1||||||ERYTHIND|ERYTHEMA INDICATOR||||MEQ/ML|||ECL UNIT|NOT DONE||N|U|N|4||88||FOLLOW-UP|1967-04-09||1962-11-07|||1967-08-03||1967-06-17
TRIAL STUDY 134XCP|RP|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MG/ML/MIN|||/LPF|NOT DONE||N|NA|NA|4||88||RUN-IN|1961-12-13||1967-06-23|||1970-07-27||1967-06-10
TRIAL STUDY 134XCP|RP|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||YD|||MEQ/KG|NOT DONE||NA|NA|N|5||7||BASELINE|1962-04-04||1964-11-26|||1964-01-28||1971-08-17
TRIAL STUDY 134XCP|RP|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||/VF|||ML/DL|NOT DONE||U|NA|Y|5||7||BASELINE|1965-10-25||1965-06-12|||1971-08-09||1961-06-29
TRIAL STUDY 134XCP|RP|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||PACK|||STEPS|NOT DONE||U|Y|U|1||38||OPEN LABEL TREATMENT|1965-03-29||1970-03-22|||1964-11-27||1963-01-14
TRIAL STUDY 134XCP|RP|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||BAG|||COPIES/UL|NOT DONE||N|U|Y|1||38||CONTINUATION TREATMENT|1967-01-26||1972-04-18|||1972-05-09||1972-01-12
TRIAL STUDY 134XCP|RP|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|1||||||ERYTHIND|ERYTHEMA INDICATOR||||TUBE|||TITER|NOT DONE||NA|N|U|2||58||CONTINUATION TREATMENT|1961-11-19||1970-06-17|||1972-01-30||1963-03-30
TRIAL STUDY 134XCP|RP|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|2||||||ULCERIND|ULCER INDICATOR||||PLUG|||EIA UNIT|NOT DONE||U|N|NA|2||58||LONG-TERM FOLLOW-UP|1960-04-21||1964-02-22|||1967-03-08||1961-05-06
TRIAL STUDY 134XCP|RP|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||UEQ/L|||ML/MIN/1.73M2|NOT DONE||NA|NA|U|3||39||SCREENING|1967-09-10||1962-05-17|||1963-01-13||1966-08-02
TRIAL STUDY 134XCP|RP|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|2||||||MENFDUR|MENSES FLOW DURATION||||PPB|||C|NOT DONE||Y|U|NA|3||39||WASHOUT|1968-11-09||1965-09-26|||1969-12-15||1970-07-14
TRIAL STUDY 134XCP|RP|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||BAU|||U/ML|NOT DONE||NA|Y|Y|4||88||INDUCTION TREATMENT|1965-08-01||1965-01-22|||1970-07-20||1968-04-07
TRIAL STUDY 134XCP|RP|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|2||||||MENARAGE|MENARCHE AGE||||G/G|||MG/KG/MIN|NOT DONE||NA|NA|N|4||88||TREATMENT|1965-03-16||1970-08-21|||1965-01-31||1971-03-12
TRIAL STUDY 134XCP|RP|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|1||||||RASHIND|RASH INDICATOR||||CAL|||BEAM BREAKS|NOT DONE||NA|NA|NA|5||7||LONG-TERM FOLLOW-UP|1963-05-14||1965-06-21|||1967-08-10||1966-02-02
TRIAL STUDY 134XCP|RP|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||ML/M2|||MKAT|NOT DONE||NA|NA|Y|5||7||FOLLOW-UP|1969-10-28||1967-04-25|||1966-11-28||1972-12-12
TRIAL STUDY 134XCP|RP|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||NMOL|||U/MG|NOT DONE||Y|U|N|1||38||OBSERVATION|1963-05-05||1967-08-01|||1964-04-15||1968-05-15
TRIAL STUDY 134XCP|RP|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||FG|||IU/MMOL|NOT DONE||N|NA|NA|1||38||WASHOUT|1967-08-28||1969-08-05|||1962-04-02||1970-06-02
TRIAL STUDY 134XCP|RP|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ML*CMH2O|||UMOL|NOT DONE||Y|Y|Y|2||58||CONTINUATION TREATMENT|1961-10-18||1972-02-09|||1972-08-19||1963-09-13
TRIAL STUDY 134XCP|RP|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|2||||||BLISTIND|BLISTERING INDICATOR||||ML/ANIMAL/WK|||CI|NOT DONE||U|U|N|2||58||SCREENING|1964-08-07||1969-01-07|||1971-04-21||1965-03-08
TRIAL STUDY 134XCP|RP|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||DPM/100MG|||MG/H|NOT DONE||Y|Y|Y|3||39||OBSERVATION|1968-02-06||1965-02-06|||1971-02-06||1973-05-29
TRIAL STUDY 134XCP|RP|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|2||||||INTP|INTERPRETATION||||FMOL|||RATIO|NOT DONE||U|N|N|3||39||BASELINE|1960-08-18||1972-10-14|||1970-07-20||1965-04-16
TRIAL STUDY 134XCP|RP|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||LINEAR FT*LB|||U/10^12 RBC|NOT DONE||U|Y|U|4||88||INDUCTION TREATMENT|1960-10-28||1964-05-03|||1967-04-11||1962-04-12
TRIAL STUDY 134XCP|RP|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|2||||||RASHIND|RASH INDICATOR||||/DAY|||SFC/10^6 PBMC|NOT DONE||U|NA|Y|4||88||BASELINE|1968-09-26||1966-07-14|||1960-05-17||1965-03-06
TRIAL STUDY 134XCP|RP|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MBQ|||SHOCK WAVE|NOT DONE||NA|Y|U|5||7||SCREENING|1970-10-25||1966-08-05|||1973-03-13||1961-07-26
TRIAL STUDY 134XCP|RP|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|2||||||GRAVIND|GRAVIDA INDICATOR||||MS/MMHG|||DPM|NOT DONE||Y|N|NA|5||7||BASELINE|1969-01-28||1967-05-15|||1967-07-06||1961-03-16
TRIAL STUDY 134XCP|RP|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||ELISA UNIT/ML|||NMOL/L/MIN|NOT DONE||N|Y|Y|1||38||LONG-TERM FOLLOW-UP|1960-06-17||1964-03-23|||1966-07-31||1972-06-16
TRIAL STUDY 134XCP|RP|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||LOG10 TCID 50/UL|||FMOL/G|NOT DONE||NA|U|NA|1||38||FOLLOW-UP|1966-07-30||1972-06-18|||1961-02-28||1963-04-08
TRIAL STUDY 134XCP|RP|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|1||||||DSCHGIND|DISCHARGE INDICATOR||||BQ/L|||FEU|NOT DONE||N|Y|NA|2||58||OPEN LABEL TREATMENT|1962-11-25||1970-06-24|||1972-10-07||1968-10-06
TRIAL STUDY 134XCP|RP|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||CI/L|||ANSON U|NOT DONE||NA|NA|U|2||58||OPEN LABEL TREATMENT|1971-04-24||1962-12-13|||1962-10-27||1960-12-09
TRIAL STUDY 134XCP|RP|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||UMOL/L|||LOG10 CCID 50/DOSE|NOT DONE||U|U|NA|3||39||TREATMENT|1972-08-11||1973-04-08|||1963-06-12||1964-01-18
TRIAL STUDY 134XCP|RP|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|2||||||ABORTN|NUMBER OF ABORTIONS||||UG/KG/DAY|||LOZENGE|NOT DONE||U|NA|NA|3||39||LONG-TERM FOLLOW-UP|1972-11-03||1961-07-22|||1972-10-03||1964-11-11
TRIAL STUDY 134XCP|RP|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|1||||||INTP|INTERPRETATION||||UG/CM2|||10^3 ORGANISMS|NOT DONE||Y|NA|NA|4||88||OBSERVATION|1960-09-15||1970-03-06|||1970-12-16||1965-08-28
TRIAL STUDY 134XCP|RP|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||BREATHS/MIN|||U/10^12 RBC|NOT DONE||Y|NA|U|4||88||WASHOUT|1963-09-18||1964-02-21|||1969-11-30||1961-06-24
TRIAL STUDY 134XCP|RP|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|1||||||MENOSTAT|MENOPAUSE STATUS||||10^6 COPIES/ML|||MEQ/L|NOT DONE||U|Y|NA|5||7||OBSERVATION|1964-06-17||1961-09-23|||1972-05-17||1962-11-09
TRIAL STUDY 134XCP|RP|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|2||||||MASSIND|MASS INDICATOR||||TORR|||UM|NOT DONE||NA|N|Y|5||7||WASHOUT|1962-09-12||1967-03-16|||1971-12-09||1972-09-18
TRIAL STUDY 134XCP|RP|A4A5E66A-E65C-4234-8858-E69D04AB1593|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||/100 HPFS|||UG/M2|NOT DONE||Y|Y|U|1||38||LONG-TERM FOLLOW-UP|1968-02-24||1968-10-28|||1960-03-15||1964-07-21
TRIAL STUDY 134XCP|RP|A4A5E66A-E65C-4234-8858-E69D04AB1593|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||NSEC|||UG/DOSE|NOT DONE||N|Y|U|1||38||TREATMENT|1966-04-06||1967-10-16|||1961-01-14||1968-07-23
TRIAL STUDY 134XCP|RP|A4A5E66A-E65C-4234-8858-E69D04AB1593|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^6 CFU/G|||BEAM BREAKS|NOT DONE||N|U|N|2||58||FOLLOW-UP|1966-01-24||1966-04-02|||1967-08-24||1970-12-15
TRIAL STUDY 134XCP|RP|A4A5E66A-E65C-4234-8858-E69D04AB1593|2||||||MENOAGE|MENOPAUSE AGE||||UG/G/DAY|||NKAT/G HB|NOT DONE||NA|NA|N|2||58||BASELINE|1965-07-09||1971-08-25|||1966-09-03||1965-06-14
TRIAL STUDY 134XCP|RP|A4A5E66A-E65C-4234-8858-E69D04AB1593|1||||||FUNDHT|FUNDAL HEIGHT||||UL/ML|||UG/DOSE|NOT DONE||N|U|Y|3||39||INDUCTION TREATMENT|1960-08-28||1971-05-05|||1967-06-05||1970-08-07
TRIAL STUDY 134XCP|RP|A4A5E66A-E65C-4234-8858-E69D04AB1593|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||KG/MOL|||BQ/KG|NOT DONE||NA|NA|Y|3||39||TREATMENT|1962-05-15||1966-04-06|||1972-02-27||1965-01-13
TRIAL STUDY 134XCP|RP|A4A5E66A-E65C-4234-8858-E69D04AB1593|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||CD|||U/G/DAY|NOT DONE||N|U|Y|4||88||BLINDED TREATMENT|1972-07-07||1973-02-26|||1969-09-08||1964-02-14
TRIAL STUDY 134XCP|RP|A4A5E66A-E65C-4234-8858-E69D04AB1593|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||MG/G/H|||BQ/L|NOT DONE||U|NA|Y|4||88||BASELINE|1966-12-22||1970-02-01|||1963-01-20||1968-06-10
TRIAL STUDY 134XCP|RP|A4A5E66A-E65C-4234-8858-E69D04AB1593|1||||||BLISTIND|BLISTERING INDICATOR||||USP U|||DAMOL/L|NOT DONE||NA|Y|NA|5||7||LONG-TERM FOLLOW-UP|1973-07-14||1963-03-21|||1968-04-18||1969-05-24
TRIAL STUDY 134XCP|RP|A4A5E66A-E65C-4234-8858-E69D04AB1593|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||LB|||CI/UG|NOT DONE||Y|N|NA|5||7||OPEN LABEL TREATMENT|1969-03-22||1972-02-14|||1966-07-08||1962-11-01
TRIAL STUDY 134XCP|RP|0EA46DA5-4291-4585-9745-08BFA60BED3F|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||LOG10 CCID 50/DOSE|||MG/H|NOT DONE||N|N|N|1||38||TREATMENT|1961-09-24||1962-07-15|||1968-01-09||1967-03-14
TRIAL STUDY 134XCP|RP|0EA46DA5-4291-4585-9745-08BFA60BED3F|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||FT2|||AMFI|NOT DONE||N|NA|Y|1||38||BLINDED TREATMENT|1967-11-18||1962-11-16|||1964-07-11||1960-07-28
TRIAL STUDY 134XCP|RP|0EA46DA5-4291-4585-9745-08BFA60BED3F|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MIN|||PATCH|NOT DONE||NA|N|Y|2||58||OPEN LABEL TREATMENT|1965-11-06||1971-05-22|||1961-09-06||1961-03-01
TRIAL STUDY 134XCP|RP|0EA46DA5-4291-4585-9745-08BFA60BED3F|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||ML/S|||CM/S|NOT DONE||Y|Y|NA|2||58||SCREENING|1967-03-10||1966-03-12|||1973-08-07||1960-05-14
TRIAL STUDY 134XCP|RP|0EA46DA5-4291-4585-9745-08BFA60BED3F|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||TESLA|||/LSQN|NOT DONE||Y|Y|Y|3||39||WASHOUT|1961-12-14||1970-12-25|||1968-01-10||1970-03-16
TRIAL STUDY 134XCP|RP|0EA46DA5-4291-4585-9745-08BFA60BED3F|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||IU/KG/H|||TCID 50/DOSE|NOT DONE||Y|NA|N|3||39||OBSERVATION|1964-11-11||1965-11-19|||1971-08-15||1965-06-19
TRIAL STUDY 134XCP|RP|0EA46DA5-4291-4585-9745-08BFA60BED3F|1||||||BRTHN|NUMBER OF BIRTHS||||PMOL/L|||TRACE|NOT DONE||N|U|N|4||88||OBSERVATION|1970-05-23||1960-09-27|||1962-03-12||1969-05-27
TRIAL STUDY 134XCP|RP|0EA46DA5-4291-4585-9745-08BFA60BED3F|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||CMOL/L|||10^7 CFU/ML|NOT DONE||U|NA|U|4||88||BLINDED TREATMENT|1972-10-15||1966-05-19|||1970-01-31||1970-09-24
TRIAL STUDY 134XCP|RP|0EA46DA5-4291-4585-9745-08BFA60BED3F|1||||||PRGENDTC|DATE PREGNANCY ENDED||||HENRY|||UV*SEC|NOT DONE||Y|Y|NA|5||7||RUN-IN|1968-10-25||1963-11-08|||1961-09-18||1966-05-26
TRIAL STUDY 134XCP|RP|0EA46DA5-4291-4585-9745-08BFA60BED3F|2||||||MASSIND|MASS INDICATOR||||LM|||10^6 CFU/G|NOT DONE||U|NA|Y|5||7||TREATMENT|1969-01-28||1969-03-04|||1967-08-23||1960-10-18
TRIAL STUDY 134XCP|RP|F54E494F-7EC2-41E7-A969-DF7151EA08E9|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||G/G/DAY|||PACKET|NOT DONE||U|N|NA|1||38||RUN-IN|1969-12-18||1960-01-30|||1964-06-21||1965-12-06
TRIAL STUDY 134XCP|RP|F54E494F-7EC2-41E7-A969-DF7151EA08E9|2||||||DSCHGIND|DISCHARGE INDICATOR||||UG/L|||MCI|NOT DONE||N|Y|Y|1||38||INDUCTION TREATMENT|1972-05-11||1961-04-27|||1960-10-22||1973-08-17
TRIAL STUDY 134XCP|RP|F54E494F-7EC2-41E7-A969-DF7151EA08E9|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||CM H2O|||USEC|NOT DONE||NA|NA|N|2||58||SCREENING|1971-10-04||1968-10-20|||1969-04-02||1964-01-29
TRIAL STUDY 134XCP|RP|F54E494F-7EC2-41E7-A969-DF7151EA08E9|2||||||PRGENDTC|DATE PREGNANCY ENDED||||UG/M2/H|||ML/100G/MIN|NOT DONE||U|Y|U|2||58||BASELINE|1967-04-27||1970-11-07|||1971-10-04||1966-03-03
TRIAL STUDY 134XCP|RP|F54E494F-7EC2-41E7-A969-DF7151EA08E9|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^6 ORGANISMS|||PIXELS/CM|NOT DONE||Y|Y|U|3||39||BASELINE|1960-10-28||1970-02-23|||1970-03-20||1960-09-21
TRIAL STUDY 134XCP|RP|F54E494F-7EC2-41E7-A969-DF7151EA08E9|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PMOL/L/H|||ML/DAY|NOT DONE||N|U|Y|3||39||BLINDED TREATMENT|1963-11-30||1964-09-21|||1972-10-08||1964-07-26
TRIAL STUDY 134XCP|RP|F54E494F-7EC2-41E7-A969-DF7151EA08E9|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||DEG|||/MIN|NOT DONE||N|N|NA|4||88||RUN-IN|1964-05-02||1970-10-02|||1966-04-24||1970-09-03
TRIAL STUDY 134XCP|RP|F54E494F-7EC2-41E7-A969-DF7151EA08E9|2||||||THICK|THICKNESS||||MMU/ML|||MDFI|NOT DONE||Y|NA|Y|4||88||WASHOUT|1972-08-22||1969-11-23|||1965-10-29||1965-09-16
TRIAL STUDY 134XCP|RP|F54E494F-7EC2-41E7-A969-DF7151EA08E9|1||||||INABOIND|INDUCED ABORTION INDICATOR||||PL|||LOG10 TCID 50/UL|NOT DONE||Y|Y|NA|5||7||TREATMENT|1968-11-24||1973-06-17|||1965-05-16||1960-03-17
TRIAL STUDY 134XCP|RP|F54E494F-7EC2-41E7-A969-DF7151EA08E9|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MMOL/MIN/KPA|||MMU/ML|NOT DONE||U|NA|NA|5||7||OPEN LABEL TREATMENT|1967-11-10||1963-08-29|||1965-07-25||1969-12-28
TRIAL STUDY 134XCP|RP|3C4215F7-A7FA-4177-8B84-FD26FEB43039|1||||||BCMETHOD|BIRTH CONTROL METHOD||||ENZYME U/L|||LOG10 PFU/ML|NOT DONE||N|U|N|1||38||OBSERVATION|1964-06-11||1970-10-18|||1969-12-30||1964-05-11
TRIAL STUDY 134XCP|RP|3C4215F7-A7FA-4177-8B84-FD26FEB43039|2||||||BRTHN|NUMBER OF BIRTHS||||MU/L|||KS|NOT DONE||NA|Y|Y|1||38||BASELINE|1972-10-08||1968-07-26|||1967-07-24||1967-10-13
TRIAL STUDY 134XCP|RP|3C4215F7-A7FA-4177-8B84-FD26FEB43039|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||CMOL|||/MM2|NOT DONE||Y|Y|Y|2||58||BLINDED TREATMENT|1960-08-11||1965-03-05|||1963-12-21||1962-07-05
TRIAL STUDY 134XCP|RP|3C4215F7-A7FA-4177-8B84-FD26FEB43039|2||||||PEELIND|PEELING INDICATOR||||AGU/ML|||WEEKS|NOT DONE||U|N|Y|2||58||RUN-IN|1967-09-14||1964-07-05|||1966-07-28||1970-02-19
TRIAL STUDY 134XCP|RP|3C4215F7-A7FA-4177-8B84-FD26FEB43039|1||||||PREGNN|NUMBER OF PREGNANCIES||||KUSP|||10^7 CFU|NOT DONE||N|N|NA|3||39||SCREENING|1967-03-09||1969-11-26|||1964-03-11||1963-05-24
TRIAL STUDY 134XCP|RP|3C4215F7-A7FA-4177-8B84-FD26FEB43039|2||||||MASSIND|MASS INDICATOR||||SIEMENS|||MS/MMHG|NOT DONE||NA|NA|U|3||39||TREATMENT|1967-08-24||1966-06-09|||1967-01-05||1972-01-09
TRIAL STUDY 134XCP|RP|3C4215F7-A7FA-4177-8B84-FD26FEB43039|1||||||ABORTN|NUMBER OF ABORTIONS||||MEQ/UL|||IU/G|NOT DONE||Y|NA|N|4||88||OBSERVATION|1963-02-27||1960-12-13|||1961-04-15||1966-08-18
TRIAL STUDY 134XCP|RP|3C4215F7-A7FA-4177-8B84-FD26FEB43039|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||M|||KBQ/UL|NOT DONE||U|U|Y|4||88||INDUCTION TREATMENT|1960-08-01||1965-03-19|||1968-04-16||1961-03-09
TRIAL STUDY 134XCP|RP|3C4215F7-A7FA-4177-8B84-FD26FEB43039|1||||||ULCERIND|ULCER INDICATOR||||PMOL/DAY|||MG/KG|NOT DONE||NA|NA|NA|5||7||FOLLOW-UP|1972-07-09||1963-05-04|||1961-04-20||1961-12-13
TRIAL STUDY 134XCP|RP|3C4215F7-A7FA-4177-8B84-FD26FEB43039|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||ML/CAGE/WK|||KN/CM2|NOT DONE||U|Y|U|5||7||INDUCTION TREATMENT|1960-01-26||1961-04-19|||1973-03-08||1961-01-04
TRIAL STUDY 134XCP|RP|797C71A3-375E-466E-BDA8-A2828C9C45BB|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MV|||UMOL/L|NOT DONE||Y|Y|N|1||38||RUN-IN|1965-07-09||1968-03-10|||1972-12-17||1962-10-31
TRIAL STUDY 134XCP|RP|797C71A3-375E-466E-BDA8-A2828C9C45BB|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||LOG10 TCID 50/UL|||ML/MMHG|NOT DONE||NA|N|Y|1||38||SCREENING|1969-06-12||1971-08-27|||1965-02-25||1970-02-09
TRIAL STUDY 134XCP|RP|797C71A3-375E-466E-BDA8-A2828C9C45BB|1||||||INTP|INTERPRETATION||||CFU/G|||PKAT/L|NOT DONE||N|Y|N|2||58||WASHOUT|1963-07-27||1968-09-28|||1964-07-02||1969-09-18
TRIAL STUDY 134XCP|RP|797C71A3-375E-466E-BDA8-A2828C9C45BB|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||10^3 DNA COPIES/ML|||10^3 CFU|NOT DONE||N|N|U|2||58||WASHOUT|1970-06-29||1962-10-09|||1969-03-28||1968-08-23
TRIAL STUDY 134XCP|RP|797C71A3-375E-466E-BDA8-A2828C9C45BB|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||/10^5|||KG/M2|NOT DONE||Y|Y|U|3||39||BLINDED TREATMENT|1964-02-04||1972-04-06|||1972-07-15||1971-12-03
TRIAL STUDY 134XCP|RP|797C71A3-375E-466E-BDA8-A2828C9C45BB|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UL/KG/DAY|||BQ/KG|NOT DONE||N|U|U|3||39||BASELINE|1971-06-30||1967-01-19|||1961-09-09||1969-12-11
TRIAL STUDY 134XCP|RP|797C71A3-375E-466E-BDA8-A2828C9C45BB|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UKAT|||TSP|NOT DONE||Y|Y|NA|4||88||INDUCTION TREATMENT|1968-12-14||1962-04-12|||1973-07-15||1962-12-31
TRIAL STUDY 134XCP|RP|797C71A3-375E-466E-BDA8-A2828C9C45BB|2||||||MENARAGE|MENARCHE AGE||||UMOL/H/MMOL|||U/M2/MIN|NOT DONE||U|Y|U|4||88||SCREENING|1970-08-06||1973-05-04|||1970-08-18||1973-07-31
TRIAL STUDY 134XCP|RP|797C71A3-375E-466E-BDA8-A2828C9C45BB|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||RPM|||PG/L|NOT DONE||NA|NA|U|5||7||WASHOUT|1960-09-22||1964-07-28|||1968-07-13||1967-01-18
TRIAL STUDY 134XCP|RP|797C71A3-375E-466E-BDA8-A2828C9C45BB|2||||||STILBIND|STILLBIRTH INDICATOR||||ML/CM3/MIN|||YEARS|NOT DONE||U|NA|N|5||7||BLINDED TREATMENT|1970-11-10||1963-01-29|||1973-06-08||1969-09-24
TRIAL STUDY 134XCP|RP|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UM/DAY|||10^3/HPF|NOT DONE||N|N|Y|1||38||BLINDED TREATMENT|1960-01-17||1967-04-23|||1972-04-03||1967-12-18
TRIAL STUDY 134XCP|RP|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|2||||||DLVRMODE|MODE OF DELIVERY||||PLUG|||UL/KG/DAY|NOT DONE||Y|NA|Y|1||38||CONTINUATION TREATMENT|1964-09-04||1960-02-10|||1967-12-08||1969-08-09
TRIAL STUDY 134XCP|RP|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||PPTH|||/VF|NOT DONE||NA|U|N|2||58||OBSERVATION|1972-10-11||1968-12-14|||1969-12-18||1969-11-04
TRIAL STUDY 134XCP|RP|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||G/CAGE|||LX|NOT DONE||N|Y|NA|2||58||BASELINE|1967-03-07||1964-04-01|||1965-04-11||1961-11-26
TRIAL STUDY 134XCP|RP|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||PPTH|||PG/DL|NOT DONE||U|NA|N|3||39||INDUCTION TREATMENT|1972-11-09||1966-07-05|||1970-04-14||1964-02-12
TRIAL STUDY 134XCP|RP|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||G/ANIMAL/DAY|||LOG10 IU/ML|NOT DONE||Y|Y|NA|3||39||BLINDED TREATMENT|1964-03-31||1960-02-03|||1972-07-08||1970-02-12
TRIAL STUDY 134XCP|RP|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||10^8 PFU|||UIU/DL|NOT DONE||N|N|U|4||88||OPEN LABEL TREATMENT|1970-10-20||1963-12-19|||1969-02-26||1961-04-30
TRIAL STUDY 134XCP|RP|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^3/HPF|||AMFI|NOT DONE||U|U|NA|4||88||CONTINUATION TREATMENT|1963-10-15||1961-07-01|||1964-09-11||1970-03-29
TRIAL STUDY 134XCP|RP|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||IU/MMOL|||MEQ/MMOL|NOT DONE||U|Y|N|5||7||RUN-IN|1971-08-29||1960-05-06|||1969-04-18||1972-12-24
TRIAL STUDY 134XCP|RP|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||10^6/EJACULATE U|||TSP EQ|NOT DONE||N|NA|U|5||7||FOLLOW-UP|1967-08-11||1967-07-11|||1967-01-29||1970-04-20
TRIAL STUDY 134XCP|RP|5617A5B9-AEE0-4118-9113-3755ED8E961A|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||PIPE|||NMOL/KG/DAY|NOT DONE||N|Y|Y|1||38||OPEN LABEL TREATMENT|1961-02-19||1967-11-13|||1965-10-09||1969-02-17
TRIAL STUDY 134XCP|RP|5617A5B9-AEE0-4118-9113-3755ED8E961A|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||ML/DOSE|||PA|NOT DONE||N|Y|U|1||38||WASHOUT|1960-03-23||1967-02-08|||1971-07-03||1965-07-24
TRIAL STUDY 134XCP|RP|5617A5B9-AEE0-4118-9113-3755ED8E961A|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||PACK|||ENZYME U|NOT DONE||NA|Y|U|2||58||OPEN LABEL TREATMENT|1961-02-20||1960-09-17|||1968-04-16||1973-02-02
TRIAL STUDY 134XCP|RP|5617A5B9-AEE0-4118-9113-3755ED8E961A|2||||||EDEMAIND|EDEMA INDICATOR||||EP U|||TAMPON|NOT DONE||N|Y|NA|2||58||OBSERVATION|1968-11-12||1966-10-25|||1960-03-17||1969-11-21
TRIAL STUDY 134XCP|RP|5617A5B9-AEE0-4118-9113-3755ED8E961A|1||||||BRTHN|NUMBER OF BIRTHS||||JDF UNIT|||MSEC|NOT DONE||Y|Y|NA|3||39||WASHOUT|1967-01-07||1967-02-12|||1966-07-07||1972-05-16
TRIAL STUDY 134XCP|RP|5617A5B9-AEE0-4118-9113-3755ED8E961A|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MOL/MOL|||NEEDLE GAUGE|NOT DONE||U|N|U|3||39||OBSERVATION|1972-08-05||1967-05-29|||1968-11-25||1964-01-08
TRIAL STUDY 134XCP|RP|5617A5B9-AEE0-4118-9113-3755ED8E961A|1||||||MENOSTAT|MENOPAUSE STATUS||||DAGU/ML|||NM|NOT DONE||U|Y|NA|4||88||BLINDED TREATMENT|1964-03-31||1962-06-22|||1963-09-17||1965-10-18
TRIAL STUDY 134XCP|RP|5617A5B9-AEE0-4118-9113-3755ED8E961A|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||L/S/KPA|||MOL/ML|NOT DONE||NA|NA|U|4||88||OPEN LABEL TREATMENT|1964-11-17||1970-11-30|||1966-10-16||1965-12-18
TRIAL STUDY 134XCP|RP|5617A5B9-AEE0-4118-9113-3755ED8E961A|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MS/MMHG|||MEQ/UG|NOT DONE||NA|N|Y|5||7||OBSERVATION|1966-04-14||1971-09-10|||1965-09-28||1962-08-25
TRIAL STUDY 134XCP|RP|5617A5B9-AEE0-4118-9113-3755ED8E961A|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||10^5/HPF|||IU/MMOL|NOT DONE||NA|Y|Y|5||7||OBSERVATION|1962-12-03||1965-08-15|||1964-03-19||1969-09-13
TRIAL STUDY 134XCP|RP|7ECE0F95-910A-4FB3-9435-73805E498415|1||||||PREGIND|PREGNANT INDICATOR||||PM|||OZ EQ|NOT DONE||Y|NA|Y|1||38||BASELINE|1961-06-08||1960-05-20|||1972-01-25||1962-01-20
TRIAL STUDY 134XCP|RP|7ECE0F95-910A-4FB3-9435-73805E498415|2||||||BLISTIND|BLISTERING INDICATOR||||PNU/ML|||10^3 COPIES/ML|NOT DONE||Y|N|N|1||38||FOLLOW-UP|1965-07-15||1968-03-14|||1964-02-12||1962-11-29
TRIAL STUDY 134XCP|RP|7ECE0F95-910A-4FB3-9435-73805E498415|1||||||TNDRIND|TENDERNESS INDICATOR||||10^3 ORGANISMS/G|||GMFI|NOT DONE||N|Y|Y|2||58||OBSERVATION|1960-03-10||1966-10-26|||1972-11-25||1972-04-04
TRIAL STUDY 134XCP|RP|7ECE0F95-910A-4FB3-9435-73805E498415|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||USIEMENS|||AMU|NOT DONE||U|N|NA|2||58||CONTINUATION TREATMENT|1963-08-29||1965-04-13|||1961-08-07||1962-11-26
TRIAL STUDY 134XCP|RP|7ECE0F95-910A-4FB3-9435-73805E498415|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||L/DAY|||UG/G/H|NOT DONE||Y|N|U|3||39||TREATMENT|1963-08-04||1969-07-23|||1970-01-21||1971-03-14
TRIAL STUDY 134XCP|RP|7ECE0F95-910A-4FB3-9435-73805E498415|2||||||DLVRMODE|MODE OF DELIVERY||||OI50|||MANSON U/ML|NOT DONE||U|Y|U|3||39||INDUCTION TREATMENT|1967-10-26||1971-06-14|||1973-05-19||1962-07-11
TRIAL STUDY 134XCP|RP|7ECE0F95-910A-4FB3-9435-73805E498415|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||TAMPON|||HZ|NOT DONE||Y|Y|N|4||88||OBSERVATION|1969-04-24||1960-11-12|||1969-10-19||1966-05-14
TRIAL STUDY 134XCP|RP|7ECE0F95-910A-4FB3-9435-73805E498415|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ENZYME U|||HR/DAY|NOT DONE||NA|U|N|4||88||SCREENING|1964-04-28||1971-05-06|||1964-11-03||1961-05-07
TRIAL STUDY 134XCP|RP|7ECE0F95-910A-4FB3-9435-73805E498415|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||/VF|||BAU/ML|NOT DONE||U|N|NA|5||7||LONG-TERM FOLLOW-UP|1964-11-03||1961-10-10|||1973-01-30||1965-04-12
TRIAL STUDY 134XCP|RP|7ECE0F95-910A-4FB3-9435-73805E498415|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||ELISA UNIT/DOSE|||10^10/L|NOT DONE||U|NA|Y|5||7||BASELINE|1968-08-04||1969-05-05|||1961-01-27||1964-06-23
TRIAL STUDY 134XCP|RP|83EDB0FE-728D-453F-8DB2-7D44202EEB43|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||GTT|||NFIU|NOT DONE||N|U|NA|1||38||INDUCTION TREATMENT|1971-01-20||1962-10-14|||1972-08-26||1967-10-29
TRIAL STUDY 134XCP|RP|83EDB0FE-728D-453F-8DB2-7D44202EEB43|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||DAMOL/L|||PUFF|NOT DONE||U|NA|N|1||38||RUN-IN|1961-01-21||1966-07-22|||1972-07-22||1970-08-26
TRIAL STUDY 134XCP|RP|83EDB0FE-728D-453F-8DB2-7D44202EEB43|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UG/MIN|||EU|NOT DONE||U|Y|NA|2||58||BASELINE|1964-05-25||1967-09-29|||1966-04-29||1972-08-26
TRIAL STUDY 134XCP|RP|83EDB0FE-728D-453F-8DB2-7D44202EEB43|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||NMOL/KG/DAY|||PFU/ML|NOT DONE||N|NA|Y|2||58||RUN-IN|1967-12-11||1966-11-04|||1972-11-18||1967-11-15
TRIAL STUDY 134XCP|RP|83EDB0FE-728D-453F-8DB2-7D44202EEB43|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||V/SEC|||BAU/ML|NOT DONE||N|Y|N|3||39||INDUCTION TREATMENT|1964-12-10||1968-04-15|||1968-11-11||1970-08-05
TRIAL STUDY 134XCP|RP|83EDB0FE-728D-453F-8DB2-7D44202EEB43|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||FOZ_US|||MEQ/UL|NOT DONE||Y|U|N|3||39||SCREENING|1964-03-31||1960-05-23|||1964-01-23||1962-10-13
TRIAL STUDY 134XCP|RP|83EDB0FE-728D-453F-8DB2-7D44202EEB43|1||||||MENOAGE|MENOPAUSE AGE||||BQ/KG|||MMHG/L/MIN|NOT DONE||NA|Y|Y|4||88||TREATMENT|1964-02-25||1965-04-03|||1964-03-29||1962-02-20
TRIAL STUDY 134XCP|RP|83EDB0FE-728D-453F-8DB2-7D44202EEB43|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||/MM|||L/MIN|NOT DONE||U|N|U|4||88||BLINDED TREATMENT|1973-04-07||1968-02-22|||1973-08-28||1972-04-16
TRIAL STUDY 134XCP|RP|83EDB0FE-728D-453F-8DB2-7D44202EEB43|1||||||INTP|INTERPRETATION||||UU/L|||H*%|NOT DONE||Y|NA|U|5||7||BLINDED TREATMENT|1961-10-22||1968-01-10|||1973-03-28||1961-07-09
TRIAL STUDY 134XCP|RP|83EDB0FE-728D-453F-8DB2-7D44202EEB43|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MG/L|||PG/L|NOT DONE||U|U|NA|5||7||WASHOUT|1962-11-18||1972-04-07|||1968-02-07||1970-02-22
TRIAL STUDY 134XCP|RP|35589D89-B019-4C5E-8A4B-BFA58E894A9C|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||ABSORBANCE U|||AMOL|NOT DONE||N|U|NA|1||38||BLINDED TREATMENT|1964-04-06||1965-02-19|||1961-07-18||1968-11-11
TRIAL STUDY 134XCP|RP|35589D89-B019-4C5E-8A4B-BFA58E894A9C|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MG/L FEU|||UMOL/MIN|NOT DONE||N|N|Y|1||38||CONTINUATION TREATMENT|1968-10-17||1967-07-23|||1962-01-12||1969-11-02
TRIAL STUDY 134XCP|RP|35589D89-B019-4C5E-8A4B-BFA58E894A9C|1||||||MENOSTAT|MENOPAUSE STATUS||||CI/G|||AMOL|NOT DONE||Y|U|N|2||58||OPEN LABEL TREATMENT|1970-05-26||1962-06-23|||1969-12-31||1962-02-06
TRIAL STUDY 134XCP|RP|35589D89-B019-4C5E-8A4B-BFA58E894A9C|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||OZ|||PMOL/L/H|NOT DONE||NA|N|NA|2||58||LONG-TERM FOLLOW-UP|1966-10-08||1972-12-02|||1967-08-22||1963-04-24
TRIAL STUDY 134XCP|RP|35589D89-B019-4C5E-8A4B-BFA58E894A9C|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||CGY|||LOG EID 50/DOSE|NOT DONE||Y|Y|N|3||39||FOLLOW-UP|1961-08-25||1968-05-14|||1973-08-02||1966-03-17
TRIAL STUDY 134XCP|RP|35589D89-B019-4C5E-8A4B-BFA58E894A9C|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||TRACE|||CPM|NOT DONE||NA|NA|N|3||39||RUN-IN|1966-10-24||1967-01-27|||1964-06-16||1967-11-17
TRIAL STUDY 134XCP|RP|35589D89-B019-4C5E-8A4B-BFA58E894A9C|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||L/H|||ML/M2|NOT DONE||U|NA|N|4||88||OPEN LABEL TREATMENT|1970-06-10||1964-11-24|||1973-01-17||1965-08-20
TRIAL STUDY 134XCP|RP|35589D89-B019-4C5E-8A4B-BFA58E894A9C|2||||||MENOAGE|MENOPAUSE AGE||||PACK|||GENEQ/ML|NOT DONE||NA|NA|Y|4||88||INDUCTION TREATMENT|1967-01-14||1964-10-19|||1964-05-11||1973-02-02
TRIAL STUDY 134XCP|RP|35589D89-B019-4C5E-8A4B-BFA58E894A9C|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||KPA/L/SEC|||CD/M2|NOT DONE||NA|N|U|5||7||LONG-TERM FOLLOW-UP|1967-03-03||1963-04-09|||1963-03-04||1972-10-20
TRIAL STUDY 134XCP|RP|35589D89-B019-4C5E-8A4B-BFA58E894A9C|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||ENZYME U/L|||TABLET|NOT DONE||U|U|N|5||7||SCREENING|1962-07-04||1965-03-23|||1966-01-06||1969-01-22
TRIAL STUDY 134XCP|RP|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|1||||||PEELIND|PEELING INDICATOR||||MOSM/KG|||K|NOT DONE||U|Y|NA|1||38||BASELINE|1970-03-03||1970-11-04|||1960-05-01||1968-01-24
TRIAL STUDY 134XCP|RP|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|2||||||DSCHGIND|DISCHARGE INDICATOR||||10^6/EJACULATE U|||UG/MIN|NOT DONE||U|NA|U|1||38||BASELINE|1965-08-18||1965-03-15|||1963-03-13||1964-03-02
TRIAL STUDY 134XCP|RP|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|1||||||MENOAGE|MENOPAUSE AGE||||UV*SEC|||L/DAY|NOT DONE||Y|N|NA|2||58||OPEN LABEL TREATMENT|1967-09-03||1971-11-04|||1961-11-26||1971-01-04
TRIAL STUDY 134XCP|RP|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|2||||||GRAVIND|GRAVIDA INDICATOR||||MCI/KG|||CP|NOT DONE||U|N|NA|2||58||CONTINUATION TREATMENT|1971-02-10||1963-04-14|||1967-02-26||1972-11-02
TRIAL STUDY 134XCP|RP|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|1||||||INABOIND|INDUCED ABORTION INDICATOR||||DDU|||UM|NOT DONE||NA|U|U|3||39||FOLLOW-UP|1960-08-10||1968-08-06|||1972-01-26||1973-07-25
TRIAL STUDY 134XCP|RP|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|2||||||ABORTN|NUMBER OF ABORTIONS||||FT3|||10^7 TCID 50/DOSE|NOT DONE||Y|U|N|3||39||CONTINUATION TREATMENT|1964-06-15||1969-02-23|||1965-02-25||1970-01-10
TRIAL STUDY 134XCP|RP|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|1||||||INTP|INTERPRETATION||||CI/ML|||ELISA UNIT|NOT DONE||Y|Y|NA|4||88||WASHOUT|1964-04-22||1960-09-19|||1960-02-08||1964-11-17
TRIAL STUDY 134XCP|RP|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|2||||||PEELIND|PEELING INDICATOR||||MOL/DAY|||10^6 ORGANISMS/ML|NOT DONE||Y|U|NA|4||88||INDUCTION TREATMENT|1970-11-09||1963-03-12|||1973-03-10||1963-01-10
TRIAL STUDY 134XCP|RP|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|1||||||PREGIND|PREGNANT INDICATOR||||ML/M2/MIN|||BQ/UL|NOT DONE||N|NA|U|5||7||SCREENING|1973-04-11||1962-08-31|||1972-08-17||1969-02-11
TRIAL STUDY 134XCP|RP|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MU/L|||MG/KG/WEEK|NOT DONE||N|NA|Y|5||7||RUN-IN|1972-06-19||1964-07-16|||1962-10-26||1967-12-08
TRIAL STUDY 134XCP|RP|21934F6E-8333-413B-931C-DF115519F394|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||PL|||ML/MIN|NOT DONE||U|N|NA|1||38||FOLLOW-UP|1966-10-01||1964-08-30|||1972-12-22||1961-09-08
TRIAL STUDY 134XCP|RP|21934F6E-8333-413B-931C-DF115519F394|2||||||MENFDUR|MENSES FLOW DURATION||||UGEQ/L|||VIAL|NOT DONE||N|N|NA|1||38||BLINDED TREATMENT|1971-01-15||1961-09-28|||1972-09-23||1961-03-22
TRIAL STUDY 134XCP|RP|21934F6E-8333-413B-931C-DF115519F394|1||||||MENOAGE|MENOPAUSE AGE||||10^6 COPIES/ML|||U/KG/DAY|NOT DONE||Y|Y|U|2||58||WASHOUT|1969-12-18||1961-07-19|||1969-10-20||1971-10-26
TRIAL STUDY 134XCP|RP|21934F6E-8333-413B-931C-DF115519F394|2||||||STILBIND|STILLBIRTH INDICATOR||||KEV|||G/DAY|NOT DONE||U|NA|Y|2||58||TREATMENT|1963-08-01||1970-08-24|||1972-12-23||1966-11-14
TRIAL STUDY 134XCP|RP|21934F6E-8333-413B-931C-DF115519F394|1||||||ERYTHIND|ERYTHEMA INDICATOR||||UG/KG/MIN|||VIAL|NOT DONE||U|NA|NA|3||39||LONG-TERM FOLLOW-UP|1969-09-18||1962-07-18|||1968-11-03||1962-08-28
TRIAL STUDY 134XCP|RP|21934F6E-8333-413B-931C-DF115519F394|2||||||MENOSTAT|MENOPAUSE STATUS||||PMOL/L/H|||BQ/UG|NOT DONE||NA|Y|N|3||39||FOLLOW-UP|1962-01-09||1971-06-21|||1967-08-07||1962-06-08
TRIAL STUDY 134XCP|RP|21934F6E-8333-413B-931C-DF115519F394|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MONTHS|||ML/KG/DAY|NOT DONE||NA|U|N|4||88||WASHOUT|1972-03-24||1960-01-05|||1967-09-20||1960-09-07
TRIAL STUDY 134XCP|RP|21934F6E-8333-413B-931C-DF115519F394|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||KDA|||KG/CM2|NOT DONE||U|NA|Y|4||88||SCREENING|1971-03-23||1970-05-02|||1966-01-27||1972-05-31
TRIAL STUDY 134XCP|RP|21934F6E-8333-413B-931C-DF115519F394|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||CYLINDER|||CL|NOT DONE||N|N|NA|5||7||FOLLOW-UP|1971-08-01||1972-01-16|||1963-11-06||1970-10-05
TRIAL STUDY 134XCP|RP|21934F6E-8333-413B-931C-DF115519F394|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||/7.5 ML|||ML/H|NOT DONE||U|N|U|5||7||SCREENING|1960-03-16||1966-09-04|||1966-11-06||1960-03-03
TRIAL STUDY 134XCP|RP|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||10^8 PFU|||TSP|NOT DONE||U|N|N|1||38||BASELINE|1965-09-23||1969-07-22|||1966-09-25||1968-01-08
TRIAL STUDY 134XCP|RP|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UG/MOL|||%(V/V)|NOT DONE||U|Y|NA|1||38||FOLLOW-UP|1972-03-27||1960-08-24|||1969-01-01||1968-10-10
TRIAL STUDY 134XCP|RP|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|1||||||PEELIND|PEELING INDICATOR||||SPRAY|||UG/M2/H|NOT DONE||N|Y|NA|2||58||BASELINE|1963-02-02||1972-12-23|||1972-06-08||1968-10-29
TRIAL STUDY 134XCP|RP|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|2||||||MENOAGE|MENOPAUSE AGE||||SEC|||1/(S*KPA)|NOT DONE||N|Y|U|2||58||RUN-IN|1963-04-24||1961-03-24|||1963-11-12||1965-10-06
TRIAL STUDY 134XCP|RP|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||L/S|||IU/ML|NOT DONE||N|U|NA|3||39||WASHOUT|1960-12-14||1970-09-16|||1966-07-23||1973-08-31
TRIAL STUDY 134XCP|RP|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||10^4 CFU|||POUCH|NOT DONE||N|NA|NA|3||39||LONG-TERM FOLLOW-UP|1973-02-12||1965-08-14|||1967-10-25||1970-05-01
TRIAL STUDY 134XCP|RP|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||IU/MMOL|||IU/ML|NOT DONE||U|U|U|4||88||RUN-IN|1968-04-18||1960-08-24|||1962-06-07||1973-01-22
TRIAL STUDY 134XCP|RP|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||UCI/KG|||10^9 ORGANISMS/ML|NOT DONE||N|N|NA|4||88||CONTINUATION TREATMENT|1960-10-19||1967-10-29|||1965-12-06||1967-05-04
TRIAL STUDY 134XCP|RP|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|1||||||DSCHGIND|DISCHARGE INDICATOR||||10^3 ORGANISMS|||NSEC|NOT DONE||N|N|Y|5||7||CONTINUATION TREATMENT|1964-11-18||1966-07-28|||1972-04-24||1966-05-01
TRIAL STUDY 134XCP|RP|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|2||||||DLVRMODE|MODE OF DELIVERY||||G|||MONTHS|NOT DONE||N|Y|Y|5||7||BLINDED TREATMENT|1966-02-19||1968-08-10|||1964-07-03||1960-02-19
TRIAL STUDY 134XCP|RP|E31F3DEB-BCA2-4660-935D-BAEBC4238866|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||LOG10 TCID 50/UL|||USP U|NOT DONE||NA|N|U|1||38||BLINDED TREATMENT|1966-02-28||1965-07-22|||1969-09-16||1965-11-10
TRIAL STUDY 134XCP|RP|E31F3DEB-BCA2-4660-935D-BAEBC4238866|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||KS|||GENEQ|NOT DONE||Y|NA|NA|1||38||FOLLOW-UP|1966-11-30||1965-01-08|||1962-05-09||1972-11-21
TRIAL STUDY 134XCP|RP|E31F3DEB-BCA2-4660-935D-BAEBC4238866|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^6 U|||KM|NOT DONE||Y|NA|Y|2||58||OPEN LABEL TREATMENT|1961-08-09||1962-01-19|||1966-08-18||1972-12-10
TRIAL STUDY 134XCP|RP|E31F3DEB-BCA2-4660-935D-BAEBC4238866|2||||||THICK|THICKNESS||||U/G/MIN|||ML/MIN/MMHG|NOT DONE||N|N|U|2||58||FOLLOW-UP|1962-04-17||1967-09-30|||1972-08-16||1969-03-26
TRIAL STUDY 134XCP|RP|E31F3DEB-BCA2-4660-935D-BAEBC4238866|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||RAD|||KBQ|NOT DONE||NA|NA|Y|3||39||TREATMENT|1960-07-24||1969-06-13|||1963-05-19||1972-08-10
TRIAL STUDY 134XCP|RP|E31F3DEB-BCA2-4660-935D-BAEBC4238866|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||U/L|||PPB|NOT DONE||N|N|N|3||39||BASELINE|1967-06-04||1971-04-25|||1965-02-05||1970-09-30
TRIAL STUDY 134XCP|RP|E31F3DEB-BCA2-4660-935D-BAEBC4238866|1||||||PUSTIND|PUSTULE INDICATOR||||LX|||DAGU/ML|NOT DONE||N|U|N|4||88||OBSERVATION|1972-05-17||1968-06-17|||1968-01-01||1962-07-17
TRIAL STUDY 134XCP|RP|E31F3DEB-BCA2-4660-935D-BAEBC4238866|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||CD/M2|||ML/CAGE|NOT DONE||NA|NA|NA|4||88||FOLLOW-UP|1962-02-16||1964-09-18|||1967-09-02||1968-08-29
TRIAL STUDY 134XCP|RP|E31F3DEB-BCA2-4660-935D-BAEBC4238866|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||BEATS/MIN|||MG/CM2|NOT DONE||Y|N|N|5||7||INDUCTION TREATMENT|1970-02-20||1971-08-03|||1970-10-09||1963-03-03
TRIAL STUDY 134XCP|RP|E31F3DEB-BCA2-4660-935D-BAEBC4238866|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||PPTR|||SPRAY|NOT DONE||Y|NA|Y|5||7||FOLLOW-UP|1969-03-21||1965-10-22|||1968-07-04||1972-02-25
TRIAL STUDY 134XCP|RP|8310989D-82CC-456C-965A-E38AC9EA073F|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||SACHET|||/2500 WBC|NOT DONE||N|U|NA|1||38||LONG-TERM FOLLOW-UP|1968-06-25||1966-06-30|||1961-01-17||1970-07-30
TRIAL STUDY 134XCP|RP|8310989D-82CC-456C-965A-E38AC9EA073F|2||||||BRTHN|NUMBER OF BIRTHS||||BQ/ML|||/DAY|NOT DONE||Y|Y|Y|1||38||LONG-TERM FOLLOW-UP|1972-02-09||1972-05-06|||1965-10-18||1967-10-07
TRIAL STUDY 134XCP|RP|8310989D-82CC-456C-965A-E38AC9EA073F|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||DYN|||LINEAR FT*LB|NOT DONE||Y|Y|U|2||58||OPEN LABEL TREATMENT|1972-04-23||1971-05-17|||1960-06-16||1971-04-28
TRIAL STUDY 134XCP|RP|8310989D-82CC-456C-965A-E38AC9EA073F|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||PKAT|||MMOL/DAY|NOT DONE||NA|NA|NA|2||58||OPEN LABEL TREATMENT|1965-08-05||1960-03-30|||1970-07-24||1969-12-22
TRIAL STUDY 134XCP|RP|8310989D-82CC-456C-965A-E38AC9EA073F|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^6 U|||MG/DAY|NOT DONE||U|N|NA|3||39||SCREENING|1971-11-05||1973-07-24|||1970-12-05||1972-04-16
TRIAL STUDY 134XCP|RP|8310989D-82CC-456C-965A-E38AC9EA073F|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||AGU/ML|||ENZYME U/M2|NOT DONE||U|Y|U|3||39||TREATMENT|1965-07-08||1960-05-10|||1968-05-05||1970-02-06
TRIAL STUDY 134XCP|RP|8310989D-82CC-456C-965A-E38AC9EA073F|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||10^6 IU|||MEQ/MMOL|NOT DONE||N|Y|Y|4||88||BASELINE|1963-09-03||1962-04-30|||1970-06-07||1964-05-11
TRIAL STUDY 134XCP|RP|8310989D-82CC-456C-965A-E38AC9EA073F|2||||||INABOIND|INDUCED ABORTION INDICATOR||||FT2|||10^9 CFU/G|NOT DONE||Y|N|N|4||88||TREATMENT|1966-05-26||1968-04-01|||1963-06-21||1968-06-23
TRIAL STUDY 134XCP|RP|8310989D-82CC-456C-965A-E38AC9EA073F|1||||||MENARAGE|MENARCHE AGE||||CMOL|||/2000 RBC|NOT DONE||Y|NA|N|5||7||SCREENING|1961-06-23||1967-09-11|||1973-01-24||1968-02-09
TRIAL STUDY 134XCP|RP|8310989D-82CC-456C-965A-E38AC9EA073F|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ML/CM|||10^3 RNA COPIES/ML|NOT DONE||Y|NA|N|5||7||OPEN LABEL TREATMENT|1965-01-17||1966-08-03|||1963-06-07||1967-03-10
TRIAL STUDY 134XCP|RP|826D8DC2-E407-481C-93D8-5169DBDF99C4|1||||||STILBIND|STILLBIRTH INDICATOR||||CAL|||MOL/G|NOT DONE||NA|NA|NA|1||38||LONG-TERM FOLLOW-UP|1973-07-29||1969-02-11|||1968-08-21||1970-07-21
TRIAL STUDY 134XCP|RP|826D8DC2-E407-481C-93D8-5169DBDF99C4|2||||||ABORTN|NUMBER OF ABORTIONS||||PIPE|||BQ/G|NOT DONE||N|Y|U|1||38||INDUCTION TREATMENT|1960-12-22||1971-03-01|||1964-10-02||1969-03-13
TRIAL STUDY 134XCP|RP|826D8DC2-E407-481C-93D8-5169DBDF99C4|1||||||BLISTIND|BLISTERING INDICATOR||||L/L|||VP/ML|NOT DONE||NA|U|Y|2||58||INDUCTION TREATMENT|1971-06-01||1972-05-30|||1963-09-21||1960-09-01
TRIAL STUDY 134XCP|RP|826D8DC2-E407-481C-93D8-5169DBDF99C4|2||||||MENARAGE|MENARCHE AGE||||UM2|||ABSORBANCE U/MIN|NOT DONE||NA|Y|NA|2||58||TREATMENT|1969-11-28||1961-09-11|||1967-12-09||1971-04-21
TRIAL STUDY 134XCP|RP|826D8DC2-E407-481C-93D8-5169DBDF99C4|1||||||STILBIND|STILLBIRTH INDICATOR||||MG/M2|||G/CAGE|NOT DONE||U|NA|U|3||39||TREATMENT|1968-07-18||1963-04-14|||1961-11-06||1968-01-11
TRIAL STUDY 134XCP|RP|826D8DC2-E407-481C-93D8-5169DBDF99C4|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UU/L|||BQ/G|NOT DONE||Y|N|U|3||39||OBSERVATION|1963-07-27||1961-03-19|||1965-09-24||1960-05-09
TRIAL STUDY 134XCP|RP|826D8DC2-E407-481C-93D8-5169DBDF99C4|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||UG/G/MIN|||FARAD|NOT DONE||Y|N|N|4||88||FOLLOW-UP|1969-08-10||1962-04-27|||1960-04-23||1960-03-14
TRIAL STUDY 134XCP|RP|826D8DC2-E407-481C-93D8-5169DBDF99C4|2||||||PRGENDTC|DATE PREGNANCY ENDED||||ARBITRARY U|||CONTAINER|NOT DONE||NA|U|NA|4||88||OBSERVATION|1967-03-03||1964-08-29|||1961-05-08||1969-06-28
TRIAL STUDY 134XCP|RP|826D8DC2-E407-481C-93D8-5169DBDF99C4|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||BAU/ML|||V/SEC|NOT DONE||N|NA|Y|5||7||INDUCTION TREATMENT|1963-05-29||1965-10-19|||1960-02-10||1971-02-24
TRIAL STUDY 134XCP|RP|826D8DC2-E407-481C-93D8-5169DBDF99C4|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MOSM/L|||KEV|NOT DONE||NA|Y|Y|5||7||FOLLOW-UP|1966-08-09||1970-09-28|||1969-07-07||1962-02-09
TRIAL STUDY 134XCP|RP|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||DYN|||ENZYME U/G HB|NOT DONE||U|Y|N|1||38||WASHOUT|1960-02-19||1971-07-05|||1971-12-25||1970-02-25
TRIAL STUDY 134XCP|RP|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|2||||||PUSTIND|PUSTULE INDICATOR||||LM|||UU/DL|NOT DONE||N|N|U|1||38||BASELINE|1965-12-13||1961-02-06|||1969-11-15||1965-08-14
TRIAL STUDY 134XCP|RP|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MPL U|||OZ EQ|NOT DONE||N|U|Y|2||58||BASELINE|1973-07-25||1960-11-26|||1972-10-07||1969-11-26
TRIAL STUDY 134XCP|RP|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|2||||||STILBIND|STILLBIRTH INDICATOR||||GMFI|||MEQ/G|NOT DONE||U|N|Y|2||58||OBSERVATION|1968-12-27||1970-07-16|||1971-07-01||1966-06-06
TRIAL STUDY 134XCP|RP|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||UMOL/H/MMOL|||V|NOT DONE||NA|N|NA|3||39||TREATMENT|1960-03-05||1972-03-14|||1968-06-25||1967-10-07
TRIAL STUDY 134XCP|RP|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|2||||||PREGST|PREGNANT DURING THE STUDY||||MM2|||MG/DAY|NOT DONE||Y|NA|U|3||39||OBSERVATION|1966-08-26||1960-08-22|||1972-03-11||1970-07-15
TRIAL STUDY 134XCP|RP|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|1||||||PEELIND|PEELING INDICATOR||||MG/L FEU|||MM2|NOT DONE||NA|N|U|4||88||WASHOUT|1961-01-05||1968-09-05|||1969-04-23||1966-12-01
TRIAL STUDY 134XCP|RP|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||KCAL/DAY|||TBSP|NOT DONE||NA|NA|NA|4||88||TREATMENT|1961-10-23||1969-02-16|||1969-04-09||1961-11-07
TRIAL STUDY 134XCP|RP|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MOL/MG|||ECL UNIT|NOT DONE||N|Y|Y|5||7||SCREENING|1965-08-11||1963-01-26|||1965-03-19||1965-12-14
TRIAL STUDY 134XCP|RP|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MEQ/DAY|||10^6 ORGANISMS/G|NOT DONE||U|Y|Y|5||7||LONG-TERM FOLLOW-UP|1967-08-29||1964-06-03|||1965-09-27||1973-04-12
TRIAL STUDY 134XCP|RP|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|1||||||INABOIND|INDUCED ABORTION INDICATOR||||CAPLET|||HOMEOPATHIC DILUTION|NOT DONE||N|N|NA|1||38||INDUCTION TREATMENT|1973-06-22||1962-05-17|||1972-01-08||1964-06-04
TRIAL STUDY 134XCP|RP|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|2||||||BRTHN|NUMBER OF BIRTHS||||G/ANIMAL|||GBQ/MG|NOT DONE||U|Y|U|1||38||FOLLOW-UP|1970-03-18||1963-01-09|||1971-01-20||1968-08-28
TRIAL STUDY 134XCP|RP|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|1||||||INABOIND|INDUCED ABORTION INDICATOR||||GY|||10^9/L|NOT DONE||Y|NA|NA|2||58||BASELINE|1963-09-15||1963-09-05|||1961-07-13||1965-05-19
TRIAL STUDY 134XCP|RP|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MOL/ML|||LENS|NOT DONE||U|N|N|2||58||SCREENING|1962-03-06||1968-11-04|||1973-04-20||1963-06-08
TRIAL STUDY 134XCP|RP|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||CM H2O|||UV2|NOT DONE||U|U|NA|3||39||BLINDED TREATMENT|1965-08-20||1961-09-16|||1962-08-31||1960-05-04
TRIAL STUDY 134XCP|RP|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||BOLUS|||F|NOT DONE||Y|NA|NA|3||39||BLINDED TREATMENT|1964-10-03||1961-04-14|||1965-04-07||1966-04-05
TRIAL STUDY 134XCP|RP|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|1||||||EDEMAIND|EDEMA INDICATOR||||PFU/DOSE|||MMOL2/L2|NOT DONE||N|Y|NA|4||88||TREATMENT|1964-09-17||1961-09-07|||1969-10-25||1972-06-28
TRIAL STUDY 134XCP|RP|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|2||||||PREGIND|PREGNANT INDICATOR||||U/DL|||FEU|NOT DONE||Y|NA|U|4||88||LONG-TERM FOLLOW-UP|1966-01-13||1969-02-12|||1972-02-18||1964-02-15
TRIAL STUDY 134XCP|RP|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MAC50|||MMAL|NOT DONE||U|Y|N|5||7||CONTINUATION TREATMENT|1968-02-16||1967-03-21|||1963-01-26||1960-12-05
TRIAL STUDY 134XCP|RP|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/CM2|||MJOULE/CM2|NOT DONE||N|N|U|5||7||TREATMENT|1965-04-02||1972-05-23|||1963-08-22||1964-02-05
TRIAL STUDY 134XCP|RP|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|1||||||PREGST|PREGNANT DURING THE STUDY||||SBE/ML|||ML/DOSE|NOT DONE||U|N|NA|1||38||TREATMENT|1968-05-23||1961-12-18|||1971-07-26||1967-11-23
TRIAL STUDY 134XCP|RP|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|2||||||ABORTN|NUMBER OF ABORTIONS||||MOL/G|||IU/G|NOT DONE||U|Y|N|1||38||LONG-TERM FOLLOW-UP|1960-06-03||1973-05-20|||1967-03-04||1961-07-18
TRIAL STUDY 134XCP|RP|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||PELLET|||BEL|NOT DONE||Y|U|Y|2||58||RUN-IN|1964-09-23||1968-08-03|||1961-12-23||1973-08-28
TRIAL STUDY 134XCP|RP|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|2||||||PRGENDTC|DATE PREGNANCY ENDED||||10^7 PFU|||PPM|NOT DONE||Y|Y|Y|2||58||FOLLOW-UP|1961-01-27||1966-06-07|||1967-01-27||1963-08-26
TRIAL STUDY 134XCP|RP|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|1||||||PEELIND|PEELING INDICATOR||||TRANSDUCING UNIT/ML|||MG/ML/MIN|NOT DONE||Y|U|N|3||39||LONG-TERM FOLLOW-UP|1967-03-02||1968-01-21|||1969-01-07||1969-01-06
TRIAL STUDY 134XCP|RP|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UG/L|||K|NOT DONE||Y|N|Y|3||39||FOLLOW-UP|1962-08-12||1963-04-24|||1962-11-10||1970-09-19
TRIAL STUDY 134XCP|RP|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|1||||||PEELIND|PEELING INDICATOR||||WEEKS|||ML/MIN/1.73M2|NOT DONE||U|U|NA|4||88||SCREENING|1964-02-10||1962-09-01|||1962-09-17||1963-04-19
TRIAL STUDY 134XCP|RP|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||U/G/DAY|||LX|NOT DONE||N|N|N|4||88||INDUCTION TREATMENT|1962-07-09||1972-12-09|||1973-07-19||1961-03-28
TRIAL STUDY 134XCP|RP|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|1||||||FUNDHT|FUNDAL HEIGHT||||HZ/S|||HOUNSFIELD UNIT|NOT DONE||NA|Y|U|5||7||CONTINUATION TREATMENT|1964-08-18||1971-06-14|||1973-06-02||1971-09-28
TRIAL STUDY 134XCP|RP|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||U/DL|||RFU|NOT DONE||NA|NA|N|5||7||TREATMENT|1964-09-24||1962-05-20|||1961-02-16||1972-10-14
TRIAL STUDY 134XCP|RP|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|1||||||FUNDHT|FUNDAL HEIGHT||||PKAT/L|||KPA|NOT DONE||Y|NA|NA|1||38||OPEN LABEL TREATMENT|1965-02-17||1970-07-11|||1969-04-06||1961-06-03
TRIAL STUDY 134XCP|RP|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|2||||||PREGIND|PREGNANT INDICATOR||||UMOL/DAY|||DYN|NOT DONE||Y|NA|U|1||38||WASHOUT|1967-09-23||1972-07-31|||1967-04-20||1964-03-03
TRIAL STUDY 134XCP|RP|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||CGY|||UMOL/DAY|NOT DONE||NA|N|N|2||58||RUN-IN|1964-03-13||1963-10-14|||1960-11-24||1968-06-25
TRIAL STUDY 134XCP|RP|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UIU/DL|||CM H2O|NOT DONE||Y|N|N|2||58||RUN-IN|1972-03-31||1973-07-15|||1963-06-01||1967-06-15
TRIAL STUDY 134XCP|RP|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||PPM|||L/H|NOT DONE||N|NA|Y|3||39||BASELINE|1964-10-30||1963-07-11|||1969-03-27||1962-11-12
TRIAL STUDY 134XCP|RP|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||GENEQ|||U/ML|NOT DONE||U|N|NA|3||39||SCREENING|1965-07-15||1965-03-28|||1969-10-23||1965-01-28
TRIAL STUDY 134XCP|RP|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^3 ORGANISMS/ML|||QUANTITY SUFFICIENT|NOT DONE||N|U|U|4||88||BLINDED TREATMENT|1963-03-06||1973-01-01|||1963-10-17||1964-05-23
TRIAL STUDY 134XCP|RP|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||%(W/V)|||UG/M2/DAY|NOT DONE||Y|N|NA|4||88||SCREENING|1960-09-02||1962-03-11|||1969-01-02||1966-12-12
TRIAL STUDY 134XCP|RP|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||ML/G/MIN|||TSP EQ|NOT DONE||Y|N|N|5||7||CONTINUATION TREATMENT|1966-12-10||1972-07-04|||1965-05-31||1963-07-23
TRIAL STUDY 134XCP|RP|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||CUP EQ|||NGEQ/L|NOT DONE||U|N|Y|5||7||OBSERVATION|1972-07-22||1971-06-14|||1965-09-11||1970-06-16
TRIAL STUDY 134XCP|RP|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||AG|||/7.5 ML|NOT DONE||Y|U|U|1||38||INDUCTION TREATMENT|1964-02-09||1970-09-21|||1971-12-08||1968-01-17
TRIAL STUDY 134XCP|RP|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|2||||||MENOSTAT|MENOPAUSE STATUS||||G/U|||DPM/0.5 ML|NOT DONE||Y|NA|Y|1||38||LONG-TERM FOLLOW-UP|1962-01-06||1967-08-24|||1964-04-07||1971-05-14
TRIAL STUDY 134XCP|RP|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|1||||||PEELIND|PEELING INDICATOR||||ECL UNIT|||10^9 ORGANISMS|NOT DONE||Y|NA|Y|2||58||BLINDED TREATMENT|1965-07-12||1966-07-28|||1971-07-28||1966-09-27
TRIAL STUDY 134XCP|RP|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||POINT|||DB|NOT DONE||N|N|Y|2||58||OPEN LABEL TREATMENT|1967-09-18||1964-08-13|||1965-01-03||1970-05-05
TRIAL STUDY 134XCP|RP|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|1||||||DLVRMODE|MODE OF DELIVERY||||100 IU/ML|||PATCH|NOT DONE||NA|U|Y|3||39||OBSERVATION|1961-10-17||1965-05-25|||1966-04-08||1970-06-02
TRIAL STUDY 134XCP|RP|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|2||||||MASSIND|MASS INDICATOR||||MG/ML/MIN|||/MIN|NOT DONE||U|NA|Y|3||39||FOLLOW-UP|1962-01-31||1961-08-22|||1961-05-29||1960-02-19
TRIAL STUDY 134XCP|RP|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MIN*MG/ML|||NEWTON|NOT DONE||Y|Y|U|4||88||BASELINE|1961-11-19||1972-02-12|||1965-02-01||1960-12-23
TRIAL STUDY 134XCP|RP|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||U/M2/MIN|||MMU/ML|NOT DONE||N|Y|NA|4||88||OBSERVATION|1961-12-28||1966-09-20|||1970-07-13||1970-11-13
TRIAL STUDY 134XCP|RP|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|1||||||ERYTHIND|ERYTHEMA INDICATOR||||SIEMENS|||10^9 ORGANISMS|NOT DONE||NA|N|U|5||7||BLINDED TREATMENT|1971-03-20||1960-05-17|||1971-03-24||1969-08-24
TRIAL STUDY 134XCP|RP|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|2||||||PREGIND|PREGNANT INDICATOR||||GBQ/MG|||APPLICATION|NOT DONE||NA|Y|NA|5||7||FOLLOW-UP|1960-08-08||1969-04-12|||1969-04-15||1963-10-19
TRIAL STUDY 134XCP|RP|B396F12E-7BF5-47CC-AFD1-1B679066B106|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||NFIU|||ML/BREATH|NOT DONE||N|Y|NA|1||38||RUN-IN|1962-12-22||1961-05-02|||1962-07-22||1965-10-31
TRIAL STUDY 134XCP|RP|B396F12E-7BF5-47CC-AFD1-1B679066B106|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||APPLICATION|||/DAY|NOT DONE||Y|Y|N|1||38||WASHOUT|1973-07-16||1962-02-25|||1971-06-14||1963-09-14
TRIAL STUDY 134XCP|RP|B396F12E-7BF5-47CC-AFD1-1B679066B106|1||||||RASHIND|RASH INDICATOR||||PFU|||10^9 ORGANISMS|NOT DONE||NA|NA|NA|2||58||BLINDED TREATMENT|1968-10-28||1973-01-28|||1970-09-26||1971-05-28
TRIAL STUDY 134XCP|RP|B396F12E-7BF5-47CC-AFD1-1B679066B106|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||U/CL|||/10^4|NOT DONE||U|Y|NA|2||58||OBSERVATION|1963-04-13||1973-01-03|||1972-06-04||1970-11-10
TRIAL STUDY 134XCP|RP|B396F12E-7BF5-47CC-AFD1-1B679066B106|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MG/KG/DAY|||PFU/DOSE|NOT DONE||NA|NA|Y|3||39||FOLLOW-UP|1960-04-26||1971-01-25|||1963-11-06||1960-03-27
TRIAL STUDY 134XCP|RP|B396F12E-7BF5-47CC-AFD1-1B679066B106|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||CYCLE/MIN|||MEQ/ML|NOT DONE||NA|U|NA|3||39||SCREENING|1965-10-01||1970-05-17|||1970-07-14||1970-03-23
TRIAL STUDY 134XCP|RP|B396F12E-7BF5-47CC-AFD1-1B679066B106|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||PMOL|||EID 50/ML|NOT DONE||N|U|U|4||88||TREATMENT|1963-10-05||1962-12-15|||1965-09-27||1961-05-13
TRIAL STUDY 134XCP|RP|B396F12E-7BF5-47CC-AFD1-1B679066B106|2||||||THICK|THICKNESS||||MU/L|||PSI|NOT DONE||Y|U|Y|4||88||SCREENING|1972-12-30||1967-02-10|||1973-05-11||1967-02-01
TRIAL STUDY 134XCP|RP|B396F12E-7BF5-47CC-AFD1-1B679066B106|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||ML/DAY|||10^9 CFU/ML|NOT DONE||N|U|NA|5||7||BASELINE|1968-06-18||1972-05-07|||1961-08-18||1968-06-25
TRIAL STUDY 134XCP|RP|B396F12E-7BF5-47CC-AFD1-1B679066B106|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||DAGU|||10^12/L|NOT DONE||N|N|NA|5||7||BASELINE|1968-12-21||1973-06-09|||1968-01-28||1966-10-02
TRIAL STUDY 134XCP|RP|2936B26A-9A8D-4C28-90A7-6131837F255F|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||ML/100G/MIN|||MG/L|NOT DONE||NA|NA|Y|1||38||INDUCTION TREATMENT|1966-11-10||1969-10-05|||1968-11-08||1962-10-07
TRIAL STUDY 134XCP|RP|2936B26A-9A8D-4C28-90A7-6131837F255F|2||||||MASSIND|MASS INDICATOR||||10^12/L|||MM/MIN|NOT DONE||Y|NA|Y|1||38||SCREENING|1960-10-26||1967-04-18|||1971-02-22||1971-01-01
TRIAL STUDY 134XCP|RP|2936B26A-9A8D-4C28-90A7-6131837F255F|1||||||MENOAGE|MENOPAUSE AGE||||MEQ/MMOL|||PT_BR|NOT DONE||N|N|NA|2||58||WASHOUT|1968-05-24||1970-03-07|||1966-07-29||1964-06-17
TRIAL STUDY 134XCP|RP|2936B26A-9A8D-4C28-90A7-6131837F255F|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||NKAT/G HB|||UG/CM2|NOT DONE||U|NA|U|2||58||RUN-IN|1964-09-09||1964-02-07|||1971-06-11||1963-05-31
TRIAL STUDY 134XCP|RP|2936B26A-9A8D-4C28-90A7-6131837F255F|1||||||ULCERIND|ULCER INDICATOR||||KG/CM|||DNA COPIES/ML|NOT DONE||N|N|U|3||39||INDUCTION TREATMENT|1970-05-25||1967-07-27|||1964-11-09||1971-07-25
TRIAL STUDY 134XCP|RP|2936B26A-9A8D-4C28-90A7-6131837F255F|2||||||BRTHN|NUMBER OF BIRTHS||||BOTTLE|||ENZYME U/M2|NOT DONE||N|Y|Y|3||39||OPEN LABEL TREATMENT|1960-07-04||1970-12-28|||1970-05-25||1969-03-03
TRIAL STUDY 134XCP|RP|2936B26A-9A8D-4C28-90A7-6131837F255F|1||||||PUSTIND|PUSTULE INDICATOR||||UIU/L|||NMOL/L/MIN|NOT DONE||N|U|Y|4||88||INDUCTION TREATMENT|1967-04-22||1961-04-30|||1963-04-23||1962-05-24
TRIAL STUDY 134XCP|RP|2936B26A-9A8D-4C28-90A7-6131837F255F|2||||||BLISTIND|BLISTERING INDICATOR||||ELISA UNIT/DOSE|||G/ANIMAL|NOT DONE||Y|N|NA|4||88||WASHOUT|1970-06-16||1962-10-21|||1971-05-07||1968-03-10
TRIAL STUDY 134XCP|RP|2936B26A-9A8D-4C28-90A7-6131837F255F|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||NMOL BCE/MMOL|||CI/KG|NOT DONE||Y|N|NA|5||7||LONG-TERM FOLLOW-UP|1961-07-27||1973-08-08|||1970-11-28||1968-11-11
TRIAL STUDY 134XCP|RP|2936B26A-9A8D-4C28-90A7-6131837F255F|2||||||TNDRIND|TENDERNESS INDICATOR||||MBP|||UEQ|NOT DONE||U|Y|U|5||7||LONG-TERM FOLLOW-UP|1970-06-03||1961-09-03|||1969-10-16||1965-07-16
TRIAL STUDY 134XCP|RP|901A91DC-9EF3-4A20-A35D-9C426A5C640B|1||||||MENOAGE|MENOPAUSE AGE||||/MM|||GPL U/ML|NOT DONE||N|N|U|1||38||CONTINUATION TREATMENT|1964-05-11||1965-08-29|||1968-08-20||1964-09-01
TRIAL STUDY 134XCP|RP|901A91DC-9EF3-4A20-A35D-9C426A5C640B|2||||||PEELIND|PEELING INDICATOR||||GBQ|||PIPE|NOT DONE||Y|NA|Y|1||38||INDUCTION TREATMENT|1967-02-27||1969-04-11|||1963-09-07||1969-06-12
TRIAL STUDY 134XCP|RP|901A91DC-9EF3-4A20-A35D-9C426A5C640B|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||VG/ML|||%/S|NOT DONE||Y|U|NA|2||58||SCREENING|1964-02-07||1969-04-20|||1963-09-28||1960-03-03
TRIAL STUDY 134XCP|RP|901A91DC-9EF3-4A20-A35D-9C426A5C640B|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||PMOL/L/H|||MM/2H|NOT DONE||N|NA|Y|2||58||BASELINE|1964-05-27||1964-08-09|||1966-12-11||1962-06-02
TRIAL STUDY 134XCP|RP|901A91DC-9EF3-4A20-A35D-9C426A5C640B|1||||||ULCERIND|ULCER INDICATOR||||ML/100G/MIN|||CMHG|NOT DONE||U|N|N|3||39||TREATMENT|1966-12-10||1964-01-06|||1960-01-08||1969-09-04
TRIAL STUDY 134XCP|RP|901A91DC-9EF3-4A20-A35D-9C426A5C640B|2||||||TNDRIND|TENDERNESS INDICATOR||||ML/CM H2O|||GPL U|NOT DONE||NA|N|NA|3||39||BLINDED TREATMENT|1964-11-09||1971-11-03|||1964-01-24||1966-11-16
TRIAL STUDY 134XCP|RP|901A91DC-9EF3-4A20-A35D-9C426A5C640B|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ML/CAGE|||ML/DAY|NOT DONE||N|N|NA|4||88||SCREENING|1961-06-23||1968-08-05|||1964-02-27||1961-05-26
TRIAL STUDY 134XCP|RP|901A91DC-9EF3-4A20-A35D-9C426A5C640B|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||U/KG/MIN|||TITER|NOT DONE||N|Y|Y|4||88||OPEN LABEL TREATMENT|1964-09-27||1972-01-07|||1969-10-19||1965-10-10
TRIAL STUDY 134XCP|RP|901A91DC-9EF3-4A20-A35D-9C426A5C640B|1||||||PREGNN|NUMBER OF PREGNANCIES||||MEQ/MMOL|||ML/MMHG|NOT DONE||Y|Y|N|5||7||WASHOUT|1971-08-24||1963-04-22|||1964-04-12||1967-02-04
TRIAL STUDY 134XCP|RP|901A91DC-9EF3-4A20-A35D-9C426A5C640B|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||NMOL/ML/MIN|||IU/G HB|NOT DONE||U|N|U|5||7||BLINDED TREATMENT|1971-05-11||1973-01-04|||1967-09-29||1968-06-24
TRIAL STUDY 134XCP|RP|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UIU/L|||%/S|NOT DONE||NA|Y|N|1||38||INDUCTION TREATMENT|1967-01-26||1964-09-26|||1972-10-07||1973-01-03
TRIAL STUDY 134XCP|RP|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||PKAT|||MGEQ|NOT DONE||NA|NA|Y|1||38||TREATMENT|1968-10-04||1969-07-20|||1965-11-01||1970-11-29
TRIAL STUDY 134XCP|RP|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||GPS U|||ML/KG/H|NOT DONE||U|U|NA|2||58||OBSERVATION|1971-12-20||1962-02-20|||1963-11-04||1973-08-10
TRIAL STUDY 134XCP|RP|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|2||||||MENOSTAT|MENOPAUSE STATUS||||UG/G/DAY|||MMOL/KG|NOT DONE||Y|NA|N|2||58||RUN-IN|1961-12-01||1964-06-07|||1963-10-01||1963-01-16
TRIAL STUDY 134XCP|RP|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||L/KG|||/MM2|NOT DONE||U|NA|Y|3||39||CONTINUATION TREATMENT|1970-09-30||1964-12-12|||1968-03-06||1964-09-03
TRIAL STUDY 134XCP|RP|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|2||||||EDEMAIND|EDEMA INDICATOR||||TRANSDUCING UNIT|||OZ|NOT DONE||NA|U|U|3||39||CONTINUATION TREATMENT|1970-11-14||1970-03-24|||1966-08-28||1960-05-21
TRIAL STUDY 134XCP|RP|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UG/MOL|||G/M2/DAY|NOT DONE||N|N|N|4||88||BASELINE|1963-11-12||1964-08-14|||1963-04-08||1962-03-04
TRIAL STUDY 134XCP|RP|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|2||||||ERYTHIND|ERYTHEMA INDICATOR||||PG|||MMOL/KG|NOT DONE||Y|NA|NA|4||88||BASELINE|1961-08-25||1972-04-11|||1967-12-01||1972-11-29
TRIAL STUDY 134XCP|RP|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||TABLET|||MPS U|NOT DONE||U|Y|U|5||7||RUN-IN|1968-07-06||1973-09-03|||1969-03-06||1969-12-07
TRIAL STUDY 134XCP|RP|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|2||||||BLISTIND|BLISTERING INDICATOR||||/10^3|||TAMPON|NOT DONE||N|U|U|5||7||OPEN LABEL TREATMENT|1968-05-17||1961-02-18|||1960-03-01||1967-05-25
TRIAL STUDY 134XCP|RP|5A7F2C89-5398-4119-8EA0-B432FF8942A4|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^6 IU|||DDU|NOT DONE||N|Y|Y|1||38||WASHOUT|1969-12-02||1973-06-26|||1969-07-09||1971-11-04
TRIAL STUDY 134XCP|RP|5A7F2C89-5398-4119-8EA0-B432FF8942A4|2||||||THICK|THICKNESS||||UEQ|||UMOL/MG/MIN|NOT DONE||N|NA|U|1||38||FOLLOW-UP|1960-10-23||1971-04-08|||1965-11-10||1967-07-29
TRIAL STUDY 134XCP|RP|5A7F2C89-5398-4119-8EA0-B432FF8942A4|1||||||PREGNN|NUMBER OF PREGNANCIES||||UG/ANIMAL|||UCI|NOT DONE||Y|U|NA|2||58||WASHOUT|1969-07-11||1971-12-07|||1965-11-06||1961-10-04
TRIAL STUDY 134XCP|RP|5A7F2C89-5398-4119-8EA0-B432FF8942A4|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||/10^5|||UG|NOT DONE||U|N|N|2||58||FOLLOW-UP|1966-07-30||1971-01-31|||1971-04-08||1965-02-01
TRIAL STUDY 134XCP|RP|5A7F2C89-5398-4119-8EA0-B432FF8942A4|1||||||MENOAGE|MENOPAUSE AGE||||AMP|||MMOL/MOL|NOT DONE||Y|N|Y|3||39||OPEN LABEL TREATMENT|1970-10-18||1972-12-15|||1967-11-27||1969-09-10
TRIAL STUDY 134XCP|RP|5A7F2C89-5398-4119-8EA0-B432FF8942A4|2||||||BRTHN|NUMBER OF BIRTHS||||RING|||STEPS/MIN|NOT DONE||NA|NA|Y|3||39||INDUCTION TREATMENT|1961-07-02||1961-02-08|||1971-09-22||1970-03-22
TRIAL STUDY 134XCP|RP|5A7F2C89-5398-4119-8EA0-B432FF8942A4|1||||||PRGENDTC|DATE PREGNANCY ENDED||||FRAMES/S|||GBQ/MG|NOT DONE||N|NA|U|4||88||SCREENING|1973-04-26||1970-07-10|||1965-03-26||1963-05-15
TRIAL STUDY 134XCP|RP|5A7F2C89-5398-4119-8EA0-B432FF8942A4|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||TCID 50/DOSE|||SPRAY|NOT DONE||N|Y|N|4||88||SCREENING|1960-03-11||1967-05-04|||1965-09-22||1971-05-24
TRIAL STUDY 134XCP|RP|5A7F2C89-5398-4119-8EA0-B432FF8942A4|1||||||PREGNN|NUMBER OF PREGNANCIES||||G/L|||UL/KG/DAY|NOT DONE||NA|U|Y|5||7||WASHOUT|1972-01-19||1962-05-20|||1967-04-01||1972-11-14
TRIAL STUDY 134XCP|RP|5A7F2C89-5398-4119-8EA0-B432FF8942A4|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||M3|||L/DAY|NOT DONE||N|Y|N|5||7||SCREENING|1960-09-29||1972-08-18|||1971-04-24||1964-08-26
TRIAL STUDY 134XCP|RP|898FB78B-63D1-4ECE-B6B8-34750E958D93|1||||||FUNDHT|FUNDAL HEIGHT||||POUCH|||ABSORBANCE U|NOT DONE||N|U|N|1||38||OPEN LABEL TREATMENT|1965-05-30||1966-11-19|||1965-01-19||1964-07-02
TRIAL STUDY 134XCP|RP|898FB78B-63D1-4ECE-B6B8-34750E958D93|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||V/V|||10^6 CFU/ML|NOT DONE||N|N|NA|1||38||WASHOUT|1960-09-29||1964-01-08|||1964-08-15||1970-09-28
TRIAL STUDY 134XCP|RP|898FB78B-63D1-4ECE-B6B8-34750E958D93|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ABSORBANCE U/MIN|||COPIES/UG|NOT DONE||NA|NA|U|2||58||WASHOUT|1973-06-27||1967-01-18|||1966-08-14||1962-08-13
TRIAL STUDY 134XCP|RP|898FB78B-63D1-4ECE-B6B8-34750E958D93|2||||||GRAVIND|GRAVIDA INDICATOR||||ENZYME U/M2|||UG/ANIMAL|NOT DONE||Y|N|NA|2||58||FOLLOW-UP|1970-10-13||1961-06-08|||1969-12-15||1966-01-06
TRIAL STUDY 134XCP|RP|898FB78B-63D1-4ECE-B6B8-34750E958D93|1||||||PRGENDTC|DATE PREGNANCY ENDED||||UG|||LENS|NOT DONE||NA|NA|NA|3||39||SCREENING|1970-12-08||1964-09-28|||1964-08-04||1968-03-29
TRIAL STUDY 134XCP|RP|898FB78B-63D1-4ECE-B6B8-34750E958D93|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||OHM|||U/DL|NOT DONE||U|Y|Y|3||39||LONG-TERM FOLLOW-UP|1970-05-17||1971-12-19|||1964-09-02||1966-06-13
TRIAL STUDY 134XCP|RP|898FB78B-63D1-4ECE-B6B8-34750E958D93|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||%(V/V)|||ML*CMH2O|NOT DONE||Y|U|N|4||88||CONTINUATION TREATMENT|1966-12-15||1969-09-06|||1962-09-12||1970-03-12
TRIAL STUDY 134XCP|RP|898FB78B-63D1-4ECE-B6B8-34750E958D93|2||||||ABORTN|NUMBER OF ABORTIONS||||CD*S/M2|||MM|NOT DONE||Y|U|NA|4||88||SCREENING|1968-10-30||1965-04-03|||1970-04-09||1962-03-21
TRIAL STUDY 134XCP|RP|898FB78B-63D1-4ECE-B6B8-34750E958D93|1||||||PRGENDTC|DATE PREGNANCY ENDED||||MM/MIN|||CYLINDER|NOT DONE||NA|U|N|5||7||RUN-IN|1961-01-03||1971-12-15|||1970-05-24||1967-11-19
TRIAL STUDY 134XCP|RP|898FB78B-63D1-4ECE-B6B8-34750E958D93|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MG/MIN|||PACKAGE|NOT DONE||Y|Y|U|5||7||OPEN LABEL TREATMENT|1960-11-25||1969-01-15|||1972-12-07||1967-10-04
TRIAL STUDY 134XCP|RP|AF1E7141-5390-4928-9F49-94E1C7464A63|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MV*MIN|||HZ|NOT DONE||U|N|NA|1||38||INDUCTION TREATMENT|1960-05-25||1962-10-27|||1963-07-06||1971-09-24
TRIAL STUDY 134XCP|RP|AF1E7141-5390-4928-9F49-94E1C7464A63|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ML/G/DAY|||LOG10 TCID 50/UL|NOT DONE||N|N|NA|1||38||SCREENING|1966-11-09||1963-08-16|||1961-05-04||1973-02-07
TRIAL STUDY 134XCP|RP|AF1E7141-5390-4928-9F49-94E1C7464A63|1||||||ABORTN|NUMBER OF ABORTIONS||||UKAT/10^12 RBC|||USP U|NOT DONE||Y|U|N|2||58||SCREENING|1966-11-07||1962-09-10|||1970-12-20||1967-03-09
TRIAL STUDY 134XCP|RP|AF1E7141-5390-4928-9F49-94E1C7464A63|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||ANTI-XA IU|||CMOL|NOT DONE||Y|Y|Y|2||58||FOLLOW-UP|1960-03-22||1971-11-11|||1965-01-23||1960-01-04
TRIAL STUDY 134XCP|RP|AF1E7141-5390-4928-9F49-94E1C7464A63|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UV|||MMHG|NOT DONE||U|U|N|3||39||LONG-TERM FOLLOW-UP|1969-07-13||1966-10-27|||1970-09-29||1960-03-23
TRIAL STUDY 134XCP|RP|AF1E7141-5390-4928-9F49-94E1C7464A63|2||||||MENOSTAT|MENOPAUSE STATUS||||MGEQ|||CAL|NOT DONE||Y|U|NA|3||39||WASHOUT|1961-12-02||1969-11-16|||1960-12-03||1968-02-24
TRIAL STUDY 134XCP|RP|AF1E7141-5390-4928-9F49-94E1C7464A63|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||BQ/G|||UGEQ|NOT DONE||NA|N|Y|4||88||CONTINUATION TREATMENT|1963-09-26||1960-06-09|||1965-09-21||1965-06-23
TRIAL STUDY 134XCP|RP|AF1E7141-5390-4928-9F49-94E1C7464A63|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||/MM2|||TUBE|NOT DONE||U|NA|NA|4||88||OPEN LABEL TREATMENT|1968-09-22||1969-01-27|||1963-12-13||1962-03-02
TRIAL STUDY 134XCP|RP|AF1E7141-5390-4928-9F49-94E1C7464A63|1||||||FUNDHT|FUNDAL HEIGHT||||MET|||BQ/MG|NOT DONE||U|U|U|5||7||INDUCTION TREATMENT|1966-07-29||1965-06-27|||1960-10-29||1970-01-15
TRIAL STUDY 134XCP|RP|AF1E7141-5390-4928-9F49-94E1C7464A63|2||||||FUNDHT|FUNDAL HEIGHT||||PFU/DOSE|||LOG10 ELISA UNIT|NOT DONE||NA|Y|Y|5||7||SCREENING|1966-07-10||1967-10-19|||1963-09-04||1972-07-18
TRIAL STUDY 134XCP|RP|2188CADE-EE6F-4F14-8049-5EDD72020185|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||LENS|||YEARS|NOT DONE||Y|NA|N|1||38||BASELINE|1964-11-08||1961-09-03|||1967-02-24||1968-07-20
TRIAL STUDY 134XCP|RP|2188CADE-EE6F-4F14-8049-5EDD72020185|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MU|||CI/UG|NOT DONE||N|Y|U|1||38||OPEN LABEL TREATMENT|1973-07-23||1973-05-04|||1965-04-08||1966-08-07
TRIAL STUDY 134XCP|RP|2188CADE-EE6F-4F14-8049-5EDD72020185|1||||||PEELIND|PEELING INDICATOR||||10^3 CFU/G|||INHALATION|NOT DONE||NA|U|Y|2||58||CONTINUATION TREATMENT|1966-11-15||1969-05-24|||1968-01-05||1970-04-16
TRIAL STUDY 134XCP|RP|2188CADE-EE6F-4F14-8049-5EDD72020185|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MM/2H|||STRIP|NOT DONE||U|N|U|2||58||INDUCTION TREATMENT|1962-01-07||1961-06-12|||1966-08-26||1970-05-16
TRIAL STUDY 134XCP|RP|2188CADE-EE6F-4F14-8049-5EDD72020185|1||||||MENOSTAT|MENOPAUSE STATUS||||DDU|||LOG10 CCID 50/DOSE|NOT DONE||NA|N|U|3||39||INDUCTION TREATMENT|1969-03-01||1972-04-29|||1969-12-16||1963-06-27
TRIAL STUDY 134XCP|RP|2188CADE-EE6F-4F14-8049-5EDD72020185|2||||||EDEMAIND|EDEMA INDICATOR||||/500 WBC|||MOSM/KG|NOT DONE||N|N|U|3||39||LONG-TERM FOLLOW-UP|1965-03-27||1962-07-21|||1973-06-16||1973-01-03
TRIAL STUDY 134XCP|RP|2188CADE-EE6F-4F14-8049-5EDD72020185|1||||||PEELIND|PEELING INDICATOR||||GRAIN|||AMPULE|NOT DONE||NA|U|NA|4||88||BASELINE|1963-09-29||1963-12-13|||1965-01-30||1963-08-08
TRIAL STUDY 134XCP|RP|2188CADE-EE6F-4F14-8049-5EDD72020185|2||||||MENARAGE|MENARCHE AGE||||10^6/L|||GENEQ|NOT DONE||NA|NA|NA|4||88||TREATMENT|1962-11-01||1968-03-25|||1963-03-26||1970-07-04
TRIAL STUDY 134XCP|RP|2188CADE-EE6F-4F14-8049-5EDD72020185|1||||||DSCHGIND|DISCHARGE INDICATOR||||CONTAINER|||/LSQN|NOT DONE||NA|N|Y|5||7||OPEN LABEL TREATMENT|1972-01-07||1964-05-06|||1969-06-22||1964-10-22
TRIAL STUDY 134XCP|RP|2188CADE-EE6F-4F14-8049-5EDD72020185|2||||||DLVRMODE|MODE OF DELIVERY||||ML/CAGE|||DPM/MG|NOT DONE||Y|U|Y|5||7||SCREENING|1964-04-13||1964-12-28|||1970-01-03||1961-03-31
TRIAL STUDY 134XCP|RP|DFF30783-4496-4134-8201-67C727683A7D|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||FG|||MG/M2/DAY|NOT DONE||Y|U|U|1||38||SCREENING|1966-04-05||1967-10-04|||1967-04-16||1969-09-04
TRIAL STUDY 134XCP|RP|DFF30783-4496-4134-8201-67C727683A7D|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||10^10/L|||JDF UNIT|NOT DONE||NA|NA|NA|1||38||BASELINE|1960-05-31||1971-04-05|||1973-02-06||1965-04-30
TRIAL STUDY 134XCP|RP|DFF30783-4496-4134-8201-67C727683A7D|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||/WK|||CD/M2|NOT DONE||NA|NA|Y|2||58||OPEN LABEL TREATMENT|1973-02-06||1970-05-25|||1972-06-22||1968-07-04
TRIAL STUDY 134XCP|RP|DFF30783-4496-4134-8201-67C727683A7D|2||||||BLISTIND|BLISTERING INDICATOR||||KG/CM2|||FIU|NOT DONE||N|Y|U|2||58||TREATMENT|1967-07-13||1963-01-09|||1964-06-04||1960-05-21
TRIAL STUDY 134XCP|RP|DFF30783-4496-4134-8201-67C727683A7D|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||/KG|||DYN|NOT DONE||U|NA|N|3||39||WASHOUT|1971-02-04||1963-12-11|||1967-08-18||1962-10-26
TRIAL STUDY 134XCP|RP|DFF30783-4496-4134-8201-67C727683A7D|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||CFU/G|||MILE|NOT DONE||U|U|U|3||39||INDUCTION TREATMENT|1969-08-22||1967-11-13|||1962-01-29||1966-11-23
TRIAL STUDY 134XCP|RP|DFF30783-4496-4134-8201-67C727683A7D|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||CFU/G|||COPIES/UL|NOT DONE||NA|U|N|4||88||SCREENING|1973-07-03||1960-05-18|||1973-06-07||1964-03-11
TRIAL STUDY 134XCP|RP|DFF30783-4496-4134-8201-67C727683A7D|2||||||INABOIND|INDUCED ABORTION INDICATOR||||FOZ_BR|||KBQ/UL|NOT DONE||Y|Y|U|4||88||TREATMENT|1963-12-16||1966-07-21|||1964-03-28||1966-03-25
TRIAL STUDY 134XCP|RP|DFF30783-4496-4134-8201-67C727683A7D|1||||||ABORTN|NUMBER OF ABORTIONS||||DIP|||UL/DOSE|NOT DONE||NA|Y|Y|5||7||CONTINUATION TREATMENT|1972-08-15||1970-04-03|||1965-01-23||1970-01-20
TRIAL STUDY 134XCP|RP|DFF30783-4496-4134-8201-67C727683A7D|2||||||DSCHGIND|DISCHARGE INDICATOR||||BOWL|||MN|NOT DONE||U|N|U|5||7||TREATMENT|1972-10-19||1969-03-02|||1963-09-22||1962-09-01
TRIAL STUDY 134XCP|RP|970170C0-8FF0-4D24-84E8-1195272D55C0|1||||||MENARAGE|MENARCHE AGE||||CM H2O|||CI/UL|NOT DONE||NA|NA|N|1||38||SCREENING|1968-08-11||1960-03-24|||1969-01-15||1965-08-18
TRIAL STUDY 134XCP|RP|970170C0-8FF0-4D24-84E8-1195272D55C0|2||||||BLISTIND|BLISTERING INDICATOR||||U.CARR|||MU/G|NOT DONE||NA|N|U|1||38||BASELINE|1965-11-15||1967-08-24|||1965-07-28||1972-05-27
TRIAL STUDY 134XCP|RP|970170C0-8FF0-4D24-84E8-1195272D55C0|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MEQ|||ML/DOSE|NOT DONE||NA|Y|N|2||58||SCREENING|1960-11-09||1972-04-25|||1972-01-28||1970-06-18
TRIAL STUDY 134XCP|RP|970170C0-8FF0-4D24-84E8-1195272D55C0|2||||||PUSTIND|PUSTULE INDICATOR||||ROENTGEN|||LOG10 ELISA UNIT/DOSE|NOT DONE||NA|U|NA|2||58||BASELINE|1966-11-01||1964-04-11|||1964-03-16||1968-12-08
TRIAL STUDY 134XCP|RP|970170C0-8FF0-4D24-84E8-1195272D55C0|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MMOL/L|||ML/BEAT|NOT DONE||NA|NA|N|3||39||WASHOUT|1967-12-01||1972-05-24|||1971-11-25||1970-11-24
TRIAL STUDY 134XCP|RP|970170C0-8FF0-4D24-84E8-1195272D55C0|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||COPIES/UL|||/LPF|NOT DONE||NA|N|N|3||39||LONG-TERM FOLLOW-UP|1965-11-21||1966-02-27|||1967-08-24||1968-11-03
TRIAL STUDY 134XCP|RP|970170C0-8FF0-4D24-84E8-1195272D55C0|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^3 ORGANISMS/G|||L/S|NOT DONE||NA|N|U|4||88||WASHOUT|1960-12-23||1961-02-02|||1961-12-21||1968-11-26
TRIAL STUDY 134XCP|RP|970170C0-8FF0-4D24-84E8-1195272D55C0|2||||||MENOAGE|MENOPAUSE AGE||||MET*MIN|||BEATS/MIN|NOT DONE||N|Y|Y|4||88||LONG-TERM FOLLOW-UP|1964-02-19||1969-01-01|||1961-08-27||1969-06-15
TRIAL STUDY 134XCP|RP|970170C0-8FF0-4D24-84E8-1195272D55C0|1||||||MENOAGE|MENOPAUSE AGE||||PACKET|||KPA|NOT DONE||Y|U|Y|5||7||OBSERVATION|1960-06-28||1969-06-02|||1964-08-18||1967-03-24
TRIAL STUDY 134XCP|RP|970170C0-8FF0-4D24-84E8-1195272D55C0|2||||||BCMETHOD|BIRTH CONTROL METHOD||||U/G/H|||BU/ML|NOT DONE||N|Y|NA|5||7||BASELINE|1968-05-11||1972-06-09|||1972-05-15||1967-08-23
TRIAL STUDY 134XCP|RP|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||10^6/EJACULATE U|||UG/MOL|NOT DONE||NA|N|NA|1||38||FOLLOW-UP|1967-10-28||1969-02-25|||1968-01-08||1963-04-02
TRIAL STUDY 134XCP|RP|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MG/M2/DAY|||DEG2|NOT DONE||N|Y|N|1||38||WASHOUT|1968-11-13||1960-05-08|||1969-01-16||1967-09-01
TRIAL STUDY 134XCP|RP|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||PM|||LOG10 PFU|NOT DONE||U|N|N|2||58||RUN-IN|1969-12-21||1965-11-30|||1970-08-30||1962-07-29
TRIAL STUDY 134XCP|RP|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|2||||||ABORTN|NUMBER OF ABORTIONS||||VG/ML|||U/G/MIN|NOT DONE||Y|N|Y|2||58||OPEN LABEL TREATMENT|1964-02-15||1964-01-21|||1967-08-25||1964-07-01
TRIAL STUDY 134XCP|RP|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||USP U|||HR/DAY|NOT DONE||N|Y|N|3||39||SCREENING|1968-02-12||1962-07-13|||1972-08-16||1971-09-16
TRIAL STUDY 134XCP|RP|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|2||||||INABOIND|INDUCED ABORTION INDICATOR||||KM/H|||NEEDLE GAUGE|NOT DONE||N|U|U|3||39||OPEN LABEL TREATMENT|1971-05-08||1966-05-12|||1973-04-08||1964-01-12
TRIAL STUDY 134XCP|RP|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MMOL/G|||/KG|NOT DONE||N|N|NA|4||88||LONG-TERM FOLLOW-UP|1970-03-05||1970-04-22|||1967-01-18||1964-05-26
TRIAL STUDY 134XCP|RP|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MMHG*MIN/L|||SQU/ML|NOT DONE||N|NA|NA|4||88||SCREENING|1968-03-17||1965-03-30|||1972-11-22||1965-10-09
TRIAL STUDY 134XCP|RP|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ML/M2/MIN|||FT3|NOT DONE||Y|U|N|5||7||INDUCTION TREATMENT|1964-04-30||1971-10-08|||1967-10-20||1972-01-31
TRIAL STUDY 134XCP|RP|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||G/CM2|||MMOL/KG|NOT DONE||NA|NA|Y|5||7||CONTINUATION TREATMENT|1961-03-17||1972-04-24|||1965-04-07||1973-05-13
TRIAL STUDY 134XCP|RP|69CC47A3-DA90-4919-889E-E0008ED689FA|1||||||THICK|THICKNESS||||C|||U/ANIMAL|NOT DONE||U|NA|N|1||38||RUN-IN|1964-02-14||1967-10-05|||1973-06-24||1966-12-09
TRIAL STUDY 134XCP|RP|69CC47A3-DA90-4919-889E-E0008ED689FA|2||||||PUSTIND|PUSTULE INDICATOR||||HOMEOPATHIC DILUTION|||G/G/DAY|NOT DONE||Y|NA|NA|1||38||CONTINUATION TREATMENT|1960-04-06||1973-02-15|||1967-04-01||1971-07-05
TRIAL STUDY 134XCP|RP|69CC47A3-DA90-4919-889E-E0008ED689FA|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||CUP EQ|||10^6 CFU/G|NOT DONE||U|U|Y|2||58||FOLLOW-UP|1964-07-27||1969-08-15|||1968-04-15||1967-03-01
TRIAL STUDY 134XCP|RP|69CC47A3-DA90-4919-889E-E0008ED689FA|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||LOG10 COPIES/ML|||HENRY|NOT DONE||N|U|Y|2||58||LONG-TERM FOLLOW-UP|1972-02-19||1965-06-02|||1960-02-20||1969-09-04
TRIAL STUDY 134XCP|RP|69CC47A3-DA90-4919-889E-E0008ED689FA|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||MMOL/G|||GPELISA UNIT/ML|NOT DONE||U|U|NA|3||39||LONG-TERM FOLLOW-UP|1960-03-25||1969-10-15|||1967-08-29||1963-01-08
TRIAL STUDY 134XCP|RP|69CC47A3-DA90-4919-889E-E0008ED689FA|2||||||MENARAGE|MENARCHE AGE||||DYN|||YD|NOT DONE||U|Y|Y|3||39||LONG-TERM FOLLOW-UP|1970-06-27||1967-08-06|||1962-09-12||1966-02-07
TRIAL STUDY 134XCP|RP|69CC47A3-DA90-4919-889E-E0008ED689FA|1||||||PEELIND|PEELING INDICATOR||||KG|||JOULE|NOT DONE||NA|NA|NA|4||88||TREATMENT|1969-01-07||1961-12-28|||1961-11-05||1962-02-10
TRIAL STUDY 134XCP|RP|69CC47A3-DA90-4919-889E-E0008ED689FA|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||DNA COPIES/UG|||MM/2H|NOT DONE||U|N|U|4||88||OBSERVATION|1965-10-20||1968-01-10|||1962-06-21||1964-04-02
TRIAL STUDY 134XCP|RP|69CC47A3-DA90-4919-889E-E0008ED689FA|1||||||PREGIND|PREGNANT INDICATOR||||UV|||UG/KG/MIN|NOT DONE||Y|Y|U|5||7||WASHOUT|1966-07-10||1970-02-06|||1962-11-07||1970-07-12
TRIAL STUDY 134XCP|RP|69CC47A3-DA90-4919-889E-E0008ED689FA|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||MN|||FMOL/L/SEC|NOT DONE||NA|NA|NA|5||7||RUN-IN|1971-08-23||1966-12-20|||1968-04-24||1971-09-10
TRIAL STUDY 134XCP|RP|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|1||||||DLVRMODE|MODE OF DELIVERY||||UKAT/10^12 RBC|||L/MIN|NOT DONE||NA|N|Y|1||38||SCREENING|1964-02-04||1969-12-04|||1972-07-31||1960-04-29
TRIAL STUDY 134XCP|RP|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||FOZ_BR|||10^3 ORGANISMS/ML|NOT DONE||N|NA|NA|1||38||INDUCTION TREATMENT|1960-12-13||1972-01-22|||1968-11-20||1960-02-28
TRIAL STUDY 134XCP|RP|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|1||||||MENFDUR|MENSES FLOW DURATION||||BOWL|||KCAL|NOT DONE||Y|Y|Y|2||58||TREATMENT|1965-11-15||1963-10-09|||1960-06-24||1960-08-01
TRIAL STUDY 134XCP|RP|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||10^6 ORGANISMS|||UG/KG|NOT DONE||N|N|Y|2||58||TREATMENT|1960-09-06||1966-12-02|||1962-05-21||1972-06-07
TRIAL STUDY 134XCP|RP|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||UG/KG/H|||FRACTION OF 1|NOT DONE||Y|N|NA|3||39||OPEN LABEL TREATMENT|1964-04-10||1969-12-23|||1966-11-25||1968-09-25
TRIAL STUDY 134XCP|RP|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UG/H|||ML/DAY|NOT DONE||Y|NA|U|3||39||FOLLOW-UP|1963-03-10||1962-06-04|||1965-03-10||1963-09-03
TRIAL STUDY 134XCP|RP|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|1||||||INABOIND|INDUCED ABORTION INDICATOR||||M3|||UG/M2/DAY|NOT DONE||N|U|N|4||88||WASHOUT|1961-05-08||1960-10-22|||1968-01-01||1965-03-03
TRIAL STUDY 134XCP|RP|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|2||||||PUSTIND|PUSTULE INDICATOR||||IMPLANT|||TITER|NOT DONE||Y|NA|N|4||88||INDUCTION TREATMENT|1961-02-10||1960-11-15|||1961-02-27||1964-03-20
TRIAL STUDY 134XCP|RP|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ML/S|||STEPS|NOT DONE||N|Y|NA|5||7||TREATMENT|1963-05-16||1965-02-18|||1963-10-20||1968-02-02
TRIAL STUDY 134XCP|RP|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||LOG10 ELISA UNIT/DOSE|||DAYS|NOT DONE||Y|N|U|5||7||FOLLOW-UP|1968-01-13||1971-03-13|||1960-05-07||1969-12-26
TRIAL STUDY 134XCP|RP|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|1||||||MENARAGE|MENARCHE AGE||||PFU|||KBQ|NOT DONE||NA|NA|U|1||38||RUN-IN|1961-09-10||1963-01-02|||1971-09-24||1962-06-18
TRIAL STUDY 134XCP|RP|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||UKAT|||MIN/DAY|NOT DONE||U|N|U|1||38||FOLLOW-UP|1972-06-13||1961-03-22|||1960-01-24||1965-04-18
TRIAL STUDY 134XCP|RP|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|1||||||BCMETHOD|BIRTH CONTROL METHOD||||FINGERTIP UNIT|||PKAT/L|NOT DONE||U|N|U|2||58||INDUCTION TREATMENT|1968-06-13||1968-09-01|||1971-04-12||1971-10-30
TRIAL STUDY 134XCP|RP|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MG/H|||UL/KG/DAY|NOT DONE||U|Y|Y|2||58||LONG-TERM FOLLOW-UP|1969-08-21||1973-03-13|||1966-09-13||1972-03-28
TRIAL STUDY 134XCP|RP|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||VG/ML|||APL U|NOT DONE||Y|U|N|3||39||RUN-IN|1963-12-31||1967-04-24|||1961-12-30||1963-04-01
TRIAL STUDY 134XCP|RP|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MAMP|||DPM|NOT DONE||NA|U|U|3||39||OPEN LABEL TREATMENT|1970-10-13||1965-05-25|||1972-02-16||1960-09-24
TRIAL STUDY 134XCP|RP|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|1||||||MASSIND|MASS INDICATOR||||MG/ML/DAY|||BQ/ML|NOT DONE||N|Y|NA|4||88||TREATMENT|1969-01-10||1970-11-21|||1971-06-16||1966-09-02
TRIAL STUDY 134XCP|RP|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||/VF|||VP/DOSE|NOT DONE||Y|NA|U|4||88||TREATMENT|1967-03-23||1969-06-04|||1972-04-21||1967-07-05
TRIAL STUDY 134XCP|RP|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||10^6 CFU/ML|||PRESSOR UNITS|NOT DONE||NA|U|N|5||7||OPEN LABEL TREATMENT|1968-10-14||1961-12-24|||1970-12-25||1961-09-07
TRIAL STUDY 134XCP|RP|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|2||||||ERYTHIND|ERYTHEMA INDICATOR||||/VF|||FRAMES/S|NOT DONE||U|N|NA|5||7||TREATMENT|1969-08-20||1968-03-17|||1967-01-12||1969-11-21
TRIAL STUDY 134XCP|RP|0281E055-F419-4BA2-89CE-23EC7428CDA0|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||LOZENGE|||STRIP|NOT DONE||NA|U|U|1||38||LONG-TERM FOLLOW-UP|1965-05-22||1969-02-08|||1972-04-10||1961-09-13
TRIAL STUDY 134XCP|RP|0281E055-F419-4BA2-89CE-23EC7428CDA0|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||EP U|||SPRAY|NOT DONE||Y|N|U|1||38||TREATMENT|1969-10-21||1964-06-27|||1971-11-10||1967-09-13
TRIAL STUDY 134XCP|RP|0281E055-F419-4BA2-89CE-23EC7428CDA0|1||||||PREGNN|NUMBER OF PREGNANCIES||||BISCUIT|||UMOL|NOT DONE||NA|NA|NA|2||58||CONTINUATION TREATMENT|1972-11-12||1963-07-24|||1973-06-05||1967-03-28
TRIAL STUDY 134XCP|RP|0281E055-F419-4BA2-89CE-23EC7428CDA0|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||GBQ/UG|||RNA COPIES/ML|NOT DONE||Y|U|U|2||58||OBSERVATION|1972-08-22||1966-02-05|||1968-06-07||1965-05-13
TRIAL STUDY 134XCP|RP|0281E055-F419-4BA2-89CE-23EC7428CDA0|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||COULOMB|||MG/G/H|NOT DONE||NA|N|Y|3||39||CONTINUATION TREATMENT|1972-06-13||1961-03-21|||1965-03-13||1972-12-17
TRIAL STUDY 134XCP|RP|0281E055-F419-4BA2-89CE-23EC7428CDA0|2||||||ULCERIND|ULCER INDICATOR||||UG/DL|||LOG10 COPIES/ML|NOT DONE||N|NA|Y|3||39||WASHOUT|1971-04-04||1963-05-31|||1964-02-01||1970-11-06
TRIAL STUDY 134XCP|RP|0281E055-F419-4BA2-89CE-23EC7428CDA0|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UCI/L|||MM/SEC|NOT DONE||N|Y|Y|4||88||TREATMENT|1961-12-11||1968-03-09|||1964-10-12||1969-11-13
TRIAL STUDY 134XCP|RP|0281E055-F419-4BA2-89CE-23EC7428CDA0|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PG/DL|||ML/ANIMAL/WK|NOT DONE||Y|U|U|4||88||LONG-TERM FOLLOW-UP|1960-03-13||1969-03-14|||1963-01-11||1973-04-03
TRIAL STUDY 134XCP|RP|0281E055-F419-4BA2-89CE-23EC7428CDA0|1||||||FUNDHT|FUNDAL HEIGHT||||MHZ|||TITER|NOT DONE||N|U|Y|5||7||OBSERVATION|1972-01-18||1969-06-19|||1972-08-28||1968-01-22
TRIAL STUDY 134XCP|RP|0281E055-F419-4BA2-89CE-23EC7428CDA0|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||NMOL|||ML/CM H2O|NOT DONE||NA|NA|NA|5||7||CONTINUATION TREATMENT|1972-04-12||1967-04-13|||1969-08-14||1964-07-28
TRIAL STUDY 134XCP|RP|23CE1310-DBB3-4135-8E11-2A870CE42D50|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||UG/KG/H|||MMOL/G|NOT DONE||Y|U|Y|1||38||FOLLOW-UP|1968-02-05||1971-06-20|||1971-10-24||1963-09-23
TRIAL STUDY 134XCP|RP|23CE1310-DBB3-4135-8E11-2A870CE42D50|2||||||GRAVIND|GRAVIDA INDICATOR||||WAFER|||HZ/S|NOT DONE||NA|Y|NA|1||38||BLINDED TREATMENT|1969-06-13||1971-06-19|||1966-05-14||1971-10-02
TRIAL STUDY 134XCP|RP|23CE1310-DBB3-4135-8E11-2A870CE42D50|1||||||PRGENDTC|DATE PREGNANCY ENDED||||ECL UNIT|||EID 50/ML|NOT DONE||Y|U|Y|2||58||OPEN LABEL TREATMENT|1964-04-21||1962-10-21|||1960-09-18||1965-03-09
TRIAL STUDY 134XCP|RP|23CE1310-DBB3-4135-8E11-2A870CE42D50|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||POINT|||IU/KG|NOT DONE||N|N|NA|2||58||TREATMENT|1965-11-09||1972-11-13|||1971-05-26||1964-08-18
TRIAL STUDY 134XCP|RP|23CE1310-DBB3-4135-8E11-2A870CE42D50|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^3 DNA COPIES/ML|||SUPPOSITORY|NOT DONE||N|N|Y|3||39||SCREENING|1960-08-27||1963-09-27|||1965-10-23||1962-11-01
TRIAL STUDY 134XCP|RP|23CE1310-DBB3-4135-8E11-2A870CE42D50|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||NCI|||MMOL2/L2|NOT DONE||N|U|N|3||39||OBSERVATION|1960-06-22||1969-02-21|||1960-11-28||1966-02-12
TRIAL STUDY 134XCP|RP|23CE1310-DBB3-4135-8E11-2A870CE42D50|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||NSEC|||EVENTS|NOT DONE||NA|Y|U|4||88||CONTINUATION TREATMENT|1963-04-26||1961-12-18|||1969-09-18||1970-08-06
TRIAL STUDY 134XCP|RP|23CE1310-DBB3-4135-8E11-2A870CE42D50|2||||||BCMETHOD|BIRTH CONTROL METHOD||||M/SEC2|||U/M2|NOT DONE||NA|Y|NA|4||88||TREATMENT|1964-04-28||1962-11-23|||1969-05-27||1971-10-23
TRIAL STUDY 134XCP|RP|23CE1310-DBB3-4135-8E11-2A870CE42D50|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||CG|||/200 HPFS|NOT DONE||Y|N|U|5||7||FOLLOW-UP|1971-09-15||1969-11-09|||1960-05-14||1973-07-20
TRIAL STUDY 134XCP|RP|23CE1310-DBB3-4135-8E11-2A870CE42D50|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||CM/S|||/H|NOT DONE||N|U|U|5||7||RUN-IN|1963-08-23||1973-01-02|||1967-05-30||1966-08-22
TRIAL STUDY 134XCP|RP|CC80D8A2-7D71-428B-9599-C0D0312B8691|1||||||DSCHGIND|DISCHARGE INDICATOR||||FMOL/G|||RING|NOT DONE||N|U|Y|1||38||INDUCTION TREATMENT|1972-06-17||1963-12-13|||1961-10-27||1966-11-29
TRIAL STUDY 134XCP|RP|CC80D8A2-7D71-428B-9599-C0D0312B8691|2||||||PREGST|PREGNANT DURING THE STUDY||||UV2|||10^9 CFU/G|NOT DONE||U|N|NA|1||38||OPEN LABEL TREATMENT|1970-03-04||1965-12-31|||1969-03-05||1966-12-03
TRIAL STUDY 134XCP|RP|CC80D8A2-7D71-428B-9599-C0D0312B8691|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||NMOL BCE/L|||U|NOT DONE||Y|Y|NA|2||58||WASHOUT|1960-02-19||1969-07-21|||1961-07-16||1966-01-29
TRIAL STUDY 134XCP|RP|CC80D8A2-7D71-428B-9599-C0D0312B8691|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||AGU/ML|||MV*MIN|NOT DONE||U|Y|U|2||58||OPEN LABEL TREATMENT|1967-10-16||1972-08-08|||1960-12-09||1963-02-21
TRIAL STUDY 134XCP|RP|CC80D8A2-7D71-428B-9599-C0D0312B8691|1||||||ERYTHIND|ERYTHEMA INDICATOR||||PG/CELL|||G/ANIMAL|NOT DONE||N|N|U|3||39||WASHOUT|1973-05-14||1964-01-09|||1972-01-11||1961-12-30
TRIAL STUDY 134XCP|RP|CC80D8A2-7D71-428B-9599-C0D0312B8691|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MMHG/SEC|||ML/MIN/1.73M2|NOT DONE||Y|Y|Y|3||39||FOLLOW-UP|1963-11-17||1962-08-31|||1967-01-19||1969-07-30
TRIAL STUDY 134XCP|RP|CC80D8A2-7D71-428B-9599-C0D0312B8691|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||RNA COPIES/ML|||10^3 ORGANISMS|NOT DONE||Y|U|U|4||88||RUN-IN|1971-12-25||1973-03-31|||1970-10-21||1964-10-05
TRIAL STUDY 134XCP|RP|CC80D8A2-7D71-428B-9599-C0D0312B8691|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^5/HPF|||MG/M2|NOT DONE||U|N|N|4||88||CONTINUATION TREATMENT|1969-06-18||1966-07-31|||1969-06-20||1971-09-22
TRIAL STUDY 134XCP|RP|CC80D8A2-7D71-428B-9599-C0D0312B8691|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||G/G|||UG/DOSE|NOT DONE||NA|NA|NA|5||7||WASHOUT|1970-11-03||1967-01-31|||1966-12-14||1967-12-14
TRIAL STUDY 134XCP|RP|CC80D8A2-7D71-428B-9599-C0D0312B8691|2||||||ABORTN|NUMBER OF ABORTIONS||||UU/DL|||DYN|NOT DONE||Y|N|N|5||7||FOLLOW-UP|1972-05-29||1960-02-11|||1962-04-07||1972-05-21
TRIAL STUDY 134XCP|RP|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||10^8/L|||UG/KG/DAY|NOT DONE||NA|U|N|1||38||OPEN LABEL TREATMENT|1961-06-14||1963-03-21|||1972-04-28||1969-12-26
TRIAL STUDY 134XCP|RP|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MG/M2/DAY|||ML/MMHG|NOT DONE||Y|NA|N|1||38||OBSERVATION|1964-05-13||1971-10-04|||1968-04-04||1966-07-09
TRIAL STUDY 134XCP|RP|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|1||||||PEELIND|PEELING INDICATOR||||UM/DAY|||10^6 ORGANISMS|NOT DONE||Y|NA|NA|2||58||BLINDED TREATMENT|1966-12-05||1969-03-26|||1964-11-06||1973-08-20
TRIAL STUDY 134XCP|RP|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||IU/KG|||MG/DOSE|NOT DONE||NA|U|Y|2||58||RUN-IN|1963-08-18||1962-05-03|||1972-09-03||1961-08-25
TRIAL STUDY 134XCP|RP|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|1||||||FUNDHT|FUNDAL HEIGHT||||HZ|||GPL U/ML|NOT DONE||NA|Y|U|3||39||INDUCTION TREATMENT|1962-05-27||1962-12-16|||1972-11-18||1969-02-18
TRIAL STUDY 134XCP|RP|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|2||||||RASHIND|RASH INDICATOR||||AMFI|||ANSON U|NOT DONE||N|Y|U|3||39||FOLLOW-UP|1971-12-12||1963-03-16|||1966-03-21||1962-02-17
TRIAL STUDY 134XCP|RP|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|1||||||MENARAGE|MENARCHE AGE||||CYCLE/MIN|||NG/DAY|NOT DONE||Y|U|U|4||88||OPEN LABEL TREATMENT|1966-08-14||1969-04-16|||1966-09-09||1961-03-19
TRIAL STUDY 134XCP|RP|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ML*CMH2O|||ML/MMHG/MIN/L|NOT DONE||N|U|Y|4||88||FOLLOW-UP|1964-04-23||1966-06-15|||1971-12-11||1966-08-27
TRIAL STUDY 134XCP|RP|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||G/CAGE|||LOG10 CFU/ML|NOT DONE||U|U|N|5||7||FOLLOW-UP|1960-09-14||1973-03-24|||1963-11-22||1969-06-28
TRIAL STUDY 134XCP|RP|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||G/DL|||UL/KG/DAY|NOT DONE||NA|N|N|5||7||WASHOUT|1963-10-17||1964-08-14|||1966-09-19||1963-05-01
TRIAL STUDY 134XCP|RP|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|1||||||MENARAGE|MENARCHE AGE||||FT2|||GRAVITATIONAL UNIT|NOT DONE||U|NA|U|1||38||SCREENING|1962-02-25||1962-08-23|||1966-02-26||1966-07-01
TRIAL STUDY 134XCP|RP|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||PA|||USP U|NOT DONE||U|U|N|1||38||LONG-TERM FOLLOW-UP|1967-07-30||1972-07-04|||1966-06-01||1968-05-31
TRIAL STUDY 134XCP|RP|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MET*MIN|||MET*H|NOT DONE||N|NA|NA|2||58||BASELINE|1967-03-17||1960-11-04|||1969-04-20||1960-10-17
TRIAL STUDY 134XCP|RP|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|2||||||RASHIND|RASH INDICATOR||||MOL/ML|||U/KG|NOT DONE||NA|Y|Y|2||58||RUN-IN|1963-04-26||1969-04-23|||1968-10-11||1963-09-11
TRIAL STUDY 134XCP|RP|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MET|||U/M2|NOT DONE||NA|U|U|3||39||FOLLOW-UP|1972-08-29||1971-04-19|||1963-02-08||1972-03-20
TRIAL STUDY 134XCP|RP|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|2||||||THICK|THICKNESS||||H*%|||10^9 CFU/ML|NOT DONE||NA|U|NA|3||39||SCREENING|1961-01-31||1962-09-17|||1967-11-21||1973-07-31
TRIAL STUDY 134XCP|RP|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||UG/L/H|||/10^5|NOT DONE||NA|Y|N|4||88||OBSERVATION|1972-07-08||1972-09-08|||1967-05-06||1963-08-12
TRIAL STUDY 134XCP|RP|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|2||||||INTP|INTERPRETATION||||MM2|||S^-1(%O2)^-1|NOT DONE||U|N|Y|4||88||TREATMENT|1971-06-09||1961-01-17|||1964-12-27||1969-03-15
TRIAL STUDY 134XCP|RP|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|1||||||MENARAGE|MENARCHE AGE||||CCID 50/DOSE|||NEEDLE GAUGE|NOT DONE||U|N|NA|5||7||FOLLOW-UP|1969-01-26||1970-04-17|||1971-01-26||1972-06-01
TRIAL STUDY 134XCP|RP|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|2||||||ERYTHIND|ERYTHEMA INDICATOR||||CL|||L/DAY|NOT DONE||N|Y|Y|5||7||BASELINE|1964-06-06||1961-04-17|||1965-03-10||1964-11-05
TRIAL STUDY 134XCP|RP|3D25A735-6298-4AF4-91CC-AE8D481DF552|1||||||THICK|THICKNESS||||PMOL|||ML/ANIMAL|NOT DONE||Y|N|NA|1||38||BASELINE|1971-05-19||1962-01-04|||1972-12-17||1972-08-05
TRIAL STUDY 134XCP|RP|3D25A735-6298-4AF4-91CC-AE8D481DF552|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||TROCHE|||DAGU/ML|NOT DONE||Y|Y|NA|1||38||INDUCTION TREATMENT|1966-08-27||1960-02-29|||1963-11-07||1968-06-10
TRIAL STUDY 134XCP|RP|3D25A735-6298-4AF4-91CC-AE8D481DF552|1||||||DSCHGIND|DISCHARGE INDICATOR||||ML/KG/H|||YD|NOT DONE||NA|NA|N|2||58||FOLLOW-UP|1970-10-14||1970-11-06|||1964-07-15||1964-05-29
TRIAL STUDY 134XCP|RP|3D25A735-6298-4AF4-91CC-AE8D481DF552|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||BQ/G|||NG/DAY|NOT DONE||Y|U|N|2||58||RUN-IN|1964-01-18||1972-10-16|||1967-12-27||1968-12-26
TRIAL STUDY 134XCP|RP|3D25A735-6298-4AF4-91CC-AE8D481DF552|1||||||PREGNN|NUMBER OF PREGNANCIES||||10^6 CFU/G|||ML/DOSE|NOT DONE||Y|Y|N|3||39||SCREENING|1964-11-07||1962-06-19|||1967-02-27||1964-03-25
TRIAL STUDY 134XCP|RP|3D25A735-6298-4AF4-91CC-AE8D481DF552|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||CUP|||MAMP|NOT DONE||Y|NA|Y|3||39||CONTINUATION TREATMENT|1967-02-04||1967-04-29|||1961-09-24||1961-03-01
TRIAL STUDY 134XCP|RP|3D25A735-6298-4AF4-91CC-AE8D481DF552|1||||||ULCERIND|ULCER INDICATOR||||PA|||MEQ/L|NOT DONE||NA|U|Y|4||88||INDUCTION TREATMENT|1969-02-11||1970-12-18|||1970-07-30||1973-01-19
TRIAL STUDY 134XCP|RP|3D25A735-6298-4AF4-91CC-AE8D481DF552|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||CCID 50/DOSE|||FRAMES/S|NOT DONE||N|Y|NA|4||88||OPEN LABEL TREATMENT|1967-08-08||1970-03-19|||1967-11-15||1967-11-14
TRIAL STUDY 134XCP|RP|3D25A735-6298-4AF4-91CC-AE8D481DF552|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||PMOL|||HR/DAY|NOT DONE||NA|NA|N|5||7||TREATMENT|1962-04-22||1972-09-27|||1969-08-23||1961-05-29
TRIAL STUDY 134XCP|RP|3D25A735-6298-4AF4-91CC-AE8D481DF552|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||KG/CM|||UG/CM2|NOT DONE||NA|U|U|5||7||TREATMENT|1964-03-08||1971-01-13|||1963-07-18||1963-07-07
TRIAL STUDY 134XCP|RP|C249E38B-B454-47D9-8D8B-E2F6A434BA21|1||||||PUSTIND|PUSTULE INDICATOR||||UGEQ/L|||UG/M2/DAY|NOT DONE||Y|Y|NA|1||38||INDUCTION TREATMENT|1973-01-25||1968-05-17|||1973-01-15||1965-01-22
TRIAL STUDY 134XCP|RP|C249E38B-B454-47D9-8D8B-E2F6A434BA21|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||OZ|||/5X10^4 WBC|NOT DONE||NA|U|U|1||38||WASHOUT|1966-06-07||1962-12-17|||1970-10-29||1970-08-07
TRIAL STUDY 134XCP|RP|C249E38B-B454-47D9-8D8B-E2F6A434BA21|1||||||TNDRIND|TENDERNESS INDICATOR||||ML/CAGE/WK|||10^9 CFU/ML|NOT DONE||NA|N|U|2||58||FOLLOW-UP|1964-05-19||1962-01-31|||1970-08-01||1962-12-15
TRIAL STUDY 134XCP|RP|C249E38B-B454-47D9-8D8B-E2F6A434BA21|2||||||MENFDUR|MENSES FLOW DURATION||||MBQ/UL|||10^6/HPF|NOT DONE||NA|U|U|2||58||BLINDED TREATMENT|1964-07-21||1972-07-12|||1973-07-19||1970-03-19
TRIAL STUDY 134XCP|RP|C249E38B-B454-47D9-8D8B-E2F6A434BA21|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||U/G HB|||/H|NOT DONE||U|NA|Y|3||39||WASHOUT|1969-02-26||1961-01-14|||1971-08-11||1964-09-23
TRIAL STUDY 134XCP|RP|C249E38B-B454-47D9-8D8B-E2F6A434BA21|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^3 COPIES/ML|||UKAT|NOT DONE||Y|U|Y|3||39||BASELINE|1972-08-23||1965-02-28|||1972-04-26||1973-08-14
TRIAL STUDY 134XCP|RP|C249E38B-B454-47D9-8D8B-E2F6A434BA21|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||CM|||NFIU|NOT DONE||U|Y|Y|4||88||OBSERVATION|1963-02-04||1963-12-24|||1964-02-07||1965-03-18
TRIAL STUDY 134XCP|RP|C249E38B-B454-47D9-8D8B-E2F6A434BA21|2||||||TNDRIND|TENDERNESS INDICATOR||||ECL UNIT|||G/M2|NOT DONE||Y|N|U|4||88||INDUCTION TREATMENT|1970-12-16||1968-07-21|||1968-11-11||1968-10-04
TRIAL STUDY 134XCP|RP|C249E38B-B454-47D9-8D8B-E2F6A434BA21|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||TABLET|||UG/L FEU|NOT DONE||Y|Y|N|5||7||OBSERVATION|1967-04-19||1965-10-18|||1966-12-24||1961-06-27
TRIAL STUDY 134XCP|RP|C249E38B-B454-47D9-8D8B-E2F6A434BA21|2||||||STILBIND|STILLBIRTH INDICATOR||||/10^5|||UMOL/MOL|NOT DONE||N|U|U|5||7||BLINDED TREATMENT|1968-05-04||1961-10-18|||1973-08-29||1963-12-22
TRIAL STUDY 134XCP|RP|4540D569-1DD0-4984-89DB-6F9A391397FE|1||||||MASSIND|MASS INDICATOR||||%/S|||IU/G|NOT DONE||Y|U|N|1||38||CONTINUATION TREATMENT|1960-06-19||1962-01-31|||1964-07-15||1970-08-12
TRIAL STUDY 134XCP|RP|4540D569-1DD0-4984-89DB-6F9A391397FE|2||||||BRTHN|NUMBER OF BIRTHS||||CARTRIDGE|||MG/CM2|NOT DONE||NA|U|N|1||38||WASHOUT|1972-12-01||1969-12-05|||1972-12-28||1970-02-04
TRIAL STUDY 134XCP|RP|4540D569-1DD0-4984-89DB-6F9A391397FE|1||||||DSCHGIND|DISCHARGE INDICATOR||||CP|||MCI/KG|NOT DONE||Y|Y|N|2||58||CONTINUATION TREATMENT|1967-05-25||1969-02-17|||1966-12-08||1964-06-21
TRIAL STUDY 134XCP|RP|4540D569-1DD0-4984-89DB-6F9A391397FE|2||||||INABOIND|INDUCED ABORTION INDICATOR||||UMOL/MOL|||UG/MIN|NOT DONE||Y|Y|Y|2||58||WASHOUT|1971-11-16||1962-12-04|||1960-03-18||1960-12-29
TRIAL STUDY 134XCP|RP|4540D569-1DD0-4984-89DB-6F9A391397FE|1||||||INTP|INTERPRETATION||||UG/M2/DAY|||IU/DL|NOT DONE||Y|Y|Y|3||39||OBSERVATION|1967-12-12||1965-08-31|||1965-12-30||1964-07-25
TRIAL STUDY 134XCP|RP|4540D569-1DD0-4984-89DB-6F9A391397FE|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||KHZ|||YD|NOT DONE||N|U|N|3||39||SCREENING|1968-03-17||1969-10-15|||1970-10-16||1960-01-31
TRIAL STUDY 134XCP|RP|4540D569-1DD0-4984-89DB-6F9A391397FE|1||||||PREGNN|NUMBER OF PREGNANCIES||||MG/M2/H|||U/L|NOT DONE||NA|Y|N|4||88||INDUCTION TREATMENT|1963-01-24||1963-05-22|||1962-08-12||1963-06-27
TRIAL STUDY 134XCP|RP|4540D569-1DD0-4984-89DB-6F9A391397FE|2||||||BLISTIND|BLISTERING INDICATOR||||MM/MIN|||WEEKS|NOT DONE||Y|Y|Y|4||88||WASHOUT|1960-10-13||1961-09-28|||1963-09-10||1963-01-04
TRIAL STUDY 134XCP|RP|4540D569-1DD0-4984-89DB-6F9A391397FE|1||||||GRAVIND|GRAVIDA INDICATOR||||BP|||KG/M2|NOT DONE||N|Y|U|5||7||CONTINUATION TREATMENT|1969-02-14||1961-10-29|||1969-06-04||1969-09-11
TRIAL STUDY 134XCP|RP|4540D569-1DD0-4984-89DB-6F9A391397FE|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||NSEC|||CP|NOT DONE||U|U|N|5||7||OBSERVATION|1973-02-26||1962-05-02|||1965-02-22||1973-02-26
TRIAL STUDY 134XCP|RP|DC1D666E-4920-4B60-A520-D183BCDE0E85|1||||||ABORTN|NUMBER OF ABORTIONS||||OHM|||ML/MIN/1.73M2|NOT DONE||Y|U|U|1||38||SCREENING|1966-02-03||1969-03-16|||1971-03-23||1966-10-01
TRIAL STUDY 134XCP|RP|DC1D666E-4920-4B60-A520-D183BCDE0E85|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MIN*MG/ML|||/CMH2O|NOT DONE||Y|N|Y|1||38||LONG-TERM FOLLOW-UP|1972-11-18||1972-11-26|||1964-10-14||1964-12-29
TRIAL STUDY 134XCP|RP|DC1D666E-4920-4B60-A520-D183BCDE0E85|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UG/KG/DAY|||GPS U|NOT DONE||Y|NA|U|2||58||LONG-TERM FOLLOW-UP|1966-07-04||1970-11-29|||1961-02-10||1960-12-26
TRIAL STUDY 134XCP|RP|DC1D666E-4920-4B60-A520-D183BCDE0E85|2||||||INTP|INTERPRETATION||||DAGU|||NG/DL|NOT DONE||NA|N|NA|2||58||FOLLOW-UP|1968-10-12||1969-08-16|||1960-06-10||1963-11-04
TRIAL STUDY 134XCP|RP|DC1D666E-4920-4B60-A520-D183BCDE0E85|1||||||PREGST|PREGNANT DURING THE STUDY||||CD|||ABSORBANCE U/MIN|NOT DONE||N|Y|N|3||39||LONG-TERM FOLLOW-UP|1961-10-23||1973-07-18|||1965-10-31||1970-03-20
TRIAL STUDY 134XCP|RP|DC1D666E-4920-4B60-A520-D183BCDE0E85|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MPH|||ML/M2/MIN|NOT DONE||U|U|NA|3||39||OBSERVATION|1962-05-12||1972-10-14|||1965-02-05||1973-06-30
TRIAL STUDY 134XCP|RP|DC1D666E-4920-4B60-A520-D183BCDE0E85|1||||||MENFDUR|MENSES FLOW DURATION||||/LPF|||CAPLET|NOT DONE||NA|Y|N|4||88||FOLLOW-UP|1969-05-11||1969-10-01|||1973-05-05||1971-12-03
TRIAL STUDY 134XCP|RP|DC1D666E-4920-4B60-A520-D183BCDE0E85|2||||||MENFDUR|MENSES FLOW DURATION||||IN|||IU/KG|NOT DONE||Y|N|U|4||88||INDUCTION TREATMENT|1961-05-18||1970-05-05|||1962-11-30||1966-01-22
TRIAL STUDY 134XCP|RP|DC1D666E-4920-4B60-A520-D183BCDE0E85|1||||||PRGENDTC|DATE PREGNANCY ENDED||||CONTAINER|||10^9 CFU/G|NOT DONE||Y|N|Y|5||7||SCREENING|1962-05-06||1962-12-12|||1966-01-27||1964-04-24
TRIAL STUDY 134XCP|RP|DC1D666E-4920-4B60-A520-D183BCDE0E85|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||PNU/ML|||LOG EID 50/DOSE|NOT DONE||Y|N|U|5||7||RUN-IN|1970-08-31||1971-12-03|||1968-05-09||1960-01-03
TRIAL STUDY 134XCP|RP|A015D12B-C03B-4371-8D1F-F03D60542BA7|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||DAYS|||MIN|NOT DONE||NA|Y|U|1||38||INDUCTION TREATMENT|1969-03-23||1961-11-10|||1971-02-03||1967-01-17
TRIAL STUDY 134XCP|RP|A015D12B-C03B-4371-8D1F-F03D60542BA7|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||FT2|||ENZYME U/L|NOT DONE||NA|N|N|1||38||BASELINE|1963-02-18||1962-07-16|||1960-08-01||1969-04-07
TRIAL STUDY 134XCP|RP|A015D12B-C03B-4371-8D1F-F03D60542BA7|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||LOG10 TCID 50/DOSE|||SCOOPFUL|NOT DONE||U|NA|NA|2||58||FOLLOW-UP|1971-05-24||1962-01-29|||1961-08-21||1961-11-15
TRIAL STUDY 134XCP|RP|A015D12B-C03B-4371-8D1F-F03D60542BA7|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UG/CM2|||LM|NOT DONE||N|U|N|2||58||WASHOUT|1960-08-30||1970-09-24|||1965-02-01||1967-09-19
TRIAL STUDY 134XCP|RP|A015D12B-C03B-4371-8D1F-F03D60542BA7|1||||||GRAVIND|GRAVIDA INDICATOR||||MU|||CIGAR|NOT DONE||Y|Y|U|3||39||WASHOUT|1966-05-29||1965-04-13|||1968-05-21||1963-08-07
TRIAL STUDY 134XCP|RP|A015D12B-C03B-4371-8D1F-F03D60542BA7|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||ECL UNIT|||HOURS|NOT DONE||U|N|N|3||39||TREATMENT|1965-01-20||1973-05-21|||1969-09-24||1968-01-06
TRIAL STUDY 134XCP|RP|A015D12B-C03B-4371-8D1F-F03D60542BA7|1||||||DLVRMODE|MODE OF DELIVERY||||10^6 ORGANISMS|||PMOL/DL|NOT DONE||U|N|U|4||88||BLINDED TREATMENT|1965-10-30||1972-01-25|||1960-08-11||1969-01-24
TRIAL STUDY 134XCP|RP|A015D12B-C03B-4371-8D1F-F03D60542BA7|2||||||BCMETHOD|BIRTH CONTROL METHOD||||UIU/L|||DAGU|NOT DONE||Y|U|NA|4||88||FOLLOW-UP|1965-06-21||1962-09-03|||1971-09-20||1961-11-09
TRIAL STUDY 134XCP|RP|A015D12B-C03B-4371-8D1F-F03D60542BA7|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||TRACE|||DDU|NOT DONE||Y|N|N|5||7||BASELINE|1970-07-26||1962-02-10|||1971-03-08||1972-06-01
TRIAL STUDY 134XCP|RP|A015D12B-C03B-4371-8D1F-F03D60542BA7|2||||||PRGENDTC|DATE PREGNANCY ENDED||||LOG10 PFU/ML|||UMOL/L/H|NOT DONE||Y|U|N|5||7||SCREENING|1971-11-17||1961-07-17|||1960-03-27||1968-11-26
TRIAL STUDY 134XCP|RP|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||MBQ/UL|||ANTI-XA IU/ML|NOT DONE||U|N|Y|1||38||LONG-TERM FOLLOW-UP|1972-03-26||1971-09-14|||1971-11-25||1971-06-20
TRIAL STUDY 134XCP|RP|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||M3|||MV/SEC|NOT DONE||Y|Y|N|1||38||RUN-IN|1961-05-11||1965-03-12|||1968-09-25||1963-10-29
TRIAL STUDY 134XCP|RP|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||/100 WBC|||ML/M2/H|NOT DONE||N|Y|N|2||58||OBSERVATION|1962-11-14||1961-10-10|||1968-11-19||1969-01-10
TRIAL STUDY 134XCP|RP|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||FT|||ML|NOT DONE||Y|N|N|2||58||SCREENING|1965-03-18||1964-02-01|||1972-08-07||1963-02-14
TRIAL STUDY 134XCP|RP|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|1||||||EDEMAIND|EDEMA INDICATOR||||MEQ/DL|||FG|NOT DONE||U|Y|Y|3||39||BASELINE|1960-03-09||1969-04-06|||1961-10-25||1968-07-01
TRIAL STUDY 134XCP|RP|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|2||||||PREGIND|PREGNANT INDICATOR||||DRUM|||UG/DAY|NOT DONE||N|U|U|3||39||LONG-TERM FOLLOW-UP|1963-04-24||1971-10-29|||1968-03-03||1963-04-14
TRIAL STUDY 134XCP|RP|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|1||||||BCMETHOD|BIRTH CONTROL METHOD||||SYRINGE|||/500 WBC|NOT DONE||NA|U|Y|4||88||TREATMENT|1968-01-15||1960-09-05|||1963-07-31||1969-07-28
TRIAL STUDY 134XCP|RP|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|2||||||MASSIND|MASS INDICATOR||||JAR|||NKAT/L|NOT DONE||Y|Y|Y|4||88||LONG-TERM FOLLOW-UP|1969-11-26||1970-06-20|||1972-06-03||1973-05-28
TRIAL STUDY 134XCP|RP|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|1||||||ERYTHIND|ERYTHEMA INDICATOR||||ML/M2/DAY|||/LSQN|NOT DONE||U|Y|U|5||7||CONTINUATION TREATMENT|1966-11-28||1963-12-31|||1972-10-25||1961-11-04
TRIAL STUDY 134XCP|RP|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||PMOL/DL|||U/G HB|NOT DONE||U|Y|Y|5||7||TREATMENT|1962-11-24||1961-02-12|||1962-09-04||1972-08-12
TRIAL STUDY 134XCP|RP|34AC7973-686F-45A2-999A-1A36C7874F91|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||10^9/G|||NMOL/MOL|NOT DONE||N|N|Y|1||38||BLINDED TREATMENT|1967-05-30||1961-06-03|||1973-03-07||1968-05-15
TRIAL STUDY 134XCP|RP|34AC7973-686F-45A2-999A-1A36C7874F91|2||||||MENFDUR|MENSES FLOW DURATION||||UMOL/DAY|||YEARS|NOT DONE||Y|Y|U|1||38||CONTINUATION TREATMENT|1973-01-02||1965-08-22|||1961-12-03||1971-01-16
TRIAL STUDY 134XCP|RP|34AC7973-686F-45A2-999A-1A36C7874F91|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^9 ORGANISMS/G|||NMOL/DAY|NOT DONE||NA|Y|U|2||58||RUN-IN|1965-07-26||1972-08-28|||1965-09-16||1968-12-07
TRIAL STUDY 134XCP|RP|34AC7973-686F-45A2-999A-1A36C7874F91|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||PHERESIS UNIT|||/7.5 ML|NOT DONE||NA|NA|Y|2||58||TREATMENT|1968-10-29||1966-09-10|||1971-05-13||1966-10-15
TRIAL STUDY 134XCP|RP|34AC7973-686F-45A2-999A-1A36C7874F91|1||||||PREGNN|NUMBER OF PREGNANCIES||||PMOL/DL|||ML/KG|NOT DONE||N|Y|Y|3||39||FOLLOW-UP|1965-09-23||1969-04-23|||1961-01-22||1960-12-20
TRIAL STUDY 134XCP|RP|34AC7973-686F-45A2-999A-1A36C7874F91|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MMOL/MIN/KPA/L|||LOG10 CFU/G|NOT DONE||NA|NA|U|3||39||INDUCTION TREATMENT|1967-06-05||1973-06-29|||1967-06-19||1960-02-04
TRIAL STUDY 134XCP|RP|34AC7973-686F-45A2-999A-1A36C7874F91|1||||||BCMETHOD|BIRTH CONTROL METHOD||||CI/ML|||LOG10 COPIES/ML|NOT DONE||U|Y|N|4||88||TREATMENT|1972-10-18||1967-03-02|||1970-08-02||1971-03-05
TRIAL STUDY 134XCP|RP|34AC7973-686F-45A2-999A-1A36C7874F91|2||||||ULCERIND|ULCER INDICATOR||||PACK|||MKAT|NOT DONE||N|NA|Y|4||88||OBSERVATION|1973-04-22||1967-05-31|||1968-12-25||1968-08-08
TRIAL STUDY 134XCP|RP|34AC7973-686F-45A2-999A-1A36C7874F91|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UV2|||USP U|NOT DONE||NA|Y|NA|5||7||WASHOUT|1970-08-11||1967-01-15|||1960-09-05||1967-04-24
TRIAL STUDY 134XCP|RP|34AC7973-686F-45A2-999A-1A36C7874F91|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||NKAT|||TRACE|NOT DONE||Y|N|Y|5||7||BASELINE|1969-12-06||1972-03-13|||1973-03-31||1971-08-15
TRIAL STUDY 134XCP|RP|5AE66AC0-ECB6-49A2-859F-871B9A15E624|1||||||STILBIND|STILLBIRTH INDICATOR||||10^9/DOSE|||MMOL/S|NOT DONE||NA|U|Y|1||38||OBSERVATION|1965-06-06||1971-04-23|||1960-08-02||1963-12-04
TRIAL STUDY 134XCP|RP|5AE66AC0-ECB6-49A2-859F-871B9A15E624|2||||||FUNDHT|FUNDAL HEIGHT||||UMOL/DAY|||KPA|NOT DONE||N|NA|Y|1||38||WASHOUT|1964-02-21||1961-07-22|||1960-03-29||1962-04-23
TRIAL STUDY 134XCP|RP|5AE66AC0-ECB6-49A2-859F-871B9A15E624|1||||||PUSTIND|PUSTULE INDICATOR||||PFU|||EU|NOT DONE||Y|N|N|2||58||OBSERVATION|1967-12-08||1963-07-07|||1965-09-19||1965-11-29
TRIAL STUDY 134XCP|RP|5AE66AC0-ECB6-49A2-859F-871B9A15E624|2||||||GRAVIND|GRAVIDA INDICATOR||||MMOL/MIN/KPA|||NG|NOT DONE||U|N|NA|2||58||SCREENING|1965-05-17||1973-01-04|||1972-08-05||1963-09-30
TRIAL STUDY 134XCP|RP|5AE66AC0-ECB6-49A2-859F-871B9A15E624|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||NEWTON|||/MBP|NOT DONE||U|Y|N|3||39||TREATMENT|1965-08-22||1962-08-13|||1965-05-23||1969-09-17
TRIAL STUDY 134XCP|RP|5AE66AC0-ECB6-49A2-859F-871B9A15E624|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||NKAT/L|||/H|NOT DONE||U|NA|N|3||39||LONG-TERM FOLLOW-UP|1964-06-09||1963-10-01|||1969-02-05||1960-10-29
TRIAL STUDY 134XCP|RP|5AE66AC0-ECB6-49A2-859F-871B9A15E624|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MG/M2/MIN|||POINT|NOT DONE||N|U|N|4||88||OPEN LABEL TREATMENT|1968-02-27||1969-05-01|||1961-03-21||1960-10-28
TRIAL STUDY 134XCP|RP|5AE66AC0-ECB6-49A2-859F-871B9A15E624|2||||||BRTHN|NUMBER OF BIRTHS||||/LPF|||LOG10 TCID 50/UL|NOT DONE||N|U|N|4||88||CONTINUATION TREATMENT|1972-10-07||1961-10-11|||1960-03-15||1973-04-25
TRIAL STUDY 134XCP|RP|5AE66AC0-ECB6-49A2-859F-871B9A15E624|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||IN|||MMOL/MIN/KPA|NOT DONE||U|U|N|5||7||FOLLOW-UP|1964-10-08||1967-01-22|||1960-09-01||1964-01-15
TRIAL STUDY 134XCP|RP|5AE66AC0-ECB6-49A2-859F-871B9A15E624|2||||||MENARAGE|MENARCHE AGE||||10^12 IU/L|||PFU/ML|NOT DONE||U|U|N|5||7||SCREENING|1962-01-08||1965-06-21|||1969-03-12||1966-11-08
TRIAL STUDY 134XCP|RP|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||FOZ_US|||EU|NOT DONE||Y|NA|Y|1||38||FOLLOW-UP|1967-12-10||1971-03-15|||1965-02-11||1967-02-12
TRIAL STUDY 134XCP|RP|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|2||||||ULCERIND|ULCER INDICATOR||||NMOL/L|||/2500 WBC|NOT DONE||Y|NA|U|1||38||WASHOUT|1967-05-24||1966-08-23|||1971-01-27||1963-01-03
TRIAL STUDY 134XCP|RP|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|1||||||THICK|THICKNESS||||UU/L|||LOG10 TCID 50/UL|NOT DONE||N|NA|Y|2||58||FOLLOW-UP|1964-08-04||1965-01-26|||1965-06-27||1964-03-12
TRIAL STUDY 134XCP|RP|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|2||||||FUNDHT|FUNDAL HEIGHT||||PMOL/10^9 CELLS|||MU|NOT DONE||NA|Y|N|2||58||SCREENING|1966-03-28||1971-11-21|||1960-12-13||1964-12-08
TRIAL STUDY 134XCP|RP|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|1||||||BRTHN|NUMBER OF BIRTHS||||UMOL/DAY|||BQ/L|NOT DONE||N|NA|U|3||39||LONG-TERM FOLLOW-UP|1963-02-10||1973-04-19|||1963-01-10||1966-05-17
TRIAL STUDY 134XCP|RP|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||K|||NMOL BCE/MMOL|NOT DONE||N|U|U|3||39||TREATMENT|1963-07-12||1962-02-10|||1965-09-08||1966-12-14
TRIAL STUDY 134XCP|RP|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||LM|||FINGERTIP UNIT|NOT DONE||N|Y|NA|4||88||TREATMENT|1973-02-01||1970-12-15|||1968-04-23||1968-10-30
TRIAL STUDY 134XCP|RP|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||LM|||MOL/ML|NOT DONE||N|Y|NA|4||88||FOLLOW-UP|1960-04-11||1965-03-01|||1971-04-30||1970-10-13
TRIAL STUDY 134XCP|RP|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|1||||||EDEMAIND|EDEMA INDICATOR||||OZ EQ|||USIEMENS|NOT DONE||Y|Y|Y|5||7||WASHOUT|1967-05-06||1963-04-24|||1971-10-21||1960-08-24
TRIAL STUDY 134XCP|RP|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|2||||||DSCHGIND|DISCHARGE INDICATOR||||HZ|||AGU/ML|NOT DONE||U|Y|NA|5||7||CONTINUATION TREATMENT|1960-05-03||1971-04-15|||1971-01-22||1964-05-31
TRIAL STUDY 134XCP|RP|59A9826F-4C2F-482A-8888-F649544318BE|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||CI/G|||DL|NOT DONE||Y|U|N|1||38||OBSERVATION|1967-02-22||1961-08-15|||1962-11-27||1962-09-14
TRIAL STUDY 134XCP|RP|59A9826F-4C2F-482A-8888-F649544318BE|2||||||TNDRIND|TENDERNESS INDICATOR||||UMOL/H/MMOL|||MEQ/L|NOT DONE||NA|U|N|1||38||WASHOUT|1964-12-22||1970-11-07|||1960-03-17||1963-06-29
TRIAL STUDY 134XCP|RP|59A9826F-4C2F-482A-8888-F649544318BE|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MEQ/KG|||DPM/ML|NOT DONE||Y|U|N|2||58||INDUCTION TREATMENT|1971-12-13||1960-01-25|||1968-05-16||1966-06-15
TRIAL STUDY 134XCP|RP|59A9826F-4C2F-482A-8888-F649544318BE|2||||||PRGENDTC|DATE PREGNANCY ENDED||||G|||CI/ML|NOT DONE||Y|NA|NA|2||58||BLINDED TREATMENT|1969-02-01||1969-01-19|||1969-01-25||1968-11-21
TRIAL STUDY 134XCP|RP|59A9826F-4C2F-482A-8888-F649544318BE|1||||||FUNDHT|FUNDAL HEIGHT||||BU|||BOWL|NOT DONE||U|U|Y|3||39||FOLLOW-UP|1973-08-10||1965-05-17|||1960-01-28||1969-08-16
TRIAL STUDY 134XCP|RP|59A9826F-4C2F-482A-8888-F649544318BE|2||||||PREGST|PREGNANT DURING THE STUDY||||10^6/L|||CPM|NOT DONE||U|Y|U|3||39||LONG-TERM FOLLOW-UP|1964-08-31||1967-12-08|||1970-05-17||1963-07-25
TRIAL STUDY 134XCP|RP|59A9826F-4C2F-482A-8888-F649544318BE|1||||||BRTHN|NUMBER OF BIRTHS||||UMOL/MG/MIN|||PATCH|NOT DONE||Y|U|U|4||88||TREATMENT|1960-07-04||1967-04-02|||1971-06-04||1960-10-03
TRIAL STUDY 134XCP|RP|59A9826F-4C2F-482A-8888-F649544318BE|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||/DAY|||G/DAY|NOT DONE||Y|N|NA|4||88||FOLLOW-UP|1968-07-30||1971-03-04|||1968-06-06||1969-06-28
TRIAL STUDY 134XCP|RP|59A9826F-4C2F-482A-8888-F649544318BE|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||AG|||UCI|NOT DONE||NA|N|U|5||7||SCREENING|1967-12-28||1961-06-01|||1969-08-13||1960-09-23
TRIAL STUDY 134XCP|RP|59A9826F-4C2F-482A-8888-F649544318BE|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||HR/DAY|||MMAL|NOT DONE||NA|Y|U|5||7||CONTINUATION TREATMENT|1973-02-08||1973-08-01|||1961-03-26||1972-04-30
TRIAL STUDY 134XCP|RP|B6E55A62-CF0B-4BC6-84DC-038F29518909|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||UKAT/L|||MNFI|NOT DONE||U|Y|Y|1||38||RUN-IN|1964-08-23||1960-04-01|||1969-06-22||1964-02-23
TRIAL STUDY 134XCP|RP|B6E55A62-CF0B-4BC6-84DC-038F29518909|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||BAR|||NMOL/KG/DAY|NOT DONE||N|NA|U|1||38||BASELINE|1970-12-21||1971-01-23|||1966-09-23||1965-11-15
TRIAL STUDY 134XCP|RP|B6E55A62-CF0B-4BC6-84DC-038F29518909|1||||||PREGNN|NUMBER OF PREGNANCIES||||MPH|||UG/L FEU|NOT DONE||NA|U|N|2||58||BLINDED TREATMENT|1972-06-03||1962-11-10|||1964-03-28||1969-06-09
TRIAL STUDY 134XCP|RP|B6E55A62-CF0B-4BC6-84DC-038F29518909|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||10^6 ORGANISMS/MG|||MGEQ|NOT DONE||U|NA|U|2||58||OBSERVATION|1961-08-02||1971-05-27|||1968-11-18||1960-12-28
TRIAL STUDY 134XCP|RP|B6E55A62-CF0B-4BC6-84DC-038F29518909|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MEQ/KG|||ENZYME U/M2|NOT DONE||Y|NA|N|3||39||WASHOUT|1969-07-03||1973-06-13|||1966-05-17||1965-09-01
TRIAL STUDY 134XCP|RP|B6E55A62-CF0B-4BC6-84DC-038F29518909|2||||||MENOSTAT|MENOPAUSE STATUS||||LB|||FMOL|NOT DONE||N|N|NA|3||39||INDUCTION TREATMENT|1965-11-03||1964-01-10|||1962-01-06||1970-04-14
TRIAL STUDY 134XCP|RP|B6E55A62-CF0B-4BC6-84DC-038F29518909|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MMAL|||UMOL/L/H|NOT DONE||Y|NA|U|4||88||TREATMENT|1963-08-09||1972-09-25|||1972-12-27||1965-09-25
TRIAL STUDY 134XCP|RP|B6E55A62-CF0B-4BC6-84DC-038F29518909|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||BREATHS/MIN|||U/G HB|NOT DONE||U|N|Y|4||88||SCREENING|1970-01-03||1963-06-27|||1964-02-21||1961-12-16
TRIAL STUDY 134XCP|RP|B6E55A62-CF0B-4BC6-84DC-038F29518909|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||LOG EID 50/DOSE|||AFU|NOT DONE||U|U|N|5||7||CONTINUATION TREATMENT|1966-08-15||1961-08-13|||1960-01-15||1969-03-16
TRIAL STUDY 134XCP|RP|B6E55A62-CF0B-4BC6-84DC-038F29518909|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MG/G/MIN|||UL/ML|NOT DONE||Y|Y|N|5||7||BASELINE|1967-01-06||1971-02-08|||1973-01-19||1968-09-12
TRIAL STUDY 134XCP|RP|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||PFU/ML|||U|NOT DONE||Y|NA|NA|1||38||TREATMENT|1971-08-25||1961-02-12|||1964-05-21||1965-04-11
TRIAL STUDY 134XCP|RP|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|2||||||MENARAGE|MENARCHE AGE||||DRUM|||UMOL/DL|NOT DONE||U|N|N|1||38||BLINDED TREATMENT|1962-06-03||1961-08-17|||1970-12-27||1965-01-15
TRIAL STUDY 134XCP|RP|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||OI50|||GBQ/G|NOT DONE||N|NA|Y|2||58||BLINDED TREATMENT|1971-09-08||1966-12-11|||1961-05-23||1969-06-03
TRIAL STUDY 134XCP|RP|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|2||||||STILBIND|STILLBIRTH INDICATOR||||KA_U/DL|||CM/S|NOT DONE||NA|N|Y|2||58||CONTINUATION TREATMENT|1966-02-10||1970-11-27|||1960-05-27||1966-02-21
TRIAL STUDY 134XCP|RP|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||PSI|||U/G|NOT DONE||NA|Y|Y|3||39||OBSERVATION|1965-11-12||1960-04-18|||1966-03-02||1964-05-15
TRIAL STUDY 134XCP|RP|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||LOZENGE|||G|NOT DONE||Y|Y|NA|3||39||FOLLOW-UP|1962-09-15||1972-11-21|||1962-12-27||1962-09-18
TRIAL STUDY 134XCP|RP|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|1||||||PREGST|PREGNANT DURING THE STUDY||||ML/H|||KG/MOL|NOT DONE||U|U|U|4||88||LONG-TERM FOLLOW-UP|1970-08-15||1973-07-29|||1961-02-04||1972-01-13
TRIAL STUDY 134XCP|RP|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|2||||||RASHIND|RASH INDICATOR||||10^12 IU/L|||FT2|NOT DONE||NA|NA|N|4||88||RUN-IN|1969-01-16||1972-06-19|||1971-04-09||1973-04-26
TRIAL STUDY 134XCP|RP|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|1||||||MENARAGE|MENARCHE AGE||||MMOL/L|||PNU/ML|NOT DONE||U|Y|N|5||7||FOLLOW-UP|1961-04-20||1965-12-04|||1968-03-20||1971-05-31
TRIAL STUDY 134XCP|RP|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|2||||||INTP|INTERPRETATION||||GRAIN|||100 IU/ML|NOT DONE||U|Y|NA|5||7||BASELINE|1960-02-09||1965-04-22|||1963-12-08||1964-02-01
TRIAL STUDY 134XCP|RP|5577E914-C90D-4CC4-A7A8-D919C29A61D1|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||HEP|||MDFI|NOT DONE||N|NA|NA|1||38||OPEN LABEL TREATMENT|1960-10-26||1973-07-13|||1966-01-24||1973-07-17
TRIAL STUDY 134XCP|RP|5577E914-C90D-4CC4-A7A8-D919C29A61D1|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||PMOL/L|||MIU/L|NOT DONE||NA|Y|N|1||38||RUN-IN|1964-09-28||1971-06-24|||1971-12-04||1969-07-19
TRIAL STUDY 134XCP|RP|5577E914-C90D-4CC4-A7A8-D919C29A61D1|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||CL|||GPELISA UNIT/ML|NOT DONE||NA|NA|Y|2||58||FOLLOW-UP|1973-01-02||1962-02-20|||1970-09-26||1968-05-12
TRIAL STUDY 134XCP|RP|5577E914-C90D-4CC4-A7A8-D919C29A61D1|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^9 CFU/ML|||CI/L|NOT DONE||N|Y|N|2||58||BLINDED TREATMENT|1964-05-12||1972-05-23|||1971-02-13||1970-03-20
TRIAL STUDY 134XCP|RP|5577E914-C90D-4CC4-A7A8-D919C29A61D1|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||DB|||ENZYME U/L|NOT DONE||N|NA|U|3||39||WASHOUT|1965-05-19||1967-11-13|||1971-11-25||1967-09-26
TRIAL STUDY 134XCP|RP|5577E914-C90D-4CC4-A7A8-D919C29A61D1|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||UOSM|||10^6 ORGANISMS/G|NOT DONE||NA|NA|Y|3||39||WASHOUT|1961-03-11||1965-10-09|||1966-05-09||1965-09-23
TRIAL STUDY 134XCP|RP|5577E914-C90D-4CC4-A7A8-D919C29A61D1|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||CL|||UMOL/MIN|NOT DONE||Y|U|U|4||88||OPEN LABEL TREATMENT|1966-08-02||1961-04-14|||1964-03-30||1963-09-13
TRIAL STUDY 134XCP|RP|5577E914-C90D-4CC4-A7A8-D919C29A61D1|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/G|||SYRINGE|NOT DONE||N|Y|NA|4||88||SCREENING|1964-01-06||1969-03-29|||1969-02-11||1971-09-20
TRIAL STUDY 134XCP|RP|5577E914-C90D-4CC4-A7A8-D919C29A61D1|1||||||EDEMAIND|EDEMA INDICATOR||||HOMEOPATHIC DILUTION|||MG/ML/DAY|NOT DONE||U|N|N|5||7||INDUCTION TREATMENT|1968-06-06||1969-07-16|||1967-08-23||1968-07-09
TRIAL STUDY 134XCP|RP|5577E914-C90D-4CC4-A7A8-D919C29A61D1|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MOSM|||NKAT/G HB|NOT DONE||U|U|NA|5||7||RUN-IN|1964-04-06||1967-11-11|||1971-01-25||1961-11-22
TRIAL STUDY 134XCP|RP|2DBA8940-F59E-4A0D-8858-408D71DD9753|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||BQ/G|||FRAMES/S|NOT DONE||NA|Y|Y|1||38||BLINDED TREATMENT|1968-09-30||1961-01-06|||1971-05-28||1960-09-27
TRIAL STUDY 134XCP|RP|2DBA8940-F59E-4A0D-8858-408D71DD9753|2||||||INABOIND|INDUCED ABORTION INDICATOR||||10^8 PFU|||DPM/100MG|NOT DONE||N|NA|NA|1||38||OBSERVATION|1968-08-08||1971-01-15|||1961-03-16||1966-04-05
TRIAL STUDY 134XCP|RP|2DBA8940-F59E-4A0D-8858-408D71DD9753|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||G/L|||MOL|NOT DONE||N|U|NA|2||58||BASELINE|1961-10-09||1964-12-09|||1969-03-31||1967-08-12
TRIAL STUDY 134XCP|RP|2DBA8940-F59E-4A0D-8858-408D71DD9753|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||VIRTUAL PIXEL|||CAL|NOT DONE||NA|NA|NA|2||58||OBSERVATION|1971-05-22||1960-02-03|||1967-03-23||1961-05-25
TRIAL STUDY 134XCP|RP|2DBA8940-F59E-4A0D-8858-408D71DD9753|1||||||BCMETHOD|BIRTH CONTROL METHOD||||PMOL/10^9 CELLS|||MOL|NOT DONE||Y|NA|N|3||39||TREATMENT|1963-08-12||1973-05-27|||1969-03-09||1970-11-11
TRIAL STUDY 134XCP|RP|2DBA8940-F59E-4A0D-8858-408D71DD9753|2||||||STILBIND|STILLBIRTH INDICATOR||||CM2|||UMOL/L/MIN|NOT DONE||N|NA|Y|3||39||CONTINUATION TREATMENT|1969-09-21||1963-03-27|||1964-11-06||1967-06-15
TRIAL STUDY 134XCP|RP|2DBA8940-F59E-4A0D-8858-408D71DD9753|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||LOG10 TCID 50/DOSE|||MMOL/KG|NOT DONE||NA|N|U|4||88||BASELINE|1970-09-30||1960-04-01|||1969-01-13||1972-11-16
TRIAL STUDY 134XCP|RP|2DBA8940-F59E-4A0D-8858-408D71DD9753|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||IU/G|||MM|NOT DONE||NA|Y|N|4||88||WASHOUT|1963-10-06||1963-12-07|||1973-03-05||1967-07-06
TRIAL STUDY 134XCP|RP|2DBA8940-F59E-4A0D-8858-408D71DD9753|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MG/CM2|||UGEQ|NOT DONE||NA|N|Y|5||7||CONTINUATION TREATMENT|1965-08-24||1970-05-11|||1963-06-02||1966-05-18
TRIAL STUDY 134XCP|RP|2DBA8940-F59E-4A0D-8858-408D71DD9753|2||||||EDEMAIND|EDEMA INDICATOR||||MV/SEC|||NMOL/DAY|NOT DONE||U|U|U|5||7||WASHOUT|1963-08-15||1972-03-13|||1971-01-24||1972-08-28
TRIAL STUDY 134XCP|RP|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|1||||||STILBIND|STILLBIRTH INDICATOR||||U/G/MIN|||ENZYME U/L|NOT DONE||U|N|NA|1||38||SCREENING|1967-01-22||1967-06-16|||1963-07-04||1963-05-01
TRIAL STUDY 134XCP|RP|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||LOG10 PFU/ML|||M/SEC|NOT DONE||Y|NA|NA|1||38||BASELINE|1965-02-21||1965-09-17|||1960-01-10||1967-02-24
TRIAL STUDY 134XCP|RP|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||VIRTUAL PIXEL|||PM|NOT DONE||N|NA|Y|2||58||SCREENING|1966-09-01||1968-07-28|||1973-03-11||1973-07-22
TRIAL STUDY 134XCP|RP|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UMOL/MOL|||UL/ML|NOT DONE||U|U|Y|2||58||OBSERVATION|1965-08-09||1961-02-20|||1965-11-23||1967-06-09
TRIAL STUDY 134XCP|RP|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||SUPPOSITORY|||ML/MMHG/MIN/L|NOT DONE||NA|Y|Y|3||39||LONG-TERM FOLLOW-UP|1968-08-18||1966-11-08|||1960-01-14||1972-10-16
TRIAL STUDY 134XCP|RP|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||NEEDLE GAUGE|||10^4 CFU|NOT DONE||U|U|U|3||39||TREATMENT|1963-09-10||1963-08-02|||1972-02-22||1960-04-23
TRIAL STUDY 134XCP|RP|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|1||||||PREGST|PREGNANT DURING THE STUDY||||10^3 CFU/G|||MPA|NOT DONE||U|Y|NA|4||88||BASELINE|1967-05-09||1967-06-26|||1966-03-18||1968-04-06
TRIAL STUDY 134XCP|RP|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||AMOL|||CI/G|NOT DONE||Y|N|Y|4||88||WASHOUT|1964-05-02||1971-01-30|||1971-01-21||1961-11-21
TRIAL STUDY 134XCP|RP|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|1||||||MENOSTAT|MENOPAUSE STATUS||||U/MMOL|||CL|NOT DONE||Y|U|N|5||7||FOLLOW-UP|1961-06-15||1960-09-13|||1971-12-06||1973-02-11
TRIAL STUDY 134XCP|RP|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|2||||||BCMETHOD|BIRTH CONTROL METHOD||||FT2|||PG/L|NOT DONE||Y|Y|NA|5||7||RUN-IN|1960-11-01||1969-06-15|||1960-10-05||1964-10-16
TRIAL STUDY 134XCP|RP|0250EC5D-B08F-4010-9653-95E20EDD0CCA|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||UMOL/H/MMOL|||MASK|NOT DONE||N|N|Y|1||38||RUN-IN|1971-09-22||1971-08-04|||1965-06-24||1968-01-20
TRIAL STUDY 134XCP|RP|0250EC5D-B08F-4010-9653-95E20EDD0CCA|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/40 HPFS|||CUP EQ|NOT DONE||U|Y|Y|1||38||OPEN LABEL TREATMENT|1965-11-01||1971-10-12|||1972-06-30||1970-03-26
TRIAL STUDY 134XCP|RP|0250EC5D-B08F-4010-9653-95E20EDD0CCA|1||||||BCMETHOD|BIRTH CONTROL METHOD||||PFU/DOSE|||10^3 ORGANISMS/ML|NOT DONE||N|U|U|2||58||BASELINE|1972-10-26||1971-10-10|||1962-02-10||1961-02-24
TRIAL STUDY 134XCP|RP|0250EC5D-B08F-4010-9653-95E20EDD0CCA|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||TSP EQ|||ML/100G/MIN|NOT DONE||Y|U|Y|2||58||BLINDED TREATMENT|1967-06-07||1966-04-08|||1963-05-22||1960-05-18
TRIAL STUDY 134XCP|RP|0250EC5D-B08F-4010-9653-95E20EDD0CCA|1||||||THICK|THICKNESS||||PMOL/DL|||YD|NOT DONE||Y|Y|U|3||39||SCREENING|1967-02-15||1964-02-10|||1970-09-25||1962-07-05
TRIAL STUDY 134XCP|RP|0250EC5D-B08F-4010-9653-95E20EDD0CCA|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MIN*MG/ML|||CGY|NOT DONE||U|U|U|3||39||FOLLOW-UP|1965-10-21||1967-02-04|||1971-03-26||1964-03-22
TRIAL STUDY 134XCP|RP|0250EC5D-B08F-4010-9653-95E20EDD0CCA|1||||||BRTHN|NUMBER OF BIRTHS||||FMOL|||DPM/0.5 ML|NOT DONE||Y|N|NA|4||88||OPEN LABEL TREATMENT|1960-07-20||1960-12-22|||1960-04-11||1967-02-12
TRIAL STUDY 134XCP|RP|0250EC5D-B08F-4010-9653-95E20EDD0CCA|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||KG/CM|||IU/MG|NOT DONE||Y|NA|N|4||88||TREATMENT|1965-02-01||1963-09-08|||1973-06-16||1962-02-02
TRIAL STUDY 134XCP|RP|0250EC5D-B08F-4010-9653-95E20EDD0CCA|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^6 CFU/G|||UMOL/DL|NOT DONE||NA|NA|NA|5||7||SCREENING|1969-07-11||1967-01-21|||1968-02-21||1970-02-05
TRIAL STUDY 134XCP|RP|0250EC5D-B08F-4010-9653-95E20EDD0CCA|2||||||PRGENDTC|DATE PREGNANCY ENDED||||QUANTITY SUFFICIENT|||ELISA UNIT|NOT DONE||NA|U|N|5||7||INDUCTION TREATMENT|1967-09-30||1970-03-28|||1965-03-28||1968-06-27
TRIAL STUDY 134XCP|RP|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||ML/CAGE/WK|||KG/MOL|NOT DONE||Y|Y|NA|1||38||CONTINUATION TREATMENT|1972-09-15||1961-03-01|||1971-01-19||1965-05-22
TRIAL STUDY 134XCP|RP|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|2||||||ERYTHIND|ERYTHEMA INDICATOR||||TUBERCULIN UNIT|||HEP|NOT DONE||Y|Y|NA|1||38||RUN-IN|1966-09-08||1968-02-10|||1969-07-09||1972-05-05
TRIAL STUDY 134XCP|RP|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MG/CM2|||%(V/V)|NOT DONE||N|Y|NA|2||58||FOLLOW-UP|1973-07-17||1972-04-24|||1970-06-07||1973-04-04
TRIAL STUDY 134XCP|RP|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||UL/KG/DAY|||FOZ_US|NOT DONE||N|NA|U|2||58||TREATMENT|1967-10-04||1967-03-03|||1964-05-16||1969-05-26
TRIAL STUDY 134XCP|RP|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||/VF|||ML/S|NOT DONE||NA|N|NA|3||39||CONTINUATION TREATMENT|1969-11-26||1960-01-14|||1964-03-11||1966-08-10
TRIAL STUDY 134XCP|RP|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||CAPSULE|||COPIES/ML|NOT DONE||Y|N|NA|3||39||TREATMENT|1972-05-03||1967-02-27|||1967-04-15||1961-09-27
TRIAL STUDY 134XCP|RP|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|1||||||INABOIND|INDUCED ABORTION INDICATOR||||HEP|||BP|NOT DONE||Y|Y|NA|4||88||BLINDED TREATMENT|1965-02-14||1964-07-23|||1963-06-10||1960-10-16
TRIAL STUDY 134XCP|RP|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||BAU|||L/S|NOT DONE||NA|N|NA|4||88||FOLLOW-UP|1960-05-26||1967-08-07|||1972-12-19||1962-02-16
TRIAL STUDY 134XCP|RP|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||PFU/ML|||FT2|NOT DONE||N|U|NA|5||7||WASHOUT|1961-09-23||1968-12-24|||1964-08-18||1963-06-09
TRIAL STUDY 134XCP|RP|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|2||||||MENFDUR|MENSES FLOW DURATION||||CM/MIN|||ELISA UNIT|NOT DONE||N|NA|U|5||7||WASHOUT|1964-12-07||1967-06-07|||1967-09-05||1963-12-06
TRIAL STUDY 134XCP|RP|140FFC83-72C9-4BD4-AA44-C98CA42147F3|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||FINGERTIP UNIT|||BQ/KG|NOT DONE||NA|Y|N|1||38||WASHOUT|1970-07-24||1964-12-10|||1968-10-02||1972-07-07
TRIAL STUDY 134XCP|RP|140FFC83-72C9-4BD4-AA44-C98CA42147F3|2||||||INTP|INTERPRETATION||||HZ|||U/G/MIN|NOT DONE||U|N|Y|1||38||BASELINE|1960-12-05||1970-10-16|||1972-05-20||1969-02-15
TRIAL STUDY 134XCP|RP|140FFC83-72C9-4BD4-AA44-C98CA42147F3|1||||||INABOIND|INDUCED ABORTION INDICATOR||||/500 WBC|||FT|NOT DONE||U|N|Y|2||58||RUN-IN|1968-04-30||1972-09-23|||1970-11-12||1965-04-12
TRIAL STUDY 134XCP|RP|140FFC83-72C9-4BD4-AA44-C98CA42147F3|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||BQ/L|||100 IU/ML|NOT DONE||Y|U|Y|2||58||BLINDED TREATMENT|1960-08-16||1963-08-19|||1967-02-16||1961-04-04
TRIAL STUDY 134XCP|RP|140FFC83-72C9-4BD4-AA44-C98CA42147F3|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UG/H|||LOG10 TCID 50/DOSE|NOT DONE||Y|NA|NA|3||39||RUN-IN|1963-10-13||1966-05-04|||1961-03-16||1960-08-24
TRIAL STUDY 134XCP|RP|140FFC83-72C9-4BD4-AA44-C98CA42147F3|2||||||ABORTN|NUMBER OF ABORTIONS||||MPL U|||CI|NOT DONE||N|N|N|3||39||BASELINE|1962-04-05||1969-10-26|||1968-09-30||1967-08-25
TRIAL STUDY 134XCP|RP|140FFC83-72C9-4BD4-AA44-C98CA42147F3|1||||||ABORTN|NUMBER OF ABORTIONS||||CFU/G|||PMOL/L|NOT DONE||Y|U|NA|4||88||BLINDED TREATMENT|1967-12-17||1970-05-05|||1964-03-11||1972-02-01
TRIAL STUDY 134XCP|RP|140FFC83-72C9-4BD4-AA44-C98CA42147F3|2||||||PRGENDTC|DATE PREGNANCY ENDED||||DB|||TAMPON|NOT DONE||U|NA|NA|4||88||SCREENING|1968-06-21||1966-12-13|||1972-04-05||1963-10-02
TRIAL STUDY 134XCP|RP|140FFC83-72C9-4BD4-AA44-C98CA42147F3|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||DEG/MM|||MEQ/UG|NOT DONE||N|NA|NA|5||7||OBSERVATION|1961-01-02||1967-05-23|||1971-05-28||1967-06-19
TRIAL STUDY 134XCP|RP|140FFC83-72C9-4BD4-AA44-C98CA42147F3|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MM/MIN|||VIRTUAL PIXEL|NOT DONE||U|N|U|5||7||OBSERVATION|1962-01-12||1970-12-27|||1961-09-08||1964-09-20
TRIAL STUDY 134XCP|RP|7BAC399A-0523-476E-A294-C57309E573AF|1||||||PUSTIND|PUSTULE INDICATOR||||KM/H|||DDU|NOT DONE||U|N|N|1||38||WASHOUT|1963-01-30||1968-06-12|||1972-11-01||1966-06-01
TRIAL STUDY 134XCP|RP|7BAC399A-0523-476E-A294-C57309E573AF|2||||||INABOIND|INDUCED ABORTION INDICATOR||||CI|||MG/G/H|NOT DONE||NA|Y|U|1||38||INDUCTION TREATMENT|1971-07-29||1964-08-24|||1964-12-08||1966-06-14
TRIAL STUDY 134XCP|RP|7BAC399A-0523-476E-A294-C57309E573AF|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||NU/CL|||MM/2H|NOT DONE||NA|U|N|2||58||CONTINUATION TREATMENT|1961-09-21||1968-04-13|||1970-10-23||1964-08-22
TRIAL STUDY 134XCP|RP|7BAC399A-0523-476E-A294-C57309E573AF|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||IN2|||LOG10 TCID 50/DOSE|NOT DONE||Y|N|U|2||58||OBSERVATION|1961-07-06||1965-04-13|||1969-08-16||1964-08-24
TRIAL STUDY 134XCP|RP|7BAC399A-0523-476E-A294-C57309E573AF|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||%/MIN|||%(W/W)|NOT DONE||U|NA|U|3||39||FOLLOW-UP|1965-07-12||1963-04-09|||1969-02-14||1972-12-18
TRIAL STUDY 134XCP|RP|7BAC399A-0523-476E-A294-C57309E573AF|2||||||FUNDHT|FUNDAL HEIGHT||||UEQ/L|||DPM/0.5 ML|NOT DONE||U|U|Y|3||39||OBSERVATION|1964-07-05||1960-02-29|||1967-04-26||1961-03-18
TRIAL STUDY 134XCP|RP|7BAC399A-0523-476E-A294-C57309E573AF|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||ANTI-XA IU/ML|||/4.0 ML|NOT DONE||U|Y|Y|4||88||WASHOUT|1970-05-15||1967-06-25|||1968-07-22||1961-05-07
TRIAL STUDY 134XCP|RP|7BAC399A-0523-476E-A294-C57309E573AF|2||||||TNDRIND|TENDERNESS INDICATOR||||POINT|||CL|NOT DONE||U|N|NA|4||88||CONTINUATION TREATMENT|1973-03-18||1969-02-25|||1972-05-06||1962-06-09
TRIAL STUDY 134XCP|RP|7BAC399A-0523-476E-A294-C57309E573AF|1||||||PEELIND|PEELING INDICATOR||||BQ/UG|||ML/MIN|NOT DONE||NA|Y|U|5||7||TREATMENT|1967-12-26||1962-05-11|||1972-02-01||1965-06-29
TRIAL STUDY 134XCP|RP|7BAC399A-0523-476E-A294-C57309E573AF|2||||||PREGNN|NUMBER OF PREGNANCIES||||MMU/ML|||RATIO|NOT DONE||Y|U|U|5||7||TREATMENT|1960-10-09||1966-08-13|||1970-04-01||1967-07-12
TRIAL STUDY 134XCP|RP|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MG/KG/H|||/2000 RBC|NOT DONE||NA|Y|Y|1||38||OPEN LABEL TREATMENT|1971-10-02||1966-11-18|||1970-02-11||1968-05-24
TRIAL STUDY 134XCP|RP|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|2||||||PRGENDTC|DATE PREGNANCY ENDED||||HOMEOPATHIC DILUTION|||/200 HPFS|NOT DONE||N|U|NA|1||38||RUN-IN|1971-06-05||1960-03-01|||1972-05-30||1962-05-09
TRIAL STUDY 134XCP|RP|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||L/S/KPA|||MG/G/H|NOT DONE||N|Y|U|2||58||CONTINUATION TREATMENT|1966-03-05||1965-07-19|||1961-02-02||1962-02-07
TRIAL STUDY 134XCP|RP|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||PHERESIS UNIT|||/100 HPFS|NOT DONE||U|Y|U|2||58||RUN-IN|1960-01-13||1966-04-03|||1968-07-26||1972-03-29
TRIAL STUDY 134XCP|RP|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||ML/KG|||NEWTON|NOT DONE||Y|NA|N|3||39||OBSERVATION|1960-05-07||1970-07-03|||1962-04-03||1972-07-07
TRIAL STUDY 134XCP|RP|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|2||||||ULCERIND|ULCER INDICATOR||||BU/ML|||NEEDLE GAUGE|NOT DONE||Y|NA|N|3||39||CONTINUATION TREATMENT|1972-09-05||1963-03-24|||1970-06-01||1960-01-22
TRIAL STUDY 134XCP|RP|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|1||||||MASSIND|MASS INDICATOR||||ECL UNIT|||DEG2|NOT DONE||NA|N|U|4||88||OBSERVATION|1970-09-30||1969-08-22|||1964-07-12||1962-09-03
TRIAL STUDY 134XCP|RP|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|2||||||INTP|INTERPRETATION||||PT_BR|||TBSP|NOT DONE||N|Y|N|4||88||LONG-TERM FOLLOW-UP|1969-09-26||1960-10-09|||1969-12-16||1972-12-01
TRIAL STUDY 134XCP|RP|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|1||||||INABOIND|INDUCED ABORTION INDICATOR||||L/H/M2|||UMOL/L|NOT DONE||NA|NA|N|5||7||OPEN LABEL TREATMENT|1972-05-25||1960-07-30|||1969-10-08||1972-10-18
TRIAL STUDY 134XCP|RP|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|2||||||PUSTIND|PUSTULE INDICATOR||||MG|||BOX|NOT DONE||NA|N|U|5||7||BASELINE|1973-02-02||1971-02-26|||1971-10-09||1968-04-17
TRIAL STUDY 134XCP|RP|0F180E62-F840-490F-8EB3-F7DDB7132401|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||G/M2|||VG/ML|NOT DONE||Y|U|Y|1||38||BLINDED TREATMENT|1973-03-21||1970-05-31|||1973-06-29||1972-08-02
TRIAL STUDY 134XCP|RP|0F180E62-F840-490F-8EB3-F7DDB7132401|2||||||DLVRMODE|MODE OF DELIVERY||||PPB|||MIN*MG/ML|NOT DONE||N|Y|NA|1||38||SCREENING|1971-12-02||1965-07-29|||1961-07-10||1965-12-13
TRIAL STUDY 134XCP|RP|0F180E62-F840-490F-8EB3-F7DDB7132401|1||||||PREGIND|PREGNANT INDICATOR||||/SEC|||U/L|NOT DONE||NA|Y|N|2||58||WASHOUT|1973-08-06||1968-09-09|||1973-01-30||1965-10-06
TRIAL STUDY 134XCP|RP|0F180E62-F840-490F-8EB3-F7DDB7132401|2||||||FUNDHT|FUNDAL HEIGHT||||SUPPOSITORY|||U/CL|NOT DONE||NA|NA|N|2||58||RUN-IN|1964-10-16||1968-04-17|||1960-06-20||1963-10-02
TRIAL STUDY 134XCP|RP|0F180E62-F840-490F-8EB3-F7DDB7132401|1||||||PREGST|PREGNANT DURING THE STUDY||||ML/CM3/MIN|||U/KG/H|NOT DONE||N|Y|NA|3||39||WASHOUT|1964-06-20||1966-04-18|||1961-10-12||1968-06-20
TRIAL STUDY 134XCP|RP|0F180E62-F840-490F-8EB3-F7DDB7132401|2||||||PRGENDTC|DATE PREGNANCY ENDED||||IU/DAY|||PMOL/L/H|NOT DONE||NA|Y|N|3||39||RUN-IN|1972-12-14||1962-09-13|||1972-11-25||1967-08-29
TRIAL STUDY 134XCP|RP|0F180E62-F840-490F-8EB3-F7DDB7132401|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||GENEQ/ML|||/KG|NOT DONE||Y|N|Y|4||88||RUN-IN|1972-07-05||1969-01-29|||1960-12-29||1971-08-12
TRIAL STUDY 134XCP|RP|0F180E62-F840-490F-8EB3-F7DDB7132401|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||KBQ|||NEWTON|NOT DONE||Y|Y|U|4||88||BASELINE|1964-02-09||1970-11-23|||1969-06-10||1965-11-23
TRIAL STUDY 134XCP|RP|0F180E62-F840-490F-8EB3-F7DDB7132401|1||||||THICK|THICKNESS||||AMP|||DPM|NOT DONE||Y|NA|U|5||7||FOLLOW-UP|1969-06-29||1973-01-21|||1968-11-22||1972-04-06
TRIAL STUDY 134XCP|RP|0F180E62-F840-490F-8EB3-F7DDB7132401|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||S/H|||AMU|NOT DONE||N|N|U|5||7||TREATMENT|1964-10-04||1965-01-26|||1970-01-25||1965-01-27
TRIAL STUDY 134XCP|RP|80E7A428-CDDE-453F-B7D1-1B282A1835BF|1||||||ULCERIND|ULCER INDICATOR||||U/G/MIN|||U/KG/H|NOT DONE||Y|U|Y|1||38||INDUCTION TREATMENT|1965-04-19||1964-11-26|||1969-03-16||1969-04-16
TRIAL STUDY 134XCP|RP|80E7A428-CDDE-453F-B7D1-1B282A1835BF|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||EID 50/ML|||UG|NOT DONE||N|NA|Y|1||38||BASELINE|1970-05-22||1962-05-01|||1971-02-12||1961-07-28
TRIAL STUDY 134XCP|RP|80E7A428-CDDE-453F-B7D1-1B282A1835BF|1||||||MENOSTAT|MENOPAUSE STATUS||||UG/G/MIN|||KV|NOT DONE||U|N|U|2||58||SCREENING|1964-10-10||1971-06-23|||1971-05-04||1971-06-12
TRIAL STUDY 134XCP|RP|80E7A428-CDDE-453F-B7D1-1B282A1835BF|2||||||MENOAGE|MENOPAUSE AGE||||IU/G|||DPM/MG|NOT DONE||Y|NA|N|2||58||INDUCTION TREATMENT|1965-12-31||1966-01-16|||1967-04-13||1963-04-29
TRIAL STUDY 134XCP|RP|80E7A428-CDDE-453F-B7D1-1B282A1835BF|1||||||ULCERIND|ULCER INDICATOR||||CI/L|||MM/2H|NOT DONE||N|NA|Y|3||39||OBSERVATION|1970-07-26||1966-11-14|||1965-06-02||1960-04-20
TRIAL STUDY 134XCP|RP|80E7A428-CDDE-453F-B7D1-1B282A1835BF|2||||||MENOAGE|MENOPAUSE AGE||||IMPLANT|||MU|NOT DONE||NA|Y|Y|3||39||SCREENING|1963-10-02||1973-06-08|||1965-08-08||1966-05-18
TRIAL STUDY 134XCP|RP|80E7A428-CDDE-453F-B7D1-1B282A1835BF|1||||||MENFDUR|MENSES FLOW DURATION||||IU/ML|||SPRAY|NOT DONE||U|N|Y|4||88||OPEN LABEL TREATMENT|1966-02-06||1964-06-10|||1972-04-23||1971-05-20
TRIAL STUDY 134XCP|RP|80E7A428-CDDE-453F-B7D1-1B282A1835BF|2||||||RASHIND|RASH INDICATOR||||DPM/0.5 ML|||SACHET|NOT DONE||NA|U|Y|4||88||LONG-TERM FOLLOW-UP|1963-05-03||1964-09-27|||1972-05-29||1960-07-25
TRIAL STUDY 134XCP|RP|80E7A428-CDDE-453F-B7D1-1B282A1835BF|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||10^6/HPF|||TRACE|NOT DONE||N|U|N|5||7||TREATMENT|1971-04-14||1968-03-13|||1961-08-15||1964-05-16
TRIAL STUDY 134XCP|RP|80E7A428-CDDE-453F-B7D1-1B282A1835BF|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||CIGAR|||EIA UNIT|NOT DONE||NA|NA|Y|5||7||RUN-IN|1966-05-11||1968-10-13|||1971-10-09||1965-08-17
TRIAL STUDY 134XCP|RP|F1D265C4-B975-4E74-9545-122A10FE100F|1||||||PUSTIND|PUSTULE INDICATOR||||AMU|||QUANTITY SUFFICIENT|NOT DONE||Y|U|Y|1||38||SCREENING|1962-08-30||1960-11-30|||1961-10-30||1972-04-25
TRIAL STUDY 134XCP|RP|F1D265C4-B975-4E74-9545-122A10FE100F|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MMAL|||CMH2O/ML|NOT DONE||N|Y|U|1||38||BLINDED TREATMENT|1962-10-14||1961-07-09|||1963-09-30||1971-02-17
TRIAL STUDY 134XCP|RP|F1D265C4-B975-4E74-9545-122A10FE100F|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||H*%|||MEQ/MMOL|NOT DONE||N|U|NA|2||58||CONTINUATION TREATMENT|1968-02-28||1968-07-02|||1967-01-15||1960-09-27
TRIAL STUDY 134XCP|RP|F1D265C4-B975-4E74-9545-122A10FE100F|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||S^-1(%O2)^-1|||L/H|NOT DONE||U|NA|NA|2||58||SCREENING|1960-03-12||1972-09-28|||1965-05-02||1969-05-14
TRIAL STUDY 134XCP|RP|F1D265C4-B975-4E74-9545-122A10FE100F|1||||||MENFDUR|MENSES FLOW DURATION||||NMOL/MOL|||MU|NOT DONE||N|N|Y|3||39||TREATMENT|1962-04-05||1967-02-23|||1968-06-25||1972-05-08
TRIAL STUDY 134XCP|RP|F1D265C4-B975-4E74-9545-122A10FE100F|2||||||PREGST|PREGNANT DURING THE STUDY||||AMFI|||DIOPTER|NOT DONE||NA|U|NA|3||39||BASELINE|1965-07-14||1971-03-02|||1968-03-24||1963-04-27
TRIAL STUDY 134XCP|RP|F1D265C4-B975-4E74-9545-122A10FE100F|1||||||BCMETHOD|BIRTH CONTROL METHOD||||SBE/ML|||MG/DL|NOT DONE||U|N|U|4||88||BASELINE|1969-05-26||1963-03-24|||1967-02-19||1967-10-25
TRIAL STUDY 134XCP|RP|F1D265C4-B975-4E74-9545-122A10FE100F|2||||||BCMETHOD|BIRTH CONTROL METHOD||||10^9 CFU|||TORR|NOT DONE||Y|U|NA|4||88||LONG-TERM FOLLOW-UP|1962-08-15||1968-03-24|||1962-09-13||1965-08-07
TRIAL STUDY 134XCP|RP|F1D265C4-B975-4E74-9545-122A10FE100F|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^9 ORGANISMS/G|||/LSQN|NOT DONE||NA|U|N|5||7||FOLLOW-UP|1962-07-30||1961-12-19|||1961-01-25||1965-06-19
TRIAL STUDY 134XCP|RP|F1D265C4-B975-4E74-9545-122A10FE100F|2||||||PREGNN|NUMBER OF PREGNANCIES||||PMOL/DAY|||MOL/L|NOT DONE||NA|N|N|5||7||BLINDED TREATMENT|1970-10-07||1966-04-19|||1965-07-26||1964-06-24
TRIAL STUDY 134XCP|RP|7A272C35-DB2C-429D-AF31-CC7386DC8F07|1||||||EDEMAIND|EDEMA INDICATOR||||AMFI|||MEQ/UL|NOT DONE||U|Y|U|1||38||INDUCTION TREATMENT|1971-07-18||1970-01-25|||1970-05-07||1968-05-27
TRIAL STUDY 134XCP|RP|7A272C35-DB2C-429D-AF31-CC7386DC8F07|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^7 PFU|||PG|NOT DONE||N|U|Y|1||38||WASHOUT|1961-09-25||1966-04-19|||1968-06-11||1960-01-01
TRIAL STUDY 134XCP|RP|7A272C35-DB2C-429D-AF31-CC7386DC8F07|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MPL U|||UG/CM2|NOT DONE||NA|Y|Y|2||58||OBSERVATION|1961-06-10||1969-09-11|||1972-12-18||1969-02-06
TRIAL STUDY 134XCP|RP|7A272C35-DB2C-429D-AF31-CC7386DC8F07|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MU|||CFU/ML|NOT DONE||Y|U|NA|2||58||INDUCTION TREATMENT|1967-07-10||1962-08-01|||1969-01-14||1972-02-08
TRIAL STUDY 134XCP|RP|7A272C35-DB2C-429D-AF31-CC7386DC8F07|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MM|||PKAT/L|NOT DONE||Y|Y|Y|3||39||CONTINUATION TREATMENT|1971-01-20||1969-07-29|||1962-03-21||1960-09-04
TRIAL STUDY 134XCP|RP|7A272C35-DB2C-429D-AF31-CC7386DC8F07|2||||||ERYTHIND|ERYTHEMA INDICATOR||||GPELISA UNIT/ML|||PLUG|NOT DONE||Y|Y|Y|3||39||BLINDED TREATMENT|1970-10-18||1960-10-04|||1973-09-06||1961-07-17
TRIAL STUDY 134XCP|RP|7A272C35-DB2C-429D-AF31-CC7386DC8F07|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||DEG2|||CI/G|NOT DONE||N|NA|U|4||88||BLINDED TREATMENT|1965-09-08||1960-02-14|||1961-08-16||1968-03-28
TRIAL STUDY 134XCP|RP|7A272C35-DB2C-429D-AF31-CC7386DC8F07|2||||||PEELIND|PEELING INDICATOR||||IN|||MG/KG/DOSE|NOT DONE||U|N|U|4||88||CONTINUATION TREATMENT|1964-09-13||1965-10-03|||1967-06-15||1967-06-09
TRIAL STUDY 134XCP|RP|7A272C35-DB2C-429D-AF31-CC7386DC8F07|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MG/L|||AFU|NOT DONE||NA|N|U|5||7||CONTINUATION TREATMENT|1962-08-24||1960-09-28|||1965-11-15||1961-05-07
TRIAL STUDY 134XCP|RP|7A272C35-DB2C-429D-AF31-CC7386DC8F07|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UG/MOL|||KDA|NOT DONE||NA|NA|N|5||7||BASELINE|1962-10-05||1970-03-05|||1970-03-29||1964-08-01
TRIAL STUDY 134XCP|RP|FBF95CF9-933D-406A-8D67-B1F643C5F554|1||||||RASHIND|RASH INDICATOR||||MG/M2/DAY|||10^9 ORGANISMS/MG|NOT DONE||U|NA|NA|1||38||CONTINUATION TREATMENT|1962-04-10||1960-08-14|||1962-04-13||1971-11-07
TRIAL STUDY 134XCP|RP|FBF95CF9-933D-406A-8D67-B1F643C5F554|2||||||RASHIND|RASH INDICATOR||||PRESSOR UNITS|||WEBER|NOT DONE||U|NA|Y|1||38||WASHOUT|1973-03-10||1972-08-26|||1969-08-07||1967-03-18
TRIAL STUDY 134XCP|RP|FBF95CF9-933D-406A-8D67-B1F643C5F554|1||||||MENFDUR|MENSES FLOW DURATION||||L/S|||MG/KG/DAY|NOT DONE||N|Y|U|2||58||CONTINUATION TREATMENT|1961-02-14||1961-08-20|||1971-01-05||1965-04-04
TRIAL STUDY 134XCP|RP|FBF95CF9-933D-406A-8D67-B1F643C5F554|2||||||RASHIND|RASH INDICATOR||||USEC|||U/KG/MIN|NOT DONE||Y|U|N|2||58||OBSERVATION|1970-02-20||1969-08-07|||1963-09-09||1971-06-03
TRIAL STUDY 134XCP|RP|FBF95CF9-933D-406A-8D67-B1F643C5F554|1||||||RASHIND|RASH INDICATOR||||MM|||FIU|NOT DONE||NA|NA|NA|3||39||INDUCTION TREATMENT|1967-05-22||1973-01-02|||1966-07-05||1965-03-23
TRIAL STUDY 134XCP|RP|FBF95CF9-933D-406A-8D67-B1F643C5F554|2||||||FUNDHT|FUNDAL HEIGHT||||BQ/KG|||MET|NOT DONE||N|U|U|3||39||BASELINE|1963-07-13||1965-03-15|||1969-02-02||1965-07-03
TRIAL STUDY 134XCP|RP|FBF95CF9-933D-406A-8D67-B1F643C5F554|1||||||MENFDUR|MENSES FLOW DURATION||||MV2/HZ|||SIEMENS|NOT DONE||N|U|N|4||88||OPEN LABEL TREATMENT|1968-12-14||1964-04-17|||1962-11-15||1964-04-26
TRIAL STUDY 134XCP|RP|FBF95CF9-933D-406A-8D67-B1F643C5F554|2||||||DSCHGIND|DISCHARGE INDICATOR||||NL|||NFIU|NOT DONE||U|U|U|4||88||OBSERVATION|1971-06-29||1967-02-09|||1971-09-15||1963-08-27
TRIAL STUDY 134XCP|RP|FBF95CF9-933D-406A-8D67-B1F643C5F554|1||||||MENFDUR|MENSES FLOW DURATION||||10^9/G|||IU/G HB|NOT DONE||U|Y|U|5||7||LONG-TERM FOLLOW-UP|1966-12-29||1970-06-12|||1969-08-27||1966-05-21
TRIAL STUDY 134XCP|RP|FBF95CF9-933D-406A-8D67-B1F643C5F554|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||FOZ_BR|||CM|NOT DONE||N|U|U|5||7||LONG-TERM FOLLOW-UP|1969-11-08||1966-07-03|||1960-10-04||1972-08-02
TRIAL STUDY 134XCP|RP|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|1||||||BRTHN|NUMBER OF BIRTHS||||NFIU|||MS2|NOT DONE||N|N|N|1||38||FOLLOW-UP|1962-12-04||1960-05-31|||1962-08-04||1967-05-07
TRIAL STUDY 134XCP|RP|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|2||||||INTP|INTERPRETATION||||KEV|||PPTR|NOT DONE||N|Y|Y|1||38||OBSERVATION|1961-04-18||1961-12-04|||1965-05-21||1963-07-02
TRIAL STUDY 134XCP|RP|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||USEC|||IN|NOT DONE||N|N|NA|2||58||BASELINE|1962-08-24||1969-10-28|||1962-02-27||1969-10-14
TRIAL STUDY 134XCP|RP|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||RNA COPIES/ML|||PG|NOT DONE||U|N|N|2||58||BLINDED TREATMENT|1969-07-31||1960-05-21|||1965-05-11||1965-07-27
TRIAL STUDY 134XCP|RP|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^7 TCID 50/DOSE|||IU/KG/H|NOT DONE||U|Y|Y|3||39||OBSERVATION|1962-11-20||1968-10-15|||1968-09-23||1971-10-29
TRIAL STUDY 134XCP|RP|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||CMH2O/ML|||UMOL/DL|NOT DONE||Y|N|Y|3||39||LONG-TERM FOLLOW-UP|1963-03-25||1972-08-25|||1968-05-29||1962-04-03
TRIAL STUDY 134XCP|RP|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|1||||||PEELIND|PEELING INDICATOR||||GMFI|||GENEQ/ML|NOT DONE||N|Y|Y|4||88||RUN-IN|1968-08-01||1969-05-21|||1966-12-28||1964-08-13
TRIAL STUDY 134XCP|RP|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||BQ/L|||MG/KG/MIN|NOT DONE||U|Y|U|4||88||FOLLOW-UP|1962-12-05||1964-05-20|||1963-01-07||1961-12-23
TRIAL STUDY 134XCP|RP|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MG/M2/H|||GBQ/UG|NOT DONE||U|NA|Y|5||7||WASHOUT|1965-05-03||1966-02-09|||1964-02-29||1965-12-13
TRIAL STUDY 134XCP|RP|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||/7.5 ML|||NCI|NOT DONE||U|Y|N|5||7||LONG-TERM FOLLOW-UP|1973-02-17||1973-08-12|||1972-10-12||1963-02-04
TRIAL STUDY 134XCP|RP|391D2418-5359-457B-AEC5-6A48DE04DAFD|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||LOG10 CCID 50/DOSE|||ECL UNIT|NOT DONE||U|NA|U|1||38||RUN-IN|1967-05-13||1963-01-10|||1964-02-12||1965-10-13
TRIAL STUDY 134XCP|RP|391D2418-5359-457B-AEC5-6A48DE04DAFD|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MDFI|||GRAIN|NOT DONE||Y|U|U|1||38||OBSERVATION|1965-11-06||1963-01-28|||1971-07-06||1966-06-15
TRIAL STUDY 134XCP|RP|391D2418-5359-457B-AEC5-6A48DE04DAFD|1||||||PREGNN|NUMBER OF PREGNANCIES||||UMOL/L|||PM|NOT DONE||Y|N|N|2||58||BLINDED TREATMENT|1964-02-25||1967-06-03|||1964-05-05||1966-08-25
TRIAL STUDY 134XCP|RP|391D2418-5359-457B-AEC5-6A48DE04DAFD|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UMOL/DL|||10^4/HPF|NOT DONE||N|NA|N|2||58||SCREENING|1961-07-21||1969-04-05|||1964-05-13||1963-09-15
TRIAL STUDY 134XCP|RP|391D2418-5359-457B-AEC5-6A48DE04DAFD|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^4 CFU|||ML/CAGE/WK|NOT DONE||Y|N|U|3||39||FOLLOW-UP|1961-07-12||1961-05-20|||1966-11-14||1969-10-23
TRIAL STUDY 134XCP|RP|391D2418-5359-457B-AEC5-6A48DE04DAFD|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||KG/L|||MILE|NOT DONE||U|Y|N|3||39||BASELINE|1960-06-03||1967-08-03|||1962-04-03||1968-06-18
TRIAL STUDY 134XCP|RP|391D2418-5359-457B-AEC5-6A48DE04DAFD|1||||||THICK|THICKNESS||||MOL/DAY|||LINEAR FT*LB|NOT DONE||N|U|NA|4||88||LONG-TERM FOLLOW-UP|1965-08-30||1972-11-16|||1964-08-07||1970-07-07
TRIAL STUDY 134XCP|RP|391D2418-5359-457B-AEC5-6A48DE04DAFD|2||||||PEELIND|PEELING INDICATOR||||10^9 ORGANISMS/MG|||CUP|NOT DONE||N|N|NA|4||88||RUN-IN|1965-10-08||1966-04-29|||1970-05-18||1962-10-03
TRIAL STUDY 134XCP|RP|391D2418-5359-457B-AEC5-6A48DE04DAFD|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||ROENTGEN|||GENEQ|NOT DONE||N|N|Y|5||7||BASELINE|1962-12-18||1966-06-06|||1963-07-08||1966-12-03
TRIAL STUDY 134XCP|RP|391D2418-5359-457B-AEC5-6A48DE04DAFD|2||||||ABORTN|NUMBER OF ABORTIONS||||TCID 50/DOSE|||U/CL|NOT DONE||Y|NA|N|5||7||OPEN LABEL TREATMENT|1963-09-20||1966-10-31|||1965-01-20||1970-10-16
TRIAL STUDY 134XCP|RP|68F706F0-2F0B-4D50-B15C-2DFDD186112E|1||||||MASSIND|MASS INDICATOR||||IU/DL|||CFU/ML|NOT DONE||Y|NA|Y|1||38||TREATMENT|1966-12-01||1969-07-14|||1971-12-26||1970-08-12
TRIAL STUDY 134XCP|RP|68F706F0-2F0B-4D50-B15C-2DFDD186112E|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||CI/UL|||MASK|NOT DONE||N|U|NA|1||38||SCREENING|1965-01-18||1965-04-18|||1965-06-21||1964-09-12
TRIAL STUDY 134XCP|RP|68F706F0-2F0B-4D50-B15C-2DFDD186112E|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MG/ANIMAL|||G/KG|NOT DONE||U|U|NA|2||58||SCREENING|1961-04-06||1971-12-08|||1969-07-16||1967-05-29
TRIAL STUDY 134XCP|RP|68F706F0-2F0B-4D50-B15C-2DFDD186112E|2||||||EDEMAIND|EDEMA INDICATOR||||V/SEC|||NM|NOT DONE||N|NA|NA|2||58||INDUCTION TREATMENT|1969-06-10||1969-11-13|||1971-12-26||1963-10-12
TRIAL STUDY 134XCP|RP|68F706F0-2F0B-4D50-B15C-2DFDD186112E|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||VG/KG|||DPM/MG|NOT DONE||Y|Y|Y|3||39||WASHOUT|1968-10-10||1971-06-14|||1973-07-14||1970-09-26
TRIAL STUDY 134XCP|RP|68F706F0-2F0B-4D50-B15C-2DFDD186112E|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||NSEC|||FEU|NOT DONE||Y|Y|U|3||39||BLINDED TREATMENT|1960-03-18||1967-01-20|||1966-06-25||1960-06-20
TRIAL STUDY 134XCP|RP|68F706F0-2F0B-4D50-B15C-2DFDD186112E|1||||||PREGST|PREGNANT DURING THE STUDY||||ABSORBANCE U/MIN|||MANSON U/ML|NOT DONE||U|U|NA|4||88||WASHOUT|1963-10-20||1963-04-22|||1962-02-01||1961-08-28
TRIAL STUDY 134XCP|RP|68F706F0-2F0B-4D50-B15C-2DFDD186112E|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||HOURS|||10^12/L|NOT DONE||Y|Y|N|4||88||BASELINE|1972-07-25||1961-08-19|||1970-01-19||1970-11-05
TRIAL STUDY 134XCP|RP|68F706F0-2F0B-4D50-B15C-2DFDD186112E|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||PACKET|||GRAVITATIONAL UNIT|NOT DONE||NA|N|U|5||7||FOLLOW-UP|1969-07-09||1966-07-22|||1973-05-28||1973-05-09
TRIAL STUDY 134XCP|RP|68F706F0-2F0B-4D50-B15C-2DFDD186112E|2||||||MENOAGE|MENOPAUSE AGE||||DPM/100MG|||POINT|NOT DONE||Y|N|Y|5||7||FOLLOW-UP|1966-11-07||1968-07-12|||1970-10-31||1965-03-03
TRIAL STUDY 134XCP|RP|E8D4AACE-0832-482D-8266-96B7423F9459|1||||||PEELIND|PEELING INDICATOR||||RNA COPIES/ML|||10^6 DNA COPIES/ML|NOT DONE||NA|N|N|1||38||LONG-TERM FOLLOW-UP|1969-03-22||1962-03-11|||1963-01-28||1967-02-07
TRIAL STUDY 134XCP|RP|E8D4AACE-0832-482D-8266-96B7423F9459|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||NG/L|||GPELISA UNIT/ML|NOT DONE||U|NA|U|1||38||SCREENING|1970-08-20||1967-09-18|||1966-11-28||1962-10-20
TRIAL STUDY 134XCP|RP|E8D4AACE-0832-482D-8266-96B7423F9459|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MG/G/H|||VG/DOSE|NOT DONE||N|Y|NA|2||58||TREATMENT|1973-01-28||1966-09-25|||1964-10-18||1967-05-13
TRIAL STUDY 134XCP|RP|E8D4AACE-0832-482D-8266-96B7423F9459|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/MS|||LOG10 TCID 50/DOSE|NOT DONE||U|N|U|2||58||LONG-TERM FOLLOW-UP|1964-01-30||1971-06-23|||1961-01-07||1968-10-03
TRIAL STUDY 134XCP|RP|E8D4AACE-0832-482D-8266-96B7423F9459|1||||||FUNDHT|FUNDAL HEIGHT||||/SEC|||MG|NOT DONE||NA|NA|NA|3||39||BASELINE|1961-02-16||1961-04-08|||1963-12-05||1969-08-07
TRIAL STUDY 134XCP|RP|E8D4AACE-0832-482D-8266-96B7423F9459|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||U/CL|||G|NOT DONE||Y|U|N|3||39||CONTINUATION TREATMENT|1960-07-15||1973-05-09|||1960-03-17||1969-04-30
TRIAL STUDY 134XCP|RP|E8D4AACE-0832-482D-8266-96B7423F9459|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||U/KG/MIN|||BAU|NOT DONE||N|NA|N|4||88||OBSERVATION|1972-05-30||1972-09-22|||1968-10-06||1968-12-30
TRIAL STUDY 134XCP|RP|E8D4AACE-0832-482D-8266-96B7423F9459|2||||||TNDRIND|TENDERNESS INDICATOR||||DMOL|||/VF|NOT DONE||NA|N|N|4||88||INDUCTION TREATMENT|1972-04-30||1971-05-10|||1964-06-29||1972-10-04
TRIAL STUDY 134XCP|RP|E8D4AACE-0832-482D-8266-96B7423F9459|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||V/V|||MBP|NOT DONE||U|U|NA|5||7||LONG-TERM FOLLOW-UP|1966-03-20||1971-05-26|||1962-01-07||1961-07-23
TRIAL STUDY 134XCP|RP|E8D4AACE-0832-482D-8266-96B7423F9459|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||PKAT/L|||INHALATION|NOT DONE||Y|NA|Y|5||7||SCREENING|1965-12-09||1969-08-23|||1967-02-17||1964-11-25
TRIAL STUDY 134XCP|RP|F358E69F-9B9A-4637-9063-B8FECFF000B2|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||KHZ|||CUP EQ|NOT DONE||U|N|Y|1||38||OBSERVATION|1967-09-21||1960-07-30|||1962-12-13||1966-05-18
TRIAL STUDY 134XCP|RP|F358E69F-9B9A-4637-9063-B8FECFF000B2|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||10^3 ORGANISMS/ML|||ELISA UNIT/DOSE|NOT DONE||N|NA|N|1||38||CONTINUATION TREATMENT|1966-08-07||1972-07-02|||1968-09-10||1972-04-14
TRIAL STUDY 134XCP|RP|F358E69F-9B9A-4637-9063-B8FECFF000B2|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||10^6/HPF|||MMHG*MIN/L|NOT DONE||NA|NA|Y|2||58||WASHOUT|1968-10-21||1967-05-11|||1972-12-06||1967-02-15
TRIAL STUDY 134XCP|RP|F358E69F-9B9A-4637-9063-B8FECFF000B2|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ML/MMHG|||NG/MOL|NOT DONE||NA|Y|U|2||58||WASHOUT|1964-07-30||1972-12-29|||1963-08-08||1970-06-03
TRIAL STUDY 134XCP|RP|F358E69F-9B9A-4637-9063-B8FECFF000B2|1||||||PREGST|PREGNANT DURING THE STUDY||||MIN|||K|NOT DONE||N|Y|N|3||39||INDUCTION TREATMENT|1970-08-07||1969-04-08|||1960-11-16||1961-12-21
TRIAL STUDY 134XCP|RP|F358E69F-9B9A-4637-9063-B8FECFF000B2|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||HZ|||NMOL/ML/MIN|NOT DONE||Y|NA|Y|3||39||OPEN LABEL TREATMENT|1970-07-19||1973-02-15|||1969-08-21||1968-11-22
TRIAL STUDY 134XCP|RP|F358E69F-9B9A-4637-9063-B8FECFF000B2|1||||||PUSTIND|PUSTULE INDICATOR||||SCOOPFUL|||%(V/V)|NOT DONE||U|NA|Y|4||88||LONG-TERM FOLLOW-UP|1963-04-30||1970-09-03|||1963-06-09||1961-09-21
TRIAL STUDY 134XCP|RP|F358E69F-9B9A-4637-9063-B8FECFF000B2|2||||||MENOAGE|MENOPAUSE AGE||||KALLIKREIN INHIBITOR UNIT|||MG/MIN|NOT DONE||Y|Y|NA|4||88||BLINDED TREATMENT|1968-10-26||1963-11-18|||1960-05-27||1962-07-19
TRIAL STUDY 134XCP|RP|F358E69F-9B9A-4637-9063-B8FECFF000B2|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MG/L|||PMOL|NOT DONE||NA|NA|Y|5||7||INDUCTION TREATMENT|1972-08-21||1961-12-15|||1973-08-30||1973-03-18
TRIAL STUDY 134XCP|RP|F358E69F-9B9A-4637-9063-B8FECFF000B2|2||||||MENARAGE|MENARCHE AGE||||EP U|||GBQ/UG|NOT DONE||U|U|U|5||7||INDUCTION TREATMENT|1963-05-15||1965-03-30|||1964-09-19||1971-06-16
TRIAL STUDY 134XCP|RP|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|1||||||PREGNN|NUMBER OF PREGNANCIES||||IU/KG/H|||CL|NOT DONE||N|N|U|1||38||OBSERVATION|1962-02-01||1964-05-24|||1969-03-12||1968-04-16
TRIAL STUDY 134XCP|RP|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||MG/L|||UG/DL|NOT DONE||Y|U|U|1||38||FOLLOW-UP|1968-08-20||1963-03-22|||1969-12-21||1965-06-30
TRIAL STUDY 134XCP|RP|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||L/L|||U/DL|NOT DONE||U|Y|Y|2||58||BASELINE|1971-10-31||1967-03-01|||1969-04-19||1967-02-07
TRIAL STUDY 134XCP|RP|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|2||||||FUNDHT|FUNDAL HEIGHT||||APL U/ML|||IU/KG/H|NOT DONE||U|Y|NA|2||58||SCREENING|1965-05-10||1961-07-03|||1971-02-20||1961-01-28
TRIAL STUDY 134XCP|RP|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|1||||||ABORTN|NUMBER OF ABORTIONS||||10^3 COPIES/ML|||HR/DAY|NOT DONE||N|Y|NA|3||39||INDUCTION TREATMENT|1960-05-04||1966-07-15|||1963-05-30||1973-02-10
TRIAL STUDY 134XCP|RP|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||BQ/UG|||MG/G/H|NOT DONE||Y|N|NA|3||39||OBSERVATION|1960-03-14||1964-03-06|||1972-02-13||1960-01-09
TRIAL STUDY 134XCP|RP|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MG/G/MIN|||PT_BR|NOT DONE||N|NA|NA|4||88||CONTINUATION TREATMENT|1966-10-15||1967-09-25|||1967-09-25||1967-05-21
TRIAL STUDY 134XCP|RP|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||ML/DL|||10^3 DNA COPIES/ML|NOT DONE||Y|U|NA|4||88||INDUCTION TREATMENT|1962-01-25||1973-07-31|||1968-04-27||1973-07-10
TRIAL STUDY 134XCP|RP|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||10^10/L|||ANTI-XA IU|NOT DONE||N|U|NA|5||7||FOLLOW-UP|1960-04-07||1972-06-14|||1961-02-14||1962-10-01
TRIAL STUDY 134XCP|RP|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|2||||||MENFDUR|MENSES FLOW DURATION||||ANTIBODY UNIT|||CONTAINER|NOT DONE||NA|Y|N|5||7||TREATMENT|1970-12-05||1968-01-29|||1967-03-23||1973-02-28
TRIAL STUDY 134XCP|RP|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|1||||||BRTHN|NUMBER OF BIRTHS||||ML/CM3/MIN|||MG/KG/DAY|NOT DONE||Y|Y|N|1||38||FOLLOW-UP|1973-04-28||1961-04-07|||1968-07-19||1969-04-21
TRIAL STUDY 134XCP|RP|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|2||||||INABOIND|INDUCED ABORTION INDICATOR||||BOTTLE|||ML/CAGE/DAY|NOT DONE||N|NA|Y|1||38||BLINDED TREATMENT|1962-02-05||1961-09-09|||1961-06-04||1969-02-26
TRIAL STUDY 134XCP|RP|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|1||||||ERYTHIND|ERYTHEMA INDICATOR||||SV|||ANSON U|NOT DONE||NA|U|U|2||58||TREATMENT|1961-10-11||1961-05-29|||1965-07-03||1973-05-18
TRIAL STUDY 134XCP|RP|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|2||||||EDEMAIND|EDEMA INDICATOR||||MV/SEC|||KG/MOL|NOT DONE||NA|N|U|2||58||INDUCTION TREATMENT|1969-08-07||1960-07-10|||1971-11-17||1972-07-07
TRIAL STUDY 134XCP|RP|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|1||||||MENOAGE|MENOPAUSE AGE||||KIU|||MGEQ|NOT DONE||Y|Y|NA|3||39||CONTINUATION TREATMENT|1960-01-25||1964-11-13|||1966-10-21||1967-10-21
TRIAL STUDY 134XCP|RP|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|2||||||MASSIND|MASS INDICATOR||||ML/M2/H|||MG|NOT DONE||U|U|Y|3||39||CONTINUATION TREATMENT|1961-03-14||1960-02-26|||1968-07-17||1961-03-25
TRIAL STUDY 134XCP|RP|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|1||||||ABORTN|NUMBER OF ABORTIONS||||HOMEOPATHIC DILUTION|||NCI|NOT DONE||U|N|Y|4||88||TREATMENT|1963-04-04||1972-08-12|||1962-02-15||1963-10-13
TRIAL STUDY 134XCP|RP|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PMOL/G|||MMHG/L/MIN|NOT DONE||NA|NA|Y|4||88||OPEN LABEL TREATMENT|1967-05-18||1969-03-26|||1966-10-19||1971-08-21
TRIAL STUDY 134XCP|RP|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MV/SEC|||MG/DL|NOT DONE||Y|U|N|5||7||BLINDED TREATMENT|1972-02-19||1973-04-12|||1967-11-17||1968-05-23
TRIAL STUDY 134XCP|RP|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||U|||SV|NOT DONE||N|NA|N|5||7||TREATMENT|1966-03-30||1965-11-17|||1969-08-03||1972-10-07
TRIAL STUDY 134XCP|RP|586B4529-9808-4205-B3D6-5C4A1DAFA922|1||||||PREGIND|PREGNANT INDICATOR||||NM|||NMOL BCE/NMOL|NOT DONE||Y|NA|NA|1||38||SCREENING|1972-10-31||1972-03-05|||1970-12-28||1960-07-11
TRIAL STUDY 134XCP|RP|586B4529-9808-4205-B3D6-5C4A1DAFA922|2||||||MENARAGE|MENARCHE AGE||||DNA COPIES/UG|||LENS|NOT DONE||Y|NA|NA|1||38||LONG-TERM FOLLOW-UP|1964-09-24||1969-05-11|||1972-10-29||1970-07-25
TRIAL STUDY 134XCP|RP|586B4529-9808-4205-B3D6-5C4A1DAFA922|1||||||THICK|THICKNESS||||MG/G/H|||TAMPON|NOT DONE||U|N|Y|2||58||FOLLOW-UP|1969-08-10||1965-10-06|||1969-10-15||1960-11-03
TRIAL STUDY 134XCP|RP|586B4529-9808-4205-B3D6-5C4A1DAFA922|2||||||RASHIND|RASH INDICATOR||||UKAT/L|||MMHG/L/MIN|NOT DONE||Y|U|U|2||58||TREATMENT|1960-12-08||1965-04-24|||1969-10-23||1972-11-25
TRIAL STUDY 134XCP|RP|586B4529-9808-4205-B3D6-5C4A1DAFA922|1||||||PEELIND|PEELING INDICATOR||||SBE/ML|||P|NOT DONE||Y|NA|U|3||39||TREATMENT|1970-08-24||1972-12-31|||1960-06-30||1969-02-14
TRIAL STUDY 134XCP|RP|586B4529-9808-4205-B3D6-5C4A1DAFA922|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MU/G|||IU/DL|NOT DONE||U|N|NA|3||39||CONTINUATION TREATMENT|1961-08-08||1972-06-28|||1965-12-23||1962-11-28
TRIAL STUDY 134XCP|RP|586B4529-9808-4205-B3D6-5C4A1DAFA922|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||AMU|||%(W/V)|NOT DONE||U|NA|NA|4||88||FOLLOW-UP|1973-01-15||1966-05-05|||1962-04-05||1966-03-04
TRIAL STUDY 134XCP|RP|586B4529-9808-4205-B3D6-5C4A1DAFA922|2||||||BLISTIND|BLISTERING INDICATOR||||10^3 CFU|||FT3|NOT DONE||U|N|N|4||88||RUN-IN|1965-09-20||1962-06-30|||1967-04-24||1963-08-19
TRIAL STUDY 134XCP|RP|586B4529-9808-4205-B3D6-5C4A1DAFA922|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||AMPULE|||OI50|NOT DONE||U|Y|Y|5||7||LONG-TERM FOLLOW-UP|1965-12-28||1966-12-08|||1971-01-14||1960-09-06
TRIAL STUDY 134XCP|RP|586B4529-9808-4205-B3D6-5C4A1DAFA922|2||||||MENARAGE|MENARCHE AGE||||PUFF|||CMOL/L|NOT DONE||Y|N|N|5||7||TREATMENT|1972-09-12||1967-05-03|||1971-04-12||1963-10-11
TRIAL STUDY 134XCP|RP|54685EFC-EE92-4591-B059-24145A3E6D69|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||/CMH2O|||CAL|NOT DONE||Y|N|U|1||38||INDUCTION TREATMENT|1972-12-20||1969-08-30|||1969-09-29||1961-12-28
TRIAL STUDY 134XCP|RP|54685EFC-EE92-4591-B059-24145A3E6D69|2||||||PUSTIND|PUSTULE INDICATOR||||L/L|||ML/M2/DAY|NOT DONE||Y|NA|Y|1||38||INDUCTION TREATMENT|1962-06-19||1969-01-09|||1970-08-29||1964-06-17
TRIAL STUDY 134XCP|RP|54685EFC-EE92-4591-B059-24145A3E6D69|1||||||DLVRMODE|MODE OF DELIVERY||||DAYS/MONTH|||ATM|NOT DONE||Y|NA|N|2||58||SCREENING|1965-05-31||1961-02-04|||1961-11-05||1972-08-10
TRIAL STUDY 134XCP|RP|54685EFC-EE92-4591-B059-24145A3E6D69|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||10^6/L|||UG/H|NOT DONE||N|NA|Y|2||58||INDUCTION TREATMENT|1960-10-19||1967-03-22|||1964-03-12||1969-05-13
TRIAL STUDY 134XCP|RP|54685EFC-EE92-4591-B059-24145A3E6D69|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MMOL/L|||TSP EQ|NOT DONE||U|NA|U|3||39||SCREENING|1960-02-08||1966-11-28|||1964-07-18||1967-12-22
TRIAL STUDY 134XCP|RP|54685EFC-EE92-4591-B059-24145A3E6D69|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^4/L|||UCI/L|NOT DONE||Y|Y|N|3||39||LONG-TERM FOLLOW-UP|1971-11-22||1969-12-04|||1970-07-31||1961-09-29
TRIAL STUDY 134XCP|RP|54685EFC-EE92-4591-B059-24145A3E6D69|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||U/M2|||/500 WBC|NOT DONE||NA|N|NA|4||88||SCREENING|1967-12-28||1967-05-02|||1973-07-23||1972-12-09
TRIAL STUDY 134XCP|RP|54685EFC-EE92-4591-B059-24145A3E6D69|2||||||MENFDUR|MENSES FLOW DURATION||||/100 HPFS|||/HPF|NOT DONE||U|Y|N|4||88||OBSERVATION|1964-02-13||1972-08-04|||1973-07-17||1973-03-23
TRIAL STUDY 134XCP|RP|54685EFC-EE92-4591-B059-24145A3E6D69|1||||||PREGNN|NUMBER OF PREGNANCIES||||CD*S/M2|||10^7 CFU/ML|NOT DONE||NA|N|U|5||7||TREATMENT|1972-07-10||1961-10-27|||1973-02-26||1969-12-30
TRIAL STUDY 134XCP|RP|54685EFC-EE92-4591-B059-24145A3E6D69|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||NMOL/DAY|||MMU/ML|NOT DONE||NA|NA|U|5||7||SCREENING|1969-07-13||1962-02-27|||1964-09-09||1961-10-09
TRIAL STUDY 134XCP|RP|7BD32505-61D5-4862-8896-B3E41D3EE779|1||||||DSCHGIND|DISCHARGE INDICATOR||||HZ|||10^3 ORGANISMS|NOT DONE||NA|N|N|1||38||LONG-TERM FOLLOW-UP|1970-07-13||1967-04-22|||1973-09-01||1969-03-30
TRIAL STUDY 134XCP|RP|7BD32505-61D5-4862-8896-B3E41D3EE779|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||SACHET|||U/ML|NOT DONE||Y|U|Y|1||38||OPEN LABEL TREATMENT|1966-05-26||1965-11-14|||1969-07-09||1970-03-14
TRIAL STUDY 134XCP|RP|7BD32505-61D5-4862-8896-B3E41D3EE779|1||||||ABORTN|NUMBER OF ABORTIONS||||%(W/V)|||MANSON U/ML|NOT DONE||Y|NA|N|2||58||FOLLOW-UP|1973-06-16||1966-11-21|||1961-09-21||1960-03-06
TRIAL STUDY 134XCP|RP|7BD32505-61D5-4862-8896-B3E41D3EE779|2||||||MENFDUR|MENSES FLOW DURATION||||G|||M/SEC2|NOT DONE||Y|NA|NA|2||58||OBSERVATION|1966-09-28||1971-11-01|||1962-07-15||1971-12-08
TRIAL STUDY 134XCP|RP|7BD32505-61D5-4862-8896-B3E41D3EE779|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||/CMH2O|||PPB|NOT DONE||N|N|U|3||39||OBSERVATION|1968-08-18||1966-08-28|||1965-11-22||1966-07-21
TRIAL STUDY 134XCP|RP|7BD32505-61D5-4862-8896-B3E41D3EE779|2||||||INTP|INTERPRETATION||||RNA COPIES/ML|||PG/DL|NOT DONE||Y|Y|NA|3||39||BASELINE|1968-02-22||1972-09-16|||1960-10-17||1963-11-17
TRIAL STUDY 134XCP|RP|7BD32505-61D5-4862-8896-B3E41D3EE779|1||||||DLVRMODE|MODE OF DELIVERY||||IU/DL|||IU/MMOL|NOT DONE||NA|Y|Y|4||88||LONG-TERM FOLLOW-UP|1971-10-13||1961-02-17|||1963-10-26||1970-01-26
TRIAL STUDY 134XCP|RP|7BD32505-61D5-4862-8896-B3E41D3EE779|2||||||STILBIND|STILLBIRTH INDICATOR||||NG/DAY|||PNU/ML|NOT DONE||U|U|N|4||88||INDUCTION TREATMENT|1971-11-04||1961-10-02|||1968-09-01||1962-11-26
TRIAL STUDY 134XCP|RP|7BD32505-61D5-4862-8896-B3E41D3EE779|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||MG/KG|||MEQ/DL|NOT DONE||Y|NA|U|5||7||WASHOUT|1973-01-11||1963-11-08|||1964-11-29||1970-11-13
TRIAL STUDY 134XCP|RP|7BD32505-61D5-4862-8896-B3E41D3EE779|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||PFU/DOSE|||U/10^12 RBC|NOT DONE||U|N|U|5||7||BASELINE|1968-03-20||1965-05-24|||1970-03-17||1961-02-17
TRIAL STUDY 134XCP|RP|3461C227-E30F-482B-B404-026FE0CA3549|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||/100 HPFS|||CAPSULE|NOT DONE||U|N|U|1||38||FOLLOW-UP|1962-10-21||1960-05-17|||1968-09-23||1964-01-02
TRIAL STUDY 134XCP|RP|3461C227-E30F-482B-B404-026FE0CA3549|2||||||PRGENDTC|DATE PREGNANCY ENDED||||KPA/L/SEC|||DAGU/ML|NOT DONE||N|U|U|1||38||WASHOUT|1963-10-09||1961-03-06|||1965-05-21||1973-07-14
TRIAL STUDY 134XCP|RP|3461C227-E30F-482B-B404-026FE0CA3549|1||||||MENOSTAT|MENOPAUSE STATUS||||FL|||UG/H|NOT DONE||Y|NA|N|2||58||BLINDED TREATMENT|1964-06-30||1965-09-05|||1972-07-13||1970-10-31
TRIAL STUDY 134XCP|RP|3461C227-E30F-482B-B404-026FE0CA3549|2||||||PRGENDTC|DATE PREGNANCY ENDED||||UG/L/H|||UG/KG/DAY|NOT DONE||Y|NA|U|2||58||CONTINUATION TREATMENT|1964-03-25||1968-06-22|||1962-09-28||1960-08-08
TRIAL STUDY 134XCP|RP|3461C227-E30F-482B-B404-026FE0CA3549|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||G/KG|||SYRINGE|NOT DONE||Y|U|Y|3||39||OPEN LABEL TREATMENT|1969-09-25||1961-10-19|||1966-12-29||1963-12-05
TRIAL STUDY 134XCP|RP|3461C227-E30F-482B-B404-026FE0CA3549|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||DAYS/WK|||CL|NOT DONE||N|N|Y|3||39||BASELINE|1963-11-28||1966-02-09|||1965-02-28||1964-08-28
TRIAL STUDY 134XCP|RP|3461C227-E30F-482B-B404-026FE0CA3549|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||10^4/HPF|||MG/DAY|NOT DONE||N|Y|NA|4||88||CONTINUATION TREATMENT|1964-06-07||1968-11-05|||1971-05-29||1966-04-22
TRIAL STUDY 134XCP|RP|3461C227-E30F-482B-B404-026FE0CA3549|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||ML/ANIMAL|||MEQ/UL|NOT DONE||U|U|Y|4||88||INDUCTION TREATMENT|1968-06-26||1966-02-13|||1970-03-07||1972-12-17
TRIAL STUDY 134XCP|RP|3461C227-E30F-482B-B404-026FE0CA3549|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||NMOL BCE/MMOL|||UL/ML|NOT DONE||N|Y|N|5||7||BASELINE|1965-12-22||1972-06-05|||1963-02-12||1960-12-12
TRIAL STUDY 134XCP|RP|3461C227-E30F-482B-B404-026FE0CA3549|2||||||MENOSTAT|MENOPAUSE STATUS||||MKAT|||G/L|NOT DONE||U|Y|NA|5||7||BLINDED TREATMENT|1962-08-05||1961-10-05|||1962-10-14||1963-06-22
TRIAL STUDY 134XCP|RP|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||U/ANIMAL|||BAG|NOT DONE||Y|N|U|1||38||OPEN LABEL TREATMENT|1962-06-05||1971-02-12|||1962-09-22||1961-11-03
TRIAL STUDY 134XCP|RP|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||UG/KG/H|||UU/DL|NOT DONE||U|Y|Y|1||38||BASELINE|1972-04-06||1965-02-02|||1970-10-30||1961-11-10
TRIAL STUDY 134XCP|RP|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MPL U/ML|||MMHG|NOT DONE||U|U|NA|2||58||BLINDED TREATMENT|1971-08-03||1967-01-02|||1965-05-06||1963-02-28
TRIAL STUDY 134XCP|RP|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UMOL/MG/MIN|||ML/ANIMAL/DAY|NOT DONE||NA|NA|NA|2||58||INDUCTION TREATMENT|1967-05-01||1962-03-10|||1972-06-16||1967-01-29
TRIAL STUDY 134XCP|RP|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||PSI|||MIU/L|NOT DONE||N|U|N|3||39||WASHOUT|1965-02-22||1962-04-18|||1966-10-13||1962-05-23
TRIAL STUDY 134XCP|RP|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||U/CL|||MG/KG/DAY|NOT DONE||Y|N|U|3||39||LONG-TERM FOLLOW-UP|1963-01-29||1973-08-01|||1969-09-16||1968-12-24
TRIAL STUDY 134XCP|RP|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|1||||||INABOIND|INDUCED ABORTION INDICATOR||||LOG10 TCID 50/DOSE|||U/M2/DAY|NOT DONE||U|U|N|4||88||BLINDED TREATMENT|1961-08-10||1962-11-29|||1962-03-07||1970-09-16
TRIAL STUDY 134XCP|RP|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||BQ/KG|||GENEQ/ML|NOT DONE||U|Y|N|4||88||TREATMENT|1972-04-10||1969-06-17|||1970-04-21||1963-01-14
TRIAL STUDY 134XCP|RP|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||RFU|||C|NOT DONE||NA|U|U|5||7||BASELINE|1965-06-28||1964-10-16|||1960-11-11||1966-10-06
TRIAL STUDY 134XCP|RP|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|2||||||STILBIND|STILLBIRTH INDICATOR||||MV/SEC|||VP/DOSE|NOT DONE||N|Y|Y|5||7||WASHOUT|1967-12-04||1968-06-04|||1967-08-15||1972-10-29
TRIAL STUDY 134XCP|RP|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||ENZYME U|||BOLUS|NOT DONE||NA|Y|N|1||38||OBSERVATION|1961-05-14||1970-09-26|||1967-02-18||1966-06-16
TRIAL STUDY 134XCP|RP|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|2||||||MASSIND|MASS INDICATOR||||F|||ML/M2/H|NOT DONE||Y|NA|Y|1||38||OPEN LABEL TREATMENT|1973-01-14||1962-11-15|||1970-04-01||1969-04-22
TRIAL STUDY 134XCP|RP|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||PPTR|||DNA COPIES/UG|NOT DONE||NA|N|N|2||58||SCREENING|1971-09-09||1960-03-05|||1967-09-14||1969-06-30
TRIAL STUDY 134XCP|RP|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MJOULE/CM2|||GENEQ/ML|NOT DONE||Y|NA|N|2||58||CONTINUATION TREATMENT|1972-07-10||1971-06-30|||1970-08-12||1972-10-07
TRIAL STUDY 134XCP|RP|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||UM/DAY|||%(W/V)|NOT DONE||NA|NA|N|3||39||INDUCTION TREATMENT|1966-12-04||1972-07-20|||1962-10-24||1963-06-21
TRIAL STUDY 134XCP|RP|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|2||||||STILBIND|STILLBIRTH INDICATOR||||H*%|||DEG|NOT DONE||N|Y|U|3||39||INDUCTION TREATMENT|1973-09-01||1965-12-14|||1972-07-02||1970-09-09
TRIAL STUDY 134XCP|RP|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|1||||||PUSTIND|PUSTULE INDICATOR||||MIN|||MHZ|NOT DONE||NA|N|U|4||88||OBSERVATION|1961-10-15||1960-01-21|||1960-05-10||1965-03-14
TRIAL STUDY 134XCP|RP|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|2||||||ULCERIND|ULCER INDICATOR||||G/DL|||/MM|NOT DONE||Y|NA|NA|4||88||TREATMENT|1970-10-07||1969-07-29|||1970-12-15||1969-03-31
TRIAL STUDY 134XCP|RP|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MMOL2/L2|||ML/G/DAY|NOT DONE||NA|N|NA|5||7||INDUCTION TREATMENT|1967-05-09||1971-11-05|||1960-02-14||1969-03-02
TRIAL STUDY 134XCP|RP|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||LOG10 PFU/ML|||PSEC|NOT DONE||Y|N|N|5||7||INDUCTION TREATMENT|1970-01-10||1969-08-30|||1969-10-05||1961-03-20
TRIAL STUDY 134XCP|RP|C7C91F63-87B7-4E62-B5F3-39979F74E955|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||/H|||KG/CM|NOT DONE||N|N|NA|1||38||TREATMENT|1966-07-29||1960-03-21|||1963-03-11||1970-02-13
TRIAL STUDY 134XCP|RP|C7C91F63-87B7-4E62-B5F3-39979F74E955|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||IU/MG|||MEQ/G|NOT DONE||NA|NA|Y|1||38||BASELINE|1962-11-28||1960-06-03|||1968-05-10||1963-08-13
TRIAL STUDY 134XCP|RP|C7C91F63-87B7-4E62-B5F3-39979F74E955|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UMOL/L|||PIXELS/IN|NOT DONE||Y|Y|NA|2||58||SCREENING|1968-06-29||1971-07-11|||1965-09-18||1966-02-13
TRIAL STUDY 134XCP|RP|C7C91F63-87B7-4E62-B5F3-39979F74E955|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||PT_US|||IU/MG|NOT DONE||U|Y|NA|2||58||BLINDED TREATMENT|1964-08-05||1965-06-25|||1969-12-26||1961-08-20
TRIAL STUDY 134XCP|RP|C7C91F63-87B7-4E62-B5F3-39979F74E955|1||||||ABORTN|NUMBER OF ABORTIONS||||PA|||OHM|NOT DONE||Y|NA|NA|3||39||TREATMENT|1969-09-04||1960-09-01|||1962-02-28||1972-06-21
TRIAL STUDY 134XCP|RP|C7C91F63-87B7-4E62-B5F3-39979F74E955|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||ENZYME U|||AGU/ML|NOT DONE||N|U|N|3||39||SCREENING|1966-03-23||1969-07-07|||1963-04-30||1963-07-20
TRIAL STUDY 134XCP|RP|C7C91F63-87B7-4E62-B5F3-39979F74E955|1||||||INABOIND|INDUCED ABORTION INDICATOR||||UG/DAY|||FRAMES/S|NOT DONE||NA|N|NA|4||88||OBSERVATION|1966-01-19||1971-09-29|||1964-10-30||1967-05-03
TRIAL STUDY 134XCP|RP|C7C91F63-87B7-4E62-B5F3-39979F74E955|2||||||PREGST|PREGNANT DURING THE STUDY||||CI/G|||EU|NOT DONE||N|U|U|4||88||CONTINUATION TREATMENT|1964-09-10||1971-09-05|||1972-06-23||1960-11-27
TRIAL STUDY 134XCP|RP|C7C91F63-87B7-4E62-B5F3-39979F74E955|1||||||INABOIND|INDUCED ABORTION INDICATOR||||NU/CL|||PIXELS/IN|NOT DONE||U|N|U|5||7||BASELINE|1973-04-12||1961-06-28|||1960-06-11||1971-01-29
TRIAL STUDY 134XCP|RP|C7C91F63-87B7-4E62-B5F3-39979F74E955|2||||||MENARAGE|MENARCHE AGE||||MS2|||SUPPOSITORY|NOT DONE||N|Y|N|5||7||SCREENING|1968-02-06||1972-11-04|||1967-12-13||1969-12-19
TRIAL STUDY 134XCP|RP|D6659F53-6DF6-4F88-BF9A-160E2D057028|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||/MIN|||10^9 CFU/G|NOT DONE||N|N|U|1||38||TREATMENT|1962-10-30||1965-01-07|||1964-06-01||1962-10-23
TRIAL STUDY 134XCP|RP|D6659F53-6DF6-4F88-BF9A-160E2D057028|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||U/M2|||MOL/DAY|NOT DONE||N|N|Y|1||38||INDUCTION TREATMENT|1961-02-02||1971-09-29|||1964-07-05||1967-10-15
TRIAL STUDY 134XCP|RP|D6659F53-6DF6-4F88-BF9A-160E2D057028|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||NL|||NM|NOT DONE||NA|Y|U|2||58||WASHOUT|1965-12-08||1964-10-26|||1960-08-03||1962-12-23
TRIAL STUDY 134XCP|RP|D6659F53-6DF6-4F88-BF9A-160E2D057028|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||M/SEC|||UMOL/MOL|NOT DONE||NA|N|NA|2||58||SCREENING|1964-10-12||1961-08-15|||1962-05-27||1973-05-06
TRIAL STUDY 134XCP|RP|D6659F53-6DF6-4F88-BF9A-160E2D057028|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||ATM|||CPM|NOT DONE||NA|NA|NA|3||39||WASHOUT|1962-07-28||1971-12-20|||1962-11-12||1961-06-11
TRIAL STUDY 134XCP|RP|D6659F53-6DF6-4F88-BF9A-160E2D057028|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||U/CL|||U/10^12 RBC|NOT DONE||NA|Y|Y|3||39||WASHOUT|1967-05-19||1961-01-27|||1973-06-28||1969-03-16
TRIAL STUDY 134XCP|RP|D6659F53-6DF6-4F88-BF9A-160E2D057028|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||FMOL/L/SEC|||DEG/MM|NOT DONE||N|Y|U|4||88||SCREENING|1970-06-27||1961-04-20|||1961-02-27||1961-09-29
TRIAL STUDY 134XCP|RP|D6659F53-6DF6-4F88-BF9A-160E2D057028|2||||||FUNDHT|FUNDAL HEIGHT||||FIU|||1/(S*KPA)|NOT DONE||N|Y|Y|4||88||OBSERVATION|1967-10-11||1973-01-04|||1973-01-22||1961-01-26
TRIAL STUDY 134XCP|RP|D6659F53-6DF6-4F88-BF9A-160E2D057028|1||||||PUSTIND|PUSTULE INDICATOR||||CUP|||DRUM|NOT DONE||U|Y|N|5||7||WASHOUT|1971-03-09||1971-10-26|||1962-07-13||1962-07-03
TRIAL STUDY 134XCP|RP|D6659F53-6DF6-4F88-BF9A-160E2D057028|2||||||BRTHN|NUMBER OF BIRTHS||||ML/MIN/1.73M2|||NMOL/MOL|NOT DONE||N|N|Y|5||7||CONTINUATION TREATMENT|1969-09-19||1969-08-22|||1972-01-24||1962-08-21
TRIAL STUDY 134XCP|RP|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|1||||||PUSTIND|PUSTULE INDICATOR||||MBP|||LOG10 IU/ML|NOT DONE||Y|U|Y|1||38||INDUCTION TREATMENT|1965-04-17||1967-05-03|||1964-02-19||1967-09-25
TRIAL STUDY 134XCP|RP|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||IU/G HB|||AMU|NOT DONE||NA|N|NA|1||38||BASELINE|1963-01-17||1968-09-23|||1962-07-24||1968-11-06
TRIAL STUDY 134XCP|RP|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|1||||||DLVRMODE|MODE OF DELIVERY||||MU/L|||MV*MIN|NOT DONE||Y|U|Y|2||58||OBSERVATION|1967-09-27||1961-07-31|||1962-08-13||1970-12-23
TRIAL STUDY 134XCP|RP|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|2||||||THICK|THICKNESS||||LOG10 COPIES/ML|||MEQ/KG|NOT DONE||Y|NA|N|2||58||SCREENING|1968-12-11||1966-08-26|||1964-09-28||1968-03-21
TRIAL STUDY 134XCP|RP|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||10^3/L|||ML/G/H|NOT DONE||NA|NA|N|3||39||WASHOUT|1962-05-04||1960-04-30|||1960-08-22||1960-12-29
TRIAL STUDY 134XCP|RP|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|2||||||MASSIND|MASS INDICATOR||||KM|||BQ/UL|NOT DONE||U|N|N|3||39||CONTINUATION TREATMENT|1961-03-08||1971-07-01|||1960-03-17||1969-03-30
TRIAL STUDY 134XCP|RP|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||CCID 50/DOSE|||VG/KG|NOT DONE||U|NA|N|4||88||OPEN LABEL TREATMENT|1969-11-19||1970-02-17|||1968-03-04||1961-10-21
TRIAL STUDY 134XCP|RP|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^6 CFU/G|||MET*H|NOT DONE||U|NA|Y|4||88||CONTINUATION TREATMENT|1961-11-20||1972-04-29|||1970-10-03||1963-02-28
TRIAL STUDY 134XCP|RP|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||RPM|||MG/KG/MIN|NOT DONE||U|NA|N|5||7||TREATMENT|1962-08-22||1964-07-30|||1964-10-03||1967-02-02
TRIAL STUDY 134XCP|RP|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|2||||||BRTHN|NUMBER OF BIRTHS||||MEQ|||PMOL/10^10 CELLS|NOT DONE||NA|NA|NA|5||7||BASELINE|1966-12-15||1971-06-10|||1963-03-11||1969-11-10
TRIAL STUDY 134XCP|RP|91B36C93-3ADF-4570-B355-BC81B097EEFC|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||KPA/L/SEC|||APS U|NOT DONE||NA|NA|NA|1||38||TREATMENT|1968-09-13||1963-11-26|||1965-07-27||1967-01-06
TRIAL STUDY 134XCP|RP|91B36C93-3ADF-4570-B355-BC81B097EEFC|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||PATCH|||MEQ/L|NOT DONE||NA|Y|N|1||38||INDUCTION TREATMENT|1960-11-02||1962-05-13|||1964-01-01||1972-04-13
TRIAL STUDY 134XCP|RP|91B36C93-3ADF-4570-B355-BC81B097EEFC|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||TRACE|||/100 WBC|NOT DONE||U|Y|NA|2||58||RUN-IN|1972-09-10||1965-09-07|||1972-03-03||1966-06-25
TRIAL STUDY 134XCP|RP|91B36C93-3ADF-4570-B355-BC81B097EEFC|2||||||ULCERIND|ULCER INDICATOR||||PPB|||SCOOPFUL|NOT DONE||Y|NA|NA|2||58||FOLLOW-UP|1960-11-27||1971-10-31|||1970-07-24||1969-06-02
TRIAL STUDY 134XCP|RP|91B36C93-3ADF-4570-B355-BC81B097EEFC|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MPL U|||PMOL|NOT DONE||Y|Y|Y|3||39||OPEN LABEL TREATMENT|1961-03-23||1972-06-08|||1970-01-23||1973-06-30
TRIAL STUDY 134XCP|RP|91B36C93-3ADF-4570-B355-BC81B097EEFC|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||VIAL|||CI/MG|NOT DONE||U|Y|Y|3||39||LONG-TERM FOLLOW-UP|1961-12-03||1966-09-30|||1962-10-17||1969-06-05
TRIAL STUDY 134XCP|RP|91B36C93-3ADF-4570-B355-BC81B097EEFC|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MCI/L|||PIXELS/CM|NOT DONE||Y|U|Y|4||88||CONTINUATION TREATMENT|1969-10-06||1971-02-16|||1962-01-05||1966-02-02
TRIAL STUDY 134XCP|RP|91B36C93-3ADF-4570-B355-BC81B097EEFC|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||U/G/H|||NMOL/ML/MIN|NOT DONE||NA|U|Y|4||88||BLINDED TREATMENT|1972-05-27||1968-07-21|||1962-08-28||1969-02-17
TRIAL STUDY 134XCP|RP|91B36C93-3ADF-4570-B355-BC81B097EEFC|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||UCI/KG|||SCOOPFUL|NOT DONE||Y|U|N|5||7||TREATMENT|1970-11-24||1960-02-05|||1963-12-23||1961-03-13
TRIAL STUDY 134XCP|RP|91B36C93-3ADF-4570-B355-BC81B097EEFC|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UMOL/MIN|||MIU/L|NOT DONE||Y|N|NA|5||7||LONG-TERM FOLLOW-UP|1963-04-17||1961-12-27|||1960-03-28||1969-10-06
TRIAL STUDY 134XCP|RP|ADD0DDE5-166F-4C20-B3C3-31B131509771|1||||||BCMETHOD|BIRTH CONTROL METHOD||||MDFI|||IU/MMOL|NOT DONE||N|NA|U|1||38||LONG-TERM FOLLOW-UP|1968-10-01||1968-06-13|||1960-07-23||1961-02-24
TRIAL STUDY 134XCP|RP|ADD0DDE5-166F-4C20-B3C3-31B131509771|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ENZYME U/G HB|||BQ|NOT DONE||N|N|N|1||38||FOLLOW-UP|1960-04-27||1973-05-21|||1967-03-27||1966-12-07
TRIAL STUDY 134XCP|RP|ADD0DDE5-166F-4C20-B3C3-31B131509771|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MMAL|||10^6/EJACULATE U|NOT DONE||N|U|Y|2||58||SCREENING|1965-06-16||1970-12-19|||1972-03-06||1967-08-21
TRIAL STUDY 134XCP|RP|ADD0DDE5-166F-4C20-B3C3-31B131509771|2||||||INTP|INTERPRETATION||||ML/CAGE/WK|||MM3/MM2/YEAR|NOT DONE||N|Y|N|2||58||OBSERVATION|1965-11-15||1971-08-31|||1968-11-28||1961-01-31
TRIAL STUDY 134XCP|RP|ADD0DDE5-166F-4C20-B3C3-31B131509771|1||||||PREGNN|NUMBER OF PREGNANCIES||||UG/DL|||SYRINGE|NOT DONE||U|U|U|3||39||LONG-TERM FOLLOW-UP|1964-05-09||1971-09-14|||1960-06-13||1964-05-30
TRIAL STUDY 134XCP|RP|ADD0DDE5-166F-4C20-B3C3-31B131509771|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||G|||MG2/DL2|NOT DONE||Y|U|N|3||39||SCREENING|1960-12-20||1962-10-03|||1971-07-23||1966-10-03
TRIAL STUDY 134XCP|RP|ADD0DDE5-166F-4C20-B3C3-31B131509771|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||TUBERCULIN UNIT/ML|||10^9 CFU/G|NOT DONE||U|NA|NA|4||88||BASELINE|1972-10-14||1965-07-21|||1968-04-04||1967-11-12
TRIAL STUDY 134XCP|RP|ADD0DDE5-166F-4C20-B3C3-31B131509771|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MU/L|||ML/SEC/1.73M2|NOT DONE||N|N|Y|4||88||FOLLOW-UP|1972-11-11||1971-07-11|||1966-01-07||1969-03-12
TRIAL STUDY 134XCP|RP|ADD0DDE5-166F-4C20-B3C3-31B131509771|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||DPM|||M/SEC|NOT DONE||U|N|U|5||7||RUN-IN|1960-07-31||1965-02-11|||1961-02-12||1960-07-12
TRIAL STUDY 134XCP|RP|ADD0DDE5-166F-4C20-B3C3-31B131509771|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||LOG10 PFU|||/100 WBC|NOT DONE||Y|N|NA|5||7||WASHOUT|1971-11-04||1966-11-05|||1963-04-05||1971-10-19
TRIAL STUDY 134XCP|RP|4265CC9E-26AF-4A14-B9AA-04A246E2523C|1||||||BRTHN|NUMBER OF BIRTHS||||UCI/L|||TROCHE|NOT DONE||NA|NA|Y|1||38||LONG-TERM FOLLOW-UP|1966-09-06||1966-12-28|||1963-04-16||1960-01-15
TRIAL STUDY 134XCP|RP|4265CC9E-26AF-4A14-B9AA-04A246E2523C|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||BQ/KG|||ML/CM H2O|NOT DONE||N|U|NA|1||38||BLINDED TREATMENT|1967-02-07||1967-02-15|||1970-12-17||1962-05-29
TRIAL STUDY 134XCP|RP|4265CC9E-26AF-4A14-B9AA-04A246E2523C|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||G|||RFU|NOT DONE||N|NA|NA|2||58||RUN-IN|1962-12-19||1962-05-10|||1963-01-02||1963-11-24
TRIAL STUDY 134XCP|RP|4265CC9E-26AF-4A14-B9AA-04A246E2523C|2||||||ERYTHIND|ERYTHEMA INDICATOR||||10^3/L|||UIU/DL|NOT DONE||Y|N|U|2||58||OBSERVATION|1973-07-15||1964-04-02|||1960-05-02||1968-08-11
TRIAL STUDY 134XCP|RP|4265CC9E-26AF-4A14-B9AA-04A246E2523C|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UMOL/L/MIN|||JAR|NOT DONE||N|Y|NA|3||39||OBSERVATION|1973-02-13||1966-01-15|||1968-01-15||1963-10-23
TRIAL STUDY 134XCP|RP|4265CC9E-26AF-4A14-B9AA-04A246E2523C|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/WK|||F|NOT DONE||NA|U|U|3||39||CONTINUATION TREATMENT|1972-02-14||1960-06-13|||1963-01-31||1972-10-14
TRIAL STUDY 134XCP|RP|4265CC9E-26AF-4A14-B9AA-04A246E2523C|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MV*MIN|||UMOL/DAY|NOT DONE||U|Y|NA|4||88||OPEN LABEL TREATMENT|1962-02-28||1972-01-23|||1973-04-28||1961-07-02
TRIAL STUDY 134XCP|RP|4265CC9E-26AF-4A14-B9AA-04A246E2523C|2||||||ABORTN|NUMBER OF ABORTIONS||||MOL/ML|||FMOL/L/SEC|NOT DONE||NA|Y|N|4||88||CONTINUATION TREATMENT|1961-02-07||1967-11-08|||1970-10-06||1970-09-29
TRIAL STUDY 134XCP|RP|4265CC9E-26AF-4A14-B9AA-04A246E2523C|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||POUCH|||DAGU|NOT DONE||N|NA|NA|5||7||FOLLOW-UP|1960-01-23||1960-08-30|||1970-09-26||1961-06-29
TRIAL STUDY 134XCP|RP|4265CC9E-26AF-4A14-B9AA-04A246E2523C|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||UG/G/DAY|||PMOL/DAY|NOT DONE||Y|U|Y|5||7||TREATMENT|1962-04-01||1973-03-07|||1971-12-21||1963-02-14
TRIAL STUDY 134XCP|RP|96F268D3-7441-415C-95C9-A6B70C1718D5|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||FT2|||NL|NOT DONE||N|N|Y|1||38||OBSERVATION|1964-10-27||1960-07-11|||1963-11-28||1972-07-25
TRIAL STUDY 134XCP|RP|96F268D3-7441-415C-95C9-A6B70C1718D5|2||||||BCMETHOD|BIRTH CONTROL METHOD||||MG/KG/WEEK|||BQ|NOT DONE||NA|Y|N|1||38||WASHOUT|1973-01-09||1971-06-05|||1961-12-06||1965-11-29
TRIAL STUDY 134XCP|RP|96F268D3-7441-415C-95C9-A6B70C1718D5|1||||||ULCERIND|ULCER INDICATOR||||MEQ|||U/ANIMAL|NOT DONE||N|NA|NA|2||58||BASELINE|1964-01-07||1971-11-23|||1967-08-06||1973-07-07
TRIAL STUDY 134XCP|RP|96F268D3-7441-415C-95C9-A6B70C1718D5|2||||||ULCERIND|ULCER INDICATOR||||USIEMENS|||EVENTS|NOT DONE||U|U|N|2||58||INDUCTION TREATMENT|1961-09-30||1968-11-08|||1971-12-11||1964-05-10
TRIAL STUDY 134XCP|RP|96F268D3-7441-415C-95C9-A6B70C1718D5|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MG/ANIMAL|||CAL|NOT DONE||NA|NA|Y|3||39||SCREENING|1963-09-27||1964-08-31|||1973-03-21||1966-07-30
TRIAL STUDY 134XCP|RP|96F268D3-7441-415C-95C9-A6B70C1718D5|2||||||GRAVIND|GRAVIDA INDICATOR||||UG/M2/H|||MOL/L|NOT DONE||N|U|N|3||39||RUN-IN|1968-07-13||1960-12-26|||1971-10-05||1963-10-09
TRIAL STUDY 134XCP|RP|96F268D3-7441-415C-95C9-A6B70C1718D5|1||||||TNDRIND|TENDERNESS INDICATOR||||PFU/ANIMAL|||MIU/L|NOT DONE||NA|U|U|4||88||OBSERVATION|1972-01-16||1970-07-14|||1961-01-07||1969-09-02
TRIAL STUDY 134XCP|RP|96F268D3-7441-415C-95C9-A6B70C1718D5|2||||||TNDRIND|TENDERNESS INDICATOR||||WEBER|||FT3|NOT DONE||Y|U|N|4||88||BASELINE|1963-03-21||1963-05-28|||1960-04-26||1970-08-26
TRIAL STUDY 134XCP|RP|96F268D3-7441-415C-95C9-A6B70C1718D5|1||||||MENOSTAT|MENOPAUSE STATUS||||UG/MOL|||CM2|NOT DONE||N|U|NA|5||7||INDUCTION TREATMENT|1966-06-26||1968-12-06|||1969-12-10||1965-07-06
TRIAL STUDY 134XCP|RP|96F268D3-7441-415C-95C9-A6B70C1718D5|2||||||PUSTIND|PUSTULE INDICATOR||||10^9 ORGANISMS/ML|||PMOL/DAY|NOT DONE||Y|U|NA|5||7||TREATMENT|1967-06-02||1971-06-08|||1964-11-27||1965-12-14
TRIAL STUDY 134XCP|RP|15D32D1F-AEE2-474C-956E-461FB087D7B0|1||||||PEELIND|PEELING INDICATOR||||M/SEC|||MOL/L|NOT DONE||N|NA|NA|1||38||INDUCTION TREATMENT|1970-12-07||1971-05-30|||1969-07-06||1967-08-16
TRIAL STUDY 134XCP|RP|15D32D1F-AEE2-474C-956E-461FB087D7B0|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||PPTH|||ML/KG|NOT DONE||Y|N|N|1||38||BLINDED TREATMENT|1961-11-04||1968-04-29|||1972-06-10||1960-10-11
TRIAL STUDY 134XCP|RP|15D32D1F-AEE2-474C-956E-461FB087D7B0|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||VG/DOSE|||MBQ|NOT DONE||U|Y|Y|2||58||SCREENING|1962-11-26||1965-12-18|||1971-10-11||1961-07-02
TRIAL STUDY 134XCP|RP|15D32D1F-AEE2-474C-956E-461FB087D7B0|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||VOXEL|||KPA|NOT DONE||N|NA|N|2||58||FOLLOW-UP|1972-06-24||1960-11-04|||1964-03-01||1960-10-14
TRIAL STUDY 134XCP|RP|15D32D1F-AEE2-474C-956E-461FB087D7B0|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||%(W/W)|||MG/L FEU|NOT DONE||U|N|NA|3||39||OPEN LABEL TREATMENT|1971-04-10||1968-12-01|||1961-03-26||1961-08-17
TRIAL STUDY 134XCP|RP|15D32D1F-AEE2-474C-956E-461FB087D7B0|2||||||RASHIND|RASH INDICATOR||||MOSM/KG|||GBQ/MG|NOT DONE||NA|Y|NA|3||39||SCREENING|1966-04-06||1963-01-13|||1962-01-07||1962-10-11
TRIAL STUDY 134XCP|RP|15D32D1F-AEE2-474C-956E-461FB087D7B0|1||||||ABORTN|NUMBER OF ABORTIONS||||JAR|||STEPS|NOT DONE||NA|NA|Y|4||88||WASHOUT|1966-02-17||1972-12-12|||1961-07-29||1968-12-12
TRIAL STUDY 134XCP|RP|15D32D1F-AEE2-474C-956E-461FB087D7B0|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UG/L DDU|||UM/S|NOT DONE||U|U|NA|4||88||RUN-IN|1970-12-08||1964-12-02|||1972-07-08||1969-02-14
TRIAL STUDY 134XCP|RP|15D32D1F-AEE2-474C-956E-461FB087D7B0|1||||||STILBIND|STILLBIRTH INDICATOR||||MV/SEC|||COPIES/ML|NOT DONE||NA|U|U|5||7||FOLLOW-UP|1964-08-13||1963-08-03|||1972-08-04||1971-02-18
TRIAL STUDY 134XCP|RP|15D32D1F-AEE2-474C-956E-461FB087D7B0|2||||||STILBIND|STILLBIRTH INDICATOR||||10^4 CFU|||MM3/MM2/YEAR|NOT DONE||N|Y|Y|5||7||FOLLOW-UP|1968-05-23||1972-08-13|||1966-04-20||1969-06-19
TRIAL STUDY 134XCP|RP|DB42C81A-D644-455D-9D95-42131EF2BFE5|1||||||PUSTIND|PUSTULE INDICATOR||||FMOL/G|||MASK|NOT DONE||NA|N|U|1||38||BASELINE|1961-11-29||1961-03-08|||1970-02-01||1960-12-08
TRIAL STUDY 134XCP|RP|DB42C81A-D644-455D-9D95-42131EF2BFE5|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||EIA UNIT|||/SEC|NOT DONE||Y|NA|Y|1||38||FOLLOW-UP|1965-11-18||1971-03-10|||1962-01-26||1972-04-27
TRIAL STUDY 134XCP|RP|DB42C81A-D644-455D-9D95-42131EF2BFE5|1||||||BCMETHOD|BIRTH CONTROL METHOD||||FINGERTIP UNIT|||MET*H|NOT DONE||U|U|U|2||58||LONG-TERM FOLLOW-UP|1964-06-26||1969-08-29|||1970-12-02||1969-03-02
TRIAL STUDY 134XCP|RP|DB42C81A-D644-455D-9D95-42131EF2BFE5|2||||||BLISTIND|BLISTERING INDICATOR||||CUP EQ|||10^9/L|NOT DONE||Y|Y|U|2||58||RUN-IN|1965-11-24||1963-07-11|||1971-03-08||1968-09-21
TRIAL STUDY 134XCP|RP|DB42C81A-D644-455D-9D95-42131EF2BFE5|1||||||BLISTIND|BLISTERING INDICATOR||||/MS|||IU/KG|NOT DONE||U|N|U|3||39||SCREENING|1965-08-03||1961-10-05|||1967-01-13||1970-07-16
TRIAL STUDY 134XCP|RP|DB42C81A-D644-455D-9D95-42131EF2BFE5|2||||||BRTHN|NUMBER OF BIRTHS||||EU|||ELISA UNIT/ML|NOT DONE||U|NA|NA|3||39||FOLLOW-UP|1967-05-04||1967-06-22|||1967-02-03||1962-02-13
TRIAL STUDY 134XCP|RP|DB42C81A-D644-455D-9D95-42131EF2BFE5|1||||||BCMETHOD|BIRTH CONTROL METHOD||||CI/KG|||ML/G/MIN|NOT DONE||NA|NA|N|4||88||SCREENING|1973-05-04||1963-10-08|||1972-02-21||1963-04-21
TRIAL STUDY 134XCP|RP|DB42C81A-D644-455D-9D95-42131EF2BFE5|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||G/ANIMAL|||PMOL/DL|NOT DONE||NA|N|Y|4||88||FOLLOW-UP|1965-08-28||1964-11-12|||1973-08-13||1967-12-05
TRIAL STUDY 134XCP|RP|DB42C81A-D644-455D-9D95-42131EF2BFE5|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||BP|||IU/ML|NOT DONE||U|Y|N|5||7||WASHOUT|1960-12-08||1963-05-02|||1971-10-02||1969-08-04
TRIAL STUDY 134XCP|RP|DB42C81A-D644-455D-9D95-42131EF2BFE5|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UG/DL|||COPIES/UL|NOT DONE||NA|U|NA|5||7||TREATMENT|1969-11-15||1972-03-30|||1965-02-01||1972-05-23
TRIAL STUDY 134XCP|RP|4B01CC59-51D3-4499-9AB1-DF446006CB8D|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||TESLA|||MV/SEC|NOT DONE||NA|U|N|1||38||BLINDED TREATMENT|1963-05-26||1967-06-19|||1966-12-16||1973-01-17
TRIAL STUDY 134XCP|RP|4B01CC59-51D3-4499-9AB1-DF446006CB8D|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MS/MMHG|||BEAM BREAKS|NOT DONE||Y|N|U|1||38||FOLLOW-UP|1965-02-02||1973-03-25|||1969-02-04||1962-03-26
TRIAL STUDY 134XCP|RP|4B01CC59-51D3-4499-9AB1-DF446006CB8D|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||BOTTLE|||IU|NOT DONE||NA|NA|NA|2||58||OPEN LABEL TREATMENT|1972-03-23||1971-06-20|||1968-10-09||1967-09-25
TRIAL STUDY 134XCP|RP|4B01CC59-51D3-4499-9AB1-DF446006CB8D|2||||||DLVRMODE|MODE OF DELIVERY||||MANSON U/ML|||TUBE|NOT DONE||Y|U|U|2||58||CONTINUATION TREATMENT|1968-10-02||1967-05-03|||1968-04-03||1964-11-07
TRIAL STUDY 134XCP|RP|4B01CC59-51D3-4499-9AB1-DF446006CB8D|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||/2000 RBC|||V/V|NOT DONE||U|N|Y|3||39||RUN-IN|1961-08-20||1963-09-16|||1961-02-17||1965-09-20
TRIAL STUDY 134XCP|RP|4B01CC59-51D3-4499-9AB1-DF446006CB8D|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||DEG/S|||LOG10 ELISA UNIT|NOT DONE||Y|U|NA|3||39||CONTINUATION TREATMENT|1970-01-01||1964-01-12|||1971-05-30||1972-12-22
TRIAL STUDY 134XCP|RP|4B01CC59-51D3-4499-9AB1-DF446006CB8D|1||||||TNDRIND|TENDERNESS INDICATOR||||MMOL2/L2|||WEBER|NOT DONE||U|N|Y|4||88||WASHOUT|1968-09-18||1965-08-31|||1960-11-12||1961-06-08
TRIAL STUDY 134XCP|RP|4B01CC59-51D3-4499-9AB1-DF446006CB8D|2||||||BCMETHOD|BIRTH CONTROL METHOD||||G/G|||AMFI|NOT DONE||NA|U|NA|4||88||SCREENING|1962-12-28||1966-05-18|||1966-09-19||1961-12-17
TRIAL STUDY 134XCP|RP|4B01CC59-51D3-4499-9AB1-DF446006CB8D|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MG2/DL2|||FEU|NOT DONE||N|NA|NA|5||7||WASHOUT|1964-02-18||1971-03-03|||1963-03-01||1964-05-30
TRIAL STUDY 134XCP|RP|4B01CC59-51D3-4499-9AB1-DF446006CB8D|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||PIXELS/CM|||LOZENGE|NOT DONE||U|Y|NA|5||7||BASELINE|1972-10-08||1960-09-06|||1972-02-26||1973-03-25
TRIAL STUDY 134XCP|RP|B69774FC-1151-45DD-B329-6C21C2F29603|1||||||DLVRMODE|MODE OF DELIVERY||||TESLA|||MEQ|NOT DONE||NA|N|Y|1||38||LONG-TERM FOLLOW-UP|1961-02-04||1970-02-20|||1969-05-20||1966-08-05
TRIAL STUDY 134XCP|RP|B69774FC-1151-45DD-B329-6C21C2F29603|2||||||ULCERIND|ULCER INDICATOR||||CM/S|||UG/M2/DAY|NOT DONE||U|NA|Y|1||38||LONG-TERM FOLLOW-UP|1966-07-05||1967-03-09|||1966-03-19||1964-03-15
TRIAL STUDY 134XCP|RP|B69774FC-1151-45DD-B329-6C21C2F29603|1||||||INTP|INTERPRETATION||||10^6/L|||L/H/M2|NOT DONE||N|NA|Y|2||58||TREATMENT|1962-04-19||1962-10-26|||1962-06-06||1964-12-17
TRIAL STUDY 134XCP|RP|B69774FC-1151-45DD-B329-6C21C2F29603|2||||||STILBIND|STILLBIRTH INDICATOR||||COPIES/ML|||MG/MOL|NOT DONE||N|Y|NA|2||58||INDUCTION TREATMENT|1962-07-01||1972-01-16|||1970-06-06||1965-03-23
TRIAL STUDY 134XCP|RP|B69774FC-1151-45DD-B329-6C21C2F29603|1||||||BRTHN|NUMBER OF BIRTHS||||10^7 CFU/ML|||UG/G/DAY|NOT DONE||Y|NA|Y|3||39||SCREENING|1969-05-06||1966-02-16|||1966-07-22||1969-02-08
TRIAL STUDY 134XCP|RP|B69774FC-1151-45DD-B329-6C21C2F29603|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||BQ/MG|||SFC/10^6 PBMC|NOT DONE||NA|U|N|3||39||CONTINUATION TREATMENT|1971-04-21||1972-12-09|||1971-05-28||1960-01-09
TRIAL STUDY 134XCP|RP|B69774FC-1151-45DD-B329-6C21C2F29603|1||||||DSCHGIND|DISCHARGE INDICATOR||||BAU/ML|||HENRY|NOT DONE||NA|NA|U|4||88||SCREENING|1963-02-12||1967-03-15|||1972-05-31||1962-02-07
TRIAL STUDY 134XCP|RP|B69774FC-1151-45DD-B329-6C21C2F29603|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||RATIO|||MG/ANIMAL|NOT DONE||N|N|N|4||88||BLINDED TREATMENT|1969-03-13||1967-06-15|||1968-01-02||1968-12-27
TRIAL STUDY 134XCP|RP|B69774FC-1151-45DD-B329-6C21C2F29603|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||DAYS/MONTH|||C|NOT DONE||N|NA|NA|5||7||SCREENING|1967-03-24||1968-01-23|||1966-09-03||1960-01-07
TRIAL STUDY 134XCP|RP|B69774FC-1151-45DD-B329-6C21C2F29603|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||NCI|||MV/SEC|NOT DONE||U|Y|NA|5||7||FOLLOW-UP|1966-10-09||1971-04-26|||1971-09-17||1960-01-13
TRIAL STUDY 134XCP|RP|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|1||||||MENARAGE|MENARCHE AGE||||ML/MIN/MMHG|||PELLET|NOT DONE||U|Y|NA|1||38||BLINDED TREATMENT|1968-04-21||1969-08-04|||1973-06-13||1961-02-21
TRIAL STUDY 134XCP|RP|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|2||||||BRTHN|NUMBER OF BIRTHS||||PPTH|||UV|NOT DONE||U|NA|NA|1||38||CONTINUATION TREATMENT|1969-08-22||1962-06-18|||1965-10-06||1969-06-20
TRIAL STUDY 134XCP|RP|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UG/H|||CAN|NOT DONE||N|U|NA|2||58||INDUCTION TREATMENT|1969-08-24||1969-02-24|||1970-01-03||1965-04-04
TRIAL STUDY 134XCP|RP|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|2||||||PREGST|PREGNANT DURING THE STUDY||||KG/L|||USEC|NOT DONE||NA|NA|NA|2||58||OBSERVATION|1973-05-22||1965-10-06|||1963-03-10||1962-09-10
TRIAL STUDY 134XCP|RP|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||M3|||LOG EID 50/DOSE|NOT DONE||N|NA|Y|3||39||CONTINUATION TREATMENT|1964-07-18||1960-11-28|||1969-06-04||1962-09-11
TRIAL STUDY 134XCP|RP|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||S^-1(%O2)^-1|||PUFF|NOT DONE||N|N|Y|3||39||TREATMENT|1965-05-09||1963-10-27|||1960-02-19||1969-04-16
TRIAL STUDY 134XCP|RP|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|1||||||PREGNN|NUMBER OF PREGNANCIES||||MBP|||MMHG*MIN/L|NOT DONE||U|U|Y|4||88||OPEN LABEL TREATMENT|1962-09-16||1967-07-05|||1971-02-11||1963-07-16
TRIAL STUDY 134XCP|RP|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||FOZ_US|||USP U|NOT DONE||NA|NA|U|4||88||TREATMENT|1973-09-07||1960-08-11|||1973-03-30||1972-12-22
TRIAL STUDY 134XCP|RP|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||MIN*MG/ML|||GY/H|NOT DONE||NA|NA|N|5||7||TREATMENT|1965-11-25||1964-01-11|||1968-02-22||1965-01-19
TRIAL STUDY 134XCP|RP|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||LOG10 TCID 50/UL|||PRESSOR UNITS|NOT DONE||U|N|N|5||7||LONG-TERM FOLLOW-UP|1962-03-01||1967-05-14|||1968-04-05||1960-01-07
TRIAL STUDY 134XCP|RP|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||NG/MOL|||DAGU/ML|NOT DONE||Y|U|N|1||38||WASHOUT|1960-01-06||1960-06-08|||1960-09-18||1960-08-18
TRIAL STUDY 134XCP|RP|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|2||||||INTP|INTERPRETATION||||FRAMES/S|||SCOOPFUL|NOT DONE||U|U|U|1||38||INDUCTION TREATMENT|1968-06-14||1965-07-06|||1962-01-03||1963-10-07
TRIAL STUDY 134XCP|RP|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||BOX|||FMOL/G|NOT DONE||NA|Y|NA|2||58||BASELINE|1966-01-07||1972-11-06|||1970-08-14||1967-10-16
TRIAL STUDY 134XCP|RP|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|2||||||BRTHN|NUMBER OF BIRTHS||||DDU|||POUCH|NOT DONE||U|NA|Y|2||58||INDUCTION TREATMENT|1963-08-26||1966-09-16|||1961-02-21||1962-11-24
TRIAL STUDY 134XCP|RP|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||PT_US|||TSP EQ|NOT DONE||Y|N|NA|3||39||INDUCTION TREATMENT|1960-04-10||1964-05-31|||1969-09-28||1966-11-13
TRIAL STUDY 134XCP|RP|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|2||||||GRAVIND|GRAVIDA INDICATOR||||UGEQ|||CYLINDER|NOT DONE||Y|U|Y|3||39||INDUCTION TREATMENT|1968-11-21||1962-10-08|||1963-01-04||1961-03-06
TRIAL STUDY 134XCP|RP|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|1||||||THICK|THICKNESS||||PG/CELL|||MM2|NOT DONE||NA|NA|U|4||88||BASELINE|1962-07-31||1965-02-12|||1966-01-27||1961-10-08
TRIAL STUDY 134XCP|RP|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MEQ/ML|||ML/M2/DAY|NOT DONE||NA|Y|Y|4||88||RUN-IN|1961-07-06||1961-06-25|||1962-12-12||1972-04-13
TRIAL STUDY 134XCP|RP|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|1||||||THICK|THICKNESS||||ML/S|||10^9 CFU/ML|NOT DONE||NA|Y|N|5||7||CONTINUATION TREATMENT|1972-03-29||1966-10-23|||1962-05-13||1972-03-28
TRIAL STUDY 134XCP|RP|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|2||||||STILBIND|STILLBIRTH INDICATOR||||KM/H|||CM/S|NOT DONE||U|N|NA|5||7||WASHOUT|1969-02-23||1973-09-02|||1962-05-15||1963-03-22
TRIAL STUDY 134XCP|RP|674B4474-6D52-4DE2-8342-EDB28F577BB5|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||IU/KG|||MG/L|NOT DONE||Y|NA|Y|1||38||INDUCTION TREATMENT|1962-07-05||1973-04-26|||1968-01-12||1966-04-26
TRIAL STUDY 134XCP|RP|674B4474-6D52-4DE2-8342-EDB28F577BB5|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||SFC/10^6 PBMC|||ML/CAGE/WK|NOT DONE||NA|Y|N|1||38||LONG-TERM FOLLOW-UP|1963-02-10||1972-06-20|||1960-03-03||1967-01-13
TRIAL STUDY 134XCP|RP|674B4474-6D52-4DE2-8342-EDB28F577BB5|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^6/HPF|||DROP|NOT DONE||N|U|NA|2||58||CONTINUATION TREATMENT|1962-09-23||1964-07-25|||1971-10-31||1965-09-02
TRIAL STUDY 134XCP|RP|674B4474-6D52-4DE2-8342-EDB28F577BB5|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||ABSORBANCE U/MIN|||MEQ/MMOL|NOT DONE||U|Y|U|2||58||FOLLOW-UP|1967-02-22||1969-01-10|||1971-11-13||1972-10-15
TRIAL STUDY 134XCP|RP|674B4474-6D52-4DE2-8342-EDB28F577BB5|1||||||THICK|THICKNESS||||EU|||CI/ML|NOT DONE||N|N|U|3||39||INDUCTION TREATMENT|1966-09-11||1972-08-03|||1963-06-21||1960-11-10
TRIAL STUDY 134XCP|RP|674B4474-6D52-4DE2-8342-EDB28F577BB5|2||||||MASSIND|MASS INDICATOR||||10^3 ORGANISMS|||MG/MOL|NOT DONE||Y|U|NA|3||39||RUN-IN|1969-06-27||1964-12-05|||1969-10-25||1965-12-05
TRIAL STUDY 134XCP|RP|674B4474-6D52-4DE2-8342-EDB28F577BB5|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UMOL/KG/MIN|||UU/L|NOT DONE||NA|Y|Y|4||88||CONTINUATION TREATMENT|1964-10-31||1973-02-19|||1971-12-12||1961-03-06
TRIAL STUDY 134XCP|RP|674B4474-6D52-4DE2-8342-EDB28F577BB5|2||||||TNDRIND|TENDERNESS INDICATOR||||10^7 TCID 50/DOSE|||VG/ML|NOT DONE||U|Y|U|4||88||LONG-TERM FOLLOW-UP|1968-10-13||1961-06-26|||1964-09-28||1972-03-31
TRIAL STUDY 134XCP|RP|674B4474-6D52-4DE2-8342-EDB28F577BB5|1||||||MASSIND|MASS INDICATOR||||PACK YEAR|||L/H/M2|NOT DONE||N|U|U|5||7||INDUCTION TREATMENT|1972-01-02||1971-05-15|||1969-11-03||1961-03-13
TRIAL STUDY 134XCP|RP|674B4474-6D52-4DE2-8342-EDB28F577BB5|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||U/M2/DAY|||FEU|NOT DONE||Y|U|N|5||7||SCREENING|1972-03-02||1960-04-09|||1970-05-16||1972-06-15
TRIAL STUDY 134XCP|RP|AF634AD4-086A-47EE-A5DB-A4B6833356C7|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MANSON U/ML|||CI/G|NOT DONE||NA|N|N|1||38||SCREENING|1970-09-14||1972-06-09|||1965-07-10||1970-08-22
TRIAL STUDY 134XCP|RP|AF634AD4-086A-47EE-A5DB-A4B6833356C7|2||||||PRGENDTC|DATE PREGNANCY ENDED||||K|||U/MMOL|NOT DONE||NA|NA|NA|1||38||INDUCTION TREATMENT|1967-07-17||1966-11-03|||1967-08-26||1970-06-23
TRIAL STUDY 134XCP|RP|AF634AD4-086A-47EE-A5DB-A4B6833356C7|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||FRAMES/S|||UV*SEC|NOT DONE||NA|Y|U|2||58||OPEN LABEL TREATMENT|1960-12-06||1966-06-06|||1961-12-13||1965-11-25
TRIAL STUDY 134XCP|RP|AF634AD4-086A-47EE-A5DB-A4B6833356C7|2||||||PUSTIND|PUSTULE INDICATOR||||MOL/DAY|||KA_U/DL|NOT DONE||NA|Y|N|2||58||OPEN LABEL TREATMENT|1965-12-30||1960-11-25|||1972-04-02||1965-04-30
TRIAL STUDY 134XCP|RP|AF634AD4-086A-47EE-A5DB-A4B6833356C7|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UG/L FEU|||NCI|NOT DONE||U|N|Y|3||39||TREATMENT|1968-08-14||1962-04-26|||1962-07-30||1970-11-30
TRIAL STUDY 134XCP|RP|AF634AD4-086A-47EE-A5DB-A4B6833356C7|2||||||GRAVIND|GRAVIDA INDICATOR||||MG/DL|||VIRTUAL PIXEL|NOT DONE||U|Y|Y|3||39||WASHOUT|1965-10-17||1966-01-22|||1962-02-23||1965-04-22
TRIAL STUDY 134XCP|RP|AF634AD4-086A-47EE-A5DB-A4B6833356C7|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||IU/G|||BAU|NOT DONE||Y|NA|N|4||88||CONTINUATION TREATMENT|1968-11-05||1968-11-20|||1971-05-24||1973-06-18
TRIAL STUDY 134XCP|RP|AF634AD4-086A-47EE-A5DB-A4B6833356C7|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MET*H|||MNFI|NOT DONE||Y|Y|N|4||88||INDUCTION TREATMENT|1970-09-25||1969-09-15|||1971-03-31||1969-08-14
TRIAL STUDY 134XCP|RP|AF634AD4-086A-47EE-A5DB-A4B6833356C7|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||G/M2/DAY|||/MS|NOT DONE||Y|N|NA|5||7||FOLLOW-UP|1967-02-19||1969-09-16|||1965-06-05||1961-08-09
TRIAL STUDY 134XCP|RP|AF634AD4-086A-47EE-A5DB-A4B6833356C7|2||||||DSCHGIND|DISCHARGE INDICATOR||||F|||MEQ/UG|NOT DONE||Y|N|NA|5||7||FOLLOW-UP|1971-03-03||1973-01-02|||1967-06-03||1973-06-26
TRIAL STUDY 134XCP|RP|89298058-EB86-4892-97D6-1B87277DF7FC|1||||||ABORTN|NUMBER OF ABORTIONS||||KDA|||MG/L|NOT DONE||N|N|U|1||38||WASHOUT|1960-08-12||1968-09-12|||1963-10-06||1970-07-11
TRIAL STUDY 134XCP|RP|89298058-EB86-4892-97D6-1B87277DF7FC|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||KG/CM|||AG|NOT DONE||U|NA|Y|1||38||LONG-TERM FOLLOW-UP|1963-06-14||1963-10-16|||1963-06-19||1965-01-04
TRIAL STUDY 134XCP|RP|89298058-EB86-4892-97D6-1B87277DF7FC|1||||||ABORTN|NUMBER OF ABORTIONS||||GPL U/ML|||10^9/G|NOT DONE||NA|Y|U|2||58||OPEN LABEL TREATMENT|1966-10-15||1965-10-13|||1960-05-23||1972-08-24
TRIAL STUDY 134XCP|RP|89298058-EB86-4892-97D6-1B87277DF7FC|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||F|||PMOL/DL|NOT DONE||N|U|N|2||58||OBSERVATION|1972-01-05||1962-11-03|||1960-09-02||1962-10-04
TRIAL STUDY 134XCP|RP|89298058-EB86-4892-97D6-1B87277DF7FC|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MG/MIN|||DAGU|NOT DONE||N|U|Y|3||39||WASHOUT|1960-01-31||1966-11-19|||1965-12-19||1964-11-14
TRIAL STUDY 134XCP|RP|89298058-EB86-4892-97D6-1B87277DF7FC|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||EIA UNIT|||DAYS/WK|NOT DONE||N|U|NA|3||39||TREATMENT|1966-02-24||1970-10-24|||1967-07-20||1968-03-13
TRIAL STUDY 134XCP|RP|89298058-EB86-4892-97D6-1B87277DF7FC|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||BOX|||PHERESIS UNIT|NOT DONE||U|N|U|4||88||TREATMENT|1962-04-01||1965-06-26|||1964-11-20||1964-10-15
TRIAL STUDY 134XCP|RP|89298058-EB86-4892-97D6-1B87277DF7FC|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||ML/G/DAY|||ML/G/DAY|NOT DONE||NA|NA|Y|4||88||BASELINE|1967-10-25||1963-06-12|||1964-12-16||1972-02-09
TRIAL STUDY 134XCP|RP|89298058-EB86-4892-97D6-1B87277DF7FC|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||VP/DOSE|||NG/DAY|NOT DONE||Y|N|Y|5||7||CONTINUATION TREATMENT|1972-11-22||1973-07-09|||1966-05-19||1969-09-15
TRIAL STUDY 134XCP|RP|89298058-EB86-4892-97D6-1B87277DF7FC|2||||||BLISTIND|BLISTERING INDICATOR||||TUBE|||CMH2O*S2/ML|NOT DONE||NA|N|N|5||7||SCREENING|1963-01-21||1960-05-01|||1961-04-07||1961-01-31
TRIAL STUDY 134XCP|RP|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|1||||||FUNDHT|FUNDAL HEIGHT||||UMOL/H/MMOL|||MGEQ|NOT DONE||Y|U|U|1||38||BLINDED TREATMENT|1973-04-02||1964-07-15|||1964-03-24||1963-09-24
TRIAL STUDY 134XCP|RP|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|2||||||MENOAGE|MENOPAUSE AGE||||UIU/DL|||KM|NOT DONE||NA|N|U|1||38||LONG-TERM FOLLOW-UP|1972-08-05||1963-10-19|||1970-03-28||1973-06-13
TRIAL STUDY 134XCP|RP|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||ML/S|||KS|NOT DONE||U|Y|NA|2||58||BASELINE|1965-10-12||1971-01-11|||1961-06-10||1967-09-01
TRIAL STUDY 134XCP|RP|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||/100 WBC|||AMU|NOT DONE||Y|U|N|2||58||OPEN LABEL TREATMENT|1963-08-18||1965-11-25|||1969-10-29||1964-08-10
TRIAL STUDY 134XCP|RP|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|1||||||PREGIND|PREGNANT INDICATOR||||10^3 CFU/ML|||U/MMOL|NOT DONE||N|Y|Y|3||39||SCREENING|1967-02-25||1964-10-17|||1961-11-05||1971-10-25
TRIAL STUDY 134XCP|RP|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|2||||||BLISTIND|BLISTERING INDICATOR||||BEL|||MMHG*MIN/L|NOT DONE||N|Y|NA|3||39||SCREENING|1973-01-29||1969-11-14|||1960-10-02||1963-05-26
TRIAL STUDY 134XCP|RP|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|1||||||ULCERIND|ULCER INDICATOR||||DAYS|||UM|NOT DONE||N|NA|Y|4||88||LONG-TERM FOLLOW-UP|1967-06-26||1961-04-10|||1966-06-09||1967-05-15
TRIAL STUDY 134XCP|RP|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|2||||||INTP|INTERPRETATION||||M2|||10^6 DNA COPIES/ML|NOT DONE||Y|NA|NA|4||88||LONG-TERM FOLLOW-UP|1973-06-13||1971-09-01|||1965-07-12||1970-05-31
TRIAL STUDY 134XCP|RP|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||APPLICATION|||U/ML|NOT DONE||U|N|NA|5||7||RUN-IN|1965-08-31||1962-02-04|||1965-12-09||1970-03-24
TRIAL STUDY 134XCP|RP|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|2||||||PEELIND|PEELING INDICATOR||||CL|||U/MMOL|NOT DONE||NA|N|N|5||7||BASELINE|1969-07-28||1966-03-29|||1966-03-04||1962-05-07
TRIAL STUDY 134XCP|RP|D5235188-810B-431F-A6EF-E50DAA57F5E7|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||SV|||MIN*MG/ML|NOT DONE||NA|Y|Y|1||38||INDUCTION TREATMENT|1960-08-29||1972-01-15|||1961-05-01||1969-06-17
TRIAL STUDY 134XCP|RP|D5235188-810B-431F-A6EF-E50DAA57F5E7|2||||||THICK|THICKNESS||||UU/L|||OSM|NOT DONE||U|U|N|1||38||BASELINE|1968-12-12||1960-04-12|||1968-10-08||1969-11-29
TRIAL STUDY 134XCP|RP|D5235188-810B-431F-A6EF-E50DAA57F5E7|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||ENZYME U|||UG/L DDU|NOT DONE||NA|U|NA|2||58||LONG-TERM FOLLOW-UP|1972-06-25||1964-04-04|||1968-08-16||1963-03-24
TRIAL STUDY 134XCP|RP|D5235188-810B-431F-A6EF-E50DAA57F5E7|2||||||DSCHGIND|DISCHARGE INDICATOR||||DMOL|||CS|NOT DONE||Y|Y|Y|2||58||INDUCTION TREATMENT|1972-10-07||1960-02-29|||1966-06-12||1965-03-23
TRIAL STUDY 134XCP|RP|D5235188-810B-431F-A6EF-E50DAA57F5E7|1||||||MENOSTAT|MENOPAUSE STATUS||||IU/ML|||MMOL/MIN/KPA|NOT DONE||NA|U|N|3||39||INDUCTION TREATMENT|1961-06-30||1970-06-14|||1960-10-02||1970-07-02
TRIAL STUDY 134XCP|RP|D5235188-810B-431F-A6EF-E50DAA57F5E7|2||||||BLISTIND|BLISTERING INDICATOR||||MOL/DAY|||BREATHS/MIN|NOT DONE||U|U|U|3||39||TREATMENT|1969-09-29||1971-03-12|||1973-05-29||1963-01-12
TRIAL STUDY 134XCP|RP|D5235188-810B-431F-A6EF-E50DAA57F5E7|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||SUPPOSITORY|||UG/ANIMAL|NOT DONE||N|NA|N|4||88||CONTINUATION TREATMENT|1968-11-05||1969-03-06|||1963-07-22||1968-03-01
TRIAL STUDY 134XCP|RP|D5235188-810B-431F-A6EF-E50DAA57F5E7|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||/500 WBC|||MEQ/UL|NOT DONE||NA|N|Y|4||88||INDUCTION TREATMENT|1964-01-04||1962-06-17|||1968-08-08||1965-12-01
TRIAL STUDY 134XCP|RP|D5235188-810B-431F-A6EF-E50DAA57F5E7|1||||||PREGST|PREGNANT DURING THE STUDY||||MOL/G|||MG/M2/MIN|NOT DONE||NA|N|NA|5||7||OPEN LABEL TREATMENT|1970-03-26||1960-04-27|||1970-08-03||1968-08-01
TRIAL STUDY 134XCP|RP|D5235188-810B-431F-A6EF-E50DAA57F5E7|2||||||BLISTIND|BLISTERING INDICATOR||||CD*S/M2|||ML/S|NOT DONE||NA|Y|NA|5||7||INDUCTION TREATMENT|1963-09-08||1963-09-30|||1964-06-12||1969-06-12
TRIAL STUDY 134XCP|RP|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MV/SEC|||MPH|NOT DONE||NA|U|Y|1||38||FOLLOW-UP|1963-11-01||1972-02-23|||1962-10-14||1960-02-20
TRIAL STUDY 134XCP|RP|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|2||||||PUSTIND|PUSTULE INDICATOR||||C|||HR/DAY|NOT DONE||NA|U|N|1||38||FOLLOW-UP|1962-07-23||1973-02-18|||1970-01-17||1972-07-10
TRIAL STUDY 134XCP|RP|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|1||||||PEELIND|PEELING INDICATOR||||CCID 50/ML|||MPA|NOT DONE||N|N|NA|2||58||OBSERVATION|1965-05-07||1961-10-17|||1968-12-09||1963-09-12
TRIAL STUDY 134XCP|RP|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|2||||||PUSTIND|PUSTULE INDICATOR||||MG/M2/DAY|||CMH2O*S/ML|NOT DONE||U|N|U|2||58||TREATMENT|1971-04-08||1960-02-10|||1970-10-06||1964-11-05
TRIAL STUDY 134XCP|RP|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|1||||||PUSTIND|PUSTULE INDICATOR||||MOSM/KG|||TUBERCULIN UNIT|NOT DONE||NA|NA|Y|3||39||RUN-IN|1973-08-16||1961-09-02|||1964-12-11||1962-10-10
TRIAL STUDY 134XCP|RP|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||CI/L|||U.CARR|NOT DONE||NA|N|U|3||39||TREATMENT|1973-03-03||1966-09-10|||1963-11-04||1972-05-05
TRIAL STUDY 134XCP|RP|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|1||||||MENARAGE|MENARCHE AGE||||UL/DOSE|||CPM|NOT DONE||U|N|Y|4||88||INDUCTION TREATMENT|1963-07-15||1963-06-18|||1971-07-31||1970-11-07
TRIAL STUDY 134XCP|RP|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|2||||||BCMETHOD|BIRTH CONTROL METHOD||||KIT|||MJOULE/CM2|NOT DONE||Y|U|Y|4||88||FOLLOW-UP|1969-11-24||1971-11-17|||1964-01-08||1973-04-22
TRIAL STUDY 134XCP|RP|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^9 CFU/G|||INHALATION|NOT DONE||Y|Y|Y|5||7||BASELINE|1962-02-04||1960-02-20|||1972-07-14||1964-11-06
TRIAL STUDY 134XCP|RP|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||10^6/L|||AG|NOT DONE||U|N|Y|5||7||BLINDED TREATMENT|1961-02-07||1970-05-10|||1968-08-13||1967-10-24
TRIAL STUDY 134XCP|RP|E3BB136E-0913-43FB-B760-CBE939F0C4D2|1||||||BCMETHOD|BIRTH CONTROL METHOD||||JDF UNIT|||MMHG*MIN/L|NOT DONE||U|U|N|1||38||SCREENING|1960-09-15||1966-06-24|||1965-12-19||1966-01-16
TRIAL STUDY 134XCP|RP|E3BB136E-0913-43FB-B760-CBE939F0C4D2|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||NMOL BCE/NMOL|||ABSORBANCE U/ML|NOT DONE||N|U|NA|1||38||INDUCTION TREATMENT|1968-12-28||1960-11-24|||1967-12-10||1969-03-29
TRIAL STUDY 134XCP|RP|E3BB136E-0913-43FB-B760-CBE939F0C4D2|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^3/HPF|||PPM|NOT DONE||Y|U|Y|2||58||BASELINE|1961-06-29||1967-10-15|||1972-11-22||1961-02-03
TRIAL STUDY 134XCP|RP|E3BB136E-0913-43FB-B760-CBE939F0C4D2|2||||||MENOSTAT|MENOPAUSE STATUS||||UG/M2|||P|NOT DONE||N|NA|NA|2||58||RUN-IN|1964-12-05||1965-11-14|||1971-06-03||1960-03-13
TRIAL STUDY 134XCP|RP|E3BB136E-0913-43FB-B760-CBE939F0C4D2|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||GBQ/MG|||FIU|NOT DONE||Y|NA|U|3||39||SCREENING|1968-03-16||1962-07-20|||1966-08-23||1969-07-10
TRIAL STUDY 134XCP|RP|E3BB136E-0913-43FB-B760-CBE939F0C4D2|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||ML/KG|||USEC|NOT DONE||U|N|N|3||39||BASELINE|1966-11-01||1965-09-10|||1962-02-28||1965-01-30
TRIAL STUDY 134XCP|RP|E3BB136E-0913-43FB-B760-CBE939F0C4D2|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UEQ/L|||UG/KG/H|NOT DONE||Y|NA|NA|4||88||WASHOUT|1972-04-14||1969-02-10|||1973-06-29||1964-12-19
TRIAL STUDY 134XCP|RP|E3BB136E-0913-43FB-B760-CBE939F0C4D2|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MEQ/KG|||MOL/G|NOT DONE||N|NA|U|4||88||OBSERVATION|1965-08-17||1972-08-07|||1967-07-18||1970-02-03
TRIAL STUDY 134XCP|RP|E3BB136E-0913-43FB-B760-CBE939F0C4D2|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||U/M2|||MN|NOT DONE||N|U|Y|5||7||OPEN LABEL TREATMENT|1962-07-13||1960-08-31|||1972-01-12||1964-12-08
TRIAL STUDY 134XCP|RP|E3BB136E-0913-43FB-B760-CBE939F0C4D2|2||||||TNDRIND|TENDERNESS INDICATOR||||ML/ANIMAL/DAY|||NU/CL|NOT DONE||NA|N|NA|5||7||SCREENING|1964-08-04||1968-08-20|||1963-06-05||1973-03-15
TRIAL STUDY 134XCP|RP|60C25341-42CE-4532-8F99-25B8305C4ED5|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||DIOPTER|||U/ML|NOT DONE||NA|NA|Y|1||38||BASELINE|1965-01-28||1969-02-15|||1973-08-11||1963-05-10
TRIAL STUDY 134XCP|RP|60C25341-42CE-4532-8F99-25B8305C4ED5|2||||||ABORTN|NUMBER OF ABORTIONS||||/MIN|||YD|NOT DONE||N|Y|Y|1||38||OBSERVATION|1973-01-02||1970-12-15|||1962-09-30||1960-10-05
TRIAL STUDY 134XCP|RP|60C25341-42CE-4532-8F99-25B8305C4ED5|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UG/KG|||FT|NOT DONE||N|N|Y|2||58||FOLLOW-UP|1962-02-27||1963-07-18|||1960-06-03||1965-08-30
TRIAL STUDY 134XCP|RP|60C25341-42CE-4532-8F99-25B8305C4ED5|2||||||PREGNN|NUMBER OF PREGNANCIES||||BU/ML|||FT3|NOT DONE||NA|U|N|2||58||OPEN LABEL TREATMENT|1969-05-05||1967-05-12|||1964-10-20||1961-11-17
TRIAL STUDY 134XCP|RP|60C25341-42CE-4532-8F99-25B8305C4ED5|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||PIXELS/CM|||NMOL/DAY|NOT DONE||NA|Y|N|3||39||BLINDED TREATMENT|1969-07-22||1969-12-04|||1961-03-04||1965-03-01
TRIAL STUDY 134XCP|RP|60C25341-42CE-4532-8F99-25B8305C4ED5|2||||||BLISTIND|BLISTERING INDICATOR||||OD UNIT|||PG/DL|NOT DONE||Y|U|NA|3||39||OBSERVATION|1969-11-09||1962-01-24|||1970-08-01||1961-07-24
TRIAL STUDY 134XCP|RP|60C25341-42CE-4532-8F99-25B8305C4ED5|1||||||ULCERIND|ULCER INDICATOR||||DEG2|||UOSM|NOT DONE||NA|N|N|4||88||LONG-TERM FOLLOW-UP|1971-10-20||1964-08-18|||1965-09-09||1960-09-25
TRIAL STUDY 134XCP|RP|60C25341-42CE-4532-8F99-25B8305C4ED5|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^3 RNA COPIES/ML|||CI/UG|NOT DONE||N|N|N|4||88||OPEN LABEL TREATMENT|1963-02-25||1968-10-14|||1968-10-01||1969-12-27
TRIAL STUDY 134XCP|RP|60C25341-42CE-4532-8F99-25B8305C4ED5|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||DYN|||MG/ML/DAY|NOT DONE||Y|NA|Y|5||7||RUN-IN|1962-09-01||1973-08-04|||1962-04-27||1970-03-07
TRIAL STUDY 134XCP|RP|60C25341-42CE-4532-8F99-25B8305C4ED5|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^9/G|||UCI/KG|NOT DONE||NA|N|Y|5||7||LONG-TERM FOLLOW-UP|1964-01-30||1968-10-16|||1970-03-01||1969-12-25
TRIAL STUDY 134XCP|RP|42B54D88-E5B5-4828-958B-4B64F07E34B3|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||NG/L|||STEPS/MIN|NOT DONE||NA|Y|N|1||38||CONTINUATION TREATMENT|1973-06-28||1961-10-08|||1970-03-31||1971-04-16
TRIAL STUDY 134XCP|RP|42B54D88-E5B5-4828-958B-4B64F07E34B3|2||||||MENARAGE|MENARCHE AGE||||10^6/EJACULATE U|||FOZ_BR|NOT DONE||NA|U|U|1||38||SCREENING|1967-07-18||1964-08-27|||1961-12-04||1971-10-01
TRIAL STUDY 134XCP|RP|42B54D88-E5B5-4828-958B-4B64F07E34B3|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||MM/SEC|||MASK|NOT DONE||NA|Y|N|2||58||OBSERVATION|1973-04-06||1965-10-18|||1960-11-07||1961-09-25
TRIAL STUDY 134XCP|RP|42B54D88-E5B5-4828-958B-4B64F07E34B3|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||NSEC|||IU/G|NOT DONE||Y|U|U|2||58||OBSERVATION|1970-07-15||1961-09-28|||1960-05-31||1972-04-21
TRIAL STUDY 134XCP|RP|42B54D88-E5B5-4828-958B-4B64F07E34B3|1||||||MASSIND|MASS INDICATOR||||MPS U|||MET*H|NOT DONE||U|NA|NA|3||39||BLINDED TREATMENT|1969-03-12||1964-03-13|||1961-02-15||1970-09-17
TRIAL STUDY 134XCP|RP|42B54D88-E5B5-4828-958B-4B64F07E34B3|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||NMOL/KG/DAY|||DAYS/WK|NOT DONE||N|Y|NA|3||39||RUN-IN|1968-09-22||1964-02-01|||1966-04-02||1964-07-04
TRIAL STUDY 134XCP|RP|42B54D88-E5B5-4828-958B-4B64F07E34B3|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||U|||MU/L|NOT DONE||U|U|Y|4||88||BASELINE|1972-08-26||1970-01-15|||1965-11-02||1971-12-30
TRIAL STUDY 134XCP|RP|42B54D88-E5B5-4828-958B-4B64F07E34B3|2||||||ULCERIND|ULCER INDICATOR||||DISK|||MOL/L|NOT DONE||NA|U|NA|4||88||BASELINE|1960-06-07||1963-09-19|||1973-06-23||1960-04-05
TRIAL STUDY 134XCP|RP|42B54D88-E5B5-4828-958B-4B64F07E34B3|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||ANSON U|||V/SEC|NOT DONE||Y|NA|U|5||7||OBSERVATION|1969-10-31||1967-02-14|||1968-05-25||1968-10-17
TRIAL STUDY 134XCP|RP|42B54D88-E5B5-4828-958B-4B64F07E34B3|2||||||ERYTHIND|ERYTHEMA INDICATOR||||H*%|||UG/MOL|NOT DONE||U|N|U|5||7||WASHOUT|1964-11-17||1967-08-13|||1961-06-10||1960-06-17
TRIAL STUDY 134XCP|RP|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UMOL/DL|||10^6 CFU|NOT DONE||N|NA|N|1||38||OBSERVATION|1973-02-24||1966-02-06|||1967-06-18||1971-05-10
TRIAL STUDY 134XCP|RP|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||AMU|||/MM|NOT DONE||N|Y|NA|1||38||WASHOUT|1966-11-15||1973-01-23|||1965-08-27||1963-08-24
TRIAL STUDY 134XCP|RP|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||POUCH|||PT_US|NOT DONE||N|U|U|2||58||WASHOUT|1963-12-09||1964-01-19|||1963-01-05||1966-02-09
TRIAL STUDY 134XCP|RP|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|2||||||GRAVIND|GRAVIDA INDICATOR||||AMU|||FARAD|NOT DONE||N|U|Y|2||58||INDUCTION TREATMENT|1969-04-28||1960-08-13|||1968-12-13||1960-06-07
TRIAL STUDY 134XCP|RP|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MAMP|||CYCLE/MIN|NOT DONE||N|NA|Y|3||39||BLINDED TREATMENT|1972-02-11||1971-04-08|||1969-09-15||1968-09-13
TRIAL STUDY 134XCP|RP|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||PACKAGE|||ML/CM3/MIN|NOT DONE||NA|NA|Y|3||39||CONTINUATION TREATMENT|1970-12-14||1968-11-11|||1969-12-07||1964-02-10
TRIAL STUDY 134XCP|RP|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|1||||||TNDRIND|TENDERNESS INDICATOR||||UG/CM2|||KPA|NOT DONE||N|N|NA|4||88||BLINDED TREATMENT|1970-11-15||1964-11-14|||1966-05-26||1972-04-29
TRIAL STUDY 134XCP|RP|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|2||||||PUSTIND|PUSTULE INDICATOR||||DEG/MM|||VIAL|NOT DONE||Y|NA|U|4||88||FOLLOW-UP|1965-07-03||1968-04-16|||1973-05-10||1964-11-19
TRIAL STUDY 134XCP|RP|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|1||||||FUNDHT|FUNDAL HEIGHT||||MOL/DAY|||UG/M2/MIN|NOT DONE||N|N|NA|5||7||SCREENING|1972-02-20||1972-04-30|||1969-12-27||1968-08-30
TRIAL STUDY 134XCP|RP|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||ML/G/MIN|||10^5/HPF|NOT DONE||Y|NA|U|5||7||BASELINE|1964-11-13||1966-04-09|||1968-10-06||1964-06-13
TRIAL STUDY 134XCP|RP|1FD985ED-A573-4A00-8902-214A7F182F28|1||||||DSCHGIND|DISCHARGE INDICATOR||||CMH2O*S/ML|||MEQ/KG|NOT DONE||Y|N|N|1||38||CONTINUATION TREATMENT|1960-07-03||1970-06-26|||1965-01-30||1964-01-11
TRIAL STUDY 134XCP|RP|1FD985ED-A573-4A00-8902-214A7F182F28|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||L/H/M2|||10^6 IU/ML|NOT DONE||Y|Y|Y|1||38||BASELINE|1973-07-07||1969-06-26|||1971-05-26||1966-06-01
TRIAL STUDY 134XCP|RP|1FD985ED-A573-4A00-8902-214A7F182F28|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||/2000 RBC|||UG/DL|NOT DONE||Y|N|NA|2||58||TREATMENT|1967-06-11||1973-08-05|||1971-10-27||1968-03-31
TRIAL STUDY 134XCP|RP|1FD985ED-A573-4A00-8902-214A7F182F28|2||||||BLISTIND|BLISTERING INDICATOR||||IU/DL|||IU/MG|NOT DONE||NA|N|NA|2||58||CONTINUATION TREATMENT|1972-02-25||1968-04-06|||1960-05-13||1960-06-06
TRIAL STUDY 134XCP|RP|1FD985ED-A573-4A00-8902-214A7F182F28|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||KM/H|||MPL U/ML|NOT DONE||U|NA|NA|3||39||OPEN LABEL TREATMENT|1972-09-04||1964-08-31|||1968-08-13||1961-05-10
TRIAL STUDY 134XCP|RP|1FD985ED-A573-4A00-8902-214A7F182F28|2||||||BLISTIND|BLISTERING INDICATOR||||MOL|||LOG10 PFU/ML|NOT DONE||N|U|U|3||39||OBSERVATION|1973-09-01||1973-04-19|||1961-05-03||1966-09-04
TRIAL STUDY 134XCP|RP|1FD985ED-A573-4A00-8902-214A7F182F28|1||||||PEELIND|PEELING INDICATOR||||PIPE|||LOG10 ELISA UNIT/DOSE|NOT DONE||Y|Y|N|4||88||BLINDED TREATMENT|1964-04-11||1969-02-19|||1962-03-17||1963-01-06
TRIAL STUDY 134XCP|RP|1FD985ED-A573-4A00-8902-214A7F182F28|2||||||STILBIND|STILLBIRTH INDICATOR||||U/KG/MIN|||%/S|NOT DONE||U|U|N|4||88||BLINDED TREATMENT|1973-07-28||1965-04-02|||1960-12-16||1968-08-16
TRIAL STUDY 134XCP|RP|1FD985ED-A573-4A00-8902-214A7F182F28|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||ML/100G/MIN|||%(W/W)|NOT DONE||U|NA|N|5||7||TREATMENT|1960-08-19||1973-03-09|||1962-10-18||1970-08-25
TRIAL STUDY 134XCP|RP|1FD985ED-A573-4A00-8902-214A7F182F28|2||||||PUSTIND|PUSTULE INDICATOR||||U/G/MIN|||MG/DL|NOT DONE||N|U|N|5||7||OPEN LABEL TREATMENT|1960-02-09||1963-10-17|||1964-08-26||1960-04-25
TRIAL STUDY 134XCP|RP|A2FD338A-F994-4399-BD02-99CB299F768E|1||||||PREGST|PREGNANT DURING THE STUDY||||GRAVITATIONAL UNIT|||10^6 CFU/G|NOT DONE||NA|U|NA|1||38||BASELINE|1962-04-04||1967-06-28|||1972-01-05||1963-12-02
TRIAL STUDY 134XCP|RP|A2FD338A-F994-4399-BD02-99CB299F768E|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||IU/KG|||P|NOT DONE||NA|Y|Y|1||38||LONG-TERM FOLLOW-UP|1964-06-28||1973-04-06|||1968-01-18||1965-09-10
TRIAL STUDY 134XCP|RP|A2FD338A-F994-4399-BD02-99CB299F768E|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||10^4/L|||UL/KG/DAY|NOT DONE||Y|Y|Y|2||58||SCREENING|1969-04-27||1972-11-28|||1970-05-25||1968-02-14
TRIAL STUDY 134XCP|RP|A2FD338A-F994-4399-BD02-99CB299F768E|2||||||BLISTIND|BLISTERING INDICATOR||||/MM2|||BEAM BREAKS|NOT DONE||N|NA|U|2||58||WASHOUT|1961-09-09||1968-03-31|||1966-08-17||1966-12-16
TRIAL STUDY 134XCP|RP|A2FD338A-F994-4399-BD02-99CB299F768E|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||VG/KG|||UMOL/MOL|NOT DONE||N|U|Y|3||39||OPEN LABEL TREATMENT|1968-05-30||1964-05-11|||1968-02-02||1960-09-29
TRIAL STUDY 134XCP|RP|A2FD338A-F994-4399-BD02-99CB299F768E|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||TITER|||ML/MMHG|NOT DONE||N|U|NA|3||39||SCREENING|1961-07-29||1962-06-12|||1968-12-16||1967-09-04
TRIAL STUDY 134XCP|RP|A2FD338A-F994-4399-BD02-99CB299F768E|1||||||RASHIND|RASH INDICATOR||||ENZYME U|||PIXELS/IN|NOT DONE||U|NA|Y|4||88||TREATMENT|1966-04-26||1960-02-26|||1964-09-04||1973-01-04
TRIAL STUDY 134XCP|RP|A2FD338A-F994-4399-BD02-99CB299F768E|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UOSM|||FMOL/L/SEC|NOT DONE||U|U|NA|4||88||INDUCTION TREATMENT|1967-09-04||1973-09-01|||1965-09-01||1961-12-03
TRIAL STUDY 134XCP|RP|A2FD338A-F994-4399-BD02-99CB299F768E|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||PMOL/10^10 CELLS|||DEG/MM|NOT DONE||N|N|N|5||7||INDUCTION TREATMENT|1965-10-26||1965-04-20|||1971-08-14||1972-06-07
TRIAL STUDY 134XCP|RP|A2FD338A-F994-4399-BD02-99CB299F768E|2||||||MENARAGE|MENARCHE AGE||||U/MG|||SQU/ML|NOT DONE||U|Y|U|5||7||INDUCTION TREATMENT|1968-01-07||1971-10-13|||1961-06-17||1971-08-16
TRIAL STUDY 134XCP|RP|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||UV|||CMH2O/ML|NOT DONE||U|N|NA|1||38||WASHOUT|1972-06-22||1963-05-09|||1970-09-19||1972-04-01
TRIAL STUDY 134XCP|RP|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||IU/ML|||MG/M2/MIN|NOT DONE||U|U|U|1||38||CONTINUATION TREATMENT|1967-07-28||1964-04-06|||1973-05-07||1961-04-01
TRIAL STUDY 134XCP|RP|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||BAU/ML|||CIGARETTE|NOT DONE||U|Y|NA|2||58||WASHOUT|1966-12-08||1966-04-03|||1972-04-18||1963-10-10
TRIAL STUDY 134XCP|RP|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||10^9/L|||OZ EQ|NOT DONE||N|Y|Y|2||58||TREATMENT|1972-11-29||1966-11-27|||1963-03-20||1964-01-04
TRIAL STUDY 134XCP|RP|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|1||||||PEELIND|PEELING INDICATOR||||HENRY|||TROCHE|NOT DONE||NA|Y|Y|3||39||BASELINE|1963-04-24||1965-12-19|||1969-01-14||1968-11-01
TRIAL STUDY 134XCP|RP|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||PFU/DOSE|||UV2|NOT DONE||Y|NA|U|3||39||RUN-IN|1962-01-27||1971-01-12|||1967-10-28||1972-04-17
TRIAL STUDY 134XCP|RP|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|1||||||EDEMAIND|EDEMA INDICATOR||||10^6/EJACULATE U|||MEQ/G|NOT DONE||N|N|U|4||88||SCREENING|1972-09-25||1973-01-29|||1972-01-15||1972-10-08
TRIAL STUDY 134XCP|RP|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|2||||||MASSIND|MASS INDICATOR||||ML/KG/MIN|||SHOCK WAVE|NOT DONE||Y|N|U|4||88||LONG-TERM FOLLOW-UP|1963-05-12||1973-08-22|||1963-06-11||1967-05-20
TRIAL STUDY 134XCP|RP|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||IU/L|||V|NOT DONE||U|NA|Y|5||7||WASHOUT|1962-03-23||1964-10-22|||1963-10-29||1967-10-22
TRIAL STUDY 134XCP|RP|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||/2500 WBC|||VG/DOSE|NOT DONE||Y|N|U|5||7||WASHOUT|1960-03-21||1970-12-22|||1967-05-31||1960-09-29
TRIAL STUDY 134XCP|RP|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|1||||||ABORTN|NUMBER OF ABORTIONS||||ML/M2|||UMOL/L/SEC|NOT DONE||N|U|NA|1||38||CONTINUATION TREATMENT|1963-07-30||1965-06-29|||1972-09-21||1970-07-18
TRIAL STUDY 134XCP|RP|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MET*H|||CD|NOT DONE||N|NA|Y|1||38||RUN-IN|1968-06-06||1965-08-13|||1962-07-31||1967-05-06
TRIAL STUDY 134XCP|RP|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|1||||||MENFDUR|MENSES FLOW DURATION||||CM H2O|||RFU|NOT DONE||N|N|Y|2||58||BASELINE|1967-09-09||1970-02-22|||1972-05-29||1967-12-08
TRIAL STUDY 134XCP|RP|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|2||||||MENOSTAT|MENOPAUSE STATUS||||TSP|||L/H|NOT DONE||U|U|NA|2||58||TREATMENT|1964-05-23||1972-11-13|||1973-07-03||1966-09-16
TRIAL STUDY 134XCP|RP|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|1||||||DLVRMODE|MODE OF DELIVERY||||ML/ANIMAL|||MIU/L|NOT DONE||Y|NA|NA|3||39||INDUCTION TREATMENT|1962-02-12||1966-06-14|||1964-01-09||1961-01-28
TRIAL STUDY 134XCP|RP|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|2||||||DLVRMODE|MODE OF DELIVERY||||KG/M2|||KG/CM2|NOT DONE||N|Y|NA|3||39||RUN-IN|1962-10-24||1971-05-10|||1962-12-26||1961-11-16
TRIAL STUDY 134XCP|RP|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|1||||||RASHIND|RASH INDICATOR||||MM/MIN|||OHM|NOT DONE||NA|Y|Y|4||88||INDUCTION TREATMENT|1963-11-29||1967-01-03|||1971-11-13||1972-03-09
TRIAL STUDY 134XCP|RP|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|2||||||STILBIND|STILLBIRTH INDICATOR||||U/MMOL|||MONTHS|NOT DONE||U|NA|N|4||88||SCREENING|1965-01-19||1970-07-04|||1965-09-17||1972-04-15
TRIAL STUDY 134XCP|RP|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^3/HPF|||MG/MIN|NOT DONE||U|U|Y|5||7||OBSERVATION|1969-01-23||1967-01-14|||1968-12-25||1965-03-29
TRIAL STUDY 134XCP|RP|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||EVENTS|||NMOL/L/MIN|NOT DONE||N|U|N|5||7||TREATMENT|1973-03-14||1961-05-22|||1964-05-26||1971-04-29
TRIAL STUDY 134XCP|RP|A8821AEE-49EB-4687-BB63-361BC3B8B182|1||||||MENARAGE|MENARCHE AGE||||MU/L|||AMU|NOT DONE||Y|N|U|1||38||INDUCTION TREATMENT|1962-10-18||1970-10-24|||1962-06-02||1960-07-07
TRIAL STUDY 134XCP|RP|A8821AEE-49EB-4687-BB63-361BC3B8B182|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MMU/ML|||UKAT/L|NOT DONE||Y|U|NA|1||38||BLINDED TREATMENT|1965-02-28||1961-03-22|||1973-04-09||1967-07-21
TRIAL STUDY 134XCP|RP|A8821AEE-49EB-4687-BB63-361BC3B8B182|1||||||BCMETHOD|BIRTH CONTROL METHOD||||10^12 IU/L|||UG/MIN|NOT DONE||NA|U|NA|2||58||OPEN LABEL TREATMENT|1967-10-05||1962-10-16|||1972-06-23||1969-10-01
TRIAL STUDY 134XCP|RP|A8821AEE-49EB-4687-BB63-361BC3B8B182|2||||||MENFDUR|MENSES FLOW DURATION||||DAGU/ML|||NKAT/L|NOT DONE||N|Y|Y|2||58||OPEN LABEL TREATMENT|1971-08-25||1970-05-13|||1970-11-19||1971-02-26
TRIAL STUDY 134XCP|RP|A8821AEE-49EB-4687-BB63-361BC3B8B182|1||||||FUNDHT|FUNDAL HEIGHT||||AMU|||FRAMES/S|NOT DONE||NA|NA|U|3||39||LONG-TERM FOLLOW-UP|1967-11-15||1963-03-17|||1964-03-17||1964-02-17
TRIAL STUDY 134XCP|RP|A8821AEE-49EB-4687-BB63-361BC3B8B182|2||||||PREGNN|NUMBER OF PREGNANCIES||||UMOL/MG/MIN|||BREATHS/30S|NOT DONE||U|Y|Y|3||39||BASELINE|1973-03-13||1964-05-11|||1969-02-09||1965-03-11
TRIAL STUDY 134XCP|RP|A8821AEE-49EB-4687-BB63-361BC3B8B182|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MJOULE/CM2|||KEV|NOT DONE||Y|N|NA|4||88||BLINDED TREATMENT|1973-06-18||1973-08-20|||1968-07-10||1973-06-14
TRIAL STUDY 134XCP|RP|A8821AEE-49EB-4687-BB63-361BC3B8B182|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||COULOMB|||JDF UNIT|NOT DONE||U|NA|Y|4||88||TREATMENT|1964-10-13||1966-03-03|||1966-09-13||1965-09-13
TRIAL STUDY 134XCP|RP|A8821AEE-49EB-4687-BB63-361BC3B8B182|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MASK|||G/ANIMAL/DAY|NOT DONE||U|N|NA|5||7||CONTINUATION TREATMENT|1969-01-20||1971-01-23|||1971-11-08||1967-07-15
TRIAL STUDY 134XCP|RP|A8821AEE-49EB-4687-BB63-361BC3B8B182|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||GMFI|||U|NOT DONE||N|U|NA|5||7||OPEN LABEL TREATMENT|1960-09-01||1965-12-06|||1971-02-04||1971-07-17
TRIAL STUDY 134XCP|RP|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||CY/CM|||DRUM|NOT DONE||U|N|U|1||38||LONG-TERM FOLLOW-UP|1967-02-14||1966-04-11|||1972-10-11||1962-02-06
TRIAL STUDY 134XCP|RP|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|2||||||BRTHN|NUMBER OF BIRTHS||||UL/KG/DAY|||NMOL/L/MIN|NOT DONE||U|N|NA|1||38||OPEN LABEL TREATMENT|1969-06-24||1972-07-09|||1970-02-24||1971-05-27
TRIAL STUDY 134XCP|RP|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||ML/DL|||MMOL/KG|NOT DONE||NA|N|Y|2||58||LONG-TERM FOLLOW-UP|1970-10-08||1963-02-02|||1960-08-19||1961-08-13
TRIAL STUDY 134XCP|RP|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^9 ORGANISMS/G|||SBE/ML|NOT DONE||Y|U|NA|2||58||INDUCTION TREATMENT|1967-07-12||1973-05-26|||1971-11-03||1972-11-15
TRIAL STUDY 134XCP|RP|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||VG/ML|||TAMPON|NOT DONE||U|Y|Y|3||39||LONG-TERM FOLLOW-UP|1960-12-10||1968-09-23|||1960-01-20||1962-07-23
TRIAL STUDY 134XCP|RP|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|2||||||THICK|THICKNESS||||C|||NL|NOT DONE||U|NA|U|3||39||INDUCTION TREATMENT|1967-03-13||1961-05-01|||1971-04-20||1968-07-27
TRIAL STUDY 134XCP|RP|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|1||||||THICK|THICKNESS||||OZ|||MCI/KG|NOT DONE||Y|NA|Y|4||88||BASELINE|1966-02-19||1963-05-29|||1968-07-06||1966-05-21
TRIAL STUDY 134XCP|RP|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|2||||||ABORTN|NUMBER OF ABORTIONS||||TUBE|||MOL/L|NOT DONE||N|NA|Y|4||88||INDUCTION TREATMENT|1966-08-31||1967-05-01|||1964-07-15||1962-05-21
TRIAL STUDY 134XCP|RP|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||GBQ/UG|||MG/KG|NOT DONE||N|NA|Y|5||7||RUN-IN|1970-11-10||1973-01-03|||1970-04-26||1966-02-28
TRIAL STUDY 134XCP|RP|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||U/M2|||F|NOT DONE||U|U|U|5||7||RUN-IN|1962-03-19||1969-09-02|||1970-02-28||1963-02-02
TRIAL STUDY 134XCP|RP|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|1||||||ABORTN|NUMBER OF ABORTIONS||||U/G/MIN|||PMOL/10^10 CELLS|NOT DONE||NA|N|Y|1||38||CONTINUATION TREATMENT|1964-07-06||1967-03-18|||1967-11-19||1965-10-08
TRIAL STUDY 134XCP|RP|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|2||||||PRGENDTC|DATE PREGNANCY ENDED||||MMU/ML|||BQ/UL|NOT DONE||NA|U|N|1||38||FOLLOW-UP|1966-10-13||1972-01-11|||1965-07-23||1964-04-29
TRIAL STUDY 134XCP|RP|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|1||||||DLVRMODE|MODE OF DELIVERY||||U|||/2000 RBC|NOT DONE||NA|N|Y|2||58||WASHOUT|1966-01-21||1963-07-12|||1964-05-02||1972-01-31
TRIAL STUDY 134XCP|RP|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|2||||||MENARAGE|MENARCHE AGE||||ML/DL|||VIAL|NOT DONE||U|Y|Y|2||58||BLINDED TREATMENT|1966-01-02||1969-08-29|||1965-04-06||1960-06-11
TRIAL STUDY 134XCP|RP|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|1||||||DLVRMODE|MODE OF DELIVERY||||MEQ/DL|||PACKAGE|NOT DONE||U|Y|NA|3||39||BLINDED TREATMENT|1973-08-17||1966-12-23|||1966-03-11||1971-09-24
TRIAL STUDY 134XCP|RP|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|2||||||THICK|THICKNESS||||MOSM/KG|||GAUSS|NOT DONE||Y|U|NA|3||39||LONG-TERM FOLLOW-UP|1966-04-09||1972-08-19|||1969-05-04||1973-03-25
TRIAL STUDY 134XCP|RP|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|1||||||DLVRMODE|MODE OF DELIVERY||||CUP|||CM/MIN|NOT DONE||N|Y|N|4||88||OPEN LABEL TREATMENT|1962-07-29||1965-07-14|||1966-11-12||1972-12-28
TRIAL STUDY 134XCP|RP|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|2||||||PREGNN|NUMBER OF PREGNANCIES||||BEAM BREAKS|||UCI/L|NOT DONE||N|NA|Y|4||88||WASHOUT|1961-11-26||1966-07-01|||1962-05-12||1965-12-11
TRIAL STUDY 134XCP|RP|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||PSEC|||AMPULE|NOT DONE||U|NA|U|5||7||LONG-TERM FOLLOW-UP|1960-05-04||1966-08-21|||1965-03-02||1973-09-05
TRIAL STUDY 134XCP|RP|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|2||||||PREGST|PREGNANT DURING THE STUDY||||IU/DAY|||UEQ/L|NOT DONE||N|NA|NA|5||7||LONG-TERM FOLLOW-UP|1972-07-17||1966-01-02|||1962-11-28||1965-06-21
TRIAL STUDY 134XCP|RP|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||UCI|||IU/KG/H|NOT DONE||Y|Y|U|1||38||OBSERVATION|1969-05-11||1966-08-18|||1960-09-09||1971-04-13
TRIAL STUDY 134XCP|RP|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|2||||||INABOIND|INDUCED ABORTION INDICATOR||||ML/M2/DAY|||MMHG/L/MIN|NOT DONE||Y|NA|U|1||38||TREATMENT|1961-08-22||1965-02-04|||1964-04-13||1969-10-17
TRIAL STUDY 134XCP|RP|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|1||||||ERYTHIND|ERYTHEMA INDICATOR||||PG/CELL|||10^7 PFU|NOT DONE||U|Y|Y|2||58||SCREENING|1962-05-27||1960-07-17|||1965-06-13||1971-08-25
TRIAL STUDY 134XCP|RP|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||FARAD|||CMH2O*S2/ML|NOT DONE||Y|Y|U|2||58||INDUCTION TREATMENT|1964-02-07||1962-03-14|||1963-02-14||1969-09-08
TRIAL STUDY 134XCP|RP|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|1||||||BCMETHOD|BIRTH CONTROL METHOD||||G/ANIMAL/WK|||10^7 CFU|NOT DONE||U|NA|NA|3||39||LONG-TERM FOLLOW-UP|1972-11-24||1969-08-20|||1971-08-04||1968-03-24
TRIAL STUDY 134XCP|RP|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MOL/ML|||MM/H|NOT DONE||N|NA|U|3||39||WASHOUT|1972-05-31||1973-08-12|||1962-05-24||1962-02-25
TRIAL STUDY 134XCP|RP|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MG/ML/DAY|||BU/ML|NOT DONE||Y|Y|U|4||88||INDUCTION TREATMENT|1961-11-19||1965-03-01|||1970-07-23||1973-05-02
TRIAL STUDY 134XCP|RP|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MOL/ML|||LOG10 TCID 50/ML|NOT DONE||NA|U|Y|4||88||CONTINUATION TREATMENT|1962-02-05||1965-02-08|||1964-10-23||1972-07-07
TRIAL STUDY 134XCP|RP|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MMOL/L|||LOG10 TCID 50/UL|NOT DONE||NA|N|NA|5||7||TREATMENT|1970-12-07||1970-02-23|||1962-02-24||1965-07-16
TRIAL STUDY 134XCP|RP|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|2||||||INABOIND|INDUCED ABORTION INDICATOR||||G/G/DAY|||BQ/MG|NOT DONE||N|U|U|5||7||SCREENING|1967-10-15||1963-08-03|||1961-03-17||1969-11-12
TRIAL STUDY 134XCP|RP|E711C534-E58F-4B41-95CC-24E938D89B61|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||S/H|||UMOL/DAY|NOT DONE||Y|NA|N|1||38||OBSERVATION|1966-05-05||1968-09-26|||1973-01-26||1965-03-08
TRIAL STUDY 134XCP|RP|E711C534-E58F-4B41-95CC-24E938D89B61|2||||||INABOIND|INDUCED ABORTION INDICATOR||||NSEC|||DL|NOT DONE||N|NA|Y|1||38||LONG-TERM FOLLOW-UP|1967-03-09||1970-06-21|||1973-05-19||1968-11-17
TRIAL STUDY 134XCP|RP|E711C534-E58F-4B41-95CC-24E938D89B61|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||PL|||10^9 CFU/G|NOT DONE||Y|NA|Y|2||58||BASELINE|1961-10-27||1971-06-11|||1965-09-12||1962-10-24
TRIAL STUDY 134XCP|RP|E711C534-E58F-4B41-95CC-24E938D89B61|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||STEPS/MIN|||HEP|NOT DONE||U|U|N|2||58||INDUCTION TREATMENT|1969-08-15||1961-02-03|||1961-04-23||1973-02-06
TRIAL STUDY 134XCP|RP|E711C534-E58F-4B41-95CC-24E938D89B61|1||||||FUNDHT|FUNDAL HEIGHT||||KDA|||NEEDLE GAUGE|NOT DONE||U|N|Y|3||39||OPEN LABEL TREATMENT|1964-04-13||1972-12-19|||1961-07-14||1968-06-18
TRIAL STUDY 134XCP|RP|E711C534-E58F-4B41-95CC-24E938D89B61|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PACK|||10^3/L|NOT DONE||U|U|NA|3||39||OBSERVATION|1960-06-05||1971-07-29|||1968-05-08||1966-09-20
TRIAL STUDY 134XCP|RP|E711C534-E58F-4B41-95CC-24E938D89B61|1||||||PRGENDTC|DATE PREGNANCY ENDED||||IU/KG/H|||MMOL/KG|NOT DONE||Y|U|N|4||88||LONG-TERM FOLLOW-UP|1964-08-23||1966-06-28|||1969-10-16||1973-08-08
TRIAL STUDY 134XCP|RP|E711C534-E58F-4B41-95CC-24E938D89B61|2||||||GRAVIND|GRAVIDA INDICATOR||||PATCH|||MG/KG/H|NOT DONE||N|U|NA|4||88||INDUCTION TREATMENT|1972-06-11||1961-09-17|||1969-10-05||1960-12-15
TRIAL STUDY 134XCP|RP|E711C534-E58F-4B41-95CC-24E938D89B61|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MMHG|||UG/MIN|NOT DONE||U|N|Y|5||7||BLINDED TREATMENT|1960-05-11||1961-11-29|||1968-03-09||1967-09-07
TRIAL STUDY 134XCP|RP|E711C534-E58F-4B41-95CC-24E938D89B61|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||PMOL/10^9 CELLS|||CS|NOT DONE||NA|Y|U|5||7||RUN-IN|1972-06-26||1972-01-21|||1964-10-04||1970-11-29
TRIAL STUDY 134XCP|RP|83938342-C01F-491A-84A7-F85D327F112D|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||DAGU/ML|||UU/DL|NOT DONE||U|NA|Y|1||38||CONTINUATION TREATMENT|1969-05-19||1968-04-28|||1960-02-03||1965-06-17
TRIAL STUDY 134XCP|RP|83938342-C01F-491A-84A7-F85D327F112D|2||||||PRGENDTC|DATE PREGNANCY ENDED||||10^8 PFU|||U/G/MIN|NOT DONE||N|U|N|1||38||BASELINE|1973-08-24||1965-11-23|||1960-04-27||1967-12-25
TRIAL STUDY 134XCP|RP|83938342-C01F-491A-84A7-F85D327F112D|1||||||DLVRMODE|MODE OF DELIVERY||||HEP|||ML/BEAT|NOT DONE||Y|NA|U|2||58||OPEN LABEL TREATMENT|1972-12-13||1969-01-22|||1970-05-31||1970-02-04
TRIAL STUDY 134XCP|RP|83938342-C01F-491A-84A7-F85D327F112D|2||||||PREGNN|NUMBER OF PREGNANCIES||||PMOL/10^10 CELLS|||ENZYME U|NOT DONE||N|Y|U|2||58||OPEN LABEL TREATMENT|1964-11-17||1962-01-22|||1969-08-13||1968-09-06
TRIAL STUDY 134XCP|RP|83938342-C01F-491A-84A7-F85D327F112D|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||PACK YEAR|||/40 HPFS|NOT DONE||NA|NA|NA|3||39||LONG-TERM FOLLOW-UP|1966-10-14||1969-12-31|||1962-06-20||1972-07-28
TRIAL STUDY 134XCP|RP|83938342-C01F-491A-84A7-F85D327F112D|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||NFIU|||MBQ|NOT DONE||Y|Y|U|3||39||OBSERVATION|1972-05-29||1964-05-08|||1970-02-23||1967-05-27
TRIAL STUDY 134XCP|RP|83938342-C01F-491A-84A7-F85D327F112D|1||||||PREGIND|PREGNANT INDICATOR||||TSP|||U/ANIMAL|NOT DONE||U|Y|Y|4||88||OBSERVATION|1968-09-20||1968-12-07|||1968-08-01||1964-09-11
TRIAL STUDY 134XCP|RP|83938342-C01F-491A-84A7-F85D327F112D|2||||||ABORTN|NUMBER OF ABORTIONS||||UKAT/10^12 RBC|||CMH2O/ML|NOT DONE||Y|NA|Y|4||88||TREATMENT|1967-10-26||1968-04-24|||1960-09-18||1970-07-19
TRIAL STUDY 134XCP|RP|83938342-C01F-491A-84A7-F85D327F112D|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||DMOL|||CAN|NOT DONE||U|NA|Y|5||7||OBSERVATION|1963-05-20||1968-04-06|||1960-05-04||1968-04-19
TRIAL STUDY 134XCP|RP|83938342-C01F-491A-84A7-F85D327F112D|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||NMOL/G|||PHERESIS UNIT|NOT DONE||N|N|Y|5||7||LONG-TERM FOLLOW-UP|1963-07-23||1973-08-09|||1965-04-22||1963-03-27
TRIAL STUDY 134XCP|RP|731665AB-4418-4943-BFC5-D78F03C8D423|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||MGEQ|||U/G|NOT DONE||Y|N|Y|1||38||CONTINUATION TREATMENT|1961-10-16||1966-10-14|||1966-11-10||1964-08-04
TRIAL STUDY 134XCP|RP|731665AB-4418-4943-BFC5-D78F03C8D423|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||BQ/L|||DAYS/WK|NOT DONE||N|NA|N|1||38||SCREENING|1968-08-26||1965-10-09|||1965-02-28||1962-03-21
TRIAL STUDY 134XCP|RP|731665AB-4418-4943-BFC5-D78F03C8D423|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||MCI/KG|||CG|NOT DONE||Y|N|U|2||58||INDUCTION TREATMENT|1970-07-18||1972-08-02|||1967-03-13||1970-02-16
TRIAL STUDY 134XCP|RP|731665AB-4418-4943-BFC5-D78F03C8D423|2||||||MASSIND|MASS INDICATOR||||TITER|||SV|NOT DONE||NA|Y|N|2||58||TREATMENT|1962-11-28||1966-03-13|||1965-09-06||1964-12-24
TRIAL STUDY 134XCP|RP|731665AB-4418-4943-BFC5-D78F03C8D423|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||GY/H|||H/WK|NOT DONE||NA|Y|N|3||39||BASELINE|1964-01-13||1961-06-08|||1972-07-25||1966-05-17
TRIAL STUDY 134XCP|RP|731665AB-4418-4943-BFC5-D78F03C8D423|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||%|||MILE|NOT DONE||Y|NA|NA|3||39||WASHOUT|1968-05-31||1963-01-02|||1965-05-05||1966-02-14
TRIAL STUDY 134XCP|RP|731665AB-4418-4943-BFC5-D78F03C8D423|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||TESLA|||UG/L DDU|NOT DONE||N|N|N|4||88||BASELINE|1961-12-11||1969-02-09|||1968-05-07||1963-03-10
TRIAL STUDY 134XCP|RP|731665AB-4418-4943-BFC5-D78F03C8D423|2||||||EDEMAIND|EDEMA INDICATOR||||GBQ/UG|||PA|NOT DONE||NA|Y|Y|4||88||SCREENING|1963-07-15||1970-05-30|||1967-05-04||1968-02-12
TRIAL STUDY 134XCP|RP|731665AB-4418-4943-BFC5-D78F03C8D423|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||BQ|||NL|NOT DONE||U|U|Y|5||7||OBSERVATION|1963-01-04||1961-09-14|||1960-04-06||1963-08-20
TRIAL STUDY 134XCP|RP|731665AB-4418-4943-BFC5-D78F03C8D423|2||||||RASHIND|RASH INDICATOR||||ML/CM|||PRESSOR UNITS|NOT DONE||Y|Y|N|5||7||BLINDED TREATMENT|1973-08-31||1963-09-03|||1972-01-16||1966-05-26
TRIAL STUDY 134XCP|RP|3E337B9F-D718-4FE6-83D8-E05BC77CA872|1||||||GRAVIND|GRAVIDA INDICATOR||||UEQ|||ANSON U|NOT DONE||Y|NA|Y|1||38||BLINDED TREATMENT|1972-10-12||1961-08-02|||1965-03-02||1967-04-02
TRIAL STUDY 134XCP|RP|3E337B9F-D718-4FE6-83D8-E05BC77CA872|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||BQ/UG|||U/KG|NOT DONE||U|Y|Y|1||38||BLINDED TREATMENT|1970-12-11||1971-05-27|||1963-10-09||1973-02-19
TRIAL STUDY 134XCP|RP|3E337B9F-D718-4FE6-83D8-E05BC77CA872|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MG/KG/DOSE|||10^7 PFU|NOT DONE||U|Y|Y|2||58||OPEN LABEL TREATMENT|1967-04-11||1966-04-18|||1967-09-01||1965-07-25
TRIAL STUDY 134XCP|RP|3E337B9F-D718-4FE6-83D8-E05BC77CA872|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||RPM|||PHERESIS UNIT|NOT DONE||N|U|N|2||58||FOLLOW-UP|1973-07-22||1966-07-03|||1970-07-11||1962-02-13
TRIAL STUDY 134XCP|RP|3E337B9F-D718-4FE6-83D8-E05BC77CA872|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UMOL/L/SEC|||UEQ|NOT DONE||NA|NA|N|3||39||CONTINUATION TREATMENT|1972-08-16||1961-01-22|||1961-05-12||1970-01-20
TRIAL STUDY 134XCP|RP|3E337B9F-D718-4FE6-83D8-E05BC77CA872|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||FOZ_BR|||LB|NOT DONE||N|NA|NA|3||39||BASELINE|1969-09-26||1961-12-31|||1964-08-27||1972-07-30
TRIAL STUDY 134XCP|RP|3E337B9F-D718-4FE6-83D8-E05BC77CA872|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||CAPLET|||MEQ/DL|NOT DONE||Y|NA|N|4||88||LONG-TERM FOLLOW-UP|1963-02-14||1966-04-03|||1963-08-02||1968-09-14
TRIAL STUDY 134XCP|RP|3E337B9F-D718-4FE6-83D8-E05BC77CA872|2||||||FUNDHT|FUNDAL HEIGHT||||PG|||M2|NOT DONE||Y|Y|U|4||88||BLINDED TREATMENT|1972-11-13||1964-07-28|||1969-10-20||1960-01-19
TRIAL STUDY 134XCP|RP|3E337B9F-D718-4FE6-83D8-E05BC77CA872|1||||||INABOIND|INDUCED ABORTION INDICATOR||||DYN|||CI/UL|NOT DONE||Y|U|U|5||7||FOLLOW-UP|1972-08-18||1965-03-09|||1963-08-15||1962-04-01
TRIAL STUDY 134XCP|RP|3E337B9F-D718-4FE6-83D8-E05BC77CA872|2||||||PREGIND|PREGNANT INDICATOR||||10^3 ORGANISMS|||NM|NOT DONE||NA|NA|N|5||7||SCREENING|1969-01-14||1965-04-19|||1971-11-03||1973-08-06
TRIAL STUDY 134XCP|RP|D5243E6E-2521-4331-ABFB-75112D06F771|1||||||DLVRMODE|MODE OF DELIVERY||||U/ANIMAL|||UCI/KG|NOT DONE||NA|Y|NA|1||38||CONTINUATION TREATMENT|1967-06-29||1962-12-09|||1972-03-18||1961-10-29
TRIAL STUDY 134XCP|RP|D5243E6E-2521-4331-ABFB-75112D06F771|2||||||PREGIND|PREGNANT INDICATOR||||MM/SEC|||MG/KG/MIN|NOT DONE||N|NA|Y|1||38||INDUCTION TREATMENT|1967-10-18||1964-01-07|||1960-02-22||1973-03-05
TRIAL STUDY 134XCP|RP|D5243E6E-2521-4331-ABFB-75112D06F771|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||10^9/DOSE|||DRINK|NOT DONE||NA|Y|NA|2||58||SCREENING|1965-08-16||1969-09-13|||1961-01-17||1972-08-20
TRIAL STUDY 134XCP|RP|D5243E6E-2521-4331-ABFB-75112D06F771|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||TSP EQ|||FRACTION OF 1|NOT DONE||U|Y|Y|2||58||CONTINUATION TREATMENT|1973-01-13||1968-07-14|||1965-06-15||1964-10-07
TRIAL STUDY 134XCP|RP|D5243E6E-2521-4331-ABFB-75112D06F771|1||||||MASSIND|MASS INDICATOR||||10^9 CFU|||FMOL/L|NOT DONE||Y|N|NA|3||39||BLINDED TREATMENT|1970-05-25||1960-10-24|||1964-08-18||1961-02-28
TRIAL STUDY 134XCP|RP|D5243E6E-2521-4331-ABFB-75112D06F771|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||S^-1(%O2)^-1|||U/DL|NOT DONE||U|U|Y|3||39||INDUCTION TREATMENT|1967-01-13||1962-10-01|||1973-03-18||1963-05-19
TRIAL STUDY 134XCP|RP|D5243E6E-2521-4331-ABFB-75112D06F771|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||CP|||POINT|NOT DONE||NA|N|U|4||88||SCREENING|1967-05-30||1973-07-08|||1961-02-27||1965-08-25
TRIAL STUDY 134XCP|RP|D5243E6E-2521-4331-ABFB-75112D06F771|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||PA|||UG/M2/MIN|NOT DONE||U|N|U|4||88||WASHOUT|1967-06-13||1971-01-26|||1962-09-23||1964-11-02
TRIAL STUDY 134XCP|RP|D5243E6E-2521-4331-ABFB-75112D06F771|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||SEC|||PACK|NOT DONE||NA|N|N|5||7||LONG-TERM FOLLOW-UP|1962-11-24||1972-10-19|||1962-12-20||1971-10-26
TRIAL STUDY 134XCP|RP|D5243E6E-2521-4331-ABFB-75112D06F771|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||10^9 CFU|||KG|NOT DONE||U|U|N|5||7||BASELINE|1968-03-14||1970-07-04|||1960-11-20||1968-08-28
TRIAL STUDY 134XCP|RP|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|1||||||INTP|INTERPRETATION||||PPM|||DRINK|NOT DONE||U|U|U|1||38||OBSERVATION|1966-04-21||1965-02-28|||1968-02-07||1962-09-21
TRIAL STUDY 134XCP|RP|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||%(V/V)|||PRESSOR UNITS|NOT DONE||N|N|N|1||38||OPEN LABEL TREATMENT|1969-06-01||1973-06-23|||1963-07-14||1967-12-18
TRIAL STUDY 134XCP|RP|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|1||||||BCMETHOD|BIRTH CONTROL METHOD||||BU/ML|||NMOL/DAY|NOT DONE||N|Y|NA|2||58||SCREENING|1963-11-21||1970-09-03|||1967-05-25||1967-07-11
TRIAL STUDY 134XCP|RP|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^3 ORGANISMS|||MCI/L|NOT DONE||Y|N|N|2||58||BLINDED TREATMENT|1962-11-29||1960-10-26|||1960-07-24||1961-12-24
TRIAL STUDY 134XCP|RP|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|1||||||PEELIND|PEELING INDICATOR||||U/MG|||PIXELS/CM|NOT DONE||Y|N|U|3||39||OPEN LABEL TREATMENT|1970-09-15||1964-06-20|||1966-01-12||1966-11-17
TRIAL STUDY 134XCP|RP|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||KG/CM|||ML/KG|NOT DONE||NA|N|U|3||39||OPEN LABEL TREATMENT|1972-10-16||1972-10-26|||1962-12-25||1963-06-14
TRIAL STUDY 134XCP|RP|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|1||||||PUSTIND|PUSTULE INDICATOR||||CMOL/L|||MONTHS|NOT DONE||N|Y|N|4||88||LONG-TERM FOLLOW-UP|1963-09-26||1961-04-27|||1960-11-03||1972-12-21
TRIAL STUDY 134XCP|RP|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MMOL/DAY|||TABLET|NOT DONE||NA|N|U|4||88||BLINDED TREATMENT|1964-03-21||1963-03-19|||1971-02-25||1963-07-02
TRIAL STUDY 134XCP|RP|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||10^3 ORGANISMS/ML|||K|NOT DONE||NA|U|U|5||7||LONG-TERM FOLLOW-UP|1969-06-12||1967-12-22|||1960-11-14||1967-01-25
TRIAL STUDY 134XCP|RP|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||GMFI|||MEQ/L|NOT DONE||Y|NA|Y|5||7||OBSERVATION|1962-01-07||1971-06-13|||1966-12-07||1967-02-13
TRIAL STUDY 134XCP|RP|5B3E406E-F2A5-4F25-8271-DC1FABA40138|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||DNA COPIES/ML|||MPL U/ML|NOT DONE||NA|U|U|1||38||OPEN LABEL TREATMENT|1964-11-18||1969-07-28|||1967-07-01||1966-07-13
TRIAL STUDY 134XCP|RP|5B3E406E-F2A5-4F25-8271-DC1FABA40138|2||||||BCMETHOD|BIRTH CONTROL METHOD||||TAMPON|||PACK|NOT DONE||Y|NA|NA|1||38||BASELINE|1964-01-11||1967-11-08|||1965-01-12||1966-09-05
TRIAL STUDY 134XCP|RP|5B3E406E-F2A5-4F25-8271-DC1FABA40138|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||DPM/ML|||10^9 ORGANISMS/ML|NOT DONE||Y|U|N|2||58||TREATMENT|1966-07-19||1969-08-26|||1967-01-23||1969-07-09
TRIAL STUDY 134XCP|RP|5B3E406E-F2A5-4F25-8271-DC1FABA40138|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||BP|||BQ/UG|NOT DONE||U|NA|N|2||58||INDUCTION TREATMENT|1969-03-06||1969-09-10|||1964-10-05||1972-08-25
TRIAL STUDY 134XCP|RP|5B3E406E-F2A5-4F25-8271-DC1FABA40138|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||L/H|||G/M2/DAY|NOT DONE||Y|N|Y|3||39||INDUCTION TREATMENT|1966-10-06||1972-05-06|||1967-04-06||1961-08-08
TRIAL STUDY 134XCP|RP|5B3E406E-F2A5-4F25-8271-DC1FABA40138|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||DMOL|||10^8 PFU|NOT DONE||NA|Y|Y|3||39||LONG-TERM FOLLOW-UP|1961-07-02||1963-11-03|||1962-03-14||1969-09-16
TRIAL STUDY 134XCP|RP|5B3E406E-F2A5-4F25-8271-DC1FABA40138|1||||||FUNDHT|FUNDAL HEIGHT||||10^3/HPF|||/40 HPFS|NOT DONE||NA|NA|Y|4||88||OBSERVATION|1971-10-17||1965-03-15|||1965-02-12||1973-01-09
TRIAL STUDY 134XCP|RP|5B3E406E-F2A5-4F25-8271-DC1FABA40138|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||DAMOL/L|||UMOL/L|NOT DONE||NA|N|N|4||88||CONTINUATION TREATMENT|1973-06-18||1970-04-21|||1968-10-07||1966-10-26
TRIAL STUDY 134XCP|RP|5B3E406E-F2A5-4F25-8271-DC1FABA40138|1||||||FUNDHT|FUNDAL HEIGHT||||RING|||DISK|NOT DONE||Y|Y|NA|5||7||INDUCTION TREATMENT|1960-12-25||1973-02-19|||1960-06-19||1969-03-03
TRIAL STUDY 134XCP|RP|5B3E406E-F2A5-4F25-8271-DC1FABA40138|2||||||MASSIND|MASS INDICATOR||||UCI/KG|||OZ|NOT DONE||N|N|N|5||7||INDUCTION TREATMENT|1962-11-20||1967-08-25|||1967-05-01||1963-06-07
TRIAL STUDY 134XCP|RP|D5262627-52D7-42F5-B4BA-D7E6FA243959|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||KA_U/DL|||/2000 RBC|NOT DONE||N|U|U|1||38||TREATMENT|1961-10-24||1966-05-28|||1962-07-03||1972-04-18
TRIAL STUDY 134XCP|RP|D5262627-52D7-42F5-B4BA-D7E6FA243959|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MG|||DL|NOT DONE||Y|U|Y|1||38||SCREENING|1963-09-14||1970-06-12|||1971-01-25||1963-09-20
TRIAL STUDY 134XCP|RP|D5262627-52D7-42F5-B4BA-D7E6FA243959|1||||||DLVRMODE|MODE OF DELIVERY||||MOL/G|||MMOL2/L2|NOT DONE||U|NA|N|2||58||WASHOUT|1971-04-09||1966-04-15|||1965-01-18||1972-05-19
TRIAL STUDY 134XCP|RP|D5262627-52D7-42F5-B4BA-D7E6FA243959|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MG/M2/H|||YD|NOT DONE||Y|U|Y|2||58||BASELINE|1972-07-15||1967-06-02|||1971-03-12||1971-01-10
TRIAL STUDY 134XCP|RP|D5262627-52D7-42F5-B4BA-D7E6FA243959|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||PMOL/10^9 CELLS|||10^4/HPF|NOT DONE||NA|Y|Y|3||39||LONG-TERM FOLLOW-UP|1966-04-09||1960-11-23|||1967-06-30||1970-04-07
TRIAL STUDY 134XCP|RP|D5262627-52D7-42F5-B4BA-D7E6FA243959|2||||||STILBIND|STILLBIRTH INDICATOR||||KUSP|||MAC50|NOT DONE||NA|N|N|3||39||FOLLOW-UP|1965-05-25||1973-06-19|||1969-04-14||1970-08-19
TRIAL STUDY 134XCP|RP|D5262627-52D7-42F5-B4BA-D7E6FA243959|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||LOG10 TCID 50/DOSE|||BE/ML|NOT DONE||NA|Y|U|4||88||WASHOUT|1969-08-26||1962-11-12|||1962-04-16||1966-11-10
TRIAL STUDY 134XCP|RP|D5262627-52D7-42F5-B4BA-D7E6FA243959|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||V/SEC|||PUFF|NOT DONE||NA|N|Y|4||88||INDUCTION TREATMENT|1969-03-26||1960-01-30|||1960-08-27||1968-11-07
TRIAL STUDY 134XCP|RP|D5262627-52D7-42F5-B4BA-D7E6FA243959|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||GY|||UM|NOT DONE||N|NA|Y|5||7||WASHOUT|1960-02-18||1960-01-11|||1973-01-06||1967-04-08
TRIAL STUDY 134XCP|RP|D5262627-52D7-42F5-B4BA-D7E6FA243959|2||||||RASHIND|RASH INDICATOR||||POINT|||BQ|NOT DONE||NA|N|NA|5||7||LONG-TERM FOLLOW-UP|1969-04-03||1971-01-22|||1972-04-02||1968-07-12
TRIAL STUDY 134XCP|RP|C550278D-F171-42D0-8C34-D60824A3FE98|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^6/EJACULATE U|||/MM|NOT DONE||NA|U|U|1||38||LONG-TERM FOLLOW-UP|1966-03-19||1961-08-17|||1972-05-07||1967-01-14
TRIAL STUDY 134XCP|RP|C550278D-F171-42D0-8C34-D60824A3FE98|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UCI|||K|NOT DONE||N|N|Y|1||38||TREATMENT|1960-09-26||1961-08-18|||1966-08-28||1970-06-25
TRIAL STUDY 134XCP|RP|C550278D-F171-42D0-8C34-D60824A3FE98|1||||||STILBIND|STILLBIRTH INDICATOR||||MG/DAY|||U.CARR|NOT DONE||NA|U|U|2||58||OPEN LABEL TREATMENT|1969-08-09||1971-03-02|||1966-07-03||1970-08-11
TRIAL STUDY 134XCP|RP|C550278D-F171-42D0-8C34-D60824A3FE98|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||G/G|||LOG10 TCID 50/ML|NOT DONE||N|NA|Y|2||58||BLINDED TREATMENT|1968-07-23||1965-06-07|||1967-05-03||1960-02-25
TRIAL STUDY 134XCP|RP|C550278D-F171-42D0-8C34-D60824A3FE98|1||||||ULCERIND|ULCER INDICATOR||||MEQ/G|||DEG|NOT DONE||Y|NA|Y|3||39||BLINDED TREATMENT|1972-03-30||1962-03-14|||1961-10-10||1960-10-12
TRIAL STUDY 134XCP|RP|C550278D-F171-42D0-8C34-D60824A3FE98|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||CP|||CMHG|NOT DONE||N|U|N|3||39||SCREENING|1961-01-14||1963-01-28|||1969-05-10||1964-05-21
TRIAL STUDY 134XCP|RP|C550278D-F171-42D0-8C34-D60824A3FE98|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MIU/L|||G/CM2|NOT DONE||N|N|Y|4||88||TREATMENT|1963-07-05||1964-01-02|||1961-03-06||1973-02-05
TRIAL STUDY 134XCP|RP|C550278D-F171-42D0-8C34-D60824A3FE98|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||/10^3|||ENZYME U|NOT DONE||U|NA|Y|4||88||RUN-IN|1961-08-21||1965-10-18|||1969-11-10||1961-07-09
TRIAL STUDY 134XCP|RP|C550278D-F171-42D0-8C34-D60824A3FE98|1||||||DSCHGIND|DISCHARGE INDICATOR||||KCAL|||NGEQ/L|NOT DONE||U|NA|Y|5||7||LONG-TERM FOLLOW-UP|1964-05-20||1965-09-03|||1964-12-04||1967-02-19
TRIAL STUDY 134XCP|RP|C550278D-F171-42D0-8C34-D60824A3FE98|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||PATCH|||BQ/MG|NOT DONE||U|N|N|5||7||INDUCTION TREATMENT|1971-10-22||1960-04-10|||1963-01-28||1961-05-18
TRIAL STUDY 134XCP|RP|5E76262E-FE1E-40C9-B147-3C792F768F48|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||CAPSULE|||%/MIN|NOT DONE||NA|Y|NA|1||38||FOLLOW-UP|1962-10-23||1968-03-19|||1962-09-19||1972-10-09
TRIAL STUDY 134XCP|RP|5E76262E-FE1E-40C9-B147-3C792F768F48|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||IU/KG/H|||HENRY|NOT DONE||NA|Y|U|1||38||OPEN LABEL TREATMENT|1960-08-19||1971-07-07|||1973-05-01||1973-04-15
TRIAL STUDY 134XCP|RP|5E76262E-FE1E-40C9-B147-3C792F768F48|1||||||FUNDHT|FUNDAL HEIGHT||||CI/G|||PMOL/10^9 CELLS|NOT DONE||N|NA|U|2||58||SCREENING|1972-04-18||1965-09-08|||1970-12-17||1963-10-07
TRIAL STUDY 134XCP|RP|5E76262E-FE1E-40C9-B147-3C792F768F48|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||FG|||ANTIBODY UNIT|NOT DONE||NA|NA|Y|2||58||INDUCTION TREATMENT|1965-11-24||1966-12-20|||1964-01-09||1967-07-29
TRIAL STUDY 134XCP|RP|5E76262E-FE1E-40C9-B147-3C792F768F48|1||||||PREGNN|NUMBER OF PREGNANCIES||||U|||PMOL/L|NOT DONE||N|Y|U|3||39||INDUCTION TREATMENT|1965-03-03||1966-04-23|||1965-07-01||1967-03-15
TRIAL STUDY 134XCP|RP|5E76262E-FE1E-40C9-B147-3C792F768F48|2||||||DLVRMODE|MODE OF DELIVERY||||INHALATION|||ABSORBANCE U|NOT DONE||NA|U|N|3||39||LONG-TERM FOLLOW-UP|1972-10-30||1968-03-20|||1972-10-17||1963-02-07
TRIAL STUDY 134XCP|RP|5E76262E-FE1E-40C9-B147-3C792F768F48|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||LOG10 PFU|||CL|NOT DONE||Y|NA|NA|4||88||CONTINUATION TREATMENT|1972-07-02||1961-08-11|||1967-12-19||1963-06-10
TRIAL STUDY 134XCP|RP|5E76262E-FE1E-40C9-B147-3C792F768F48|2||||||STILBIND|STILLBIRTH INDICATOR||||/40 HPFS|||/DAY|NOT DONE||U|Y|NA|4||88||SCREENING|1970-07-21||1971-11-11|||1966-01-30||1969-04-16
TRIAL STUDY 134XCP|RP|5E76262E-FE1E-40C9-B147-3C792F768F48|1||||||RASHIND|RASH INDICATOR||||10^6 DNA COPIES/ML|||MOL/MG|NOT DONE||NA|Y|Y|5||7||TREATMENT|1970-05-23||1969-11-30|||1972-01-10||1969-06-24
TRIAL STUDY 134XCP|RP|5E76262E-FE1E-40C9-B147-3C792F768F48|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||10^3 CFU|||CIGARETTE|NOT DONE||Y|Y|U|5||7||LONG-TERM FOLLOW-UP|1963-12-31||1968-11-17|||1968-05-19||1973-01-14
TRIAL STUDY 134XCP|RP|2F21921D-D18C-43EE-A39E-91A93B262B8C|1||||||MENARAGE|MENARCHE AGE||||KPA/L/SEC|||MG/KG/WEEK|NOT DONE||U|N|N|1||38||CONTINUATION TREATMENT|1972-02-20||1968-07-16|||1960-07-22||1972-12-30
TRIAL STUDY 134XCP|RP|2F21921D-D18C-43EE-A39E-91A93B262B8C|2||||||BLISTIND|BLISTERING INDICATOR||||ATM|||/DAY|NOT DONE||Y|U|N|1||38||OBSERVATION|1960-05-02||1969-10-02|||1964-09-16||1963-09-29
TRIAL STUDY 134XCP|RP|2F21921D-D18C-43EE-A39E-91A93B262B8C|1||||||DSCHGIND|DISCHARGE INDICATOR||||/SEC|||CI/ML|NOT DONE||NA|NA|NA|2||58||FOLLOW-UP|1966-03-10||1973-07-17|||1966-11-29||1967-11-14
TRIAL STUDY 134XCP|RP|2F21921D-D18C-43EE-A39E-91A93B262B8C|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MGEQ|||10^6 ORGANISMS/ML|NOT DONE||Y|U|N|2||58||WASHOUT|1969-12-07||1969-05-10|||1971-08-24||1965-01-09
TRIAL STUDY 134XCP|RP|2F21921D-D18C-43EE-A39E-91A93B262B8C|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MV*MIN|||10^6/HPF|NOT DONE||N|U|NA|3||39||SCREENING|1971-12-16||1968-07-13|||1971-03-20||1963-10-28
TRIAL STUDY 134XCP|RP|2F21921D-D18C-43EE-A39E-91A93B262B8C|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||DMOL|||GENEQ|NOT DONE||Y|Y|Y|3||39||INDUCTION TREATMENT|1964-08-11||1967-11-12|||1968-09-13||1960-02-28
TRIAL STUDY 134XCP|RP|2F21921D-D18C-43EE-A39E-91A93B262B8C|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||ML/KG/DAY|||COPIES/ML|NOT DONE||N|U|U|4||88||INDUCTION TREATMENT|1960-11-01||1971-05-14|||1962-04-08||1970-11-27
TRIAL STUDY 134XCP|RP|2F21921D-D18C-43EE-A39E-91A93B262B8C|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||SV|||/10^5|NOT DONE||NA|N|N|4||88||OBSERVATION|1972-06-24||1960-08-04|||1970-10-06||1964-09-27
TRIAL STUDY 134XCP|RP|2F21921D-D18C-43EE-A39E-91A93B262B8C|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^6 CFU|||G/M2|NOT DONE||U|Y|N|5||7||RUN-IN|1961-11-11||1963-10-30|||1972-06-03||1961-12-30
TRIAL STUDY 134XCP|RP|2F21921D-D18C-43EE-A39E-91A93B262B8C|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^5/L|||IU/DL|NOT DONE||N|N|Y|5||7||CONTINUATION TREATMENT|1968-11-08||1965-01-30|||1963-07-17||1967-07-22
TRIAL STUDY 134XCP|RP|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|1||||||MENARAGE|MENARCHE AGE||||NG/DL|||MOSM/L|NOT DONE||NA|NA|Y|1||38||OPEN LABEL TREATMENT|1967-04-23||1963-04-12|||1960-06-07||1970-01-24
TRIAL STUDY 134XCP|RP|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||/100 HPFS|||UG/L DDU|NOT DONE||N|U|NA|1||38||WASHOUT|1962-11-22||1967-04-04|||1961-09-28||1964-03-31
TRIAL STUDY 134XCP|RP|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||10^6/EJACULATE U|||GPL U/ML|NOT DONE||U|N|N|2||58||INDUCTION TREATMENT|1973-02-07||1969-04-12|||1964-05-13||1968-11-08
TRIAL STUDY 134XCP|RP|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||KIU|||10^6 RNA COPIES/ML|NOT DONE||Y|NA|NA|2||58||BLINDED TREATMENT|1973-05-11||1972-12-09|||1962-12-18||1962-05-02
TRIAL STUDY 134XCP|RP|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||BEL|||10^6 ORGANISMS/ML|NOT DONE||NA|N|U|3||39||BASELINE|1968-12-10||1967-12-07|||1962-10-06||1961-07-26
TRIAL STUDY 134XCP|RP|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||NG/MOL|||MPL U|NOT DONE||N|U|Y|3||39||WASHOUT|1964-02-22||1964-12-05|||1969-02-23||1964-11-03
TRIAL STUDY 134XCP|RP|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MESF|||MPS U|NOT DONE||U|NA|Y|4||88||WASHOUT|1969-03-26||1965-11-25|||1964-10-17||1965-07-03
TRIAL STUDY 134XCP|RP|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|2||||||PRGENDTC|DATE PREGNANCY ENDED||||LOG10 ELISA UNIT|||MV*MIN|NOT DONE||U|U|Y|4||88||LONG-TERM FOLLOW-UP|1962-06-29||1970-08-09|||1969-03-09||1961-05-28
TRIAL STUDY 134XCP|RP|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||BEL|||BREATHS/30S|NOT DONE||NA|U|U|5||7||OBSERVATION|1969-10-13||1964-05-08|||1964-02-10||1967-11-06
TRIAL STUDY 134XCP|RP|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||VG/KG|||IU/DAY|NOT DONE||U|Y|U|5||7||TREATMENT|1969-01-14||1961-05-10|||1969-06-23||1966-08-06
TRIAL STUDY 134XCP|RP|55985646-0224-4442-90C5-EFEDF990E88C|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||UG/G/MIN|||G/ANIMAL/WK|NOT DONE||U|Y|NA|1||38||TREATMENT|1970-06-08||1961-01-15|||1968-10-20||1963-08-15
TRIAL STUDY 134XCP|RP|55985646-0224-4442-90C5-EFEDF990E88C|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UV2|||U/ML|NOT DONE||NA|N|Y|1||38||SCREENING|1964-03-10||1971-10-22|||1963-03-29||1970-03-23
TRIAL STUDY 134XCP|RP|55985646-0224-4442-90C5-EFEDF990E88C|1||||||RASHIND|RASH INDICATOR||||CG|||IU/KG/H|NOT DONE||Y|Y|U|2||58||FOLLOW-UP|1960-01-02||1973-07-23|||1967-03-01||1965-01-20
TRIAL STUDY 134XCP|RP|55985646-0224-4442-90C5-EFEDF990E88C|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||UV*SEC|||CD|NOT DONE||U|U|Y|2||58||BLINDED TREATMENT|1960-04-08||1967-03-28|||1971-05-22||1960-10-22
TRIAL STUDY 134XCP|RP|55985646-0224-4442-90C5-EFEDF990E88C|1||||||MENOSTAT|MENOPAUSE STATUS||||BEL|||LOG10 CCID 50/DOSE|NOT DONE||N|U|NA|3||39||BASELINE|1968-08-17||1970-05-18|||1960-02-12||1972-11-10
TRIAL STUDY 134XCP|RP|55985646-0224-4442-90C5-EFEDF990E88C|2||||||EDEMAIND|EDEMA INDICATOR||||MCI/KG|||U/ML|NOT DONE||N|U|Y|3||39||RUN-IN|1967-09-18||1967-12-10|||1960-12-22||1969-09-05
TRIAL STUDY 134XCP|RP|55985646-0224-4442-90C5-EFEDF990E88C|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||/MM2|||STEPS|NOT DONE||N|U|NA|4||88||INDUCTION TREATMENT|1967-07-13||1962-06-01|||1964-11-09||1968-04-30
TRIAL STUDY 134XCP|RP|55985646-0224-4442-90C5-EFEDF990E88C|2||||||THICK|THICKNESS||||UMOL/H/MMOL|||KG/M2|NOT DONE||NA|NA|U|4||88||TREATMENT|1967-04-09||1962-02-28|||1965-12-14||1967-07-16
TRIAL STUDY 134XCP|RP|55985646-0224-4442-90C5-EFEDF990E88C|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MEQ/DAY|||U/KG/H|NOT DONE||Y|N|NA|5||7||TREATMENT|1962-11-23||1962-11-22|||1973-02-04||1962-04-14
TRIAL STUDY 134XCP|RP|55985646-0224-4442-90C5-EFEDF990E88C|2||||||PREGIND|PREGNANT INDICATOR||||10^8 PFU|||L/DAY|NOT DONE||U|Y|Y|5||7||CONTINUATION TREATMENT|1964-06-12||1965-06-01|||1964-06-01||1967-08-17
TRIAL STUDY 134XCP|RP|86509C90-3C57-4755-A06F-79C620779371|1||||||MENARAGE|MENARCHE AGE||||BAG|||PMOL/DAY|NOT DONE||N|N|N|1||38||BLINDED TREATMENT|1962-04-07||1960-01-15|||1962-04-20||1967-09-06
TRIAL STUDY 134XCP|RP|86509C90-3C57-4755-A06F-79C620779371|2||||||BLISTIND|BLISTERING INDICATOR||||MMOL/DAY|||DEG|NOT DONE||Y|Y|U|1||38||OBSERVATION|1971-10-14||1964-02-01|||1967-08-23||1965-01-10
TRIAL STUDY 134XCP|RP|86509C90-3C57-4755-A06F-79C620779371|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||KPA|||UG/M2/H|NOT DONE||N|U|NA|2||58||TREATMENT|1973-07-19||1965-12-20|||1963-06-11||1967-09-06
TRIAL STUDY 134XCP|RP|86509C90-3C57-4755-A06F-79C620779371|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||10^3 ORGANISMS/ML|||BREATHS/30S|NOT DONE||N|N|U|2||58||RUN-IN|1960-10-27||1966-01-27|||1973-05-01||1966-06-09
TRIAL STUDY 134XCP|RP|86509C90-3C57-4755-A06F-79C620779371|1||||||EDEMAIND|EDEMA INDICATOR||||SHOCK WAVE|||OI50|NOT DONE||U|U|N|3||39||INDUCTION TREATMENT|1971-11-06||1960-12-01|||1970-02-13||1972-08-27
TRIAL STUDY 134XCP|RP|86509C90-3C57-4755-A06F-79C620779371|2||||||STILBIND|STILLBIRTH INDICATOR||||BU/ML|||GY/MIN|NOT DONE||Y|N|Y|3||39||BLINDED TREATMENT|1963-01-25||1972-04-23|||1960-12-16||1972-03-08
TRIAL STUDY 134XCP|RP|86509C90-3C57-4755-A06F-79C620779371|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||10^4/HPF|||ANSON U|NOT DONE||Y|NA|NA|4||88||BASELINE|1967-11-11||1968-02-19|||1965-12-06||1973-01-23
TRIAL STUDY 134XCP|RP|86509C90-3C57-4755-A06F-79C620779371|2||||||PREGIND|PREGNANT INDICATOR||||UMOL/L/H|||/10^4|NOT DONE||U|Y|Y|4||88||FOLLOW-UP|1966-04-17||1969-05-09|||1965-12-29||1968-04-13
TRIAL STUDY 134XCP|RP|86509C90-3C57-4755-A06F-79C620779371|1||||||FUNDHT|FUNDAL HEIGHT||||/2500 WBC|||CYLINDER|NOT DONE||Y|N|Y|5||7||OBSERVATION|1960-12-31||1969-02-19|||1963-10-12||1971-07-16
TRIAL STUDY 134XCP|RP|86509C90-3C57-4755-A06F-79C620779371|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||DIP|||MM3/MM2/YEAR|NOT DONE||Y|N|Y|5||7||INDUCTION TREATMENT|1968-06-28||1971-02-19|||1969-04-29||1963-05-30
TRIAL STUDY 134XCP|RP|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|1||||||PREGST|PREGNANT DURING THE STUDY||||GENEQ/ML|||DPM/MG|NOT DONE||N|Y|Y|1||38||FOLLOW-UP|1972-02-29||1965-02-08|||1962-10-28||1962-01-18
TRIAL STUDY 134XCP|RP|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||BEL|||G/KG/DAY|NOT DONE||NA|Y|NA|1||38||LONG-TERM FOLLOW-UP|1968-08-24||1971-01-08|||1962-03-27||1971-04-27
TRIAL STUDY 134XCP|RP|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MET*H|||10^6 CFU/G|NOT DONE||N|U|Y|2||58||OPEN LABEL TREATMENT|1961-12-05||1973-04-25|||1965-08-25||1968-12-01
TRIAL STUDY 134XCP|RP|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||IU/KG/H|||IU/DL|NOT DONE||U|NA|Y|2||58||SCREENING|1972-09-05||1969-07-30|||1962-08-06||1968-03-30
TRIAL STUDY 134XCP|RP|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||10^6 ORGANISMS|||10^3 CFU/ML|NOT DONE||N|U|Y|3||39||WASHOUT|1970-05-28||1971-11-05|||1963-01-14||1967-10-18
TRIAL STUDY 134XCP|RP|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||DEG/MM|||JAR|NOT DONE||Y|NA|U|3||39||OBSERVATION|1964-06-02||1960-05-01|||1966-03-21||1964-07-16
TRIAL STUDY 134XCP|RP|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||KAT|||/LSQN|NOT DONE||NA|NA|NA|4||88||LONG-TERM FOLLOW-UP|1964-08-06||1970-06-16|||1970-02-16||1972-06-10
TRIAL STUDY 134XCP|RP|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|2||||||TNDRIND|TENDERNESS INDICATOR||||10^6 CFU/ML|||U/MG|NOT DONE||Y|NA|U|4||88||TREATMENT|1971-02-05||1972-05-25|||1966-04-05||1971-06-12
TRIAL STUDY 134XCP|RP|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|1||||||PREGNN|NUMBER OF PREGNANCIES||||DEG2|||ELISA UNIT/DOSE|NOT DONE||Y|Y|Y|5||7||OBSERVATION|1965-04-20||1962-06-17|||1967-07-25||1965-09-15
TRIAL STUDY 134XCP|RP|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||SCOOPFUL|||RING|NOT DONE||N|U|N|5||7||WASHOUT|1972-03-09||1966-09-26|||1969-01-14||1960-05-16
TRIAL STUDY 134XCP|RP|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|1||||||BCMETHOD|BIRTH CONTROL METHOD||||MBQ|||DPM/MG|NOT DONE||Y|NA|Y|1||38||LONG-TERM FOLLOW-UP|1964-09-12||1972-08-28|||1969-08-31||1970-02-02
TRIAL STUDY 134XCP|RP|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|2||||||MENOSTAT|MENOPAUSE STATUS||||SQU/ML|||CFU/G|NOT DONE||NA|U|NA|1||38||OBSERVATION|1960-01-26||1970-09-13|||1971-01-25||1963-01-16
TRIAL STUDY 134XCP|RP|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|1||||||PUSTIND|PUSTULE INDICATOR||||SCM|||TUBERCULIN UNIT/ML|NOT DONE||N|N|N|2||58||SCREENING|1960-04-06||1971-01-17|||1971-02-17||1968-04-26
TRIAL STUDY 134XCP|RP|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|2||||||PUSTIND|PUSTULE INDICATOR||||NM|||KCAL/DAY|NOT DONE||NA|N|U|2||58||BLINDED TREATMENT|1969-10-13||1964-08-18|||1967-08-30||1967-01-09
TRIAL STUDY 134XCP|RP|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|1||||||INABOIND|INDUCED ABORTION INDICATOR||||DRAM|||TRANSDUCING UNIT/ML|NOT DONE||Y|N|Y|3||39||CONTINUATION TREATMENT|1972-08-13||1970-07-16|||1966-02-01||1969-02-12
TRIAL STUDY 134XCP|RP|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||GY/H|||L/L|NOT DONE||NA|U|NA|3||39||FOLLOW-UP|1965-06-21||1967-07-06|||1971-05-30||1967-08-11
TRIAL STUDY 134XCP|RP|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|1||||||PREGST|PREGNANT DURING THE STUDY||||WEBER|||BQ/G|NOT DONE||NA|U|U|4||88||OPEN LABEL TREATMENT|1962-10-31||1964-12-10|||1972-08-03||1965-11-17
TRIAL STUDY 134XCP|RP|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||UMOL/KG/MIN|||RPM|NOT DONE||Y|U|N|4||88||SCREENING|1967-03-29||1972-03-02|||1967-10-19||1969-02-12
TRIAL STUDY 134XCP|RP|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|1||||||PUSTIND|PUSTULE INDICATOR||||L/S|||/WK|NOT DONE||N|U|NA|5||7||CONTINUATION TREATMENT|1966-11-20||1963-01-23|||1969-12-04||1973-06-04
TRIAL STUDY 134XCP|RP|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|2||||||BCMETHOD|BIRTH CONTROL METHOD||||IN2|||GTT|NOT DONE||NA|N|N|5||7||WASHOUT|1960-11-04||1970-09-15|||1970-09-15||1962-04-13
TRIAL STUDY 134XCP|RP|0FFBFF7C-7C64-411E-8D07-C959F0886023|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||ML/ANIMAL/WK|||MG/ANIMAL|NOT DONE||U|NA|U|1||38||SCREENING|1964-11-03||1965-11-21|||1963-03-28||1961-12-10
TRIAL STUDY 134XCP|RP|0FFBFF7C-7C64-411E-8D07-C959F0886023|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||/CMH2O|||ML/M2/H|NOT DONE||Y|U|U|1||38||CONTINUATION TREATMENT|1965-08-30||1969-02-09|||1973-06-28||1968-03-24
TRIAL STUDY 134XCP|RP|0FFBFF7C-7C64-411E-8D07-C959F0886023|1||||||BLISTIND|BLISTERING INDICATOR||||ENZYME U/M2|||NEWTON|NOT DONE||U|U|N|2||58||RUN-IN|1970-05-10||1962-12-23|||1961-06-20||1964-11-19
TRIAL STUDY 134XCP|RP|0FFBFF7C-7C64-411E-8D07-C959F0886023|2||||||GRAVIND|GRAVIDA INDICATOR||||L/DAY|||HOUNSFIELD UNIT|NOT DONE||NA|N|U|2||58||SCREENING|1966-03-05||1973-07-27|||1970-10-31||1960-02-24
TRIAL STUDY 134XCP|RP|0FFBFF7C-7C64-411E-8D07-C959F0886023|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||G/U|||UM/DAY|NOT DONE||U|NA|NA|3||39||BASELINE|1965-02-16||1964-09-30|||1967-08-07||1965-12-03
TRIAL STUDY 134XCP|RP|0FFBFF7C-7C64-411E-8D07-C959F0886023|2||||||THICK|THICKNESS||||SIEMENS|||10^7 CFU/ML|NOT DONE||U|NA|NA|3||39||LONG-TERM FOLLOW-UP|1963-10-09||1961-05-26|||1973-04-09||1968-02-24
TRIAL STUDY 134XCP|RP|0FFBFF7C-7C64-411E-8D07-C959F0886023|1||||||PREGNN|NUMBER OF PREGNANCIES||||MU|||MMHG|NOT DONE||U|U|Y|4||88||FOLLOW-UP|1970-01-29||1965-08-25|||1963-05-16||1960-02-26
TRIAL STUDY 134XCP|RP|0FFBFF7C-7C64-411E-8D07-C959F0886023|2||||||INTP|INTERPRETATION||||ML/KG/MIN|||TCID 50/DOSE|NOT DONE||N|U|Y|4||88||INDUCTION TREATMENT|1972-10-28||1970-08-27|||1962-11-30||1960-12-20
TRIAL STUDY 134XCP|RP|0FFBFF7C-7C64-411E-8D07-C959F0886023|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||U/MG|||UMOL/MG/MIN|NOT DONE||N|Y|U|5||7||CONTINUATION TREATMENT|1965-12-21||1970-01-01|||1960-02-22||1967-10-10
TRIAL STUDY 134XCP|RP|0FFBFF7C-7C64-411E-8D07-C959F0886023|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||CD*S/M2|||TCID 50/DOSE|NOT DONE||Y|Y|NA|5||7||OBSERVATION|1969-01-14||1970-02-13|||1972-01-12||1969-11-28
TRIAL STUDY 134XCP|RP|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UG/G/H|||MEQ/KG|NOT DONE||NA|U|NA|1||38||BASELINE|1966-11-21||1971-06-27|||1962-06-20||1973-02-23
TRIAL STUDY 134XCP|RP|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|2||||||PREGNN|NUMBER OF PREGNANCIES||||UU/L|||ANTI-XA IU|NOT DONE||Y|NA|U|1||38||WASHOUT|1966-02-11||1972-06-02|||1962-01-24||1968-01-15
TRIAL STUDY 134XCP|RP|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||KS|||%|NOT DONE||NA|N|N|2||58||TREATMENT|1967-10-18||1970-05-25|||1960-03-30||1966-10-27
TRIAL STUDY 134XCP|RP|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^3 CFU/ML|||KDA|NOT DONE||N|Y|U|2||58||OBSERVATION|1964-09-25||1968-04-12|||1965-12-04||1971-10-04
TRIAL STUDY 134XCP|RP|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||BQ/G|||MG/CM2|NOT DONE||U|N|Y|3||39||BLINDED TREATMENT|1970-01-17||1966-07-11|||1961-02-02||1966-03-03
TRIAL STUDY 134XCP|RP|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|2||||||PRGENDTC|DATE PREGNANCY ENDED||||KPA|||PNU/ML|NOT DONE||N|NA|NA|3||39||RUN-IN|1965-12-10||1971-12-19|||1973-02-24||1963-08-07
TRIAL STUDY 134XCP|RP|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||VOXEL|||10^6 CFU/ML|NOT DONE||N|N|N|4||88||INDUCTION TREATMENT|1973-05-02||1966-11-24|||1963-06-24||1965-09-03
TRIAL STUDY 134XCP|RP|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||G/CAGE|||NEBULE|NOT DONE||U|N|NA|4||88||SCREENING|1970-08-15||1965-10-01|||1965-12-11||1965-10-14
TRIAL STUDY 134XCP|RP|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||VG/ML|||MG/MOL|NOT DONE||N|Y|Y|5||7||INDUCTION TREATMENT|1960-05-14||1967-08-24|||1963-10-01||1960-02-15
TRIAL STUDY 134XCP|RP|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^6 CFU|||10^6 ORGANISMS/G|NOT DONE||NA|Y|Y|5||7||SCREENING|1970-08-10||1964-08-04|||1960-02-09||1972-10-22
TRIAL STUDY 134XCP|RP|5DC5F780-264A-4EB1-BEA5-28209D416FEB|1||||||BLISTIND|BLISTERING INDICATOR||||10^5/L|||KV|NOT DONE||NA|N|Y|1||38||INDUCTION TREATMENT|1970-10-23||1971-08-20|||1968-08-21||1968-07-23
TRIAL STUDY 134XCP|RP|5DC5F780-264A-4EB1-BEA5-28209D416FEB|2||||||BRTHN|NUMBER OF BIRTHS||||YD|||USEC|NOT DONE||Y|Y|U|1||38||RUN-IN|1960-11-04||1965-07-07|||1960-08-07||1965-11-02
TRIAL STUDY 134XCP|RP|5DC5F780-264A-4EB1-BEA5-28209D416FEB|1||||||BLISTIND|BLISTERING INDICATOR||||KCAL|||G/L|NOT DONE||U|Y|Y|2||58||SCREENING|1967-11-25||1962-10-14|||1965-05-30||1969-05-09
TRIAL STUDY 134XCP|RP|5DC5F780-264A-4EB1-BEA5-28209D416FEB|2||||||FUNDHT|FUNDAL HEIGHT||||ELISA UNIT|||10^6 CFU/G|NOT DONE||N|NA|U|2||58||FOLLOW-UP|1961-09-30||1973-06-30|||1964-06-09||1963-06-11
TRIAL STUDY 134XCP|RP|5DC5F780-264A-4EB1-BEA5-28209D416FEB|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||APL U/ML|||KDA|NOT DONE||U|N|U|3||39||CONTINUATION TREATMENT|1964-07-12||1969-05-11|||1972-07-17||1964-11-03
TRIAL STUDY 134XCP|RP|5DC5F780-264A-4EB1-BEA5-28209D416FEB|2||||||PREGST|PREGNANT DURING THE STUDY||||10^3/HPF|||MMOL/MIN/KPA/L|NOT DONE||Y|NA|NA|3||39||RUN-IN|1967-04-15||1961-10-09|||1965-01-07||1961-12-31
TRIAL STUDY 134XCP|RP|5DC5F780-264A-4EB1-BEA5-28209D416FEB|1||||||MENARAGE|MENARCHE AGE||||/5X10^4 WBC|||U/KG|NOT DONE||N|NA|Y|4||88||BASELINE|1962-05-19||1965-11-17|||1971-06-08||1964-03-28
TRIAL STUDY 134XCP|RP|5DC5F780-264A-4EB1-BEA5-28209D416FEB|2||||||BCMETHOD|BIRTH CONTROL METHOD||||U/G HB|||10^9/L|NOT DONE||NA|NA|NA|4||88||FOLLOW-UP|1965-07-29||1963-08-30|||1963-12-23||1968-12-17
TRIAL STUDY 134XCP|RP|5DC5F780-264A-4EB1-BEA5-28209D416FEB|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||MCI|||UCI|NOT DONE||NA|Y|U|5||7||TREATMENT|1968-09-30||1963-04-20|||1971-05-28||1965-04-22
TRIAL STUDY 134XCP|RP|5DC5F780-264A-4EB1-BEA5-28209D416FEB|2||||||PREGNN|NUMBER OF PREGNANCIES||||BU/ML|||/H|NOT DONE||Y|NA|U|5||7||TREATMENT|1963-05-07||1969-12-18|||1970-06-18||1972-08-29
TRIAL STUDY 134XCP|RP|DDBCA084-DD05-4FA0-9083-7CD31CECA420|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^9/DOSE|||CAPFUL|NOT DONE||U|NA|U|1||38||FOLLOW-UP|1962-04-05||1960-06-19|||1960-01-07||1970-03-25
TRIAL STUDY 134XCP|RP|DDBCA084-DD05-4FA0-9083-7CD31CECA420|2||||||MENARAGE|MENARCHE AGE||||L/H|||GBQ/UG|NOT DONE||N|U|Y|1||38||OBSERVATION|1968-10-30||1970-07-22|||1964-12-05||1971-12-17
TRIAL STUDY 134XCP|RP|DDBCA084-DD05-4FA0-9083-7CD31CECA420|1||||||ERYTHIND|ERYTHEMA INDICATOR||||NMOL BCE/MMOL|||/100 WBC|NOT DONE||Y|U|N|2||58||LONG-TERM FOLLOW-UP|1965-04-25||1968-11-12|||1973-03-28||1963-07-19
TRIAL STUDY 134XCP|RP|DDBCA084-DD05-4FA0-9083-7CD31CECA420|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||KN/CM2|||UMOL/H/MMOL|NOT DONE||N|NA|U|2||58||WASHOUT|1973-06-06||1966-09-27|||1968-07-14||1967-03-09
TRIAL STUDY 134XCP|RP|DDBCA084-DD05-4FA0-9083-7CD31CECA420|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||UG/L/H|||LOG10 PFU|NOT DONE||NA|Y|N|3||39||SCREENING|1965-09-03||1960-05-09|||1960-06-23||1965-06-12
TRIAL STUDY 134XCP|RP|DDBCA084-DD05-4FA0-9083-7CD31CECA420|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MPL U|||PG|NOT DONE||U|U|NA|3||39||WASHOUT|1969-01-14||1973-01-03|||1965-01-04||1961-09-22
TRIAL STUDY 134XCP|RP|DDBCA084-DD05-4FA0-9083-7CD31CECA420|1||||||MENARAGE|MENARCHE AGE||||TUBE|||NMOL/DAY|NOT DONE||U|Y|U|4||88||WASHOUT|1970-02-04||1970-02-02|||1963-03-29||1973-08-16
TRIAL STUDY 134XCP|RP|DDBCA084-DD05-4FA0-9083-7CD31CECA420|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||10^9 ORGANISMS/G|||LOG10 TCID 50/DOSE|NOT DONE||U|U|Y|4||88||CONTINUATION TREATMENT|1971-07-25||1971-08-20|||1967-05-07||1963-02-12
TRIAL STUDY 134XCP|RP|DDBCA084-DD05-4FA0-9083-7CD31CECA420|1||||||INTP|INTERPRETATION||||ML/BEAT|||MV*MIN|NOT DONE||N|U|U|5||7||CONTINUATION TREATMENT|1963-03-17||1960-11-07|||1961-03-27||1973-02-06
TRIAL STUDY 134XCP|RP|DDBCA084-DD05-4FA0-9083-7CD31CECA420|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MG/DL|||MET*H|NOT DONE||NA|NA|Y|5||7||BASELINE|1972-09-20||1960-12-23|||1965-04-07||1968-05-03
TRIAL STUDY 134XCP|RP|65A5AAA6-A817-45F8-9BA8-584E9627AB26|1||||||INABOIND|INDUCED ABORTION INDICATOR||||KIU|||ML/M2/DAY|NOT DONE||U|N|U|1||38||FOLLOW-UP|1967-02-08||1963-06-04|||1962-09-18||1961-08-10
TRIAL STUDY 134XCP|RP|65A5AAA6-A817-45F8-9BA8-584E9627AB26|2||||||BLISTIND|BLISTERING INDICATOR||||JAR|||SUPPOSITORY|NOT DONE||NA|Y|Y|1||38||SCREENING|1966-10-03||1967-11-28|||1971-03-02||1968-06-20
TRIAL STUDY 134XCP|RP|65A5AAA6-A817-45F8-9BA8-584E9627AB26|1||||||EDEMAIND|EDEMA INDICATOR||||ML/S/M2|||10^7 PFU|NOT DONE||U|NA|NA|2||58||OBSERVATION|1971-03-24||1966-01-15|||1971-12-06||1970-01-11
TRIAL STUDY 134XCP|RP|65A5AAA6-A817-45F8-9BA8-584E9627AB26|2||||||PREGIND|PREGNANT INDICATOR||||NU/CL|||MPL U|NOT DONE||N|N|NA|2||58||TREATMENT|1965-09-11||1965-05-12|||1969-10-13||1967-12-24
TRIAL STUDY 134XCP|RP|65A5AAA6-A817-45F8-9BA8-584E9627AB26|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UM2|||MV*MIN|NOT DONE||U|U|U|3||39||WASHOUT|1960-04-09||1964-04-13|||1966-07-16||1964-08-16
TRIAL STUDY 134XCP|RP|65A5AAA6-A817-45F8-9BA8-584E9627AB26|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||ML/G/MIN|||CARTRIDGE|NOT DONE||N|N|U|3||39||SCREENING|1967-11-07||1972-03-22|||1970-01-30||1969-03-20
TRIAL STUDY 134XCP|RP|65A5AAA6-A817-45F8-9BA8-584E9627AB26|1||||||PREGST|PREGNANT DURING THE STUDY||||U|||MHZ|NOT DONE||U|Y|U|4||88||LONG-TERM FOLLOW-UP|1963-01-23||1960-05-17|||1960-12-03||1969-05-29
TRIAL STUDY 134XCP|RP|65A5AAA6-A817-45F8-9BA8-584E9627AB26|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||CP|||10^3 CFU/G|NOT DONE||U|NA|NA|4||88||INDUCTION TREATMENT|1972-10-02||1972-10-21|||1973-08-04||1964-12-14
TRIAL STUDY 134XCP|RP|65A5AAA6-A817-45F8-9BA8-584E9627AB26|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||CMH2O/ML|||MG2/DL2|NOT DONE||U|NA|U|5||7||CONTINUATION TREATMENT|1964-05-13||1968-09-01|||1969-05-21||1968-01-10
TRIAL STUDY 134XCP|RP|65A5AAA6-A817-45F8-9BA8-584E9627AB26|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||BQ|||CM|NOT DONE||NA|N|N|5||7||TREATMENT|1969-10-22||1964-05-19|||1967-12-19||1969-04-25
TRIAL STUDY 134XCP|RP|854AD9A5-A869-41C7-9AF0-43383CE64B86|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||KA_U/DL|||NMOL/L|NOT DONE||N|U|U|1||38||BASELINE|1960-09-07||1965-12-24|||1970-12-10||1961-12-08
TRIAL STUDY 134XCP|RP|854AD9A5-A869-41C7-9AF0-43383CE64B86|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||PHERESIS UNIT|||L|NOT DONE||NA|N|NA|1||38||CONTINUATION TREATMENT|1964-11-02||1971-09-13|||1968-10-21||1967-06-28
TRIAL STUDY 134XCP|RP|854AD9A5-A869-41C7-9AF0-43383CE64B86|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||VIAL|||AMU|NOT DONE||Y|U|Y|2||58||BLINDED TREATMENT|1969-04-21||1964-10-14|||1968-07-27||1964-07-31
TRIAL STUDY 134XCP|RP|854AD9A5-A869-41C7-9AF0-43383CE64B86|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MIN/DAY|||TBSP|NOT DONE||U|Y|N|2||58||OPEN LABEL TREATMENT|1965-04-20||1964-12-28|||1964-10-05||1963-07-23
TRIAL STUDY 134XCP|RP|854AD9A5-A869-41C7-9AF0-43383CE64B86|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||G/U|||10^9/L|NOT DONE||Y|Y|N|3||39||WASHOUT|1961-03-09||1966-11-18|||1967-12-28||1971-03-03
TRIAL STUDY 134XCP|RP|854AD9A5-A869-41C7-9AF0-43383CE64B86|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ABSORBANCE U/ML|||HEP|NOT DONE||NA|U|N|3||39||LONG-TERM FOLLOW-UP|1971-02-14||1963-02-28|||1972-08-13||1968-02-25
TRIAL STUDY 134XCP|RP|854AD9A5-A869-41C7-9AF0-43383CE64B86|1||||||THICK|THICKNESS||||KM/H|||/MS|NOT DONE||U|N|U|4||88||TREATMENT|1972-12-11||1969-08-12|||1969-02-11||1969-07-15
TRIAL STUDY 134XCP|RP|854AD9A5-A869-41C7-9AF0-43383CE64B86|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^6 CFU/ML|||/100 WBC|NOT DONE||Y|U|U|4||88||BLINDED TREATMENT|1966-06-10||1960-10-11|||1963-11-25||1960-11-12
TRIAL STUDY 134XCP|RP|854AD9A5-A869-41C7-9AF0-43383CE64B86|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||PT_BR|||CD/M2|NOT DONE||Y|N|Y|5||7||FOLLOW-UP|1973-08-15||1964-02-07|||1965-10-23||1963-02-17
TRIAL STUDY 134XCP|RP|854AD9A5-A869-41C7-9AF0-43383CE64B86|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||PNU/ML|||/DAY|NOT DONE||U|N|U|5||7||OBSERVATION|1970-11-19||1972-10-08|||1960-05-29||1962-02-19
TRIAL STUDY 134XCP|RP|008F02C8-B28A-490E-A77A-F32584DA06FA|1||||||STILBIND|STILLBIRTH INDICATOR||||BAG|||MM3/MM2/YEAR|NOT DONE||U|NA|NA|1||38||OBSERVATION|1969-03-09||1972-12-07|||1960-02-12||1960-01-19
TRIAL STUDY 134XCP|RP|008F02C8-B28A-490E-A77A-F32584DA06FA|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||KPA|||USEC|NOT DONE||N|Y|Y|1||38||OPEN LABEL TREATMENT|1962-10-17||1968-07-22|||1968-06-16||1964-10-05
TRIAL STUDY 134XCP|RP|008F02C8-B28A-490E-A77A-F32584DA06FA|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||PG/DL|||ML/H|NOT DONE||U|U|NA|2||58||CONTINUATION TREATMENT|1971-11-13||1966-08-18|||1967-05-11||1965-01-11
TRIAL STUDY 134XCP|RP|008F02C8-B28A-490E-A77A-F32584DA06FA|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||PIXELS/CM|||ML/(MIN*100ML)|NOT DONE||N|Y|NA|2||58||RUN-IN|1965-06-04||1965-07-15|||1972-08-06||1967-02-06
TRIAL STUDY 134XCP|RP|008F02C8-B28A-490E-A77A-F32584DA06FA|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||10^7/L|||ML/M2/H|NOT DONE||N|NA|Y|3||39||CONTINUATION TREATMENT|1966-10-15||1961-11-06|||1960-05-17||1966-01-10
TRIAL STUDY 134XCP|RP|008F02C8-B28A-490E-A77A-F32584DA06FA|2||||||MASSIND|MASS INDICATOR||||CI/UL|||CIGAR|NOT DONE||NA|NA|Y|3||39||OPEN LABEL TREATMENT|1964-03-26||1964-12-10|||1972-02-13||1962-03-02
TRIAL STUDY 134XCP|RP|008F02C8-B28A-490E-A77A-F32584DA06FA|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MESF|||MEQ/KG|NOT DONE||Y|U|U|4||88||BASELINE|1964-02-01||1971-12-20|||1964-09-03||1970-03-22
TRIAL STUDY 134XCP|RP|008F02C8-B28A-490E-A77A-F32584DA06FA|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||CI/L|||U.CARR|NOT DONE||NA|Y|Y|4||88||LONG-TERM FOLLOW-UP|1961-01-22||1971-01-05|||1973-06-19||1968-05-15
TRIAL STUDY 134XCP|RP|008F02C8-B28A-490E-A77A-F32584DA06FA|1||||||INTP|INTERPRETATION||||WEEKS|||ML/CM|NOT DONE||N|U|NA|5||7||CONTINUATION TREATMENT|1960-08-19||1967-05-22|||1971-11-03||1963-08-20
TRIAL STUDY 134XCP|RP|008F02C8-B28A-490E-A77A-F32584DA06FA|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||BAU|||MPL U/ML|NOT DONE||N|U|N|5||7||FOLLOW-UP|1960-11-19||1972-07-21|||1972-03-12||1960-03-20
TRIAL STUDY 134XCP|RP|7C06549D-596C-4C47-BD0B-119DF6CD67AC|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||U/G|||10^3 ORGANISMS|NOT DONE||U|Y|U|1||38||LONG-TERM FOLLOW-UP|1962-11-05||1961-06-26|||1971-01-12||1964-01-13
TRIAL STUDY 134XCP|RP|7C06549D-596C-4C47-BD0B-119DF6CD67AC|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||10^4 CFU/ML|||MDFI|NOT DONE||NA|NA|Y|1||38||WASHOUT|1969-02-20||1971-05-15|||1972-12-22||1973-02-04
TRIAL STUDY 134XCP|RP|7C06549D-596C-4C47-BD0B-119DF6CD67AC|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||DEG/S|||HENRY|NOT DONE||NA|U|U|2||58||RUN-IN|1973-09-06||1971-08-15|||1973-06-18||1960-12-01
TRIAL STUDY 134XCP|RP|7C06549D-596C-4C47-BD0B-119DF6CD67AC|2||||||INABOIND|INDUCED ABORTION INDICATOR||||L/MIN/M2|||DRINK|NOT DONE||NA|Y|NA|2||58||BLINDED TREATMENT|1970-03-04||1970-04-03|||1969-05-08||1972-05-03
TRIAL STUDY 134XCP|RP|7C06549D-596C-4C47-BD0B-119DF6CD67AC|1||||||BLISTIND|BLISTERING INDICATOR||||BAG|||MMOL/MIN/KPA|NOT DONE||U|Y|N|3||39||OPEN LABEL TREATMENT|1963-06-25||1970-11-30|||1965-06-10||1968-06-10
TRIAL STUDY 134XCP|RP|7C06549D-596C-4C47-BD0B-119DF6CD67AC|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||OZ EQ|||PACK|NOT DONE||U|N|Y|3||39||INDUCTION TREATMENT|1960-04-30||1962-08-11|||1963-09-16||1966-06-20
TRIAL STUDY 134XCP|RP|7C06549D-596C-4C47-BD0B-119DF6CD67AC|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^6 IU|||MG/ML/DAY|NOT DONE||Y|NA|U|4||88||WASHOUT|1964-05-23||1964-06-04|||1966-10-12||1964-03-23
TRIAL STUDY 134XCP|RP|7C06549D-596C-4C47-BD0B-119DF6CD67AC|2||||||ABORTN|NUMBER OF ABORTIONS||||BREATHS/MIN|||GENEQ|NOT DONE||N|N|N|4||88||BLINDED TREATMENT|1960-12-27||1972-09-29|||1966-01-13||1971-01-08
TRIAL STUDY 134XCP|RP|7C06549D-596C-4C47-BD0B-119DF6CD67AC|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||UG/L/H|||/7.5 ML|NOT DONE||N|Y|Y|5||7||TREATMENT|1962-03-24||1960-09-27|||1973-04-02||1969-10-31
TRIAL STUDY 134XCP|RP|7C06549D-596C-4C47-BD0B-119DF6CD67AC|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||/100 HPFS|||BQ/UG|NOT DONE||U|Y|U|5||7||LONG-TERM FOLLOW-UP|1968-02-23||1967-01-05|||1962-09-15||1971-03-11
TRIAL STUDY 134XCP|RP|39A00D93-61B9-44C5-9672-005A1F9A93EB|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||G/ANIMAL/WK|||COPIES/UG|NOT DONE||U|NA|Y|1||38||INDUCTION TREATMENT|1971-04-15||1967-10-11|||1968-02-10||1973-06-11
TRIAL STUDY 134XCP|RP|39A00D93-61B9-44C5-9672-005A1F9A93EB|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MMHG/L/MIN|||DPM/ML|NOT DONE||U|NA|U|1||38||LONG-TERM FOLLOW-UP|1963-12-27||1972-12-11|||1961-05-23||1961-12-16
TRIAL STUDY 134XCP|RP|39A00D93-61B9-44C5-9672-005A1F9A93EB|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||LOG10 IU/ML|||ELISA UNIT|NOT DONE||Y|U|Y|2||58||RUN-IN|1972-07-17||1968-08-31|||1960-08-14||1960-12-15
TRIAL STUDY 134XCP|RP|39A00D93-61B9-44C5-9672-005A1F9A93EB|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||V/V|||FFU|NOT DONE||N|U|NA|2||58||OBSERVATION|1963-12-17||1963-02-06|||1967-10-19||1966-11-23
TRIAL STUDY 134XCP|RP|39A00D93-61B9-44C5-9672-005A1F9A93EB|1||||||PRGENDTC|DATE PREGNANCY ENDED||||10^9/G|||G/ANIMAL/WK|NOT DONE||Y|NA|NA|3||39||OBSERVATION|1969-11-09||1962-02-11|||1961-10-22||1971-02-20
TRIAL STUDY 134XCP|RP|39A00D93-61B9-44C5-9672-005A1F9A93EB|2||||||ABORTN|NUMBER OF ABORTIONS||||AMPULE|||KHZ|NOT DONE||U|NA|Y|3||39||BASELINE|1960-10-19||1962-07-29|||1969-06-08||1973-06-06
TRIAL STUDY 134XCP|RP|39A00D93-61B9-44C5-9672-005A1F9A93EB|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||LOG10 COPIES/ML|||10^6 CFU|NOT DONE||Y|N|Y|4||88||SCREENING|1972-10-21||1961-04-27|||1967-07-08||1968-07-06
TRIAL STUDY 134XCP|RP|39A00D93-61B9-44C5-9672-005A1F9A93EB|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||APL U/ML|||UM/DAY|NOT DONE||Y|N|NA|4||88||SCREENING|1971-02-24||1971-08-21|||1962-06-11||1962-09-15
TRIAL STUDY 134XCP|RP|39A00D93-61B9-44C5-9672-005A1F9A93EB|1||||||PUSTIND|PUSTULE INDICATOR||||MANSON U/ML|||MET*H|NOT DONE||U|NA|Y|5||7||BLINDED TREATMENT|1961-04-13||1964-11-02|||1962-03-21||1969-12-14
TRIAL STUDY 134XCP|RP|39A00D93-61B9-44C5-9672-005A1F9A93EB|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||BAR|||PG/L|NOT DONE||U|NA|N|5||7||LONG-TERM FOLLOW-UP|1972-11-04||1972-05-18|||1961-11-04||1962-06-23
TRIAL STUDY 134XCP|RP|71B78EFA-AE7A-4248-9A59-63885131F1D1|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||LOG10 PFU|||FRAMES/S|NOT DONE||U|U|NA|1||38||BLINDED TREATMENT|1961-06-23||1970-07-31|||1966-08-13||1973-07-04
TRIAL STUDY 134XCP|RP|71B78EFA-AE7A-4248-9A59-63885131F1D1|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ML/100G/MIN|||GBQ/G|NOT DONE||U|U|Y|1||38||FOLLOW-UP|1969-10-23||1967-05-21|||1960-03-29||1967-01-16
TRIAL STUDY 134XCP|RP|71B78EFA-AE7A-4248-9A59-63885131F1D1|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||PACKET|||G/U|NOT DONE||U|NA|Y|2||58||TREATMENT|1967-04-20||1972-12-01|||1970-07-08||1963-10-06
TRIAL STUDY 134XCP|RP|71B78EFA-AE7A-4248-9A59-63885131F1D1|2||||||THICK|THICKNESS||||NFIU|||U.CARR|NOT DONE||U|U|NA|2||58||RUN-IN|1969-11-10||1973-05-19|||1969-09-11||1961-08-13
TRIAL STUDY 134XCP|RP|71B78EFA-AE7A-4248-9A59-63885131F1D1|1||||||MENFDUR|MENSES FLOW DURATION||||KALLIKREIN INHIBITOR UNIT|||UCI/KG|NOT DONE||Y|NA|Y|3||39||TREATMENT|1961-08-31||1970-06-11|||1966-12-17||1969-07-20
TRIAL STUDY 134XCP|RP|71B78EFA-AE7A-4248-9A59-63885131F1D1|2||||||PUSTIND|PUSTULE INDICATOR||||PACKAGE|||OD UNIT|NOT DONE||Y|NA|N|3||39||FOLLOW-UP|1971-02-21||1973-08-20|||1960-09-05||1970-11-18
TRIAL STUDY 134XCP|RP|71B78EFA-AE7A-4248-9A59-63885131F1D1|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MOL|||PACK|NOT DONE||N|Y|NA|4||88||LONG-TERM FOLLOW-UP|1967-01-23||1968-10-25|||1971-12-02||1972-07-14
TRIAL STUDY 134XCP|RP|71B78EFA-AE7A-4248-9A59-63885131F1D1|2||||||PEELIND|PEELING INDICATOR||||SV|||OD UNIT|NOT DONE||Y|NA|Y|4||88||WASHOUT|1972-01-08||1966-12-22|||1965-06-05||1966-06-26
TRIAL STUDY 134XCP|RP|71B78EFA-AE7A-4248-9A59-63885131F1D1|1||||||THICK|THICKNESS||||ANTI-XA IU/ML|||ML/DAY|NOT DONE||U|NA|U|5||7||OPEN LABEL TREATMENT|1966-03-06||1961-07-18|||1973-01-29||1973-08-07
TRIAL STUDY 134XCP|RP|71B78EFA-AE7A-4248-9A59-63885131F1D1|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||/LSQN|||MG/ML/DAY|NOT DONE||U|NA|N|5||7||LONG-TERM FOLLOW-UP|1960-06-11||1968-04-16|||1964-05-28||1973-04-27
TRIAL STUDY 134XCP|RP|CE28B885-422E-471D-895C-DE8F41CD9FE9|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UG/M2/H|||MMOL/DAY|NOT DONE||NA|Y|NA|1||38||OPEN LABEL TREATMENT|1964-06-06||1970-12-31|||1962-03-30||1964-09-07
TRIAL STUDY 134XCP|RP|CE28B885-422E-471D-895C-DE8F41CD9FE9|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^6/G|||MPL U|NOT DONE||Y|U|Y|1||38||BASELINE|1971-01-12||1968-08-09|||1971-07-31||1963-11-08
TRIAL STUDY 134XCP|RP|CE28B885-422E-471D-895C-DE8F41CD9FE9|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||KM|||CP|NOT DONE||N|N|NA|2||58||SCREENING|1961-05-15||1963-06-03|||1970-04-26||1965-04-08
TRIAL STUDY 134XCP|RP|CE28B885-422E-471D-895C-DE8F41CD9FE9|2||||||PRGENDTC|DATE PREGNANCY ENDED||||FT3|||TUBERCULIN UNIT|NOT DONE||Y|NA|U|2||58||OBSERVATION|1968-04-24||1966-08-04|||1970-05-02||1967-11-05
TRIAL STUDY 134XCP|RP|CE28B885-422E-471D-895C-DE8F41CD9FE9|1||||||MENARAGE|MENARCHE AGE||||PACK YEAR|||KG|NOT DONE||U|U|N|3||39||RUN-IN|1968-06-30||1973-06-24|||1961-01-04||1972-01-28
TRIAL STUDY 134XCP|RP|CE28B885-422E-471D-895C-DE8F41CD9FE9|2||||||ULCERIND|ULCER INDICATOR||||U/MG|||KCAL/DAY|NOT DONE||U|U|N|3||39||BLINDED TREATMENT|1961-04-10||1972-01-27|||1972-12-14||1968-09-09
TRIAL STUDY 134XCP|RP|CE28B885-422E-471D-895C-DE8F41CD9FE9|1||||||PREGIND|PREGNANT INDICATOR||||RING|||GPS U|NOT DONE||U|NA|Y|4||88||CONTINUATION TREATMENT|1970-07-04||1965-10-29|||1971-01-10||1965-05-09
TRIAL STUDY 134XCP|RP|CE28B885-422E-471D-895C-DE8F41CD9FE9|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||10^3 ORGANISMS/ML|||U/KG/DAY|NOT DONE||N|NA|NA|4||88||INDUCTION TREATMENT|1964-03-27||1960-11-11|||1962-07-28||1960-05-05
TRIAL STUDY 134XCP|RP|CE28B885-422E-471D-895C-DE8F41CD9FE9|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||ML/M2/H|||MG/H|NOT DONE||NA|N|NA|5||7||LONG-TERM FOLLOW-UP|1970-05-03||1973-03-29|||1968-01-17||1972-05-06
TRIAL STUDY 134XCP|RP|CE28B885-422E-471D-895C-DE8F41CD9FE9|2||||||PREGNN|NUMBER OF PREGNANCIES||||10^12/L|||GBQ|NOT DONE||U|U|NA|5||7||INDUCTION TREATMENT|1969-08-02||1967-09-01|||1967-07-24||1971-05-30
TRIAL STUDY 134XCP|RP|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||CARTRIDGE|||FINGERTIP UNIT|NOT DONE||N|N|U|1||38||BASELINE|1961-12-19||1969-02-10|||1969-11-23||1967-05-17
TRIAL STUDY 134XCP|RP|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|2||||||PRGENDTC|DATE PREGNANCY ENDED||||MKAT|||10^6/EJACULATE U|NOT DONE||U|Y|N|1||38||BASELINE|1965-09-07||1966-05-19|||1971-03-25||1966-07-20
TRIAL STUDY 134XCP|RP|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|1||||||MENOAGE|MENOPAUSE AGE||||UG/L|||BQ/UL|NOT DONE||NA|NA|NA|2||58||LONG-TERM FOLLOW-UP|1968-09-29||1968-04-27|||1965-08-31||1963-12-02
TRIAL STUDY 134XCP|RP|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||CUP EQ|||BQ/G|NOT DONE||N|NA|U|2||58||BASELINE|1971-09-03||1973-08-09|||1967-02-11||1963-04-07
TRIAL STUDY 134XCP|RP|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|1||||||INTP|INTERPRETATION||||ML/KG|||MOL/DAY|NOT DONE||U|NA|NA|3||39||RUN-IN|1970-09-24||1966-05-31|||1971-06-09||1966-01-28
TRIAL STUDY 134XCP|RP|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|2||||||INTP|INTERPRETATION||||L/DAY|||NMOL BCE/NMOL|NOT DONE||NA|U|NA|3||39||FOLLOW-UP|1969-04-01||1962-10-06|||1967-01-01||1963-10-07
TRIAL STUDY 134XCP|RP|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|1||||||DSCHGIND|DISCHARGE INDICATOR||||10^7 CFU|||SFC/10^6 PBMC|NOT DONE||U|N|U|4||88||WASHOUT|1967-01-10||1967-04-28|||1969-06-10||1961-12-07
TRIAL STUDY 134XCP|RP|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||SCM|||SYRINGE|NOT DONE||Y|U|U|4||88||SCREENING|1966-10-27||1962-11-17|||1963-05-26||1960-08-17
TRIAL STUDY 134XCP|RP|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|1||||||MENFDUR|MENSES FLOW DURATION||||ML/ANIMAL/WK|||U/G/MIN|NOT DONE||Y|Y|U|5||7||FOLLOW-UP|1963-04-30||1973-03-31|||1961-04-11||1972-07-19
TRIAL STUDY 134XCP|RP|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||KAT|||CD|NOT DONE||NA|N|Y|5||7||SCREENING|1962-07-15||1962-07-13|||1973-01-08||1971-02-12
TRIAL STUDY 134XCP|RP|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||KS|||BLOCKS|NOT DONE||N|U|N|1||38||FOLLOW-UP|1964-11-08||1968-12-10|||1965-07-02||1967-05-13
TRIAL STUDY 134XCP|RP|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|2||||||BRTHN|NUMBER OF BIRTHS||||LOG10 PFU/ML|||ML/KG/MIN|NOT DONE||NA|N|Y|1||38||BASELINE|1962-03-02||1973-03-02|||1966-11-08||1972-10-23
TRIAL STUDY 134XCP|RP|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|1||||||PEELIND|PEELING INDICATOR||||KG|||ML/S/M2|NOT DONE||U|Y|NA|2||58||OBSERVATION|1961-11-08||1965-04-04|||1963-09-21||1973-07-02
TRIAL STUDY 134XCP|RP|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|2||||||DLVRMODE|MODE OF DELIVERY||||NMOL/ML/MIN|||L/L|NOT DONE||NA|U|Y|2||58||SCREENING|1972-09-14||1970-12-24|||1966-06-13||1970-06-21
TRIAL STUDY 134XCP|RP|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UCI/KG|||ML/MIN/1.73M2|NOT DONE||U|U|N|3||39||BASELINE|1960-02-02||1964-04-22|||1966-04-06||1972-12-02
TRIAL STUDY 134XCP|RP|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|2||||||BCMETHOD|BIRTH CONTROL METHOD||||IU/G|||BAR|NOT DONE||NA|NA|Y|3||39||INDUCTION TREATMENT|1972-08-29||1970-03-18|||1973-03-24||1964-08-18
TRIAL STUDY 134XCP|RP|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MILE|||L|NOT DONE||U|Y|N|4||88||INDUCTION TREATMENT|1960-09-14||1967-04-15|||1963-02-16||1961-09-14
TRIAL STUDY 134XCP|RP|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||U/M2/H|||L/MIN|NOT DONE||U|Y|U|4||88||SCREENING|1968-04-23||1961-02-23|||1973-04-10||1963-07-30
TRIAL STUDY 134XCP|RP|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||PPTH|||MG/G/MIN|NOT DONE||N|NA|Y|5||7||OPEN LABEL TREATMENT|1961-10-28||1960-08-13|||1961-09-22||1964-10-17
TRIAL STUDY 134XCP|RP|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|2||||||RASHIND|RASH INDICATOR||||ANTIBODY UNIT|||CIGARETTE|NOT DONE||N|NA|U|5||7||WASHOUT|1961-09-27||1963-06-03|||1960-07-31||1960-06-05
TRIAL STUDY 134XCP|RP|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||10^3 ORGANISMS/G|||NMOL/DAY|NOT DONE||U|NA|N|1||38||BASELINE|1964-10-03||1969-02-10|||1965-06-27||1971-09-27
TRIAL STUDY 134XCP|RP|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||NMOL/L|||UG/DOSE|NOT DONE||NA|U|U|1||38||RUN-IN|1967-10-24||1972-06-08|||1965-01-16||1971-07-28
TRIAL STUDY 134XCP|RP|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|1||||||RASHIND|RASH INDICATOR||||UL|||NMOL/L/MIN|NOT DONE||NA|N|Y|2||58||OBSERVATION|1966-08-05||1972-02-11|||1965-03-12||1962-03-12
TRIAL STUDY 134XCP|RP|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||BQ/G|||IN|NOT DONE||U|N|U|2||58||OPEN LABEL TREATMENT|1962-12-09||1963-02-12|||1961-06-01||1969-07-07
TRIAL STUDY 134XCP|RP|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||/H|||L|NOT DONE||U|N|N|3||39||OBSERVATION|1963-09-07||1970-01-31|||1972-06-13||1973-01-03
TRIAL STUDY 134XCP|RP|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|2||||||EDEMAIND|EDEMA INDICATOR||||UL/KG/DAY|||CD|NOT DONE||N|N|U|3||39||SCREENING|1972-06-29||1966-03-12|||1972-06-24||1963-04-17
TRIAL STUDY 134XCP|RP|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|1||||||BRTHN|NUMBER OF BIRTHS||||IU/MG|||EU|NOT DONE||Y|Y|Y|4||88||CONTINUATION TREATMENT|1969-04-01||1965-04-01|||1962-12-11||1970-07-26
TRIAL STUDY 134XCP|RP|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|2||||||MASSIND|MASS INDICATOR||||ML/100G/MIN|||M3|NOT DONE||NA|NA|N|4||88||BLINDED TREATMENT|1967-03-16||1969-04-30|||1973-02-01||1964-01-09
TRIAL STUDY 134XCP|RP|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MG/M2/MIN|||DPM/100MG|NOT DONE||U|U|N|5||7||WASHOUT|1972-08-31||1962-10-18|||1962-05-05||1967-02-08
TRIAL STUDY 134XCP|RP|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MV|||ML/G/MIN|NOT DONE||Y|NA|N|5||7||SCREENING|1970-05-08||1961-01-03|||1964-05-29||1963-07-17
TRIAL STUDY 134XCP|RP|3AA56307-0D09-4C82-91B6-717A7C503EFE|1||||||THICK|THICKNESS||||UG/M2/H|||ML/ANIMAL/WK|NOT DONE||NA|U|Y|1||38||SCREENING|1964-09-27||1961-12-04|||1973-05-22||1962-05-23
TRIAL STUDY 134XCP|RP|3AA56307-0D09-4C82-91B6-717A7C503EFE|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||S/H|||10^9/L|NOT DONE||U|Y|U|1||38||OPEN LABEL TREATMENT|1962-10-16||1960-10-19|||1970-11-23||1961-06-19
TRIAL STUDY 134XCP|RP|3AA56307-0D09-4C82-91B6-717A7C503EFE|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||G/ANIMAL|||CONTAINER|NOT DONE||Y|N|U|2||58||TREATMENT|1966-01-04||1962-09-02|||1969-02-01||1967-08-20
TRIAL STUDY 134XCP|RP|3AA56307-0D09-4C82-91B6-717A7C503EFE|2||||||INTP|INTERPRETATION||||ML/MMHG|||ROENTGEN|NOT DONE||N|NA|U|2||58||BASELINE|1966-01-05||1964-05-26|||1966-06-23||1971-05-28
TRIAL STUDY 134XCP|RP|3AA56307-0D09-4C82-91B6-717A7C503EFE|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||/10^3|||NMOL/ML/MIN|NOT DONE||Y|U|N|3||39||CONTINUATION TREATMENT|1971-03-22||1969-05-19|||1963-04-24||1963-02-14
TRIAL STUDY 134XCP|RP|3AA56307-0D09-4C82-91B6-717A7C503EFE|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||/500 WBC|||PT_BR|NOT DONE||Y|U|NA|3||39||FOLLOW-UP|1961-08-13||1965-08-25|||1972-11-25||1965-11-14
TRIAL STUDY 134XCP|RP|3AA56307-0D09-4C82-91B6-717A7C503EFE|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MG/KG/WEEK|||CM|NOT DONE||Y|NA|U|4||88||CONTINUATION TREATMENT|1960-02-18||1963-02-21|||1973-01-28||1968-05-18
TRIAL STUDY 134XCP|RP|3AA56307-0D09-4C82-91B6-717A7C503EFE|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||BEL|||MEQ/DL|NOT DONE||U|U|N|4||88||LONG-TERM FOLLOW-UP|1965-07-24||1965-08-02|||1963-12-17||1970-09-18
TRIAL STUDY 134XCP|RP|3AA56307-0D09-4C82-91B6-717A7C503EFE|1||||||BCMETHOD|BIRTH CONTROL METHOD||||COPIES/ML|||U/G/DAY|NOT DONE||Y|U|Y|5||7||FOLLOW-UP|1965-10-03||1969-07-02|||1971-11-07||1961-01-03
TRIAL STUDY 134XCP|RP|3AA56307-0D09-4C82-91B6-717A7C503EFE|2||||||STILBIND|STILLBIRTH INDICATOR||||%|||CY/CM|NOT DONE||N|U|N|5||7||INDUCTION TREATMENT|1971-02-02||1960-10-06|||1970-01-05||1964-10-10
TRIAL STUDY 134XCP|RP|811AE318-625A-4913-8B18-2D318AF04EAC|1||||||PRGENDTC|DATE PREGNANCY ENDED||||ML/CAGE/WK|||UM2|NOT DONE||U|N|N|1||38||LONG-TERM FOLLOW-UP|1972-10-03||1962-02-05|||1965-02-01||1973-05-21
TRIAL STUDY 134XCP|RP|811AE318-625A-4913-8B18-2D318AF04EAC|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MS2|||LX|NOT DONE||U|U|U|1||38||OBSERVATION|1970-05-25||1973-04-05|||1967-09-29||1960-07-11
TRIAL STUDY 134XCP|RP|811AE318-625A-4913-8B18-2D318AF04EAC|1||||||PREGST|PREGNANT DURING THE STUDY||||CI/UG|||LOG10 TCID 50/ML|NOT DONE||N|NA|NA|2||58||CONTINUATION TREATMENT|1967-01-02||1964-10-28|||1964-08-02||1960-03-31
TRIAL STUDY 134XCP|RP|811AE318-625A-4913-8B18-2D318AF04EAC|2||||||ERYTHIND|ERYTHEMA INDICATOR||||MOL/DAY|||CI/L|NOT DONE||N|Y|U|2||58||OBSERVATION|1972-11-09||1964-01-06|||1967-05-14||1968-11-27
TRIAL STUDY 134XCP|RP|811AE318-625A-4913-8B18-2D318AF04EAC|1||||||BRTHN|NUMBER OF BIRTHS||||MG/M2/DAY|||ANTI-XA IU|NOT DONE||U|U|N|3||39||FOLLOW-UP|1967-12-16||1960-05-31|||1967-10-03||1961-02-04
TRIAL STUDY 134XCP|RP|811AE318-625A-4913-8B18-2D318AF04EAC|2||||||MENFDUR|MENSES FLOW DURATION||||USIEMENS|||PMOL/L|NOT DONE||U|Y|Y|3||39||FOLLOW-UP|1972-01-07||1966-11-10|||1973-03-10||1972-12-23
TRIAL STUDY 134XCP|RP|811AE318-625A-4913-8B18-2D318AF04EAC|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||IU/G HB|||10^3 DNA COPIES/ML|NOT DONE||Y|N|NA|4||88||SCREENING|1967-07-14||1971-03-08|||1965-03-05||1969-05-08
TRIAL STUDY 134XCP|RP|811AE318-625A-4913-8B18-2D318AF04EAC|2||||||FUNDHT|FUNDAL HEIGHT||||CMH2O*S2/ML|||HOMEOPATHIC DILUTION|NOT DONE||Y|Y|U|4||88||BLINDED TREATMENT|1971-11-14||1971-04-26|||1970-07-07||1961-02-05
TRIAL STUDY 134XCP|RP|811AE318-625A-4913-8B18-2D318AF04EAC|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||PG|||MMOL/DAY|NOT DONE||U|Y|N|5||7||CONTINUATION TREATMENT|1972-09-23||1964-07-01|||1969-05-25||1963-01-07
TRIAL STUDY 134XCP|RP|811AE318-625A-4913-8B18-2D318AF04EAC|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||IN2|||MV/SEC|NOT DONE||U|U|Y|5||7||BLINDED TREATMENT|1964-11-30||1963-06-23|||1969-06-13||1972-12-25
TRIAL STUDY 134XCP|RP|E8F0AF72-5DB4-41D5-814E-5E280A027E94|1||||||THICK|THICKNESS||||CMH2O/ML|||PRESSOR UNITS|NOT DONE||NA|NA|NA|1||38||OBSERVATION|1971-09-09||1968-09-11|||1970-03-11||1963-06-08
TRIAL STUDY 134XCP|RP|E8F0AF72-5DB4-41D5-814E-5E280A027E94|2||||||PRGENDTC|DATE PREGNANCY ENDED||||UCI|||DYN|NOT DONE||Y|N|U|1||38||RUN-IN|1968-09-05||1973-06-11|||1960-10-16||1973-05-31
TRIAL STUDY 134XCP|RP|E8F0AF72-5DB4-41D5-814E-5E280A027E94|1||||||TNDRIND|TENDERNESS INDICATOR||||BOTTLE|||KAT|NOT DONE||Y|U|Y|2||58||BLINDED TREATMENT|1971-11-11||1970-03-07|||1965-03-14||1963-01-26
TRIAL STUDY 134XCP|RP|E8F0AF72-5DB4-41D5-814E-5E280A027E94|2||||||RASHIND|RASH INDICATOR||||U/G|||DYN|NOT DONE||Y|N|Y|2||58||LONG-TERM FOLLOW-UP|1963-05-20||1965-07-06|||1970-04-10||1960-03-17
TRIAL STUDY 134XCP|RP|E8F0AF72-5DB4-41D5-814E-5E280A027E94|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MMOL/MIN/KPA/L|||BEAM BREAKS|NOT DONE||N|NA|Y|3||39||BASELINE|1972-06-19||1971-03-11|||1969-01-22||1966-09-27
TRIAL STUDY 134XCP|RP|E8F0AF72-5DB4-41D5-814E-5E280A027E94|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||BREATHS/MIN|||U/KG|NOT DONE||U|NA|U|3||39||CONTINUATION TREATMENT|1970-04-26||1971-11-17|||1966-05-08||1968-08-12
TRIAL STUDY 134XCP|RP|E8F0AF72-5DB4-41D5-814E-5E280A027E94|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||10^4 CFU|||G/MOL|NOT DONE||Y|U|NA|4||88||SCREENING|1964-07-27||1966-04-20|||1969-02-13||1963-09-08
TRIAL STUDY 134XCP|RP|E8F0AF72-5DB4-41D5-814E-5E280A027E94|2||||||PREGNN|NUMBER OF PREGNANCIES||||MIU/L|||EJACULATE U|NOT DONE||N|U|U|4||88||INDUCTION TREATMENT|1966-01-19||1973-07-09|||1961-09-01||1965-11-24
TRIAL STUDY 134XCP|RP|E8F0AF72-5DB4-41D5-814E-5E280A027E94|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||/7.5 ML|||10^7 CFU|NOT DONE||U|NA|N|5||7||SCREENING|1963-05-30||1964-12-30|||1961-12-08||1963-02-28
TRIAL STUDY 134XCP|RP|E8F0AF72-5DB4-41D5-814E-5E280A027E94|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MNFI|||ML/M2/MIN|NOT DONE||Y|NA|U|5||7||SCREENING|1963-04-30||1964-05-12|||1967-01-21||1969-12-16
TRIAL STUDY 134XCP|RP|3B726736-01B3-4A69-ABFB-C6255E341E69|1||||||PRGENDTC|DATE PREGNANCY ENDED||||ML/SEC/1.73M2|||ML/BEAT|NOT DONE||U|Y|N|1||38||BASELINE|1965-01-29||1962-03-03|||1964-05-23||1963-02-08
TRIAL STUDY 134XCP|RP|3B726736-01B3-4A69-ABFB-C6255E341E69|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MOL/ML|||UIU/L|NOT DONE||NA|N|NA|1||38||OBSERVATION|1961-07-13||1963-10-30|||1964-10-24||1969-09-02
TRIAL STUDY 134XCP|RP|3B726736-01B3-4A69-ABFB-C6255E341E69|1||||||PEELIND|PEELING INDICATOR||||NG|||AMFI|NOT DONE||Y|U|Y|2||58||OBSERVATION|1968-03-28||1964-10-30|||1973-02-01||1972-12-16
TRIAL STUDY 134XCP|RP|3B726736-01B3-4A69-ABFB-C6255E341E69|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||CS|||KM|NOT DONE||N|N|Y|2||58||OPEN LABEL TREATMENT|1968-10-12||1963-04-26|||1969-10-03||1962-11-03
TRIAL STUDY 134XCP|RP|3B726736-01B3-4A69-ABFB-C6255E341E69|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||BOTTLE|||CIGARETTE|NOT DONE||U|NA|N|3||39||CONTINUATION TREATMENT|1963-08-28||1966-06-14|||1967-12-30||1962-11-17
TRIAL STUDY 134XCP|RP|3B726736-01B3-4A69-ABFB-C6255E341E69|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MBQ/UL|||GPS U|NOT DONE||U|U|Y|3||39||WASHOUT|1962-03-11||1967-04-07|||1967-03-23||1960-09-05
TRIAL STUDY 134XCP|RP|3B726736-01B3-4A69-ABFB-C6255E341E69|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||PMOL/L/H|||PPTR|NOT DONE||Y|U|N|4||88||WASHOUT|1965-10-12||1972-04-29|||1963-10-07||1971-01-19
TRIAL STUDY 134XCP|RP|3B726736-01B3-4A69-ABFB-C6255E341E69|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||PIXELS/CM|||U/KG/H|NOT DONE||NA|U|U|4||88||LONG-TERM FOLLOW-UP|1961-08-13||1969-12-25|||1965-08-21||1965-01-29
TRIAL STUDY 134XCP|RP|3B726736-01B3-4A69-ABFB-C6255E341E69|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||RFU|||UG/CM2|NOT DONE||Y|Y|U|5||7||SCREENING|1966-09-28||1964-08-21|||1963-09-20||1971-07-18
TRIAL STUDY 134XCP|RP|3B726736-01B3-4A69-ABFB-C6255E341E69|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||UM/S|||PMOL/DL|NOT DONE||Y|U|NA|5||7||WASHOUT|1971-01-29||1970-01-19|||1968-06-08||1966-11-02
TRIAL STUDY 134XCP|RP|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|1||||||FUNDHT|FUNDAL HEIGHT||||CM2|||G|NOT DONE||N|U|N|1||38||LONG-TERM FOLLOW-UP|1972-12-11||1964-05-16|||1969-07-28||1965-12-12
TRIAL STUDY 134XCP|RP|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||INHALATION|||ML/MMHG|NOT DONE||NA|NA|N|1||38||BLINDED TREATMENT|1960-07-16||1966-09-19|||1970-04-12||1966-06-08
TRIAL STUDY 134XCP|RP|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||FRAMES/S|||PIPE|NOT DONE||NA|Y|Y|2||58||SCREENING|1970-07-10||1972-09-26|||1960-06-14||1962-06-01
TRIAL STUDY 134XCP|RP|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|2||||||PEELIND|PEELING INDICATOR||||FINGERTIP UNIT|||10^6/HPF|NOT DONE||Y|U|U|2||58||WASHOUT|1964-07-14||1968-09-04|||1967-08-31||1972-02-12
TRIAL STUDY 134XCP|RP|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||BOTTLE|||10^9 CFU/G|NOT DONE||Y|N|U|3||39||OBSERVATION|1965-06-25||1964-09-22|||1971-07-09||1968-07-19
TRIAL STUDY 134XCP|RP|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||ML/KG/H|||MIN|NOT DONE||NA|Y|NA|3||39||OBSERVATION|1963-03-07||1965-05-24|||1966-01-18||1963-03-29
TRIAL STUDY 134XCP|RP|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|1||||||PREGST|PREGNANT DURING THE STUDY||||ML/G/H|||MG/ML/MIN|NOT DONE||NA|Y|U|4||88||OBSERVATION|1972-12-10||1971-05-19|||1965-03-29||1963-07-11
TRIAL STUDY 134XCP|RP|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||PNU/ML|||DRAM|NOT DONE||Y|Y|NA|4||88||WASHOUT|1964-10-22||1972-04-05|||1973-07-08||1961-07-13
TRIAL STUDY 134XCP|RP|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|1||||||DLVRMODE|MODE OF DELIVERY||||PFU/ML|||TORR|NOT DONE||Y|U|Y|5||7||RUN-IN|1966-03-13||1972-03-02|||1971-02-15||1970-06-18
TRIAL STUDY 134XCP|RP|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||M/SEC|||UMOL/L/MIN|NOT DONE||U|NA|N|5||7||BLINDED TREATMENT|1964-07-14||1966-12-26|||1960-06-16||1968-06-27
TRIAL STUDY 134XCP|RP|0535EF31-5388-4CC0-8567-44F4C20975EC|1||||||BRTHN|NUMBER OF BIRTHS||||UMOL/MOL|||CMOL/L|NOT DONE||U|U|Y|1||38||WASHOUT|1960-10-02||1972-05-04|||1967-12-13||1965-05-28
TRIAL STUDY 134XCP|RP|0535EF31-5388-4CC0-8567-44F4C20975EC|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||ML/MIN/MMHG|||MG/MOL|NOT DONE||N|NA|Y|1||38||LONG-TERM FOLLOW-UP|1961-10-31||1965-01-08|||1963-11-25||1965-02-08
TRIAL STUDY 134XCP|RP|0535EF31-5388-4CC0-8567-44F4C20975EC|1||||||INTP|INTERPRETATION||||CAN|||KG/CM2|NOT DONE||U|NA|U|2||58||FOLLOW-UP|1971-07-10||1965-01-25|||1968-10-31||1966-09-30
TRIAL STUDY 134XCP|RP|0535EF31-5388-4CC0-8567-44F4C20975EC|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||KM|||BQ/G|NOT DONE||U|Y|NA|2||58||OPEN LABEL TREATMENT|1969-12-29||1970-08-13|||1971-02-06||1970-04-16
TRIAL STUDY 134XCP|RP|0535EF31-5388-4CC0-8567-44F4C20975EC|1||||||PREGIND|PREGNANT INDICATOR||||PPTH|||PT_BR|NOT DONE||NA|NA|NA|3||39||BASELINE|1962-10-03||1972-12-14|||1969-03-07||1962-08-16
TRIAL STUDY 134XCP|RP|0535EF31-5388-4CC0-8567-44F4C20975EC|2||||||PEELIND|PEELING INDICATOR||||COPIES/UG|||GY/MIN|NOT DONE||NA|NA|NA|3||39||BLINDED TREATMENT|1960-02-15||1967-11-10|||1962-12-03||1961-10-02
TRIAL STUDY 134XCP|RP|0535EF31-5388-4CC0-8567-44F4C20975EC|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MM/2H|||10^7 CFU|NOT DONE||U|Y|Y|4||88||RUN-IN|1964-03-19||1968-10-23|||1966-11-20||1972-11-11
TRIAL STUDY 134XCP|RP|0535EF31-5388-4CC0-8567-44F4C20975EC|2||||||MENOAGE|MENOPAUSE AGE||||/2000 RBC|||ELISA UNIT/ML|NOT DONE||U|Y|Y|4||88||LONG-TERM FOLLOW-UP|1967-03-08||1968-10-14|||1966-04-02||1971-07-29
TRIAL STUDY 134XCP|RP|0535EF31-5388-4CC0-8567-44F4C20975EC|1||||||MENOAGE|MENOPAUSE AGE||||AMP|||DIP|NOT DONE||U|Y|NA|5||7||BASELINE|1962-04-09||1965-06-12|||1968-05-28||1972-03-08
TRIAL STUDY 134XCP|RP|0535EF31-5388-4CC0-8567-44F4C20975EC|2||||||ERYTHIND|ERYTHEMA INDICATOR||||LOZENGE|||MBQ|NOT DONE||N|N|N|5||7||TREATMENT|1962-05-02||1968-12-14|||1970-05-07||1969-06-04
TRIAL STUDY 134XCP|RP|F149BD98-0802-4C18-8599-426C5258D513|1||||||PRGENDTC|DATE PREGNANCY ENDED||||KCAL/DAY|||WATT|NOT DONE||NA|Y|N|1||38||FOLLOW-UP|1964-04-27||1969-03-23|||1964-08-14||1971-06-06
TRIAL STUDY 134XCP|RP|F149BD98-0802-4C18-8599-426C5258D513|2||||||ERYTHIND|ERYTHEMA INDICATOR||||UG/M2|||TAMPON|NOT DONE||U|N|NA|1||38||OBSERVATION|1967-07-03||1971-06-09|||1970-04-12||1967-01-07
TRIAL STUDY 134XCP|RP|F149BD98-0802-4C18-8599-426C5258D513|1||||||BRTHN|NUMBER OF BIRTHS||||CAN|||TORR|NOT DONE||N|NA|N|2||58||INDUCTION TREATMENT|1970-06-13||1964-03-31|||1965-04-24||1967-02-08
TRIAL STUDY 134XCP|RP|F149BD98-0802-4C18-8599-426C5258D513|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||UG/G/H|||10^6 DNA COPIES/ML|NOT DONE||U|U|NA|2||58||BASELINE|1966-04-12||1963-11-17|||1970-12-03||1965-10-08
TRIAL STUDY 134XCP|RP|F149BD98-0802-4C18-8599-426C5258D513|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MOL/MG|||BEAM BREAKS|NOT DONE||N|U|Y|3||39||RUN-IN|1970-07-15||1969-05-19|||1961-10-30||1966-01-09
TRIAL STUDY 134XCP|RP|F149BD98-0802-4C18-8599-426C5258D513|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||NG/DL|||SACHET|NOT DONE||NA|NA|U|3||39||CONTINUATION TREATMENT|1961-02-21||1963-04-25|||1961-06-23||1960-07-13
TRIAL STUDY 134XCP|RP|F149BD98-0802-4C18-8599-426C5258D513|1||||||FUNDHT|FUNDAL HEIGHT||||ML/ANIMAL/WK|||LOG10 TCID 50/ML|NOT DONE||U|Y|U|4||88||WASHOUT|1972-11-24||1971-03-25|||1962-11-05||1971-07-10
TRIAL STUDY 134XCP|RP|F149BD98-0802-4C18-8599-426C5258D513|2||||||MASSIND|MASS INDICATOR||||10^9 ORGANISMS|||ML/CAGE|NOT DONE||Y|N|U|4||88||INDUCTION TREATMENT|1961-04-23||1962-03-16|||1970-03-31||1961-02-18
TRIAL STUDY 134XCP|RP|F149BD98-0802-4C18-8599-426C5258D513|1||||||MENOSTAT|MENOPAUSE STATUS||||ML/MIN/MMHG|||KBQ|NOT DONE||N|N|N|5||7||WASHOUT|1961-03-08||1965-07-27|||1967-09-03||1972-10-17
TRIAL STUDY 134XCP|RP|F149BD98-0802-4C18-8599-426C5258D513|2||||||ERYTHIND|ERYTHEMA INDICATOR||||10^3 COPIES/ML|||% INHIBITION|NOT DONE||U|N|NA|5||7||OBSERVATION|1962-12-11||1972-11-04|||1971-01-03||1972-12-12
TRIAL STUDY 134XCP|RP|5A31D035-90D2-4BD0-AE08-839862D6E0DF|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||PMOL/10^9 CELLS|||LOG10 TCID 50/DOSE|NOT DONE||Y|U|N|1||38||WASHOUT|1962-09-15||1972-07-26|||1967-04-14||1971-10-16
TRIAL STUDY 134XCP|RP|5A31D035-90D2-4BD0-AE08-839862D6E0DF|2||||||INTP|INTERPRETATION||||MCI|||AU/ML|NOT DONE||Y|NA|N|1||38||BASELINE|1960-02-27||1965-03-29|||1960-01-24||1967-06-06
TRIAL STUDY 134XCP|RP|5A31D035-90D2-4BD0-AE08-839862D6E0DF|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||%/S|||V/SEC|NOT DONE||N|NA|Y|2||58||CONTINUATION TREATMENT|1968-01-17||1968-06-15|||1971-12-23||1966-04-22
TRIAL STUDY 134XCP|RP|5A31D035-90D2-4BD0-AE08-839862D6E0DF|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||G/CAGE/WK|||U/DL|NOT DONE||U|N|U|2||58||BASELINE|1960-09-26||1965-06-02|||1963-10-30||1964-03-30
TRIAL STUDY 134XCP|RP|5A31D035-90D2-4BD0-AE08-839862D6E0DF|1||||||BCMETHOD|BIRTH CONTROL METHOD||||LOG10 CFU/ML|||QUANTITY SUFFICIENT|NOT DONE||U|NA|N|3||39||WASHOUT|1971-06-20||1971-09-18|||1967-07-21||1964-04-22
TRIAL STUDY 134XCP|RP|5A31D035-90D2-4BD0-AE08-839862D6E0DF|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||KALLIKREIN INHIBITOR UNIT|||HOMEOPATHIC DILUTION|NOT DONE||N|U|NA|3||39||WASHOUT|1962-05-26||1963-09-04|||1973-05-11||1965-03-29
TRIAL STUDY 134XCP|RP|5A31D035-90D2-4BD0-AE08-839862D6E0DF|1||||||MENOSTAT|MENOPAUSE STATUS||||KV|||MG/MOL|NOT DONE||U|N|NA|4||88||WASHOUT|1965-06-10||1964-05-10|||1962-08-23||1971-10-30
TRIAL STUDY 134XCP|RP|5A31D035-90D2-4BD0-AE08-839862D6E0DF|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||10^5/L|||/CMH2O|NOT DONE||Y|N|Y|4||88||INDUCTION TREATMENT|1966-02-25||1964-01-19|||1963-09-30||1960-06-02
TRIAL STUDY 134XCP|RP|5A31D035-90D2-4BD0-AE08-839862D6E0DF|1||||||STILBIND|STILLBIRTH INDICATOR||||MV2/HZ|||ML/MMHG/MIN/L|NOT DONE||NA|NA|Y|5||7||OBSERVATION|1962-05-01||1973-07-07|||1969-06-16||1967-09-16
TRIAL STUDY 134XCP|RP|5A31D035-90D2-4BD0-AE08-839862D6E0DF|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ANTI-XA IU/ML|||UG/L FEU|NOT DONE||U|Y|N|5||7||LONG-TERM FOLLOW-UP|1969-11-29||1970-10-30|||1966-12-26||1967-02-25
TRIAL STUDY 134XCP|RP|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||LOG10 IU/ML|||PMOL/10^9 CELLS|NOT DONE||Y|Y|Y|1||38||LONG-TERM FOLLOW-UP|1964-05-31||1972-01-05|||1966-08-06||1969-01-08
TRIAL STUDY 134XCP|RP|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||/2000 RBC|||PFU/ANIMAL|NOT DONE||U|NA|NA|1||38||TREATMENT|1963-08-12||1969-03-17|||1966-05-01||1970-10-22
TRIAL STUDY 134XCP|RP|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UV*SEC|||ML/M2/MIN|NOT DONE||U|NA|Y|2||58||CONTINUATION TREATMENT|1963-06-20||1963-08-10|||1968-10-22||1961-11-15
TRIAL STUDY 134XCP|RP|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|2||||||TNDRIND|TENDERNESS INDICATOR||||CAN|||AG|NOT DONE||U|U|N|2||58||WASHOUT|1968-08-19||1965-09-26|||1970-03-04||1970-01-04
TRIAL STUDY 134XCP|RP|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||PMOL/10^10 CELLS|||10^7 CFU/ML|NOT DONE||N|Y|NA|3||39||OBSERVATION|1967-02-25||1964-08-15|||1971-04-16||1967-11-08
TRIAL STUDY 134XCP|RP|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UG/CM2|||KM/H|NOT DONE||Y|Y|NA|3||39||FOLLOW-UP|1966-04-08||1960-03-23|||1966-01-26||1963-07-24
TRIAL STUDY 134XCP|RP|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||CGY|||/HPF|NOT DONE||Y|Y|NA|4||88||INDUCTION TREATMENT|1963-03-08||1971-05-12|||1967-05-16||1970-07-19
TRIAL STUDY 134XCP|RP|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UG/DL|||RNA COPIES/ML|NOT DONE||NA|NA|Y|4||88||BASELINE|1970-04-04||1963-05-04|||1971-09-25||1964-06-29
TRIAL STUDY 134XCP|RP|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|1||||||DLVRMODE|MODE OF DELIVERY||||CP|||STEPS|NOT DONE||Y|U|N|5||7||FOLLOW-UP|1963-06-23||1962-03-06|||1972-10-05||1971-08-31
TRIAL STUDY 134XCP|RP|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||DNA COPIES/UG|||MOL/G|NOT DONE||Y|N|N|5||7||LONG-TERM FOLLOW-UP|1966-06-25||1960-02-09|||1961-07-12||1963-11-25
TRIAL STUDY 134XCP|RP|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UG/L FEU|||BQ|NOT DONE||U|N|Y|1||38||BLINDED TREATMENT|1963-12-24||1972-09-19|||1968-08-26||1966-12-25
TRIAL STUDY 134XCP|RP|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|2||||||ULCERIND|ULCER INDICATOR||||ML/(MIN*100ML)|||MV/SEC|NOT DONE||U|NA|N|1||38||TREATMENT|1963-04-24||1963-01-11|||1963-03-31||1966-10-28
TRIAL STUDY 134XCP|RP|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||ELISA UNIT/ML|||JDF UNIT|NOT DONE||Y|Y|U|2||58||RUN-IN|1969-11-09||1963-01-26|||1968-08-20||1972-06-29
TRIAL STUDY 134XCP|RP|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||GBQ|||MBP|NOT DONE||Y|Y|U|2||58||WASHOUT|1970-09-13||1960-11-18|||1964-03-20||1964-10-29
TRIAL STUDY 134XCP|RP|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UGEQ|||/MONTH|NOT DONE||U|Y|Y|3||39||RUN-IN|1966-10-18||1968-02-21|||1962-07-03||1960-01-13
TRIAL STUDY 134XCP|RP|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|2||||||FUNDHT|FUNDAL HEIGHT||||%(V/V)|||MIN/DAY|NOT DONE||NA|N|Y|3||39||SCREENING|1967-07-04||1961-05-31|||1966-10-01||1968-06-03
TRIAL STUDY 134XCP|RP|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MG2/DL2|||ML/MMHG|NOT DONE||N|Y|N|4||88||BLINDED TREATMENT|1961-10-21||1967-09-19|||1971-05-11||1960-10-03
TRIAL STUDY 134XCP|RP|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|2||||||MENFDUR|MENSES FLOW DURATION||||VG/KG|||/HPF|NOT DONE||NA|U|N|4||88||OPEN LABEL TREATMENT|1972-06-23||1971-09-04|||1970-05-13||1969-08-16
TRIAL STUDY 134XCP|RP|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|1||||||THICK|THICKNESS||||CP|||10^6 ORGANISMS|NOT DONE||NA|NA|NA|5||7||INDUCTION TREATMENT|1963-10-17||1963-11-22|||1963-08-18||1967-02-15
TRIAL STUDY 134XCP|RP|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||M|||SFC/10^6 PBMC|NOT DONE||Y|Y|N|5||7||OBSERVATION|1963-01-10||1964-02-27|||1965-03-16||1963-06-18
TRIAL STUDY 134XCP|RP|9C9398A4-38BC-40A7-880D-4549A676F69B|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||YD|||IU/DAY|NOT DONE||NA|N|N|1||38||LONG-TERM FOLLOW-UP|1970-10-07||1968-12-03|||1969-12-28||1960-07-02
TRIAL STUDY 134XCP|RP|9C9398A4-38BC-40A7-880D-4549A676F69B|2||||||MENOAGE|MENOPAUSE AGE||||LOG EID 50/DOSE|||MG/DL|NOT DONE||N|NA|NA|1||38||LONG-TERM FOLLOW-UP|1972-01-11||1961-08-28|||1964-12-07||1965-05-21
TRIAL STUDY 134XCP|RP|9C9398A4-38BC-40A7-880D-4549A676F69B|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||ML/KG/H|||MDFI|NOT DONE||NA|N|Y|2||58||CONTINUATION TREATMENT|1960-07-25||1962-01-27|||1966-12-05||1963-12-24
TRIAL STUDY 134XCP|RP|9C9398A4-38BC-40A7-880D-4549A676F69B|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||POUCH|||100 IU/ML|NOT DONE||Y|NA|U|2||58||FOLLOW-UP|1970-06-13||1962-10-18|||1971-10-03||1968-10-13
TRIAL STUDY 134XCP|RP|9C9398A4-38BC-40A7-880D-4549A676F69B|1||||||GRAVIND|GRAVIDA INDICATOR||||CMH2O/ML|||CAN|NOT DONE||NA|Y|Y|3||39||RUN-IN|1960-01-14||1960-09-10|||1963-11-24||1967-03-13
TRIAL STUDY 134XCP|RP|9C9398A4-38BC-40A7-880D-4549A676F69B|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||UMOL/MOL|||/MBP|NOT DONE||N|U|N|3||39||BLINDED TREATMENT|1969-02-18||1969-06-01|||1966-09-10||1962-08-03
TRIAL STUDY 134XCP|RP|9C9398A4-38BC-40A7-880D-4549A676F69B|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||L/L|||GMFI|NOT DONE||U|N|NA|4||88||CONTINUATION TREATMENT|1968-02-10||1972-09-23|||1960-03-18||1964-03-09
TRIAL STUDY 134XCP|RP|9C9398A4-38BC-40A7-880D-4549A676F69B|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||STEPS|||CCID 50/ML|NOT DONE||Y|N|Y|4||88||BASELINE|1970-04-03||1970-08-06|||1962-01-02||1966-09-12
TRIAL STUDY 134XCP|RP|9C9398A4-38BC-40A7-880D-4549A676F69B|1||||||TNDRIND|TENDERNESS INDICATOR||||MG/G/MIN|||/500 WBC|NOT DONE||U|N|NA|5||7||OBSERVATION|1961-07-28||1964-07-22|||1970-04-11||1961-04-09
TRIAL STUDY 134XCP|RP|9C9398A4-38BC-40A7-880D-4549A676F69B|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||BQ/MG|||BAR|NOT DONE||Y|N|Y|5||7||WASHOUT|1973-01-12||1972-09-06|||1969-06-12||1964-12-03
TRIAL STUDY 134XCP|RP|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||ENZYME U|||KEV|NOT DONE||Y|U|NA|1||38||LONG-TERM FOLLOW-UP|1967-12-02||1968-04-02|||1969-10-18||1965-11-10
TRIAL STUDY 134XCP|RP|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||CCID 50/ML|||10^6/L|NOT DONE||U|U|Y|1||38||RUN-IN|1964-05-12||1963-05-28|||1960-07-05||1969-01-20
TRIAL STUDY 134XCP|RP|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UG/KG|||EU|NOT DONE||N|U|N|2||58||LONG-TERM FOLLOW-UP|1969-01-09||1963-06-11|||1965-11-14||1972-07-11
TRIAL STUDY 134XCP|RP|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|2||||||BCMETHOD|BIRTH CONTROL METHOD||||APS U|||10^9/G|NOT DONE||NA|NA|N|2||58||CONTINUATION TREATMENT|1965-04-29||1967-10-19|||1960-11-11||1967-11-15
TRIAL STUDY 134XCP|RP|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|1||||||PREGIND|PREGNANT INDICATOR||||KALLIKREIN INHIBITOR UNIT|||CI/KG|NOT DONE||NA|NA|U|3||39||WASHOUT|1972-03-14||1969-12-21|||1971-01-20||1968-12-28
TRIAL STUDY 134XCP|RP|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||U|||JDF UNIT|NOT DONE||U|Y|U|3||39||FOLLOW-UP|1965-09-07||1966-09-18|||1973-08-02||1964-10-18
TRIAL STUDY 134XCP|RP|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||U/G/DAY|||ML/MMHG|NOT DONE||U|N|U|4||88||SCREENING|1971-04-05||1963-02-16|||1962-01-26||1960-11-13
TRIAL STUDY 134XCP|RP|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||ML/M2/MIN|||UG/M2/H|NOT DONE||U|N|Y|4||88||FOLLOW-UP|1964-10-20||1967-08-21|||1968-09-10||1972-06-28
TRIAL STUDY 134XCP|RP|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||LOG10 COPIES/ML|||U/G HB|NOT DONE||NA|Y|N|5||7||TREATMENT|1969-11-07||1970-05-21|||1967-02-08||1966-11-24
TRIAL STUDY 134XCP|RP|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||CI/KG|||EU|NOT DONE||N|Y|U|5||7||RUN-IN|1963-02-28||1960-05-10|||1960-07-19||1970-10-16
TRIAL STUDY 134XCP|RP|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||PG/CELL|||HR/DAY|NOT DONE||NA|N|Y|1||38||WASHOUT|1967-04-16||1960-06-24|||1961-08-15||1972-12-01
TRIAL STUDY 134XCP|RP|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MOL/ML|||CM|NOT DONE||Y|Y|U|1||38||BASELINE|1964-08-05||1964-08-26|||1971-01-05||1971-01-18
TRIAL STUDY 134XCP|RP|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MG/KG/H|||10^3 RNA COPIES/ML|NOT DONE||N|U|U|2||58||SCREENING|1966-04-17||1967-09-02|||1963-05-05||1973-05-20
TRIAL STUDY 134XCP|RP|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|2||||||MASSIND|MASS INDICATOR||||UL/ML|||M/SEC2|NOT DONE||N|N|Y|2||58||INDUCTION TREATMENT|1973-06-30||1963-06-19|||1964-10-17||1968-09-13
TRIAL STUDY 134XCP|RP|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||10^9 ORGANISMS/ML|||IN2|NOT DONE||NA|N|N|3||39||INDUCTION TREATMENT|1963-02-05||1972-02-05|||1971-07-01||1965-01-10
TRIAL STUDY 134XCP|RP|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|2||||||PEELIND|PEELING INDICATOR||||DNA COPIES/UG|||MONTHS|NOT DONE||Y|N|N|3||39||BLINDED TREATMENT|1962-01-14||1964-01-23|||1971-08-02||1970-07-20
TRIAL STUDY 134XCP|RP|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MM/MIN|||STRIP|NOT DONE||U|N|U|4||88||OBSERVATION|1970-12-24||1965-07-07|||1970-12-20||1963-04-02
TRIAL STUDY 134XCP|RP|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||LOG10 CFU/G|||MM/2H|NOT DONE||U|U|NA|4||88||OBSERVATION|1964-11-05||1972-05-11|||1964-12-05||1964-09-27
TRIAL STUDY 134XCP|RP|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|1||||||PUSTIND|PUSTULE INDICATOR||||MIU/L|||UG/L DDU|NOT DONE||Y|Y|U|5||7||OBSERVATION|1968-06-13||1963-04-18|||1967-11-15||1965-02-28
TRIAL STUDY 134XCP|RP|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|2||||||THICK|THICKNESS||||TRANSDUCING UNIT/ML|||VG/KG|NOT DONE||N|NA|Y|5||7||LONG-TERM FOLLOW-UP|1965-03-14||1973-05-16|||1972-09-08||1963-02-24
TRIAL STUDY 134XCP|RP|1E049F70-8E29-458F-BF37-13450BC9227E|1||||||THICK|THICKNESS||||/500 WBC|||MESF|NOT DONE||NA|NA|NA|1||38||BASELINE|1972-10-01||1973-02-06|||1969-12-07||1967-10-23
TRIAL STUDY 134XCP|RP|1E049F70-8E29-458F-BF37-13450BC9227E|2||||||ULCERIND|ULCER INDICATOR||||BQ/MG|||SACHET|NOT DONE||Y|NA|Y|1||38||SCREENING|1973-06-04||1961-09-07|||1968-06-24||1967-03-14
TRIAL STUDY 134XCP|RP|1E049F70-8E29-458F-BF37-13450BC9227E|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||CYCLE/MIN|||EQ|NOT DONE||N|Y|U|2||58||BLINDED TREATMENT|1960-09-03||1965-05-03|||1966-06-03||1970-12-02
TRIAL STUDY 134XCP|RP|1E049F70-8E29-458F-BF37-13450BC9227E|2||||||DLVRMODE|MODE OF DELIVERY||||TUBERCULIN UNIT|||/200 HPFS|NOT DONE||U|N|Y|2||58||CONTINUATION TREATMENT|1967-02-12||1964-12-18|||1960-02-23||1972-05-20
TRIAL STUDY 134XCP|RP|1E049F70-8E29-458F-BF37-13450BC9227E|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||KCAL|||10^6 CFU/G|NOT DONE||U|N|U|3||39||TREATMENT|1962-04-28||1963-06-06|||1964-01-25||1961-04-02
TRIAL STUDY 134XCP|RP|1E049F70-8E29-458F-BF37-13450BC9227E|2||||||DSCHGIND|DISCHARGE INDICATOR||||CI/MG|||ML/DAY|NOT DONE||NA|NA|U|3||39||LONG-TERM FOLLOW-UP|1969-05-25||1965-01-27|||1971-01-06||1963-05-30
TRIAL STUDY 134XCP|RP|1E049F70-8E29-458F-BF37-13450BC9227E|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||NGEQ/L|||BAU|NOT DONE||Y|NA|NA|4||88||BLINDED TREATMENT|1965-07-10||1962-11-19|||1973-05-17||1969-07-05
TRIAL STUDY 134XCP|RP|1E049F70-8E29-458F-BF37-13450BC9227E|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||KN/CM2|||%|NOT DONE||Y|NA|NA|4||88||CONTINUATION TREATMENT|1968-11-09||1967-11-09|||1962-12-17||1963-07-10
TRIAL STUDY 134XCP|RP|1E049F70-8E29-458F-BF37-13450BC9227E|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MG|||LOG EID 50/DOSE|NOT DONE||Y|N|Y|5||7||INDUCTION TREATMENT|1968-01-07||1960-01-18|||1964-12-23||1961-04-11
TRIAL STUDY 134XCP|RP|1E049F70-8E29-458F-BF37-13450BC9227E|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MOL/DAY|||%(W/V)|NOT DONE||N|N|NA|5||7||SCREENING|1967-12-11||1973-01-12|||1965-04-26||1972-07-02
TRIAL STUDY 134XCP|RP|7A612F0F-943A-4283-9A11-B8E8E8D68D66|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||GENEQ|||SPRAY|NOT DONE||N|N|N|1||38||BLINDED TREATMENT|1966-06-03||1964-08-05|||1970-11-29||1970-03-19
TRIAL STUDY 134XCP|RP|7A612F0F-943A-4283-9A11-B8E8E8D68D66|2||||||PREGST|PREGNANT DURING THE STUDY||||KAT|||USIEMENS|NOT DONE||U|NA|N|1||38||WASHOUT|1961-07-12||1968-08-18|||1965-04-04||1961-01-09
TRIAL STUDY 134XCP|RP|7A612F0F-943A-4283-9A11-B8E8E8D68D66|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||UG/ANIMAL|||UL/DOSE|NOT DONE||Y|Y|U|2||58||BLINDED TREATMENT|1963-07-13||1972-11-24|||1960-04-19||1971-07-05
TRIAL STUDY 134XCP|RP|7A612F0F-943A-4283-9A11-B8E8E8D68D66|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||PACKET|||MV2/HZ|NOT DONE||Y|N|U|2||58||BLINDED TREATMENT|1967-06-23||1963-07-14|||1963-08-22||1963-01-19
TRIAL STUDY 134XCP|RP|7A612F0F-943A-4283-9A11-B8E8E8D68D66|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MOSM/KG|||HR/DAY|NOT DONE||Y|NA|U|3||39||BASELINE|1971-10-17||1971-01-15|||1970-06-13||1964-04-07
TRIAL STUDY 134XCP|RP|7A612F0F-943A-4283-9A11-B8E8E8D68D66|2||||||PREGNN|NUMBER OF PREGNANCIES||||MG/ANIMAL|||M|NOT DONE||NA|N|U|3||39||OBSERVATION|1964-02-21||1966-09-08|||1970-05-03||1972-06-10
TRIAL STUDY 134XCP|RP|7A612F0F-943A-4283-9A11-B8E8E8D68D66|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||NMOL/L/MIN|||BAG|NOT DONE||NA|N|U|4||88||FOLLOW-UP|1967-12-01||1966-06-20|||1967-03-06||1965-03-17
TRIAL STUDY 134XCP|RP|7A612F0F-943A-4283-9A11-B8E8E8D68D66|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MANSON U/ML|||PKAT|NOT DONE||NA|U|U|4||88||TREATMENT|1961-12-25||1961-01-24|||1966-04-23||1968-09-20
TRIAL STUDY 134XCP|RP|7A612F0F-943A-4283-9A11-B8E8E8D68D66|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||COAT|||G/ANIMAL|NOT DONE||N|U|N|5||7||TREATMENT|1962-09-16||1964-11-12|||1967-07-15||1969-03-19
TRIAL STUDY 134XCP|RP|7A612F0F-943A-4283-9A11-B8E8E8D68D66|2||||||EDEMAIND|EDEMA INDICATOR||||10^3 CFU/ML|||MV|NOT DONE||Y|N|N|5||7||SCREENING|1972-09-21||1969-07-16|||1964-10-17||1970-07-26
TRIAL STUDY 134XCP|RP|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UG/KG/MIN|||PIXELS/IN|NOT DONE||Y|N|U|1||38||RUN-IN|1960-09-08||1972-03-14|||1970-08-28||1962-12-13
TRIAL STUDY 134XCP|RP|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||QUANTITY SUFFICIENT|||/LSQN|NOT DONE||U|N|NA|1||38||CONTINUATION TREATMENT|1961-03-25||1971-04-15|||1967-03-05||1960-02-07
TRIAL STUDY 134XCP|RP|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||CONTAINER|||10^6/HPF|NOT DONE||N|N|N|2||58||BASELINE|1967-01-19||1961-04-29|||1971-03-13||1967-05-02
TRIAL STUDY 134XCP|RP|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|2||||||MASSIND|MASS INDICATOR||||10^3 ORGANISMS/G|||UV|NOT DONE||Y|N|Y|2||58||CONTINUATION TREATMENT|1967-06-27||1962-08-17|||1964-05-11||1970-12-04
TRIAL STUDY 134XCP|RP|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||TRANSDUCING UNIT/ML|||ML/BEAT|NOT DONE||NA|Y|NA|3||39||SCREENING|1973-01-18||1966-06-24|||1960-03-02||1967-05-08
TRIAL STUDY 134XCP|RP|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|2||||||PREGNN|NUMBER OF PREGNANCIES||||L/MIN|||NM|NOT DONE||N|N|Y|3||39||SCREENING|1967-12-01||1961-08-25|||1960-05-27||1967-06-09
TRIAL STUDY 134XCP|RP|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||UMOL/L/SEC|||CM/S|NOT DONE||U|Y|Y|4||88||BLINDED TREATMENT|1969-07-13||1961-11-19|||1971-10-08||1967-06-19
TRIAL STUDY 134XCP|RP|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|2||||||ABORTN|NUMBER OF ABORTIONS||||/MS|||UG/CM2|NOT DONE||Y|NA|Y|4||88||OBSERVATION|1963-06-16||1969-10-21|||1971-09-18||1967-05-15
TRIAL STUDY 134XCP|RP|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|1||||||BCMETHOD|BIRTH CONTROL METHOD||||UMOL/MG/MIN|||U/KG/DAY|NOT DONE||U|Y|NA|5||7||OBSERVATION|1960-07-16||1965-05-19|||1962-10-29||1962-05-05
TRIAL STUDY 134XCP|RP|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|2||||||THICK|THICKNESS||||NGEQ/L|||UM/DAY|NOT DONE||N|U|Y|5||7||OPEN LABEL TREATMENT|1961-02-19||1970-09-18|||1969-01-23||1961-03-24
TRIAL STUDY 134XCP|RP|8C86A799-2717-46E8-99C2-76D11AAB54D7|1||||||MENOSTAT|MENOPAUSE STATUS||||ARBITRARY U|||BQ/KG|NOT DONE||U|NA|N|1||38||TREATMENT|1971-11-20||1973-03-23|||1970-09-22||1973-06-20
TRIAL STUDY 134XCP|RP|8C86A799-2717-46E8-99C2-76D11AAB54D7|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||M3|||POINT|NOT DONE||Y|NA|NA|1||38||TREATMENT|1972-04-03||1972-01-02|||1961-02-10||1972-11-06
TRIAL STUDY 134XCP|RP|8C86A799-2717-46E8-99C2-76D11AAB54D7|1||||||MENOSTAT|MENOPAUSE STATUS||||%|||10^4/HPF|NOT DONE||NA|U|NA|2||58||SCREENING|1970-03-25||1961-11-24|||1970-10-18||1961-07-12
TRIAL STUDY 134XCP|RP|8C86A799-2717-46E8-99C2-76D11AAB54D7|2||||||PREGST|PREGNANT DURING THE STUDY||||KPA|||S/H|NOT DONE||N|NA|Y|2||58||WASHOUT|1964-08-29||1963-08-26|||1968-01-31||1960-07-20
TRIAL STUDY 134XCP|RP|8C86A799-2717-46E8-99C2-76D11AAB54D7|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MG/KG/WEEK|||SYRINGE|NOT DONE||U|N|U|3||39||BASELINE|1961-02-02||1961-01-15|||1962-03-10||1973-06-15
TRIAL STUDY 134XCP|RP|8C86A799-2717-46E8-99C2-76D11AAB54D7|2||||||DSCHGIND|DISCHARGE INDICATOR||||/100 HPFS|||UM2|NOT DONE||Y|NA|NA|3||39||OPEN LABEL TREATMENT|1966-06-27||1964-01-01|||1972-06-17||1971-10-21
TRIAL STUDY 134XCP|RP|8C86A799-2717-46E8-99C2-76D11AAB54D7|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||DPM/MG|||ML/MIN|NOT DONE||N|Y|U|4||88||OBSERVATION|1970-08-27||1960-08-04|||1967-07-14||1962-01-20
TRIAL STUDY 134XCP|RP|8C86A799-2717-46E8-99C2-76D11AAB54D7|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||CI/L|||G/ANIMAL/DAY|NOT DONE||NA|Y|U|4||88||OPEN LABEL TREATMENT|1961-05-30||1961-07-21|||1960-08-08||1967-09-27
TRIAL STUDY 134XCP|RP|8C86A799-2717-46E8-99C2-76D11AAB54D7|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||COPIES/ML|||VP/ML|NOT DONE||U|U|U|5||7||BLINDED TREATMENT|1967-12-31||1965-08-19|||1968-08-06||1972-06-30
TRIAL STUDY 134XCP|RP|8C86A799-2717-46E8-99C2-76D11AAB54D7|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||IU/KG/H|||10^5/HPF|NOT DONE||U|U|U|5||7||RUN-IN|1963-04-09||1970-09-12|||1963-02-15||1960-05-26
TRIAL STUDY 134XCP|RP|727807A8-A180-4589-A553-E3C82E1D3CF2|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||COAT|||GBQ/MG|NOT DONE||NA|U|NA|1||38||RUN-IN|1973-03-12||1964-09-20|||1968-04-20||1961-07-19
TRIAL STUDY 134XCP|RP|727807A8-A180-4589-A553-E3C82E1D3CF2|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||L|||L/MIN/M2|NOT DONE||Y|U|Y|1||38||BLINDED TREATMENT|1967-05-08||1973-04-16|||1972-07-13||1966-06-06
TRIAL STUDY 134XCP|RP|727807A8-A180-4589-A553-E3C82E1D3CF2|1||||||INTP|INTERPRETATION||||POUCH|||10^11/L|NOT DONE||Y|N|N|2||58||BASELINE|1960-12-28||1971-07-10|||1967-05-31||1963-08-12
TRIAL STUDY 134XCP|RP|727807A8-A180-4589-A553-E3C82E1D3CF2|2||||||PREGST|PREGNANT DURING THE STUDY||||GPL U|||UMOL/MOL|NOT DONE||N|NA|N|2||58||RUN-IN|1969-02-14||1963-05-09|||1961-03-16||1963-09-08
TRIAL STUDY 134XCP|RP|727807A8-A180-4589-A553-E3C82E1D3CF2|1||||||EDEMAIND|EDEMA INDICATOR||||TRACE|||ANSON U|NOT DONE||Y|N|Y|3||39||BLINDED TREATMENT|1971-09-26||1963-03-31|||1962-11-08||1968-02-03
TRIAL STUDY 134XCP|RP|727807A8-A180-4589-A553-E3C82E1D3CF2|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MIU/L|||UMOL/MOL|NOT DONE||N|Y|N|3||39||OBSERVATION|1970-06-30||1965-12-09|||1960-10-10||1965-08-08
TRIAL STUDY 134XCP|RP|727807A8-A180-4589-A553-E3C82E1D3CF2|1||||||ULCERIND|ULCER INDICATOR||||DNA COPIES/ML|||DDU|NOT DONE||N|N|N|4||88||FOLLOW-UP|1969-08-25||1969-05-16|||1971-02-13||1967-12-05
TRIAL STUDY 134XCP|RP|727807A8-A180-4589-A553-E3C82E1D3CF2|2||||||PREGST|PREGNANT DURING THE STUDY||||10^3 ORGANISMS|||BOLUS|NOT DONE||N|N|Y|4||88||SCREENING|1961-06-25||1969-08-11|||1972-10-31||1967-05-22
TRIAL STUDY 134XCP|RP|727807A8-A180-4589-A553-E3C82E1D3CF2|1||||||EDEMAIND|EDEMA INDICATOR||||UL/KG/DAY|||UG/KG/MIN|NOT DONE||Y|NA|NA|5||7||LONG-TERM FOLLOW-UP|1961-12-28||1968-08-13|||1965-06-20||1971-04-10
TRIAL STUDY 134XCP|RP|727807A8-A180-4589-A553-E3C82E1D3CF2|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/DL|||MG/G/H|NOT DONE||N|N|N|5||7||TREATMENT|1961-07-17||1960-09-07|||1961-02-15||1962-01-17
TRIAL STUDY 134XCP|RP|BFFB5321-5FC7-4465-8579-D75865306359|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||ANTIBODY UNIT|||10^6 COPIES/ML|NOT DONE||U|Y|N|1||38||TREATMENT|1962-03-22||1964-06-29|||1971-02-03||1967-05-29
TRIAL STUDY 134XCP|RP|BFFB5321-5FC7-4465-8579-D75865306359|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||IU/L|||U/L|NOT DONE||Y|U|NA|1||38||WASHOUT|1973-01-05||1961-08-22|||1968-12-06||1970-01-17
TRIAL STUDY 134XCP|RP|BFFB5321-5FC7-4465-8579-D75865306359|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||10^6/G|||IU/KG/H|NOT DONE||NA|NA|U|2||58||RUN-IN|1963-12-15||1961-12-30|||1967-09-01||1973-07-30
TRIAL STUDY 134XCP|RP|BFFB5321-5FC7-4465-8579-D75865306359|2||||||PREGST|PREGNANT DURING THE STUDY||||HEP|||MET*MIN|NOT DONE||Y|U|N|2||58||CONTINUATION TREATMENT|1963-06-09||1966-01-14|||1967-12-09||1963-05-14
TRIAL STUDY 134XCP|RP|BFFB5321-5FC7-4465-8579-D75865306359|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||INHALATION|||G/KG|NOT DONE||Y|NA|N|3||39||WASHOUT|1967-01-04||1971-01-15|||1967-12-11||1970-02-14
TRIAL STUDY 134XCP|RP|BFFB5321-5FC7-4465-8579-D75865306359|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MG/CM2|||UMOL/L|NOT DONE||NA|NA|NA|3||39||BASELINE|1965-02-21||1965-09-05|||1964-08-23||1970-11-21
TRIAL STUDY 134XCP|RP|BFFB5321-5FC7-4465-8579-D75865306359|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MG/MOL|||TSP EQ|NOT DONE||U|U|Y|4||88||SCREENING|1964-03-13||1969-08-19|||1969-02-15||1965-05-02
TRIAL STUDY 134XCP|RP|BFFB5321-5FC7-4465-8579-D75865306359|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||EID 50/DOSE|||10^6 CFU/ML|NOT DONE||U|N|Y|4||88||CONTINUATION TREATMENT|1960-04-15||1968-04-19|||1972-01-25||1972-01-13
TRIAL STUDY 134XCP|RP|BFFB5321-5FC7-4465-8579-D75865306359|1||||||INTP|INTERPRETATION||||CM|||MG/MIN|NOT DONE||U|NA|Y|5||7||RUN-IN|1971-07-18||1961-07-24|||1966-06-17||1964-08-14
TRIAL STUDY 134XCP|RP|BFFB5321-5FC7-4465-8579-D75865306359|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||ML/KG|||MG/KG/DAY|NOT DONE||U|NA|NA|5||7||RUN-IN|1960-11-09||1966-02-12|||1960-03-18||1962-05-09
TRIAL STUDY 134XCP|RP|12F9A745-F76D-4222-B37E-22AF93981ECE|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MG/DL|||UG/L DDU|NOT DONE||Y|N|U|1||38||BLINDED TREATMENT|1973-02-08||1967-05-17|||1967-11-11||1967-09-13
TRIAL STUDY 134XCP|RP|12F9A745-F76D-4222-B37E-22AF93981ECE|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||PMOL/G|||%(W/V)|NOT DONE||N|NA|Y|1||38||CONTINUATION TREATMENT|1963-03-03||1966-08-10|||1966-08-30||1970-09-09
TRIAL STUDY 134XCP|RP|12F9A745-F76D-4222-B37E-22AF93981ECE|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||10^6 CFU/G|||MN|NOT DONE||Y|N|U|2||58||INDUCTION TREATMENT|1961-03-08||1967-11-23|||1967-08-11||1962-08-09
TRIAL STUDY 134XCP|RP|12F9A745-F76D-4222-B37E-22AF93981ECE|2||||||PEELIND|PEELING INDICATOR||||OZ|||MANSON U/ML|NOT DONE||Y|U|Y|2||58||WASHOUT|1973-09-04||1969-12-13|||1960-01-05||1969-12-15
TRIAL STUDY 134XCP|RP|12F9A745-F76D-4222-B37E-22AF93981ECE|1||||||TNDRIND|TENDERNESS INDICATOR||||MG/KG/H|||/HPF|NOT DONE||NA|N|NA|3||39||WASHOUT|1972-10-15||1966-12-18|||1964-11-24||1962-07-22
TRIAL STUDY 134XCP|RP|12F9A745-F76D-4222-B37E-22AF93981ECE|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||PACKAGE|||GRAVITATIONAL UNIT|NOT DONE||NA|Y|N|3||39||LONG-TERM FOLLOW-UP|1966-12-20||1963-03-14|||1972-05-15||1973-02-22
TRIAL STUDY 134XCP|RP|12F9A745-F76D-4222-B37E-22AF93981ECE|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ECL UNIT|||G/DAY|NOT DONE||N|NA|U|4||88||RUN-IN|1964-09-28||1965-02-25|||1969-12-08||1971-12-28
TRIAL STUDY 134XCP|RP|12F9A745-F76D-4222-B37E-22AF93981ECE|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^7 CFU/ML|||EID 50/ML|NOT DONE||N|N|N|4||88||BASELINE|1961-08-03||1961-09-17|||1971-10-19||1960-11-08
TRIAL STUDY 134XCP|RP|12F9A745-F76D-4222-B37E-22AF93981ECE|1||||||STILBIND|STILLBIRTH INDICATOR||||10^7 CFU|||GPL U|NOT DONE||NA|Y|U|5||7||FOLLOW-UP|1970-06-30||1967-08-07|||1973-06-30||1969-10-03
TRIAL STUDY 134XCP|RP|12F9A745-F76D-4222-B37E-22AF93981ECE|2||||||MENOSTAT|MENOPAUSE STATUS||||MG/DL|||MIN|NOT DONE||N|NA|U|5||7||RUN-IN|1966-11-06||1963-08-04|||1963-04-30||1969-12-28
TRIAL STUDY 134XCP|RP|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|1||||||GRAVIND|GRAVIDA INDICATOR||||CONTAINER|||SBE/ML|NOT DONE||Y|U|NA|1||38||OPEN LABEL TREATMENT|1964-02-02||1969-05-10|||1961-02-15||1961-04-17
TRIAL STUDY 134XCP|RP|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|2||||||INTP|INTERPRETATION||||APS U|||UG/DL|NOT DONE||N|Y|Y|1||38||RUN-IN|1970-11-17||1968-11-03|||1971-02-06||1964-06-13
TRIAL STUDY 134XCP|RP|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|1||||||MENARAGE|MENARCHE AGE||||MMOL/MIN/KPA/L|||PA|NOT DONE||NA|Y|N|2||58||SCREENING|1965-09-29||1966-04-03|||1960-03-05||1969-06-09
TRIAL STUDY 134XCP|RP|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|2||||||PREGIND|PREGNANT INDICATOR||||NMOL/KG/DAY|||DRAM|NOT DONE||U|Y|Y|2||58||LONG-TERM FOLLOW-UP|1966-03-01||1971-02-05|||1964-02-25||1969-07-07
TRIAL STUDY 134XCP|RP|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|1||||||BCMETHOD|BIRTH CONTROL METHOD||||UG/G/H|||10^3 COPIES/ML|NOT DONE||U|U|U|3||39||OPEN LABEL TREATMENT|1969-02-15||1962-10-19|||1961-03-30||1965-10-04
TRIAL STUDY 134XCP|RP|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|2||||||GRAVIND|GRAVIDA INDICATOR||||COULOMB|||FEU|NOT DONE||N|Y|Y|3||39||FOLLOW-UP|1969-11-10||1972-08-31|||1966-07-31||1963-12-21
TRIAL STUDY 134XCP|RP|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||10^6 IU|||CMOL|NOT DONE||N|NA|NA|4||88||FOLLOW-UP|1969-10-11||1971-10-29|||1960-07-26||1961-11-24
TRIAL STUDY 134XCP|RP|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|2||||||FUNDHT|FUNDAL HEIGHT||||EVENTS|||UGEQ|NOT DONE||NA|Y|NA|4||88||BASELINE|1973-01-08||1965-07-15|||1968-04-03||1972-02-12
TRIAL STUDY 134XCP|RP|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|1||||||PRGENDTC|DATE PREGNANCY ENDED||||G/CAGE/WK|||MASK|NOT DONE||Y|N|U|5||7||FOLLOW-UP|1970-09-23||1965-05-07|||1971-06-24||1960-12-08
TRIAL STUDY 134XCP|RP|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|2||||||DSCHGIND|DISCHARGE INDICATOR||||UKAT/L|||GLOBULE|NOT DONE||U|Y|Y|5||7||LONG-TERM FOLLOW-UP|1962-02-25||1971-02-17|||1960-03-28||1971-12-22
TRIAL STUDY 134XCP|RP|37693A38-D8A0-4313-A4D1-56E282579636|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MIN/DAY|||ML/S/M2|NOT DONE||U|N|NA|1||38||BASELINE|1970-11-10||1960-12-19|||1973-01-01||1963-01-11
TRIAL STUDY 134XCP|RP|37693A38-D8A0-4313-A4D1-56E282579636|2||||||ABORTN|NUMBER OF ABORTIONS||||KA_U/DL|||MEQ/ML|NOT DONE||NA|U|N|1||38||RUN-IN|1964-04-17||1969-06-30|||1961-09-09||1962-01-22
TRIAL STUDY 134XCP|RP|37693A38-D8A0-4313-A4D1-56E282579636|1||||||GRAVIND|GRAVIDA INDICATOR||||ANTI-XA IU|||DB|NOT DONE||Y|N|Y|2||58||WASHOUT|1964-07-03||1968-01-14|||1963-05-04||1963-11-10
TRIAL STUDY 134XCP|RP|37693A38-D8A0-4313-A4D1-56E282579636|2||||||PREGNN|NUMBER OF PREGNANCIES||||TCID 50/DOSE|||ML/MIN|NOT DONE||U|U|U|2||58||BASELINE|1972-08-21||1971-10-10|||1962-09-11||1969-08-22
TRIAL STUDY 134XCP|RP|37693A38-D8A0-4313-A4D1-56E282579636|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||%(W/W)|||APL U/ML|NOT DONE||U|N|N|3||39||LONG-TERM FOLLOW-UP|1962-11-27||1961-09-05|||1961-12-26||1972-03-26
TRIAL STUDY 134XCP|RP|37693A38-D8A0-4313-A4D1-56E282579636|2||||||MENOAGE|MENOPAUSE AGE||||AMP|||UGEQ|NOT DONE||NA|Y|NA|3||39||WASHOUT|1968-07-19||1966-07-01|||1965-07-06||1969-02-22
TRIAL STUDY 134XCP|RP|37693A38-D8A0-4313-A4D1-56E282579636|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||KUSP|||PIXELS/CM|NOT DONE||NA|N|U|4||88||OBSERVATION|1966-09-08||1963-02-23|||1962-12-31||1965-04-02
TRIAL STUDY 134XCP|RP|37693A38-D8A0-4313-A4D1-56E282579636|2||||||PREGST|PREGNANT DURING THE STUDY||||G/ANIMAL/WK|||TUBERCULIN UNIT|NOT DONE||Y|Y|Y|4||88||OBSERVATION|1970-08-14||1966-12-21|||1969-02-23||1972-04-21
TRIAL STUDY 134XCP|RP|37693A38-D8A0-4313-A4D1-56E282579636|1||||||MENFDUR|MENSES FLOW DURATION||||10^8/L|||NG/MOL|NOT DONE||N|Y|N|5||7||INDUCTION TREATMENT|1964-01-19||1969-04-12|||1972-02-06||1960-09-25
TRIAL STUDY 134XCP|RP|37693A38-D8A0-4313-A4D1-56E282579636|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||SYRINGE|||/10^3|NOT DONE||Y|Y|NA|5||7||BLINDED TREATMENT|1960-09-04||1962-06-05|||1969-05-01||1964-11-21
TRIAL STUDY 134XCP|RP|5C48E0BB-FD52-47F5-8759-6126ECB47B80|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||EU|||G/M2|NOT DONE||U|NA|N|1||38||BLINDED TREATMENT|1971-06-28||1961-02-21|||1962-04-16||1972-12-01
TRIAL STUDY 134XCP|RP|5C48E0BB-FD52-47F5-8759-6126ECB47B80|2||||||TNDRIND|TENDERNESS INDICATOR||||MMHG|||PPTR|NOT DONE||N|Y|Y|1||38||OPEN LABEL TREATMENT|1970-05-18||1964-03-11|||1971-02-20||1963-08-03
TRIAL STUDY 134XCP|RP|5C48E0BB-FD52-47F5-8759-6126ECB47B80|1||||||ERYTHIND|ERYTHEMA INDICATOR||||10^3 DNA COPIES/ML|||DL|NOT DONE||NA|U|U|2||58||OBSERVATION|1966-10-01||1964-07-05|||1963-06-24||1968-12-18
TRIAL STUDY 134XCP|RP|5C48E0BB-FD52-47F5-8759-6126ECB47B80|2||||||FUNDHT|FUNDAL HEIGHT||||MG/KG/MIN|||HEP|NOT DONE||N|N|U|2||58||OPEN LABEL TREATMENT|1968-06-22||1964-04-08|||1960-01-25||1967-06-28
TRIAL STUDY 134XCP|RP|5C48E0BB-FD52-47F5-8759-6126ECB47B80|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||10^6 IU|||MU|NOT DONE||NA|N|N|3||39||OBSERVATION|1970-03-25||1960-07-15|||1965-01-25||1967-08-03
TRIAL STUDY 134XCP|RP|5C48E0BB-FD52-47F5-8759-6126ECB47B80|2||||||MASSIND|MASS INDICATOR||||MG/L FEU|||CMH2O*S2/ML|NOT DONE||NA|Y|N|3||39||BASELINE|1970-02-03||1968-03-07|||1970-06-26||1970-03-22
TRIAL STUDY 134XCP|RP|5C48E0BB-FD52-47F5-8759-6126ECB47B80|1||||||PEELIND|PEELING INDICATOR||||UG/M2/MIN|||ELISA UNIT/DOSE|NOT DONE||U|U|N|4||88||LONG-TERM FOLLOW-UP|1970-08-05||1972-12-17|||1970-03-22||1969-08-03
TRIAL STUDY 134XCP|RP|5C48E0BB-FD52-47F5-8759-6126ECB47B80|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||LENS|||CI/L|NOT DONE||U|Y|NA|4||88||OPEN LABEL TREATMENT|1970-05-13||1969-01-06|||1968-06-18||1970-02-23
TRIAL STUDY 134XCP|RP|5C48E0BB-FD52-47F5-8759-6126ECB47B80|1||||||TNDRIND|TENDERNESS INDICATOR||||ML/M2|||ML*CMH2O|NOT DONE||U|N|Y|5||7||SCREENING|1970-01-25||1969-10-04|||1965-06-19||1971-03-25
TRIAL STUDY 134XCP|RP|5C48E0BB-FD52-47F5-8759-6126ECB47B80|2||||||MENFDUR|MENSES FLOW DURATION||||NL|||MMHG/L/MIN|NOT DONE||U|U|U|5||7||BASELINE|1972-06-29||1960-08-11|||1968-01-08||1962-12-14
TRIAL STUDY 134XCP|RP|5B420A5A-DB2C-48D2-8E9B-97639F49F182|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||G/CAGE|||U/KG/MIN|NOT DONE||U|U|U|1||38||TREATMENT|1971-08-05||1962-01-21|||1969-04-05||1960-10-30
TRIAL STUDY 134XCP|RP|5B420A5A-DB2C-48D2-8E9B-97639F49F182|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||HOMEOPATHIC DILUTION|||NMOL|NOT DONE||N|NA|Y|1||38||FOLLOW-UP|1962-03-25||1963-10-07|||1962-02-16||1961-05-18
TRIAL STUDY 134XCP|RP|5B420A5A-DB2C-48D2-8E9B-97639F49F182|1||||||ULCERIND|ULCER INDICATOR||||DAMOL/L|||TABLET|NOT DONE||U|Y|NA|2||58||RUN-IN|1969-06-19||1970-01-03|||1969-09-06||1969-08-23
TRIAL STUDY 134XCP|RP|5B420A5A-DB2C-48D2-8E9B-97639F49F182|2||||||PRGENDTC|DATE PREGNANCY ENDED||||ENZYME U/M2|||ML/ANIMAL/DAY|NOT DONE||Y|N|N|2||58||BASELINE|1972-06-19||1960-12-11|||1965-02-12||1960-10-04
TRIAL STUDY 134XCP|RP|5B420A5A-DB2C-48D2-8E9B-97639F49F182|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||KG/L|||KHZ|NOT DONE||NA|U|Y|3||39||BASELINE|1962-02-18||1960-06-04|||1967-12-11||1963-03-01
TRIAL STUDY 134XCP|RP|5B420A5A-DB2C-48D2-8E9B-97639F49F182|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||KG/L|||G/L|NOT DONE||Y|U|U|3||39||LONG-TERM FOLLOW-UP|1969-12-22||1969-06-14|||1973-05-14||1962-08-18
TRIAL STUDY 134XCP|RP|5B420A5A-DB2C-48D2-8E9B-97639F49F182|1||||||MENFDUR|MENSES FLOW DURATION||||MPH|||UCI|NOT DONE||N|Y|N|4||88||RUN-IN|1969-08-26||1968-07-10|||1970-09-26||1964-07-11
TRIAL STUDY 134XCP|RP|5B420A5A-DB2C-48D2-8E9B-97639F49F182|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||STEPS|||PFU|NOT DONE||U|N|U|4||88||FOLLOW-UP|1966-05-21||1971-12-10|||1967-01-22||1965-01-04
TRIAL STUDY 134XCP|RP|5B420A5A-DB2C-48D2-8E9B-97639F49F182|1||||||PRGENDTC|DATE PREGNANCY ENDED||||/2500 WBC|||1/(S*KPA)|NOT DONE||NA|NA|N|5||7||WASHOUT|1971-07-06||1960-12-02|||1964-08-23||1970-07-09
TRIAL STUDY 134XCP|RP|5B420A5A-DB2C-48D2-8E9B-97639F49F182|2||||||BRTHN|NUMBER OF BIRTHS||||CCID 50/ML|||TUBERCULIN UNIT/ML|NOT DONE||U|NA|NA|5||7||CONTINUATION TREATMENT|1969-02-10||1973-07-12|||1961-03-30||1963-07-15
TRIAL STUDY 134XCP|RP|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|1||||||GRAVIND|GRAVIDA INDICATOR||||UIU/L|||MOL/MOL|NOT DONE||U|N|NA|1||38||FOLLOW-UP|1961-04-11||1962-02-06|||1967-08-11||1970-06-24
TRIAL STUDY 134XCP|RP|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||10^4 CFU/ML|||ML/CAGE/WK|NOT DONE||Y|N|NA|1||38||FOLLOW-UP|1967-05-11||1970-08-31|||1961-02-28||1962-01-07
TRIAL STUDY 134XCP|RP|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||QUANTITY SUFFICIENT|||SBE/ML|NOT DONE||NA|U|U|2||58||SCREENING|1970-12-25||1972-11-05|||1963-07-26||1963-04-04
TRIAL STUDY 134XCP|RP|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|2||||||PREGNN|NUMBER OF PREGNANCIES||||MOL|||U/G HB|NOT DONE||N|Y|Y|2||58||CONTINUATION TREATMENT|1971-06-10||1967-06-21|||1971-03-01||1971-05-01
TRIAL STUDY 134XCP|RP|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MEQ/DAY|||CCID 50/ML|NOT DONE||Y|Y|NA|3||39||TREATMENT|1967-04-09||1972-03-18|||1971-12-07||1964-10-30
TRIAL STUDY 134XCP|RP|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|2||||||STILBIND|STILLBIRTH INDICATOR||||BQ/UL|||S^-1(%O2)^-1|NOT DONE||N|U|NA|3||39||INDUCTION TREATMENT|1967-05-10||1962-04-11|||1964-11-03||1965-06-30
TRIAL STUDY 134XCP|RP|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|1||||||PREGST|PREGNANT DURING THE STUDY||||UG/G/DAY|||PMOL/10^10 CELLS|NOT DONE||Y|NA|U|4||88||TREATMENT|1962-03-15||1972-08-05|||1966-09-06||1961-07-28
TRIAL STUDY 134XCP|RP|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|2||||||INTP|INTERPRETATION||||G/CAGE|||PATCH|NOT DONE||NA|U|N|4||88||BLINDED TREATMENT|1963-01-18||1971-08-04|||1968-08-12||1967-07-09
TRIAL STUDY 134XCP|RP|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|1||||||EDEMAIND|EDEMA INDICATOR||||KEV|||ML/M2/H|NOT DONE||N|U|NA|5||7||FOLLOW-UP|1960-02-11||1970-07-25|||1969-07-16||1963-10-21
TRIAL STUDY 134XCP|RP|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ABSORBANCE U/ML|||ABSORBANCE U|NOT DONE||Y|NA|NA|5||7||INDUCTION TREATMENT|1970-02-20||1968-06-24|||1960-10-31||1973-03-14
TRIAL STUDY 134XCP|RP|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UEQ|||USEC|NOT DONE||Y|Y|N|1||38||RUN-IN|1967-07-20||1972-02-14|||1966-10-22||1972-04-20
TRIAL STUDY 134XCP|RP|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||UMOL/L/H|||F|NOT DONE||NA|Y|NA|1||38||RUN-IN|1963-07-17||1960-05-02|||1971-06-12||1970-03-31
TRIAL STUDY 134XCP|RP|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MET*H|||KA_U/DL|NOT DONE||NA|N|N|2||58||INDUCTION TREATMENT|1971-01-27||1963-05-27|||1963-02-09||1969-03-29
TRIAL STUDY 134XCP|RP|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|2||||||ULCERIND|ULCER INDICATOR||||UG/CM2|||UG/G/H|NOT DONE||Y|N|U|2||58||OBSERVATION|1965-03-03||1971-01-24|||1970-01-27||1967-01-27
TRIAL STUDY 134XCP|RP|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||STEPS/MIN|||ML/M2/H|NOT DONE||N|N|N|3||39||TREATMENT|1969-02-11||1961-05-26|||1967-07-15||1965-09-12
TRIAL STUDY 134XCP|RP|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|2||||||MASSIND|MASS INDICATOR||||UG/MIN|||BQ/UG|NOT DONE||U|U|NA|3||39||CONTINUATION TREATMENT|1965-09-16||1970-01-05|||1962-03-20||1962-01-04
TRIAL STUDY 134XCP|RP|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||UMOL|||GRAVITATIONAL UNIT|NOT DONE||N|U|Y|4||88||WASHOUT|1970-07-10||1962-04-06|||1972-02-14||1966-01-01
TRIAL STUDY 134XCP|RP|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||M|||UMOL/L/SEC|NOT DONE||NA|N|NA|4||88||INDUCTION TREATMENT|1960-05-23||1964-07-04|||1964-11-12||1971-01-04
TRIAL STUDY 134XCP|RP|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||NKAT/G HB|||AGU/ML|NOT DONE||NA|U|N|5||7||CONTINUATION TREATMENT|1960-03-04||1965-10-13|||1963-10-01||1963-12-03
TRIAL STUDY 134XCP|RP|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|2||||||INABOIND|INDUCED ABORTION INDICATOR||||UMOL/DAY|||CFU/G|NOT DONE||Y|N|Y|5||7||RUN-IN|1964-09-08||1971-01-06|||1963-06-12||1962-01-31
TRIAL STUDY 134XCP|RP|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|1||||||MENOSTAT|MENOPAUSE STATUS||||L/H/M2|||ECL UNIT|NOT DONE||U|Y|NA|1||38||BASELINE|1960-03-17||1965-05-14|||1960-08-22||1963-08-09
TRIAL STUDY 134XCP|RP|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||KBQ/UL|||HZ/S|NOT DONE||NA|U|N|1||38||TREATMENT|1967-05-19||1973-07-29|||1967-03-10||1969-05-11
TRIAL STUDY 134XCP|RP|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||FT|||UMOL/L|NOT DONE||N|Y|N|2||58||BLINDED TREATMENT|1967-09-01||1962-03-02|||1960-08-18||1960-10-12
TRIAL STUDY 134XCP|RP|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||PG/DL|||SEC|NOT DONE||Y|N|N|2||58||INDUCTION TREATMENT|1964-07-18||1960-02-13|||1965-06-03||1960-01-21
TRIAL STUDY 134XCP|RP|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||CI/UG|||L|NOT DONE||N|U|U|3||39||BASELINE|1962-07-27||1970-08-03|||1960-08-12||1972-01-21
TRIAL STUDY 134XCP|RP|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UIU/L|||10^3 DNA COPIES/ML|NOT DONE||Y|Y|NA|3||39||TREATMENT|1970-12-12||1967-10-23|||1972-10-12||1962-09-03
TRIAL STUDY 134XCP|RP|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|1||||||TNDRIND|TENDERNESS INDICATOR||||ML/CM H2O|||UG/CM2|NOT DONE||N|N|Y|4||88||OPEN LABEL TREATMENT|1970-09-20||1966-10-14|||1962-01-23||1965-03-18
TRIAL STUDY 134XCP|RP|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|2||||||ERYTHIND|ERYTHEMA INDICATOR||||10^7 CFU|||IU/MMOL|NOT DONE||N|Y|U|4||88||SCREENING|1966-08-12||1971-04-25|||1961-05-09||1961-10-25
TRIAL STUDY 134XCP|RP|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||EID 50/DOSE|||PMOL|NOT DONE||N|Y|NA|5||7||OPEN LABEL TREATMENT|1960-04-06||1969-02-27|||1969-11-19||1973-04-02
TRIAL STUDY 134XCP|RP|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||ANSON U|||STEPS/MIN|NOT DONE||U|N|NA|5||7||SCREENING|1966-02-13||1961-05-30|||1971-02-10||1969-06-06
TRIAL STUDY 134XCP|RP|9B95CE9F-E755-463A-92EC-07A55EE8A58F|1||||||ULCERIND|ULCER INDICATOR||||EQ|||ML/MIN|NOT DONE||Y|N|Y|1||38||INDUCTION TREATMENT|1970-08-08||1964-04-17|||1967-04-14||1962-01-01
TRIAL STUDY 134XCP|RP|9B95CE9F-E755-463A-92EC-07A55EE8A58F|2||||||ULCERIND|ULCER INDICATOR||||ML/MIN|||BQ/UL|NOT DONE||NA|NA|U|1||38||OBSERVATION|1966-06-11||1961-09-23|||1972-08-20||1970-07-03
TRIAL STUDY 134XCP|RP|9B95CE9F-E755-463A-92EC-07A55EE8A58F|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||OHM|||PM|NOT DONE||U|U|U|2||58||OPEN LABEL TREATMENT|1969-06-23||1966-04-14|||1961-08-07||1969-10-09
TRIAL STUDY 134XCP|RP|9B95CE9F-E755-463A-92EC-07A55EE8A58F|2||||||PEELIND|PEELING INDICATOR||||L/DAY|||L/H/M2|NOT DONE||U|Y|NA|2||58||FOLLOW-UP|1970-08-28||1961-05-08|||1970-01-22||1969-04-17
TRIAL STUDY 134XCP|RP|9B95CE9F-E755-463A-92EC-07A55EE8A58F|1||||||INABOIND|INDUCED ABORTION INDICATOR||||VP/ML|||K|NOT DONE||Y|N|Y|3||39||BLINDED TREATMENT|1970-11-08||1967-04-27|||1962-02-06||1961-06-01
TRIAL STUDY 134XCP|RP|9B95CE9F-E755-463A-92EC-07A55EE8A58F|2||||||ABORTN|NUMBER OF ABORTIONS||||PPTR|||NKAT|NOT DONE||NA|N|NA|3||39||BLINDED TREATMENT|1972-10-02||1968-12-23|||1965-01-22||1967-11-27
TRIAL STUDY 134XCP|RP|9B95CE9F-E755-463A-92EC-07A55EE8A58F|1||||||PREGIND|PREGNANT INDICATOR||||GBQ/UG|||PL|NOT DONE||N|N|N|4||88||SCREENING|1972-10-27||1969-03-09|||1964-06-22||1961-10-19
TRIAL STUDY 134XCP|RP|9B95CE9F-E755-463A-92EC-07A55EE8A58F|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||H*%|||LENS|NOT DONE||U|NA|U|4||88||OPEN LABEL TREATMENT|1968-08-27||1972-11-08|||1969-09-02||1964-08-06
TRIAL STUDY 134XCP|RP|9B95CE9F-E755-463A-92EC-07A55EE8A58F|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||/500 WBC|||BE/ML|NOT DONE||NA|U|NA|5||7||INDUCTION TREATMENT|1973-07-10||1971-02-23|||1970-05-07||1973-06-07
TRIAL STUDY 134XCP|RP|9B95CE9F-E755-463A-92EC-07A55EE8A58F|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||GPELISA UNIT/ML|||GBQ/MG|NOT DONE||N|N|Y|5||7||CONTINUATION TREATMENT|1973-06-02||1963-08-22|||1966-10-03||1971-09-30
TRIAL STUDY 134XCP|RP|ED388A78-3B06-4529-861A-0174E7F345C2|1||||||DLVRMODE|MODE OF DELIVERY||||MMHG|||LOG10 CFU/ML|NOT DONE||NA|U|N|1||38||SCREENING|1966-02-08||1969-12-03|||1966-10-08||1966-01-04
TRIAL STUDY 134XCP|RP|ED388A78-3B06-4529-861A-0174E7F345C2|2||||||ERYTHIND|ERYTHEMA INDICATOR||||NG/DL|||/500 WBC|NOT DONE||N|NA|Y|1||38||CONTINUATION TREATMENT|1963-09-02||1961-01-07|||1964-08-27||1964-08-18
TRIAL STUDY 134XCP|RP|ED388A78-3B06-4529-861A-0174E7F345C2|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||ABSORBANCE U/ML|||PACK|NOT DONE||Y|N|Y|2||58||RUN-IN|1973-07-22||1971-12-30|||1965-12-06||1965-07-21
TRIAL STUDY 134XCP|RP|ED388A78-3B06-4529-861A-0174E7F345C2|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MG|||U/KG/DAY|NOT DONE||NA|U|U|2||58||BASELINE|1963-04-17||1972-09-14|||1962-08-01||1967-08-14
TRIAL STUDY 134XCP|RP|ED388A78-3B06-4529-861A-0174E7F345C2|1||||||RASHIND|RASH INDICATOR||||NKAT|||VP/ML|NOT DONE||U|NA|NA|3||39||BLINDED TREATMENT|1968-03-06||1962-12-02|||1960-12-16||1971-09-26
TRIAL STUDY 134XCP|RP|ED388A78-3B06-4529-861A-0174E7F345C2|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||JDF UNIT|||/10^5|NOT DONE||NA|NA|N|3||39||RUN-IN|1965-10-10||1960-02-25|||1962-01-17||1960-08-16
TRIAL STUDY 134XCP|RP|ED388A78-3B06-4529-861A-0174E7F345C2|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UMOL/DL|||G/KG/DAY|NOT DONE||U|U|U|4||88||LONG-TERM FOLLOW-UP|1965-06-28||1973-08-25|||1972-02-17||1964-03-21
TRIAL STUDY 134XCP|RP|ED388A78-3B06-4529-861A-0174E7F345C2|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||SCM|||KG/M2|NOT DONE||NA|NA|N|4||88||RUN-IN|1968-02-23||1964-08-19|||1971-01-30||1971-09-15
TRIAL STUDY 134XCP|RP|ED388A78-3B06-4529-861A-0174E7F345C2|1||||||THICK|THICKNESS||||CI/UG|||RATIO|NOT DONE||NA|Y|Y|5||7||LONG-TERM FOLLOW-UP|1970-09-13||1970-12-04|||1960-10-01||1965-07-12
TRIAL STUDY 134XCP|RP|ED388A78-3B06-4529-861A-0174E7F345C2|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ML/KG/DAY|||LOG EID 50/DOSE|NOT DONE||N|N|U|5||7||OBSERVATION|1967-11-20||1966-08-30|||1963-06-01||1973-08-24
TRIAL STUDY 134XCP|RP|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|1||||||THICK|THICKNESS||||IN|||/MS|NOT DONE||NA|U|Y|1||38||RUN-IN|1964-02-09||1973-01-07|||1967-11-06||1961-01-03
TRIAL STUDY 134XCP|RP|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||HPA|||10^6/HPF|NOT DONE||N|N|N|1||38||CONTINUATION TREATMENT|1972-01-23||1971-08-30|||1966-09-01||1967-09-06
TRIAL STUDY 134XCP|RP|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||VOXEL|||RPM|NOT DONE||U|Y|NA|2||58||BASELINE|1963-12-03||1966-11-29|||1963-12-17||1966-06-11
TRIAL STUDY 134XCP|RP|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||UG/L|||CMH2O/ML|NOT DONE||Y|N|N|2||58||WASHOUT|1960-03-10||1967-08-25|||1970-09-23||1966-10-12
TRIAL STUDY 134XCP|RP|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||10^9/L|||TSP|NOT DONE||Y|Y|U|3||39||INDUCTION TREATMENT|1966-05-28||1966-10-17|||1966-07-12||1970-07-13
TRIAL STUDY 134XCP|RP|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|2||||||ERYTHIND|ERYTHEMA INDICATOR||||TRANSDUCING UNIT|||PPTH|NOT DONE||NA|NA|Y|3||39||INDUCTION TREATMENT|1969-07-25||1962-02-11|||1961-01-23||1969-08-05
TRIAL STUDY 134XCP|RP|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|1||||||MENOAGE|MENOPAUSE AGE||||IU/MG|||MG/MIN|NOT DONE||N|N|N|4||88||BLINDED TREATMENT|1972-01-12||1965-12-26|||1973-08-01||1965-12-18
TRIAL STUDY 134XCP|RP|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|2||||||GRAVIND|GRAVIDA INDICATOR||||MCI/KG|||FRACTION OF 1|NOT DONE||Y|Y|Y|4||88||OBSERVATION|1966-08-29||1964-11-21|||1968-11-19||1961-08-23
TRIAL STUDY 134XCP|RP|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||DRAM|||/MM2|NOT DONE||N|N|N|5||7||OPEN LABEL TREATMENT|1965-06-20||1963-05-05|||1965-03-24||1971-10-04
TRIAL STUDY 134XCP|RP|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|2||||||PEELIND|PEELING INDICATOR||||H*%|||UG/MOL|NOT DONE||Y|Y|U|5||7||TREATMENT|1964-01-31||1971-09-11|||1972-12-25||1967-10-06
TRIAL STUDY 134XCP|RP|172AB680-362D-488C-9DF1-E1C8E386980D|1||||||ABORTN|NUMBER OF ABORTIONS||||ML/KG/H|||S^-1(%O2)^-1|NOT DONE||NA|Y|NA|1||38||LONG-TERM FOLLOW-UP|1965-09-06||1962-12-18|||1972-10-05||1972-02-21
TRIAL STUDY 134XCP|RP|172AB680-362D-488C-9DF1-E1C8E386980D|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||/5X10^4 WBC|||U/MMOL|NOT DONE||NA|N|N|1||38||OPEN LABEL TREATMENT|1964-07-11||1967-08-26|||1965-04-27||1968-03-05
TRIAL STUDY 134XCP|RP|172AB680-362D-488C-9DF1-E1C8E386980D|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MAC50|||10^9/L|NOT DONE||U|NA|Y|2||58||FOLLOW-UP|1962-05-17||1964-06-15|||1970-02-10||1967-08-29
TRIAL STUDY 134XCP|RP|172AB680-362D-488C-9DF1-E1C8E386980D|2||||||MENOAGE|MENOPAUSE AGE||||EP U|||ML/CM3/MIN|NOT DONE||NA|U|NA|2||58||WASHOUT|1967-07-25||1960-01-28|||1960-11-03||1962-01-03
TRIAL STUDY 134XCP|RP|172AB680-362D-488C-9DF1-E1C8E386980D|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||KDA|||CM/S|NOT DONE||NA|NA|U|3||39||OBSERVATION|1969-12-12||1964-09-29|||1964-07-17||1964-01-22
TRIAL STUDY 134XCP|RP|172AB680-362D-488C-9DF1-E1C8E386980D|2||||||PREGST|PREGNANT DURING THE STUDY||||10^6 ORGANISMS/MG|||FRAMES/S|NOT DONE||NA|N|N|3||39||FOLLOW-UP|1969-03-05||1963-04-18|||1965-09-30||1969-10-06
TRIAL STUDY 134XCP|RP|172AB680-362D-488C-9DF1-E1C8E386980D|1||||||GRAVIND|GRAVIDA INDICATOR||||ML/S|||ML/G/MIN|NOT DONE||U|U|N|4||88||TREATMENT|1963-12-31||1963-11-08|||1961-03-18||1960-01-22
TRIAL STUDY 134XCP|RP|172AB680-362D-488C-9DF1-E1C8E386980D|2||||||MENARAGE|MENARCHE AGE||||NG/DL|||G/M2|NOT DONE||U|Y|NA|4||88||INDUCTION TREATMENT|1970-10-10||1969-05-01|||1973-09-06||1967-10-12
TRIAL STUDY 134XCP|RP|172AB680-362D-488C-9DF1-E1C8E386980D|1||||||PRGENDTC|DATE PREGNANCY ENDED||||HEP|||MESF|NOT DONE||NA|Y|NA|5||7||WASHOUT|1973-01-26||1964-11-16|||1960-01-08||1964-03-17
TRIAL STUDY 134XCP|RP|172AB680-362D-488C-9DF1-E1C8E386980D|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||/H|||10^6/EJACULATE U|NOT DONE||Y|U|U|5||7||WASHOUT|1969-02-21||1972-08-06|||1971-09-08||1968-08-22
TRIAL STUDY 134XCP|RP|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|1||||||BRTHN|NUMBER OF BIRTHS||||% INHIBITION|||CMHG|NOT DONE||U|NA|NA|1||38||TREATMENT|1968-06-21||1961-06-09|||1965-10-17||1969-05-05
TRIAL STUDY 134XCP|RP|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|2||||||EDEMAIND|EDEMA INDICATOR||||ML/BREATH|||MIN/DAY|NOT DONE||Y|NA|Y|1||38||SCREENING|1962-01-15||1960-11-23|||1970-06-01||1969-02-18
TRIAL STUDY 134XCP|RP|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||EIA UNIT|||PMOL/G|NOT DONE||N|Y|N|2||58||TREATMENT|1969-06-11||1964-04-28|||1972-05-21||1963-06-22
TRIAL STUDY 134XCP|RP|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|2||||||BCMETHOD|BIRTH CONTROL METHOD||||10^8 PFU|||CM|NOT DONE||Y|Y|NA|2||58||FOLLOW-UP|1961-01-23||1964-05-23|||1963-07-24||1972-05-11
TRIAL STUDY 134XCP|RP|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|1||||||BRTHN|NUMBER OF BIRTHS||||UMOL|||BQ/UG|NOT DONE||Y|NA|Y|3||39||RUN-IN|1964-05-15||1961-10-15|||1970-02-23||1972-09-27
TRIAL STUDY 134XCP|RP|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||MPH|||IN|NOT DONE||N|N|Y|3||39||INDUCTION TREATMENT|1968-07-20||1969-09-15|||1960-09-06||1970-01-05
TRIAL STUDY 134XCP|RP|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||APS U|||C|NOT DONE||NA|NA|U|4||88||LONG-TERM FOLLOW-UP|1963-04-23||1964-12-06|||1964-03-02||1961-04-03
TRIAL STUDY 134XCP|RP|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||BISCUIT|||AMPULE|NOT DONE||NA|NA|NA|4||88||CONTINUATION TREATMENT|1962-10-24||1968-11-26|||1968-02-22||1970-08-17
TRIAL STUDY 134XCP|RP|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|1||||||PEELIND|PEELING INDICATOR||||MG/L FEU|||MAC50|NOT DONE||NA|Y|N|5||7||SCREENING|1972-02-21||1972-10-23|||1963-05-31||1971-10-12
TRIAL STUDY 134XCP|RP|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|2||||||PREGST|PREGNANT DURING THE STUDY||||DEG/MM|||PG/CELL|NOT DONE||U|N|NA|5||7||FOLLOW-UP|1973-02-06||1968-02-05|||1966-10-29||1970-01-20
TRIAL STUDY 134XCP|RP|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|1||||||GRAVIND|GRAVIDA INDICATOR||||UL/ML|||G/CM2|NOT DONE||N|N|N|1||38||BASELINE|1973-07-15||1965-02-10|||1960-07-06||1968-01-15
TRIAL STUDY 134XCP|RP|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|2||||||EDEMAIND|EDEMA INDICATOR||||IU/DAY|||L/MIN|NOT DONE||Y|N|NA|1||38||TREATMENT|1965-08-26||1970-05-08|||1971-09-12||1973-06-12
TRIAL STUDY 134XCP|RP|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||V/V|||PPTR|NOT DONE||U|NA|U|2||58||TREATMENT|1972-08-08||1965-05-24|||1967-04-01||1965-11-02
TRIAL STUDY 134XCP|RP|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||QUANTITY SUFFICIENT|||FMOL/G|NOT DONE||Y|U|U|2||58||RUN-IN|1971-06-23||1967-02-06|||1965-08-31||1972-09-27
TRIAL STUDY 134XCP|RP|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|1||||||FUNDHT|FUNDAL HEIGHT||||/WK|||KPA|NOT DONE||U|Y|U|3||39||LONG-TERM FOLLOW-UP|1966-02-05||1965-11-13|||1967-10-26||1963-04-01
TRIAL STUDY 134XCP|RP|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|2||||||BLISTIND|BLISTERING INDICATOR||||MPS U|||ML/SEC/1.73M2|NOT DONE||NA|N|U|3||39||OPEN LABEL TREATMENT|1968-08-14||1969-12-27|||1963-11-10||1967-09-20
TRIAL STUDY 134XCP|RP|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|1||||||PEELIND|PEELING INDICATOR||||UKAT|||GBQ/UG|NOT DONE||NA|Y|N|4||88||TREATMENT|1964-07-20||1969-03-09|||1960-12-14||1970-01-12
TRIAL STUDY 134XCP|RP|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MG/DOSE|||IU/KG/H|NOT DONE||N|N|NA|4||88||SCREENING|1961-10-04||1966-11-28|||1964-03-22||1963-07-09
TRIAL STUDY 134XCP|RP|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UG/L DDU|||IU/MMOL|NOT DONE||NA|NA|U|5||7||FOLLOW-UP|1970-12-01||1962-11-18|||1972-11-25||1967-10-20
TRIAL STUDY 134XCP|RP|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|2||||||TNDRIND|TENDERNESS INDICATOR||||ELISA UNIT|||MEQ/UG|NOT DONE||U|Y|NA|5||7||BASELINE|1966-12-16||1962-04-18|||1963-03-02||1961-06-16
TRIAL STUDY 134XCP|RP|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|1||||||THICK|THICKNESS||||UL/ML|||YD|NOT DONE||N|NA|Y|1||38||BASELINE|1966-06-19||1963-06-07|||1967-10-28||1967-01-01
TRIAL STUDY 134XCP|RP|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||LOG10 CCID 50/DOSE|||CM2|NOT DONE||N|N|U|1||38||RUN-IN|1973-03-03||1971-03-17|||1972-12-18||1969-01-12
TRIAL STUDY 134XCP|RP|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||L|||UIU/DL|NOT DONE||U|Y|U|2||58||BLINDED TREATMENT|1968-06-29||1971-12-05|||1969-01-24||1968-05-08
TRIAL STUDY 134XCP|RP|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||PATCH|||IMPLANT|NOT DONE||Y|U|U|2||58||CONTINUATION TREATMENT|1960-03-22||1960-05-14|||1962-06-22||1969-02-07
TRIAL STUDY 134XCP|RP|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||CMOL/L|||ELISA UNIT/ML|NOT DONE||NA|U|NA|3||39||BASELINE|1962-06-29||1961-02-26|||1961-06-27||1966-10-30
TRIAL STUDY 134XCP|RP|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|2||||||GRAVIND|GRAVIDA INDICATOR||||CD*S/M2|||MG/KG|NOT DONE||Y|U|N|3||39||SCREENING|1972-03-03||1973-08-28|||1968-09-01||1966-08-27
TRIAL STUDY 134XCP|RP|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|1||||||RASHIND|RASH INDICATOR||||PHERESIS UNIT|||NG/DL|NOT DONE||Y|NA|NA|4||88||BASELINE|1970-11-03||1969-03-22|||1964-03-18||1964-07-21
TRIAL STUDY 134XCP|RP|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|2||||||TNDRIND|TENDERNESS INDICATOR||||10^3/L|||ML/100G/MIN|NOT DONE||U|N|U|4||88||WASHOUT|1961-03-27||1963-08-16|||1966-04-15||1970-01-09
TRIAL STUDY 134XCP|RP|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||GLOBULE|||10^3 ORGANISMS|NOT DONE||U|NA|NA|5||7||BLINDED TREATMENT|1969-04-08||1962-12-22|||1961-02-19||1965-09-29
TRIAL STUDY 134XCP|RP|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|2||||||MASSIND|MASS INDICATOR||||TSP EQ|||LX|NOT DONE||NA|NA|NA|5||7||WASHOUT|1971-06-06||1970-05-18|||1966-07-07||1967-04-20
TRIAL STUDY 134XCP|RP|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||FT3|||10^3 ORGANISMS/ML|NOT DONE||Y|N|NA|1||38||OBSERVATION|1969-12-05||1969-02-07|||1965-07-16||1973-07-23
TRIAL STUDY 134XCP|RP|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||DRAM|||UCI|NOT DONE||U|U|U|1||38||FOLLOW-UP|1966-02-13||1962-01-10|||1960-03-16||1972-03-14
TRIAL STUDY 134XCP|RP|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||GY|||TRANSDUCING UNIT|NOT DONE||N|NA|N|2||58||OBSERVATION|1968-01-17||1965-05-09|||1967-03-04||1972-03-25
TRIAL STUDY 134XCP|RP|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|2||||||MENOAGE|MENOPAUSE AGE||||/WK|||ROENTGEN|NOT DONE||N|U|N|2||58||BASELINE|1966-09-14||1967-11-22|||1968-01-10||1969-06-05
TRIAL STUDY 134XCP|RP|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||CI/UL|||DEG|NOT DONE||N|N|N|3||39||SCREENING|1967-04-11||1963-08-15|||1965-05-04||1971-10-03
TRIAL STUDY 134XCP|RP|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||G/U|||NG|NOT DONE||N|NA|Y|3||39||BASELINE|1972-08-13||1965-01-05|||1971-11-27||1967-08-24
TRIAL STUDY 134XCP|RP|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|1||||||MENFDUR|MENSES FLOW DURATION||||CYCLE/MIN|||KBQ/UL|NOT DONE||U|N|Y|4||88||INDUCTION TREATMENT|1969-12-01||1967-06-17|||1972-11-01||1965-05-19
TRIAL STUDY 134XCP|RP|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||U/KG/MIN|||PKAT/L|NOT DONE||U|U|Y|4||88||WASHOUT|1967-09-17||1972-07-08|||1973-05-18||1970-03-02
TRIAL STUDY 134XCP|RP|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|1||||||PREGNN|NUMBER OF PREGNANCIES||||PFU/ML|||MN|NOT DONE||NA|NA|NA|5||7||LONG-TERM FOLLOW-UP|1964-05-11||1973-09-07|||1969-02-03||1968-07-30
TRIAL STUDY 134XCP|RP|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|2||||||BCMETHOD|BIRTH CONTROL METHOD||||TRACE|||NMOL BCE/NMOL|NOT DONE||U|U|Y|5||7||FOLLOW-UP|1960-01-03||1961-05-13|||1973-07-08||1968-04-04
TRIAL STUDY 134XCP|RP|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||L/L|||PPTR|NOT DONE||U|N|Y|1||38||SCREENING|1969-04-22||1962-12-21|||1967-09-24||1969-01-30
TRIAL STUDY 134XCP|RP|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||BAU/ML|||FOZ_US|NOT DONE||NA|Y|U|1||38||LONG-TERM FOLLOW-UP|1967-01-20||1961-02-25|||1963-01-14||1962-05-26
TRIAL STUDY 134XCP|RP|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^6 DNA COPIES/ML|||10^3 CFU/ML|NOT DONE||Y|U|NA|2||58||BLINDED TREATMENT|1968-03-15||1962-11-22|||1968-12-26||1969-09-28
TRIAL STUDY 134XCP|RP|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|2||||||PRGENDTC|DATE PREGNANCY ENDED||||PMOL|||U/M2/H|NOT DONE||NA|N|N|2||58||OPEN LABEL TREATMENT|1969-06-28||1968-06-25|||1972-09-08||1966-07-31
TRIAL STUDY 134XCP|RP|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|1||||||EDEMAIND|EDEMA INDICATOR||||UG/DOSE|||PACKAGE|NOT DONE||N|NA|NA|3||39||OPEN LABEL TREATMENT|1962-02-05||1970-04-26|||1960-09-21||1969-08-02
TRIAL STUDY 134XCP|RP|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/2000 RBC|||MPL U|NOT DONE||NA|NA|NA|3||39||BLINDED TREATMENT|1960-04-24||1973-05-04|||1968-01-27||1968-02-09
TRIAL STUDY 134XCP|RP|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|1||||||PUSTIND|PUSTULE INDICATOR||||ARBITRARY U|||QUANTITY SUFFICIENT|NOT DONE||N|U|N|4||88||INDUCTION TREATMENT|1960-03-28||1969-05-30|||1966-04-07||1970-10-06
TRIAL STUDY 134XCP|RP|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|2||||||ABORTN|NUMBER OF ABORTIONS||||HENRY|||MMHG/L/MIN|NOT DONE||N|NA|U|4||88||WASHOUT|1972-04-06||1965-12-19|||1968-03-11||1965-10-30
TRIAL STUDY 134XCP|RP|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|1||||||EDEMAIND|EDEMA INDICATOR||||CG|||DEG|NOT DONE||Y|NA|NA|5||7||INDUCTION TREATMENT|1962-05-18||1972-08-21|||1964-02-14||1968-02-24
TRIAL STUDY 134XCP|RP|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|2||||||PREGNN|NUMBER OF PREGNANCIES||||NMOL/ML/MIN|||MSEC|NOT DONE||Y|NA|U|5||7||SCREENING|1962-07-13||1960-08-04|||1972-03-06||1964-01-28
TRIAL STUDY 134XCP|RP|740D80F1-8BD5-4409-8087-E48F94363362|1||||||DLVRMODE|MODE OF DELIVERY||||10^6 CFU/G|||G/M2|NOT DONE||Y|N|Y|1||38||BASELINE|1960-08-27||1968-05-20|||1968-05-04||1966-08-05
TRIAL STUDY 134XCP|RP|740D80F1-8BD5-4409-8087-E48F94363362|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||10^9 CFU|||ML*CMH2O|NOT DONE||NA|Y|Y|1||38||SCREENING|1964-08-12||1963-08-30|||1967-07-29||1964-05-20
TRIAL STUDY 134XCP|RP|740D80F1-8BD5-4409-8087-E48F94363362|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||S/H|||MIN/DAY|NOT DONE||NA|N|Y|2||58||OBSERVATION|1967-05-01||1969-02-12|||1971-08-12||1968-10-23
TRIAL STUDY 134XCP|RP|740D80F1-8BD5-4409-8087-E48F94363362|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MMHG/L/MIN|||NSEC|NOT DONE||Y|U|NA|2||58||CONTINUATION TREATMENT|1962-08-29||1967-05-09|||1969-11-03||1966-12-27
TRIAL STUDY 134XCP|RP|740D80F1-8BD5-4409-8087-E48F94363362|1||||||PRGENDTC|DATE PREGNANCY ENDED||||MV|||STEPS/MIN|NOT DONE||Y|NA|NA|3||39||BASELINE|1965-08-06||1963-10-15|||1971-03-21||1968-10-29
TRIAL STUDY 134XCP|RP|740D80F1-8BD5-4409-8087-E48F94363362|2||||||ERYTHIND|ERYTHEMA INDICATOR||||PATCH|||KG|NOT DONE||Y|NA|NA|3||39||SCREENING|1965-04-20||1972-11-01|||1964-02-06||1960-02-18
TRIAL STUDY 134XCP|RP|740D80F1-8BD5-4409-8087-E48F94363362|1||||||PREGNN|NUMBER OF PREGNANCIES||||LX|||1/(S*KPA)|NOT DONE||N|NA|Y|4||88||WASHOUT|1973-04-29||1962-01-23|||1969-12-17||1971-06-20
TRIAL STUDY 134XCP|RP|740D80F1-8BD5-4409-8087-E48F94363362|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||U/M2/MIN|||BOX|NOT DONE||U|N|Y|4||88||OPEN LABEL TREATMENT|1961-04-17||1970-12-05|||1969-03-06||1970-09-12
TRIAL STUDY 134XCP|RP|740D80F1-8BD5-4409-8087-E48F94363362|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||CMOL/L|||MEQ/MMOL|NOT DONE||Y|NA|Y|5||7||CONTINUATION TREATMENT|1966-08-28||1970-12-26|||1961-03-08||1970-07-05
TRIAL STUDY 134XCP|RP|740D80F1-8BD5-4409-8087-E48F94363362|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||ML/S|||10^3 RNA COPIES/ML|NOT DONE||N|Y|NA|5||7||OPEN LABEL TREATMENT|1966-09-06||1968-05-09|||1968-12-06||1960-04-17
TRIAL STUDY 134XCP|RP|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||IMPLANT|||JOULE|NOT DONE||U|Y|NA|1||38||RUN-IN|1971-02-10||1973-06-22|||1970-05-31||1966-10-08
TRIAL STUDY 134XCP|RP|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||ECL UNIT|||10^6 ORGANISMS/ML|NOT DONE||N|N|NA|1||38||TREATMENT|1964-02-27||1968-03-13|||1969-07-10||1962-09-06
TRIAL STUDY 134XCP|RP|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||CP|||UG/L|NOT DONE||Y|NA|Y|2||58||BLINDED TREATMENT|1965-10-31||1960-07-27|||1967-02-16||1972-04-07
TRIAL STUDY 134XCP|RP|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||DAYS/MONTH|||MEQ/ML|NOT DONE||N|NA|Y|2||58||RUN-IN|1966-04-22||1966-07-22|||1971-01-15||1962-07-28
TRIAL STUDY 134XCP|RP|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||NM|||ML/CM3/MIN|NOT DONE||U|N|U|3||39||LONG-TERM FOLLOW-UP|1972-07-02||1962-02-23|||1965-10-26||1961-04-10
TRIAL STUDY 134XCP|RP|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|2||||||ERYTHIND|ERYTHEMA INDICATOR||||CD/M2|||MG|NOT DONE||Y|Y|NA|3||39||WASHOUT|1972-06-02||1962-08-11|||1962-05-14||1970-08-30
TRIAL STUDY 134XCP|RP|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|1||||||FUNDHT|FUNDAL HEIGHT||||BREATHS/MIN|||TUBERCULIN UNIT/ML|NOT DONE||N|Y|NA|4||88||INDUCTION TREATMENT|1970-05-16||1963-05-17|||1970-05-17||1964-05-15
TRIAL STUDY 134XCP|RP|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|2||||||ERYTHIND|ERYTHEMA INDICATOR||||UG/M2/DAY|||M2|NOT DONE||NA|N|NA|4||88||FOLLOW-UP|1968-09-14||1962-03-08|||1965-12-12||1973-05-15
TRIAL STUDY 134XCP|RP|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||KIU|||PG/CELL|NOT DONE||NA|NA|U|5||7||BASELINE|1969-02-10||1969-01-10|||1968-08-09||1963-10-02
TRIAL STUDY 134XCP|RP|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|2||||||BCMETHOD|BIRTH CONTROL METHOD||||/100 WBC|||BAU|NOT DONE||N|U|N|5||7||BLINDED TREATMENT|1960-03-25||1973-03-30|||1965-03-22||1963-09-30
TRIAL STUDY 134XCP|RP|12AD3838-F986-4A27-8AEE-59C387988B0F|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||DROP|||CGY|NOT DONE||U|NA|U|1||38||RUN-IN|1965-10-10||1967-10-22|||1971-10-09||1971-01-08
TRIAL STUDY 134XCP|RP|12AD3838-F986-4A27-8AEE-59C387988B0F|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||HZ|||UKAT/L|NOT DONE||N|Y|N|1||38||RUN-IN|1965-10-24||1966-02-24|||1961-10-02||1971-11-09
TRIAL STUDY 134XCP|RP|12AD3838-F986-4A27-8AEE-59C387988B0F|1||||||ABORTN|NUMBER OF ABORTIONS||||V/V|||CM2|NOT DONE||Y|N|N|2||58||INDUCTION TREATMENT|1963-03-07||1970-01-27|||1966-05-07||1963-03-11
TRIAL STUDY 134XCP|RP|12AD3838-F986-4A27-8AEE-59C387988B0F|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||CARTRIDGE|||KS|NOT DONE||NA|NA|Y|2||58||BLINDED TREATMENT|1965-02-20||1967-10-01|||1960-05-18||1966-11-21
TRIAL STUDY 134XCP|RP|12AD3838-F986-4A27-8AEE-59C387988B0F|1||||||DLVRMODE|MODE OF DELIVERY||||EP U|||U|NOT DONE||U|U|U|3||39||CONTINUATION TREATMENT|1968-11-15||1970-07-02|||1973-09-06||1962-06-26
TRIAL STUDY 134XCP|RP|12AD3838-F986-4A27-8AEE-59C387988B0F|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||BQ|||KG/CM|NOT DONE||NA|N|NA|3||39||INDUCTION TREATMENT|1960-12-13||1968-01-02|||1973-06-07||1965-08-16
TRIAL STUDY 134XCP|RP|12AD3838-F986-4A27-8AEE-59C387988B0F|1||||||DLVRMODE|MODE OF DELIVERY||||MOSM/L|||U.CARR|NOT DONE||N|N|U|4||88||INDUCTION TREATMENT|1967-05-27||1973-06-09|||1971-05-25||1972-05-17
TRIAL STUDY 134XCP|RP|12AD3838-F986-4A27-8AEE-59C387988B0F|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||NL|||OD UNIT|NOT DONE||U|Y|NA|4||88||FOLLOW-UP|1967-06-24||1973-05-25|||1966-06-04||1964-10-26
TRIAL STUDY 134XCP|RP|12AD3838-F986-4A27-8AEE-59C387988B0F|1||||||PREGST|PREGNANT DURING THE STUDY||||PG/CELL|||ML/KG/MIN|NOT DONE||N|U|NA|5||7||RUN-IN|1969-04-09||1961-04-27|||1969-10-28||1960-08-07
TRIAL STUDY 134XCP|RP|12AD3838-F986-4A27-8AEE-59C387988B0F|2||||||ERYTHIND|ERYTHEMA INDICATOR||||UV2|||MAMP|NOT DONE||NA|U|N|5||7||FOLLOW-UP|1970-03-18||1968-07-18|||1968-05-11||1966-07-21
TRIAL STUDY 134XCP|RP|441F1A21-6350-478A-9719-75B053182B78|1||||||ULCERIND|ULCER INDICATOR||||G/DAY|||MOSM|NOT DONE||NA|N|U|1||38||TREATMENT|1971-12-03||1969-10-09|||1967-02-08||1961-11-24
TRIAL STUDY 134XCP|RP|441F1A21-6350-478A-9719-75B053182B78|2||||||INTP|INTERPRETATION||||WAFER|||TSP|NOT DONE||NA|Y|U|1||38||BLINDED TREATMENT|1964-02-20||1960-10-07|||1967-02-20||1966-11-17
TRIAL STUDY 134XCP|RP|441F1A21-6350-478A-9719-75B053182B78|1||||||PUSTIND|PUSTULE INDICATOR||||KM|||RNA COPIES/ML|NOT DONE||U|Y|Y|2||58||RUN-IN|1961-07-18||1965-09-03|||1969-10-25||1966-12-18
TRIAL STUDY 134XCP|RP|441F1A21-6350-478A-9719-75B053182B78|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||10^6/L|||ML/SEC/1.73M2|NOT DONE||NA|U|N|2||58||TREATMENT|1964-09-22||1972-09-13|||1960-07-03||1960-10-06
TRIAL STUDY 134XCP|RP|441F1A21-6350-478A-9719-75B053182B78|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||DPM/0.5 ML|||LOG10 CFU/ML|NOT DONE||NA|NA|Y|3||39||CONTINUATION TREATMENT|1966-12-05||1968-12-29|||1963-06-18||1962-08-25
TRIAL STUDY 134XCP|RP|441F1A21-6350-478A-9719-75B053182B78|2||||||DLVRMODE|MODE OF DELIVERY||||MG/ML/DAY|||/2500 WBC|NOT DONE||N|U|N|3||39||OBSERVATION|1960-12-25||1965-04-03|||1965-11-28||1972-03-01
TRIAL STUDY 134XCP|RP|441F1A21-6350-478A-9719-75B053182B78|1||||||DLVRMODE|MODE OF DELIVERY||||L/H|||V/V|NOT DONE||Y|Y|NA|4||88||TREATMENT|1971-08-11||1963-04-09|||1964-07-11||1960-07-29
TRIAL STUDY 134XCP|RP|441F1A21-6350-478A-9719-75B053182B78|2||||||THICK|THICKNESS||||PT_BR|||UM/S|NOT DONE||N|Y|NA|4||88||OBSERVATION|1965-10-26||1968-01-04|||1973-06-11||1967-04-20
TRIAL STUDY 134XCP|RP|441F1A21-6350-478A-9719-75B053182B78|1||||||INABOIND|INDUCED ABORTION INDICATOR||||GMFI|||MEQ|NOT DONE||NA|NA|NA|5||7||BASELINE|1961-10-02||1973-08-16|||1965-03-23||1965-05-20
TRIAL STUDY 134XCP|RP|441F1A21-6350-478A-9719-75B053182B78|2||||||MENOSTAT|MENOPAUSE STATUS||||PIXEL|||PMOL|NOT DONE||U|N|Y|5||7||WASHOUT|1972-05-16||1968-07-12|||1969-06-14||1963-05-30
TRIAL STUDY 134XCP|RP|A69520E2-01A5-4CBC-AFC9-00324531779F|1||||||BRTHN|NUMBER OF BIRTHS||||BQ/L|||HZ/S|NOT DONE||NA|Y|NA|1||38||BLINDED TREATMENT|1970-06-20||1967-07-26|||1972-07-15||1968-07-06
TRIAL STUDY 134XCP|RP|A69520E2-01A5-4CBC-AFC9-00324531779F|2||||||PEELIND|PEELING INDICATOR||||/SEC|||L/H/M2|NOT DONE||N|NA|U|1||38||TREATMENT|1969-10-05||1960-07-22|||1968-11-24||1960-11-26
TRIAL STUDY 134XCP|RP|A69520E2-01A5-4CBC-AFC9-00324531779F|1||||||TNDRIND|TENDERNESS INDICATOR||||PPTH|||MEQ|NOT DONE||N|NA|U|2||58||OPEN LABEL TREATMENT|1962-05-29||1966-12-17|||1964-12-13||1970-12-28
TRIAL STUDY 134XCP|RP|A69520E2-01A5-4CBC-AFC9-00324531779F|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||DIOPTER|||PPB|NOT DONE||N|N|U|2||58||RUN-IN|1970-06-21||1970-10-12|||1960-04-07||1964-01-01
TRIAL STUDY 134XCP|RP|A69520E2-01A5-4CBC-AFC9-00324531779F|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||AMFI|||BQ/UG|NOT DONE||Y|Y|N|3||39||SCREENING|1967-10-04||1969-02-11|||1963-04-30||1961-09-18
TRIAL STUDY 134XCP|RP|A69520E2-01A5-4CBC-AFC9-00324531779F|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||ROENTGEN|||KG/CM2|NOT DONE||Y|U|U|3||39||SCREENING|1960-09-14||1963-04-24|||1971-08-30||1968-03-27
TRIAL STUDY 134XCP|RP|A69520E2-01A5-4CBC-AFC9-00324531779F|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||GY/MIN|||FINGERTIP UNIT|NOT DONE||N|NA|U|4||88||LONG-TERM FOLLOW-UP|1973-04-12||1968-02-13|||1969-05-23||1963-10-28
TRIAL STUDY 134XCP|RP|A69520E2-01A5-4CBC-AFC9-00324531779F|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||GENEQ/ML|||/DAY|NOT DONE||Y|Y|NA|4||88||BASELINE|1961-09-24||1971-12-22|||1964-05-31||1966-11-28
TRIAL STUDY 134XCP|RP|A69520E2-01A5-4CBC-AFC9-00324531779F|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||HZ/S|||ML/MIN/1.73M2|NOT DONE||N|N|U|5||7||LONG-TERM FOLLOW-UP|1960-06-20||1969-05-04|||1962-09-03||1973-09-02
TRIAL STUDY 134XCP|RP|A69520E2-01A5-4CBC-AFC9-00324531779F|2||||||PUSTIND|PUSTULE INDICATOR||||BE/ML|||SBE/ML|NOT DONE||N|U|Y|5||7||SCREENING|1971-03-10||1967-10-17|||1962-05-04||1967-12-19
TRIAL STUDY 134XCP|RP|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||BEL|||10^5/L|NOT DONE||NA|Y|N|1||38||WASHOUT|1964-10-26||1967-09-06|||1967-01-15||1968-03-13
TRIAL STUDY 134XCP|RP|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|2||||||BLISTIND|BLISTERING INDICATOR||||MG/ANIMAL|||ML/DAY|NOT DONE||N|N|NA|1||38||WASHOUT|1964-09-22||1960-12-25|||1966-03-08||1965-02-25
TRIAL STUDY 134XCP|RP|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|1||||||MENARAGE|MENARCHE AGE||||MEQ/L|||JOULE|NOT DONE||N|U|NA|2||58||BLINDED TREATMENT|1962-03-20||1968-09-15|||1971-08-03||1969-06-14
TRIAL STUDY 134XCP|RP|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||CYCLE/MIN|||VG/KG|NOT DONE||Y|U|U|2||58||BASELINE|1961-09-15||1972-07-09|||1960-07-27||1961-01-08
TRIAL STUDY 134XCP|RP|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||10^9/G|||LB|NOT DONE||Y|NA|Y|3||39||TREATMENT|1964-01-17||1972-11-20|||1960-04-07||1972-05-06
TRIAL STUDY 134XCP|RP|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MNFI|||DMOL|NOT DONE||N|U|N|3||39||RUN-IN|1968-06-25||1971-12-13|||1965-04-14||1973-05-20
TRIAL STUDY 134XCP|RP|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||KIT|||MPL U|NOT DONE||U|N|NA|4||88||CONTINUATION TREATMENT|1961-12-13||1965-08-29|||1967-07-29||1972-07-19
TRIAL STUDY 134XCP|RP|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|2||||||MENARAGE|MENARCHE AGE||||UL/DOSE|||VG/ML|NOT DONE||N|Y|NA|4||88||CONTINUATION TREATMENT|1965-05-02||1973-03-01|||1968-12-23||1960-01-12
TRIAL STUDY 134XCP|RP|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UG/DAY|||UG/DOSE|NOT DONE||U|Y|U|5||7||FOLLOW-UP|1969-12-09||1966-09-12|||1960-11-12||1968-09-23
TRIAL STUDY 134XCP|RP|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|2||||||ERYTHIND|ERYTHEMA INDICATOR||||MM3/MM2/YEAR|||LOZENGE|NOT DONE||NA|NA|N|5||7||FOLLOW-UP|1962-06-26||1969-10-15|||1960-08-12||1972-05-04
TRIAL STUDY 134XCP|RP|C361B153-4623-4F03-9D81-8316B1046F35|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||BQ/MG|||CONTAINER|NOT DONE||N|U|Y|1||38||LONG-TERM FOLLOW-UP|1964-01-08||1966-11-27|||1960-05-05||1973-08-12
TRIAL STUDY 134XCP|RP|C361B153-4623-4F03-9D81-8316B1046F35|2||||||PREGST|PREGNANT DURING THE STUDY||||MG/M2/H|||MG/ANIMAL|NOT DONE||NA|NA|N|1||38||LONG-TERM FOLLOW-UP|1966-01-25||1963-02-23|||1970-01-20||1962-04-06
TRIAL STUDY 134XCP|RP|C361B153-4623-4F03-9D81-8316B1046F35|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||GTT|||1/(S*KPA)|NOT DONE||N|Y|Y|2||58||TREATMENT|1969-08-22||1967-05-21|||1968-05-20||1962-06-13
TRIAL STUDY 134XCP|RP|C361B153-4623-4F03-9D81-8316B1046F35|2||||||PREGNN|NUMBER OF PREGNANCIES||||MMOL/L|||L/MIN/M2|NOT DONE||N|Y|U|2||58||SCREENING|1971-12-02||1972-04-08|||1971-03-11||1971-05-05
TRIAL STUDY 134XCP|RP|C361B153-4623-4F03-9D81-8316B1046F35|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||PLUG|||U/MMOL|NOT DONE||U|Y|U|3||39||OPEN LABEL TREATMENT|1970-08-27||1968-11-29|||1960-02-03||1971-11-30
TRIAL STUDY 134XCP|RP|C361B153-4623-4F03-9D81-8316B1046F35|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||CI/UG|||MKAT|NOT DONE||N|N|N|3||39||OPEN LABEL TREATMENT|1965-12-02||1963-04-08|||1963-12-28||1973-05-02
TRIAL STUDY 134XCP|RP|C361B153-4623-4F03-9D81-8316B1046F35|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UG/DL|||/10^3|NOT DONE||Y|U|NA|4||88||SCREENING|1966-09-15||1962-12-21|||1966-11-27||1973-05-27
TRIAL STUDY 134XCP|RP|C361B153-4623-4F03-9D81-8316B1046F35|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||V/SEC|||UOSM|NOT DONE||NA|Y|NA|4||88||LONG-TERM FOLLOW-UP|1964-07-30||1965-10-15|||1964-05-30||1969-04-26
TRIAL STUDY 134XCP|RP|C361B153-4623-4F03-9D81-8316B1046F35|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||IU/MMOL|||FOZ_US|NOT DONE||U|NA|N|5||7||WASHOUT|1972-09-24||1962-02-28|||1969-04-01||1970-06-01
TRIAL STUDY 134XCP|RP|C361B153-4623-4F03-9D81-8316B1046F35|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||ML/KG/DAY|||FRACTION OF 1|NOT DONE||NA|U|NA|5||7||INDUCTION TREATMENT|1971-09-08||1969-02-14|||1962-06-02||1961-04-18
TRIAL STUDY 134XCP|RP|8FF0A93C-26D1-49E9-853F-B063A958FE1E|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||KM|||DNA COPIES/UG|NOT DONE||Y|NA|U|1||38||TREATMENT|1965-08-20||1964-08-20|||1966-04-28||1963-07-17
TRIAL STUDY 134XCP|RP|8FF0A93C-26D1-49E9-853F-B063A958FE1E|2||||||MENOSTAT|MENOPAUSE STATUS||||NG/L|||PG/L|NOT DONE||N|N|N|1||38||LONG-TERM FOLLOW-UP|1964-03-23||1972-07-15|||1963-04-30||1971-08-06
TRIAL STUDY 134XCP|RP|8FF0A93C-26D1-49E9-853F-B063A958FE1E|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UG/M2/DAY|||10^6 CFU/G|NOT DONE||U|U|NA|2||58||FOLLOW-UP|1967-02-18||1963-04-11|||1971-06-04||1962-04-27
TRIAL STUDY 134XCP|RP|8FF0A93C-26D1-49E9-853F-B063A958FE1E|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MPL U|||AMU|NOT DONE||N|N|Y|2||58||OBSERVATION|1972-09-29||1960-02-17|||1967-06-23||1968-04-12
TRIAL STUDY 134XCP|RP|8FF0A93C-26D1-49E9-853F-B063A958FE1E|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||CI/MG|||L/S|NOT DONE||NA|NA|NA|3||39||CONTINUATION TREATMENT|1972-09-22||1963-10-22|||1970-09-10||1964-04-15
TRIAL STUDY 134XCP|RP|8FF0A93C-26D1-49E9-853F-B063A958FE1E|2||||||MASSIND|MASS INDICATOR||||GRAVITATIONAL UNIT|||FOZ_US|NOT DONE||NA|N|NA|3||39||OPEN LABEL TREATMENT|1965-06-28||1963-01-29|||1965-10-05||1964-01-23
TRIAL STUDY 134XCP|RP|8FF0A93C-26D1-49E9-853F-B063A958FE1E|1||||||PEELIND|PEELING INDICATOR||||MV/SEC|||MDFI|NOT DONE||NA|N|Y|4||88||SCREENING|1970-12-25||1963-10-30|||1962-08-23||1972-08-03
TRIAL STUDY 134XCP|RP|8FF0A93C-26D1-49E9-853F-B063A958FE1E|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||10^12 IU/L|||PPM|NOT DONE||Y|NA|Y|4||88||OBSERVATION|1966-07-01||1963-04-04|||1968-12-19||1973-06-03
TRIAL STUDY 134XCP|RP|8FF0A93C-26D1-49E9-853F-B063A958FE1E|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||CI/UG|||PG/L|NOT DONE||NA|Y|N|5||7||TREATMENT|1972-06-17||1973-02-11|||1964-05-17||1961-04-07
TRIAL STUDY 134XCP|RP|8FF0A93C-26D1-49E9-853F-B063A958FE1E|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||CM|||UM2|NOT DONE||NA|Y|Y|5||7||TREATMENT|1972-04-09||1964-10-26|||1972-10-25||1973-02-11
TRIAL STUDY 134XCP|RP|31D8814B-5542-4540-B955-24410D42F1EF|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||RAD|||FG|NOT DONE||U|Y|NA|1||38||FOLLOW-UP|1965-10-04||1966-12-10|||1960-01-31||1968-07-02
TRIAL STUDY 134XCP|RP|31D8814B-5542-4540-B955-24410D42F1EF|2||||||BCMETHOD|BIRTH CONTROL METHOD||||10^4 CFU/ML|||MM3/MM2/YEAR|NOT DONE||U|U|Y|1||38||SCREENING|1971-12-17||1963-08-28|||1969-03-20||1971-04-20
TRIAL STUDY 134XCP|RP|31D8814B-5542-4540-B955-24410D42F1EF|1||||||INTP|INTERPRETATION||||FOZ_BR|||BE/ML|NOT DONE||N|U|Y|2||58||SCREENING|1960-09-19||1970-10-20|||1964-11-14||1970-11-22
TRIAL STUDY 134XCP|RP|31D8814B-5542-4540-B955-24410D42F1EF|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PT_US|||MG/KG/MIN|NOT DONE||U|N|NA|2||58||SCREENING|1969-12-11||1971-07-28|||1971-05-30||1963-01-07
TRIAL STUDY 134XCP|RP|31D8814B-5542-4540-B955-24410D42F1EF|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MILE|||/SEC|NOT DONE||N|U|U|3||39||BASELINE|1968-02-01||1968-09-30|||1973-01-26||1971-02-25
TRIAL STUDY 134XCP|RP|31D8814B-5542-4540-B955-24410D42F1EF|2||||||FUNDHT|FUNDAL HEIGHT||||U|||H/WK|NOT DONE||U|N|NA|3||39||OBSERVATION|1969-04-03||1968-03-10|||1961-11-30||1963-03-27
TRIAL STUDY 134XCP|RP|31D8814B-5542-4540-B955-24410D42F1EF|1||||||BCMETHOD|BIRTH CONTROL METHOD||||KG/M2|||GBQ|NOT DONE||NA|Y|NA|4||88||INDUCTION TREATMENT|1971-12-09||1973-08-16|||1969-01-19||1965-09-08
TRIAL STUDY 134XCP|RP|31D8814B-5542-4540-B955-24410D42F1EF|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||%/MIN|||ENZYME U/L|NOT DONE||Y|U|Y|4||88||OPEN LABEL TREATMENT|1961-12-16||1967-07-30|||1967-08-16||1972-09-30
TRIAL STUDY 134XCP|RP|31D8814B-5542-4540-B955-24410D42F1EF|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||C|||APPLICATION|NOT DONE||U|NA|U|5||7||OPEN LABEL TREATMENT|1962-05-17||1967-03-24|||1960-08-31||1962-01-29
TRIAL STUDY 134XCP|RP|31D8814B-5542-4540-B955-24410D42F1EF|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||KEV|||MIN*MG/ML|NOT DONE||U|N|U|5||7||OBSERVATION|1971-06-12||1961-03-11|||1971-08-16||1972-05-31
TRIAL STUDY 134XCP|RP|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UG/M2/H|||L/H|NOT DONE||Y|U|U|1||38||OBSERVATION|1968-06-17||1968-11-15|||1962-01-07||1961-02-09
TRIAL STUDY 134XCP|RP|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|2||||||PEELIND|PEELING INDICATOR||||LM|||APL U|NOT DONE||U|N|U|1||38||SCREENING|1970-10-07||1961-06-23|||1964-06-22||1973-08-14
TRIAL STUDY 134XCP|RP|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||DPM/0.5 ML|||ML*CMH2O|NOT DONE||Y|Y|Y|2||58||CONTINUATION TREATMENT|1965-04-26||1965-02-03|||1973-02-06||1970-09-13
TRIAL STUDY 134XCP|RP|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|2||||||MASSIND|MASS INDICATOR||||MMOL/G|||CY/CM|NOT DONE||NA|NA|NA|2||58||OBSERVATION|1964-07-05||1971-12-23|||1965-05-04||1967-04-04
TRIAL STUDY 134XCP|RP|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^6 COPIES/ML|||MEQ/UL|NOT DONE||NA|N|Y|3||39||TREATMENT|1970-03-26||1965-04-20|||1963-01-26||1963-10-20
TRIAL STUDY 134XCP|RP|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UKAT/L|||/40 HPFS|NOT DONE||NA|Y|U|3||39||INDUCTION TREATMENT|1962-09-11||1970-06-01|||1968-01-01||1960-02-29
TRIAL STUDY 134XCP|RP|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|1||||||INABOIND|INDUCED ABORTION INDICATOR||||KCAL/DAY|||PMOL|NOT DONE||U|U|U|4||88||CONTINUATION TREATMENT|1969-09-03||1972-09-25|||1961-03-01||1968-05-20
TRIAL STUDY 134XCP|RP|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||/MS|||CI/MG|NOT DONE||Y|NA|U|4||88||FOLLOW-UP|1960-09-16||1970-05-30|||1969-08-29||1969-07-25
TRIAL STUDY 134XCP|RP|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|1||||||PRGENDTC|DATE PREGNANCY ENDED||||BREATHS/MIN|||UGEQ/L|NOT DONE||NA|N|Y|5||7||OBSERVATION|1965-12-01||1972-06-10|||1966-06-07||1971-12-12
TRIAL STUDY 134XCP|RP|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|2||||||EDEMAIND|EDEMA INDICATOR||||IU/G|||KG|NOT DONE||Y|N|U|5||7||CONTINUATION TREATMENT|1962-08-23||1969-07-18|||1961-04-14||1972-09-23
TRIAL STUDY 134XCP|RP|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|1||||||INABOIND|INDUCED ABORTION INDICATOR||||TUBE|||AMFI|NOT DONE||Y|N|Y|1||38||TREATMENT|1960-08-28||1972-09-08|||1960-10-16||1962-11-07
TRIAL STUDY 134XCP|RP|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UM2|||GPL U|NOT DONE||N|N|N|1||38||TREATMENT|1970-11-07||1964-08-25|||1960-03-21||1965-07-09
TRIAL STUDY 134XCP|RP|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MOL/DAY|||BE/ML|NOT DONE||Y|U|Y|2||58||BLINDED TREATMENT|1967-06-27||1971-07-31|||1968-06-24||1972-09-24
TRIAL STUDY 134XCP|RP|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|2||||||PUSTIND|PUSTULE INDICATOR||||U/KG/H|||/HPF|NOT DONE||Y|Y|NA|2||58||OBSERVATION|1964-02-26||1961-03-28|||1960-02-09||1963-03-17
TRIAL STUDY 134XCP|RP|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||UG/L|||G/MOL|NOT DONE||N|U|NA|3||39||TREATMENT|1963-05-15||1964-12-28|||1964-01-24||1970-01-14
TRIAL STUDY 134XCP|RP|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||KG/MOL|||10^9 ORGANISMS/G|NOT DONE||N|Y|NA|3||39||FOLLOW-UP|1967-09-14||1962-02-11|||1962-05-22||1971-10-17
TRIAL STUDY 134XCP|RP|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||GLOBULE|||SACHET|NOT DONE||U|N|N|4||88||WASHOUT|1967-08-29||1970-06-30|||1969-08-19||1963-11-05
TRIAL STUDY 134XCP|RP|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||BQ/L|||ML/ANIMAL/DAY|NOT DONE||Y|Y|N|4||88||BASELINE|1962-01-19||1960-01-05|||1973-01-03||1973-01-09
TRIAL STUDY 134XCP|RP|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|1||||||PEELIND|PEELING INDICATOR||||UG/L DDU|||10^6 ORGANISMS/MG|NOT DONE||Y|N|NA|5||7||TREATMENT|1972-05-01||1972-08-07|||1973-06-22||1972-02-06
TRIAL STUDY 134XCP|RP|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|2||||||EDEMAIND|EDEMA INDICATOR||||IU/MG|||UM2|NOT DONE||U|NA|NA|5||7||WASHOUT|1970-03-05||1966-01-28|||1960-07-18||1971-01-13
TRIAL STUDY 134XCP|RP|15BFC17A-2F55-441A-AB99-76D270D62367|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||UKAT/10^12 RBC|||CL|NOT DONE||U|N|N|1||38||BLINDED TREATMENT|1964-08-15||1970-06-25|||1969-05-17||1961-07-01
TRIAL STUDY 134XCP|RP|15BFC17A-2F55-441A-AB99-76D270D62367|2||||||MENFDUR|MENSES FLOW DURATION||||NG/MOL|||GAUSS|NOT DONE||N|Y|U|1||38||SCREENING|1969-10-01||1969-09-03|||1967-12-24||1967-05-26
TRIAL STUDY 134XCP|RP|15BFC17A-2F55-441A-AB99-76D270D62367|1||||||DSCHGIND|DISCHARGE INDICATOR||||ARBITRARY U|||NL|NOT DONE||Y|Y|N|2||58||TREATMENT|1964-03-06||1964-04-14|||1966-04-29||1969-12-09
TRIAL STUDY 134XCP|RP|15BFC17A-2F55-441A-AB99-76D270D62367|2||||||DSCHGIND|DISCHARGE INDICATOR||||KG|||UU/DL|NOT DONE||U|U|Y|2||58||FOLLOW-UP|1967-09-05||1968-10-16|||1969-10-24||1968-08-26
TRIAL STUDY 134XCP|RP|15BFC17A-2F55-441A-AB99-76D270D62367|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||GY|||DEG|NOT DONE||Y|U|N|3||39||FOLLOW-UP|1966-11-11||1969-12-05|||1972-08-19||1963-04-14
TRIAL STUDY 134XCP|RP|15BFC17A-2F55-441A-AB99-76D270D62367|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||10^7/L|||BQ/MG|NOT DONE||N|U|N|3||39||OBSERVATION|1973-04-30||1967-01-28|||1963-02-18||1962-11-25
TRIAL STUDY 134XCP|RP|15BFC17A-2F55-441A-AB99-76D270D62367|1||||||PRGENDTC|DATE PREGNANCY ENDED||||MG|||MG/KG/MIN|NOT DONE||Y|Y|NA|4||88||RUN-IN|1966-08-07||1963-11-22|||1961-07-11||1962-01-04
TRIAL STUDY 134XCP|RP|15BFC17A-2F55-441A-AB99-76D270D62367|2||||||TNDRIND|TENDERNESS INDICATOR||||PACKAGE|||MV/SEC|NOT DONE||NA|NA|N|4||88||RUN-IN|1963-10-25||1961-05-25|||1968-09-28||1966-02-12
TRIAL STUDY 134XCP|RP|15BFC17A-2F55-441A-AB99-76D270D62367|1||||||MENOAGE|MENOPAUSE AGE||||1/(S*KPA)|||10^5/L|NOT DONE||N|U|NA|5||7||WASHOUT|1973-04-21||1961-10-13|||1965-09-22||1972-04-27
TRIAL STUDY 134XCP|RP|15BFC17A-2F55-441A-AB99-76D270D62367|2||||||FUNDHT|FUNDAL HEIGHT||||MONTHS|||SUPPOSITORY|NOT DONE||N|U|NA|5||7||WASHOUT|1970-03-13||1961-03-17|||1971-05-20||1969-03-22
TRIAL STUDY 134XCP|RP|CA231D77-1A1F-49F3-8172-06709A1330B7|1||||||INABOIND|INDUCED ABORTION INDICATOR||||PIXELS/IN|||TRANSDUCING UNIT|NOT DONE||U|N|U|1||38||TREATMENT|1969-07-17||1972-06-01|||1968-06-15||1963-03-17
TRIAL STUDY 134XCP|RP|CA231D77-1A1F-49F3-8172-06709A1330B7|2||||||STILBIND|STILLBIRTH INDICATOR||||/LSQN|||UMOL/L/H|NOT DONE||NA|U|N|1||38||OPEN LABEL TREATMENT|1964-05-09||1963-06-14|||1967-11-03||1965-12-04
TRIAL STUDY 134XCP|RP|CA231D77-1A1F-49F3-8172-06709A1330B7|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MU/G|||LOG10 TCID 50/DOSE|NOT DONE||NA|Y|N|2||58||CONTINUATION TREATMENT|1965-12-02||1962-09-27|||1966-07-06||1967-01-02
TRIAL STUDY 134XCP|RP|CA231D77-1A1F-49F3-8172-06709A1330B7|2||||||BLISTIND|BLISTERING INDICATOR||||PACK YEAR|||10^3 CFU/G|NOT DONE||NA|N|N|2||58||LONG-TERM FOLLOW-UP|1964-08-15||1971-01-25|||1962-05-25||1968-03-15
TRIAL STUDY 134XCP|RP|CA231D77-1A1F-49F3-8172-06709A1330B7|1||||||INABOIND|INDUCED ABORTION INDICATOR||||ENZYME U/L|||MS/MMHG|NOT DONE||N|N|Y|3||39||RUN-IN|1961-11-22||1961-09-27|||1970-07-12||1969-03-01
TRIAL STUDY 134XCP|RP|CA231D77-1A1F-49F3-8172-06709A1330B7|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||BREATHS/MIN|||COAT|NOT DONE||Y|N|NA|3||39||SCREENING|1963-11-06||1964-04-28|||1968-11-03||1963-09-09
TRIAL STUDY 134XCP|RP|CA231D77-1A1F-49F3-8172-06709A1330B7|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PMOL/DL|||MOL/G|NOT DONE||N|N|NA|4||88||BLINDED TREATMENT|1966-01-13||1972-01-30|||1960-06-24||1967-06-10
TRIAL STUDY 134XCP|RP|CA231D77-1A1F-49F3-8172-06709A1330B7|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||/CMH2O|||QUANTITY SUFFICIENT|NOT DONE||NA|NA|NA|4||88||CONTINUATION TREATMENT|1973-02-14||1961-06-14|||1972-10-06||1973-08-13
TRIAL STUDY 134XCP|RP|CA231D77-1A1F-49F3-8172-06709A1330B7|1||||||BCMETHOD|BIRTH CONTROL METHOD||||10^3 CFU/ML|||MOL/MOL|NOT DONE||NA|NA|N|5||7||FOLLOW-UP|1973-07-17||1966-09-21|||1963-11-06||1963-06-04
TRIAL STUDY 134XCP|RP|CA231D77-1A1F-49F3-8172-06709A1330B7|2||||||DLVRMODE|MODE OF DELIVERY||||MV2/HZ|||MEQ/DAY|NOT DONE||Y|NA|N|5||7||LONG-TERM FOLLOW-UP|1960-01-15||1964-09-15|||1962-08-09||1964-04-17
TRIAL STUDY 134XCP|RP|7A4D6074-E870-40E8-B567-D069BCB7DA9F|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||DAYS/MONTH|||ENZYME U/G HB|NOT DONE||N|U|Y|1||38||TREATMENT|1961-05-24||1973-03-12|||1961-02-18||1972-07-09
TRIAL STUDY 134XCP|RP|7A4D6074-E870-40E8-B567-D069BCB7DA9F|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||GMFI|||10^9 CFU/ML|NOT DONE||NA|U|N|1||38||LONG-TERM FOLLOW-UP|1962-01-03||1963-11-28|||1969-11-26||1961-02-27
TRIAL STUDY 134XCP|RP|7A4D6074-E870-40E8-B567-D069BCB7DA9F|1||||||PREGST|PREGNANT DURING THE STUDY||||UGEQ|||PFU/DOSE|NOT DONE||Y|N|Y|2||58||OPEN LABEL TREATMENT|1960-05-04||1967-02-23|||1969-04-21||1965-10-04
TRIAL STUDY 134XCP|RP|7A4D6074-E870-40E8-B567-D069BCB7DA9F|2||||||PUSTIND|PUSTULE INDICATOR||||WAFER|||CFU/ML|NOT DONE||U|Y|NA|2||58||CONTINUATION TREATMENT|1962-08-05||1963-06-29|||1973-06-19||1969-10-17
TRIAL STUDY 134XCP|RP|7A4D6074-E870-40E8-B567-D069BCB7DA9F|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UOSM|||BE/ML|NOT DONE||N|N|Y|3||39||FOLLOW-UP|1962-05-10||1964-07-11|||1962-05-02||1968-02-20
TRIAL STUDY 134XCP|RP|7A4D6074-E870-40E8-B567-D069BCB7DA9F|2||||||ABORTN|NUMBER OF ABORTIONS||||PPM|||MMOL|NOT DONE||Y|N|N|3||39||TREATMENT|1971-05-25||1969-05-21|||1963-07-31||1962-09-08
TRIAL STUDY 134XCP|RP|7A4D6074-E870-40E8-B567-D069BCB7DA9F|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||BAG|||SCOOPFUL|NOT DONE||Y|N|N|4||88||BLINDED TREATMENT|1972-05-03||1963-02-21|||1960-04-11||1968-11-21
TRIAL STUDY 134XCP|RP|7A4D6074-E870-40E8-B567-D069BCB7DA9F|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||KG/CM|||G/ANIMAL|NOT DONE||U|N|NA|4||88||OBSERVATION|1965-11-06||1968-07-28|||1969-08-18||1968-08-17
TRIAL STUDY 134XCP|RP|7A4D6074-E870-40E8-B567-D069BCB7DA9F|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||NMOL|||PKAT/L|NOT DONE||U|N|Y|5||7||OPEN LABEL TREATMENT|1960-12-08||1970-04-10|||1969-04-05||1966-10-24
TRIAL STUDY 134XCP|RP|7A4D6074-E870-40E8-B567-D069BCB7DA9F|2||||||ULCERIND|ULCER INDICATOR||||ML/CAGE/DAY|||PMOL/L|NOT DONE||NA|NA|N|5||7||CONTINUATION TREATMENT|1963-09-22||1967-11-01|||1970-04-10||1961-05-14
TRIAL STUDY 134XCP|RP|3DDD2A7E-B955-424B-B485-54E81D0E0699|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||PIXELS/IN|||CM/MIN|NOT DONE||Y|U|NA|1||38||INDUCTION TREATMENT|1966-10-03||1969-11-01|||1973-07-11||1965-05-23
TRIAL STUDY 134XCP|RP|3DDD2A7E-B955-424B-B485-54E81D0E0699|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||PIXELS/CM|||GY|NOT DONE||U|NA|NA|1||38||WASHOUT|1960-03-19||1965-02-07|||1972-03-10||1971-12-26
TRIAL STUDY 134XCP|RP|3DDD2A7E-B955-424B-B485-54E81D0E0699|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^6 IU|||10^6 CFU/G|NOT DONE||NA|N|N|2||58||INDUCTION TREATMENT|1961-11-19||1971-04-08|||1972-04-29||1968-01-21
TRIAL STUDY 134XCP|RP|3DDD2A7E-B955-424B-B485-54E81D0E0699|2||||||EDEMAIND|EDEMA INDICATOR||||NMOL BCE/L|||10^6/L|NOT DONE||U|NA|U|2||58||BLINDED TREATMENT|1973-02-24||1963-08-03|||1969-07-05||1969-10-17
TRIAL STUDY 134XCP|RP|3DDD2A7E-B955-424B-B485-54E81D0E0699|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||NMOL/ML/MIN|||DPM/100MG|NOT DONE||U|U|Y|3||39||CONTINUATION TREATMENT|1967-04-29||1971-03-16|||1967-05-10||1965-08-24
TRIAL STUDY 134XCP|RP|3DDD2A7E-B955-424B-B485-54E81D0E0699|2||||||MASSIND|MASS INDICATOR||||NKAT/G HB|||L/H/M2|NOT DONE||N|NA|Y|3||39||RUN-IN|1968-09-26||1962-07-31|||1965-12-19||1961-04-08
TRIAL STUDY 134XCP|RP|3DDD2A7E-B955-424B-B485-54E81D0E0699|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||/2500 WBC|||10^8/L|NOT DONE||N|N|NA|4||88||TREATMENT|1960-05-09||1966-02-11|||1973-07-21||1964-04-13
TRIAL STUDY 134XCP|RP|3DDD2A7E-B955-424B-B485-54E81D0E0699|2||||||ERYTHIND|ERYTHEMA INDICATOR||||L/S|||CI|NOT DONE||N|N|Y|4||88||TREATMENT|1970-09-27||1967-08-02|||1962-04-13||1963-07-08
TRIAL STUDY 134XCP|RP|3DDD2A7E-B955-424B-B485-54E81D0E0699|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MONTHS|||CIGAR|NOT DONE||N|NA|Y|5||7||FOLLOW-UP|1961-07-07||1970-12-18|||1970-10-25||1973-04-11
TRIAL STUDY 134XCP|RP|3DDD2A7E-B955-424B-B485-54E81D0E0699|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||G/DL|||PSI|NOT DONE||N|U|U|5||7||OBSERVATION|1970-09-07||1963-08-14|||1969-09-04||1962-09-16
TRIAL STUDY 134XCP|RP|D6757E79-3104-468E-BADC-8CCB51BFAE87|1||||||INTP|INTERPRETATION||||LOG10 COPIES/ML|||CAPLET|NOT DONE||Y|U|Y|1||38||OPEN LABEL TREATMENT|1969-11-04||1962-06-11|||1960-12-24||1973-03-13
TRIAL STUDY 134XCP|RP|D6757E79-3104-468E-BADC-8CCB51BFAE87|2||||||STILBIND|STILLBIRTH INDICATOR||||POUCH|||COPIES/UL|NOT DONE||NA|NA|U|1||38||CONTINUATION TREATMENT|1969-02-11||1970-02-08|||1966-03-15||1967-10-18
TRIAL STUDY 134XCP|RP|D6757E79-3104-468E-BADC-8CCB51BFAE87|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||PFU/ML|||PL|NOT DONE||Y|Y|N|2||58||RUN-IN|1973-01-23||1961-01-08|||1968-01-26||1963-02-01
TRIAL STUDY 134XCP|RP|D6757E79-3104-468E-BADC-8CCB51BFAE87|2||||||MENOSTAT|MENOPAUSE STATUS||||U/MG|||MU|NOT DONE||NA|Y|NA|2||58||WASHOUT|1964-05-23||1961-09-12|||1965-11-15||1963-07-05
TRIAL STUDY 134XCP|RP|D6757E79-3104-468E-BADC-8CCB51BFAE87|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MMOL/S|||MMOL/MIN/KPA|NOT DONE||N|Y|NA|3||39||LONG-TERM FOLLOW-UP|1968-09-04||1962-12-07|||1962-01-31||1972-10-22
TRIAL STUDY 134XCP|RP|D6757E79-3104-468E-BADC-8CCB51BFAE87|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||SYRINGE|||NG/MOL|NOT DONE||NA|U|Y|3||39||OBSERVATION|1969-02-16||1970-10-21|||1963-03-19||1966-08-07
TRIAL STUDY 134XCP|RP|D6757E79-3104-468E-BADC-8CCB51BFAE87|1||||||DLVRMODE|MODE OF DELIVERY||||% INHIBITION|||LOG10 IU/ML|NOT DONE||U|U|U|4||88||RUN-IN|1960-04-27||1967-05-23|||1967-06-27||1970-12-22
TRIAL STUDY 134XCP|RP|D6757E79-3104-468E-BADC-8CCB51BFAE87|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||LX|||PACK YEAR|NOT DONE||U|U|N|4||88||TREATMENT|1963-08-04||1964-05-11|||1968-07-26||1960-12-29
TRIAL STUDY 134XCP|RP|D6757E79-3104-468E-BADC-8CCB51BFAE87|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||UG/MOL|||IU/ML|NOT DONE||U|U|N|5||7||WASHOUT|1969-09-03||1968-04-07|||1972-06-13||1973-09-06
TRIAL STUDY 134XCP|RP|D6757E79-3104-468E-BADC-8CCB51BFAE87|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||/LSQN|||KEV|NOT DONE||Y|NA|NA|5||7||RUN-IN|1961-09-09||1964-10-21|||1962-04-19||1966-06-17
TRIAL STUDY 134XCP|RP|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||/H|||ML/G/DAY|NOT DONE||NA|U|NA|1||38||LONG-TERM FOLLOW-UP|1972-04-05||1964-08-22|||1962-09-16||1970-12-18
TRIAL STUDY 134XCP|RP|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||10^6 IU/ML|||UMOL/L/SEC|NOT DONE||N|N|U|1||38||BLINDED TREATMENT|1969-01-26||1972-01-01|||1967-08-09||1969-09-02
TRIAL STUDY 134XCP|RP|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||/10^4|||LOG10 PFU|NOT DONE||NA|N|NA|2||58||FOLLOW-UP|1965-10-20||1962-03-25|||1971-11-18||1968-12-20
TRIAL STUDY 134XCP|RP|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MS/MMHG|||M|NOT DONE||NA|NA|Y|2||58||INDUCTION TREATMENT|1968-04-02||1965-06-17|||1971-02-13||1971-12-24
TRIAL STUDY 134XCP|RP|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UG/G/DAY|||S/H|NOT DONE||N|N|Y|3||39||INDUCTION TREATMENT|1963-03-27||1960-09-28|||1966-04-17||1971-06-28
TRIAL STUDY 134XCP|RP|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||DAYS/MONTH|||LOZENGE|NOT DONE||Y|U|Y|3||39||LONG-TERM FOLLOW-UP|1967-06-21||1964-10-27|||1966-06-10||1964-05-17
TRIAL STUDY 134XCP|RP|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||/H|||VIRTUAL PIXEL|NOT DONE||Y|NA|Y|4||88||TREATMENT|1960-12-10||1970-12-28|||1961-05-14||1962-08-03
TRIAL STUDY 134XCP|RP|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||ML/G/MIN|||NGEQ/L|NOT DONE||NA|U|U|4||88||FOLLOW-UP|1963-04-03||1961-11-01|||1972-07-09||1971-01-03
TRIAL STUDY 134XCP|RP|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|1||||||DSCHGIND|DISCHARGE INDICATOR||||RING|||/100 WBC|NOT DONE||Y|U|N|5||7||TREATMENT|1962-07-04||1968-08-02|||1972-09-24||1972-04-27
TRIAL STUDY 134XCP|RP|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||10^10/L|||BOWL|NOT DONE||Y|N|Y|5||7||RUN-IN|1961-09-25||1961-02-27|||1968-11-01||1970-07-18
TRIAL STUDY 134XCP|RP|FBAA59F4-154C-40CC-B740-A87769BFEC45|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||LOG10 IU/ML|||10^5/L|NOT DONE||Y|N|U|1||38||OPEN LABEL TREATMENT|1967-05-27||1963-12-07|||1963-01-18||1968-07-03
TRIAL STUDY 134XCP|RP|FBAA59F4-154C-40CC-B740-A87769BFEC45|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||NMOL BCE/NMOL|||KG|NOT DONE||Y|U|NA|1||38||BLINDED TREATMENT|1967-12-04||1969-11-25|||1971-12-05||1967-05-16
TRIAL STUDY 134XCP|RP|FBAA59F4-154C-40CC-B740-A87769BFEC45|1||||||PREGNN|NUMBER OF PREGNANCIES||||SEC|||/100 WBC|NOT DONE||N|NA|U|2||58||WASHOUT|1965-05-28||1962-08-03|||1964-09-16||1969-06-13
TRIAL STUDY 134XCP|RP|FBAA59F4-154C-40CC-B740-A87769BFEC45|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||/KG|||UMOL/DAY|NOT DONE||NA|NA|Y|2||58||LONG-TERM FOLLOW-UP|1969-12-29||1970-03-09|||1966-02-27||1967-02-28
TRIAL STUDY 134XCP|RP|FBAA59F4-154C-40CC-B740-A87769BFEC45|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||10^6 ORGANISMS|||CI/UL|NOT DONE||NA|Y|U|3||39||SCREENING|1960-07-22||1964-10-23|||1972-01-09||1967-01-29
TRIAL STUDY 134XCP|RP|FBAA59F4-154C-40CC-B740-A87769BFEC45|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||INHALATION|||ML/S/M2|NOT DONE||N|Y|Y|3||39||SCREENING|1965-06-17||1970-09-27|||1970-06-13||1961-09-14
TRIAL STUDY 134XCP|RP|FBAA59F4-154C-40CC-B740-A87769BFEC45|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||UMOL/L/SEC|||CFU/G|NOT DONE||N|U|NA|4||88||SCREENING|1960-07-29||1972-07-15|||1973-05-21||1962-10-01
TRIAL STUDY 134XCP|RP|FBAA59F4-154C-40CC-B740-A87769BFEC45|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||GPELISA UNIT/ML|||NEBULE|NOT DONE||U|U|Y|4||88||INDUCTION TREATMENT|1964-04-03||1969-04-30|||1961-02-24||1960-08-01
TRIAL STUDY 134XCP|RP|FBAA59F4-154C-40CC-B740-A87769BFEC45|1||||||INABOIND|INDUCED ABORTION INDICATOR||||UV|||MOSM/L|NOT DONE||U|NA|Y|5||7||BASELINE|1972-08-21||1964-11-15|||1960-02-15||1964-12-11
TRIAL STUDY 134XCP|RP|FBAA59F4-154C-40CC-B740-A87769BFEC45|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^3 CFU/ML|||KG/L|NOT DONE||NA|NA|NA|5||7||RUN-IN|1972-09-23||1967-09-04|||1971-10-09||1961-02-06
TRIAL STUDY 134XCP|RP|9A9E638B-426B-4F3E-8363-50DC2617FD63|1||||||BLISTIND|BLISTERING INDICATOR||||FRAMES/S|||%|NOT DONE||Y|U|NA|1||38||LONG-TERM FOLLOW-UP|1962-11-13||1961-11-12|||1963-04-29||1965-09-18
TRIAL STUDY 134XCP|RP|9A9E638B-426B-4F3E-8363-50DC2617FD63|2||||||EDEMAIND|EDEMA INDICATOR||||ML/G/H|||OHM|NOT DONE||Y|NA|U|1||38||CONTINUATION TREATMENT|1961-03-22||1963-11-30|||1971-11-08||1961-02-18
TRIAL STUDY 134XCP|RP|9A9E638B-426B-4F3E-8363-50DC2617FD63|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^3 COPIES/ML|||LOG10 TCID 50/DOSE|NOT DONE||U|N|Y|2||58||TREATMENT|1969-09-25||1968-01-21|||1965-05-12||1966-06-19
TRIAL STUDY 134XCP|RP|9A9E638B-426B-4F3E-8363-50DC2617FD63|2||||||PRGENDTC|DATE PREGNANCY ENDED||||UCI|||UG/G/MIN|NOT DONE||N|U|NA|2||58||OBSERVATION|1964-04-18||1962-06-26|||1970-10-04||1964-01-09
TRIAL STUDY 134XCP|RP|9A9E638B-426B-4F3E-8363-50DC2617FD63|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MOSM/L|||BQ|NOT DONE||Y|N|U|3||39||BLINDED TREATMENT|1972-03-15||1964-08-08|||1973-07-08||1964-06-03
TRIAL STUDY 134XCP|RP|9A9E638B-426B-4F3E-8363-50DC2617FD63|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||LOG10 COPIES/ML|||MG/MIN|NOT DONE||Y|N|N|3||39||WASHOUT|1972-11-11||1972-09-27|||1960-01-24||1964-11-21
TRIAL STUDY 134XCP|RP|9A9E638B-426B-4F3E-8363-50DC2617FD63|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UKAT|||ABSORBANCE U/MIN|NOT DONE||Y|NA|N|4||88||OPEN LABEL TREATMENT|1967-10-08||1961-02-02|||1961-10-02||1972-10-16
TRIAL STUDY 134XCP|RP|9A9E638B-426B-4F3E-8363-50DC2617FD63|2||||||ULCERIND|ULCER INDICATOR||||ATM|||CD|NOT DONE||Y|NA|U|4||88||TREATMENT|1968-09-18||1972-12-25|||1967-12-31||1971-08-31
TRIAL STUDY 134XCP|RP|9A9E638B-426B-4F3E-8363-50DC2617FD63|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||OZ|||FMOL/L/SEC|NOT DONE||N|NA|Y|5||7||BASELINE|1971-08-26||1961-06-01|||1971-07-29||1970-01-10
TRIAL STUDY 134XCP|RP|9A9E638B-426B-4F3E-8363-50DC2617FD63|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||DMOL|||PSEC|NOT DONE||NA|Y|U|5||7||CONTINUATION TREATMENT|1965-06-01||1970-06-14|||1969-05-20||1971-05-20
TRIAL STUDY 134XCP|RP|9995CD08-2650-4711-8F04-E41183E28B21|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^8/L|||UG|NOT DONE||U|NA|U|1||38||INDUCTION TREATMENT|1961-07-16||1968-06-30|||1960-11-10||1962-09-25
TRIAL STUDY 134XCP|RP|9995CD08-2650-4711-8F04-E41183E28B21|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MMOL2/L2|||MM|NOT DONE||U|Y|N|1||38||TREATMENT|1968-10-02||1966-11-27|||1966-08-15||1969-01-28
TRIAL STUDY 134XCP|RP|9995CD08-2650-4711-8F04-E41183E28B21|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||/WK|||10^6 U|NOT DONE||NA|Y|N|2||58||BLINDED TREATMENT|1965-09-13||1967-01-15|||1971-10-27||1963-05-15
TRIAL STUDY 134XCP|RP|9995CD08-2650-4711-8F04-E41183E28B21|2||||||MASSIND|MASS INDICATOR||||ML/BEAT|||TESLA|NOT DONE||U|NA|Y|2||58||RUN-IN|1971-06-04||1972-09-20|||1964-01-11||1960-08-31
TRIAL STUDY 134XCP|RP|9995CD08-2650-4711-8F04-E41183E28B21|1||||||MENFDUR|MENSES FLOW DURATION||||U.CARR|||NL|NOT DONE||Y|Y|Y|3||39||BLINDED TREATMENT|1967-06-03||1962-07-29|||1973-09-07||1965-09-19
TRIAL STUDY 134XCP|RP|9995CD08-2650-4711-8F04-E41183E28B21|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||HR/DAY|||COPIES/UL|NOT DONE||N|NA|N|3||39||BLINDED TREATMENT|1962-09-13||1967-06-12|||1962-01-29||1968-02-05
TRIAL STUDY 134XCP|RP|9995CD08-2650-4711-8F04-E41183E28B21|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MEQ/ML|||LOZENGE|NOT DONE||U|NA|NA|4||88||SCREENING|1961-07-17||1967-11-30|||1973-08-24||1965-02-07
TRIAL STUDY 134XCP|RP|9995CD08-2650-4711-8F04-E41183E28B21|2||||||MENOSTAT|MENOPAUSE STATUS||||IU/DL|||G/CM2|NOT DONE||Y|N|U|4||88||TREATMENT|1963-10-29||1966-02-14|||1962-11-07||1961-03-22
TRIAL STUDY 134XCP|RP|9995CD08-2650-4711-8F04-E41183E28B21|1||||||BLISTIND|BLISTERING INDICATOR||||PKAT|||BP|NOT DONE||U|N|U|5||7||BLINDED TREATMENT|1967-07-22||1961-08-13|||1963-01-19||1970-10-10
TRIAL STUDY 134XCP|RP|9995CD08-2650-4711-8F04-E41183E28B21|2||||||TNDRIND|TENDERNESS INDICATOR||||MONTHS|||L/KG|NOT DONE||N|NA|Y|5||7||OPEN LABEL TREATMENT|1960-08-29||1962-03-19|||1963-06-11||1973-08-20
TRIAL STUDY 134XCP|RP|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||LOG10 ELISA UNIT/DOSE|||10^6 U|NOT DONE||NA|U|Y|1||38||CONTINUATION TREATMENT|1973-02-14||1968-06-30|||1967-11-04||1964-08-14
TRIAL STUDY 134XCP|RP|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||ABSORBANCE U|||SCOOPFUL|NOT DONE||NA|N|N|1||38||BLINDED TREATMENT|1964-01-04||1961-07-20|||1969-09-08||1965-10-19
TRIAL STUDY 134XCP|RP|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||FT2|||FT3|NOT DONE||U|U|Y|2||58||CONTINUATION TREATMENT|1963-02-23||1966-02-24|||1965-06-08||1960-07-29
TRIAL STUDY 134XCP|RP|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MJOULE/CM2|||10^4/L|NOT DONE||NA|U|N|2||58||FOLLOW-UP|1972-01-04||1968-05-05|||1965-01-12||1965-05-19
TRIAL STUDY 134XCP|RP|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^4 CFU|||BAU/ML|NOT DONE||N|N|N|3||39||FOLLOW-UP|1964-04-22||1961-03-27|||1969-11-15||1971-09-01
TRIAL STUDY 134XCP|RP|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MMOL/KG|||BQ/ML|NOT DONE||Y|U|Y|3||39||WASHOUT|1965-12-15||1972-04-03|||1963-11-24||1972-05-27
TRIAL STUDY 134XCP|RP|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||UMOL/MOL|||VP/DOSE|NOT DONE||NA|N|N|4||88||TREATMENT|1966-12-24||1969-12-18|||1968-03-25||1963-07-27
TRIAL STUDY 134XCP|RP|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UM|||10^4/HPF|NOT DONE||N|N|Y|4||88||OBSERVATION|1962-01-02||1969-07-17|||1965-01-04||1962-12-24
TRIAL STUDY 134XCP|RP|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|1||||||MASSIND|MASS INDICATOR||||P|||UG/M2|NOT DONE||NA|U|Y|5||7||SCREENING|1966-08-14||1970-06-22|||1960-02-03||1968-03-11
TRIAL STUDY 134XCP|RP|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|2||||||MENARAGE|MENARCHE AGE||||L/H/M2|||CFU/G|NOT DONE||N|Y|Y|5||7||CONTINUATION TREATMENT|1970-01-25||1972-06-25|||1970-03-04||1970-12-19
TRIAL STUDY 134XCP|RP|DE805225-C632-46E6-B673-DA0D864D47F7|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||GY/H|||MIN*MG/ML|NOT DONE||N|N|Y|1||38||OBSERVATION|1967-04-05||1966-06-15|||1969-11-08||1968-08-09
TRIAL STUDY 134XCP|RP|DE805225-C632-46E6-B673-DA0D864D47F7|2||||||FUNDHT|FUNDAL HEIGHT||||LENS|||/MONTH|NOT DONE||NA|NA|U|1||38||CONTINUATION TREATMENT|1965-06-08||1967-04-26|||1969-06-22||1969-03-06
TRIAL STUDY 134XCP|RP|DE805225-C632-46E6-B673-DA0D864D47F7|1||||||DLVRMODE|MODE OF DELIVERY||||UMOL/DAY|||NG/L|NOT DONE||N|N|Y|2||58||OBSERVATION|1961-09-18||1967-07-04|||1967-03-11||1972-12-03
TRIAL STUDY 134XCP|RP|DE805225-C632-46E6-B673-DA0D864D47F7|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||GLOBULE|||10^5/L|NOT DONE||N|N|U|2||58||SCREENING|1963-03-22||1967-04-18|||1971-09-25||1971-05-29
TRIAL STUDY 134XCP|RP|DE805225-C632-46E6-B673-DA0D864D47F7|1||||||PREGNN|NUMBER OF PREGNANCIES||||KCAL/DAY|||U/G/H|NOT DONE||N|N|NA|3||39||CONTINUATION TREATMENT|1967-06-08||1973-06-10|||1972-09-27||1971-09-06
TRIAL STUDY 134XCP|RP|DE805225-C632-46E6-B673-DA0D864D47F7|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||QUANTITY SUFFICIENT|||KIU|NOT DONE||Y|NA|N|3||39||BASELINE|1968-06-08||1964-08-15|||1970-01-04||1963-10-29
TRIAL STUDY 134XCP|RP|DE805225-C632-46E6-B673-DA0D864D47F7|1||||||MASSIND|MASS INDICATOR||||U/M2/MIN|||NL|NOT DONE||N|U|U|4||88||FOLLOW-UP|1967-01-01||1960-05-31|||1969-06-10||1967-06-01
TRIAL STUDY 134XCP|RP|DE805225-C632-46E6-B673-DA0D864D47F7|2||||||DSCHGIND|DISCHARGE INDICATOR||||UV*SEC|||10^3 COPIES/ML|NOT DONE||NA|Y|U|4||88||OBSERVATION|1973-01-31||1969-08-07|||1971-01-30||1960-10-14
TRIAL STUDY 134XCP|RP|DE805225-C632-46E6-B673-DA0D864D47F7|1||||||THICK|THICKNESS||||NU/CL|||UKAT/10^12 RBC|NOT DONE||U|NA|U|5||7||BASELINE|1965-05-29||1972-06-10|||1970-12-06||1961-11-13
TRIAL STUDY 134XCP|RP|DE805225-C632-46E6-B673-DA0D864D47F7|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||LOG10 ELISA UNIT|||HZ/S|NOT DONE||N|N|U|5||7||WASHOUT|1960-05-19||1965-06-09|||1960-04-28||1960-08-29
TRIAL STUDY 134XCP|RP|9C921E89-706F-46E8-ADE3-A806289D43A5|1||||||DLVRMODE|MODE OF DELIVERY||||M3|||10^6 CFU/G|NOT DONE||NA|U|U|1||38||OBSERVATION|1973-08-03||1966-10-05|||1964-07-05||1969-12-26
TRIAL STUDY 134XCP|RP|9C921E89-706F-46E8-ADE3-A806289D43A5|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||PATCH|||MMU/ML|NOT DONE||U|N|Y|1||38||INDUCTION TREATMENT|1971-03-12||1969-08-13|||1972-01-07||1967-01-16
TRIAL STUDY 134XCP|RP|9C921E89-706F-46E8-ADE3-A806289D43A5|1||||||FUNDHT|FUNDAL HEIGHT||||SACHET|||MMOL|NOT DONE||Y|U|U|2||58||OPEN LABEL TREATMENT|1971-06-08||1960-02-05|||1967-02-21||1963-04-22
TRIAL STUDY 134XCP|RP|9C921E89-706F-46E8-ADE3-A806289D43A5|2||||||PREGNN|NUMBER OF PREGNANCIES||||10^3 COPIES/ML|||UEQ|NOT DONE||U|N|Y|2||58||FOLLOW-UP|1964-12-07||1963-12-24|||1971-06-20||1968-06-26
TRIAL STUDY 134XCP|RP|9C921E89-706F-46E8-ADE3-A806289D43A5|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||10^7 TCID 50/DOSE|||UL/KG/DAY|NOT DONE||Y|NA|Y|3||39||TREATMENT|1964-08-17||1962-10-17|||1970-05-28||1972-12-29
TRIAL STUDY 134XCP|RP|9C921E89-706F-46E8-ADE3-A806289D43A5|2||||||MENOAGE|MENOPAUSE AGE||||BREATHS/30S|||PLUG|NOT DONE||N|Y|NA|3||39||SCREENING|1963-03-20||1961-01-26|||1962-07-30||1968-05-19
TRIAL STUDY 134XCP|RP|9C921E89-706F-46E8-ADE3-A806289D43A5|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||TBSP|||LOG10 PFU/ML|NOT DONE||U|NA|U|4||88||WASHOUT|1971-05-14||1963-04-29|||1971-04-15||1963-07-14
TRIAL STUDY 134XCP|RP|9C921E89-706F-46E8-ADE3-A806289D43A5|2||||||MENFDUR|MENSES FLOW DURATION||||U/MMOL|||G/CAGE|NOT DONE||Y|NA|NA|4||88||CONTINUATION TREATMENT|1966-07-24||1968-05-21|||1965-06-15||1970-02-18
TRIAL STUDY 134XCP|RP|9C921E89-706F-46E8-ADE3-A806289D43A5|1||||||MASSIND|MASS INDICATOR||||KG/L|||MNFI|NOT DONE||Y|NA|NA|5||7||WASHOUT|1968-08-10||1972-03-15|||1972-03-04||1966-03-03
TRIAL STUDY 134XCP|RP|9C921E89-706F-46E8-ADE3-A806289D43A5|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PPB|||10^6/G|NOT DONE||NA|U|NA|5||7||CONTINUATION TREATMENT|1962-12-05||1970-07-24|||1965-08-08||1961-04-27
TRIAL STUDY 134XCP|RP|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UG/KG/H|||MMOL|NOT DONE||NA|U|N|1||38||INDUCTION TREATMENT|1963-06-21||1960-06-10|||1963-09-07||1973-06-18
TRIAL STUDY 134XCP|RP|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||IU/MMOL|||U/G/DAY|NOT DONE||U|NA|NA|1||38||LONG-TERM FOLLOW-UP|1969-01-03||1966-11-25|||1966-01-29||1964-11-15
TRIAL STUDY 134XCP|RP|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|1||||||DSCHGIND|DISCHARGE INDICATOR||||BOLUS|||MG/MIN|NOT DONE||U|U|U|2||58||FOLLOW-UP|1967-10-25||1970-05-05|||1968-03-27||1968-06-24
TRIAL STUDY 134XCP|RP|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|2||||||MENARAGE|MENARCHE AGE||||UG/H|||BQ/MG|NOT DONE||Y|U|Y|2||58||OPEN LABEL TREATMENT|1969-01-09||1968-03-18|||1966-03-04||1968-12-12
TRIAL STUDY 134XCP|RP|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|1||||||MENFDUR|MENSES FLOW DURATION||||NMOL/L/MIN|||STEPS|NOT DONE||N|U|U|3||39||LONG-TERM FOLLOW-UP|1970-10-03||1964-04-21|||1963-08-30||1970-09-28
TRIAL STUDY 134XCP|RP|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|2||||||PREGST|PREGNANT DURING THE STUDY||||/SEC|||UU/L|NOT DONE||U|NA|N|3||39||BASELINE|1967-04-13||1969-12-09|||1966-06-12||1968-10-18
TRIAL STUDY 134XCP|RP|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||PG/L|||L/S|NOT DONE||NA|NA|N|4||88||OBSERVATION|1972-04-04||1967-06-12|||1965-08-28||1971-08-23
TRIAL STUDY 134XCP|RP|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||FMOL/G|||IU/MG|NOT DONE||NA|NA|U|4||88||SCREENING|1964-03-06||1964-08-14|||1973-02-22||1966-02-22
TRIAL STUDY 134XCP|RP|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||ML/G/DAY|||LOG10 TCID 50/ML|NOT DONE||NA|Y|U|5||7||OBSERVATION|1963-09-17||1965-01-24|||1972-07-13||1969-12-25
TRIAL STUDY 134XCP|RP|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||RATIO|||NEEDLE GAUGE|NOT DONE||Y|U|N|5||7||OPEN LABEL TREATMENT|1964-08-31||1963-12-03|||1965-10-19||1966-01-13
TRIAL STUDY 134XCP|RP|17C2A52E-1232-4CBB-A809-9DC2C863366A|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||G/L|||100 IU/ML|NOT DONE||N|N|Y|1||38||INDUCTION TREATMENT|1966-10-20||1971-05-17|||1960-06-19||1967-12-22
TRIAL STUDY 134XCP|RP|17C2A52E-1232-4CBB-A809-9DC2C863366A|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^3 COPIES/ML|||AMU|NOT DONE||N|NA|U|1||38||LONG-TERM FOLLOW-UP|1973-06-25||1965-02-20|||1969-09-27||1965-08-04
TRIAL STUDY 134XCP|RP|17C2A52E-1232-4CBB-A809-9DC2C863366A|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||HOUNSFIELD UNIT|||PKAT/L|NOT DONE||Y|NA|NA|2||58||SCREENING|1965-05-06||1968-07-22|||1966-03-24||1962-10-28
TRIAL STUDY 134XCP|RP|17C2A52E-1232-4CBB-A809-9DC2C863366A|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||BU|||ML/KG|NOT DONE||N|N|U|2||58||OPEN LABEL TREATMENT|1969-01-05||1966-08-29|||1965-08-06||1968-06-14
TRIAL STUDY 134XCP|RP|17C2A52E-1232-4CBB-A809-9DC2C863366A|1||||||GRAVIND|GRAVIDA INDICATOR||||SACHET|||MG/G/MIN|NOT DONE||NA|N|NA|3||39||OBSERVATION|1960-09-14||1970-09-09|||1970-05-23||1961-12-02
TRIAL STUDY 134XCP|RP|17C2A52E-1232-4CBB-A809-9DC2C863366A|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||APS U|||MJOULE/CM2|NOT DONE||U|Y|U|3||39||BLINDED TREATMENT|1968-03-16||1964-11-30|||1967-07-24||1969-09-18
TRIAL STUDY 134XCP|RP|17C2A52E-1232-4CBB-A809-9DC2C863366A|1||||||PEELIND|PEELING INDICATOR||||10^4/L|||H/WK|NOT DONE||Y|NA|U|4||88||BLINDED TREATMENT|1968-07-12||1969-01-14|||1960-05-05||1969-03-13
TRIAL STUDY 134XCP|RP|17C2A52E-1232-4CBB-A809-9DC2C863366A|2||||||FUNDHT|FUNDAL HEIGHT||||MEQ/UG|||TROCHE|NOT DONE||N|U|N|4||88||WASHOUT|1973-05-18||1971-03-14|||1961-08-15||1972-08-19
TRIAL STUDY 134XCP|RP|17C2A52E-1232-4CBB-A809-9DC2C863366A|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MEQ/ML|||TBSP|NOT DONE||U|N|NA|5||7||LONG-TERM FOLLOW-UP|1973-08-28||1960-12-30|||1971-10-21||1960-12-19
TRIAL STUDY 134XCP|RP|17C2A52E-1232-4CBB-A809-9DC2C863366A|2||||||MENOAGE|MENOPAUSE AGE||||FMOL|||WATT|NOT DONE||NA|N|NA|5||7||OPEN LABEL TREATMENT|1965-04-12||1970-12-09|||1972-08-17||1964-07-06
TRIAL STUDY 134XCP|RP|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|1||||||DSCHGIND|DISCHARGE INDICATOR||||/HPF|||PFU/ANIMAL|NOT DONE||U|NA|NA|1||38||OBSERVATION|1962-01-07||1964-05-05|||1963-04-13||1965-01-21
TRIAL STUDY 134XCP|RP|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|2||||||EDEMAIND|EDEMA INDICATOR||||SPRAY|||ANSON U|NOT DONE||N|N|N|1||38||INDUCTION TREATMENT|1963-03-19||1961-10-11|||1970-01-27||1965-05-14
TRIAL STUDY 134XCP|RP|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|1||||||PRGENDTC|DATE PREGNANCY ENDED||||G/G/DAY|||FEU|NOT DONE||Y|NA|Y|2||58||OBSERVATION|1966-01-30||1965-02-05|||1971-01-25||1972-07-24
TRIAL STUDY 134XCP|RP|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|2||||||PREGST|PREGNANT DURING THE STUDY||||EJACULATE U|||MG/G/H|NOT DONE||U|Y|NA|2||58||BASELINE|1964-02-28||1961-02-22|||1963-11-03||1969-07-31
TRIAL STUDY 134XCP|RP|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||VIRTUAL PIXEL|||TSP|NOT DONE||U|NA|Y|3||39||BASELINE|1961-12-23||1968-09-10|||1963-06-29||1969-01-04
TRIAL STUDY 134XCP|RP|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|2||||||PREGNN|NUMBER OF PREGNANCIES||||PFU/DOSE|||SPRAY|NOT DONE||Y|U|U|3||39||CONTINUATION TREATMENT|1966-04-04||1964-08-15|||1973-01-09||1970-03-13
TRIAL STUDY 134XCP|RP|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||KUSP|||DAYS/WK|NOT DONE||Y|Y|U|4||88||WASHOUT|1969-05-11||1963-10-22|||1967-06-16||1968-06-08
TRIAL STUDY 134XCP|RP|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||ELISA UNIT|||UEQ|NOT DONE||Y|Y|Y|4||88||RUN-IN|1972-06-15||1965-03-03|||1972-08-09||1962-05-01
TRIAL STUDY 134XCP|RP|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|1||||||PEELIND|PEELING INDICATOR||||CGY|||CAN|NOT DONE||N|N|NA|5||7||OPEN LABEL TREATMENT|1972-11-10||1963-07-05|||1967-07-22||1969-01-29
TRIAL STUDY 134XCP|RP|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||CI/UL|||%/S|NOT DONE||Y|NA|NA|5||7||FOLLOW-UP|1968-02-12||1966-05-01|||1966-02-03||1960-01-02
TRIAL STUDY 134XCP|RP|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|1||||||INABOIND|INDUCED ABORTION INDICATOR||||L/MIN/M2|||NEWTON|NOT DONE||N|N|NA|1||38||SCREENING|1964-08-04||1970-07-21|||1964-04-15||1960-05-11
TRIAL STUDY 134XCP|RP|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||10^7 CFU|||AU/ML|NOT DONE||Y|Y|N|1||38||RUN-IN|1966-06-26||1960-07-09|||1969-08-13||1964-01-04
TRIAL STUDY 134XCP|RP|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|1||||||ERYTHIND|ERYTHEMA INDICATOR||||/7.5 ML|||/KG|NOT DONE||NA|NA|NA|2||58||BLINDED TREATMENT|1968-04-04||1963-12-22|||1973-05-20||1963-01-06
TRIAL STUDY 134XCP|RP|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|2||||||EDEMAIND|EDEMA INDICATOR||||/MBP|||VP/DOSE|NOT DONE||NA|Y|NA|2||58||INDUCTION TREATMENT|1969-03-20||1970-08-11|||1960-05-25||1972-05-30
TRIAL STUDY 134XCP|RP|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|1||||||PRGENDTC|DATE PREGNANCY ENDED||||CFU/G|||10^6/L|NOT DONE||Y|N|Y|3||39||WASHOUT|1964-12-08||1964-06-16|||1969-04-30||1963-05-22
TRIAL STUDY 134XCP|RP|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||FMOL/L/SEC|||DEG/MM|NOT DONE||U|U|Y|3||39||SCREENING|1967-05-03||1962-10-26|||1964-02-04||1961-08-07
TRIAL STUDY 134XCP|RP|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|1||||||PUSTIND|PUSTULE INDICATOR||||10^6/G|||MMHG/SEC|NOT DONE||NA|NA|N|4||88||OPEN LABEL TREATMENT|1968-09-01||1970-05-15|||1971-07-29||1967-10-10
TRIAL STUDY 134XCP|RP|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|2||||||ABORTN|NUMBER OF ABORTIONS||||TITER|||EU|NOT DONE||NA|U|N|4||88||FOLLOW-UP|1963-03-08||1961-07-14|||1967-06-25||1962-12-04
TRIAL STUDY 134XCP|RP|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MG|||G/KG|NOT DONE||NA|NA|NA|5||7||SCREENING|1964-12-14||1972-09-08|||1963-11-26||1960-11-03
TRIAL STUDY 134XCP|RP|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PIXELS/IN|||CI/KG|NOT DONE||Y|U|NA|5||7||FOLLOW-UP|1960-06-25||1960-01-11|||1964-10-26||1972-12-20
TRIAL STUDY 134XCP|RP|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|1||||||PREGST|PREGNANT DURING THE STUDY||||U/G/H|||MILE|NOT DONE||Y|Y|U|1||38||CONTINUATION TREATMENT|1960-04-13||1967-06-25|||1960-07-05||1964-03-05
TRIAL STUDY 134XCP|RP|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|2||||||STILBIND|STILLBIRTH INDICATOR||||KG/L|||DPM/MG|NOT DONE||U|NA|U|1||38||OPEN LABEL TREATMENT|1969-06-21||1968-05-07|||1969-12-25||1964-10-07
TRIAL STUDY 134XCP|RP|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ENZYME U/G HB|||UIU/L|NOT DONE||NA|N|U|2||58||OPEN LABEL TREATMENT|1960-12-14||1961-04-07|||1964-07-28||1972-01-19
TRIAL STUDY 134XCP|RP|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MM/SEC|||NMOL/L/H|NOT DONE||U|N|U|2||58||LONG-TERM FOLLOW-UP|1968-04-18||1964-03-15|||1965-12-07||1968-04-23
TRIAL STUDY 134XCP|RP|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||L/MIN|||MOL/DAY|NOT DONE||N|NA|U|3||39||SCREENING|1960-06-14||1971-07-16|||1971-02-01||1962-11-04
TRIAL STUDY 134XCP|RP|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||UG/DAY|||DYN|NOT DONE||N|Y|NA|3||39||TREATMENT|1966-12-09||1962-07-01|||1972-08-04||1973-02-13
TRIAL STUDY 134XCP|RP|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|1||||||PUSTIND|PUSTULE INDICATOR||||10^10/L|||/SEC|NOT DONE||NA|NA|N|4||88||OPEN LABEL TREATMENT|1969-10-27||1967-03-31|||1968-01-23||1968-02-06
TRIAL STUDY 134XCP|RP|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|2||||||PUSTIND|PUSTULE INDICATOR||||MG/ML/DAY|||MG/L FEU|NOT DONE||NA|NA|NA|4||88||OBSERVATION|1967-03-23||1969-08-21|||1963-05-24||1971-03-29
TRIAL STUDY 134XCP|RP|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|1||||||BRTHN|NUMBER OF BIRTHS||||G/DAY|||ML/CM|NOT DONE||NA|NA|N|5||7||TREATMENT|1973-04-13||1960-07-29|||1967-03-26||1965-06-22
TRIAL STUDY 134XCP|RP|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|2||||||ABORTN|NUMBER OF ABORTIONS||||DRAM|||U/10^12 RBC|NOT DONE||NA|N|Y|5||7||TREATMENT|1962-05-27||1973-03-24|||1963-05-10||1961-06-13
TRIAL STUDY 134XCP|RP|585A17D7-12A3-40C8-811F-339497B9D09C|1||||||PREGIND|PREGNANT INDICATOR||||BU|||G/DL|NOT DONE||U|U|U|1||38||OBSERVATION|1961-10-05||1973-07-05|||1970-08-02||1972-09-20
TRIAL STUDY 134XCP|RP|585A17D7-12A3-40C8-811F-339497B9D09C|2||||||PRGENDTC|DATE PREGNANCY ENDED||||L/S/KPA|||L/MIN|NOT DONE||Y|Y|NA|1||38||TREATMENT|1964-05-12||1967-09-26|||1971-12-03||1970-09-13
TRIAL STUDY 134XCP|RP|585A17D7-12A3-40C8-811F-339497B9D09C|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||/WK|||V/V|NOT DONE||U|NA|U|2||58||SCREENING|1972-03-29||1973-02-21|||1972-11-14||1964-06-01
TRIAL STUDY 134XCP|RP|585A17D7-12A3-40C8-811F-339497B9D09C|2||||||PREGNN|NUMBER OF PREGNANCIES||||GBQ/G|||FG|NOT DONE||U|N|U|2||58||OBSERVATION|1960-03-20||1971-04-09|||1972-08-19||1967-08-01
TRIAL STUDY 134XCP|RP|585A17D7-12A3-40C8-811F-339497B9D09C|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MET*H|||SYRINGE|NOT DONE||N|NA|N|3||39||RUN-IN|1973-03-29||1967-11-09|||1970-10-06||1968-02-08
TRIAL STUDY 134XCP|RP|585A17D7-12A3-40C8-811F-339497B9D09C|2||||||PUSTIND|PUSTULE INDICATOR||||L/S/KPA|||UG/L/H|NOT DONE||Y|N|NA|3||39||INDUCTION TREATMENT|1972-12-27||1960-09-25|||1965-12-03||1964-10-28
TRIAL STUDY 134XCP|RP|585A17D7-12A3-40C8-811F-339497B9D09C|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||G/CAGE|||NG/DL|NOT DONE||N|U|NA|4||88||BLINDED TREATMENT|1972-08-06||1966-02-05|||1969-09-08||1972-03-14
TRIAL STUDY 134XCP|RP|585A17D7-12A3-40C8-811F-339497B9D09C|2||||||DLVRMODE|MODE OF DELIVERY||||ML/S/M2|||NG|NOT DONE||NA|NA|N|4||88||OPEN LABEL TREATMENT|1965-11-27||1962-01-13|||1963-12-28||1972-12-17
TRIAL STUDY 134XCP|RP|585A17D7-12A3-40C8-811F-339497B9D09C|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||M/SEC2|||GENEQ/ML|NOT DONE||U|Y|U|5||7||SCREENING|1963-11-13||1960-07-11|||1960-07-27||1971-12-11
TRIAL STUDY 134XCP|RP|585A17D7-12A3-40C8-811F-339497B9D09C|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||U/KG/H|||PUFF|NOT DONE||NA|NA|U|5||7||INDUCTION TREATMENT|1960-09-06||1965-07-22|||1967-04-16||1961-08-01
TRIAL STUDY 134XCP|RP|D777661E-DF03-4221-88CC-34EB805EF5DB|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||U/KG/MIN|||BQ/KG|NOT DONE||NA|N|Y|1||38||BASELINE|1965-12-31||1968-04-12|||1961-08-06||1960-01-19
TRIAL STUDY 134XCP|RP|D777661E-DF03-4221-88CC-34EB805EF5DB|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MG/KG/DOSE|||DB|NOT DONE||NA|NA|N|1||38||LONG-TERM FOLLOW-UP|1970-01-07||1960-10-18|||1964-06-07||1966-12-25
TRIAL STUDY 134XCP|RP|D777661E-DF03-4221-88CC-34EB805EF5DB|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||%(W/W)|||ANTIBODY UNIT|NOT DONE||N|Y|N|2||58||BLINDED TREATMENT|1971-10-20||1973-03-21|||1969-09-24||1960-08-29
TRIAL STUDY 134XCP|RP|D777661E-DF03-4221-88CC-34EB805EF5DB|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UMOL/MG/MIN|||PM|NOT DONE||N|N|U|2||58||OBSERVATION|1970-03-15||1961-12-21|||1968-08-21||1961-01-31
TRIAL STUDY 134XCP|RP|D777661E-DF03-4221-88CC-34EB805EF5DB|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MOL|||WAFER|NOT DONE||U|N|NA|3||39||LONG-TERM FOLLOW-UP|1970-04-21||1965-02-03|||1960-05-18||1968-02-27
TRIAL STUDY 134XCP|RP|D777661E-DF03-4221-88CC-34EB805EF5DB|2||||||DSCHGIND|DISCHARGE INDICATOR||||NL|||ROENTGEN|NOT DONE||U|N|U|3||39||OBSERVATION|1966-09-16||1962-10-14|||1962-08-06||1964-08-03
TRIAL STUDY 134XCP|RP|D777661E-DF03-4221-88CC-34EB805EF5DB|1||||||PUSTIND|PUSTULE INDICATOR||||CPM|||UG/MIN|NOT DONE||NA|N|Y|4||88||FOLLOW-UP|1971-04-05||1968-12-24|||1968-05-15||1970-10-27
TRIAL STUDY 134XCP|RP|D777661E-DF03-4221-88CC-34EB805EF5DB|2||||||PREGNN|NUMBER OF PREGNANCIES||||ML/CAGE/DAY|||10^3 RNA COPIES/ML|NOT DONE||NA|Y|Y|4||88||WASHOUT|1968-02-27||1973-01-21|||1962-03-07||1971-02-28
TRIAL STUDY 134XCP|RP|D777661E-DF03-4221-88CC-34EB805EF5DB|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||RPM|||V/SEC|NOT DONE||N|N|Y|5||7||FOLLOW-UP|1960-04-17||1963-06-20|||1961-05-14||1964-07-18
TRIAL STUDY 134XCP|RP|D777661E-DF03-4221-88CC-34EB805EF5DB|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||TUBERCULIN UNIT|||10^6 U|NOT DONE||U|U|Y|5||7||INDUCTION TREATMENT|1965-03-23||1968-04-05|||1973-01-01||1965-02-15
TRIAL STUDY 134XCP|RP|67828FC5-94DE-4A68-83DE-F86AA8F86D72|1||||||FUNDHT|FUNDAL HEIGHT||||MG/KG/DAY|||MM3/MM2/YEAR|NOT DONE||N|U|N|1||38||BASELINE|1961-12-18||1967-02-16|||1967-10-21||1973-02-08
TRIAL STUDY 134XCP|RP|67828FC5-94DE-4A68-83DE-F86AA8F86D72|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||G/U|||FT|NOT DONE||Y|Y|U|1||38||LONG-TERM FOLLOW-UP|1969-08-13||1967-03-30|||1968-01-08||1967-03-23
TRIAL STUDY 134XCP|RP|67828FC5-94DE-4A68-83DE-F86AA8F86D72|1||||||THICK|THICKNESS||||/LSQN|||MG/M2/H|NOT DONE||Y|NA|N|2||58||WASHOUT|1960-03-23||1973-07-20|||1967-09-27||1963-07-30
TRIAL STUDY 134XCP|RP|67828FC5-94DE-4A68-83DE-F86AA8F86D72|2||||||FUNDHT|FUNDAL HEIGHT||||PFU|||NKAT/L|NOT DONE||NA|U|NA|2||58||WASHOUT|1970-04-09||1969-10-24|||1970-10-15||1969-10-25
TRIAL STUDY 134XCP|RP|67828FC5-94DE-4A68-83DE-F86AA8F86D72|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||NMOL BCE/L|||MV|NOT DONE||Y|NA|Y|3||39||RUN-IN|1960-04-17||1968-06-20|||1960-10-30||1971-10-08
TRIAL STUDY 134XCP|RP|67828FC5-94DE-4A68-83DE-F86AA8F86D72|2||||||EDEMAIND|EDEMA INDICATOR||||OD UNIT|||UIU/DL|NOT DONE||N|N|Y|3||39||RUN-IN|1968-08-12||1965-11-16|||1962-11-08||1963-11-11
TRIAL STUDY 134XCP|RP|67828FC5-94DE-4A68-83DE-F86AA8F86D72|1||||||ABORTN|NUMBER OF ABORTIONS||||MMOL/MIN/KPA/L|||BAU/ML|NOT DONE||Y|U|U|4||88||BASELINE|1968-09-08||1970-06-24|||1968-04-19||1960-11-25
TRIAL STUDY 134XCP|RP|67828FC5-94DE-4A68-83DE-F86AA8F86D72|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||ABSORBANCE U/ML|||UG/MOL|NOT DONE||NA|N|N|4||88||INDUCTION TREATMENT|1973-05-03||1965-12-08|||1972-01-06||1972-05-05
TRIAL STUDY 134XCP|RP|67828FC5-94DE-4A68-83DE-F86AA8F86D72|1||||||MENOAGE|MENOPAUSE AGE||||MMHG/L/MIN|||10^3/HPF|NOT DONE||N|NA|N|5||7||FOLLOW-UP|1969-10-23||1967-12-11|||1969-07-05||1963-12-12
TRIAL STUDY 134XCP|RP|67828FC5-94DE-4A68-83DE-F86AA8F86D72|2||||||DLVRMODE|MODE OF DELIVERY||||UG/MIN|||H*%|NOT DONE||N|NA|Y|5||7||TREATMENT|1963-06-06||1967-03-29|||1960-04-07||1972-08-27
TRIAL STUDY 134XCP|RP|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|1||||||INTP|INTERPRETATION||||POINT|||BQ/UG|NOT DONE||Y|N|N|1||38||LONG-TERM FOLLOW-UP|1973-03-29||1967-12-26|||1961-05-27||1965-06-20
TRIAL STUDY 134XCP|RP|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||TROCHE|||IN|NOT DONE||N|U|Y|1||38||LONG-TERM FOLLOW-UP|1962-05-14||1963-06-09|||1961-01-24||1970-06-14
TRIAL STUDY 134XCP|RP|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|1||||||INABOIND|INDUCED ABORTION INDICATOR||||HZ|||IU/DL|NOT DONE||Y|NA|N|2||58||OPEN LABEL TREATMENT|1962-06-25||1962-10-08|||1962-03-18||1963-02-26
TRIAL STUDY 134XCP|RP|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MHZ|||DAGU/ML|NOT DONE||N|Y|U|2||58||BLINDED TREATMENT|1969-05-22||1966-09-13|||1961-08-18||1973-08-06
TRIAL STUDY 134XCP|RP|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|1||||||MENARAGE|MENARCHE AGE||||DYN|||BOWL|NOT DONE||Y|Y|Y|3||39||OBSERVATION|1968-07-09||1962-03-20|||1965-09-19||1962-05-01
TRIAL STUDY 134XCP|RP|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||DAGU|||CP|NOT DONE||Y|N|Y|3||39||SCREENING|1963-03-24||1968-07-22|||1971-07-12||1968-06-23
TRIAL STUDY 134XCP|RP|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|1||||||MENOAGE|MENOPAUSE AGE||||10^6 ORGANISMS|||BQ/L|NOT DONE||N|N|Y|4||88||CONTINUATION TREATMENT|1960-02-11||1968-09-23|||1962-03-30||1973-05-16
TRIAL STUDY 134XCP|RP|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|2||||||EDEMAIND|EDEMA INDICATOR||||MU/G|||VG/DOSE|NOT DONE||U|U|N|4||88||BLINDED TREATMENT|1966-02-08||1971-12-17|||1967-06-20||1969-09-12
TRIAL STUDY 134XCP|RP|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||SBE/ML|||PMOL/L/H|NOT DONE||N|U|U|5||7||OBSERVATION|1969-10-07||1972-05-31|||1968-03-18||1968-06-11
TRIAL STUDY 134XCP|RP|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||KG/M2|||WEBER|NOT DONE||Y|NA|U|5||7||LONG-TERM FOLLOW-UP|1967-06-21||1961-03-10|||1962-05-09||1972-10-23
TRIAL STUDY 134XCP|RP|650E5DFA-08CC-413C-B43D-070E61353E6E|1||||||BRTHN|NUMBER OF BIRTHS||||MPL U|||TUBERCULIN UNIT/ML|NOT DONE||NA|Y|Y|1||38||OBSERVATION|1966-01-19||1970-11-21|||1969-12-19||1967-03-15
TRIAL STUDY 134XCP|RP|650E5DFA-08CC-413C-B43D-070E61353E6E|2||||||PREGST|PREGNANT DURING THE STUDY||||WAFER|||PMOL/10^9 CELLS|NOT DONE||U|U|Y|1||38||TREATMENT|1968-03-09||1966-03-01|||1963-07-17||1961-02-25
TRIAL STUDY 134XCP|RP|650E5DFA-08CC-413C-B43D-070E61353E6E|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||WATT|||NMOL/L|NOT DONE||NA|U|N|2||58||WASHOUT|1966-10-06||1968-12-29|||1964-09-06||1960-06-10
TRIAL STUDY 134XCP|RP|650E5DFA-08CC-413C-B43D-070E61353E6E|2||||||BRTHN|NUMBER OF BIRTHS||||NMOL/G|||G/ANIMAL|NOT DONE||N|N|N|2||58||CONTINUATION TREATMENT|1960-05-31||1961-12-23|||1972-07-18||1973-06-22
TRIAL STUDY 134XCP|RP|650E5DFA-08CC-413C-B43D-070E61353E6E|1||||||ULCERIND|ULCER INDICATOR||||10^3 DNA COPIES/ML|||DIP|NOT DONE||U|U|Y|3||39||SCREENING|1971-12-18||1964-03-11|||1968-12-29||1964-11-14
TRIAL STUDY 134XCP|RP|650E5DFA-08CC-413C-B43D-070E61353E6E|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||PIXELS/IN|||L/DAY|NOT DONE||N|NA|N|3||39||OPEN LABEL TREATMENT|1969-11-15||1962-07-08|||1971-02-26||1963-09-26
TRIAL STUDY 134XCP|RP|650E5DFA-08CC-413C-B43D-070E61353E6E|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||10^6 DNA COPIES/ML|||ANTIBODY UNIT|NOT DONE||NA|NA|N|4||88||SCREENING|1961-11-19||1961-04-07|||1960-04-08||1960-11-06
TRIAL STUDY 134XCP|RP|650E5DFA-08CC-413C-B43D-070E61353E6E|2||||||PEELIND|PEELING INDICATOR||||CI/G|||FOZ_US|NOT DONE||Y|N|N|4||88||OPEN LABEL TREATMENT|1970-03-13||1962-08-16|||1965-06-28||1961-09-06
TRIAL STUDY 134XCP|RP|650E5DFA-08CC-413C-B43D-070E61353E6E|1||||||MASSIND|MASS INDICATOR||||10^6 CFU|||STEPS/MIN|NOT DONE||U|N|U|5||7||BASELINE|1968-08-16||1967-07-16|||1965-10-01||1970-08-28
TRIAL STUDY 134XCP|RP|650E5DFA-08CC-413C-B43D-070E61353E6E|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||CMOL/L|||PMOL|NOT DONE||NA|NA|Y|5||7||TREATMENT|1964-11-02||1962-07-18|||1967-03-02||1972-04-16
TRIAL STUDY 134XCP|RP|71716F05-3ABE-4A2A-B9DD-2201A63087ED|1||||||GRAVIND|GRAVIDA INDICATOR||||JDF UNIT|||H/WK|NOT DONE||Y|NA|N|1||38||FOLLOW-UP|1967-02-09||1969-03-24|||1966-06-15||1960-01-03
TRIAL STUDY 134XCP|RP|71716F05-3ABE-4A2A-B9DD-2201A63087ED|2||||||PRGENDTC|DATE PREGNANCY ENDED||||MGEQ|||TITER|NOT DONE||U|Y|NA|1||38||RUN-IN|1967-02-16||1961-06-12|||1972-02-17||1967-01-29
TRIAL STUDY 134XCP|RP|71716F05-3ABE-4A2A-B9DD-2201A63087ED|1||||||PRGENDTC|DATE PREGNANCY ENDED||||DNA COPIES/UG|||MEQ/DL|NOT DONE||NA|NA|N|2||58||CONTINUATION TREATMENT|1970-01-20||1970-06-10|||1960-06-26||1961-09-23
TRIAL STUDY 134XCP|RP|71716F05-3ABE-4A2A-B9DD-2201A63087ED|2||||||PREGIND|PREGNANT INDICATOR||||UCI/L|||10^3 RNA COPIES/ML|NOT DONE||N|N|U|2||58||WASHOUT|1960-10-27||1971-08-11|||1968-05-31||1967-05-26
TRIAL STUDY 134XCP|RP|71716F05-3ABE-4A2A-B9DD-2201A63087ED|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||%/S|||CI/ML|NOT DONE||N|N|NA|3||39||CONTINUATION TREATMENT|1966-02-12||1962-05-15|||1963-05-05||1961-04-26
TRIAL STUDY 134XCP|RP|71716F05-3ABE-4A2A-B9DD-2201A63087ED|2||||||ULCERIND|ULCER INDICATOR||||AMPULE|||DYN|NOT DONE||Y|U|N|3||39||TREATMENT|1963-11-18||1966-05-02|||1967-02-14||1970-06-14
TRIAL STUDY 134XCP|RP|71716F05-3ABE-4A2A-B9DD-2201A63087ED|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||UOSM|||MEQ/UL|NOT DONE||NA|NA|N|4||88||LONG-TERM FOLLOW-UP|1971-07-15||1967-07-19|||1963-11-13||1963-10-09
TRIAL STUDY 134XCP|RP|71716F05-3ABE-4A2A-B9DD-2201A63087ED|2||||||DSCHGIND|DISCHARGE INDICATOR||||UU/DL|||L/H/M2|NOT DONE||N|NA|U|4||88||INDUCTION TREATMENT|1964-03-14||1971-01-13|||1963-03-21||1966-05-19
TRIAL STUDY 134XCP|RP|71716F05-3ABE-4A2A-B9DD-2201A63087ED|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||SUPPOSITORY|||10^4/HPF|NOT DONE||N|N|U|5||7||WASHOUT|1964-03-26||1962-10-09|||1971-12-05||1964-07-19
TRIAL STUDY 134XCP|RP|71716F05-3ABE-4A2A-B9DD-2201A63087ED|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||FOZ_BR|||MEQ/L|NOT DONE||NA|NA|U|5||7||CONTINUATION TREATMENT|1970-06-30||1965-01-23|||1966-02-21||1966-09-26
TRIAL STUDY 134XCP|RP|EF9208B0-4DF0-4029-AB67-8F87662D3E90|1||||||INABOIND|INDUCED ABORTION INDICATOR||||FEU|||KS|NOT DONE||Y|N|N|1||38||CONTINUATION TREATMENT|1972-01-24||1964-09-12|||1963-06-24||1972-11-16
TRIAL STUDY 134XCP|RP|EF9208B0-4DF0-4029-AB67-8F87662D3E90|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||G/M2/DAY|||PELLET|NOT DONE||U|NA|N|1||38||TREATMENT|1960-06-29||1962-12-15|||1972-04-20||1965-01-20
TRIAL STUDY 134XCP|RP|EF9208B0-4DF0-4029-AB67-8F87662D3E90|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||OZ|||ML/M2/H|NOT DONE||U|Y|NA|2||58||SCREENING|1968-04-24||1972-06-05|||1961-05-22||1971-11-06
TRIAL STUDY 134XCP|RP|EF9208B0-4DF0-4029-AB67-8F87662D3E90|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||BQ/UL|||FT3|NOT DONE||NA|Y|U|2||58||CONTINUATION TREATMENT|1971-09-26||1970-09-18|||1972-03-14||1965-11-21
TRIAL STUDY 134XCP|RP|EF9208B0-4DF0-4029-AB67-8F87662D3E90|1||||||ERYTHIND|ERYTHEMA INDICATOR||||M|||BQ/UG|NOT DONE||N|Y|Y|3||39||INDUCTION TREATMENT|1972-09-15||1969-12-01|||1972-11-05||1969-06-22
TRIAL STUDY 134XCP|RP|EF9208B0-4DF0-4029-AB67-8F87662D3E90|2||||||DSCHGIND|DISCHARGE INDICATOR||||G/ANIMAL|||/100 WBC|NOT DONE||N|NA|Y|3||39||SCREENING|1961-10-21||1962-08-15|||1971-05-05||1966-10-27
TRIAL STUDY 134XCP|RP|EF9208B0-4DF0-4029-AB67-8F87662D3E90|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||ATM|||PFU/DOSE|NOT DONE||NA|N|U|4||88||WASHOUT|1964-10-12||1962-12-01|||1960-06-13||1972-06-17
TRIAL STUDY 134XCP|RP|EF9208B0-4DF0-4029-AB67-8F87662D3E90|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||GY/H|||ML/M2/H|NOT DONE||U|U|U|4||88||OPEN LABEL TREATMENT|1971-10-03||1966-05-06|||1960-01-06||1963-04-27
TRIAL STUDY 134XCP|RP|EF9208B0-4DF0-4029-AB67-8F87662D3E90|1||||||MENOAGE|MENOPAUSE AGE||||BQ|||CMH2O*S/ML|NOT DONE||NA|U|U|5||7||CONTINUATION TREATMENT|1964-10-08||1966-10-20|||1973-02-19||1961-11-02
TRIAL STUDY 134XCP|RP|EF9208B0-4DF0-4029-AB67-8F87662D3E90|2||||||MASSIND|MASS INDICATOR||||NMOL/DAY|||UG/M2/DAY|NOT DONE||NA|N|U|5||7||CONTINUATION TREATMENT|1971-07-07||1964-08-12|||1970-12-09||1970-03-06
TRIAL STUDY 134XCP|RP|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|1||||||ERYTHIND|ERYTHEMA INDICATOR||||UMOL/DAY|||UG/G/H|NOT DONE||Y|NA|Y|1||38||SCREENING|1967-05-05||1969-08-24|||1966-10-30||1964-06-10
TRIAL STUDY 134XCP|RP|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||BOWL|||10^9 ORGANISMS/G|NOT DONE||U|Y|N|1||38||SCREENING|1969-08-27||1968-11-30|||1970-04-25||1967-08-06
TRIAL STUDY 134XCP|RP|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MOL/G|||/DAY|NOT DONE||NA|Y|Y|2||58||BASELINE|1961-05-10||1966-04-19|||1966-08-19||1962-10-14
TRIAL STUDY 134XCP|RP|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|2||||||MENFDUR|MENSES FLOW DURATION||||GBQ/G|||MOL/MOL|NOT DONE||NA|Y|Y|2||58||INDUCTION TREATMENT|1963-06-30||1964-12-15|||1964-08-15||1970-09-06
TRIAL STUDY 134XCP|RP|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||FT2|||KUSP|NOT DONE||N|U|Y|3||39||RUN-IN|1971-07-14||1963-02-16|||1967-12-07||1972-01-26
TRIAL STUDY 134XCP|RP|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||L/DAY|||M3|NOT DONE||N|U|NA|3||39||WASHOUT|1969-06-09||1966-05-08|||1970-01-10||1969-04-01
TRIAL STUDY 134XCP|RP|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|1||||||FUNDHT|FUNDAL HEIGHT||||DAYS/WK|||PIXEL|NOT DONE||Y|U|Y|4||88||INDUCTION TREATMENT|1970-07-31||1966-09-09|||1969-12-26||1963-11-10
TRIAL STUDY 134XCP|RP|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|2||||||INABOIND|INDUCED ABORTION INDICATOR||||KALLIKREIN INHIBITOR UNIT|||PA|NOT DONE||U|N|Y|4||88||BASELINE|1966-07-22||1961-03-16|||1962-02-17||1962-03-25
TRIAL STUDY 134XCP|RP|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|1||||||ABORTN|NUMBER OF ABORTIONS||||MET|||UL/DOSE|NOT DONE||U|U|Y|5||7||BASELINE|1973-06-09||1968-11-28|||1968-06-14||1968-06-22
TRIAL STUDY 134XCP|RP|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||CI/UG|||/40 HPFS|NOT DONE||N|NA|NA|5||7||INDUCTION TREATMENT|1961-06-14||1967-08-13|||1970-03-11||1973-07-22
TRIAL STUDY 134XCP|RP|25580765-CB09-4BE3-8DED-C0068C69E9C4|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||10^8/L|||MAMP|NOT DONE||NA|Y|U|1||38||RUN-IN|1963-07-27||1968-04-25|||1967-10-29||1962-06-14
TRIAL STUDY 134XCP|RP|25580765-CB09-4BE3-8DED-C0068C69E9C4|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||DEG/S|||CUP|NOT DONE||NA|NA|U|1||38||RUN-IN|1968-11-14||1969-01-08|||1963-10-03||1973-06-13
TRIAL STUDY 134XCP|RP|25580765-CB09-4BE3-8DED-C0068C69E9C4|1||||||DSCHGIND|DISCHARGE INDICATOR||||IMPLANT|||RNA COPIES/ML|NOT DONE||U|U|Y|2||58||WASHOUT|1969-04-22||1969-12-29|||1961-11-09||1960-07-19
TRIAL STUDY 134XCP|RP|25580765-CB09-4BE3-8DED-C0068C69E9C4|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||TAMPON|||MMHG/SEC|NOT DONE||N|NA|U|2||58||FOLLOW-UP|1966-01-06||1965-02-04|||1964-08-11||1967-09-25
TRIAL STUDY 134XCP|RP|25580765-CB09-4BE3-8DED-C0068C69E9C4|1||||||ABORTN|NUMBER OF ABORTIONS||||ML/ANIMAL/WK|||F|NOT DONE||N|U|Y|3||39||FOLLOW-UP|1970-09-04||1970-02-10|||1970-12-30||1970-08-30
TRIAL STUDY 134XCP|RP|25580765-CB09-4BE3-8DED-C0068C69E9C4|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||PG/CELL|||MOL/MOL|NOT DONE||Y|NA|Y|3||39||TREATMENT|1972-09-02||1969-03-15|||1963-03-28||1968-02-24
TRIAL STUDY 134XCP|RP|25580765-CB09-4BE3-8DED-C0068C69E9C4|1||||||STILBIND|STILLBIRTH INDICATOR||||ENZYME U/G HB|||L|NOT DONE||NA|N|Y|4||88||CONTINUATION TREATMENT|1970-09-21||1963-02-26|||1971-10-25||1963-03-10
TRIAL STUDY 134XCP|RP|25580765-CB09-4BE3-8DED-C0068C69E9C4|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MM2|||10^3 ORGANISMS/ML|NOT DONE||U|NA|Y|4||88||CONTINUATION TREATMENT|1966-03-02||1971-07-17|||1968-08-05||1967-10-23
TRIAL STUDY 134XCP|RP|25580765-CB09-4BE3-8DED-C0068C69E9C4|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||G/CM2|||MM/2H|NOT DONE||N|U|U|5||7||CONTINUATION TREATMENT|1970-12-30||1969-11-15|||1970-04-17||1964-05-14
TRIAL STUDY 134XCP|RP|25580765-CB09-4BE3-8DED-C0068C69E9C4|2||||||STILBIND|STILLBIRTH INDICATOR||||UU/DL|||DAYS|NOT DONE||Y|U|Y|5||7||SCREENING|1966-09-23||1966-10-18|||1973-01-24||1963-12-16
TRIAL STUDY 134XCP|RP|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MEQ/L|||KPA|NOT DONE||Y|NA|U|1||38||OPEN LABEL TREATMENT|1960-01-10||1965-05-25|||1971-09-15||1964-05-07
TRIAL STUDY 134XCP|RP|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||BAR|||KAT|NOT DONE||NA|U|Y|1||38||WASHOUT|1960-03-20||1963-03-09|||1961-04-17||1966-07-13
TRIAL STUDY 134XCP|RP|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||UL|||PG/CELL|NOT DONE||Y|N|Y|2||58||INDUCTION TREATMENT|1966-08-24||1971-06-20|||1964-04-26||1966-01-03
TRIAL STUDY 134XCP|RP|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||GENEQ|||NMOL BCE/MMOL|NOT DONE||Y|Y|NA|2||58||RUN-IN|1967-04-18||1972-02-09|||1966-02-02||1962-04-12
TRIAL STUDY 134XCP|RP|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|1||||||STILBIND|STILLBIRTH INDICATOR||||M/SEC|||PELLET|NOT DONE||Y|NA|U|3||39||TREATMENT|1961-07-11||1967-01-23|||1971-04-01||1964-03-11
TRIAL STUDY 134XCP|RP|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||BREATHS/MIN|||EJACULATE U|NOT DONE||N|NA|NA|3||39||BLINDED TREATMENT|1971-08-09||1969-10-14|||1961-10-29||1964-05-04
TRIAL STUDY 134XCP|RP|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||WATT|||MIN|NOT DONE||Y|N|Y|4||88||OPEN LABEL TREATMENT|1968-05-17||1968-08-04|||1973-06-05||1971-09-17
TRIAL STUDY 134XCP|RP|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||AMPULE|||UG/KG|NOT DONE||NA|N|NA|4||88||RUN-IN|1960-12-30||1962-10-16|||1961-01-20||1960-05-22
TRIAL STUDY 134XCP|RP|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||M|||DDU|NOT DONE||NA|Y|U|5||7||WASHOUT|1965-02-16||1972-02-21|||1963-01-04||1962-12-22
TRIAL STUDY 134XCP|RP|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MSEC|||ML/G/MIN|NOT DONE||Y|N|NA|5||7||OBSERVATION|1960-02-28||1963-07-14|||1961-09-08||1968-07-17
TRIAL STUDY 134XCP|RP|A902F087-3BF4-4387-80F9-DDCDDCE1813E|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||KA_U/DL|||MJOULE/CM2|NOT DONE||N|Y|U|1||38||RUN-IN|1962-02-08||1973-03-27|||1965-11-21||1966-05-10
TRIAL STUDY 134XCP|RP|A902F087-3BF4-4387-80F9-DDCDDCE1813E|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||/2000 RBC|||UMOL/L/SEC|NOT DONE||Y|N|Y|1||38||OPEN LABEL TREATMENT|1967-09-20||1973-03-11|||1962-08-21||1970-04-19
TRIAL STUDY 134XCP|RP|A902F087-3BF4-4387-80F9-DDCDDCE1813E|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||UGEQ|||MEQ/UL|NOT DONE||Y|U|Y|2||58||FOLLOW-UP|1970-12-23||1967-09-22|||1972-03-18||1964-04-17
TRIAL STUDY 134XCP|RP|A902F087-3BF4-4387-80F9-DDCDDCE1813E|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MBQ|||GPS U|NOT DONE||N|N|NA|2||58||SCREENING|1970-07-11||1964-07-12|||1964-03-29||1965-10-29
TRIAL STUDY 134XCP|RP|A902F087-3BF4-4387-80F9-DDCDDCE1813E|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MAC50|||/MIN|NOT DONE||U|N|U|3||39||OBSERVATION|1971-12-25||1971-11-26|||1965-03-27||1971-08-11
TRIAL STUDY 134XCP|RP|A902F087-3BF4-4387-80F9-DDCDDCE1813E|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UKAT/10^12 RBC|||ML/ANIMAL/WK|NOT DONE||N|Y|N|3||39||TREATMENT|1973-02-09||1973-08-01|||1963-05-01||1971-01-31
TRIAL STUDY 134XCP|RP|A902F087-3BF4-4387-80F9-DDCDDCE1813E|1||||||MENFDUR|MENSES FLOW DURATION||||UG/ANIMAL|||10^11/L|NOT DONE||U|N|Y|4||88||INDUCTION TREATMENT|1966-08-11||1964-10-22|||1963-04-06||1965-06-15
TRIAL STUDY 134XCP|RP|A902F087-3BF4-4387-80F9-DDCDDCE1813E|2||||||ULCERIND|ULCER INDICATOR||||MU|||M/SEC2|NOT DONE||NA|N|NA|4||88||TREATMENT|1969-03-06||1971-10-28|||1966-10-30||1964-10-11
TRIAL STUDY 134XCP|RP|A902F087-3BF4-4387-80F9-DDCDDCE1813E|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||TABLET|||CAPLET|NOT DONE||N|Y|NA|5||7||OPEN LABEL TREATMENT|1969-03-02||1961-03-10|||1964-04-27||1963-08-03
TRIAL STUDY 134XCP|RP|A902F087-3BF4-4387-80F9-DDCDDCE1813E|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||ML/CAGE|||CIGARETTE|NOT DONE||U|N|Y|5||7||INDUCTION TREATMENT|1967-09-09||1963-02-01|||1968-09-16||1964-05-10
TRIAL STUDY 134XCP|RP|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||KUSP|||COPIES/UL|NOT DONE||U|Y|U|1||38||TREATMENT|1969-01-05||1966-05-09|||1960-03-19||1968-08-26
TRIAL STUDY 134XCP|RP|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MMOL/MIN/KPA|||SPRAY|NOT DONE||NA|NA|NA|1||38||OBSERVATION|1966-10-10||1973-08-14|||1972-12-19||1965-12-09
TRIAL STUDY 134XCP|RP|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|1||||||MASSIND|MASS INDICATOR||||FT3|||ML/BREATH|NOT DONE||Y|N|N|2||58||FOLLOW-UP|1960-09-02||1966-11-13|||1972-06-02||1967-10-21
TRIAL STUDY 134XCP|RP|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||KG/L|||UG/M2/DAY|NOT DONE||U|N|NA|2||58||BASELINE|1962-12-02||1971-06-26|||1963-04-20||1971-07-08
TRIAL STUDY 134XCP|RP|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||PPM|||UG/MOL|NOT DONE||NA|NA|NA|3||39||LONG-TERM FOLLOW-UP|1966-06-08||1962-11-24|||1966-07-12||1967-08-25
TRIAL STUDY 134XCP|RP|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||10^3 COPIES/ML|||MG/ANIMAL|NOT DONE||NA|N|U|3||39||SCREENING|1967-11-23||1961-06-26|||1963-06-28||1963-05-02
TRIAL STUDY 134XCP|RP|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|1||||||INABOIND|INDUCED ABORTION INDICATOR||||/500 WBC|||PUFF|NOT DONE||U|N|N|4||88||TREATMENT|1963-05-14||1964-01-17|||1960-01-23||1971-03-04
TRIAL STUDY 134XCP|RP|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|2||||||INABOIND|INDUCED ABORTION INDICATOR||||TITER|||PG/CELL|NOT DONE||Y|N|U|4||88||CONTINUATION TREATMENT|1963-09-23||1961-09-20|||1963-08-28||1960-11-22
TRIAL STUDY 134XCP|RP|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|1||||||EDEMAIND|EDEMA INDICATOR||||10^3 CFU/G|||UM|NOT DONE||Y|NA|NA|5||7||WASHOUT|1962-03-28||1960-11-06|||1963-06-05||1964-08-03
TRIAL STUDY 134XCP|RP|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UKAT/10^12 RBC|||SV|NOT DONE||Y|U|N|5||7||BLINDED TREATMENT|1962-11-09||1967-11-28|||1972-12-05||1961-06-10
TRIAL STUDY 134XCP|RP|415F9206-A793-437C-B227-BD245DBF40AB|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/(MIN*100ML)|||MET*H|NOT DONE||N|N|N|1||38||TREATMENT|1967-05-13||1966-07-15|||1964-08-30||1971-06-20
TRIAL STUDY 134XCP|RP|415F9206-A793-437C-B227-BD245DBF40AB|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||CMOL|||ML/H|NOT DONE||NA|Y|N|1||38||SCREENING|1962-03-01||1964-01-01|||1967-06-10||1966-09-16
TRIAL STUDY 134XCP|RP|415F9206-A793-437C-B227-BD245DBF40AB|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||U/M2/MIN|||FRAMES/S|NOT DONE||U|Y|U|2||58||INDUCTION TREATMENT|1965-12-21||1960-08-25|||1965-09-19||1964-11-29
TRIAL STUDY 134XCP|RP|415F9206-A793-437C-B227-BD245DBF40AB|2||||||PRGENDTC|DATE PREGNANCY ENDED||||PMOL/10^10 CELLS|||DAGU|NOT DONE||U|Y|N|2||58||CONTINUATION TREATMENT|1965-06-15||1960-04-26|||1966-08-10||1972-10-13
TRIAL STUDY 134XCP|RP|415F9206-A793-437C-B227-BD245DBF40AB|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||EID 50/ML|||KBQ|NOT DONE||U|Y|Y|3||39||FOLLOW-UP|1961-07-03||1960-02-17|||1970-01-30||1968-01-27
TRIAL STUDY 134XCP|RP|415F9206-A793-437C-B227-BD245DBF40AB|2||||||INTP|INTERPRETATION||||BQ/MG|||WEBER|NOT DONE||Y|N|Y|3||39||FOLLOW-UP|1960-07-27||1965-08-08|||1967-02-26||1967-08-31
TRIAL STUDY 134XCP|RP|415F9206-A793-437C-B227-BD245DBF40AB|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^4/L|||DAGU/ML|NOT DONE||U|NA|N|4||88||RUN-IN|1967-02-19||1970-07-21|||1964-10-15||1963-08-13
TRIAL STUDY 134XCP|RP|415F9206-A793-437C-B227-BD245DBF40AB|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||DEG/MM|||U/M2/DAY|NOT DONE||U|N|U|4||88||BLINDED TREATMENT|1966-06-30||1965-02-14|||1967-12-31||1960-05-25
TRIAL STUDY 134XCP|RP|415F9206-A793-437C-B227-BD245DBF40AB|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||10^3 ORGANISMS/ML|||KM|NOT DONE||Y|NA|Y|5||7||WASHOUT|1960-12-23||1972-07-14|||1969-06-18||1966-02-25
TRIAL STUDY 134XCP|RP|415F9206-A793-437C-B227-BD245DBF40AB|2||||||INTP|INTERPRETATION||||EVENTS|||L/H/M2|NOT DONE||N|U|U|5||7||OPEN LABEL TREATMENT|1964-05-03||1965-02-02|||1968-06-20||1962-11-11
TRIAL STUDY 134XCP|RP|C580BA02-D031-4875-AC02-347AA65C4C6C|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||10^6/L|||KG/MOL|NOT DONE||N|N|N|1||38||LONG-TERM FOLLOW-UP|1966-04-07||1969-12-10|||1961-04-27||1960-10-01
TRIAL STUDY 134XCP|RP|C580BA02-D031-4875-AC02-347AA65C4C6C|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||LINEAR FT*LB|||DPM/ML|NOT DONE||NA|NA|NA|1||38||TREATMENT|1968-08-07||1970-01-09|||1972-04-19||1962-08-03
TRIAL STUDY 134XCP|RP|C580BA02-D031-4875-AC02-347AA65C4C6C|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||NEWTON|||10^6/EJACULATE U|NOT DONE||Y|Y|U|2||58||OBSERVATION|1966-03-05||1970-11-10|||1964-05-01||1967-09-19
TRIAL STUDY 134XCP|RP|C580BA02-D031-4875-AC02-347AA65C4C6C|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||NFIU|||10^7 CFU/ML|NOT DONE||Y|Y|U|2||58||LONG-TERM FOLLOW-UP|1971-10-09||1970-10-20|||1964-07-31||1965-09-25
TRIAL STUDY 134XCP|RP|C580BA02-D031-4875-AC02-347AA65C4C6C|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||DPM/0.5 ML|||PPM|NOT DONE||N|NA|U|3||39||CONTINUATION TREATMENT|1965-10-13||1961-05-21|||1966-01-09||1965-06-29
TRIAL STUDY 134XCP|RP|C580BA02-D031-4875-AC02-347AA65C4C6C|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||GPL U|||VG/ML|NOT DONE||NA|N|N|3||39||INDUCTION TREATMENT|1961-12-30||1965-08-03|||1961-10-08||1966-11-29
TRIAL STUDY 134XCP|RP|C580BA02-D031-4875-AC02-347AA65C4C6C|1||||||GRAVIND|GRAVIDA INDICATOR||||G/ANIMAL/WK|||LOG10 PFU/ML|NOT DONE||NA|Y|U|4||88||CONTINUATION TREATMENT|1963-11-15||1970-04-16|||1965-11-16||1967-04-17
TRIAL STUDY 134XCP|RP|C580BA02-D031-4875-AC02-347AA65C4C6C|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||IU/DAY|||BREATHS/MIN|NOT DONE||N|U|N|4||88||RUN-IN|1966-09-01||1961-07-28|||1971-03-12||1961-07-17
TRIAL STUDY 134XCP|RP|C580BA02-D031-4875-AC02-347AA65C4C6C|1||||||ABORTN|NUMBER OF ABORTIONS||||GPL U/ML|||ML/M2/MIN|NOT DONE||N|Y|N|5||7||CONTINUATION TREATMENT|1969-09-08||1962-09-24|||1968-02-28||1969-12-21
TRIAL STUDY 134XCP|RP|C580BA02-D031-4875-AC02-347AA65C4C6C|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||G/G/DAY|||10^10/L|NOT DONE||U|Y|U|5||7||BLINDED TREATMENT|1966-01-31||1963-12-10|||1967-01-20||1972-01-09
TRIAL STUDY 134XCP|RP|4DD6944D-662E-4C9A-A663-601B657BCF5E|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||CI/MG|||CD/M2|NOT DONE||NA|Y|U|1||38||SCREENING|1966-03-17||1965-09-29|||1972-10-20||1971-05-10
TRIAL STUDY 134XCP|RP|4DD6944D-662E-4C9A-A663-601B657BCF5E|2||||||PREGNN|NUMBER OF PREGNANCIES||||RATIO|||U/G HB|NOT DONE||U|N|U|1||38||WASHOUT|1967-04-08||1960-06-11|||1962-08-12||1970-01-28
TRIAL STUDY 134XCP|RP|4DD6944D-662E-4C9A-A663-601B657BCF5E|1||||||INABOIND|INDUCED ABORTION INDICATOR||||UG/M2/H|||LOG10 CFU/ML|NOT DONE||Y|U|NA|2||58||CONTINUATION TREATMENT|1965-04-25||1961-03-25|||1962-06-01||1960-10-23
TRIAL STUDY 134XCP|RP|4DD6944D-662E-4C9A-A663-601B657BCF5E|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||OD UNIT|||USP U|NOT DONE||NA|NA|U|2||58||BLINDED TREATMENT|1967-12-09||1972-07-08|||1966-09-05||1965-11-20
TRIAL STUDY 134XCP|RP|4DD6944D-662E-4C9A-A663-601B657BCF5E|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||PMOL/10^10 CELLS|||CARTRIDGE|NOT DONE||U|N|NA|3||39||BLINDED TREATMENT|1972-02-08||1964-07-21|||1966-03-21||1973-05-30
TRIAL STUDY 134XCP|RP|4DD6944D-662E-4C9A-A663-601B657BCF5E|2||||||PRGENDTC|DATE PREGNANCY ENDED||||PPM|||OSM|NOT DONE||NA|N|U|3||39||SCREENING|1962-02-16||1968-06-22|||1966-08-03||1969-05-07
TRIAL STUDY 134XCP|RP|4DD6944D-662E-4C9A-A663-601B657BCF5E|1||||||BCMETHOD|BIRTH CONTROL METHOD||||G/CM2|||UMOL/MG/MIN|NOT DONE||NA|U|U|4||88||LONG-TERM FOLLOW-UP|1960-03-26||1972-04-11|||1962-10-02||1965-12-08
TRIAL STUDY 134XCP|RP|4DD6944D-662E-4C9A-A663-601B657BCF5E|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||CMHG|||BU|NOT DONE||NA|NA|Y|4||88||OPEN LABEL TREATMENT|1968-03-31||1966-12-15|||1960-09-30||1964-02-25
TRIAL STUDY 134XCP|RP|4DD6944D-662E-4C9A-A663-601B657BCF5E|1||||||MENOAGE|MENOPAUSE AGE||||TSP|||AMOL|NOT DONE||Y|NA|U|5||7||OPEN LABEL TREATMENT|1970-10-12||1972-12-16|||1964-12-12||1967-01-21
TRIAL STUDY 134XCP|RP|4DD6944D-662E-4C9A-A663-601B657BCF5E|2||||||MENOAGE|MENOPAUSE AGE||||RNA COPIES/ML|||MMOL/L|NOT DONE||Y|NA|Y|5||7||SCREENING|1967-06-05||1963-05-03|||1962-12-08||1968-07-10
TRIAL STUDY 134XCP|RP|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||DPM/MG|||G/L|NOT DONE||Y|NA|N|1||38||BASELINE|1965-03-17||1960-11-21|||1969-07-24||1971-09-02
TRIAL STUDY 134XCP|RP|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|2||||||ABORTN|NUMBER OF ABORTIONS||||MG/G/MIN|||10^12 IU/L|NOT DONE||Y|NA|U|1||38||OPEN LABEL TREATMENT|1965-08-31||1972-04-07|||1973-01-20||1969-09-12
TRIAL STUDY 134XCP|RP|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||UG/KG|||CI/ML|NOT DONE||N|U|NA|2||58||INDUCTION TREATMENT|1960-11-24||1971-08-28|||1969-11-16||1968-12-13
TRIAL STUDY 134XCP|RP|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|2||||||BCMETHOD|BIRTH CONTROL METHOD||||GPELISA UNIT/ML|||10^6/EJACULATE U|NOT DONE||NA|Y|N|2||58||INDUCTION TREATMENT|1973-05-18||1973-07-20|||1960-12-20||1963-08-24
TRIAL STUDY 134XCP|RP|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|1||||||MENFDUR|MENSES FLOW DURATION||||10^6/EJACULATE U|||L/KG|NOT DONE||U|U|NA|3||39||CONTINUATION TREATMENT|1961-09-21||1960-01-16|||1965-08-21||1962-08-10
TRIAL STUDY 134XCP|RP|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||PSI|||MMOL/L|NOT DONE||NA|N|U|3||39||INDUCTION TREATMENT|1970-07-21||1969-10-28|||1963-12-18||1963-10-18
TRIAL STUDY 134XCP|RP|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MILE|||10^6 IU|NOT DONE||NA|N|Y|4||88||LONG-TERM FOLLOW-UP|1965-08-07||1969-10-02|||1961-06-01||1965-04-25
TRIAL STUDY 134XCP|RP|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||M|||MOL|NOT DONE||Y|N|NA|4||88||FOLLOW-UP|1964-09-17||1968-05-09|||1963-02-16||1964-08-01
TRIAL STUDY 134XCP|RP|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|1||||||PREGNN|NUMBER OF PREGNANCIES||||MG/H|||NMOL/G|NOT DONE||Y|NA|Y|5||7||FOLLOW-UP|1966-09-07||1963-04-24|||1960-05-15||1970-01-29
TRIAL STUDY 134XCP|RP|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|2||||||BLISTIND|BLISTERING INDICATOR||||EID 50/ML|||MMOL/MIN/KPA/L|NOT DONE||N|NA|U|5||7||TREATMENT|1967-07-05||1968-06-25|||1965-07-04||1971-04-21
TRIAL STUDY 134XCP|RP|69A130F1-44A1-4091-BF0C-FF8087CC9940|1||||||PREGNN|NUMBER OF PREGNANCIES||||MMOL/G|||AMU|NOT DONE||U|Y|Y|1||38||OPEN LABEL TREATMENT|1968-03-07||1964-05-10|||1962-01-23||1973-01-15
TRIAL STUDY 134XCP|RP|69A130F1-44A1-4091-BF0C-FF8087CC9940|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MV/SEC|||GY/MIN|NOT DONE||Y|N|U|1||38||CONTINUATION TREATMENT|1963-10-19||1963-10-03|||1963-07-03||1962-07-22
TRIAL STUDY 134XCP|RP|69A130F1-44A1-4091-BF0C-FF8087CC9940|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||PACK|||ML/DL|NOT DONE||NA|NA|NA|2||58||BASELINE|1969-06-06||1963-10-05|||1960-07-12||1970-06-24
TRIAL STUDY 134XCP|RP|69A130F1-44A1-4091-BF0C-FF8087CC9940|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||DROP|||MPH|NOT DONE||NA|N|U|2||58||FOLLOW-UP|1963-01-13||1969-05-24|||1965-06-14||1967-04-28
TRIAL STUDY 134XCP|RP|69A130F1-44A1-4091-BF0C-FF8087CC9940|1||||||DLVRMODE|MODE OF DELIVERY||||/10^4|||UG/L FEU|NOT DONE||Y|N|N|3||39||LONG-TERM FOLLOW-UP|1968-06-15||1962-10-20|||1966-10-30||1965-12-12
TRIAL STUDY 134XCP|RP|69A130F1-44A1-4091-BF0C-FF8087CC9940|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MMOL/MIN/KPA|||UKAT/L|NOT DONE||NA|N|Y|3||39||OBSERVATION|1972-06-12||1960-03-27|||1968-05-18||1963-09-09
TRIAL STUDY 134XCP|RP|69A130F1-44A1-4091-BF0C-FF8087CC9940|1||||||PUSTIND|PUSTULE INDICATOR||||MG/DAY|||ML/KG|NOT DONE||Y|N|N|4||88||BLINDED TREATMENT|1970-03-15||1963-06-04|||1971-12-11||1973-01-10
TRIAL STUDY 134XCP|RP|69A130F1-44A1-4091-BF0C-FF8087CC9940|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||UG/M2/H|||M|NOT DONE||NA|NA|U|4||88||BLINDED TREATMENT|1961-04-16||1972-11-12|||1972-02-13||1962-08-14
TRIAL STUDY 134XCP|RP|69A130F1-44A1-4091-BF0C-FF8087CC9940|1||||||MENOAGE|MENOPAUSE AGE||||U/KG/DAY|||GENEQ|NOT DONE||N|Y|Y|5||7||WASHOUT|1970-03-07||1960-02-04|||1968-05-12||1969-03-23
TRIAL STUDY 134XCP|RP|69A130F1-44A1-4091-BF0C-FF8087CC9940|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||LM|||MCI/KG|NOT DONE||N|NA|N|5||7||BASELINE|1961-08-10||1972-06-16|||1960-04-20||1969-01-31
TRIAL STUDY 134XCP|RP|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|1||||||MASSIND|MASS INDICATOR||||P|||STEPS|NOT DONE||N|N|N|1||38||INDUCTION TREATMENT|1961-06-19||1970-06-23|||1963-08-21||1969-03-10
TRIAL STUDY 134XCP|RP|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||OI50|||MV*MIN|NOT DONE||Y|Y|NA|1||38||TREATMENT|1969-05-20||1972-12-27|||1973-09-05||1971-04-02
TRIAL STUDY 134XCP|RP|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||WAFER|||UIU/DL|NOT DONE||U|Y|NA|2||58||OBSERVATION|1971-09-15||1965-04-12|||1961-03-27||1968-06-26
TRIAL STUDY 134XCP|RP|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||CS|||UG/DOSE|NOT DONE||N|U|U|2||58||BASELINE|1970-09-26||1966-04-09|||1968-04-03||1961-12-20
TRIAL STUDY 134XCP|RP|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|1||||||TNDRIND|TENDERNESS INDICATOR||||L/MIN|||GENEQ/ML|NOT DONE||N|Y|Y|3||39||OPEN LABEL TREATMENT|1970-02-25||1963-11-21|||1962-01-28||1962-01-25
TRIAL STUDY 134XCP|RP|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|2||||||ABORTN|NUMBER OF ABORTIONS||||GPL U/ML|||MOL|NOT DONE||N|Y|U|3||39||SCREENING|1968-11-05||1967-02-25|||1972-03-31||1973-01-04
TRIAL STUDY 134XCP|RP|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||CMHG|||10^3 RNA COPIES/ML|NOT DONE||N|N|U|4||88||BLINDED TREATMENT|1972-02-28||1966-02-20|||1969-10-16||1965-03-17
TRIAL STUDY 134XCP|RP|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|2||||||INTP|INTERPRETATION||||%/MIN|||HENRY|NOT DONE||U|NA|NA|4||88||OPEN LABEL TREATMENT|1968-06-11||1968-04-26|||1966-08-16||1964-12-31
TRIAL STUDY 134XCP|RP|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MG/KG/DAY|||DAYS/MONTH|NOT DONE||NA|U|Y|5||7||OBSERVATION|1963-08-21||1972-12-09|||1965-03-21||1972-02-20
TRIAL STUDY 134XCP|RP|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MAC50|||KCAL/DAY|NOT DONE||Y|U|U|5||7||CONTINUATION TREATMENT|1966-05-08||1960-12-02|||1970-07-01||1965-04-16
TRIAL STUDY 134XCP|RP|96C60715-2EDE-40FD-B41C-ECD1E5065C81|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||NMOL/L/MIN|||ML/MMHG/MIN/L|NOT DONE||Y|Y|Y|1||38||SCREENING|1966-06-13||1963-12-12|||1966-06-25||1969-03-05
TRIAL STUDY 134XCP|RP|96C60715-2EDE-40FD-B41C-ECD1E5065C81|2||||||INTP|INTERPRETATION||||FRAMES/S|||OZ|NOT DONE||NA|U|N|1||38||OPEN LABEL TREATMENT|1964-12-24||1971-12-15|||1963-04-15||1968-08-07
TRIAL STUDY 134XCP|RP|96C60715-2EDE-40FD-B41C-ECD1E5065C81|1||||||PREGNN|NUMBER OF PREGNANCIES||||UCI/KG|||CFU/G|NOT DONE||U|Y|N|2||58||BLINDED TREATMENT|1964-06-30||1973-08-24|||1970-04-27||1961-05-27
TRIAL STUDY 134XCP|RP|96C60715-2EDE-40FD-B41C-ECD1E5065C81|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||U/KG|||TAMPON|NOT DONE||N|NA|NA|2||58||INDUCTION TREATMENT|1967-04-18||1964-04-17|||1970-02-01||1962-03-13
TRIAL STUDY 134XCP|RP|96C60715-2EDE-40FD-B41C-ECD1E5065C81|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MG/DAY|||LOG10 ELISA UNIT/DOSE|NOT DONE||Y|Y|N|3||39||TREATMENT|1973-02-03||1972-07-17|||1966-03-09||1962-05-04
TRIAL STUDY 134XCP|RP|96C60715-2EDE-40FD-B41C-ECD1E5065C81|2||||||MENOAGE|MENOPAUSE AGE||||MG/DAY|||LOG10 CFU/G|NOT DONE||U|N|N|3||39||CONTINUATION TREATMENT|1963-12-25||1972-11-30|||1972-04-08||1970-05-20
TRIAL STUDY 134XCP|RP|96C60715-2EDE-40FD-B41C-ECD1E5065C81|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||BQ/G|||10^7 PFU|NOT DONE||NA|NA|U|4||88||INDUCTION TREATMENT|1971-02-14||1969-04-12|||1960-09-19||1962-07-29
TRIAL STUDY 134XCP|RP|96C60715-2EDE-40FD-B41C-ECD1E5065C81|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||IN2|||TRANSDUCING UNIT/ML|NOT DONE||U|Y|Y|4||88||LONG-TERM FOLLOW-UP|1972-05-29||1966-11-18|||1963-01-09||1967-01-14
TRIAL STUDY 134XCP|RP|96C60715-2EDE-40FD-B41C-ECD1E5065C81|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||CMOL/L|||NEWTON|NOT DONE||NA|NA|N|5||7||RUN-IN|1961-01-23||1960-05-31|||1961-07-25||1962-09-14
TRIAL STUDY 134XCP|RP|96C60715-2EDE-40FD-B41C-ECD1E5065C81|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||SYRINGE|||PG|NOT DONE||NA|Y|N|5||7||TREATMENT|1970-05-05||1966-08-07|||1960-12-18||1965-09-29
TRIAL STUDY 134XCP|RP|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MEQ/KG|||KBQ/UL|NOT DONE||Y|N|NA|1||38||SCREENING|1969-12-20||1965-02-25|||1962-10-30||1966-11-30
TRIAL STUDY 134XCP|RP|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||ML/G/MIN|||UV*SEC|NOT DONE||NA|Y|N|1||38||OPEN LABEL TREATMENT|1971-10-22||1967-09-26|||1960-02-07||1963-06-03
TRIAL STUDY 134XCP|RP|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||MBQ|||/5X10^4 WBC|NOT DONE||NA|Y|Y|2||58||LONG-TERM FOLLOW-UP|1962-03-05||1971-07-20|||1971-10-23||1969-08-17
TRIAL STUDY 134XCP|RP|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||BQ/G|||GMFI|NOT DONE||NA|NA|Y|2||58||BASELINE|1972-07-21||1960-12-21|||1963-06-15||1970-01-05
TRIAL STUDY 134XCP|RP|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|1||||||GRAVIND|GRAVIDA INDICATOR||||MPA|||/7.5 ML|NOT DONE||N|N|U|3||39||RUN-IN|1971-10-25||1970-06-15|||1964-05-16||1967-03-10
TRIAL STUDY 134XCP|RP|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|2||||||MASSIND|MASS INDICATOR||||KHZ|||OI50|NOT DONE||Y|U|N|3||39||FOLLOW-UP|1964-01-04||1963-06-21|||1961-05-12||1972-07-20
TRIAL STUDY 134XCP|RP|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||ARBITRARY U|||FRAMES/S|NOT DONE||NA|U|Y|4||88||BLINDED TREATMENT|1962-04-29||1965-09-24|||1972-09-08||1964-11-22
TRIAL STUDY 134XCP|RP|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|2||||||BLISTIND|BLISTERING INDICATOR||||QUANTITY SUFFICIENT|||LM|NOT DONE||U|Y|U|4||88||BASELINE|1964-10-04||1970-09-02|||1965-12-07||1960-12-23
TRIAL STUDY 134XCP|RP|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MPL U/ML|||ML/MMHG|NOT DONE||Y|N|U|5||7||WASHOUT|1967-01-21||1960-06-01|||1963-03-06||1960-12-26
TRIAL STUDY 134XCP|RP|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|2||||||INTP|INTERPRETATION||||10^3/L|||COPIES/UL|NOT DONE||NA|NA|NA|5||7||CONTINUATION TREATMENT|1961-12-01||1964-01-27|||1967-12-03||1970-06-06
TRIAL STUDY 134XCP|RP|8452DD7A-4DC9-4BDF-B670-AE5B49292805|1||||||MASSIND|MASS INDICATOR||||DB|||FMOL|NOT DONE||Y|U|Y|1||38||BASELINE|1961-02-02||1971-01-05|||1969-02-16||1962-08-23
TRIAL STUDY 134XCP|RP|8452DD7A-4DC9-4BDF-B670-AE5B49292805|2||||||INTP|INTERPRETATION||||VG/DOSE|||KCAL|NOT DONE||U|N|Y|1||38||TREATMENT|1971-01-19||1969-01-28|||1968-05-23||1969-03-02
TRIAL STUDY 134XCP|RP|8452DD7A-4DC9-4BDF-B670-AE5B49292805|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||%(W/V)|||10^6 CFU|NOT DONE||Y|NA|NA|2||58||LONG-TERM FOLLOW-UP|1967-11-26||1965-05-17|||1971-11-26||1961-10-19
TRIAL STUDY 134XCP|RP|8452DD7A-4DC9-4BDF-B670-AE5B49292805|2||||||DLVRMODE|MODE OF DELIVERY||||U/M2|||MG/KG|NOT DONE||N|N|NA|2||58||OPEN LABEL TREATMENT|1969-03-08||1967-01-02|||1966-05-06||1961-10-04
TRIAL STUDY 134XCP|RP|8452DD7A-4DC9-4BDF-B670-AE5B49292805|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||NEBULE|||GY/MIN|NOT DONE||NA|NA|U|3||39||RUN-IN|1972-05-21||1969-10-28|||1964-09-13||1968-05-29
TRIAL STUDY 134XCP|RP|8452DD7A-4DC9-4BDF-B670-AE5B49292805|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||CMHG|||OZ EQ|NOT DONE||N|U|NA|3||39||FOLLOW-UP|1961-12-28||1972-09-30|||1960-06-30||1963-10-23
TRIAL STUDY 134XCP|RP|8452DD7A-4DC9-4BDF-B670-AE5B49292805|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||GY/H|||MOL|NOT DONE||NA|NA|U|4||88||WASHOUT|1966-04-08||1962-05-02|||1971-07-04||1972-02-19
TRIAL STUDY 134XCP|RP|8452DD7A-4DC9-4BDF-B670-AE5B49292805|2||||||BLISTIND|BLISTERING INDICATOR||||BREATHS/30S|||ABSORBANCE U/MIN|NOT DONE||N|N|N|4||88||CONTINUATION TREATMENT|1965-05-18||1968-05-09|||1967-12-01||1968-02-03
TRIAL STUDY 134XCP|RP|8452DD7A-4DC9-4BDF-B670-AE5B49292805|1||||||MENARAGE|MENARCHE AGE||||PFU|||U/10^12 RBC|NOT DONE||NA|NA|NA|5||7||SCREENING|1964-01-25||1968-08-18|||1960-12-08||1970-09-04
TRIAL STUDY 134XCP|RP|8452DD7A-4DC9-4BDF-B670-AE5B49292805|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MMHG*MIN/L|||CP|NOT DONE||N|U|U|5||7||SCREENING|1965-05-29||1966-12-02|||1962-05-18||1968-11-05
TRIAL STUDY 134XCP|RP|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||RFU|||NG/L|NOT DONE||U|Y|N|1||38||FOLLOW-UP|1964-05-28||1963-07-25|||1966-05-29||1970-08-28
TRIAL STUDY 134XCP|RP|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||SV|||PPTR|NOT DONE||Y|Y|NA|1||38||SCREENING|1961-02-25||1961-10-17|||1965-02-28||1967-11-25
TRIAL STUDY 134XCP|RP|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|1||||||MENFDUR|MENSES FLOW DURATION||||CI/MG|||GENEQ/ML|NOT DONE||N|NA|U|2||58||OPEN LABEL TREATMENT|1969-01-24||1967-02-13|||1969-04-29||1961-09-30
TRIAL STUDY 134XCP|RP|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|2||||||BRTHN|NUMBER OF BIRTHS||||DISK|||G/CAGE/WK|NOT DONE||U|Y|Y|2||58||TREATMENT|1968-12-18||1972-08-23|||1962-07-08||1962-03-27
TRIAL STUDY 134XCP|RP|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|1||||||ULCERIND|ULCER INDICATOR||||UG/M2|||MG/KG/DAY|NOT DONE||U|N|N|3||39||WASHOUT|1960-10-07||1967-12-24|||1967-03-30||1973-07-27
TRIAL STUDY 134XCP|RP|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||L/L|||1/(S*KPA)|NOT DONE||Y|U|Y|3||39||BLINDED TREATMENT|1969-03-04||1964-08-18|||1967-03-22||1963-11-19
TRIAL STUDY 134XCP|RP|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MIN*MG/ML|||/DAY|NOT DONE||N|NA|NA|4||88||FOLLOW-UP|1968-02-11||1967-07-25|||1964-05-15||1971-03-03
TRIAL STUDY 134XCP|RP|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||NEWTON|||UG/KG|NOT DONE||N|NA|N|4||88||RUN-IN|1969-03-16||1962-12-21|||1967-05-13||1965-11-08
TRIAL STUDY 134XCP|RP|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MG/KG/MIN|||/2000 RBC|NOT DONE||NA|Y|Y|5||7||BASELINE|1963-09-19||1968-09-17|||1964-02-26||1968-04-12
TRIAL STUDY 134XCP|RP|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MNFI|||CI/UG|NOT DONE||Y|U|N|5||7||OPEN LABEL TREATMENT|1964-06-17||1966-06-18|||1962-08-07||1962-08-15
TRIAL STUDY 134XCP|RP|30108497-140B-499E-8924-8BFCDC57457A|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MG/KG|||APS U|NOT DONE||U|NA|NA|1||38||RUN-IN|1971-04-11||1963-10-01|||1962-03-19||1960-04-18
TRIAL STUDY 134XCP|RP|30108497-140B-499E-8924-8BFCDC57457A|2||||||BLISTIND|BLISTERING INDICATOR||||ROENTGEN|||BOX|NOT DONE||N|U|Y|1||38||RUN-IN|1970-09-06||1969-10-27|||1971-12-16||1965-12-27
TRIAL STUDY 134XCP|RP|30108497-140B-499E-8924-8BFCDC57457A|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MMOL/G|||NCI|NOT DONE||NA|U|U|2||58||RUN-IN|1963-07-01||1965-03-09|||1960-03-03||1966-12-18
TRIAL STUDY 134XCP|RP|30108497-140B-499E-8924-8BFCDC57457A|2||||||ABORTN|NUMBER OF ABORTIONS||||ML/G/H|||IU/MMOL|NOT DONE||U|NA|U|2||58||WASHOUT|1967-11-22||1966-03-23|||1962-10-15||1960-04-03
TRIAL STUDY 134XCP|RP|30108497-140B-499E-8924-8BFCDC57457A|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||MM3/MM2/YEAR|||FINGERTIP UNIT|NOT DONE||U|N|Y|3||39||OBSERVATION|1968-09-14||1963-12-22|||1965-03-20||1967-08-12
TRIAL STUDY 134XCP|RP|30108497-140B-499E-8924-8BFCDC57457A|2||||||GRAVIND|GRAVIDA INDICATOR||||FT|||GBQ/G|NOT DONE||Y|NA|Y|3||39||FOLLOW-UP|1964-08-20||1972-07-19|||1973-08-27||1971-08-21
TRIAL STUDY 134XCP|RP|30108497-140B-499E-8924-8BFCDC57457A|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||PMOL|||UEQ/L|NOT DONE||N|NA|N|4||88||TREATMENT|1970-05-19||1968-10-15|||1972-01-11||1961-10-05
TRIAL STUDY 134XCP|RP|30108497-140B-499E-8924-8BFCDC57457A|2||||||BLISTIND|BLISTERING INDICATOR||||MEQ|||LOG10 TCID 50/UL|NOT DONE||Y|NA|N|4||88||TREATMENT|1967-05-26||1971-05-27|||1970-01-10||1965-10-29
TRIAL STUDY 134XCP|RP|30108497-140B-499E-8924-8BFCDC57457A|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||PMOL|||MG/L|NOT DONE||U|N|U|5||7||INDUCTION TREATMENT|1962-05-18||1965-03-19|||1969-01-08||1963-02-08
TRIAL STUDY 134XCP|RP|30108497-140B-499E-8924-8BFCDC57457A|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MS2|||MOL/MOL|NOT DONE||Y|NA|NA|5||7||WASHOUT|1965-05-18||1969-05-31|||1971-01-06||1964-09-23
TRIAL STUDY 134XCP|RP|5FFEF358-5014-497F-A091-6EF27A1BCF7D|1||||||MENFDUR|MENSES FLOW DURATION||||STEPS/MIN|||SV|NOT DONE||NA|Y|U|1||38||LONG-TERM FOLLOW-UP|1971-01-01||1962-05-28|||1967-08-08||1961-08-01
TRIAL STUDY 134XCP|RP|5FFEF358-5014-497F-A091-6EF27A1BCF7D|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||KEV|||UV2|NOT DONE||Y|Y|Y|1||38||CONTINUATION TREATMENT|1971-06-01||1972-04-03|||1966-07-03||1962-03-08
TRIAL STUDY 134XCP|RP|5FFEF358-5014-497F-A091-6EF27A1BCF7D|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||DRAM|||KHZ|NOT DONE||NA|N|Y|2||58||LONG-TERM FOLLOW-UP|1967-02-19||1966-09-28|||1965-03-18||1972-12-11
TRIAL STUDY 134XCP|RP|5FFEF358-5014-497F-A091-6EF27A1BCF7D|2||||||DSCHGIND|DISCHARGE INDICATOR||||LOG10 COPIES/ML|||VP/ML|NOT DONE||U|N|NA|2||58||LONG-TERM FOLLOW-UP|1962-10-24||1970-03-10|||1971-10-30||1960-01-20
TRIAL STUDY 134XCP|RP|5FFEF358-5014-497F-A091-6EF27A1BCF7D|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||G/CM2|||G/M2|NOT DONE||U|N|Y|3||39||WASHOUT|1962-04-08||1973-05-25|||1969-09-19||1969-06-24
TRIAL STUDY 134XCP|RP|5FFEF358-5014-497F-A091-6EF27A1BCF7D|2||||||ABORTN|NUMBER OF ABORTIONS||||V|||10^11/L|NOT DONE||N|Y|NA|3||39||RUN-IN|1966-03-11||1970-07-19|||1965-10-20||1961-04-04
TRIAL STUDY 134XCP|RP|5FFEF358-5014-497F-A091-6EF27A1BCF7D|1||||||ULCERIND|ULCER INDICATOR||||DL|||PPM|NOT DONE||N|U|N|4||88||RUN-IN|1963-04-22||1968-05-19|||1967-09-11||1967-08-06
TRIAL STUDY 134XCP|RP|5FFEF358-5014-497F-A091-6EF27A1BCF7D|2||||||INTP|INTERPRETATION||||AGU/ML|||PATCH|NOT DONE||Y|NA|Y|4||88||BASELINE|1967-12-08||1969-11-09|||1965-07-29||1966-08-02
TRIAL STUDY 134XCP|RP|5FFEF358-5014-497F-A091-6EF27A1BCF7D|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UV2|||10^6 COPIES/ML|NOT DONE||NA|NA|N|5||7||TREATMENT|1967-07-14||1963-12-10|||1960-07-26||1961-03-04
TRIAL STUDY 134XCP|RP|5FFEF358-5014-497F-A091-6EF27A1BCF7D|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||HOUNSFIELD UNIT|||10^6 CFU/G|NOT DONE||U|NA|U|5||7||BLINDED TREATMENT|1964-10-17||1964-08-13|||1972-07-30||1963-05-13
TRIAL STUDY 134XCP|RP|9DFBE459-22E4-4BA7-A993-AC06D6644562|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MET*MIN|||ML/CAGE/DAY|NOT DONE||U|N|N|1||38||RUN-IN|1963-10-22||1967-08-23|||1960-02-29||1962-05-04
TRIAL STUDY 134XCP|RP|9DFBE459-22E4-4BA7-A993-AC06D6644562|2||||||MENARAGE|MENARCHE AGE||||UG/CM2|||UG|NOT DONE||U|NA|NA|1||38||RUN-IN|1971-06-17||1971-02-04|||1967-10-22||1967-11-18
TRIAL STUDY 134XCP|RP|9DFBE459-22E4-4BA7-A993-AC06D6644562|1||||||DLVRMODE|MODE OF DELIVERY||||UKAT/L|||CG|NOT DONE||U|U|U|2||58||FOLLOW-UP|1970-11-05||1972-01-23|||1965-07-02||1969-05-13
TRIAL STUDY 134XCP|RP|9DFBE459-22E4-4BA7-A993-AC06D6644562|2||||||BRTHN|NUMBER OF BIRTHS||||ML/KG/MIN|||KCAL|NOT DONE||N|Y|N|2||58||BLINDED TREATMENT|1967-01-22||1970-11-14|||1966-09-16||1965-03-14
TRIAL STUDY 134XCP|RP|9DFBE459-22E4-4BA7-A993-AC06D6644562|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||G/CAGE/DAY|||CAPSULE|NOT DONE||U|N|U|3||39||SCREENING|1971-02-07||1972-06-25|||1971-12-16||1963-02-02
TRIAL STUDY 134XCP|RP|9DFBE459-22E4-4BA7-A993-AC06D6644562|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||BU/ML|||10^3 CFU/ML|NOT DONE||N|NA|U|3||39||RUN-IN|1962-10-27||1962-12-06|||1972-05-21||1963-06-08
TRIAL STUDY 134XCP|RP|9DFBE459-22E4-4BA7-A993-AC06D6644562|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||GRAIN|||PSEC|NOT DONE||Y|NA|U|4||88||TREATMENT|1965-10-10||1967-03-09|||1962-07-06||1967-08-09
TRIAL STUDY 134XCP|RP|9DFBE459-22E4-4BA7-A993-AC06D6644562|2||||||DLVRMODE|MODE OF DELIVERY||||CIGARETTE|||ANTIBODY UNIT|NOT DONE||N|NA|U|4||88||FOLLOW-UP|1964-05-09||1969-08-19|||1961-12-24||1970-06-26
TRIAL STUDY 134XCP|RP|9DFBE459-22E4-4BA7-A993-AC06D6644562|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MIN*MG/ML|||DPM|NOT DONE||N|Y|NA|5||7||INDUCTION TREATMENT|1964-11-19||1964-08-02|||1962-01-02||1965-11-11
TRIAL STUDY 134XCP|RP|9DFBE459-22E4-4BA7-A993-AC06D6644562|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||BISCUIT|||U/CL|NOT DONE||Y|U|U|5||7||FOLLOW-UP|1970-12-31||1970-05-07|||1967-06-03||1964-09-22
TRIAL STUDY 134XCP|RP|850B35FA-69C7-44AD-A471-964C59C4CFD8|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||G/CM2|||FRACTION OF 1|NOT DONE||NA|NA|Y|1||38||SCREENING|1968-06-30||1967-05-13|||1967-01-23||1972-06-21
TRIAL STUDY 134XCP|RP|850B35FA-69C7-44AD-A471-964C59C4CFD8|2||||||BCMETHOD|BIRTH CONTROL METHOD||||/LSQN|||KIU|NOT DONE||Y|N|NA|1||38||CONTINUATION TREATMENT|1971-08-31||1973-02-27|||1961-11-27||1963-05-05
TRIAL STUDY 134XCP|RP|850B35FA-69C7-44AD-A471-964C59C4CFD8|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||BQ/UL|||UG/ML/H|NOT DONE||NA|U|NA|2||58||TREATMENT|1968-05-29||1970-06-23|||1971-12-18||1969-09-03
TRIAL STUDY 134XCP|RP|850B35FA-69C7-44AD-A471-964C59C4CFD8|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||IU/DAY|||U/10^12 RBC|NOT DONE||NA|N|N|2||58||LONG-TERM FOLLOW-UP|1966-05-26||1962-10-02|||1970-08-24||1969-08-23
TRIAL STUDY 134XCP|RP|850B35FA-69C7-44AD-A471-964C59C4CFD8|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||DRINK|||G/M2|NOT DONE||Y|Y|U|3||39||OPEN LABEL TREATMENT|1966-11-25||1962-07-18|||1960-05-31||1963-06-30
TRIAL STUDY 134XCP|RP|850B35FA-69C7-44AD-A471-964C59C4CFD8|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||/10^4|||UM/S|NOT DONE||N|U|U|3||39||OBSERVATION|1968-05-19||1965-03-27|||1973-02-26||1964-07-22
TRIAL STUDY 134XCP|RP|850B35FA-69C7-44AD-A471-964C59C4CFD8|1||||||INABOIND|INDUCED ABORTION INDICATOR||||L|||GY|NOT DONE||NA|U|Y|4||88||OBSERVATION|1973-02-07||1966-12-04|||1971-08-04||1966-03-15
TRIAL STUDY 134XCP|RP|850B35FA-69C7-44AD-A471-964C59C4CFD8|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||NMOL/KG/DAY|||/MONTH|NOT DONE||U|U|N|4||88||LONG-TERM FOLLOW-UP|1970-09-05||1960-01-04|||1960-04-26||1963-06-25
TRIAL STUDY 134XCP|RP|850B35FA-69C7-44AD-A471-964C59C4CFD8|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||RPM|||G/ANIMAL/DAY|NOT DONE||NA|N|U|5||7||BLINDED TREATMENT|1973-03-02||1961-06-07|||1973-04-26||1972-11-06
TRIAL STUDY 134XCP|RP|850B35FA-69C7-44AD-A471-964C59C4CFD8|2||||||EDEMAIND|EDEMA INDICATOR||||ENZYME U/L|||UMOL/L/H|NOT DONE||U|Y|Y|5||7||LONG-TERM FOLLOW-UP|1969-07-02||1970-05-16|||1965-03-24||1965-12-04
TRIAL STUDY 134XCP|RP|981B890E-1257-4F04-A974-6006401F78CC|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||UU/L|||IU/DAY|NOT DONE||U|N|NA|1||38||FOLLOW-UP|1966-05-15||1969-04-27|||1973-09-01||1963-03-29
TRIAL STUDY 134XCP|RP|981B890E-1257-4F04-A974-6006401F78CC|2||||||MENFDUR|MENSES FLOW DURATION||||NL|||MIN|NOT DONE||Y|Y|NA|1||38||TREATMENT|1969-04-05||1972-08-07|||1965-02-15||1969-03-07
TRIAL STUDY 134XCP|RP|981B890E-1257-4F04-A974-6006401F78CC|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||BISCUIT|||APPLICATION|NOT DONE||N|NA|NA|2||58||BASELINE|1962-02-14||1968-11-20|||1962-09-19||1966-06-14
TRIAL STUDY 134XCP|RP|981B890E-1257-4F04-A974-6006401F78CC|2||||||BRTHN|NUMBER OF BIRTHS||||G/ANIMAL/DAY|||ML/KG/MIN|NOT DONE||Y|U|U|2||58||BASELINE|1968-03-10||1960-11-22|||1964-05-10||1972-09-27
TRIAL STUDY 134XCP|RP|981B890E-1257-4F04-A974-6006401F78CC|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||ML/CM|||UMOL/L/H|NOT DONE||Y|Y|Y|3||39||INDUCTION TREATMENT|1972-02-17||1962-04-04|||1969-09-28||1963-06-20
TRIAL STUDY 134XCP|RP|981B890E-1257-4F04-A974-6006401F78CC|2||||||MENOAGE|MENOPAUSE AGE||||/LPF|||LB|NOT DONE||Y|NA|U|3||39||RUN-IN|1964-10-26||1964-06-26|||1960-11-26||1968-05-29
TRIAL STUDY 134XCP|RP|981B890E-1257-4F04-A974-6006401F78CC|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||PIXELS/IN|||UMOL/H/MMOL|NOT DONE||N|NA|U|4||88||WASHOUT|1961-02-16||1963-10-06|||1968-05-12||1966-03-27
TRIAL STUDY 134XCP|RP|981B890E-1257-4F04-A974-6006401F78CC|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MCI|||PPTH|NOT DONE||NA|U|Y|4||88||BASELINE|1971-06-12||1964-02-01|||1971-02-25||1966-01-16
TRIAL STUDY 134XCP|RP|981B890E-1257-4F04-A974-6006401F78CC|1||||||BCMETHOD|BIRTH CONTROL METHOD||||UG/MIN|||L/S/KPA|NOT DONE||Y|NA|U|5||7||RUN-IN|1963-03-24||1970-02-01|||1960-08-07||1965-03-12
TRIAL STUDY 134XCP|RP|981B890E-1257-4F04-A974-6006401F78CC|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MMAL|||S*KPA|NOT DONE||Y|Y|U|5||7||TREATMENT|1970-02-09||1970-02-04|||1963-03-03||1972-06-23
TRIAL STUDY 134XCP|RP|52FF8D96-64AD-498D-8B28-3DDD015796E3|1||||||GRAVIND|GRAVIDA INDICATOR||||DB|||UMOL/H/MMOL|NOT DONE||N|U|Y|1||38||BASELINE|1972-04-26||1970-08-04|||1961-10-04||1971-10-02
TRIAL STUDY 134XCP|RP|52FF8D96-64AD-498D-8B28-3DDD015796E3|2||||||DLVRMODE|MODE OF DELIVERY||||L/S|||MG/MIN|NOT DONE||N|N|NA|1||38||CONTINUATION TREATMENT|1970-09-04||1962-05-22|||1963-03-01||1965-02-26
TRIAL STUDY 134XCP|RP|52FF8D96-64AD-498D-8B28-3DDD015796E3|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||NG/L|||PG/CELL|NOT DONE||N|N|N|2||58||WASHOUT|1973-08-10||1965-03-13|||1968-03-11||1967-11-23
TRIAL STUDY 134XCP|RP|52FF8D96-64AD-498D-8B28-3DDD015796E3|2||||||THICK|THICKNESS||||CAN|||BLOCKS|NOT DONE||Y|N|NA|2||58||SCREENING|1962-07-09||1973-03-19|||1970-12-25||1971-11-11
TRIAL STUDY 134XCP|RP|52FF8D96-64AD-498D-8B28-3DDD015796E3|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||CMH2O*S/ML|||U.CARR|NOT DONE||Y|U|NA|3||39||BASELINE|1967-10-15||1966-05-09|||1960-10-29||1960-10-24
TRIAL STUDY 134XCP|RP|52FF8D96-64AD-498D-8B28-3DDD015796E3|2||||||PREGNN|NUMBER OF PREGNANCIES||||/40 HPFS|||UMOL/DL|NOT DONE||U|N|Y|3||39||BLINDED TREATMENT|1964-04-15||1969-08-24|||1971-08-21||1961-11-15
TRIAL STUDY 134XCP|RP|52FF8D96-64AD-498D-8B28-3DDD015796E3|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MMOL/MOL|||KV|NOT DONE||N|NA|U|4||88||RUN-IN|1967-02-12||1964-03-01|||1969-12-18||1963-06-16
TRIAL STUDY 134XCP|RP|52FF8D96-64AD-498D-8B28-3DDD015796E3|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||10^6 COPIES/ML|||CARTRIDGE|NOT DONE||NA|NA|N|4||88||LONG-TERM FOLLOW-UP|1961-06-07||1970-12-07|||1961-12-17||1971-12-14
TRIAL STUDY 134XCP|RP|52FF8D96-64AD-498D-8B28-3DDD015796E3|1||||||RASHIND|RASH INDICATOR||||UM2|||LOG10 CFU/ML|NOT DONE||U|NA|N|5||7||LONG-TERM FOLLOW-UP|1971-01-31||1960-02-11|||1967-06-03||1963-02-13
TRIAL STUDY 134XCP|RP|52FF8D96-64AD-498D-8B28-3DDD015796E3|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UM2|||TAMPON|NOT DONE||U|NA|Y|5||7||BLINDED TREATMENT|1968-04-23||1972-11-19|||1962-06-09||1969-04-04
TRIAL STUDY 134XCP|RP|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||KA_U/DL|||BOX|NOT DONE||U|N|U|1||38||FOLLOW-UP|1966-01-09||1965-02-03|||1970-05-14||1960-11-05
TRIAL STUDY 134XCP|RP|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||KBQ|||ML/MIN|NOT DONE||NA|Y|U|1||38||FOLLOW-UP|1971-06-16||1961-05-21|||1970-01-22||1971-02-21
TRIAL STUDY 134XCP|RP|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|1||||||RASHIND|RASH INDICATOR||||NEEDLE GAUGE|||ML/CM H2O|NOT DONE||U|Y|Y|2||58||BASELINE|1972-03-13||1962-02-11|||1963-04-06||1963-10-10
TRIAL STUDY 134XCP|RP|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ANTI-XA IU/ML|||HENRY|NOT DONE||N|U|Y|2||58||FOLLOW-UP|1972-11-09||1960-07-17|||1964-01-07||1973-07-30
TRIAL STUDY 134XCP|RP|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MPL U/ML|||BEATS/MIN|NOT DONE||U|N|NA|3||39||TREATMENT|1966-11-09||1967-06-17|||1971-01-06||1963-05-29
TRIAL STUDY 134XCP|RP|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|2||||||INABOIND|INDUCED ABORTION INDICATOR||||KG/CM|||CM/S|NOT DONE||Y|U|N|3||39||RUN-IN|1961-02-03||1962-12-09|||1970-04-24||1968-06-30
TRIAL STUDY 134XCP|RP|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|1||||||PREGNN|NUMBER OF PREGNANCIES||||ML/CAGE/DAY|||U/MG|NOT DONE||Y|U|NA|4||88||RUN-IN|1965-11-23||1967-07-01|||1960-03-02||1972-03-16
TRIAL STUDY 134XCP|RP|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||L/MIN|||DDU|NOT DONE||U|NA|Y|4||88||CONTINUATION TREATMENT|1963-10-30||1963-11-22|||1972-06-17||1961-12-03
TRIAL STUDY 134XCP|RP|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||U/10^12 RBC|||UIU/DL|NOT DONE||Y|Y|NA|5||7||FOLLOW-UP|1962-01-23||1968-02-21|||1960-05-30||1966-09-19
TRIAL STUDY 134XCP|RP|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|2||||||ULCERIND|ULCER INDICATOR||||GENEQ/ML|||MG/M2/DAY|NOT DONE||Y|NA|Y|5||7||LONG-TERM FOLLOW-UP|1964-01-28||1972-08-23|||1971-11-22||1964-11-22
TRIAL STUDY 134XCP|RP|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|1||||||STILBIND|STILLBIRTH INDICATOR||||GY|||SQU/ML|NOT DONE||Y|U|U|1||38||TREATMENT|1968-04-29||1960-03-10|||1965-05-09||1960-08-08
TRIAL STUDY 134XCP|RP|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MG/G/MIN|||HENRY|NOT DONE||NA|Y|NA|1||38||LONG-TERM FOLLOW-UP|1973-03-30||1965-01-15|||1967-09-20||1973-04-11
TRIAL STUDY 134XCP|RP|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||CFU/G|||10^11/L|NOT DONE||NA|N|U|2||58||TREATMENT|1966-10-16||1963-05-16|||1969-08-16||1961-11-15
TRIAL STUDY 134XCP|RP|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MM/2H|||PT_US|NOT DONE||U|NA|N|2||58||SCREENING|1962-12-24||1969-01-19|||1967-06-18||1971-12-17
TRIAL STUDY 134XCP|RP|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|1||||||MENOSTAT|MENOPAUSE STATUS||||GPL U|||NCI|NOT DONE||N|NA|U|3||39||RUN-IN|1969-12-04||1965-08-11|||1970-03-27||1964-07-19
TRIAL STUDY 134XCP|RP|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|2||||||GRAVIND|GRAVIDA INDICATOR||||CMOL/L|||NKAT/G HB|NOT DONE||NA|Y|U|3||39||CONTINUATION TREATMENT|1969-04-01||1968-02-24|||1963-08-07||1961-05-16
TRIAL STUDY 134XCP|RP|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||10^11/L|||FT3|NOT DONE||NA|NA|N|4||88||BLINDED TREATMENT|1961-01-04||1960-05-06|||1967-12-14||1969-12-25
TRIAL STUDY 134XCP|RP|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|2||||||INABOIND|INDUCED ABORTION INDICATOR||||10^9 ORGANISMS/MG|||G/KG/DAY|NOT DONE||Y|NA|N|4||88||CONTINUATION TREATMENT|1960-04-20||1962-06-29|||1968-10-17||1960-05-31
TRIAL STUDY 134XCP|RP|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|1||||||PRGENDTC|DATE PREGNANCY ENDED||||VP/ML|||10^6/L|NOT DONE||NA|NA|U|5||7||BLINDED TREATMENT|1962-11-21||1971-06-19|||1968-03-26||1962-07-15
TRIAL STUDY 134XCP|RP|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||DAGU|||USEC|NOT DONE||Y|N|U|5||7||OPEN LABEL TREATMENT|1963-06-06||1961-06-09|||1960-05-14||1970-07-05
TRIAL STUDY 134XCP|RP|CD65CBB8-D056-4738-93A8-FF465534961B|1||||||RASHIND|RASH INDICATOR||||10^9 CFU|||10^6 CFU|NOT DONE||Y|N|U|1||38||CONTINUATION TREATMENT|1966-04-05||1960-09-22|||1963-06-21||1973-06-01
TRIAL STUDY 134XCP|RP|CD65CBB8-D056-4738-93A8-FF465534961B|2||||||ULCERIND|ULCER INDICATOR||||CMH2O*S/ML|||MAC50|NOT DONE||U|N|NA|1||38||RUN-IN|1962-01-24||1973-06-24|||1968-08-18||1963-08-13
TRIAL STUDY 134XCP|RP|CD65CBB8-D056-4738-93A8-FF465534961B|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||PMOL/L/H|||10^6 IU|NOT DONE||Y|NA|N|2||58||FOLLOW-UP|1964-11-10||1971-04-04|||1972-07-21||1972-02-12
TRIAL STUDY 134XCP|RP|CD65CBB8-D056-4738-93A8-FF465534961B|2||||||PREGST|PREGNANT DURING THE STUDY||||HEP|||CD|NOT DONE||N|NA|NA|2||58||OPEN LABEL TREATMENT|1972-06-13||1962-02-02|||1969-04-17||1962-01-24
TRIAL STUDY 134XCP|RP|CD65CBB8-D056-4738-93A8-FF465534961B|1||||||INABOIND|INDUCED ABORTION INDICATOR||||GY/MIN|||AMPULE|NOT DONE||N|Y|NA|3||39||CONTINUATION TREATMENT|1969-01-06||1971-08-26|||1965-11-19||1968-02-23
TRIAL STUDY 134XCP|RP|CD65CBB8-D056-4738-93A8-FF465534961B|2||||||PUSTIND|PUSTULE INDICATOR||||USP U|||CM/S|NOT DONE||U|NA|Y|3||39||OPEN LABEL TREATMENT|1968-08-20||1968-05-29|||1967-12-18||1965-08-28
TRIAL STUDY 134XCP|RP|CD65CBB8-D056-4738-93A8-FF465534961B|1||||||DSCHGIND|DISCHARGE INDICATOR||||H/WK|||MHZ|NOT DONE||N|NA|Y|4||88||TREATMENT|1960-08-29||1962-09-26|||1967-11-04||1971-03-19
TRIAL STUDY 134XCP|RP|CD65CBB8-D056-4738-93A8-FF465534961B|2||||||GRAVIND|GRAVIDA INDICATOR||||G/CAGE/WK|||1/(S*KPA)|NOT DONE||N|U|NA|4||88||TREATMENT|1967-06-12||1960-03-25|||1962-08-08||1964-03-17
TRIAL STUDY 134XCP|RP|CD65CBB8-D056-4738-93A8-FF465534961B|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MPH|||/DAY|NOT DONE||U|U|Y|5||7||TREATMENT|1964-01-06||1961-01-02|||1972-07-12||1969-01-01
TRIAL STUDY 134XCP|RP|CD65CBB8-D056-4738-93A8-FF465534961B|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||TCID 50/DOSE|||NG/DAY|NOT DONE||Y|Y|N|5||7||FOLLOW-UP|1960-04-03||1970-12-22|||1960-10-17||1966-08-20
TRIAL STUDY 134XCP|RP|7F014394-ABE2-45F8-891F-2DE808762532|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MDFI|||LB|NOT DONE||Y|U|N|1||38||WASHOUT|1973-05-02||1972-01-05|||1969-09-09||1966-08-30
TRIAL STUDY 134XCP|RP|7F014394-ABE2-45F8-891F-2DE808762532|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||UG/DAY|||OD UNIT|NOT DONE||N|Y|N|1||38||FOLLOW-UP|1962-02-18||1969-05-26|||1972-06-07||1969-10-28
TRIAL STUDY 134XCP|RP|7F014394-ABE2-45F8-891F-2DE808762532|1||||||INABOIND|INDUCED ABORTION INDICATOR||||DAYS/WK|||KM|NOT DONE||N|NA|U|2||58||SCREENING|1972-03-05||1962-05-02|||1964-05-23||1969-02-12
TRIAL STUDY 134XCP|RP|7F014394-ABE2-45F8-891F-2DE808762532|2||||||TNDRIND|TENDERNESS INDICATOR||||DIP|||NKAT/L|NOT DONE||NA|U|Y|2||58||BASELINE|1971-05-09||1961-11-22|||1960-01-24||1970-05-02
TRIAL STUDY 134XCP|RP|7F014394-ABE2-45F8-891F-2DE808762532|1||||||INTP|INTERPRETATION||||UM|||EU|NOT DONE||Y|Y|Y|3||39||BASELINE|1961-01-01||1961-05-20|||1963-12-09||1972-10-07
TRIAL STUDY 134XCP|RP|7F014394-ABE2-45F8-891F-2DE808762532|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||FEU|||MG/KG/DOSE|NOT DONE||N|N|Y|3||39||SCREENING|1973-07-03||1962-05-28|||1968-10-16||1969-07-08
TRIAL STUDY 134XCP|RP|7F014394-ABE2-45F8-891F-2DE808762532|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ANTI-XA IU/ML|||10^3 COPIES/ML|NOT DONE||Y|NA|U|4||88||BASELINE|1969-01-23||1970-10-28|||1972-12-23||1971-09-18
TRIAL STUDY 134XCP|RP|7F014394-ABE2-45F8-891F-2DE808762532|2||||||RASHIND|RASH INDICATOR||||LX|||MGEQ|NOT DONE||U|U|N|4||88||INDUCTION TREATMENT|1965-09-23||1967-03-01|||1964-01-02||1965-12-11
TRIAL STUDY 134XCP|RP|7F014394-ABE2-45F8-891F-2DE808762532|1||||||MASSIND|MASS INDICATOR||||PFU/ANIMAL|||ELISA UNIT/ML|NOT DONE||NA|NA|N|5||7||SCREENING|1968-02-16||1965-06-13|||1963-11-01||1962-11-17
TRIAL STUDY 134XCP|RP|7F014394-ABE2-45F8-891F-2DE808762532|2||||||PREGNN|NUMBER OF PREGNANCIES||||MMOL/KG|||MM3/MM2/YEAR|NOT DONE||Y|U|U|5||7||BLINDED TREATMENT|1968-03-25||1972-08-24|||1967-11-12||1961-06-04
TRIAL STUDY 134XCP|RP|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||IU/MG|||ML/M2/DAY|NOT DONE||U|N|NA|1||38||INDUCTION TREATMENT|1971-07-10||1960-10-21|||1966-09-29||1973-08-15
TRIAL STUDY 134XCP|RP|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|2||||||BRTHN|NUMBER OF BIRTHS||||MMU/ML|||U/10^12 RBC|NOT DONE||NA|U|NA|1||38||LONG-TERM FOLLOW-UP|1972-05-06||1968-05-02|||1963-11-27||1971-02-26
TRIAL STUDY 134XCP|RP|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||CAN|||KPA/L/SEC|NOT DONE||N|Y|NA|2||58||LONG-TERM FOLLOW-UP|1967-01-31||1964-01-02|||1961-02-16||1966-05-16
TRIAL STUDY 134XCP|RP|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|2||||||FUNDHT|FUNDAL HEIGHT||||ELISA UNIT/DOSE|||UG/L/H|NOT DONE||NA|N|U|2||58||FOLLOW-UP|1973-06-06||1971-08-12|||1961-04-26||1973-05-23
TRIAL STUDY 134XCP|RP|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MAC50|||MV*MIN|NOT DONE||U|U|Y|3||39||OBSERVATION|1964-10-27||1964-06-27|||1963-12-23||1964-12-07
TRIAL STUDY 134XCP|RP|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||LOG10 CFU/ML|||MG/KG/WEEK|NOT DONE||U|N|N|3||39||SCREENING|1969-12-23||1973-07-25|||1960-04-12||1971-11-23
TRIAL STUDY 134XCP|RP|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|1||||||PREGNN|NUMBER OF PREGNANCIES||||BQ/KG|||OD UNIT|NOT DONE||N|NA|N|4||88||OBSERVATION|1962-05-19||1971-06-29|||1960-01-15||1972-02-13
TRIAL STUDY 134XCP|RP|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|2||||||PREGIND|PREGNANT INDICATOR||||S^-1(%O2)^-1|||MIN|NOT DONE||NA|NA|U|4||88||BLINDED TREATMENT|1969-09-10||1962-10-31|||1970-01-14||1969-03-25
TRIAL STUDY 134XCP|RP|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|1||||||TNDRIND|TENDERNESS INDICATOR||||MNFI|||ENZYME U/L|NOT DONE||NA|NA|N|5||7||WASHOUT|1973-03-04||1968-01-13|||1972-02-19||1965-10-21
TRIAL STUDY 134XCP|RP|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||ENZYME U/L|||OSM|NOT DONE||NA|U|N|5||7||WASHOUT|1961-12-06||1973-05-13|||1970-08-23||1969-12-11
TRIAL STUDY 134XCP|RP|FB781158-BB8A-4A75-BD55-00D6A5C72720|1||||||TNDRIND|TENDERNESS INDICATOR||||NG|||MM/H|NOT DONE||Y|N|Y|1||38||LONG-TERM FOLLOW-UP|1965-08-05||1970-11-24|||1965-07-16||1970-02-01
TRIAL STUDY 134XCP|RP|FB781158-BB8A-4A75-BD55-00D6A5C72720|2||||||MENFDUR|MENSES FLOW DURATION||||UKAT|||ML/ANIMAL/WK|NOT DONE||U|Y|U|1||38||CONTINUATION TREATMENT|1966-07-10||1970-01-08|||1969-01-20||1972-03-31
TRIAL STUDY 134XCP|RP|FB781158-BB8A-4A75-BD55-00D6A5C72720|1||||||PRGENDTC|DATE PREGNANCY ENDED||||ML/S|||CY/CM|NOT DONE||N|U|Y|2||58||CONTINUATION TREATMENT|1963-11-14||1963-02-13|||1968-09-03||1962-11-14
TRIAL STUDY 134XCP|RP|FB781158-BB8A-4A75-BD55-00D6A5C72720|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||KEV|||MDFI|NOT DONE||N|Y|U|2||58||SCREENING|1963-11-24||1964-08-10|||1960-08-13||1967-05-19
TRIAL STUDY 134XCP|RP|FB781158-BB8A-4A75-BD55-00D6A5C72720|1||||||GRAVIND|GRAVIDA INDICATOR||||MESF|||CCID 50/ML|NOT DONE||U|U|U|3||39||FOLLOW-UP|1964-12-03||1963-09-15|||1964-06-01||1968-03-02
TRIAL STUDY 134XCP|RP|FB781158-BB8A-4A75-BD55-00D6A5C72720|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||%|||NEBULE|NOT DONE||N|NA|U|3||39||LONG-TERM FOLLOW-UP|1963-02-28||1968-06-22|||1969-07-20||1963-09-01
TRIAL STUDY 134XCP|RP|FB781158-BB8A-4A75-BD55-00D6A5C72720|1||||||PUSTIND|PUSTULE INDICATOR||||CMHG|||ML/(MIN*100ML)|NOT DONE||Y|U|U|4||88||OPEN LABEL TREATMENT|1969-10-01||1966-09-15|||1965-08-21||1967-11-29
TRIAL STUDY 134XCP|RP|FB781158-BB8A-4A75-BD55-00D6A5C72720|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||%(W/W)|||ML/BREATH|NOT DONE||U|Y|N|4||88||CONTINUATION TREATMENT|1970-09-01||1962-10-15|||1961-04-08||1973-01-15
TRIAL STUDY 134XCP|RP|FB781158-BB8A-4A75-BD55-00D6A5C72720|1||||||PRGENDTC|DATE PREGNANCY ENDED||||MET|||L/MIN|NOT DONE||N|U|Y|5||7||OBSERVATION|1967-04-01||1972-02-14|||1961-12-02||1961-01-24
TRIAL STUDY 134XCP|RP|FB781158-BB8A-4A75-BD55-00D6A5C72720|2||||||MENARAGE|MENARCHE AGE||||HZ/S|||G/DL|NOT DONE||N|N|Y|5||7||WASHOUT|1973-04-08||1967-04-23|||1964-06-06||1968-09-02
TRIAL STUDY 134XCP|RP|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|1||||||MENOSTAT|MENOPAUSE STATUS||||U/KG/MIN|||COPIES/ML|NOT DONE||N|U|U|1||38||LONG-TERM FOLLOW-UP|1971-01-31||1962-09-08|||1966-07-04||1960-09-29
TRIAL STUDY 134XCP|RP|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/CAGE/DAY|||ML/G/H|NOT DONE||N|NA|N|1||38||OBSERVATION|1965-11-21||1972-05-11|||1963-05-16||1972-10-04
TRIAL STUDY 134XCP|RP|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|1||||||EDEMAIND|EDEMA INDICATOR||||MMOL/MOL|||GBQ|NOT DONE||NA|Y|NA|2||58||TREATMENT|1972-12-09||1972-01-30|||1960-03-30||1971-01-02
TRIAL STUDY 134XCP|RP|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MG/G/H|||10^6 ORGANISMS/G|NOT DONE||NA|NA|U|2||58||BASELINE|1964-02-20||1969-09-06|||1961-09-24||1970-04-28
TRIAL STUDY 134XCP|RP|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|1||||||BRTHN|NUMBER OF BIRTHS||||UG/L/H|||10^7 PFU|NOT DONE||N|U|U|3||39||OBSERVATION|1972-07-29||1972-05-06|||1960-07-12||1966-11-11
TRIAL STUDY 134XCP|RP|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|2||||||ULCERIND|ULCER INDICATOR||||U/MG|||MG/G/MIN|NOT DONE||N|NA|N|3||39||SCREENING|1961-10-04||1964-02-28|||1968-12-08||1965-08-09
TRIAL STUDY 134XCP|RP|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||H*%|||VG/KG|NOT DONE||N|U|U|4||88||OPEN LABEL TREATMENT|1967-12-26||1969-12-13|||1960-06-04||1966-08-22
TRIAL STUDY 134XCP|RP|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||S^-1(%O2)^-1|||DL|NOT DONE||NA|Y|Y|4||88||LONG-TERM FOLLOW-UP|1972-02-02||1969-05-06|||1969-08-03||1972-05-27
TRIAL STUDY 134XCP|RP|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|1||||||PEELIND|PEELING INDICATOR||||ML/MMHG/MIN/L|||BU|NOT DONE||NA|NA|NA|5||7||OBSERVATION|1962-03-01||1969-01-31|||1962-08-05||1972-08-23
TRIAL STUDY 134XCP|RP|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||LOG10 TCID 50/ML|||MMOL/KG|NOT DONE||U|Y|U|5||7||BLINDED TREATMENT|1971-10-20||1960-04-14|||1968-11-23||1972-06-07
TRIAL STUDY 134XCP|RP|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|1||||||STILBIND|STILLBIRTH INDICATOR||||LOG10 PFU|||CI/KG|NOT DONE||U|NA|NA|1||38||FOLLOW-UP|1963-03-08||1960-03-01|||1971-02-06||1962-03-24
TRIAL STUDY 134XCP|RP|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|2||||||PREGIND|PREGNANT INDICATOR||||MU/L|||MGEQ|NOT DONE||Y|NA|Y|1||38||BLINDED TREATMENT|1965-02-03||1966-02-28|||1960-05-18||1960-02-03
TRIAL STUDY 134XCP|RP|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||CUP EQ|||MG2/DL2|NOT DONE||NA|U|Y|2||58||RUN-IN|1963-11-13||1970-05-06|||1966-01-26||1971-05-27
TRIAL STUDY 134XCP|RP|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|2||||||PUSTIND|PUSTULE INDICATOR||||PL|||EP U|NOT DONE||NA|NA|N|2||58||SCREENING|1972-09-14||1964-12-29|||1964-07-18||1971-07-29
TRIAL STUDY 134XCP|RP|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||DYN|||PACK YEAR|NOT DONE||NA|Y|Y|3||39||TREATMENT|1970-12-19||1967-10-05|||1967-06-25||1970-06-18
TRIAL STUDY 134XCP|RP|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MG|||NG/DAY|NOT DONE||N|N|N|3||39||OPEN LABEL TREATMENT|1968-07-13||1972-01-07|||1960-03-14||1961-10-31
TRIAL STUDY 134XCP|RP|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|1||||||BCMETHOD|BIRTH CONTROL METHOD||||/MBP|||MN|NOT DONE||Y|NA|N|4||88||WASHOUT|1969-06-15||1967-02-05|||1970-04-24||1967-11-22
TRIAL STUDY 134XCP|RP|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|2||||||ABORTN|NUMBER OF ABORTIONS||||BOWL|||L/MIN/M2|NOT DONE||NA|U|N|4||88||RUN-IN|1972-02-18||1966-03-22|||1971-06-28||1962-12-03
TRIAL STUDY 134XCP|RP|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|1||||||ULCERIND|ULCER INDICATOR||||%/MIN|||ARBITRARY U|NOT DONE||N|NA|U|5||7||RUN-IN|1964-04-09||1962-07-01|||1968-07-09||1960-10-01
TRIAL STUDY 134XCP|RP|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|2||||||PRGENDTC|DATE PREGNANCY ENDED||||MMU/ML|||PG/DL|NOT DONE||N|NA|U|5||7||OPEN LABEL TREATMENT|1971-02-16||1964-05-24|||1968-11-25||1968-04-17
TRIAL STUDY 134XCP|RP|505A1BB6-135A-4839-BB9E-6DD37F49DC45|1||||||BCMETHOD|BIRTH CONTROL METHOD||||EID 50/ML|||CAPLET|NOT DONE||N|U|U|1||38||WASHOUT|1966-07-15||1967-12-10|||1971-12-20||1971-12-12
TRIAL STUDY 134XCP|RP|505A1BB6-135A-4839-BB9E-6DD37F49DC45|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||PLUG|||ML/100G/MIN|NOT DONE||Y|NA|Y|1||38||OPEN LABEL TREATMENT|1967-09-28||1971-07-03|||1969-04-10||1968-08-27
TRIAL STUDY 134XCP|RP|505A1BB6-135A-4839-BB9E-6DD37F49DC45|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||AMU|||BAG|NOT DONE||Y|Y|U|2||58||FOLLOW-UP|1964-07-25||1963-06-15|||1969-06-04||1964-08-03
TRIAL STUDY 134XCP|RP|505A1BB6-135A-4839-BB9E-6DD37F49DC45|2||||||MENFDUR|MENSES FLOW DURATION||||MOL/G|||10^3 CFU/G|NOT DONE||Y|Y|Y|2||58||SCREENING|1963-12-21||1972-12-11|||1963-05-20||1963-02-05
TRIAL STUDY 134XCP|RP|505A1BB6-135A-4839-BB9E-6DD37F49DC45|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||CAPLET|||EP U|NOT DONE||NA|Y|Y|3||39||RUN-IN|1966-01-06||1963-07-18|||1971-04-06||1960-02-16
TRIAL STUDY 134XCP|RP|505A1BB6-135A-4839-BB9E-6DD37F49DC45|2||||||ABORTN|NUMBER OF ABORTIONS||||10^9/DOSE|||L/MIN/M2|NOT DONE||NA|Y|N|3||39||INDUCTION TREATMENT|1970-03-10||1960-06-21|||1966-02-22||1960-10-27
TRIAL STUDY 134XCP|RP|505A1BB6-135A-4839-BB9E-6DD37F49DC45|1||||||PREGIND|PREGNANT INDICATOR||||10^9/DOSE|||%/S|NOT DONE||Y|U|U|4||88||FOLLOW-UP|1963-10-23||1967-07-27|||1973-05-19||1965-09-10
TRIAL STUDY 134XCP|RP|505A1BB6-135A-4839-BB9E-6DD37F49DC45|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^10/L|||ANTI-XA IU/ML|NOT DONE||U|Y|NA|4||88||SCREENING|1963-03-20||1969-12-24|||1961-06-30||1960-03-11
TRIAL STUDY 134XCP|RP|505A1BB6-135A-4839-BB9E-6DD37F49DC45|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||DAYS|||10^4/L|NOT DONE||NA|N|NA|5||7||BLINDED TREATMENT|1967-01-22||1966-01-23|||1967-08-07||1970-11-11
TRIAL STUDY 134XCP|RP|505A1BB6-135A-4839-BB9E-6DD37F49DC45|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||UG/KG/DAY|||MG/M2/H|NOT DONE||N|Y|Y|5||7||CONTINUATION TREATMENT|1962-10-13||1967-02-21|||1969-11-08||1965-09-24
TRIAL STUDY 134XCP|RP|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|1||||||PEELIND|PEELING INDICATOR||||/100 HPFS|||ML*CMH2O|NOT DONE||Y|NA|NA|1||38||RUN-IN|1962-11-11||1964-08-08|||1964-10-08||1967-07-13
TRIAL STUDY 134XCP|RP|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ML/CM H2O|||DAMOL/L|NOT DONE||NA|U|U|1||38||LONG-TERM FOLLOW-UP|1970-10-06||1963-07-03|||1964-02-17||1960-12-11
TRIAL STUDY 134XCP|RP|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UU/DL|||H*%|NOT DONE||N|NA|NA|2||58||BASELINE|1968-03-05||1973-05-05|||1962-04-13||1970-03-19
TRIAL STUDY 134XCP|RP|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||EP U|||UG/KG/DAY|NOT DONE||U|U|N|2||58||WASHOUT|1972-01-13||1970-08-01|||1964-04-21||1970-03-20
TRIAL STUDY 134XCP|RP|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||LOG10 CFU/G|||KG/MOL|NOT DONE||NA|U|Y|3||39||CONTINUATION TREATMENT|1961-04-04||1969-07-26|||1965-10-22||1971-01-05
TRIAL STUDY 134XCP|RP|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UG/H|||PG|NOT DONE||N|Y|Y|3||39||INDUCTION TREATMENT|1964-09-18||1966-12-12|||1973-01-29||1966-09-10
TRIAL STUDY 134XCP|RP|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||BQ/UG|||M|NOT DONE||N|N|U|4||88||WASHOUT|1968-11-03||1965-04-28|||1968-07-28||1968-07-06
TRIAL STUDY 134XCP|RP|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||CM H2O|||MEQ/UL|NOT DONE||N|N|Y|4||88||BASELINE|1970-09-23||1962-06-08|||1973-06-19||1964-12-21
TRIAL STUDY 134XCP|RP|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|1||||||PRGENDTC|DATE PREGNANCY ENDED||||MET*MIN|||10^9 CFU/G|NOT DONE||NA|Y|Y|5||7||OPEN LABEL TREATMENT|1963-04-08||1963-01-12|||1962-05-18||1966-09-15
TRIAL STUDY 134XCP|RP|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||EID 50/ML|||/10^3|NOT DONE||N|NA|NA|5||7||WASHOUT|1960-11-30||1966-02-09|||1966-05-19||1968-10-27
TRIAL STUDY 134XCP|RP|16F375DC-DC27-461B-969E-1269DC53F4D9|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||UM2|||DPM/MG|NOT DONE||U|NA|U|1||38||OPEN LABEL TREATMENT|1965-05-03||1962-02-02|||1966-03-23||1973-01-17
TRIAL STUDY 134XCP|RP|16F375DC-DC27-461B-969E-1269DC53F4D9|2||||||EDEMAIND|EDEMA INDICATOR||||PKAT|||MG|NOT DONE||U|Y|N|1||38||OPEN LABEL TREATMENT|1964-08-08||1972-04-24|||1966-10-09||1968-09-02
TRIAL STUDY 134XCP|RP|16F375DC-DC27-461B-969E-1269DC53F4D9|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MM/MIN|||10^7/L|NOT DONE||Y|Y|Y|2||58||BLINDED TREATMENT|1961-07-19||1962-09-16|||1973-02-18||1966-10-18
TRIAL STUDY 134XCP|RP|16F375DC-DC27-461B-969E-1269DC53F4D9|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||GBQ/UG|||%/MIN|NOT DONE||U|NA|N|2||58||INDUCTION TREATMENT|1969-12-13||1969-08-08|||1967-06-19||1967-07-05
TRIAL STUDY 134XCP|RP|16F375DC-DC27-461B-969E-1269DC53F4D9|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||ML/S|||FT|NOT DONE||N|N|N|3||39||CONTINUATION TREATMENT|1966-05-21||1964-01-05|||1972-05-24||1964-02-18
TRIAL STUDY 134XCP|RP|16F375DC-DC27-461B-969E-1269DC53F4D9|2||||||INABOIND|INDUCED ABORTION INDICATOR||||LOG10 TCID 50/ML|||MM2|NOT DONE||NA|NA|U|3||39||OBSERVATION|1964-09-16||1960-08-16|||1966-03-12||1961-06-18
TRIAL STUDY 134XCP|RP|16F375DC-DC27-461B-969E-1269DC53F4D9|1||||||THICK|THICKNESS||||CMH2O*S/ML|||CI/UG|NOT DONE||NA|N|NA|4||88||OBSERVATION|1966-02-06||1972-07-13|||1963-09-05||1960-08-20
TRIAL STUDY 134XCP|RP|16F375DC-DC27-461B-969E-1269DC53F4D9|2||||||MENOSTAT|MENOPAUSE STATUS||||%(W/V)|||V/SEC|NOT DONE||NA|Y|NA|4||88||INDUCTION TREATMENT|1966-03-11||1967-01-05|||1961-04-05||1971-03-10
TRIAL STUDY 134XCP|RP|16F375DC-DC27-461B-969E-1269DC53F4D9|1||||||STILBIND|STILLBIRTH INDICATOR||||SHOCK WAVE|||PACKAGE|NOT DONE||N|N|U|5||7||CONTINUATION TREATMENT|1969-08-09||1967-07-27|||1966-02-19||1964-06-13
TRIAL STUDY 134XCP|RP|16F375DC-DC27-461B-969E-1269DC53F4D9|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||U/L|||PFU/ANIMAL|NOT DONE||U|NA|U|5||7||FOLLOW-UP|1969-05-27||1965-11-27|||1960-06-14||1972-10-15
TRIAL STUDY 134XCP|RP|17BF9A68-265F-4FCC-A499-615A1B71A8D6|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||KG/MOL|||UCI|NOT DONE||Y|Y|N|1||38||OBSERVATION|1972-06-12||1966-11-18|||1961-09-04||1969-06-13
TRIAL STUDY 134XCP|RP|17BF9A68-265F-4FCC-A499-615A1B71A8D6|2||||||TNDRIND|TENDERNESS INDICATOR||||ML/S|||CIGARETTE|NOT DONE||NA|N|U|1||38||CONTINUATION TREATMENT|1964-08-20||1969-03-19|||1962-11-19||1961-08-21
TRIAL STUDY 134XCP|RP|17BF9A68-265F-4FCC-A499-615A1B71A8D6|1||||||STILBIND|STILLBIRTH INDICATOR||||MG/KG/DAY|||UG/L FEU|NOT DONE||N|NA|N|2||58||LONG-TERM FOLLOW-UP|1967-09-03||1966-01-19|||1972-06-18||1968-03-15
TRIAL STUDY 134XCP|RP|17BF9A68-265F-4FCC-A499-615A1B71A8D6|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MG2/DL2|||MOSM|NOT DONE||U|NA|Y|2||58||INDUCTION TREATMENT|1967-05-03||1963-06-03|||1964-11-25||1964-02-02
TRIAL STUDY 134XCP|RP|17BF9A68-265F-4FCC-A499-615A1B71A8D6|1||||||PEELIND|PEELING INDICATOR||||M/SEC|||G/G/DAY|NOT DONE||NA|Y|Y|3||39||RUN-IN|1960-02-14||1965-02-26|||1972-05-27||1965-02-22
TRIAL STUDY 134XCP|RP|17BF9A68-265F-4FCC-A499-615A1B71A8D6|2||||||EDEMAIND|EDEMA INDICATOR||||UGEQ|||CUP EQ|NOT DONE||NA|U|U|3||39||OPEN LABEL TREATMENT|1967-04-21||1971-09-11|||1966-10-16||1972-07-15
TRIAL STUDY 134XCP|RP|17BF9A68-265F-4FCC-A499-615A1B71A8D6|1||||||TNDRIND|TENDERNESS INDICATOR||||G/G/DAY|||ML/M2/MIN|NOT DONE||U|N|N|4||88||SCREENING|1970-03-08||1965-02-17|||1960-12-04||1964-03-20
TRIAL STUDY 134XCP|RP|17BF9A68-265F-4FCC-A499-615A1B71A8D6|2||||||THICK|THICKNESS||||MEQ/UL|||UM2|NOT DONE||NA|N|NA|4||88||BLINDED TREATMENT|1962-07-12||1967-03-13|||1971-01-25||1973-02-16
TRIAL STUDY 134XCP|RP|17BF9A68-265F-4FCC-A499-615A1B71A8D6|1||||||RASHIND|RASH INDICATOR||||10^9/G|||UG/DL|NOT DONE||N|NA|N|5||7||FOLLOW-UP|1971-07-23||1970-02-28|||1968-10-16||1962-03-31
TRIAL STUDY 134XCP|RP|17BF9A68-265F-4FCC-A499-615A1B71A8D6|2||||||ULCERIND|ULCER INDICATOR||||GLOBULE|||U/G/MIN|NOT DONE||U|U|Y|5||7||TREATMENT|1960-11-10||1968-07-11|||1965-09-21||1965-06-11
TRIAL STUDY 134XCP|RP|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MMOL/MIN/KPA|||MM|NOT DONE||NA|N|N|1||38||WASHOUT|1970-12-07||1970-07-23|||1969-07-20||1960-01-01
TRIAL STUDY 134XCP|RP|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||CD|||10^6 U|NOT DONE||NA|Y|NA|1||38||RUN-IN|1964-08-05||1962-05-25|||1964-10-16||1966-11-07
TRIAL STUDY 134XCP|RP|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|1||||||PREGIND|PREGNANT INDICATOR||||MM/MIN|||EIA UNIT|NOT DONE||Y|U|U|2||58||WASHOUT|1961-12-29||1966-05-02|||1960-10-08||1972-12-04
TRIAL STUDY 134XCP|RP|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||AU/ML|||ML/MIN|NOT DONE||Y|U|NA|2||58||OPEN LABEL TREATMENT|1972-10-14||1962-03-24|||1964-03-24||1960-07-17
TRIAL STUDY 134XCP|RP|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|1||||||INABOIND|INDUCED ABORTION INDICATOR||||PFU/ANIMAL|||UG/H|NOT DONE||U|NA|NA|3||39||LONG-TERM FOLLOW-UP|1969-05-03||1973-08-28|||1968-03-20||1965-01-12
TRIAL STUDY 134XCP|RP|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|2||||||MASSIND|MASS INDICATOR||||G/DAY|||AMFI|NOT DONE||U|N|Y|3||39||BLINDED TREATMENT|1963-12-16||1960-02-23|||1972-05-22||1963-06-15
TRIAL STUDY 134XCP|RP|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|1||||||BRTHN|NUMBER OF BIRTHS||||SCM|||MG/KG/H|NOT DONE||Y|NA|N|4||88||OBSERVATION|1964-05-24||1965-09-24|||1964-06-29||1964-11-16
TRIAL STUDY 134XCP|RP|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^6 ORGANISMS|||U.CARR|NOT DONE||N|U|Y|4||88||OPEN LABEL TREATMENT|1960-03-14||1971-12-25|||1963-07-13||1969-11-25
TRIAL STUDY 134XCP|RP|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|1||||||MENOAGE|MENOPAUSE AGE||||PFU|||PNU/ML|NOT DONE||Y|U|U|5||7||RUN-IN|1968-09-16||1964-11-29|||1966-08-02||1969-08-14
TRIAL STUDY 134XCP|RP|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|2||||||FUNDHT|FUNDAL HEIGHT||||KPA|||MG/CM2|NOT DONE||Y|Y|NA|5||7||OBSERVATION|1962-10-01||1971-11-30|||1961-10-20||1966-02-01
TRIAL STUDY 134XCP|RP|B842981B-AD7A-4A03-8E84-D5FC887BAD60|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||DEG/MM|||MG|NOT DONE||Y|N|NA|1||38||OPEN LABEL TREATMENT|1972-04-08||1971-09-03|||1973-08-25||1970-11-14
TRIAL STUDY 134XCP|RP|B842981B-AD7A-4A03-8E84-D5FC887BAD60|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||STEPS|||TRACE|NOT DONE||U|NA|NA|1||38||OPEN LABEL TREATMENT|1968-06-30||1972-09-17|||1965-08-03||1967-01-26
TRIAL STUDY 134XCP|RP|B842981B-AD7A-4A03-8E84-D5FC887BAD60|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||KG/L|||ENZYME U/L|NOT DONE||N|N|NA|2||58||WASHOUT|1969-12-09||1966-05-28|||1963-03-14||1962-02-14
TRIAL STUDY 134XCP|RP|B842981B-AD7A-4A03-8E84-D5FC887BAD60|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||DNA COPIES/UG|||TABLET|NOT DONE||NA|N|Y|2||58||OBSERVATION|1968-01-14||1961-10-02|||1967-12-04||1971-04-10
TRIAL STUDY 134XCP|RP|B842981B-AD7A-4A03-8E84-D5FC887BAD60|1||||||BCMETHOD|BIRTH CONTROL METHOD||||UG/G/MIN|||MEQ/UG|NOT DONE||N|Y|U|3||39||RUN-IN|1963-04-27||1965-04-10|||1973-06-21||1972-03-23
TRIAL STUDY 134XCP|RP|B842981B-AD7A-4A03-8E84-D5FC887BAD60|2||||||BRTHN|NUMBER OF BIRTHS||||NMOL/L|||/200 HPFS|NOT DONE||NA|U|Y|3||39||LONG-TERM FOLLOW-UP|1972-10-09||1962-01-17|||1965-08-05||1960-02-11
TRIAL STUDY 134XCP|RP|B842981B-AD7A-4A03-8E84-D5FC887BAD60|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||DEG|||IU/KG|NOT DONE||N|N|Y|4||88||SCREENING|1967-12-01||1963-10-05|||1963-01-17||1961-08-15
TRIAL STUDY 134XCP|RP|B842981B-AD7A-4A03-8E84-D5FC887BAD60|2||||||DSCHGIND|DISCHARGE INDICATOR||||HOMEOPATHIC DILUTION|||PKAT|NOT DONE||NA|N|N|4||88||OBSERVATION|1963-04-07||1966-12-25|||1968-05-16||1965-06-08
TRIAL STUDY 134XCP|RP|B842981B-AD7A-4A03-8E84-D5FC887BAD60|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||APL U|||MEQ/UG|NOT DONE||N|N|NA|5||7||OPEN LABEL TREATMENT|1960-06-30||1962-04-14|||1970-08-04||1967-10-18
TRIAL STUDY 134XCP|RP|B842981B-AD7A-4A03-8E84-D5FC887BAD60|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||NMOL/ML/MIN|||UG/M2/H|NOT DONE||Y|N|NA|5||7||BLINDED TREATMENT|1969-12-10||1971-12-09|||1967-11-05||1966-08-15
TRIAL STUDY 134XCP|RP|07F7C4E7-7722-4916-AB89-46EF540E2BD7|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UG/L/H|||NEBULE|NOT DONE||Y|N|Y|1||38||TREATMENT|1963-12-11||1966-12-21|||1968-09-15||1961-09-06
TRIAL STUDY 134XCP|RP|07F7C4E7-7722-4916-AB89-46EF540E2BD7|2||||||FUNDHT|FUNDAL HEIGHT||||/LPF|||HEP|NOT DONE||NA|N|N|1||38||CONTINUATION TREATMENT|1971-11-15||1965-04-22|||1964-01-09||1972-05-22
TRIAL STUDY 134XCP|RP|07F7C4E7-7722-4916-AB89-46EF540E2BD7|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||IU/KG|||MG/KG|NOT DONE||NA|Y|NA|2||58||BLINDED TREATMENT|1967-07-09||1965-06-29|||1966-11-02||1964-04-16
TRIAL STUDY 134XCP|RP|07F7C4E7-7722-4916-AB89-46EF540E2BD7|2||||||ULCERIND|ULCER INDICATOR||||FOZ_BR|||MCI|NOT DONE||N|Y|U|2||58||LONG-TERM FOLLOW-UP|1963-09-04||1967-12-04|||1970-07-26||1967-10-06
TRIAL STUDY 134XCP|RP|07F7C4E7-7722-4916-AB89-46EF540E2BD7|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MEQ/L|||10^6 IU|NOT DONE||N|U|N|3||39||OPEN LABEL TREATMENT|1963-03-22||1970-09-12|||1971-07-15||1967-08-19
TRIAL STUDY 134XCP|RP|07F7C4E7-7722-4916-AB89-46EF540E2BD7|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||10^7/L|||UG/ANIMAL|NOT DONE||Y|NA|N|3||39||BLINDED TREATMENT|1961-06-09||1966-08-11|||1962-03-26||1971-02-11
TRIAL STUDY 134XCP|RP|07F7C4E7-7722-4916-AB89-46EF540E2BD7|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||U/KG|||/200 HPFS|NOT DONE||Y|Y|NA|4||88||FOLLOW-UP|1970-08-27||1972-11-06|||1969-06-04||1967-02-09
TRIAL STUDY 134XCP|RP|07F7C4E7-7722-4916-AB89-46EF540E2BD7|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||CMOL|||K|NOT DONE||NA|N|U|4||88||WASHOUT|1964-08-18||1969-03-28|||1973-07-04||1971-09-02
TRIAL STUDY 134XCP|RP|07F7C4E7-7722-4916-AB89-46EF540E2BD7|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||/2500 WBC|||JDF UNIT|NOT DONE||NA|N|NA|5||7||BLINDED TREATMENT|1966-02-17||1963-04-26|||1968-01-05||1962-02-07
TRIAL STUDY 134XCP|RP|07F7C4E7-7722-4916-AB89-46EF540E2BD7|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/DL|||U/KG/H|NOT DONE||N|NA|NA|5||7||WASHOUT|1973-05-20||1965-11-13|||1964-12-05||1964-06-19
TRIAL STUDY 134XCP|RP|58661394-906E-43F3-8935-150DF240A04C|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^9 CFU/ML|||NMOL/KG/DAY|NOT DONE||Y|Y|N|1||38||OBSERVATION|1964-12-21||1962-03-14|||1968-12-06||1967-07-27
TRIAL STUDY 134XCP|RP|58661394-906E-43F3-8935-150DF240A04C|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||UG/ANIMAL|||PM|NOT DONE||U|Y|U|1||38||CONTINUATION TREATMENT|1966-02-17||1968-02-19|||1961-06-08||1965-03-11
TRIAL STUDY 134XCP|RP|58661394-906E-43F3-8935-150DF240A04C|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UG/KG/DAY|||HZ/S|NOT DONE||NA|NA|U|2||58||BASELINE|1964-11-26||1962-08-18|||1967-10-24||1965-11-25
TRIAL STUDY 134XCP|RP|58661394-906E-43F3-8935-150DF240A04C|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||OI50|||/7.5 ML|NOT DONE||Y|Y|NA|2||58||CONTINUATION TREATMENT|1968-06-17||1970-08-31|||1970-06-01||1962-07-06
TRIAL STUDY 134XCP|RP|58661394-906E-43F3-8935-150DF240A04C|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||LOG10 TCID 50/UL|||UG/ANIMAL|NOT DONE||Y|U|NA|3||39||BASELINE|1963-04-03||1965-08-14|||1963-06-30||1963-12-31
TRIAL STUDY 134XCP|RP|58661394-906E-43F3-8935-150DF240A04C|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||NG/DAY|||NG/DAY|NOT DONE||U|U|NA|3||39||OBSERVATION|1960-02-16||1961-02-20|||1963-01-04||1971-08-11
TRIAL STUDY 134XCP|RP|58661394-906E-43F3-8935-150DF240A04C|1||||||PREGST|PREGNANT DURING THE STUDY||||UMOL/KG/MIN|||UM/DAY|NOT DONE||Y|U|NA|4||88||LONG-TERM FOLLOW-UP|1963-10-25||1961-12-08|||1962-06-26||1963-04-26
TRIAL STUDY 134XCP|RP|58661394-906E-43F3-8935-150DF240A04C|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MU/G|||NKAT/L|NOT DONE||U|Y|U|4||88||BLINDED TREATMENT|1965-07-01||1963-06-29|||1963-03-26||1966-04-17
TRIAL STUDY 134XCP|RP|58661394-906E-43F3-8935-150DF240A04C|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||BOWL|||BOLUS|NOT DONE||N|U|U|5||7||BLINDED TREATMENT|1961-06-20||1967-09-26|||1971-02-06||1972-06-03
TRIAL STUDY 134XCP|RP|58661394-906E-43F3-8935-150DF240A04C|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||DRINK|||SHOCK WAVE|NOT DONE||NA|U|U|5||7||TREATMENT|1972-12-29||1971-07-18|||1967-09-10||1967-03-03
TRIAL STUDY 134XCP|RP|B70F3694-B764-4B39-BFB9-B1281ED091B8|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||EP U|||STRIP|NOT DONE||N|Y|Y|1||38||INDUCTION TREATMENT|1961-07-10||1963-11-03|||1961-07-24||1971-08-09
TRIAL STUDY 134XCP|RP|B70F3694-B764-4B39-BFB9-B1281ED091B8|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||FOZ_US|||UG/H|NOT DONE||N|NA|Y|1||38||TREATMENT|1963-11-26||1966-06-29|||1961-01-08||1967-07-03
TRIAL STUDY 134XCP|RP|B70F3694-B764-4B39-BFB9-B1281ED091B8|1||||||BCMETHOD|BIRTH CONTROL METHOD||||CAPLET|||MOL/DAY|NOT DONE||N|N|Y|2||58||CONTINUATION TREATMENT|1963-06-23||1963-03-27|||1963-06-22||1967-05-13
TRIAL STUDY 134XCP|RP|B70F3694-B764-4B39-BFB9-B1281ED091B8|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||TRANSDUCING UNIT|||/10^4|NOT DONE||NA|NA|N|2||58||OBSERVATION|1968-04-19||1961-11-14|||1972-09-03||1970-01-30
TRIAL STUDY 134XCP|RP|B70F3694-B764-4B39-BFB9-B1281ED091B8|1||||||MENARAGE|MENARCHE AGE||||10^3 CFU/G|||MPA|NOT DONE||Y|U|Y|3||39||BASELINE|1967-05-15||1962-08-02|||1970-12-13||1970-08-21
TRIAL STUDY 134XCP|RP|B70F3694-B764-4B39-BFB9-B1281ED091B8|2||||||FUNDHT|FUNDAL HEIGHT||||M/SEC2|||ENZYME U/L|NOT DONE||NA|NA|Y|3||39||BLINDED TREATMENT|1964-06-22||1961-10-14|||1961-09-30||1967-03-03
TRIAL STUDY 134XCP|RP|B70F3694-B764-4B39-BFB9-B1281ED091B8|1||||||MASSIND|MASS INDICATOR||||ML/MMHG/MIN/L|||FL|NOT DONE||NA|U|U|4||88||CONTINUATION TREATMENT|1973-02-05||1973-09-05|||1966-04-24||1965-10-05
TRIAL STUDY 134XCP|RP|B70F3694-B764-4B39-BFB9-B1281ED091B8|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||NMOL/KG/DAY|||ENZYME U/M2|NOT DONE||N|N|NA|4||88||BLINDED TREATMENT|1966-02-26||1963-02-21|||1960-09-17||1964-04-25
TRIAL STUDY 134XCP|RP|B70F3694-B764-4B39-BFB9-B1281ED091B8|1||||||PEELIND|PEELING INDICATOR||||MS/MMHG|||TROCHE|NOT DONE||Y|NA|U|5||7||LONG-TERM FOLLOW-UP|1960-08-13||1963-04-15|||1968-11-26||1963-04-02
TRIAL STUDY 134XCP|RP|B70F3694-B764-4B39-BFB9-B1281ED091B8|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||TABLET|||NKAT/L|NOT DONE||N|NA|NA|5||7||INDUCTION TREATMENT|1972-03-04||1970-01-28|||1961-08-15||1968-11-06
TRIAL STUDY 134XCP|RP|5B2471DB-807A-44F8-9529-D2319CCFE017|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||TCID 50/DOSE|||KPA/L/SEC|NOT DONE||NA|U|U|1||38||INDUCTION TREATMENT|1967-04-13||1969-01-01|||1967-01-14||1960-09-15
TRIAL STUDY 134XCP|RP|5B2471DB-807A-44F8-9529-D2319CCFE017|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||GY/MIN|||MMOL/MIN/KPA|NOT DONE||NA|N|U|1||38||LONG-TERM FOLLOW-UP|1963-05-14||1963-07-09|||1973-02-26||1965-08-06
TRIAL STUDY 134XCP|RP|5B2471DB-807A-44F8-9529-D2319CCFE017|1||||||ABORTN|NUMBER OF ABORTIONS||||MET*H|||10^8 PFU|NOT DONE||NA|NA|NA|2||58||TREATMENT|1960-10-30||1961-02-24|||1967-10-03||1969-09-02
TRIAL STUDY 134XCP|RP|5B2471DB-807A-44F8-9529-D2319CCFE017|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||U/M2|||MAMP|NOT DONE||NA|NA|U|2||58||RUN-IN|1964-03-02||1962-09-14|||1963-08-25||1960-06-05
TRIAL STUDY 134XCP|RP|5B2471DB-807A-44F8-9529-D2319CCFE017|1||||||BRTHN|NUMBER OF BIRTHS||||UG/KG/H|||VP/DOSE|NOT DONE||N|U|NA|3||39||OBSERVATION|1973-04-30||1964-01-24|||1963-05-01||1963-09-06
TRIAL STUDY 134XCP|RP|5B2471DB-807A-44F8-9529-D2319CCFE017|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||BQ/MG|||G/CM2|NOT DONE||U|NA|Y|3||39||BASELINE|1972-07-02||1973-03-08|||1969-04-11||1973-03-18
TRIAL STUDY 134XCP|RP|5B2471DB-807A-44F8-9529-D2319CCFE017|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^6 IU/ML|||/SEC|NOT DONE||NA|Y|NA|4||88||OPEN LABEL TREATMENT|1961-11-07||1972-07-24|||1963-10-21||1968-05-24
TRIAL STUDY 134XCP|RP|5B2471DB-807A-44F8-9529-D2319CCFE017|2||||||PUSTIND|PUSTULE INDICATOR||||UG/M2/DAY|||UMOL/H/MMOL|NOT DONE||N|U|U|4||88||OBSERVATION|1972-12-14||1969-04-08|||1961-02-09||1963-12-07
TRIAL STUDY 134XCP|RP|5B2471DB-807A-44F8-9529-D2319CCFE017|1||||||BLISTIND|BLISTERING INDICATOR||||FMOL/G|||10^6 U|NOT DONE||U|NA|N|5||7||SCREENING|1962-12-13||1963-04-11|||1972-11-04||1968-09-14
TRIAL STUDY 134XCP|RP|5B2471DB-807A-44F8-9529-D2319CCFE017|2||||||MENOAGE|MENOPAUSE AGE||||/500 WBC|||PA|NOT DONE||Y|Y|U|5||7||LONG-TERM FOLLOW-UP|1962-11-23||1963-11-24|||1964-08-06||1967-12-16
TRIAL STUDY 134XCP|RP|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|1||||||PREGNN|NUMBER OF PREGNANCIES||||MG/KG/WEEK|||EJACULATE U|NOT DONE||Y|U|NA|1||38||BLINDED TREATMENT|1962-07-02||1961-08-05|||1962-03-28||1972-03-05
TRIAL STUDY 134XCP|RP|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|2||||||INTP|INTERPRETATION||||MHZ|||CFU/G|NOT DONE||Y|Y|N|1||38||OPEN LABEL TREATMENT|1967-07-02||1969-04-29|||1961-04-17||1966-09-21
TRIAL STUDY 134XCP|RP|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||EVENTS|||/5X10^4 WBC|NOT DONE||NA|U|U|2||58||OPEN LABEL TREATMENT|1968-12-23||1961-06-27|||1972-12-18||1967-10-29
TRIAL STUDY 134XCP|RP|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||/MM|||KG/CM2|NOT DONE||Y|U|Y|2||58||SCREENING|1960-09-11||1972-06-09|||1965-08-31||1967-08-09
TRIAL STUDY 134XCP|RP|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||HOMEOPATHIC DILUTION|||APPLICATION|NOT DONE||U|NA|NA|3||39||OPEN LABEL TREATMENT|1972-02-26||1964-05-13|||1968-05-10||1964-03-15
TRIAL STUDY 134XCP|RP|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MG/MOL|||U/M2/MIN|NOT DONE||N|Y|U|3||39||LONG-TERM FOLLOW-UP|1966-09-10||1966-08-09|||1967-03-07||1964-10-05
TRIAL STUDY 134XCP|RP|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^9/DOSE|||PACKET|NOT DONE||Y|NA|NA|4||88||RUN-IN|1966-06-14||1960-03-08|||1961-07-05||1968-02-22
TRIAL STUDY 134XCP|RP|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MMHG/L/MIN|||ML/MIN/MMHG|NOT DONE||NA|NA|NA|4||88||LONG-TERM FOLLOW-UP|1967-06-16||1966-11-04|||1962-06-12||1966-04-02
TRIAL STUDY 134XCP|RP|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||BU|||NMOL|NOT DONE||NA|Y|NA|5||7||TREATMENT|1968-08-15||1962-01-29|||1965-09-24||1960-09-22
TRIAL STUDY 134XCP|RP|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||U/M2|||L/H|NOT DONE||NA|U|Y|5||7||TREATMENT|1967-04-12||1967-12-21|||1961-03-15||1972-04-27
TRIAL STUDY 134XCP|RP|A6E00A2C-7DBC-4577-8873-C780F5A6B400|1||||||INTP|INTERPRETATION||||MG/DL|||G/CAGE|NOT DONE||U|NA|NA|1||38||OBSERVATION|1972-09-03||1973-02-15|||1964-07-09||1963-08-31
TRIAL STUDY 134XCP|RP|A6E00A2C-7DBC-4577-8873-C780F5A6B400|2||||||ERYTHIND|ERYTHEMA INDICATOR||||MOL|||KUSP|NOT DONE||NA|Y|N|1||38||LONG-TERM FOLLOW-UP|1961-05-17||1967-05-30|||1969-05-04||1970-12-08
TRIAL STUDY 134XCP|RP|A6E00A2C-7DBC-4577-8873-C780F5A6B400|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ML/KG|||G/CAGE/WK|NOT DONE||U|Y|Y|2||58||BLINDED TREATMENT|1964-08-12||1971-09-15|||1973-05-12||1969-05-08
TRIAL STUDY 134XCP|RP|A6E00A2C-7DBC-4577-8873-C780F5A6B400|2||||||MENOAGE|MENOPAUSE AGE||||DPM/MG|||U/M2/DAY|NOT DONE||N|Y|U|2||58||WASHOUT|1970-08-25||1960-06-23|||1972-09-02||1970-04-21
TRIAL STUDY 134XCP|RP|A6E00A2C-7DBC-4577-8873-C780F5A6B400|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||CMH2O*S/ML|||ML/MIN/MMHG|NOT DONE||N|NA|N|3||39||RUN-IN|1967-07-17||1965-08-29|||1964-12-08||1972-06-30
TRIAL STUDY 134XCP|RP|A6E00A2C-7DBC-4577-8873-C780F5A6B400|2||||||FUNDHT|FUNDAL HEIGHT||||%/MIN|||/5X10^4 WBC|NOT DONE||N|N|N|3||39||OBSERVATION|1971-10-15||1968-10-15|||1961-04-21||1962-03-08
TRIAL STUDY 134XCP|RP|A6E00A2C-7DBC-4577-8873-C780F5A6B400|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||JAR|||% INHIBITION|NOT DONE||Y|Y|NA|4||88||FOLLOW-UP|1963-07-11||1965-09-22|||1969-06-25||1965-05-18
TRIAL STUDY 134XCP|RP|A6E00A2C-7DBC-4577-8873-C780F5A6B400|2||||||ERYTHIND|ERYTHEMA INDICATOR||||CIGAR|||NMOL/L/H|NOT DONE||NA|U|N|4||88||OBSERVATION|1965-07-07||1961-10-08|||1966-04-18||1971-03-03
TRIAL STUDY 134XCP|RP|A6E00A2C-7DBC-4577-8873-C780F5A6B400|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||DNA COPIES/ML|||MET|NOT DONE||NA|NA|Y|5||7||BASELINE|1971-07-27||1960-07-02|||1960-09-07||1967-02-14
TRIAL STUDY 134XCP|RP|A6E00A2C-7DBC-4577-8873-C780F5A6B400|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MMAL|||MG/M2/DAY|NOT DONE||Y|NA|N|5||7||BLINDED TREATMENT|1961-11-25||1967-08-04|||1967-04-04||1967-08-28
TRIAL STUDY 134XCP|RP|06611015-E99C-466B-B0B3-EBE10EA9E627|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||RING|||10^3 ORGANISMS|NOT DONE||N|U|U|1||38||INDUCTION TREATMENT|1971-11-02||1971-12-12|||1964-07-26||1966-08-16
TRIAL STUDY 134XCP|RP|06611015-E99C-466B-B0B3-EBE10EA9E627|2||||||ABORTN|NUMBER OF ABORTIONS||||UG/ANIMAL|||10^9 ORGANISMS/MG|NOT DONE||Y|Y|NA|1||38||FOLLOW-UP|1967-02-09||1970-05-02|||1966-05-02||1966-11-06
TRIAL STUDY 134XCP|RP|06611015-E99C-466B-B0B3-EBE10EA9E627|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||/500 WBC|||UG/DAY|NOT DONE||Y|NA|Y|2||58||BLINDED TREATMENT|1964-10-13||1961-12-03|||1969-05-31||1968-05-08
TRIAL STUDY 134XCP|RP|06611015-E99C-466B-B0B3-EBE10EA9E627|2||||||MENOAGE|MENOPAUSE AGE||||BP|||PMOL/DAY|NOT DONE||NA|U|NA|2||58||INDUCTION TREATMENT|1966-08-19||1966-05-25|||1961-05-25||1964-02-18
TRIAL STUDY 134XCP|RP|06611015-E99C-466B-B0B3-EBE10EA9E627|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||PFU|||MIN|NOT DONE||NA|NA|NA|3||39||WASHOUT|1964-08-27||1961-10-28|||1965-04-10||1971-09-09
TRIAL STUDY 134XCP|RP|06611015-E99C-466B-B0B3-EBE10EA9E627|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||CMH2O*S2/ML|||BOTTLE|NOT DONE||NA|NA|U|3||39||OBSERVATION|1973-01-03||1960-09-06|||1967-06-16||1961-03-31
TRIAL STUDY 134XCP|RP|06611015-E99C-466B-B0B3-EBE10EA9E627|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||NEWTON|||GENEQ|NOT DONE||N|N|N|4||88||RUN-IN|1960-10-26||1960-07-28|||1964-08-22||1969-10-01
TRIAL STUDY 134XCP|RP|06611015-E99C-466B-B0B3-EBE10EA9E627|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MV/SEC|||ML/G/DAY|NOT DONE||U|U|Y|4||88||LONG-TERM FOLLOW-UP|1962-10-10||1969-01-10|||1968-11-04||1965-12-27
TRIAL STUDY 134XCP|RP|06611015-E99C-466B-B0B3-EBE10EA9E627|1||||||TNDRIND|TENDERNESS INDICATOR||||UKAT|||LOG10 CFU/ML|NOT DONE||NA|NA|Y|5||7||LONG-TERM FOLLOW-UP|1968-08-19||1961-09-11|||1965-07-26||1966-09-29
TRIAL STUDY 134XCP|RP|06611015-E99C-466B-B0B3-EBE10EA9E627|2||||||PREGNN|NUMBER OF PREGNANCIES||||SFC/10^6 PBMC|||BOX|NOT DONE||U|N|N|5||7||WASHOUT|1963-05-25||1962-02-22|||1961-02-13||1963-11-22
TRIAL STUDY 134XCP|RP|5AF91C46-87FC-4714-B956-A4ECFC87C30A|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MV2/HZ|||MMOL/MIN/KPA|NOT DONE||U|N|N|1||38||BLINDED TREATMENT|1965-02-20||1970-02-05|||1961-10-15||1961-11-03
TRIAL STUDY 134XCP|RP|5AF91C46-87FC-4714-B956-A4ECFC87C30A|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||TBSP|||/HPF|NOT DONE||Y|N|U|1||38||WASHOUT|1968-12-02||1970-02-05|||1971-03-20||1971-08-19
TRIAL STUDY 134XCP|RP|5AF91C46-87FC-4714-B956-A4ECFC87C30A|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||/LPF|||M/SEC2|NOT DONE||Y|Y|U|2||58||RUN-IN|1971-05-11||1971-03-06|||1965-02-03||1967-05-16
TRIAL STUDY 134XCP|RP|5AF91C46-87FC-4714-B956-A4ECFC87C30A|2||||||DLVRMODE|MODE OF DELIVERY||||L/H/M2|||/200 HPFS|NOT DONE||U|NA|NA|2||58||BASELINE|1962-12-24||1965-03-08|||1972-09-16||1960-02-07
TRIAL STUDY 134XCP|RP|5AF91C46-87FC-4714-B956-A4ECFC87C30A|1||||||ABORTN|NUMBER OF ABORTIONS||||PFU/ML|||PIXELS/IN|NOT DONE||U|N|NA|3||39||WASHOUT|1960-09-05||1972-03-20|||1961-11-28||1960-02-23
TRIAL STUDY 134XCP|RP|5AF91C46-87FC-4714-B956-A4ECFC87C30A|2||||||PRGENDTC|DATE PREGNANCY ENDED||||PPB|||SQU/ML|NOT DONE||Y|U|U|3||39||BLINDED TREATMENT|1963-09-18||1970-01-21|||1971-07-06||1969-12-11
TRIAL STUDY 134XCP|RP|5AF91C46-87FC-4714-B956-A4ECFC87C30A|1||||||RASHIND|RASH INDICATOR||||MMOL/MIN/KPA|||U/ANIMAL|NOT DONE||N|N|Y|4||88||TREATMENT|1965-03-19||1971-02-12|||1965-05-22||1966-09-22
TRIAL STUDY 134XCP|RP|5AF91C46-87FC-4714-B956-A4ECFC87C30A|2||||||PREGIND|PREGNANT INDICATOR||||10^3 COPIES/ML|||IN|NOT DONE||N|NA|N|4||88||TREATMENT|1964-07-09||1966-05-11|||1964-06-29||1962-03-01
TRIAL STUDY 134XCP|RP|5AF91C46-87FC-4714-B956-A4ECFC87C30A|1||||||STILBIND|STILLBIRTH INDICATOR||||MESF|||%|NOT DONE||NA|N|NA|5||7||FOLLOW-UP|1960-06-26||1960-01-08|||1960-05-05||1961-08-13
TRIAL STUDY 134XCP|RP|5AF91C46-87FC-4714-B956-A4ECFC87C30A|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||DPM/0.5 ML|||CM/S|NOT DONE||N|N|Y|5||7||RUN-IN|1962-05-19||1971-06-02|||1970-05-23||1971-04-03
TRIAL STUDY 134XCP|RP|3DEA7E00-77B9-4710-A37E-577F925BFBD8|1||||||ERYTHIND|ERYTHEMA INDICATOR||||DIOPTER|||MOL/ML|NOT DONE||Y|Y|Y|1||38||RUN-IN|1972-03-23||1963-06-17|||1972-08-31||1970-09-15
TRIAL STUDY 134XCP|RP|3DEA7E00-77B9-4710-A37E-577F925BFBD8|2||||||PREGIND|PREGNANT INDICATOR||||CAPFUL|||F|NOT DONE||U|Y|U|1||38||OBSERVATION|1965-12-04||1960-11-06|||1970-01-01||1968-08-11
TRIAL STUDY 134XCP|RP|3DEA7E00-77B9-4710-A37E-577F925BFBD8|1||||||MENARAGE|MENARCHE AGE||||MG|||CI/MG|NOT DONE||N|U|Y|2||58||RUN-IN|1964-11-05||1972-01-17|||1961-08-24||1969-05-06
TRIAL STUDY 134XCP|RP|3DEA7E00-77B9-4710-A37E-577F925BFBD8|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||NM|||FG|NOT DONE||N|NA|U|2||58||TREATMENT|1966-04-26||1968-12-13|||1973-02-16||1971-03-01
TRIAL STUDY 134XCP|RP|3DEA7E00-77B9-4710-A37E-577F925BFBD8|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MS/MMHG|||FRACTION OF 1|NOT DONE||Y|Y|NA|3||39||BASELINE|1971-01-20||1963-01-10|||1967-01-21||1962-10-28
TRIAL STUDY 134XCP|RP|3DEA7E00-77B9-4710-A37E-577F925BFBD8|2||||||EDEMAIND|EDEMA INDICATOR||||ML/ANIMAL/WK|||LOG10 PFU|NOT DONE||NA|Y|U|3||39||OBSERVATION|1966-03-28||1968-08-11|||1969-11-09||1972-07-11
TRIAL STUDY 134XCP|RP|3DEA7E00-77B9-4710-A37E-577F925BFBD8|1||||||MENOSTAT|MENOPAUSE STATUS||||UU/L|||MMHG*MIN/L|NOT DONE||NA|N|N|4||88||LONG-TERM FOLLOW-UP|1965-06-08||1962-05-06|||1970-08-05||1961-10-21
TRIAL STUDY 134XCP|RP|3DEA7E00-77B9-4710-A37E-577F925BFBD8|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||10^6/L|||COPIES/UL|NOT DONE||U|U|N|4||88||FOLLOW-UP|1964-11-29||1973-05-15|||1960-02-25||1971-01-14
TRIAL STUDY 134XCP|RP|3DEA7E00-77B9-4710-A37E-577F925BFBD8|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||NG|||ML/S/M2|NOT DONE||N|N|Y|5||7||BASELINE|1964-02-22||1964-03-11|||1960-09-13||1966-05-12
TRIAL STUDY 134XCP|RP|3DEA7E00-77B9-4710-A37E-577F925BFBD8|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MBP|||10^9 CFU|NOT DONE||Y|Y|Y|5||7||TREATMENT|1961-02-26||1970-05-28|||1960-12-14||1964-04-18
TRIAL STUDY 134XCP|RP|DC79E350-1B89-4518-8B42-5858F5270928|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||1/(S*KPA)|||MG/KG/DOSE|NOT DONE||NA|N|N|1||38||BLINDED TREATMENT|1964-08-29||1961-05-07|||1966-02-16||1970-08-29
TRIAL STUDY 134XCP|RP|DC79E350-1B89-4518-8B42-5858F5270928|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||BOTTLE|||FOZ_BR|NOT DONE||U|NA|Y|1||38||WASHOUT|1964-06-25||1970-08-10|||1962-06-09||1963-06-05
TRIAL STUDY 134XCP|RP|DC79E350-1B89-4518-8B42-5858F5270928|1||||||PREGNN|NUMBER OF PREGNANCIES||||10^6 CFU/ML|||GMFI|NOT DONE||NA|U|N|2||58||WASHOUT|1966-09-06||1962-06-09|||1967-08-21||1965-09-13
TRIAL STUDY 134XCP|RP|DC79E350-1B89-4518-8B42-5858F5270928|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MG|||FT2|NOT DONE||U|Y|U|2||58||RUN-IN|1967-05-15||1961-03-02|||1960-08-18||1969-10-24
TRIAL STUDY 134XCP|RP|DC79E350-1B89-4518-8B42-5858F5270928|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||PPTR|||ML/S/M2|NOT DONE||NA|N|U|3||39||OBSERVATION|1963-07-06||1966-06-27|||1967-07-18||1969-08-27
TRIAL STUDY 134XCP|RP|DC79E350-1B89-4518-8B42-5858F5270928|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||BQ/G|||10^6 COPIES/ML|NOT DONE||Y|NA|NA|3||39||LONG-TERM FOLLOW-UP|1971-07-24||1973-07-04|||1965-11-24||1960-06-30
TRIAL STUDY 134XCP|RP|DC79E350-1B89-4518-8B42-5858F5270928|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||CMH2O*S/ML|||DRINK|NOT DONE||Y|U|Y|4||88||RUN-IN|1962-10-03||1964-11-22|||1969-07-15||1963-07-30
TRIAL STUDY 134XCP|RP|DC79E350-1B89-4518-8B42-5858F5270928|2||||||TNDRIND|TENDERNESS INDICATOR||||EU|||UCI|NOT DONE||U|Y|Y|4||88||BLINDED TREATMENT|1969-05-03||1969-04-07|||1971-11-24||1962-12-07
TRIAL STUDY 134XCP|RP|DC79E350-1B89-4518-8B42-5858F5270928|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||TSP EQ|||NG/DAY|NOT DONE||N|NA|NA|5||7||FOLLOW-UP|1965-11-14||1963-10-18|||1972-01-30||1964-12-24
TRIAL STUDY 134XCP|RP|DC79E350-1B89-4518-8B42-5858F5270928|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||% INHIBITION|||CL|NOT DONE||N|NA|U|5||7||WASHOUT|1966-06-03||1971-11-04|||1960-04-06||1964-12-28
TRIAL STUDY 134XCP|RP|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|1||||||PRGENDTC|DATE PREGNANCY ENDED||||U/ANIMAL|||SACHET|NOT DONE||NA|NA|Y|1||38||BASELINE|1965-02-16||1967-09-06|||1970-03-04||1961-10-12
TRIAL STUDY 134XCP|RP|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|2||||||FUNDHT|FUNDAL HEIGHT||||IU|||HENRY|NOT DONE||NA|Y|NA|1||38||BLINDED TREATMENT|1970-10-15||1970-09-13|||1970-10-08||1969-09-02
TRIAL STUDY 134XCP|RP|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|1||||||DLVRMODE|MODE OF DELIVERY||||GRAVITATIONAL UNIT|||UMOL/L/SEC|NOT DONE||Y|U|Y|2||58||CONTINUATION TREATMENT|1965-01-02||1966-07-17|||1972-09-29||1964-01-17
TRIAL STUDY 134XCP|RP|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||TRANSDUCING UNIT/ML|||PMOL/L/H|NOT DONE||N|N|NA|2||58||OPEN LABEL TREATMENT|1965-04-21||1965-12-08|||1961-09-15||1968-09-27
TRIAL STUDY 134XCP|RP|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MMHG|||MIN/DAY|NOT DONE||NA|NA|Y|3||39||OBSERVATION|1966-06-13||1960-09-26|||1961-02-13||1971-10-22
TRIAL STUDY 134XCP|RP|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||CD*S/M2|||PPB|NOT DONE||Y|U|Y|3||39||OPEN LABEL TREATMENT|1967-03-01||1968-08-08|||1969-03-28||1965-05-07
TRIAL STUDY 134XCP|RP|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||NMOL/DAY|||U|NOT DONE||Y|Y|U|4||88||OPEN LABEL TREATMENT|1966-01-10||1970-02-10|||1965-02-03||1962-08-06
TRIAL STUDY 134XCP|RP|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|2||||||PEELIND|PEELING INDICATOR||||ML/M2/DAY|||%/MIN|NOT DONE||NA|U|N|4||88||BLINDED TREATMENT|1972-02-02||1966-05-15|||1973-02-02||1964-08-12
TRIAL STUDY 134XCP|RP|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||G/M2/DAY|||PMOL/L|NOT DONE||NA|U|U|5||7||LONG-TERM FOLLOW-UP|1964-02-29||1960-07-13|||1967-03-14||1962-12-22
TRIAL STUDY 134XCP|RP|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|2||||||MENFDUR|MENSES FLOW DURATION||||GPL U|||MM2|NOT DONE||NA|U|U|5||7||BASELINE|1969-06-17||1969-03-11|||1960-12-26||1970-01-07
TRIAL STUDY 134XCP|RP|7F51014D-D2B5-4956-9DD6-52676EB66ED7|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||% INHIBITION|||CI/UG|NOT DONE||N|U|N|1||38||RUN-IN|1960-04-12||1972-06-20|||1966-05-18||1971-03-29
TRIAL STUDY 134XCP|RP|7F51014D-D2B5-4956-9DD6-52676EB66ED7|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||IU/G HB|||ENZYME U/M2|NOT DONE||N|NA|N|1||38||OPEN LABEL TREATMENT|1963-08-12||1968-10-16|||1960-02-06||1962-07-28
TRIAL STUDY 134XCP|RP|7F51014D-D2B5-4956-9DD6-52676EB66ED7|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||BOTTLE|||MOL|NOT DONE||U|NA|N|2||58||OPEN LABEL TREATMENT|1971-03-30||1964-02-08|||1973-01-19||1972-03-29
TRIAL STUDY 134XCP|RP|7F51014D-D2B5-4956-9DD6-52676EB66ED7|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||BQ/UL|||L/MIN/M2|NOT DONE||U|N|N|2||58||BASELINE|1970-04-05||1969-04-30|||1967-04-28||1966-04-02
TRIAL STUDY 134XCP|RP|7F51014D-D2B5-4956-9DD6-52676EB66ED7|1||||||PEELIND|PEELING INDICATOR||||STEPS|||TCID 50/DOSE|NOT DONE||NA|N|NA|3||39||INDUCTION TREATMENT|1968-08-01||1960-09-26|||1970-02-21||1973-03-19
TRIAL STUDY 134XCP|RP|7F51014D-D2B5-4956-9DD6-52676EB66ED7|2||||||THICK|THICKNESS||||BEAM BREAKS|||GRAIN|NOT DONE||N|Y|U|3||39||OBSERVATION|1971-11-17||1968-04-22|||1970-10-19||1963-05-15
TRIAL STUDY 134XCP|RP|7F51014D-D2B5-4956-9DD6-52676EB66ED7|1||||||PUSTIND|PUSTULE INDICATOR||||MG/KG/MIN|||MESF|NOT DONE||U|U|Y|4||88||LONG-TERM FOLLOW-UP|1968-10-11||1968-04-07|||1963-08-08||1970-04-27
TRIAL STUDY 134XCP|RP|7F51014D-D2B5-4956-9DD6-52676EB66ED7|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||RAD|||COPIES/ML|NOT DONE||U|Y|Y|4||88||CONTINUATION TREATMENT|1965-04-19||1960-05-09|||1968-12-30||1961-04-09
TRIAL STUDY 134XCP|RP|7F51014D-D2B5-4956-9DD6-52676EB66ED7|1||||||THICK|THICKNESS||||KALLIKREIN INHIBITOR UNIT|||ML|NOT DONE||N|N|U|5||7||OBSERVATION|1963-06-26||1966-01-24|||1967-09-25||1969-05-08
TRIAL STUDY 134XCP|RP|7F51014D-D2B5-4956-9DD6-52676EB66ED7|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||PKAT|||ML/S|NOT DONE||N|U|NA|5||7||OPEN LABEL TREATMENT|1960-06-19||1972-10-07|||1967-04-18||1967-03-22
TRIAL STUDY 134XCP|RP|0568B2DD-3184-472D-89C6-66A5CE8AE00F|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||UKAT|||IU/MG|NOT DONE||Y|U|U|1||38||OBSERVATION|1965-09-29||1965-04-04|||1969-04-10||1964-05-23
TRIAL STUDY 134XCP|RP|0568B2DD-3184-472D-89C6-66A5CE8AE00F|2||||||MENFDUR|MENSES FLOW DURATION||||CARTRIDGE|||CUP|NOT DONE||NA|Y|NA|1||38||OBSERVATION|1969-05-23||1967-10-17|||1961-11-11||1972-06-24
TRIAL STUDY 134XCP|RP|0568B2DD-3184-472D-89C6-66A5CE8AE00F|1||||||INABOIND|INDUCED ABORTION INDICATOR||||UG/M2/DAY|||ML/M2/DAY|NOT DONE||Y|NA|U|2||58||INDUCTION TREATMENT|1967-09-10||1968-09-08|||1968-09-01||1972-05-17
TRIAL STUDY 134XCP|RP|0568B2DD-3184-472D-89C6-66A5CE8AE00F|2||||||GRAVIND|GRAVIDA INDICATOR||||U/M2/DAY|||% INHIBITION|NOT DONE||N|U|U|2||58||LONG-TERM FOLLOW-UP|1972-10-16||1970-10-07|||1960-02-07||1965-09-14
TRIAL STUDY 134XCP|RP|0568B2DD-3184-472D-89C6-66A5CE8AE00F|1||||||RASHIND|RASH INDICATOR||||G/CAGE/DAY|||MET|NOT DONE||N|U|N|3||39||BASELINE|1968-05-12||1971-09-29|||1962-06-21||1960-04-12
TRIAL STUDY 134XCP|RP|0568B2DD-3184-472D-89C6-66A5CE8AE00F|2||||||BCMETHOD|BIRTH CONTROL METHOD||||USP U|||BEATS/MIN|NOT DONE||Y|N|U|3||39||BLINDED TREATMENT|1961-01-14||1963-06-09|||1967-08-01||1967-03-04
TRIAL STUDY 134XCP|RP|0568B2DD-3184-472D-89C6-66A5CE8AE00F|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||U/CL|||10^5/L|NOT DONE||N|N|U|4||88||CONTINUATION TREATMENT|1961-08-16||1960-02-29|||1961-05-11||1972-01-15
TRIAL STUDY 134XCP|RP|0568B2DD-3184-472D-89C6-66A5CE8AE00F|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||10^9 CFU/ML|||G/KG|NOT DONE||U|NA|Y|4||88||BLINDED TREATMENT|1968-09-22||1971-01-06|||1966-03-16||1973-08-18
TRIAL STUDY 134XCP|RP|0568B2DD-3184-472D-89C6-66A5CE8AE00F|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MMOL2/L2|||%/S|NOT DONE||NA|N|U|5||7||CONTINUATION TREATMENT|1960-02-21||1968-06-25|||1962-06-20||1971-11-08
TRIAL STUDY 134XCP|RP|0568B2DD-3184-472D-89C6-66A5CE8AE00F|2||||||DSCHGIND|DISCHARGE INDICATOR||||KAT|||IU/ML|NOT DONE||U|U|U|5||7||INDUCTION TREATMENT|1973-03-18||1961-12-21|||1973-07-13||1962-07-15
TRIAL STUDY 134XCP|RP|275DC6A6-598C-4997-A442-4A3916AC42BD|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UG/DOSE|||10^9 CFU|NOT DONE||Y|N|U|1||38||OPEN LABEL TREATMENT|1967-07-27||1965-03-17|||1967-04-21||1968-07-23
TRIAL STUDY 134XCP|RP|275DC6A6-598C-4997-A442-4A3916AC42BD|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||PMOL|||NM|NOT DONE||NA|N|Y|1||38||OBSERVATION|1966-09-30||1967-05-06|||1967-07-10||1967-03-22
TRIAL STUDY 134XCP|RP|275DC6A6-598C-4997-A442-4A3916AC42BD|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||TRANSDUCING UNIT/ML|||MOL/DAY|NOT DONE||Y|U|NA|2||58||TREATMENT|1964-09-03||1962-03-23|||1970-02-22||1970-05-23
TRIAL STUDY 134XCP|RP|275DC6A6-598C-4997-A442-4A3916AC42BD|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||CP|||10^6 COPIES/ML|NOT DONE||U|U|N|2||58||FOLLOW-UP|1962-03-07||1963-05-25|||1964-05-17||1971-03-06
TRIAL STUDY 134XCP|RP|275DC6A6-598C-4997-A442-4A3916AC42BD|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||LB|||H*%|NOT DONE||U|U|N|3||39||OPEN LABEL TREATMENT|1963-08-20||1964-02-26|||1961-09-30||1971-03-08
TRIAL STUDY 134XCP|RP|275DC6A6-598C-4997-A442-4A3916AC42BD|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||DEG|||DNA COPIES/UG|NOT DONE||Y|N|Y|3||39||TREATMENT|1965-07-02||1964-06-14|||1962-12-03||1972-05-03
TRIAL STUDY 134XCP|RP|275DC6A6-598C-4997-A442-4A3916AC42BD|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||DIP|||BU|NOT DONE||N|Y|U|4||88||WASHOUT|1961-12-07||1965-07-04|||1969-10-13||1968-06-22
TRIAL STUDY 134XCP|RP|275DC6A6-598C-4997-A442-4A3916AC42BD|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ML/BEAT|||MAC50|NOT DONE||N|NA|N|4||88||BLINDED TREATMENT|1971-10-21||1973-05-09|||1965-02-10||1972-04-08
TRIAL STUDY 134XCP|RP|275DC6A6-598C-4997-A442-4A3916AC42BD|1||||||ERYTHIND|ERYTHEMA INDICATOR||||H/WK|||MEQ/KG|NOT DONE||U|Y|N|5||7||BASELINE|1965-06-03||1965-11-23|||1961-04-09||1971-10-21
TRIAL STUDY 134XCP|RP|275DC6A6-598C-4997-A442-4A3916AC42BD|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MDFI|||ML/CAGE/DAY|NOT DONE||NA|N|U|5||7||WASHOUT|1962-12-13||1970-08-15|||1969-02-26||1971-06-25
TRIAL STUDY 134XCP|RP|B949F90F-524D-4494-A63C-A05F56421EA1|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ML/MIN/MMHG|||KBQ|NOT DONE||Y|NA|U|1||38||BLINDED TREATMENT|1964-03-22||1966-10-07|||1971-08-15||1967-05-11
TRIAL STUDY 134XCP|RP|B949F90F-524D-4494-A63C-A05F56421EA1|2||||||PREGNN|NUMBER OF PREGNANCIES||||PM|||VOXEL|NOT DONE||U|U|Y|1||38||WASHOUT|1964-06-02||1968-03-19|||1966-04-26||1973-03-18
TRIAL STUDY 134XCP|RP|B949F90F-524D-4494-A63C-A05F56421EA1|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||UG/KG/MIN|||MG/KG/MIN|NOT DONE||U|U|N|2||58||FOLLOW-UP|1970-03-30||1972-02-18|||1965-08-24||1966-12-30
TRIAL STUDY 134XCP|RP|B949F90F-524D-4494-A63C-A05F56421EA1|2||||||PREGNN|NUMBER OF PREGNANCIES||||ML/100G/MIN|||UMOL/MOL|NOT DONE||U|N|U|2||58||FOLLOW-UP|1961-08-30||1971-05-08|||1971-02-11||1961-01-03
TRIAL STUDY 134XCP|RP|B949F90F-524D-4494-A63C-A05F56421EA1|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||STEPS/MIN|||ANTIBODY UNIT|NOT DONE||Y|N|U|3||39||TREATMENT|1967-09-20||1969-05-14|||1961-05-23||1969-09-05
TRIAL STUDY 134XCP|RP|B949F90F-524D-4494-A63C-A05F56421EA1|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||U/MG|||UMOL/DL|NOT DONE||N|U|NA|3||39||BASELINE|1962-05-12||1968-04-03|||1964-09-23||1961-05-27
TRIAL STUDY 134XCP|RP|B949F90F-524D-4494-A63C-A05F56421EA1|1||||||ERYTHIND|ERYTHEMA INDICATOR||||MNFI|||ELISA UNIT|NOT DONE||NA|U|Y|4||88||SCREENING|1972-11-03||1961-05-18|||1967-01-02||1968-07-01
TRIAL STUDY 134XCP|RP|B949F90F-524D-4494-A63C-A05F56421EA1|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^9 CFU|||STEPS|NOT DONE||Y|Y|N|4||88||TREATMENT|1960-11-28||1964-11-08|||1965-09-12||1972-02-01
TRIAL STUDY 134XCP|RP|B949F90F-524D-4494-A63C-A05F56421EA1|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MEQ/UG|||SPRAY|NOT DONE||N|U|U|5||7||FOLLOW-UP|1967-01-26||1966-06-04|||1971-08-14||1960-06-27
TRIAL STUDY 134XCP|RP|B949F90F-524D-4494-A63C-A05F56421EA1|2||||||ULCERIND|ULCER INDICATOR||||UG/L/H|||10^6/EJACULATE U|NOT DONE||U|NA|Y|5||7||INDUCTION TREATMENT|1971-09-29||1966-09-29|||1969-12-06||1971-01-23
TRIAL STUDY 134XCP|RP|152411EA-E7DA-4230-A8A6-163C8A8C0A58|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||/4.0 ML|||MEQ/G|NOT DONE||N|NA|U|1||38||TREATMENT|1964-12-01||1961-11-30|||1970-02-27||1970-01-21
TRIAL STUDY 134XCP|RP|152411EA-E7DA-4230-A8A6-163C8A8C0A58|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||CAPSULE|||UG/KG/MIN|NOT DONE||Y|N|N|1||38||BLINDED TREATMENT|1967-01-14||1967-03-15|||1970-03-29||1970-03-23
TRIAL STUDY 134XCP|RP|152411EA-E7DA-4230-A8A6-163C8A8C0A58|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||FMOL|||10^3/HPF|NOT DONE||Y|Y|NA|2||58||SCREENING|1962-07-21||1972-03-03|||1960-11-03||1972-10-08
TRIAL STUDY 134XCP|RP|152411EA-E7DA-4230-A8A6-163C8A8C0A58|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||MEQ/DAY|||ML/ANIMAL/DAY|NOT DONE||NA|NA|N|2||58||RUN-IN|1961-04-21||1966-07-31|||1968-01-13||1968-01-30
TRIAL STUDY 134XCP|RP|152411EA-E7DA-4230-A8A6-163C8A8C0A58|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MIU/L|||MU/G|NOT DONE||U|N|NA|3||39||OPEN LABEL TREATMENT|1963-11-10||1971-02-20|||1961-07-13||1961-09-27
TRIAL STUDY 134XCP|RP|152411EA-E7DA-4230-A8A6-163C8A8C0A58|2||||||THICK|THICKNESS||||MOL/MOL|||TABLET|NOT DONE||Y|Y|NA|3||39||SCREENING|1971-06-06||1962-03-20|||1968-02-17||1964-03-22
TRIAL STUDY 134XCP|RP|152411EA-E7DA-4230-A8A6-163C8A8C0A58|1||||||BCMETHOD|BIRTH CONTROL METHOD||||ABSORBANCE U/ML|||TBSP|NOT DONE||NA|U|NA|4||88||LONG-TERM FOLLOW-UP|1967-03-10||1972-03-27|||1963-11-11||1962-08-13
TRIAL STUDY 134XCP|RP|152411EA-E7DA-4230-A8A6-163C8A8C0A58|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||MOL/MOL|||CS|NOT DONE||Y|U|N|4||88||INDUCTION TREATMENT|1962-04-09||1961-10-27|||1966-08-10||1971-04-07
TRIAL STUDY 134XCP|RP|152411EA-E7DA-4230-A8A6-163C8A8C0A58|1||||||MASSIND|MASS INDICATOR||||10^8/L|||G/ANIMAL/WK|NOT DONE||U|U|U|5||7||OBSERVATION|1967-05-12||1970-07-30|||1964-09-18||1964-02-23
TRIAL STUDY 134XCP|RP|152411EA-E7DA-4230-A8A6-163C8A8C0A58|2||||||INABOIND|INDUCED ABORTION INDICATOR||||DPM/ML|||UG/MIN|NOT DONE||NA|Y|N|5||7||WASHOUT|1965-05-20||1972-06-27|||1970-01-05||1960-08-11
TRIAL STUDY 134XCP|RP|AB78662C-F90A-4193-9AC7-5621B497A18F|1||||||PREGST|PREGNANT DURING THE STUDY||||GAUSS|||MOL/MOL|NOT DONE||N|Y|Y|1||38||OPEN LABEL TREATMENT|1962-05-06||1965-10-05|||1962-09-14||1971-02-25
TRIAL STUDY 134XCP|RP|AB78662C-F90A-4193-9AC7-5621B497A18F|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||PFU/ANIMAL|||COAT|NOT DONE||U|Y|Y|1||38||OBSERVATION|1970-02-11||1967-03-02|||1966-07-06||1960-12-05
TRIAL STUDY 134XCP|RP|AB78662C-F90A-4193-9AC7-5621B497A18F|1||||||PREGNN|NUMBER OF PREGNANCIES||||S*KPA|||LOG10 COPIES/ML|NOT DONE||N|N|Y|2||58||FOLLOW-UP|1965-12-08||1969-12-15|||1962-11-05||1968-01-23
TRIAL STUDY 134XCP|RP|AB78662C-F90A-4193-9AC7-5621B497A18F|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MMOL/G|||MG/ML/MIN|NOT DONE||Y|N|Y|2||58||LONG-TERM FOLLOW-UP|1962-09-10||1969-11-08|||1970-04-02||1964-12-01
TRIAL STUDY 134XCP|RP|AB78662C-F90A-4193-9AC7-5621B497A18F|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||BOWL|||PPB|NOT DONE||N|Y|Y|3||39||RUN-IN|1967-03-26||1961-11-18|||1967-05-29||1967-04-29
TRIAL STUDY 134XCP|RP|AB78662C-F90A-4193-9AC7-5621B497A18F|2||||||STILBIND|STILLBIRTH INDICATOR||||10^11/L|||PMOL/G|NOT DONE||NA|NA|Y|3||39||INDUCTION TREATMENT|1972-08-13||1961-05-23|||1969-07-18||1962-01-28
TRIAL STUDY 134XCP|RP|AB78662C-F90A-4193-9AC7-5621B497A18F|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^7 TCID 50/DOSE|||10^3/L|NOT DONE||Y|N|U|4||88||LONG-TERM FOLLOW-UP|1963-09-03||1971-09-02|||1963-03-21||1969-02-25
TRIAL STUDY 134XCP|RP|AB78662C-F90A-4193-9AC7-5621B497A18F|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||LOG10 CFU/G|||FEU|NOT DONE||N|NA|NA|4||88||OBSERVATION|1962-08-06||1965-10-23|||1967-11-04||1972-09-25
TRIAL STUDY 134XCP|RP|AB78662C-F90A-4193-9AC7-5621B497A18F|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||PFU|||G/DAY|NOT DONE||N|N|NA|5||7||RUN-IN|1972-02-26||1968-04-19|||1968-02-06||1966-06-21
TRIAL STUDY 134XCP|RP|AB78662C-F90A-4193-9AC7-5621B497A18F|2||||||PUSTIND|PUSTULE INDICATOR||||U/DL|||KUSP|NOT DONE||N|NA|N|5||7||OPEN LABEL TREATMENT|1972-07-06||1968-12-13|||1966-01-16||1973-07-22
TRIAL STUDY 134XCP|RP|84CD31FD-BCB9-4439-84F7-11C63D578108|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||GBQ/MG|||BQ/G|NOT DONE||N|Y|N|1||38||OBSERVATION|1961-08-19||1971-08-12|||1965-06-28||1960-04-23
TRIAL STUDY 134XCP|RP|84CD31FD-BCB9-4439-84F7-11C63D578108|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||NEEDLE GAUGE|||MG/L|NOT DONE||U|N|N|1||38||FOLLOW-UP|1970-05-31||1961-02-28|||1968-01-29||1965-09-21
TRIAL STUDY 134XCP|RP|84CD31FD-BCB9-4439-84F7-11C63D578108|1||||||PEELIND|PEELING INDICATOR||||UG/M2|||MMOL/L|NOT DONE||N|U|N|2||58||RUN-IN|1967-03-02||1973-05-20|||1972-11-11||1968-05-13
TRIAL STUDY 134XCP|RP|84CD31FD-BCB9-4439-84F7-11C63D578108|2||||||RASHIND|RASH INDICATOR||||EQ|||10^3 DNA COPIES/ML|NOT DONE||NA|N|N|2||58||OBSERVATION|1972-05-31||1961-03-29|||1963-10-07||1968-11-12
TRIAL STUDY 134XCP|RP|84CD31FD-BCB9-4439-84F7-11C63D578108|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^9 ORGANISMS/ML|||HR/DAY|NOT DONE||N|U|U|3||39||FOLLOW-UP|1968-10-11||1972-05-05|||1972-07-14||1970-09-12
TRIAL STUDY 134XCP|RP|84CD31FD-BCB9-4439-84F7-11C63D578108|2||||||PUSTIND|PUSTULE INDICATOR||||IN2|||BAU|NOT DONE||Y|NA|NA|3||39||BASELINE|1971-08-16||1966-11-21|||1963-01-25||1961-10-14
TRIAL STUDY 134XCP|RP|84CD31FD-BCB9-4439-84F7-11C63D578108|1||||||PREGIND|PREGNANT INDICATOR||||GLOBULE|||NU/CL|NOT DONE||N|NA|N|4||88||SCREENING|1965-01-07||1963-03-01|||1960-12-01||1971-10-07
TRIAL STUDY 134XCP|RP|84CD31FD-BCB9-4439-84F7-11C63D578108|2||||||EDEMAIND|EDEMA INDICATOR||||CM/S|||UL/KG/DAY|NOT DONE||N|NA|N|4||88||INDUCTION TREATMENT|1965-12-11||1971-03-29|||1966-11-17||1966-01-23
TRIAL STUDY 134XCP|RP|84CD31FD-BCB9-4439-84F7-11C63D578108|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PACKET|||KALLIKREIN INHIBITOR UNIT|NOT DONE||NA|N|N|5||7||CONTINUATION TREATMENT|1963-11-05||1967-05-08|||1966-06-06||1972-06-14
TRIAL STUDY 134XCP|RP|84CD31FD-BCB9-4439-84F7-11C63D578108|2||||||GRAVIND|GRAVIDA INDICATOR||||UG/G/DAY|||ENZYME U/L|NOT DONE||NA|N|U|5||7||BASELINE|1961-09-22||1967-07-27|||1968-01-14||1971-09-29
TRIAL STUDY 134XCP|RP|BB9A976D-48AC-4618-9BA1-683D97240F2B|1||||||RASHIND|RASH INDICATOR||||PFU/ML|||10^12/L|NOT DONE||U|N|NA|1||38||OBSERVATION|1965-06-17||1972-10-01|||1964-10-19||1971-08-14
TRIAL STUDY 134XCP|RP|BB9A976D-48AC-4618-9BA1-683D97240F2B|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||VP/DOSE|||UCI/L|NOT DONE||NA|U|Y|1||38||WASHOUT|1969-12-24||1970-09-13|||1963-05-01||1965-08-26
TRIAL STUDY 134XCP|RP|BB9A976D-48AC-4618-9BA1-683D97240F2B|1||||||FUNDHT|FUNDAL HEIGHT||||MBP|||ROENTGEN|NOT DONE||U|U|U|2||58||FOLLOW-UP|1964-02-18||1961-08-13|||1965-02-03||1973-01-22
TRIAL STUDY 134XCP|RP|BB9A976D-48AC-4618-9BA1-683D97240F2B|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MPH|||TRANSDUCING UNIT|NOT DONE||NA|NA|Y|2||58||FOLLOW-UP|1973-04-20||1964-10-26|||1970-04-20||1963-01-20
TRIAL STUDY 134XCP|RP|BB9A976D-48AC-4618-9BA1-683D97240F2B|1||||||RASHIND|RASH INDICATOR||||10^7 CFU/ML|||NMOL/L|NOT DONE||NA|NA|N|3||39||RUN-IN|1965-01-26||1969-01-08|||1960-07-28||1962-03-31
TRIAL STUDY 134XCP|RP|BB9A976D-48AC-4618-9BA1-683D97240F2B|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||CM/S|||L/H/M2|NOT DONE||N|NA|Y|3||39||TREATMENT|1962-11-13||1969-03-26|||1969-04-19||1962-02-21
TRIAL STUDY 134XCP|RP|BB9A976D-48AC-4618-9BA1-683D97240F2B|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||10^9 ORGANISMS/ML|||PL|NOT DONE||U|N|NA|4||88||FOLLOW-UP|1967-01-25||1966-12-21|||1970-06-21||1970-09-23
TRIAL STUDY 134XCP|RP|BB9A976D-48AC-4618-9BA1-683D97240F2B|2||||||MENOAGE|MENOPAUSE AGE||||MM2|||GPS U|NOT DONE||N|NA|U|4||88||WASHOUT|1965-03-18||1965-11-22|||1967-06-04||1969-09-17
TRIAL STUDY 134XCP|RP|BB9A976D-48AC-4618-9BA1-683D97240F2B|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||PPTH|||PMOL/DAY|NOT DONE||Y|U|Y|5||7||BLINDED TREATMENT|1971-04-29||1969-08-28|||1966-04-17||1961-02-27
TRIAL STUDY 134XCP|RP|BB9A976D-48AC-4618-9BA1-683D97240F2B|2||||||ABORTN|NUMBER OF ABORTIONS||||ML/ANIMAL/DAY|||DPM/ML|NOT DONE||Y|N|Y|5||7||SCREENING|1964-01-25||1962-01-13|||1970-08-05||1966-10-03
TRIAL STUDY 134XCP|RP|FA440C9B-0D7A-4656-BF17-D46289567FB0|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||ABSORBANCE U/MIN|||NMOL/MOL|NOT DONE||Y|Y|NA|1||38||WASHOUT|1970-01-02||1961-09-21|||1963-08-29||1968-08-26
TRIAL STUDY 134XCP|RP|FA440C9B-0D7A-4656-BF17-D46289567FB0|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||/100 HPFS|||IU/DL|NOT DONE||U|N|U|1||38||OBSERVATION|1967-05-27||1961-05-29|||1963-08-11||1970-02-08
TRIAL STUDY 134XCP|RP|FA440C9B-0D7A-4656-BF17-D46289567FB0|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||GENEQ/ML|||NSEC|NOT DONE||N|U|U|2||58||BLINDED TREATMENT|1963-04-23||1964-06-29|||1966-01-12||1963-09-08
TRIAL STUDY 134XCP|RP|FA440C9B-0D7A-4656-BF17-D46289567FB0|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MET|||DIOPTER|NOT DONE||U|NA|NA|2||58||RUN-IN|1960-12-09||1971-01-10|||1973-08-14||1967-02-28
TRIAL STUDY 134XCP|RP|FA440C9B-0D7A-4656-BF17-D46289567FB0|1||||||MENARAGE|MENARCHE AGE||||UMOL/KG/MIN|||AMP|NOT DONE||N|N|U|3||39||BASELINE|1965-11-03||1964-04-18|||1970-12-14||1970-08-08
TRIAL STUDY 134XCP|RP|FA440C9B-0D7A-4656-BF17-D46289567FB0|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MONTHS|||APL U/ML|NOT DONE||U|N|Y|3||39||WASHOUT|1972-07-05||1960-01-29|||1960-05-01||1970-11-06
TRIAL STUDY 134XCP|RP|FA440C9B-0D7A-4656-BF17-D46289567FB0|1||||||BLISTIND|BLISTERING INDICATOR||||1/(S*KPA)|||L/H|NOT DONE||N|U|U|4||88||OBSERVATION|1966-11-14||1965-06-14|||1969-07-13||1965-01-26
TRIAL STUDY 134XCP|RP|FA440C9B-0D7A-4656-BF17-D46289567FB0|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||10^9 CFU|||CUP EQ|NOT DONE||NA|Y|NA|4||88||WASHOUT|1970-09-16||1966-11-17|||1966-02-17||1961-02-24
TRIAL STUDY 134XCP|RP|FA440C9B-0D7A-4656-BF17-D46289567FB0|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||CFU/G|||NMOL/DAY|NOT DONE||Y|Y|U|5||7||CONTINUATION TREATMENT|1968-08-21||1973-03-23|||1962-10-30||1964-10-31
TRIAL STUDY 134XCP|RP|FA440C9B-0D7A-4656-BF17-D46289567FB0|2||||||DLVRMODE|MODE OF DELIVERY||||KBQ/UL|||CAPSULE|NOT DONE||N|Y|N|5||7||FOLLOW-UP|1966-06-06||1960-06-18|||1964-08-11||1960-04-20
TRIAL STUDY 134XCP|RP|1706BA4E-D2AB-4877-974A-17BDBD834FFF|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||U/G HB|||IN|NOT DONE||U|Y|U|1||38||OBSERVATION|1971-04-29||1972-08-02|||1964-03-09||1969-03-16
TRIAL STUDY 134XCP|RP|1706BA4E-D2AB-4877-974A-17BDBD834FFF|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||GENEQ|||BQ/ML|NOT DONE||U|NA|U|1||38||WASHOUT|1965-04-27||1963-02-27|||1965-08-24||1961-10-11
TRIAL STUDY 134XCP|RP|1706BA4E-D2AB-4877-974A-17BDBD834FFF|1||||||PREGST|PREGNANT DURING THE STUDY||||UM|||DAYS|NOT DONE||N|Y|U|2||58||RUN-IN|1969-08-17||1963-02-18|||1964-10-20||1963-10-13
TRIAL STUDY 134XCP|RP|1706BA4E-D2AB-4877-974A-17BDBD834FFF|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ML/KG/H|||ML/S|NOT DONE||NA|N|NA|2||58||RUN-IN|1960-08-31||1962-06-14|||1963-07-29||1963-02-04
TRIAL STUDY 134XCP|RP|1706BA4E-D2AB-4877-974A-17BDBD834FFF|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||NKAT|||LB|NOT DONE||NA|U|U|3||39||LONG-TERM FOLLOW-UP|1968-09-01||1971-07-10|||1971-02-17||1961-10-23
TRIAL STUDY 134XCP|RP|1706BA4E-D2AB-4877-974A-17BDBD834FFF|2||||||DLVRMODE|MODE OF DELIVERY||||MESF|||U/KG/H|NOT DONE||NA|N|N|3||39||BLINDED TREATMENT|1969-01-03||1963-01-08|||1963-10-20||1967-05-22
TRIAL STUDY 134XCP|RP|1706BA4E-D2AB-4877-974A-17BDBD834FFF|1||||||EDEMAIND|EDEMA INDICATOR||||CMOL|||HOURS|NOT DONE||Y|Y|Y|4||88||BLINDED TREATMENT|1967-09-26||1970-10-18|||1969-02-04||1973-08-11
TRIAL STUDY 134XCP|RP|1706BA4E-D2AB-4877-974A-17BDBD834FFF|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||MEQ/G|||NMOL/MOL|NOT DONE||U|Y|U|4||88||LONG-TERM FOLLOW-UP|1971-12-31||1965-09-26|||1973-03-24||1968-01-31
TRIAL STUDY 134XCP|RP|1706BA4E-D2AB-4877-974A-17BDBD834FFF|1||||||PREGST|PREGNANT DURING THE STUDY||||ML/100G/MIN|||10^4/HPF|NOT DONE||Y|Y|N|5||7||WASHOUT|1966-12-26||1960-01-07|||1968-01-09||1964-06-07
TRIAL STUDY 134XCP|RP|1706BA4E-D2AB-4877-974A-17BDBD834FFF|2||||||STILBIND|STILLBIRTH INDICATOR||||MG/CM2|||UCI/L|NOT DONE||Y|Y|N|5||7||INDUCTION TREATMENT|1964-10-17||1965-03-26|||1966-02-22||1960-06-11
TRIAL STUDY 134XCP|RP|15E3DD06-7F28-499B-9CF5-6EE5875095B5|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||ROENTGEN|||TESLA|NOT DONE||NA|N|Y|1||38||CONTINUATION TREATMENT|1968-05-28||1960-02-06|||1962-03-11||1964-08-08
TRIAL STUDY 134XCP|RP|15E3DD06-7F28-499B-9CF5-6EE5875095B5|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||VIAL|||STEPS|NOT DONE||U|U|U|1||38||FOLLOW-UP|1966-01-14||1966-08-09|||1969-03-31||1964-10-15
TRIAL STUDY 134XCP|RP|15E3DD06-7F28-499B-9CF5-6EE5875095B5|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||DAGU/ML|||GPL U/ML|NOT DONE||Y|NA|NA|2||58||BLINDED TREATMENT|1971-04-09||1973-06-29|||1961-05-27||1972-07-14
TRIAL STUDY 134XCP|RP|15E3DD06-7F28-499B-9CF5-6EE5875095B5|2||||||BLISTIND|BLISTERING INDICATOR||||OZ|||UMOL/MG/MIN|NOT DONE||Y|NA|N|2||58||BASELINE|1960-01-14||1961-05-07|||1960-09-09||1969-04-06
TRIAL STUDY 134XCP|RP|15E3DD06-7F28-499B-9CF5-6EE5875095B5|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||NMOL/KG/DAY|||MM/2H|NOT DONE||U|U|Y|3||39||RUN-IN|1972-04-09||1962-04-12|||1964-06-06||1965-01-08
TRIAL STUDY 134XCP|RP|15E3DD06-7F28-499B-9CF5-6EE5875095B5|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||GBQ/UG|||DNA COPIES/UG|NOT DONE||N|U|NA|3||39||BLINDED TREATMENT|1961-07-27||1973-05-15|||1968-08-31||1970-10-01
TRIAL STUDY 134XCP|RP|15E3DD06-7F28-499B-9CF5-6EE5875095B5|1||||||PREGST|PREGNANT DURING THE STUDY||||UV*SEC|||PFU/ML|NOT DONE||U|N|N|4||88||SCREENING|1967-01-25||1962-09-15|||1963-09-01||1969-10-19
TRIAL STUDY 134XCP|RP|15E3DD06-7F28-499B-9CF5-6EE5875095B5|2||||||PREGST|PREGNANT DURING THE STUDY||||10^3 ORGANISMS/ML|||UGEQ/L|NOT DONE||U|U|N|4||88||OPEN LABEL TREATMENT|1966-12-11||1969-06-03|||1965-04-03||1963-05-20
TRIAL STUDY 134XCP|RP|15E3DD06-7F28-499B-9CF5-6EE5875095B5|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PMOL|||/KG|NOT DONE||Y|Y|NA|5||7||SCREENING|1963-05-10||1967-03-20|||1960-04-16||1966-11-05
TRIAL STUDY 134XCP|RP|15E3DD06-7F28-499B-9CF5-6EE5875095B5|2||||||ULCERIND|ULCER INDICATOR||||/10^5|||MG/MOL|NOT DONE||NA|NA|Y|5||7||OBSERVATION|1966-07-10||1963-04-21|||1966-01-04||1972-05-07
TRIAL STUDY 134XCP|RP|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|1||||||BRTHN|NUMBER OF BIRTHS||||MU/G|||DAGU/ML|NOT DONE||Y|U|N|1||38||BLINDED TREATMENT|1970-07-14||1973-06-22|||1962-12-31||1966-09-16
TRIAL STUDY 134XCP|RP|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^4 CFU/ML|||S^-1(%O2)^-1|NOT DONE||N|NA|NA|1||38||BASELINE|1972-01-13||1967-02-12|||1965-04-07||1963-09-04
TRIAL STUDY 134XCP|RP|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|1||||||INTP|INTERPRETATION||||SYRINGE|||MEQ/KG|NOT DONE||U|U|Y|2||58||OBSERVATION|1973-05-24||1968-09-08|||1972-02-22||1968-09-12
TRIAL STUDY 134XCP|RP|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||KN/CM2|||KG/M2|NOT DONE||U|U|N|2||58||INDUCTION TREATMENT|1962-09-16||1962-09-27|||1972-11-02||1966-01-10
TRIAL STUDY 134XCP|RP|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|1||||||PREGIND|PREGNANT INDICATOR||||NMOL/KG/DAY|||MHZ|NOT DONE||N|U|N|3||39||RUN-IN|1963-08-17||1972-03-28|||1972-04-13||1963-09-14
TRIAL STUDY 134XCP|RP|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||10^9 CFU|||IU/MG|NOT DONE||U|NA|NA|3||39||RUN-IN|1963-04-21||1962-03-21|||1966-11-10||1971-01-13
TRIAL STUDY 134XCP|RP|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|1||||||ABORTN|NUMBER OF ABORTIONS||||PACKET|||MPH|NOT DONE||Y|NA|U|4||88||WASHOUT|1962-04-20||1964-09-30|||1961-11-15||1966-08-19
TRIAL STUDY 134XCP|RP|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|2||||||EDEMAIND|EDEMA INDICATOR||||10^3 COPIES/ML|||G/CAGE/WK|NOT DONE||NA|N|U|4||88||OBSERVATION|1969-05-16||1968-07-07|||1966-08-04||1965-04-23
TRIAL STUDY 134XCP|RP|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|1||||||MENARAGE|MENARCHE AGE||||10^7 CFU|||FRACTION OF 1|NOT DONE||U|Y|U|5||7||CONTINUATION TREATMENT|1973-08-18||1973-06-19|||1968-02-13||1967-02-17
TRIAL STUDY 134XCP|RP|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|2||||||BLISTIND|BLISTERING INDICATOR||||MOL/MOL|||/100 WBC|NOT DONE||Y|NA|NA|5||7||SCREENING|1972-07-10||1971-02-06|||1968-11-29||1968-02-23
TRIAL STUDY 134XCP|RP|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||PMOL/DL|||CD|NOT DONE||U|U|Y|1||38||OPEN LABEL TREATMENT|1969-06-10||1962-09-11|||1963-02-17||1967-06-22
TRIAL STUDY 134XCP|RP|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|2||||||PREGNN|NUMBER OF PREGNANCIES||||SBE/ML|||/KG|NOT DONE||NA|U|U|1||38||BASELINE|1960-05-30||1960-03-02|||1970-07-23||1963-08-10
TRIAL STUDY 134XCP|RP|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|1||||||INTP|INTERPRETATION||||L|||ML/H|NOT DONE||N|N|Y|2||58||BLINDED TREATMENT|1971-07-12||1973-04-09|||1962-01-27||1970-10-27
TRIAL STUDY 134XCP|RP|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^6/G|||NMOL/MOL|NOT DONE||N|N|N|2||58||INDUCTION TREATMENT|1962-12-03||1966-02-03|||1965-11-14||1970-08-30
TRIAL STUDY 134XCP|RP|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|1||||||PREGST|PREGNANT DURING THE STUDY||||IMPLANT|||U/G HB|NOT DONE||N|U|Y|3||39||TREATMENT|1966-06-04||1971-03-01|||1963-06-09||1961-05-05
TRIAL STUDY 134XCP|RP|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|2||||||MENARAGE|MENARCHE AGE||||ML/KG|||DL|NOT DONE||NA|NA|U|3||39||SCREENING|1969-03-28||1969-04-22|||1963-03-05||1964-05-24
TRIAL STUDY 134XCP|RP|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||BOWL|||IMPLANT|NOT DONE||U|U|N|4||88||OPEN LABEL TREATMENT|1968-03-27||1962-04-02|||1965-09-24||1963-08-10
TRIAL STUDY 134XCP|RP|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||NKAT|||CG|NOT DONE||NA|Y|Y|4||88||BASELINE|1965-08-11||1960-11-05|||1967-10-10||1961-03-15
TRIAL STUDY 134XCP|RP|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||IU/KG|||G/CM2|NOT DONE||N|U|Y|5||7||BLINDED TREATMENT|1969-04-01||1960-11-21|||1966-04-03||1965-05-04
TRIAL STUDY 134XCP|RP|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|2||||||PUSTIND|PUSTULE INDICATOR||||CAPLET|||L/MIN|NOT DONE||U|U|Y|5||7||INDUCTION TREATMENT|1961-09-23||1964-07-28|||1972-01-12||1961-11-20
TRIAL STUDY 134XCP|RP|87ED1C08-AF47-4827-A897-E8FC24A69ECC|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MG/DAY|||CM H2O|NOT DONE||NA|U|N|1||38||LONG-TERM FOLLOW-UP|1961-07-15||1969-03-22|||1964-07-22||1962-02-23
TRIAL STUDY 134XCP|RP|87ED1C08-AF47-4827-A897-E8FC24A69ECC|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ML/KG/MIN|||UKAT|NOT DONE||Y|N|NA|1||38||SCREENING|1966-06-29||1964-02-21|||1961-12-08||1973-06-14
TRIAL STUDY 134XCP|RP|87ED1C08-AF47-4827-A897-E8FC24A69ECC|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||KIU|||10^6 RNA COPIES/ML|NOT DONE||N|U|NA|2||58||BLINDED TREATMENT|1964-01-08||1967-12-03|||1962-10-10||1966-07-06
TRIAL STUDY 134XCP|RP|87ED1C08-AF47-4827-A897-E8FC24A69ECC|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MM/H|||CMHG|NOT DONE||U|Y|Y|2||58||CONTINUATION TREATMENT|1970-02-26||1965-10-10|||1971-12-27||1961-03-11
TRIAL STUDY 134XCP|RP|87ED1C08-AF47-4827-A897-E8FC24A69ECC|1||||||PREGIND|PREGNANT INDICATOR||||RING|||VOXEL|NOT DONE||U|N|Y|3||39||RUN-IN|1970-12-27||1965-10-02|||1969-05-24||1971-10-23
TRIAL STUDY 134XCP|RP|87ED1C08-AF47-4827-A897-E8FC24A69ECC|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||PMOL/DL|||AMFI|NOT DONE||N|Y|NA|3||39||WASHOUT|1966-05-27||1960-10-05|||1969-03-18||1967-09-09
TRIAL STUDY 134XCP|RP|87ED1C08-AF47-4827-A897-E8FC24A69ECC|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||ML/DAY|||IU/DL|NOT DONE||NA|U|NA|4||88||FOLLOW-UP|1962-08-19||1971-11-01|||1968-02-28||1969-11-21
TRIAL STUDY 134XCP|RP|87ED1C08-AF47-4827-A897-E8FC24A69ECC|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||G/ANIMAL|||UG/MIN|NOT DONE||U|U|NA|4||88||TREATMENT|1964-11-15||1967-06-29|||1962-04-21||1966-05-15
TRIAL STUDY 134XCP|RP|87ED1C08-AF47-4827-A897-E8FC24A69ECC|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||LX|||KPA/L/SEC|NOT DONE||N|U|NA|5||7||BASELINE|1968-09-02||1966-03-20|||1962-05-13||1968-07-11
TRIAL STUDY 134XCP|RP|87ED1C08-AF47-4827-A897-E8FC24A69ECC|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||KS|||P|NOT DONE||U|U|NA|5||7||SCREENING|1963-11-05||1970-09-23|||1962-02-25||1967-08-03
TRIAL STUDY 134XCP|RP|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|1||||||GRAVIND|GRAVIDA INDICATOR||||NKAT/G HB|||10^3 COPIES/ML|NOT DONE||N|Y|NA|1||38||BASELINE|1960-07-30||1963-12-12|||1961-05-22||1969-11-16
TRIAL STUDY 134XCP|RP|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||BOLUS|||IU/G HB|NOT DONE||Y|NA|NA|1||38||BASELINE|1962-08-25||1964-04-05|||1970-12-05||1967-12-08
TRIAL STUDY 134XCP|RP|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MET|||PIPE|NOT DONE||U|N|Y|2||58||FOLLOW-UP|1964-05-23||1968-03-03|||1969-11-09||1962-01-22
TRIAL STUDY 134XCP|RP|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|2||||||DLVRMODE|MODE OF DELIVERY||||MG/KG|||MV*MIN|NOT DONE||NA|Y|NA|2||58||BASELINE|1966-08-30||1963-06-28|||1965-03-16||1963-10-02
TRIAL STUDY 134XCP|RP|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||ML/(MIN*100ML)|||CAPFUL|NOT DONE||U|NA|N|3||39||TREATMENT|1969-07-17||1964-02-01|||1968-10-07||1966-04-04
TRIAL STUDY 134XCP|RP|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|2||||||BRTHN|NUMBER OF BIRTHS||||FEU|||10^7/L|NOT DONE||U|U|N|3||39||FOLLOW-UP|1971-11-04||1973-03-17|||1967-09-04||1973-07-05
TRIAL STUDY 134XCP|RP|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||INHALATION|||CMOL/L|NOT DONE||U|U|NA|4||88||OBSERVATION|1965-07-01||1966-06-29|||1968-10-02||1971-03-17
TRIAL STUDY 134XCP|RP|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||LOG10 COPIES/ML|||MGEQ|NOT DONE||U|Y|NA|4||88||CONTINUATION TREATMENT|1964-10-03||1961-04-13|||1965-06-05||1967-12-10
TRIAL STUDY 134XCP|RP|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|1||||||RASHIND|RASH INDICATOR||||MBQ|||AMP|NOT DONE||NA|Y|NA|5||7||WASHOUT|1960-08-26||1973-03-07|||1962-09-05||1966-08-13
TRIAL STUDY 134XCP|RP|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|2||||||STILBIND|STILLBIRTH INDICATOR||||CI|||DDU|NOT DONE||Y|Y|Y|5||7||INDUCTION TREATMENT|1961-10-05||1964-12-15|||1964-01-20||1968-01-11
TRIAL STUDY 134XCP|RP|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||P|||KA_U/DL|NOT DONE||NA|N|NA|1||38||TREATMENT|1966-11-14||1960-12-17|||1969-12-07||1963-01-24
TRIAL STUDY 134XCP|RP|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||S/H|||/MBP|NOT DONE||N|N|NA|1||38||WASHOUT|1967-05-16||1960-10-04|||1961-11-12||1968-05-28
TRIAL STUDY 134XCP|RP|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|1||||||MENOSTAT|MENOPAUSE STATUS||||NMOL BCE/L|||LOZENGE|NOT DONE||U|N|NA|2||58||SCREENING|1962-05-11||1967-04-13|||1965-02-13||1971-04-07
TRIAL STUDY 134XCP|RP|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||NU/CL|||GBQ/G|NOT DONE||Y|U|U|2||58||OBSERVATION|1960-03-07||1968-05-05|||1968-01-05||1960-10-02
TRIAL STUDY 134XCP|RP|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|1||||||PREGIND|PREGNANT INDICATOR||||/HPF|||SFC/10^6 PBMC|NOT DONE||U|Y|NA|3||39||BLINDED TREATMENT|1967-01-31||1966-04-17|||1962-12-30||1968-07-06
TRIAL STUDY 134XCP|RP|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MEQ/UL|||GY/MIN|NOT DONE||NA|N|N|3||39||TREATMENT|1971-03-30||1966-07-19|||1963-10-26||1968-12-22
TRIAL STUDY 134XCP|RP|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||FOZ_BR|||UMOL/MG/MIN|NOT DONE||N|N|NA|4||88||OBSERVATION|1966-07-31||1972-04-01|||1962-08-14||1970-04-27
TRIAL STUDY 134XCP|RP|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||FG|||RAD|NOT DONE||Y|NA|U|4||88||BLINDED TREATMENT|1967-04-11||1962-05-27|||1960-09-13||1967-04-05
TRIAL STUDY 134XCP|RP|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||U/ML|||10^9 CFU|NOT DONE||Y|Y|U|5||7||OPEN LABEL TREATMENT|1967-04-09||1962-06-22|||1969-01-11||1973-06-18
TRIAL STUDY 134XCP|RP|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|2||||||INABOIND|INDUCED ABORTION INDICATOR||||UCI/L|||CGY|NOT DONE||NA|U|U|5||7||OBSERVATION|1973-06-28||1967-07-22|||1967-07-20||1967-09-19
TRIAL STUDY 134XCP|RP|C817A043-1331-47AB-A627-D85893F9D61A|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||KIU|||LOG10 CFU/G|NOT DONE||NA|Y|U|1||38||OPEN LABEL TREATMENT|1969-11-02||1968-10-16|||1967-10-22||1972-02-28
TRIAL STUDY 134XCP|RP|C817A043-1331-47AB-A627-D85893F9D61A|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||ML/M2/H|||MEQ|NOT DONE||Y|Y|NA|1||38||INDUCTION TREATMENT|1967-03-20||1960-07-26|||1963-06-02||1967-08-24
TRIAL STUDY 134XCP|RP|C817A043-1331-47AB-A627-D85893F9D61A|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||IU/MMOL|||CG|NOT DONE||NA|N|U|2||58||BLINDED TREATMENT|1965-06-20||1968-02-19|||1968-02-09||1963-04-14
TRIAL STUDY 134XCP|RP|C817A043-1331-47AB-A627-D85893F9D61A|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||LOG10 COPIES/ML|||MG/KG/H|NOT DONE||U|N|U|2||58||CONTINUATION TREATMENT|1963-01-28||1961-11-21|||1966-01-16||1966-10-10
TRIAL STUDY 134XCP|RP|C817A043-1331-47AB-A627-D85893F9D61A|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||BEATS/MIN|||CMOL|NOT DONE||U|N|N|3||39||RUN-IN|1963-05-16||1964-12-28|||1965-05-07||1961-01-02
TRIAL STUDY 134XCP|RP|C817A043-1331-47AB-A627-D85893F9D61A|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||EJACULATE U|||STRIP|NOT DONE||NA|N|U|3||39||BASELINE|1971-08-16||1971-12-21|||1966-05-18||1969-11-26
TRIAL STUDY 134XCP|RP|C817A043-1331-47AB-A627-D85893F9D61A|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||KIT|||QUANTITY SUFFICIENT|NOT DONE||NA|U|NA|4||88||WASHOUT|1969-01-17||1965-01-07|||1965-08-11||1972-11-21
TRIAL STUDY 134XCP|RP|C817A043-1331-47AB-A627-D85893F9D61A|2||||||BCMETHOD|BIRTH CONTROL METHOD||||AMFI|||PSEC|NOT DONE||NA|N|N|4||88||TREATMENT|1962-04-16||1964-09-10|||1964-10-31||1968-05-03
TRIAL STUDY 134XCP|RP|C817A043-1331-47AB-A627-D85893F9D61A|1||||||INABOIND|INDUCED ABORTION INDICATOR||||10^6 U|||10^6 ORGANISMS/G|NOT DONE||N|Y|Y|5||7||SCREENING|1972-03-19||1970-07-04|||1973-07-13||1966-05-18
TRIAL STUDY 134XCP|RP|C817A043-1331-47AB-A627-D85893F9D61A|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^9 CFU/G|||CD/M2|NOT DONE||U|U|NA|5||7||RUN-IN|1968-03-13||1968-08-22|||1960-04-26||1970-06-02
TRIAL STUDY 134XCP|RP|DDD6F5D1-AE97-412C-A161-869C4178223A|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MAC50|||UG/DAY|NOT DONE||NA|Y|NA|1||38||BLINDED TREATMENT|1960-05-01||1964-06-11|||1967-06-17||1969-07-29
TRIAL STUDY 134XCP|RP|DDD6F5D1-AE97-412C-A161-869C4178223A|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||10^7 PFU|||UIU/L|NOT DONE||N|U|U|1||38||LONG-TERM FOLLOW-UP|1961-08-05||1967-06-30|||1964-06-03||1971-01-12
TRIAL STUDY 134XCP|RP|DDD6F5D1-AE97-412C-A161-869C4178223A|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MG/M2/MIN|||MG/ML/DAY|NOT DONE||NA|NA|NA|2||58||INDUCTION TREATMENT|1968-08-19||1968-11-23|||1960-07-14||1971-08-03
TRIAL STUDY 134XCP|RP|DDD6F5D1-AE97-412C-A161-869C4178223A|2||||||BLISTIND|BLISTERING INDICATOR||||MG/ML/MIN|||MOL|NOT DONE||NA|NA|NA|2||58||WASHOUT|1961-07-24||1963-12-22|||1961-09-20||1966-01-04
TRIAL STUDY 134XCP|RP|DDD6F5D1-AE97-412C-A161-869C4178223A|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||TAMPON|||GPELISA UNIT/ML|NOT DONE||N|N|U|3||39||RUN-IN|1973-07-20||1964-05-19|||1968-12-17||1968-08-08
TRIAL STUDY 134XCP|RP|DDD6F5D1-AE97-412C-A161-869C4178223A|2||||||STILBIND|STILLBIRTH INDICATOR||||MEQ/UG|||KG/L|NOT DONE||U|U|NA|3||39||BLINDED TREATMENT|1971-04-20||1972-06-04|||1971-06-26||1969-08-07
TRIAL STUDY 134XCP|RP|DDD6F5D1-AE97-412C-A161-869C4178223A|1||||||PREGIND|PREGNANT INDICATOR||||%(W/V)|||UKAT|NOT DONE||U|U|NA|4||88||OPEN LABEL TREATMENT|1971-07-05||1968-04-28|||1969-10-28||1966-02-07
TRIAL STUDY 134XCP|RP|DDD6F5D1-AE97-412C-A161-869C4178223A|2||||||PEELIND|PEELING INDICATOR||||DISK|||NG/L|NOT DONE||NA|NA|U|4||88||TREATMENT|1973-04-19||1966-04-01|||1962-07-22||1963-02-11
TRIAL STUDY 134XCP|RP|DDD6F5D1-AE97-412C-A161-869C4178223A|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||TAMPON|||PT_US|NOT DONE||Y|U|NA|5||7||WASHOUT|1962-05-29||1963-04-03|||1972-05-05||1962-03-10
TRIAL STUDY 134XCP|RP|DDD6F5D1-AE97-412C-A161-869C4178223A|2||||||MENARAGE|MENARCHE AGE||||UG/CM2|||10^6/L|NOT DONE||U|N|N|5||7||LONG-TERM FOLLOW-UP|1971-08-02||1965-04-14|||1968-07-18||1960-02-17
TRIAL STUDY 134XCP|RP|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|1||||||ABORTN|NUMBER OF ABORTIONS||||NMOL BCE/MMOL|||CI|NOT DONE||NA|N|Y|1||38||TREATMENT|1970-08-31||1963-02-17|||1970-02-28||1971-04-22
TRIAL STUDY 134XCP|RP|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||LOG10 IU/ML|||VIRTUAL PIXEL|NOT DONE||U|NA|N|1||38||SCREENING|1970-01-16||1962-02-24|||1963-08-12||1964-01-12
TRIAL STUDY 134XCP|RP|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||CCID 50/DOSE|||PPTH|NOT DONE||Y|Y|Y|2||58||SCREENING|1965-08-20||1960-11-02|||1962-12-10||1960-07-10
TRIAL STUDY 134XCP|RP|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MESF|||UG/G/H|NOT DONE||Y|N|N|2||58||TREATMENT|1962-08-23||1968-07-26|||1968-10-04||1967-08-07
TRIAL STUDY 134XCP|RP|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||VP/DOSE|||NMOL BCE/MMOL|NOT DONE||NA|N|Y|3||39||LONG-TERM FOLLOW-UP|1969-03-15||1964-05-20|||1970-08-25||1964-07-24
TRIAL STUDY 134XCP|RP|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MMHG|||NEWTON|NOT DONE||N|NA|U|3||39||WASHOUT|1964-03-28||1961-05-04|||1972-09-26||1963-08-28
TRIAL STUDY 134XCP|RP|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|1||||||ULCERIND|ULCER INDICATOR||||VG/ML|||10^9/L|NOT DONE||NA|NA|Y|4||88||CONTINUATION TREATMENT|1972-06-03||1973-01-12|||1962-12-29||1968-12-06
TRIAL STUDY 134XCP|RP|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MANSON U/ML|||CI|NOT DONE||U|N|NA|4||88||WASHOUT|1969-03-22||1961-01-28|||1962-11-05||1968-08-12
TRIAL STUDY 134XCP|RP|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|1||||||TNDRIND|TENDERNESS INDICATOR||||LOG10 CFU/ML|||UV2|NOT DONE||U|NA|N|5||7||BASELINE|1966-05-22||1969-05-13|||1971-09-05||1964-08-11
TRIAL STUDY 134XCP|RP|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||10^9 CFU/ML|||UMOL/KG/MIN|NOT DONE||Y|N|NA|5||7||FOLLOW-UP|1966-03-28||1967-04-10|||1972-11-13||1964-10-27
TRIAL STUDY 134XCP|RP|25FB07EA-3CB8-430D-B775-CA0E9918C069|1||||||BCMETHOD|BIRTH CONTROL METHOD||||EQ|||U|NOT DONE||NA|U|Y|1||38||OPEN LABEL TREATMENT|1960-10-29||1962-02-14|||1961-12-17||1969-04-09
TRIAL STUDY 134XCP|RP|25FB07EA-3CB8-430D-B775-CA0E9918C069|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||RING|||BREATHS/30S|NOT DONE||U|Y|Y|1||38||FOLLOW-UP|1963-07-17||1973-07-14|||1967-02-06||1960-09-18
TRIAL STUDY 134XCP|RP|25FB07EA-3CB8-430D-B775-CA0E9918C069|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||IN2|||AMU|NOT DONE||Y|U|Y|2||58||CONTINUATION TREATMENT|1963-03-29||1964-07-21|||1965-09-15||1962-12-17
TRIAL STUDY 134XCP|RP|25FB07EA-3CB8-430D-B775-CA0E9918C069|2||||||TNDRIND|TENDERNESS INDICATOR||||10^9/DOSE|||NMOL/L/MIN|NOT DONE||NA|Y|NA|2||58||SCREENING|1967-05-08||1966-10-14|||1972-05-10||1968-10-28
TRIAL STUDY 134XCP|RP|25FB07EA-3CB8-430D-B775-CA0E9918C069|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||ML/MIN/1.73M2|||UV2|NOT DONE||NA|U|N|3||39||CONTINUATION TREATMENT|1973-03-17||1961-08-10|||1969-06-21||1969-05-07
TRIAL STUDY 134XCP|RP|25FB07EA-3CB8-430D-B775-CA0E9918C069|2||||||EDEMAIND|EDEMA INDICATOR||||NG/L|||NL|NOT DONE||Y|NA|U|3||39||CONTINUATION TREATMENT|1970-09-24||1972-03-15|||1961-10-14||1965-02-15
TRIAL STUDY 134XCP|RP|25FB07EA-3CB8-430D-B775-CA0E9918C069|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MG/G/H|||10^11/L|NOT DONE||N|NA|NA|4||88||BASELINE|1960-10-28||1970-01-13|||1971-08-13||1964-02-28
TRIAL STUDY 134XCP|RP|25FB07EA-3CB8-430D-B775-CA0E9918C069|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||MOL/MG|||CFU/G|NOT DONE||NA|Y|NA|4||88||FOLLOW-UP|1967-01-27||1966-07-17|||1973-03-31||1968-12-18
TRIAL STUDY 134XCP|RP|25FB07EA-3CB8-430D-B775-CA0E9918C069|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||/MIN|||DNA COPIES/UG|NOT DONE||NA|N|N|5||7||LONG-TERM FOLLOW-UP|1971-02-10||1970-08-22|||1967-11-19||1972-02-20
TRIAL STUDY 134XCP|RP|25FB07EA-3CB8-430D-B775-CA0E9918C069|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||WATT|||UG/KG/MIN|NOT DONE||NA|NA|N|5||7||OPEN LABEL TREATMENT|1969-08-17||1966-06-10|||1965-12-17||1962-03-28
TRIAL STUDY 134XCP|RP|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|1||||||STILBIND|STILLBIRTH INDICATOR||||COULOMB|||DNA COPIES/UG|NOT DONE||NA|N|Y|1||38||WASHOUT|1973-07-15||1966-09-24|||1967-12-11||1960-06-02
TRIAL STUDY 134XCP|RP|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|2||||||MENARAGE|MENARCHE AGE||||10^9 ORGANISMS/MG|||10^3 ORGANISMS/ML|NOT DONE||U|Y|U|1||38||SCREENING|1965-10-27||1969-07-29|||1966-09-06||1962-05-28
TRIAL STUDY 134XCP|RP|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|1||||||EDEMAIND|EDEMA INDICATOR||||MET*MIN|||ML/G/H|NOT DONE||N|N|N|2||58||OPEN LABEL TREATMENT|1967-10-23||1960-01-27|||1964-03-07||1963-08-27
TRIAL STUDY 134XCP|RP|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||ROENTGEN|||ML/S/M2|NOT DONE||U|Y|U|2||58||OBSERVATION|1965-12-12||1970-11-25|||1973-05-04||1970-02-21
TRIAL STUDY 134XCP|RP|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MMOL|||COULOMB|NOT DONE||Y|Y|NA|3||39||BASELINE|1970-04-14||1972-06-19|||1968-02-20||1965-11-19
TRIAL STUDY 134XCP|RP|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|2||||||PEELIND|PEELING INDICATOR||||AU/ML|||JOULE|NOT DONE||N|NA|N|3||39||CONTINUATION TREATMENT|1969-06-16||1973-08-15|||1969-03-12||1962-09-07
TRIAL STUDY 134XCP|RP|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MEQ/DAY|||CIGAR|NOT DONE||Y|NA|U|4||88||FOLLOW-UP|1968-07-28||1972-11-05|||1962-04-05||1961-09-22
TRIAL STUDY 134XCP|RP|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MPA|||10^6 IU|NOT DONE||U|Y|NA|4||88||SCREENING|1960-01-07||1964-07-11|||1972-04-01||1962-08-20
TRIAL STUDY 134XCP|RP|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|1||||||BRTHN|NUMBER OF BIRTHS||||POINT|||UMOL/L|NOT DONE||N|N|N|5||7||SCREENING|1966-10-09||1966-03-30|||1967-11-29||1960-10-31
TRIAL STUDY 134XCP|RP|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||CAPSULE|||RPM|NOT DONE||U|Y|U|5||7||RUN-IN|1960-01-03||1961-05-07|||1963-07-22||1967-01-10
TRIAL STUDY 134XCP|RP|B49B9695-9815-4B7B-9F96-4EE6A4432062|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ML/H|||LOG EID 50/DOSE|NOT DONE||U|Y|U|1||38||BLINDED TREATMENT|1968-02-22||1963-06-06|||1968-07-19||1963-07-22
TRIAL STUDY 134XCP|RP|B49B9695-9815-4B7B-9F96-4EE6A4432062|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UOSM|||10^7/L|NOT DONE||U|Y|N|1||38||INDUCTION TREATMENT|1967-07-30||1969-05-21|||1967-12-19||1970-08-14
TRIAL STUDY 134XCP|RP|B49B9695-9815-4B7B-9F96-4EE6A4432062|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||NEEDLE GAUGE|||MMOL/MIN/KPA/L|NOT DONE||Y|Y|Y|2||58||FOLLOW-UP|1970-11-30||1964-01-15|||1970-01-03||1968-06-24
TRIAL STUDY 134XCP|RP|B49B9695-9815-4B7B-9F96-4EE6A4432062|2||||||PREGST|PREGNANT DURING THE STUDY||||CAPSULE|||FIU|NOT DONE||U|N|U|2||58||WASHOUT|1960-10-17||1963-12-06|||1968-12-02||1972-07-02
TRIAL STUDY 134XCP|RP|B49B9695-9815-4B7B-9F96-4EE6A4432062|1||||||MASSIND|MASS INDICATOR||||DPM/100MG|||/CMH2O|NOT DONE||NA|Y|NA|3||39||OPEN LABEL TREATMENT|1971-09-17||1969-12-16|||1960-06-07||1972-12-19
TRIAL STUDY 134XCP|RP|B49B9695-9815-4B7B-9F96-4EE6A4432062|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||IU/L|||NG/MOL|NOT DONE||U|U|N|3||39||WASHOUT|1971-12-19||1965-04-26|||1969-01-08||1963-05-03
TRIAL STUDY 134XCP|RP|B49B9695-9815-4B7B-9F96-4EE6A4432062|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UU/DL|||CYLINDER|NOT DONE||N|U|Y|4||88||BASELINE|1972-09-16||1970-09-12|||1970-01-06||1964-03-21
TRIAL STUDY 134XCP|RP|B49B9695-9815-4B7B-9F96-4EE6A4432062|2||||||ULCERIND|ULCER INDICATOR||||OSM|||ML/G/H|NOT DONE||N|Y|Y|4||88||TREATMENT|1967-05-09||1966-04-02|||1960-06-05||1968-07-14
TRIAL STUDY 134XCP|RP|B49B9695-9815-4B7B-9F96-4EE6A4432062|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||WEBER|||ML/BEAT|NOT DONE||U|Y|N|5||7||INDUCTION TREATMENT|1973-05-23||1969-10-13|||1968-05-02||1961-10-22
TRIAL STUDY 134XCP|RP|B49B9695-9815-4B7B-9F96-4EE6A4432062|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||CM2|||MIN*MG/ML|NOT DONE||N|U|N|5||7||BLINDED TREATMENT|1961-11-21||1969-09-12|||1962-03-04||1963-07-31
TRIAL STUDY 134XCP|RP|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MOSM/KG|||U/MMOL|NOT DONE||Y|U|Y|1||38||CONTINUATION TREATMENT|1962-01-18||1962-10-08|||1967-03-27||1967-05-29
TRIAL STUDY 134XCP|RP|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|2||||||MASSIND|MASS INDICATOR||||MGEQ|||U/ML|NOT DONE||NA|Y|N|1||38||OBSERVATION|1968-06-15||1968-07-10|||1963-04-09||1962-03-03
TRIAL STUDY 134XCP|RP|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||M2|||GBQ/G|NOT DONE||N|N|NA|2||58||OPEN LABEL TREATMENT|1961-04-17||1965-07-14|||1968-05-24||1965-11-15
TRIAL STUDY 134XCP|RP|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|2||||||PEELIND|PEELING INDICATOR||||U/G/MIN|||LOG EID 50/DOSE|NOT DONE||NA|N|U|2||58||INDUCTION TREATMENT|1965-05-19||1970-07-07|||1961-11-12||1971-10-12
TRIAL STUDY 134XCP|RP|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||PLUG|||COPIES/ML|NOT DONE||U|N|U|3||39||OPEN LABEL TREATMENT|1960-12-11||1965-03-16|||1968-04-17||1963-03-13
TRIAL STUDY 134XCP|RP|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|2||||||THICK|THICKNESS||||GY/MIN|||MHZ|NOT DONE||Y|Y|NA|3||39||OPEN LABEL TREATMENT|1963-10-05||1972-12-18|||1970-02-12||1963-02-22
TRIAL STUDY 134XCP|RP|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||GY|||/MIN|NOT DONE||NA|NA|NA|4||88||WASHOUT|1972-12-30||1966-07-27|||1963-11-11||1965-10-13
TRIAL STUDY 134XCP|RP|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|2||||||DSCHGIND|DISCHARGE INDICATOR||||MMHG/SEC|||10^7 CFU|NOT DONE||N|NA|N|4||88||RUN-IN|1962-12-01||1963-12-07|||1965-05-18||1966-09-07
TRIAL STUDY 134XCP|RP|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||KN/CM2|||MG/M2|NOT DONE||NA|U|Y|5||7||LONG-TERM FOLLOW-UP|1972-02-03||1971-03-31|||1969-05-16||1963-08-10
TRIAL STUDY 134XCP|RP|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||DEG/S|||VG/DOSE|NOT DONE||Y|Y|U|5||7||FOLLOW-UP|1963-03-17||1969-08-23|||1971-02-18||1969-06-10
TRIAL STUDY 134XCP|RP|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|1||||||RASHIND|RASH INDICATOR||||HOUNSFIELD UNIT|||ABSORBANCE U/ML|NOT DONE||N|N|Y|1||38||OPEN LABEL TREATMENT|1967-07-01||1969-03-04|||1971-04-24||1967-05-07
TRIAL STUDY 134XCP|RP|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||U/ANIMAL|||FT3|NOT DONE||N|N|NA|1||38||BLINDED TREATMENT|1964-01-24||1970-07-10|||1964-05-16||1964-05-21
TRIAL STUDY 134XCP|RP|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|1||||||MENARAGE|MENARCHE AGE||||MMU/ML|||UCI/L|NOT DONE||N|NA|U|2||58||WASHOUT|1968-09-25||1973-08-24|||1970-03-25||1969-07-28
TRIAL STUDY 134XCP|RP|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||OD UNIT|||/2000 RBC|NOT DONE||N|N|NA|2||58||TREATMENT|1969-08-18||1963-08-17|||1964-11-13||1963-10-03
TRIAL STUDY 134XCP|RP|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||ANTIBODY UNIT|||PMOL/10^9 CELLS|NOT DONE||N|Y|NA|3||39||INDUCTION TREATMENT|1964-06-13||1971-03-22|||1965-01-27||1963-03-31
TRIAL STUDY 134XCP|RP|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|2||||||TNDRIND|TENDERNESS INDICATOR||||UV*SEC|||VOXEL|NOT DONE||NA|U|U|3||39||LONG-TERM FOLLOW-UP|1969-03-03||1973-05-08|||1967-07-03||1963-04-30
TRIAL STUDY 134XCP|RP|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|1||||||BRTHN|NUMBER OF BIRTHS||||/MIN|||AG|NOT DONE||U|N|U|4||88||OPEN LABEL TREATMENT|1963-11-22||1960-02-13|||1969-08-05||1972-08-09
TRIAL STUDY 134XCP|RP|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||G/G|||UMOL/MIN|NOT DONE||U|N|NA|4||88||FOLLOW-UP|1971-07-28||1970-10-10|||1960-09-23||1962-01-12
TRIAL STUDY 134XCP|RP|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|1||||||TNDRIND|TENDERNESS INDICATOR||||MIU/L|||ML/M2/MIN|NOT DONE||N|U|NA|5||7||INDUCTION TREATMENT|1972-06-22||1961-08-08|||1964-10-25||1964-05-25
TRIAL STUDY 134XCP|RP|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||PT_BR|||MMHG/L/MIN|NOT DONE||U|N|NA|5||7||OBSERVATION|1967-06-05||1968-05-08|||1960-05-30||1961-09-24
TRIAL STUDY 134XCP|RP|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||/10^5|||MEQ/L|NOT DONE||N|N|N|1||38||OPEN LABEL TREATMENT|1967-11-28||1965-01-05|||1963-10-23||1961-03-10
TRIAL STUDY 134XCP|RP|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|2||||||BLISTIND|BLISTERING INDICATOR||||10^4/HPF|||NFIU|NOT DONE||Y|NA|NA|1||38||TREATMENT|1961-03-28||1963-07-04|||1966-08-02||1973-08-24
TRIAL STUDY 134XCP|RP|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||CAN|||MCI|NOT DONE||Y|U|NA|2||58||INDUCTION TREATMENT|1966-01-24||1961-07-19|||1970-10-01||1960-10-07
TRIAL STUDY 134XCP|RP|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|2||||||RASHIND|RASH INDICATOR||||ML/ANIMAL/DAY|||PM|NOT DONE||Y|Y|U|2||58||INDUCTION TREATMENT|1966-12-15||1961-05-01|||1973-05-04||1962-11-30
TRIAL STUDY 134XCP|RP|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||%(W/W)|||MCI|NOT DONE||Y|N|Y|3||39||SCREENING|1964-02-19||1965-04-27|||1966-03-14||1967-12-16
TRIAL STUDY 134XCP|RP|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||/2000 RBC|||MMHG/L/MIN|NOT DONE||U|Y|NA|3||39||BLINDED TREATMENT|1970-08-14||1971-03-14|||1962-09-03||1962-06-11
TRIAL STUDY 134XCP|RP|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|1||||||TNDRIND|TENDERNESS INDICATOR||||100 IU/ML|||MBP|NOT DONE||N|Y|NA|4||88||CONTINUATION TREATMENT|1971-02-26||1970-02-15|||1968-12-25||1970-07-03
TRIAL STUDY 134XCP|RP|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|2||||||INTP|INTERPRETATION||||SEC|||IU/G HB|NOT DONE||U|N|N|4||88||LONG-TERM FOLLOW-UP|1966-02-06||1967-04-08|||1965-05-08||1963-02-22
TRIAL STUDY 134XCP|RP|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||S^-1(%O2)^-1|||MG/MOL|NOT DONE||NA|NA|N|5||7||TREATMENT|1961-11-16||1968-06-27|||1965-05-03||1971-04-22
TRIAL STUDY 134XCP|RP|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|2||||||ULCERIND|ULCER INDICATOR||||S/H|||MMOL/G|NOT DONE||Y|U|U|5||7||OPEN LABEL TREATMENT|1962-07-13||1968-12-19|||1962-04-24||1972-04-05
TRIAL STUDY 134XCP|RP|07A934C8-0237-4B37-9FDD-503B8BF94357|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||LM|||UG/L|NOT DONE||NA|U|NA|1||38||FOLLOW-UP|1967-01-21||1964-11-14|||1963-01-13||1965-04-16
TRIAL STUDY 134XCP|RP|07A934C8-0237-4B37-9FDD-503B8BF94357|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||BQ/MG|||BLOCKS|NOT DONE||NA|U|NA|1||38||INDUCTION TREATMENT|1971-12-16||1968-10-15|||1966-04-21||1960-03-25
TRIAL STUDY 134XCP|RP|07A934C8-0237-4B37-9FDD-503B8BF94357|1||||||MASSIND|MASS INDICATOR||||MEQ/L|||UMOL/L/MIN|NOT DONE||Y|U|U|2||58||RUN-IN|1966-09-07||1960-03-24|||1961-08-10||1966-03-10
TRIAL STUDY 134XCP|RP|07A934C8-0237-4B37-9FDD-503B8BF94357|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||CUP EQ|||UMOL/H/MMOL|NOT DONE||U|NA|Y|2||58||FOLLOW-UP|1964-08-17||1968-01-04|||1962-08-14||1971-06-06
TRIAL STUDY 134XCP|RP|07A934C8-0237-4B37-9FDD-503B8BF94357|1||||||MENFDUR|MENSES FLOW DURATION||||10^6/G|||VG/KG|NOT DONE||Y|U|NA|3||39||TREATMENT|1963-06-12||1971-11-10|||1973-06-19||1965-12-24
TRIAL STUDY 134XCP|RP|07A934C8-0237-4B37-9FDD-503B8BF94357|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||NGEQ/L|||UV*SEC|NOT DONE||N|NA|N|3||39||CONTINUATION TREATMENT|1973-06-22||1965-09-07|||1972-12-10||1961-01-05
TRIAL STUDY 134XCP|RP|07A934C8-0237-4B37-9FDD-503B8BF94357|1||||||PRGENDTC|DATE PREGNANCY ENDED||||10^6/L|||UG/DOSE|NOT DONE||U|N|N|4||88||LONG-TERM FOLLOW-UP|1961-04-27||1960-11-01|||1963-11-12||1967-07-09
TRIAL STUDY 134XCP|RP|07A934C8-0237-4B37-9FDD-503B8BF94357|2||||||ABORTN|NUMBER OF ABORTIONS||||ANTI-XA IU|||OD UNIT|NOT DONE||Y|NA|N|4||88||WASHOUT|1967-12-16||1961-02-08|||1962-05-01||1963-10-17
TRIAL STUDY 134XCP|RP|07A934C8-0237-4B37-9FDD-503B8BF94357|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||CAPFUL|||MG/G/H|NOT DONE||N|NA|NA|5||7||RUN-IN|1970-07-07||1964-09-19|||1970-11-13||1965-05-19
TRIAL STUDY 134XCP|RP|07A934C8-0237-4B37-9FDD-503B8BF94357|2||||||MENFDUR|MENSES FLOW DURATION||||10^9/L|||FRAMES/S|NOT DONE||NA|NA|NA|5||7||RUN-IN|1971-08-26||1970-01-28|||1962-03-06||1965-08-19
TRIAL STUDY 134XCP|RP|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||DPM/0.5 ML|||M/SEC2|NOT DONE||U|Y|N|1||38||CONTINUATION TREATMENT|1963-10-04||1963-06-12|||1963-09-12||1972-09-19
TRIAL STUDY 134XCP|RP|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|2||||||BCMETHOD|BIRTH CONTROL METHOD||||UL/ML|||/4.0 ML|NOT DONE||Y|U|U|1||38||BLINDED TREATMENT|1973-01-11||1965-12-31|||1961-02-10||1970-07-04
TRIAL STUDY 134XCP|RP|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||S^-1(%O2)^-1|||U/KG/DAY|NOT DONE||NA|Y|U|2||58||OBSERVATION|1968-01-06||1963-05-29|||1965-02-15||1965-12-28
TRIAL STUDY 134XCP|RP|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||PIXELS/IN|||10^12 IU/L|NOT DONE||U|U|Y|2||58||BASELINE|1969-08-05||1969-04-20|||1967-03-30||1973-01-28
TRIAL STUDY 134XCP|RP|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|1||||||PEELIND|PEELING INDICATOR||||MMHG|||BEAM BREAKS|NOT DONE||N|U|NA|3||39||OPEN LABEL TREATMENT|1961-12-13||1966-04-13|||1962-12-04||1970-11-16
TRIAL STUDY 134XCP|RP|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|2||||||EDEMAIND|EDEMA INDICATOR||||AMOL|||UGEQ/L|NOT DONE||NA|U|N|3||39||LONG-TERM FOLLOW-UP|1964-01-16||1964-07-13|||1964-05-14||1964-11-06
TRIAL STUDY 134XCP|RP|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||ML/BREATH|||TROCHE|NOT DONE||U|NA|N|4||88||FOLLOW-UP|1960-12-19||1966-08-20|||1972-06-12||1960-05-31
TRIAL STUDY 134XCP|RP|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||G/DAY|||10^5/HPF|NOT DONE||N|NA|N|4||88||BASELINE|1968-01-18||1969-09-25|||1970-05-12||1962-12-29
TRIAL STUDY 134XCP|RP|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|1||||||DSCHGIND|DISCHARGE INDICATOR||||KPA|||%(W/W)|NOT DONE||N|U|NA|5||7||OBSERVATION|1971-06-06||1964-08-11|||1970-01-19||1962-11-01
TRIAL STUDY 134XCP|RP|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|2||||||DSCHGIND|DISCHARGE INDICATOR||||10^4 CFU/ML|||PG|NOT DONE||U|Y|N|5||7||FOLLOW-UP|1960-02-17||1971-12-28|||1965-01-08||1969-12-28
TRIAL STUDY 134XCP|RP|10E1249E-10AC-45E8-9896-84C7B0F548BC|1||||||MENOAGE|MENOPAUSE AGE||||MG/G/H|||10^8/L|NOT DONE||U|Y|NA|1||38||INDUCTION TREATMENT|1972-04-24||1972-07-20|||1973-02-05||1967-07-30
TRIAL STUDY 134XCP|RP|10E1249E-10AC-45E8-9896-84C7B0F548BC|2||||||PREGIND|PREGNANT INDICATOR||||DISK|||BEL|NOT DONE||NA|Y|Y|1||38||RUN-IN|1960-06-16||1964-11-07|||1965-10-19||1972-03-18
TRIAL STUDY 134XCP|RP|10E1249E-10AC-45E8-9896-84C7B0F548BC|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||RFU|||DEG|NOT DONE||Y|U|U|2||58||LONG-TERM FOLLOW-UP|1962-06-20||1973-04-13|||1964-03-04||1961-11-18
TRIAL STUDY 134XCP|RP|10E1249E-10AC-45E8-9896-84C7B0F548BC|2||||||DSCHGIND|DISCHARGE INDICATOR||||SIEMENS|||UIU/L|NOT DONE||NA|N|N|2||58||TREATMENT|1963-10-13||1964-04-21|||1973-03-25||1966-07-14
TRIAL STUDY 134XCP|RP|10E1249E-10AC-45E8-9896-84C7B0F548BC|1||||||MENOSTAT|MENOPAUSE STATUS||||USEC|||MG/DAY|NOT DONE||N|Y|NA|3||39||OBSERVATION|1966-07-24||1965-02-22|||1969-04-22||1962-09-19
TRIAL STUDY 134XCP|RP|10E1249E-10AC-45E8-9896-84C7B0F548BC|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||LOG10 ELISA UNIT|||LOG10 COPIES/ML|NOT DONE||N|NA|NA|3||39||OBSERVATION|1962-01-31||1964-10-09|||1968-04-22||1967-12-01
TRIAL STUDY 134XCP|RP|10E1249E-10AC-45E8-9896-84C7B0F548BC|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MG/KG/MIN|||U/KG/MIN|NOT DONE||NA|N|Y|4||88||WASHOUT|1971-12-05||1971-07-09|||1964-04-12||1962-12-20
TRIAL STUDY 134XCP|RP|10E1249E-10AC-45E8-9896-84C7B0F548BC|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||LOG10 ELISA UNIT/DOSE|||MBQ|NOT DONE||Y|Y|N|4||88||LONG-TERM FOLLOW-UP|1967-08-11||1967-12-30|||1962-09-08||1960-11-20
TRIAL STUDY 134XCP|RP|10E1249E-10AC-45E8-9896-84C7B0F548BC|1||||||PREGNN|NUMBER OF PREGNANCIES||||CM|||SUPPOSITORY|NOT DONE||U|NA|U|5||7||BASELINE|1966-09-25||1966-03-18|||1962-04-19||1968-12-31
TRIAL STUDY 134XCP|RP|10E1249E-10AC-45E8-9896-84C7B0F548BC|2||||||BRTHN|NUMBER OF BIRTHS||||ML/KG/MIN|||BOLUS|NOT DONE||U|U|NA|5||7||BASELINE|1966-06-27||1964-10-25|||1973-02-14||1968-01-07
TRIAL STUDY 134XCP|RP|6CA97CE0-D120-4E14-A82F-4799D2699110|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||SUPPOSITORY|||10^9 ORGANISMS/G|NOT DONE||NA|U|U|1||38||LONG-TERM FOLLOW-UP|1973-04-25||1968-09-15|||1970-06-30||1972-03-25
TRIAL STUDY 134XCP|RP|6CA97CE0-D120-4E14-A82F-4799D2699110|2||||||PRGENDTC|DATE PREGNANCY ENDED||||DAGU|||UG/KG/H|NOT DONE||Y|NA|N|1||38||RUN-IN|1972-02-19||1969-09-22|||1973-06-05||1963-05-07
TRIAL STUDY 134XCP|RP|6CA97CE0-D120-4E14-A82F-4799D2699110|1||||||ABORTN|NUMBER OF ABORTIONS||||10^6 DNA COPIES/ML|||10^9/DOSE|NOT DONE||NA|Y|Y|2||58||RUN-IN|1960-01-04||1962-09-19|||1971-07-11||1966-11-15
TRIAL STUDY 134XCP|RP|6CA97CE0-D120-4E14-A82F-4799D2699110|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||UL/KG/DAY|||COULOMB|NOT DONE||N|Y|N|2||58||BASELINE|1962-07-31||1962-08-22|||1964-06-16||1963-04-15
TRIAL STUDY 134XCP|RP|6CA97CE0-D120-4E14-A82F-4799D2699110|1||||||BRTHN|NUMBER OF BIRTHS||||YEARS|||U/L|NOT DONE||NA|NA|U|3||39||TREATMENT|1963-07-29||1961-03-15|||1972-06-25||1964-02-29
TRIAL STUDY 134XCP|RP|6CA97CE0-D120-4E14-A82F-4799D2699110|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ML/M2/H|||VIAL|NOT DONE||Y|N|N|3||39||CONTINUATION TREATMENT|1970-04-05||1966-05-09|||1970-06-05||1967-04-04
TRIAL STUDY 134XCP|RP|6CA97CE0-D120-4E14-A82F-4799D2699110|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||BOWL|||COPIES/UG|NOT DONE||NA|N|Y|4||88||SCREENING|1963-03-15||1970-07-06|||1967-11-30||1969-01-25
TRIAL STUDY 134XCP|RP|6CA97CE0-D120-4E14-A82F-4799D2699110|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UV|||/200 HPFS|NOT DONE||NA|N|NA|4||88||SCREENING|1970-07-06||1971-05-06|||1968-12-03||1972-08-06
TRIAL STUDY 134XCP|RP|6CA97CE0-D120-4E14-A82F-4799D2699110|1||||||PREGNN|NUMBER OF PREGNANCIES||||U/M2/H|||DEG|NOT DONE||N|Y|U|5||7||BASELINE|1971-03-06||1971-11-12|||1963-03-16||1971-09-07
TRIAL STUDY 134XCP|RP|6CA97CE0-D120-4E14-A82F-4799D2699110|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||10^9 ORGANISMS/MG|||PACK YEAR|NOT DONE||N|N|NA|5||7||BASELINE|1962-12-08||1967-11-20|||1968-07-08||1972-08-09
TRIAL STUDY 134XCP|RP|D807C3F6-0955-4742-A29B-815682559530|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||SV|||PMOL/L/H|NOT DONE||NA|NA|U|1||38||RUN-IN|1969-04-05||1972-05-31|||1960-04-08||1973-07-13
TRIAL STUDY 134XCP|RP|D807C3F6-0955-4742-A29B-815682559530|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||AMU|||HPA|NOT DONE||NA|N|N|1||38||BASELINE|1961-07-27||1967-09-04|||1973-03-12||1960-06-15
TRIAL STUDY 134XCP|RP|D807C3F6-0955-4742-A29B-815682559530|1||||||BLISTIND|BLISTERING INDICATOR||||VIRTUAL PIXEL|||/2000 RBC|NOT DONE||NA|Y|NA|2||58||OPEN LABEL TREATMENT|1971-08-19||1964-06-10|||1960-06-23||1966-04-26
TRIAL STUDY 134XCP|RP|D807C3F6-0955-4742-A29B-815682559530|2||||||PRGENDTC|DATE PREGNANCY ENDED||||U/M2|||UL/DOSE|NOT DONE||U|NA|Y|2||58||RUN-IN|1968-06-17||1965-01-11|||1969-05-29||1961-11-28
TRIAL STUDY 134XCP|RP|D807C3F6-0955-4742-A29B-815682559530|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||/200 HPFS|||ANTI-XA IU/ML|NOT DONE||Y|NA|Y|3||39||WASHOUT|1962-10-15||1969-02-18|||1961-04-13||1968-05-13
TRIAL STUDY 134XCP|RP|D807C3F6-0955-4742-A29B-815682559530|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||V|||/100 WBC|NOT DONE||N|NA|Y|3||39||LONG-TERM FOLLOW-UP|1962-12-18||1970-12-01|||1960-04-15||1965-03-28
TRIAL STUDY 134XCP|RP|D807C3F6-0955-4742-A29B-815682559530|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||KG/MOL|||10^6/EJACULATE U|NOT DONE||U|Y|Y|4||88||SCREENING|1973-08-21||1964-04-07|||1965-12-24||1972-11-17
TRIAL STUDY 134XCP|RP|D807C3F6-0955-4742-A29B-815682559530|2||||||EDEMAIND|EDEMA INDICATOR||||/40 HPFS|||FFU|NOT DONE||Y|N|U|4||88||LONG-TERM FOLLOW-UP|1968-11-19||1972-06-21|||1973-03-26||1968-04-08
TRIAL STUDY 134XCP|RP|D807C3F6-0955-4742-A29B-815682559530|1||||||STILBIND|STILLBIRTH INDICATOR||||PA|||P|NOT DONE||U|Y|Y|5||7||RUN-IN|1960-03-28||1971-04-28|||1966-12-29||1972-07-07
TRIAL STUDY 134XCP|RP|D807C3F6-0955-4742-A29B-815682559530|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||UMOL/MOL|||DPM/ML|NOT DONE||Y|Y|U|5||7||BASELINE|1972-11-06||1970-03-15|||1963-01-12||1972-02-27
TRIAL STUDY 134XCP|RP|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MG/G/H|||PFU|NOT DONE||Y|Y|Y|1||38||SCREENING|1969-09-04||1970-06-29|||1966-10-04||1964-11-19
TRIAL STUDY 134XCP|RP|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||UG/KG/DAY|||ML/KG/DAY|NOT DONE||N|U|N|1||38||CONTINUATION TREATMENT|1963-09-20||1966-12-05|||1963-03-17||1961-09-23
TRIAL STUDY 134XCP|RP|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||NMOL/KG/DAY|||KDA|NOT DONE||N|N|U|2||58||LONG-TERM FOLLOW-UP|1970-11-19||1972-11-02|||1960-10-26||1960-08-30
TRIAL STUDY 134XCP|RP|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||V/V|||KHZ|NOT DONE||NA|N|NA|2||58||LONG-TERM FOLLOW-UP|1970-11-12||1962-05-07|||1971-02-04||1962-08-12
TRIAL STUDY 134XCP|RP|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|1||||||PUSTIND|PUSTULE INDICATOR||||/MIN|||H/WK|NOT DONE||U|N|U|3||39||FOLLOW-UP|1972-02-19||1963-01-14|||1972-02-10||1964-09-16
TRIAL STUDY 134XCP|RP|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||G/M2/DAY|||/VF|NOT DONE||Y|N|Y|3||39||FOLLOW-UP|1961-10-09||1968-05-25|||1964-01-21||1964-10-25
TRIAL STUDY 134XCP|RP|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|1||||||INTP|INTERPRETATION||||SCOOPFUL|||FIU|NOT DONE||Y|N|NA|4||88||OPEN LABEL TREATMENT|1967-01-31||1960-02-18|||1970-08-20||1969-11-26
TRIAL STUDY 134XCP|RP|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||STRIP|||PM|NOT DONE||N|N|U|4||88||OBSERVATION|1973-06-11||1965-04-24|||1968-07-10||1967-07-03
TRIAL STUDY 134XCP|RP|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||U/G HB|||UL|NOT DONE||Y|NA|Y|5||7||RUN-IN|1970-07-16||1964-12-14|||1961-07-13||1963-10-02
TRIAL STUDY 134XCP|RP|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|2||||||MENOAGE|MENOPAUSE AGE||||APPLICATION|||USEC|NOT DONE||NA|NA|NA|5||7||RUN-IN|1961-12-16||1968-08-16|||1968-12-24||1972-01-19
TRIAL STUDY 134XCP|RP|38C36B22-EC60-4D40-A1B6-71B17F8C8625|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||EID 50/ML|||10^3/L|NOT DONE||Y|N|NA|1||38||WASHOUT|1972-10-07||1965-06-16|||1965-10-03||1973-06-18
TRIAL STUDY 134XCP|RP|38C36B22-EC60-4D40-A1B6-71B17F8C8625|2||||||ABORTN|NUMBER OF ABORTIONS||||UCI/L|||PFU/ANIMAL|NOT DONE||NA|Y|N|1||38||WASHOUT|1968-04-04||1968-06-18|||1964-03-28||1962-03-02
TRIAL STUDY 134XCP|RP|38C36B22-EC60-4D40-A1B6-71B17F8C8625|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||V/V|||U/KG/DAY|NOT DONE||NA|Y|U|2||58||RUN-IN|1967-08-14||1970-06-14|||1967-10-26||1964-05-30
TRIAL STUDY 134XCP|RP|38C36B22-EC60-4D40-A1B6-71B17F8C8625|2||||||DLVRMODE|MODE OF DELIVERY||||KEV|||U/MG|NOT DONE||NA|NA|Y|2||58||FOLLOW-UP|1969-09-03||1965-03-01|||1968-02-13||1961-12-23
TRIAL STUDY 134XCP|RP|38C36B22-EC60-4D40-A1B6-71B17F8C8625|1||||||ERYTHIND|ERYTHEMA INDICATOR||||AMU|||MAMP|NOT DONE||U|N|N|3||39||TREATMENT|1969-04-30||1967-08-18|||1961-05-30||1965-03-30
TRIAL STUDY 134XCP|RP|38C36B22-EC60-4D40-A1B6-71B17F8C8625|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||UMOL/L|||ELISA UNIT/DOSE|NOT DONE||N|NA|N|3||39||TREATMENT|1967-06-01||1961-02-05|||1960-03-08||1960-05-14
TRIAL STUDY 134XCP|RP|38C36B22-EC60-4D40-A1B6-71B17F8C8625|1||||||ERYTHIND|ERYTHEMA INDICATOR||||LOG10 TCID 50/DOSE|||GENEQ/ML|NOT DONE||N|N|N|4||88||TREATMENT|1969-06-15||1967-10-19|||1971-07-30||1968-06-13
TRIAL STUDY 134XCP|RP|38C36B22-EC60-4D40-A1B6-71B17F8C8625|2||||||THICK|THICKNESS||||NG/MOL|||NKAT/L|NOT DONE||Y|N|U|4||88||RUN-IN|1966-01-09||1970-04-02|||1960-11-20||1969-12-31
TRIAL STUDY 134XCP|RP|38C36B22-EC60-4D40-A1B6-71B17F8C8625|1||||||RASHIND|RASH INDICATOR||||INHALATION|||/WK|NOT DONE||U|NA|U|5||7||SCREENING|1961-05-21||1963-12-31|||1964-12-11||1962-02-17
TRIAL STUDY 134XCP|RP|38C36B22-EC60-4D40-A1B6-71B17F8C8625|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MOL/ML|||KIU|NOT DONE||Y|Y|U|5||7||FOLLOW-UP|1960-03-28||1968-12-18|||1968-05-03||1961-06-01
TRIAL STUDY 134XCP|RP|E2F4144C-543D-4F55-A94E-58F244FB21D1|1||||||BCMETHOD|BIRTH CONTROL METHOD||||ML/MIN/1.73M2|||OD UNIT|NOT DONE||NA|U|U|1||38||BASELINE|1971-05-25||1968-03-28|||1972-03-07||1970-03-31
TRIAL STUDY 134XCP|RP|E2F4144C-543D-4F55-A94E-58F244FB21D1|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||CAL|||IU/MMOL|NOT DONE||N|NA|U|1||38||OBSERVATION|1966-02-16||1972-02-19|||1961-04-13||1973-01-09
TRIAL STUDY 134XCP|RP|E2F4144C-543D-4F55-A94E-58F244FB21D1|1||||||MENOSTAT|MENOPAUSE STATUS||||S*KPA|||MG/MIN|NOT DONE||U|NA|U|2||58||BASELINE|1971-10-03||1961-03-05|||1964-03-08||1969-08-08
TRIAL STUDY 134XCP|RP|E2F4144C-543D-4F55-A94E-58F244FB21D1|2||||||PREGIND|PREGNANT INDICATOR||||LOG10 TCID 50/DOSE|||UL/ML|NOT DONE||Y|U|Y|2||58||LONG-TERM FOLLOW-UP|1961-11-16||1961-11-11|||1973-07-09||1963-02-04
TRIAL STUDY 134XCP|RP|E2F4144C-543D-4F55-A94E-58F244FB21D1|1||||||PUSTIND|PUSTULE INDICATOR||||CCID 50/ML|||VOXEL|NOT DONE||U|Y|U|3||39||BASELINE|1960-02-27||1968-04-20|||1963-03-01||1960-01-13
TRIAL STUDY 134XCP|RP|E2F4144C-543D-4F55-A94E-58F244FB21D1|2||||||INTP|INTERPRETATION||||UMOL/MOL|||GBQ/G|NOT DONE||NA|N|N|3||39||RUN-IN|1972-03-19||1963-02-06|||1960-07-17||1972-11-29
TRIAL STUDY 134XCP|RP|E2F4144C-543D-4F55-A94E-58F244FB21D1|1||||||BRTHN|NUMBER OF BIRTHS||||DMOL|||DNA COPIES/UG|NOT DONE||U|U|N|4||88||BASELINE|1971-06-02||1964-07-10|||1968-12-28||1969-12-04
TRIAL STUDY 134XCP|RP|E2F4144C-543D-4F55-A94E-58F244FB21D1|2||||||BRTHN|NUMBER OF BIRTHS||||WEBER|||GAUSS|NOT DONE||Y|N|U|4||88||LONG-TERM FOLLOW-UP|1966-09-14||1961-09-12|||1973-07-02||1965-02-08
TRIAL STUDY 134XCP|RP|E2F4144C-543D-4F55-A94E-58F244FB21D1|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||/LPF|||10^4 CFU/ML|NOT DONE||NA|N|Y|5||7||SCREENING|1973-01-23||1970-07-14|||1964-03-12||1963-07-04
TRIAL STUDY 134XCP|RP|E2F4144C-543D-4F55-A94E-58F244FB21D1|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||ML/M2/H|||MBQ|NOT DONE||U|U|Y|5||7||TREATMENT|1970-05-05||1966-10-04|||1964-02-27||1964-09-04
TRIAL STUDY 134XCP|RP|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||COULOMB|||NMOL|NOT DONE||U|N|N|1||38||INDUCTION TREATMENT|1960-11-13||1962-05-10|||1962-10-12||1961-03-03
TRIAL STUDY 134XCP|RP|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UV*SEC|||TESLA|NOT DONE||NA|NA|NA|1||38||OPEN LABEL TREATMENT|1962-02-25||1968-09-05|||1961-01-06||1973-05-18
TRIAL STUDY 134XCP|RP|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|1||||||DLVRMODE|MODE OF DELIVERY||||PG|||UL/DOSE|NOT DONE||U|NA|Y|2||58||TREATMENT|1961-08-18||1961-08-27|||1970-02-01||1971-05-05
TRIAL STUDY 134XCP|RP|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||MET*H|||CM2|NOT DONE||Y|U|N|2||58||BLINDED TREATMENT|1965-05-07||1965-07-24|||1965-09-14||1970-08-04
TRIAL STUDY 134XCP|RP|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||/H|||TRANSDUCING UNIT|NOT DONE||N|U|U|3||39||LONG-TERM FOLLOW-UP|1961-01-26||1960-11-27|||1962-05-30||1967-07-21
TRIAL STUDY 134XCP|RP|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||KV|||ENZYME U|NOT DONE||U|U|Y|3||39||WASHOUT|1970-07-07||1960-01-03|||1970-08-24||1969-04-27
TRIAL STUDY 134XCP|RP|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|1||||||PUSTIND|PUSTULE INDICATOR||||FFU|||GMFI|NOT DONE||NA|NA|U|4||88||WASHOUT|1964-04-23||1967-07-13|||1964-04-03||1963-06-13
TRIAL STUDY 134XCP|RP|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|2||||||ABORTN|NUMBER OF ABORTIONS||||PKAT|||MOL/ML|NOT DONE||N|U|NA|4||88||OPEN LABEL TREATMENT|1971-01-16||1961-03-15|||1971-04-21||1971-04-14
TRIAL STUDY 134XCP|RP|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||AMU|||COULOMB|NOT DONE||N|NA|N|5||7||INDUCTION TREATMENT|1971-01-07||1961-02-15|||1961-08-05||1961-01-12
TRIAL STUDY 134XCP|RP|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|2||||||STILBIND|STILLBIRTH INDICATOR||||NKAT/G HB|||/40 HPFS|NOT DONE||U|U|U|5||7||BASELINE|1960-07-03||1970-09-01|||1970-08-01||1962-11-22
TRIAL STUDY 134XCP|RP|49B857CF-22F2-406F-A269-54944B23C236|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||LINEAR FT*LB|||1/(S*KPA)|NOT DONE||Y|U|U|1||38||INDUCTION TREATMENT|1972-09-04||1961-08-07|||1967-06-14||1965-06-24
TRIAL STUDY 134XCP|RP|49B857CF-22F2-406F-A269-54944B23C236|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||U|||MG/DL|NOT DONE||U|Y|N|1||38||BLINDED TREATMENT|1969-03-08||1962-01-10|||1969-11-24||1973-08-11
TRIAL STUDY 134XCP|RP|49B857CF-22F2-406F-A269-54944B23C236|1||||||MASSIND|MASS INDICATOR||||UIU/DL|||L|NOT DONE||Y|U|Y|2||58||OBSERVATION|1961-01-22||1973-02-07|||1969-10-18||1961-02-02
TRIAL STUDY 134XCP|RP|49B857CF-22F2-406F-A269-54944B23C236|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||ENZYME U/L|||ML/MIN/MMHG|NOT DONE||N|Y|NA|2||58||INDUCTION TREATMENT|1973-07-03||1965-11-23|||1970-06-28||1963-11-16
TRIAL STUDY 134XCP|RP|49B857CF-22F2-406F-A269-54944B23C236|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||DEG2|||SCOOPFUL|NOT DONE||NA|Y|N|3||39||SCREENING|1963-01-07||1969-01-25|||1961-08-04||1961-09-01
TRIAL STUDY 134XCP|RP|49B857CF-22F2-406F-A269-54944B23C236|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^7 CFU/ML|||MANSON U/ML|NOT DONE||NA|NA|N|3||39||OBSERVATION|1961-10-20||1969-12-30|||1971-04-02||1967-07-30
TRIAL STUDY 134XCP|RP|49B857CF-22F2-406F-A269-54944B23C236|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MAC50|||UMOL/KG/MIN|NOT DONE||N|NA|U|4||88||RUN-IN|1968-02-04||1966-11-24|||1968-07-21||1973-07-07
TRIAL STUDY 134XCP|RP|49B857CF-22F2-406F-A269-54944B23C236|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||USIEMENS|||KHZ|NOT DONE||NA|Y|Y|4||88||LONG-TERM FOLLOW-UP|1966-10-07||1969-12-03|||1964-06-24||1966-07-12
TRIAL STUDY 134XCP|RP|49B857CF-22F2-406F-A269-54944B23C236|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||WEEKS|||BP|NOT DONE||Y|N|NA|5||7||TREATMENT|1972-04-16||1964-04-19|||1964-11-09||1966-01-11
TRIAL STUDY 134XCP|RP|49B857CF-22F2-406F-A269-54944B23C236|2||||||INTP|INTERPRETATION||||L/DAY|||MPA|NOT DONE||U|NA|NA|5||7||INDUCTION TREATMENT|1963-09-28||1962-06-24|||1971-02-09||1971-08-22
TRIAL STUDY 134XCP|RP|E09B394B-9E48-4132-B430-991DF1953A81|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||CMHG|||MG/KG/WEEK|NOT DONE||N|NA|Y|1||38||OPEN LABEL TREATMENT|1970-09-23||1966-08-27|||1971-02-18||1963-02-26
TRIAL STUDY 134XCP|RP|E09B394B-9E48-4132-B430-991DF1953A81|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||KG/MOL|||PACKAGE|NOT DONE||NA|U|NA|1||38||OBSERVATION|1962-04-04||1971-03-27|||1961-11-10||1965-12-30
TRIAL STUDY 134XCP|RP|E09B394B-9E48-4132-B430-991DF1953A81|1||||||INABOIND|INDUCED ABORTION INDICATOR||||/DAY|||OSM|NOT DONE||N|NA|U|2||58||FOLLOW-UP|1964-02-13||1968-01-04|||1962-07-05||1972-02-06
TRIAL STUDY 134XCP|RP|E09B394B-9E48-4132-B430-991DF1953A81|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MMHG|||KALLIKREIN INHIBITOR UNIT|NOT DONE||N|N|U|2||58||OPEN LABEL TREATMENT|1967-10-31||1970-03-18|||1960-10-25||1971-04-14
TRIAL STUDY 134XCP|RP|E09B394B-9E48-4132-B430-991DF1953A81|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||IU/ML|||DPM/ML|NOT DONE||Y|NA|NA|3||39||BLINDED TREATMENT|1967-05-29||1966-10-24|||1973-05-24||1964-04-09
TRIAL STUDY 134XCP|RP|E09B394B-9E48-4132-B430-991DF1953A81|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||ML/DAY|||NFIU|NOT DONE||U|NA|N|3||39||FOLLOW-UP|1967-12-01||1960-08-15|||1964-07-05||1962-08-04
TRIAL STUDY 134XCP|RP|E09B394B-9E48-4132-B430-991DF1953A81|1||||||RASHIND|RASH INDICATOR||||CI|||PL|NOT DONE||U|U|U|4||88||WASHOUT|1964-08-08||1969-09-09|||1969-06-16||1968-03-09
TRIAL STUDY 134XCP|RP|E09B394B-9E48-4132-B430-991DF1953A81|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||TUBERCULIN UNIT|||MU/G|NOT DONE||N|N|N|4||88||BASELINE|1970-06-18||1971-05-19|||1969-07-27||1971-02-18
TRIAL STUDY 134XCP|RP|E09B394B-9E48-4132-B430-991DF1953A81|1||||||THICK|THICKNESS||||PUFF|||VP/DOSE|NOT DONE||N|Y|U|5||7||CONTINUATION TREATMENT|1970-11-23||1960-10-17|||1966-01-17||1967-08-31
TRIAL STUDY 134XCP|RP|E09B394B-9E48-4132-B430-991DF1953A81|2||||||MENFDUR|MENSES FLOW DURATION||||AMU|||UU/L|NOT DONE||N|N|U|5||7||BASELINE|1973-04-25||1972-04-01|||1966-05-16||1971-11-11
TRIAL STUDY 134XCP|RP|5FB65CB2-DB12-4D00-818E-C51992DC7273|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||ML/CM|||10^9 CFU|NOT DONE||U|NA|U|1||38||TREATMENT|1962-12-15||1966-04-26|||1963-02-20||1969-03-02
TRIAL STUDY 134XCP|RP|5FB65CB2-DB12-4D00-818E-C51992DC7273|2||||||PREGNN|NUMBER OF PREGNANCIES||||UMOL/DAY|||G/DAY|NOT DONE||N|U|Y|1||38||TREATMENT|1973-04-01||1971-04-07|||1973-01-18||1968-06-25
TRIAL STUDY 134XCP|RP|5FB65CB2-DB12-4D00-818E-C51992DC7273|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||FOZ_BR|||YEARS|NOT DONE||Y|U|N|2||58||INDUCTION TREATMENT|1965-07-17||1968-11-29|||1964-06-08||1970-11-06
TRIAL STUDY 134XCP|RP|5FB65CB2-DB12-4D00-818E-C51992DC7273|2||||||MASSIND|MASS INDICATOR||||MET*H|||IU/DAY|NOT DONE||N|Y|Y|2||58||BASELINE|1971-10-07||1964-04-23|||1970-08-08||1964-05-11
TRIAL STUDY 134XCP|RP|5FB65CB2-DB12-4D00-818E-C51992DC7273|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||UCI/L|||UG/ANIMAL|NOT DONE||Y|U|N|3||39||TREATMENT|1961-06-13||1973-04-21|||1972-02-11||1962-07-26
TRIAL STUDY 134XCP|RP|5FB65CB2-DB12-4D00-818E-C51992DC7273|2||||||MENOSTAT|MENOPAUSE STATUS||||SPRAY|||CI/UG|NOT DONE||N|Y|N|3||39||TREATMENT|1972-09-04||1972-03-19|||1964-06-29||1967-08-19
TRIAL STUDY 134XCP|RP|5FB65CB2-DB12-4D00-818E-C51992DC7273|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||10^6 IU|||ML/MMHG|NOT DONE||U|Y|N|4||88||BLINDED TREATMENT|1972-02-20||1962-08-31|||1963-08-22||1963-12-16
TRIAL STUDY 134XCP|RP|5FB65CB2-DB12-4D00-818E-C51992DC7273|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||MG/ANIMAL|||APPLICATION|NOT DONE||Y|Y|U|4||88||BASELINE|1969-04-30||1965-10-20|||1972-07-28||1961-03-12
TRIAL STUDY 134XCP|RP|5FB65CB2-DB12-4D00-818E-C51992DC7273|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||CMH2O*S2/ML|||ML/DL|NOT DONE||N|NA|N|5||7||FOLLOW-UP|1960-05-04||1973-06-07|||1967-10-03||1973-04-03
TRIAL STUDY 134XCP|RP|5FB65CB2-DB12-4D00-818E-C51992DC7273|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||L/KG|||PIXELS/CM|NOT DONE||NA|Y|U|5||7||FOLLOW-UP|1967-04-04||1970-07-11|||1971-10-10||1972-05-22
TRIAL STUDY 134XCP|RP|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||S^-1(%O2)^-1|||POINT|NOT DONE||Y|N|Y|1||38||WASHOUT|1970-05-12||1964-02-26|||1970-08-28||1965-01-02
TRIAL STUDY 134XCP|RP|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|2||||||MENARAGE|MENARCHE AGE||||NMOL/L/H|||ML/KG|NOT DONE||Y|Y|U|1||38||FOLLOW-UP|1960-01-23||1960-11-07|||1967-06-19||1968-08-25
TRIAL STUDY 134XCP|RP|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||/10^3|||UU/DL|NOT DONE||Y|U|NA|2||58||BLINDED TREATMENT|1960-06-30||1973-05-11|||1965-12-03||1968-04-03
TRIAL STUDY 134XCP|RP|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|2||||||GRAVIND|GRAVIDA INDICATOR||||IU/L|||U/G|NOT DONE||Y|Y|Y|2||58||CONTINUATION TREATMENT|1961-10-25||1973-05-11|||1961-04-12||1963-07-17
TRIAL STUDY 134XCP|RP|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|1||||||ERYTHIND|ERYTHEMA INDICATOR||||KPA/L/SEC|||NG/DL|NOT DONE||NA|N|N|3||39||WASHOUT|1964-12-28||1970-10-20|||1966-02-06||1961-04-03
TRIAL STUDY 134XCP|RP|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|2||||||PRGENDTC|DATE PREGNANCY ENDED||||10^7/L|||WEBER|NOT DONE||U|NA|N|3||39||RUN-IN|1965-11-29||1969-05-15|||1972-09-12||1964-10-01
TRIAL STUDY 134XCP|RP|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||CAL|||EP U|NOT DONE||U|U|Y|4||88||BASELINE|1966-05-25||1968-10-14|||1966-07-09||1962-11-28
TRIAL STUDY 134XCP|RP|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|2||||||PEELIND|PEELING INDICATOR||||M|||PRESSOR UNITS|NOT DONE||Y|N|U|4||88||FOLLOW-UP|1972-07-18||1973-03-01|||1971-08-03||1960-01-11
TRIAL STUDY 134XCP|RP|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||U|||BU/ML|NOT DONE||Y|N|N|5||7||INDUCTION TREATMENT|1970-07-23||1973-05-12|||1972-04-05||1960-07-16
TRIAL STUDY 134XCP|RP|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||PA|||U/KG/MIN|NOT DONE||NA|U|NA|5||7||SCREENING|1965-04-05||1964-09-27|||1964-09-26||1971-03-31
TRIAL STUDY 134XCP|RP|CB6A1101-1EF8-476D-BD15-B60EF323D740|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||V/SEC|||DEG/MM|NOT DONE||N|NA|Y|1||38||BASELINE|1973-01-08||1967-01-09|||1961-11-06||1966-09-20
TRIAL STUDY 134XCP|RP|CB6A1101-1EF8-476D-BD15-B60EF323D740|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UG/G/MIN|||BAR|NOT DONE||N|U|NA|1||38||OPEN LABEL TREATMENT|1965-08-28||1960-07-04|||1967-01-15||1961-10-27
TRIAL STUDY 134XCP|RP|CB6A1101-1EF8-476D-BD15-B60EF323D740|1||||||PREGNN|NUMBER OF PREGNANCIES||||SACHET|||PFU/DOSE|NOT DONE||Y|U|NA|2||58||OBSERVATION|1960-01-21||1960-12-25|||1972-04-10||1965-05-29
TRIAL STUDY 134XCP|RP|CB6A1101-1EF8-476D-BD15-B60EF323D740|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||ATM|||ML*CMH2O|NOT DONE||N|Y|Y|2||58||BLINDED TREATMENT|1969-10-04||1960-09-28|||1965-04-26||1968-06-19
TRIAL STUDY 134XCP|RP|CB6A1101-1EF8-476D-BD15-B60EF323D740|1||||||TNDRIND|TENDERNESS INDICATOR||||UMOL/L/MIN|||NL|NOT DONE||U|Y|Y|3||39||BLINDED TREATMENT|1968-01-12||1972-12-20|||1964-06-08||1968-07-28
TRIAL STUDY 134XCP|RP|CB6A1101-1EF8-476D-BD15-B60EF323D740|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||HPA|||SFC/10^6 PBMC|NOT DONE||U|N|N|3||39||BLINDED TREATMENT|1971-09-24||1967-03-10|||1965-08-03||1963-02-24
TRIAL STUDY 134XCP|RP|CB6A1101-1EF8-476D-BD15-B60EF323D740|1||||||TNDRIND|TENDERNESS INDICATOR||||10^11/L|||10^7 PFU|NOT DONE||Y|N|U|4||88||FOLLOW-UP|1960-11-15||1966-05-05|||1965-11-09||1969-02-09
TRIAL STUDY 134XCP|RP|CB6A1101-1EF8-476D-BD15-B60EF323D740|2||||||MENOAGE|MENOPAUSE AGE||||WATT|||CY/CM|NOT DONE||Y|N|NA|4||88||BASELINE|1962-07-27||1962-04-03|||1962-01-19||1965-06-14
TRIAL STUDY 134XCP|RP|CB6A1101-1EF8-476D-BD15-B60EF323D740|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||NMOL BCE/L|||ML/DOSE|NOT DONE||NA|NA|U|5||7||OPEN LABEL TREATMENT|1972-10-22||1970-12-28|||1967-03-31||1966-11-02
TRIAL STUDY 134XCP|RP|CB6A1101-1EF8-476D-BD15-B60EF323D740|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||U/MMOL|||10^5/L|NOT DONE||N|N|N|5||7||INDUCTION TREATMENT|1962-06-29||1963-06-30|||1961-07-12||1965-04-03
TRIAL STUDY 134XCP|RP|3AED1654-6D9A-40EE-A560-99F51C469D63|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||10^9/DOSE|||DPM/100MG|NOT DONE||Y|NA|U|1||38||INDUCTION TREATMENT|1960-04-28||1969-10-13|||1970-04-21||1968-09-28
TRIAL STUDY 134XCP|RP|3AED1654-6D9A-40EE-A560-99F51C469D63|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||DIOPTER|||DEG/S|NOT DONE||U|Y|N|1||38||CONTINUATION TREATMENT|1970-02-06||1961-10-03|||1968-12-06||1961-08-27
TRIAL STUDY 134XCP|RP|3AED1654-6D9A-40EE-A560-99F51C469D63|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||L/S|||MG/M2/MIN|NOT DONE||U|N|U|2||58||CONTINUATION TREATMENT|1961-01-05||1972-01-09|||1965-11-24||1965-04-06
TRIAL STUDY 134XCP|RP|3AED1654-6D9A-40EE-A560-99F51C469D63|2||||||EDEMAIND|EDEMA INDICATOR||||SCM|||NMOL BCE/NMOL|NOT DONE||N|Y|NA|2||58||OBSERVATION|1969-12-16||1966-03-14|||1972-06-21||1961-01-30
TRIAL STUDY 134XCP|RP|3AED1654-6D9A-40EE-A560-99F51C469D63|1||||||PUSTIND|PUSTULE INDICATOR||||YD|||/100 WBC|NOT DONE||N|N|U|3||39||CONTINUATION TREATMENT|1972-03-13||1961-06-09|||1966-03-02||1960-05-20
TRIAL STUDY 134XCP|RP|3AED1654-6D9A-40EE-A560-99F51C469D63|2||||||THICK|THICKNESS||||UM/DAY|||USIEMENS|NOT DONE||N|NA|N|3||39||CONTINUATION TREATMENT|1966-08-18||1972-10-01|||1971-03-28||1969-11-14
TRIAL STUDY 134XCP|RP|3AED1654-6D9A-40EE-A560-99F51C469D63|1||||||FUNDHT|FUNDAL HEIGHT||||PACK|||UKAT/10^12 RBC|NOT DONE||U|U|NA|4||88||SCREENING|1960-11-24||1968-09-02|||1968-05-02||1969-02-17
TRIAL STUDY 134XCP|RP|3AED1654-6D9A-40EE-A560-99F51C469D63|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||UMOL/L|||TROCHE|NOT DONE||Y|U|Y|4||88||INDUCTION TREATMENT|1963-04-03||1973-07-04|||1961-10-04||1963-11-19
TRIAL STUDY 134XCP|RP|3AED1654-6D9A-40EE-A560-99F51C469D63|1||||||MENOSTAT|MENOPAUSE STATUS||||UL/DOSE|||UMOL/L/MIN|NOT DONE||N|N|U|5||7||BLINDED TREATMENT|1968-02-13||1971-07-21|||1964-06-05||1970-11-27
TRIAL STUDY 134XCP|RP|3AED1654-6D9A-40EE-A560-99F51C469D63|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MIN*MG/ML|||L/DAY|NOT DONE||N|NA|N|5||7||FOLLOW-UP|1968-08-25||1963-06-09|||1966-01-04||1960-12-10
TRIAL STUDY 134XCP|RP|4C13FD80-8950-4194-B76C-F46B643BED82|1||||||INTP|INTERPRETATION||||KV|||AMP|NOT DONE||U|NA|U|1||38||BASELINE|1964-06-16||1960-05-18|||1961-10-17||1966-07-04
TRIAL STUDY 134XCP|RP|4C13FD80-8950-4194-B76C-F46B643BED82|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MSEC|||CM|NOT DONE||U|U|N|1||38||LONG-TERM FOLLOW-UP|1969-12-02||1962-06-28|||1961-09-01||1970-02-27
TRIAL STUDY 134XCP|RP|4C13FD80-8950-4194-B76C-F46B643BED82|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||KHZ|||LOG10 ELISA UNIT|NOT DONE||U|Y|NA|2||58||OBSERVATION|1960-04-09||1964-01-16|||1960-08-23||1973-07-05
TRIAL STUDY 134XCP|RP|4C13FD80-8950-4194-B76C-F46B643BED82|2||||||GRAVIND|GRAVIDA INDICATOR||||CM/MIN|||NKAT/L|NOT DONE||U|U|Y|2||58||RUN-IN|1962-11-25||1965-08-12|||1965-03-13||1962-06-24
TRIAL STUDY 134XCP|RP|4C13FD80-8950-4194-B76C-F46B643BED82|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||UG/L/H|||/2000 RBC|NOT DONE||Y|Y|NA|3||39||LONG-TERM FOLLOW-UP|1964-05-11||1968-11-23|||1961-01-18||1972-08-24
TRIAL STUDY 134XCP|RP|4C13FD80-8950-4194-B76C-F46B643BED82|2||||||BLISTIND|BLISTERING INDICATOR||||G/CAGE|||G|NOT DONE||U|N|NA|3||39||RUN-IN|1965-10-27||1960-01-24|||1969-06-29||1968-08-10
TRIAL STUDY 134XCP|RP|4C13FD80-8950-4194-B76C-F46B643BED82|1||||||INABOIND|INDUCED ABORTION INDICATOR||||HOMEOPATHIC DILUTION|||UV2|NOT DONE||U|Y|NA|4||88||FOLLOW-UP|1967-05-11||1964-10-12|||1962-12-28||1972-03-27
TRIAL STUDY 134XCP|RP|4C13FD80-8950-4194-B76C-F46B643BED82|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||NMOL/DAY|||MMU/ML|NOT DONE||U|Y|Y|4||88||TREATMENT|1962-09-25||1963-11-24|||1971-08-19||1972-11-05
TRIAL STUDY 134XCP|RP|4C13FD80-8950-4194-B76C-F46B643BED82|1||||||THICK|THICKNESS||||ML/ANIMAL/WK|||MEQ/UG|NOT DONE||N|NA|NA|5||7||LONG-TERM FOLLOW-UP|1969-08-04||1961-05-26|||1972-07-07||1968-02-11
TRIAL STUDY 134XCP|RP|4C13FD80-8950-4194-B76C-F46B643BED82|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||ROENTGEN|||VP/ML|NOT DONE||Y|U|N|5||7||BASELINE|1963-08-21||1963-04-04|||1965-02-02||1962-07-03
TRIAL STUDY 134XCP|RP|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||ML/S|||U/G|NOT DONE||U|N|Y|1||38||OBSERVATION|1964-12-28||1973-01-17|||1970-01-16||1971-07-02
TRIAL STUDY 134XCP|RP|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||LENS|||GENEQ/ML|NOT DONE||N|N|N|1||38||WASHOUT|1972-12-03||1972-04-04|||1964-02-14||1973-05-31
TRIAL STUDY 134XCP|RP|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||U/M2|||BQ|NOT DONE||Y|U|N|2||58||LONG-TERM FOLLOW-UP|1962-10-02||1962-09-27|||1964-08-04||1971-08-01
TRIAL STUDY 134XCP|RP|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|2||||||BCMETHOD|BIRTH CONTROL METHOD||||ML/KG|||MS2|NOT DONE||NA|U|Y|2||58||BASELINE|1966-06-09||1966-05-23|||1961-08-17||1970-07-01
TRIAL STUDY 134XCP|RP|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|1||||||PEELIND|PEELING INDICATOR||||INHALATION|||CM/MIN|NOT DONE||Y|U|Y|3||39||OBSERVATION|1961-09-22||1961-03-21|||1971-10-31||1961-05-12
TRIAL STUDY 134XCP|RP|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|2||||||INTP|INTERPRETATION||||CCID 50/ML|||ML|NOT DONE||N|U|NA|3||39||OBSERVATION|1969-05-28||1970-04-15|||1968-04-08||1964-04-15
TRIAL STUDY 134XCP|RP|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||VG/KG|||PPM|NOT DONE||NA|N|Y|4||88||WASHOUT|1966-07-11||1965-02-08|||1960-09-21||1962-09-05
TRIAL STUDY 134XCP|RP|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|2||||||DLVRMODE|MODE OF DELIVERY||||UCI/KG|||MMHG*MIN/L|NOT DONE||Y|NA|NA|4||88||FOLLOW-UP|1963-11-11||1969-12-08|||1961-02-17||1970-06-02
TRIAL STUDY 134XCP|RP|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||MM|||MG/M2/H|NOT DONE||Y|N|N|5||7||BLINDED TREATMENT|1964-02-01||1969-05-27|||1970-05-10||1970-09-07
TRIAL STUDY 134XCP|RP|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MESF|||UG/KG/H|NOT DONE||NA|N|Y|5||7||OBSERVATION|1962-03-01||1965-03-19|||1971-06-27||1961-06-11
TRIAL STUDY 134XCP|RP|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||F|||IN2|NOT DONE||Y|Y|N|1||38||LONG-TERM FOLLOW-UP|1964-05-18||1972-11-14|||1965-07-25||1964-05-20
TRIAL STUDY 134XCP|RP|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|2||||||TNDRIND|TENDERNESS INDICATOR||||MET*MIN|||MAMP|NOT DONE||NA|NA|NA|1||38||RUN-IN|1964-01-28||1960-06-22|||1960-04-08||1964-04-05
TRIAL STUDY 134XCP|RP|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|1||||||BLISTIND|BLISTERING INDICATOR||||FFU|||AMPULE|NOT DONE||U|U|NA|2||58||WASHOUT|1966-08-30||1972-12-31|||1970-07-25||1967-06-27
TRIAL STUDY 134XCP|RP|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||EID 50/ML|||GAUSS|NOT DONE||Y|N|NA|2||58||SCREENING|1964-02-23||1962-06-07|||1964-10-03||1969-01-07
TRIAL STUDY 134XCP|RP|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||GBQ/MG|||FT|NOT DONE||NA|NA|NA|3||39||TREATMENT|1960-05-04||1961-03-16|||1972-08-29||1962-08-20
TRIAL STUDY 134XCP|RP|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||10^3 CFU|||CUP EQ|NOT DONE||U|U|U|3||39||TREATMENT|1970-10-16||1965-04-11|||1961-12-18||1972-09-16
TRIAL STUDY 134XCP|RP|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||M2|||10^7 PFU|NOT DONE||NA|N|NA|4||88||BASELINE|1969-09-03||1971-06-07|||1973-05-01||1971-11-29
TRIAL STUDY 134XCP|RP|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||EU|||PKAT|NOT DONE||Y|N|N|4||88||INDUCTION TREATMENT|1965-04-27||1961-05-24|||1968-12-16||1962-06-11
TRIAL STUDY 134XCP|RP|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|1||||||ERYTHIND|ERYTHEMA INDICATOR||||DEG|||VOXEL|NOT DONE||NA|N|NA|5||7||OPEN LABEL TREATMENT|1966-10-24||1965-05-21|||1964-06-23||1967-04-13
TRIAL STUDY 134XCP|RP|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^7/L|||U/G/DAY|NOT DONE||NA|NA|U|5||7||INDUCTION TREATMENT|1971-04-26||1970-04-19|||1962-11-17||1966-02-14
TRIAL STUDY 134XCP|RP|CFFA0003-098B-486E-82DB-30838F6541DD|1||||||ERYTHIND|ERYTHEMA INDICATOR||||ML/SEC/1.73M2|||10^6 RNA COPIES/ML|NOT DONE||U|N|U|1||38||SCREENING|1973-04-29||1970-08-12|||1960-09-13||1966-02-22
TRIAL STUDY 134XCP|RP|CFFA0003-098B-486E-82DB-30838F6541DD|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||KBQ/UL|||MMHG*MIN/L|NOT DONE||Y|Y|Y|1||38||INDUCTION TREATMENT|1965-10-20||1960-04-14|||1962-01-15||1963-01-10
TRIAL STUDY 134XCP|RP|CFFA0003-098B-486E-82DB-30838F6541DD|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||PPB|||PMOL/DL|NOT DONE||N|Y|Y|2||58||WASHOUT|1967-09-13||1964-08-09|||1972-05-01||1967-04-12
TRIAL STUDY 134XCP|RP|CFFA0003-098B-486E-82DB-30838F6541DD|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||U/ANIMAL|||MM2|NOT DONE||Y|N|Y|2||58||BASELINE|1964-05-08||1964-07-21|||1970-01-14||1965-03-12
TRIAL STUDY 134XCP|RP|CFFA0003-098B-486E-82DB-30838F6541DD|1||||||MASSIND|MASS INDICATOR||||IU/G|||MS2|NOT DONE||U|Y|U|3||39||WASHOUT|1969-11-08||1961-03-08|||1960-11-28||1967-09-03
TRIAL STUDY 134XCP|RP|CFFA0003-098B-486E-82DB-30838F6541DD|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MG/ML/MIN|||PELLET|NOT DONE||Y|Y|NA|3||39||BLINDED TREATMENT|1969-04-20||1970-09-03|||1972-07-30||1967-12-19
TRIAL STUDY 134XCP|RP|CFFA0003-098B-486E-82DB-30838F6541DD|1||||||MENOSTAT|MENOPAUSE STATUS||||ML/MIN|||10^10/L|NOT DONE||Y|U|U|4||88||SCREENING|1970-09-15||1962-11-13|||1967-07-16||1966-02-21
TRIAL STUDY 134XCP|RP|CFFA0003-098B-486E-82DB-30838F6541DD|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UG/KG/DAY|||PMOL/L/H|NOT DONE||N|U|U|4||88||OPEN LABEL TREATMENT|1970-01-28||1969-06-09|||1961-06-25||1961-02-06
TRIAL STUDY 134XCP|RP|CFFA0003-098B-486E-82DB-30838F6541DD|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^9 ORGANISMS|||UGEQ/L|NOT DONE||U|Y|NA|5||7||OPEN LABEL TREATMENT|1960-03-25||1963-02-04|||1965-08-27||1966-01-31
TRIAL STUDY 134XCP|RP|CFFA0003-098B-486E-82DB-30838F6541DD|2||||||BLISTIND|BLISTERING INDICATOR||||NMOL/L|||UG/KG/MIN|NOT DONE||NA|NA|U|5||7||INDUCTION TREATMENT|1967-04-03||1968-06-21|||1969-02-21||1960-05-31
TRIAL STUDY 134XCP|RP|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|1||||||FUNDHT|FUNDAL HEIGHT||||G/ANIMAL|||COULOMB|NOT DONE||U|U|U|1||38||RUN-IN|1960-07-11||1964-05-14|||1963-03-23||1973-09-07
TRIAL STUDY 134XCP|RP|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||CUP|||MG/MIN|NOT DONE||N|Y|Y|1||38||BASELINE|1968-03-14||1970-09-03|||1971-05-15||1964-09-24
TRIAL STUDY 134XCP|RP|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||HOURS|||MM|NOT DONE||N|N|NA|2||58||BASELINE|1962-07-02||1966-08-18|||1969-02-17||1961-08-04
TRIAL STUDY 134XCP|RP|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|2||||||EDEMAIND|EDEMA INDICATOR||||F|||G/M2|NOT DONE||N|Y|NA|2||58||FOLLOW-UP|1963-03-31||1967-10-28|||1971-07-05||1968-11-06
TRIAL STUDY 134XCP|RP|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|1||||||PREGIND|PREGNANT INDICATOR||||NMOL BCE/NMOL|||AMPULE|NOT DONE||U|NA|N|3||39||INDUCTION TREATMENT|1967-09-05||1961-06-04|||1972-08-08||1960-04-08
TRIAL STUDY 134XCP|RP|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|2||||||MASSIND|MASS INDICATOR||||10^11/L|||/10^5|NOT DONE||NA|U|Y|3||39||OBSERVATION|1962-03-01||1968-02-17|||1969-06-16||1972-07-07
TRIAL STUDY 134XCP|RP|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||YEARS|||BU|NOT DONE||N|Y|U|4||88||OBSERVATION|1961-10-11||1966-03-13|||1960-02-20||1961-11-11
TRIAL STUDY 134XCP|RP|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|2||||||BCMETHOD|BIRTH CONTROL METHOD||||PSI|||CYCLE/MIN|NOT DONE||NA|Y|U|4||88||CONTINUATION TREATMENT|1971-04-27||1968-03-07|||1972-12-16||1961-10-19
TRIAL STUDY 134XCP|RP|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|1||||||TNDRIND|TENDERNESS INDICATOR||||MG2/DL2|||LOG10 PFU/ML|NOT DONE||NA|NA|Y|5||7||WASHOUT|1969-02-24||1961-03-28|||1965-07-24||1960-09-04
TRIAL STUDY 134XCP|RP|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||L/KG|||PPTR|NOT DONE||Y|N|NA|5||7||FOLLOW-UP|1962-02-04||1966-02-21|||1970-02-09||1965-01-22
TRIAL STUDY 134XCP|RP|3F29184F-1963-4EC7-881A-61C9DEF95D2D|1||||||PREGNN|NUMBER OF PREGNANCIES||||KIU|||G/L|NOT DONE||Y|U|NA|1||38||BLINDED TREATMENT|1962-08-18||1969-01-16|||1961-12-15||1961-11-08
TRIAL STUDY 134XCP|RP|3F29184F-1963-4EC7-881A-61C9DEF95D2D|2||||||MENARAGE|MENARCHE AGE||||ML/CAGE/DAY|||KHZ|NOT DONE||Y|NA|U|1||38||OBSERVATION|1967-12-23||1961-11-28|||1973-01-31||1961-07-05
TRIAL STUDY 134XCP|RP|3F29184F-1963-4EC7-881A-61C9DEF95D2D|1||||||GRAVIND|GRAVIDA INDICATOR||||IU/KG/H|||SHOCK WAVE|NOT DONE||Y|N|U|2||58||WASHOUT|1968-06-21||1969-10-03|||1964-05-19||1965-12-30
TRIAL STUDY 134XCP|RP|3F29184F-1963-4EC7-881A-61C9DEF95D2D|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||INHALATION|||MG/M2/DAY|NOT DONE||N|Y|Y|2||58||FOLLOW-UP|1968-04-17||1972-08-06|||1967-01-18||1964-04-07
TRIAL STUDY 134XCP|RP|3F29184F-1963-4EC7-881A-61C9DEF95D2D|1||||||INTP|INTERPRETATION||||UG/KG/H|||MOL|NOT DONE||Y|U|NA|3||39||WASHOUT|1963-04-06||1968-06-06|||1966-04-30||1961-11-24
TRIAL STUDY 134XCP|RP|3F29184F-1963-4EC7-881A-61C9DEF95D2D|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||HZ|||UMOL/H/MMOL|NOT DONE||N|NA|U|3||39||SCREENING|1970-01-10||1968-03-24|||1964-06-27||1964-11-20
TRIAL STUDY 134XCP|RP|3F29184F-1963-4EC7-881A-61C9DEF95D2D|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||U/ANIMAL|||M3|NOT DONE||Y|N|NA|4||88||RUN-IN|1960-10-28||1962-04-28|||1967-10-18||1962-12-02
TRIAL STUDY 134XCP|RP|3F29184F-1963-4EC7-881A-61C9DEF95D2D|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||ML/KG|||POINT|NOT DONE||N|U|Y|4||88||SCREENING|1971-08-22||1961-04-11|||1961-12-19||1962-01-13
TRIAL STUDY 134XCP|RP|3F29184F-1963-4EC7-881A-61C9DEF95D2D|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||DRUM|||MMOL/MOL|NOT DONE||N|N|Y|5||7||OBSERVATION|1966-04-10||1971-03-07|||1968-05-18||1973-03-26
TRIAL STUDY 134XCP|RP|3F29184F-1963-4EC7-881A-61C9DEF95D2D|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||V/V|||U/ML|NOT DONE||NA|Y|N|5||7||WASHOUT|1964-11-28||1972-04-06|||1965-04-27||1962-06-08
TRIAL STUDY 134XCP|RP|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|1||||||ULCERIND|ULCER INDICATOR||||MONTHS|||ABSORBANCE U|NOT DONE||NA|N|NA|1||38||CONTINUATION TREATMENT|1965-01-15||1962-08-04|||1971-09-25||1964-10-22
TRIAL STUDY 134XCP|RP|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MPS U|||CMOL/L|NOT DONE||Y|Y|Y|1||38||BASELINE|1965-10-09||1970-01-23|||1973-07-21||1970-05-11
TRIAL STUDY 134XCP|RP|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|1||||||BCMETHOD|BIRTH CONTROL METHOD||||NMOL/DAY|||UCI/KG|NOT DONE||N|N|N|2||58||TREATMENT|1964-09-12||1960-01-29|||1964-11-01||1973-08-01
TRIAL STUDY 134XCP|RP|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||HOMEOPATHIC DILUTION|||10^3 DNA COPIES/ML|NOT DONE||Y|NA|Y|2||58||OBSERVATION|1965-05-01||1961-05-26|||1963-02-28||1967-01-23
TRIAL STUDY 134XCP|RP|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|1||||||GRAVIND|GRAVIDA INDICATOR||||TUBERCULIN UNIT/ML|||MG/G/H|NOT DONE||N|Y|U|3||39||INDUCTION TREATMENT|1969-09-28||1964-10-01|||1971-08-07||1970-05-21
TRIAL STUDY 134XCP|RP|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|2||||||BLISTIND|BLISTERING INDICATOR||||NG|||RAD|NOT DONE||Y|U|Y|3||39||LONG-TERM FOLLOW-UP|1968-07-07||1960-09-22|||1968-11-11||1965-04-06
TRIAL STUDY 134XCP|RP|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||PIPE|||PFU/DOSE|NOT DONE||NA|Y|U|4||88||INDUCTION TREATMENT|1965-12-27||1969-10-23|||1964-09-09||1972-05-11
TRIAL STUDY 134XCP|RP|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|2||||||MASSIND|MASS INDICATOR||||EJACULATE U|||DAGU/ML|NOT DONE||Y|N|N|4||88||BLINDED TREATMENT|1969-08-29||1966-10-01|||1965-05-02||1971-10-13
TRIAL STUDY 134XCP|RP|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MN|||PMOL/DAY|NOT DONE||Y|NA|N|5||7||OBSERVATION|1963-10-14||1961-09-24|||1964-08-23||1962-11-16
TRIAL STUDY 134XCP|RP|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||TRANSDUCING UNIT|||NMOL/G|NOT DONE||N|U|NA|5||7||LONG-TERM FOLLOW-UP|1970-01-19||1962-03-17|||1963-11-08||1966-08-21
TRIAL STUDY 134XCP|RP|D9C32CF1-51C7-412D-A030-682B2860F89D|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||ENZYME U|||MMOL/G|NOT DONE||NA|NA|Y|1||38||BASELINE|1965-05-15||1967-08-13|||1970-10-19||1971-05-03
TRIAL STUDY 134XCP|RP|D9C32CF1-51C7-412D-A030-682B2860F89D|2||||||MENFDUR|MENSES FLOW DURATION||||NMOL/KG/DAY|||NGEQ/L|NOT DONE||N|U|NA|1||38||OBSERVATION|1960-06-25||1968-09-24|||1961-10-12||1972-08-15
TRIAL STUDY 134XCP|RP|D9C32CF1-51C7-412D-A030-682B2860F89D|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||NG|||UIU/DL|NOT DONE||NA|Y|Y|2||58||RUN-IN|1967-03-22||1970-07-20|||1969-09-13||1967-03-09
TRIAL STUDY 134XCP|RP|D9C32CF1-51C7-412D-A030-682B2860F89D|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||GRAIN|||UG/M2/DAY|NOT DONE||U|Y|NA|2||58||FOLLOW-UP|1961-12-19||1961-12-06|||1971-01-21||1970-10-23
TRIAL STUDY 134XCP|RP|D9C32CF1-51C7-412D-A030-682B2860F89D|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||FARAD|||ABSORBANCE U/MIN|NOT DONE||Y|N|N|3||39||BASELINE|1967-10-29||1964-06-29|||1970-04-04||1963-10-27
TRIAL STUDY 134XCP|RP|D9C32CF1-51C7-412D-A030-682B2860F89D|2||||||ABORTN|NUMBER OF ABORTIONS||||NG/MOL|||UKAT/10^12 RBC|NOT DONE||NA|NA|NA|3||39||OPEN LABEL TREATMENT|1960-12-05||1963-08-15|||1967-11-12||1973-08-18
TRIAL STUDY 134XCP|RP|D9C32CF1-51C7-412D-A030-682B2860F89D|1||||||MASSIND|MASS INDICATOR||||MOL/ML|||L/L|NOT DONE||NA|Y|NA|4||88||INDUCTION TREATMENT|1960-01-21||1964-08-20|||1969-02-01||1969-02-14
TRIAL STUDY 134XCP|RP|D9C32CF1-51C7-412D-A030-682B2860F89D|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||ML/CM H2O|||MDFI|NOT DONE||NA|NA|U|4||88||OBSERVATION|1966-08-21||1969-06-10|||1973-06-23||1964-05-30
TRIAL STUDY 134XCP|RP|D9C32CF1-51C7-412D-A030-682B2860F89D|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||KPA|||HPA|NOT DONE||U|NA|NA|5||7||RUN-IN|1966-11-06||1973-09-02|||1967-03-27||1968-03-19
TRIAL STUDY 134XCP|RP|D9C32CF1-51C7-412D-A030-682B2860F89D|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||GY|||PMOL/DAY|NOT DONE||NA|U|NA|5||7||BLINDED TREATMENT|1970-07-21||1963-08-09|||1962-06-08||1970-07-03
TRIAL STUDY 134XCP|RP|102F6B51-5A86-497B-A36D-13FB77928C39|1||||||PREGST|PREGNANT DURING THE STUDY||||EID 50/DOSE|||NMOL/G|NOT DONE||N|Y|U|1||38||WASHOUT|1960-11-17||1973-06-23|||1962-08-26||1969-01-02
TRIAL STUDY 134XCP|RP|102F6B51-5A86-497B-A36D-13FB77928C39|2||||||MASSIND|MASS INDICATOR||||CM|||L/DAY|NOT DONE||NA|N|Y|1||38||WASHOUT|1973-06-23||1969-04-03|||1968-10-14||1970-06-14
TRIAL STUDY 134XCP|RP|102F6B51-5A86-497B-A36D-13FB77928C39|1||||||MASSIND|MASS INDICATOR||||KCAL|||MMHG|NOT DONE||NA|NA|Y|2||58||LONG-TERM FOLLOW-UP|1960-04-27||1960-09-08|||1963-07-14||1966-06-18
TRIAL STUDY 134XCP|RP|102F6B51-5A86-497B-A36D-13FB77928C39|2||||||INABOIND|INDUCED ABORTION INDICATOR||||DPM/0.5 ML|||KG/MOL|NOT DONE||U|Y|Y|2||58||WASHOUT|1965-11-01||1967-12-07|||1969-01-02||1968-04-10
TRIAL STUDY 134XCP|RP|102F6B51-5A86-497B-A36D-13FB77928C39|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||L/L|||TABLET|NOT DONE||Y|N|NA|3||39||WASHOUT|1973-03-11||1962-05-10|||1972-08-09||1963-06-07
TRIAL STUDY 134XCP|RP|102F6B51-5A86-497B-A36D-13FB77928C39|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||VP/ML|||BLOCKS|NOT DONE||N|NA|Y|3||39||INDUCTION TREATMENT|1966-11-02||1965-09-29|||1973-04-28||1965-08-09
TRIAL STUDY 134XCP|RP|102F6B51-5A86-497B-A36D-13FB77928C39|1||||||FUNDHT|FUNDAL HEIGHT||||UG/M2/DAY|||/CMH2O|NOT DONE||U|N|N|4||88||SCREENING|1971-02-04||1965-07-02|||1973-04-04||1966-12-04
TRIAL STUDY 134XCP|RP|102F6B51-5A86-497B-A36D-13FB77928C39|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/G|||UG/KG/DAY|NOT DONE||U|Y|N|4||88||BASELINE|1973-01-30||1967-01-24|||1961-12-20||1968-02-15
TRIAL STUDY 134XCP|RP|102F6B51-5A86-497B-A36D-13FB77928C39|1||||||PREGIND|PREGNANT INDICATOR||||DAGU|||LOG10 IU/ML|NOT DONE||N|N|NA|5||7||SCREENING|1973-03-14||1963-10-13|||1962-04-07||1966-10-19
TRIAL STUDY 134XCP|RP|102F6B51-5A86-497B-A36D-13FB77928C39|2||||||PRGENDTC|DATE PREGNANCY ENDED||||KM/H|||JAR|NOT DONE||NA|NA|NA|5||7||CONTINUATION TREATMENT|1962-03-23||1970-12-01|||1970-12-24||1967-04-19
TRIAL STUDY 134XCP|RP|C123D04C-1AA4-418D-B68C-EC9D410376F0|1||||||STILBIND|STILLBIRTH INDICATOR||||MOL/DAY|||NMOL/L|NOT DONE||U|Y|NA|1||38||SCREENING|1963-07-12||1961-02-16|||1967-07-05||1963-05-19
TRIAL STUDY 134XCP|RP|C123D04C-1AA4-418D-B68C-EC9D410376F0|2||||||PEELIND|PEELING INDICATOR||||ML/DAY|||MOL/MOL|NOT DONE||Y|Y|U|1||38||OPEN LABEL TREATMENT|1968-12-04||1970-08-17|||1965-10-05||1972-11-03
TRIAL STUDY 134XCP|RP|C123D04C-1AA4-418D-B68C-EC9D410376F0|1||||||ERYTHIND|ERYTHEMA INDICATOR||||FRACTION OF 1|||MG/ML/MIN|NOT DONE||U|Y|Y|2||58||RUN-IN|1971-09-22||1963-02-26|||1962-11-14||1968-10-05
TRIAL STUDY 134XCP|RP|C123D04C-1AA4-418D-B68C-EC9D410376F0|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||10^9 CFU|||ML/KG/H|NOT DONE||NA|Y|N|2||58||INDUCTION TREATMENT|1969-08-08||1964-06-26|||1964-04-03||1966-09-30
TRIAL STUDY 134XCP|RP|C123D04C-1AA4-418D-B68C-EC9D410376F0|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||G/CAGE/DAY|||CM/S|NOT DONE||NA|U|N|3||39||INDUCTION TREATMENT|1967-04-15||1963-04-07|||1961-01-29||1967-09-09
TRIAL STUDY 134XCP|RP|C123D04C-1AA4-418D-B68C-EC9D410376F0|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||CCID 50/ML|||MM|NOT DONE||U|NA|U|3||39||FOLLOW-UP|1961-11-10||1971-10-22|||1963-04-26||1963-12-23
TRIAL STUDY 134XCP|RP|C123D04C-1AA4-418D-B68C-EC9D410376F0|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||LOG10 COPIES/ML|||SFC/10^6 PBMC|NOT DONE||N|NA|U|4||88||INDUCTION TREATMENT|1969-05-24||1960-11-24|||1969-03-12||1965-11-15
TRIAL STUDY 134XCP|RP|C123D04C-1AA4-418D-B68C-EC9D410376F0|2||||||BLISTIND|BLISTERING INDICATOR||||MOL|||USIEMENS|NOT DONE||U|N|U|4||88||FOLLOW-UP|1960-03-10||1964-11-26|||1968-11-27||1962-05-08
TRIAL STUDY 134XCP|RP|C123D04C-1AA4-418D-B68C-EC9D410376F0|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||MV2/HZ|||NMOL|NOT DONE||U|U|N|5||7||RUN-IN|1967-04-16||1964-01-18|||1966-05-08||1960-06-07
TRIAL STUDY 134XCP|RP|C123D04C-1AA4-418D-B68C-EC9D410376F0|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||L/L|||NG|NOT DONE||U|U|Y|5||7||BLINDED TREATMENT|1966-04-07||1962-05-03|||1967-09-06||1969-02-15
TRIAL STUDY 134XCP|RP|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UG/DAY|||/MM2|NOT DONE||U|N|N|1||38||LONG-TERM FOLLOW-UP|1962-01-08||1963-03-11|||1968-03-06||1966-03-31
TRIAL STUDY 134XCP|RP|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||UOSM|||CI|NOT DONE||Y|N|U|1||38||INDUCTION TREATMENT|1970-04-03||1967-07-24|||1971-08-03||1965-08-20
TRIAL STUDY 134XCP|RP|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|1||||||PUSTIND|PUSTULE INDICATOR||||MG/CM2|||KM/H|NOT DONE||NA|NA|U|2||58||OPEN LABEL TREATMENT|1970-03-16||1961-06-20|||1972-10-06||1966-01-07
TRIAL STUDY 134XCP|RP|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|2||||||INTP|INTERPRETATION||||MEQ/DAY|||SCOOPFUL|NOT DONE||Y|Y|U|2||58||LONG-TERM FOLLOW-UP|1966-12-01||1964-01-05|||1967-09-21||1960-12-11
TRIAL STUDY 134XCP|RP|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||PFU/ANIMAL|||RING|NOT DONE||NA|NA|NA|3||39||RUN-IN|1973-06-07||1965-05-11|||1968-08-29||1962-05-19
TRIAL STUDY 134XCP|RP|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|2||||||MENOSTAT|MENOPAUSE STATUS||||EP U|||SCM|NOT DONE||U|Y|U|3||39||FOLLOW-UP|1969-03-14||1963-07-06|||1963-06-28||1971-05-26
TRIAL STUDY 134XCP|RP|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|1||||||PREGIND|PREGNANT INDICATOR||||KM/H|||UG/KG|NOT DONE||N|N|U|4||88||TREATMENT|1964-06-15||1963-03-14|||1971-09-06||1969-10-18
TRIAL STUDY 134XCP|RP|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||CUP|||GY/MIN|NOT DONE||Y|Y|U|4||88||RUN-IN|1962-01-01||1966-10-07|||1964-07-15||1962-07-15
TRIAL STUDY 134XCP|RP|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|1||||||ULCERIND|ULCER INDICATOR||||MET|||DIOPTER|NOT DONE||U|NA|NA|5||7||CONTINUATION TREATMENT|1960-12-12||1963-09-17|||1960-12-02||1961-01-17
TRIAL STUDY 134XCP|RP|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^3 ORGANISMS/G|||MMOL/MIN/KPA|NOT DONE||N|NA|NA|5||7||INDUCTION TREATMENT|1968-04-19||1964-05-23|||1960-01-24||1966-10-11
TRIAL STUDY 134XCP|RP|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||USEC|||POUCH|NOT DONE||U|N|Y|1||38||INDUCTION TREATMENT|1968-10-20||1961-06-16|||1969-01-20||1962-07-20
TRIAL STUDY 134XCP|RP|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MOL/L|||PPB|NOT DONE||N|N|N|1||38||TREATMENT|1962-03-15||1960-05-01|||1969-01-08||1964-05-31
TRIAL STUDY 134XCP|RP|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||U/G/MIN|||ANTI-XA IU/ML|NOT DONE||N|U|N|2||58||INDUCTION TREATMENT|1963-10-22||1966-06-18|||1967-11-21||1966-02-11
TRIAL STUDY 134XCP|RP|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||/40 HPFS|||NMOL BCE/MMOL|NOT DONE||U|U|NA|2||58||BASELINE|1966-02-03||1960-01-30|||1965-11-09||1967-11-30
TRIAL STUDY 134XCP|RP|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ML/BEAT|||PIPE|NOT DONE||N|NA|Y|3||39||FOLLOW-UP|1972-09-18||1961-02-07|||1969-01-30||1969-05-22
TRIAL STUDY 134XCP|RP|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MOSM|||MMOL/MIN/KPA/L|NOT DONE||Y|U|U|3||39||RUN-IN|1962-04-15||1962-07-18|||1961-12-16||1969-08-12
TRIAL STUDY 134XCP|RP|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|1||||||BCMETHOD|BIRTH CONTROL METHOD||||CCID 50/ML|||NG/DAY|NOT DONE||U|Y|Y|4||88||INDUCTION TREATMENT|1970-09-15||1965-09-20|||1966-10-09||1961-02-03
TRIAL STUDY 134XCP|RP|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|2||||||MENOSTAT|MENOPAUSE STATUS||||ML/G/MIN|||KDA|NOT DONE||NA|N|N|4||88||CONTINUATION TREATMENT|1972-10-19||1971-11-08|||1962-06-05||1960-11-26
TRIAL STUDY 134XCP|RP|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|1||||||PREGST|PREGNANT DURING THE STUDY||||DPM/100MG|||ML/MMHG|NOT DONE||U|U|Y|5||7||INDUCTION TREATMENT|1969-03-09||1960-04-25|||1961-11-01||1972-04-07
TRIAL STUDY 134XCP|RP|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||DNA COPIES/ML|||HEP|NOT DONE||N|U|U|5||7||CONTINUATION TREATMENT|1964-09-05||1969-08-15|||1960-09-14||1969-07-02
TRIAL STUDY 134XCP|RP|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||FOZ_BR|||UGEQ/L|NOT DONE||U|Y|Y|1||38||BASELINE|1970-03-01||1964-12-16|||1966-09-25||1969-02-06
TRIAL STUDY 134XCP|RP|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||G/M2|||POUCH|NOT DONE||N|NA|Y|1||38||BLINDED TREATMENT|1961-07-03||1960-07-31|||1962-08-14||1961-08-13
TRIAL STUDY 134XCP|RP|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MN|||U/G/MIN|NOT DONE||N|N|Y|2||58||WASHOUT|1973-05-27||1961-03-20|||1961-10-27||1968-01-20
TRIAL STUDY 134XCP|RP|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|2||||||DLVRMODE|MODE OF DELIVERY||||MDFI|||CG|NOT DONE||Y|NA|NA|2||58||BLINDED TREATMENT|1969-04-11||1967-09-29|||1971-04-20||1969-02-20
TRIAL STUDY 134XCP|RP|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||M2|||YD|NOT DONE||U|NA|NA|3||39||OBSERVATION|1960-07-03||1964-09-25|||1966-01-27||1969-12-25
TRIAL STUDY 134XCP|RP|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|2||||||PREGIND|PREGNANT INDICATOR||||LOG10 ELISA UNIT/DOSE|||CM|NOT DONE||NA|Y|N|3||39||INDUCTION TREATMENT|1973-04-14||1971-10-18|||1969-08-02||1960-01-16
TRIAL STUDY 134XCP|RP|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||10^9/L|||G/KG/DAY|NOT DONE||U|Y|Y|4||88||OPEN LABEL TREATMENT|1972-06-11||1969-04-01|||1965-05-31||1966-09-30
TRIAL STUDY 134XCP|RP|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|2||||||MASSIND|MASS INDICATOR||||U/G/DAY|||UGEQ|NOT DONE||NA|U|Y|4||88||CONTINUATION TREATMENT|1970-11-07||1968-11-05|||1962-02-05||1969-09-18
TRIAL STUDY 134XCP|RP|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||/MIN|||MG2/DL2|NOT DONE||U|U|U|5||7||WASHOUT|1964-08-06||1966-10-05|||1966-08-02||1964-02-25
TRIAL STUDY 134XCP|RP|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||MESF|||CAL|NOT DONE||U|NA|N|5||7||OBSERVATION|1964-02-09||1963-12-10|||1965-12-12||1962-12-02
TRIAL STUDY 134XCP|RP|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|1||||||ERYTHIND|ERYTHEMA INDICATOR||||UKAT/10^12 RBC|||CAPFUL|NOT DONE||N|U|N|1||38||SCREENING|1967-12-13||1971-02-17|||1965-11-30||1968-12-10
TRIAL STUDY 134XCP|RP|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MOL/G|||KPA/L/SEC|NOT DONE||U|U|NA|1||38||BLINDED TREATMENT|1972-07-10||1962-04-14|||1971-09-26||1969-04-23
TRIAL STUDY 134XCP|RP|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|1||||||BCMETHOD|BIRTH CONTROL METHOD||||USIEMENS|||TRANSDUCING UNIT/ML|NOT DONE||NA|NA|N|2||58||OBSERVATION|1960-11-04||1972-02-27|||1964-02-01||1972-09-29
TRIAL STUDY 134XCP|RP|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|2||||||FUNDHT|FUNDAL HEIGHT||||KCAL|||M/SEC|NOT DONE||NA|U|N|2||58||BASELINE|1969-02-23||1965-03-30|||1973-01-10||1963-07-31
TRIAL STUDY 134XCP|RP|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||MPA|||10^6 DNA COPIES/ML|NOT DONE||NA|U|N|3||39||BLINDED TREATMENT|1971-12-12||1973-03-16|||1970-05-13||1962-12-27
TRIAL STUDY 134XCP|RP|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||10^9/DOSE|||MANSON U/ML|NOT DONE||Y|N|N|3||39||BASELINE|1970-01-22||1969-12-05|||1963-02-02||1968-03-19
TRIAL STUDY 134XCP|RP|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||PIXEL|||ML/G/DAY|NOT DONE||NA|N|Y|4||88||FOLLOW-UP|1960-11-03||1969-01-10|||1969-01-11||1965-07-16
TRIAL STUDY 134XCP|RP|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||DRUM|||M/SEC2|NOT DONE||N|Y|NA|4||88||BASELINE|1971-07-03||1973-05-25|||1960-01-24||1965-07-19
TRIAL STUDY 134XCP|RP|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|1||||||BRTHN|NUMBER OF BIRTHS||||ML/KG/H|||UU/DL|NOT DONE||U|N|NA|5||7||BASELINE|1966-07-04||1965-02-03|||1965-01-22||1964-09-13
TRIAL STUDY 134XCP|RP|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||CMOL/L|||TUBERCULIN UNIT|NOT DONE||Y|U|N|5||7||OBSERVATION|1965-08-10||1960-09-13|||1972-08-12||1963-04-06
TRIAL STUDY 134XCP|RP|E3310689-5727-4970-A675-A58931E406FA|1||||||EDEMAIND|EDEMA INDICATOR||||KV|||ENZYME U|NOT DONE||Y|N|NA|1||38||RUN-IN|1960-09-18||1972-05-19|||1967-03-16||1969-11-11
TRIAL STUDY 134XCP|RP|E3310689-5727-4970-A675-A58931E406FA|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||/MONTH|||U/KG|NOT DONE||Y|U|N|1||38||LONG-TERM FOLLOW-UP|1969-11-05||1961-11-08|||1972-11-06||1963-10-30
TRIAL STUDY 134XCP|RP|E3310689-5727-4970-A675-A58931E406FA|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||ML/KG/DAY|||10^6 CFU/G|NOT DONE||U|U|N|2||58||BASELINE|1960-06-14||1969-05-01|||1965-09-03||1972-11-03
TRIAL STUDY 134XCP|RP|E3310689-5727-4970-A675-A58931E406FA|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||UG/M2|||L/MIN|NOT DONE||Y|Y|N|2||58||OPEN LABEL TREATMENT|1960-03-14||1969-10-01|||1964-11-04||1971-12-15
TRIAL STUDY 134XCP|RP|E3310689-5727-4970-A675-A58931E406FA|1||||||PRGENDTC|DATE PREGNANCY ENDED||||ML/H|||G/CM2|NOT DONE||U|NA|NA|3||39||BASELINE|1970-06-19||1966-02-03|||1965-10-02||1961-04-09
TRIAL STUDY 134XCP|RP|E3310689-5727-4970-A675-A58931E406FA|2||||||MASSIND|MASS INDICATOR||||UV*SEC|||PPM|NOT DONE||Y|N|NA|3||39||WASHOUT|1968-10-10||1962-08-20|||1969-08-27||1964-09-11
TRIAL STUDY 134XCP|RP|E3310689-5727-4970-A675-A58931E406FA|1||||||BRTHN|NUMBER OF BIRTHS||||UG/KG|||UCI|NOT DONE||N|Y|NA|4||88||WASHOUT|1968-02-04||1970-05-23|||1966-11-01||1972-03-27
TRIAL STUDY 134XCP|RP|E3310689-5727-4970-A675-A58931E406FA|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UGEQ|||MBQ|NOT DONE||NA|NA|N|4||88||TREATMENT|1960-01-11||1973-06-02|||1968-05-28||1960-09-20
TRIAL STUDY 134XCP|RP|E3310689-5727-4970-A675-A58931E406FA|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||ML/KG/MIN|||MPS U|NOT DONE||Y|N|U|5||7||RUN-IN|1973-08-13||1961-07-02|||1965-07-06||1973-03-03
TRIAL STUDY 134XCP|RP|E3310689-5727-4970-A675-A58931E406FA|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||DAYS/MONTH|||CIGARETTE|NOT DONE||Y|U|Y|5||7||INDUCTION TREATMENT|1969-06-25||1970-03-23|||1971-09-08||1965-02-28
TRIAL STUDY 134XCP|RP|D5359BBA-960E-4392-996A-BCDD8637894A|1||||||DLVRMODE|MODE OF DELIVERY||||U|||OD UNIT|NOT DONE||NA|NA|U|1||38||BLINDED TREATMENT|1962-04-30||1965-06-28|||1966-04-04||1968-04-02
TRIAL STUDY 134XCP|RP|D5359BBA-960E-4392-996A-BCDD8637894A|2||||||MENOSTAT|MENOPAUSE STATUS||||DPM|||ML/CM|NOT DONE||N|N|U|1||38||SCREENING|1965-05-04||1971-08-05|||1968-09-21||1966-01-20
TRIAL STUDY 134XCP|RP|D5359BBA-960E-4392-996A-BCDD8637894A|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||BQ/G|||DRINK|NOT DONE||U|N|N|2||58||OBSERVATION|1970-03-07||1965-10-08|||1964-07-20||1969-08-12
TRIAL STUDY 134XCP|RP|D5359BBA-960E-4392-996A-BCDD8637894A|2||||||DLVRMODE|MODE OF DELIVERY||||UG/KG|||S/H|NOT DONE||NA|N|U|2||58||BASELINE|1962-02-09||1961-05-06|||1967-08-07||1960-12-26
TRIAL STUDY 134XCP|RP|D5359BBA-960E-4392-996A-BCDD8637894A|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MEQ/DAY|||ATM|NOT DONE||Y|N|U|3||39||BLINDED TREATMENT|1969-11-23||1968-12-05|||1973-05-17||1962-03-30
TRIAL STUDY 134XCP|RP|D5359BBA-960E-4392-996A-BCDD8637894A|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UKAT/10^12 RBC|||/WK|NOT DONE||NA|U|Y|3||39||BLINDED TREATMENT|1961-07-31||1963-08-24|||1970-10-31||1962-09-24
TRIAL STUDY 134XCP|RP|D5359BBA-960E-4392-996A-BCDD8637894A|1||||||MENFDUR|MENSES FLOW DURATION||||MG/M2|||FIU|NOT DONE||N|NA|U|4||88||TREATMENT|1967-09-22||1966-04-19|||1965-01-28||1969-10-26
TRIAL STUDY 134XCP|RP|D5359BBA-960E-4392-996A-BCDD8637894A|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||V|||UG/ML/H|NOT DONE||NA|U|N|4||88||INDUCTION TREATMENT|1960-04-08||1965-12-28|||1970-09-12||1966-05-18
TRIAL STUDY 134XCP|RP|D5359BBA-960E-4392-996A-BCDD8637894A|1||||||PREGNN|NUMBER OF PREGNANCIES||||CD*S/M2|||FRACTION OF 1|NOT DONE||U|U|N|5||7||OPEN LABEL TREATMENT|1962-04-05||1971-05-03|||1961-04-27||1973-02-27
TRIAL STUDY 134XCP|RP|D5359BBA-960E-4392-996A-BCDD8637894A|2||||||PEELIND|PEELING INDICATOR||||RAD|||10^10/L|NOT DONE||NA|NA|Y|5||7||CONTINUATION TREATMENT|1971-11-09||1962-11-28|||1969-05-02||1969-11-26
TRIAL STUDY 134XCP|RP|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||NMOL/L/H|||/HPF|NOT DONE||N|NA|N|1||38||OPEN LABEL TREATMENT|1965-09-13||1969-05-29|||1967-02-01||1964-07-26
TRIAL STUDY 134XCP|RP|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||10^6/G|||10^8/L|NOT DONE||N|U|Y|1||38||CONTINUATION TREATMENT|1962-12-07||1971-08-31|||1968-09-26||1962-08-21
TRIAL STUDY 134XCP|RP|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||U/KG/H|||/10^5|NOT DONE||NA|Y|NA|2||58||LONG-TERM FOLLOW-UP|1973-03-16||1973-02-21|||1972-04-30||1969-02-18
TRIAL STUDY 134XCP|RP|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|2||||||THICK|THICKNESS||||CI/UG|||KIT|NOT DONE||Y|NA|N|2||58||CONTINUATION TREATMENT|1963-10-26||1960-05-19|||1961-03-26||1965-12-13
TRIAL STUDY 134XCP|RP|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||CUP|||/MIN|NOT DONE||NA|Y|U|3||39||BLINDED TREATMENT|1970-02-10||1961-05-10|||1970-11-09||1964-05-30
TRIAL STUDY 134XCP|RP|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|2||||||MENFDUR|MENSES FLOW DURATION||||10^6 CFU/G|||MEQ/DL|NOT DONE||Y|Y|U|3||39||WASHOUT|1963-08-11||1962-07-22|||1973-05-18||1972-09-15
TRIAL STUDY 134XCP|RP|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||CD|||M/SEC2|NOT DONE||NA|Y|N|4||88||CONTINUATION TREATMENT|1968-12-25||1964-05-15|||1972-11-07||1966-05-18
TRIAL STUDY 134XCP|RP|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||10^9/G|||NGEQ/L|NOT DONE||Y|N|N|4||88||CONTINUATION TREATMENT|1960-05-27||1972-02-20|||1969-01-07||1969-09-02
TRIAL STUDY 134XCP|RP|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MMHG*MIN/L|||PACKAGE|NOT DONE||N|N|Y|5||7||OPEN LABEL TREATMENT|1969-04-12||1968-06-11|||1967-05-06||1961-06-14
TRIAL STUDY 134XCP|RP|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|2||||||ULCERIND|ULCER INDICATOR||||USEC|||/2000 RBC|NOT DONE||NA|Y|NA|5||7||TREATMENT|1973-01-10||1960-03-31|||1961-12-01||1966-09-02
TRIAL STUDY 134XCP|RP|EED3F55E-892E-46C6-8B0A-30D2E1112072|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||PIPE|||PT_BR|NOT DONE||U|U|NA|1||38||OBSERVATION|1967-10-27||1964-09-17|||1971-04-13||1962-08-29
TRIAL STUDY 134XCP|RP|EED3F55E-892E-46C6-8B0A-30D2E1112072|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||G/U|||MV*MIN|NOT DONE||N|Y|N|1||38||CONTINUATION TREATMENT|1970-02-06||1966-07-13|||1962-07-14||1970-08-18
TRIAL STUDY 134XCP|RP|EED3F55E-892E-46C6-8B0A-30D2E1112072|1||||||FUNDHT|FUNDAL HEIGHT||||ML/SEC/1.73M2|||ELISA UNIT/ML|NOT DONE||NA|U|U|2||58||SCREENING|1968-11-03||1971-07-16|||1962-05-27||1966-09-21
TRIAL STUDY 134XCP|RP|EED3F55E-892E-46C6-8B0A-30D2E1112072|2||||||PREGST|PREGNANT DURING THE STUDY||||/DAY|||RNA COPIES/ML|NOT DONE||NA|Y|Y|2||58||WASHOUT|1960-01-05||1965-06-01|||1969-01-09||1962-11-18
TRIAL STUDY 134XCP|RP|EED3F55E-892E-46C6-8B0A-30D2E1112072|1||||||PREGNN|NUMBER OF PREGNANCIES||||FT2|||MEQ/KG|NOT DONE||N|N|N|3||39||LONG-TERM FOLLOW-UP|1970-11-28||1973-08-22|||1971-03-06||1963-06-07
TRIAL STUDY 134XCP|RP|EED3F55E-892E-46C6-8B0A-30D2E1112072|2||||||TNDRIND|TENDERNESS INDICATOR||||LOG10 TCID 50/DOSE|||IU/MG|NOT DONE||N|NA|NA|3||39||BASELINE|1968-08-09||1969-12-28|||1963-09-06||1965-10-18
TRIAL STUDY 134XCP|RP|EED3F55E-892E-46C6-8B0A-30D2E1112072|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||IU/G|||UMOL/L/MIN|NOT DONE||N|U|NA|4||88||OBSERVATION|1972-04-24||1962-03-30|||1961-02-27||1966-02-18
TRIAL STUDY 134XCP|RP|EED3F55E-892E-46C6-8B0A-30D2E1112072|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||L/S/KPA|||ANTI-XA IU/ML|NOT DONE||NA|N|U|4||88||OPEN LABEL TREATMENT|1963-02-22||1962-09-17|||1966-07-25||1971-04-02
TRIAL STUDY 134XCP|RP|EED3F55E-892E-46C6-8B0A-30D2E1112072|1||||||PEELIND|PEELING INDICATOR||||KUSP|||ML/100G/MIN|NOT DONE||NA|N|Y|5||7||WASHOUT|1963-07-13||1966-01-05|||1960-09-18||1961-03-19
TRIAL STUDY 134XCP|RP|EED3F55E-892E-46C6-8B0A-30D2E1112072|2||||||MENFDUR|MENSES FLOW DURATION||||P|||MOSM/KG|NOT DONE||U|N|Y|5||7||RUN-IN|1962-01-19||1962-01-11|||1966-09-02||1969-03-13
TRIAL STUDY 134XCP|RP|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|1||||||PREGST|PREGNANT DURING THE STUDY||||BEAM BREAKS|||UKAT|NOT DONE||U|NA|Y|1||38||LONG-TERM FOLLOW-UP|1965-08-30||1963-06-08|||1960-04-05||1966-05-11
TRIAL STUDY 134XCP|RP|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|2||||||GRAVIND|GRAVIDA INDICATOR||||MOL/MOL|||GPS U|NOT DONE||N|N|N|1||38||WASHOUT|1960-09-22||1971-12-11|||1967-05-07||1971-08-04
TRIAL STUDY 134XCP|RP|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||BAU|||IMPLANT|NOT DONE||NA|Y|N|2||58||BASELINE|1968-10-17||1968-05-01|||1972-12-05||1961-09-15
TRIAL STUDY 134XCP|RP|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||BLOCKS|||PIXELS/CM|NOT DONE||Y|U|Y|2||58||LONG-TERM FOLLOW-UP|1968-07-28||1962-12-13|||1969-11-21||1968-07-15
TRIAL STUDY 134XCP|RP|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||CAL|||UG/L/H|NOT DONE||U|NA|NA|3||39||TREATMENT|1968-07-16||1970-02-21|||1968-04-16||1965-10-27
TRIAL STUDY 134XCP|RP|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|2||||||PRGENDTC|DATE PREGNANCY ENDED||||/H|||MDFI|NOT DONE||Y|N|NA|3||39||INDUCTION TREATMENT|1963-07-18||1962-05-27|||1972-09-27||1972-01-25
TRIAL STUDY 134XCP|RP|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MG/DAY|||10^4 CFU/ML|NOT DONE||Y|N|NA|4||88||OPEN LABEL TREATMENT|1966-12-09||1962-04-13|||1967-03-27||1973-02-13
TRIAL STUDY 134XCP|RP|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|2||||||FUNDHT|FUNDAL HEIGHT||||PACK|||ROENTGEN|NOT DONE||NA|NA|NA|4||88||BASELINE|1963-09-27||1964-08-22|||1971-06-13||1962-09-20
TRIAL STUDY 134XCP|RP|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MEQ/DL|||KUSP|NOT DONE||U|NA|N|5||7||TREATMENT|1971-02-19||1964-12-01|||1962-01-09||1970-08-20
TRIAL STUDY 134XCP|RP|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||GPS U|||G/M2|NOT DONE||Y|U|U|5||7||FOLLOW-UP|1972-09-13||1960-05-25|||1967-11-07||1962-01-23
TRIAL STUDY 134XCP|RP|B865DADD-9A4E-4521-A2E8-104D709F4144|1||||||PREGNN|NUMBER OF PREGNANCIES||||CS|||GPS U|NOT DONE||N|Y|Y|1||38||CONTINUATION TREATMENT|1960-04-17||1971-10-04|||1963-11-13||1968-01-19
TRIAL STUDY 134XCP|RP|B865DADD-9A4E-4521-A2E8-104D709F4144|2||||||INABOIND|INDUCED ABORTION INDICATOR||||GPS U|||MEQ/ML|NOT DONE||NA|U|NA|1||38||WASHOUT|1964-03-22||1968-03-09|||1969-11-01||1972-06-14
TRIAL STUDY 134XCP|RP|B865DADD-9A4E-4521-A2E8-104D709F4144|1||||||RASHIND|RASH INDICATOR||||PMOL/DAY|||DIP|NOT DONE||NA|NA|Y|2||58||INDUCTION TREATMENT|1971-03-03||1960-12-09|||1972-10-12||1968-10-09
TRIAL STUDY 134XCP|RP|B865DADD-9A4E-4521-A2E8-104D709F4144|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||ML/KG|||FRACTION OF 1|NOT DONE||NA|Y|N|2||58||INDUCTION TREATMENT|1961-08-16||1963-12-08|||1966-03-08||1966-04-25
TRIAL STUDY 134XCP|RP|B865DADD-9A4E-4521-A2E8-104D709F4144|1||||||ABORTN|NUMBER OF ABORTIONS||||FG|||GRAIN|NOT DONE||N|NA|Y|3||39||TREATMENT|1960-08-25||1961-10-13|||1965-10-07||1968-01-04
TRIAL STUDY 134XCP|RP|B865DADD-9A4E-4521-A2E8-104D709F4144|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MG/M2/MIN|||KG/MOL|NOT DONE||Y|Y|NA|3||39||OBSERVATION|1963-02-15||1967-11-17|||1971-12-08||1969-06-10
TRIAL STUDY 134XCP|RP|B865DADD-9A4E-4521-A2E8-104D709F4144|1||||||PRGENDTC|DATE PREGNANCY ENDED||||UGEQ/L|||%|NOT DONE||N|N|Y|4||88||RUN-IN|1967-06-28||1961-11-23|||1963-06-22||1966-10-22
TRIAL STUDY 134XCP|RP|B865DADD-9A4E-4521-A2E8-104D709F4144|2||||||BCMETHOD|BIRTH CONTROL METHOD||||MOL/DAY|||10^3/HPF|NOT DONE||U|N|Y|4||88||RUN-IN|1964-02-08||1971-04-04|||1972-07-13||1967-07-29
TRIAL STUDY 134XCP|RP|B865DADD-9A4E-4521-A2E8-104D709F4144|1||||||FUNDHT|FUNDAL HEIGHT||||PFU/DOSE|||UMOL/DL|NOT DONE||NA|NA|Y|5||7||INDUCTION TREATMENT|1965-08-08||1960-01-09|||1962-09-10||1960-08-03
TRIAL STUDY 134XCP|RP|B865DADD-9A4E-4521-A2E8-104D709F4144|2||||||DLVRMODE|MODE OF DELIVERY||||AMP|||UGEQ/L|NOT DONE||N|NA|NA|5||7||INDUCTION TREATMENT|1961-08-17||1967-02-20|||1963-12-29||1960-10-27
TRIAL STUDY 134XCP|RP|D8C78860-7893-4239-8F29-A0EE98C90310|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||WAFER|||JOULE|NOT DONE||Y|NA|U|1||38||BASELINE|1968-11-05||1972-09-29|||1968-12-07||1972-11-21
TRIAL STUDY 134XCP|RP|D8C78860-7893-4239-8F29-A0EE98C90310|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||ATM|||SCOOPFUL|NOT DONE||N|NA|NA|1||38||BLINDED TREATMENT|1962-08-22||1966-05-15|||1964-03-27||1971-12-23
TRIAL STUDY 134XCP|RP|D8C78860-7893-4239-8F29-A0EE98C90310|1||||||PREGIND|PREGNANT INDICATOR||||G/MOL|||AMPULE|NOT DONE||NA|NA|N|2||58||OBSERVATION|1966-10-26||1964-06-18|||1973-04-08||1973-07-24
TRIAL STUDY 134XCP|RP|D8C78860-7893-4239-8F29-A0EE98C90310|2||||||MASSIND|MASS INDICATOR||||U.CARR|||U.CARR|NOT DONE||Y|N|Y|2||58||OBSERVATION|1967-05-28||1963-03-28|||1971-09-03||1964-03-14
TRIAL STUDY 134XCP|RP|D8C78860-7893-4239-8F29-A0EE98C90310|1||||||BLISTIND|BLISTERING INDICATOR||||10^6 U|||ML/KG/H|NOT DONE||U|NA|Y|3||39||RUN-IN|1972-07-29||1971-03-29|||1963-11-18||1971-04-17
TRIAL STUDY 134XCP|RP|D8C78860-7893-4239-8F29-A0EE98C90310|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||CI/UG|||PFU/ML|NOT DONE||N|NA|N|3||39||CONTINUATION TREATMENT|1971-02-06||1964-01-28|||1973-01-18||1972-03-04
TRIAL STUDY 134XCP|RP|D8C78860-7893-4239-8F29-A0EE98C90310|1||||||FUNDHT|FUNDAL HEIGHT||||GMFI|||UG/ML/H|NOT DONE||NA|Y|N|4||88||WASHOUT|1972-03-10||1971-09-13|||1973-07-17||1966-07-10
TRIAL STUDY 134XCP|RP|D8C78860-7893-4239-8F29-A0EE98C90310|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^6/EJACULATE U|||PMOL/DAY|NOT DONE||NA|N|Y|4||88||OPEN LABEL TREATMENT|1960-04-12||1971-04-09|||1971-04-04||1965-05-08
TRIAL STUDY 134XCP|RP|D8C78860-7893-4239-8F29-A0EE98C90310|1||||||FUNDHT|FUNDAL HEIGHT||||UG/M2|||MU/L|NOT DONE||NA|Y|NA|5||7||WASHOUT|1960-03-10||1966-11-11|||1971-09-26||1960-04-21
TRIAL STUDY 134XCP|RP|D8C78860-7893-4239-8F29-A0EE98C90310|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||EID 50/DOSE|||GENEQ/ML|NOT DONE||U|U|U|5||7||WASHOUT|1966-12-10||1964-11-06|||1963-09-13||1964-04-06
TRIAL STUDY 134XCP|RP|841D0118-C3F9-4169-B43E-D88CEB2795BA|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||TSP EQ|||PMOL/L/H|NOT DONE||N|N|NA|1||38||SCREENING|1966-09-14||1964-04-22|||1966-06-09||1969-11-06
TRIAL STUDY 134XCP|RP|841D0118-C3F9-4169-B43E-D88CEB2795BA|2||||||ULCERIND|ULCER INDICATOR||||KS|||CS|NOT DONE||Y|U|U|1||38||LONG-TERM FOLLOW-UP|1966-11-09||1972-09-09|||1971-07-11||1965-02-13
TRIAL STUDY 134XCP|RP|841D0118-C3F9-4169-B43E-D88CEB2795BA|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||FRACTION OF 1|||MEQ/L|NOT DONE||NA|Y|U|2||58||INDUCTION TREATMENT|1960-10-24||1964-11-29|||1963-08-28||1964-08-07
TRIAL STUDY 134XCP|RP|841D0118-C3F9-4169-B43E-D88CEB2795BA|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||GBQ|||10^3 ORGANISMS/G|NOT DONE||Y|Y|Y|2||58||OBSERVATION|1968-05-05||1962-07-23|||1971-05-02||1965-03-03
TRIAL STUDY 134XCP|RP|841D0118-C3F9-4169-B43E-D88CEB2795BA|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||NG/DAY|||POINT|NOT DONE||N|U|Y|3||39||INDUCTION TREATMENT|1972-02-03||1965-07-30|||1971-05-11||1961-11-18
TRIAL STUDY 134XCP|RP|841D0118-C3F9-4169-B43E-D88CEB2795BA|2||||||MENARAGE|MENARCHE AGE||||SACHET|||MMHG|NOT DONE||U|U|N|3||39||CONTINUATION TREATMENT|1962-05-18||1966-10-10|||1970-08-07||1969-07-24
TRIAL STUDY 134XCP|RP|841D0118-C3F9-4169-B43E-D88CEB2795BA|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MMU/ML|||U/G HB|NOT DONE||U|Y|Y|4||88||BLINDED TREATMENT|1960-09-04||1964-02-14|||1968-09-28||1963-08-03
TRIAL STUDY 134XCP|RP|841D0118-C3F9-4169-B43E-D88CEB2795BA|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||PUFF|||BLOCKS|NOT DONE||Y|NA|NA|4||88||FOLLOW-UP|1966-07-30||1962-03-09|||1962-06-22||1972-04-12
TRIAL STUDY 134XCP|RP|841D0118-C3F9-4169-B43E-D88CEB2795BA|1||||||MENOAGE|MENOPAUSE AGE||||IU/DL|||PPTR|NOT DONE||U|NA|U|5||7||FOLLOW-UP|1963-03-12||1968-09-10|||1960-10-24||1963-06-14
TRIAL STUDY 134XCP|RP|841D0118-C3F9-4169-B43E-D88CEB2795BA|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ML/KG/DAY|||MJOULE/CM2|NOT DONE||U|NA|NA|5||7||RUN-IN|1973-05-09||1967-08-10|||1970-09-09||1973-01-31
TRIAL STUDY 134XCP|RP|9C3C0334-F7A4-4530-A6D3-574C039979E7|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||NMOL/ML/MIN|||RNA COPIES/ML|NOT DONE||U|Y|NA|1||38||OPEN LABEL TREATMENT|1969-03-15||1972-01-06|||1960-11-29||1964-02-13
TRIAL STUDY 134XCP|RP|9C3C0334-F7A4-4530-A6D3-574C039979E7|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||NMOL/L/H|||ML/M2/MIN|NOT DONE||NA|Y|NA|1||38||LONG-TERM FOLLOW-UP|1969-03-21||1965-09-15|||1966-07-16||1968-08-13
TRIAL STUDY 134XCP|RP|9C3C0334-F7A4-4530-A6D3-574C039979E7|1||||||TNDRIND|TENDERNESS INDICATOR||||10^7 CFU/ML|||10^6 U|NOT DONE||NA|Y|U|2||58||INDUCTION TREATMENT|1963-08-08||1966-11-06|||1964-01-29||1964-05-26
TRIAL STUDY 134XCP|RP|9C3C0334-F7A4-4530-A6D3-574C039979E7|2||||||MENFDUR|MENSES FLOW DURATION||||MEQ/L|||PELLET|NOT DONE||Y|Y|NA|2||58||OPEN LABEL TREATMENT|1961-06-18||1963-08-15|||1973-05-03||1969-02-22
TRIAL STUDY 134XCP|RP|9C3C0334-F7A4-4530-A6D3-574C039979E7|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MANSON U/ML|||P|NOT DONE||NA|Y|Y|3||39||FOLLOW-UP|1965-05-19||1962-12-18|||1971-08-27||1966-04-06
TRIAL STUDY 134XCP|RP|9C3C0334-F7A4-4530-A6D3-574C039979E7|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MGEQ|||10^3 CFU/ML|NOT DONE||U|NA|Y|3||39||BLINDED TREATMENT|1971-12-23||1967-06-07|||1966-06-11||1965-04-05
TRIAL STUDY 134XCP|RP|9C3C0334-F7A4-4530-A6D3-574C039979E7|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||OHM|||COULOMB|NOT DONE||Y|N|N|4||88||LONG-TERM FOLLOW-UP|1964-01-26||1965-12-28|||1966-03-03||1967-09-12
TRIAL STUDY 134XCP|RP|9C3C0334-F7A4-4530-A6D3-574C039979E7|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MAC50|||10^6/EJACULATE U|NOT DONE||NA|NA|U|4||88||CONTINUATION TREATMENT|1968-01-05||1961-11-16|||1966-07-16||1960-07-08
TRIAL STUDY 134XCP|RP|9C3C0334-F7A4-4530-A6D3-574C039979E7|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||ML/DAY|||UG/MOL|NOT DONE||U|U|U|5||7||CONTINUATION TREATMENT|1963-12-13||1963-12-15|||1968-07-02||1972-01-27
TRIAL STUDY 134XCP|RP|9C3C0334-F7A4-4530-A6D3-574C039979E7|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||CMH2O/ML|||MOL/DAY|NOT DONE||NA|NA|Y|5||7||FOLLOW-UP|1965-10-19||1966-03-22|||1968-03-19||1966-07-25
TRIAL STUDY 134XCP|RP|FE955CB9-9992-4521-8788-7597AF40F214|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||ML/SEC/1.73M2|||10^6/EJACULATE U|NOT DONE||N|Y|U|1||38||OPEN LABEL TREATMENT|1963-03-18||1967-02-07|||1972-01-06||1968-09-28
TRIAL STUDY 134XCP|RP|FE955CB9-9992-4521-8788-7597AF40F214|2||||||MASSIND|MASS INDICATOR||||BE/ML|||LX|NOT DONE||NA|NA|U|1||38||LONG-TERM FOLLOW-UP|1967-06-13||1972-03-13|||1963-12-07||1972-03-07
TRIAL STUDY 134XCP|RP|FE955CB9-9992-4521-8788-7597AF40F214|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||DAYS/WK|||MG/M2|NOT DONE||NA|Y|Y|2||58||BLINDED TREATMENT|1962-05-11||1964-01-30|||1971-08-31||1971-02-03
TRIAL STUDY 134XCP|RP|FE955CB9-9992-4521-8788-7597AF40F214|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||LOG EID 50/DOSE|||MM|NOT DONE||Y|NA|Y|2||58||BASELINE|1967-01-20||1961-07-14|||1966-02-04||1963-11-29
TRIAL STUDY 134XCP|RP|FE955CB9-9992-4521-8788-7597AF40F214|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||DRUM|||PIXEL|NOT DONE||Y|NA|N|3||39||LONG-TERM FOLLOW-UP|1972-09-26||1967-08-01|||1972-04-23||1969-09-27
TRIAL STUDY 134XCP|RP|FE955CB9-9992-4521-8788-7597AF40F214|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||DL|||KIT|NOT DONE||N|Y|N|3||39||CONTINUATION TREATMENT|1964-10-06||1966-11-18|||1969-03-14||1967-04-20
TRIAL STUDY 134XCP|RP|FE955CB9-9992-4521-8788-7597AF40F214|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||L/H|||EID 50/DOSE|NOT DONE||N|Y|NA|4||88||OPEN LABEL TREATMENT|1963-08-08||1965-09-11|||1962-10-19||1972-11-25
TRIAL STUDY 134XCP|RP|FE955CB9-9992-4521-8788-7597AF40F214|2||||||DSCHGIND|DISCHARGE INDICATOR||||MMOL/S|||L/S/KPA|NOT DONE||Y|NA|NA|4||88||BASELINE|1972-08-30||1962-05-19|||1961-07-01||1972-03-14
TRIAL STUDY 134XCP|RP|FE955CB9-9992-4521-8788-7597AF40F214|1||||||STILBIND|STILLBIRTH INDICATOR||||TSP EQ|||ML|NOT DONE||U|Y|N|5||7||CONTINUATION TREATMENT|1969-05-14||1972-06-18|||1961-03-10||1971-08-13
TRIAL STUDY 134XCP|RP|FE955CB9-9992-4521-8788-7597AF40F214|2||||||PREGNN|NUMBER OF PREGNANCIES||||L/KG|||F|NOT DONE||NA|U|Y|5||7||BLINDED TREATMENT|1966-01-20||1965-08-11|||1973-03-02||1963-11-16
TRIAL STUDY 134XCP|RP|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||TESLA|||V/SEC|NOT DONE||NA|U|U|1||38||SCREENING|1960-06-30||1960-06-10|||1963-03-10||1971-12-06
TRIAL STUDY 134XCP|RP|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||DPM|||GLOBULE|NOT DONE||NA|NA|N|1||38||LONG-TERM FOLLOW-UP|1965-02-17||1961-09-13|||1963-06-14||1962-08-21
TRIAL STUDY 134XCP|RP|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|1||||||INTP|INTERPRETATION||||U/MG|||APL U|NOT DONE||Y|Y|U|2||58||WASHOUT|1972-02-12||1966-10-28|||1972-11-23||1971-11-06
TRIAL STUDY 134XCP|RP|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||CGY|||10^6 ORGANISMS/G|NOT DONE||N|U|N|2||58||OBSERVATION|1970-10-27||1965-05-15|||1965-10-24||1972-04-26
TRIAL STUDY 134XCP|RP|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||POUCH|||CMH2O/ML|NOT DONE||U|NA|U|3||39||WASHOUT|1970-08-09||1963-09-28|||1972-02-28||1965-04-03
TRIAL STUDY 134XCP|RP|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||10^6 IU/ML|||JDF UNIT|NOT DONE||NA|U|NA|3||39||TREATMENT|1962-10-19||1969-02-06|||1966-06-26||1965-04-01
TRIAL STUDY 134XCP|RP|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|1||||||INABOIND|INDUCED ABORTION INDICATOR||||KALLIKREIN INHIBITOR UNIT|||H/WK|NOT DONE||Y|Y|Y|4||88||INDUCTION TREATMENT|1973-04-21||1966-12-08|||1968-05-07||1962-11-02
TRIAL STUDY 134XCP|RP|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||ML/ANIMAL/DAY|||CAPFUL|NOT DONE||N|U|N|4||88||RUN-IN|1973-08-26||1967-01-22|||1965-07-14||1972-07-07
TRIAL STUDY 134XCP|RP|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|1||||||RASHIND|RASH INDICATOR||||LOG10 TCID 50/UL|||L/MIN|NOT DONE||Y|NA|Y|5||7||TREATMENT|1965-09-28||1965-02-07|||1969-10-29||1960-02-19
TRIAL STUDY 134XCP|RP|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ML/DL|||PACKET|NOT DONE||U|U|NA|5||7||TREATMENT|1972-12-15||1971-04-30|||1961-05-07||1965-06-24
TRIAL STUDY 134XCP|RP|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ML/S|||TRANSDUCING UNIT|NOT DONE||N|N|NA|1||38||INDUCTION TREATMENT|1970-11-19||1962-09-05|||1972-06-30||1960-10-28
TRIAL STUDY 134XCP|RP|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||10^6 ORGANISMS/ML|||MM|NOT DONE||Y|NA|U|1||38||SCREENING|1971-10-12||1970-10-24|||1973-05-25||1961-06-13
TRIAL STUDY 134XCP|RP|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|1||||||BLISTIND|BLISTERING INDICATOR||||10^8 PFU|||IU/ML|NOT DONE||U|NA|NA|2||58||CONTINUATION TREATMENT|1961-09-12||1965-06-12|||1960-11-18||1962-12-20
TRIAL STUDY 134XCP|RP|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|2||||||RASHIND|RASH INDICATOR||||DYN|||HEP|NOT DONE||Y|NA|NA|2||58||RUN-IN|1968-01-02||1966-02-05|||1966-08-16||1966-12-26
TRIAL STUDY 134XCP|RP|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||GLOBULE|||10^5/HPF|NOT DONE||Y|Y|NA|3||39||SCREENING|1966-04-09||1973-03-25|||1969-10-09||1965-09-23
TRIAL STUDY 134XCP|RP|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||UG/KG/DAY|||ML/CAGE|NOT DONE||N|U|Y|3||39||WASHOUT|1966-04-07||1970-07-18|||1966-04-15||1969-12-09
TRIAL STUDY 134XCP|RP|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|1||||||FUNDHT|FUNDAL HEIGHT||||BQ/KG|||PSI|NOT DONE||NA|N|N|4||88||OBSERVATION|1965-05-07||1963-05-04|||1964-12-27||1969-04-21
TRIAL STUDY 134XCP|RP|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|2||||||EDEMAIND|EDEMA INDICATOR||||MG/KG/H|||UG/ANIMAL|NOT DONE||Y|U|NA|4||88||RUN-IN|1960-08-20||1968-01-25|||1963-03-24||1968-09-16
TRIAL STUDY 134XCP|RP|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|1||||||INABOIND|INDUCED ABORTION INDICATOR||||ML/KG/H|||10^4 CFU/ML|NOT DONE||N|N|N|5||7||INDUCTION TREATMENT|1966-06-20||1965-05-31|||1973-02-01||1969-12-13
TRIAL STUDY 134XCP|RP|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|2||||||GRAVIND|GRAVIDA INDICATOR||||K|||NG|NOT DONE||U|U|NA|5||7||WASHOUT|1970-03-22||1967-12-27|||1973-04-16||1961-09-17
TRIAL STUDY 134XCP|RP|28B6CF51-A007-4CED-8247-37BD468F41C5|1||||||DSCHGIND|DISCHARGE INDICATOR||||U.CARR|||ABSORBANCE U/MIN|NOT DONE||U|NA|NA|1||38||INDUCTION TREATMENT|1963-03-01||1973-07-09|||1960-05-15||1965-11-29
TRIAL STUDY 134XCP|RP|28B6CF51-A007-4CED-8247-37BD468F41C5|2||||||ABORTN|NUMBER OF ABORTIONS||||UMOL/L/MIN|||KCAL|NOT DONE||Y|N|N|1||38||FOLLOW-UP|1962-03-27||1966-06-30|||1963-02-18||1965-10-31
TRIAL STUDY 134XCP|RP|28B6CF51-A007-4CED-8247-37BD468F41C5|1||||||PREGIND|PREGNANT INDICATOR||||PMOL/10^9 CELLS|||%/MIN|NOT DONE||Y|NA|NA|2||58||BLINDED TREATMENT|1971-05-26||1970-03-12|||1969-11-15||1963-02-13
TRIAL STUDY 134XCP|RP|28B6CF51-A007-4CED-8247-37BD468F41C5|2||||||INABOIND|INDUCED ABORTION INDICATOR||||PACKAGE|||ML/CM3/MIN|NOT DONE||U|NA|NA|2||58||BASELINE|1962-12-28||1971-02-19|||1962-08-11||1969-04-21
TRIAL STUDY 134XCP|RP|28B6CF51-A007-4CED-8247-37BD468F41C5|1||||||MENOAGE|MENOPAUSE AGE||||/40 HPFS|||UG/CM2|NOT DONE||NA|U|U|3||39||OBSERVATION|1960-08-05||1960-06-22|||1965-04-22||1969-02-19
TRIAL STUDY 134XCP|RP|28B6CF51-A007-4CED-8247-37BD468F41C5|2||||||EDEMAIND|EDEMA INDICATOR||||CD/M2|||10^7 CFU|NOT DONE||NA|N|NA|3||39||INDUCTION TREATMENT|1972-05-23||1961-06-23|||1973-01-04||1972-06-23
TRIAL STUDY 134XCP|RP|28B6CF51-A007-4CED-8247-37BD468F41C5|1||||||PUSTIND|PUSTULE INDICATOR||||UMOL/H/MMOL|||PMOL/10^9 CELLS|NOT DONE||NA|NA|N|4||88||RUN-IN|1960-02-17||1960-10-13|||1969-04-30||1965-12-14
TRIAL STUDY 134XCP|RP|28B6CF51-A007-4CED-8247-37BD468F41C5|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||IN2|||SHOCK WAVE|NOT DONE||U|Y|Y|4||88||OPEN LABEL TREATMENT|1960-09-27||1965-04-22|||1962-02-23||1965-04-05
TRIAL STUDY 134XCP|RP|28B6CF51-A007-4CED-8247-37BD468F41C5|1||||||RASHIND|RASH INDICATOR||||10^9 ORGANISMS|||MMOL/KG|NOT DONE||U|Y|U|5||7||LONG-TERM FOLLOW-UP|1969-02-16||1964-08-08|||1962-10-24||1962-09-17
TRIAL STUDY 134XCP|RP|28B6CF51-A007-4CED-8247-37BD468F41C5|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||UG/L/H|||UL/ML|NOT DONE||Y|U|NA|5||7||BASELINE|1964-12-06||1961-07-14|||1966-11-29||1973-08-13
TRIAL STUDY 134XCP|RP|4E600C41-1B27-4042-B48E-B60489701D2D|1||||||MENFDUR|MENSES FLOW DURATION||||NMOL/L/H|||AFU|NOT DONE||Y|N|U|1||38||LONG-TERM FOLLOW-UP|1971-06-10||1962-07-05|||1966-04-03||1972-08-13
TRIAL STUDY 134XCP|RP|4E600C41-1B27-4042-B48E-B60489701D2D|2||||||MENFDUR|MENSES FLOW DURATION||||ML/H|||10^6 IU/ML|NOT DONE||Y|NA|NA|1||38||OPEN LABEL TREATMENT|1969-02-14||1973-02-19|||1964-04-05||1969-10-25
TRIAL STUDY 134XCP|RP|4E600C41-1B27-4042-B48E-B60489701D2D|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||DAGU|||10^6 CFU/G|NOT DONE||U|U|N|2||58||RUN-IN|1972-02-22||1963-02-11|||1966-02-17||1966-10-21
TRIAL STUDY 134XCP|RP|4E600C41-1B27-4042-B48E-B60489701D2D|2||||||PREGIND|PREGNANT INDICATOR||||CM2|||CM/MIN|NOT DONE||U|NA|U|2||58||FOLLOW-UP|1971-05-01||1960-11-20|||1969-01-13||1966-05-06
TRIAL STUDY 134XCP|RP|4E600C41-1B27-4042-B48E-B60489701D2D|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||S*KPA|||UG/DL|NOT DONE||N|NA|U|3||39||OBSERVATION|1971-04-28||1973-08-16|||1961-10-10||1962-05-09
TRIAL STUDY 134XCP|RP|4E600C41-1B27-4042-B48E-B60489701D2D|2||||||MASSIND|MASS INDICATOR||||USIEMENS|||MV2/HZ|NOT DONE||N|NA|U|3||39||LONG-TERM FOLLOW-UP|1970-10-04||1967-03-21|||1971-06-27||1968-12-10
TRIAL STUDY 134XCP|RP|4E600C41-1B27-4042-B48E-B60489701D2D|1||||||THICK|THICKNESS||||COULOMB|||ML/G/H|NOT DONE||NA|N|Y|4||88||OPEN LABEL TREATMENT|1967-09-22||1966-04-15|||1970-10-14||1968-05-25
TRIAL STUDY 134XCP|RP|4E600C41-1B27-4042-B48E-B60489701D2D|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||USEC|||10^3 COPIES/ML|NOT DONE||Y|Y|N|4||88||RUN-IN|1961-05-07||1963-12-15|||1961-10-14||1962-09-19
TRIAL STUDY 134XCP|RP|4E600C41-1B27-4042-B48E-B60489701D2D|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||CM H2O|||F|NOT DONE||Y|U|Y|5||7||FOLLOW-UP|1960-10-17||1964-11-24|||1969-11-15||1969-08-11
TRIAL STUDY 134XCP|RP|4E600C41-1B27-4042-B48E-B60489701D2D|2||||||PRGENDTC|DATE PREGNANCY ENDED||||DAGU/ML|||ABSORBANCE U/MIN|NOT DONE||Y|N|NA|5||7||FOLLOW-UP|1963-09-20||1962-03-30|||1969-09-28||1970-10-04
TRIAL STUDY 134XCP|RP|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||KN/CM2|||TUBERCULIN UNIT|NOT DONE||U|U|U|1||38||BASELINE|1960-08-09||1967-02-23|||1969-07-05||1966-09-12
TRIAL STUDY 134XCP|RP|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||KM/H|||GRAIN|NOT DONE||U|NA|N|1||38||INDUCTION TREATMENT|1969-11-16||1967-01-08|||1968-12-15||1968-01-02
TRIAL STUDY 134XCP|RP|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|1||||||MASSIND|MASS INDICATOR||||10^4/L|||GY|NOT DONE||NA|N|N|2||58||LONG-TERM FOLLOW-UP|1962-06-13||1965-09-25|||1967-05-31||1960-10-03
TRIAL STUDY 134XCP|RP|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||UU/L|||GBQ|NOT DONE||U|U|Y|2||58||WASHOUT|1972-04-26||1964-12-29|||1961-08-17||1961-03-09
TRIAL STUDY 134XCP|RP|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ANTI-XA IU|||BEATS/MIN|NOT DONE||Y|NA|Y|3||39||LONG-TERM FOLLOW-UP|1963-12-26||1970-09-10|||1972-02-18||1960-05-22
TRIAL STUDY 134XCP|RP|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|2||||||MENARAGE|MENARCHE AGE||||GAUSS|||G/DAY|NOT DONE||Y|NA|Y|3||39||CONTINUATION TREATMENT|1962-06-07||1972-10-08|||1971-04-04||1967-08-24
TRIAL STUDY 134XCP|RP|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|1||||||MENFDUR|MENSES FLOW DURATION||||10^9/L|||10^6 ORGANISMS/ML|NOT DONE||Y|NA|Y|4||88||CONTINUATION TREATMENT|1973-03-08||1971-03-13|||1960-01-04||1967-05-10
TRIAL STUDY 134XCP|RP|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|2||||||MENOSTAT|MENOPAUSE STATUS||||CMOL|||UM/S|NOT DONE||NA|U|Y|4||88||FOLLOW-UP|1966-12-24||1972-04-23|||1967-12-20||1960-04-28
TRIAL STUDY 134XCP|RP|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||G/CAGE|||DEG/S|NOT DONE||NA|U|U|5||7||SCREENING|1968-08-09||1963-09-10|||1967-06-29||1972-03-04
TRIAL STUDY 134XCP|RP|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|2||||||PREGNN|NUMBER OF PREGNANCIES||||ML/DOSE|||LOG10 ELISA UNIT/DOSE|NOT DONE||NA|N|U|5||7||RUN-IN|1967-04-02||1963-02-10|||1963-12-12||1969-03-26
TRIAL STUDY 134XCP|RP|00D760E7-DC21-41A8-AD28-FF48A5C21E83|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||UM|||ML/CM|NOT DONE||NA|N|N|1||38||INDUCTION TREATMENT|1966-05-31||1971-11-02|||1968-04-20||1967-01-12
TRIAL STUDY 134XCP|RP|00D760E7-DC21-41A8-AD28-FF48A5C21E83|2||||||EDEMAIND|EDEMA INDICATOR||||PPTR|||10^5/HPF|NOT DONE||N|N|NA|1||38||SCREENING|1970-09-29||1963-02-08|||1963-01-26||1967-07-14
TRIAL STUDY 134XCP|RP|00D760E7-DC21-41A8-AD28-FF48A5C21E83|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||WEBER|||MG/DL|NOT DONE||Y|U|NA|2||58||BASELINE|1967-12-05||1961-08-27|||1972-02-22||1963-10-15
TRIAL STUDY 134XCP|RP|00D760E7-DC21-41A8-AD28-FF48A5C21E83|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||L/MIN|||LOG10 ELISA UNIT/DOSE|NOT DONE||N|NA|N|2||58||OPEN LABEL TREATMENT|1964-06-10||1968-02-23|||1967-02-05||1963-05-07
TRIAL STUDY 134XCP|RP|00D760E7-DC21-41A8-AD28-FF48A5C21E83|1||||||PREGIND|PREGNANT INDICATOR||||CYCLE/MIN|||S*KPA|NOT DONE||U|U|N|3||39||BASELINE|1962-05-12||1962-01-13|||1969-07-28||1968-12-28
TRIAL STUDY 134XCP|RP|00D760E7-DC21-41A8-AD28-FF48A5C21E83|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||L/L|||VIAL|NOT DONE||U|Y|U|3||39||OBSERVATION|1960-09-27||1961-09-12|||1971-11-22||1973-05-21
TRIAL STUDY 134XCP|RP|00D760E7-DC21-41A8-AD28-FF48A5C21E83|1||||||DSCHGIND|DISCHARGE INDICATOR||||UG/KG/DAY|||JAR|NOT DONE||U|NA|Y|4||88||LONG-TERM FOLLOW-UP|1961-05-28||1969-12-07|||1967-07-03||1960-08-04
TRIAL STUDY 134XCP|RP|00D760E7-DC21-41A8-AD28-FF48A5C21E83|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||/H|||G/DL|NOT DONE||U|N|Y|4||88||SCREENING|1965-09-29||1963-10-22|||1971-01-14||1963-08-16
TRIAL STUDY 134XCP|RP|00D760E7-DC21-41A8-AD28-FF48A5C21E83|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||U/KG/DAY|||MG/G/MIN|NOT DONE||Y|NA|Y|5||7||OBSERVATION|1969-04-29||1971-07-15|||1970-08-24||1964-08-18
TRIAL STUDY 134XCP|RP|00D760E7-DC21-41A8-AD28-FF48A5C21E83|2||||||ABORTN|NUMBER OF ABORTIONS||||UM/S|||/CMH2O|NOT DONE||NA|Y|Y|5||7||RUN-IN|1970-12-18||1963-01-19|||1960-04-23||1970-07-29
TRIAL STUDY 134XCP|RP|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||PPM|||UCI|NOT DONE||Y|U|NA|1||38||RUN-IN|1969-09-22||1965-09-30|||1963-08-05||1969-07-29
TRIAL STUDY 134XCP|RP|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||PNU/ML|||BEAM BREAKS|NOT DONE||N|NA|Y|1||38||FOLLOW-UP|1963-03-03||1960-04-22|||1969-12-20||1964-11-11
TRIAL STUDY 134XCP|RP|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|1||||||BLISTIND|BLISTERING INDICATOR||||TRACE|||MIU/L|NOT DONE||U|U|Y|2||58||BLINDED TREATMENT|1963-11-23||1969-07-10|||1960-03-23||1963-06-28
TRIAL STUDY 134XCP|RP|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|2||||||DSCHGIND|DISCHARGE INDICATOR||||U/MG|||10^5/L|NOT DONE||N|U|N|2||58||WASHOUT|1965-10-19||1967-08-15|||1970-01-09||1965-12-13
TRIAL STUDY 134XCP|RP|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||U/G/DAY|||MG|NOT DONE||NA|N|NA|3||39||FOLLOW-UP|1969-09-04||1964-07-29|||1970-05-31||1973-03-12
TRIAL STUDY 134XCP|RP|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|2||||||PREGST|PREGNANT DURING THE STUDY||||CM/S|||/10^4|NOT DONE||N|U|N|3||39||OPEN LABEL TREATMENT|1962-02-09||1963-03-27|||1965-08-18||1961-03-01
TRIAL STUDY 134XCP|RP|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|1||||||DSCHGIND|DISCHARGE INDICATOR||||/5X10^4 WBC|||10^3 DNA COPIES/ML|NOT DONE||N|N|U|4||88||CONTINUATION TREATMENT|1970-04-05||1970-07-14|||1970-09-01||1971-11-24
TRIAL STUDY 134XCP|RP|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|2||||||PREGST|PREGNANT DURING THE STUDY||||CG|||ANTI-XA IU|NOT DONE||NA|N|Y|4||88||INDUCTION TREATMENT|1973-01-20||1971-05-23|||1964-02-14||1967-09-06
TRIAL STUDY 134XCP|RP|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MEQ/DAY|||SQU/ML|NOT DONE||U|NA|NA|5||7||FOLLOW-UP|1970-01-26||1960-10-22|||1965-09-15||1966-03-24
TRIAL STUDY 134XCP|RP|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|2||||||STILBIND|STILLBIRTH INDICATOR||||CMH2O*S/ML|||KM/H|NOT DONE||N|U|NA|5||7||FOLLOW-UP|1973-09-05||1968-08-16|||1961-12-28||1966-09-27
TRIAL STUDY 134XCP|RP|4EC25C9E-F259-405B-8B7D-3C9640FB9748|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||GAUSS|||G|NOT DONE||U|Y|Y|1||38||FOLLOW-UP|1960-11-13||1973-05-23|||1961-09-06||1963-12-30
TRIAL STUDY 134XCP|RP|4EC25C9E-F259-405B-8B7D-3C9640FB9748|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MG|||NMOL/DAY|NOT DONE||Y|NA|N|1||38||RUN-IN|1960-12-31||1965-12-12|||1972-03-08||1963-09-15
TRIAL STUDY 134XCP|RP|4EC25C9E-F259-405B-8B7D-3C9640FB9748|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||KALLIKREIN INHIBITOR UNIT|||QUANTITY SUFFICIENT|NOT DONE||U|NA|U|2||58||WASHOUT|1970-03-08||1963-01-12|||1962-09-15||1961-06-19
TRIAL STUDY 134XCP|RP|4EC25C9E-F259-405B-8B7D-3C9640FB9748|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||NKAT/G HB|||M3|NOT DONE||N|N|N|2||58||INDUCTION TREATMENT|1971-01-04||1967-10-28|||1970-01-09||1969-02-04
TRIAL STUDY 134XCP|RP|4EC25C9E-F259-405B-8B7D-3C9640FB9748|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||CYCLE/MIN|||VIRTUAL PIXEL|NOT DONE||Y|NA|N|3||39||RUN-IN|1971-03-25||1963-12-16|||1971-12-12||1963-11-08
TRIAL STUDY 134XCP|RP|4EC25C9E-F259-405B-8B7D-3C9640FB9748|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||10^6 IU|||ABSORBANCE U/ML|NOT DONE||Y|N|Y|3||39||TREATMENT|1972-04-06||1964-01-05|||1968-09-21||1966-07-22
TRIAL STUDY 134XCP|RP|4EC25C9E-F259-405B-8B7D-3C9640FB9748|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^3 ORGANISMS/ML|||NGEQ/L|NOT DONE||Y|NA|Y|4||88||WASHOUT|1968-09-01||1972-02-05|||1963-10-15||1966-02-05
TRIAL STUDY 134XCP|RP|4EC25C9E-F259-405B-8B7D-3C9640FB9748|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||PMOL/L|||CMH2O*S2/ML|NOT DONE||NA|Y|Y|4||88||WASHOUT|1965-08-22||1961-08-15|||1967-02-15||1965-12-19
TRIAL STUDY 134XCP|RP|4EC25C9E-F259-405B-8B7D-3C9640FB9748|1||||||PEELIND|PEELING INDICATOR||||PMOL|||G/U|NOT DONE||Y|N|Y|5||7||OBSERVATION|1962-11-10||1963-07-09|||1972-05-14||1973-01-14
TRIAL STUDY 134XCP|RP|4EC25C9E-F259-405B-8B7D-3C9640FB9748|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UG/M2/MIN|||PA|NOT DONE||U|NA|U|5||7||LONG-TERM FOLLOW-UP|1968-11-08||1960-12-24|||1971-12-08||1960-11-12
TRIAL STUDY 134XCP|RP|FF1CC617-040D-42E9-AD31-32E7B8DAED24|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||CD*S/M2|||GBQ|NOT DONE||NA|Y|NA|1||38||OPEN LABEL TREATMENT|1971-01-29||1964-04-19|||1964-09-02||1963-11-15
TRIAL STUDY 134XCP|RP|FF1CC617-040D-42E9-AD31-32E7B8DAED24|2||||||FUNDHT|FUNDAL HEIGHT||||ML/S|||NMOL/DAY|NOT DONE||U|U|Y|1||38||BLINDED TREATMENT|1973-03-10||1973-06-08|||1966-06-15||1965-09-18
TRIAL STUDY 134XCP|RP|FF1CC617-040D-42E9-AD31-32E7B8DAED24|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UG/H|||TCID 50/DOSE|NOT DONE||Y|Y|Y|2||58||RUN-IN|1966-01-11||1971-12-29|||1961-09-12||1970-01-17
TRIAL STUDY 134XCP|RP|FF1CC617-040D-42E9-AD31-32E7B8DAED24|2||||||PREGST|PREGNANT DURING THE STUDY||||UIU/DL|||NU/CL|NOT DONE||N|U|Y|2||58||WASHOUT|1972-06-30||1963-04-24|||1967-07-05||1962-05-01
TRIAL STUDY 134XCP|RP|FF1CC617-040D-42E9-AD31-32E7B8DAED24|1||||||BLISTIND|BLISTERING INDICATOR||||AGU/ML|||BEAM BREAKS|NOT DONE||NA|N|Y|3||39||TREATMENT|1971-11-11||1960-01-15|||1963-12-18||1962-06-28
TRIAL STUDY 134XCP|RP|FF1CC617-040D-42E9-AD31-32E7B8DAED24|2||||||ERYTHIND|ERYTHEMA INDICATOR||||MAMP|||UV|NOT DONE||N|U|NA|3||39||INDUCTION TREATMENT|1968-01-18||1969-10-02|||1972-05-15||1964-03-06
TRIAL STUDY 134XCP|RP|FF1CC617-040D-42E9-AD31-32E7B8DAED24|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||BQ/L|||BU/ML|NOT DONE||U|N|U|4||88||TREATMENT|1970-03-19||1967-02-24|||1971-09-24||1971-03-10
TRIAL STUDY 134XCP|RP|FF1CC617-040D-42E9-AD31-32E7B8DAED24|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||BREATHS/30S|||OSM|NOT DONE||NA|N|U|4||88||CONTINUATION TREATMENT|1965-03-30||1962-05-28|||1965-03-02||1968-03-05
TRIAL STUDY 134XCP|RP|FF1CC617-040D-42E9-AD31-32E7B8DAED24|1||||||MENOSTAT|MENOPAUSE STATUS||||MMAL|||ML/DL|NOT DONE||Y|U|Y|5||7||LONG-TERM FOLLOW-UP|1971-01-08||1960-02-23|||1968-07-19||1973-01-16
TRIAL STUDY 134XCP|RP|FF1CC617-040D-42E9-AD31-32E7B8DAED24|2||||||PRGENDTC|DATE PREGNANCY ENDED||||UG/M2/MIN|||ML/DAY|NOT DONE||NA|U|Y|5||7||LONG-TERM FOLLOW-UP|1963-09-24||1969-03-22|||1973-03-22||1968-04-03
TRIAL STUDY 134XCP|RP|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||CCID 50/DOSE|||AMU|NOT DONE||NA|Y|NA|1||38||BLINDED TREATMENT|1969-11-19||1963-11-04|||1971-12-19||1962-01-20
TRIAL STUDY 134XCP|RP|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||LOG10 CFU/ML|||UU/DL|NOT DONE||U|NA|Y|1||38||SCREENING|1973-05-01||1968-06-24|||1969-11-09||1967-07-31
TRIAL STUDY 134XCP|RP|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||CMHG|||10^3 ORGANISMS|NOT DONE||NA|U|NA|2||58||LONG-TERM FOLLOW-UP|1965-12-12||1968-07-07|||1963-07-05||1973-07-08
TRIAL STUDY 134XCP|RP|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||NMOL/MOL|||K|NOT DONE||U|Y|Y|2||58||RUN-IN|1972-08-13||1963-01-22|||1972-08-06||1970-08-05
TRIAL STUDY 134XCP|RP|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MSEC|||CAPLET|NOT DONE||U|Y|Y|3||39||LONG-TERM FOLLOW-UP|1972-04-03||1964-06-18|||1970-08-26||1968-09-24
TRIAL STUDY 134XCP|RP|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||ML/CM3/MIN|||NM|NOT DONE||NA|Y|U|3||39||SCREENING|1971-10-11||1969-09-12|||1967-05-19||1967-01-05
TRIAL STUDY 134XCP|RP|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|1||||||THICK|THICKNESS||||DEG/MM|||10^3 ORGANISMS/ML|NOT DONE||Y|U|N|4||88||SCREENING|1961-06-12||1973-02-12|||1973-02-02||1962-12-24
TRIAL STUDY 134XCP|RP|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|2||||||MENOAGE|MENOPAUSE AGE||||PM|||/LPF|NOT DONE||NA|U|Y|4||88||OPEN LABEL TREATMENT|1962-04-14||1966-12-25|||1963-07-27||1960-02-23
TRIAL STUDY 134XCP|RP|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|1||||||BRTHN|NUMBER OF BIRTHS||||KPA/L/SEC|||10^6/G|NOT DONE||U|NA|Y|5||7||BLINDED TREATMENT|1963-07-31||1962-06-29|||1968-07-11||1972-10-17
TRIAL STUDY 134XCP|RP|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MG/ML/MIN|||U/G/MIN|NOT DONE||U|N|Y|5||7||FOLLOW-UP|1961-12-09||1967-11-10|||1961-06-26||1967-01-30
TRIAL STUDY 134XCP|RP|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||/2500 WBC|||KIU|NOT DONE||Y|N|N|1||38||OPEN LABEL TREATMENT|1963-09-02||1972-11-28|||1963-05-06||1962-03-19
TRIAL STUDY 134XCP|RP|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|2||||||ERYTHIND|ERYTHEMA INDICATOR||||MPL U|||PACKAGE|NOT DONE||Y|Y|NA|1||38||FOLLOW-UP|1961-06-15||1972-02-28|||1965-08-31||1965-09-08
TRIAL STUDY 134XCP|RP|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||BOLUS|||LOG10 ELISA UNIT|NOT DONE||U|Y|N|2||58||BLINDED TREATMENT|1971-03-19||1966-12-18|||1969-07-25||1965-03-25
TRIAL STUDY 134XCP|RP|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||/MM|||K|NOT DONE||Y|U|Y|2||58||CONTINUATION TREATMENT|1966-01-14||1967-06-21|||1970-08-19||1961-12-04
TRIAL STUDY 134XCP|RP|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||U/M2|||UG/KG/MIN|NOT DONE||NA|NA|U|3||39||WASHOUT|1965-05-10||1961-06-21|||1964-09-21||1964-02-10
TRIAL STUDY 134XCP|RP|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||G/KG|||10^9 ORGANISMS/ML|NOT DONE||U|NA|U|3||39||BLINDED TREATMENT|1969-01-12||1973-03-29|||1961-02-02||1963-11-11
TRIAL STUDY 134XCP|RP|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||MIN|||MPL U/ML|NOT DONE||U|NA|NA|4||88||RUN-IN|1962-07-19||1963-01-16|||1960-02-12||1969-09-13
TRIAL STUDY 134XCP|RP|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||FMOL/L/SEC|||DPM|NOT DONE||N|U|NA|4||88||INDUCTION TREATMENT|1967-10-23||1966-09-25|||1967-07-29||1973-03-21
TRIAL STUDY 134XCP|RP|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|1||||||PREGIND|PREGNANT INDICATOR||||U/MG|||BAU/ML|NOT DONE||NA|N|U|5||7||RUN-IN|1972-08-30||1963-07-11|||1964-10-10||1967-08-28
TRIAL STUDY 134XCP|RP|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||G/U|||U/M2|NOT DONE||Y|N|U|5||7||SCREENING|1966-12-06||1963-01-02|||1966-08-17||1965-11-17
TRIAL STUDY 134XCP|RP|BFA83769-F31F-49AE-8C43-49046C719D69|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||KS|||UG/DL|NOT DONE||U|NA|U|1||38||INDUCTION TREATMENT|1961-04-04||1972-02-03|||1962-08-02||1960-06-07
TRIAL STUDY 134XCP|RP|BFA83769-F31F-49AE-8C43-49046C719D69|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||USIEMENS|||UM2|NOT DONE||U|Y|N|1||38||OPEN LABEL TREATMENT|1964-08-19||1969-07-05|||1965-10-19||1962-09-25
TRIAL STUDY 134XCP|RP|BFA83769-F31F-49AE-8C43-49046C719D69|1||||||PRGENDTC|DATE PREGNANCY ENDED||||UU/L|||NMOL/ML/MIN|NOT DONE||NA|Y|U|2||58||TREATMENT|1961-11-12||1971-10-18|||1961-04-17||1968-10-29
TRIAL STUDY 134XCP|RP|BFA83769-F31F-49AE-8C43-49046C719D69|2||||||MENOAGE|MENOPAUSE AGE||||ML/G/DAY|||10^4/HPF|NOT DONE||NA|U|NA|2||58||TREATMENT|1973-05-06||1961-09-14|||1962-06-30||1966-06-18
TRIAL STUDY 134XCP|RP|BFA83769-F31F-49AE-8C43-49046C719D69|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||GY/MIN|||FMOL/L/SEC|NOT DONE||N|U|N|3||39||BASELINE|1970-08-28||1965-01-09|||1960-05-27||1962-12-27
TRIAL STUDY 134XCP|RP|BFA83769-F31F-49AE-8C43-49046C719D69|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MMOL/MIN/KPA/L|||MCI/L|NOT DONE||Y|Y|Y|3||39||OBSERVATION|1965-04-01||1968-11-14|||1962-01-19||1964-08-25
TRIAL STUDY 134XCP|RP|BFA83769-F31F-49AE-8C43-49046C719D69|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MOL/MOL|||JOULE|NOT DONE||U|N|NA|4||88||WASHOUT|1966-03-25||1964-05-11|||1963-05-08||1962-06-07
TRIAL STUDY 134XCP|RP|BFA83769-F31F-49AE-8C43-49046C719D69|2||||||MENOAGE|MENOPAUSE AGE||||10^3 DNA COPIES/ML|||KIT|NOT DONE||N|NA|U|4||88||FOLLOW-UP|1964-04-14||1966-03-18|||1972-04-29||1971-03-28
TRIAL STUDY 134XCP|RP|BFA83769-F31F-49AE-8C43-49046C719D69|1||||||MENOSTAT|MENOPAUSE STATUS||||UG/G/H|||BEAM BREAKS|NOT DONE||Y|N|NA|5||7||FOLLOW-UP|1968-09-08||1972-04-21|||1960-11-08||1969-03-03
TRIAL STUDY 134XCP|RP|BFA83769-F31F-49AE-8C43-49046C719D69|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||VP/DOSE|||V/SEC|NOT DONE||NA|NA|U|5||7||LONG-TERM FOLLOW-UP|1962-02-06||1970-04-15|||1969-12-30||1964-01-24
TRIAL STUDY 134XCP|RP|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|1||||||PEELIND|PEELING INDICATOR||||UV*SEC|||10^6 ORGANISMS|NOT DONE||Y|NA|Y|1||38||BLINDED TREATMENT|1969-11-25||1971-02-27|||1971-09-27||1965-03-28
TRIAL STUDY 134XCP|RP|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||PIXELS/CM|||COULOMB|NOT DONE||N|N|U|1||38||RUN-IN|1961-06-30||1964-03-07|||1960-10-26||1972-10-06
TRIAL STUDY 134XCP|RP|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|1||||||MENOSTAT|MENOPAUSE STATUS||||ML/KG/H|||CGY|NOT DONE||U|NA|N|2||58||BLINDED TREATMENT|1973-08-22||1970-06-18|||1970-03-14||1971-07-04
TRIAL STUDY 134XCP|RP|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||CM2|||MPL U|NOT DONE||N|N|U|2||58||INDUCTION TREATMENT|1966-05-31||1964-11-07|||1967-03-31||1967-03-14
TRIAL STUDY 134XCP|RP|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||UMOL/DL|||CI/UG|NOT DONE||NA|U|N|3||39||WASHOUT|1965-11-12||1965-02-28|||1966-12-04||1969-11-07
TRIAL STUDY 134XCP|RP|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||10^8 PFU|||NM|NOT DONE||U|NA|Y|3||39||INDUCTION TREATMENT|1962-01-21||1972-03-25|||1972-02-02||1968-01-08
TRIAL STUDY 134XCP|RP|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||G/CAGE|||UG/CM2|NOT DONE||U|Y|U|4||88||FOLLOW-UP|1972-06-05||1963-07-19|||1973-02-10||1965-05-19
TRIAL STUDY 134XCP|RP|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||KA_U/DL|||DMOL|NOT DONE||NA|N|Y|4||88||INDUCTION TREATMENT|1964-12-06||1967-07-28|||1964-03-18||1965-04-11
TRIAL STUDY 134XCP|RP|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||NMOL|||MMOL2/L2|NOT DONE||Y|U|Y|5||7||FOLLOW-UP|1961-05-06||1969-09-11|||1961-06-03||1961-08-09
TRIAL STUDY 134XCP|RP|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|2||||||PRGENDTC|DATE PREGNANCY ENDED||||STRIP|||EP U|NOT DONE||NA|U|U|5||7||CONTINUATION TREATMENT|1972-10-14||1968-08-13|||1970-01-10||1963-10-09
TRIAL STUDY 134XCP|RP|91838668-D463-4728-A581-2E1987592885|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||10^3 CFU/G|||SPRAY|NOT DONE||N|N|Y|1||38||TREATMENT|1972-12-08||1972-05-17|||1963-10-26||1964-12-08
TRIAL STUDY 134XCP|RP|91838668-D463-4728-A581-2E1987592885|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||KBQ|||MN|NOT DONE||NA|N|NA|1||38||INDUCTION TREATMENT|1966-08-10||1965-11-06|||1969-11-13||1966-03-24
TRIAL STUDY 134XCP|RP|91838668-D463-4728-A581-2E1987592885|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||SYRINGE|||ELISA UNIT/ML|NOT DONE||Y|NA|N|2||58||OBSERVATION|1971-09-28||1973-01-23|||1966-05-14||1962-11-15
TRIAL STUDY 134XCP|RP|91838668-D463-4728-A581-2E1987592885|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||UIU/DL|||CAN|NOT DONE||U|U|N|2||58||FOLLOW-UP|1969-06-25||1969-12-21|||1971-02-20||1964-10-26
TRIAL STUDY 134XCP|RP|91838668-D463-4728-A581-2E1987592885|1||||||PREGIND|PREGNANT INDICATOR||||10^9/DOSE|||TESLA|NOT DONE||N|U|NA|3||39||OBSERVATION|1967-10-12||1965-01-27|||1973-09-02||1972-09-08
TRIAL STUDY 134XCP|RP|91838668-D463-4728-A581-2E1987592885|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MDFI|||PMOL/DAY|NOT DONE||U|N|Y|3||39||TREATMENT|1960-04-09||1962-12-05|||1961-08-23||1962-03-14
TRIAL STUDY 134XCP|RP|91838668-D463-4728-A581-2E1987592885|1||||||MASSIND|MASS INDICATOR||||ENZYME U/G HB|||PFU/DOSE|NOT DONE||U|NA|U|4||88||WASHOUT|1970-03-18||1963-11-21|||1963-10-11||1966-12-03
TRIAL STUDY 134XCP|RP|91838668-D463-4728-A581-2E1987592885|2||||||BRTHN|NUMBER OF BIRTHS||||CY/CM|||CFU/G|NOT DONE||Y|U|U|4||88||BLINDED TREATMENT|1962-12-29||1971-08-17|||1961-10-03||1973-06-13
TRIAL STUDY 134XCP|RP|91838668-D463-4728-A581-2E1987592885|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||U|||GBQ/MG|NOT DONE||Y|N|NA|5||7||TREATMENT|1972-01-25||1963-08-04|||1968-11-18||1961-12-02
TRIAL STUDY 134XCP|RP|91838668-D463-4728-A581-2E1987592885|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||G/G/DAY|||JAR|NOT DONE||NA|NA|NA|5||7||SCREENING|1962-05-08||1970-06-07|||1966-10-05||1963-01-18
TRIAL STUDY 134XCP|RP|DE440A90-82D5-4269-A48B-47E2F5495440|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||BQ/ML|||10^8 PFU|NOT DONE||N|U|NA|1||38||RUN-IN|1965-08-02||1967-06-07|||1961-02-12||1970-12-10
TRIAL STUDY 134XCP|RP|DE440A90-82D5-4269-A48B-47E2F5495440|2||||||PREGST|PREGNANT DURING THE STUDY||||PKAT|||ATM|NOT DONE||U|U|U|1||38||RUN-IN|1970-05-04||1960-04-08|||1973-07-30||1965-07-03
TRIAL STUDY 134XCP|RP|DE440A90-82D5-4269-A48B-47E2F5495440|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||UG/KG/DAY|||SCOOPFUL|NOT DONE||NA|NA|Y|2||58||LONG-TERM FOLLOW-UP|1969-11-12||1966-04-13|||1964-11-01||1967-12-13
TRIAL STUDY 134XCP|RP|DE440A90-82D5-4269-A48B-47E2F5495440|2||||||ABORTN|NUMBER OF ABORTIONS||||FT2|||RING|NOT DONE||Y|N|U|2||58||LONG-TERM FOLLOW-UP|1963-10-27||1966-07-31|||1961-08-14||1967-04-08
TRIAL STUDY 134XCP|RP|DE440A90-82D5-4269-A48B-47E2F5495440|1||||||ABORTN|NUMBER OF ABORTIONS||||EID 50/ML|||RPM|NOT DONE||NA|N|Y|3||39||OPEN LABEL TREATMENT|1971-07-16||1960-04-16|||1971-12-24||1961-09-28
TRIAL STUDY 134XCP|RP|DE440A90-82D5-4269-A48B-47E2F5495440|2||||||BRTHN|NUMBER OF BIRTHS||||AMFI|||DPM|NOT DONE||N|NA|NA|3||39||INDUCTION TREATMENT|1968-10-30||1965-08-21|||1960-02-07||1973-07-24
TRIAL STUDY 134XCP|RP|DE440A90-82D5-4269-A48B-47E2F5495440|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||ELISA UNIT|||DEG/S|NOT DONE||Y|Y|NA|4||88||OBSERVATION|1962-09-16||1961-02-21|||1972-06-12||1967-04-27
TRIAL STUDY 134XCP|RP|DE440A90-82D5-4269-A48B-47E2F5495440|2||||||MENOSTAT|MENOPAUSE STATUS||||STEPS|||MM/H|NOT DONE||Y|NA|Y|4||88||SCREENING|1969-09-08||1969-08-07|||1967-02-18||1960-07-07
TRIAL STUDY 134XCP|RP|DE440A90-82D5-4269-A48B-47E2F5495440|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||10^12 IU/L|||EVENTS|NOT DONE||Y|U|N|5||7||OPEN LABEL TREATMENT|1968-05-01||1971-08-07|||1960-03-16||1965-02-18
TRIAL STUDY 134XCP|RP|DE440A90-82D5-4269-A48B-47E2F5495440|2||||||ULCERIND|ULCER INDICATOR||||/2500 WBC|||BQ/UL|NOT DONE||Y|NA|N|5||7||BASELINE|1960-09-26||1970-07-07|||1961-04-14||1972-07-19
TRIAL STUDY 134XCP|RP|74CA3A61-3179-43F1-8721-2582F50C44EF|1||||||PREGIND|PREGNANT INDICATOR||||YEARS|||CI/UG|NOT DONE||N|Y|Y|1||38||CONTINUATION TREATMENT|1962-09-20||1970-11-08|||1960-10-06||1969-11-30
TRIAL STUDY 134XCP|RP|74CA3A61-3179-43F1-8721-2582F50C44EF|2||||||BLISTIND|BLISTERING INDICATOR||||DNA COPIES/UG|||PFU/ANIMAL|NOT DONE||N|U|N|1||38||BASELINE|1962-10-10||1966-09-16|||1970-07-07||1969-10-07
TRIAL STUDY 134XCP|RP|74CA3A61-3179-43F1-8721-2582F50C44EF|1||||||PUSTIND|PUSTULE INDICATOR||||MM/SEC|||ENZYME U/G HB|NOT DONE||NA|N|Y|2||58||INDUCTION TREATMENT|1966-01-26||1970-09-25|||1967-01-31||1964-06-08
TRIAL STUDY 134XCP|RP|74CA3A61-3179-43F1-8721-2582F50C44EF|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||ELISA UNIT/ML|||STEPS/MIN|NOT DONE||U|N|NA|2||58||INDUCTION TREATMENT|1970-11-29||1963-06-04|||1963-12-29||1973-04-22
TRIAL STUDY 134XCP|RP|74CA3A61-3179-43F1-8721-2582F50C44EF|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||1/(S*KPA)|||PMOL/G|NOT DONE||N|Y|Y|3||39||OBSERVATION|1972-11-18||1966-05-02|||1965-05-19||1971-04-13
TRIAL STUDY 134XCP|RP|74CA3A61-3179-43F1-8721-2582F50C44EF|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||HEP|||KS|NOT DONE||NA|N|U|3||39||CONTINUATION TREATMENT|1968-05-14||1969-10-11|||1964-03-24||1972-08-04
TRIAL STUDY 134XCP|RP|74CA3A61-3179-43F1-8721-2582F50C44EF|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MG/KG/DOSE|||PNU/ML|NOT DONE||Y|U|NA|4||88||OPEN LABEL TREATMENT|1963-03-01||1961-01-11|||1962-09-06||1963-06-06
TRIAL STUDY 134XCP|RP|74CA3A61-3179-43F1-8721-2582F50C44EF|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||BAG|||UMOL/MOL|NOT DONE||U|N|NA|4||88||BLINDED TREATMENT|1967-12-05||1969-02-14|||1970-09-07||1973-05-31
TRIAL STUDY 134XCP|RP|74CA3A61-3179-43F1-8721-2582F50C44EF|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MCI/KG|||AFU|NOT DONE||N|U|NA|5||7||INDUCTION TREATMENT|1968-05-16||1966-09-24|||1964-02-18||1968-02-02
TRIAL STUDY 134XCP|RP|74CA3A61-3179-43F1-8721-2582F50C44EF|2||||||ABORTN|NUMBER OF ABORTIONS||||GBQ/MG|||ML/MMHG|NOT DONE||Y|Y|Y|5||7||WASHOUT|1966-09-11||1964-08-01|||1971-02-09||1972-03-30
TRIAL STUDY 134XCP|RP|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||UG/ML/H|||ML/M2/MIN|NOT DONE||Y|NA|U|1||38||WASHOUT|1963-12-03||1969-06-14|||1966-04-18||1967-03-04
TRIAL STUDY 134XCP|RP|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|2||||||INABOIND|INDUCED ABORTION INDICATOR||||CM H2O|||IU/DAY|NOT DONE||Y|U|NA|1||38||WASHOUT|1966-08-28||1965-05-28|||1964-08-04||1960-08-21
TRIAL STUDY 134XCP|RP|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MMOL/KG|||UG/KG|NOT DONE||U|U|Y|2||58||TREATMENT|1967-10-20||1971-05-05|||1962-12-18||1973-05-31
TRIAL STUDY 134XCP|RP|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MHZ|||PACK|NOT DONE||U|U|NA|2||58||BLINDED TREATMENT|1967-09-05||1961-04-20|||1968-02-29||1967-04-25
TRIAL STUDY 134XCP|RP|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||HOMEOPATHIC DILUTION|||IU/DAY|NOT DONE||NA|NA|N|3||39||INDUCTION TREATMENT|1966-11-20||1965-07-01|||1964-12-28||1969-04-11
TRIAL STUDY 134XCP|RP|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||F|||UG/CM2|NOT DONE||NA|U|Y|3||39||BLINDED TREATMENT|1968-04-19||1971-10-27|||1972-01-07||1965-11-12
TRIAL STUDY 134XCP|RP|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|1||||||EDEMAIND|EDEMA INDICATOR||||RFU|||MMHG|NOT DONE||NA|U|NA|4||88||BLINDED TREATMENT|1971-12-08||1964-07-02|||1964-10-23||1961-05-06
TRIAL STUDY 134XCP|RP|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||SPRAY|||MG/G/H|NOT DONE||NA|NA|N|4||88||TREATMENT|1971-07-11||1960-04-20|||1967-03-18||1973-06-25
TRIAL STUDY 134XCP|RP|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|1||||||DLVRMODE|MODE OF DELIVERY||||/KG|||MBQ/UL|NOT DONE||N|U|Y|5||7||OPEN LABEL TREATMENT|1965-01-04||1966-06-03|||1966-10-11||1972-12-08
TRIAL STUDY 134XCP|RP|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|2||||||PREGST|PREGNANT DURING THE STUDY||||CD/M2|||DPM/MG|NOT DONE||NA|U|NA|5||7||FOLLOW-UP|1965-06-16||1962-03-19|||1972-05-05||1966-03-30
TRIAL STUDY 134XCP|RP|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|1||||||TNDRIND|TENDERNESS INDICATOR||||CARTRIDGE|||10^6/HPF|NOT DONE||NA|N|U|1||38||LONG-TERM FOLLOW-UP|1963-01-28||1961-12-07|||1967-11-30||1963-01-31
TRIAL STUDY 134XCP|RP|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||KIU|||OD UNIT|NOT DONE||N|N|Y|1||38||BLINDED TREATMENT|1965-07-19||1971-05-30|||1969-06-12||1961-07-28
TRIAL STUDY 134XCP|RP|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||ML|||MIN/DAY|NOT DONE||N|N|U|2||58||OPEN LABEL TREATMENT|1967-03-21||1972-06-06|||1970-06-29||1966-02-16
TRIAL STUDY 134XCP|RP|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UG/ML/H|||MV*MIN|NOT DONE||NA|Y|Y|2||58||OPEN LABEL TREATMENT|1973-07-02||1962-08-07|||1961-05-11||1971-12-14
TRIAL STUDY 134XCP|RP|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|1||||||PREGNN|NUMBER OF PREGNANCIES||||MANSON U/ML|||NU/CL|NOT DONE||U|NA|N|3||39||LONG-TERM FOLLOW-UP|1965-06-28||1967-02-13|||1962-12-09||1970-10-28
TRIAL STUDY 134XCP|RP|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||YD|||MCI|NOT DONE||NA|Y|NA|3||39||RUN-IN|1963-03-01||1972-10-22|||1964-12-16||1971-04-10
TRIAL STUDY 134XCP|RP|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||ML/S|||U/CL|NOT DONE||N|NA|NA|4||88||BASELINE|1970-09-15||1960-03-16|||1963-05-09||1964-08-31
TRIAL STUDY 134XCP|RP|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||IU/DAY|||UMOL/L/H|NOT DONE||NA|Y|NA|4||88||OBSERVATION|1963-07-27||1972-04-04|||1963-01-19||1960-01-19
TRIAL STUDY 134XCP|RP|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||PPB|||TABLET|NOT DONE||N|N|Y|5||7||INDUCTION TREATMENT|1972-10-07||1965-01-21|||1961-10-01||1968-05-22
TRIAL STUDY 134XCP|RP|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||KG/L|||UG/ML/H|NOT DONE||U|Y|Y|5||7||RUN-IN|1972-07-12||1968-12-02|||1965-12-09||1964-07-01
TRIAL STUDY 134XCP|RP|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MHZ|||10^8 PFU|NOT DONE||Y|Y|Y|1||38||OPEN LABEL TREATMENT|1966-05-18||1966-06-12|||1960-11-16||1973-05-02
TRIAL STUDY 134XCP|RP|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|2||||||PEELIND|PEELING INDICATOR||||MPL U/ML|||USEC|NOT DONE||N|NA|U|1||38||TREATMENT|1971-07-04||1971-03-06|||1963-03-22||1969-04-07
TRIAL STUDY 134XCP|RP|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|1||||||DLVRMODE|MODE OF DELIVERY||||IU/KG|||BOWL|NOT DONE||N|U|N|2||58||SCREENING|1961-06-03||1968-11-21|||1961-03-28||1969-11-01
TRIAL STUDY 134XCP|RP|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||UV*SEC|||FEU|NOT DONE||Y|U|NA|2||58||INDUCTION TREATMENT|1965-12-01||1967-12-28|||1962-04-15||1972-06-12
TRIAL STUDY 134XCP|RP|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ML/MIN/1.73M2|||VP/DOSE|NOT DONE||Y|NA|U|3||39||CONTINUATION TREATMENT|1963-11-11||1972-06-14|||1971-10-09||1964-10-19
TRIAL STUDY 134XCP|RP|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|2||||||DLVRMODE|MODE OF DELIVERY||||U/M2|||IU/KG/H|NOT DONE||U|Y|U|3||39||BASELINE|1966-01-02||1964-04-15|||1964-03-07||1965-03-16
TRIAL STUDY 134XCP|RP|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|1||||||EDEMAIND|EDEMA INDICATOR||||10^7 TCID 50/DOSE|||MMHG|NOT DONE||U|NA|U|4||88||FOLLOW-UP|1964-02-10||1962-11-01|||1972-01-06||1962-12-06
TRIAL STUDY 134XCP|RP|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|2||||||MENOAGE|MENOPAUSE AGE||||U/M2/MIN|||LINEAR FT*LB|NOT DONE||NA|N|U|4||88||CONTINUATION TREATMENT|1961-02-08||1971-11-05|||1970-08-20||1962-11-23
TRIAL STUDY 134XCP|RP|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|1||||||EDEMAIND|EDEMA INDICATOR||||MCI/L|||AFU|NOT DONE||NA|Y|NA|5||7||OBSERVATION|1964-07-23||1966-07-24|||1967-07-24||1967-04-05
TRIAL STUDY 134XCP|RP|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|2||||||PREGIND|PREGNANT INDICATOR||||MMHG/SEC|||FOZ_US|NOT DONE||N|N|U|5||7||OPEN LABEL TREATMENT|1965-09-17||1969-09-17|||1965-06-18||1972-08-21
TRIAL STUDY 134XCP|RP|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||POUCH|||BE/ML|NOT DONE||N|NA|U|1||38||BLINDED TREATMENT|1969-07-20||1960-07-13|||1966-07-28||1970-04-12
TRIAL STUDY 134XCP|RP|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||G/DL|||10^3 COPIES/ML|NOT DONE||Y|N|Y|1||38||WASHOUT|1960-02-16||1970-09-20|||1966-11-03||1970-10-12
TRIAL STUDY 134XCP|RP|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|1||||||BLISTIND|BLISTERING INDICATOR||||MV|||/CMH2O|NOT DONE||NA|Y|U|2||58||TREATMENT|1969-11-03||1967-09-07|||1968-09-22||1970-10-13
TRIAL STUDY 134XCP|RP|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||CI/L|||CMHG|NOT DONE||U|U|N|2||58||OBSERVATION|1968-04-28||1961-11-16|||1965-10-16||1972-08-19
TRIAL STUDY 134XCP|RP|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||IU|||MPS U|NOT DONE||Y|NA|N|3||39||CONTINUATION TREATMENT|1960-07-07||1962-11-07|||1960-03-06||1961-03-29
TRIAL STUDY 134XCP|RP|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||NKAT|||H/WK|NOT DONE||U|U|NA|3||39||CONTINUATION TREATMENT|1961-07-29||1963-08-23|||1960-02-24||1960-10-29
TRIAL STUDY 134XCP|RP|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||V|||FIU|NOT DONE||Y|N|NA|4||88||RUN-IN|1969-03-01||1962-07-05|||1963-08-27||1969-02-10
TRIAL STUDY 134XCP|RP|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|2||||||PUSTIND|PUSTULE INDICATOR||||ML/MIN/MMHG|||V/SEC|NOT DONE||NA|Y|NA|4||88||INDUCTION TREATMENT|1970-04-10||1971-09-07|||1965-09-20||1965-02-20
TRIAL STUDY 134XCP|RP|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|1||||||EDEMAIND|EDEMA INDICATOR||||MOSM/L|||10^6 U|NOT DONE||NA|N|Y|5||7||WASHOUT|1966-12-27||1968-10-30|||1970-08-05||1967-06-19
TRIAL STUDY 134XCP|RP|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||USIEMENS|||UCI/KG|NOT DONE||Y|Y|Y|5||7||WASHOUT|1963-12-09||1971-08-23|||1962-01-20||1964-05-16
TRIAL STUDY 134XCP|RP|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||LOG10 CFU/ML|||%(V/V)|NOT DONE||Y|NA|NA|1||38||OPEN LABEL TREATMENT|1973-03-21||1961-09-18|||1964-04-23||1971-02-23
TRIAL STUDY 134XCP|RP|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|2||||||DLVRMODE|MODE OF DELIVERY||||MG/DOSE|||UG/CM2|NOT DONE||Y|Y|U|1||38||FOLLOW-UP|1967-09-08||1964-05-28|||1965-11-11||1973-09-02
TRIAL STUDY 134XCP|RP|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|1||||||TNDRIND|TENDERNESS INDICATOR||||UGEQ|||EQ|NOT DONE||NA|U|N|2||58||LONG-TERM FOLLOW-UP|1963-01-13||1967-05-30|||1960-09-02||1973-02-08
TRIAL STUDY 134XCP|RP|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|2||||||MASSIND|MASS INDICATOR||||ML/M2/H|||ARBITRARY U|NOT DONE||N|N|U|2||58||SCREENING|1964-03-10||1960-02-21|||1966-10-04||1970-03-20
TRIAL STUDY 134XCP|RP|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||BQ/ML|||CYLINDER|NOT DONE||NA|N|Y|3||39||TREATMENT|1964-09-25||1971-02-04|||1964-03-30||1965-09-19
TRIAL STUDY 134XCP|RP|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||BU|||10^4 CFU|NOT DONE||U|Y|N|3||39||RUN-IN|1961-10-19||1966-02-23|||1970-04-16||1963-12-11
TRIAL STUDY 134XCP|RP|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|1||||||TNDRIND|TENDERNESS INDICATOR||||CUP|||TITER|NOT DONE||N|NA|NA|4||88||INDUCTION TREATMENT|1967-06-16||1964-08-05|||1962-08-07||1963-06-27
TRIAL STUDY 134XCP|RP|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||BQ/L|||UG/KG/MIN|NOT DONE||Y|Y|N|4||88||WASHOUT|1969-10-17||1969-12-11|||1965-11-18||1966-10-10
TRIAL STUDY 134XCP|RP|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||DIOPTER|||CMOL|NOT DONE||N|Y|N|5||7||TREATMENT|1968-06-16||1971-12-30|||1973-08-24||1969-11-04
TRIAL STUDY 134XCP|RP|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||MMOL/DAY|||CAPLET|NOT DONE||N|U|Y|5||7||RUN-IN|1972-12-31||1972-10-26|||1970-01-19||1966-08-03
TRIAL STUDY 134XCP|RP|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|1||||||BCMETHOD|BIRTH CONTROL METHOD||||MOL/G|||10^6 RNA COPIES/ML|NOT DONE||N|N|NA|1||38||OBSERVATION|1965-09-08||1971-04-21|||1966-04-24||1960-03-18
TRIAL STUDY 134XCP|RP|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||FMOL/G|||MIN*MG/ML|NOT DONE||U|N|NA|1||38||TREATMENT|1961-10-29||1960-07-21|||1971-09-24||1972-10-08
TRIAL STUDY 134XCP|RP|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|1||||||PUSTIND|PUSTULE INDICATOR||||RFU|||CM/S|NOT DONE||U|NA|NA|2||58||BLINDED TREATMENT|1973-01-18||1960-05-29|||1971-07-28||1961-01-04
TRIAL STUDY 134XCP|RP|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|2||||||RASHIND|RASH INDICATOR||||CI/MG|||OSM|NOT DONE||N|NA|NA|2||58||RUN-IN|1968-07-30||1968-03-18|||1973-02-17||1965-11-30
TRIAL STUDY 134XCP|RP|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|1||||||DLVRMODE|MODE OF DELIVERY||||G/ANIMAL/WK|||UG/DOSE|NOT DONE||N|Y|U|3||39||OPEN LABEL TREATMENT|1972-07-29||1966-12-29|||1969-01-27||1962-10-15
TRIAL STUDY 134XCP|RP|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||UMOL/DL|||TITER|NOT DONE||NA|U|U|3||39||TREATMENT|1962-12-07||1971-07-07|||1962-01-26||1973-03-08
TRIAL STUDY 134XCP|RP|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|1||||||PUSTIND|PUSTULE INDICATOR||||NMOL|||NMOL/L|NOT DONE||N|Y|Y|4||88||WASHOUT|1972-06-19||1970-05-19|||1960-02-15||1971-01-12
TRIAL STUDY 134XCP|RP|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|2||||||FUNDHT|FUNDAL HEIGHT||||MV*MIN|||EIA UNIT|NOT DONE||U|U|N|4||88||RUN-IN|1969-09-10||1963-10-27|||1966-08-01||1966-01-23
TRIAL STUDY 134XCP|RP|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|1||||||DSCHGIND|DISCHARGE INDICATOR||||DISK|||MEQ/DAY|NOT DONE||U|Y|NA|5||7||INDUCTION TREATMENT|1962-06-22||1963-02-07|||1966-12-06||1964-02-04
TRIAL STUDY 134XCP|RP|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|2||||||THICK|THICKNESS||||PACKET|||CI|NOT DONE||U|Y|NA|5||7||BLINDED TREATMENT|1973-01-24||1964-04-15|||1961-10-21||1964-11-21
TRIAL STUDY 134XCP|RP|687E56D1-7E45-4598-819A-A0D8D770F406|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||NMOL/L/H|||EID 50/ML|NOT DONE||N|Y|N|1||38||LONG-TERM FOLLOW-UP|1960-02-01||1960-12-21|||1968-09-08||1973-08-12
TRIAL STUDY 134XCP|RP|687E56D1-7E45-4598-819A-A0D8D770F406|2||||||PREGIND|PREGNANT INDICATOR||||MEQ/ML|||GRAIN|NOT DONE||NA|U|U|1||38||LONG-TERM FOLLOW-UP|1963-03-05||1973-06-28|||1972-07-18||1966-01-27
TRIAL STUDY 134XCP|RP|687E56D1-7E45-4598-819A-A0D8D770F406|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||DB|||G/CM2|NOT DONE||Y|U|NA|2||58||LONG-TERM FOLLOW-UP|1972-01-20||1967-01-11|||1964-01-31||1973-05-01
TRIAL STUDY 134XCP|RP|687E56D1-7E45-4598-819A-A0D8D770F406|2||||||PREGIND|PREGNANT INDICATOR||||/MM|||GPS U|NOT DONE||U|U|Y|2||58||SCREENING|1965-07-15||1960-12-03|||1961-11-05||1962-10-17
TRIAL STUDY 134XCP|RP|687E56D1-7E45-4598-819A-A0D8D770F406|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||FINGERTIP UNIT|||KG/MOL|NOT DONE||Y|Y|U|3||39||BLINDED TREATMENT|1966-01-23||1964-03-25|||1966-09-29||1962-01-04
TRIAL STUDY 134XCP|RP|687E56D1-7E45-4598-819A-A0D8D770F406|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MV2/HZ|||DEG|NOT DONE||Y|NA|U|3||39||BLINDED TREATMENT|1963-02-19||1967-04-09|||1962-10-27||1969-03-01
TRIAL STUDY 134XCP|RP|687E56D1-7E45-4598-819A-A0D8D770F406|1||||||INABOIND|INDUCED ABORTION INDICATOR||||AG|||MG/M2|NOT DONE||U|U|U|4||88||RUN-IN|1964-07-01||1968-09-05|||1960-02-07||1973-07-13
TRIAL STUDY 134XCP|RP|687E56D1-7E45-4598-819A-A0D8D770F406|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MEQ/ML|||FIU|NOT DONE||Y|U|N|4||88||CONTINUATION TREATMENT|1964-07-16||1973-05-26|||1960-01-19||1971-07-24
TRIAL STUDY 134XCP|RP|687E56D1-7E45-4598-819A-A0D8D770F406|1||||||RASHIND|RASH INDICATOR||||U/10^12 RBC|||MOL/MG|NOT DONE||U|U|Y|5||7||OPEN LABEL TREATMENT|1969-08-27||1964-06-13|||1961-01-24||1967-01-01
TRIAL STUDY 134XCP|RP|687E56D1-7E45-4598-819A-A0D8D770F406|2||||||PUSTIND|PUSTULE INDICATOR||||MOL/MG|||UEQ/L|NOT DONE||N|Y|Y|5||7||SCREENING|1971-11-03||1969-10-15|||1960-08-13||1962-03-20
TRIAL STUDY 134XCP|RP|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||ML*CMH2O|||PSEC|NOT DONE||NA|Y|U|1||38||FOLLOW-UP|1961-04-27||1971-02-25|||1970-08-20||1970-07-06
TRIAL STUDY 134XCP|RP|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|2||||||PRGENDTC|DATE PREGNANCY ENDED||||MEQ|||CM H2O|NOT DONE||U|U|NA|1||38||WASHOUT|1960-10-11||1973-02-06|||1963-01-05||1973-01-17
TRIAL STUDY 134XCP|RP|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|1||||||PRGENDTC|DATE PREGNANCY ENDED||||UL/ML|||ANTI-XA IU/ML|NOT DONE||N|N|Y|2||58||LONG-TERM FOLLOW-UP|1961-12-01||1961-10-14|||1961-08-22||1969-01-09
TRIAL STUDY 134XCP|RP|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MOL/G|||PMOL/10^10 CELLS|NOT DONE||NA|NA|NA|2||58||LONG-TERM FOLLOW-UP|1960-03-07||1972-08-27|||1967-04-01||1963-12-07
TRIAL STUDY 134XCP|RP|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||10^4 CFU/ML|||UG/KG|NOT DONE||Y|NA|NA|3||39||OPEN LABEL TREATMENT|1973-08-12||1960-03-25|||1966-04-04||1965-07-29
TRIAL STUDY 134XCP|RP|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||GBQ/MG|||ML/DOSE|NOT DONE||U|Y|U|3||39||OPEN LABEL TREATMENT|1971-07-27||1963-01-01|||1963-12-24||1961-02-09
TRIAL STUDY 134XCP|RP|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||UMOL/MOL|||ML/CAGE/DAY|NOT DONE||N|U|U|4||88||BLINDED TREATMENT|1966-10-23||1970-09-01|||1972-05-31||1964-02-13
TRIAL STUDY 134XCP|RP|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|2||||||INABOIND|INDUCED ABORTION INDICATOR||||KAT|||CI/KG|NOT DONE||U|U|U|4||88||LONG-TERM FOLLOW-UP|1965-04-23||1967-06-28|||1970-09-09||1964-02-05
TRIAL STUDY 134XCP|RP|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|1||||||MASSIND|MASS INDICATOR||||MEQ/G|||TRANSDUCING UNIT/ML|NOT DONE||Y|Y|U|5||7||OPEN LABEL TREATMENT|1964-12-13||1969-09-07|||1960-05-07||1961-09-21
TRIAL STUDY 134XCP|RP|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|2||||||FUNDHT|FUNDAL HEIGHT||||/MM|||ML/MIN/MMHG|NOT DONE||Y|NA|U|5||7||SCREENING|1971-09-28||1972-07-22|||1968-04-25||1961-11-27
TRIAL STUDY 134XCP|RP|F536FDD9-881B-41AD-B863-FE8AB14062A1|1||||||MENOSTAT|MENOPAUSE STATUS||||CD*S/M2|||TUBERCULIN UNIT/ML|NOT DONE||N|NA|NA|1||38||TREATMENT|1961-01-11||1965-02-20|||1973-08-01||1960-08-13
TRIAL STUDY 134XCP|RP|F536FDD9-881B-41AD-B863-FE8AB14062A1|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||OZ EQ|||10^6 COPIES/ML|NOT DONE||N|N|Y|1||38||RUN-IN|1968-10-06||1961-09-21|||1971-10-21||1969-04-23
TRIAL STUDY 134XCP|RP|F536FDD9-881B-41AD-B863-FE8AB14062A1|1||||||INTP|INTERPRETATION||||POUCH|||CYCLE/MIN|NOT DONE||N|NA|N|2||58||OBSERVATION|1964-12-27||1961-08-19|||1964-11-22||1961-02-20
TRIAL STUDY 134XCP|RP|F536FDD9-881B-41AD-B863-FE8AB14062A1|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||DB|||TABLET|NOT DONE||NA|N|U|2||58||WASHOUT|1972-10-13||1973-04-11|||1962-08-19||1972-11-08
TRIAL STUDY 134XCP|RP|F536FDD9-881B-41AD-B863-FE8AB14062A1|1||||||MASSIND|MASS INDICATOR||||FOZ_BR|||MOL/G|NOT DONE||NA|NA|N|3||39||CONTINUATION TREATMENT|1966-01-19||1963-02-24|||1960-02-08||1970-09-30
TRIAL STUDY 134XCP|RP|F536FDD9-881B-41AD-B863-FE8AB14062A1|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||CM|||UEQ/L|NOT DONE||N|N|Y|3||39||SCREENING|1966-06-06||1971-04-21|||1970-04-14||1964-02-06
TRIAL STUDY 134XCP|RP|F536FDD9-881B-41AD-B863-FE8AB14062A1|1||||||MENFDUR|MENSES FLOW DURATION||||MSEC|||/100 WBC|NOT DONE||NA|Y|U|4||88||BLINDED TREATMENT|1960-03-13||1964-06-28|||1970-11-07||1972-03-12
TRIAL STUDY 134XCP|RP|F536FDD9-881B-41AD-B863-FE8AB14062A1|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||CMH2O*S2/ML|||CAPFUL|NOT DONE||Y|N|Y|4||88||CONTINUATION TREATMENT|1971-12-15||1965-06-28|||1969-12-22||1966-04-20
TRIAL STUDY 134XCP|RP|F536FDD9-881B-41AD-B863-FE8AB14062A1|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UG/G/DAY|||10^6 CFU/ML|NOT DONE||NA|U|Y|5||7||BASELINE|1971-07-03||1968-03-19|||1963-12-24||1963-08-20
TRIAL STUDY 134XCP|RP|F536FDD9-881B-41AD-B863-FE8AB14062A1|2||||||TNDRIND|TENDERNESS INDICATOR||||NMOL/L|||CARTRIDGE|NOT DONE||Y|Y|U|5||7||RUN-IN|1973-09-03||1960-10-16|||1969-01-22||1965-08-08
TRIAL STUDY 134XCP|RP|CB726766-A812-45B3-95CA-D1AD8F697FD3|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||KG/L|||GPL U|NOT DONE||Y|NA|U|1||38||SCREENING|1964-08-31||1960-06-21|||1971-11-21||1967-01-25
TRIAL STUDY 134XCP|RP|CB726766-A812-45B3-95CA-D1AD8F697FD3|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||UMOL|||10^6 ORGANISMS/ML|NOT DONE||Y|NA|NA|1||38||BLINDED TREATMENT|1971-10-31||1971-01-05|||1961-07-16||1965-08-20
TRIAL STUDY 134XCP|RP|CB726766-A812-45B3-95CA-D1AD8F697FD3|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||LOG10 TCID 50/UL|||HOUNSFIELD UNIT|NOT DONE||Y|Y|Y|2||58||INDUCTION TREATMENT|1973-01-02||1973-03-10|||1960-08-05||1962-03-31
TRIAL STUDY 134XCP|RP|CB726766-A812-45B3-95CA-D1AD8F697FD3|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MOL/L|||ML/M2|NOT DONE||Y|U|U|2||58||BASELINE|1972-12-14||1973-03-08|||1963-11-24||1960-08-02
TRIAL STUDY 134XCP|RP|CB726766-A812-45B3-95CA-D1AD8F697FD3|1||||||PRGENDTC|DATE PREGNANCY ENDED||||CG|||10^7 PFU|NOT DONE||NA|U|NA|3||39||CONTINUATION TREATMENT|1970-08-13||1960-11-30|||1965-03-02||1965-07-20
TRIAL STUDY 134XCP|RP|CB726766-A812-45B3-95CA-D1AD8F697FD3|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||10^9 ORGANISMS/MG|||ABSORBANCE U/ML|NOT DONE||U|Y|Y|3||39||SCREENING|1961-06-27||1963-06-16|||1961-07-07||1969-09-22
TRIAL STUDY 134XCP|RP|CB726766-A812-45B3-95CA-D1AD8F697FD3|1||||||BLISTIND|BLISTERING INDICATOR||||/500 WBC|||UEQ|NOT DONE||U|U|U|4||88||BLINDED TREATMENT|1964-09-07||1971-02-25|||1964-04-29||1971-03-28
TRIAL STUDY 134XCP|RP|CB726766-A812-45B3-95CA-D1AD8F697FD3|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||/2500 WBC|||CG|NOT DONE||N|U|N|4||88||INDUCTION TREATMENT|1964-03-11||1964-10-21|||1971-02-12||1968-07-10
TRIAL STUDY 134XCP|RP|CB726766-A812-45B3-95CA-D1AD8F697FD3|1||||||DLVRMODE|MODE OF DELIVERY||||CIGAR|||U/G HB|NOT DONE||N|Y|NA|5||7||TREATMENT|1964-10-16||1965-08-21|||1968-10-27||1965-06-06
TRIAL STUDY 134XCP|RP|CB726766-A812-45B3-95CA-D1AD8F697FD3|2||||||INABOIND|INDUCED ABORTION INDICATOR||||MNFI|||MMOL/L|NOT DONE||NA|N|N|5||7||BASELINE|1972-10-11||1969-02-05|||1963-06-23||1963-08-22
TRIAL STUDY 134XCP|RP|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||G/MOL|||MG/M2/DAY|NOT DONE||N|NA|U|1||38||BLINDED TREATMENT|1967-07-24||1962-04-28|||1972-05-05||1961-04-18
TRIAL STUDY 134XCP|RP|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|2||||||ERYTHIND|ERYTHEMA INDICATOR||||M3|||ML/KG/MIN|NOT DONE||U|NA|NA|1||38||TREATMENT|1963-08-03||1962-11-03|||1971-11-26||1962-09-12
TRIAL STUDY 134XCP|RP|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|1||||||DLVRMODE|MODE OF DELIVERY||||TAMPON|||10^9 CFU/ML|NOT DONE||NA|NA|Y|2||58||RUN-IN|1960-05-11||1972-04-07|||1969-01-15||1962-11-13
TRIAL STUDY 134XCP|RP|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ML/MMHG/MIN/L|||GY|NOT DONE||U|Y|N|2||58||LONG-TERM FOLLOW-UP|1970-10-13||1968-07-15|||1973-03-11||1961-02-01
TRIAL STUDY 134XCP|RP|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MOL/L|||G/CAGE/DAY|NOT DONE||Y|NA|NA|3||39||WASHOUT|1967-03-11||1960-09-29|||1966-10-08||1970-03-16
TRIAL STUDY 134XCP|RP|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||MG/ML/DAY|||MMHG/L/MIN|NOT DONE||N|U|Y|3||39||RUN-IN|1960-03-15||1962-05-02|||1965-07-28||1960-05-18
TRIAL STUDY 134XCP|RP|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|1||||||ERYTHIND|ERYTHEMA INDICATOR||||MOL/L|||ENZYME U/G HB|NOT DONE||NA|N|N|4||88||FOLLOW-UP|1971-02-15||1960-06-16|||1965-04-15||1964-09-21
TRIAL STUDY 134XCP|RP|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/MMHG|||U/DL|NOT DONE||Y|N|Y|4||88||LONG-TERM FOLLOW-UP|1968-10-28||1966-04-02|||1972-07-27||1960-01-07
TRIAL STUDY 134XCP|RP|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||OZ EQ|||ML/KG|NOT DONE||NA|Y|NA|5||7||INDUCTION TREATMENT|1972-04-09||1971-03-02|||1968-06-10||1961-08-27
TRIAL STUDY 134XCP|RP|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|2||||||GRAVIND|GRAVIDA INDICATOR||||PRESSOR UNITS|||FRACTION OF 1|NOT DONE||Y|U|NA|5||7||OPEN LABEL TREATMENT|1964-05-25||1968-03-25|||1968-01-28||1966-09-17
TRIAL STUDY 134XCP|RP|20DC654F-595C-410D-A340-465A23434D42|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||ENZYME U/M2|||UG/ANIMAL|NOT DONE||U|Y|U|1||38||SCREENING|1961-09-15||1970-05-25|||1960-12-16||1969-05-19
TRIAL STUDY 134XCP|RP|20DC654F-595C-410D-A340-465A23434D42|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||OHM|||MG/ML/MIN|NOT DONE||NA|NA|NA|1||38||WASHOUT|1968-03-26||1965-01-09|||1968-06-16||1972-02-27
TRIAL STUDY 134XCP|RP|20DC654F-595C-410D-A340-465A23434D42|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||CIGAR|||UEQ|NOT DONE||N|Y|Y|2||58||INDUCTION TREATMENT|1972-05-09||1971-05-10|||1972-08-05||1960-10-17
TRIAL STUDY 134XCP|RP|20DC654F-595C-410D-A340-465A23434D42|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||AGU/ML|||10^6 U|NOT DONE||NA|Y|N|2||58||CONTINUATION TREATMENT|1962-06-28||1966-07-09|||1967-10-19||1960-07-17
TRIAL STUDY 134XCP|RP|20DC654F-595C-410D-A340-465A23434D42|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||IU/G HB|||MMHG*MIN/L|NOT DONE||NA|Y|Y|3||39||CONTINUATION TREATMENT|1973-02-20||1961-05-06|||1970-10-05||1968-09-27
TRIAL STUDY 134XCP|RP|20DC654F-595C-410D-A340-465A23434D42|2||||||PEELIND|PEELING INDICATOR||||APPLICATION|||PRESSOR UNITS|NOT DONE||Y|NA|Y|3||39||LONG-TERM FOLLOW-UP|1960-10-26||1963-04-15|||1973-02-28||1963-02-26
TRIAL STUDY 134XCP|RP|20DC654F-595C-410D-A340-465A23434D42|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||MPL U|||UOSM|NOT DONE||N|NA|N|4||88||BASELINE|1966-09-24||1965-08-01|||1967-05-11||1971-12-16
TRIAL STUDY 134XCP|RP|20DC654F-595C-410D-A340-465A23434D42|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||L/H/M2|||MG/M2/H|NOT DONE||U|NA|U|4||88||BASELINE|1968-04-09||1968-05-13|||1960-08-20||1966-02-22
TRIAL STUDY 134XCP|RP|20DC654F-595C-410D-A340-465A23434D42|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||10^9/G|||BQ|NOT DONE||N|U|Y|5||7||CONTINUATION TREATMENT|1967-08-23||1961-10-19|||1960-10-20||1973-05-02
TRIAL STUDY 134XCP|RP|20DC654F-595C-410D-A340-465A23434D42|2||||||BCMETHOD|BIRTH CONTROL METHOD||||MG/CM2|||UM|NOT DONE||U|N|Y|5||7||WASHOUT|1963-12-06||1971-11-15|||1973-08-24||1964-07-18
TRIAL STUDY 134XCP|RP|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|1||||||INABOIND|INDUCED ABORTION INDICATOR||||BQ|||/7.5 ML|NOT DONE||N|NA|Y|1||38||FOLLOW-UP|1971-07-25||1968-08-19|||1968-02-24||1967-07-28
TRIAL STUDY 134XCP|RP|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|2||||||ULCERIND|ULCER INDICATOR||||HEP|||/MBP|NOT DONE||N|U|Y|1||38||INDUCTION TREATMENT|1961-08-01||1968-04-24|||1971-06-21||1969-04-08
TRIAL STUDY 134XCP|RP|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|1||||||PREGNN|NUMBER OF PREGNANCIES||||UG/L/H|||10^3 COPIES/ML|NOT DONE||Y|Y|U|2||58||RUN-IN|1966-01-09||1964-07-07|||1963-02-03||1966-09-01
TRIAL STUDY 134XCP|RP|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||OSM|||%/MIN|NOT DONE||Y|N|NA|2||58||TREATMENT|1967-09-28||1969-04-30|||1967-11-12||1971-06-14
TRIAL STUDY 134XCP|RP|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||U/MG|||MMOL2/L2|NOT DONE||U|NA|Y|3||39||RUN-IN|1971-12-18||1967-01-18|||1965-12-18||1962-04-03
TRIAL STUDY 134XCP|RP|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||TORR|||10^3 RNA COPIES/ML|NOT DONE||U|U|N|3||39||TREATMENT|1968-02-15||1966-06-10|||1962-09-12||1970-01-28
TRIAL STUDY 134XCP|RP|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|1||||||FUNDHT|FUNDAL HEIGHT||||CS|||LOG10 TCID 50/DOSE|NOT DONE||U|N|NA|4||88||INDUCTION TREATMENT|1972-04-02||1971-11-11|||1967-09-20||1962-12-14
TRIAL STUDY 134XCP|RP|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||VIRTUAL PIXEL|||10^6 CFU|NOT DONE||N|N|N|4||88||SCREENING|1973-04-16||1971-08-10|||1972-01-05||1967-10-04
TRIAL STUDY 134XCP|RP|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|1||||||PUSTIND|PUSTULE INDICATOR||||MG/H|||KALLIKREIN INHIBITOR UNIT|NOT DONE||U|Y|U|5||7||LONG-TERM FOLLOW-UP|1970-07-29||1968-11-17|||1973-01-06||1962-06-06
TRIAL STUDY 134XCP|RP|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||GBQ|||KHZ|NOT DONE||N|N|U|5||7||BASELINE|1969-07-01||1966-10-22|||1962-05-02||1972-01-15
TRIAL STUDY 134XCP|RP|4EA8DC88-09C8-4954-A469-D8E12F01CB56|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||10^3 CFU/G|||/4.0 ML|NOT DONE||Y|N|NA|1||38||CONTINUATION TREATMENT|1970-12-07||1967-07-24|||1964-04-03||1970-07-31
TRIAL STUDY 134XCP|RP|4EA8DC88-09C8-4954-A469-D8E12F01CB56|2||||||MASSIND|MASS INDICATOR||||LOG10 TCID 50/ML|||MG/KG/MIN|NOT DONE||NA|N|NA|1||38||CONTINUATION TREATMENT|1972-06-25||1966-02-25|||1969-09-07||1968-11-26
TRIAL STUDY 134XCP|RP|4EA8DC88-09C8-4954-A469-D8E12F01CB56|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||EID 50/DOSE|||FMOL/L/SEC|NOT DONE||NA|U|NA|2||58||BLINDED TREATMENT|1964-08-16||1967-08-29|||1967-07-29||1968-05-31
TRIAL STUDY 134XCP|RP|4EA8DC88-09C8-4954-A469-D8E12F01CB56|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||RPM|||JOULE|NOT DONE||U|Y|NA|2||58||SCREENING|1960-09-15||1969-09-03|||1968-01-03||1964-10-30
TRIAL STUDY 134XCP|RP|4EA8DC88-09C8-4954-A469-D8E12F01CB56|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||10^7 TCID 50/DOSE|||AMU|NOT DONE||Y|N|NA|3||39||RUN-IN|1962-09-27||1968-02-19|||1969-02-26||1962-11-09
TRIAL STUDY 134XCP|RP|4EA8DC88-09C8-4954-A469-D8E12F01CB56|2||||||FUNDHT|FUNDAL HEIGHT||||RFU|||10^4 CFU|NOT DONE||NA|U|N|3||39||FOLLOW-UP|1971-04-11||1970-12-06|||1972-02-05||1961-08-29
TRIAL STUDY 134XCP|RP|4EA8DC88-09C8-4954-A469-D8E12F01CB56|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MBQ/UL|||UG/KG/MIN|NOT DONE||NA|NA|NA|4||88||BASELINE|1965-02-10||1962-08-06|||1965-05-19||1965-09-09
TRIAL STUDY 134XCP|RP|4EA8DC88-09C8-4954-A469-D8E12F01CB56|2||||||RASHIND|RASH INDICATOR||||MU|||HZ|NOT DONE||NA|Y|NA|4||88||TREATMENT|1963-12-23||1971-11-17|||1968-10-10||1972-10-29
TRIAL STUDY 134XCP|RP|4EA8DC88-09C8-4954-A469-D8E12F01CB56|1||||||FUNDHT|FUNDAL HEIGHT||||JAR|||DRAM|NOT DONE||U|N|U|5||7||INDUCTION TREATMENT|1960-01-26||1964-02-06|||1968-07-25||1970-02-14
TRIAL STUDY 134XCP|RP|4EA8DC88-09C8-4954-A469-D8E12F01CB56|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||ML/100G/MIN|||RNA COPIES/ML|NOT DONE||U|NA|N|5||7||WASHOUT|1961-10-06||1972-06-08|||1970-06-01||1967-06-02
TRIAL STUDY 134XCP|RP|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|1||||||MENARAGE|MENARCHE AGE||||UU/L|||FMOL|NOT DONE||N|Y|NA|1||38||BLINDED TREATMENT|1965-03-12||1969-10-07|||1969-02-24||1973-07-16
TRIAL STUDY 134XCP|RP|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||LOZENGE|||PG|NOT DONE||Y|U|N|1||38||FOLLOW-UP|1962-07-15||1962-06-12|||1969-06-04||1968-08-16
TRIAL STUDY 134XCP|RP|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ELISA UNIT/ML|||MV|NOT DONE||U|NA|N|2||58||BASELINE|1966-09-17||1963-03-04|||1963-05-09||1971-12-11
TRIAL STUDY 134XCP|RP|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||%(V/V)|||CAPFUL|NOT DONE||Y|Y|U|2||58||CONTINUATION TREATMENT|1966-05-18||1967-04-10|||1973-01-02||1963-08-07
TRIAL STUDY 134XCP|RP|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||NMOL/L/MIN|||LOG EID 50/DOSE|NOT DONE||NA|Y|U|3||39||BLINDED TREATMENT|1971-03-18||1969-01-05|||1970-10-30||1971-05-04
TRIAL STUDY 134XCP|RP|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||PLUG|||MMOL/MIN/KPA|NOT DONE||NA|N|NA|3||39||INDUCTION TREATMENT|1972-09-25||1973-03-30|||1964-07-24||1965-09-20
TRIAL STUDY 134XCP|RP|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MJOULE/CM2|||CI/KG|NOT DONE||U|Y|U|4||88||INDUCTION TREATMENT|1964-06-13||1962-12-11|||1965-06-15||1960-05-16
TRIAL STUDY 134XCP|RP|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|2||||||MENFDUR|MENSES FLOW DURATION||||ATM|||PACK|NOT DONE||Y|U|U|4||88||FOLLOW-UP|1971-11-24||1968-10-10|||1972-10-12||1967-10-16
TRIAL STUDY 134XCP|RP|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||GBQ/MG|||RFU|NOT DONE||N|Y|Y|5||7||OBSERVATION|1965-03-18||1963-09-29|||1961-11-10||1964-09-25
TRIAL STUDY 134XCP|RP|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|2||||||INABOIND|INDUCED ABORTION INDICATOR||||COPIES/UL|||ML/CM3/MIN|NOT DONE||N|U|NA|5||7||FOLLOW-UP|1973-07-26||1962-10-10|||1966-12-11||1962-04-21
TRIAL STUDY 134XCP|RP|521B1614-9092-4F89-A47F-728C66E01B23|1||||||TNDRIND|TENDERNESS INDICATOR||||UMOL/L/SEC|||AMU|NOT DONE||N|N|N|1||38||SCREENING|1961-12-11||1970-07-10|||1969-07-30||1971-04-28
TRIAL STUDY 134XCP|RP|521B1614-9092-4F89-A47F-728C66E01B23|2||||||PEELIND|PEELING INDICATOR||||BQ|||UIU/DL|NOT DONE||NA|NA|N|1||38||SCREENING|1967-04-20||1970-11-04|||1961-07-14||1970-12-17
TRIAL STUDY 134XCP|RP|521B1614-9092-4F89-A47F-728C66E01B23|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ABSORBANCE U/MIN|||TUBE|NOT DONE||U|N|Y|2||58||BASELINE|1973-05-22||1961-07-13|||1961-05-29||1964-08-06
TRIAL STUDY 134XCP|RP|521B1614-9092-4F89-A47F-728C66E01B23|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||PKAT/L|||ML/CAGE|NOT DONE||N|N|U|2||58||TREATMENT|1970-02-15||1966-10-20|||1972-09-10||1968-07-24
TRIAL STUDY 134XCP|RP|521B1614-9092-4F89-A47F-728C66E01B23|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||SBE/ML|||P|NOT DONE||N|N|Y|3||39||BASELINE|1971-12-24||1965-06-15|||1965-09-30||1964-09-18
TRIAL STUDY 134XCP|RP|521B1614-9092-4F89-A47F-728C66E01B23|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||DROP|||UG/M2|NOT DONE||N|Y|U|3||39||BLINDED TREATMENT|1960-03-28||1963-08-12|||1962-12-13||1967-08-15
TRIAL STUDY 134XCP|RP|521B1614-9092-4F89-A47F-728C66E01B23|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||/10^4|||PACKAGE|NOT DONE||NA|U|U|4||88||TREATMENT|1969-08-19||1961-06-01|||1963-02-17||1962-09-05
TRIAL STUDY 134XCP|RP|521B1614-9092-4F89-A47F-728C66E01B23|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||LOG10 PFU/ML|||PT_BR|NOT DONE||N|U|NA|4||88||BASELINE|1964-05-02||1966-01-21|||1965-12-27||1969-11-11
TRIAL STUDY 134XCP|RP|521B1614-9092-4F89-A47F-728C66E01B23|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||10^9 ORGANISMS/ML|||MG/CM2|NOT DONE||N|N|N|5||7||WASHOUT|1961-07-01||1972-03-15|||1960-03-17||1964-12-27
TRIAL STUDY 134XCP|RP|521B1614-9092-4F89-A47F-728C66E01B23|2||||||THICK|THICKNESS||||MEQ/DAY|||MOSM/KG|NOT DONE||N|N|Y|5||7||BASELINE|1965-06-17||1973-03-18|||1960-03-01||1960-09-03
TRIAL STUDY 134XCP|RP|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|1||||||PREGNN|NUMBER OF PREGNANCIES||||HENRY|||PACK YEAR|NOT DONE||Y|N|N|1||38||SCREENING|1966-03-18||1961-11-18|||1965-02-03||1972-10-30
TRIAL STUDY 134XCP|RP|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||10^3 CFU|||DMOL|NOT DONE||U|Y|N|1||38||OPEN LABEL TREATMENT|1971-02-24||1972-10-02|||1971-11-17||1970-07-22
TRIAL STUDY 134XCP|RP|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UL/ML|||CI/G|NOT DONE||NA|N|Y|2||58||WASHOUT|1966-05-23||1970-11-29|||1972-08-01||1963-04-26
TRIAL STUDY 134XCP|RP|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||U/KG/H|||NFIU|NOT DONE||N|Y|U|2||58||LONG-TERM FOLLOW-UP|1965-11-17||1972-06-20|||1965-10-16||1967-10-29
TRIAL STUDY 134XCP|RP|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||M|||MU|NOT DONE||NA|U|U|3||39||RUN-IN|1964-05-16||1969-04-19|||1967-08-01||1965-05-09
TRIAL STUDY 134XCP|RP|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||VG/DOSE|||FFU|NOT DONE||Y|N|U|3||39||CONTINUATION TREATMENT|1969-07-02||1970-12-04|||1969-05-17||1969-10-24
TRIAL STUDY 134XCP|RP|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|1||||||MENOSTAT|MENOPAUSE STATUS||||OZ|||SIEMENS|NOT DONE||N|U|Y|4||88||OBSERVATION|1973-02-15||1970-02-23|||1965-01-17||1963-09-07
TRIAL STUDY 134XCP|RP|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|2||||||BLISTIND|BLISTERING INDICATOR||||MG2/DL2|||G/U|NOT DONE||Y|Y|NA|4||88||LONG-TERM FOLLOW-UP|1970-04-11||1968-06-03|||1965-01-31||1966-04-15
TRIAL STUDY 134XCP|RP|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||HOURS|||POINT|NOT DONE||N|NA|NA|5||7||LONG-TERM FOLLOW-UP|1964-05-04||1970-03-17|||1973-08-12||1963-03-29
TRIAL STUDY 134XCP|RP|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||FINGERTIP UNIT|||GENEQ/ML|NOT DONE||NA|U|N|5||7||INDUCTION TREATMENT|1965-12-13||1961-10-22|||1969-10-12||1970-09-23
TRIAL STUDY 134XCP|RP|FF6B8B49-3C82-459D-A35D-61136FC594D2|1||||||TNDRIND|TENDERNESS INDICATOR||||ML*CMH2O|||PFU/ML|NOT DONE||Y|N|N|1||38||TREATMENT|1972-02-07||1966-11-13|||1970-02-22||1968-07-16
TRIAL STUDY 134XCP|RP|FF6B8B49-3C82-459D-A35D-61136FC594D2|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||CGY|||HPA|NOT DONE||NA|N|U|1||38||RUN-IN|1966-06-15||1961-11-07|||1961-04-18||1960-09-10
TRIAL STUDY 134XCP|RP|FF6B8B49-3C82-459D-A35D-61136FC594D2|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||NMOL/DAY|||L|NOT DONE||U|U|Y|2||58||WASHOUT|1964-05-13||1970-05-27|||1961-05-11||1964-07-08
TRIAL STUDY 134XCP|RP|FF6B8B49-3C82-459D-A35D-61136FC594D2|2||||||PEELIND|PEELING INDICATOR||||G/DAY|||KM|NOT DONE||NA|N|N|2||58||BLINDED TREATMENT|1970-09-14||1970-01-19|||1962-12-25||1972-12-23
TRIAL STUDY 134XCP|RP|FF6B8B49-3C82-459D-A35D-61136FC594D2|1||||||PUSTIND|PUSTULE INDICATOR||||PACK|||FINGERTIP UNIT|NOT DONE||Y|N|Y|3||39||OBSERVATION|1964-01-13||1971-01-23|||1965-01-18||1970-11-14
TRIAL STUDY 134XCP|RP|FF6B8B49-3C82-459D-A35D-61136FC594D2|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||ML/BEAT|||DEG|NOT DONE||Y|U|N|3||39||INDUCTION TREATMENT|1969-10-27||1970-11-01|||1972-04-29||1966-08-08
TRIAL STUDY 134XCP|RP|FF6B8B49-3C82-459D-A35D-61136FC594D2|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||DAMOL/L|||MG/ML/MIN|NOT DONE||N|U|Y|4||88||BASELINE|1967-04-22||1967-07-08|||1968-11-15||1960-01-17
TRIAL STUDY 134XCP|RP|FF6B8B49-3C82-459D-A35D-61136FC594D2|2||||||PEELIND|PEELING INDICATOR||||U/G/H|||UEQ|NOT DONE||Y|N|U|4||88||BLINDED TREATMENT|1966-11-04||1973-09-06|||1966-04-26||1965-10-19
TRIAL STUDY 134XCP|RP|FF6B8B49-3C82-459D-A35D-61136FC594D2|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||G/ANIMAL/DAY|||UG/MOL|NOT DONE||N|NA|U|5||7||SCREENING|1969-12-15||1961-09-02|||1968-07-10||1967-12-10
TRIAL STUDY 134XCP|RP|FF6B8B49-3C82-459D-A35D-61136FC594D2|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||APPLICATION|||VOXEL|NOT DONE||NA|NA|U|5||7||RUN-IN|1971-08-30||1968-02-05|||1970-06-27||1965-11-25
TRIAL STUDY 134XCP|RP|2196D9F4-937A-4662-B24B-AC9D472E0393|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MM2|||MAC50|NOT DONE||NA|U|N|1||38||OBSERVATION|1968-05-03||1965-04-05|||1960-07-17||1966-12-04
TRIAL STUDY 134XCP|RP|2196D9F4-937A-4662-B24B-AC9D472E0393|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||ML/MIN/MMHG|||MONTHS|NOT DONE||NA|Y|N|1||38||OBSERVATION|1970-01-03||1961-05-17|||1972-12-16||1973-06-16
TRIAL STUDY 134XCP|RP|2196D9F4-937A-4662-B24B-AC9D472E0393|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||DIOPTER|||MESF|NOT DONE||U|N|Y|2||58||RUN-IN|1969-05-13||1968-09-04|||1961-11-04||1972-05-17
TRIAL STUDY 134XCP|RP|2196D9F4-937A-4662-B24B-AC9D472E0393|2||||||PRGENDTC|DATE PREGNANCY ENDED||||NMOL/KG/DAY|||KAT|NOT DONE||Y|N|U|2||58||INDUCTION TREATMENT|1972-11-01||1963-11-26|||1971-09-23||1961-07-14
TRIAL STUDY 134XCP|RP|2196D9F4-937A-4662-B24B-AC9D472E0393|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||NG/MOL|||COULOMB|NOT DONE||U|NA|N|3||39||CONTINUATION TREATMENT|1964-11-27||1965-01-08|||1969-12-21||1964-05-24
TRIAL STUDY 134XCP|RP|2196D9F4-937A-4662-B24B-AC9D472E0393|2||||||INABOIND|INDUCED ABORTION INDICATOR||||U/G/MIN|||/CMH2O|NOT DONE||Y|Y|Y|3||39||OPEN LABEL TREATMENT|1967-12-19||1970-02-07|||1965-01-22||1968-03-03
TRIAL STUDY 134XCP|RP|2196D9F4-937A-4662-B24B-AC9D472E0393|1||||||PREGST|PREGNANT DURING THE STUDY||||NL|||/VF|NOT DONE||U|N|Y|4||88||LONG-TERM FOLLOW-UP|1968-08-18||1970-08-01|||1960-02-23||1960-07-15
TRIAL STUDY 134XCP|RP|2196D9F4-937A-4662-B24B-AC9D472E0393|2||||||ABORTN|NUMBER OF ABORTIONS||||KG/L|||/HPF|NOT DONE||NA|N|NA|4||88||BLINDED TREATMENT|1963-11-19||1969-11-14|||1972-09-27||1970-04-12
TRIAL STUDY 134XCP|RP|2196D9F4-937A-4662-B24B-AC9D472E0393|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||HZ|||M3|NOT DONE||NA|Y|U|5||7||TREATMENT|1972-04-13||1961-10-10|||1960-10-31||1968-02-29
TRIAL STUDY 134XCP|RP|2196D9F4-937A-4662-B24B-AC9D472E0393|2||||||ERYTHIND|ERYTHEMA INDICATOR||||MMOL/MIN/KPA|||DEG/S|NOT DONE||U|NA|Y|5||7||SCREENING|1970-04-13||1967-11-04|||1972-09-15||1966-03-16
TRIAL STUDY 134XCP|RP|F192452A-4088-46AA-9DD1-8D14809E18F6|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||10^3 CFU/G|||/MM2|NOT DONE||NA|NA|N|1||38||BLINDED TREATMENT|1972-01-27||1968-08-15|||1962-03-13||1960-03-08
TRIAL STUDY 134XCP|RP|F192452A-4088-46AA-9DD1-8D14809E18F6|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||UG/L DDU|||10^9 ORGANISMS/MG|NOT DONE||Y|NA|NA|1||38||INDUCTION TREATMENT|1961-08-21||1970-03-05|||1964-12-11||1964-10-27
TRIAL STUDY 134XCP|RP|F192452A-4088-46AA-9DD1-8D14809E18F6|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||WAFER|||NMOL/L/H|NOT DONE||U|NA|NA|2||58||BLINDED TREATMENT|1961-05-14||1968-03-21|||1967-09-11||1972-10-08
TRIAL STUDY 134XCP|RP|F192452A-4088-46AA-9DD1-8D14809E18F6|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||CCID 50/ML|||TITER|NOT DONE||NA|Y|NA|2||58||SCREENING|1961-06-06||1965-03-26|||1971-10-03||1972-01-01
TRIAL STUDY 134XCP|RP|F192452A-4088-46AA-9DD1-8D14809E18F6|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MBQ|||KG/L|NOT DONE||NA|NA|Y|3||39||SCREENING|1964-05-03||1969-06-02|||1960-10-10||1964-07-22
TRIAL STUDY 134XCP|RP|F192452A-4088-46AA-9DD1-8D14809E18F6|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||LOG10 CFU/ML|||KBQ/UL|NOT DONE||Y|Y|N|3||39||FOLLOW-UP|1973-07-11||1965-11-15|||1964-04-18||1967-08-31
TRIAL STUDY 134XCP|RP|F192452A-4088-46AA-9DD1-8D14809E18F6|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||RFU|||UG|NOT DONE||Y|U|U|4||88||BASELINE|1973-03-27||1966-08-06|||1962-10-04||1963-07-31
TRIAL STUDY 134XCP|RP|F192452A-4088-46AA-9DD1-8D14809E18F6|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||NG|||VP/DOSE|NOT DONE||U|NA|NA|4||88||SCREENING|1963-01-18||1970-01-24|||1960-02-08||1965-07-25
TRIAL STUDY 134XCP|RP|F192452A-4088-46AA-9DD1-8D14809E18F6|1||||||EDEMAIND|EDEMA INDICATOR||||HZ/S|||MONTHS|NOT DONE||Y|N|U|5||7||OBSERVATION|1972-04-16||1963-05-28|||1970-10-13||1969-12-18
TRIAL STUDY 134XCP|RP|F192452A-4088-46AA-9DD1-8D14809E18F6|2||||||PREGST|PREGNANT DURING THE STUDY||||IU/KG|||/MONTH|NOT DONE||U|N|N|5||7||BASELINE|1961-03-27||1964-10-26|||1964-08-03||1965-07-25
TRIAL STUDY 134XCP|RP|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|1||||||PEELIND|PEELING INDICATOR||||PL|||MKAT|NOT DONE||NA|U|NA|1||38||OPEN LABEL TREATMENT|1962-09-27||1969-11-13|||1967-02-07||1966-03-05
TRIAL STUDY 134XCP|RP|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|2||||||ULCERIND|ULCER INDICATOR||||L/DAY|||DEG|NOT DONE||NA|U|NA|1||38||TREATMENT|1961-10-29||1969-07-21|||1967-09-21||1971-02-20
TRIAL STUDY 134XCP|RP|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|1||||||PUSTIND|PUSTULE INDICATOR||||MEQ/G|||MMOL/MIN/KPA/L|NOT DONE||Y|N|U|2||58||BASELINE|1970-02-12||1962-01-20|||1960-07-19||1972-05-30
TRIAL STUDY 134XCP|RP|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|2||||||BLISTIND|BLISTERING INDICATOR||||UIU/L|||/10^3|NOT DONE||N|NA|Y|2||58||SCREENING|1965-02-18||1971-08-30|||1973-06-14||1965-06-09
TRIAL STUDY 134XCP|RP|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|1||||||ABORTN|NUMBER OF ABORTIONS||||FRAMES/S|||NGEQ/L|NOT DONE||N|N|NA|3||39||CONTINUATION TREATMENT|1961-08-05||1969-03-06|||1967-12-09||1962-05-30
TRIAL STUDY 134XCP|RP|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||PRESSOR UNITS|||PA|NOT DONE||U|U|U|3||39||CONTINUATION TREATMENT|1966-01-05||1961-11-22|||1965-10-18||1969-11-30
TRIAL STUDY 134XCP|RP|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|1||||||PUSTIND|PUSTULE INDICATOR||||FOZ_BR|||/MS|NOT DONE||NA|Y|U|4||88||INDUCTION TREATMENT|1970-01-03||1961-03-19|||1966-07-15||1961-05-18
TRIAL STUDY 134XCP|RP|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|2||||||INTP|INTERPRETATION||||UL|||NEEDLE GAUGE|NOT DONE||Y|U|U|4||88||TREATMENT|1963-11-07||1970-11-19|||1964-01-08||1962-06-13
TRIAL STUDY 134XCP|RP|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||ML/G/DAY|||MM/H|NOT DONE||U|U|Y|5||7||INDUCTION TREATMENT|1971-04-03||1961-10-12|||1963-08-20||1969-10-07
TRIAL STUDY 134XCP|RP|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||MMU/ML|||PMOL/G|NOT DONE||N|NA|U|5||7||FOLLOW-UP|1971-05-03||1962-04-08|||1970-05-30||1969-09-19
TRIAL STUDY 134XCP|RP|0D51A87E-2597-4B2D-A7B5-E533790E917D|1||||||PREGST|PREGNANT DURING THE STUDY||||CM H2O|||LOG10 CFU/G|NOT DONE||U|U|Y|1||38||RUN-IN|1973-06-08||1963-05-24|||1969-05-31||1966-08-24
TRIAL STUDY 134XCP|RP|0D51A87E-2597-4B2D-A7B5-E533790E917D|2||||||PREGNN|NUMBER OF PREGNANCIES||||MIN*MG/ML|||PACK|NOT DONE||Y|N|N|1||38||INDUCTION TREATMENT|1970-10-29||1969-11-21|||1964-11-02||1961-03-23
TRIAL STUDY 134XCP|RP|0D51A87E-2597-4B2D-A7B5-E533790E917D|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UMOL/KG/MIN|||MU/L|NOT DONE||N|N|NA|2||58||RUN-IN|1972-11-18||1963-12-21|||1963-03-21||1962-05-31
TRIAL STUDY 134XCP|RP|0D51A87E-2597-4B2D-A7B5-E533790E917D|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||WATT|||10^9/G|NOT DONE||U|N|NA|2||58||OBSERVATION|1971-05-28||1968-04-27|||1963-12-25||1961-09-24
TRIAL STUDY 134XCP|RP|0D51A87E-2597-4B2D-A7B5-E533790E917D|1||||||MENFDUR|MENSES FLOW DURATION||||PRESSOR UNITS|||YEARS|NOT DONE||NA|N|NA|3||39||OPEN LABEL TREATMENT|1972-02-05||1973-04-07|||1960-03-28||1965-08-12
TRIAL STUDY 134XCP|RP|0D51A87E-2597-4B2D-A7B5-E533790E917D|2||||||BLISTIND|BLISTERING INDICATOR||||/MBP|||ML/H|NOT DONE||N|N|U|3||39||FOLLOW-UP|1971-10-20||1965-12-16|||1965-02-19||1973-02-03
TRIAL STUDY 134XCP|RP|0D51A87E-2597-4B2D-A7B5-E533790E917D|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||DEG2|||UGEQ/L|NOT DONE||N|U|N|4||88||OBSERVATION|1963-12-08||1963-03-29|||1960-06-29||1961-06-06
TRIAL STUDY 134XCP|RP|0D51A87E-2597-4B2D-A7B5-E533790E917D|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||10^5/L|||GPELISA UNIT/ML|NOT DONE||N|U|N|4||88||INDUCTION TREATMENT|1968-01-15||1968-07-27|||1967-05-27||1965-07-26
TRIAL STUDY 134XCP|RP|0D51A87E-2597-4B2D-A7B5-E533790E917D|1||||||BRTHN|NUMBER OF BIRTHS||||10^9/DOSE|||PFU/ML|NOT DONE||N|Y|Y|5||7||RUN-IN|1964-10-17||1971-11-13|||1968-06-19||1967-10-30
TRIAL STUDY 134XCP|RP|0D51A87E-2597-4B2D-A7B5-E533790E917D|2||||||DLVRMODE|MODE OF DELIVERY||||MU/G|||L/DAY|NOT DONE||U|N|N|5||7||BLINDED TREATMENT|1961-07-06||1968-11-04|||1971-01-25||1962-05-17
TRIAL STUDY 134XCP|RP|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||PG|||ML/CAGE|NOT DONE||NA|Y|NA|1||38||OPEN LABEL TREATMENT|1965-05-01||1971-10-09|||1968-03-30||1968-08-31
TRIAL STUDY 134XCP|RP|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|2||||||PEELIND|PEELING INDICATOR||||MMOL/L|||NEBULE|NOT DONE||Y|U|NA|1||38||CONTINUATION TREATMENT|1972-07-02||1964-09-18|||1961-07-12||1972-01-07
TRIAL STUDY 134XCP|RP|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||GRAIN|||BQ/MG|NOT DONE||NA|N|N|2||58||INDUCTION TREATMENT|1960-03-18||1963-12-13|||1963-12-20||1971-07-29
TRIAL STUDY 134XCP|RP|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||FINGERTIP UNIT|||MG/DAY|NOT DONE||N|Y|NA|2||58||INDUCTION TREATMENT|1971-09-04||1963-01-26|||1973-05-26||1971-12-07
TRIAL STUDY 134XCP|RP|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||USIEMENS|||TABLET|NOT DONE||NA|N|NA|3||39||WASHOUT|1973-09-07||1964-05-08|||1966-01-13||1960-03-20
TRIAL STUDY 134XCP|RP|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||10^3 COPIES/ML|||MPS U|NOT DONE||Y|U|NA|3||39||CONTINUATION TREATMENT|1966-08-09||1969-10-10|||1963-09-03||1965-03-24
TRIAL STUDY 134XCP|RP|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||UL/KG/DAY|||BAU|NOT DONE||U|Y|Y|4||88||TREATMENT|1967-11-14||1965-07-01|||1966-10-27||1961-12-19
TRIAL STUDY 134XCP|RP|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||AMPULE|||STEPS/MIN|NOT DONE||N|U|N|4||88||SCREENING|1961-06-03||1966-09-20|||1960-03-14||1965-03-23
TRIAL STUDY 134XCP|RP|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||YEARS|||TBSP|NOT DONE||U|U|U|5||7||OBSERVATION|1971-10-23||1969-01-21|||1960-12-02||1966-09-27
TRIAL STUDY 134XCP|RP|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|2||||||RASHIND|RASH INDICATOR||||SBE/ML|||UV*SEC|NOT DONE||U|NA|U|5||7||FOLLOW-UP|1961-05-12||1972-04-15|||1964-02-04||1964-02-12
TRIAL STUDY 134XCP|RP|16075684-F04D-4CB8-970A-0819378790EB|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||BAU|||COPIES/ML|NOT DONE||U|N|N|1||38||WASHOUT|1965-10-20||1969-02-26|||1963-08-09||1962-12-16
TRIAL STUDY 134XCP|RP|16075684-F04D-4CB8-970A-0819378790EB|2||||||DLVRMODE|MODE OF DELIVERY||||LX|||10^7 TCID 50/DOSE|NOT DONE||N|U|NA|1||38||OBSERVATION|1963-01-09||1963-11-17|||1962-10-20||1963-11-06
TRIAL STUDY 134XCP|RP|16075684-F04D-4CB8-970A-0819378790EB|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||NG/DL|||U|NOT DONE||Y|U|N|2||58||CONTINUATION TREATMENT|1961-11-30||1968-01-10|||1969-05-24||1965-09-04
TRIAL STUDY 134XCP|RP|16075684-F04D-4CB8-970A-0819378790EB|2||||||GRAVIND|GRAVIDA INDICATOR||||FMOL/L/SEC|||DPM/ML|NOT DONE||Y|Y|NA|2||58||BLINDED TREATMENT|1964-06-22||1967-11-13|||1969-10-24||1966-02-02
TRIAL STUDY 134XCP|RP|16075684-F04D-4CB8-970A-0819378790EB|1||||||GRAVIND|GRAVIDA INDICATOR||||10^10/L|||MV*MIN|NOT DONE||Y|NA|NA|3||39||OBSERVATION|1972-01-02||1966-12-25|||1968-12-01||1963-08-23
TRIAL STUDY 134XCP|RP|16075684-F04D-4CB8-970A-0819378790EB|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MV2/HZ|||LOG10 IU/ML|NOT DONE||NA|U|Y|3||39||RUN-IN|1967-04-04||1971-11-29|||1966-01-07||1967-07-15
TRIAL STUDY 134XCP|RP|16075684-F04D-4CB8-970A-0819378790EB|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||10^6/HPF|||G/DL|NOT DONE||Y|U|NA|4||88||WASHOUT|1972-09-28||1962-01-01|||1964-06-15||1966-11-19
TRIAL STUDY 134XCP|RP|16075684-F04D-4CB8-970A-0819378790EB|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||BOWL|||G/ANIMAL/DAY|NOT DONE||U|Y|U|4||88||SCREENING|1964-10-30||1972-03-30|||1965-01-21||1972-09-29
TRIAL STUDY 134XCP|RP|16075684-F04D-4CB8-970A-0819378790EB|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||ML/DL|||NEWTON|NOT DONE||U|Y|Y|5||7||TREATMENT|1971-09-12||1967-06-14|||1963-03-26||1961-01-05
TRIAL STUDY 134XCP|RP|16075684-F04D-4CB8-970A-0819378790EB|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||UL|||/LSQN|NOT DONE||N|Y|Y|5||7||BLINDED TREATMENT|1964-09-18||1963-03-09|||1961-02-28||1960-11-02
TRIAL STUDY 134XCP|RP|3527E844-D4D5-480A-B6D6-04C5DC0A3380|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||CAPSULE|||KUSP|NOT DONE||N|NA|U|1||38||OPEN LABEL TREATMENT|1971-08-08||1962-03-05|||1965-03-17||1970-04-14
TRIAL STUDY 134XCP|RP|3527E844-D4D5-480A-B6D6-04C5DC0A3380|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||PT_US|||PMOL/L|NOT DONE||NA|N|N|1||38||WASHOUT|1971-10-05||1964-02-08|||1961-09-25||1971-02-07
TRIAL STUDY 134XCP|RP|3527E844-D4D5-480A-B6D6-04C5DC0A3380|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||G/G|||MMOL/KG|NOT DONE||NA|Y|N|2||58||CONTINUATION TREATMENT|1964-06-03||1973-07-18|||1964-06-06||1962-03-18
TRIAL STUDY 134XCP|RP|3527E844-D4D5-480A-B6D6-04C5DC0A3380|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||VG/ML|||CGY|NOT DONE||U|NA|U|2||58||RUN-IN|1970-03-23||1969-02-18|||1969-12-01||1962-05-27
TRIAL STUDY 134XCP|RP|3527E844-D4D5-480A-B6D6-04C5DC0A3380|1||||||DLVRMODE|MODE OF DELIVERY||||ML/S/M2|||10^3 ORGANISMS/ML|NOT DONE||NA|U|N|3||39||LONG-TERM FOLLOW-UP|1969-10-21||1969-09-14|||1966-03-28||1964-04-10
TRIAL STUDY 134XCP|RP|3527E844-D4D5-480A-B6D6-04C5DC0A3380|2||||||STILBIND|STILLBIRTH INDICATOR||||10^6 U|||MOL/L|NOT DONE||Y|NA|U|3||39||SCREENING|1969-10-21||1972-09-23|||1966-12-29||1971-11-06
TRIAL STUDY 134XCP|RP|3527E844-D4D5-480A-B6D6-04C5DC0A3380|1||||||MENOAGE|MENOPAUSE AGE||||CG|||/LPF|NOT DONE||NA|NA|NA|4||88||OBSERVATION|1964-06-07||1966-12-20|||1961-04-06||1968-11-11
TRIAL STUDY 134XCP|RP|3527E844-D4D5-480A-B6D6-04C5DC0A3380|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/KG|||KA_U/DL|NOT DONE||N|NA|N|4||88||BLINDED TREATMENT|1968-09-23||1973-03-10|||1971-03-08||1963-02-15
TRIAL STUDY 134XCP|RP|3527E844-D4D5-480A-B6D6-04C5DC0A3380|1||||||ABORTN|NUMBER OF ABORTIONS||||NKAT/G HB|||P|NOT DONE||NA|N|N|5||7||SCREENING|1969-11-18||1962-02-14|||1969-10-16||1968-11-16
TRIAL STUDY 134XCP|RP|3527E844-D4D5-480A-B6D6-04C5DC0A3380|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||G/U|||PACK|NOT DONE||N|NA|N|5||7||BLINDED TREATMENT|1970-05-23||1961-12-19|||1969-06-22||1967-10-02
TRIAL STUDY 134XCP|RP|DFB0DF52-4D95-4A26-B28F-071774D78426|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||CCID 50/ML|||%/MIN|NOT DONE||U|N|Y|1||38||SCREENING|1965-07-28||1961-01-02|||1970-07-08||1965-08-11
TRIAL STUDY 134XCP|RP|DFB0DF52-4D95-4A26-B28F-071774D78426|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MHZ|||TUBERCULIN UNIT|NOT DONE||Y|U|Y|1||38||BLINDED TREATMENT|1969-10-03||1961-09-23|||1966-03-31||1966-10-31
TRIAL STUDY 134XCP|RP|DFB0DF52-4D95-4A26-B28F-071774D78426|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||FEU|||UEQ/L|NOT DONE||NA|N|Y|2||58||FOLLOW-UP|1967-08-20||1971-03-04|||1973-05-30||1966-05-22
TRIAL STUDY 134XCP|RP|DFB0DF52-4D95-4A26-B28F-071774D78426|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||EU|||EJACULATE U|NOT DONE||N|U|N|2||58||LONG-TERM FOLLOW-UP|1971-07-19||1970-02-10|||1972-07-23||1965-02-17
TRIAL STUDY 134XCP|RP|DFB0DF52-4D95-4A26-B28F-071774D78426|1||||||MASSIND|MASS INDICATOR||||10^6 COPIES/ML|||PFU/ML|NOT DONE||Y|Y|NA|3||39||SCREENING|1973-02-18||1963-03-08|||1960-11-10||1961-05-24
TRIAL STUDY 134XCP|RP|DFB0DF52-4D95-4A26-B28F-071774D78426|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||BOWL|||PMOL/L|NOT DONE||NA|N|NA|3||39||OPEN LABEL TREATMENT|1973-07-05||1971-09-02|||1962-03-16||1963-04-18
TRIAL STUDY 134XCP|RP|DFB0DF52-4D95-4A26-B28F-071774D78426|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||KIU|||GLOBULE|NOT DONE||U|NA|N|4||88||TREATMENT|1963-03-09||1965-12-13|||1969-02-27||1960-03-25
TRIAL STUDY 134XCP|RP|DFB0DF52-4D95-4A26-B28F-071774D78426|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||EU|||ECL UNIT|NOT DONE||U|N|U|4||88||BASELINE|1968-06-06||1970-04-14|||1969-02-12||1961-11-30
TRIAL STUDY 134XCP|RP|DFB0DF52-4D95-4A26-B28F-071774D78426|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||UG/KG|||LOG10 CCID 50/DOSE|NOT DONE||N|N|Y|5||7||WASHOUT|1972-07-30||1964-12-10|||1966-02-27||1968-07-27
TRIAL STUDY 134XCP|RP|DFB0DF52-4D95-4A26-B28F-071774D78426|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||L/S|||M|NOT DONE||NA|N|NA|5||7||OPEN LABEL TREATMENT|1961-03-31||1972-10-15|||1970-11-24||1970-07-08
TRIAL STUDY 134XCP|RP|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MEQ/UL|||UG/KG/H|NOT DONE||NA|U|NA|1||38||INDUCTION TREATMENT|1961-01-29||1968-11-19|||1960-01-06||1960-02-01
TRIAL STUDY 134XCP|RP|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|2||||||ABORTN|NUMBER OF ABORTIONS||||NG|||10^12 IU/L|NOT DONE||U|N|Y|1||38||LONG-TERM FOLLOW-UP|1960-05-10||1972-09-20|||1968-09-13||1967-06-06
TRIAL STUDY 134XCP|RP|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MEQ/KG|||LOG10 ELISA UNIT/DOSE|NOT DONE||Y|N|N|2||58||OBSERVATION|1960-08-16||1968-08-28|||1969-09-07||1960-08-05
TRIAL STUDY 134XCP|RP|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||NMOL/L/MIN|||ML/KG/H|NOT DONE||U|N|Y|2||58||INDUCTION TREATMENT|1966-06-26||1967-03-06|||1971-09-08||1961-07-17
TRIAL STUDY 134XCP|RP|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||OD UNIT|||PACK YEAR|NOT DONE||U|U|NA|3||39||SCREENING|1968-12-22||1968-04-27|||1967-06-01||1962-12-12
TRIAL STUDY 134XCP|RP|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|2||||||MENOAGE|MENOPAUSE AGE||||MOL/L|||AMOL|NOT DONE||N|U|N|3||39||BLINDED TREATMENT|1970-08-02||1965-12-02|||1962-10-03||1972-09-28
TRIAL STUDY 134XCP|RP|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||CI/ML|||MMOL/MOL|NOT DONE||U|N|Y|4||88||FOLLOW-UP|1962-12-07||1972-04-12|||1966-10-04||1968-05-06
TRIAL STUDY 134XCP|RP|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||GTT|||CAPFUL|NOT DONE||Y|U|U|4||88||TREATMENT|1968-05-22||1967-08-15|||1963-05-20||1970-11-07
TRIAL STUDY 134XCP|RP|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|1||||||EDEMAIND|EDEMA INDICATOR||||RATIO|||CI/ML|NOT DONE||Y|N|NA|5||7||WASHOUT|1963-06-13||1972-10-10|||1970-02-21||1969-09-03
TRIAL STUDY 134XCP|RP|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|2||||||TNDRIND|TENDERNESS INDICATOR||||LOG10 TCID 50/UL|||NG/DL|NOT DONE||NA|Y|U|5||7||FOLLOW-UP|1961-12-03||1969-09-26|||1963-04-05||1971-07-05
TRIAL STUDY 134XCP|RP|CFF20837-0091-467E-ABDE-72645BAFC849|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||UG/MIN|||MMOL2/L2|NOT DONE||U|NA|NA|1||38||BLINDED TREATMENT|1964-06-19||1965-08-02|||1964-10-16||1965-11-01
TRIAL STUDY 134XCP|RP|CFF20837-0091-467E-ABDE-72645BAFC849|2||||||MENOSTAT|MENOPAUSE STATUS||||KG/M2|||GMFI|NOT DONE||N|N|NA|1||38||OPEN LABEL TREATMENT|1962-11-10||1964-11-04|||1969-08-21||1968-12-09
TRIAL STUDY 134XCP|RP|CFF20837-0091-467E-ABDE-72645BAFC849|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||PMOL/G|||UG/M2/DAY|NOT DONE||NA|Y|N|2||58||TREATMENT|1966-09-26||1968-12-08|||1961-04-07||1966-04-09
TRIAL STUDY 134XCP|RP|CFF20837-0091-467E-ABDE-72645BAFC849|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||UG/KG/H|||UMOL/H/MMOL|NOT DONE||Y|NA|U|2||58||OBSERVATION|1964-03-13||1967-08-19|||1973-01-18||1961-02-19
TRIAL STUDY 134XCP|RP|CFF20837-0091-467E-ABDE-72645BAFC849|1||||||MENOAGE|MENOPAUSE AGE||||CI/ML|||GBQ|NOT DONE||Y|N|N|3||39||TREATMENT|1960-08-31||1972-06-13|||1969-04-30||1960-10-24
TRIAL STUDY 134XCP|RP|CFF20837-0091-467E-ABDE-72645BAFC849|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||10^6 ORGANISMS/G|||L/S/KPA|NOT DONE||U|NA|Y|3||39||LONG-TERM FOLLOW-UP|1964-04-19||1964-12-12|||1962-01-31||1969-08-17
TRIAL STUDY 134XCP|RP|CFF20837-0091-467E-ABDE-72645BAFC849|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||BAR|||10^12/L|NOT DONE||Y|U|NA|4||88||BLINDED TREATMENT|1968-03-07||1971-07-06|||1970-07-27||1962-09-12
TRIAL STUDY 134XCP|RP|CFF20837-0091-467E-ABDE-72645BAFC849|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UG/G/MIN|||SBE/ML|NOT DONE||U|N|NA|4||88||BLINDED TREATMENT|1960-09-18||1962-05-21|||1965-03-03||1960-03-02
TRIAL STUDY 134XCP|RP|CFF20837-0091-467E-ABDE-72645BAFC849|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||UMOL|||/WK|NOT DONE||N|N|Y|5||7||SCREENING|1971-02-03||1963-02-28|||1968-05-25||1971-08-04
TRIAL STUDY 134XCP|RP|CFF20837-0091-467E-ABDE-72645BAFC849|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||UG/MOL|||BQ|NOT DONE||NA|N|Y|5||7||SCREENING|1967-09-22||1970-10-31|||1970-10-08||1961-07-18
TRIAL STUDY 134XCP|RP|C79756C8-8601-4770-8BC2-7A530428BA82|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/5X10^4 WBC|||U/MG|NOT DONE||U|N|NA|1||38||TREATMENT|1966-08-12||1971-05-16|||1965-12-11||1972-11-11
TRIAL STUDY 134XCP|RP|C79756C8-8601-4770-8BC2-7A530428BA82|2||||||DLVRMODE|MODE OF DELIVERY||||TSP|||IMPLANT|NOT DONE||Y|NA|NA|1||38||OBSERVATION|1967-09-12||1965-02-07|||1971-01-31||1969-11-16
TRIAL STUDY 134XCP|RP|C79756C8-8601-4770-8BC2-7A530428BA82|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||PPM|||10^3 CFU/ML|NOT DONE||Y|U|NA|2||58||FOLLOW-UP|1970-08-21||1971-10-17|||1964-11-18||1967-11-14
TRIAL STUDY 134XCP|RP|C79756C8-8601-4770-8BC2-7A530428BA82|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MCI/L|||/SEC|NOT DONE||Y|Y|U|2||58||LONG-TERM FOLLOW-UP|1963-02-22||1966-04-27|||1961-09-14||1968-04-06
TRIAL STUDY 134XCP|RP|C79756C8-8601-4770-8BC2-7A530428BA82|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||NM|||H*%|NOT DONE||U|N|U|3||39||BASELINE|1962-05-11||1969-02-02|||1964-12-01||1970-08-16
TRIAL STUDY 134XCP|RP|C79756C8-8601-4770-8BC2-7A530428BA82|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||G/G|||KG/MOL|NOT DONE||Y|Y|NA|3||39||LONG-TERM FOLLOW-UP|1960-03-28||1962-02-22|||1963-03-10||1968-07-12
TRIAL STUDY 134XCP|RP|C79756C8-8601-4770-8BC2-7A530428BA82|1||||||GRAVIND|GRAVIDA INDICATOR||||PATCH|||BREATHS/MIN|NOT DONE||U|U|NA|4||88||LONG-TERM FOLLOW-UP|1968-07-21||1971-07-10|||1972-09-03||1965-01-20
TRIAL STUDY 134XCP|RP|C79756C8-8601-4770-8BC2-7A530428BA82|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MIN/DAY|||10^7 CFU|NOT DONE||NA|N|U|4||88||SCREENING|1969-04-06||1972-03-29|||1969-06-28||1960-12-20
TRIAL STUDY 134XCP|RP|C79756C8-8601-4770-8BC2-7A530428BA82|1||||||MENOSTAT|MENOPAUSE STATUS||||CI/UG|||10^9 CFU/G|NOT DONE||U|NA|NA|5||7||BLINDED TREATMENT|1965-07-17||1972-10-29|||1970-08-08||1963-11-14
TRIAL STUDY 134XCP|RP|C79756C8-8601-4770-8BC2-7A530428BA82|2||||||RASHIND|RASH INDICATOR||||CAPFUL|||GBQ/UG|NOT DONE||U|U|N|5||7||OPEN LABEL TREATMENT|1967-09-02||1972-07-19|||1970-04-23||1971-08-09
TRIAL STUDY 134XCP|RP|5533A669-828B-4CA3-BEC3-849CE7384167|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||WATT|||UG/KG/MIN|NOT DONE||NA|U|N|1||38||CONTINUATION TREATMENT|1971-09-26||1972-06-22|||1964-06-16||1971-10-29
TRIAL STUDY 134XCP|RP|5533A669-828B-4CA3-BEC3-849CE7384167|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||/40 HPFS|||/HPF|NOT DONE||NA|Y|N|1||38||LONG-TERM FOLLOW-UP|1962-02-09||1968-08-17|||1966-01-05||1970-07-19
TRIAL STUDY 134XCP|RP|5533A669-828B-4CA3-BEC3-849CE7384167|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MGEQ|||NMOL/L/MIN|NOT DONE||Y|NA|U|2||58||BASELINE|1963-03-27||1971-02-04|||1972-02-07||1964-12-01
TRIAL STUDY 134XCP|RP|5533A669-828B-4CA3-BEC3-849CE7384167|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MU|||NFIU|NOT DONE||NA|N|U|2||58||TREATMENT|1964-12-25||1968-06-19|||1973-04-03||1964-07-18
TRIAL STUDY 134XCP|RP|5533A669-828B-4CA3-BEC3-849CE7384167|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||SQU/ML|||MMU/ML|NOT DONE||N|Y|N|3||39||LONG-TERM FOLLOW-UP|1967-07-06||1966-11-03|||1963-09-17||1964-06-17
TRIAL STUDY 134XCP|RP|5533A669-828B-4CA3-BEC3-849CE7384167|2||||||PRGENDTC|DATE PREGNANCY ENDED||||M2|||MSEC|NOT DONE||Y|U|Y|3||39||SCREENING|1970-04-24||1960-08-01|||1971-02-25||1969-03-06
TRIAL STUDY 134XCP|RP|5533A669-828B-4CA3-BEC3-849CE7384167|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||U/DL|||CI/G|NOT DONE||Y|N|NA|4||88||RUN-IN|1965-04-17||1968-11-19|||1970-08-07||1964-03-27
TRIAL STUDY 134XCP|RP|5533A669-828B-4CA3-BEC3-849CE7384167|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||FINGERTIP UNIT|||VIAL|NOT DONE||N|N|U|4||88||LONG-TERM FOLLOW-UP|1968-11-09||1973-03-02|||1964-11-11||1969-12-13
TRIAL STUDY 134XCP|RP|5533A669-828B-4CA3-BEC3-849CE7384167|1||||||TNDRIND|TENDERNESS INDICATOR||||MG/M2/H|||OHM|NOT DONE||U|Y|U|5||7||CONTINUATION TREATMENT|1965-08-07||1972-07-14|||1970-03-19||1968-02-27
TRIAL STUDY 134XCP|RP|5533A669-828B-4CA3-BEC3-849CE7384167|2||||||TNDRIND|TENDERNESS INDICATOR||||10^12 IU/L|||MU|NOT DONE||Y|N|Y|5||7||INDUCTION TREATMENT|1964-01-12||1970-10-14|||1968-10-27||1963-06-28
TRIAL STUDY 134XCP|RP|C711ADD3-F398-4161-BE13-B75BEDF91402|1||||||THICK|THICKNESS||||ABSORBANCE U|||UG/G/DAY|NOT DONE||Y|NA|U|1||38||FOLLOW-UP|1963-01-29||1972-05-14|||1972-06-25||1973-08-06
TRIAL STUDY 134XCP|RP|C711ADD3-F398-4161-BE13-B75BEDF91402|2||||||BLISTIND|BLISTERING INDICATOR||||MG/DOSE|||TORR|NOT DONE||Y|NA|U|1||38||CONTINUATION TREATMENT|1970-10-29||1962-03-17|||1971-01-22||1971-08-18
TRIAL STUDY 134XCP|RP|C711ADD3-F398-4161-BE13-B75BEDF91402|1||||||GRAVIND|GRAVIDA INDICATOR||||OI50|||NKAT/L|NOT DONE||NA|NA|Y|2||58||TREATMENT|1970-07-27||1967-06-20|||1966-10-26||1962-10-15
TRIAL STUDY 134XCP|RP|C711ADD3-F398-4161-BE13-B75BEDF91402|2||||||PREGIND|PREGNANT INDICATOR||||NCI|||/2000 RBC|NOT DONE||NA|U|U|2||58||RUN-IN|1971-05-13||1962-05-06|||1964-12-10||1960-09-25
TRIAL STUDY 134XCP|RP|C711ADD3-F398-4161-BE13-B75BEDF91402|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MOSM/L|||G/CAGE|NOT DONE||Y|U|Y|3||39||BASELINE|1961-05-15||1963-06-01|||1961-05-25||1971-02-01
TRIAL STUDY 134XCP|RP|C711ADD3-F398-4161-BE13-B75BEDF91402|2||||||RASHIND|RASH INDICATOR||||TUBERCULIN UNIT/ML|||MMOL/S|NOT DONE||N|U|NA|3||39||CONTINUATION TREATMENT|1965-03-15||1964-11-10|||1963-06-20||1969-05-06
TRIAL STUDY 134XCP|RP|C711ADD3-F398-4161-BE13-B75BEDF91402|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||FMOL/L/SEC|||10^9 ORGANISMS|NOT DONE||N|Y|N|4||88||FOLLOW-UP|1967-09-29||1973-07-30|||1963-02-18||1971-12-11
TRIAL STUDY 134XCP|RP|C711ADD3-F398-4161-BE13-B75BEDF91402|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||DMOL|||COPIES/ML|NOT DONE||U|N|Y|4||88||RUN-IN|1965-04-20||1969-07-28|||1967-02-13||1971-09-06
TRIAL STUDY 134XCP|RP|C711ADD3-F398-4161-BE13-B75BEDF91402|1||||||RASHIND|RASH INDICATOR||||VP/DOSE|||MKAT|NOT DONE||NA|U|N|5||7||RUN-IN|1965-09-09||1967-01-09|||1964-01-29||1966-08-24
TRIAL STUDY 134XCP|RP|C711ADD3-F398-4161-BE13-B75BEDF91402|2||||||BLISTIND|BLISTERING INDICATOR||||KIT|||KG/M2|NOT DONE||N|N|Y|5||7||OPEN LABEL TREATMENT|1967-11-11||1970-06-22|||1966-06-26||1971-07-21
TRIAL STUDY 134XCP|RP|2CD70FFA-5977-4718-961B-6D67368F99B8|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MCI/KG|||SCOOPFUL|NOT DONE||NA|U|N|1||38||CONTINUATION TREATMENT|1961-07-27||1967-03-26|||1963-02-07||1963-04-12
TRIAL STUDY 134XCP|RP|2CD70FFA-5977-4718-961B-6D67368F99B8|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||IU/MG|||FOZ_BR|NOT DONE||N|Y|Y|1||38||OPEN LABEL TREATMENT|1964-07-16||1972-06-13|||1966-04-24||1973-05-31
TRIAL STUDY 134XCP|RP|2CD70FFA-5977-4718-961B-6D67368F99B8|1||||||INTP|INTERPRETATION||||TBSP|||MET*MIN|NOT DONE||U|U|U|2||58||TREATMENT|1969-01-20||1962-06-09|||1968-06-23||1971-06-01
TRIAL STUDY 134XCP|RP|2CD70FFA-5977-4718-961B-6D67368F99B8|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MG/DOSE|||DPM/ML|NOT DONE||Y|U|Y|2||58||LONG-TERM FOLLOW-UP|1964-08-29||1969-07-17|||1963-04-27||1969-04-07
TRIAL STUDY 134XCP|RP|2CD70FFA-5977-4718-961B-6D67368F99B8|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MONTHS|||10^6 CFU|NOT DONE||Y|N|NA|3||39||OBSERVATION|1971-07-22||1972-10-07|||1972-03-10||1973-06-13
TRIAL STUDY 134XCP|RP|2CD70FFA-5977-4718-961B-6D67368F99B8|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||U/G/H|||BLOCKS|NOT DONE||Y|N|U|3||39||TREATMENT|1971-06-20||1964-09-01|||1968-10-01||1964-07-03
TRIAL STUDY 134XCP|RP|2CD70FFA-5977-4718-961B-6D67368F99B8|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||UG/DL|||PMOL/G|NOT DONE||Y|U|Y|4||88||BASELINE|1968-06-30||1965-04-15|||1963-08-03||1968-06-04
TRIAL STUDY 134XCP|RP|2CD70FFA-5977-4718-961B-6D67368F99B8|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||UMOL/MOL|||VIRTUAL PIXEL|NOT DONE||N|Y|N|4||88||LONG-TERM FOLLOW-UP|1961-07-27||1963-11-11|||1970-07-28||1966-04-29
TRIAL STUDY 134XCP|RP|2CD70FFA-5977-4718-961B-6D67368F99B8|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||LOG10 ELISA UNIT|||CD/M2|NOT DONE||U|N|U|5||7||INDUCTION TREATMENT|1966-08-24||1962-12-25|||1971-08-11||1967-12-02
TRIAL STUDY 134XCP|RP|2CD70FFA-5977-4718-961B-6D67368F99B8|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||10^3 CFU|||MIN*MG/ML|NOT DONE||NA|NA|Y|5||7||SCREENING|1963-02-17||1966-06-29|||1971-09-25||1965-08-01
TRIAL STUDY 134XCP|RP|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|1||||||PREGNN|NUMBER OF PREGNANCIES||||LINEAR FT*LB|||HENRY|NOT DONE||Y|Y|NA|1||38||BLINDED TREATMENT|1963-09-06||1970-01-15|||1971-04-11||1963-02-11
TRIAL STUDY 134XCP|RP|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||JDF UNIT|||G/DAY|NOT DONE||N|Y|Y|1||38||FOLLOW-UP|1971-02-04||1971-09-30|||1966-12-29||1969-01-05
TRIAL STUDY 134XCP|RP|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^3 ORGANISMS/ML|||DIP|NOT DONE||U|N|Y|2||58||CONTINUATION TREATMENT|1971-05-31||1960-04-07|||1971-06-10||1968-09-03
TRIAL STUDY 134XCP|RP|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||PACK|||KPA|NOT DONE||Y|U|NA|2||58||OPEN LABEL TREATMENT|1973-04-16||1964-04-17|||1965-04-21||1961-08-24
TRIAL STUDY 134XCP|RP|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ABSORBANCE U/MIN|||NG/MOL|NOT DONE||Y|Y|NA|3||39||FOLLOW-UP|1961-01-20||1965-09-02|||1965-03-04||1965-05-27
TRIAL STUDY 134XCP|RP|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|2||||||PREGIND|PREGNANT INDICATOR||||MOL/MOL|||UKAT/L|NOT DONE||U|NA|NA|3||39||OPEN LABEL TREATMENT|1963-01-27||1964-04-17|||1970-09-14||1965-11-27
TRIAL STUDY 134XCP|RP|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MEQ/UG|||MEQ/UG|NOT DONE||U|Y|U|4||88||LONG-TERM FOLLOW-UP|1972-09-29||1970-12-21|||1968-10-15||1966-11-30
TRIAL STUDY 134XCP|RP|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MG/KG/WEEK|||P|NOT DONE||N|N|Y|4||88||RUN-IN|1968-11-23||1967-02-12|||1970-09-27||1972-06-21
TRIAL STUDY 134XCP|RP|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||DB|||ML|NOT DONE||U|N|NA|5||7||WASHOUT|1963-03-19||1965-11-27|||1967-07-17||1970-05-04
TRIAL STUDY 134XCP|RP|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MOL/MOL|||MCI/L|NOT DONE||Y|NA|Y|5||7||OBSERVATION|1967-03-21||1970-09-01|||1961-05-23||1964-01-18
TRIAL STUDY 134XCP|RP|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||APS U|||KN/CM2|NOT DONE||NA|NA|NA|1||38||LONG-TERM FOLLOW-UP|1966-12-20||1968-04-06|||1967-06-03||1971-06-20
TRIAL STUDY 134XCP|RP|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|2||||||INTP|INTERPRETATION||||/MM|||CMH2O*S2/ML|NOT DONE||Y|U|N|1||38||INDUCTION TREATMENT|1967-01-09||1970-03-03|||1973-04-02||1962-04-13
TRIAL STUDY 134XCP|RP|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MOL/DAY|||IU/G|NOT DONE||U|Y|U|2||58||RUN-IN|1971-02-16||1965-05-27|||1962-07-09||1967-05-24
TRIAL STUDY 134XCP|RP|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||CI/MG|||H/WK|NOT DONE||U|U|N|2||58||RUN-IN|1968-01-12||1971-03-01|||1968-10-12||1960-01-15
TRIAL STUDY 134XCP|RP|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|1||||||MASSIND|MASS INDICATOR||||L/L|||PUFF|NOT DONE||Y|N|N|3||39||INDUCTION TREATMENT|1971-01-26||1964-02-15|||1970-01-02||1969-05-16
TRIAL STUDY 134XCP|RP|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|2||||||MENOSTAT|MENOPAUSE STATUS||||NKAT/G HB|||/100 HPFS|NOT DONE||NA|U|Y|3||39||BLINDED TREATMENT|1972-03-28||1971-11-02|||1962-05-21||1968-04-03
TRIAL STUDY 134XCP|RP|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|1||||||MENARAGE|MENARCHE AGE||||ML/100G/MIN|||F|NOT DONE||U|Y|N|4||88||SCREENING|1969-12-20||1961-11-26|||1969-02-21||1962-02-20
TRIAL STUDY 134XCP|RP|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||EJACULATE U|||PLUG|NOT DONE||NA|Y|U|4||88||CONTINUATION TREATMENT|1965-01-06||1960-09-11|||1966-02-28||1967-06-26
TRIAL STUDY 134XCP|RP|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||NEBULE|||UMOL|NOT DONE||NA|Y|N|5||7||OPEN LABEL TREATMENT|1961-08-01||1960-09-06|||1972-10-02||1971-05-12
TRIAL STUDY 134XCP|RP|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MG/G/H|||ML/M2/DAY|NOT DONE||N|NA|Y|5||7||OBSERVATION|1969-04-17||1961-12-08|||1969-01-08||1966-02-08
TRIAL STUDY 134XCP|RP|43E00B7D-684F-4BAC-A135-E65C22B191AD|1||||||RASHIND|RASH INDICATOR||||TROCHE|||NG/DAY|NOT DONE||NA|N|N|1||38||FOLLOW-UP|1968-11-13||1963-07-03|||1968-09-13||1967-01-30
TRIAL STUDY 134XCP|RP|43E00B7D-684F-4BAC-A135-E65C22B191AD|2||||||PUSTIND|PUSTULE INDICATOR||||ML/ANIMAL/DAY|||MG/G/H|NOT DONE||N|N|N|1||38||TREATMENT|1962-05-05||1966-02-28|||1969-03-08||1971-09-18
TRIAL STUDY 134XCP|RP|43E00B7D-684F-4BAC-A135-E65C22B191AD|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MNFI|||ML/G/DAY|NOT DONE||U|NA|NA|2||58||SCREENING|1962-01-25||1961-06-14|||1966-03-02||1963-11-26
TRIAL STUDY 134XCP|RP|43E00B7D-684F-4BAC-A135-E65C22B191AD|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||MGEQ|||MM|NOT DONE||U|U|Y|2||58||FOLLOW-UP|1967-08-21||1971-02-28|||1965-05-25||1963-05-27
TRIAL STUDY 134XCP|RP|43E00B7D-684F-4BAC-A135-E65C22B191AD|1||||||FUNDHT|FUNDAL HEIGHT||||CIGAR|||KG/CM|NOT DONE||Y|U|N|3||39||RUN-IN|1964-01-30||1961-06-08|||1964-01-08||1969-01-16
TRIAL STUDY 134XCP|RP|43E00B7D-684F-4BAC-A135-E65C22B191AD|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||10^3 DNA COPIES/ML|||FINGERTIP UNIT|NOT DONE||U|U|NA|3||39||BLINDED TREATMENT|1966-01-26||1966-11-30|||1968-10-22||1971-03-17
TRIAL STUDY 134XCP|RP|43E00B7D-684F-4BAC-A135-E65C22B191AD|1||||||GRAVIND|GRAVIDA INDICATOR||||BOX|||UKAT/10^12 RBC|NOT DONE||N|N|U|4||88||INDUCTION TREATMENT|1963-05-03||1963-01-21|||1966-03-06||1968-10-05
TRIAL STUDY 134XCP|RP|43E00B7D-684F-4BAC-A135-E65C22B191AD|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||NMOL/MOL|||MMAL|NOT DONE||N|U|Y|4||88||RUN-IN|1961-12-12||1962-03-02|||1962-07-18||1963-07-11
TRIAL STUDY 134XCP|RP|43E00B7D-684F-4BAC-A135-E65C22B191AD|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||10^6 ORGANISMS/MG|||COPIES/UL|NOT DONE||NA|U|NA|5||7||OBSERVATION|1965-01-12||1968-10-31|||1961-07-05||1963-04-20
TRIAL STUDY 134XCP|RP|43E00B7D-684F-4BAC-A135-E65C22B191AD|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||EID 50/ML|||TUBE|NOT DONE||N|N|Y|5||7||OBSERVATION|1969-12-17||1961-05-16|||1968-12-26||1968-11-04
TRIAL STUDY 134XCP|RP|25680BE0-7CE5-4B76-A48E-2D977A07E749|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||UG/G/H|||MMOL/L|NOT DONE||NA|NA|U|1||38||TREATMENT|1971-09-19||1968-12-13|||1968-07-03||1966-08-27
TRIAL STUDY 134XCP|RP|25680BE0-7CE5-4B76-A48E-2D977A07E749|2||||||BLISTIND|BLISTERING INDICATOR||||U/KG/MIN|||IN|NOT DONE||Y|U|U|1||38||RUN-IN|1968-12-13||1966-07-28|||1967-06-02||1961-11-11
TRIAL STUDY 134XCP|RP|25680BE0-7CE5-4B76-A48E-2D977A07E749|1||||||FUNDHT|FUNDAL HEIGHT||||COPIES/UG|||TESLA|NOT DONE||N|U|N|2||58||OPEN LABEL TREATMENT|1968-10-09||1961-10-07|||1960-08-27||1965-12-15
TRIAL STUDY 134XCP|RP|25680BE0-7CE5-4B76-A48E-2D977A07E749|2||||||FUNDHT|FUNDAL HEIGHT||||CGY|||BEAM BREAKS|NOT DONE||NA|NA|Y|2||58||CONTINUATION TREATMENT|1973-02-23||1969-04-27|||1960-04-29||1967-03-01
TRIAL STUDY 134XCP|RP|25680BE0-7CE5-4B76-A48E-2D977A07E749|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||YEARS|||UIU/DL|NOT DONE||NA|Y|NA|3||39||OBSERVATION|1963-10-07||1969-01-09|||1965-09-24||1965-08-11
TRIAL STUDY 134XCP|RP|25680BE0-7CE5-4B76-A48E-2D977A07E749|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||ML/MIN|||CM2|NOT DONE||Y|U|NA|3||39||WASHOUT|1970-06-23||1965-10-08|||1970-06-17||1971-08-27
TRIAL STUDY 134XCP|RP|25680BE0-7CE5-4B76-A48E-2D977A07E749|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||EP U|||10^12/L|NOT DONE||U|NA|NA|4||88||OBSERVATION|1972-05-13||1963-06-24|||1963-03-11||1969-11-15
TRIAL STUDY 134XCP|RP|25680BE0-7CE5-4B76-A48E-2D977A07E749|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||CM2|||LOG10 ELISA UNIT/DOSE|NOT DONE||N|N|N|4||88||RUN-IN|1972-07-09||1967-03-02|||1969-09-07||1961-12-21
TRIAL STUDY 134XCP|RP|25680BE0-7CE5-4B76-A48E-2D977A07E749|1||||||ABORTN|NUMBER OF ABORTIONS||||UIU/DL|||PSEC|NOT DONE||NA|N|U|5||7||WASHOUT|1971-11-15||1960-04-25|||1965-07-18||1960-07-12
TRIAL STUDY 134XCP|RP|25680BE0-7CE5-4B76-A48E-2D977A07E749|2||||||INABOIND|INDUCED ABORTION INDICATOR||||G|||V/V|NOT DONE||NA|N|Y|5||7||OPEN LABEL TREATMENT|1970-12-01||1967-11-24|||1968-05-10||1961-09-13
TRIAL STUDY 134XCP|RP|67CA2619-351F-493E-93B2-5CDC9AF99C8B|1||||||ULCERIND|ULCER INDICATOR||||UM2|||DEG2|NOT DONE||Y|NA|Y|1||38||BASELINE|1962-06-11||1965-09-13|||1970-02-21||1964-04-22
TRIAL STUDY 134XCP|RP|67CA2619-351F-493E-93B2-5CDC9AF99C8B|2||||||STILBIND|STILLBIRTH INDICATOR||||UGEQ|||TRANSDUCING UNIT/ML|NOT DONE||U|N|N|1||38||CONTINUATION TREATMENT|1969-07-07||1970-06-14|||1973-09-03||1960-08-15
TRIAL STUDY 134XCP|RP|67CA2619-351F-493E-93B2-5CDC9AF99C8B|1||||||MENFDUR|MENSES FLOW DURATION||||UMOL/L/H|||ML/ANIMAL/WK|NOT DONE||U|U|N|2||58||BASELINE|1960-09-04||1972-04-07|||1971-06-09||1968-02-10
TRIAL STUDY 134XCP|RP|67CA2619-351F-493E-93B2-5CDC9AF99C8B|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||DDU|||LOG10 CFU/G|NOT DONE||NA|Y|U|2||58||BASELINE|1962-04-14||1971-07-24|||1968-06-23||1963-08-25
TRIAL STUDY 134XCP|RP|67CA2619-351F-493E-93B2-5CDC9AF99C8B|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||GY/MIN|||/HPF|NOT DONE||NA|NA|Y|3||39||WASHOUT|1968-12-02||1971-07-19|||1968-10-24||1972-06-02
TRIAL STUDY 134XCP|RP|67CA2619-351F-493E-93B2-5CDC9AF99C8B|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||LOG10 CCID 50/DOSE|||WEEKS|NOT DONE||N|N|Y|3||39||WASHOUT|1964-10-20||1960-02-22|||1967-01-08||1960-06-11
TRIAL STUDY 134XCP|RP|67CA2619-351F-493E-93B2-5CDC9AF99C8B|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||LOG10 IU/ML|||ML/100G/MIN|NOT DONE||N|NA|Y|4||88||INDUCTION TREATMENT|1961-11-01||1965-02-13|||1968-06-23||1961-09-14
TRIAL STUDY 134XCP|RP|67CA2619-351F-493E-93B2-5CDC9AF99C8B|2||||||BCMETHOD|BIRTH CONTROL METHOD||||CGY|||10^6/L|NOT DONE||U|NA|NA|4||88||LONG-TERM FOLLOW-UP|1965-05-16||1964-09-02|||1970-08-07||1965-08-16
TRIAL STUDY 134XCP|RP|67CA2619-351F-493E-93B2-5CDC9AF99C8B|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||ENZYME U|||CYCLE/MIN|NOT DONE||U|Y|NA|5||7||OPEN LABEL TREATMENT|1961-04-14||1972-05-15|||1960-12-25||1972-05-15
TRIAL STUDY 134XCP|RP|67CA2619-351F-493E-93B2-5CDC9AF99C8B|2||||||MENFDUR|MENSES FLOW DURATION||||UG/M2|||CI/MG|NOT DONE||NA|Y|U|5||7||OPEN LABEL TREATMENT|1972-11-18||1960-04-24|||1963-09-16||1962-05-20
TRIAL STUDY 134XCP|RP|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||FINGERTIP UNIT|||ENZYME U|NOT DONE||U|U|N|1||38||BASELINE|1967-08-26||1967-04-30|||1973-07-04||1973-06-07
TRIAL STUDY 134XCP|RP|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||U/KG/DAY|||/4.0 ML|NOT DONE||N|NA|NA|1||38||TREATMENT|1971-01-27||1961-09-15|||1967-09-16||1964-06-30
TRIAL STUDY 134XCP|RP|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|1||||||PREGNN|NUMBER OF PREGNANCIES||||UCI|||ML/MIN/MMHG|NOT DONE||NA|N|Y|2||58||CONTINUATION TREATMENT|1963-02-03||1966-05-27|||1961-01-30||1969-07-26
TRIAL STUDY 134XCP|RP|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|2||||||MENOAGE|MENOPAUSE AGE||||PSI|||BQ/UG|NOT DONE||Y|U|U|2||58||OPEN LABEL TREATMENT|1968-04-10||1965-07-02|||1973-05-11||1961-01-05
TRIAL STUDY 134XCP|RP|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|1||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||MOL/L|||F|NOT DONE||U|U|U|3||39||BASELINE|1967-01-29||1970-04-16|||1965-11-26||1971-03-24
TRIAL STUDY 134XCP|RP|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||G/DL|||MG/G/MIN|NOT DONE||Y|N|Y|3||39||LONG-TERM FOLLOW-UP|1964-03-27||1969-10-27|||1962-08-09||1965-07-20
TRIAL STUDY 134XCP|RP|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|1||||||MENOSTAT|MENOPAUSE STATUS||||DEG/S|||KM|NOT DONE||Y|N|U|4||88||CONTINUATION TREATMENT|1961-06-05||1972-02-22|||1967-12-22||1970-04-03
TRIAL STUDY 134XCP|RP|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||CM|||UG/H|NOT DONE||N|Y|U|4||88||OPEN LABEL TREATMENT|1963-07-13||1970-02-15|||1973-03-23||1970-12-29
TRIAL STUDY 134XCP|RP|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|1||||||MENOAGE|MENOPAUSE AGE||||FIU|||POUCH|NOT DONE||NA|NA|Y|5||7||OPEN LABEL TREATMENT|1972-10-19||1969-09-19|||1968-05-04||1967-04-18
TRIAL STUDY 134XCP|RP|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||USIEMENS|||ANTIBODY UNIT|NOT DONE||U|U|Y|5||7||INDUCTION TREATMENT|1962-08-06||1970-08-29|||1963-04-11||1962-10-10
TRIAL STUDY 134XCP|RP|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|1||||||DSCHGIND|DISCHARGE INDICATOR||||U/CL|||ML/G/DAY|NOT DONE||Y|NA|NA|1||38||BLINDED TREATMENT|1964-08-20||1970-12-24|||1964-03-15||1973-03-12
TRIAL STUDY 134XCP|RP|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|2||||||BRTHN|NUMBER OF BIRTHS||||10^3 COPIES/ML|||FOZ_BR|NOT DONE||N|U|U|1||38||INDUCTION TREATMENT|1967-06-06||1962-08-15|||1970-05-07||1964-12-28
TRIAL STUDY 134XCP|RP|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||/2500 WBC|||UG/G/H|NOT DONE||N|NA|NA|2||58||BASELINE|1966-06-10||1973-05-23|||1973-06-13||1968-07-24
TRIAL STUDY 134XCP|RP|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||NG/L|||DEG|NOT DONE||NA|Y|U|2||58||LONG-TERM FOLLOW-UP|1967-10-25||1971-08-14|||1963-04-02||1965-09-09
TRIAL STUDY 134XCP|RP|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||UMOL/KG/MIN|||U/DL|NOT DONE||Y|N|Y|3||39||BLINDED TREATMENT|1961-04-20||1970-03-20|||1967-01-07||1971-06-08
TRIAL STUDY 134XCP|RP|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|2||||||DSCHGIND|DISCHARGE INDICATOR||||L/L|||PT_US|NOT DONE||U|N|N|3||39||RUN-IN|1968-09-18||1968-03-21|||1971-09-26||1970-10-19
TRIAL STUDY 134XCP|RP|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|1||||||INABOIND|INDUCED ABORTION INDICATOR||||DL|||PFU/ML|NOT DONE||Y|Y|N|4||88||SCREENING|1969-01-10||1964-11-02|||1971-03-22||1965-12-02
TRIAL STUDY 134XCP|RP|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||UG/CM2|||MMU/ML|NOT DONE||N|U|N|4||88||CONTINUATION TREATMENT|1962-05-19||1971-10-17|||1970-06-08||1970-01-03
TRIAL STUDY 134XCP|RP|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||HOURS|||NMOL/ML/MIN|NOT DONE||N|N|Y|5||7||OPEN LABEL TREATMENT|1962-09-19||1962-09-06|||1968-11-09||1963-12-22
TRIAL STUDY 134XCP|RP|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|2||||||PRGENDTC|DATE PREGNANCY ENDED||||UMOL/L/H|||USEC|NOT DONE||N|U|NA|5||7||BASELINE|1970-08-05||1973-08-24|||1966-11-04||1966-11-11
TRIAL STUDY 134XCP|RP|51B01BE3-230D-4AE0-A229-81EF519EA932|1||||||RASHIND|RASH INDICATOR||||L/S/KPA|||KG/L|NOT DONE||N|N|Y|1||38||OPEN LABEL TREATMENT|1970-04-13||1967-04-18|||1963-09-17||1967-01-10
TRIAL STUDY 134XCP|RP|51B01BE3-230D-4AE0-A229-81EF519EA932|2||||||EDEMAIND|EDEMA INDICATOR||||CIGAR|||UG/KG/MIN|NOT DONE||Y|NA|Y|1||38||RUN-IN|1963-04-11||1964-05-18|||1960-01-11||1970-01-13
TRIAL STUDY 134XCP|RP|51B01BE3-230D-4AE0-A229-81EF519EA932|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||M2|||10^3 ORGANISMS/G|NOT DONE||NA|NA|U|2||58||WASHOUT|1962-11-01||1965-07-19|||1970-05-18||1966-11-18
TRIAL STUDY 134XCP|RP|51B01BE3-230D-4AE0-A229-81EF519EA932|2||||||EDEMAIND|EDEMA INDICATOR||||MMOL/G|||NKAT/L|NOT DONE||NA|NA|N|2||58||FOLLOW-UP|1972-11-13||1967-05-16|||1964-05-17||1971-08-04
TRIAL STUDY 134XCP|RP|51B01BE3-230D-4AE0-A229-81EF519EA932|1||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MNFI|||PG/CELL|NOT DONE||Y|N|N|3||39||LONG-TERM FOLLOW-UP|1973-02-05||1966-04-21|||1960-02-22||1962-01-16
TRIAL STUDY 134XCP|RP|51B01BE3-230D-4AE0-A229-81EF519EA932|2||||||EDEMAIND|EDEMA INDICATOR||||10^3 DNA COPIES/ML|||YEARS|NOT DONE||NA|N|Y|3||39||LONG-TERM FOLLOW-UP|1972-01-17||1972-05-25|||1968-10-04||1964-03-15
TRIAL STUDY 134XCP|RP|51B01BE3-230D-4AE0-A229-81EF519EA932|1||||||EDEMAIND|EDEMA INDICATOR||||UG/M2|||MIU/L|NOT DONE||Y|U|Y|4||88||OBSERVATION|1970-06-26||1969-06-19|||1966-04-07||1971-10-22
TRIAL STUDY 134XCP|RP|51B01BE3-230D-4AE0-A229-81EF519EA932|2||||||MASSIND|MASS INDICATOR||||AMPULE|||G/CM2|NOT DONE||N|N|NA|4||88||WASHOUT|1971-06-26||1960-10-28|||1970-08-27||1963-04-05
TRIAL STUDY 134XCP|RP|51B01BE3-230D-4AE0-A229-81EF519EA932|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||NMOL/L/H|||PMOL/G|NOT DONE||N|NA|U|5||7||OPEN LABEL TREATMENT|1969-06-19||1964-03-07|||1973-07-01||1970-02-18
TRIAL STUDY 134XCP|RP|51B01BE3-230D-4AE0-A229-81EF519EA932|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||MPS U|||10^6 CFU/ML|NOT DONE||Y|Y|NA|5||7||BASELINE|1971-02-19||1971-01-18|||1973-01-26||1960-04-19
TRIAL STUDY 134XCP|RP|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||MMAL|||ELISA UNIT|NOT DONE||NA|NA|Y|1||38||OBSERVATION|1963-02-01||1973-01-30|||1972-04-26||1965-06-27
TRIAL STUDY 134XCP|RP|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||UL/ML|||OZ EQ|NOT DONE||NA|U|U|1||38||BLINDED TREATMENT|1966-12-16||1965-08-29|||1961-08-10||1960-10-24
TRIAL STUDY 134XCP|RP|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|1||||||DSCHGIND|DISCHARGE INDICATOR||||BP|||UKAT/L|NOT DONE||NA|Y|N|2||58||WASHOUT|1971-01-15||1966-07-29|||1966-01-01||1963-05-04
TRIAL STUDY 134XCP|RP|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||L/S/KPA|||MOL/MOL|NOT DONE||Y|U|U|2||58||INDUCTION TREATMENT|1966-10-13||1967-06-28|||1964-08-09||1968-06-10
TRIAL STUDY 134XCP|RP|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MOL/MG|||FFU|NOT DONE||Y|NA|NA|3||39||OPEN LABEL TREATMENT|1972-01-03||1963-09-19|||1962-07-26||1970-01-19
TRIAL STUDY 134XCP|RP|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||PACK YEAR|||10^7/L|NOT DONE||U|U|NA|3||39||LONG-TERM FOLLOW-UP|1960-08-13||1961-01-29|||1972-10-30||1965-02-21
TRIAL STUDY 134XCP|RP|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MCI/KG|||MPH|NOT DONE||N|N|NA|4||88||SCREENING|1963-05-12||1967-06-13|||1970-05-18||1968-07-12
TRIAL STUDY 134XCP|RP|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|2||||||DLVRMODE|MODE OF DELIVERY||||10^9 ORGANISMS/G|||PKAT|NOT DONE||U|U|NA|4||88||INDUCTION TREATMENT|1960-08-29||1962-02-04|||1970-10-29||1962-11-13
TRIAL STUDY 134XCP|RP|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|1||||||FUNDHT|FUNDAL HEIGHT||||U/MMOL|||10^11/L|NOT DONE||Y|U|NA|5||7||WASHOUT|1969-08-16||1967-09-14|||1963-03-15||1964-05-18
TRIAL STUDY 134XCP|RP|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||NKAT|||UMOL/MIN|NOT DONE||U|U|NA|5||7||BASELINE|1964-03-03||1972-06-12|||1967-07-04||1964-01-01
TRIAL STUDY 134XCP|RP|01FD66DA-C67B-48A7-9320-F29C6C226155|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||G/G/DAY|||PSEC|NOT DONE||NA|Y|U|1||38||SCREENING|1963-01-04||1969-05-23|||1961-10-08||1969-04-10
TRIAL STUDY 134XCP|RP|01FD66DA-C67B-48A7-9320-F29C6C226155|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/MIN/1.73M2|||L/L|NOT DONE||Y|N|N|1||38||BLINDED TREATMENT|1966-05-27||1969-02-25|||1969-11-22||1960-03-15
TRIAL STUDY 134XCP|RP|01FD66DA-C67B-48A7-9320-F29C6C226155|1||||||INABOIND|INDUCED ABORTION INDICATOR||||VG/KG|||10^3 CFU|NOT DONE||NA|Y|Y|2||58||OBSERVATION|1968-08-27||1969-11-07|||1969-01-13||1960-11-17
TRIAL STUDY 134XCP|RP|01FD66DA-C67B-48A7-9320-F29C6C226155|2||||||INTP|INTERPRETATION||||ML/CAGE|||ML/M2/DAY|NOT DONE||N|NA|NA|2||58||BASELINE|1963-11-30||1972-03-29|||1960-01-04||1970-10-31
TRIAL STUDY 134XCP|RP|01FD66DA-C67B-48A7-9320-F29C6C226155|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||CYLINDER|||/2000 RBC|NOT DONE||Y|Y|N|3||39||INDUCTION TREATMENT|1972-12-09||1962-10-08|||1964-09-21||1973-05-06
TRIAL STUDY 134XCP|RP|01FD66DA-C67B-48A7-9320-F29C6C226155|2||||||INABOIND|INDUCED ABORTION INDICATOR||||10^6/HPF|||NSEC|NOT DONE||N|N|Y|3||39||CONTINUATION TREATMENT|1971-08-03||1964-10-08|||1971-01-04||1960-02-25
TRIAL STUDY 134XCP|RP|01FD66DA-C67B-48A7-9320-F29C6C226155|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||PG/L|||PATCH|NOT DONE||Y|NA|U|4||88||BASELINE|1961-05-06||1970-03-03|||1968-01-10||1972-11-24
TRIAL STUDY 134XCP|RP|01FD66DA-C67B-48A7-9320-F29C6C226155|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||UG/G/DAY|||PACK|NOT DONE||Y|U|Y|4||88||BLINDED TREATMENT|1973-07-28||1962-03-15|||1962-12-11||1965-04-08
TRIAL STUDY 134XCP|RP|01FD66DA-C67B-48A7-9320-F29C6C226155|1||||||PREGNN|NUMBER OF PREGNANCIES||||10^9 CFU|||LX|NOT DONE||U|Y|U|5||7||WASHOUT|1961-08-19||1965-08-13|||1963-04-11||1967-09-24
TRIAL STUDY 134XCP|RP|01FD66DA-C67B-48A7-9320-F29C6C226155|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||EP U|||ML/(MIN*100ML)|NOT DONE||U|N|NA|5||7||LONG-TERM FOLLOW-UP|1970-11-22||1969-09-24|||1962-07-04||1967-09-23
TRIAL STUDY 134XCP|RP|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|1||||||ERYTHIND|ERYTHEMA INDICATOR||||EVENTS|||UG/ML/H|NOT DONE||Y|NA|U|1||38||OBSERVATION|1964-10-23||1963-09-28|||1969-03-16||1964-03-30
TRIAL STUDY 134XCP|RP|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||10^6 IU/ML|||MOL/ML|NOT DONE||U|Y|U|1||38||OPEN LABEL TREATMENT|1967-09-01||1964-09-29|||1971-09-02||1964-03-14
TRIAL STUDY 134XCP|RP|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|1||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||SFC/10^6 PBMC|||MJOULE/CM2|NOT DONE||NA|U|N|2||58||OBSERVATION|1967-11-04||1960-07-12|||1964-09-17||1969-06-27
TRIAL STUDY 134XCP|RP|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|2||||||FUNDHT|FUNDAL HEIGHT||||U/KG/DAY|||MPL U|NOT DONE||N|U|N|2||58||BLINDED TREATMENT|1964-02-23||1962-01-18|||1968-03-22||1967-10-13
TRIAL STUDY 134XCP|RP|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||NEBULE|||LINEAR FT*LB|NOT DONE||N|Y|Y|3||39||SCREENING|1960-03-18||1962-10-21|||1970-10-28||1969-04-25
TRIAL STUDY 134XCP|RP|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||BAR|||MOSM/L|NOT DONE||Y|U|Y|3||39||CONTINUATION TREATMENT|1967-12-23||1964-09-05|||1964-10-16||1964-10-10
TRIAL STUDY 134XCP|RP|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|1||||||FUNDHT|FUNDAL HEIGHT||||10^6 CFU/G|||UG/MIN|NOT DONE||Y|Y|U|4||88||OPEN LABEL TREATMENT|1967-04-25||1960-12-17|||1964-09-19||1960-03-28
TRIAL STUDY 134XCP|RP|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|2||||||TNDRIND|TENDERNESS INDICATOR||||MEQ/ML|||/10^3|NOT DONE||NA|NA|N|4||88||RUN-IN|1971-11-17||1968-12-18|||1960-10-09||1966-05-27
TRIAL STUDY 134XCP|RP|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|1||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||PIXEL|||G/ANIMAL/WK|NOT DONE||NA|N|N|5||7||OPEN LABEL TREATMENT|1972-03-08||1962-04-11|||1971-08-29||1963-02-10
TRIAL STUDY 134XCP|RP|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|2||||||PRGENDTC|DATE PREGNANCY ENDED||||10^7 CFU/ML|||RING|NOT DONE||U|N|Y|5||7||CONTINUATION TREATMENT|1973-06-07||1969-08-23|||1964-10-22||1960-10-12
TRIAL STUDY 134XCP|RP|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|1||||||BCMETHOD|BIRTH CONTROL METHOD||||DPM/MG|||KG/MOL|NOT DONE||Y|N|U|1||38||RUN-IN|1968-01-25||1966-08-31|||1966-03-17||1973-04-02
TRIAL STUDY 134XCP|RP|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ENZYME U/M2|||G/ANIMAL|NOT DONE||Y|Y|Y|1||38||WASHOUT|1962-05-19||1965-11-04|||1961-12-27||1972-01-27
TRIAL STUDY 134XCP|RP|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|1||||||BCMETHOD|BIRTH CONTROL METHOD||||PT_US|||CUP|NOT DONE||U|N|Y|2||58||INDUCTION TREATMENT|1963-08-30||1970-02-05|||1968-08-20||1964-10-23
TRIAL STUDY 134XCP|RP|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|2||||||MENOAGE|MENOPAUSE AGE||||ELISA UNIT/ML|||GMFI|NOT DONE||N|N|Y|2||58||TREATMENT|1971-12-01||1964-01-26|||1968-02-21||1969-04-05
TRIAL STUDY 134XCP|RP|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||NMOL/ML/MIN|||FARAD|NOT DONE||U|Y|N|3||39||TREATMENT|1971-08-05||1973-09-08|||1963-09-07||1961-12-23
TRIAL STUDY 134XCP|RP|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|2||||||STILBIND|STILLBIRTH INDICATOR||||ELISA UNIT/ML|||10^6 DNA COPIES/ML|NOT DONE||Y|N|N|3||39||LONG-TERM FOLLOW-UP|1965-11-24||1968-12-07|||1962-12-29||1970-09-02
TRIAL STUDY 134XCP|RP|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|1||||||MENARAGE|MENARCHE AGE||||PMOL/DAY|||KG/MOL|NOT DONE||Y|NA|Y|4||88||SCREENING|1970-09-23||1961-04-27|||1960-04-16||1970-02-18
TRIAL STUDY 134XCP|RP|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||KEV|||U/M2/MIN|NOT DONE||NA|U|U|4||88||FOLLOW-UP|1965-05-15||1966-03-08|||1971-12-21||1971-11-11
TRIAL STUDY 134XCP|RP|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|1||||||INABOIND|INDUCED ABORTION INDICATOR||||MONTHS|||DAYS/WK|NOT DONE||N|N|N|5||7||RUN-IN|1966-02-05||1967-08-23|||1971-10-08||1970-09-16
TRIAL STUDY 134XCP|RP|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|2||||||PREGNN|NUMBER OF PREGNANCIES||||CM|||ML|NOT DONE||U|NA|U|5||7||BASELINE|1969-11-15||1972-08-13|||1972-12-11||1972-01-04
TRIAL STUDY 134XCP|RP|81E3641F-6145-4B3C-9E26-8DEC1200509D|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||PG/CELL|||M/SEC2|NOT DONE||NA|U|U|1||38||BASELINE|1966-10-10||1968-10-05|||1965-06-05||1963-07-30
TRIAL STUDY 134XCP|RP|81E3641F-6145-4B3C-9E26-8DEC1200509D|2||||||MENFDUR|MENSES FLOW DURATION||||ML/G/H|||APL U|NOT DONE||U|N|U|1||38||RUN-IN|1964-12-21||1966-11-28|||1961-01-01||1968-07-14
TRIAL STUDY 134XCP|RP|81E3641F-6145-4B3C-9E26-8DEC1200509D|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||HOMEOPATHIC DILUTION|||MG/KG/DAY|NOT DONE||NA|NA|Y|2||58||OBSERVATION|1966-04-19||1961-01-27|||1967-05-19||1969-04-01
TRIAL STUDY 134XCP|RP|81E3641F-6145-4B3C-9E26-8DEC1200509D|2||||||THICK|THICKNESS||||UG/ML/H|||MOSM|NOT DONE||NA|NA|NA|2||58||FOLLOW-UP|1972-01-15||1962-01-31|||1962-04-06||1964-04-09
TRIAL STUDY 134XCP|RP|81E3641F-6145-4B3C-9E26-8DEC1200509D|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UKAT/L|||MG/G/H|NOT DONE||N|N|N|3||39||BLINDED TREATMENT|1966-12-04||1963-08-25|||1961-05-22||1961-02-06
TRIAL STUDY 134XCP|RP|81E3641F-6145-4B3C-9E26-8DEC1200509D|2||||||BCMETHOD|BIRTH CONTROL METHOD||||10^9 CFU|||IU/G HB|NOT DONE||N|U|N|3||39||CONTINUATION TREATMENT|1963-10-20||1963-09-07|||1964-04-23||1971-03-17
TRIAL STUDY 134XCP|RP|81E3641F-6145-4B3C-9E26-8DEC1200509D|1||||||TNDRIND|TENDERNESS INDICATOR||||IU|||U/KG/MIN|NOT DONE||NA|N|N|4||88||CONTINUATION TREATMENT|1969-07-05||1962-11-22|||1970-12-02||1972-04-13
TRIAL STUDY 134XCP|RP|81E3641F-6145-4B3C-9E26-8DEC1200509D|2||||||BRTHN|NUMBER OF BIRTHS||||PFU|||WEEKS|NOT DONE||Y|Y|N|4||88||INDUCTION TREATMENT|1968-10-05||1966-08-28|||1969-03-23||1960-01-31
TRIAL STUDY 134XCP|RP|81E3641F-6145-4B3C-9E26-8DEC1200509D|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||U/CL|||CARTRIDGE|NOT DONE||NA|Y|NA|5||7||FOLLOW-UP|1966-07-19||1965-07-29|||1962-10-08||1964-11-04
TRIAL STUDY 134XCP|RP|81E3641F-6145-4B3C-9E26-8DEC1200509D|2||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MOL/ML|||DAYS/WK|NOT DONE||U|NA|U|5||7||OPEN LABEL TREATMENT|1972-10-12||1970-05-31|||1973-06-12||1966-11-23
TRIAL STUDY 134XCP|RP|8F3D0A71-FD09-4E43-BC54-0562AF99306E|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||PMOL/L/H|||SPRAY|NOT DONE||N|N|U|1||38||SCREENING|1973-08-25||1968-02-24|||1960-11-25||1968-03-20
TRIAL STUDY 134XCP|RP|8F3D0A71-FD09-4E43-BC54-0562AF99306E|2||||||DLVRMODE|MODE OF DELIVERY||||BQ/MG|||UM|NOT DONE||Y|Y|Y|1||38||BASELINE|1960-08-08||1965-06-15|||1960-10-30||1965-12-03
TRIAL STUDY 134XCP|RP|8F3D0A71-FD09-4E43-BC54-0562AF99306E|1||||||BLISTIND|BLISTERING INDICATOR||||MET*MIN|||MG/ML/MIN|NOT DONE||NA|NA|NA|2||58||OBSERVATION|1960-06-06||1968-10-08|||1962-08-25||1968-09-23
TRIAL STUDY 134XCP|RP|8F3D0A71-FD09-4E43-BC54-0562AF99306E|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||POUCH|||IU|NOT DONE||NA|U|U|2||58||INDUCTION TREATMENT|1964-04-24||1962-08-14|||1967-03-12||1971-04-10
TRIAL STUDY 134XCP|RP|8F3D0A71-FD09-4E43-BC54-0562AF99306E|1||||||PREGNN|NUMBER OF PREGNANCIES||||LOG10 CFU/G|||G/ANIMAL/DAY|NOT DONE||N|Y|N|3||39||LONG-TERM FOLLOW-UP|1968-05-17||1961-08-14|||1972-01-24||1973-08-24
TRIAL STUDY 134XCP|RP|8F3D0A71-FD09-4E43-BC54-0562AF99306E|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||/WK|||TABLET|NOT DONE||Y|Y|N|3||39||BLINDED TREATMENT|1967-09-12||1963-06-06|||1970-12-18||1971-01-18
TRIAL STUDY 134XCP|RP|8F3D0A71-FD09-4E43-BC54-0562AF99306E|1||||||PRGENDTC|DATE PREGNANCY ENDED||||NCI|||GENEQ/ML|NOT DONE||N|U|Y|4||88||OBSERVATION|1973-04-26||1972-11-17|||1965-10-10||1963-06-04
TRIAL STUDY 134XCP|RP|8F3D0A71-FD09-4E43-BC54-0562AF99306E|2||||||PUSTIND|PUSTULE INDICATOR||||PA|||10^3 ORGANISMS/ML|NOT DONE||Y|U|Y|4||88||INDUCTION TREATMENT|1968-08-17||1966-11-18|||1963-05-23||1965-03-12
TRIAL STUDY 134XCP|RP|8F3D0A71-FD09-4E43-BC54-0562AF99306E|1||||||DSCHGIND|DISCHARGE INDICATOR||||HOUNSFIELD UNIT|||S/H|NOT DONE||N|Y|U|5||7||TREATMENT|1969-09-04||1968-02-04|||1963-05-30||1961-07-20
TRIAL STUDY 134XCP|RP|8F3D0A71-FD09-4E43-BC54-0562AF99306E|2||||||FUNDHT|FUNDAL HEIGHT||||/MIN|||UG/L/H|NOT DONE||NA|NA|NA|5||7||CONTINUATION TREATMENT|1968-06-26||1961-02-08|||1961-12-04||1969-04-23
TRIAL STUDY 134XCP|RP|BE750F04-5992-42B5-A084-A33D6FBBFD2E|1||||||DLVRMODE|MODE OF DELIVERY||||PG/CELL|||UG/M2/DAY|NOT DONE||U|N|U|1||38||RUN-IN|1968-12-08||1963-11-09|||1971-12-12||1960-11-14
TRIAL STUDY 134XCP|RP|BE750F04-5992-42B5-A084-A33D6FBBFD2E|2||||||MENOSTAT|MENOPAUSE STATUS||||10^8/L|||UV|NOT DONE||NA|Y|U|1||38||TREATMENT|1968-04-18||1968-04-20|||1961-06-26||1966-04-06
TRIAL STUDY 134XCP|RP|BE750F04-5992-42B5-A084-A33D6FBBFD2E|1||||||MENOSTAT|MENOPAUSE STATUS||||EID 50/ML|||ABSORBANCE U|NOT DONE||U|Y|U|2||58||TREATMENT|1973-08-25||1972-03-24|||1968-02-15||1961-02-12
TRIAL STUDY 134XCP|RP|BE750F04-5992-42B5-A084-A33D6FBBFD2E|2||||||THICK|THICKNESS||||GPS U|||PNU/ML|NOT DONE||NA|U|U|2||58||SCREENING|1973-08-22||1965-02-18|||1971-01-11||1963-03-04
TRIAL STUDY 134XCP|RP|BE750F04-5992-42B5-A084-A33D6FBBFD2E|1||||||DLVRMODE|MODE OF DELIVERY||||MMOL/DAY|||CM|NOT DONE||U|NA|Y|3||39||WASHOUT|1972-05-17||1966-04-13|||1962-07-24||1973-03-13
TRIAL STUDY 134XCP|RP|BE750F04-5992-42B5-A084-A33D6FBBFD2E|2||||||BLISTIND|BLISTERING INDICATOR||||10^6 DNA COPIES/ML|||TBSP|NOT DONE||NA|N|U|3||39||OBSERVATION|1971-12-12||1963-07-14|||1970-11-22||1969-11-16
TRIAL STUDY 134XCP|RP|BE750F04-5992-42B5-A084-A33D6FBBFD2E|1||||||EDEMAIND|EDEMA INDICATOR||||MMOL/S|||/4.0 ML|NOT DONE||N|U|Y|4||88||RUN-IN|1966-06-28||1962-06-14|||1961-12-07||1969-10-23
TRIAL STUDY 134XCP|RP|BE750F04-5992-42B5-A084-A33D6FBBFD2E|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||MMOL/DAY|||G/KG|NOT DONE||N|N|NA|4||88||SCREENING|1968-01-05||1971-04-04|||1963-12-26||1961-08-07
TRIAL STUDY 134XCP|RP|BE750F04-5992-42B5-A084-A33D6FBBFD2E|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||PUFF|||ML/BEAT|NOT DONE||Y|NA|NA|5||7||RUN-IN|1972-08-01||1964-08-17|||1972-01-06||1961-05-18
TRIAL STUDY 134XCP|RP|BE750F04-5992-42B5-A084-A33D6FBBFD2E|2||||||PUSTIND|PUSTULE INDICATOR||||10^6 ORGANISMS|||LOG10 CCID 50/DOSE|NOT DONE||Y|NA|Y|5||7||RUN-IN|1962-07-26||1966-12-02|||1968-02-05||1971-12-04
TRIAL STUDY 134XCP|RP|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||10^9/L|||MOSM/KG|NOT DONE||U|U|NA|1||38||LONG-TERM FOLLOW-UP|1963-08-28||1964-01-07|||1964-01-07||1964-10-08
TRIAL STUDY 134XCP|RP|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||NKAT/L|||MOL|NOT DONE||N|U|NA|1||38||LONG-TERM FOLLOW-UP|1971-02-28||1970-04-13|||1961-04-03||1963-11-26
TRIAL STUDY 134XCP|RP|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|1||||||TNDRIND|TENDERNESS INDICATOR||||MOL/DAY|||BEL|NOT DONE||Y|N|NA|2||58||LONG-TERM FOLLOW-UP|1968-04-07||1967-06-29|||1964-05-18||1965-05-29
TRIAL STUDY 134XCP|RP|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||LOG10 ELISA UNIT/DOSE|||UMOL/H/MMOL|NOT DONE||Y|N|N|2||58||OPEN LABEL TREATMENT|1966-03-31||1969-11-03|||1961-08-19||1971-11-27
TRIAL STUDY 134XCP|RP|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|1||||||BLISTIND|BLISTERING INDICATOR||||MU/G|||MM2|NOT DONE||NA|NA|N|3||39||OPEN LABEL TREATMENT|1961-09-06||1961-07-29|||1964-10-13||1965-06-17
TRIAL STUDY 134XCP|RP|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|2||||||ULCERIND|ULCER INDICATOR||||CUP EQ|||10^6 U|NOT DONE||Y|NA|N|3||39||CONTINUATION TREATMENT|1965-04-12||1961-04-23|||1969-05-31||1967-07-08
TRIAL STUDY 134XCP|RP|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||BREATHS/MIN|||CYCLE/MIN|NOT DONE||Y|Y|N|4||88||CONTINUATION TREATMENT|1961-08-28||1969-11-01|||1970-11-27||1964-01-10
TRIAL STUDY 134XCP|RP|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|2||||||PREGNN|NUMBER OF PREGNANCIES||||KIU|||U.CARR|NOT DONE||U|NA|U|4||88||RUN-IN|1964-03-03||1973-05-27|||1963-12-15||1969-11-23
TRIAL STUDY 134XCP|RP|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|1||||||FUNDHT|FUNDAL HEIGHT||||SPRAY|||CI/ML|NOT DONE||NA|Y|U|5||7||OBSERVATION|1960-04-11||1967-08-10|||1970-06-26||1961-12-06
TRIAL STUDY 134XCP|RP|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MKAT|||MEQ/UG|NOT DONE||NA|NA|N|5||7||BLINDED TREATMENT|1961-01-11||1968-12-07|||1972-07-16||1967-06-08
TRIAL STUDY 134XCP|RP|8417B146-336C-4777-A566-C1D086F39430|1||||||RASHIND|RASH INDICATOR||||KIT|||10^7 CFU/ML|NOT DONE||Y|N|N|1||38||FOLLOW-UP|1960-04-15||1960-09-06|||1971-04-14||1966-03-15
TRIAL STUDY 134XCP|RP|8417B146-336C-4777-A566-C1D086F39430|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||ML/SEC/1.73M2|||MEQ/UL|NOT DONE||U|Y|N|1||38||SCREENING|1970-09-03||1967-01-03|||1962-11-11||1970-10-08
TRIAL STUDY 134XCP|RP|8417B146-336C-4777-A566-C1D086F39430|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UG/KG/DAY|||AG|NOT DONE||NA|N|Y|2||58||SCREENING|1969-05-31||1969-02-03|||1962-04-26||1962-08-04
TRIAL STUDY 134XCP|RP|8417B146-336C-4777-A566-C1D086F39430|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||PACK YEAR|||CAPFUL|NOT DONE||NA|Y|U|2||58||RUN-IN|1969-04-07||1962-01-03|||1971-05-23||1968-06-18
TRIAL STUDY 134XCP|RP|8417B146-336C-4777-A566-C1D086F39430|1||||||MENARAGE|MENARCHE AGE||||FMOL|||CD|NOT DONE||NA|Y|N|3||39||CONTINUATION TREATMENT|1970-08-22||1970-11-11|||1970-02-02||1968-01-29
TRIAL STUDY 134XCP|RP|8417B146-336C-4777-A566-C1D086F39430|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||MG/KG|||NMOL/DAY|NOT DONE||N|N|U|3||39||CONTINUATION TREATMENT|1961-01-19||1960-11-30|||1960-01-17||1965-04-19
TRIAL STUDY 134XCP|RP|8417B146-336C-4777-A566-C1D086F39430|1||||||ULCERIND|ULCER INDICATOR||||MG/ML/DAY|||IU/DL|NOT DONE||NA|N|NA|4||88||CONTINUATION TREATMENT|1963-12-10||1964-11-18|||1968-08-12||1960-03-08
TRIAL STUDY 134XCP|RP|8417B146-336C-4777-A566-C1D086F39430|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||WATT|||% INHIBITION|NOT DONE||N|Y|NA|4||88||OBSERVATION|1966-12-01||1964-05-20|||1971-06-14||1969-06-11
TRIAL STUDY 134XCP|RP|8417B146-336C-4777-A566-C1D086F39430|1||||||PRGENDTC|DATE PREGNANCY ENDED||||10^3 ORGANISMS|||CM2|NOT DONE||N|Y|Y|5||7||OPEN LABEL TREATMENT|1968-08-21||1961-08-18|||1969-06-28||1973-05-15
TRIAL STUDY 134XCP|RP|8417B146-336C-4777-A566-C1D086F39430|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||DAMOL/L|||MMOL/S|NOT DONE||NA|U|NA|5||7||OBSERVATION|1966-02-28||1971-01-07|||1970-03-14||1967-08-01
TRIAL STUDY 134XCP|RP|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||MG/KG|||V/SEC|NOT DONE||NA|NA|N|1||38||LONG-TERM FOLLOW-UP|1970-05-21||1969-12-07|||1960-03-11||1969-04-09
TRIAL STUDY 134XCP|RP|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||FRACTION OF 1|||CD/M2|NOT DONE||NA|N|U|1||38||BLINDED TREATMENT|1967-04-07||1969-06-23|||1973-09-04||1969-05-07
TRIAL STUDY 134XCP|RP|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||U/M2/DAY|||MONTHS|NOT DONE||N|U|U|2||58||CONTINUATION TREATMENT|1963-03-16||1966-07-06|||1968-02-21||1965-03-12
TRIAL STUDY 134XCP|RP|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MET*MIN|||MOL/MOL|NOT DONE||NA|NA|U|2||58||INDUCTION TREATMENT|1965-10-04||1964-09-17|||1961-03-05||1963-09-21
TRIAL STUDY 134XCP|RP|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|1||||||INABOIND|INDUCED ABORTION INDICATOR||||ANSON U|||/MS|NOT DONE||NA|N|U|3||39||BLINDED TREATMENT|1971-01-21||1971-09-06|||1969-02-22||1967-08-22
TRIAL STUDY 134XCP|RP|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||10^7 TCID 50/DOSE|||UU/DL|NOT DONE||U|Y|NA|3||39||FOLLOW-UP|1970-07-15||1971-06-29|||1971-06-23||1964-08-18
TRIAL STUDY 134XCP|RP|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|1||||||PREGST|PREGNANT DURING THE STUDY||||UIU/L|||YEARS|NOT DONE||NA|NA|Y|4||88||OBSERVATION|1966-12-17||1961-10-07|||1969-08-04||1962-04-09
TRIAL STUDY 134XCP|RP|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|2||||||MENARAGE|MENARCHE AGE||||CUP|||UG/KG/H|NOT DONE||U|Y|NA|4||88||OPEN LABEL TREATMENT|1967-10-30||1970-02-18|||1961-02-03||1961-01-25
TRIAL STUDY 134XCP|RP|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|1||||||THICK|THICKNESS||||FMOL|||MMAL|NOT DONE||NA|NA|U|5||7||OPEN LABEL TREATMENT|1968-09-20||1961-10-17|||1973-06-04||1969-05-14
TRIAL STUDY 134XCP|RP|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|2||||||EDEMAIND|EDEMA INDICATOR||||UCI/L|||U/MMOL|NOT DONE||NA|Y|Y|5||7||INDUCTION TREATMENT|1964-10-30||1970-10-04|||1965-03-09||1960-05-18
TRIAL STUDY 134XCP|RP|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|1||||||ABORTN|NUMBER OF ABORTIONS||||NEBULE|||MMHG*MIN/L|NOT DONE||NA|U|U|1||38||LONG-TERM FOLLOW-UP|1970-08-07||1964-12-21|||1960-01-22||1966-01-09
TRIAL STUDY 134XCP|RP|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|2||||||STILBIND|STILLBIRTH INDICATOR||||UKAT/L|||MSEC|NOT DONE||U|U|NA|1||38||SCREENING|1964-08-20||1971-11-30|||1961-10-21||1971-02-16
TRIAL STUDY 134XCP|RP|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|1||||||TNDRIND|TENDERNESS INDICATOR||||10^12/L|||BU/ML|NOT DONE||U|NA|U|2||58||SCREENING|1961-11-19||1970-07-02|||1961-12-16||1965-12-30
TRIAL STUDY 134XCP|RP|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|2||||||GRAVIND|GRAVIDA INDICATOR||||10^5/HPF|||ML/MMHG/MIN/L|NOT DONE||NA|U|U|2||58||LONG-TERM FOLLOW-UP|1973-08-17||1972-03-30|||1972-07-22||1967-08-28
TRIAL STUDY 134XCP|RP|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|1||||||BLISTIND|BLISTERING INDICATOR||||COPIES/ML|||ABSORBANCE U|NOT DONE||U|N|U|3||39||BASELINE|1970-08-29||1960-05-14|||1963-12-05||1961-08-22
TRIAL STUDY 134XCP|RP|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|2||||||MENOAGE|MENOPAUSE AGE||||KA_U/DL|||10^3/HPF|NOT DONE||Y|N|NA|3||39||FOLLOW-UP|1964-01-26||1968-01-21|||1967-09-20||1964-03-18
TRIAL STUDY 134XCP|RP|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|1||||||PRGENDTC|DATE PREGNANCY ENDED||||BAU/ML|||PMOL/DL|NOT DONE||Y|Y|N|4||88||BLINDED TREATMENT|1963-07-05||1968-05-21|||1965-05-16||1968-10-13
TRIAL STUDY 134XCP|RP|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||L/KG|||MM/2H|NOT DONE||Y|U|N|4||88||OPEN LABEL TREATMENT|1960-04-01||1964-11-11|||1966-11-17||1962-09-04
TRIAL STUDY 134XCP|RP|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|1||||||MASSIND|MASS INDICATOR||||GBQ|||NMOL BCE/L|NOT DONE||N|N|Y|5||7||INDUCTION TREATMENT|1961-06-06||1962-03-03|||1973-03-31||1962-09-08
TRIAL STUDY 134XCP|RP|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||10^9 CFU/ML|||BQ/G|NOT DONE||U|U|Y|5||7||CONTINUATION TREATMENT|1972-02-24||1964-03-30|||1963-05-13||1968-08-14
TRIAL STUDY 134XCP|RP|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MM/MIN|||G/CAGE/WK|NOT DONE||NA|Y|NA|1||38||RUN-IN|1966-11-27||1962-02-24|||1967-07-02||1967-03-27
TRIAL STUDY 134XCP|RP|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|2||||||INABOIND|INDUCED ABORTION INDICATOR||||VG/ML|||PG|NOT DONE||U|N|NA|1||38||WASHOUT|1972-05-09||1966-11-06|||1967-12-30||1969-12-16
TRIAL STUDY 134XCP|RP|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|1||||||PREGNN|NUMBER OF PREGNANCIES||||10^12 IU/L|||MG/M2|NOT DONE||U|NA|U|2||58||CONTINUATION TREATMENT|1963-09-17||1964-07-23|||1964-10-08||1972-02-08
TRIAL STUDY 134XCP|RP|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|2||||||THICK|THICKNESS||||10^9/G|||ML/DAY|NOT DONE||NA|U|NA|2||58||RUN-IN|1965-11-17||1967-07-19|||1970-09-04||1967-06-08
TRIAL STUDY 134XCP|RP|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||KM|||BEATS/MIN|NOT DONE||U|N|Y|3||39||BASELINE|1960-01-09||1967-06-14|||1970-05-06||1970-11-16
TRIAL STUDY 134XCP|RP|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MG/ANIMAL|||10^5/L|NOT DONE||N|U|N|3||39||FOLLOW-UP|1960-08-12||1964-04-27|||1965-08-23||1971-12-15
TRIAL STUDY 134XCP|RP|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|1||||||BCMETHOD|BIRTH CONTROL METHOD||||FT2|||10^6 ORGANISMS/G|NOT DONE||Y|N|NA|4||88||BLINDED TREATMENT|1969-03-25||1968-02-08|||1962-10-12||1963-09-19
TRIAL STUDY 134XCP|RP|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||ML/SEC/1.73M2|||10^6/G|NOT DONE||U|N|NA|4||88||INDUCTION TREATMENT|1970-11-14||1961-07-06|||1967-08-23||1969-04-29
TRIAL STUDY 134XCP|RP|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||L/MIN/M2|||HOURS|NOT DONE||U|Y|U|5||7||FOLLOW-UP|1972-04-22||1969-06-23|||1963-06-01||1973-04-09
TRIAL STUDY 134XCP|RP|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|2||||||BLISTIND|BLISTERING INDICATOR||||MMHG|||KCAL/DAY|NOT DONE||N|Y|NA|5||7||RUN-IN|1969-05-28||1971-03-05|||1973-04-02||1973-05-04
TRIAL STUDY 134XCP|RP|2926D795-9C17-4440-8411-68525E93E78D|1||||||BCMETHOD|BIRTH CONTROL METHOD||||DPM/0.5 ML|||U/MG|NOT DONE||N|U|Y|1||38||SCREENING|1973-03-27||1972-09-22|||1966-03-21||1965-09-18
TRIAL STUDY 134XCP|RP|2926D795-9C17-4440-8411-68525E93E78D|2||||||MENARAGE|MENARCHE AGE||||MMOL/MOL|||MEQ/KG|NOT DONE||NA|U|Y|1||38||CONTINUATION TREATMENT|1969-04-16||1963-08-09|||1967-05-27||1965-01-05
TRIAL STUDY 134XCP|RP|2926D795-9C17-4440-8411-68525E93E78D|1||||||DLVRMODE|MODE OF DELIVERY||||UEQ/L|||ML/G/MIN|NOT DONE||NA|Y|N|2||58||WASHOUT|1972-03-09||1968-10-08|||1965-09-23||1972-10-16
TRIAL STUDY 134XCP|RP|2926D795-9C17-4440-8411-68525E93E78D|2||||||PREGIND|PREGNANT INDICATOR||||IN|||MG/MOL|NOT DONE||NA|U|U|2||58||RUN-IN|1969-11-15||1966-07-17|||1964-01-12||1964-01-02
TRIAL STUDY 134XCP|RP|2926D795-9C17-4440-8411-68525E93E78D|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||10^3 CFU|||MEQ/UL|NOT DONE||NA|N|U|3||39||INDUCTION TREATMENT|1971-06-24||1971-06-08|||1969-08-06||1968-01-12
TRIAL STUDY 134XCP|RP|2926D795-9C17-4440-8411-68525E93E78D|2||||||THICK|THICKNESS||||ML/KG/MIN|||MJOULE/CM2|NOT DONE||Y|U|N|3||39||RUN-IN|1973-06-28||1962-11-12|||1966-01-11||1968-02-23
TRIAL STUDY 134XCP|RP|2926D795-9C17-4440-8411-68525E93E78D|1||||||ERYTHIND|ERYTHEMA INDICATOR||||ML/CAGE|||NG/L|NOT DONE||N|U|Y|4||88||BLINDED TREATMENT|1966-09-05||1966-10-19|||1967-06-26||1964-08-18
TRIAL STUDY 134XCP|RP|2926D795-9C17-4440-8411-68525E93E78D|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||AU/ML|||GAUSS|NOT DONE||Y|U|Y|4||88||SCREENING|1960-12-19||1972-02-06|||1960-03-09||1970-03-21
TRIAL STUDY 134XCP|RP|2926D795-9C17-4440-8411-68525E93E78D|1||||||MENOAGE|MENOPAUSE AGE||||DEG/S|||U/DL|NOT DONE||Y|NA|Y|5||7||FOLLOW-UP|1966-05-18||1972-07-29|||1966-06-15||1973-05-16
TRIAL STUDY 134XCP|RP|2926D795-9C17-4440-8411-68525E93E78D|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||10^6 ORGANISMS|||ML/BREATH|NOT DONE||NA|U|NA|5||7||INDUCTION TREATMENT|1971-08-31||1964-02-02|||1972-11-13||1965-08-06
TRIAL STUDY 134XCP|RP|BA3378F3-C308-469F-9818-9AD811086548|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||BU|||VP/DOSE|NOT DONE||U|NA|NA|1||38||RUN-IN|1969-10-25||1973-03-13|||1965-05-28||1968-01-01
TRIAL STUDY 134XCP|RP|BA3378F3-C308-469F-9818-9AD811086548|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||PT_US|||CAPFUL|NOT DONE||Y|Y|NA|1||38||SCREENING|1967-12-02||1965-10-18|||1962-06-02||1964-06-28
TRIAL STUDY 134XCP|RP|BA3378F3-C308-469F-9818-9AD811086548|1||||||THICK|THICKNESS||||U/G/MIN|||H/WK|NOT DONE||N|Y|N|2||58||BASELINE|1971-07-26||1971-02-16|||1969-11-26||1962-04-21
TRIAL STUDY 134XCP|RP|BA3378F3-C308-469F-9818-9AD811086548|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||KV|||MMHG*MIN/L|NOT DONE||U|NA|NA|2||58||OPEN LABEL TREATMENT|1971-10-29||1970-07-05|||1967-04-22||1961-07-29
TRIAL STUDY 134XCP|RP|BA3378F3-C308-469F-9818-9AD811086548|1||||||FUNDHT|FUNDAL HEIGHT||||PIPE|||CAPFUL|NOT DONE||U|NA|NA|3||39||CONTINUATION TREATMENT|1970-08-14||1966-06-24|||1969-01-29||1966-10-03
TRIAL STUDY 134XCP|RP|BA3378F3-C308-469F-9818-9AD811086548|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MG/ML/DAY|||KG/CM2|NOT DONE||U|Y|Y|3||39||WASHOUT|1969-07-01||1961-09-23|||1970-12-01||1972-04-01
TRIAL STUDY 134XCP|RP|BA3378F3-C308-469F-9818-9AD811086548|1||||||TNDRIND|TENDERNESS INDICATOR||||NKAT/L|||NMOL/L/MIN|NOT DONE||NA|NA|Y|4||88||RUN-IN|1971-04-22||1969-11-10|||1962-01-29||1960-11-06
TRIAL STUDY 134XCP|RP|BA3378F3-C308-469F-9818-9AD811086548|2||||||MASSIND|MASS INDICATOR||||MHZ|||EIA UNIT|NOT DONE||U|N|N|4||88||WASHOUT|1968-12-25||1966-09-01|||1960-08-10||1964-12-28
TRIAL STUDY 134XCP|RP|BA3378F3-C308-469F-9818-9AD811086548|1||||||MASSIND|MASS INDICATOR||||CUP EQ|||U|NOT DONE||NA|NA|N|5||7||INDUCTION TREATMENT|1963-06-21||1964-12-14|||1961-04-23||1960-11-15
TRIAL STUDY 134XCP|RP|BA3378F3-C308-469F-9818-9AD811086548|2||||||MENOSTAT|MENOPAUSE STATUS||||M2|||10^3 RNA COPIES/ML|NOT DONE||U|N|NA|5||7||BASELINE|1965-03-17||1969-08-17|||1964-12-28||1967-12-01
TRIAL STUDY 134XCP|RP|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|1||||||PREGNN|NUMBER OF PREGNANCIES||||10^6/L|||10^3 CFU|NOT DONE||Y|NA|Y|1||38||RUN-IN|1971-05-18||1968-02-14|||1973-04-28||1973-05-09
TRIAL STUDY 134XCP|RP|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|2||||||INTP|INTERPRETATION||||OD UNIT|||BQ/KG|NOT DONE||NA|Y|NA|1||38||OBSERVATION|1965-06-20||1963-08-03|||1962-12-24||1969-10-24
TRIAL STUDY 134XCP|RP|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|1||||||GRAVIND|GRAVIDA INDICATOR||||CGY|||SEC|NOT DONE||U|NA|N|2||58||BASELINE|1965-04-05||1972-09-03|||1961-04-16||1962-03-12
TRIAL STUDY 134XCP|RP|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||POUCH|||G/KG|NOT DONE||N|U|U|2||58||FOLLOW-UP|1965-10-04||1962-09-20|||1962-10-29||1961-05-16
TRIAL STUDY 134XCP|RP|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||ML/CM3/MIN|||HZ|NOT DONE||U|N|U|3||39||RUN-IN|1968-05-07||1967-09-17|||1965-04-26||1963-10-04
TRIAL STUDY 134XCP|RP|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|2||||||PREGNN|NUMBER OF PREGNANCIES||||L/S/KPA|||DPM/100MG|NOT DONE||N|U|NA|3||39||WASHOUT|1960-07-08||1962-08-16|||1963-02-04||1963-07-04
TRIAL STUDY 134XCP|RP|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MIU/L|||MS/MMHG|NOT DONE||Y|N|NA|4||88||BLINDED TREATMENT|1972-01-28||1972-02-09|||1970-11-01||1973-02-22
TRIAL STUDY 134XCP|RP|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||G/M2/DAY|||ML/BEAT|NOT DONE||U|Y|U|4||88||LONG-TERM FOLLOW-UP|1962-02-17||1961-10-12|||1966-11-08||1964-05-28
TRIAL STUDY 134XCP|RP|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||ML/MMHG/MIN/L|||G/DL|NOT DONE||N|Y|Y|5||7||TREATMENT|1971-06-22||1963-06-30|||1969-05-31||1960-05-30
TRIAL STUDY 134XCP|RP|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|2||||||BLISTIND|BLISTERING INDICATOR||||MMOL/MIN/KPA|||MG/ANIMAL|NOT DONE||Y|Y|Y|5||7||INDUCTION TREATMENT|1971-09-29||1969-01-27|||1963-05-30||1972-04-19
TRIAL STUDY 134XCP|RP|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||ML/CM|||G/KG/DAY|NOT DONE||Y|U|Y|1||38||WASHOUT|1965-03-05||1962-10-30|||1971-03-12||1964-04-16
TRIAL STUDY 134XCP|RP|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|2||||||RASHIND|RASH INDICATOR||||IMPLANT|||MMOL/DAY|NOT DONE||N|N|Y|1||38||BLINDED TREATMENT|1964-01-28||1964-02-07|||1967-01-29||1967-09-02
TRIAL STUDY 134XCP|RP|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|1||||||BRTHN|NUMBER OF BIRTHS||||NMOL/MOL|||UM|NOT DONE||Y|NA|NA|2||58||WASHOUT|1963-01-11||1973-06-30|||1965-06-26||1962-08-31
TRIAL STUDY 134XCP|RP|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|2||||||THICK|THICKNESS||||BISCUIT|||10^6 COPIES/ML|NOT DONE||U|Y|U|2||58||TREATMENT|1961-01-28||1972-07-10|||1967-12-08||1965-07-18
TRIAL STUDY 134XCP|RP|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||/40 HPFS|||LB|NOT DONE||NA|N|U|3||39||BASELINE|1973-07-15||1966-03-03|||1968-09-04||1966-04-08
TRIAL STUDY 134XCP|RP|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|2||||||ERYTHIND|ERYTHEMA INDICATOR||||STEPS/MIN|||MOL/L|NOT DONE||Y|N|NA|3||39||BLINDED TREATMENT|1971-08-22||1972-06-26|||1968-06-09||1962-07-14
TRIAL STUDY 134XCP|RP|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|1||||||MENARAGE|MENARCHE AGE||||MG/KG/DAY|||MESF|NOT DONE||NA|NA|Y|4||88||CONTINUATION TREATMENT|1961-04-30||1968-01-29|||1967-11-06||1963-06-17
TRIAL STUDY 134XCP|RP|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||G/DAY|||BU|NOT DONE||Y|U|Y|4||88||OPEN LABEL TREATMENT|1960-10-24||1973-05-08|||1964-09-05||1967-04-18
TRIAL STUDY 134XCP|RP|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|1||||||TNDRIND|TENDERNESS INDICATOR||||10^6 IU|||MBQ/UL|NOT DONE||Y|N|Y|5||7||CONTINUATION TREATMENT|1971-09-29||1970-05-07|||1961-10-20||1960-12-09
TRIAL STUDY 134XCP|RP|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||UV*SEC|||MOL/MG|NOT DONE||Y|Y|U|5||7||TREATMENT|1963-11-23||1961-02-02|||1965-04-18||1970-06-21
TRIAL STUDY 134XCP|RP|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|1||||||MASSIND|MASS INDICATOR||||POINT|||CI/UL|NOT DONE||NA|N|Y|1||38||WASHOUT|1968-08-15||1966-04-20|||1961-02-12||1970-07-16
TRIAL STUDY 134XCP|RP|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|2||||||PREGIND|PREGNANT INDICATOR||||EID 50/ML|||CY/CM|NOT DONE||N|N|U|1||38||OBSERVATION|1970-06-04||1972-11-25|||1970-10-27||1964-08-08
TRIAL STUDY 134XCP|RP|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||BISCUIT|||UCI/L|NOT DONE||NA|Y|N|2||58||SCREENING|1964-04-25||1964-04-22|||1968-10-18||1968-05-06
TRIAL STUDY 134XCP|RP|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|2||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||MIN|||UG/ML/H|NOT DONE||N|N|NA|2||58||FOLLOW-UP|1966-12-22||1965-07-22|||1963-10-26||1967-08-03
TRIAL STUDY 134XCP|RP|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||IU/G|||10^3 ORGANISMS/ML|NOT DONE||Y|Y|NA|3||39||WASHOUT|1963-09-16||1969-01-12|||1961-09-23||1961-08-12
TRIAL STUDY 134XCP|RP|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|2||||||EDEMAIND|EDEMA INDICATOR||||KA_U/DL|||BQ/G|NOT DONE||N|Y|U|3||39||INDUCTION TREATMENT|1965-10-21||1966-05-26|||1969-01-05||1964-09-15
TRIAL STUDY 134XCP|RP|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||NU/CL|||UV*SEC|NOT DONE||U|NA|NA|4||88||INDUCTION TREATMENT|1963-01-04||1960-01-15|||1963-10-29||1965-09-29
TRIAL STUDY 134XCP|RP|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|2||||||INABOIND|INDUCED ABORTION INDICATOR||||10^6/EJACULATE U|||MBQ/UL|NOT DONE||Y|Y|NA|4||88||OBSERVATION|1964-10-02||1973-04-22|||1966-02-23||1970-09-06
TRIAL STUDY 134XCP|RP|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MG/L|||TUBERCULIN UNIT|NOT DONE||U|Y|N|5||7||BASELINE|1972-05-27||1960-10-02|||1972-04-28||1969-11-30
TRIAL STUDY 134XCP|RP|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|2||||||PREGIND|PREGNANT INDICATOR||||BQ/UL|||IMPLANT|NOT DONE||U|U|NA|5||7||OPEN LABEL TREATMENT|1964-03-18||1964-11-16|||1963-08-08||1972-05-03
TRIAL STUDY 134XCP|RP|15594D4E-1DAE-449F-AA52-9B0A926D9985|1||||||INTP|INTERPRETATION||||ML/DL|||G|NOT DONE||Y|Y|Y|1||38||BLINDED TREATMENT|1969-05-05||1972-09-25|||1966-05-18||1960-10-31
TRIAL STUDY 134XCP|RP|15594D4E-1DAE-449F-AA52-9B0A926D9985|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||TAMPON|||L/S/KPA|NOT DONE||NA|NA|NA|1||38||BLINDED TREATMENT|1972-09-07||1961-09-25|||1970-10-02||1970-07-30
TRIAL STUDY 134XCP|RP|15594D4E-1DAE-449F-AA52-9B0A926D9985|1||||||PREGNN|NUMBER OF PREGNANCIES||||KDA|||MEQ/UL|NOT DONE||Y|NA|NA|2||58||RUN-IN|1966-03-07||1964-03-21|||1970-04-19||1968-10-28
TRIAL STUDY 134XCP|RP|15594D4E-1DAE-449F-AA52-9B0A926D9985|2||||||INTP|INTERPRETATION||||ELISA UNIT/DOSE|||MG/MOL|NOT DONE||U|NA|Y|2||58||FOLLOW-UP|1965-03-02||1971-07-22|||1961-10-05||1966-09-23
TRIAL STUDY 134XCP|RP|15594D4E-1DAE-449F-AA52-9B0A926D9985|1||||||BRTHN|NUMBER OF BIRTHS||||UG/KG/H|||DIOPTER|NOT DONE||U|NA|N|3||39||RUN-IN|1973-06-10||1973-03-05|||1967-11-17||1965-07-18
TRIAL STUDY 134XCP|RP|15594D4E-1DAE-449F-AA52-9B0A926D9985|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||10^6/EJACULATE U|||OZ|NOT DONE||U|N|Y|3||39||TREATMENT|1971-11-15||1962-02-04|||1965-06-19||1960-06-21
TRIAL STUDY 134XCP|RP|15594D4E-1DAE-449F-AA52-9B0A926D9985|1||||||PUSTIND|PUSTULE INDICATOR||||IMPLANT|||MGEQ|NOT DONE||NA|Y|U|4||88||RUN-IN|1968-03-20||1969-11-26|||1972-07-22||1966-04-09
TRIAL STUDY 134XCP|RP|15594D4E-1DAE-449F-AA52-9B0A926D9985|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||10^6 RNA COPIES/ML|||MMOL/G|NOT DONE||N|NA|N|4||88||SCREENING|1962-10-09||1964-11-24|||1960-07-09||1966-09-10
TRIAL STUDY 134XCP|RP|15594D4E-1DAE-449F-AA52-9B0A926D9985|1||||||ULCERIND|ULCER INDICATOR||||UG/G/H|||AFU|NOT DONE||Y|NA|N|5||7||SCREENING|1973-03-24||1963-10-26|||1970-12-18||1969-09-29
TRIAL STUDY 134XCP|RP|15594D4E-1DAE-449F-AA52-9B0A926D9985|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||MMAL|||BISCUIT|NOT DONE||NA|U|NA|5||7||OPEN LABEL TREATMENT|1970-12-30||1970-03-11|||1961-10-18||1964-04-11
TRIAL STUDY 134XCP|RP|079DEA7B-A617-4787-9872-025F4248ABFF|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||/500 WBC|||S*KPA|NOT DONE||NA|Y|N|1||38||BASELINE|1970-05-16||1968-12-10|||1972-12-31||1972-01-30
TRIAL STUDY 134XCP|RP|079DEA7B-A617-4787-9872-025F4248ABFF|2||||||PUSTIND|PUSTULE INDICATOR||||U/G/H|||DL|NOT DONE||N|U|U|1||38||WASHOUT|1962-02-26||1972-01-06|||1961-05-22||1962-06-15
TRIAL STUDY 134XCP|RP|079DEA7B-A617-4787-9872-025F4248ABFF|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||WAFER|||CAPSULE|NOT DONE||NA|U|NA|2||58||SCREENING|1966-12-31||1971-12-29|||1961-10-12||1962-01-13
TRIAL STUDY 134XCP|RP|079DEA7B-A617-4787-9872-025F4248ABFF|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||MG/L|||PFU/DOSE|NOT DONE||NA|Y|N|2||58||FOLLOW-UP|1972-05-23||1963-02-05|||1972-08-24||1965-08-07
TRIAL STUDY 134XCP|RP|079DEA7B-A617-4787-9872-025F4248ABFF|1||||||ULCERIND|ULCER INDICATOR||||UG/CM2|||ML/M2/DAY|NOT DONE||N|N|N|3||39||FOLLOW-UP|1966-05-03||1971-06-09|||1964-05-26||1960-11-21
TRIAL STUDY 134XCP|RP|079DEA7B-A617-4787-9872-025F4248ABFF|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||U/M2/H|||GY|NOT DONE||N|U|N|3||39||CONTINUATION TREATMENT|1960-06-14||1968-10-11|||1971-09-19||1961-09-05
TRIAL STUDY 134XCP|RP|079DEA7B-A617-4787-9872-025F4248ABFF|1||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||MEQ/MMOL|||DMOL|NOT DONE||U|U|NA|4||88||OPEN LABEL TREATMENT|1969-10-26||1960-02-13|||1960-07-20||1968-10-22
TRIAL STUDY 134XCP|RP|079DEA7B-A617-4787-9872-025F4248ABFF|2||||||ERYTHIND|ERYTHEMA INDICATOR||||MPA|||CAPSULE|NOT DONE||N|Y|U|4||88||CONTINUATION TREATMENT|1966-05-14||1960-01-29|||1970-02-13||1960-02-29
TRIAL STUDY 134XCP|RP|079DEA7B-A617-4787-9872-025F4248ABFF|1||||||DLVRMODE|MODE OF DELIVERY||||ENZYME U/G HB|||MM/H|NOT DONE||NA|NA|N|5||7||CONTINUATION TREATMENT|1971-08-23||1964-06-12|||1961-12-31||1968-01-02
TRIAL STUDY 134XCP|RP|079DEA7B-A617-4787-9872-025F4248ABFF|2||||||PRGENDTC|DATE PREGNANCY ENDED||||10^8 PFU|||CUP EQ|NOT DONE||NA|U|N|5||7||TREATMENT|1962-02-03||1968-09-05|||1973-03-24||1970-08-05
TRIAL STUDY 134XCP|RP|3178AE30-9653-4470-84E4-FB0E4587DF6B|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||10^6/EJACULATE U|||TESLA|NOT DONE||Y|Y|U|1||38||WASHOUT|1962-04-17||1966-04-24|||1966-10-28||1968-03-21
TRIAL STUDY 134XCP|RP|3178AE30-9653-4470-84E4-FB0E4587DF6B|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||GBQ|||EIA UNIT|NOT DONE||NA|U|U|1||38||FOLLOW-UP|1969-12-22||1961-04-28|||1961-06-13||1965-06-15
TRIAL STUDY 134XCP|RP|3178AE30-9653-4470-84E4-FB0E4587DF6B|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||PIXEL|||IU/DL|NOT DONE||NA|N|N|2||58||RUN-IN|1965-05-14||1965-12-12|||1962-04-09||1973-08-06
TRIAL STUDY 134XCP|RP|3178AE30-9653-4470-84E4-FB0E4587DF6B|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||L/H/M2|||%(W/W)|NOT DONE||Y|Y|Y|2||58||BLINDED TREATMENT|1971-12-28||1968-06-23|||1961-06-16||1967-05-14
TRIAL STUDY 134XCP|RP|3178AE30-9653-4470-84E4-FB0E4587DF6B|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MG/KG|||RFU|NOT DONE||U|Y|NA|3||39||FOLLOW-UP|1965-11-20||1971-08-28|||1967-07-21||1965-09-26
TRIAL STUDY 134XCP|RP|3178AE30-9653-4470-84E4-FB0E4587DF6B|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||YEARS|||GBQ/UG|NOT DONE||N|U|N|3||39||WASHOUT|1971-09-02||1972-07-24|||1960-02-21||1963-05-01
TRIAL STUDY 134XCP|RP|3178AE30-9653-4470-84E4-FB0E4587DF6B|1||||||THICK|THICKNESS||||GMFI|||10^6/EJACULATE U|NOT DONE||Y|NA|U|4||88||CONTINUATION TREATMENT|1966-10-30||1962-07-01|||1966-11-22||1964-10-25
TRIAL STUDY 134XCP|RP|3178AE30-9653-4470-84E4-FB0E4587DF6B|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||LOG10 TCID 50/DOSE|||V|NOT DONE||Y|N|NA|4||88||OPEN LABEL TREATMENT|1960-08-31||1968-08-31|||1962-03-14||1961-02-10
TRIAL STUDY 134XCP|RP|3178AE30-9653-4470-84E4-FB0E4587DF6B|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||KG/MOL|||BOX|NOT DONE||U|NA|Y|5||7||INDUCTION TREATMENT|1967-07-13||1961-01-09|||1973-01-11||1973-05-01
TRIAL STUDY 134XCP|RP|3178AE30-9653-4470-84E4-FB0E4587DF6B|2||||||INABOIND|INDUCED ABORTION INDICATOR||||M2|||PG/CELL|NOT DONE||Y|U|U|5||7||TREATMENT|1962-08-27||1969-05-24|||1973-05-03||1963-09-11
TRIAL STUDY 134XCP|RP|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|1||||||PREGST|PREGNANT DURING THE STUDY||||WEEKS|||ML/MIN/MMHG|NOT DONE||N|U|N|1||38||LONG-TERM FOLLOW-UP|1967-10-04||1965-04-14|||1968-01-07||1971-12-12
TRIAL STUDY 134XCP|RP|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|2||||||PEELIND|PEELING INDICATOR||||FG|||G/G/DAY|NOT DONE||Y|N|N|1||38||LONG-TERM FOLLOW-UP|1963-06-25||1962-12-16|||1966-09-07||1961-02-09
TRIAL STUDY 134XCP|RP|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|1||||||DSCHGIND|DISCHARGE INDICATOR||||DEG2|||SPRAY|NOT DONE||Y|NA|N|2||58||OBSERVATION|1971-12-06||1963-03-12|||1972-05-24||1964-09-18
TRIAL STUDY 134XCP|RP|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||STRIP|||10^12 IU/L|NOT DONE||N|N|Y|2||58||WASHOUT|1967-04-24||1966-08-28|||1972-03-09||1967-07-02
TRIAL STUDY 134XCP|RP|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||APL U/ML|||MIN/DAY|NOT DONE||NA|NA|Y|3||39||BLINDED TREATMENT|1963-03-26||1972-08-27|||1963-04-28||1960-07-16
TRIAL STUDY 134XCP|RP|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|2||||||FUNDHT|FUNDAL HEIGHT||||U/KG/H|||OZ|NOT DONE||Y|Y|Y|3||39||INDUCTION TREATMENT|1966-06-25||1972-01-12|||1960-01-31||1961-08-24
TRIAL STUDY 134XCP|RP|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|1||||||TNDRIND|TENDERNESS INDICATOR||||APS U|||CI/L|NOT DONE||NA|U|U|4||88||OBSERVATION|1960-07-11||1962-12-11|||1962-04-15||1969-08-05
TRIAL STUDY 134XCP|RP|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|2||||||INTP|INTERPRETATION||||SFC/10^6 PBMC|||G/CAGE/DAY|NOT DONE||N|U|NA|4||88||TREATMENT|1971-01-14||1961-01-21|||1972-02-21||1970-02-25
TRIAL STUDY 134XCP|RP|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|1||||||ULCERIND|ULCER INDICATOR||||BE/ML|||SACHET|NOT DONE||NA|Y|N|5||7||BLINDED TREATMENT|1973-03-21||1971-01-28|||1961-01-02||1961-03-03
TRIAL STUDY 134XCP|RP|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MG/M2/DAY|||NEWTON|NOT DONE||N|N|NA|5||7||RUN-IN|1971-10-16||1961-10-29|||1961-04-09||1960-01-24
TRIAL STUDY 134XCP|RP|D274C760-A607-4DA8-ACD3-346EF6E191D2|1||||||MASSIND|MASS INDICATOR||||10^6 ORGANISMS/MG|||BREATHS/MIN|NOT DONE||NA|U|N|1||38||FOLLOW-UP|1962-11-23||1969-12-31|||1967-09-22||1964-09-11
TRIAL STUDY 134XCP|RP|D274C760-A607-4DA8-ACD3-346EF6E191D2|2||||||BRTHN|NUMBER OF BIRTHS||||WAFER|||NL|NOT DONE||NA|NA|NA|1||38||BLINDED TREATMENT|1965-09-27||1971-10-04|||1967-03-13||1970-12-30
TRIAL STUDY 134XCP|RP|D274C760-A607-4DA8-ACD3-346EF6E191D2|1||||||MENARAGE|MENARCHE AGE||||/H|||KN/CM2|NOT DONE||NA|Y|NA|2||58||INDUCTION TREATMENT|1971-05-16||1965-04-15|||1965-05-29||1968-08-17
TRIAL STUDY 134XCP|RP|D274C760-A607-4DA8-ACD3-346EF6E191D2|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||PIXEL|||CI/L|NOT DONE||N|NA|U|2||58||BLINDED TREATMENT|1966-05-26||1960-12-06|||1971-03-17||1964-02-29
TRIAL STUDY 134XCP|RP|D274C760-A607-4DA8-ACD3-346EF6E191D2|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||UG/KG/DAY|||MSEC|NOT DONE||Y|N|Y|3||39||WASHOUT|1967-08-20||1961-04-15|||1971-01-24||1967-07-21
TRIAL STUDY 134XCP|RP|D274C760-A607-4DA8-ACD3-346EF6E191D2|2||||||PREGIND|PREGNANT INDICATOR||||GTT|||MV2/HZ|NOT DONE||U|N|NA|3||39||LONG-TERM FOLLOW-UP|1966-08-09||1972-02-18|||1966-07-19||1966-04-16
TRIAL STUDY 134XCP|RP|D274C760-A607-4DA8-ACD3-346EF6E191D2|1||||||PREGST|PREGNANT DURING THE STUDY||||AGU/ML|||NMOL/L/H|NOT DONE||NA|N|NA|4||88||WASHOUT|1973-05-28||1970-04-28|||1970-04-10||1960-04-05
TRIAL STUDY 134XCP|RP|D274C760-A607-4DA8-ACD3-346EF6E191D2|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||ML/ANIMAL/WK|||LOG10 IU/ML|NOT DONE||N|N|N|4||88||BLINDED TREATMENT|1966-08-15||1969-05-25|||1964-01-31||1963-07-27
TRIAL STUDY 134XCP|RP|D274C760-A607-4DA8-ACD3-346EF6E191D2|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||CD|||UG/M2/MIN|NOT DONE||N|Y|U|5||7||WASHOUT|1973-07-04||1967-08-12|||1965-04-20||1969-01-15
TRIAL STUDY 134XCP|RP|D274C760-A607-4DA8-ACD3-346EF6E191D2|2||||||MENOSTAT|MENOPAUSE STATUS||||PPB|||MBQ/UL|NOT DONE||N|U|N|5||7||BASELINE|1970-07-02||1972-11-10|||1968-03-24||1972-01-31
TRIAL STUDY 134XCP|RP|F5B7E82D-49AD-422E-9C38-5681105094AA|1||||||PEELIND|PEELING INDICATOR||||MEQ/KG|||P|NOT DONE||N|U|NA|1||38||INDUCTION TREATMENT|1960-05-17||1969-06-06|||1967-08-05||1964-05-10
TRIAL STUDY 134XCP|RP|F5B7E82D-49AD-422E-9C38-5681105094AA|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||CD|||/MM|NOT DONE||N|N|Y|1||38||BLINDED TREATMENT|1966-07-06||1969-06-10|||1965-06-29||1964-01-05
TRIAL STUDY 134XCP|RP|F5B7E82D-49AD-422E-9C38-5681105094AA|1||||||DLVRMODE|MODE OF DELIVERY||||ML/M2/H|||MCI/L|NOT DONE||NA|U|NA|2||58||TREATMENT|1967-04-25||1969-10-21|||1961-11-14||1967-11-17
TRIAL STUDY 134XCP|RP|F5B7E82D-49AD-422E-9C38-5681105094AA|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||MV2/HZ|||10^3 RNA COPIES/ML|NOT DONE||N|Y|Y|2||58||CONTINUATION TREATMENT|1962-04-13||1964-11-02|||1961-12-12||1965-02-18
TRIAL STUDY 134XCP|RP|F5B7E82D-49AD-422E-9C38-5681105094AA|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||/VF|||DRUM|NOT DONE||NA|Y|Y|3||39||FOLLOW-UP|1963-02-24||1971-01-26|||1972-06-08||1973-08-20
TRIAL STUDY 134XCP|RP|F5B7E82D-49AD-422E-9C38-5681105094AA|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||APL U|||AMFI|NOT DONE||NA|NA|U|3||39||TREATMENT|1968-05-26||1964-07-29|||1960-01-21||1962-02-14
TRIAL STUDY 134XCP|RP|F5B7E82D-49AD-422E-9C38-5681105094AA|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||ML/DAY|||UG/M2|NOT DONE||NA|NA|Y|4||88||TREATMENT|1964-12-01||1963-08-03|||1965-03-29||1972-04-27
TRIAL STUDY 134XCP|RP|F5B7E82D-49AD-422E-9C38-5681105094AA|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||PMOL/L/H|||NKAT/G HB|NOT DONE||N|U|Y|4||88||BASELINE|1960-07-07||1960-06-02|||1973-09-06||1961-11-30
TRIAL STUDY 134XCP|RP|F5B7E82D-49AD-422E-9C38-5681105094AA|1||||||MENARAGE|MENARCHE AGE||||/10^5|||UMOL/L/SEC|NOT DONE||U|NA|U|5||7||CONTINUATION TREATMENT|1960-05-29||1971-09-03|||1973-07-09||1971-11-14
TRIAL STUDY 134XCP|RP|F5B7E82D-49AD-422E-9C38-5681105094AA|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||UG/KG/MIN|||CCID 50/DOSE|NOT DONE||U|Y|Y|5||7||INDUCTION TREATMENT|1972-01-14||1966-02-14|||1969-06-14||1966-02-12
TRIAL STUDY 134XCP|RP|AF8D32B4-B2CC-4EE3-A612-179814C691B8|1||||||MENOSTAT|MENOPAUSE STATUS||||10^6/HPF|||U/10^12 RBC|NOT DONE||NA|Y|NA|1||38||LONG-TERM FOLLOW-UP|1963-09-30||1963-01-11|||1966-09-13||1970-03-11
TRIAL STUDY 134XCP|RP|AF8D32B4-B2CC-4EE3-A612-179814C691B8|2||||||INTP|INTERPRETATION||||/MIN|||AMPULE|NOT DONE||N|N|NA|1||38||INDUCTION TREATMENT|1965-11-15||1968-08-14|||1973-01-04||1962-03-17
TRIAL STUDY 134XCP|RP|AF8D32B4-B2CC-4EE3-A612-179814C691B8|1||||||PREGST|PREGNANT DURING THE STUDY||||DDU|||WEEKS|NOT DONE||N|NA|N|2||58||BLINDED TREATMENT|1973-05-16||1967-04-06|||1972-02-11||1968-08-26
TRIAL STUDY 134XCP|RP|AF8D32B4-B2CC-4EE3-A612-179814C691B8|2||||||THICK|THICKNESS||||10^6 IU/ML|||CIGAR|NOT DONE||N|Y|U|2||58||RUN-IN|1973-01-22||1970-04-04|||1960-01-03||1969-09-23
TRIAL STUDY 134XCP|RP|AF8D32B4-B2CC-4EE3-A612-179814C691B8|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||GBQ|||UMOL/L|NOT DONE||NA|Y|U|3||39||INDUCTION TREATMENT|1969-04-17||1973-08-17|||1968-05-25||1972-06-03
TRIAL STUDY 134XCP|RP|AF8D32B4-B2CC-4EE3-A612-179814C691B8|2||||||MENOSTAT|MENOPAUSE STATUS||||VG/KG|||GY|NOT DONE||N|NA|N|3||39||BLINDED TREATMENT|1970-01-14||1970-09-14|||1973-07-21||1971-07-22
TRIAL STUDY 134XCP|RP|AF8D32B4-B2CC-4EE3-A612-179814C691B8|1||||||STILBIND|STILLBIRTH INDICATOR||||BQ/L|||MOSM/L|NOT DONE||U|NA|N|4||88||OPEN LABEL TREATMENT|1962-08-05||1966-06-02|||1965-02-22||1967-07-17
TRIAL STUDY 134XCP|RP|AF8D32B4-B2CC-4EE3-A612-179814C691B8|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||NG/MOL|||10^6 IU/ML|NOT DONE||N|Y|U|4||88||OPEN LABEL TREATMENT|1966-08-30||1966-05-01|||1967-05-19||1960-05-01
TRIAL STUDY 134XCP|RP|AF8D32B4-B2CC-4EE3-A612-179814C691B8|1||||||RASHIND|RASH INDICATOR||||UEQ|||SQU/ML|NOT DONE||Y|U|Y|5||7||SCREENING|1962-05-24||1961-08-03|||1964-04-02||1971-02-21
TRIAL STUDY 134XCP|RP|AF8D32B4-B2CC-4EE3-A612-179814C691B8|2||||||MENFDUR|MENSES FLOW DURATION||||BQ/UG|||10^6 ORGANISMS/MG|NOT DONE||Y|NA|U|5||7||SCREENING|1970-10-23||1965-02-24|||1966-04-18||1966-01-27
TRIAL STUDY 134XCP|RP|64153B43-9DDC-473D-97E1-0E2E8C3E8116|1||||||MENFDUR|MENSES FLOW DURATION||||/500 WBC|||AMFI|NOT DONE||Y|N|N|1||38||OPEN LABEL TREATMENT|1971-07-20||1971-01-26|||1973-09-05||1970-10-12
TRIAL STUDY 134XCP|RP|64153B43-9DDC-473D-97E1-0E2E8C3E8116|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||TUBE|||KALLIKREIN INHIBITOR UNIT|NOT DONE||NA|N|U|1||38||OPEN LABEL TREATMENT|1963-02-13||1965-04-09|||1969-12-15||1973-05-04
TRIAL STUDY 134XCP|RP|64153B43-9DDC-473D-97E1-0E2E8C3E8116|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MG|||AMPULE|NOT DONE||Y|U|Y|2||58||OPEN LABEL TREATMENT|1964-06-28||1968-07-31|||1963-02-05||1970-04-30
TRIAL STUDY 134XCP|RP|64153B43-9DDC-473D-97E1-0E2E8C3E8116|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||OHM|||PFU|NOT DONE||N|Y|U|2||58||RUN-IN|1964-05-17||1961-07-06|||1964-06-13||1962-07-09
TRIAL STUDY 134XCP|RP|64153B43-9DDC-473D-97E1-0E2E8C3E8116|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MIN*MG/ML|||%(V/V)|NOT DONE||NA|U|U|3||39||RUN-IN|1962-07-16||1971-12-03|||1964-08-22||1964-06-04
TRIAL STUDY 134XCP|RP|64153B43-9DDC-473D-97E1-0E2E8C3E8116|2||||||ERYTHIND|ERYTHEMA INDICATOR||||ML/100G/MIN|||BQ/UL|NOT DONE||Y|NA|Y|3||39||OBSERVATION|1967-08-18||1968-06-30|||1972-12-24||1972-01-13
TRIAL STUDY 134XCP|RP|64153B43-9DDC-473D-97E1-0E2E8C3E8116|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||UEQ|||NU/CL|NOT DONE||NA|U|N|4||88||RUN-IN|1966-11-28||1962-09-16|||1969-02-19||1965-07-01
TRIAL STUDY 134XCP|RP|64153B43-9DDC-473D-97E1-0E2E8C3E8116|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||ML/CM3/MIN|||ML/M2/MIN|NOT DONE||N|U|Y|4||88||LONG-TERM FOLLOW-UP|1970-12-11||1968-10-20|||1971-03-03||1970-01-10
TRIAL STUDY 134XCP|RP|64153B43-9DDC-473D-97E1-0E2E8C3E8116|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||GPELISA UNIT/ML|||1/(S*KPA)|NOT DONE||Y|N|N|5||7||LONG-TERM FOLLOW-UP|1961-07-30||1972-12-08|||1960-10-08||1967-07-09
TRIAL STUDY 134XCP|RP|64153B43-9DDC-473D-97E1-0E2E8C3E8116|2||||||GRAVIND|GRAVIDA INDICATOR||||GTT|||DEG/S|NOT DONE||Y|Y|NA|5||7||BASELINE|1970-09-12||1972-09-12|||1966-04-05||1972-10-25
TRIAL STUDY 134XCP|RP|0F5775AD-1D20-4B59-8558-8A41C12E03D0|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||NMOL/ML/MIN|||RAD|NOT DONE||NA|NA|U|1||38||CONTINUATION TREATMENT|1964-12-03||1965-08-28|||1972-08-26||1964-11-23
TRIAL STUDY 134XCP|RP|0F5775AD-1D20-4B59-8558-8A41C12E03D0|2||||||THICK|THICKNESS||||PMOL/10^10 CELLS|||NG|NOT DONE||NA|U|U|1||38||FOLLOW-UP|1969-07-11||1970-08-19|||1966-01-03||1964-02-15
TRIAL STUDY 134XCP|RP|0F5775AD-1D20-4B59-8558-8A41C12E03D0|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||NG|||MM/H|NOT DONE||U|NA|Y|2||58||CONTINUATION TREATMENT|1973-01-16||1965-12-28|||1961-03-10||1966-10-08
TRIAL STUDY 134XCP|RP|0F5775AD-1D20-4B59-8558-8A41C12E03D0|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||CMOL/L|||BISCUIT|NOT DONE||Y|N|NA|2||58||OBSERVATION|1973-08-12||1968-03-31|||1971-05-21||1966-09-24
TRIAL STUDY 134XCP|RP|0F5775AD-1D20-4B59-8558-8A41C12E03D0|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MPL U/ML|||LOG10 ELISA UNIT|NOT DONE||NA|NA|NA|3||39||RUN-IN|1969-01-29||1973-03-25|||1965-05-18||1961-01-19
TRIAL STUDY 134XCP|RP|0F5775AD-1D20-4B59-8558-8A41C12E03D0|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MOSM/KG|||ANTI-XA IU/ML|NOT DONE||N|N|Y|3||39||WASHOUT|1963-03-13||1966-02-05|||1969-04-13||1968-06-22
TRIAL STUDY 134XCP|RP|0F5775AD-1D20-4B59-8558-8A41C12E03D0|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||10^4 CFU/ML|||BQ/UG|NOT DONE||U|U|U|4||88||CONTINUATION TREATMENT|1961-06-05||1960-08-11|||1969-05-01||1971-07-09
TRIAL STUDY 134XCP|RP|0F5775AD-1D20-4B59-8558-8A41C12E03D0|2||||||MENOSTAT|MENOPAUSE STATUS||||KN/CM2|||M|NOT DONE||Y|N|N|4||88||OBSERVATION|1971-10-01||1962-06-08|||1962-11-16||1965-03-15
TRIAL STUDY 134XCP|RP|0F5775AD-1D20-4B59-8558-8A41C12E03D0|1||||||PRGENDTC|DATE PREGNANCY ENDED||||EU|||GBQ/MG|NOT DONE||U|Y|U|5||7||LONG-TERM FOLLOW-UP|1973-09-03||1963-11-17|||1966-11-09||1963-12-18
TRIAL STUDY 134XCP|RP|0F5775AD-1D20-4B59-8558-8A41C12E03D0|2||||||INABOIND|INDUCED ABORTION INDICATOR||||U/G HB|||KBQ|NOT DONE||N|NA|N|5||7||LONG-TERM FOLLOW-UP|1960-12-20||1964-10-27|||1972-04-21||1969-08-01
TRIAL STUDY 134XCP|RP|DF533087-690C-489A-9163-9D4503B7BCC9|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||PNU/ML|||UMOL/L/H|NOT DONE||U|N|NA|1||38||FOLLOW-UP|1971-08-06||1962-03-07|||1963-05-13||1963-03-28
TRIAL STUDY 134XCP|RP|DF533087-690C-489A-9163-9D4503B7BCC9|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||UGEQ|||KG/L|NOT DONE||N|N|U|1||38||LONG-TERM FOLLOW-UP|1972-03-06||1963-08-24|||1970-06-03||1965-02-23
TRIAL STUDY 134XCP|RP|DF533087-690C-489A-9163-9D4503B7BCC9|1||||||INTP|INTERPRETATION||||10^10/L|||LOZENGE|NOT DONE||U|Y|Y|2||58||SCREENING|1961-04-23||1969-02-13|||1960-07-28||1970-08-12
TRIAL STUDY 134XCP|RP|DF533087-690C-489A-9163-9D4503B7BCC9|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||COPIES/UG|||PIXEL|NOT DONE||U|NA|N|2||58||RUN-IN|1967-11-05||1970-09-03|||1971-07-13||1968-11-22
TRIAL STUDY 134XCP|RP|DF533087-690C-489A-9163-9D4503B7BCC9|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||U/M2/DAY|||BQ/ML|NOT DONE||Y|Y|Y|3||39||BASELINE|1968-04-21||1973-06-05|||1966-11-01||1968-08-02
TRIAL STUDY 134XCP|RP|DF533087-690C-489A-9163-9D4503B7BCC9|2||||||BRTHLVN|NUMBER OF LIVE BIRTHS||||BAR|||GRAVITATIONAL UNIT|NOT DONE||N|NA|Y|3||39||OBSERVATION|1968-11-11||1961-08-13|||1963-04-02||1970-01-18
TRIAL STUDY 134XCP|RP|DF533087-690C-489A-9163-9D4503B7BCC9|1||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||COULOMB|||K|NOT DONE||Y|U|Y|4||88||INDUCTION TREATMENT|1962-07-04||1970-08-17|||1963-09-02||1965-06-01
TRIAL STUDY 134XCP|RP|DF533087-690C-489A-9163-9D4503B7BCC9|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||10^6 ORGANISMS/G|||G/KG|NOT DONE||Y|N|Y|4||88||INDUCTION TREATMENT|1970-02-18||1961-10-13|||1960-11-01||1968-04-23
TRIAL STUDY 134XCP|RP|DF533087-690C-489A-9163-9D4503B7BCC9|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||PMOL/DAY|||ML/SEC/1.73M2|NOT DONE||N|Y|N|5||7||RUN-IN|1969-01-21||1961-10-14|||1966-06-19||1962-07-10
TRIAL STUDY 134XCP|RP|DF533087-690C-489A-9163-9D4503B7BCC9|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UM/S|||ML/MIN|NOT DONE||Y|U|NA|5||7||SCREENING|1963-09-06||1966-12-30|||1964-06-08||1964-09-18
TRIAL STUDY 134XCP|RP|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|1||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||/500 WBC|||KA_U/DL|NOT DONE||Y|Y|N|1||38||FOLLOW-UP|1973-06-13||1969-07-23|||1962-10-06||1964-04-14
TRIAL STUDY 134XCP|RP|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|2||||||RASHIND|RASH INDICATOR||||MG/ML/DAY|||OI50|NOT DONE||NA|NA|U|1||38||WASHOUT|1964-12-11||1968-07-09|||1971-11-29||1963-05-12
TRIAL STUDY 134XCP|RP|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|1||||||GRAVIND|GRAVIDA INDICATOR||||GTT|||%/S|NOT DONE||U|N|Y|2||58||BASELINE|1961-08-10||1970-10-27|||1970-09-26||1965-01-07
TRIAL STUDY 134XCP|RP|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|2||||||DSCHGIND|DISCHARGE INDICATOR||||DRUM|||L/S|NOT DONE||U|NA|U|2||58||SCREENING|1966-08-21||1972-10-07|||1963-11-08||1973-02-26
TRIAL STUDY 134XCP|RP|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|1||||||PEELIND|PEELING INDICATOR||||MG/M2/DAY|||UMOL/MOL|NOT DONE||NA|U|NA|3||39||CONTINUATION TREATMENT|1965-08-02||1967-07-27|||1962-09-10||1967-07-18
TRIAL STUDY 134XCP|RP|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|2||||||PRGENDTC|DATE PREGNANCY ENDED||||NG/DL|||FMOL/L/SEC|NOT DONE||NA|NA|Y|3||39||TREATMENT|1962-04-24||1971-03-15|||1966-11-19||1967-10-01
TRIAL STUDY 134XCP|RP|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|1||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||NMOL|||DEG|NOT DONE||NA|U|Y|4||88||TREATMENT|1973-06-08||1971-04-13|||1972-08-13||1972-06-21
TRIAL STUDY 134XCP|RP|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|2||||||MENOSTAT|MENOPAUSE STATUS||||HEP|||ML/DAY|NOT DONE||NA|NA|N|4||88||CONTINUATION TREATMENT|1973-07-25||1961-05-11|||1969-03-10||1962-10-18
TRIAL STUDY 134XCP|RP|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|1||||||VBSFRQD|VAGINAL BLEEDING/SPOTTING FREQ DESC||||MILE|||CIGARETTE|NOT DONE||U|NA|NA|5||7||CONTINUATION TREATMENT|1969-07-29||1971-03-29|||1969-05-25||1972-07-21
TRIAL STUDY 134XCP|RP|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|2||||||INABOIND|INDUCED ABORTION INDICATOR||||ARBITRARY U|||DEG2|NOT DONE||U|U|NA|5||7||INDUCTION TREATMENT|1965-02-27||1961-06-08|||1973-05-04||1970-02-16
TRIAL STUDY 134XCP|RP|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|1||||||FUNDHT|FUNDAL HEIGHT||||FEU|||UM2|NOT DONE||N|Y|U|1||38||OPEN LABEL TREATMENT|1963-07-18||1970-11-04|||1965-06-14||1962-08-15
TRIAL STUDY 134XCP|RP|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|2||||||BRTHN|NUMBER OF BIRTHS||||FIU|||CAPSULE|NOT DONE||NA|U|U|1||38||BLINDED TREATMENT|1962-12-12||1966-02-01|||1962-10-22||1960-05-05
TRIAL STUDY 134XCP|RP|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|1||||||RASHIND|RASH INDICATOR||||MU/L|||MGEQ|NOT DONE||N|U|NA|2||58||WASHOUT|1970-12-19||1971-05-06|||1972-11-02||1963-11-30
TRIAL STUDY 134XCP|RP|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|2||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MG/M2/DAY|||/HPF|NOT DONE||NA|NA|NA|2||58||CONTINUATION TREATMENT|1966-01-05||1964-01-02|||1972-10-01||1968-09-27
TRIAL STUDY 134XCP|RP|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|1||||||FUNDHT|FUNDAL HEIGHT||||ML/G/MIN|||ANTI-XA IU|NOT DONE||Y|N|NA|3||39||OBSERVATION|1961-08-29||1970-06-25|||1969-06-05||1963-04-18
TRIAL STUDY 134XCP|RP|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||FMOL|||/MM|NOT DONE||U|N|N|3||39||OPEN LABEL TREATMENT|1963-11-13||1973-06-20|||1971-09-03||1962-08-26
TRIAL STUDY 134XCP|RP|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|1||||||PREGIND|PREGNANT INDICATOR||||MEQ/ML|||/KG|NOT DONE||Y|N|NA|4||88||LONG-TERM FOLLOW-UP|1969-09-29||1963-06-19|||1963-02-17||1964-02-20
TRIAL STUDY 134XCP|RP|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||KIT|||BQ/UL|NOT DONE||NA|N|Y|4||88||CONTINUATION TREATMENT|1969-11-12||1969-09-26|||1970-07-26||1970-08-28
TRIAL STUDY 134XCP|RP|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|1||||||MASSIND|MASS INDICATOR||||CCID 50/ML|||BREATHS/30S|NOT DONE||Y|Y|N|5||7||LONG-TERM FOLLOW-UP|1971-09-09||1966-04-03|||1967-06-13||1963-05-19
TRIAL STUDY 134XCP|RP|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UMOL/KG/MIN|||DPM/ML|NOT DONE||U|U|U|5||7||WASHOUT|1966-04-07||1970-05-11|||1969-06-12||1971-10-29
TRIAL STUDY 134XCP|RP|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|1||||||MENFDUR|MENSES FLOW DURATION||||NG/MOL|||10^6 U|NOT DONE||N|N|NA|1||38||WASHOUT|1968-07-05||1973-01-18|||1962-02-14||1962-06-03
TRIAL STUDY 134XCP|RP|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|2||||||MASSIND|MASS INDICATOR||||PATCH|||NMOL|NOT DONE||U|N|NA|1||38||CONTINUATION TREATMENT|1962-04-24||1970-02-24|||1966-10-16||1971-11-25
TRIAL STUDY 134XCP|RP|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|1||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||HPA|||10^3 ORGANISMS/G|NOT DONE||Y|U|N|2||58||RUN-IN|1962-05-02||1962-12-28|||1964-03-29||1967-03-13
TRIAL STUDY 134XCP|RP|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|2||||||TNDRIND|TENDERNESS INDICATOR||||UV*SEC|||% INHIBITION|NOT DONE||Y|Y|NA|2||58||FOLLOW-UP|1972-01-07||1972-09-10|||1967-05-13||1965-10-08
TRIAL STUDY 134XCP|RP|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|1||||||GRAVIND|GRAVIDA INDICATOR||||UCI/KG|||MKAT|NOT DONE||N|U|NA|3||39||CONTINUATION TREATMENT|1973-06-15||1964-04-17|||1964-04-27||1962-01-30
TRIAL STUDY 134XCP|RP|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|2||||||INTP|INTERPRETATION||||/LSQN|||SUPPOSITORY|NOT DONE||U|N|NA|3||39||TREATMENT|1963-06-29||1962-10-06|||1971-09-10||1968-08-18
TRIAL STUDY 134XCP|RP|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||MG/DAY|||PM|NOT DONE||N|Y|U|4||88||BASELINE|1969-07-18||1965-06-25|||1962-01-07||1964-11-15
TRIAL STUDY 134XCP|RP|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|2||||||INTP|INTERPRETATION||||LENS|||MG/CM2|NOT DONE||NA|Y|Y|4||88||BLINDED TREATMENT|1960-03-28||1964-04-22|||1972-06-02||1965-07-26
TRIAL STUDY 134XCP|RP|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||BREATHS/MIN|||CAN|NOT DONE||NA|U|U|5||7||RUN-IN|1969-01-17||1971-06-09|||1965-04-05||1970-06-12
TRIAL STUDY 134XCP|RP|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||ML/SEC/1.73M2|||%/S|NOT DONE||NA|Y|U|5||7||BLINDED TREATMENT|1967-06-24||1972-10-24|||1967-08-30||1968-08-21
TRIAL STUDY 134XCP|RP|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|1||||||DLVRMODE|MODE OF DELIVERY||||MBQ|||CAPSULE|NOT DONE||U|U|NA|1||38||WASHOUT|1962-07-28||1963-06-18|||1960-10-29||1967-12-16
TRIAL STUDY 134XCP|RP|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||UMOL/DAY|||MBP|NOT DONE||U|N|NA|1||38||LONG-TERM FOLLOW-UP|1965-04-14||1966-12-26|||1960-08-12||1962-09-16
TRIAL STUDY 134XCP|RP|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|1||||||ABORTN|NUMBER OF ABORTIONS||||/4.0 ML|||VIAL|NOT DONE||Y|N|U|2||58||CONTINUATION TREATMENT|1966-08-13||1971-05-24|||1960-05-29||1972-04-17
TRIAL STUDY 134XCP|RP|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|2||||||BCMETHOD|BIRTH CONTROL METHOD||||TITER|||JAR|NOT DONE||Y|Y|U|2||58||BASELINE|1970-01-27||1970-04-08|||1961-10-23||1971-01-05
TRIAL STUDY 134XCP|RP|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|1||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MMOL/DAY|||STEPS|NOT DONE||Y|Y|NA|3||39||OBSERVATION|1966-11-05||1964-01-23|||1960-09-24||1972-09-09
TRIAL STUDY 134XCP|RP|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UL/DOSE|||ANTI-XA IU/ML|NOT DONE||N|U|U|3||39||BLINDED TREATMENT|1971-10-08||1971-02-11|||1966-10-31||1967-04-08
TRIAL STUDY 134XCP|RP|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||G/G|||NU/CL|NOT DONE||N|NA|NA|4||88||LONG-TERM FOLLOW-UP|1969-06-16||1969-04-15|||1966-08-21||1965-12-11
TRIAL STUDY 134XCP|RP|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UMOL/L/H|||VOXEL|NOT DONE||U|NA|U|4||88||SCREENING|1963-12-23||1965-01-01|||1973-02-01||1969-08-07
TRIAL STUDY 134XCP|RP|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||APL U|||YD|NOT DONE||U|NA|Y|5||7||BASELINE|1973-05-19||1960-10-06|||1971-01-23||1967-05-08
TRIAL STUDY 134XCP|RP|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|2||||||MENOSTAT|MENOPAUSE STATUS||||FOZ_BR|||LM|NOT DONE||U|U|U|5||7||LONG-TERM FOLLOW-UP|1966-01-24||1962-08-19|||1968-11-11||1963-07-12
TRIAL STUDY 134XCP|RP|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||CMHG|||PG/L|NOT DONE||U|NA|U|1||38||BASELINE|1960-08-23||1969-08-30|||1968-08-08||1962-06-22
TRIAL STUDY 134XCP|RP|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|2||||||BRTHN|NUMBER OF BIRTHS||||UG/KG/H|||MMHG*MIN/L|NOT DONE||NA|NA|Y|1||38||FOLLOW-UP|1966-04-15||1966-05-28|||1964-08-02||1973-01-27
TRIAL STUDY 134XCP|RP|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||U/M2/H|||BP|NOT DONE||N|Y|U|2||58||OBSERVATION|1970-05-19||1961-04-12|||1970-12-22||1971-10-25
TRIAL STUDY 134XCP|RP|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|2||||||MASSIND|MASS INDICATOR||||TORR|||IU/MG|NOT DONE||NA|U|N|2||58||FOLLOW-UP|1965-09-22||1966-12-19|||1966-08-09||1962-03-29
TRIAL STUDY 134XCP|RP|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|1||||||ERYTHIND|ERYTHEMA INDICATOR||||PIXEL|||ML/KG|NOT DONE||N|N|N|3||39||SCREENING|1963-05-15||1966-05-04|||1969-08-23||1968-06-03
TRIAL STUDY 134XCP|RP|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|2||||||EDEMAIND|EDEMA INDICATOR||||SQU/ML|||OSM|NOT DONE||NA|N|NA|3||39||RUN-IN|1970-11-09||1968-09-27|||1964-02-24||1963-06-09
TRIAL STUDY 134XCP|RP|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|1||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||NMOL BCE/L|||SIEMENS|NOT DONE||NA|NA|NA|4||88||FOLLOW-UP|1967-04-20||1966-05-28|||1961-04-16||1964-11-17
TRIAL STUDY 134XCP|RP|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|2||||||FETLDTHN|NUMBER OF LATE FETAL DEATHS||||U/G/H|||10^3/HPF|NOT DONE||Y|Y|U|4||88||BASELINE|1963-11-28||1972-04-03|||1966-09-15||1960-09-21
TRIAL STUDY 134XCP|RP|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|1||||||ABORTN|NUMBER OF ABORTIONS||||NMOL|||U/ML|NOT DONE||Y|NA|NA|5||7||BLINDED TREATMENT|1966-08-27||1968-11-30|||1965-02-05||1968-11-07
TRIAL STUDY 134XCP|RP|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||H/WK|||UMOL/DL|NOT DONE||NA|U|N|5||7||RUN-IN|1967-11-09||1961-07-18|||1962-10-20||1966-11-09
TRIAL STUDY 134XCP|RP|219A70B2-48A6-407C-B901-9847583DB5F4|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||WEEKS|||MILE|NOT DONE||N|U|U|1||38||TREATMENT|1964-06-20||1963-02-18|||1964-10-04||1969-09-15
TRIAL STUDY 134XCP|RP|219A70B2-48A6-407C-B901-9847583DB5F4|2||||||ECCHYIND|ECCHYMOSIS INDICATOR||||HZ|||10^12 IU/L|NOT DONE||Y|N|Y|1||38||CONTINUATION TREATMENT|1968-12-06||1960-09-10|||1971-03-01||1971-08-29
TRIAL STUDY 134XCP|RP|219A70B2-48A6-407C-B901-9847583DB5F4|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||KG/MOL|||UL/DOSE|NOT DONE||Y|NA|NA|2||58||CONTINUATION TREATMENT|1969-10-08||1968-09-19|||1961-09-10||1966-03-12
TRIAL STUDY 134XCP|RP|219A70B2-48A6-407C-B901-9847583DB5F4|2||||||PCONFIND|PREGNANCY CONFIRMED INDICATOR||||MG/KG/MIN|||GBQ/MG|NOT DONE||NA|NA|U|2||58||OPEN LABEL TREATMENT|1963-08-07||1965-12-18|||1972-12-30||1963-07-22
TRIAL STUDY 134XCP|RP|219A70B2-48A6-407C-B901-9847583DB5F4|1||||||MASSIND|MASS INDICATOR||||YD|||KALLIKREIN INHIBITOR UNIT|NOT DONE||U|N|U|3||39||WASHOUT|1971-01-09||1972-05-11|||1964-07-11||1973-08-15
TRIAL STUDY 134XCP|RP|219A70B2-48A6-407C-B901-9847583DB5F4|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||PHERESIS UNIT|||/7.5 ML|NOT DONE||N|Y|N|3||39||INDUCTION TREATMENT|1971-01-09||1971-11-30|||1962-10-04||1971-08-21
TRIAL STUDY 134XCP|RP|219A70B2-48A6-407C-B901-9847583DB5F4|1||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||C|||CM/MIN|NOT DONE||U|U|U|4||88||CONTINUATION TREATMENT|1965-06-15||1970-11-05|||1963-11-08||1962-04-20
TRIAL STUDY 134XCP|RP|219A70B2-48A6-407C-B901-9847583DB5F4|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||FRACTION OF 1|||AMP|NOT DONE||U|Y|N|4||88||FOLLOW-UP|1960-06-18||1965-01-10|||1969-05-08||1967-06-29
TRIAL STUDY 134XCP|RP|219A70B2-48A6-407C-B901-9847583DB5F4|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||NG/DAY|||UKAT/L|NOT DONE||Y|Y|N|5||7||BLINDED TREATMENT|1973-04-20||1972-08-19|||1971-01-18||1965-08-22
TRIAL STUDY 134XCP|RP|219A70B2-48A6-407C-B901-9847583DB5F4|2||||||GRAVIND|GRAVIDA INDICATOR||||ANTI-XA IU|||UU/DL|NOT DONE||Y|NA|NA|5||7||INDUCTION TREATMENT|1961-05-24||1961-09-20|||1970-03-07||1968-09-01
TRIAL STUDY 134XCP|RP|CF3AC42D-DFBA-448E-A688-46A87D6264EB|1||||||DLVRMODE|MODE OF DELIVERY||||VIAL|||MOL|NOT DONE||Y|Y|N|1||38||LONG-TERM FOLLOW-UP|1962-07-18||1972-04-03|||1965-06-10||1965-01-01
TRIAL STUDY 134XCP|RP|CF3AC42D-DFBA-448E-A688-46A87D6264EB|2||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||NMOL/KG/DAY|||KBQ/UL|NOT DONE||NA|Y|N|1||38||WASHOUT|1963-07-31||1972-01-23|||1971-08-16||1968-11-01
TRIAL STUDY 134XCP|RP|CF3AC42D-DFBA-448E-A688-46A87D6264EB|1||||||MENFDUR|MENSES FLOW DURATION||||MKAT|||TBSP|NOT DONE||Y|N|Y|2||58||FOLLOW-UP|1963-02-07||1973-07-30|||1961-11-25||1968-12-26
TRIAL STUDY 134XCP|RP|CF3AC42D-DFBA-448E-A688-46A87D6264EB|2||||||BRTHSTN|NUMBER OF STILLBIRTHS||||10^10/L|||M/SEC2|NOT DONE||N|U|Y|2||58||WASHOUT|1966-08-11||1960-06-07|||1972-02-03||1971-12-01
TRIAL STUDY 134XCP|RP|CF3AC42D-DFBA-448E-A688-46A87D6264EB|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||NG/DAY|||ML*CMH2O|NOT DONE||U|U|NA|3||39||INDUCTION TREATMENT|1969-07-29||1966-03-25|||1969-03-27||1967-10-23
TRIAL STUDY 134XCP|RP|CF3AC42D-DFBA-448E-A688-46A87D6264EB|2||||||THICK|THICKNESS||||UL|||UG/KG/H|NOT DONE||NA|U|N|3||39||OPEN LABEL TREATMENT|1966-06-10||1966-02-23|||1968-01-03||1965-03-07
TRIAL STUDY 134XCP|RP|CF3AC42D-DFBA-448E-A688-46A87D6264EB|1||||||INABOIND|INDUCED ABORTION INDICATOR||||G/M2|||MN|NOT DONE||NA|Y|Y|4||88||WASHOUT|1961-01-20||1966-11-24|||1965-08-08||1970-06-27
TRIAL STUDY 134XCP|RP|CF3AC42D-DFBA-448E-A688-46A87D6264EB|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||GBQ/G|||KN/CM2|NOT DONE||Y|U|N|4||88||BASELINE|1962-10-22||1968-01-26|||1963-07-02||1963-10-02
TRIAL STUDY 134XCP|RP|CF3AC42D-DFBA-448E-A688-46A87D6264EB|1||||||MENOAGE|MENOPAUSE AGE||||APS U|||CYLINDER|NOT DONE||U|NA|U|5||7||SCREENING|1960-09-15||1967-09-02|||1961-06-25||1972-02-16
TRIAL STUDY 134XCP|RP|CF3AC42D-DFBA-448E-A688-46A87D6264EB|2||||||GRAVIND|GRAVIDA INDICATOR||||ML/ANIMAL|||CAL|NOT DONE||Y|Y|U|5||7||INDUCTION TREATMENT|1962-10-17||1964-07-11|||1965-01-05||1965-02-09
TRIAL STUDY 134XCP|RP|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|1||||||INTP|INTERPRETATION||||IU/L|||UG/CM2|NOT DONE||U|Y|U|1||38||SCREENING|1960-01-26||1963-07-24|||1966-08-21||1960-08-29
TRIAL STUDY 134XCP|RP|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|2||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||/100 HPFS|||LOZENGE|NOT DONE||N|Y|U|1||38||TREATMENT|1964-02-14||1972-04-21|||1970-02-12||1970-12-10
TRIAL STUDY 134XCP|RP|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|1||||||RASHIND|RASH INDICATOR||||NG/L|||TSP|NOT DONE||N|Y|U|2||58||FOLLOW-UP|1973-08-09||1969-05-18|||1969-01-30||1969-11-03
TRIAL STUDY 134XCP|RP|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|2||||||RASHIND|RASH INDICATOR||||UKAT/L|||10^6 U|NOT DONE||NA|NA|U|2||58||BLINDED TREATMENT|1970-11-22||1963-01-06|||1960-11-11||1972-06-30
TRIAL STUDY 134XCP|RP|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||GBQ/G|||%/S|NOT DONE||U|N|Y|3||39||INDUCTION TREATMENT|1968-08-23||1963-03-03|||1960-07-10||1963-01-14
TRIAL STUDY 134XCP|RP|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||KCAL|||ML/MMHG/MIN/L|NOT DONE||N|U|U|3||39||SCREENING|1965-08-03||1971-05-05|||1961-07-15||1964-08-18
TRIAL STUDY 134XCP|RP|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|1||||||MENOAGE|MENOPAUSE AGE||||NGEQ/L|||10^6 IU/ML|NOT DONE||N|U|NA|4||88||TREATMENT|1966-03-28||1973-07-20|||1972-08-04||1973-03-23
TRIAL STUDY 134XCP|RP|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|2||||||BRTHN|NUMBER OF BIRTHS||||MOL/DAY|||10^6 IU/ML|NOT DONE||Y|N|U|4||88||OBSERVATION|1971-01-05||1967-03-19|||1960-02-13||1963-07-26
TRIAL STUDY 134XCP|RP|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||U/M2|||BQ/ML|NOT DONE||U|Y|U|5||7||OBSERVATION|1965-04-09||1967-09-04|||1971-09-04||1969-03-08
TRIAL STUDY 134XCP|RP|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||UG|||MEQ/DAY|NOT DONE||N|N|NA|5||7||WASHOUT|1963-03-13||1960-03-21|||1962-12-13||1970-04-28
TRIAL STUDY 134XCP|RP|D19D43A5-DFE6-415D-86B7-6A767A357BC9|1||||||MENOAGE|MENOPAUSE AGE||||DYN|||VG/DOSE|NOT DONE||Y|N|N|1||38||OPEN LABEL TREATMENT|1961-05-18||1960-07-13|||1965-10-03||1968-07-15
TRIAL STUDY 134XCP|RP|D19D43A5-DFE6-415D-86B7-6A767A357BC9|2||||||MENARAGE|MENARCHE AGE||||AMFI|||LOG10 TCID 50/ML|NOT DONE||U|N|N|1||38||OBSERVATION|1966-07-04||1963-06-27|||1968-11-14||1963-08-08
TRIAL STUDY 134XCP|RP|D19D43A5-DFE6-415D-86B7-6A767A357BC9|1||||||MSCRGIND|MISCARRIAGE INDICATOR||||P|||ML/(MIN*100ML)|NOT DONE||N|Y|N|2||58||OPEN LABEL TREATMENT|1972-02-12||1971-05-18|||1971-04-26||1963-11-29
TRIAL STUDY 134XCP|RP|D19D43A5-DFE6-415D-86B7-6A767A357BC9|2||||||MENFRD|MENSES FLOW RATE DESCRIPTION||||KG/L|||10^4/HPF|NOT DONE||Y|N|N|2||58||LONG-TERM FOLLOW-UP|1967-10-08||1969-02-19|||1971-05-25||1960-03-01
TRIAL STUDY 134XCP|RP|D19D43A5-DFE6-415D-86B7-6A767A357BC9|1||||||ECCHYIND|ECCHYMOSIS INDICATOR||||MNFI|||NU/CL|NOT DONE||NA|N|N|3||39||SCREENING|1961-05-01||1964-08-05|||1960-12-02||1972-04-17
TRIAL STUDY 134XCP|RP|D19D43A5-DFE6-415D-86B7-6A767A357BC9|2||||||DLVRMODE|MODE OF DELIVERY||||MANSON U/ML|||/5X10^4 WBC|NOT DONE||U|N|NA|3||39||FOLLOW-UP|1964-09-05||1961-07-13|||1963-10-31||1970-06-02
TRIAL STUDY 134XCP|RP|D19D43A5-DFE6-415D-86B7-6A767A357BC9|1||||||DSCHGIND|DISCHARGE INDICATOR||||BOLUS|||TBSP|NOT DONE||N|N|N|4||88||OBSERVATION|1962-02-18||1966-08-09|||1969-07-19||1960-03-04
TRIAL STUDY 134XCP|RP|D19D43A5-DFE6-415D-86B7-6A767A357BC9|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||IN|||G/CAGE|NOT DONE||Y|Y|Y|4||88||SCREENING|1962-01-29||1966-04-03|||1961-03-29||1961-06-16
TRIAL STUDY 134XCP|RP|D19D43A5-DFE6-415D-86B7-6A767A357BC9|1||||||DSCHGIND|DISCHARGE INDICATOR||||MOL/G|||IU/KG/H|NOT DONE||N|Y|NA|5||7||SCREENING|1966-05-09||1969-09-27|||1961-02-11||1961-07-25
TRIAL STUDY 134XCP|RP|D19D43A5-DFE6-415D-86B7-6A767A357BC9|2||||||DSCHGIND|DISCHARGE INDICATOR||||V/SEC|||ML/MIN/1.73M2|NOT DONE||NA|N|Y|5||7||OBSERVATION|1966-05-06||1961-08-24|||1967-04-22||1963-07-15
TRIAL STUDY 134XCP|RP|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|1||||||BLISTIND|BLISTERING INDICATOR||||MMOL2/L2|||NGEQ/L|NOT DONE||U|U|Y|1||38||BLINDED TREATMENT|1969-10-19||1972-11-24|||1972-02-28||1966-04-27
TRIAL STUDY 134XCP|RP|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|2||||||MENSDUR|MENSTRUAL CYCLE DURATION||||MMOL/MIN/KPA|||GPS U|NOT DONE||N|Y|U|1||38||BASELINE|1961-06-18||1968-09-28|||1963-02-26||1973-03-11
TRIAL STUDY 134XCP|RP|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|1||||||PUSTIND|PUSTULE INDICATOR||||LINEAR FT*LB|||GPS U|NOT DONE||NA|N|Y|2||58||SCREENING|1962-11-14||1969-05-03|||1962-06-26||1960-01-13
TRIAL STUDY 134XCP|RP|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UG/G/DAY|||MDFI|NOT DONE||N|Y|NA|2||58||INDUCTION TREATMENT|1963-11-10||1960-11-11|||1968-02-16||1963-03-02
TRIAL STUDY 134XCP|RP|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ML/CAGE|||LB|NOT DONE||NA|Y|NA|3||39||OPEN LABEL TREATMENT|1966-04-01||1963-03-02|||1968-12-22||1963-05-06
TRIAL STUDY 134XCP|RP|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|2||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||U/KG/MIN|||NKAT/L|NOT DONE||N|Y|U|3||39||INDUCTION TREATMENT|1960-02-22||1969-12-23|||1961-11-13||1966-01-01
TRIAL STUDY 134XCP|RP|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|1||||||INABOIND|INDUCED ABORTION INDICATOR||||UV*SEC|||UG/L FEU|NOT DONE||NA|NA|NA|4||88||RUN-IN|1968-09-22||1964-07-10|||1972-01-20||1972-07-02
TRIAL STUDY 134XCP|RP|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|2||||||PEELIND|PEELING INDICATOR||||MHZ|||MOL/G|NOT DONE||NA|NA|NA|4||88||WASHOUT|1970-07-12||1973-01-10|||1971-12-21||1967-04-26
TRIAL STUDY 134XCP|RP|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|1||||||ERYTHIND|ERYTHEMA INDICATOR||||IU/KG/H|||U/CL|NOT DONE||U|N|N|5||7||FOLLOW-UP|1960-09-18||1973-06-19|||1969-06-02||1968-08-02
TRIAL STUDY 134XCP|RP|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|2||||||MASSIND|MASS INDICATOR||||CAPFUL|||ABSORBANCE U/MIN|NOT DONE||NA|Y|NA|5||7||OBSERVATION|1972-02-29||1963-01-10|||1962-06-19||1965-10-26
TRIAL STUDY 134XCP|RP|7D307F63-4A25-4E7D-9980-16764AE5C4A4|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||UM|||10^6 ORGANISMS|NOT DONE||Y|U|N|1||38||LONG-TERM FOLLOW-UP|1967-10-05||1972-08-25|||1966-07-14||1970-07-29
TRIAL STUDY 134XCP|RP|7D307F63-4A25-4E7D-9980-16764AE5C4A4|2||||||PRGENDTC|DATE PREGNANCY ENDED||||CCID 50/ML|||DPM/MG|NOT DONE||Y|U|NA|1||38||TREATMENT|1970-02-05||1961-05-14|||1971-12-27||1971-11-29
TRIAL STUDY 134XCP|RP|7D307F63-4A25-4E7D-9980-16764AE5C4A4|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||CI/KG|||VIAL|NOT DONE||Y|NA|Y|2||58||FOLLOW-UP|1967-08-20||1972-09-13|||1965-11-12||1961-11-05
TRIAL STUDY 134XCP|RP|7D307F63-4A25-4E7D-9980-16764AE5C4A4|2||||||ECTPREGN|NUMBER OF ECTOPIC PREGNANCIES||||G/ANIMAL/WK|||BOTTLE|NOT DONE||Y|U|N|2||58||CONTINUATION TREATMENT|1962-01-14||1964-12-27|||1965-06-17||1971-11-04
TRIAL STUDY 134XCP|RP|7D307F63-4A25-4E7D-9980-16764AE5C4A4|1||||||INTP|INTERPRETATION||||MG/DAY|||UMOL/L/H|NOT DONE||N|N|NA|3||39||RUN-IN|1967-12-13||1968-05-05|||1971-01-02||1969-09-17
TRIAL STUDY 134XCP|RP|7D307F63-4A25-4E7D-9980-16764AE5C4A4|2||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||APS U|||S/H|NOT DONE||N|N|NA|3||39||RUN-IN|1966-10-08||1960-09-11|||1960-11-06||1968-02-11
TRIAL STUDY 134XCP|RP|7D307F63-4A25-4E7D-9980-16764AE5C4A4|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||TUBE|||%|NOT DONE||U|NA|Y|4||88||WASHOUT|1971-12-28||1970-05-19|||1968-11-08||1960-06-10
TRIAL STUDY 134XCP|RP|7D307F63-4A25-4E7D-9980-16764AE5C4A4|2||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||L/MIN/M2|||M2|NOT DONE||Y|NA|U|4||88||RUN-IN|1961-04-25||1965-09-15|||1965-11-28||1969-01-03
TRIAL STUDY 134XCP|RP|7D307F63-4A25-4E7D-9980-16764AE5C4A4|1||||||GRAVIND|GRAVIDA INDICATOR||||MCI/KG|||MBQ/UL|NOT DONE||N|U|U|5||7||TREATMENT|1966-04-23||1965-02-27|||1967-12-04||1960-01-09
TRIAL STUDY 134XCP|RP|7D307F63-4A25-4E7D-9980-16764AE5C4A4|2||||||INABOIND|INDUCED ABORTION INDICATOR||||APS U|||LOG10 CFU/ML|NOT DONE||U|U|N|5||7||TREATMENT|1962-06-15||1960-09-03|||1966-11-14||1967-11-28
TRIAL STUDY 134XCP|RP|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|1||||||ERYTHIND|ERYTHEMA INDICATOR||||CD/M2|||UG/L DDU|NOT DONE||Y|Y|Y|1||38||FOLLOW-UP|1971-07-21||1969-08-20|||1967-07-18||1965-06-21
TRIAL STUDY 134XCP|RP|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||UMOL/MIN|||FMOL/G|NOT DONE||NA|Y|Y|1||38||LONG-TERM FOLLOW-UP|1960-02-19||1966-08-06|||1971-10-17||1961-06-21
TRIAL STUDY 134XCP|RP|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|1||||||ULCERIND|ULCER INDICATOR||||MILE|||GTT|NOT DONE||NA|NA|NA|2||58||OPEN LABEL TREATMENT|1973-06-10||1963-07-17|||1962-11-29||1962-02-22
TRIAL STUDY 134XCP|RP|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||MPS U|||DEG/S|NOT DONE||U|U|U|2||58||TREATMENT|1964-11-14||1965-07-02|||1971-10-24||1965-03-19
TRIAL STUDY 134XCP|RP|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||APL U/ML|||GY/MIN|NOT DONE||Y|Y|Y|3||39||TREATMENT|1961-07-27||1961-09-22|||1965-04-27||1970-02-14
TRIAL STUDY 134XCP|RP|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|2||||||FUNDHT|FUNDAL HEIGHT||||MHZ|||ATM|NOT DONE||Y|Y|N|3||39||TREATMENT|1960-05-01||1969-01-31|||1967-12-21||1972-05-02
TRIAL STUDY 134XCP|RP|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|1||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||UOSM|||MET*MIN|NOT DONE||NA|NA|NA|4||88||BASELINE|1969-12-09||1967-07-28|||1962-07-17||1968-04-19
TRIAL STUDY 134XCP|RP|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||TAMPON|||DEG2|NOT DONE||U|Y|N|4||88||INDUCTION TREATMENT|1971-05-08||1972-09-11|||1961-11-11||1971-05-26
TRIAL STUDY 134XCP|RP|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||CARTRIDGE|||V|NOT DONE||Y|NA|U|5||7||FOLLOW-UP|1967-07-29||1962-04-22|||1966-04-05||1973-06-29
TRIAL STUDY 134XCP|RP|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||PG/L|||MG/DOSE|NOT DONE||Y|U|NA|5||7||TREATMENT|1961-04-11||1963-08-24|||1971-11-08||1961-07-16
TRIAL STUDY 134XCP|RP|F4718E0D-4DD9-442E-8907-076551C83AEE|1||||||INTP|INTERPRETATION||||10^6 ORGANISMS/G|||KBQ|NOT DONE||NA|U|U|1||38||BLINDED TREATMENT|1964-12-30||1961-10-21|||1960-01-08||1971-08-15
TRIAL STUDY 134XCP|RP|F4718E0D-4DD9-442E-8907-076551C83AEE|2||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||ELISA UNIT/ML|||MMHG/L/MIN|NOT DONE||N|Y|N|1||38||CONTINUATION TREATMENT|1964-09-02||1964-03-25|||1961-08-04||1962-05-23
TRIAL STUDY 134XCP|RP|F4718E0D-4DD9-442E-8907-076551C83AEE|1||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||IU/MMOL|||AMU|NOT DONE||Y|Y|N|2||58||OPEN LABEL TREATMENT|1972-01-01||1962-05-20|||1966-08-05||1965-10-17
TRIAL STUDY 134XCP|RP|F4718E0D-4DD9-442E-8907-076551C83AEE|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||DIP|||ML/M2/H|NOT DONE||Y|NA|NA|2||58||RUN-IN|1966-07-22||1972-03-24|||1960-04-27||1963-12-05
TRIAL STUDY 134XCP|RP|F4718E0D-4DD9-442E-8907-076551C83AEE|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||KA_U/DL|||10^9/DOSE|NOT DONE||Y|Y|Y|3||39||LONG-TERM FOLLOW-UP|1961-02-15||1969-02-08|||1960-05-17||1963-10-04
TRIAL STUDY 134XCP|RP|F4718E0D-4DD9-442E-8907-076551C83AEE|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||VOXEL|||UMOL/L/SEC|NOT DONE||N|Y|N|3||39||INDUCTION TREATMENT|1973-08-13||1963-06-18|||1969-06-18||1960-07-08
TRIAL STUDY 134XCP|RP|F4718E0D-4DD9-442E-8907-076551C83AEE|1||||||TRMPGCAT|TERM PREGNANCY CATEGORY||||MKAT|||VP/ML|NOT DONE||N|U|N|4||88||SCREENING|1964-06-13||1972-03-09|||1970-04-24||1960-05-26
TRIAL STUDY 134XCP|RP|F4718E0D-4DD9-442E-8907-076551C83AEE|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||U/ANIMAL|||MU|NOT DONE||N|Y|N|4||88||BLINDED TREATMENT|1961-02-15||1967-10-18|||1968-01-25||1971-10-04
TRIAL STUDY 134XCP|RP|F4718E0D-4DD9-442E-8907-076551C83AEE|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||G/DAY|||UG/KG/MIN|NOT DONE||N|NA|NA|5||7||BASELINE|1972-01-19||1970-09-03|||1961-08-13||1960-10-27
TRIAL STUDY 134XCP|RP|F4718E0D-4DD9-442E-8907-076551C83AEE|2||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||10^6 IU|||K|NOT DONE||U|U|U|5||7||CONTINUATION TREATMENT|1970-08-02||1962-02-19|||1969-01-05||1967-05-05
TRIAL STUDY 134XCP|RP|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|1||||||BLISTIND|BLISTERING INDICATOR||||LOG10 IU/ML|||ML/CAGE|NOT DONE||NA|N|N|1||38||CONTINUATION TREATMENT|1966-10-06||1960-06-30|||1966-08-25||1969-12-29
TRIAL STUDY 134XCP|RP|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|2||||||MENARAGE|MENARCHE AGE||||CM2|||ML/M2/H|NOT DONE||Y|U|N|1||38||BASELINE|1965-12-05||1966-11-22|||1962-02-12||1966-10-11
TRIAL STUDY 134XCP|RP|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|1||||||MENOAGE|MENOPAUSE AGE||||CI/G|||L/H/M2|NOT DONE||NA|NA|U|2||58||SCREENING|1967-03-31||1965-01-02|||1960-04-15||1968-10-27
TRIAL STUDY 134XCP|RP|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||MU/G|||OZ|NOT DONE||NA|N|NA|2||58||OPEN LABEL TREATMENT|1967-05-01||1962-08-14|||1964-07-01||1968-07-29
TRIAL STUDY 134XCP|RP|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||HZ|||BOX|NOT DONE||N|Y|NA|3||39||OPEN LABEL TREATMENT|1972-11-06||1968-03-14|||1964-10-04||1969-09-22
TRIAL STUDY 134XCP|RP|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||KCAL|||DRINK|NOT DONE||Y|Y|NA|3||39||WASHOUT|1963-03-28||1968-04-11|||1962-12-15||1971-08-15
TRIAL STUDY 134XCP|RP|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||VG/DOSE|||NU/CL|NOT DONE||U|Y|U|4||88||CONTINUATION TREATMENT|1961-04-03||1971-02-20|||1968-02-17||1967-12-02
TRIAL STUDY 134XCP|RP|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|2||||||STILBIND|STILLBIRTH INDICATOR||||MG/M2|||PHERESIS UNIT|NOT DONE||N|U|Y|4||88||BLINDED TREATMENT|1962-11-09||1971-05-06|||1966-12-14||1965-06-12
TRIAL STUDY 134XCP|RP|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||10^8 PFU|||QUANTITY SUFFICIENT|NOT DONE||NA|N|N|5||7||LONG-TERM FOLLOW-UP|1962-09-29||1973-04-17|||1967-12-14||1960-03-05
TRIAL STUDY 134XCP|RP|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||BEL|||ML/CM H2O|NOT DONE||NA|N|Y|5||7||TREATMENT|1972-10-23||1965-10-01|||1972-12-02||1968-05-18
TRIAL STUDY 134XCP|RP|E86F996D-3A96-4C36-82B2-1AC4B4906F49|1||||||MENARAGE|MENARCHE AGE||||MOL|||/LPF|NOT DONE||NA|U|NA|1||38||OBSERVATION|1971-11-01||1960-12-03|||1967-11-06||1966-02-26
TRIAL STUDY 134XCP|RP|E86F996D-3A96-4C36-82B2-1AC4B4906F49|2||||||CHILDPOT|CHILDBEARING POTENTIAL||||10^6 COPIES/ML|||FOZ_BR|NOT DONE||N|NA|Y|1||38||SCREENING|1967-11-11||1969-04-05|||1966-12-15||1963-10-22
TRIAL STUDY 134XCP|RP|E86F996D-3A96-4C36-82B2-1AC4B4906F49|1||||||DLVRMODE|MODE OF DELIVERY||||HPA|||BOTTLE|NOT DONE||U|U|NA|2||58||INDUCTION TREATMENT|1967-11-14||1967-07-20|||1971-11-30||1963-10-22
TRIAL STUDY 134XCP|RP|E86F996D-3A96-4C36-82B2-1AC4B4906F49|2||||||PUSTIND|PUSTULE INDICATOR||||MG/MIN|||BOTTLE|NOT DONE||NA|N|U|2||58||SCREENING|1972-01-11||1960-12-07|||1961-05-21||1968-08-19
TRIAL STUDY 134XCP|RP|E86F996D-3A96-4C36-82B2-1AC4B4906F49|1||||||PREGIND|PREGNANT INDICATOR||||CIGAR|||CMH2O/ML|NOT DONE||U|N|N|3||39||INDUCTION TREATMENT|1963-07-22||1971-07-19|||1960-11-23||1965-01-02
TRIAL STUDY 134XCP|RP|E86F996D-3A96-4C36-82B2-1AC4B4906F49|2||||||PREGST|PREGNANT DURING THE STUDY||||UV2|||IU|NOT DONE||N|NA|NA|3||39||TREATMENT|1964-08-17||1963-02-16|||1970-03-14||1969-05-14
TRIAL STUDY 134XCP|RP|E86F996D-3A96-4C36-82B2-1AC4B4906F49|1||||||MENOSTAT|MENOPAUSE STATUS||||KDA|||PFU/DOSE|NOT DONE||Y|U|NA|4||88||BASELINE|1970-03-17||1966-06-05|||1969-04-10||1973-05-16
TRIAL STUDY 134XCP|RP|E86F996D-3A96-4C36-82B2-1AC4B4906F49|2||||||INABOIND|INDUCED ABORTION INDICATOR||||PSI|||UMOL/L|NOT DONE||U|U|NA|4||88||OBSERVATION|1971-07-15||1970-10-14|||1965-08-25||1961-09-26
TRIAL STUDY 134XCP|RP|E86F996D-3A96-4C36-82B2-1AC4B4906F49|1||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||FIU|||BQ/UL|NOT DONE||NA|U|NA|5||7||FOLLOW-UP|1971-07-18||1971-10-14|||1966-11-29||1962-08-14
TRIAL STUDY 134XCP|RP|E86F996D-3A96-4C36-82B2-1AC4B4906F49|2||||||BCMETHOD|BIRTH CONTROL METHOD||||UV|||10^9/DOSE|NOT DONE||N|N|NA|5||7||BASELINE|1967-11-21||1972-11-26|||1969-12-06||1963-10-23
TRIAL STUDY 134XCP|RP|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|1||||||FUNDHT|FUNDAL HEIGHT||||U/KG/MIN|||DAYS/WK|NOT DONE||U|N|N|1||38||CONTINUATION TREATMENT|1966-05-27||1965-05-23|||1965-03-20||1968-07-26
TRIAL STUDY 134XCP|RP|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|2||||||EDLVRDTC|ESTIMATED DATE OF DELIVERY||||ENZYME U|||ML/G/H|NOT DONE||Y|U|N|1||38||WASHOUT|1968-07-03||1965-09-03|||1971-01-05||1961-09-23
TRIAL STUDY 134XCP|RP|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|1||||||BRTHPRN|NUMBER OF PREMATURE LIVE BIRTHS||||MIN*MG/ML|||FT2|NOT DONE||U|U|U|2||58||INDUCTION TREATMENT|1964-05-19||1964-07-04|||1971-10-18||1964-01-12
TRIAL STUDY 134XCP|RP|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|2||||||FULLTRMN|NUMBER OF FULL TERM BIRTHS||||PFU/ANIMAL|||/HPF|NOT DONE||N|U|Y|2||58||OBSERVATION|1968-08-18||1966-04-17|||1962-10-17||1972-11-03
TRIAL STUDY 134XCP|RP|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|1||||||LMPSTDTC|LAST MENSTRUAL PERIOD START DATE||||ML/SEC/1.73M2|||DDU|NOT DONE||U|N|Y|3||39||SCREENING|1963-01-20||1969-10-29|||1971-07-14||1962-02-07
TRIAL STUDY 134XCP|RP|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||ML/MMHG|||FT2|NOT DONE||Y|U|U|3||39||SCREENING|1967-06-23||1960-07-25|||1972-06-04||1970-12-26
TRIAL STUDY 134XCP|RP|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|1||||||PREGST|PREGNANT DURING THE STUDY||||CI/UG|||OSM|NOT DONE||NA|U|U|4||88||FOLLOW-UP|1970-02-06||1971-03-16|||1960-07-28||1965-11-01
TRIAL STUDY 134XCP|RP|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|2||||||MENFDUR|MENSES FLOW DURATION||||%(W/W)|||MV*MIN|NOT DONE||U|NA|N|4||88||CONTINUATION TREATMENT|1962-11-07||1971-06-11|||1966-04-24||1965-01-30
TRIAL STUDY 134XCP|RP|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||ANTI-XA IU/ML|||PACKET|NOT DONE||U|NA|Y|5||7||TREATMENT|1968-06-16||1969-02-23|||1973-01-05||1960-01-31
TRIAL STUDY 134XCP|RP|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||FMOL/L|||UG/H|NOT DONE||NA|NA|Y|5||7||RUN-IN|1967-03-27||1969-04-13|||1966-10-31||1962-09-02
TRIAL STUDY 134XCP|RP|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|1||||||DLVRMODE|MODE OF DELIVERY||||M|||MG/DL|NOT DONE||Y|NA|Y|1||38||SCREENING|1972-04-10||1971-12-09|||1970-06-14||1972-05-04
TRIAL STUDY 134XCP|RP|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||L/H/M2|||DROP|NOT DONE||N|N|NA|1||38||OPEN LABEL TREATMENT|1970-12-14||1967-04-02|||1962-04-18||1971-02-22
TRIAL STUDY 134XCP|RP|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|1||||||MENOSTAT|MENOPAUSE STATUS||||10^5/L|||LOG10 TCID 50/DOSE|NOT DONE||NA|NA|N|2||58||WASHOUT|1972-03-29||1971-06-02|||1966-02-25||1972-08-28
TRIAL STUDY 134XCP|RP|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||LOG10 ELISA UNIT|||UMOL/DL|NOT DONE||Y|U|Y|2||58||WASHOUT|1966-05-02||1963-12-15|||1960-04-03||1964-06-07
TRIAL STUDY 134XCP|RP|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|1||||||MENREG|MENSTRUAL CYCLE REGULARITY||||SHOCK WAVE|||EP U|NOT DONE||N|Y|N|3||39||INDUCTION TREATMENT|1967-04-20||1964-05-22|||1967-02-28||1961-12-27
TRIAL STUDY 134XCP|RP|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|2||||||MTENDIND|MOTION TENDERNESS INDICATOR||||UMOL/L|||SBE/ML|NOT DONE||Y|U|U|3||39||WASHOUT|1970-12-31||1970-03-22|||1962-04-27||1962-02-28
TRIAL STUDY 134XCP|RP|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||ARBITRARY U|||BREATHS/30S|NOT DONE||NA|NA|N|4||88||RUN-IN|1963-08-05||1972-08-10|||1965-07-12||1969-04-14
TRIAL STUDY 134XCP|RP|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|2||||||HSPGCIND|HOSP DUE TO PREGNANCY COMPLICATION IND||||G/L|||WEEKS|NOT DONE||N|NA|U|4||88||CONTINUATION TREATMENT|1962-09-11||1965-02-19|||1963-12-08||1964-08-19
TRIAL STUDY 134XCP|RP|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|1||||||BCMETHOD|BIRTH CONTROL METHOD||||DRINK|||PL|NOT DONE||Y|Y|N|5||7||BASELINE|1972-01-22||1963-10-09|||1967-06-11||1970-06-05
TRIAL STUDY 134XCP|RP|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|2||||||EDEMAIND|EDEMA INDICATOR||||PG/CELL|||TORR|NOT DONE||NA|Y|NA|5||7||OBSERVATION|1961-07-23||1962-11-28|||1963-04-03||1970-11-27
TRIAL STUDY 134XCP|RP|28E9B15E-4757-42F5-8AE7-2C868904F88B|1||||||PUSTIND|PUSTULE INDICATOR||||KCAL/DAY|||KG/MOL|NOT DONE||NA|N|NA|1||38||INDUCTION TREATMENT|1961-04-24||1969-03-28|||1960-10-08||1964-07-30
TRIAL STUDY 134XCP|RP|28E9B15E-4757-42F5-8AE7-2C868904F88B|2||||||PREGIND|PREGNANT INDICATOR||||MEQ/DAY|||PIXELS/CM|NOT DONE||NA|U|Y|1||38||OPEN LABEL TREATMENT|1964-06-26||1960-06-26|||1960-01-12||1967-04-28
TRIAL STUDY 134XCP|RP|28E9B15E-4757-42F5-8AE7-2C868904F88B|1||||||BRTHSTN|NUMBER OF STILLBIRTHS||||ML/G/MIN|||G/M2/DAY|NOT DONE||N|U|Y|2||58||SCREENING|1968-06-23||1969-11-17|||1972-11-28||1967-07-04
TRIAL STUDY 134XCP|RP|28E9B15E-4757-42F5-8AE7-2C868904F88B|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||UMOL/L/SEC|||MMOL/KG|NOT DONE||U|NA|N|2||58||CONTINUATION TREATMENT|1968-11-12||1966-07-02|||1971-10-11||1966-09-23
TRIAL STUDY 134XCP|RP|28E9B15E-4757-42F5-8AE7-2C868904F88B|1||||||CHILDPOT|CHILDBEARING POTENTIAL||||UMOL/L/H|||10^9/G|NOT DONE||N|U|Y|3||39||OPEN LABEL TREATMENT|1964-10-07||1969-12-17|||1962-04-22||1961-08-02
TRIAL STUDY 134XCP|RP|28E9B15E-4757-42F5-8AE7-2C868904F88B|2||||||BRTLVIND|LIVE BIRTH INDICATOR||||TCID 50/DOSE|||ABSORBANCE U/ML|NOT DONE||Y|Y|N|3||39||OPEN LABEL TREATMENT|1964-08-22||1962-06-26|||1972-02-25||1965-09-04
TRIAL STUDY 134XCP|RP|28E9B15E-4757-42F5-8AE7-2C868904F88B|1||||||PREGNN|NUMBER OF PREGNANCIES||||UG/MOL|||10^6 IU|NOT DONE||Y|Y|NA|4||88||SCREENING|1972-05-24||1965-11-05|||1967-04-08||1965-08-09
TRIAL STUDY 134XCP|RP|28E9B15E-4757-42F5-8AE7-2C868904F88B|2||||||ABORTN|NUMBER OF ABORTIONS||||KG/M2|||IU/ML|NOT DONE||N|Y|U|4||88||WASHOUT|1971-10-21||1961-04-03|||1971-11-09||1972-11-01
TRIAL STUDY 134XCP|RP|28E9B15E-4757-42F5-8AE7-2C868904F88B|1||||||BRTLVIND|LIVE BIRTH INDICATOR||||MNFI|||10^6/G|NOT DONE||NA|U|NA|5||7||CONTINUATION TREATMENT|1969-09-07||1969-09-24|||1960-04-11||1968-07-11
TRIAL STUDY 134XCP|RP|28E9B15E-4757-42F5-8AE7-2C868904F88B|2||||||EDEMAIND|EDEMA INDICATOR||||G/G/DAY|||NG/DAY|NOT DONE||NA|NA|N|5||7||CONTINUATION TREATMENT|1972-10-16||1967-09-19|||1968-04-19||1961-05-13
TRIAL STUDY 134XCP|RP|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||BQ/L|||10^4 CFU|NOT DONE||U|NA|N|1||38||WASHOUT|1968-12-05||1970-05-03|||1961-07-03||1967-03-01
TRIAL STUDY 134XCP|RP|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|2||||||RASHIND|RASH INDICATOR||||NG/MOL|||FG|NOT DONE||U|U|U|1||38||BLINDED TREATMENT|1971-10-05||1967-01-22|||1972-05-09||1970-12-19
TRIAL STUDY 134XCP|RP|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|1||||||PEELIND|PEELING INDICATOR||||10^7/L|||TROCHE|NOT DONE||Y|N|NA|2||58||OBSERVATION|1972-11-29||1967-02-26|||1960-01-09||1960-06-26
TRIAL STUDY 134XCP|RP|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|2||||||BCMETHOD|BIRTH CONTROL METHOD||||MPH|||10^9/G|NOT DONE||N|N|NA|2||58||OPEN LABEL TREATMENT|1966-05-24||1963-07-09|||1961-06-21||1966-07-11
TRIAL STUDY 134XCP|RP|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|1||||||ERLYTRMN|NUMBER OF EARLY TERM BIRTHS||||UMOL/DL|||FARAD|NOT DONE||N|N|NA|3||39||LONG-TERM FOLLOW-UP|1968-10-30||1966-10-19|||1972-02-15||1968-12-25
TRIAL STUDY 134XCP|RP|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|2||||||MSCRGIND|MISCARRIAGE INDICATOR||||KUSP|||CAPFUL|NOT DONE||NA|Y|N|3||39||CONTINUATION TREATMENT|1967-04-23||1968-03-18|||1967-06-25||1965-12-21
TRIAL STUDY 134XCP|RP|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|1||||||BTHGLIND|BARTHOLIN'S GLAND ABNORMALITY INDICATOR||||FT2|||GENEQ/ML|NOT DONE||N|U|NA|4||88||OPEN LABEL TREATMENT|1971-04-29||1964-12-05|||1973-07-23||1972-04-21
TRIAL STUDY 134XCP|RP|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|2||||||PRDCEIND|PRODUCTS OF CONCEPTION EXAMINED IND||||LOG10 PFU/ML|||GRAVITATIONAL UNIT|NOT DONE||U|U|U|4||88||WASHOUT|1964-03-19||1966-06-16|||1960-10-28||1968-04-21
TRIAL STUDY 134XCP|RP|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|1||||||PREGIND|PREGNANT INDICATOR||||UG/CM2|||10^4 CFU|NOT DONE||NA|U|N|5||7||BASELINE|1972-04-27||1964-05-09|||1963-01-02||1965-10-21
TRIAL STUDY 134XCP|RP|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|2||||||CABNIND|CONGENITAL ABNORMALITY INDICATOR||||10^9 ORGANISMS/MG|||VP/DOSE|NOT DONE||U|U|U|5||7||OPEN LABEL TREATMENT|1972-12-03||1969-07-18|||1961-10-22||1967-04-28
TRIAL STUDY 134XCP|RP|2E1011F1-A091-4E7E-B661-477A1F6DD39A|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||10^7 PFU|||LOG EID 50/DOSE|NOT DONE||U|Y|N|1||38||INDUCTION TREATMENT|1965-12-21||1967-12-16|||1968-02-17||1960-09-14
TRIAL STUDY 134XCP|RP|2E1011F1-A091-4E7E-B661-477A1F6DD39A|2||||||EDCDTC|ESTIMATED DATE OF CONCEPTION||||NM|||DYN|NOT DONE||N|NA|Y|1||38||INDUCTION TREATMENT|1968-09-01||1962-01-31|||1972-01-21||1962-04-09
TRIAL STUDY 134XCP|RP|2E1011F1-A091-4E7E-B661-477A1F6DD39A|1||||||PREMBTHN|NUMBER OF PREMATURE BIRTHS||||TCID 50/DOSE|||MMHG/SEC|NOT DONE||N|NA|U|2||58||OBSERVATION|1970-10-11||1960-04-07|||1962-06-09||1961-01-26
TRIAL STUDY 134XCP|RP|2E1011F1-A091-4E7E-B661-477A1F6DD39A|2||||||BCMETHOD|BIRTH CONTROL METHOD||||CM|||ML/M2/H|NOT DONE||NA|N|NA|2||58||RUN-IN|1965-07-12||1972-03-08|||1963-12-02||1966-03-04
TRIAL STUDY 134XCP|RP|2E1011F1-A091-4E7E-B661-477A1F6DD39A|1||||||PEELIND|PEELING INDICATOR||||10^6 CFU/G|||S*KPA|NOT DONE||NA|NA|N|3||39||SCREENING|1961-07-19||1973-04-05|||1969-08-22||1963-08-09
TRIAL STUDY 134XCP|RP|2E1011F1-A091-4E7E-B661-477A1F6DD39A|2||||||INABORTN|NUMBER OF INDUCED ABORTIONS||||DAYS/WK|||ML/ANIMAL/DAY|NOT DONE||N|U|U|3||39||OBSERVATION|1971-02-10||1963-02-12|||1970-06-07||1967-05-11
TRIAL STUDY 134XCP|RP|2E1011F1-A091-4E7E-B661-477A1F6DD39A|1||||||BLISTIND|BLISTERING INDICATOR||||TSP EQ|||CI|NOT DONE||U|U|U|4||88||TREATMENT|1961-06-09||1962-10-19|||1967-08-29||1971-12-24
TRIAL STUDY 134XCP|RP|2E1011F1-A091-4E7E-B661-477A1F6DD39A|2||||||PREGNN|NUMBER OF PREGNANCIES||||CM H2O|||MM/H|NOT DONE||N|NA|N|4||88||CONTINUATION TREATMENT|1970-06-30||1960-12-19|||1964-11-14||1973-02-25
TRIAL STUDY 134XCP|RP|2E1011F1-A091-4E7E-B661-477A1F6DD39A|1||||||TNDRIND|TENDERNESS INDICATOR||||CFU/ML|||KG/CM2|NOT DONE||Y|N|U|5||7||CONTINUATION TREATMENT|1971-09-02||1962-02-06|||1973-04-15||1966-02-14
TRIAL STUDY 134XCP|RP|2E1011F1-A091-4E7E-B661-477A1F6DD39A|2||||||MENREG|MENSTRUAL CYCLE REGULARITY||||/100 HPFS|||10^9 CFU|NOT DONE||Y|N|N|5||7||LONG-TERM FOLLOW-UP|1960-08-24||1969-08-31|||1971-07-02||1972-08-06
TRIAL STUDY 134XCP|RP|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||MEQ/KG|||UGEQ/L|NOT DONE||U|U|U|1||38||BLINDED TREATMENT|1962-06-19||1970-07-04|||1963-11-16||1963-09-08
TRIAL STUDY 134XCP|RP|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|2||||||PRGENDTC|DATE PREGNANCY ENDED||||CMOL|||UMOL/MG/MIN|NOT DONE||Y|N|NA|1||38||LONG-TERM FOLLOW-UP|1971-12-16||1969-05-06|||1971-12-23||1968-01-06
TRIAL STUDY 134XCP|RP|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MOL/MG|||CUP|NOT DONE||Y|N|Y|2||58||OBSERVATION|1971-07-24||1960-07-06|||1970-09-17||1972-02-18
TRIAL STUDY 134XCP|RP|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|2||||||THICK|THICKNESS||||DEG/MM|||M/SEC|NOT DONE||Y|NA|NA|2||58||TREATMENT|1973-05-15||1966-04-11|||1964-02-19||1969-10-01
TRIAL STUDY 134XCP|RP|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|1||||||ENMPSDTC|EST NEXT MENSTRUAL PERIOD START DATE||||U/M2|||KG/L|NOT DONE||Y|N|U|3||39||WASHOUT|1961-04-17||1971-05-30|||1961-08-31||1963-03-06
TRIAL STUDY 134XCP|RP|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|2||||||SPABORTN|NUMBER OF SPONTANEOUS ABORTIONS||||DPM/100MG|||JOULE|NOT DONE||U|Y|U|3||39||OPEN LABEL TREATMENT|1973-03-29||1963-04-07|||1968-03-03||1972-12-19
TRIAL STUDY 134XCP|RP|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|1||||||BRTHFTN|NUMBER FULL TERM LIVE BIRTHS||||IU/G|||NSEC|NOT DONE||Y|Y|Y|4||88||INDUCTION TREATMENT|1960-07-20||1961-10-12|||1961-02-14||1966-01-13
TRIAL STUDY 134XCP|RP|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|2||||||EGESTAGE|ESTIMATED GESTATIONAL AGE||||MV*MIN|||NEEDLE GAUGE|NOT DONE||NA|Y|U|4||88||TREATMENT|1965-03-21||1966-12-31|||1968-08-13||1962-09-20
TRIAL STUDY 134XCP|RP|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|1||||||MTENDIND|MOTION TENDERNESS INDICATOR||||TABLET|||DDU|NOT DONE||Y|NA|U|5||7||OPEN LABEL TREATMENT|1961-03-19||1965-05-16|||1960-10-27||1972-10-21
TRIAL STUDY 134XCP|RP|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|2||||||BLEEDIND|ABNORMAL BLEEDING INDICATOR||||UG/G/MIN|||/10^3|NOT DONE||Y|N|U|5||7||FOLLOW-UP|1963-12-29||1970-05-22|||1972-05-20||1969-12-22
TRIAL STUDY 134XCP|RP|176B6882-0C9E-435E-9842-FF8714BC9CAF|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MG2/DL2|||TRANSDUCING UNIT/ML|NOT DONE||U|N|NA|1||38||FOLLOW-UP|1969-08-11||1971-11-03|||1971-08-20||1973-08-01
TRIAL STUDY 134XCP|RP|176B6882-0C9E-435E-9842-FF8714BC9CAF|2||||||PREGST|PREGNANT DURING THE STUDY||||JAR|||KA_U/DL|NOT DONE||N|N|NA|1||38||TREATMENT|1961-09-18||1965-07-09|||1966-12-28||1970-09-02
TRIAL STUDY 134XCP|RP|176B6882-0C9E-435E-9842-FF8714BC9CAF|1||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||10^10/L|||MOSM/L|NOT DONE||N|U|N|2||58||OPEN LABEL TREATMENT|1973-08-25||1960-03-01|||1964-03-10||1961-04-28
TRIAL STUDY 134XCP|RP|176B6882-0C9E-435E-9842-FF8714BC9CAF|2||||||TNDRIND|TENDERNESS INDICATOR||||CM/MIN|||%/S|NOT DONE||U|NA|U|2||58||BASELINE|1968-04-10||1964-04-17|||1964-04-05||1973-05-02
TRIAL STUDY 134XCP|RP|176B6882-0C9E-435E-9842-FF8714BC9CAF|1||||||MENSDUR|MENSTRUAL CYCLE DURATION||||NMOL/KG/DAY|||ML/CAGE|NOT DONE||Y|N|N|3||39||TREATMENT|1966-07-15||1967-06-21|||1969-01-20||1968-08-07
TRIAL STUDY 134XCP|RP|176B6882-0C9E-435E-9842-FF8714BC9CAF|2||||||ULCERIND|ULCER INDICATOR||||DYN|||MAMP|NOT DONE||U|NA|U|3||39||OPEN LABEL TREATMENT|1962-08-30||1968-01-15|||1964-01-09||1972-08-24
TRIAL STUDY 134XCP|RP|176B6882-0C9E-435E-9842-FF8714BC9CAF|1||||||SKGLAIND|SKENE'S GLAND ABNORMALITY INDICATOR||||MCI/KG|||UL|NOT DONE||NA|NA|N|4||88||FOLLOW-UP|1962-08-06||1972-08-26|||1970-02-18||1961-05-25
TRIAL STUDY 134XCP|RP|176B6882-0C9E-435E-9842-FF8714BC9CAF|2||||||PRVPREGN|NUMBER OF PREVIOUS PREGNANCIES||||KS|||10^9 ORGANISMS/G|NOT DONE||Y|N|U|4||88||BASELINE|1972-11-05||1968-06-27|||1963-01-06||1960-01-02
TRIAL STUDY 134XCP|RP|176B6882-0C9E-435E-9842-FF8714BC9CAF|1||||||PRGENDTC|DATE PREGNANCY ENDED||||10^6 ORGANISMS/MG|||PMOL/L/H|NOT DONE||U|Y|N|5||7||FOLLOW-UP|1966-11-07||1967-08-01|||1967-07-12||1961-08-08
TRIAL STUDY 134XCP|RP|176B6882-0C9E-435E-9842-FF8714BC9CAF|2||||||PRGENDTC|DATE PREGNANCY ENDED||||UG/ML/H|||COPIES/ML|NOT DONE||U|Y|NA|5||7||WASHOUT|1962-11-07||1973-05-27|||1964-09-16||1962-07-24
